data_2iue_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2iue _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.88 142.47 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.48 1.512 . . . . 0.0 109.377 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -119.46 113.17 20.36 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.083 1.753 . . . . 0.0 108.327 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.21 126.24 51.98 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.725 -0.609 . . . . 0.0 109.977 177.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -114.62 108.91 17.44 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 123.572 1.653 . . . . 0.0 111.284 174.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -84.01 99.2 10.27 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 112.713 -2.04 . . . . 0.0 113.584 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.4 mt -91.59 129.26 37.59 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.828 0.851 . . . . 0.0 109.675 168.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . 0.253 2.7 ppp? -137.45 156.63 47.95 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 169.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.02 131.81 10.63 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.149 1.833 . . . . 0.0 113.156 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.8 mp -107.42 29.57 7.04 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.917 2.087 . . . . 0.0 111.891 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 CA--C 1.537 0.478 0 O-C-N 120.328 -1.483 . . . . 0.0 113.025 178.743 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.9 t . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 122.383 1.087 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.01 82.22 0.31 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 127.837 2.637 . . . . 0.0 106.605 -172.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -79.37 127.73 32.45 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.9 mt -123.38 130.91 73.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.311 0.577 . . . . 0.0 111.217 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.05 161.51 18.42 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 126.618 2.056 . . . . 0.0 110.278 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -141.28 133.31 27.7 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.82 145.51 16.25 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 121.404 0.446 . . . . 0.0 112.274 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.8 m -114.71 142.08 46.98 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.733 1.213 . . . . 0.0 110.332 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -152.77 155.04 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 120.913 -1.117 . . . . 0.0 108.984 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -152.47 -62.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.607 1.163 . . . . 0.0 109.426 173.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.25 25.5 t30 177.47 -19.43 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 128.917 2.887 . . . . 0.0 111.972 168.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -50.31 -40.91 50.02 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.068 0.849 . . . . 0.0 109.7 168.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.365 3.7 t 163.92 -177.61 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 131.622 3.969 . . . . 0.0 112.158 167.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -85.45 129.8 34.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.344 1.858 . . . . 0.0 108.533 169.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -117.73 112.22 20.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.45 1.1 . . . . 0.0 108.84 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -72.93 122.07 21.07 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.5 mt -103.86 -54.08 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.558 -0.714 . . . . 0.0 111.048 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.1 tp -130.98 120.72 23.91 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.257 0.551 . . . . 0.0 111.669 -175.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -57.85 149.57 22.24 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.705 1.202 . . . . 0.0 111.112 169.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 28.8 mt -48.03 108.8 0.18 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.115 1.366 . . . . 0.0 111.311 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 125.608 1.563 . . . . 0.0 111.823 -174.837 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.0 t -126.8 -140.54 0.27 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.273 1.429 . . . . 0.0 109.323 169.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -147.35 158.56 27.76 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-N 120.562 1.528 . . . . 0.0 115.715 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -160.6 148.41 16.1 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.951 1.7 . . . . 0.0 111.728 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.8 tp -68.06 -55.6 11.97 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.792 1.237 . . . . 0.0 112.223 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.59 136.17 50.92 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.632 0.773 . . . . 0.0 112.069 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.272 7.5 t -70.66 -39.84 9.84 Favored Pre-proline 0 N--CA 1.474 0.762 0 CA-C-O 115.766 -2.064 . . . . 0.0 113.456 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.42 140.07 56.49 Favored 'Trans proline' 0 C--N 1.356 0.939 0 CA-C-N 123.405 2.252 . . . . 0.0 111.693 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -107.4 -179.3 3.88 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.27 1.828 . . . . 0.0 112.738 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -109.18 18.99 30.27 Favored Glycine 0 N--CA 1.479 1.56 0 O-C-N 120.68 -1.262 . . . . 0.0 116.019 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -29.22 62.37 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -169.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.34 -28.15 67.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.47 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.72 -34.12 77.46 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 120.126 1.33 . . . . 0.0 112.273 171.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.7 -46.46 78.9 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 118.417 -0.801 . . . . 0.0 109.216 169.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.1 t -53.61 -40.13 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.017 0.826 . . . . 0.0 111.774 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.29 -61.9 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.433 1.093 . . . . 0.0 110.852 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.9 -44.8 95.11 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 118.945 -0.55 . . . . 0.0 110.715 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.24 -40.57 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.897 0.879 . . . . 0.0 111.714 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.56 -38.22 86.62 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.436 1.017 . . . . 0.0 112.86 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.6 mt -86.31 -36.8 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.795 0.838 . . . . 0.0 113.181 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 73.6 m -77.53 55.39 1.29 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.823 2.049 . . . . 0.0 112.105 -169.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.3 mt -48.99 -42.59 38.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.453 2.301 . . . . 0.0 111.453 -176.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.98 -19.25 75.45 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.403 1.001 . . . . 0.0 114.719 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -96.58 -47.6 5.86 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.117 0.967 . . . . 0.0 110.79 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.3 mm -66.73 -36.56 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.686 0.795 . . . . 0.0 111.104 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.43 20.93 28.26 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.115 1.341 . . . . 0.0 114.123 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -53.98 121.04 7.2 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.361 1.464 . . . . 0.0 112.212 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ptm85 -107.34 -176.78 3.16 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.015 1.326 . . . . 0.0 112.164 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -73.86 11.08 0.94 Allowed 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 117.851 2.538 . . . . 0.0 117.851 -169.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.61 -129.82 1.97 Allowed Glycine 0 C--N 1.344 1.023 0 CA-C-N 121.215 1.825 . . . . 0.0 110.734 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.9 p -114.33 145.21 42.08 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.494 1.918 . . . . 0.0 107.656 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -129.05 117.87 21.59 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.416 -167.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -122.2 104.45 9.47 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -169.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.1 tt -88.6 94.96 10.06 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.216 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.0 t -77.5 116.01 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.0 tp -105.18 123.06 47.18 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 t -108.27 130.12 61.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 O-C-N 124.595 1.184 . . . . 0.0 112.445 172.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -140.89 172.91 12.04 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.805 1.642 . . . . 0.0 110.335 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -118.96 -14.54 9.38 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 127.164 2.185 . . . . 0.0 111.859 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -133.12 174.82 9.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.789 1.236 . . . . 0.0 113.457 -169.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -61.23 -174.73 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.266 1.427 . . . . 0.0 110.883 168.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -147.12 159.86 43.1 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.655 -1.278 . . . . 0.0 113.36 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -79.22 116.83 19.72 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.27 1.428 . . . . 0.0 111.52 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.9 mp -82.55 -179.23 7.36 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.097 1.359 . . . . 0.0 109.962 173.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.47 160.1 3.35 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.406 -0.809 . . . . 0.0 111.689 169.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.449 0.0 OUTLIER 56.32 -12.68 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.277 0 N-CA-C 117.487 2.402 . . . . 0.0 117.487 -173.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.26 -28.21 69.55 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.037 -1.664 . . . . 0.0 111.899 169.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.58 -25.1 67.1 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 116.818 2.155 . . . . 0.0 116.818 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -18.6 63.62 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -167.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 pp -67.05 -19.77 65.73 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 118.68 0.673 . . . . 0.0 112.734 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -96.52 11.94 66.54 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 126.415 1.96 . . . . 0.0 114.11 170.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.334 10.5 t 54.86 53.74 10.03 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 128.078 2.551 . . . . 0.0 113.882 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -116.55 69.69 0.75 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.27 1.828 . . . . 0.0 110.505 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -62.23 -40.21 95.38 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.054 -1.654 . . . . 0.0 113.799 -169.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -60.83 138.92 58.09 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -173.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 t -81.39 148.88 29.1 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.731 0.813 . . . . 0.0 110.624 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 36.4 t -55.35 131.85 46.68 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.605 0.762 . . . . 0.0 111.771 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.7 p30 -89.58 -10.82 44.64 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.697 1.199 . . . . 0.0 113.899 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.93 21.85 78.72 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 117.995 -1.447 . . . . 0.0 114.773 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -112.48 170.39 8.21 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.369 1.584 . . . . 0.0 113.141 169.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 5.5 t -71.1 133.4 46.23 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.586 1.554 . . . . 0.0 112.234 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -138.04 40.45 2.31 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.065 1.746 . . . . 0.0 112.996 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.73 125.35 42.5 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.933 1.693 . . . . 0.0 109.131 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -117.67 -84.66 0.64 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.998 0.919 . . . . 0.0 111.836 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -87.15 20.37 2.76 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.945 1.698 . . . . 0.0 113.39 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.18 -11.87 68.75 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.814 1.674 . . . . 0.0 113.641 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 97.3 mtp -91.14 144.88 25.17 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.64 1.22 . . . . 0.0 111.691 171.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -77.41 83.88 3.84 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.575 0.702 . . . . 0.0 109.231 169.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 42.3 tpt85 -56.02 -32.29 63.86 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.38 1.472 . . . . 0.0 112.942 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.7 m -73.58 -8.54 56.37 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.3 ttt85 -56.02 -27.97 55.35 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 121.337 1.881 . . . . 0.0 113.903 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.72 -18.39 73.98 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.241 -1.311 . . . . 0.0 114.601 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.265 57.8 tt0 -119.94 -80.03 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.144 0 CA-C-O 115.818 -2.039 . . . . 0.0 112.449 -170.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.88 165.74 24.96 Favored 'Trans proline' 0 C--N 1.36 1.132 0 CA-C-N 123.918 2.435 . . . . 0.0 113.937 170.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -92.4 -179.82 5.32 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -67.52 126.98 31.04 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 167.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -49.7 161.2 0.24 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.505 1.922 . . . . 0.0 115.425 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.1 p -82.84 157.78 23.0 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.099 -1.0 . . . . 0.0 112.141 169.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.05 -34.06 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.645 -1.284 . . . . 0.0 112.001 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.9 t -77.94 -24.5 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.507 0.723 . . . . 0.0 111.682 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -67.17 -34.35 77.36 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.351 -0.843 . . . . 0.0 110.944 172.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.31 -56.12 21.52 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.021 0.828 . . . . 0.0 109.542 168.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.0 -40.49 63.85 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.829 0.852 . . . . 0.0 112.625 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.4 t -62.07 -64.47 0.92 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.966 0.907 . . . . 0.0 112.245 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -73.63 -24.94 60.08 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.085 -1.634 . . . . 0.0 113.878 -169.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.4 mp -63.74 -41.42 98.04 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.269 0.941 . . . . 0.0 110.703 169.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.05 -36.88 61.8 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -69.19 -49.79 53.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.283 1.033 . . . . 0.0 110.493 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -77.42 -15.49 59.32 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.686 0.794 . . . . 0.0 111.278 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 66.96 60.21 0.53 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.189 1.796 . . . . 0.0 110.718 171.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.69 139.69 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.543 1.937 . . . . 0.0 107.988 172.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -107.9 106.16 57.91 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 119.951 1.251 . . . . 0.0 109.432 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.99 151.67 39.86 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.554 2.169 . . . . 0.0 114.005 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 82.5 mt -130.44 109.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.034 1.334 . . . . 0.0 107.801 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -78.89 80.9 5.21 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 122.093 0.949 . . . . 0.0 111.755 -175.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.8 104.81 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.992 0.917 . . . . 0.0 111.978 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.0 m -142.61 167.67 15.59 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.078 -1.639 . . . . 0.0 112.064 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -84.4 152.36 12.06 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.41 2.073 . . . . 0.0 110.951 -172.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.3 t -49.51 -43.84 45.81 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -169.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -56.8 -29.28 62.55 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -111.23 -8.2 14.39 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.633 1.973 . . . . 0.0 112.586 -170.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.2 t -54.27 -44.43 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 120.627 -1.296 . . . . 0.0 111.009 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -70.31 -6.08 32.5 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -170.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 18.4 m -87.12 -50.12 6.84 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.967 1.707 . . . . 0.0 110.19 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -73.56 -26.77 60.99 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.974 1.31 . . . . 0.0 110.307 -174.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . 0.353 7.1 pt-20 -65.73 -14.29 61.01 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.001 171.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . 0.379 0.0 OUTLIER -89.0 -22.91 22.76 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-N 120.551 1.523 . . . . 0.0 112.408 167.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.68 -19.78 60.73 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 119.682 -1.886 . . . . 0.0 110.176 169.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 98.7 m -80.28 -18.07 50.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.654 2.382 . . . . 0.0 111.949 169.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.73 -27.6 19.95 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.346 0.521 . . . . 0.0 110.38 169.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -80.26 -32.74 38.25 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 174.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 27.5 mt -110.21 101.31 47.49 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.46 150.84 64.59 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.857 2.371 . . . . 0.0 111.687 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt 86.36 -11.33 0.64 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 129.265 3.026 . . . . 0.0 113.084 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 10.2 mp -72.49 166.39 22.73 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.956 0.902 . . . . 0.0 109.817 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 69.7 p -125.24 -142.83 0.3 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.096 0.95 . . . . 0.0 109.856 170.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.2 tp -179.04 128.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 128.123 2.569 . . . . 0.0 108.482 -166.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -118.77 155.28 16.13 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . 0.276 11.2 pt-20 -105.2 94.61 5.33 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 122.903 1.335 . . . . 0.0 109.776 173.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 26.2 tp . . . . . 0 CA--C 1.54 0.595 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.981 169.543 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.1 p . . . . . 0 CA--C 1.545 0.783 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.95 108.41 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 121.993 0.901 . . . . 0.0 111.847 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -87.39 114.97 24.48 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 tt -101.82 125.39 48.48 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.866 -0.521 . . . . 0.0 110.025 170.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -117.42 109.37 16.7 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 123.531 1.634 . . . . 0.0 109.985 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -86.35 116.16 24.34 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.668 2.387 . . . . 0.0 112.444 -176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.9 mp -99.25 124.34 44.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.378 1.071 . . . . 0.0 111.061 172.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.1 ttt -114.21 135.5 53.99 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.78 132.21 13.69 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 168.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 mp -115.1 15.07 17.16 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.498 1.519 . . . . 0.0 114.197 -170.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.477 0.917 0 O-C-N 121.031 -1.043 . . . . 0.0 112.705 177.946 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 CA--C 1.546 0.794 0 CA-C-O 122.794 1.283 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.9 90.47 0.16 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 106.596 -2.602 . . . . 0.0 106.596 -175.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -78.88 145.66 34.03 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.75 0.82 . . . . 0.0 109.435 -169.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.52 132.61 70.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 124.944 1.298 . . . . 0.0 109.342 -172.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.85 156.98 26.99 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.998 1.761 . . . . 0.0 111.687 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -143.31 136.73 28.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -169.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.35 155.34 23.43 Favored Glycine 0 C--N 1.345 1.033 0 C-N-CA 124.558 1.075 . . . . 0.0 111.194 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.3 p -124.66 146.35 49.17 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.842 0.857 . . . . 0.0 111.975 -174.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.2 pp -145.42 151.95 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 50' ' ' ASN . 19.0 t -142.86 -126.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 102.6 -3.111 . . . . 0.0 102.6 169.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.417 ' H ' HG13 ' A' ' 49' ' ' VAL . 48.5 t30 -123.69 -0.6 8.57 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 120.406 1.457 . . . . 0.0 109.761 167.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.2 mmt -60.37 -39.08 85.94 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.75 1.62 . . . . 0.0 109.927 169.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.4 t 147.74 176.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.345 1 C-N-CA 132.399 4.28 . . . . 0.0 112.145 169.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -79.85 130.67 35.5 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.519 1.928 . . . . 0.0 109.327 169.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -123.66 128.97 50.42 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.282 1.039 . . . . 0.0 108.714 169.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -92.35 91.67 7.78 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.734 2.014 . . . . 0.0 111.229 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 mp -77.26 -59.87 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.45 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.4 tp -121.15 124.61 45.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.141 0.882 . . . . 0.0 112.114 -172.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.55 161.17 17.9 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 175.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.5 mt -56.29 109.01 0.53 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.129 1.772 . . . . 0.0 111.745 -171.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.6 t . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 125.549 1.54 . . . . 0.0 111.506 -177.447 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.7 t -120.54 -175.17 2.96 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.101 1.76 . . . . 0.0 111.756 171.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -148.46 157.28 27.24 Favored Glycine 0 N--CA 1.474 1.225 0 O-C-N 120.477 -1.389 . . . . 0.0 113.998 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -158.2 167.79 28.82 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.927 1.291 . . . . 0.0 114.232 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -77.57 -62.06 1.79 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.631 1.573 . . . . 0.0 112.952 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.77 151.96 43.89 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.814 0.846 . . . . 0.0 111.673 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.296 5.3 t -82.76 -41.41 0.88 Allowed Pre-proline 0 N--CA 1.479 1.005 0 CA-C-O 116.249 -1.834 . . . . 0.0 115.233 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.23 146.93 77.59 Favored 'Trans proline' 0 C--N 1.359 1.101 0 CA-C-N 123.04 2.121 . . . . 0.0 113.058 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -101.39 152.34 20.84 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.953 1.701 . . . . 0.0 113.637 -170.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.85 56.74 4.55 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 125.72 1.629 . . . . 0.0 111.662 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -84.11 -36.98 22.57 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.539 1.536 . . . . 0.0 113.327 -169.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.41 -36.84 83.83 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 122.153 -0.342 . . . . 0.0 110.852 -169.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -49.7 -41.79 44.18 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.196 1.398 . . . . 0.0 111.732 169.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.18 -52.38 28.59 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.055 -1.028 . . . . 0.0 111.498 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.4 m -59.68 -33.17 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.756 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.3 m -75.6 -51.68 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 117.215 -1.374 . . . . 0.0 112.624 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -55.74 -46.87 77.72 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 121.295 1.861 . . . . 0.0 110.175 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.6 t -59.66 -36.13 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.76 -43.37 79.99 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.986 -1.071 . . . . 0.0 112.629 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.85 -42.3 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -172.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . 0.26 21.8 p -83.79 66.48 9.1 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 121.222 1.828 . . . . 0.0 113.516 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.6 mt -43.42 -40.42 3.74 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.63 2.372 . . . . 0.0 111.583 169.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.11 -30.7 56.85 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.647 1.118 . . . . 0.0 114.794 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -104.59 -34.02 8.33 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 117.725 -1.131 . . . . 0.0 113.685 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.1 mm -64.07 -34.83 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 120.874 1.67 . . . . 0.0 110.408 169.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.59 18.31 38.77 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 117.907 -1.496 . . . . 0.0 114.126 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -54.06 147.28 12.93 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.343 1.572 . . . . 0.0 112.979 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . 0.272 0.0 OUTLIER -143.07 172.12 13.14 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.654 1.182 . . . . 0.0 114.015 172.085 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -58.54 24.35 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 121.39 3.848 . . . . 0.0 121.39 -168.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.16 -118.82 1.22 Allowed Glycine 0 CA--C 1.535 1.332 0 CA-C-N 120.912 1.687 . . . . 0.0 109.594 170.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.0 t -130.09 148.77 51.98 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 168.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -123.78 123.42 40.44 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 119.158 -0.449 . . . . 0.0 111.988 -166.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -115.32 103.49 10.86 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -170.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.0 tp -88.62 85.92 6.9 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.779 1.232 . . . . 0.0 109.527 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 66.7 t -77.28 136.85 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.3 tt -127.96 126.27 41.1 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.963 1.256 . . . . 0.0 111.541 169.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.1 t -95.46 128.01 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 126.216 1.806 . . . . 0.0 110.875 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.6 t -156.55 158.26 36.82 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.964 0.506 . . . . 0.0 110.989 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.87 0.59 11.41 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -141.44 -178.9 5.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.678 1.191 . . . . 0.0 111.867 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.95 -168.02 0.18 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.312 1.445 . . . . 0.0 112.137 -175.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -145.5 146.11 31.33 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 120.622 -1.298 . . . . 0.0 111.792 -169.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -80.23 130.02 34.91 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.826 169.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 pp -111.62 174.05 6.06 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.349 1.46 . . . . 0.0 111.344 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.33 130.16 30.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.5 mttm 93.91 -10.85 0.14 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.407 3.083 . . . . 0.0 112.003 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -67.75 -23.89 65.29 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 120.157 1.344 . . . . 0.0 112.706 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -74.65 -11.32 60.16 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.007 -1.058 . . . . 0.0 113.841 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.28 1.1 t -72.15 -21.51 61.44 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 120.458 1.481 . . . . 0.0 113.727 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.96 -37.72 84.79 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.735 1.152 . . . . 0.0 109.689 169.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.31 6.5 15.21 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.071 1.32 . . . . 0.0 113.158 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.277 52.8 m 70.06 37.8 1.64 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.309 2.244 . . . . 0.0 111.463 171.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -121.55 118.5 29.42 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.412 1.085 . . . . 0.0 111.076 169.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -105.12 -26.16 12.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.882 1.273 . . . . 0.0 112.896 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -61.35 116.18 4.44 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.067 0.849 . . . . 0.0 110.29 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 t -65.7 158.4 27.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.664 0.665 . . . . 0.0 110.003 173.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.1 t -67.44 144.61 55.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 122.043 0.925 . . . . 0.0 111.614 174.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.8 p30 -82.56 -10.75 58.85 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.054 1.342 . . . . 0.0 113.193 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.41 26.51 74.05 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.023 -0.876 . . . . 0.0 112.877 -175.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -103.29 172.92 6.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.026 1.73 . . . . 0.0 110.343 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 7.2 t -92.21 148.78 21.89 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.51 -0.744 . . . . 0.0 112.083 170.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -134.62 33.13 3.26 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.705 2.002 . . . . 0.0 112.063 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.75 161.06 13.84 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.197 0.999 . . . . 0.0 111.819 174.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -170.94 -45.26 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.571 1.948 . . . . 0.0 111.016 172.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -80.45 4.79 17.04 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.235 1.414 . . . . 0.0 112.771 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 82.73 -11.21 53.92 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.893 1.711 . . . . 0.0 112.547 -169.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.3 mtt -90.67 143.83 26.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.176 1.39 . . . . 0.0 111.118 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -74.05 95.63 2.56 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 169.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -64.09 -33.43 75.76 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.668 1.187 . . . . 0.0 113.25 -172.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.2 p -81.91 4.66 21.67 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -174.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -37.87 -35.79 0.16 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.799 2.04 . . . . 0.0 115.219 169.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.69 30.07 6.85 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 127.962 2.696 . . . . 0.0 112.521 -172.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.266 43.2 tt0 -139.75 -79.3 0.01 OUTLIER Pre-proline 0 CA--C 1.559 1.293 0 CA-C-O 115.724 -2.084 . . . . 0.0 109.593 169.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -54.18 150.4 32.43 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.574 2.85 . . . . 0.0 117.02 169.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.18 162.52 25.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 128.315 2.646 . . . . 0.0 109.316 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -55.2 140.67 37.94 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.177 -0.952 . . . . 0.0 109.729 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.09 156.91 24.31 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.667 -1.271 . . . . 0.0 112.189 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 27.2 t -81.47 154.9 26.1 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -173.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 20.2 t -59.27 -30.59 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.216 1.006 . . . . 0.0 111.652 -171.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.5 p -66.62 -37.04 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.607 1.163 . . . . 0.0 113.433 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -72.82 -32.58 65.61 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.487 -0.758 . . . . 0.0 110.495 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.33 -46.54 79.86 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -54.54 -44.78 73.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.104 0.962 . . . . 0.0 112.607 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.8 m -59.43 -53.05 62.57 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.688 0.795 . . . . 0.0 112.119 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -64.57 -43.38 94.06 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.166 -0.959 . . . . 0.0 111.81 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.65 -38.63 81.96 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.178 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.54 -36.18 65.64 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -71.72 -42.33 67.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.869 0.868 . . . . 0.0 111.643 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -80.51 -9.17 59.78 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.615 0.766 . . . . 0.0 112.412 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . 0.402 15.7 p-10 42.02 52.66 4.32 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.831 2.452 . . . . 0.0 113.245 -174.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 79.4 mt -100.49 133.67 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.334 1.854 . . . . 0.0 109.07 174.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -104.33 108.29 59.96 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-N 119.257 0.935 . . . . 0.0 112.362 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.85 140.94 52.28 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.476 2.784 . . . . 0.0 115.754 169.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.1 mm -121.56 100.59 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.519 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -74.06 75.26 1.73 Allowed 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.904 -1.122 . . . . 0.0 112.168 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . 0.255 13.4 m -76.18 110.6 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 120.762 -1.211 . . . . 0.0 112.486 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.23 141.88 17.66 Favored Pre-proline 0 N--CA 1.478 0.97 0 O-C-N 120.997 -1.065 . . . . 0.0 112.389 -171.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -51.32 150.83 14.17 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.43 3.42 . . . . 0.0 115.837 169.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.3 t -47.63 -44.87 27.23 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.374 1.87 . . . . 0.0 113.546 -169.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.8 mtp-105 -42.88 -38.56 2.22 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.614 1.565 . . . . 0.0 113.428 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.51 0.6 16.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.895 1.678 . . . . 0.0 113.322 -170.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 37.5 t -62.6 -38.97 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.615 -1.303 . . . . 0.0 111.141 -175.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -65.23 -27.19 68.49 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.077 0.853 . . . . 0.0 113.025 -174.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.7 t -84.47 -39.94 18.3 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.784 0.434 . . . . 0.0 111.009 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -69.46 -30.32 68.19 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.805 -1.184 . . . . 0.0 110.764 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -60.84 -33.05 72.45 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.158 0.436 . . . . 0.0 110.508 169.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . 0.362 0.0 OUTLIER -87.81 -18.17 29.92 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 119.07 0.85 . . . . 0.0 112.244 -178.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 20.1 mt -72.92 -25.44 61.05 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.528 -1.357 . . . . 0.0 109.812 169.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.45 -10.28 59.28 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.299 1.84 . . . . 0.0 111.518 173.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 90.9 m -89.15 -32.62 17.39 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.363 1.065 . . . . 0.0 109.364 169.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -76.79 -30.11 56.33 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 118.906 -0.568 . . . . 0.0 112.484 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 20.2 mt -118.86 109.66 39.31 Favored Pre-proline 0 N--CA 1.484 1.24 0 CA-C-N 119.114 0.87 . . . . 0.0 110.685 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -55.62 143.21 80.2 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.394 3.396 . . . . 0.0 114.225 174.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt 79.66 -8.35 1.58 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 128.755 2.822 . . . . 0.0 113.452 170.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 10.6 mt -72.9 153.78 40.86 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.286 -0.883 . . . . 0.0 109.954 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.7 p -116.89 -149.04 0.44 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 123.333 1.54 . . . . 0.0 109.432 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.1 tp -177.64 131.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 C-N-CA 127.043 2.137 . . . . 0.0 108.223 -165.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -123.73 150.67 16.96 Favored Glycine 0 N--CA 1.465 0.624 0 C-N-CA 124.37 0.986 . . . . 0.0 110.66 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -94.6 85.1 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.5 tp . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 169.504 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 CA--C 1.543 0.693 0 CA-C-O 119.371 -0.347 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.2 t -128.99 118.7 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-O 121.797 0.808 . . . . 0.0 111.785 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -87.12 127.87 35.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.978 0.911 . . . . 0.0 109.188 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mp -123.44 135.63 54.19 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -117.4 113.29 21.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 123.108 1.432 . . . . 0.0 109.078 172.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -87.46 103.29 15.37 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 126.107 1.763 . . . . 0.0 111.166 174.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.0 tp -102.22 121.59 42.55 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.674 1.19 . . . . 0.0 110.284 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.09 157.89 24.04 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 170.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.02 132.95 11.44 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.409 1.957 . . . . 0.0 110.56 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.15 23.36 13.4 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.612 1.565 . . . . 0.0 114.192 -171.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.7 p . . . . . 0 N--CA 1.479 1.016 0 O-C-N 119.42 -2.05 . . . . 0.0 114.454 -174.817 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.544 0.726 0 CA-C-O 122.957 1.361 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.53 88.02 0.21 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 106.731 -2.548 . . . . 0.0 106.731 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -98.62 137.69 36.9 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.271 1.028 . . . . 0.0 109.757 -169.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.8 tt -116.93 146.13 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.01 -170.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.77 165.12 19.08 Favored Glycine 0 N--CA 1.464 0.519 0 C-N-CA 125.524 1.535 . . . . 0.0 110.575 171.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -139.76 128.22 22.86 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.863 0.865 . . . . 0.0 113.168 -169.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.35 147.12 19.05 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 123.639 0.638 . . . . 0.0 112.229 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.8 t -114.49 148.25 38.15 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.618 1.567 . . . . 0.0 110.517 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.75 152.27 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.905 1.282 . . . . 0.0 109.462 171.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.7 t -138.0 -70.83 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.779 0.831 . . . . 0.0 108.784 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 t30 174.95 -15.75 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 131.0 3.72 . . . . 0.0 108.622 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.5 ttt -58.58 -60.19 4.21 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.87 1.668 . . . . 0.0 107.111 167.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.302 0.5 OUTLIER -173.87 169.26 4.15 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.264 2.226 . . . . 0.0 114.534 168.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -84.09 120.83 26.62 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 169.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -115.77 117.11 29.33 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 122.234 1.016 . . . . 0.0 110.279 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -74.67 110.56 9.06 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.751 1.62 . . . . 0.0 109.95 170.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.3 mt -94.63 -61.33 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.385 0.674 . . . . 0.0 110.392 -173.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.9 tp -124.99 124.74 42.64 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.034 0.934 . . . . 0.0 110.177 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 166.68 13.46 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.655 -0.653 . . . . 0.0 112.691 169.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 83.9 mt -58.15 116.05 3.31 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.74 -0.6 . . . . 0.0 111.136 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 36.8 p . . . . . 0 N--CA 1.48 1.074 0 C-N-CA 125.362 1.465 . . . . 0.0 112.244 -179.818 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.6 p -107.78 -143.78 0.38 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.079 1.352 . . . . 0.0 110.694 169.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.34 143.64 8.83 Favored Glycine 0 N--CA 1.472 1.046 0 O-C-N 120.376 -1.453 . . . . 0.0 114.622 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -160.44 150.47 17.95 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.037 1.735 . . . . 0.0 111.462 170.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.0 tp -73.68 -48.56 31.3 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -169.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.71 119.11 8.65 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 122.945 0.498 . . . . 0.0 109.926 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.9 p -71.16 -35.17 3.85 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 115.686 -2.102 . . . . 0.0 113.976 -174.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -66.0 144.9 77.96 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.375 2.05 . . . . 0.0 110.665 169.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -119.4 161.12 21.04 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -171.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.67 45.03 3.19 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 125.184 1.374 . . . . 0.0 115.598 -169.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -36.96 85.85 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.431 1.892 . . . . 0.0 114.038 -173.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.47 -33.91 76.6 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.547 0.612 . . . . 0.0 111.228 -169.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -58.02 -47.46 83.0 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.347 1.459 . . . . 0.0 111.684 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.86 -56.75 16.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.619 -1.181 . . . . 0.0 109.708 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.294 1.5 p -59.33 -36.83 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-O 117.765 -1.112 . . . . 0.0 113.366 -174.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 38.0 t -74.17 -38.96 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 121.396 1.907 . . . . 0.0 113.572 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -63.91 -40.52 96.69 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.719 1.6 . . . . 0.0 110.344 171.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -49.38 -35.51 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.291 1.037 . . . . 0.0 112.638 169.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.16 -48.21 13.52 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.9 tt -100.42 -4.63 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -171.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 72.2 m -82.5 58.34 4.11 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 119.8 -1.812 . . . . 0.0 110.483 170.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.46 -44.43 55.67 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.235 1.814 . . . . 0.0 111.262 -174.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.62 -24.98 55.05 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.141 -0.811 . . . . 0.0 114.74 -169.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -90.95 -40.59 11.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.267 1.034 . . . . 0.0 111.529 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.9 -38.48 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 118.941 0.791 . . . . 0.0 110.677 171.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.36 27.7 19.54 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.738 -1.034 . . . . 0.0 114.099 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -54.01 125.75 19.99 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.769 1.285 . . . . 0.0 111.63 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -105.06 -170.34 1.74 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.754 2.022 . . . . 0.0 112.059 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -75.13 0.23 16.93 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 118.948 2.944 . . . . 0.0 118.948 -168.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.68 -130.77 3.31 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 121.833 2.106 . . . . 0.0 112.06 -174.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.8 m -100.55 145.8 27.89 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.415 1.886 . . . . 0.0 106.93 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -135.69 128.13 30.43 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 121.395 1.907 . . . . 0.0 108.581 -168.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -133.21 115.73 15.35 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.7 tp -91.2 109.94 21.21 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.975 169.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.63 116.42 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 168.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.7 tp -95.13 134.49 37.79 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 117.276 -1.345 . . . . 0.0 108.094 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.42 124.99 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 O-C-N 123.895 0.747 . . . . 0.0 111.607 168.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.0 t -160.48 141.69 12.13 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.678 0.791 . . . . 0.0 113.067 172.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -103.74 24.41 11.25 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.94 2.096 . . . . 0.0 114.888 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -152.35 -175.69 5.38 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.144 -0.972 . . . . 0.0 112.176 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.51 -175.84 0.41 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.3 1.44 . . . . 0.0 110.806 169.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -137.15 153.84 50.38 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.664 1.185 . . . . 0.0 111.664 -170.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -83.45 132.31 34.97 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.032 0.533 . . . . 0.0 110.817 169.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 pp -117.45 173.94 6.42 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.436 1.494 . . . . 0.0 112.532 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.72 124.99 18.17 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.42 98.7 mttt 80.23 1.84 1.97 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.349 2.259 . . . . 0.0 115.039 -175.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -70.78 -15.24 62.65 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 120.848 -1.157 . . . . 0.0 108.657 166.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -57.46 -29.47 64.25 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 173.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.5 m -60.74 -26.4 67.17 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 118.162 2.653 . . . . 0.0 118.162 -167.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.329 0.0 OUTLIER -69.75 -13.08 62.11 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.894 1.679 . . . . 0.0 113.273 170.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -105.9 150.12 16.84 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 167.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.5 p -75.98 81.89 2.86 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.26 1.53 . . . . 0.0 112.601 -171.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.3 125.19 2.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.172 1.789 . . . . 0.0 110.475 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -119.56 -25.82 5.9 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.579 1.151 . . . . 0.0 113.088 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -51.56 107.23 0.18 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.673 1.589 . . . . 0.0 113.008 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.8 t -68.95 150.83 47.28 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.594 1.088 . . . . 0.0 110.952 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.1 m -55.19 131.7 45.91 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.695 1.198 . . . . 0.0 113.101 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.5 p30 -81.58 -15.28 55.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.338 0.655 . . . . 0.0 112.541 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.94 14.6 81.55 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.903 -1.498 . . . . 0.0 114.26 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -93.16 163.47 13.62 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.872 1.669 . . . . 0.0 112.384 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 20.0 t -62.89 130.85 46.62 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.793 0.837 . . . . 0.0 111.655 172.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -135.75 41.44 2.71 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.745 1.618 . . . . 0.0 112.164 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.1 tp -124.16 140.71 52.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.426 1.491 . . . . 0.0 110.943 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -150.51 -62.1 0.2 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.254 1.021 . . . . 0.0 111.286 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -70.24 -21.81 62.95 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 121.35 -19.4 8.64 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.722 1.629 . . . . 0.0 112.409 -169.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 94.7 mtp -98.31 140.52 32.46 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.628 1.571 . . . . 0.0 112.507 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -77.35 83.04 3.8 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.877 0.871 . . . . 0.0 110.456 169.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -64.36 -30.74 71.78 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.112 -0.993 . . . . 0.0 112.236 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 35.5 m -65.89 -2.12 3.57 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 175.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -52.37 -37.75 57.04 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.213 -1.554 . . . . 0.0 114.251 172.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.71 -22.24 77.4 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.694 -1.059 . . . . 0.0 114.412 -175.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.317 1.2 pt-20 -112.68 -68.43 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.198 0 CA-C-O 117.133 -1.413 . . . . 0.0 112.059 -173.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -55.36 173.0 0.36 Allowed 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 123.399 2.732 . . . . 0.0 117.265 168.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -100.46 171.51 7.7 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 127.914 2.486 . . . . 0.0 114.048 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -73.7 120.93 19.98 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 166.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.469 ' CD ' ' H ' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -70.78 144.26 50.92 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 120.932 -1.105 . . . . 0.0 110.644 -169.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 39.8 m -68.02 153.92 42.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.468 0.707 . . . . 0.0 111.737 -174.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 82.2 t -60.68 -27.64 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 120.542 -1.349 . . . . 0.0 112.794 -171.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.6 t -81.48 -27.35 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 121.323 -0.861 . . . . 0.0 112.801 171.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -67.0 -38.22 85.59 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.298 0.954 . . . . 0.0 110.253 170.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -55.56 -61.41 2.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.751 0.705 . . . . 0.0 109.19 169.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.75 -48.08 70.04 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.306 1.042 . . . . 0.0 113.569 -170.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 64.7 m -63.82 -45.35 90.01 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -64.14 -47.64 79.14 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.399 -0.813 . . . . 0.0 111.155 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.4 mt -55.58 -40.51 72.08 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.827 0.851 . . . . 0.0 112.68 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.24 -33.26 56.07 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -80.52 -25.55 38.64 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.477 1.035 . . . . 0.0 112.002 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -80.49 -13.91 58.71 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.482 0.713 . . . . 0.0 110.758 168.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 33.4 m120 60.3 36.32 20.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.215 1.806 . . . . 0.0 112.848 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 67.1 mt -95.61 145.13 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.264 1.026 . . . . 0.0 108.929 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -105.13 102.72 37.97 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -77.46 156.29 32.42 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.139 1.226 . . . . 0.0 113.267 169.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -141.42 105.93 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.568 1.547 . . . . 0.0 109.522 -169.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -75.1 73.83 2.26 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.729 -1.232 . . . . 0.0 112.756 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.6 108.87 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 O-C-N 121.235 -0.915 . . . . 0.0 111.233 169.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 34.5 m -146.62 146.64 27.57 Favored Pre-proline 0 N--CA 1.482 1.126 0 O-C-N 120.592 -1.317 . . . . 0.0 112.314 -174.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -67.57 159.75 51.13 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.844 3.03 . . . . 0.0 112.801 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.5 t -41.2 -54.14 2.99 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.453 1.901 . . . . 0.0 114.437 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -57.17 -33.2 67.21 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.69 -17.17 32.37 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.911 1.285 . . . . 0.0 113.966 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.4 t -55.73 -41.12 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 120.15 1.341 . . . . 0.0 112.113 -168.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -62.47 -37.59 86.56 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -172.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 9.6 t -84.27 -30.25 25.78 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.901 0.48 . . . . 0.0 111.3 -173.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -69.14 -32.9 72.58 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.639 -1.288 . . . . 0.0 109.211 169.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -68.37 -7.11 28.46 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.347 -0.845 . . . . 0.0 112.699 169.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -98.91 -6.59 28.59 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.04 -1.038 . . . . 0.0 112.403 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 6.2 mp -104.84 -15.37 15.21 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.546 1.538 . . . . 0.0 111.926 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 6.0 t -79.5 -23.2 43.14 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 118.995 0.816 . . . . 0.0 111.832 169.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 1.7 t -77.85 -23.41 48.93 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.676 -0.64 . . . . 0.0 110.559 172.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -82.45 -34.48 28.14 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 119.375 -0.345 . . . . 0.0 111.102 169.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 13.2 mt -117.66 80.88 14.1 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.985 0.914 . . . . 0.0 109.838 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -62.17 152.34 76.6 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.123 1.882 . . . . 0.0 110.561 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 91.26 -17.31 0.17 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 130.415 3.486 . . . . 0.0 112.505 -176.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.0 tt -74.98 155.62 37.17 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.028 1.331 . . . . 0.0 108.295 168.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.266 48.0 p -127.94 -164.08 1.33 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 169.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 10.8 mt -157.82 145.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 126.823 2.049 . . . . 0.0 109.697 -165.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -131.87 155.34 21.38 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 123.818 0.723 . . . . 0.0 112.284 170.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -85.24 98.74 10.67 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 18.2 tp . . . . . 0 CA--C 1.542 0.641 0 CA-C-N 113.422 -1.717 . . . . 0.0 107.896 168.623 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 p . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.4 t -133.26 149.21 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.513 1.125 . . . . 0.0 110.007 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -121.62 115.82 23.46 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.353 2.261 . . . . 0.0 109.088 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.51 126.14 53.23 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 120.933 -1.104 . . . . 0.0 111.252 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -112.02 111.98 23.28 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 123.162 1.458 . . . . 0.0 110.227 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -87.57 100.34 12.72 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 126.236 1.814 . . . . 0.0 112.3 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.6 tp -94.84 116.76 29.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.511 0.725 . . . . 0.0 111.104 171.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 28.4 ptm -114.99 144.26 43.88 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.89 123.8 6.33 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.96 1.267 . . . . 0.0 111.655 172.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -107.06 43.7 1.14 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.97 1.708 . . . . 0.0 111.079 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 124.106 0.963 . . . . 0.0 112.178 169.861 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.619 0.723 . . . . 0.0 109.231 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.36 85.86 0.28 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 127.669 2.557 . . . . 0.0 107.925 -169.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -80.24 140.39 36.27 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -173.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.4 tp -120.76 136.49 57.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 123.431 0.692 . . . . 0.0 110.389 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.42 147.55 18.86 Favored Glycine 0 N--CA 1.466 0.689 0 C-N-CA 124.221 0.915 . . . . 0.0 110.971 169.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -102.24 164.34 11.74 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.06 147.8 12.74 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 120.713 -1.242 . . . . 0.0 111.718 169.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.5 p -128.33 149.74 50.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.72 151.72 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.923 0.889 . . . . 0.0 111.647 -175.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 50' ' ' ASN 0.273 3.0 p -152.92 -101.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 124.096 0.958 . . . . 0.0 110.362 169.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.427 ' H ' HG12 ' A' ' 49' ' ' VAL 0.301 37.1 t30 -136.4 -11.37 1.88 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.084 1.354 . . . . 0.0 109.811 168.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 92.1 mtp -87.28 48.49 1.66 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 102.233 -3.247 . . . . 0.0 102.233 163.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.467 2.1 m 16.23 -116.41 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.506 1 C-N-CA 135.787 5.635 . . . . 0.0 116.145 -167.036 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -113.39 137.97 50.76 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.176 1.39 . . . . 0.0 112.769 -168.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -124.34 122.91 38.99 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -85.6 118.34 25.05 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.087 0.555 . . . . 0.0 109.667 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -125.33 142.19 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 126.163 1.785 . . . . 0.0 107.352 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 39.38 95.63 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 128.963 2.905 . . . . 0.0 117.244 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 161.51 5.84 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.066 0.946 . . . . 0.0 113.101 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.66 124.31 14.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.505 1.122 . . . . 0.0 111.523 -170.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.48 1.038 0 C-N-CA 125.035 1.334 . . . . 0.0 112.089 -179.958 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.2 p -106.48 -128.55 0.26 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.382 1.473 . . . . 0.0 111.169 171.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 174.76 146.71 5.82 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.359 1.457 . . . . 0.0 113.706 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.58 164.06 32.23 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.098 1.359 . . . . 0.0 112.441 170.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.3 mt -72.23 -48.59 41.67 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -169.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.29 132.97 47.29 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.077 0.551 . . . . 0.0 110.988 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.269 3.7 t -72.58 -37.73 4.58 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-O 116.186 -1.864 . . . . 0.0 113.846 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -69.38 151.83 71.27 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 122.315 2.01 . . . . 0.0 111.269 171.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -122.63 164.29 18.48 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.503 1.121 . . . . 0.0 113.499 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.71 28.64 5.8 Favored Glycine 0 N--CA 1.474 1.211 0 O-C-N 120.369 -1.457 . . . . 0.0 115.663 -170.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -47.04 -40.95 15.89 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.282 1.541 . . . . 0.0 114.747 -168.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . 0.365 5.0 mp -76.88 -19.23 57.7 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 117.98 -1.01 . . . . 0.0 113.463 -172.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.23 -41.31 98.29 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 168.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.29 -54.53 23.69 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 117.133 -1.413 . . . . 0.0 110.668 169.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.5 m -56.76 -33.47 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 120.827 1.649 . . . . 0.0 112.85 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.3 -51.78 44.26 Favored 'Isoleucine or valine' 0 C--N 1.345 0.394 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.387 172.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -60.66 -41.21 94.58 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 120.246 1.385 . . . . 0.0 110.533 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.431 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 64.6 t -56.54 -35.52 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.767 1.227 . . . . 0.0 112.318 175.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.35 -36.34 29.77 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.5 mt -83.5 -30.36 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.838 1.199 . . . . 0.0 112.548 -173.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 88.6 m -83.82 53.69 2.65 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.147 1.379 . . . . 0.0 112.35 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -55.84 -34.2 65.21 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.43 1.092 . . . . 0.0 112.462 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.62 -33.24 48.01 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 119.275 -0.736 . . . . 0.0 114.705 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -95.59 -25.52 16.13 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.045 0.922 . . . . 0.0 112.633 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.431 ' CD1' ' HA ' ' A' ' 92' ' ' VAL . 79.0 mt -82.83 -24.95 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.053 0.842 . . . . 0.0 111.179 169.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.53 24.11 61.33 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.087 -0.84 . . . . 0.0 113.807 171.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -57.87 124.91 20.83 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 118.309 1.055 . . . . 0.0 110.65 173.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -102.69 168.1 9.47 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.865 1.266 . . . . 0.0 111.224 171.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -84.28 54.97 3.15 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -172.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -94.39 -113.43 2.5 Favored Glycine 0 N--CA 1.474 1.213 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 169.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 m -127.41 136.55 51.99 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 128.005 2.522 . . . . 0.0 104.719 169.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.36 136.95 51.63 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 121.344 1.884 . . . . 0.0 110.439 -171.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -126.91 116.26 20.54 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 124.916 1.286 . . . . 0.0 112.761 -172.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.0 tp -94.53 103.2 15.16 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 171.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.68 123.39 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -113.16 128.3 56.44 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -173.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.12 129.14 56.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 124.656 1.223 . . . . 0.0 112.397 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.3 t -155.37 170.97 20.68 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.869 1.268 . . . . 0.0 110.142 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -123.23 -1.3 8.71 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -139.49 175.51 9.5 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.682 -1.261 . . . . 0.0 112.419 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -58.16 -176.25 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.775 1.63 . . . . 0.0 112.39 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -138.01 163.17 32.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 123.086 1.422 . . . . 0.0 114.078 -169.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -78.9 112.15 15.79 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.73 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 mt -80.71 163.29 23.66 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.746 0.818 . . . . 0.0 110.56 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.71 132.72 49.83 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 168.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 90.79 -11.53 0.28 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 130.496 3.519 . . . . 0.0 114.579 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -28.13 69.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 122.186 2.266 . . . . 0.0 111.657 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.1 tppt? -64.4 -7.84 11.22 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.826 1.25 . . . . 0.0 113.038 -176.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.1 t -64.96 -24.34 67.49 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 120.863 -1.148 . . . . 0.0 112.351 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.78 -32.97 74.9 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.321 0.964 . . . . 0.0 112.147 172.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -86.65 4.55 86.12 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.014 1.293 . . . . 0.0 113.854 170.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.336 31.8 p 56.39 41.47 28.91 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 129.069 2.948 . . . . 0.0 114.811 -176.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.83 109.56 21.13 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.409 1.483 . . . . 0.0 108.557 169.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -94.07 -39.26 10.7 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -59.66 129.16 40.53 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.973 0.806 . . . . 0.0 111.666 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.8 t -64.83 163.39 14.33 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.169 0.988 . . . . 0.0 111.286 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.2 p -68.54 140.88 55.64 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.347 0.594 . . . . 0.0 112.087 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.0 p30 -88.93 -14.54 36.47 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.58 25.15 73.12 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.901 -0.944 . . . . 0.0 113.444 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.4 mtp-105 -106.19 166.61 10.39 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.615 1.566 . . . . 0.0 113.121 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 82.4 m -64.34 136.87 57.55 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.191 0.996 . . . . 0.0 111.245 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -142.37 33.85 1.49 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.239 1.416 . . . . 0.0 112.162 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.4 tp -102.81 140.57 36.9 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.637 1.975 . . . . 0.0 109.903 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -146.64 -64.91 0.29 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -87.29 3.23 47.56 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.986 1.315 . . . . 0.0 114.114 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.54 -12.63 43.02 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.857 1.694 . . . . 0.0 114.007 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.5 mtt -95.28 148.58 22.26 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.661 1.731 . . . . 0.0 111.681 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -73.63 90.06 1.77 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 168.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -55.8 -42.19 75.25 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.889 0.876 . . . . 0.0 112.541 -171.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 69.1 m -75.78 2.99 10.75 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -174.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -43.05 -32.87 0.74 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 171.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.94 8.51 63.33 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.502 2.001 . . . . 0.0 115.615 -174.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.265 32.3 tt0 -131.98 -60.13 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.978 0 CA-C-N 120.53 2.165 . . . . 0.0 114.055 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -70.52 146.09 54.52 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 CA-C-N 122.516 1.934 . . . . 0.0 113.029 169.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -65.41 165.52 11.8 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 129.136 2.974 . . . . 0.0 113.136 169.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -62.27 155.28 25.24 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.389 1.09 . . . . 0.0 112.025 169.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -76.86 143.78 39.46 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.61 1.164 . . . . 0.0 110.172 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 44.2 p -73.01 153.79 40.76 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.982 0.42 . . . . 0.0 110.854 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.93 -26.09 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.386 1.075 . . . . 0.0 113.789 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.6 t -81.98 -37.19 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.107 1.363 . . . . 0.0 112.034 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -67.4 -33.3 74.91 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.124 0.875 . . . . 0.0 111.795 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.89 -56.11 17.73 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.656 0.662 . . . . 0.0 110.508 169.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -58.34 -34.47 70.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.966 0.906 . . . . 0.0 112.91 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.3 t -59.27 -65.51 0.66 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.867 0.867 . . . . 0.0 111.3 170.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -67.83 -27.62 66.87 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.187 -1.571 . . . . 0.0 113.853 -174.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -37.3 79.66 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.25 1.386 . . . . 0.0 111.751 169.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.38 -28.45 37.96 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -74.7 -39.85 61.7 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.004 0.82 . . . . 0.0 110.948 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -86.11 -13.67 46.51 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.752 1.221 . . . . 0.0 111.897 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 30.0 m120 58.46 39.92 24.59 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.907 2.083 . . . . 0.0 112.818 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.7 mt -90.99 138.22 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.824 1.65 . . . . 0.0 108.814 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -96.42 107.5 36.21 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 120.354 1.434 . . . . 0.0 110.235 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.77 149.68 43.32 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.126 1.884 . . . . 0.0 113.168 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 30.0 mt -140.97 105.82 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.638 0.775 . . . . 0.0 110.093 176.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -75.82 64.22 1.77 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.425 1.09 . . . . 0.0 113.09 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . 0.335 0.5 OUTLIER -60.32 114.01 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 119.952 -1.717 . . . . 0.0 113.38 169.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 35.5 m -151.63 150.47 26.55 Favored Pre-proline 0 N--CA 1.48 1.027 0 O-C-N 120.636 -1.29 . . . . 0.0 112.829 -172.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.41 157.18 59.42 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.325 3.35 . . . . 0.0 113.023 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.5 p -44.66 -51.39 9.22 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.828 2.051 . . . . 0.0 113.968 -170.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -52.21 -27.31 14.23 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -174.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 22.4 ptm -117.13 3.72 12.7 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.323 1.449 . . . . 0.0 114.831 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.11 -39.65 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 CA-C-N 119.994 1.27 . . . . 0.0 110.624 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -67.99 -26.73 66.06 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -170.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.7 -37.6 20.75 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.811 1.245 . . . . 0.0 110.417 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -73.2 -28.44 62.18 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.843 -1.16 . . . . 0.0 111.381 174.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . 0.314 15.0 pt-20 -77.38 0.21 23.28 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.722 1.146 . . . . 0.0 111.995 169.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -99.08 -10.33 22.72 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.201 -0.937 . . . . 0.0 111.349 168.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.86 -31.19 28.13 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.214 1.806 . . . . 0.0 108.551 169.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.2 t -77.89 -5.62 51.61 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.593 1.157 . . . . 0.0 113.387 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 7.5 t -100.91 -17.44 16.82 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.944 0.498 . . . . 0.0 110.336 168.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -82.63 -45.36 14.64 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.258 0.481 . . . . 0.0 111.499 169.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 4.0 mp -97.51 118.11 64.67 Favored Pre-proline 0 N--CA 1.475 0.793 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -76.46 143.64 24.82 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.441 2.094 . . . . 0.0 111.191 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 79.5 tttt 101.46 -22.95 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 130.253 3.421 . . . . 0.0 114.486 169.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . 0.364 0.0 OUTLIER -76.57 168.59 19.81 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 118.897 0.771 . . . . 0.0 111.74 -177.24 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.352 6.9 t -136.86 -163.3 1.4 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 122.983 1.373 . . . . 0.0 107.946 176.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 17.1 tt -157.56 136.98 3.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 126.427 1.891 . . . . 0.0 112.461 -166.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -119.53 155.72 16.02 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.627 0.632 . . . . 0.0 111.905 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -95.34 90.52 5.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 169.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 55.6 tp . . . . . 0 N--CA 1.468 0.454 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.975 169.608 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -112.46 137.83 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.645 1.578 . . . . 0.0 111.145 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -115.3 99.2 7.22 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 168.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -90.81 128.22 36.63 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.604 -0.685 . . . . 0.0 111.248 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -123.78 109.18 13.34 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 123.435 1.588 . . . . 0.0 111.767 172.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -85.63 101.46 12.74 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.261 2.224 . . . . 0.0 113.626 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.5 mt -93.47 119.44 32.56 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.8 ptm -117.75 145.15 44.68 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 169.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.58 136.21 24.38 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.7 mp -109.05 16.27 22.7 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.47 1.508 . . . . 0.0 113.171 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 CA--C 1.548 0.866 0 O-C-N 120.186 -1.571 . . . . 0.0 113.265 174.325 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.2 m . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.91 81.54 0.31 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 127.023 2.249 . . . . 0.0 108.501 -170.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -80.28 134.87 36.13 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.839 1.256 . . . . 0.0 107.743 -171.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.5 tp -119.61 142.64 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.161 0.585 . . . . 0.0 111.194 -172.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.89 160.26 29.89 Favored Glycine 0 N--CA 1.467 0.736 0 C-N-CA 125.171 1.367 . . . . 0.0 111.435 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -146.34 142.57 28.38 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -169.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.3 142.27 13.25 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.2 p -108.78 142.68 38.98 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.114 0.966 . . . . 0.0 110.615 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.297 0.6 OUTLIER -152.26 137.87 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.943 1.461 . . . . 0.0 114.943 -176.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.05 -137.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 127.577 2.351 . . . . 0.0 105.719 172.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 52' ' ' THR 0.301 10.1 m120 -98.01 -1.6 42.26 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.671 1.578 . . . . 0.0 111.992 168.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 62.9 mtt -85.6 40.93 0.87 Allowed 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 102.079 -3.304 . . . . 0.0 102.079 163.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.496 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.366 68.4 p 14.38 -113.51 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.94 1 C-N-CA 133.925 4.89 . . . . 0.0 113.946 -166.092 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -112.36 130.07 56.09 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 125.089 1.493 . . . . 0.0 111.893 -168.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -122.89 118.75 28.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 168.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -81.39 116.52 21.25 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.039 170.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 mm -89.87 -44.26 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 119.16 -0.448 . . . . 0.0 110.991 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.8 tp -151.53 123.9 8.32 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.793 0.806 . . . . 0.0 112.98 -172.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -54.97 149.34 11.88 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.599 1.96 . . . . 0.0 112.455 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.5 mt -51.15 112.97 0.81 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.048 1.339 . . . . 0.0 110.301 169.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.469 0.477 0 C-N-CA 124.173 0.989 . . . . 0.0 112.152 -173.836 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.5 m -131.75 -175.24 3.65 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.729 2.412 . . . . 0.0 110.417 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -137.0 166.77 24.84 Favored Glycine 0 N--CA 1.477 1.374 0 O-C-N 120.664 -1.272 . . . . 0.0 114.649 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -155.7 155.32 32.96 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.442 1.497 . . . . 0.0 113.069 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -56.28 -65.0 0.68 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.417 2.287 . . . . 0.0 111.296 168.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.48 145.17 41.62 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.131 0.972 . . . . 0.0 113.606 -172.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.9 m -70.68 -44.95 17.15 Favored Pre-proline 0 N--CA 1.474 0.761 0 CA-C-O 116.135 -1.888 . . . . 0.0 113.218 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -69.75 141.88 46.46 Favored 'Trans proline' 0 C--N 1.354 0.851 0 CA-C-N 122.225 1.83 . . . . 0.0 112.403 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -92.84 178.88 5.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.378 1.871 . . . . 0.0 112.773 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.43 22.41 26.72 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 125.912 1.72 . . . . 0.0 115.231 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . 0.268 2.8 tt0 -64.02 -29.67 70.8 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 119.353 3.094 . . . . 0.0 119.353 -168.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.22 -20.47 65.69 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 122.255 2.298 . . . . 0.0 112.518 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -65.07 -35.13 80.18 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.651 1.114 . . . . 0.0 111.234 169.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.04 73.97 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-O 117.086 -1.435 . . . . 0.0 110.041 168.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.292 2.1 m -61.99 -33.62 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 120.133 1.333 . . . . 0.0 112.764 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.7 p -68.8 -58.06 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 117.732 -1.128 . . . . 0.0 108.607 169.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -52.29 -53.41 44.41 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 121.184 1.811 . . . . 0.0 112.705 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.9 p -54.16 -41.6 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 119.51 1.05 . . . . 0.0 112.137 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.91 -19.25 61.3 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 mp -106.06 -30.01 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 120.081 1.31 . . . . 0.0 113.22 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 84.4 m -78.72 55.97 1.78 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.814 1.646 . . . . 0.0 111.215 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 72.7 mt -51.42 -44.12 62.18 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.148 2.179 . . . . 0.0 111.823 -171.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.3 -17.42 76.32 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.224 0.916 . . . . 0.0 114.264 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -90.76 -54.9 3.78 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.915 1.286 . . . . 0.0 110.19 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.32 -33.13 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 118.562 -0.733 . . . . 0.0 110.59 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.94 25.41 27.13 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.256 0.931 . . . . 0.0 113.432 174.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -57.27 123.95 17.16 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.172 0.986 . . . . 0.0 112.138 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.1 mtp-105 -97.27 -176.57 3.56 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.404 2.282 . . . . 0.0 110.668 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -100.77 39.13 1.41 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.078 1.351 . . . . 0.0 114.446 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -95.11 -122.47 3.83 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 169.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.1 t -113.06 143.62 44.02 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.721 1.608 . . . . 0.0 107.689 169.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -131.68 120.41 22.73 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.152 0.887 . . . . 0.0 110.117 -168.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -120.89 105.64 10.88 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -169.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.41 99.71 12.2 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.5 t -81.06 127.51 39.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.6 tt -110.47 132.43 54.19 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.4 t -119.41 121.88 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.939 0.896 . . . . 0.0 109.944 169.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.3 p -138.97 168.59 19.49 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.599 1.56 . . . . 0.0 110.189 169.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.27 2.28 2.06 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 170.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -142.25 161.22 38.57 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.962 1.705 . . . . 0.0 110.618 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -45.49 173.16 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 128.409 2.684 . . . . 0.0 117.586 -169.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -129.08 137.66 51.39 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.998 -1.064 . . . . 0.0 113.184 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -79.02 84.63 5.01 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 125.13 1.372 . . . . 0.0 112.216 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . 0.387 0.0 OUTLIER -73.08 174.65 7.61 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 119.802 -1.811 . . . . 0.0 113.432 174.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.57 134.72 1.72 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 -169.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.311 60.8 mtpt 75.27 -2.25 2.87 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 131.308 3.843 . . . . 0.0 114.898 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.98 -21.18 66.8 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.609 1.095 . . . . 0.0 112.821 169.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -69.72 -7.97 43.88 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.215 -1.553 . . . . 0.0 114.347 172.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.07 -15.55 63.79 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.196 1.362 . . . . 0.0 113.328 175.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -64.15 -21.54 66.59 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 118.802 0.728 . . . . 0.0 112.095 169.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -90.55 -128.32 3.81 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.72 1.629 . . . . 0.0 111.395 170.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.5 t -137.41 52.87 1.88 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.742 1.617 . . . . 0.0 110.132 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -133.7 88.64 2.5 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.854 1.661 . . . . 0.0 110.805 -169.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -102.73 -18.47 15.15 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -68.71 129.6 40.39 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.41 1.005 . . . . 0.0 110.832 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.0 t -69.36 161.38 29.48 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 118.822 0.737 . . . . 0.0 111.319 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.7 m -62.14 133.95 55.92 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.653 -0.654 . . . . 0.0 111.552 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -86.69 -12.58 47.93 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.66 23.99 73.67 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.276 -1.291 . . . . 0.0 114.184 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -103.32 165.13 11.22 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.144 1.472 . . . . 0.0 112.198 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 10.0 t -67.49 126.67 30.03 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.596 1.558 . . . . 0.0 109.382 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -127.34 55.86 1.57 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.637 1.575 . . . . 0.0 110.995 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.13 124.04 22.72 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.005 1.322 . . . . 0.0 109.774 -169.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -125.95 -58.45 1.38 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.34 1.056 . . . . 0.0 111.736 170.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -81.44 -21.38 38.88 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -174.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 121.91 -8.01 10.02 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.062 1.315 . . . . 0.0 114.513 -171.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 94.6 mtp -108.87 142.21 39.8 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.733 1.267 . . . . 0.0 111.364 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -67.69 83.16 0.18 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.272 1.029 . . . . 0.0 110.573 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -72.13 -15.43 61.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -169.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 86.6 p -78.07 -5.34 51.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.71 1.141 . . . . 0.0 113.223 170.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -41.68 -35.03 0.69 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.78 -5.03 81.92 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 117.517 -1.713 . . . . 0.0 114.989 -175.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -120.96 -70.71 0.02 OUTLIER Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 119.791 1.796 . . . . 0.0 112.643 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -61.08 147.18 96.42 Favored 'Trans proline' 0 C--N 1.355 0.891 0 CA-C-N 123.064 2.13 . . . . 0.0 114.919 171.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -62.05 174.87 0.78 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 130.248 3.419 . . . . 0.0 113.397 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -74.17 145.21 44.39 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.487 1.115 . . . . 0.0 112.435 172.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -67.86 131.59 45.81 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.534 0.683 . . . . 0.0 111.971 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 27.0 p -63.11 142.02 58.54 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.055 1.342 . . . . 0.0 113.396 170.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.85 -27.29 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 121.109 -0.994 . . . . 0.0 112.484 -174.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.3 t -65.38 -44.18 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 121.355 -0.84 . . . . 0.0 111.556 172.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -76.1 -20.69 57.43 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.688 -0.633 . . . . 0.0 112.062 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.29 -50.54 63.35 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.265 0.939 . . . . 0.0 108.658 168.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.49 -41.92 73.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.439 0.696 . . . . 0.0 112.615 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.8 p -68.75 -51.42 41.48 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.906 0.775 . . . . 0.0 112.416 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -67.44 -38.31 84.32 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.533 -1.354 . . . . 0.0 113.242 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.9 mp -66.21 -35.05 79.41 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.364 -0.835 . . . . 0.0 111.582 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.71 -28.71 58.71 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 172.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.37 -49.25 64.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.117 1.367 . . . . 0.0 110.026 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -91.09 -0.13 57.66 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.733 0.813 . . . . 0.0 112.907 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.3 m120 47.03 59.61 3.92 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.908 2.083 . . . . 0.0 112.492 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.7 mm -95.71 129.36 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 169.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . 0.345 10.5 pt20 -98.71 110.65 57.99 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 123.3 2.773 . . . . 0.0 108.448 169.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.89 145.44 50.65 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 124.564 3.509 . . . . 0.0 114.06 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 8.6 mm -127.29 98.69 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.509 1.524 . . . . 0.0 109.338 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -76.89 82.06 3.46 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.22 -1.55 . . . . 0.0 110.453 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.95 126.4 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 O-C-N 120.622 -1.299 . . . . 0.0 110.582 168.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 5.1 p -163.11 141.77 6.49 Favored Pre-proline 0 N--CA 1.483 1.221 0 CA-C-O 117.745 -1.122 . . . . 0.0 113.43 -169.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -63.75 157.48 51.74 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 125.033 3.822 . . . . 0.0 116.309 176.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 78.4 p -56.47 -27.0 55.77 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -169.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -56.77 -36.12 69.46 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.664 1.12 . . . . 0.0 112.701 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 52.6 ttp -116.91 -6.12 11.47 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 -169.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 51.6 t -53.99 -32.11 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.718 -1.239 . . . . 0.0 111.286 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -61.79 -34.92 76.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.912 1.285 . . . . 0.0 113.524 -175.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.8 t -92.6 -39.68 11.19 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.848 0.859 . . . . 0.0 110.397 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -69.12 -35.16 76.1 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.318 1.047 . . . . 0.0 110.084 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -68.96 -7.03 31.34 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.549 1.068 . . . . 0.0 112.667 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -99.11 -16.66 18.55 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.826 -1.171 . . . . 0.0 111.536 169.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.05 -21.78 46.33 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.697 -1.252 . . . . 0.0 109.557 169.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.3 p -79.61 -18.76 50.88 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.971 0.908 . . . . 0.0 112.919 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . 0.289 1.7 t -81.25 -17.46 49.39 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.365 0.529 . . . . 0.0 109.909 169.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -89.62 -26.23 20.88 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.826 0.451 . . . . 0.0 111.756 168.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.5 mm -111.86 85.63 6.54 Favored Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 124.984 1.313 . . . . 0.0 110.084 172.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.17 136.94 76.1 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.257 1.971 . . . . 0.0 111.517 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 87.71 -5.7 0.59 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 129.765 3.226 . . . . 0.0 114.335 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.8 tt -72.43 138.84 47.39 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.891 1.276 . . . . 0.0 108.319 169.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 41.5 p -116.92 -164.48 0.98 Allowed 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 120.349 1.431 . . . . 0.0 107.467 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.2 mt -164.53 153.43 2.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 126.052 1.741 . . . . 0.0 110.383 -167.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -140.33 141.22 11.25 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.799 168.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -80.2 82.28 6.29 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 123.628 1.68 . . . . 0.0 108.305 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 CA--C 1.541 0.626 0 CA-C-N 112.605 -2.089 . . . . 0.0 110.857 170.385 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.7 t -114.91 141.1 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.769 1.228 . . . . 0.0 110.052 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -114.25 115.74 27.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.551 1.14 . . . . 0.0 109.327 169.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 tp -100.08 129.91 46.17 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.662 0.665 . . . . 0.0 111.874 169.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -120.3 105.26 10.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 123.508 1.623 . . . . 0.0 109.564 169.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -84.0 105.84 15.19 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.54 -1.664 . . . . 0.0 111.286 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -103.3 108.5 19.75 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.726 1.21 . . . . 0.0 109.701 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.2 ptm -113.2 145.54 40.82 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.91 139.58 27.45 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.043 0.83 . . . . 0.0 111.511 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 mp -112.18 25.75 11.25 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.494 1.917 . . . . 0.0 112.529 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.3 t . . . . . 0 CA--C 1.546 0.818 0 C-N-CA 123.544 0.737 . . . . 0.0 111.345 169.61 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 122.328 1.061 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.94 84.79 0.23 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 -170.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -74.96 146.03 42.07 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.5 tt -133.05 134.45 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.64 0.776 . . . . 0.0 110.585 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.56 152.58 21.66 Favored Glycine 0 N--CA 1.467 0.752 0 C-N-CA 125.907 1.718 . . . . 0.0 111.146 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -124.08 146.98 48.23 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.415 0.686 . . . . 0.0 111.557 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.24 154.14 25.72 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 170.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.6 p -135.24 159.17 42.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.357 1.075 . . . . 0.0 113.185 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.64 147.77 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 121.347 -0.846 . . . . 0.0 111.986 -169.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . 0.306 12.0 p -154.29 -129.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 116.626 -1.654 . . . . 0.0 109.427 171.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.402 ' C ' ' H ' ' A' ' 52' ' ' THR . 4.5 t30 -95.45 -20.86 18.72 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 123.43 2.832 . . . . 0.0 112.963 169.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 46.2 mtt -80.75 49.13 1.15 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 167.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.402 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.294 12.8 p 25.17 -120.66 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.518 1 C-N-CA 132.157 4.183 . . . . 0.0 114.381 -169.057 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -107.35 133.13 52.34 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 127.483 2.313 . . . . 0.0 112.503 -167.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.2 123.85 48.79 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 169.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -97.43 127.76 43.66 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.609 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -155.67 113.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.929 0.892 . . . . 0.0 109.525 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.9 tp 96.51 83.21 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.868 3.267 . . . . 0.0 107.875 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.15 155.14 21.34 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.797 0.808 . . . . 0.0 111.149 169.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . 0.26 2.2 tm? -54.54 105.03 0.13 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 128.02 2.528 . . . . 0.0 109.689 -170.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.487 1.411 0 C-N-CA 125.71 1.604 . . . . 0.0 112.635 -169.525 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 121.084 0.469 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.9 p -119.56 -157.91 0.72 Allowed 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.761 -0.587 . . . . 0.0 110.333 168.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.66 143.12 9.64 Favored Glycine 0 CA--C 1.524 0.609 0 O-C-N 121.154 -0.967 . . . . 0.0 112.202 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 149.45 28.12 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.659 1.583 . . . . 0.0 110.79 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.01 -57.23 4.18 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -168.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.73 136.76 58.09 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.657 0.662 . . . . 0.0 111.549 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.254 6.4 t -65.84 -39.12 28.34 Favored Pre-proline 0 N--CA 1.476 0.859 0 CA-C-O 116.321 -1.799 . . . . 0.0 114.599 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.71 143.29 50.6 Favored 'Trans proline' 0 C--N 1.359 1.084 0 CA-C-N 122.71 2.003 . . . . 0.0 111.665 173.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.15 162.29 16.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.125 1.77 . . . . 0.0 112.199 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.61 42.27 2.91 Favored Glycine 0 N--CA 1.479 1.525 0 C-N-CA 125.022 1.296 . . . . 0.0 115.264 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -60.74 -29.65 69.52 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.223 1.512 . . . . 0.0 112.891 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.5 tp -65.89 -32.86 74.61 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -169.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -59.7 -54.66 43.84 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.46 -52.31 64.07 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.636 0.774 . . . . 0.0 111.72 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.258 3.1 p -61.3 -36.44 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 119.592 1.087 . . . . 0.0 112.792 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.8 -35.76 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 120.607 1.548 . . . . 0.0 113.23 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -61.91 -46.42 89.44 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.055 1.298 . . . . 0.0 110.741 172.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.9 t -54.79 -36.73 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 122.84 0.456 . . . . 0.0 111.745 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.31 -30.81 62.23 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 20.7 tt -99.01 -25.59 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 61.2 m -82.91 61.31 5.88 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 120.459 1.481 . . . . 0.0 111.512 -171.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.3 mt -49.42 -45.58 46.48 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.909 2.884 . . . . 0.0 110.977 -171.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.59 -23.08 44.32 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 114.14 -1.391 . . . . 0.0 114.135 -173.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -84.66 -46.68 11.25 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.382 1.091 . . . . 0.0 110.938 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.0 mt -79.94 -25.01 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 118.054 -0.974 . . . . 0.0 111.474 177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.06 23.9 36.57 Favored Glycine 0 N--CA 1.471 0.992 0 CA-C-N 119.548 1.067 . . . . 0.0 115.306 169.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -52.62 122.43 8.98 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.92 1.288 . . . . 0.0 112.55 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -93.71 175.03 6.89 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.732 1.213 . . . . 0.0 111.131 170.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -90.49 27.95 1.59 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 116.288 1.958 . . . . 0.0 116.288 -168.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.34 -124.69 3.79 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 120.768 -1.207 . . . . 0.0 110.797 173.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.3 m -97.85 142.5 29.53 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.742 2.017 . . . . 0.0 107.58 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -142.85 119.47 11.08 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 121.076 1.762 . . . . 0.0 110.739 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -113.97 123.28 49.33 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 126.314 1.846 . . . . 0.0 112.99 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 tt -107.87 96.03 6.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 110.112 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 77.5 t -79.93 126.97 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.1 tp -114.25 116.01 28.33 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.66 130.7 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -165.04 151.27 10.14 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 117.615 -1.183 . . . . 0.0 113.062 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -96.82 -13.64 22.43 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.565 1.946 . . . . 0.0 115.45 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -128.51 172.16 11.42 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.124 0.97 . . . . 0.0 113.371 -169.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.52 179.35 0.62 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.569 1.147 . . . . 0.0 111.603 169.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -128.4 156.46 43.13 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.034 -1.666 . . . . 0.0 113.437 -170.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -77.65 117.31 18.94 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.598 169.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.455 HD22 ' H ' ' A' ' 119' ' ' ALA . 2.8 tt -88.61 173.89 8.37 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.287 1.435 . . . . 0.0 110.015 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.455 ' H ' HD22 ' A' ' 118' ' ' LEU . . . -54.99 150.5 10.19 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.99 -1.069 . . . . 0.0 110.5 168.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt 74.06 -21.01 0.29 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.557 1.943 . . . . 0.0 114.826 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -54.01 -56.52 17.12 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.239 -1.538 . . . . 0.0 113.022 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -6.83 0.51 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 119.341 3.089 . . . . 0.0 119.341 -177.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.378 0.5 OUTLIER -64.74 -20.26 66.25 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 122.328 2.331 . . . . 0.0 111.269 174.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -50.48 -44.46 55.87 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.298 1.839 . . . . 0.0 110.241 168.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -87.02 22.3 15.41 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.702 2.096 . . . . 0.0 114.503 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 56.3 m 73.22 20.57 3.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.65 1.98 . . . . 0.0 112.415 170.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 25.2 ttp-105 -116.25 112.59 21.83 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.571 1.548 . . . . 0.0 111.035 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -117.86 -33.76 4.39 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -170.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -63.62 118.21 7.9 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 120.329 1.422 . . . . 0.0 111.304 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . 0.261 3.0 t -67.96 166.36 15.93 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -171.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.8 p -60.85 129.11 39.8 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.708 0.803 . . . . 0.0 112.905 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.7 p30 -82.66 -13.68 56.01 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.458 0.703 . . . . 0.0 112.784 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.86 1.18 66.6 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.433 1.492 . . . . 0.0 114.377 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -79.57 165.69 22.68 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.728 1.611 . . . . 0.0 114.036 -169.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 31.3 t -74.1 126.77 31.27 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.809 0.843 . . . . 0.0 109.489 169.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -141.33 39.83 1.74 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.813 1.645 . . . . 0.0 111.739 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.3 mt -103.56 148.75 25.6 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.166 1.387 . . . . 0.0 109.091 172.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -143.15 -64.5 0.4 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.34 0.656 . . . . 0.0 112.182 175.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -92.11 15.79 12.69 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.387 1.475 . . . . 0.0 113.47 177.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.71 9.4 62.78 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.119 1.342 . . . . 0.0 114.526 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 59.5 ttm -117.61 146.68 43.49 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.115 1.366 . . . . 0.0 111.027 172.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -74.35 87.63 2.02 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.877 0.871 . . . . 0.0 111.942 170.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 62.5 ttt-85 -50.62 -38.15 44.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.206 1.802 . . . . 0.0 112.582 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.0 t -64.12 -17.41 63.42 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.081 1.352 . . . . 0.0 114.632 -176.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -35.95 -50.85 0.7 Allowed 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 120.579 1.536 . . . . 0.0 114.107 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.09 -5.03 84.63 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.168 -1.351 . . . . 0.0 114.747 -172.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.327 3.0 pt-20 -129.09 -64.84 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 115.377 -2.249 . . . . 0.0 113.748 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -68.65 154.81 70.7 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 CA-C-N 124.627 2.688 . . . . 0.0 118.003 169.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . 0.288 26.8 t0 -83.89 141.5 31.25 Favored 'General case' 0 CA--C 1.551 1.01 1 C-N-CA 133.082 4.553 . . . . 0.0 114.828 -176.598 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -50.67 113.99 1.04 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.416 -0.803 . . . . 0.0 111.21 168.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.556 ' CD ' ' H ' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -54.99 153.47 6.35 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 127.469 2.307 . . . . 0.0 114.849 -173.425 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 85.9 p -83.8 153.01 24.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.107 0.963 . . . . 0.0 112.898 -177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.9 m -55.06 -27.39 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.96 -44.6 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.957 0.903 . . . . 0.0 110.929 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -28.25 65.0 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.807 -0.616 . . . . 0.0 111.311 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.8 mt -60.53 -52.55 64.69 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.883 0.765 . . . . 0.0 110.039 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.3 -45.53 84.08 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.431 1.092 . . . . 0.0 111.065 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.2 m -65.91 -47.18 75.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.49 0.716 . . . . 0.0 112.763 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.22 -42.55 98.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.066 1.303 . . . . 0.0 111.974 174.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.49 -44.67 81.98 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.158 0.983 . . . . 0.0 111.784 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.6 -24.77 62.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.413 1.085 . . . . 0.0 113.471 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -75.27 -43.56 50.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.7 0.8 . . . . 0.0 110.724 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -85.08 -13.85 49.05 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.78 39.43 20.77 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.332 1.453 . . . . 0.0 113.541 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.0 mt -82.71 149.4 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 169.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -107.39 111.34 63.11 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 120.152 1.342 . . . . 0.0 109.503 169.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -78.02 149.71 25.87 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.655 3.57 . . . . 0.0 113.346 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.9 mp -132.91 107.56 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.875 1.27 . . . . 0.0 109.274 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -74.89 71.29 2.01 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.94 -1.1 . . . . 0.0 112.748 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 95.7 t -75.31 103.39 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 120.421 -1.424 . . . . 0.0 111.742 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 22.8 m -145.27 147.73 35.13 Favored Pre-proline 0 N--CA 1.48 1.038 0 O-C-N 120.754 -1.216 . . . . 0.0 112.661 -169.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -55.34 149.99 43.43 Favored 'Trans proline' 0 C--N 1.353 0.791 1 C-N-CA 125.808 4.339 . . . . 0.0 115.744 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 36.5 p -46.73 -49.59 19.35 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.746 2.019 . . . . 0.0 113.422 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -43.22 -32.61 0.79 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.607 2.363 . . . . 0.0 115.431 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.8 ptm -118.68 -2.77 10.9 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.6 1.56 . . . . 0.0 114.75 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.78 -29.85 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-N 120.277 1.399 . . . . 0.0 111.05 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -65.11 -21.06 66.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.208 1.003 . . . . 0.0 113.525 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.55 -39.43 11.92 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.161 0.984 . . . . 0.0 111.36 177.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -73.36 -28.87 62.27 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 120.826 -1.171 . . . . 0.0 110.471 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -58.08 -23.77 55.94 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.66 0.784 . . . . 0.0 110.819 168.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -87.52 -29.54 21.26 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.517 -0.74 . . . . 0.0 110.546 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.82 -26.31 61.44 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.302 1.441 . . . . 0.0 110.138 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.295 3.2 t -80.37 -17.36 52.14 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 173.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 28.9 m -82.83 -34.37 26.89 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.637 -0.664 . . . . 0.0 109.402 169.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -78.77 -19.47 52.16 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 20.3 mt -131.74 92.9 29.36 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.504 1.122 . . . . 0.0 108.978 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -60.56 142.34 97.66 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.943 2.429 . . . . 0.0 113.415 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt 93.99 -15.35 0.12 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 130.245 3.418 . . . . 0.0 114.798 169.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.6 pp -84.24 152.3 24.28 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.7 0.682 . . . . 0.0 109.266 168.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 76.3 p -111.0 -146.61 0.41 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -170.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.1 tt 179.75 152.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 128.317 2.647 . . . . 0.0 110.538 -168.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -153.14 151.05 22.89 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 123.912 0.767 . . . . 0.0 111.811 169.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.4 84.21 5.98 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.739 1.216 . . . . 0.0 109.491 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 11.7 tp . . . . . 0 N--CA 1.472 0.629 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.356 169.379 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.0 t . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.29 123.45 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 127.071 2.149 . . . . 0.0 108.737 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -108.68 104.79 14.15 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.717 1.207 . . . . 0.0 109.513 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.1 132.17 41.76 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.882 -1.136 . . . . 0.0 112.824 173.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -121.53 110.79 16.45 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 124.426 2.06 . . . . 0.0 110.685 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -88.81 114.13 25.1 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 128.201 2.6 . . . . 0.0 113.111 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.8 mp -108.95 130.96 55.46 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.799 0.84 . . . . 0.0 111.099 169.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . 0.348 0.0 OUTLIER -128.93 151.62 49.46 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 167.299 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.16 129.54 11.68 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.964 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.53 27.63 8.62 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.43 1.892 . . . . 0.0 111.635 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 100.0 p . . . . . 0 CA--C 1.541 0.597 0 O-C-N 120.504 -1.372 . . . . 0.0 112.923 174.289 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 122.369 1.081 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.35 74.3 0.42 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 127.198 2.333 . . . . 0.0 108.235 -169.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -81.83 140.02 34.41 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.385 1.093 . . . . 0.0 108.238 -171.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.7 tt -120.32 142.94 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 117.856 0.298 . . . . 0.0 111.795 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.95 157.05 22.46 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.951 1.739 . . . . 0.0 110.1 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -128.26 142.59 51.11 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -169.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.82 141.82 12.01 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 118.729 0.695 . . . . 0.0 112.067 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.0 t -109.7 142.26 41.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.476 1.111 . . . . 0.0 110.447 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -150.48 152.28 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 120.775 -1.203 . . . . 0.0 111.766 170.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.3 t -138.72 -62.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.311 1.045 . . . . 0.0 111.06 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.3 t30 154.35 -24.88 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 1 C-N-CA 132.764 4.426 . . . . 0.0 108.24 -169.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 87.9 mtp -53.72 -50.3 66.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.64 1.176 . . . . 0.0 109.473 168.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.5 p 178.78 179.52 0.39 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 131.09 3.756 . . . . 0.0 108.846 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -98.28 125.75 43.5 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 103.561 -2.755 . . . . 0.0 103.561 166.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 65.3 tp60 -111.9 114.92 28.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 122.337 1.065 . . . . 0.0 109.184 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -82.94 113.21 20.38 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.703 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.5 pt -142.07 115.41 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.967 0.907 . . . . 0.0 109.167 168.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.3 tp 101.72 96.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 130.262 3.425 . . . . 0.0 108.611 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -63.0 163.71 9.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.047 1.339 . . . . 0.0 111.535 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.7 mt -54.37 111.68 0.84 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.373 0.669 . . . . 0.0 110.757 174.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 125.34 1.456 . . . . 0.0 112.472 -174.684 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -118.11 -152.59 0.51 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.772 1.629 . . . . 0.0 110.102 169.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -132.79 152.38 20.28 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 124.95 1.262 . . . . 0.0 114.395 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -148.03 152.95 38.29 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.974 1.71 . . . . 0.0 111.154 173.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -70.55 -82.82 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.455 1.502 . . . . 0.0 111.251 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.05 158.93 30.24 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.0 m -65.04 -46.16 73.82 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 115.856 -2.021 . . . . 0.0 115.084 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.29 138.2 65.0 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.609 2.206 . . . . 0.0 112.482 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -101.87 162.55 12.82 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.941 0.897 . . . . 0.0 112.129 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.07 10.18 49.6 Favored Glycine 0 N--CA 1.482 1.706 0 C-N-CA 124.4 1.0 . . . . 0.0 115.098 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -28.21 -46.13 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 131.197 3.799 . . . . 0.0 115.613 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.78 -34.15 52.05 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.922 2.489 . . . . 0.0 114.37 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -68.27 -40.62 81.82 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.596 -1.315 . . . . 0.0 111.81 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.63 -44.79 66.45 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.505 -0.76 . . . . 0.0 111.913 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -54.66 -38.17 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 118.951 0.796 . . . . 0.0 111.755 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -53.62 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 119.139 0.881 . . . . 0.0 111.818 173.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -60.57 -41.35 94.46 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.685 1.13 . . . . 0.0 111.525 -173.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.88 -40.18 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.165 0.586 . . . . 0.0 111.472 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.07 -38.84 89.32 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.038 -1.039 . . . . 0.0 112.193 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.5 mt -81.21 -30.39 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -174.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -84.99 65.64 9.34 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.614 -1.304 . . . . 0.0 112.663 -174.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.4 mt -46.42 -43.59 16.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.781 2.033 . . . . 0.0 111.184 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.28 -31.0 35.47 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.807 1.194 . . . . 0.0 115.136 -174.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -84.95 -43.06 14.36 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.35 1.075 . . . . 0.0 110.514 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.9 mm -72.13 -35.96 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 122.306 -0.246 . . . . 0.0 110.338 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.66 25.91 26.38 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.715 1.15 . . . . 0.0 113.857 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -55.13 122.5 11.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.645 1.178 . . . . 0.0 112.491 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -97.08 168.22 10.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.799 1.24 . . . . 0.0 111.587 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -84.24 57.72 4.4 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.13 -128.05 5.88 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 169.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.9 p -111.34 144.76 40.02 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 168.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.1 ptt-85 -146.16 119.79 9.16 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 120.698 1.59 . . . . 0.0 111.181 -170.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -120.68 131.82 54.77 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.5 tp -89.75 107.97 19.41 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.613 170.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.9 t -90.48 111.96 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 173.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.6 tp -117.09 114.42 23.71 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 119.062 0.846 . . . . 0.0 110.11 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.11 138.18 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.4 t -150.37 170.03 20.01 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 112.439 -2.164 . . . . 0.0 109.465 168.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -130.38 13.88 5.55 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.996 1.718 . . . . 0.0 113.375 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -142.58 179.35 7.02 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.891 1.676 . . . . 0.0 109.825 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -73.3 -170.84 0.85 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.355 0.597 . . . . 0.0 110.437 168.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -143.96 157.25 44.46 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.063 -1.023 . . . . 0.0 113.616 -169.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -73.58 129.94 39.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.331 172.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -105.94 178.32 4.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.832 1.653 . . . . 0.0 109.34 177.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.493 ' H ' HD23 ' A' ' 118' ' ' LEU . . . -53.62 140.68 28.17 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.077 -1.015 . . . . 0.0 112.682 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? 85.52 -26.27 0.1 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 128.883 2.873 . . . . 0.0 114.993 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . 0.256 10.6 p30 -65.36 -22.66 66.83 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 121.944 2.157 . . . . 0.0 114.767 -175.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . 0.253 0.0 OUTLIER -72.12 6.32 2.24 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 120.245 -1.535 . . . . 0.0 114.794 168.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.6 t -61.71 -26.1 67.83 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.755 -1.216 . . . . 0.0 110.155 168.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 57.6 mt -63.7 -35.05 79.29 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.071 1.748 . . . . 0.0 112.96 171.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -88.75 14.36 60.3 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.739 1.638 . . . . 0.0 113.533 172.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.323 25.9 m 41.62 54.81 3.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.375 3.07 . . . . 0.0 114.459 -174.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -100.72 110.45 22.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -85.9 -62.32 1.55 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 121.684 2.038 . . . . 0.0 112.02 -171.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.16 132.77 44.6 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.4 t -49.8 145.02 5.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.767 2.027 . . . . 0.0 111.104 170.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.4 p -65.24 145.27 56.45 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.168 0.985 . . . . 0.0 111.948 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -80.93 -12.54 59.38 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.82 16.73 78.1 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 118.737 -1.035 . . . . 0.0 113.376 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -103.59 159.78 15.3 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.922 1.289 . . . . 0.0 109.018 169.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 4.8 t -85.07 144.65 28.11 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.777 -1.202 . . . . 0.0 112.593 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -132.49 63.78 1.62 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.908 2.083 . . . . 0.0 109.609 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.13 130.04 52.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.199 1.8 . . . . 0.0 108.469 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -133.63 -69.19 0.55 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.226 0.61 . . . . 0.0 112.095 173.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.45 6.64 32.93 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.04 1.336 . . . . 0.0 114.205 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 108.82 -14.49 34.64 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.89 1.71 . . . . 0.0 114.949 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 62.2 mtt -91.54 144.46 25.53 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.285 1.542 . . . . 0.0 110.867 171.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -64.83 98.33 0.27 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 50.9 mmm-85 -56.43 -42.5 78.18 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.304 1.842 . . . . 0.0 112.268 -169.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 70.7 m -95.33 5.06 52.69 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -169.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.9 ttp-105 -47.11 -40.52 15.56 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.504 1.502 . . . . 0.0 112.995 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.73 -3.33 72.83 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 117.953 -1.471 . . . . 0.0 115.208 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.28 45.6 tt0 -120.6 -76.26 0.01 OUTLIER Pre-proline 0 CA--C 1.555 1.161 0 CA-C-O 115.84 -2.028 . . . . 0.0 111.83 176.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -58.89 160.93 16.65 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 123.147 2.565 . . . . 0.0 117.66 175.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -70.12 174.28 5.65 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 129.864 3.266 . . . . 0.0 114.91 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -81.29 123.1 28.23 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.672 1.989 . . . . 0.0 105.893 167.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.599 ' CD ' ' H ' ' A' ' 151' ' ' GLN . 0.2 OUTLIER -64.09 135.5 56.43 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 119.712 -1.868 . . . . 0.0 112.101 -177.634 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 24.6 p -67.44 155.45 38.99 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.387 -1.445 . . . . 0.0 112.087 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.69 -28.42 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 120.625 -1.297 . . . . 0.0 114.282 -169.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 52.0 t -81.54 -22.73 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.448 0.699 . . . . 0.0 112.596 175.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -63.9 -41.67 97.64 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.681 1.128 . . . . 0.0 109.013 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.6 mt -55.7 -56.6 18.51 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.345 0.521 . . . . 0.0 110.857 174.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.36 -30.1 69.34 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.0 t -65.88 -54.07 31.45 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.701 0.682 . . . . 0.0 111.357 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -63.78 -44.39 93.53 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.034 -1.041 . . . . 0.0 113.44 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mt -76.34 -23.88 54.24 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.503 -1.373 . . . . 0.0 112.042 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.99 -37.84 61.78 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 169.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.4 -34.77 63.38 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.235 0.925 . . . . 0.0 110.784 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -85.6 -7.05 59.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.117 0.967 . . . . 0.0 112.594 174.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 58.13 37.56 26.37 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.185 1.794 . . . . 0.0 113.347 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 22.9 mm -88.92 140.62 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.298 1.039 . . . . 0.0 109.193 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -102.92 101.79 23.36 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 120.743 1.611 . . . . 0.0 109.421 169.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -77.63 143.07 21.08 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.299 2.0 . . . . 0.0 112.979 174.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.6 mm -129.31 109.69 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.004 1.722 . . . . 0.0 108.881 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -75.91 71.81 2.74 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 123.648 1.69 . . . . 0.0 112.149 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.93 101.63 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 O-C-N 121.141 -0.974 . . . . 0.0 113.008 169.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 5.6 m -144.4 144.18 24.5 Favored Pre-proline 0 N--CA 1.484 1.225 0 O-C-N 120.175 -1.578 . . . . 0.0 111.707 -174.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -67.15 168.37 17.71 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.762 2.308 . . . . 0.0 115.581 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.1 t -52.13 140.88 19.86 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.499 169.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 103.13 -48.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 130.132 3.373 . . . . 0.0 110.006 -172.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -86.79 -22.45 25.88 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.1 t -50.93 -42.11 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 125.729 1.612 . . . . 0.0 111.89 -169.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -75.28 -15.88 60.48 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -172.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.54 -44.19 21.62 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.984 0.811 . . . . 0.0 109.528 172.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -71.89 -28.03 63.23 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.381 1.473 . . . . 0.0 110.656 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -65.92 -36.01 82.19 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.252 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -76.31 -26.71 56.09 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 116.732 -1.987 . . . . 0.0 110.758 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.6 -19.84 58.98 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.776 -1.203 . . . . 0.0 109.746 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.6 t -70.37 -23.84 62.86 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 119.473 1.033 . . . . 0.0 110.908 169.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 11.9 m -75.23 -31.02 60.72 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.389 0.676 . . . . 0.0 109.268 173.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -77.13 -27.64 54.03 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.873 173.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 30.3 pt -119.6 95.92 49.45 Favored Pre-proline 0 N--CA 1.489 1.503 0 CA-C-N 120.182 1.355 . . . . 0.0 113.656 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.87 138.5 51.39 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 124.11 3.207 . . . . 0.0 113.177 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 80.96 -4.1 1.75 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 128.665 2.786 . . . . 0.0 114.065 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.54 154.39 42.07 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.927 1.24 . . . . 0.0 108.583 168.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.554 ' CG2' ' H ' ' A' ' 191' ' ' ILE 0.256 1.9 m -128.11 -177.43 4.14 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 169.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.554 ' H ' ' CG2' ' A' ' 190' ' ' THR . 13.0 tt -146.22 144.49 20.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 129.587 3.155 . . . . 0.0 107.476 -168.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -128.27 146.98 17.18 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -91.1 94.53 9.64 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 60.9 tp . . . . . 0 CA--C 1.538 0.491 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.277 169.343 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.1 m . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 54.8 t -128.29 136.35 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.639 1.976 . . . . 0.0 108.917 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.57 112.03 13.87 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.807 0.843 . . . . 0.0 109.892 -175.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.93 132.13 52.4 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -117.38 103.36 10.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 123.351 1.548 . . . . 0.0 109.836 169.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -79.98 104.51 10.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.367 -1.742 . . . . 0.0 112.169 171.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 tt -103.82 126.69 51.13 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.764 0.826 . . . . 0.0 111.226 171.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.2 ptm -121.32 147.07 46.17 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 174.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.71 136.88 15.04 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.404 1.002 . . . . 0.0 112.22 170.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.55 44.41 2.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.165 1.786 . . . . 0.0 112.41 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 N--CA 1.476 0.831 0 O-C-N 120.238 -1.539 . . . . 0.0 112.805 170.074 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 121.886 0.851 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.29 78.75 0.32 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 127.408 2.432 . . . . 0.0 107.817 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -81.56 140.81 34.28 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.05 137.76 56.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.57 155.3 21.67 Favored Glycine 0 N--CA 1.464 0.552 0 C-N-CA 124.45 1.024 . . . . 0.0 111.002 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -107.28 163.52 12.95 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.275 0.63 . . . . 0.0 111.923 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.5 147.99 12.85 Favored Glycine 0 C--N 1.345 1.046 0 O-C-N 120.543 -1.348 . . . . 0.0 112.293 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.7 p -136.66 152.36 50.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.967 1.365 . . . . 0.0 114.403 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -159.78 157.46 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.035 1.334 . . . . 0.0 108.827 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.3 p -146.99 -73.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -164.01 -14.18 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.53 1.532 . . . . 0.0 111.604 169.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -48.16 -41.92 28.22 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.54 1.936 . . . . 0.0 112.903 169.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 p 160.2 -179.95 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.189 1 C-N-CA 133.732 4.813 . . . . 0.0 107.381 -171.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -102.09 135.65 43.31 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 167.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -127.59 127.26 43.57 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 123.306 1.527 . . . . 0.0 110.935 171.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -77.34 129.22 35.54 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.445 171.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.2 mt -137.18 139.35 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 127.406 2.282 . . . . 0.0 105.613 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 44.94 99.47 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.865 2.466 . . . . 0.0 116.529 -169.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -66.91 163.05 20.45 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.154 -0.966 . . . . 0.0 110.983 168.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.4 mt -52.18 117.63 2.94 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.103 0.561 . . . . 0.0 111.583 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.475 0.776 0 C-N-CA 125.326 1.451 . . . . 0.0 111.733 -174.916 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 121.221 0.534 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.1 t -109.35 -152.07 0.48 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.604 1.162 . . . . 0.0 109.028 168.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -147.17 151.13 23.45 Favored Glycine 0 N--CA 1.471 1.005 0 O-C-N 120.632 -1.293 . . . . 0.0 114.042 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.53 150.6 21.51 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.254 1.422 . . . . 0.0 111.874 172.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.61 -61.91 1.62 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.288 1.435 . . . . 0.0 112.246 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.3 136.41 51.81 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.021 0.528 . . . . 0.0 111.001 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.324 0.0 OUTLIER -70.35 -38.19 8.11 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-O 116.248 -1.834 . . . . 0.0 113.909 -176.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.51 141.71 81.6 Favored 'Trans proline' 0 C--N 1.355 0.888 0 CA-C-N 122.439 1.907 . . . . 0.0 110.844 169.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -170.83 1.72 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.223 1.009 . . . . 0.0 113.127 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -112.8 30.11 7.68 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 -169.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . 0.285 0.2 OUTLIER -70.33 -29.4 66.09 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 118.526 2.788 . . . . 0.0 118.526 -168.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 mp -66.14 -30.91 71.49 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 123.787 2.994 . . . . 0.0 112.995 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -59.95 -41.76 92.58 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.11 -0.994 . . . . 0.0 110.73 171.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.04 -49.4 72.49 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.024 -0.988 . . . . 0.0 111.379 174.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 m -58.8 -32.88 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 119.701 1.137 . . . . 0.0 112.168 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.0 t -78.02 -40.8 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 117.161 -1.399 . . . . 0.0 112.566 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -56.83 -45.23 82.46 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 121.663 2.029 . . . . 0.0 110.238 171.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.9 t -59.45 -32.37 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.31 -35.32 47.93 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.731 -1.231 . . . . 0.0 113.792 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.1 mm -93.03 -30.85 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 119.721 1.146 . . . . 0.0 113.25 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 78.4 m -79.74 52.27 1.43 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.396 1.478 . . . . 0.0 112.016 -172.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.7 mt -49.86 -41.19 44.73 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.123 2.169 . . . . 0.0 112.207 -169.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.44 -23.63 70.1 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.258 0.932 . . . . 0.0 114.534 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.43 -34.66 8.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.165 0.982 . . . . 0.0 111.531 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.65 -45.97 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 118.976 0.807 . . . . 0.0 110.095 170.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.83 26.04 10.09 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.809 1.195 . . . . 0.0 115.254 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -57.82 125.3 22.42 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.265 1.532 . . . . 0.0 112.268 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -93.02 -158.56 0.61 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.769 1.228 . . . . 0.0 112.139 172.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -90.55 0.33 57.39 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -173.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.9 -127.4 2.28 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 120.586 1.539 . . . . 0.0 111.396 -175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.2 t -114.6 140.72 48.56 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.572 1.549 . . . . 0.0 108.925 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -122.89 134.2 54.38 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 117.32 -1.324 . . . . 0.0 109.887 -168.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -129.91 113.85 15.14 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.49 98.8 9.11 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 170.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 80.4 t -83.69 116.21 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -110.33 108.03 17.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.161 -168.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.2 t -101.74 129.89 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.6 t -161.47 151.43 17.04 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -106.67 -13.5 15.27 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -169.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -137.12 -169.8 2.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.827 1.251 . . . . 0.0 110.553 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.67 -170.71 0.57 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.075 0.95 . . . . 0.0 112.745 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -139.21 149.8 44.8 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.266 1.426 . . . . 0.0 112.546 -172.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -84.68 91.81 8.03 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.031 1.332 . . . . 0.0 113.332 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.24 163.02 4.07 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 120.493 -1.379 . . . . 0.0 112.432 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -46.71 135.1 9.18 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.619 -0.676 . . . . 0.0 111.504 170.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm 97.5 -12.48 0.07 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 130.179 3.391 . . . . 0.0 112.142 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -76.8 -20.09 56.82 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.607 -1.308 . . . . 0.0 113.737 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -71.72 -1.67 14.7 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 120.023 1.283 . . . . 0.0 114.344 170.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -58.41 -36.27 73.34 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.413 1.006 . . . . 0.0 111.453 169.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.6 mt -63.94 -36.27 83.39 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.462 0.705 . . . . 0.0 112.437 173.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -82.39 13.93 37.59 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.778 1.656 . . . . 0.0 114.068 172.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.322 11.6 t 53.04 48.15 22.99 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 128.031 2.532 . . . . 0.0 113.442 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -127.43 113.66 16.48 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.728 1.211 . . . . 0.0 111.41 172.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -94.78 -30.29 14.32 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.304 1.441 . . . . 0.0 113.139 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -60.35 120.32 9.63 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.347 0.659 . . . . 0.0 110.809 -172.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.5 t -61.47 155.95 20.59 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.827 0.739 . . . . 0.0 110.599 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.405 ' HG ' ' NE2' ' A' ' 151' ' ' GLN . 8.6 t -65.01 143.19 58.12 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.655 0.74 . . . . 0.0 112.182 174.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -79.57 -29.27 41.24 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.243 1.017 . . . . 0.0 112.32 -177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.35 18.79 70.56 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.089 0.852 . . . . 0.0 113.044 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -106.88 164.51 12.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.085 1.754 . . . . 0.0 113.386 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 6.3 t -72.05 125.65 27.78 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.142 1.377 . . . . 0.0 109.639 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -134.75 41.17 2.9 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.8 1.64 . . . . 0.0 111.448 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.37 124.42 47.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.287 2.235 . . . . 0.0 109.315 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . 0.257 15.3 p-10 -115.71 -96.72 0.46 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.397 1.079 . . . . 0.0 112.608 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.25 30.25 0.28 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 121.016 1.734 . . . . 0.0 113.679 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.57 -9.32 66.64 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.915 1.721 . . . . 0.0 114.142 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 20.5 ptp -97.02 151.67 19.49 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.597 1.698 . . . . 0.0 113.034 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -84.6 80.58 9.19 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.912 0.885 . . . . 0.0 109.735 169.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.3 ttm-85 -58.63 -32.94 69.51 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 38.9 m -64.87 -8.34 14.99 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -52.94 -29.13 26.9 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 120.649 1.568 . . . . 0.0 114.109 173.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.46 1.4 87.31 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 117.99 -1.45 . . . . 0.0 115.09 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.379 0.7 OUTLIER -121.41 -79.17 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 115.89 -2.005 . . . . 0.0 112.82 178.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.89 154.35 67.14 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 CA-C-N 124.463 2.63 . . . . 0.0 115.65 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -62.02 169.41 2.68 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 129.829 3.252 . . . . 0.0 112.912 170.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -62.83 159.74 15.97 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.489 -0.757 . . . . 0.0 111.812 169.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.405 ' NE2' ' HG ' ' A' ' 131' ' ' SER . 2.5 mt-30 -81.34 140.03 35.01 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.4 -0.812 . . . . 0.0 111.271 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.3 p -80.6 151.48 29.05 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.312 1.045 . . . . 0.0 111.253 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 45.1 t -53.13 -39.09 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -168.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.42 -18.69 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 O-C-N 121.496 -0.753 . . . . 0.0 112.534 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -67.11 -36.31 81.65 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.739 1.154 . . . . 0.0 110.412 170.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -59.05 -58.59 7.98 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 168.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.16 -43.79 78.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.102 0.961 . . . . 0.0 112.976 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.8 m -58.08 -56.13 25.98 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.058 0.943 . . . . 0.0 112.371 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.292 10.6 mptt -86.84 -20.44 27.49 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -174.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.4 mp -67.46 -31.13 71.09 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.382 1.446 . . . . 0.0 109.954 168.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.63 -33.78 58.34 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.657 1.183 . . . . 0.0 114.103 172.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.5 -51.47 59.78 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.4 1.08 . . . . 0.0 110.111 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -77.91 -12.69 60.0 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.69 0.796 . . . . 0.0 111.927 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.79 47.04 18.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.563 2.345 . . . . 0.0 111.991 176.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 28.9 mm -85.43 136.98 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.861 1.264 . . . . 0.0 108.421 174.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -93.82 108.57 35.72 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 120.759 1.618 . . . . 0.0 107.859 168.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.0 138.46 25.69 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.412 3.408 . . . . 0.0 113.24 171.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.5 mm -129.31 101.93 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.987 1.315 . . . . 0.0 110.115 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -72.39 72.58 0.96 Allowed 'General case' 0 N--CA 1.476 0.832 0 O-C-N 120.636 -1.29 . . . . 0.0 112.564 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.5 p -69.73 106.36 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 O-C-N 120.78 -1.2 . . . . 0.0 113.029 170.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 31.8 m -145.41 147.07 32.29 Favored Pre-proline 0 N--CA 1.482 1.167 0 O-C-N 120.354 -1.466 . . . . 0.0 113.293 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -59.52 155.67 40.65 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 124.855 3.704 . . . . 0.0 114.849 172.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.9 t -41.62 -60.57 1.29 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.447 2.299 . . . . 0.0 114.94 -169.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -64.04 -12.5 39.11 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -171.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 66.8 mmm -99.25 -7.47 26.38 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.6 t -57.34 -36.62 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 120.272 1.396 . . . . 0.0 111.66 -169.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -69.92 -28.31 65.49 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.01 -34.83 24.23 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 118.926 0.785 . . . . 0.0 111.309 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -72.42 -30.72 64.88 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.565 -1.334 . . . . 0.0 110.325 170.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -71.26 -11.79 61.11 Favored 'General case' 0 CA--C 1.553 1.092 0 O-C-N 121.584 -0.697 . . . . 0.0 111.376 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -84.33 -47.11 11.07 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.039 -1.663 . . . . 0.0 109.969 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.81 -21.14 59.47 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 119.966 -1.709 . . . . 0.0 111.051 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.84 -16.7 61.59 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.726 0.81 . . . . 0.0 111.961 171.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.55 -25.57 28.62 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 119.487 -0.292 . . . . 0.0 110.969 170.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -87.99 -18.48 28.93 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 56.9 mt -118.35 96.48 49.85 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.285 1.034 . . . . 0.0 108.837 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -55.42 141.76 81.52 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.688 2.926 . . . . 0.0 114.439 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . 0.325 0.0 OUTLIER 81.55 -15.51 0.71 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 128.618 2.767 . . . . 0.0 113.093 171.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.5 tt -56.76 148.01 21.54 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 127.003 2.121 . . . . 0.0 108.689 169.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 77.2 p -121.41 -150.76 0.46 Allowed 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 120.784 1.629 . . . . 0.0 109.651 170.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -179.34 117.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 119.51 -1.994 . . . . 0.0 109.154 -167.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -110.6 152.68 17.36 Favored Glycine 0 N--CA 1.469 0.875 0 C-N-CA 124.83 1.205 . . . . 0.0 112.242 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -93.8 85.69 4.89 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.866 1.266 . . . . 0.0 109.175 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 47.8 tp . . . . . 0 N--CA 1.471 0.615 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.977 169.656 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.9 p . . . . . 0 CA--C 1.545 0.77 0 CA-C-O 121.621 0.724 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 t -115.91 145.67 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.947 1.699 . . . . 0.0 106.646 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.3 14.9 p-10 -136.99 111.99 8.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.736 0.779 . . . . 0.0 110.35 171.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.2 tp -96.24 134.35 39.45 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.511 1.124 . . . . 0.0 112.653 -175.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -118.68 103.16 9.42 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 123.204 1.478 . . . . 0.0 109.388 168.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -82.43 93.87 7.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.056 1.742 . . . . 0.0 111.534 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 30.5 tp -92.1 125.53 36.83 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.377 1.071 . . . . 0.0 109.619 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.466 ' CE ' ' CZ ' ' A' ' 45' ' ' PHE 0.306 0.0 OUTLIER -134.24 165.62 24.69 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 172.276 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.46 140.26 15.57 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.677 1.132 . . . . 0.0 112.343 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.59 22.63 13.43 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.15 1.78 . . . . 0.0 112.212 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 CA--C 1.539 0.528 0 O-C-N 120.586 -1.321 . . . . 0.0 110.91 169.215 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 121.289 0.566 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.42 83.69 0.24 Allowed Glycine 0 C--N 1.337 0.625 0 C-N-CA 126.776 2.132 . . . . 0.0 107.929 -169.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -77.25 151.36 35.15 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.28 138.02 53.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 117.754 0.252 . . . . 0.0 111.17 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -135.14 163.77 24.83 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 126.891 2.186 . . . . 0.0 110.9 171.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.466 ' CZ ' ' CE ' ' A' ' 10' ' ' MET . 86.1 t80 -135.5 145.27 46.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.995 0.918 . . . . 0.0 111.831 -169.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.35 147.2 18.47 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 122.568 0.128 . . . . 0.0 112.887 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.6 m -118.7 142.74 47.39 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.503 1.121 . . . . 0.0 112.036 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.79 157.12 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.726 1.21 . . . . 0.0 110.411 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 p -157.83 -52.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 124.405 1.082 . . . . 0.0 109.994 169.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 161.48 -22.9 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 131.302 3.841 . . . . 0.0 110.525 169.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -52.77 -39.93 62.69 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.642 0.777 . . . . 0.0 111.462 170.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.1 p -170.43 168.9 7.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 129.744 3.218 . . . . 0.0 110.723 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -113.11 123.65 50.76 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 101.003 -3.703 . . . . 0.0 101.003 165.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -122.03 114.04 20.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -174.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -81.64 114.63 20.45 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.637 169.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.3 mt -139.44 95.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . 0.262 2.6 tm? 107.43 94.17 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 130.703 3.601 . . . . 0.0 109.139 174.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -52.66 159.42 1.08 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.592 1.557 . . . . 0.0 112.741 170.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.7 mt -53.64 120.47 6.23 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 172.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.475 0.82 0 C-N-CA 124.511 1.124 . . . . 0.0 112.539 -172.625 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -120.24 -160.02 0.81 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.285 1.834 . . . . 0.0 111.146 169.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -156.19 155.71 26.52 Favored Glycine 0 N--CA 1.472 1.076 0 O-C-N 120.507 -1.371 . . . . 0.0 113.957 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -152.32 151.96 31.52 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.645 1.178 . . . . 0.0 112.767 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -55.68 -58.99 5.5 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.088 2.155 . . . . 0.0 112.343 174.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.72 143.98 37.63 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.266 15.1 t -70.15 -41.75 15.1 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 115.563 -2.16 . . . . 0.0 114.443 174.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.74 142.87 84.86 Favored 'Trans proline' 0 C--N 1.356 0.972 0 CA-C-N 123.421 2.257 . . . . 0.0 112.319 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -112.78 154.58 26.0 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.912 1.285 . . . . 0.0 113.43 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.04 55.76 4.79 Favored Glycine 0 N--CA 1.479 1.51 0 C-N-CA 125.664 1.602 . . . . 0.0 112.586 -172.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -83.07 -33.82 26.33 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.458 1.903 . . . . 0.0 115.689 -168.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.9 -37.95 79.31 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -171.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -51.46 -46.82 63.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.224 1.01 . . . . 0.0 111.601 169.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.48 -53.63 49.1 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.132 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.25 32.9 m -64.25 -27.41 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 119.476 1.035 . . . . 0.0 112.621 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.496 HG23 HE22 ' A' ' 155' ' ' GLN . 76.7 t -64.04 -63.01 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 119.427 1.012 . . . . 0.0 108.564 168.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -58.43 -42.78 88.04 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.171 0.896 . . . . 0.0 111.174 -173.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.0 t -55.76 -35.4 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.08 0.855 . . . . 0.0 112.428 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.71 -37.14 65.26 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.818 -1.176 . . . . 0.0 113.486 175.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.413 ' HB ' ' SG ' ' A' ' 135' ' ' CYS . 7.9 mm -93.56 -15.8 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.858 0.863 . . . . 0.0 113.017 -172.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.406 ' SG ' ' SG ' ' A' ' 135' ' ' CYS . 1.5 m -79.52 49.01 0.96 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.763 2.025 . . . . 0.0 112.58 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -49.95 -40.1 42.65 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.778 -1.201 . . . . 0.0 112.048 -175.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.71 -19.23 54.8 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -91.89 -45.52 8.33 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.917 1.359 . . . . 0.0 110.815 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.5 mm -65.85 -44.35 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.297 0.639 . . . . 0.0 109.351 175.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.33 21.9 21.0 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.998 1.285 . . . . 0.0 114.083 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -49.03 128.36 16.0 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.818 1.247 . . . . 0.0 112.087 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . 0.336 0.6 OUTLIER -113.93 -173.65 2.32 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 175.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -67.65 -2.91 7.61 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 118.792 2.886 . . . . 0.0 118.792 -168.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.29 -125.29 2.63 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 121.091 1.769 . . . . 0.0 112.268 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.4 m -111.83 115.3 28.8 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.145 1.778 . . . . 0.0 107.802 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 -99.54 128.81 45.66 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -168.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -127.19 104.25 7.86 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -168.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.97 89.38 6.05 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.187 -0.946 . . . . 0.0 111.004 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.5 t -72.29 132.57 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 tp -112.62 127.07 56.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.32 124.11 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 123.959 0.787 . . . . 0.0 110.54 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -150.14 164.66 35.05 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.613 0.765 . . . . 0.0 111.465 171.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.46 2.95 6.94 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.721 1.608 . . . . 0.0 114.765 174.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -123.12 173.13 8.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.435 1.094 . . . . 0.0 112.036 171.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -69.98 -169.14 0.24 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.752 0.821 . . . . 0.0 111.542 169.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -142.07 158.71 43.44 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.107 -0.996 . . . . 0.0 112.983 -169.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -84.29 123.84 30.59 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.172 169.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.53 HD23 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -86.43 -177.54 6.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.157 0.983 . . . . 0.0 109.47 170.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.53 ' H ' HD23 ' A' ' 118' ' ' LEU . . . -57.67 163.64 2.42 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.359 -0.838 . . . . 0.0 111.467 169.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.408 0.0 OUTLIER 55.11 -3.68 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.775 2.03 . . . . 0.0 116.162 -169.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -75.16 -28.62 60.18 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 121.313 1.87 . . . . 0.0 113.757 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -73.54 1.88 9.06 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 121.035 1.743 . . . . 0.0 113.424 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.7 t -59.83 -25.36 64.94 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.468 1.031 . . . . 0.0 111.501 169.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.4 mt -61.62 -21.16 64.13 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.405 1.882 . . . . 0.0 113.366 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -91.96 -108.34 1.64 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 169.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.277 7.1 t -152.55 40.3 0.58 Allowed 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 123.429 1.585 . . . . 0.0 111.041 169.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.02 89.64 5.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.942 1.697 . . . . 0.0 109.483 -175.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -86.07 -42.0 14.3 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.746 -0.596 . . . . 0.0 111.333 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -65.67 134.99 54.4 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.246 0.619 . . . . 0.0 109.967 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.3 p -97.19 147.22 24.31 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.548 1.139 . . . . 0.0 109.436 169.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.7 m -58.24 141.85 49.5 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.5 p30 -72.51 -11.38 60.64 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.467 1.507 . . . . 0.0 113.75 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.5 10.07 86.47 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.639 1.114 . . . . 0.0 113.329 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -84.61 176.56 8.52 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.961 1.38 . . . . 0.0 110.276 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . 0.413 ' SG ' ' HB ' ' A' ' 94' ' ' ILE . 0.6 OUTLIER -100.88 144.69 29.52 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 172.301 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -133.8 38.16 3.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.643 1.977 . . . . 0.0 110.868 -170.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 pp -62.53 160.19 14.29 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.112 1.765 . . . . 0.0 111.807 171.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -157.73 -101.46 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.72 1.208 . . . . 0.0 110.298 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.27 35.93 0.82 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.606 1.962 . . . . 0.0 113.062 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.1 18.35 55.96 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.744 1.164 . . . . 0.0 114.476 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.5 ptp -149.01 156.2 41.91 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.962 1.381 . . . . 0.0 113.905 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -68.94 104.37 2.06 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.552 1.141 . . . . 0.0 111.844 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -65.63 -42.05 91.97 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.344 0.658 . . . . 0.0 111.04 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.9 m -74.56 -3.36 30.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -172.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -44.56 -29.65 0.76 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.8 3.64 57.47 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.574 2.035 . . . . 0.0 115.962 -174.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.421 2.3 pt-20 -131.58 -49.58 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.106 0 CA-C-N 120.755 2.277 . . . . 0.0 114.68 170.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -80.02 151.08 20.97 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 CA-C-N 122.479 1.921 . . . . 0.0 113.736 167.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -75.46 165.54 24.96 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 129.155 2.982 . . . . 0.0 112.233 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -57.98 152.93 15.34 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.091 -1.006 . . . . 0.0 109.24 168.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . 0.334 3.0 mm-40 -106.46 165.42 11.29 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.4 p -73.61 161.82 29.9 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -168.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 t -61.96 -28.93 45.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.524 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.8 t -73.49 -42.56 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.265 1.026 . . . . 0.0 111.083 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.496 HE22 HG23 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -64.83 -38.03 89.62 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.489 0.586 . . . . 0.0 110.474 178.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 87.8 mt -57.19 -60.76 3.14 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.028 0.531 . . . . 0.0 110.261 170.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.83 -45.8 85.66 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -172.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.5 m -64.98 -49.59 69.67 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.839 -0.538 . . . . 0.0 112.306 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -74.66 -27.83 60.59 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.067 -1.021 . . . . 0.0 112.384 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 14.8 tp -61.12 -44.47 97.29 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.773 -1.205 . . . . 0.0 111.89 170.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.79 -24.65 61.78 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.04 0.936 . . . . 0.0 113.509 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -72.75 -44.21 61.92 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.098 1.359 . . . . 0.0 110.297 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -80.3 -18.88 47.99 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 56.2 63.74 1.91 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.763 1.625 . . . . 0.0 111.317 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 87.1 mt -113.88 137.66 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.677 1.591 . . . . 0.0 109.274 175.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -91.25 120.71 68.38 Favored Pre-proline 0 N--CA 1.475 0.784 0 CA-C-O 116.703 -1.617 . . . . 0.0 110.488 170.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -88.13 148.66 6.75 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.622 2.881 . . . . 0.0 110.477 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.83 99.17 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -76.48 69.87 2.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 122.285 1.04 . . . . 0.0 111.895 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.49 102.55 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 C-N-CA 126.315 1.846 . . . . 0.0 110.993 169.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.51 147.96 26.93 Favored Pre-proline 0 N--CA 1.481 1.123 0 O-C-N 120.265 -1.522 . . . . 0.0 113.56 -170.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -62.39 148.45 93.26 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 125.199 3.933 . . . . 0.0 115.048 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.5 t -55.16 -28.93 56.41 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -169.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -47.25 -37.12 9.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.989 1.316 . . . . 0.0 113.793 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . 0.257 0.0 OUTLIER -126.64 5.92 6.79 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.064 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.9 t -53.39 -33.63 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 120.331 -1.481 . . . . 0.0 110.969 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -21.68 66.42 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -175.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.2 t -90.81 -38.73 12.79 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.347 0.659 . . . . 0.0 110.534 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -66.66 -36.74 83.26 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.024 1.33 . . . . 0.0 111.228 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -60.0 -19.88 54.78 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.375 1.07 . . . . 0.0 111.56 168.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -110.15 6.41 22.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.843 1.257 . . . . 0.0 113.248 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 62.0 mt -95.4 -25.97 16.05 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 167.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.3 t -77.62 -14.62 59.59 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.18 1.392 . . . . 0.0 112.759 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 3.6 t -84.98 -17.56 37.24 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.712 -0.617 . . . . 0.0 110.965 169.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -92.57 -23.66 18.98 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 118.083 0.401 . . . . 0.0 112.077 169.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 50.9 mt -118.12 91.78 40.97 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 124.38 1.072 . . . . 0.0 109.39 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.54 132.61 52.86 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.778 2.318 . . . . 0.0 112.657 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.5 tttm 105.77 -18.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 130.281 3.432 . . . . 0.0 115.271 169.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . 0.396 0.0 OUTLIER -75.27 164.35 26.54 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 120.568 1.531 . . . . 0.0 112.2 176.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 37.7 p -129.13 176.41 7.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -155.06 127.87 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 128.333 2.653 . . . . 0.0 108.84 -168.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.61 154.29 16.89 Favored Glycine 0 N--CA 1.47 0.965 0 C-N-CA 124.563 1.078 . . . . 0.0 111.518 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -94.89 85.82 4.5 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.125 0.964 . . . . 0.0 109.213 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 168.381 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.9 p . . . . . 0 CA--C 1.547 0.841 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.2 t -137.76 137.28 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.228 1.811 . . . . 0.0 109.297 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -110.71 115.55 29.76 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 168.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -103.32 116.21 32.02 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.065 0.46 . . . . 0.0 110.163 169.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -105.72 103.04 12.46 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 123.919 1.819 . . . . 0.0 109.903 170.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -83.42 114.27 21.34 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 112.515 -2.13 . . . . 0.0 112.044 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 tt -114.42 124.12 51.15 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.795 0.838 . . . . 0.0 111.714 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.3 mtp -104.2 138.37 40.77 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.58 114.5 3.94 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.488 1.518 . . . . 0.0 109.66 169.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.8 mp -106.96 24.12 13.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.288 2.635 . . . . 0.0 112.705 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 p . . . . . 0 CA--C 1.543 0.686 0 O-C-N 120.297 -1.502 . . . . 0.0 113.078 171.723 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.9 p . . . . . 0 CA--C 1.552 1.025 0 CA-C-O 122.483 1.135 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.6 83.52 0.36 Allowed Glycine 0 C--N 1.345 1.035 0 C-N-CA 128.97 3.176 . . . . 0.0 108.866 -171.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -80.78 137.55 36.24 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.692 1.597 . . . . 0.0 108.433 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.33 138.25 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.613 0.765 . . . . 0.0 109.445 -173.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.86 159.2 23.85 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 125.57 1.557 . . . . 0.0 111.739 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -140.56 128.46 21.91 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -169.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -131.92 151.71 19.91 Favored Glycine 0 C--N 1.342 0.868 0 C-N-CA 124.973 1.273 . . . . 0.0 113.493 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.4 t -116.57 140.5 49.31 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.531 1.933 . . . . 0.0 111.071 173.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.17 147.23 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.173 0.989 . . . . 0.0 110.944 169.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -132.83 -60.26 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 118.314 0.506 . . . . 0.0 109.811 167.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 161.78 -34.64 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 1 C-N-CA 131.72 4.008 . . . . 0.0 107.525 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.1 mtt -46.12 -51.68 13.5 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.668 1.587 . . . . 0.0 110.806 169.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.9 p -165.75 178.76 6.38 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 128.067 2.547 . . . . 0.0 110.37 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -111.13 125.08 53.4 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 102.179 -3.267 . . . . 0.0 102.179 165.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -121.01 122.37 39.96 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.991 0.9 . . . . 0.0 110.481 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 46.8 t60 -76.68 126.97 31.9 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.724 168.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.35 -51.86 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 121.703 -0.623 . . . . 0.0 110.896 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.3 tp -129.96 121.0 25.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.719 0.808 . . . . 0.0 111.13 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.89 149.34 36.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.078 0.951 . . . . 0.0 111.707 170.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.3 mt -49.51 112.79 0.7 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.367 1.067 . . . . 0.0 110.795 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.475 0.814 0 C-N-CA 124.576 1.15 . . . . 0.0 112.386 -174.17 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.941 0.401 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.5 p -100.45 -124.88 0.17 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.608 1.563 . . . . 0.0 111.606 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.51 144.54 6.42 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.592 1.092 . . . . 0.0 114.261 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -156.37 153.67 29.31 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.286 1.435 . . . . 0.0 112.221 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.73 -50.19 65.71 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.916 1.686 . . . . 0.0 113.41 -176.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.84 137.7 42.02 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.882 0.873 . . . . 0.0 111.715 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 t -70.24 -30.87 2.05 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-O 115.725 -2.084 . . . . 0.0 115.056 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.95 141.22 26.51 Favored 'Trans proline' 0 C--N 1.358 1.055 0 CA-C-N 123.027 2.117 . . . . 0.0 112.145 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -97.46 158.53 15.43 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.71 1.204 . . . . 0.0 110.803 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.22 28.85 2.89 Favored Glycine 0 N--CA 1.48 1.599 0 O-C-N 120.653 -1.28 . . . . 0.0 114.623 174.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.24 -40.36 70.79 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.244 1.817 . . . . 0.0 111.194 -172.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.08 -25.32 68.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 117.572 -1.204 . . . . 0.0 113.095 -174.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -78.32 -31.27 48.66 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.033 1.288 . . . . 0.0 113.011 171.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.15 -45.89 75.7 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.711 -1.243 . . . . 0.0 111.574 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.71 -29.89 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.61 -60.35 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.125 0.97 . . . . 0.0 109.952 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -67.22 -38.05 84.63 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.698 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.11 -37.41 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 119.606 1.094 . . . . 0.0 112.114 173.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.97 -44.74 65.38 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.636 1.107 . . . . 0.0 113.756 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.3 mt -91.74 -20.22 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 74.4 m -79.74 51.34 1.28 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.404 -1.435 . . . . 0.0 111.407 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -49.47 -42.64 43.8 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.924 1.69 . . . . 0.0 111.177 -174.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -74.66 -22.62 76.88 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.346 0.974 . . . . 0.0 114.39 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -105.69 -34.65 7.65 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.37 1.085 . . . . 0.0 112.594 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.8 mm -70.25 -38.23 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.959 0.8 . . . . 0.0 110.446 169.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.64 27.37 9.78 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.39 1.472 . . . . 0.0 114.591 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -59.93 116.57 4.23 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.959 1.38 . . . . 0.0 112.651 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -90.65 173.96 7.76 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.243 2.617 . . . . 0.0 110.352 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -87.52 20.16 3.03 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -170.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.36 -119.56 0.96 Allowed Glycine 0 C--N 1.346 1.124 0 C-N-CA 124.528 1.061 . . . . 0.0 111.043 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.9 m -116.33 130.46 56.78 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.612 1.565 . . . . 0.0 107.051 170.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.46 132.95 53.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -171.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.36 111.01 9.24 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -167.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -105.85 98.04 7.78 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.082 0.953 . . . . 0.0 109.711 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.3 t -101.81 118.67 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 mp -111.37 131.92 54.82 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 124.245 0.966 . . . . 0.0 109.168 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.1 t -116.53 129.63 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 O-C-N 125.531 1.77 . . . . 0.0 111.159 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 t -152.43 -171.45 3.93 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.347 1.03 . . . . 0.0 109.515 169.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -140.43 2.86 1.88 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.68 -156.43 0.61 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.017 0.927 . . . . 0.0 110.845 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.91 166.53 0.98 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.816 2.046 . . . . 0.0 114.375 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -130.27 146.69 51.9 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.426 1.491 . . . . 0.0 110.507 170.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -76.94 141.77 40.33 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.007 0.432 . . . . 0.0 111.592 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.543 HD21 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -111.74 173.3 6.42 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.625 1.97 . . . . 0.0 109.533 177.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.543 ' H ' HD21 ' A' ' 118' ' ' LEU . . . -48.7 142.59 5.99 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.117 -0.989 . . . . 0.0 111.519 169.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.0 mttm 83.27 -16.52 0.56 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 129.511 3.124 . . . . 0.0 112.875 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.05 -32.08 73.62 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.239 1.381 . . . . 0.0 113.05 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -78.23 6.33 8.41 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.9 t -60.21 -31.19 69.93 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.022 1.283 . . . . 0.0 112.507 170.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.64 -19.26 61.47 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -85.53 15.2 47.55 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.494 1.521 . . . . 0.0 111.916 169.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.348 13.9 t 44.37 54.54 6.18 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 128.869 2.868 . . . . 0.0 112.504 -170.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.1 ttp180 -126.68 106.38 9.35 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.559 1.544 . . . . 0.0 109.907 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -112.66 -25.52 9.07 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -169.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -75.17 129.49 37.6 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.53 1.514 . . . . 0.0 110.829 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.6 t -68.31 167.61 14.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.925 1.29 . . . . 0.0 111.545 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.3 m -66.16 135.72 54.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.579 0.752 . . . . 0.0 112.495 172.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -83.15 -17.72 41.93 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.027 -1.046 . . . . 0.0 113.488 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.91 18.19 77.35 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.304 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.8 mtp-105 -94.49 169.85 9.91 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.842 1.257 . . . . 0.0 112.588 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.21 137.59 43.18 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.409 1.084 . . . . 0.0 110.45 169.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -145.94 44.91 1.26 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.505 1.522 . . . . 0.0 112.237 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.1 tt -118.72 132.23 56.15 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.076 0.95 . . . . 0.0 110.58 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -118.77 -75.61 0.58 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.649 1.179 . . . . 0.0 111.239 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -97.98 28.22 4.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.826 2.05 . . . . 0.0 112.792 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.51 -18.06 58.12 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.627 1.584 . . . . 0.0 113.227 -174.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 14.9 mmt -89.45 143.11 27.08 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.743 1.217 . . . . 0.0 112.495 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -71.94 91.22 1.18 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 168.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -55.92 -43.15 77.07 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.548 1.139 . . . . 0.0 112.304 -171.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.4 p -81.28 7.07 12.31 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -15.42 0.35 Allowed 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 171.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -103.2 -8.64 40.98 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.909 1.719 . . . . 0.0 115.26 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -114.53 -61.95 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 119.876 1.838 . . . . 0.0 111.84 -172.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -77.4 145.66 24.0 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.86 2.373 . . . . 0.0 113.199 168.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -66.28 171.11 5.08 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.305 2.642 . . . . 0.0 111.565 169.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -60.61 156.19 17.14 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 174.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -65.6 163.24 16.61 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.4 p -93.85 152.93 18.54 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 168.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.78 -30.6 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 O-C-N 120.621 -1.299 . . . . 0.0 111.231 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.62 -42.69 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.987 0.915 . . . . 0.0 111.061 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -73.47 -26.65 61.01 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.899 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.4 mt -63.74 -54.37 36.5 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 168.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.75 82.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.064 1.346 . . . . 0.0 113.124 -172.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 75.7 m -63.95 -51.15 65.73 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.945 0.498 . . . . 0.0 112.009 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -62.7 -38.66 91.29 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.273 -0.892 . . . . 0.0 112.162 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.8 tp -60.26 -40.33 89.95 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.353 1.061 . . . . 0.0 112.647 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.66 -24.85 63.68 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.098 0.959 . . . . 0.0 113.311 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -75.92 -44.07 42.0 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.184 0.993 . . . . 0.0 110.819 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -78.67 -16.35 57.4 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 60.8 33.26 20.11 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.987 2.115 . . . . 0.0 113.024 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.2 mt -85.59 144.24 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.122 1.369 . . . . 0.0 109.101 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -104.69 106.24 53.93 Favored Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 120.714 1.597 . . . . 0.0 113.791 171.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -75.13 137.62 21.68 Favored 'Trans proline' 0 CA--C 1.537 0.636 1 C-N-CA 125.342 4.028 . . . . 0.0 115.231 169.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.5 mt -130.98 113.44 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -75.62 79.54 2.61 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.893 0.854 . . . . 0.0 111.682 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 39.6 t -66.52 104.51 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-O 122.554 1.169 . . . . 0.0 112.151 169.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 33.3 m -142.32 164.51 32.88 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 120.321 -1.487 . . . . 0.0 110.776 -169.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -85.21 165.74 11.08 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.825 2.35 . . . . 0.0 111.81 -169.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.3 t -50.41 -38.84 45.09 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.772 1.229 . . . . 0.0 113.09 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -63.08 -21.28 66.06 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 3.5 tpt -128.23 5.74 5.83 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -170.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 89.4 t -59.43 -35.96 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 120.015 1.28 . . . . 0.0 111.537 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.27 -0.64 50.51 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -169.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 t -92.82 -36.54 12.8 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.796 0.808 . . . . 0.0 109.46 168.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -74.89 -33.94 62.13 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 124.172 0.989 . . . . 0.0 110.342 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -70.88 -15.0 62.59 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 119.293 0.951 . . . . 0.0 111.96 169.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -84.85 -28.25 26.17 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 120.32 -1.487 . . . . 0.0 111.249 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 43.3 tp -77.27 -27.16 53.06 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.314 2.246 . . . . 0.0 110.074 174.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.48 -7.97 58.02 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.11 1.764 . . . . 0.0 112.531 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 6.7 t -105.79 -15.82 14.84 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.239 0.616 . . . . 0.0 110.685 168.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -80.83 -37.37 30.17 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.313 0.506 . . . . 0.0 111.009 169.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 25.3 mt -104.13 114.9 63.97 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 124.325 1.05 . . . . 0.0 108.779 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.15 140.59 37.82 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.667 2.245 . . . . 0.0 112.432 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 47.2 tptt 82.82 -8.35 1.18 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 129.438 3.095 . . . . 0.0 113.811 170.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.5 mt -67.81 166.14 16.05 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.57 0.748 . . . . 0.0 111.883 170.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.6 p -138.59 -145.51 0.19 Allowed 'General case' 0 C--N 1.344 0.352 0 CA-C-O 122.905 1.336 . . . . 0.0 108.603 168.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.3 pt -157.02 156.86 4.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 128.798 2.839 . . . . 0.0 109.419 -167.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -134.04 153.24 20.84 Favored Glycine 0 N--CA 1.465 0.631 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 169.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -100.63 93.68 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 CA--C 1.541 0.608 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.77 169.484 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.27 127.52 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.969 1.308 . . . . 0.0 108.79 169.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -109.87 116.21 31.24 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -110.37 129.22 55.8 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.671 0.748 . . . . 0.0 111.747 173.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -110.59 113.56 26.27 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 123.418 1.58 . . . . 0.0 109.492 169.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -91.15 104.6 17.15 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 126.482 1.913 . . . . 0.0 112.222 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 tp -101.22 116.72 33.46 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.0 0.92 . . . . 0.0 112.669 177.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 59.4 mtp -97.69 141.17 31.04 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.515 1.526 . . . . 0.0 114.047 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.97 118.43 5.38 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 168.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 mp -106.91 22.99 15.1 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.799 1.64 . . . . 0.0 113.899 -169.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.0 p . . . . . 0 N--CA 1.475 0.821 0 O-C-N 120.2 -1.563 . . . . 0.0 113.522 176.589 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t . . . . . 0 CA--C 1.547 0.86 0 CA-C-O 121.999 0.904 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.05 88.11 0.18 Allowed Glycine 0 C--N 1.338 0.67 0 C-N-CA 127.34 2.4 . . . . 0.0 108.185 -169.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -94.68 141.31 28.77 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.54 1.136 . . . . 0.0 109.315 -169.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.9 tt -124.59 137.63 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.92 151.06 17.27 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 171.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -119.52 151.74 38.1 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.236 0.614 . . . . 0.0 111.596 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.18 147.57 17.67 Favored Glycine 0 C--N 1.342 0.913 0 C-N-CA 124.005 0.812 . . . . 0.0 113.45 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.9 t -118.09 150.69 38.92 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.48 1.512 . . . . 0.0 110.95 175.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.15 148.25 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.126 1.371 . . . . 0.0 108.925 172.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.59 -77.04 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.889 0.875 . . . . 0.0 109.429 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -177.83 -23.51 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 130.695 3.598 . . . . 0.0 108.201 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.3 ttt -49.26 -49.04 45.22 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.742 1.617 . . . . 0.0 109.603 167.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 173.4 175.95 0.12 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 130.59 3.556 . . . . 0.0 110.156 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -91.37 130.8 37.17 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 104.721 -2.325 . . . . 0.0 104.721 166.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -121.68 120.33 34.39 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.653 0.781 . . . . 0.0 110.119 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -83.9 117.73 23.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.936 0.894 . . . . 0.0 110.817 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 82.4 mt -130.35 108.73 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.451 1.5 . . . . 0.0 107.0 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.5 tp 87.56 112.37 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 128.26 2.624 . . . . 0.0 111.212 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.55 158.85 30.84 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.397 1.879 . . . . 0.0 109.961 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.8 mt -52.7 112.97 0.93 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.974 1.261 . . . . 0.0 110.858 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.472 0.659 0 C-N-CA 125.267 1.427 . . . . 0.0 112.474 -171.191 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.2 t -123.08 171.29 9.4 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.381 1.872 . . . . 0.0 111.012 169.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.38 152.5 17.56 Favored Glycine 0 N--CA 1.478 1.496 0 O-C-N 120.588 -1.32 . . . . 0.0 114.907 -173.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -146.3 157.38 43.79 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.925 1.69 . . . . 0.0 113.939 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 tp -83.54 -71.76 0.49 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.458 1.503 . . . . 0.0 109.724 169.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.76 148.04 40.77 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.641 1.176 . . . . 0.0 112.589 -170.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 m -59.45 -46.85 98.87 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-O 116.61 -1.662 . . . . 0.0 113.299 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -66.25 139.51 55.31 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.758 2.306 . . . . 0.0 113.174 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.37 164.52 13.82 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.003 1.321 . . . . 0.0 113.736 175.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.518 ' CA ' ' HH ' ' A' ' 150' ' ' TYR . . . -80.6 38.44 2.3 Favored Glycine 0 N--CA 1.475 1.242 0 C-N-CA 125.249 1.404 . . . . 0.0 116.582 -169.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -63.38 -38.45 91.19 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -168.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -83.92 -10.62 57.83 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -74.12 -46.86 39.99 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.991 1.269 . . . . 0.0 108.625 168.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.69 68.88 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.698 1.599 . . . . 0.0 112.058 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.2 p -54.78 -36.41 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 118.796 -0.621 . . . . 0.0 112.239 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.96 -38.9 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 116.36 -1.781 . . . . 0.0 111.687 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -52.18 -55.3 21.91 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 121.066 1.757 . . . . 0.0 109.001 172.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 73.5 t -52.49 -31.43 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.946 1.298 . . . . 0.0 113.157 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.09 -20.24 52.62 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.78 -31.4 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -174.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.2 p -79.61 67.24 5.32 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 121.846 2.112 . . . . 0.0 112.719 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.9 tp -42.58 -41.08 2.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 128.944 2.898 . . . . 0.0 111.757 172.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.95 -22.02 75.12 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 118.383 -1.231 . . . . 0.0 114.935 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -102.06 -37.15 8.3 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.034 1.417 . . . . 0.0 112.411 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.0 mm -69.39 -39.6 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.37 22.36 29.64 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.233 1.397 . . . . 0.0 113.541 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -59.24 145.58 42.36 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.002 1.401 . . . . 0.0 110.628 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -125.48 -167.22 1.66 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.32 1.048 . . . . 0.0 111.748 171.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -74.49 9.97 1.52 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -168.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.3 -136.62 2.42 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 121.365 1.893 . . . . 0.0 110.518 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -104.03 142.02 35.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.69 1.596 . . . . 0.0 107.792 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -126.22 117.81 23.86 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -167.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -114.5 128.14 56.18 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.168 0.587 . . . . 0.0 111.91 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.3 tt -107.18 95.61 5.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 169.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.1 t -83.74 124.28 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.2 tt -122.92 125.82 46.06 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -170.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 37.3 t -116.16 134.33 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 O-C-N 124.433 1.083 . . . . 0.0 111.697 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.0 t -145.76 -172.42 3.9 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.043 169.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -145.03 5.77 1.14 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.514 1.526 . . . . 0.0 114.872 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -163.01 176.35 10.21 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.764 2.026 . . . . 0.0 109.184 169.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -61.49 -177.91 0.11 Allowed 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 -171.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -127.54 160.2 32.28 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.815 1.646 . . . . 0.0 113.794 -169.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.441 ' CE1' ' HZ2' ' A' ' 122' ' ' LYS . 62.1 m-70 -77.57 128.11 33.6 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.305 0.642 . . . . 0.0 110.836 169.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.2 mp -94.68 165.74 12.35 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.953 1.301 . . . . 0.0 110.119 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.09 146.23 39.36 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.634 -0.666 . . . . 0.0 111.171 169.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 75.05 -11.84 1.02 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 128.83 2.852 . . . . 0.0 114.268 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -66.21 -23.26 66.4 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 120.303 1.41 . . . . 0.0 112.245 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.441 ' HZ2' ' CE1' ' A' ' 117' ' ' HIS . 10.5 mmpt? -70.99 1.48 5.6 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 175.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.1 t -56.78 -32.01 65.22 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.279 1.032 . . . . 0.0 111.815 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.16 -46.99 88.27 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.345 1.058 . . . . 0.0 112.273 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -90.23 21.73 30.01 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.1 1.333 . . . . 0.0 114.03 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.317 5.6 t 56.18 39.79 30.22 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 127.8 2.44 . . . . 0.0 114.444 173.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 59.9 mtt85 -106.49 117.3 33.68 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.459 1.104 . . . . 0.0 109.121 169.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -99.58 -49.68 4.32 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -66.14 119.32 11.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.773 0.715 . . . . 0.0 111.9 -170.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.9 t -74.58 156.51 36.72 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.656 0.782 . . . . 0.0 111.91 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.2 t -62.0 141.24 58.17 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.012 0.911 . . . . 0.0 113.249 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -78.13 -9.83 59.35 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.048 1.739 . . . . 0.0 112.926 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.29 0.64 90.23 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.397 -1.224 . . . . 0.0 115.527 174.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.7 mtt85 -111.12 172.13 7.06 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.216 1.508 . . . . 0.0 112.597 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 34.8 t -75.92 143.48 41.63 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -168.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -132.99 52.74 2.06 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.771 2.028 . . . . 0.0 111.317 175.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.56 132.32 46.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.896 1.678 . . . . 0.0 109.601 -175.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -145.58 -49.35 0.23 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.216 1.007 . . . . 0.0 112.153 172.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -77.79 -8.51 58.11 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.93 -6.58 37.5 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.236 1.398 . . . . 0.0 113.706 -169.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.2 mtt -130.71 143.56 50.82 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.329 1.452 . . . . 0.0 112.657 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -70.4 89.02 0.67 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.823 1.649 . . . . 0.0 112.618 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -16.1 61.05 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -170.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.7 m -89.87 -5.54 56.73 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -28.68 14.16 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.594 1.088 . . . . 0.0 113.761 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.16 -16.87 79.09 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 117.448 -1.751 . . . . 0.0 115.501 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -128.54 -67.84 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.928 0 CA-C-N 120.307 2.053 . . . . 0.0 113.677 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -50.56 141.9 32.49 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 CA-C-N 123.509 2.289 . . . . 0.0 115.536 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -68.42 178.76 1.86 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.117 2.167 . . . . 0.0 112.73 172.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.518 ' HH ' ' CA ' ' A' ' 84' ' ' GLY . 22.0 m-85 -69.58 163.85 24.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.66 1.219 . . . . 0.0 112.116 169.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -88.09 126.55 35.17 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.8 m -63.8 152.61 38.99 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.762 -0.586 . . . . 0.0 110.582 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 72.0 t -53.97 -32.96 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 O-C-N 121.681 -0.637 . . . . 0.0 111.873 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.86 -45.42 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.871 1.269 . . . . 0.0 112.52 173.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -71.61 -35.95 70.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.905 0.882 . . . . 0.0 111.169 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -59.75 -52.99 63.1 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 169.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.17 -43.09 96.09 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.9 p -67.65 -38.79 84.31 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.497 -0.752 . . . . 0.0 112.348 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.96 -35.5 72.2 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.682 -1.261 . . . . 0.0 112.863 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 97.3 mt -60.89 -41.66 96.45 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.805 0.842 . . . . 0.0 111.892 170.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.25 75.91 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.44 1.096 . . . . 0.0 113.17 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -80.91 -39.47 26.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.646 0.778 . . . . 0.0 111.753 -174.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -87.93 -6.23 58.15 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 171.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 31.1 m120 58.19 56.2 4.68 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.865 1.666 . . . . 0.0 111.52 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 51.3 mm -94.55 137.61 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.259 1.424 . . . . 0.0 109.716 171.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -107.21 109.4 62.85 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 119.843 1.201 . . . . 0.0 107.83 168.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -73.06 148.83 45.48 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.205 1.937 . . . . 0.0 112.215 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.27 99.63 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 170.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -73.78 78.37 1.58 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.498 -0.751 . . . . 0.0 111.937 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . 0.361 3.8 m -79.27 116.15 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 123.431 1.586 . . . . 0.0 113.389 174.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 28.6 m -144.23 155.94 57.86 Favored Pre-proline 0 N--CA 1.478 0.928 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.181 -169.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -78.95 153.25 25.28 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.488 2.792 . . . . 0.0 111.307 -172.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 77.1 p -37.45 -49.34 1.02 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.315 2.246 . . . . 0.0 115.061 -169.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -54.1 -38.32 65.22 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.918 1.287 . . . . 0.0 114.094 -174.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.9 ptm -103.31 -4.47 24.19 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 42.4 t -54.84 -45.26 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.4 1.0 . . . . 0.0 109.85 -171.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . 0.3 0.0 OUTLIER -76.02 -3.89 38.25 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -170.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 82.9 m -92.75 -34.24 13.98 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.33 1.052 . . . . 0.0 110.677 168.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -74.41 -25.83 59.71 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.997 -1.064 . . . . 0.0 110.183 171.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -64.6 -25.34 67.92 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.783 -1.198 . . . . 0.0 110.07 168.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -79.82 -22.84 42.54 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 120.1 -1.625 . . . . 0.0 110.517 176.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 18.4 tp -82.22 -26.13 33.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.308 2.243 . . . . 0.0 109.377 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.7 t -76.11 -13.56 60.2 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.381 -0.825 . . . . 0.0 112.976 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . 0.328 0.0 OUTLIER -99.08 -20.55 16.64 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 118.753 -0.642 . . . . 0.0 111.026 169.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -76.91 -31.06 56.44 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.17 0.895 . . . . 0.0 111.481 169.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.92 108.89 45.75 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.046 0.938 . . . . 0.0 109.954 172.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.94 145.41 56.04 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 121.978 1.785 . . . . 0.0 111.255 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt 97.42 -20.58 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 130.557 3.543 . . . . 0.0 114.509 169.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.35 166.84 22.86 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.661 0.664 . . . . 0.0 110.721 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.4 p -125.17 -150.54 0.45 Allowed 'General case' 0 C--N 1.346 0.445 0 CA-C-O 122.926 1.346 . . . . 0.0 109.206 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 11.6 tt 179.08 131.21 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 126.668 1.987 . . . . 0.0 109.843 -167.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -126.2 160.35 20.6 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.592 1.091 . . . . 0.0 112.183 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -89.58 92.16 8.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 122.651 1.215 . . . . 0.0 107.824 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 CA--C 1.538 0.498 0 CA-C-N 113.594 -1.639 . . . . 0.0 108.51 169.155 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.91 147.52 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 126.524 1.93 . . . . 0.0 107.825 172.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.38 124.94 31.38 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.242 0.544 . . . . 0.0 109.93 169.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 mp -115.02 137.88 51.5 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -121.31 107.57 12.68 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 122.8 1.286 . . . . 0.0 110.705 173.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -80.64 103.12 10.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.778 2.031 . . . . 0.0 112.049 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -100.45 113.04 25.48 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.989 1.315 . . . . 0.0 110.588 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 87.3 mtp -97.82 147.05 24.81 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -94.06 124.4 7.86 Favored Glycine 0 CA--C 1.542 1.762 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 168.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.5 mp -115.22 29.39 8.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 125.332 1.453 . . . . 0.0 114.896 -170.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.479 1.008 0 O-C-N 120.207 -1.558 . . . . 0.0 113.172 -172.918 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 122.203 1.002 . . . . 0.0 109.822 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.84 79.78 0.28 Allowed Glycine 0 C--N 1.339 0.712 0 C-N-CA 126.874 2.178 . . . . 0.0 109.0 -170.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -82.42 132.14 35.21 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -170.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.9 tp -110.66 138.41 38.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.632 0.773 . . . . 0.0 110.238 -175.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.95 159.21 22.57 Favored Glycine 0 N--CA 1.468 0.768 0 C-N-CA 125.555 1.55 . . . . 0.0 112.088 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -138.08 128.33 26.01 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -169.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.98 159.18 25.99 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 124.688 1.137 . . . . 0.0 113.978 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.6 m -134.15 140.54 46.63 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.425 1.49 . . . . 0.0 111.94 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.18 146.98 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.121 -0.987 . . . . 0.0 112.556 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.9 t -134.2 -80.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 126.105 1.762 . . . . 0.0 108.319 170.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' A' ' 52' ' ' THR 0.338 0.0 OUTLIER -168.45 -7.1 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.877 1 C-N-CA 132.862 4.465 . . . . 0.0 109.338 168.772 . . . . . . . . 5 4 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.6 mtm -77.57 46.27 0.53 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.875 1.67 . . . . 0.0 107.399 166.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.404 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.351 3.2 t 52.12 -164.5 0.07 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 130.617 3.567 . . . . 0.0 114.057 -169.546 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -108.78 130.03 55.38 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.223 2.609 . . . . 0.0 109.33 -175.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -118.07 118.58 32.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.627 0.727 . . . . 0.0 111.142 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -84.62 114.12 21.76 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.075 1.35 . . . . 0.0 109.196 169.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.8 mm -107.67 -24.12 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.7 tp -146.91 120.33 9.03 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.018 1.281 . . . . 0.0 112.161 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.07 152.0 25.19 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.017 1.727 . . . . 0.0 112.566 172.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.81 120.49 4.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.366 1.066 . . . . 0.0 110.506 175.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.227 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.1 t . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 120.623 0.249 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.1 m -107.24 -156.97 0.6 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.481 1.512 . . . . 0.0 110.899 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -156.99 153.49 24.74 Favored Glycine 0 N--CA 1.478 1.466 0 O-C-N 119.874 -1.766 . . . . 0.0 116.291 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.8 tptt -157.88 161.95 38.31 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.614 1.566 . . . . 0.0 112.475 169.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.5 mt -70.26 -47.64 60.41 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.941 1.696 . . . . 0.0 114.507 -169.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.84 137.89 42.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.438 0.695 . . . . 0.0 111.926 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.254 13.6 t -67.89 -41.14 26.78 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-O 115.816 -2.04 . . . . 0.0 113.975 173.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.15 150.29 82.06 Favored 'Trans proline' 0 C--N 1.36 1.132 0 CA-C-N 123.09 2.139 . . . . 0.0 111.924 170.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -121.93 160.28 25.14 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -171.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.07 19.07 28.27 Favored Glycine 0 N--CA 1.476 1.304 0 CA-C-O 118.175 -1.347 . . . . 0.0 116.174 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -49.5 -32.45 12.23 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.84 1.82 . . . . 0.0 113.384 -173.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.8 tp -60.16 -41.36 92.64 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.222 1.009 . . . . 0.0 113.441 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.93 -40.03 87.53 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.549 0.339 . . . . 0.0 110.767 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.54 -52.72 50.44 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 117.633 -1.175 . . . . 0.0 112.257 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -54.76 -38.12 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 120.113 1.324 . . . . 0.0 111.306 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.7 t -71.46 -39.79 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 118.943 0.792 . . . . 0.0 112.681 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -67.93 -41.44 82.56 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.514 1.052 . . . . 0.0 112.05 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.7 t -56.4 -40.4 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.194 0.598 . . . . 0.0 110.401 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.62 -40.85 80.19 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.86 -8.65 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -171.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 4.7 t -90.88 67.72 6.18 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.258 -1.526 . . . . 0.0 111.431 172.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -46.98 -42.77 18.48 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.145 1.778 . . . . 0.0 111.171 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.43 -23.54 53.73 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.43 1.014 . . . . 0.0 115.524 -170.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -94.34 -43.45 8.39 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.689 1.245 . . . . 0.0 110.351 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.4 mm -65.36 -39.23 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 118.671 -0.68 . . . . 0.0 110.439 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.43 24.49 23.84 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.44 1.019 . . . . 0.0 114.176 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -55.52 128.06 32.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.224 1.41 . . . . 0.0 113.586 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.86 173.42 6.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.236 1.814 . . . . 0.0 110.29 169.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -89.69 57.01 3.74 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.778 1.231 . . . . 0.0 112.793 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.04 -121.14 4.86 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.335 1.445 . . . . 0.0 110.235 170.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.7 p -119.57 127.91 53.42 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.524 1.93 . . . . 0.0 106.092 169.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -112.1 110.86 21.37 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.918 0.781 . . . . 0.0 110.819 -167.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -111.42 97.72 6.95 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -168.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.1 tp -87.12 94.87 9.76 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.586 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.76 116.7 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 37.9 mt -109.31 109.96 21.0 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.165 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.38 125.14 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 O-C-N 123.934 0.771 . . . . 0.0 111.83 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -161.55 150.14 15.69 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.736 0.814 . . . . 0.0 111.229 172.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -105.31 -1.21 25.46 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.338 1.455 . . . . 0.0 114.756 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -121.35 -178.44 3.78 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.496 1.118 . . . . 0.0 111.889 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -77.33 -172.51 2.5 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.648 1.179 . . . . 0.0 111.231 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -139.16 157.17 46.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.075 0.95 . . . . 0.0 112.633 -169.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -79.9 129.75 34.74 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.226 1.01 . . . . 0.0 110.717 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mp -98.99 173.21 6.95 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.851 1.26 . . . . 0.0 109.583 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.65 146.46 10.15 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.776 -0.578 . . . . 0.0 111.59 169.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 90.0 mttt 82.37 -18.98 0.43 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 128.261 2.624 . . . . 0.0 113.269 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.86 -35.71 82.01 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.002 1.273 . . . . 0.0 112.324 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -68.61 -5.28 19.08 Favored 'General case' 0 CA--C 1.551 1.0 0 O-C-N 120.927 -1.108 . . . . 0.0 113.858 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.03 -23.64 65.01 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.906 -1.121 . . . . 0.0 112.849 171.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 mp -63.74 -33.88 76.65 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.212 0.915 . . . . 0.0 110.796 169.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -84.44 16.43 34.92 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 126.127 1.823 . . . . 0.0 113.874 169.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.334 1.3 t 71.08 15.52 6.56 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 129.844 3.258 . . . . 0.0 115.095 176.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.504 ' HA ' ' HE ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -99.96 106.42 18.21 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.963 -1.086 . . . . 0.0 112.244 -177.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -88.51 -48.82 7.31 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.938 1.695 . . . . 0.0 112.411 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 -60.43 131.2 50.01 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -169.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.3 t -63.29 146.07 54.23 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.766 1.227 . . . . 0.0 111.157 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.2 p -53.72 128.95 31.55 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 125.695 1.598 . . . . 0.0 113.879 169.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -72.86 -26.62 61.52 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.422 0.689 . . . . 0.0 112.424 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.4 -25.64 7.91 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 125.697 1.618 . . . . 0.0 112.884 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -61.59 164.91 5.42 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.202 1.801 . . . . 0.0 112.878 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 38.7 t -73.53 136.74 44.1 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.522 0.729 . . . . 0.0 111.231 170.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -137.96 40.75 2.32 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.743 1.617 . . . . 0.0 111.96 172.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.96 156.19 19.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.941 0.896 . . . . 0.0 110.849 171.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.84 -80.16 0.16 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.475 1.11 . . . . 0.0 111.504 171.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.26 28.0 0.76 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.743 1.617 . . . . 0.0 112.771 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.03 -9.73 68.32 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.923 1.725 . . . . 0.0 113.454 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 13.1 mmt -96.74 146.45 24.87 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.777 1.231 . . . . 0.0 112.336 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -77.88 95.12 4.67 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.888 0.851 . . . . 0.0 110.815 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.0 ttp-105 -51.85 -40.15 60.06 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.619 1.968 . . . . 0.0 112.857 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.3 m -87.34 2.75 49.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -169.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.5 ttp85 -56.73 -33.84 66.91 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 121.731 2.06 . . . . 0.0 111.857 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.61 -4.26 87.51 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.29 1.424 . . . . 0.0 115.14 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.298 15.1 tp10 -122.42 -82.3 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.139 0 CA-C-O 115.774 -2.06 . . . . 0.0 111.051 173.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -47.13 146.8 6.0 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 123.341 2.694 . . . . 0.0 116.541 170.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.94 179.55 4.85 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -69.23 147.03 51.83 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.386 -0.822 . . . . 0.0 110.876 170.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -71.4 154.68 41.37 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.527 -0.733 . . . . 0.0 111.964 -177.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.5 p -88.5 155.91 19.39 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.704 -0.623 . . . . 0.0 111.343 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.2 t -59.27 -29.12 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 121.373 -0.829 . . . . 0.0 112.585 -169.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 37.4 t -66.8 -42.46 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.373 1.469 . . . . 0.0 111.59 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -70.49 -29.55 66.11 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.233 1.013 . . . . 0.0 111.715 -174.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.23 -54.72 29.08 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.789 0.836 . . . . 0.0 109.796 170.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.53 -37.7 68.27 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.219 1.008 . . . . 0.0 111.959 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.5 m -60.59 -65.29 0.71 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.312 1.045 . . . . 0.0 112.336 170.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.265 68.9 mmtt -76.25 -17.39 59.5 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.121 -1.612 . . . . 0.0 114.835 -169.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mp -71.72 -41.4 68.6 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.782 0.833 . . . . 0.0 109.493 168.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.32 -35.48 66.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.454 1.102 . . . . 0.0 113.853 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.9 -41.52 78.15 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.942 0.897 . . . . 0.0 110.736 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -87.96 -0.3 56.82 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 65.24 31.01 11.02 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.524 1.129 . . . . 0.0 113.012 170.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 57.2 mt -94.92 134.18 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 120.89 -1.131 . . . . 0.0 108.969 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -107.34 100.51 33.89 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-N 119.078 0.853 . . . . 0.0 111.826 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.02 154.57 74.2 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.746 2.297 . . . . 0.0 115.81 169.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 38.0 mt -132.27 110.77 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.892 1.677 . . . . 0.0 107.775 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -77.58 79.5 4.08 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 123.214 1.483 . . . . 0.0 110.844 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 89.7 t -65.98 109.04 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.583 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 27.3 m -148.38 146.52 23.05 Favored Pre-proline 0 N--CA 1.476 0.841 0 O-C-N 120.757 -1.215 . . . . 0.0 112.696 -170.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.36 151.97 27.66 Favored 'Trans proline' 0 C--N 1.351 0.696 1 C-N-CA 125.533 4.155 . . . . 0.0 114.129 169.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 68.3 p -56.81 -29.16 62.47 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -169.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 40.7 tpt85 -58.95 -36.68 75.21 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.927 1.24 . . . . 0.0 112.774 -177.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 34.5 mtt -118.1 12.79 13.7 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.436 1.272 . . . . 0.0 114.436 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 5.4 t -53.39 -34.88 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.646 1.112 . . . . 0.0 111.22 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -80.78 -15.04 57.47 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -175.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.12 -34.17 43.61 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.445 1.02 . . . . 0.0 110.383 174.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -80.58 -36.93 32.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.054 1.342 . . . . 0.0 110.342 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -62.7 -13.37 31.62 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.114 0.87 . . . . 0.0 113.072 171.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -105.01 -11.0 16.84 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -80.15 -30.56 38.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.385 1.474 . . . . 0.0 109.154 169.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 58.6 p -77.11 -11.45 59.81 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.144 1.378 . . . . 0.0 112.406 173.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.8 m -78.39 -30.72 47.97 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 168.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -81.42 -28.15 34.4 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 171.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.52 86.09 22.17 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 123.855 0.862 . . . . 0.0 110.711 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.47 149.02 92.17 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.755 2.304 . . . . 0.0 112.196 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt 89.25 -17.08 0.25 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 130.665 3.586 . . . . 0.0 113.017 -175.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.2 mt -76.03 162.39 28.09 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.272 0.629 . . . . 0.0 110.766 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.6 p -129.9 -161.5 1.12 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 48.2 mm -162.13 149.02 4.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 130.332 3.453 . . . . 0.0 109.385 -167.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.06 156.55 26.89 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 168.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -96.81 84.2 3.56 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.644 1.578 . . . . 0.0 108.374 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.471 0.576 0 CA-C-O 122.57 1.176 . . . . 0.0 110.572 169.795 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.7 p . . . . . 0 CA--C 1.546 0.801 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.33 100.97 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-O 122.127 0.965 . . . . 0.0 112.018 -175.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.97 95.93 4.93 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.687 1.195 . . . . 0.0 109.501 171.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.1 tt -90.31 121.38 32.26 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.991 0.516 . . . . 0.0 111.837 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -113.72 109.52 18.71 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 123.728 1.727 . . . . 0.0 109.213 169.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -81.18 104.88 11.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.699 -2.046 . . . . 0.0 111.718 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -108.53 111.31 23.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.618 0.767 . . . . 0.0 109.897 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 28.0 ptm -119.07 149.04 42.35 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.1 134.59 14.58 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.29 1.424 . . . . 0.0 110.892 169.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 mp -102.97 29.64 5.31 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.584 1.954 . . . . 0.0 111.608 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 p . . . . . 0 CA--C 1.539 0.551 0 C-N-CA 126.112 1.765 . . . . 0.0 113.505 -179.857 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.998 0.904 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.68 86.54 0.23 Allowed Glycine 0 C--N 1.337 0.616 0 C-N-CA 125.82 1.676 . . . . 0.0 109.086 -169.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.6 mmt-85 -72.39 138.82 47.47 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.436 1.494 . . . . 0.0 108.672 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 tt -126.6 133.25 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-N 119.062 0.846 . . . . 0.0 111.712 -177.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.89 159.68 26.54 Favored Glycine 0 N--CA 1.475 1.264 0 C-N-CA 126.035 1.778 . . . . 0.0 112.51 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -137.04 133.27 35.29 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -169.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.63 145.94 17.99 Favored Glycine 0 C--N 1.343 0.948 0 C-N-CA 124.827 1.203 . . . . 0.0 111.945 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.7 m -128.49 149.0 50.77 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.084 0.953 . . . . 0.0 112.137 -173.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.1 152.32 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-N 118.99 0.814 . . . . 0.0 113.149 -175.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.4 t -141.5 -84.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 125.152 1.381 . . . . 0.0 109.269 168.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' A' ' 52' ' ' THR . 54.0 t30 -149.54 -20.63 0.28 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.847 2.459 . . . . 0.0 108.269 169.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 76.4 mtm -75.78 50.17 0.56 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 127.514 2.325 . . . . 0.0 106.202 166.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.404 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.342 4.0 t 32.74 -149.56 0.0 OUTLIER 'General case' 0 C--N 1.345 0.375 1 C-N-CA 133.915 4.886 . . . . 0.0 116.71 -168.835 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -106.0 137.35 44.06 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 130.287 3.435 . . . . 0.0 109.343 -174.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -129.37 126.56 39.15 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 122.604 1.192 . . . . 0.0 109.739 168.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -87.35 116.65 25.59 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.851 2.06 . . . . 0.0 109.399 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.7 mt -110.01 -57.46 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.131 -169.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -103.98 117.25 33.84 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.104 0.865 . . . . 0.0 112.907 173.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -64.27 147.45 52.43 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 166.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mp -61.5 126.56 27.8 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 121.072 1.76 . . . . 0.0 110.461 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.476 0.83 0 C-N-CA 124.635 1.174 . . . . 0.0 111.469 -173.726 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.6 m -125.82 159.87 31.32 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.268 1.827 . . . . 0.0 113.138 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.63 161.79 13.49 Favored Glycine 0 N--CA 1.476 1.331 0 C-N-CA 125.089 1.328 . . . . 0.0 114.757 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -158.76 147.92 18.89 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.075 2.15 . . . . 0.0 109.654 171.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.08 -74.58 0.06 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.542 1.537 . . . . 0.0 112.193 176.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.81 154.62 41.67 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -173.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.6 m -67.19 -52.42 30.05 Favored Pre-proline 0 N--CA 1.474 0.742 0 CA-C-O 116.372 -1.775 . . . . 0.0 113.913 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -71.08 152.99 62.97 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.107 1.872 . . . . 0.0 111.661 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -133.46 158.99 41.68 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.66 34.13 2.08 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 117.309 1.684 . . . . 0.0 117.309 -168.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -74.02 -21.32 60.02 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -170.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.4 tp -56.96 -53.03 62.65 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.424 0.689 . . . . 0.0 109.79 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -63.57 -31.46 72.64 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.841 -1.162 . . . . 0.0 112.741 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.24 -51.77 68.12 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.86 170.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.64 -26.55 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 119.909 1.232 . . . . 0.0 112.851 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.9 t -70.81 -56.64 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.06 173.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -58.56 -36.78 74.46 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.55 0.614 . . . . 0.0 109.623 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.46 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 52.9 t -60.74 -31.46 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 173.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.78 -51.63 11.04 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.247 -0.908 . . . . 0.0 113.295 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.2 mm -71.28 -23.65 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 119.789 1.177 . . . . 0.0 113.31 -169.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.32 61.09 6.64 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.567 -1.333 . . . . 0.0 112.433 -173.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -46.56 -44.65 18.14 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.448 1.499 . . . . 0.0 110.821 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.97 -24.2 28.01 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.678 1.132 . . . . 0.0 115.207 -171.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -88.4 -40.95 13.13 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.829 1.315 . . . . 0.0 111.042 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 92' ' ' VAL . 27.0 mt -79.64 -31.9 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 121.321 -0.862 . . . . 0.0 110.551 176.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.81 31.76 20.07 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.666 -0.519 . . . . 0.0 113.358 169.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -55.48 120.99 8.02 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.482 1.113 . . . . 0.0 112.414 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -76.45 170.37 16.51 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.716 0.807 . . . . 0.0 111.007 169.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -89.62 52.42 2.32 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.85 0.86 . . . . 0.0 112.095 169.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.7 -119.05 3.87 Favored Glycine 0 N--CA 1.471 0.982 0 N-CA-C 105.867 -2.893 . . . . 0.0 105.867 168.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.6 t -124.76 131.38 53.46 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.23 137.5 41.28 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -168.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -136.42 104.78 5.71 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -167.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.9 tp -97.41 101.0 12.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.744 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.6 t -73.81 127.8 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 168.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.4 tp -116.26 130.12 56.62 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 169.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.257 6.5 p -141.86 129.97 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.6 t -147.3 -176.46 5.24 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 113.351 -1.75 . . . . 0.0 111.277 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -130.82 -7.98 3.99 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 127.063 2.145 . . . . 0.0 113.607 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -150.14 169.4 21.37 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.917 1.287 . . . . 0.0 112.936 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -53.14 167.52 0.17 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.554 2.342 . . . . 0.0 115.677 -170.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -92.99 163.84 13.51 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -102.59 124.07 47.47 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 165.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.5 mp -104.32 177.21 4.91 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.757 1.223 . . . . 0.0 110.538 -172.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.44 145.46 4.71 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.367 58.6 pttt 56.29 2.79 0.09 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 128.345 2.658 . . . . 0.0 116.891 -170.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -66.34 -28.91 69.03 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 121.475 1.943 . . . . 0.0 112.442 170.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . 0.329 20.1 mttt -75.14 7.61 3.22 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 176.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.6 t -70.92 -18.69 62.65 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.781 1.232 . . . . 0.0 111.209 168.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 mp -65.71 -23.76 66.83 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.196 0.998 . . . . 0.0 112.196 169.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -88.42 -130.72 3.61 Favored Glycine 0 CA--C 1.538 1.482 0 N-CA-C 106.64 -2.584 . . . . 0.0 106.64 168.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.3 m -142.2 68.4 1.32 Allowed 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 118.008 0.904 . . . . 0.0 109.28 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -134.45 81.02 1.88 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.795 1.638 . . . . 0.0 108.665 -175.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -79.49 -45.74 18.76 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.729 0.812 . . . . 0.0 111.726 -176.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -57.99 120.62 8.86 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.049 0.54 . . . . 0.0 111.341 -171.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.4 t -72.13 154.33 41.14 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-O 122.577 1.18 . . . . 0.0 111.246 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.7 p -61.46 138.46 58.27 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 127.425 2.29 . . . . 0.0 115.674 -171.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 54.4 p30 -87.69 -18.15 30.16 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -175.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.28 17.38 78.81 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.988 -0.896 . . . . 0.0 114.017 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 37.5 ttm105 -96.9 158.73 15.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.954 1.702 . . . . 0.0 110.426 174.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.71 146.16 25.81 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.07 -1.019 . . . . 0.0 112.95 169.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -140.7 55.66 1.58 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.273 1.829 . . . . 0.0 110.663 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 tt -130.67 130.13 43.49 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.34 2.256 . . . . 0.0 108.418 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -145.56 -50.07 0.24 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 169.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -72.37 -20.91 61.38 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.905 1.282 . . . . 0.0 114.107 176.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 131.37 -17.88 5.01 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.118 1.818 . . . . 0.0 114.328 -172.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 80.5 mtp -113.52 157.72 21.66 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.989 1.895 . . . . 0.0 114.116 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -73.31 91.98 1.76 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.787 0.835 . . . . 0.0 110.972 171.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -54.62 -38.57 66.98 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.313 1.045 . . . . 0.0 112.535 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 64.8 m -79.58 0.74 28.73 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -41.32 -46.31 3.23 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 120.529 1.513 . . . . 0.0 112.338 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.68 -7.75 88.02 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 117.966 -1.463 . . . . 0.0 115.161 -172.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.276 88.8 tt0 -114.5 -79.39 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.025 0 CA-C-O 115.891 -2.004 . . . . 0.0 112.141 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.92 158.22 48.39 Favored 'Trans proline' 0 C--N 1.356 0.948 0 CA-C-N 123.509 2.289 . . . . 0.0 113.275 170.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -77.27 -168.25 1.08 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.673 1.589 . . . . 0.0 113.514 170.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -69.2 144.83 53.62 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 172.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.53 153.12 43.79 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 54.6 p -85.66 150.97 24.24 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.317 -0.864 . . . . 0.0 112.833 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 70.0 t -56.0 -43.83 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.597 0.759 . . . . 0.0 110.945 -176.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.5 t -75.68 -26.66 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.005 -1.059 . . . . 0.0 112.682 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -61.24 -32.81 72.6 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.869 1.213 . . . . 0.0 110.135 170.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.6 mt -83.69 -33.06 25.24 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.809 -0.557 . . . . 0.0 112.373 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.78 84.47 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.187 0.449 . . . . 0.0 110.331 169.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.1 t -55.29 -51.62 66.08 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.229 1.012 . . . . 0.0 111.193 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -73.57 -48.82 29.94 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.7 mp -73.2 -18.63 61.23 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.701 -1.249 . . . . 0.0 112.169 -173.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.66 -30.54 41.26 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 119.115 0.871 . . . . 0.0 112.586 168.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -68.9 -48.32 63.63 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.322 1.449 . . . . 0.0 109.76 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -79.95 -8.98 59.63 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.042 1.337 . . . . 0.0 111.964 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 59.5 49.13 8.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.769 2.427 . . . . 0.0 112.794 171.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 19.2 mm -96.97 147.21 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.929 1.691 . . . . 0.0 109.671 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -105.96 102.14 37.62 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 120.82 1.645 . . . . 0.0 109.549 168.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -76.23 125.9 8.82 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.977 3.118 . . . . 0.0 113.108 169.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.51 109.49 26.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -77.13 73.31 3.71 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 122.436 1.112 . . . . 0.0 112.371 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 77.4 t -60.0 104.18 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.893 0.877 . . . . 0.0 109.468 167.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 6.3 m -149.42 148.46 26.31 Favored Pre-proline 0 N--CA 1.481 1.122 0 O-C-N 119.871 -1.768 . . . . 0.0 113.2 -173.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -58.8 153.72 48.39 Favored 'Trans proline' 0 C--N 1.354 0.838 1 C-N-CA 125.625 4.217 . . . . 0.0 116.291 178.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 29.2 t -51.74 -54.61 26.57 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -169.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 80.2 mmt-85 -60.42 -13.32 12.81 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 120.549 1.522 . . . . 0.0 114.407 -173.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 14.3 ttp -105.53 -16.52 14.69 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.431 2.293 . . . . 0.0 114.641 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.9 m -62.49 -24.83 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 122.123 2.238 . . . . 0.0 112.344 -170.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -60.27 -28.69 68.27 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.9 t -92.17 -33.56 14.67 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.172 0.589 . . . . 0.0 111.453 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -69.57 -32.25 70.92 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.377 -1.452 . . . . 0.0 109.964 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -68.05 -12.97 61.8 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.453 1.101 . . . . 0.0 112.309 169.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -96.9 -29.21 13.83 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.16 -0.963 . . . . 0.0 111.291 173.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.5 -26.81 63.76 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 119.895 -1.753 . . . . 0.0 109.758 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.4 t -81.15 -15.2 56.49 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.98 -19.44 44.06 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.805 169.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -88.78 -31.58 18.3 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 170.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 14.8 mm -101.78 111.86 64.56 Favored Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 119.547 1.067 . . . . 0.0 109.505 176.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.77 0.65 4.01 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 124.924 3.749 . . . . 0.0 119.779 -168.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -128.68 -2.95 5.36 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 -176.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.2 mt -83.21 172.75 12.29 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.93 1.241 . . . . 0.0 113.299 -169.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.446 0.1 OUTLIER -141.5 -176.42 4.73 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 167.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.9 mp -157.88 136.68 3.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 131.478 3.911 . . . . 0.0 109.354 -166.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -118.38 147.46 18.56 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 172.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -87.43 87.38 7.39 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 122.863 1.316 . . . . 0.0 107.658 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.3 tp . . . . . 0 CA--C 1.546 0.81 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.494 169.559 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 t . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 t -110.19 95.66 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.628 1.171 . . . . 0.0 110.125 -171.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -76.39 118.33 18.97 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.544 -0.723 . . . . 0.0 110.352 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.1 mt -107.25 137.79 44.66 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.685 -0.634 . . . . 0.0 110.191 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -122.49 109.48 14.41 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 122.579 1.18 . . . . 0.0 108.986 169.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -83.26 110.64 18.26 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.856 1.262 . . . . 0.0 111.808 173.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 30.3 tp -103.21 124.23 48.22 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.981 0.912 . . . . 0.0 110.62 170.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 40.7 ttp -121.88 138.68 54.3 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -169.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.53 133.58 12.62 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.943 1.259 . . . . 0.0 112.159 172.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tp -119.31 26.53 9.38 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.799 1.639 . . . . 0.0 113.3 -173.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 179.08 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 123.061 1.41 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.62 94.66 0.11 Allowed Glycine 0 CA--C 1.517 0.182 0 N-CA-C 105.898 -2.881 . . . . 0.0 105.898 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -92.36 147.47 22.89 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 122.727 0.411 . . . . 0.0 110.402 -168.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.0 tt -122.26 129.27 75.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 124.196 0.998 . . . . 0.0 109.946 -172.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.75 157.84 14.94 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.273 1.416 . . . . 0.0 110.853 172.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -141.58 131.75 24.84 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.24 155.68 24.1 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 124.407 1.004 . . . . 0.0 113.199 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 74.3 m -119.32 139.95 51.12 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.009 1.324 . . . . 0.0 111.316 -177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.3 tt -142.53 157.97 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.787 1.235 . . . . 0.0 111.328 171.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -158.46 -59.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -179.28 -28.97 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 129.861 3.264 . . . . 0.0 107.499 172.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.4 70.98 3.85 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 101.64 -3.467 . . . . 0.0 101.64 165.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.326 14.8 t 19.43 -138.45 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.763 1 C-N-CA 132.129 4.172 . . . . 0.0 116.318 -169.333 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -117.43 146.05 43.73 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 129.335 3.054 . . . . 0.0 109.892 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -134.04 123.28 24.25 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.54 0.736 . . . . 0.0 111.152 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -85.79 98.33 10.68 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.378 1.071 . . . . 0.0 110.08 169.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.5 tt -83.98 -64.24 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.504 0.722 . . . . 0.0 112.258 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 tp -109.27 117.38 33.94 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.605 1.162 . . . . 0.0 110.437 -171.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -60.59 147.76 40.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.498 0.719 . . . . 0.0 112.043 173.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.2 tt -50.41 115.13 1.32 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.554 1.942 . . . . 0.0 110.961 172.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.481 1.087 0 C-N-CA 125.073 1.349 . . . . 0.0 112.353 -170.187 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.5 p -103.19 -151.01 0.42 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.511 0.724 . . . . 0.0 111.866 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -142.87 141.53 10.69 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.375 1.464 . . . . 0.0 112.252 173.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.79 144.89 24.57 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.965 1.706 . . . . 0.0 110.652 173.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.56 -38.61 14.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -169.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.43 139.81 42.52 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.8 p -76.0 -38.63 2.51 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-O 115.89 -2.005 . . . . 0.0 114.905 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.99 136.61 53.41 Favored 'Trans proline' 0 C--N 1.355 0.885 0 CA-C-N 122.555 1.948 . . . . 0.0 112.897 171.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.22 160.38 14.57 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.548 1.539 . . . . 0.0 113.402 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.35 22.37 1.66 Allowed Glycine 0 N--CA 1.477 1.426 0 O-C-N 120.883 -1.136 . . . . 0.0 115.147 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -47.16 -34.18 5.94 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.386 2.274 . . . . 0.0 114.573 -169.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.29 -32.92 71.65 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.592 -0.718 . . . . 0.0 112.421 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -57.75 -52.11 66.81 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.307 0.958 . . . . 0.0 110.416 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.29 -49.6 76.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 116.464 -1.731 . . . . 0.0 111.18 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.4 m -55.35 -38.36 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 121.378 1.899 . . . . 0.0 114.423 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 p -86.37 -38.79 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 117.451 -1.262 . . . . 0.0 112.582 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -60.74 -44.42 96.7 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 121.161 1.8 . . . . 0.0 109.776 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.254 6.4 m -65.56 -4.11 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 120.773 1.624 . . . . 0.0 114.239 174.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.77 -18.07 17.39 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.772 1.229 . . . . 0.0 113.222 169.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.4 ' HB ' ' SG ' ' A' ' 135' ' ' CYS . 13.9 mt -104.89 -19.06 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 126.004 1.722 . . . . 0.0 111.735 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 95.3 m -73.16 42.42 0.11 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 127.338 2.255 . . . . 0.0 113.581 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -50.39 -41.41 52.02 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.027 1.331 . . . . 0.0 111.412 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.37 -26.77 46.24 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.24 0.924 . . . . 0.0 115.121 -174.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -88.54 -41.85 12.44 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.161 0.98 . . . . 0.0 110.277 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 74.6 mt -76.03 -38.44 35.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 CA-C-O 117.495 -1.241 . . . . 0.0 110.809 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.19 20.21 31.02 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 119.199 0.909 . . . . 0.0 115.145 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -52.05 125.91 16.94 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.079 1.351 . . . . 0.0 113.063 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -98.12 174.6 6.45 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.356 1.462 . . . . 0.0 113.196 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -71.76 1.55 6.72 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -174.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.25 -134.72 2.01 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 120.666 1.576 . . . . 0.0 110.223 -178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.3 t -97.58 143.29 28.41 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.865 1.266 . . . . 0.0 108.299 175.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -142.0 118.44 10.9 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 119.365 0.984 . . . . 0.0 110.183 -169.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -119.16 109.95 16.47 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -169.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.58 96.77 7.57 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.415 175.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.99 118.49 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 45.8 tp -108.97 128.97 55.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 117.765 -1.112 . . . . 0.0 109.846 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.8 t -120.91 134.79 63.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.6 t -161.24 166.54 27.56 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 112.801 -2.0 . . . . 0.0 109.624 169.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -124.03 7.72 8.61 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.856 2.062 . . . . 0.0 114.214 174.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -141.83 -177.63 5.29 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.573 1.549 . . . . 0.0 111.51 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -55.08 177.87 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.491 2.316 . . . . 0.0 114.696 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -139.34 158.78 43.56 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.82 2.048 . . . . 0.0 110.015 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -85.54 126.67 34.05 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.201 0.6 . . . . 0.0 111.368 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -91.11 176.1 6.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.481 1.512 . . . . 0.0 108.992 172.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.513 ' H ' HD23 ' A' ' 118' ' ' LEU . . . -55.22 148.78 13.73 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.177 -0.952 . . . . 0.0 112.139 169.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.1 mptt 76.55 -13.86 0.88 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.479 2.312 . . . . 0.0 113.589 -176.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -65.62 -19.34 65.87 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.254 -1.529 . . . . 0.0 111.622 169.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -24.08 66.58 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.345 3.0 t -75.66 -11.8 60.07 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 119.216 0.916 . . . . 0.0 112.13 -173.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.4 mt -60.63 -34.84 74.86 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.977 -1.077 . . . . 0.0 110.84 167.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -92.26 15.34 62.36 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.826 1.679 . . . . 0.0 113.711 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.543 0.1 OUTLIER 44.05 54.27 6.0 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 128.672 2.789 . . . . 0.0 113.917 -176.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -104.0 132.14 50.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.017 2.127 . . . . 0.0 105.59 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -113.78 -35.96 4.99 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 120.786 1.63 . . . . 0.0 113.315 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -48.07 116.86 1.67 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.789 1.236 . . . . 0.0 112.037 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.8 t -62.87 157.37 21.66 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.912 0.778 . . . . 0.0 110.164 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -66.53 132.3 47.91 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.838 -0.539 . . . . 0.0 110.622 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.82 -11.15 59.65 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.8 75.14 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 118.65 -1.083 . . . . 0.0 113.793 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -125.79 178.28 5.8 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.243 1.417 . . . . 0.0 112.328 170.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . 0.4 ' SG ' ' HB ' ' A' ' 94' ' ' ILE . 1.2 m -99.39 146.24 26.51 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -169.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -151.55 56.38 0.87 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.568 1.547 . . . . 0.0 113.289 -169.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -134.26 151.43 51.28 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.918 -1.113 . . . . 0.0 111.511 169.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -147.41 -49.95 0.18 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.209 1.004 . . . . 0.0 113.511 -169.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -80.44 -10.16 59.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.242 1.017 . . . . 0.0 112.73 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.07 -9.31 27.17 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.476 1.989 . . . . 0.0 113.928 -171.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 29.9 ttm -99.26 136.13 39.66 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.8 1.8 . . . . 0.0 111.69 174.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -66.66 95.98 0.37 Allowed 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.49 -0.756 . . . . 0.0 111.947 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -53.23 -45.33 68.66 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.22 2.208 . . . . 0.0 112.685 -178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 17.2 t -67.79 -19.65 65.12 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -168.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -48.56 -35.32 13.13 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 121.035 1.743 . . . . 0.0 114.064 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.92 -16.82 74.92 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 119.099 -0.834 . . . . 0.0 113.482 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -117.73 -84.49 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.359 0 CA-C-O 115.946 -1.978 . . . . 0.0 109.802 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -51.51 157.64 4.81 Favored 'Trans proline' 0 C--N 1.358 1.03 0 N-CA-C 120.072 3.066 . . . . 0.0 120.072 171.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -77.03 166.77 22.87 Favored 'General case' 0 N--CA 1.468 0.448 1 C-N-CA 131.875 4.07 . . . . 0.0 115.595 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -71.62 123.08 21.71 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 166.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.624 ' CD ' ' H ' ' A' ' 151' ' ' GLN . 1.0 OUTLIER -51.17 147.23 5.66 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 125.875 1.67 . . . . 0.0 112.217 171.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 7.7 t -85.11 166.25 16.8 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.982 0.896 . . . . 0.0 112.561 173.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.46 -27.9 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -168.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.2 p -84.09 -26.39 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 175.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -68.78 -34.16 75.09 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.358 -0.839 . . . . 0.0 110.293 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -58.59 -59.91 4.65 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.037 0.535 . . . . 0.0 110.297 169.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.24 -36.44 66.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.743 0.817 . . . . 0.0 113.069 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.4 t -58.89 -57.55 12.57 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.408 1.083 . . . . 0.0 112.417 175.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -81.37 -22.3 38.48 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.786 -1.196 . . . . 0.0 113.902 -174.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.4 mp -61.08 -48.02 83.63 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.117 0.967 . . . . 0.0 109.869 168.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.88 -28.78 55.51 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -67.91 -50.7 54.66 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.644 0.778 . . . . 0.0 110.179 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -84.16 -1.21 54.62 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.7 t30 64.08 31.86 13.18 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.753 1.161 . . . . 0.0 112.078 169.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.8 mt -97.75 128.61 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -103.87 115.33 63.56 Favored Pre-proline 0 N--CA 1.477 0.891 0 CA-C-N 119.461 1.028 . . . . 0.0 111.954 175.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.31 153.68 35.87 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.482 2.122 . . . . 0.0 115.803 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.04 113.57 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.789 1.636 . . . . 0.0 109.111 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -71.56 68.15 0.56 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 122.248 1.023 . . . . 0.0 112.793 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.1 t -63.85 102.13 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 O-C-N 120.035 -1.665 . . . . 0.0 111.54 170.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 16.3 m -143.45 145.27 31.12 Favored Pre-proline 0 N--CA 1.478 0.934 0 O-C-N 120.074 -1.641 . . . . 0.0 111.174 -174.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -56.96 150.25 56.69 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.79 2.993 . . . . 0.0 112.941 173.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.5 t -46.54 -44.71 18.11 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.705 1.602 . . . . 0.0 114.123 -169.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.4 ptm85 -53.54 -27.95 28.86 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 12.8 tpt -106.02 -4.53 20.39 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.684 1.594 . . . . 0.0 113.917 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.37 -35.52 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 120.239 -1.538 . . . . 0.0 112.807 -169.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -68.53 -20.32 64.55 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.9 m -88.83 -40.22 13.3 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.211 1.404 . . . . 0.0 110.202 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -70.27 -26.42 63.81 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.341 -0.849 . . . . 0.0 111.149 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.75 -16.68 64.24 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.428 1.013 . . . . 0.0 111.844 168.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -82.06 -29.46 31.86 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.742 -1.224 . . . . 0.0 111.35 169.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.55 -26.17 57.75 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.581 -1.325 . . . . 0.0 110.217 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.03 -16.48 53.19 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.612 1.565 . . . . 0.0 111.78 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.77 -28.33 24.62 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.929 0.491 . . . . 0.0 110.286 169.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -78.14 -26.19 47.74 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 62.3 mt -117.3 96.94 50.15 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 123.701 0.801 . . . . 0.0 110.062 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.34 138.98 55.67 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.248 3.299 . . . . 0.0 113.836 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt 76.28 -8.75 1.59 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 129.038 2.935 . . . . 0.0 113.721 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 tt -72.59 150.96 42.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.3 m -129.53 -139.15 0.23 Allowed 'General case' 0 C--N 1.343 0.294 0 CA-C-O 122.212 1.006 . . . . 0.0 109.549 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.9 tt -173.42 160.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 127.083 2.153 . . . . 0.0 109.807 -168.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -150.69 147.48 17.58 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 169.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.65 89.25 7.44 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.813 1.245 . . . . 0.0 108.42 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.7 tp . . . . . 0 CA--C 1.537 0.479 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.11 169.156 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.541 0.624 0 CA-C-O 119.009 -0.519 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.3 t -139.62 118.05 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 119.111 0.868 . . . . 0.0 111.883 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -93.74 122.69 36.46 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 122.888 0.475 . . . . 0.0 110.062 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -107.88 120.31 41.91 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.219 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -113.73 104.86 12.63 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 124.783 2.23 . . . . 0.0 110.183 171.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -75.63 117.72 17.7 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 111.52 -2.582 . . . . 0.0 111.761 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.5 tp -118.89 111.06 17.91 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.06 0.944 . . . . 0.0 110.79 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -114.04 137.13 52.13 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 118.821 2.897 . . . . 0.0 118.821 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.24 112.52 4.22 Favored Glycine 0 C--N 1.341 0.819 0 C-N-CA 125.639 1.59 . . . . 0.0 110.268 171.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.3 tp -98.89 28.91 4.05 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.791 1.637 . . . . 0.0 111.456 -172.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.0 p . . . . . 0 CA--C 1.543 0.686 0 O-C-N 120.253 -1.529 . . . . 0.0 114.368 -171.581 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 123.403 1.573 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.11 90.83 0.2 Allowed Glycine 0 C--N 1.332 0.348 0 N-CA-C 105.693 -2.963 . . . . 0.0 105.693 -176.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -76.17 144.13 40.71 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -170.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 mt -136.69 128.18 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 118.078 0.399 . . . . 0.0 110.084 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.91 149.42 19.36 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 126.402 1.953 . . . . 0.0 110.247 -173.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -129.89 131.89 46.21 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.626 1.17 . . . . 0.0 113.926 -169.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.03 152.81 22.95 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 171.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 75.1 p -130.29 154.22 47.85 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.427 0.691 . . . . 0.0 110.796 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.43 140.73 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -169.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.546 ' CG2' ' H ' ' A' ' 50' ' ' ASN 0.308 1.4 m -136.53 -84.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-N 119.735 1.152 . . . . 0.0 111.386 169.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.546 ' H ' ' CG2' ' A' ' 49' ' ' VAL 0.49 4.8 t-20 -156.97 -5.88 0.1 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 129.776 3.23 . . . . 0.0 111.713 169.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.0 ptp -88.99 44.45 1.21 Allowed 'General case' 0 CA--C 1.578 2.044 1 N-CA-C 98.994 -4.447 . . . . 0.0 98.994 160.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.526 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.681 14.6 m 14.23 -113.69 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.179 1 C-N-CA 137.324 6.25 . . . . 0.0 116.135 -164.941 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -112.56 136.83 51.63 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 125.727 1.892 . . . . 0.0 112.513 -168.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -124.43 120.87 33.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.654 1.181 . . . . 0.0 108.028 168.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -84.88 98.6 10.42 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.391 1.477 . . . . 0.0 110.426 169.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -86.88 -33.99 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 121.173 -0.954 . . . . 0.0 113.396 -174.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.4 tt -154.1 129.91 10.12 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.534 1.061 . . . . 0.0 111.375 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -78.79 169.23 18.56 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.4 HD12 ' CE3' ' A' ' 101' ' ' TRP . 73.3 mt -51.86 101.27 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.946 1.698 . . . . 0.0 112.075 176.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.479 1.021 0 C-N-CA 125.648 1.579 . . . . 0.0 112.32 -179.839 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.2 t -101.93 -150.67 0.41 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 127.715 2.406 . . . . 0.0 112.44 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -159.92 155.89 27.05 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 125.716 1.627 . . . . 0.0 114.573 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -162.12 162.37 28.54 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.999 1.72 . . . . 0.0 112.208 174.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -78.85 -52.64 8.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.073 1.749 . . . . 0.0 111.71 -177.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.31 136.17 46.15 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.931 0.892 . . . . 0.0 111.773 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 80.4 m -72.97 -47.84 8.15 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-O 116.178 -1.867 . . . . 0.0 113.475 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.01 148.67 89.75 Favored 'Trans proline' 0 C--N 1.355 0.89 0 CA-C-N 121.94 1.728 . . . . 0.0 110.992 171.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -123.34 174.93 7.01 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.92 1.288 . . . . 0.0 112.576 -169.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -99.74 23.13 37.32 Favored Glycine 0 N--CA 1.482 1.741 0 O-C-N 119.836 -1.79 . . . . 0.0 115.799 -170.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.13 -17.73 58.73 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 120.359 2.079 . . . . 0.0 116.239 -169.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.56 -14.09 62.36 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 174.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -72.87 -49.99 26.58 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 167.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.08 -51.11 70.54 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 116.065 -1.922 . . . . 0.0 111.652 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.8 m -52.27 -34.28 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 121.191 1.814 . . . . 0.0 112.135 -177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.4 t -87.6 -37.64 11.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 116.768 -1.587 . . . . 0.0 113.03 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -60.54 -46.6 89.58 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 121.862 2.119 . . . . 0.0 109.203 169.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.1 t -54.68 -40.19 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 125.509 1.524 . . . . 0.0 112.194 175.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.63 -42.32 64.54 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.8 mt -76.52 -38.78 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.455 1.102 . . . . 0.0 113.01 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 66.5 m -81.1 61.27 4.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.829 1.651 . . . . 0.0 110.619 -169.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.4 mt -50.79 -44.51 58.89 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.076 2.55 . . . . 0.0 111.619 -171.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.66 -22.39 66.94 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.691 -176.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -87.49 -47.89 8.38 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.963 0.905 . . . . 0.0 110.416 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.9 mp -70.29 -34.45 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.203 0.601 . . . . 0.0 110.769 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.2 29.41 8.98 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.23 1.395 . . . . 0.0 114.498 172.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.4 ' CE3' HD12 ' A' ' 59' ' ' LEU . 53.1 m95 -57.46 125.31 22.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.707 1.254 . . . . 0.0 112.952 -174.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -86.38 -177.07 6.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.195 2.198 . . . . 0.0 111.223 170.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -97.13 26.16 4.94 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.317 1.447 . . . . 0.0 114.808 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.69 -128.7 1.82 Allowed Glycine 0 CA--C 1.539 1.534 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . 0.308 7.2 t -112.72 152.52 28.98 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.536 -1.332 . . . . 0.0 108.173 167.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -130.16 129.88 44.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 117.439 -1.267 . . . . 0.0 110.362 -167.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -126.62 125.26 41.61 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.88 1.673 . . . . 0.0 115.343 -168.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 48.7 mt -97.7 103.29 15.22 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.676 0.75 . . . . 0.0 112.305 169.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 36.0 t -90.78 95.34 5.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 174.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 37.0 tp -94.8 123.84 38.5 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 170' ' ' VAL 0.273 11.6 p -113.83 139.15 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 170.213 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -164.07 156.39 17.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.24 1.816 . . . . 0.0 109.885 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -106.23 -0.2 24.69 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.58 1.552 . . . . 0.0 114.456 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -144.13 179.47 7.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.195 1.398 . . . . 0.0 111.953 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.28 -174.33 0.12 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 122.992 1.377 . . . . 0.0 113.387 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -135.28 158.57 44.02 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.492 1.917 . . . . 0.0 112.691 -169.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -86.65 130.31 34.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.065 1.346 . . . . 0.0 109.862 169.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.14 170.21 8.23 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.825 1.25 . . . . 0.0 111.634 177.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.82 133.63 42.52 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.911 0.386 . . . . 0.0 111.87 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.4 mttm 91.94 -16.14 0.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 130.596 3.558 . . . . 0.0 113.008 -174.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -63.61 -28.95 70.28 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 121.484 1.947 . . . . 0.0 112.971 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -69.39 -5.54 24.21 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 121.472 -0.768 . . . . 0.0 112.855 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.9 t -62.77 -34.35 77.06 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.445 1.098 . . . . 0.0 112.469 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.66 -28.44 67.71 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.814 0.734 . . . . 0.0 112.373 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -81.05 4.05 73.11 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.109 1.338 . . . . 0.0 113.811 169.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.6 m 75.1 31.73 0.81 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 127.843 2.457 . . . . 0.0 111.6 175.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -115.06 110.87 20.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.553 1.141 . . . . 0.0 111.216 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -96.84 -40.6 8.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.347 1.459 . . . . 0.0 112.303 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -66.35 123.06 18.94 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.992 0.814 . . . . 0.0 110.977 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.9 t -65.93 152.75 43.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.946 0.899 . . . . 0.0 110.605 175.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 t -68.97 138.27 54.43 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.312 1.053 . . . . 0.0 111.963 174.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -82.76 -13.37 56.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.159 1.784 . . . . 0.0 113.911 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.2 31.74 63.56 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.838 -0.979 . . . . 0.0 113.017 -176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -107.61 164.99 11.75 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.213 1.405 . . . . 0.0 112.714 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 26.2 t -67.51 119.45 12.33 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.864 1.265 . . . . 0.0 110.593 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -123.85 40.79 3.64 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.276 1.43 . . . . 0.0 111.838 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.4 tp -122.18 117.95 27.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.755 1.622 . . . . 0.0 108.422 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -120.34 -49.02 2.28 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.463 1.105 . . . . 0.0 108.732 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -86.46 -130.31 0.05 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.727 1.611 . . . . 0.0 108.34 168.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.33 -21.67 7.88 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.089 1.328 . . . . 0.0 113.674 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 21.0 mtt -93.26 142.79 26.92 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.788 1.294 . . . . 0.0 112.78 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -64.56 100.44 0.37 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.721 1.208 . . . . 0.0 110.351 169.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -61.77 -40.32 94.74 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.188 0.995 . . . . 0.0 112.593 -174.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 63.8 m -82.24 6.63 16.11 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 23.2 ttp-105 -47.87 -50.72 25.6 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.698 1.135 . . . . 0.0 111.49 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.39 -31.99 68.38 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-O 118.421 -1.21 . . . . 0.0 113.107 -169.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.291 6.4 tp10 -92.66 -84.57 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.104 0 CA-C-O 115.579 -2.153 . . . . 0.0 112.025 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.31 155.14 71.38 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 CA-C-N 124.646 2.695 . . . . 0.0 116.168 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -72.72 161.56 30.59 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 129.913 3.285 . . . . 0.0 113.847 176.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -52.44 138.4 27.47 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.833 0.853 . . . . 0.0 111.281 172.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.638 ' NE2' ' H ' ' A' ' 151' ' ' GLN 0.271 0.0 OUTLIER -82.18 143.78 31.17 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.094 -1.004 . . . . 0.0 112.014 178.85 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 70.6 m -74.99 148.88 39.54 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.401 1.08 . . . . 0.0 112.769 -174.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.408 ' HA ' ' HG ' ' A' ' 156' ' ' LEU 0.296 33.4 t -58.61 -22.06 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -177.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.4 t -65.33 -44.66 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 118.893 0.769 . . . . 0.0 111.553 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.42 -29.99 59.92 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.552 0.741 . . . . 0.0 110.729 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 153' ' ' VAL . 2.1 mt -63.62 -45.76 88.83 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 172.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.41 -45.89 69.55 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.222 1.009 . . . . 0.0 112.713 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 76.5 p -69.78 -38.84 76.85 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -174.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.34 -45.86 58.05 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.153 -0.967 . . . . 0.0 112.147 173.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.7 mt -53.25 -40.38 64.56 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.923 1.238 . . . . 0.0 113.24 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.73 -28.18 50.72 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -82.7 -34.39 27.33 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.571 1.078 . . . . 0.0 111.536 176.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -72.41 -18.9 61.68 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.843 0.857 . . . . 0.0 111.974 171.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 63.9 39.93 7.81 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.08 1.752 . . . . 0.0 112.314 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.05 143.56 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-O 117.052 -1.451 . . . . 0.0 109.731 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -105.34 115.67 61.64 Favored Pre-proline 0 N--CA 1.481 1.111 0 CA-C-N 121.72 2.055 . . . . 0.0 112.627 170.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -80.38 149.39 19.15 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.635 2.224 . . . . 0.0 113.093 169.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.1 mt -137.22 110.28 7.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.875 1.67 . . . . 0.0 107.107 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -72.45 73.72 1.02 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.933 0.873 . . . . 0.0 112.355 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 88.1 t -65.54 92.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 120.945 -1.097 . . . . 0.0 111.862 172.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 24.4 m -139.2 138.97 21.67 Favored Pre-proline 0 N--CA 1.479 0.993 0 O-C-N 119.729 -1.857 . . . . 0.0 110.513 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -58.53 152.53 54.48 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.558 2.839 . . . . 0.0 114.01 173.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 72.6 p -46.23 -42.72 14.7 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 116.666 2.098 . . . . 0.0 116.666 -168.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -51.37 -40.84 60.03 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 120.214 1.37 . . . . 0.0 113.509 -171.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.6 8.59 33.27 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.5 t -59.85 -42.92 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 121.036 1.744 . . . . 0.0 110.885 -176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -69.58 -13.45 62.33 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -174.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . 0.265 10.1 t -93.03 -27.5 16.95 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 118.86 0.754 . . . . 0.0 112.476 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -76.29 -29.76 57.5 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.49 -1.382 . . . . 0.0 109.509 168.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -58.03 -26.54 62.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.168 0.987 . . . . 0.0 110.818 169.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -79.4 -40.28 30.43 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.573 -0.705 . . . . 0.0 109.589 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.6 mp -79.65 -18.66 50.94 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 120.668 -1.27 . . . . 0.0 111.532 -175.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.8 t -74.89 -11.52 60.15 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.066 0.46 . . . . 0.0 110.581 168.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.31 -28.67 23.57 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.177 -0.952 . . . . 0.0 109.434 168.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -76.85 -26.56 54.41 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.27 91.09 50.03 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.536 1.134 . . . . 0.0 110.654 170.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.06 153.45 32.25 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.596 3.531 . . . . 0.0 113.692 173.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 24.9 pttt 88.29 -19.11 0.23 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 131.464 3.906 . . . . 0.0 113.229 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.64 163.91 24.54 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.794 0.838 . . . . 0.0 110.267 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 36.0 p -123.0 -145.42 0.35 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 169.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.2 tt 178.65 138.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 129.055 2.942 . . . . 0.0 107.977 -168.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -133.52 143.5 15.21 Favored Glycine 0 N--CA 1.463 0.479 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -87.87 90.09 8.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 56.1 tp . . . . . 0 CA--C 1.539 0.545 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.602 169.736 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 119.989 -0.053 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.1 t -123.86 135.6 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.394 1.478 . . . . 0.0 109.406 172.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -114.59 113.3 24.2 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 168.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.0 tp -101.21 131.89 46.98 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.056 0.455 . . . . 0.0 111.999 171.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -121.09 111.64 17.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 123.631 1.682 . . . . 0.0 109.561 169.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -88.52 107.85 19.1 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.007 -1.906 . . . . 0.0 111.597 175.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.3 tp -100.59 120.14 39.6 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.997 1.319 . . . . 0.0 111.877 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 30.8 mtp -103.97 143.9 32.25 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.88 115.38 4.97 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.701 1.619 . . . . 0.0 109.731 168.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -99.56 35.4 1.99 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.299 1.84 . . . . 0.0 111.951 -174.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 p . . . . . 0 N--CA 1.471 0.589 0 C-N-CA 124.954 1.302 . . . . 0.0 113.605 -179.512 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 121.71 0.767 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.52 83.03 0.32 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 127.512 2.482 . . . . 0.0 107.492 -177.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -85.47 146.08 27.12 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 125.484 1.514 . . . . 0.0 108.019 -169.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.261 11.9 tt -136.56 141.77 40.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.93 150.77 19.64 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 127.884 2.659 . . . . 0.0 109.816 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -126.79 130.29 49.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.36 146.19 16.63 Favored Glycine 0 C--N 1.343 0.97 0 C-N-CA 124.545 1.069 . . . . 0.0 112.626 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.9 t -119.14 143.5 47.17 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.813 1.645 . . . . 0.0 109.918 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.68 151.04 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.944 1.298 . . . . 0.0 108.581 176.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.94 -18.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 169.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 63.4 t30 117.42 -10.96 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 130.847 3.659 . . . . 0.0 111.597 -171.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.9 ttp -62.72 -44.21 96.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.93 -1.106 . . . . 0.0 108.585 169.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.5 p 176.13 -164.35 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.89 1 C-N-CA 135.234 5.413 . . . . 0.0 105.19 169.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -109.11 133.01 53.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 167.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -118.59 121.88 41.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.34 1.067 . . . . 0.0 110.638 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -80.57 111.12 16.69 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.761 169.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.5 mm -93.95 -53.6 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.218 1.007 . . . . 0.0 111.531 -173.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.8 tp -126.15 123.77 39.01 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.163 0.892 . . . . 0.0 111.897 -175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -59.09 154.34 16.01 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.086 1.354 . . . . 0.0 112.15 173.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.5 mt -59.24 111.01 1.19 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.669 1.122 . . . . 0.0 110.884 172.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 124.371 1.068 . . . . 0.0 112.746 -177.064 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 CA--C 1.547 0.865 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.1 t -92.97 -162.09 0.9 Allowed 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 126.108 1.763 . . . . 0.0 112.133 172.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -159.76 125.15 1.44 Allowed Glycine 0 N--CA 1.481 1.638 0 O-C-N 119.742 -1.849 . . . . 0.0 115.129 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -145.88 167.04 24.21 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.541 1.936 . . . . 0.0 112.836 -173.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.1 mt -95.67 -49.18 5.48 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -169.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.64 136.81 41.93 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.716 0.689 . . . . 0.0 111.033 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.279 13.0 t -64.1 -42.52 69.44 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 114.661 -2.59 . . . . 0.0 115.18 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.66 149.35 73.55 Favored 'Trans proline' 0 C--N 1.359 1.098 0 CA-C-N 123.925 2.437 . . . . 0.0 113.242 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -102.96 165.51 10.98 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.911 0.884 . . . . 0.0 111.994 173.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.45 48.16 3.1 Favored Glycine 0 N--CA 1.48 1.576 0 C-N-CA 125.766 1.651 . . . . 0.0 112.106 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -68.34 -44.14 75.95 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -169.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -72.48 -15.82 61.8 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.814 -1.179 . . . . 0.0 112.848 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -58.29 -49.96 75.31 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.351 1.432 . . . . 0.0 108.398 168.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.32 -45.77 80.16 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.836 -0.54 . . . . 0.0 111.296 171.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.81 -41.33 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 118.178 -0.915 . . . . 0.0 112.294 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.4 t -58.91 -53.19 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 119.922 1.237 . . . . 0.0 109.844 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -62.76 -51.92 65.22 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 122.414 0.286 . . . . 0.0 110.846 -173.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.0 t -56.68 -27.98 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 123.471 0.708 . . . . 0.0 111.874 177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.71 -32.62 23.43 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.83 -31.39 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.485 1.039 . . . . 0.0 112.218 -174.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 60.7 m -82.86 59.47 4.85 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.497 1.919 . . . . 0.0 111.125 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.61 -36.01 75.46 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.266 1.427 . . . . 0.0 113.051 -169.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.62 -32.97 58.82 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.376 0.512 . . . . 0.0 113.312 -174.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -94.77 -38.51 10.74 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.526 1.13 . . . . 0.0 111.354 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.4 mm -63.64 -37.04 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 120.915 1.689 . . . . 0.0 109.537 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.27 28.36 22.87 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.131 1.348 . . . . 0.0 113.818 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -57.44 119.65 6.87 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.191 1.495 . . . . 0.0 110.786 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.4 mmt-85 -83.42 -158.14 0.28 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.755 2.022 . . . . 0.0 108.805 171.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -81.69 -157.58 0.19 Allowed 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.27 -177.91 53.14 Favored Glycine 0 N--CA 1.424 -2.123 0 CA-C-O 125.541 2.745 . . . . 0.0 108.841 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.7 p -67.96 132.84 48.06 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 108.316 -3.942 . . . . 0.0 106.606 168.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.17 135.22 55.19 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 -177.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -138.48 124.62 20.23 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -166.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.4 tp -105.33 98.3 8.02 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.147 0.43 . . . . 0.0 111.011 177.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 39.5 t -80.45 121.68 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 170.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.1 tt -109.41 120.85 43.75 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.7 t -111.59 132.4 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 124.129 0.893 . . . . 0.0 112.001 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.5 t -151.24 179.39 8.34 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.445 1.098 . . . . 0.0 111.283 171.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.57 -13.22 6.57 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.653 1.981 . . . . 0.0 114.097 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -137.09 173.55 11.57 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.49 1.516 . . . . 0.0 112.981 -171.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -60.79 -169.61 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.673 1.589 . . . . 0.0 114.08 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.88 146.37 25.6 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.537 1.681 . . . . 0.0 115.537 -167.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -82.18 93.38 7.06 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.983 1.313 . . . . 0.0 113.458 176.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.478 ' H ' ' CD2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -75.69 173.23 11.35 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.856 -1.152 . . . . 0.0 113.012 170.541 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -47.57 149.07 1.25 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.833 0.853 . . . . 0.0 113.119 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.302 38.6 pttt 76.86 -16.09 0.67 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 131.13 3.772 . . . . 0.0 114.635 -175.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -63.21 -38.26 90.48 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.483 1.038 . . . . 0.0 113.173 -175.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . 0.274 13.7 mttt -86.02 12.87 8.56 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 m -62.36 -26.77 68.64 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 118.975 0.807 . . . . 0.0 108.937 167.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.4 mt -61.65 -36.67 81.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.895 1.278 . . . . 0.0 112.361 169.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -85.62 22.75 10.11 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.596 2.046 . . . . 0.0 113.437 170.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.321 3.9 t 55.52 28.07 11.22 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.669 2.787 . . . . 0.0 114.226 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -101.61 85.86 2.83 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.89 1.676 . . . . 0.0 110.364 -175.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -80.96 -45.65 16.33 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.187 0.995 . . . . 0.0 112.977 -173.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -60.44 121.09 11.22 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.231 1.012 . . . . 0.0 111.239 -169.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.0 t -68.84 143.49 54.54 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 120.184 1.356 . . . . 0.0 111.052 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.0 t -58.33 130.43 46.69 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.319 -0.863 . . . . 0.0 111.933 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.5 p30 -76.72 -9.97 59.05 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.032 1.333 . . . . 0.0 113.816 176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 71.1 23.17 78.36 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 117.797 -1.557 . . . . 0.0 114.124 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -100.16 168.19 9.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.099 1.759 . . . . 0.0 112.524 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 33.4 t -69.96 136.05 50.09 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.272 -0.893 . . . . 0.0 111.637 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -147.78 37.54 0.89 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.495 1.918 . . . . 0.0 112.053 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.7 mt -103.46 136.28 43.5 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.355 1.062 . . . . 0.0 110.768 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -155.29 135.43 13.05 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.338 1.455 . . . . 0.0 110.175 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.3 t0 52.71 27.76 5.59 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.536 1.534 . . . . 0.0 112.951 -169.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.06 -6.92 82.87 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.298 1.904 . . . . 0.0 114.793 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 38.7 mtt -98.78 142.59 30.13 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.829 1.814 . . . . 0.0 113.62 -174.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -76.32 81.13 3.08 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.14 0.976 . . . . 0.0 110.984 169.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -50.89 -44.61 59.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.303 1.441 . . . . 0.0 112.41 -175.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 94.3 p -78.95 -0.19 30.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -170.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -45.12 -39.67 6.23 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 121.125 1.784 . . . . 0.0 113.091 171.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.2 -19.43 79.63 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-O 118.297 -1.279 . . . . 0.0 114.793 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -111.65 -69.18 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 CA-C-O 116.334 -1.793 . . . . 0.0 113.154 -169.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -74.58 146.95 35.19 Favored 'Trans proline' 0 C--N 1.357 1.026 0 CA-C-N 123.697 2.356 . . . . 0.0 114.128 169.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -77.6 167.63 21.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.476 2.711 . . . . 0.0 114.606 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -53.54 148.17 9.82 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.434 1.094 . . . . 0.0 111.947 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.7 157.69 17.19 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.984 0.897 . . . . 0.0 112.38 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 73.6 m -87.36 149.27 24.61 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 168.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -56.8 -30.99 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.618 -1.301 . . . . 0.0 111.343 -175.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.18 -36.18 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.253 1.821 . . . . 0.0 112.964 173.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -75.89 -27.6 57.78 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.332 0.969 . . . . 0.0 111.572 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.52 -47.8 74.7 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.426 168.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.69 -37.33 70.73 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 99.2 p -72.24 -49.94 31.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.279 0.945 . . . . 0.0 113.119 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -70.51 -36.15 73.6 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.391 -1.443 . . . . 0.0 113.817 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.9 mt -68.58 -35.45 77.39 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.927 0.785 . . . . 0.0 112.05 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.05 -33.9 70.73 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -79.22 -44.06 22.57 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.096 0.558 . . . . 0.0 110.897 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -84.02 -0.59 52.27 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 68.96 16.07 8.8 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.676 2.391 . . . . 0.0 115.988 168.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 50.8 mt -75.28 139.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 120.623 -1.298 . . . . 0.0 110.319 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -99.45 95.84 3.91 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.097 173.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -73.82 144.82 35.45 Favored 'Trans proline' 0 C--N 1.352 0.754 0 CA-C-N 121.285 1.495 . . . . 0.0 114.564 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.7 mt -129.89 117.74 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 124.388 1.075 . . . . 0.0 110.754 170.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -78.48 76.09 4.99 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.461 1.124 . . . . 0.0 112.798 178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.8 t -64.38 103.62 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 122.185 0.993 . . . . 0.0 112.483 169.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 17.4 m -144.47 157.97 54.97 Favored Pre-proline 0 N--CA 1.484 1.253 0 CA-C-O 117.573 -1.204 . . . . 0.0 111.239 -169.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.87 165.14 32.9 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.603 2.869 . . . . 0.0 111.687 -171.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 73.9 p -52.08 -39.72 60.14 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.334 1.054 . . . . 0.0 113.338 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.7 ptt85 -63.18 -23.3 67.37 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.419 ' CE ' ' CE1' ' A' ' 179' ' ' TYR . 78.3 mtp -103.14 -22.87 13.69 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.3 t -56.47 -26.29 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 120.179 1.354 . . . . 0.0 112.009 -168.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.57 -29.88 70.91 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.918 1.287 . . . . 0.0 114.463 175.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 t -93.83 -37.98 11.47 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.889 0.876 . . . . 0.0 111.575 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.419 ' CE1' ' CE ' ' A' ' 175' ' ' MET . 12.1 m-85 -73.9 -28.5 61.57 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 120.149 -1.594 . . . . 0.0 110.233 175.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . 0.268 17.5 tt0 -66.79 -10.85 51.9 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 119.348 0.976 . . . . 0.0 112.58 172.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -99.3 -7.83 25.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.063 -1.023 . . . . 0.0 113.684 169.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.85 -28.97 22.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.702 1.201 . . . . 0.0 109.406 168.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 15.1 t -85.88 -15.89 40.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 112.784 177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 1.1 t -77.59 -25.86 50.25 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.302 -0.874 . . . . 0.0 108.751 168.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -80.19 -45.25 18.38 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.181 -0.438 . . . . 0.0 111.551 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 19.3 mt -94.81 106.53 25.25 Favored Pre-proline 0 N--CA 1.483 1.218 0 CA-C-O 118.335 -0.841 . . . . 0.0 109.469 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.87 147.17 67.98 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.41 2.073 . . . . 0.0 111.466 -173.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 83.06 -10.21 1.03 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.822 2.849 . . . . 0.0 113.693 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.1 mt -73.37 166.83 22.46 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.48 0.5 OUTLIER -143.47 -161.24 1.23 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 169.431 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.5 mt -160.52 142.7 4.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 C-N-CA 129.769 3.228 . . . . 0.0 111.982 -165.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -124.64 161.55 19.08 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.917 0.77 . . . . 0.0 111.808 169.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -92.37 100.16 12.79 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.888 1.675 . . . . 0.0 108.019 173.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 13.8 tp . . . . . 0 CA--C 1.541 0.608 0 CA-C-N 114.013 -1.449 . . . . 0.0 108.89 168.813 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 67.1 t -110.97 138.02 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.42 1.088 . . . . 0.0 109.8 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -116.56 117.94 31.25 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.184 1.393 . . . . 0.0 108.834 169.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 tp -110.28 130.52 55.53 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 118.883 0.765 . . . . 0.0 111.78 169.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -115.92 114.47 24.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 123.717 1.722 . . . . 0.0 109.092 168.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -88.46 107.66 18.98 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 127.184 2.194 . . . . 0.0 111.859 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.65 122.02 34.65 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.737 0.815 . . . . 0.0 112.013 170.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.4 mtp -103.41 131.94 50.08 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.15 114.37 3.82 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 167.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.27 21.2 15.42 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.373 1.469 . . . . 0.0 113.989 -172.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.8 p . . . . . 0 N--CA 1.474 0.748 0 O-C-N 119.679 -1.888 . . . . 0.0 112.699 -169.866 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.3 t . . . . . 0 CA--C 1.542 0.649 0 CA-C-O 122.148 0.975 . . . . 0.0 108.736 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.46 84.51 0.18 Allowed Glycine 0 C--N 1.338 0.684 0 C-N-CA 127.184 2.326 . . . . 0.0 108.382 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -91.65 135.63 33.73 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -171.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.7 tp -116.61 139.19 44.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 124.83 1.252 . . . . 0.0 110.894 -171.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.5 159.28 24.8 Favored Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.428 1.014 . . . . 0.0 113.036 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -132.27 129.13 39.19 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.37 1.468 . . . . 0.0 113.556 -169.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.72 144.65 16.57 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 124.32 0.962 . . . . 0.0 113.513 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.6 m -114.65 136.31 53.19 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.629 1.572 . . . . 0.0 111.455 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.9 tt -156.46 149.94 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 120.578 -1.327 . . . . 0.0 112.402 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.524 HG21 ' H ' ' A' ' 50' ' ' ASN . 2.3 m -150.52 -66.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 125.586 1.554 . . . . 0.0 111.898 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.524 ' H ' HG21 ' A' ' 49' ' ' VAL 0.424 29.8 t30 168.99 -13.61 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.973 1 C-N-CA 133.251 4.62 . . . . 0.0 111.482 169.278 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.0 ttt -49.32 -38.9 29.44 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 165.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.274 10.6 t 164.13 -163.16 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.967 1 C-N-CA 133.06 4.544 . . . . 0.0 109.623 168.147 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -107.98 132.38 53.57 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.812 2.445 . . . . 0.0 105.805 168.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -127.85 125.79 40.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 122.59 1.186 . . . . 0.0 110.1 169.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.73 132.02 35.5 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.921 1.288 . . . . 0.0 110.576 169.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.54 -17.37 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.39 108.6 5.0 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.84 1.655 . . . . 0.0 112.253 176.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.5 ttpm? -61.39 154.25 24.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.561 1.544 . . . . 0.0 112.607 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.0 mt -50.71 112.54 0.72 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.719 0.69 . . . . 0.0 111.876 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.479 0.989 0 C-N-CA 124.999 1.32 . . . . 0.0 111.984 178.259 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 120.539 0.209 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.1 p -94.12 -143.57 0.24 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.426 1.49 . . . . 0.0 112.718 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.75 144.72 9.59 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.561 -1.337 . . . . 0.0 114.262 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -148.65 163.74 36.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.214 1.806 . . . . 0.0 112.84 175.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.9 mt -74.44 -59.85 2.54 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.887 1.275 . . . . 0.0 112.573 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.89 136.98 54.88 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.83 0.852 . . . . 0.0 111.965 -172.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.6 p -75.72 -34.59 1.56 Allowed Pre-proline 0 N--CA 1.475 0.821 0 CA-C-O 115.512 -2.185 . . . . 0.0 113.307 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.39 140.73 44.8 Favored 'Trans proline' 0 C--N 1.354 0.842 0 CA-C-N 123.078 2.135 . . . . 0.0 108.967 169.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -104.44 -177.18 3.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.65 0.78 . . . . 0.0 112.215 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.08 9.49 72.57 Favored Glycine 0 N--CA 1.483 1.777 0 C-N-CA 124.633 1.111 . . . . 0.0 114.829 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -35.45 -55.61 0.66 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 129.192 2.997 . . . . 0.0 118.667 -169.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.29 -18.5 65.22 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 121.526 1.966 . . . . 0.0 113.134 -174.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.32 -24.08 67.7 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.421 1.464 . . . . 0.0 112.411 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.41 -44.08 25.77 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.311 -1.493 . . . . 0.0 108.129 167.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.6 t -52.5 -42.32 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.277 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.439 HG12 HE21 ' A' ' 91' ' ' GLN . 8.3 p -62.71 -55.81 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.702 1.137 . . . . 0.0 111.783 171.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.439 HE21 HG12 ' A' ' 90' ' ' VAL . 77.1 mm-40 -66.21 -42.33 88.89 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.973 0.806 . . . . 0.0 110.914 -170.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.87 -33.07 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.362 1.065 . . . . 0.0 111.728 171.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.8 68.48 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.671 1.123 . . . . 0.0 111.985 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.289 0.0 OUTLIER -96.38 -14.22 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -169.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.467 ' HG ' HD23 ' A' ' 137' ' ' LEU . 0.1 OUTLIER -79.24 60.52 3.09 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 121.17 1.804 . . . . 0.0 112.351 173.133 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.9 mt -50.95 -40.11 56.64 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.899 1.68 . . . . 0.0 111.74 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.72 -31.02 41.67 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.158 0.885 . . . . 0.0 114.852 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -89.38 -39.74 13.21 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.607 1.203 . . . . 0.0 111.132 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.6 mm -65.73 -38.49 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 120.988 -1.07 . . . . 0.0 110.048 169.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.07 26.3 34.62 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.152 0.882 . . . . 0.0 113.182 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -55.97 130.57 44.37 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.229 1.014 . . . . 0.0 112.208 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.5 mtp-105 -104.41 -168.57 1.5 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.407 2.283 . . . . 0.0 111.958 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -86.03 -0.59 55.91 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 117.017 2.229 . . . . 0.0 117.017 -169.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.48 -132.75 3.3 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 120.917 1.69 . . . . 0.0 110.972 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.5 t -99.58 147.58 25.2 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.757 1.223 . . . . 0.0 108.954 174.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -132.15 124.8 29.8 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -125.01 110.15 13.83 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -169.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 25.8 tp -92.59 98.05 11.2 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.283 175.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 t -83.45 124.64 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 174.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.2 tp -109.65 112.39 24.43 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 118.81 -0.614 . . . . 0.0 110.214 -175.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.1 t -94.83 133.24 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.297 0.639 . . . . 0.0 111.649 172.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.2 t -166.13 151.01 8.2 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.441 1.088 . . . . 0.0 109.826 167.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -110.27 4.54 20.96 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -177.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -140.98 -177.98 5.35 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.156 1.383 . . . . 0.0 112.857 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -60.72 -177.13 0.07 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.72 1.608 . . . . 0.0 112.882 169.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -140.94 148.15 39.92 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.675 1.19 . . . . 0.0 112.136 -175.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -80.21 88.92 5.45 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.128 1.371 . . . . 0.0 113.182 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.78 165.43 3.98 Favored 'General case' 0 CA--C 1.551 0.99 0 O-C-N 120.395 -1.441 . . . . 0.0 111.83 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -46.91 140.63 4.6 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.684 -0.635 . . . . 0.0 112.387 171.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 89.11 -12.28 0.39 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 129.109 2.964 . . . . 0.0 113.192 -174.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -70.36 -10.53 59.29 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 119.864 1.211 . . . . 0.0 112.759 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -49.41 -28.97 5.72 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.352 1.861 . . . . 0.0 113.96 168.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 84.9 m -66.09 -31.22 71.96 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.763 2.025 . . . . 0.0 112.877 -168.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.2 -34.13 75.7 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.147 0.579 . . . . 0.0 111.571 174.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -84.47 7.77 71.3 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.65 1.595 . . . . 0.0 114.337 170.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.274 1.3 t 61.41 15.61 6.75 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 129.383 3.073 . . . . 0.0 116.057 173.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.1 mtp85 -99.84 144.09 29.31 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.146 -0.971 . . . . 0.0 109.836 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -126.28 -8.7 6.41 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -69.74 118.12 12.2 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.706 1.139 . . . . 0.0 109.371 170.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.7 t -76.92 164.99 25.28 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.758 -0.588 . . . . 0.0 110.647 171.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 96.7 p -64.18 138.85 58.65 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -173.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -82.44 -13.22 57.13 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 174.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.82 9.2 85.06 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.927 1.251 . . . . 0.0 114.199 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -102.12 175.87 5.38 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.669 1.234 . . . . 0.0 111.164 172.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.5 142.91 32.92 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -169.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -142.7 53.82 1.4 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.704 1.602 . . . . 0.0 112.791 -169.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.467 HD23 ' HG ' ' A' ' 95' ' ' CYS 0.273 0.0 OUTLIER -140.29 105.53 5.04 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.056 0.931 . . . . 0.0 111.27 169.946 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -89.26 -45.96 9.13 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.217 1.007 . . . . 0.0 111.328 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -97.05 8.28 44.84 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.444 2.297 . . . . 0.0 113.565 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.76 -12.29 62.7 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 125.747 1.642 . . . . 0.0 114.871 169.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 78.1 mtm -97.05 132.99 42.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.021 1.329 . . . . 0.0 110.375 171.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -64.71 99.03 0.3 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.671 0.748 . . . . 0.0 111.889 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -67.16 -36.34 81.59 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.487 1.515 . . . . 0.0 112.925 -170.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.7 p -85.71 4.47 36.53 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -50.51 -42.29 54.71 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 120.503 1.501 . . . . 0.0 112.278 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.2 -33.86 69.34 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 117.974 -1.459 . . . . 0.0 112.724 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.353 82.5 tt0 -89.28 -90.9 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.415 0 CA-C-O 116.112 -1.899 . . . . 0.0 112.537 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.11 156.94 56.16 Favored 'Trans proline' 0 C--N 1.357 1.01 0 CA-C-N 124.135 2.513 . . . . 0.0 116.052 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -62.95 166.3 5.88 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 129.459 3.104 . . . . 0.0 115.037 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -62.68 132.8 53.52 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 166.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -57.78 154.34 12.11 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.914 -1.117 . . . . 0.0 113.823 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 60.1 p -77.66 162.51 26.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.477 0.711 . . . . 0.0 112.296 174.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 50.9 t -61.36 -39.11 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 121.547 -0.721 . . . . 0.0 111.352 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.2 t -81.59 -19.51 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.48 -37.64 88.08 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.241 1.382 . . . . 0.0 108.623 169.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 28.7 mt -77.25 -31.41 55.02 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 116.153 -1.88 . . . . 0.0 114.595 171.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.01 -42.19 72.24 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 121.268 1.849 . . . . 0.0 110.994 169.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 11.4 t -62.82 -54.16 43.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.595 0.758 . . . . 0.0 111.387 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.4 tppt? -69.58 -38.87 77.53 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -170.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . 0.294 0.0 OUTLIER -68.77 -33.33 73.7 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.537 1.517 . . . . 0.0 111.529 175.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.7 -32.71 64.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -69.29 -46.04 68.15 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.844 1.257 . . . . 0.0 110.056 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -86.26 -8.88 57.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.724 0.81 . . . . 0.0 113.105 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 50.64 49.27 21.2 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.001 1.72 . . . . 0.0 112.456 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.1 mt -102.69 133.58 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-O 116.535 -1.698 . . . . 0.0 106.967 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -103.09 113.46 65.84 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 121.439 1.927 . . . . 0.0 110.365 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -67.36 152.79 78.52 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.074 3.183 . . . . 0.0 114.764 173.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.8 mm -134.26 104.29 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.595 1.558 . . . . 0.0 109.371 174.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -73.19 75.98 1.29 Allowed 'General case' 0 N--CA 1.478 0.928 0 O-C-N 119.849 -1.782 . . . . 0.0 112.387 175.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . 0.258 1.9 m -72.13 103.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 123.524 1.63 . . . . 0.0 111.15 169.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 29.0 m -143.05 166.35 20.87 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 120.33 -1.481 . . . . 0.0 110.447 -169.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -80.19 161.8 23.09 Favored 'Trans proline' 0 C--N 1.35 0.619 0 CA-C-N 122.856 2.056 . . . . 0.0 110.036 -172.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.5 t -52.97 -41.97 65.07 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.952 0.501 . . . . 0.0 111.916 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -54.68 -38.67 67.25 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.607 1.163 . . . . 0.0 113.698 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 19.6 mmt -99.75 -9.38 23.1 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.755 1.222 . . . . 0.0 114.175 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -61.89 -29.64 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 120.085 1.311 . . . . 0.0 113.329 -168.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -65.39 -25.07 67.4 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.13 -43.02 20.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.519 0.728 . . . . 0.0 109.955 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -71.02 -30.42 66.62 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.421 1.089 . . . . 0.0 110.535 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -65.81 -14.9 62.29 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.122 0.569 . . . . 0.0 111.829 168.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -96.47 -30.69 13.2 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.393 -0.817 . . . . 0.0 111.599 173.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.61 -25.59 61.37 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 119.979 -1.701 . . . . 0.0 110.03 175.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.1 t -72.49 -21.99 61.13 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.739 -0.601 . . . . 0.0 111.845 173.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 37.7 m -69.71 -29.74 67.2 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -88.46 -14.42 37.92 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 24.0 mt -120.35 87.85 41.11 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.1 0.96 . . . . 0.0 110.421 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.84 134.99 61.54 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.238 2.626 . . . . 0.0 112.903 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 65.2 mttm 85.06 -10.35 0.81 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 129.431 3.092 . . . . 0.0 113.914 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 10.2 tt -65.55 149.4 50.13 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.325 -0.86 . . . . 0.0 109.098 169.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 68.6 p -123.39 -170.22 2.08 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 169.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.0 141.53 2.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 127.083 2.153 . . . . 0.0 108.125 -167.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -132.67 150.86 19.8 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 170.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . 0.262 0.9 OUTLIER -91.44 88.71 6.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 123.128 1.442 . . . . 0.0 109.099 169.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 CA--C 1.539 0.531 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.654 169.602 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.03 144.81 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.931 0.892 . . . . 0.0 110.236 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.55 97.88 5.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.063 1.745 . . . . 0.0 108.388 172.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.1 mp -90.9 122.12 33.33 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 121.542 -0.724 . . . . 0.0 112.386 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -119.78 104.2 10.01 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 123.723 1.725 . . . . 0.0 111.13 172.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -85.46 114.72 22.71 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.411 1.885 . . . . 0.0 113.459 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.49 120.0 38.15 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.318 1.447 . . . . 0.0 111.154 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.0 mtp -100.12 144.0 29.66 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 169.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.9 98.19 2.31 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 168.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.69 33.75 0.52 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.201 1.5 . . . . 0.0 114.753 -169.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.477 0.901 0 O-C-N 119.889 -1.757 . . . . 0.0 113.408 173.113 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.1 p . . . . . 0 CA--C 1.546 0.821 0 CA-C-O 122.23 1.014 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.57 89.14 0.15 Allowed Glycine 0 C--N 1.339 0.736 0 C-N-CA 126.649 2.071 . . . . 0.0 108.801 -169.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.5 mmm-85 -77.27 138.11 39.2 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 tp -124.08 133.22 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.258 0.623 . . . . 0.0 110.48 -174.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.4 160.54 27.89 Favored Glycine 0 N--CA 1.474 1.202 0 C-N-CA 125.061 1.315 . . . . 0.0 112.722 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -138.69 135.41 34.77 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.006 0.923 . . . . 0.0 112.802 -169.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.39 146.1 18.04 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 124.742 1.163 . . . . 0.0 112.443 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.4 m -118.52 131.5 56.23 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.227 1.011 . . . . 0.0 111.233 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.6 tp -140.09 147.96 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.266 -0.896 . . . . 0.0 111.792 175.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -149.74 -107.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 103.652 -2.721 . . . . 0.0 103.652 168.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.41 ' C ' ' H ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -136.09 -2.1 2.34 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.605 1.162 . . . . 0.0 110.858 168.146 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.7 mtp -78.58 41.09 0.39 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.92 2.088 . . . . 0.0 108.354 168.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.315 1.4 t 53.71 -176.13 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 129.618 3.167 . . . . 0.0 113.261 -168.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -87.24 137.88 31.96 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.363 1.465 . . . . 0.0 109.443 174.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -123.73 121.88 36.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.88 1.324 . . . . 0.0 110.456 169.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -86.69 100.04 12.19 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.487 1.915 . . . . 0.0 110.291 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.0 mm -90.35 -21.22 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 118.164 -0.922 . . . . 0.0 112.887 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.7 tp -157.02 111.72 2.76 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 144.93 43.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.715 1.206 . . . . 0.0 110.939 168.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -61.71 125.26 23.18 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.298 0.953 . . . . 0.0 110.169 -175.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.47 0.542 0 C-N-CA 123.729 0.811 . . . . 0.0 112.182 -174.645 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 71.6 p -108.38 -152.16 0.48 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 126.328 1.851 . . . . 0.0 112.231 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.37 160.4 33.05 Favored Glycine 0 N--CA 1.475 1.247 0 O-C-N 120.196 -1.565 . . . . 0.0 114.13 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -155.89 156.88 35.4 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -56.37 -63.8 1.07 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.681 2.792 . . . . 0.0 113.261 176.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.22 149.21 44.8 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.353 1.061 . . . . 0.0 113.616 -172.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.1 m -72.36 -47.01 10.44 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-O 116.138 -1.886 . . . . 0.0 113.287 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -75.09 154.47 42.08 Favored 'Trans proline' 0 C--N 1.352 0.715 0 CA-C-N 122.302 1.858 . . . . 0.0 112.527 169.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -131.77 179.68 5.92 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.476 1.51 . . . . 0.0 113.455 -178.358 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.94 34.39 4.95 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 119.393 2.517 . . . . 0.0 119.393 -168.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -50.75 -33.53 23.52 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.62 1.71 . . . . 0.0 113.648 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.4 tp -62.69 -44.08 97.16 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -175.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.18 -46.35 82.89 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.252 0.621 . . . . 0.0 109.846 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.08 -58.51 8.34 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 118.496 -0.764 . . . . 0.0 111.034 173.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.4 m -64.99 -25.28 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 119.627 1.103 . . . . 0.0 113.168 -171.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.91 -51.74 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 118.083 -0.961 . . . . 0.0 112.16 169.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -57.03 -42.01 79.64 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.974 1.261 . . . . 0.0 110.41 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.3 t -57.4 -39.16 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.242 0.617 . . . . 0.0 112.238 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.67 -32.22 69.41 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.853 1.056 . . . . 0.0 113.853 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.0 tp -102.13 -15.42 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -170.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.59 ' CB ' ' HG ' ' A' ' 135' ' ' CYS . 0.1 OUTLIER -84.33 56.89 3.98 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.534 -1.354 . . . . 0.0 112.847 179.157 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.2 mt -55.72 -38.97 70.46 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.465 1.506 . . . . 0.0 111.88 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.02 -22.96 47.07 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.524 1.059 . . . . 0.0 114.668 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -92.3 -39.58 11.42 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.465 1.133 . . . . 0.0 111.563 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.7 mt -81.91 -29.18 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 118.822 0.737 . . . . 0.0 111.264 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.34 24.7 39.01 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.027 -0.874 . . . . 0.0 114.891 169.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -49.42 129.26 18.57 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.785 1.234 . . . . 0.0 112.91 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -111.85 173.03 6.55 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.876 1.27 . . . . 0.0 112.434 170.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -81.86 41.58 0.66 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 125.671 1.588 . . . . 0.0 115.107 -170.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.14 -126.45 5.5 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 120.592 -1.318 . . . . 0.0 110.437 170.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.6 t -115.96 134.07 55.36 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.638 1.975 . . . . 0.0 107.704 171.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -124.41 131.51 53.5 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.093 0.86 . . . . 0.0 110.218 -168.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -127.08 98.5 5.33 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -169.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.6 tt -81.9 99.16 8.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.152 172.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.1 t -87.84 124.11 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 174.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 65.4 tp -108.19 117.47 34.23 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.664 1.12 . . . . 0.0 109.267 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.16 128.39 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 124.158 0.911 . . . . 0.0 110.707 170.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.7 t -162.44 163.66 27.54 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.246 1.018 . . . . 0.0 110.882 170.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -121.25 -0.44 9.9 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 116.547 2.055 . . . . 0.0 116.547 -175.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -137.17 172.66 12.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.912 0.885 . . . . 0.0 111.831 172.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -53.43 176.56 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.946 1.699 . . . . 0.0 112.58 174.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -146.04 157.19 43.86 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 120.7 -1.25 . . . . 0.0 112.293 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -79.87 133.28 36.24 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.664 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 46.8 mt -100.74 175.07 5.77 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.189 1.796 . . . . 0.0 110.886 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -47.88 137.09 10.28 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.917 0.865 . . . . 0.0 112.828 172.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 69.5 tttt 83.58 -14.45 0.7 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 130.906 3.682 . . . . 0.0 113.719 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -63.22 -21.95 66.55 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.526 1.512 . . . . 0.0 113.4 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -78.18 -5.91 53.24 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.8 -16.75 63.88 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 120.621 1.555 . . . . 0.0 112.34 171.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 57.3 mt -63.25 -24.71 67.99 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.887 0.875 . . . . 0.0 111.515 169.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -90.35 -123.02 2.53 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 126.198 1.856 . . . . 0.0 109.301 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 p -126.64 0.13 6.8 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.577 1.551 . . . . 0.0 114.319 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -85.56 109.47 18.55 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.789 0.836 . . . . 0.0 111.285 -169.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -94.38 -28.71 15.38 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -87.17 122.23 30.7 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.702 -0.623 . . . . 0.0 112.491 -169.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.3 t -57.93 144.15 40.27 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.888 0.475 . . . . 0.0 110.388 169.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 42.0 t -59.75 140.9 56.16 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.637 0.775 . . . . 0.0 112.614 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.7 p30 -80.74 -13.51 58.93 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.88 14.42 78.47 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.477 1.037 . . . . 0.0 113.423 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -98.94 170.05 9.0 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.259 1.824 . . . . 0.0 110.536 172.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . 0.59 ' HG ' ' CB ' ' A' ' 95' ' ' CYS . 0.5 OUTLIER -100.41 145.35 28.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -139.47 45.6 1.93 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.307 1.843 . . . . 0.0 111.592 -170.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.4 tt -110.08 125.13 52.64 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.68 1.992 . . . . 0.0 108.907 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -131.19 -48.66 1.0 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.613 1.165 . . . . 0.0 112.8 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -84.42 -10.66 57.32 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.493 1.517 . . . . 0.0 113.677 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 108.51 -23.71 23.87 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.199 1.857 . . . . 0.0 111.477 -169.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 80.8 mmm -82.28 145.83 29.78 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.617 1.167 . . . . 0.0 111.259 172.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -77.47 99.04 5.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.174 0.589 . . . . 0.0 109.769 169.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 42.3 ttp-105 -63.28 -38.28 90.56 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.211 1.004 . . . . 0.0 113.563 -170.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.4 p -88.56 7.37 33.55 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -168.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -47.53 -39.7 16.95 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 121.277 1.853 . . . . 0.0 112.461 169.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.13 -0.65 86.49 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 117.8 -1.555 . . . . 0.0 115.789 -174.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -127.35 -65.8 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 119.889 1.845 . . . . 0.0 110.387 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -58.98 147.25 90.86 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.498 2.799 . . . . 0.0 115.625 168.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -69.46 169.34 12.66 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 128.503 2.721 . . . . 0.0 112.87 169.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -69.0 158.06 35.52 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.423 -1.423 . . . . 0.0 108.211 168.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -78.62 157.45 28.68 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.314 -0.866 . . . . 0.0 111.257 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 92.9 p -92.81 156.18 17.16 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.248 -0.907 . . . . 0.0 110.684 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.26 -34.37 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.344 -0.848 . . . . 0.0 112.571 -171.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.9 t -69.93 -33.66 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.412 1.085 . . . . 0.0 111.596 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -68.8 -34.45 75.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.499 0.72 . . . . 0.0 111.144 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.26 -55.95 15.49 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.009 0.924 . . . . 0.0 110.253 174.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.97 76.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.041 0.937 . . . . 0.0 111.448 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.8 t -58.47 -71.43 0.11 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.166 0.986 . . . . 0.0 111.847 172.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -66.85 -34.48 77.89 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.76 -26.58 63.42 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.163 1.347 . . . . 0.0 112.866 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.1 -43.69 64.4 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.768 1.167 . . . . 0.0 113.46 173.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -80.53 -30.67 37.14 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.885 0.766 . . . . 0.0 112.578 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -82.48 -5.56 58.78 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.983 0.81 . . . . 0.0 112.242 168.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 60.64 46.91 8.78 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.007 1.323 . . . . 0.0 111.75 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 29.4 mm -100.36 135.51 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.934 1.293 . . . . 0.0 108.057 174.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -100.64 114.35 65.75 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 120.477 1.49 . . . . 0.0 109.903 170.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -74.74 145.11 32.11 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.035 1.824 . . . . 0.0 110.594 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 31.5 mt -128.73 102.08 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 125.126 1.37 . . . . 0.0 107.418 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -74.37 72.8 1.84 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.415 1.102 . . . . 0.0 112.342 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 85.3 t -70.59 97.75 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 O-C-N 120.621 -1.299 . . . . 0.0 111.193 173.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 25.4 m -147.92 145.16 20.23 Favored Pre-proline 0 N--CA 1.484 1.237 0 O-C-N 120.367 -1.458 . . . . 0.0 112.879 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -60.81 156.55 42.66 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 125.111 3.874 . . . . 0.0 116.705 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.5 t -46.62 -58.31 3.95 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.978 1.711 . . . . 0.0 114.471 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -14.67 21.8 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -171.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.0 ptm -109.3 -1.6 18.44 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.308 1.443 . . . . 0.0 114.872 172.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.2 t -65.46 -33.39 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 120.23 -1.544 . . . . 0.0 111.97 -170.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -70.74 -23.68 62.48 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.861 1.21 . . . . 0.0 113.241 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . 0.262 2.4 t -87.18 -13.39 44.1 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.059 -1.026 . . . . 0.0 112.405 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -96.38 -33.72 11.81 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.073 1.349 . . . . 0.0 109.879 168.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.62 -26.7 65.48 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.724 -1.235 . . . . 0.0 111.997 176.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -74.0 -23.48 59.45 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.052 -1.655 . . . . 0.0 110.445 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 35.5 tp -85.02 -19.48 31.93 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.304 1.842 . . . . 0.0 110.824 174.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.6 p -83.65 -6.94 59.57 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.383 0.538 . . . . 0.0 112.019 169.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 6.9 m -88.22 -34.56 17.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.678 1.591 . . . . 0.0 108.865 169.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -79.7 -37.34 35.94 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 174.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 51.0 mt -101.16 113.27 65.82 Favored Pre-proline 0 N--CA 1.478 0.963 0 CA-C-O 118.247 -0.882 . . . . 0.0 108.949 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.7 145.2 40.91 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.577 2.185 . . . . 0.0 111.423 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt 73.55 3.98 4.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 127.117 2.167 . . . . 0.0 113.736 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.69 142.6 46.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.994 1.718 . . . . 0.0 109.052 169.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 76.5 p -108.55 -158.19 0.64 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.8 tt 177.15 136.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 126.983 2.113 . . . . 0.0 110.129 -168.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -129.57 132.45 7.09 Favored Glycine 0 N--CA 1.469 0.892 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -81.99 79.12 8.59 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 124.069 1.89 . . . . 0.0 109.814 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 28.1 tp . . . . . 0 CA--C 1.546 0.826 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.662 174.734 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 t -94.3 155.08 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -151.89 101.63 2.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.345 1.069 . . . . 0.0 109.603 169.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.19 142.92 27.06 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.314 1.046 . . . . 0.0 111.717 -171.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -124.45 111.77 16.12 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 123.889 1.804 . . . . 0.0 110.861 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -83.64 101.83 11.78 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.868 -1.969 . . . . 0.0 111.921 175.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.9 tp -102.73 113.28 26.55 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.748 0.819 . . . . 0.0 111.093 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.1 ptm -120.77 151.24 39.82 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.55 141.26 23.56 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.52 1.533 . . . . 0.0 113.348 173.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.43 32.09 5.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.26 1.824 . . . . 0.0 112.255 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.3 p . . . . . 0 N--CA 1.474 0.773 0 O-C-N 119.91 -1.744 . . . . 0.0 112.194 171.289 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 122.486 1.136 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.96 88.34 0.13 Allowed Glycine 0 C--N 1.336 0.529 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -169.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -73.5 148.24 43.3 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -174.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.6 tt -123.17 135.63 62.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -139.99 161.15 26.34 Favored Glycine 0 N--CA 1.464 0.557 0 C-N-CA 125.361 1.458 . . . . 0.0 110.722 172.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -139.17 138.22 36.75 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -169.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.25 145.27 15.92 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 124.491 1.043 . . . . 0.0 112.578 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.3 m -116.13 136.22 53.21 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 125.284 1.434 . . . . 0.0 110.522 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.18 155.31 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.534 1.134 . . . . 0.0 111.197 176.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.1 p -151.93 -65.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 120.656 -1.277 . . . . 0.0 109.02 168.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 177.06 -19.66 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 130.237 3.415 . . . . 0.0 110.081 169.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 54.0 ttm -50.1 -36.84 31.23 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.009 1.324 . . . . 0.0 110.029 167.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t 167.1 -172.39 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 131.465 3.906 . . . . 0.0 109.782 169.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -103.88 131.28 51.25 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 167.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.6 pm0 -130.26 124.38 32.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 123.064 1.411 . . . . 0.0 110.793 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -94.23 104.68 16.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.14 2.176 . . . . 0.0 109.924 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . 0.361 0.0 OUTLIER -91.22 -70.01 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 117.583 -1.199 . . . . 0.0 110.799 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.8 124.49 38.87 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 121.287 1.858 . . . . 0.0 114.74 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -67.08 168.94 9.24 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.558 1.143 . . . . 0.0 110.336 167.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.5 mt -62.1 123.22 17.53 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.276 -0.89 . . . . 0.0 109.349 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 124.839 1.256 . . . . 0.0 111.291 -176.556 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.0 t . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 121.208 0.528 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.5 t -113.44 -169.51 1.51 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 127.369 2.268 . . . . 0.0 112.173 -175.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -153.65 153.86 25.12 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.162 1.363 . . . . 0.0 113.661 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -152.49 160.12 43.27 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.186 1.794 . . . . 0.0 111.037 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -87.81 -32.75 18.89 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -174.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.76 143.05 38.29 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.666 0.786 . . . . 0.0 110.026 174.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.319 13.8 t -73.56 -41.37 5.87 Favored Pre-proline 0 N--CA 1.479 0.977 0 CA-C-O 116.341 -1.79 . . . . 0.0 113.969 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.79 137.62 54.54 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.649 2.233 . . . . 0.0 113.852 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -82.67 155.93 24.1 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.932 1.693 . . . . 0.0 113.528 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.77 45.5 3.22 Favored Glycine 0 N--CA 1.485 1.916 0 O-C-N 120.399 -1.438 . . . . 0.0 109.698 168.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -74.71 -39.91 61.63 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -168.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . 0.26 5.9 mp -68.75 -30.21 68.78 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 117.042 -1.456 . . . . 0.0 110.742 -173.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -57.37 -39.53 76.21 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.979 1.718 . . . . 0.0 111.899 169.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.53 -47.38 86.43 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.302 -1.499 . . . . 0.0 111.176 170.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.0 t -54.44 -31.83 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.389 1.076 . . . . 0.0 112.382 172.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.423 ' HA ' HD22 ' A' ' 156' ' ' LEU . 40.9 t -64.75 -65.0 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.592 0.757 . . . . 0.0 111.258 172.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -69.77 -32.62 71.21 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.086 -0.959 . . . . 0.0 112.048 -169.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.53 -20.85 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.922 1.237 . . . . 0.0 113.403 171.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.02 -45.51 16.46 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 120.057 1.299 . . . . 0.0 112.295 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.5 mt -88.19 -19.85 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.45 60.11 5.83 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 119.996 -1.69 . . . . 0.0 111.698 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mp -48.26 -38.58 19.02 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.185 1.394 . . . . 0.0 111.128 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.83 -29.64 31.39 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.602 1.096 . . . . 0.0 115.497 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -89.65 -46.36 8.69 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 118.94 1.37 . . . . 0.0 110.624 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.9 mm -60.67 -49.54 84.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 172.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.61 29.51 8.19 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.177 0.894 . . . . 0.0 113.815 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.2 m95 -54.84 119.93 6.09 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 118.46 1.13 . . . . 0.0 111.462 174.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -95.82 -144.43 0.27 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.41 1.484 . . . . 0.0 111.96 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -102.1 -10.35 19.75 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 -169.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.16 -126.41 1.6 Allowed Glycine 0 C--N 1.349 1.264 0 CA-C-N 120.895 1.68 . . . . 0.0 112.86 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.4 t -112.26 147.53 36.07 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.311 1.845 . . . . 0.0 110.037 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.73 132.99 29.88 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 119.73 1.15 . . . . 0.0 113.198 -169.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -123.8 104.94 9.26 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -169.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.8 tp -85.6 88.66 7.56 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.847 172.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.3 t -79.13 123.7 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 174.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.5 tp -117.2 111.66 19.75 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 123.814 0.696 . . . . 0.0 109.503 -169.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.34 133.26 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 t -165.62 158.42 15.51 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.683 169.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -106.14 -5.51 19.29 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -174.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -138.57 -179.9 6.08 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.514 1.526 . . . . 0.0 111.423 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.11 -171.33 0.11 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.688 1.595 . . . . 0.0 113.478 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -144.81 150.42 37.13 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.109 1.364 . . . . 0.0 112.499 -170.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -74.16 133.6 42.78 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.859 0.864 . . . . 0.0 110.333 169.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.95 175.22 5.55 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.273 1.429 . . . . 0.0 109.784 170.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.91 142.54 19.07 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.836 -0.54 . . . . 0.0 111.263 169.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 86.31 -18.06 0.35 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 129.217 3.007 . . . . 0.0 112.667 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -71.58 -19.1 62.19 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 121.061 1.755 . . . . 0.0 113.0 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -74.22 -16.15 60.98 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.499 -1.375 . . . . 0.0 113.876 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.302 9.5 t -74.7 -6.63 49.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 119.556 1.071 . . . . 0.0 113.201 174.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.1 mp -64.93 -24.09 67.42 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.104 -0.998 . . . . 0.0 109.752 167.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -88.65 -123.56 2.14 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 168.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 64.1 p -126.97 16.15 7.35 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.337 1.455 . . . . 0.0 114.1 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.36 125.72 50.84 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.652 1.181 . . . . 0.0 111.932 -169.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -130.43 -20.3 2.98 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -71.52 124.58 24.98 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 121.078 1.763 . . . . 0.0 110.111 170.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.3 t -75.4 147.23 40.16 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.139 0.575 . . . . 0.0 110.722 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.4 t -63.72 135.58 56.8 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.064 1.412 . . . . 0.0 112.602 -175.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -73.94 -10.53 59.74 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.55 2.74 . . . . 0.0 114.832 -170.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.86 15.99 80.63 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.222 -1.321 . . . . 0.0 114.182 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -113.15 170.26 8.34 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.175 1.488 . . . . 0.0 110.632 169.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.3 153.24 18.12 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -169.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -147.88 45.44 1.09 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.027 1.331 . . . . 0.0 113.803 -169.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.41 150.14 20.92 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.342 1.057 . . . . 0.0 109.584 169.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -141.6 -67.79 0.39 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.856 0.862 . . . . 0.0 111.538 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -84.73 -2.64 57.88 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.524 1.53 . . . . 0.0 113.716 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.29 -8.72 38.36 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.217 1.865 . . . . 0.0 114.387 -175.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 92.4 mtp -93.41 148.94 21.62 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.308 2.054 . . . . 0.0 111.088 170.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -70.92 100.7 2.0 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.927 -1.108 . . . . 0.0 110.746 173.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -48.36 80.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.355 1.062 . . . . 0.0 110.821 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 43.5 m -74.44 8.06 2.5 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -175.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.25 -24.61 59.9 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.834 -1.166 . . . . 0.0 111.881 169.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.7 -45.23 7.94 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 118.007 -1.441 . . . . 0.0 113.574 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.303 1.7 pm0 -97.97 -62.78 0.11 Allowed Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -169.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -58.54 149.26 76.65 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.438 2.758 . . . . 0.0 117.625 169.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -74.81 161.15 29.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.87 2.468 . . . . 0.0 111.631 169.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -59.73 131.74 51.82 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 168.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -81.94 157.06 24.43 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 121.153 1.797 . . . . 0.0 112.624 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.3 m -67.8 152.42 45.6 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.111 0.964 . . . . 0.0 113.101 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.15 -26.36 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -169.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.9 m -85.21 -16.17 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -70.03 -27.14 64.42 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.752 1.16 . . . . 0.0 108.494 168.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 90' ' ' VAL . 15.2 mt -84.22 -32.87 24.28 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 117.286 -1.34 . . . . 0.0 114.036 169.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -54.23 -37.37 64.55 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 120.853 1.661 . . . . 0.0 112.398 171.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 89.2 p -68.41 -55.03 13.33 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.835 -0.54 . . . . 0.0 112.119 173.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -66.01 -29.74 70.16 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.6 mp -58.33 -54.58 45.4 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.412 1.085 . . . . 0.0 111.383 170.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.56 -24.63 58.95 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.15 -39.8 63.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.5 1.12 . . . . 0.0 111.022 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -95.52 1.09 53.77 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 174.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 66.89 30.86 7.53 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.314 1.846 . . . . 0.0 113.863 169.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 48.7 mt -89.64 137.86 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 120.705 -1.247 . . . . 0.0 109.603 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -104.59 97.53 12.55 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -74.12 150.37 42.64 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.132 1.888 . . . . 0.0 113.465 173.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 34.9 mm -139.17 106.28 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.715 1.206 . . . . 0.0 109.702 -174.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -73.01 65.62 0.76 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.657 1.183 . . . . 0.0 113.207 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.69 108.6 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 122.401 1.096 . . . . 0.0 111.187 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 28.3 m -146.3 142.01 17.07 Favored Pre-proline 0 N--CA 1.48 1.039 0 O-C-N 119.873 -1.767 . . . . 0.0 110.708 -174.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -54.17 150.78 30.88 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.197 2.598 . . . . 0.0 114.542 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.3 t -44.79 -45.04 9.83 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.347 1.859 . . . . 0.0 114.031 -170.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.33 -36.97 6.84 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.698 1.599 . . . . 0.0 113.782 -172.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.5 mtt -123.62 19.19 9.55 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.741 1.217 . . . . 0.0 114.08 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.2 t -59.52 -37.5 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 O-C-N 120.488 -1.382 . . . . 0.0 110.589 174.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -22.74 66.06 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -170.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.2 t -91.24 -33.21 15.46 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.872 1.269 . . . . 0.0 111.249 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -70.95 -37.02 72.82 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.577 -1.327 . . . . 0.0 110.324 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . 0.353 14.8 pt-20 -73.43 -2.67 23.36 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 169.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -88.63 -43.64 11.2 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.23 -0.919 . . . . 0.0 109.869 169.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . 0.264 4.8 mp -83.84 -10.08 58.3 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 119.288 -2.133 . . . . 0.0 111.93 -174.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 15.1 t -78.16 -19.64 53.57 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 167.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . 0.279 1.3 t -77.41 -19.94 55.38 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 120.881 -1.137 . . . . 0.0 109.655 168.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -83.47 -24.19 31.88 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.345 0.658 . . . . 0.0 111.373 168.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.87 78.71 23.71 Favored Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 124.618 1.167 . . . . 0.0 111.542 170.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.52 142.1 93.85 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.183 1.922 . . . . 0.0 112.122 176.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 62.6 mttm 95.17 -20.34 0.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 131.636 3.975 . . . . 0.0 113.331 -171.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.7 tt -71.03 157.48 38.14 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.495 0.1 OUTLIER -135.36 -160.64 1.07 Allowed 'General case' 0 C--N 1.346 0.416 0 O-C-N 120.009 -1.682 . . . . 0.0 108.169 169.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.97 156.29 10.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 129.025 2.93 . . . . 0.0 108.893 -168.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -137.56 134.76 7.17 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 171.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -83.12 82.21 8.35 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 169.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 20.0 tp . . . . . 0 CA--C 1.544 0.73 0 CA-C-N 113.481 -1.691 . . . . 0.0 110.609 169.865 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.543 0.703 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.2 t -125.1 140.67 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.328 1.451 . . . . 0.0 109.327 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -124.6 99.39 6.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.296 1.439 . . . . 0.0 109.194 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.0 123.31 40.69 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.181 -0.95 . . . . 0.0 111.128 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -105.45 105.94 16.21 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 123.701 1.715 . . . . 0.0 109.282 169.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -81.83 112.5 19.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.563 173.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 tt -111.34 131.54 55.09 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.372 -0.83 . . . . 0.0 112.841 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 28.4 mtp -110.61 148.49 32.1 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.57 121.35 6.45 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.578 1.561 . . . . 0.0 109.209 168.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.54 36.38 3.11 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.06 1.744 . . . . 0.0 111.697 -175.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.4 p . . . . . 0 C--N 1.324 -0.515 0 C-N-CA 125.705 1.602 . . . . 0.0 113.479 177.46 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 CA--C 1.545 0.773 0 CA-C-O 122.889 1.328 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.06 84.27 0.31 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 105.627 -2.989 . . . . 0.0 105.627 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 -84.58 133.92 34.41 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.529 1.532 . . . . 0.0 107.774 -169.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.4 tt -125.97 144.41 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 119.545 1.066 . . . . 0.0 112.296 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.27 153.61 21.98 Favored Glycine 0 N--CA 1.461 0.329 0 C-N-CA 125.84 1.686 . . . . 0.0 110.263 -176.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -138.07 130.57 29.32 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -169.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.68 149.69 20.09 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 124.92 1.247 . . . . 0.0 112.901 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.3 p -119.65 144.11 47.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.657 1.183 . . . . 0.0 111.553 174.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.98 150.44 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.518 -1.364 . . . . 0.0 108.961 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.1 t -138.36 -68.92 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 170.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.273 1.5 t-20 170.15 -4.05 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.82 1 C-N-CA 134.046 4.938 . . . . 0.0 109.477 169.421 . . . . . . . . 3 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -54.33 -39.72 67.31 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.118 0.967 . . . . 0.0 109.61 167.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 p 163.74 170.65 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.117 1 C-N-CA 134.355 5.062 . . . . 0.0 108.43 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -89.16 131.21 35.4 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 166.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -123.4 130.31 52.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.677 1.227 . . . . 0.0 110.186 177.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -104.01 104.73 14.73 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.866 2.066 . . . . 0.0 110.429 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.96 -9.35 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -173.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.4 tt -157.34 117.22 3.42 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.553 1.069 . . . . 0.0 109.927 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.02 163.74 18.68 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.825 0.85 . . . . 0.0 113.272 172.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.428 HD13 ' CE3' ' A' ' 101' ' ' TRP . 87.4 mt -49.08 104.02 0.06 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.592 1.557 . . . . 0.0 113.334 -169.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.483 1.213 0 C-N-CA 126.502 1.921 . . . . 0.0 111.221 179.458 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.8 t . . . . . 0 CA--C 1.545 0.764 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 t -101.66 -155.9 0.54 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 125.971 1.708 . . . . 0.0 112.17 172.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -146.86 150.33 22.58 Favored Glycine 0 N--CA 1.478 1.483 0 O-C-N 120.048 -1.657 . . . . 0.0 116.019 -173.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -149.75 162.38 40.37 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.918 2.087 . . . . 0.0 113.262 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -32.1 13.0 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 173.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -94.96 132.11 40.16 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.229 0.922 . . . . 0.0 110.318 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.8 p -74.25 -31.46 1.26 Allowed Pre-proline 0 N--CA 1.472 0.675 0 CA-C-O 114.274 -2.774 . . . . 0.0 115.427 -172.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -68.48 144.95 63.08 Favored 'Trans proline' 0 C--N 1.353 0.771 0 CA-C-N 123.893 2.426 . . . . 0.0 112.264 169.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -98.48 -177.3 3.64 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.889 1.276 . . . . 0.0 112.286 -176.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.96 18.28 37.07 Favored Glycine 0 N--CA 1.481 1.652 0 C-N-CA 125.621 1.581 . . . . 0.0 114.327 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -46.72 -39.18 11.11 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -169.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . 0.466 5.1 mp -80.49 7.92 8.84 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 119.899 1.227 . . . . 0.0 113.417 -177.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -80.41 -49.84 10.91 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 165.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.44 -45.23 94.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 116.893 -1.527 . . . . 0.0 112.369 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -49.95 -36.93 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 120.511 1.505 . . . . 0.0 111.653 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 63.1 t -82.59 -45.14 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.172 0.989 . . . . 0.0 111.4 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -59.57 -49.8 76.38 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.524 1.056 . . . . 0.0 109.672 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.2 t -55.97 -42.08 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.203 1.001 . . . . 0.0 111.976 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.69 85.52 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.091 -1.006 . . . . 0.0 112.919 177.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.26 -24.91 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.988 1.315 . . . . 0.0 113.667 -169.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 61.78 3.93 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.812 1.645 . . . . 0.0 110.871 -176.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.4 mt -56.23 -38.63 71.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.072 1.349 . . . . 0.0 112.0 -170.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.01 -34.49 23.98 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.877 0.751 . . . . 0.0 113.47 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -81.66 -45.4 15.81 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 125.334 1.453 . . . . 0.0 110.472 -175.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.8 mm -70.69 -33.31 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 118.915 0.78 . . . . 0.0 110.455 170.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.16 31.5 16.86 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.452 1.025 . . . . 0.0 114.542 174.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.428 ' CE3' HD13 ' A' ' 59' ' ' LEU . 23.1 m95 -56.54 129.45 40.89 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.88 1.272 . . . . 0.0 113.096 -177.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.17 170.66 7.83 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.651 1.18 . . . . 0.0 112.55 169.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -74.42 49.49 0.38 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 127.307 2.243 . . . . 0.0 114.053 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.84 -131.02 6.44 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 170.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.9 m -119.33 132.59 55.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.568 2.347 . . . . 0.0 105.7 177.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -124.61 124.79 42.98 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 119.084 0.856 . . . . 0.0 111.405 -168.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -114.04 112.47 23.31 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 123.977 0.798 . . . . 0.0 110.783 -175.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.5 tp -93.44 105.92 17.94 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 170.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.1 t -89.43 125.58 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 172.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -111.03 115.87 30.2 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.72 130.88 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 123.674 0.609 . . . . 0.0 112.611 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.4 t -158.17 164.24 36.77 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.305 1.042 . . . . 0.0 111.453 171.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -112.49 -4.36 14.22 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.85 2.06 . . . . 0.0 114.124 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -137.49 -177.36 4.75 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.476 -1.39 . . . . 0.0 113.439 171.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -61.86 -174.64 0.05 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.333 2.253 . . . . 0.0 112.262 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -140.6 139.46 34.93 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.426 1.09 . . . . 0.0 111.904 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -68.67 108.35 3.34 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.564 1.146 . . . . 0.0 111.721 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.04 177.54 3.68 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.375 0.607 . . . . 0.0 111.527 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.27 148.14 23.5 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.22 -0.925 . . . . 0.0 112.295 172.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? 78.6 -11.19 1.24 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 128.099 2.56 . . . . 0.0 112.668 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.95 -32.5 74.26 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.532 1.133 . . . . 0.0 112.398 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -70.09 0.84 5.41 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 178.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.2 t -58.82 -33.04 69.94 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.052 -1.03 . . . . 0.0 112.417 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 126' ' ' THR . 62.6 tp -65.82 -40.89 92.26 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.635 0.774 . . . . 0.0 111.473 171.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.88 27.03 1.13 Allowed Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.588 1.566 . . . . 0.0 113.392 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.443 ' H ' ' C ' ' A' ' 124' ' ' LEU . 62.7 p 61.94 5.89 1.53 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 131.536 3.935 . . . . 0.0 117.038 169.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . 0.3 48.1 mtt180 -109.99 140.75 43.65 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.939 1.245 . . . . 0.0 114.144 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -109.73 -32.37 7.11 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.14 2.576 . . . . 0.0 114.691 -168.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -71.35 123.41 22.25 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.821 0.737 . . . . 0.0 111.292 -173.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.0 t -57.73 158.25 6.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.489 1.116 . . . . 0.0 110.68 172.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.7 t -70.15 134.43 48.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.977 0.894 . . . . 0.0 111.11 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 p30 -78.13 -12.03 59.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.633 1.573 . . . . 0.0 112.647 170.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.19 8.11 73.65 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.876 1.227 . . . . 0.0 114.764 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -78.14 174.02 11.61 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.896 1.348 . . . . 0.0 109.023 168.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -93.13 148.25 22.18 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 171.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -136.2 27.57 3.17 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.886 1.674 . . . . 0.0 112.232 -171.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.3 mt -87.66 153.12 21.62 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.87 0.868 . . . . 0.0 111.008 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -148.0 -67.21 0.24 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.399 1.079 . . . . 0.0 111.44 172.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.22 9.07 27.1 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.721 1.608 . . . . 0.0 113.729 176.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 105.98 -5.47 39.5 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.803 1.668 . . . . 0.0 115.213 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -113.17 149.16 34.03 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.643 1.721 . . . . 0.0 112.277 174.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -70.71 86.61 0.67 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.456 1.102 . . . . 0.0 112.107 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -49.05 -45.11 42.34 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.067 1.347 . . . . 0.0 111.833 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 71.8 m -77.73 -0.14 25.79 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -173.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.4 ttp85 -52.43 -40.33 62.07 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 121.171 1.805 . . . . 0.0 111.658 169.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.7 -25.09 75.92 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 117.617 -1.657 . . . . 0.0 113.156 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.355 42.7 tt0 -96.84 -92.06 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.328 0 CA-C-O 115.465 -2.207 . . . . 0.0 112.041 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.97 152.94 54.71 Favored 'Trans proline' 0 C--N 1.359 1.081 0 CA-C-N 124.241 2.55 . . . . 0.0 116.395 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.01 163.35 7.98 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.819 2.448 . . . . 0.0 114.72 170.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -60.85 139.9 57.82 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 167.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.551 ' NE2' ' H ' ' A' ' 151' ' ' GLN . 0.1 OUTLIER -84.11 150.57 25.46 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.613 -1.305 . . . . 0.0 112.396 -174.55 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.1 t -68.85 148.67 49.91 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.401 0.68 . . . . 0.0 111.805 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.0 t -55.85 -29.47 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.565 1.146 . . . . 0.0 111.802 -177.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.3 -40.66 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.34 1.056 . . . . 0.0 112.138 173.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -65.41 -35.87 82.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.327 0.651 . . . . 0.0 110.141 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.2 mt -61.8 -58.12 9.22 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 173.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -54.24 -41.12 68.38 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.486 1.114 . . . . 0.0 112.919 -175.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.8 t -59.65 -54.14 49.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.886 0.874 . . . . 0.0 111.525 173.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -73.64 -33.95 64.75 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.824 -1.173 . . . . 0.0 112.903 -172.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 mt -61.1 -38.23 85.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.401 1.001 . . . . 0.0 111.978 170.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.63 -33.41 64.52 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.114 0.966 . . . . 0.0 113.514 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -68.35 -47.3 67.83 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.641 1.177 . . . . 0.0 110.496 176.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -74.45 -17.37 60.79 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.492 0.717 . . . . 0.0 111.871 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 62.84 49.26 3.71 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.964 1.706 . . . . 0.0 111.514 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.51 125.79 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.82 1.248 . . . . 0.0 108.465 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -91.42 119.79 68.51 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-O 118.38 -0.819 . . . . 0.0 108.805 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.18 152.59 14.09 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.635 2.223 . . . . 0.0 110.603 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.8 mm -138.54 105.4 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.008 1.323 . . . . 0.0 109.379 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -77.96 82.6 4.31 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.428 -1.42 . . . . 0.0 112.46 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 87.9 t -70.28 104.91 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.14 -1.391 . . . . 0.0 112.31 169.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.11 144.79 22.45 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -171.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -63.96 154.17 71.65 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 124.742 3.628 . . . . 0.0 114.912 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.7 m -41.22 -51.04 3.59 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.428 2.291 . . . . 0.0 114.877 -169.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -54.54 -26.37 31.53 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 8.9 ttm -106.02 -8.48 17.52 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.565 1.946 . . . . 0.0 114.073 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 40.1 t -55.56 -47.04 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.902 -1.124 . . . . 0.0 112.148 -168.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . 0.317 11.4 pttm -81.09 -6.18 58.51 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -174.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . 0.255 4.8 t -86.92 -26.87 23.68 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 119.337 0.971 . . . . 0.0 111.129 169.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -83.49 -23.25 32.25 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.694 -1.254 . . . . 0.0 111.471 172.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -34.8 78.49 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.16 -0.963 . . . . 0.0 109.357 167.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . 0.395 0.1 OUTLIER -83.48 1.08 43.47 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 119.915 -1.74 . . . . 0.0 112.893 -178.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -98.56 -25.98 14.56 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.965 2.506 . . . . 0.0 107.407 168.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.23 -18.11 53.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.949 -1.094 . . . . 0.0 113.897 176.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 5.3 t -85.3 -24.14 27.82 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.226 0.61 . . . . 0.0 110.004 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -79.62 -38.09 34.65 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.527 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 35.4 mt -108.66 98.63 29.7 Favored Pre-proline 0 N--CA 1.484 1.227 0 CA-C-N 118.81 0.732 . . . . 0.0 110.037 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -55.06 144.89 66.87 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.215 2.61 . . . . 0.0 112.421 169.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 78.49 -2.47 2.37 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 128.227 2.611 . . . . 0.0 114.849 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 23.2 tp -74.47 152.72 39.39 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.785 1.234 . . . . 0.0 108.464 168.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.3 m -121.12 -153.1 0.53 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 177.83 114.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.427 2.291 . . . . 0.0 108.857 -167.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -109.62 147.1 17.03 Favored Glycine 0 N--CA 1.471 1.001 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 171.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . 0.362 0.9 OUTLIER -95.53 95.66 8.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 124.053 1.882 . . . . 0.0 110.568 177.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 31.1 tp . . . . . 0 CA--C 1.539 0.547 0 CA-C-N 111.326 -2.67 . . . . 0.0 111.692 172.248 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -72.95 159.24 34.01 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.186 -1.571 . . . . 0.0 113.217 -176.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.4 m -62.42 131.94 50.9 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.291 -0.881 . . . . 0.0 113.16 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.88 142.47 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.48 1.512 . . . . 0.0 109.377 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -119.46 113.17 20.36 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.083 1.753 . . . . 0.0 108.327 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.21 126.24 51.98 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.725 -0.609 . . . . 0.0 109.977 177.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -114.62 108.91 17.44 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 123.572 1.653 . . . . 0.0 111.284 174.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -84.01 99.2 10.27 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 112.713 -2.04 . . . . 0.0 113.584 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.4 mt -91.59 129.26 37.59 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.828 0.851 . . . . 0.0 109.675 168.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . 0.253 2.7 ppp? -137.45 156.63 47.95 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 169.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.02 131.81 10.63 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.149 1.833 . . . . 0.0 113.156 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.8 mp -107.42 29.57 7.04 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.917 2.087 . . . . 0.0 111.891 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.6 p -74.31 159.91 31.79 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.328 -1.483 . . . . 0.0 113.025 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.97 -33.08 82.42 Favored Glycine 0 N--CA 1.473 1.128 0 O-C-N 120.892 -1.13 . . . . 0.0 111.607 173.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.1 m -65.91 -26.24 67.52 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.258 1.423 . . . . 0.0 113.127 172.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.83 -7.62 53.98 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 137.79 51.75 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 120.891 1.678 . . . . 0.0 108.717 169.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.5 -41.06 3.05 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.334 0.969 . . . . 0.0 110.971 -169.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -80.29 -10.87 59.76 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.468 1.107 . . . . 0.0 111.191 168.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.3 tp -58.12 -52.86 63.77 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.364 1.066 . . . . 0.0 109.819 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.1 p -49.7 -45.38 48.93 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.088 0.955 . . . . 0.0 112.326 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -64.6 -35.14 80.04 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.993 0.917 . . . . 0.0 111.637 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 p -89.96 3.3 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -93.64 -51.66 4.83 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 169.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.5 t -59.95 -45.29 93.11 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.633 1.173 . . . . 0.0 110.318 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.5 tp -79.87 83.71 5.76 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.55 -47.09 0.24 Allowed Glycine 0 C--N 1.304 -1.243 0 CA-C-N 110.59 -3.005 . . . . 0.0 109.372 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.4 p -73.51 -43.15 60.73 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.46 0.704 . . . . 0.0 111.675 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -75.97 -21.62 56.79 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.5 tt -67.33 -61.23 2.01 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 169.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.6 tt -47.24 -55.9 7.75 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.482 1.113 . . . . 0.0 112.931 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -75.11 -28.27 60.16 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.089 0.859 . . . . 0.0 113.24 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.63 -41.27 96.27 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.094 0.861 . . . . 0.0 111.355 169.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 16.1 mt -74.83 -30.7 61.46 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.408 -0.807 . . . . 0.0 112.904 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -64.19 -21.0 66.4 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.69 1.132 . . . . 0.0 113.156 172.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -81.46 -49.54 10.5 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.743 0.817 . . . . 0.0 109.474 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.71 -28.02 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.5 t -129.03 130.34 46.47 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -69.94 -22.07 63.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.462 1.105 . . . . 0.0 113.232 169.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.9 t -129.85 88.69 2.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.772 1.229 . . . . 0.0 109.272 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.01 82.22 0.31 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 127.837 2.637 . . . . 0.0 106.605 -172.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -79.37 127.73 32.45 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.9 mt -123.38 130.91 73.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.311 0.577 . . . . 0.0 111.217 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.05 161.51 18.42 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 126.618 2.056 . . . . 0.0 110.278 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -141.28 133.31 27.7 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.82 145.51 16.25 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 121.404 0.446 . . . . 0.0 112.274 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.8 m -114.71 142.08 46.98 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.733 1.213 . . . . 0.0 110.332 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -152.77 155.04 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 120.913 -1.117 . . . . 0.0 108.984 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -152.47 -62.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.607 1.163 . . . . 0.0 109.426 173.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.25 25.5 t30 177.47 -19.43 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 128.917 2.887 . . . . 0.0 111.972 168.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -50.31 -40.91 50.02 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.068 0.849 . . . . 0.0 109.7 168.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.365 3.7 t 163.92 -177.61 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 131.622 3.969 . . . . 0.0 112.158 167.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -85.45 129.8 34.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.344 1.858 . . . . 0.0 108.533 169.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -117.73 112.22 20.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.45 1.1 . . . . 0.0 108.84 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -72.93 122.07 21.07 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.5 mt -103.86 -54.08 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.558 -0.714 . . . . 0.0 111.048 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.1 tp -130.98 120.72 23.91 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.257 0.551 . . . . 0.0 111.669 -175.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -57.85 149.57 22.24 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.705 1.202 . . . . 0.0 111.112 169.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 28.8 mt -48.03 108.8 0.18 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.115 1.366 . . . . 0.0 111.311 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t -129.57 162.27 28.6 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.608 1.563 . . . . 0.0 111.823 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.36 -4.28 42.24 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.071 1.748 . . . . 0.0 113.646 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.47 102.82 15.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 127.106 3.336 . . . . 0.0 108.222 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.6 t -66.2 -53.47 36.95 Favored 'General case' 0 C--N 1.304 -1.402 2 C-N-CA 132.152 4.181 . . . . 0.0 110.434 -174.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.3 p -64.66 -19.28 65.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.335 1.054 . . . . 0.0 112.321 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . 0.303 5.1 pt20 -83.82 -47.51 11.04 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.578 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -57.96 -33.82 69.27 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.175 -0.953 . . . . 0.0 111.918 174.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -70.78 -33.36 70.68 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.356 -0.84 . . . . 0.0 111.2 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 -79.77 -31.03 40.85 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.895 1.278 . . . . 0.0 109.621 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -80.95 -32.38 34.52 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -175.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 32.4 tp -73.23 -47.95 38.98 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.717 170.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -70.07 -25.66 63.64 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.683 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -57.87 -29.84 65.34 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.587 1.155 . . . . 0.0 114.049 170.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -61.73 150.37 36.97 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -170.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.3 tp -141.37 149.7 41.46 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.173 1.389 . . . . 0.0 109.196 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.85 169.43 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.988 1.315 . . . . 0.0 112.837 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.0 t -126.8 -140.54 0.27 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.273 1.429 . . . . 0.0 109.323 169.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -147.35 158.56 27.76 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-N 120.562 1.528 . . . . 0.0 115.715 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -160.6 148.41 16.1 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.951 1.7 . . . . 0.0 111.728 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.8 tp -68.06 -55.6 11.97 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.792 1.237 . . . . 0.0 112.223 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.59 136.17 50.92 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.632 0.773 . . . . 0.0 112.069 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.272 7.5 t -70.66 -39.84 9.84 Favored Pre-proline 0 N--CA 1.474 0.762 0 CA-C-O 115.766 -2.064 . . . . 0.0 113.456 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.42 140.07 56.49 Favored 'Trans proline' 0 C--N 1.356 0.939 0 CA-C-N 123.405 2.252 . . . . 0.0 111.693 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -107.4 -179.3 3.88 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.27 1.828 . . . . 0.0 112.738 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -109.18 18.99 30.27 Favored Glycine 0 N--CA 1.479 1.56 0 O-C-N 120.68 -1.262 . . . . 0.0 116.019 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -29.22 62.37 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -169.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.34 -28.15 67.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.47 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.72 -34.12 77.46 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 120.126 1.33 . . . . 0.0 112.273 171.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.7 -46.46 78.9 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 118.417 -0.801 . . . . 0.0 109.216 169.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.1 t -53.61 -40.13 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.017 0.826 . . . . 0.0 111.774 174.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.29 -61.9 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.433 1.093 . . . . 0.0 110.852 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.9 -44.8 95.11 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 118.945 -0.55 . . . . 0.0 110.715 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.24 -40.57 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.897 0.879 . . . . 0.0 111.714 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.56 -38.22 86.62 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.436 1.017 . . . . 0.0 112.86 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.6 mt -86.31 -36.8 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.795 0.838 . . . . 0.0 113.181 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 73.6 m -77.53 55.39 1.29 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.823 2.049 . . . . 0.0 112.105 -169.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.3 mt -48.99 -42.59 38.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.453 2.301 . . . . 0.0 111.453 -176.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.98 -19.25 75.45 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.403 1.001 . . . . 0.0 114.719 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -96.58 -47.6 5.86 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.117 0.967 . . . . 0.0 110.79 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.3 mm -66.73 -36.56 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.686 0.795 . . . . 0.0 111.104 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.43 20.93 28.26 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.115 1.341 . . . . 0.0 114.123 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -53.98 121.04 7.2 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.361 1.464 . . . . 0.0 112.212 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ptm85 -107.34 -176.78 3.16 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.015 1.326 . . . . 0.0 112.164 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -73.86 11.08 0.94 Allowed 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 117.851 2.538 . . . . 0.0 117.851 -169.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.61 -129.82 1.97 Allowed Glycine 0 C--N 1.344 1.023 0 CA-C-N 121.215 1.825 . . . . 0.0 110.734 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.9 p -114.33 145.21 42.08 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.494 1.918 . . . . 0.0 107.656 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -129.05 117.87 21.59 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.416 -167.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -122.2 104.45 9.47 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -169.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.1 tt -88.6 94.96 10.06 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.216 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.0 t -77.5 116.01 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.0 tp -105.18 123.06 47.18 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 t -108.27 130.12 61.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 O-C-N 124.595 1.184 . . . . 0.0 112.445 172.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -140.89 172.91 12.04 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.805 1.642 . . . . 0.0 110.335 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -118.96 -14.54 9.38 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 127.164 2.185 . . . . 0.0 111.859 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -133.12 174.82 9.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.789 1.236 . . . . 0.0 113.457 -169.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -61.23 -174.73 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.266 1.427 . . . . 0.0 110.883 168.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -147.12 159.86 43.1 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.655 -1.278 . . . . 0.0 113.36 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -79.22 116.83 19.72 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.27 1.428 . . . . 0.0 111.52 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.9 mp -82.55 -179.23 7.36 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.097 1.359 . . . . 0.0 109.962 173.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.47 160.1 3.35 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.406 -0.809 . . . . 0.0 111.689 169.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.449 0.0 OUTLIER 56.32 -12.68 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.277 0 N-CA-C 117.487 2.402 . . . . 0.0 117.487 -173.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.26 -28.21 69.55 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.037 -1.664 . . . . 0.0 111.899 169.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.58 -25.1 67.1 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 116.818 2.155 . . . . 0.0 116.818 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -18.6 63.62 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -167.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 pp -67.05 -19.77 65.73 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 118.68 0.673 . . . . 0.0 112.734 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -96.52 11.94 66.54 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 126.415 1.96 . . . . 0.0 114.11 170.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.334 10.5 t 54.86 53.74 10.03 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 128.078 2.551 . . . . 0.0 113.882 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -116.55 69.69 0.75 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.27 1.828 . . . . 0.0 110.505 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -62.23 -40.21 95.38 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.054 -1.654 . . . . 0.0 113.799 -169.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -60.83 138.92 58.09 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -173.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 t -81.39 148.88 29.1 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.731 0.813 . . . . 0.0 110.624 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 36.4 t -55.35 131.85 46.68 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.605 0.762 . . . . 0.0 111.771 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.7 p30 -89.58 -10.82 44.64 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.697 1.199 . . . . 0.0 113.899 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.93 21.85 78.72 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 117.995 -1.447 . . . . 0.0 114.773 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -112.48 170.39 8.21 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.369 1.584 . . . . 0.0 113.141 169.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 5.5 t -71.1 133.4 46.23 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.586 1.554 . . . . 0.0 112.234 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -138.04 40.45 2.31 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.065 1.746 . . . . 0.0 112.996 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.73 125.35 42.5 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.933 1.693 . . . . 0.0 109.131 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -117.67 -84.66 0.64 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.998 0.919 . . . . 0.0 111.836 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -87.15 20.37 2.76 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.945 1.698 . . . . 0.0 113.39 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.18 -11.87 68.75 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.814 1.674 . . . . 0.0 113.641 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 97.3 mtp -91.14 144.88 25.17 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.64 1.22 . . . . 0.0 111.691 171.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -77.41 83.88 3.84 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.575 0.702 . . . . 0.0 109.231 169.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 42.3 tpt85 -56.02 -32.29 63.86 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.38 1.472 . . . . 0.0 112.942 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.7 m -73.58 -8.54 56.37 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 29.3 ttt85 -56.02 -27.97 55.35 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 121.337 1.881 . . . . 0.0 113.903 176.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.72 -18.39 73.98 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.241 -1.311 . . . . 0.0 114.601 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.265 57.8 tt0 -119.94 -80.03 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.144 0 CA-C-O 115.818 -2.039 . . . . 0.0 112.449 -170.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.88 165.74 24.96 Favored 'Trans proline' 0 C--N 1.36 1.132 0 CA-C-N 123.918 2.435 . . . . 0.0 113.937 170.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -92.4 -179.82 5.32 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -67.52 126.98 31.04 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 167.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -49.7 161.2 0.24 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.505 1.922 . . . . 0.0 115.425 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.1 p -82.84 157.78 23.0 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.099 -1.0 . . . . 0.0 112.141 169.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.05 -34.06 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.645 -1.284 . . . . 0.0 112.001 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.9 t -77.94 -24.5 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.507 0.723 . . . . 0.0 111.682 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -67.17 -34.35 77.36 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.351 -0.843 . . . . 0.0 110.944 172.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.31 -56.12 21.52 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.021 0.828 . . . . 0.0 109.542 168.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.0 -40.49 63.85 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.829 0.852 . . . . 0.0 112.625 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.4 t -62.07 -64.47 0.92 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.966 0.907 . . . . 0.0 112.245 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -73.63 -24.94 60.08 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.085 -1.634 . . . . 0.0 113.878 -169.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.4 mp -63.74 -41.42 98.04 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.269 0.941 . . . . 0.0 110.703 169.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.05 -36.88 61.8 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -69.19 -49.79 53.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.283 1.033 . . . . 0.0 110.493 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -77.42 -15.49 59.32 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.686 0.794 . . . . 0.0 111.278 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 66.96 60.21 0.53 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.189 1.796 . . . . 0.0 110.718 171.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.69 139.69 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.543 1.937 . . . . 0.0 107.988 172.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -107.9 106.16 57.91 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 119.951 1.251 . . . . 0.0 109.432 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.99 151.67 39.86 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.554 2.169 . . . . 0.0 114.005 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 82.5 mt -130.44 109.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.034 1.334 . . . . 0.0 107.801 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -78.89 80.9 5.21 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 122.093 0.949 . . . . 0.0 111.755 -175.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.8 104.81 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.992 0.917 . . . . 0.0 111.978 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.0 m -142.61 167.67 15.59 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.078 -1.639 . . . . 0.0 112.064 -169.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -84.4 152.36 12.06 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.41 2.073 . . . . 0.0 110.951 -172.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.3 t -49.51 -43.84 45.81 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -169.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -56.8 -29.28 62.55 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -111.23 -8.2 14.39 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.633 1.973 . . . . 0.0 112.586 -170.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.2 t -54.27 -44.43 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 120.627 -1.296 . . . . 0.0 111.009 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -70.31 -6.08 32.5 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -170.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 18.4 m -87.12 -50.12 6.84 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.967 1.707 . . . . 0.0 110.19 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -73.56 -26.77 60.99 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.974 1.31 . . . . 0.0 110.307 -174.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . 0.353 7.1 pt-20 -65.73 -14.29 61.01 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.001 171.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . 0.379 0.0 OUTLIER -89.0 -22.91 22.76 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-N 120.551 1.523 . . . . 0.0 112.408 167.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.68 -19.78 60.73 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 119.682 -1.886 . . . . 0.0 110.176 169.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 98.7 m -80.28 -18.07 50.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.654 2.382 . . . . 0.0 111.949 169.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.73 -27.6 19.95 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.346 0.521 . . . . 0.0 110.38 169.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -80.26 -32.74 38.25 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 174.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 27.5 mt -110.21 101.31 47.49 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.46 150.84 64.59 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.857 2.371 . . . . 0.0 111.687 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt 86.36 -11.33 0.64 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 129.265 3.026 . . . . 0.0 113.084 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 10.2 mp -72.49 166.39 22.73 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.956 0.902 . . . . 0.0 109.817 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 69.7 p -125.24 -142.83 0.3 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.096 0.95 . . . . 0.0 109.856 170.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.2 tp -179.04 128.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 128.123 2.569 . . . . 0.0 108.482 -166.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -118.77 155.28 16.13 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . 0.276 11.2 pt-20 -105.2 94.61 5.33 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 122.903 1.335 . . . . 0.0 109.776 173.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 26.2 tp -50.79 134.38 25.23 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.981 169.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 66.0 p -161.95 -161.71 0.79 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.058 1.343 . . . . 0.0 110.115 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.21 -16.09 63.15 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.108 0.963 . . . . 0.0 112.866 172.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -110.05 150.78 28.05 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.441 1.497 . . . . 0.0 112.931 172.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 36.4 p -106.83 -5.72 18.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.732 1.613 . . . . 0.0 113.588 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 59.9 p -60.38 -36.71 78.7 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.732 1.213 . . . . 0.0 111.957 -169.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -58.38 -52.2 66.6 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.565 0.746 . . . . 0.0 111.012 171.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.65 -45.28 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.145 0.978 . . . . 0.0 111.682 -175.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.79 -27.84 67.09 Favored 'General case' 0 C--O 1.219 -0.501 0 O-C-N 121.7 -0.625 . . . . 0.0 112.396 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -70.32 -10.33 58.69 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.623 -1.298 . . . . 0.0 112.394 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.29 -40.23 6.85 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.112 1.365 . . . . 0.0 108.866 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 10.1 mm -60.78 -49.48 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 5.0 mtm105 -76.95 -23.95 52.38 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 118.296 -0.859 . . . . 0.0 112.699 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -66.66 -41.04 88.82 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 120.034 1.288 . . . . 0.0 111.14 169.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -70.46 -25.86 63.37 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.665 0.786 . . . . 0.0 112.277 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -66.35 -40.15 89.62 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.163 0.985 . . . . 0.0 112.411 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.8 t -77.12 -15.26 59.61 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -71.39 -18.24 62.36 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 121.328 -0.857 . . . . 0.0 113.227 173.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.907 1.683 . . . . 0.0 113.465 -169.145 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 110.692 -0.114 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -86.51 147.1 26.11 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.445 0.698 . . . . 0.0 110.306 172.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.1 p -76.55 143.57 40.24 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.991 -1.068 . . . . 0.0 111.903 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.95 108.41 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 121.993 0.901 . . . . 0.0 111.847 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -87.39 114.97 24.48 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 tt -101.82 125.39 48.48 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.866 -0.521 . . . . 0.0 110.025 170.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -117.42 109.37 16.7 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 123.531 1.634 . . . . 0.0 109.985 169.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -86.35 116.16 24.34 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.668 2.387 . . . . 0.0 112.444 -176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.9 mp -99.25 124.34 44.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.378 1.071 . . . . 0.0 111.061 172.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.1 ttt -114.21 135.5 53.99 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.78 132.21 13.69 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 168.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 mp -115.1 15.07 17.16 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.498 1.519 . . . . 0.0 114.197 -170.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 p -74.66 174.49 9.01 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.031 -1.043 . . . . 0.0 112.705 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.47 -29.09 52.76 Favored Glycine 0 N--CA 1.477 1.397 0 O-C-N 121.102 -0.999 . . . . 0.0 115.487 -169.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 p -65.24 -25.14 67.54 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.073 1.749 . . . . 0.0 114.241 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.27 -10.42 59.74 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.502 1.521 . . . . 0.0 113.948 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -70.37 115.5 9.63 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.24 -38.6 3.24 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.097 1.332 . . . . 0.0 111.794 -169.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -65.7 -42.71 90.85 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.592 1.196 . . . . 0.0 110.309 169.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.3 tp -60.39 -31.96 70.86 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.952 0.901 . . . . 0.0 113.361 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.2 m -63.82 -44.46 93.18 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.223 0.609 . . . . 0.0 112.279 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -81.52 -15.62 54.32 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -175.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.0 m -93.26 1.34 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 119.207 0.912 . . . . 0.0 113.444 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -84.38 -35.62 23.03 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.815 1.643 . . . . 0.0 108.759 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 t -71.46 -14.76 62.24 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.997 1.319 . . . . 0.0 110.147 167.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.6 tp -80.61 95.72 6.63 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 125.584 2.612 . . . . 0.0 106.797 170.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.74 -46.32 0.08 OUTLIER Glycine 0 C--N 1.298 -1.576 1 CA-C-N 108.244 -4.071 . . . . 0.0 110.957 167.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.4 p -92.9 -34.76 13.67 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.77 1.628 . . . . 0.0 111.535 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.14 -40.33 97.28 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.629 -0.67 . . . . 0.0 110.111 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.9 tp -66.36 -49.24 67.57 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.427 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.47 -45.35 69.52 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.041 0.837 . . . . 0.0 110.602 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.4 tmmm? -65.45 -38.33 89.53 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 120.111 1.323 . . . . 0.0 111.362 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.48 -38.38 74.39 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 172.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.6 mt -80.55 -18.36 48.64 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 119.838 1.199 . . . . 0.0 113.482 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.54 -29.19 63.35 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.474 1.488 . . . . 0.0 113.785 -170.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -83.7 -31.78 25.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.086 0.554 . . . . 0.0 110.421 172.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.57 -33.55 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-O 119.046 -0.502 . . . . 0.0 111.566 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 99.6 p -160.5 148.25 16.18 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 116.885 2.179 . . . . 0.0 116.885 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -66.75 -48.42 69.17 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.088 1.355 . . . . 0.0 112.376 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.4 p -112.26 124.47 52.52 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 122.794 1.283 . . . . 0.0 111.889 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.9 90.47 0.16 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 106.596 -2.602 . . . . 0.0 106.596 -175.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -78.88 145.66 34.03 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.75 0.82 . . . . 0.0 109.435 -169.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.52 132.61 70.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 124.944 1.298 . . . . 0.0 109.342 -172.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.85 156.98 26.99 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.998 1.761 . . . . 0.0 111.687 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -143.31 136.73 28.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -169.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.35 155.34 23.43 Favored Glycine 0 C--N 1.345 1.033 0 C-N-CA 124.558 1.075 . . . . 0.0 111.194 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.3 p -124.66 146.35 49.17 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.842 0.857 . . . . 0.0 111.975 -174.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.2 pp -145.42 151.95 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 173.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 50' ' ' ASN . 19.0 t -142.86 -126.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 102.6 -3.111 . . . . 0.0 102.6 169.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.417 ' H ' HG13 ' A' ' 49' ' ' VAL . 48.5 t30 -123.69 -0.6 8.57 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 120.406 1.457 . . . . 0.0 109.761 167.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.2 mmt -60.37 -39.08 85.94 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.75 1.62 . . . . 0.0 109.927 169.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.4 t 147.74 176.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.345 1 C-N-CA 132.399 4.28 . . . . 0.0 112.145 169.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -79.85 130.67 35.5 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.519 1.928 . . . . 0.0 109.327 169.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -123.66 128.97 50.42 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.282 1.039 . . . . 0.0 108.714 169.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -92.35 91.67 7.78 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.734 2.014 . . . . 0.0 111.229 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 mp -77.26 -59.87 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.45 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.4 tp -121.15 124.61 45.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.141 0.882 . . . . 0.0 112.114 -172.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.55 161.17 17.9 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 175.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.5 mt -56.29 109.01 0.53 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.129 1.772 . . . . 0.0 111.745 -171.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.6 t -143.02 171.3 14.25 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.549 1.54 . . . . 0.0 111.506 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.07 -5.09 56.94 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.023 1.729 . . . . 0.0 113.99 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -95.61 75.04 3.23 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 125.733 2.682 . . . . 0.0 108.992 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 p -69.31 -19.59 63.88 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 128.412 2.685 . . . . 0.0 110.973 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.3 p -76.5 -15.71 59.82 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.787 1.235 . . . . 0.0 110.58 168.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . 0.328 1.4 pt20 -91.52 -26.88 18.56 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 119.229 0.922 . . . . 0.0 112.183 173.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -60.99 -23.68 65.56 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.343 1.057 . . . . 0.0 111.241 168.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -71.5 -44.25 65.03 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.239 -0.913 . . . . 0.0 109.173 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -68.04 -39.96 82.94 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 125.074 1.35 . . . . 0.0 108.988 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . 0.265 59.9 mt-10 -86.91 -19.42 28.87 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.18 -175.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.2 mt -75.39 -33.14 60.97 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 167.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.0 ttp-105 -70.83 -36.8 73.09 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 118.705 0.684 . . . . 0.0 112.352 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -73.2 -16.0 61.43 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 175.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -64.74 150.48 47.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.747 0.819 . . . . 0.0 110.479 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.75 168.4 19.9 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.789 0.835 . . . . 0.0 111.927 172.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.6 t -94.71 146.69 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.667 1.987 . . . . 0.0 111.87 -169.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.7 t -120.54 -175.17 2.96 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.101 1.76 . . . . 0.0 111.756 171.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -148.46 157.28 27.24 Favored Glycine 0 N--CA 1.474 1.225 0 O-C-N 120.477 -1.389 . . . . 0.0 113.998 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -158.2 167.79 28.82 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.927 1.291 . . . . 0.0 114.232 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -77.57 -62.06 1.79 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.631 1.573 . . . . 0.0 112.952 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.77 151.96 43.89 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.814 0.846 . . . . 0.0 111.673 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.296 5.3 t -82.76 -41.41 0.88 Allowed Pre-proline 0 N--CA 1.479 1.005 0 CA-C-O 116.249 -1.834 . . . . 0.0 115.233 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.23 146.93 77.59 Favored 'Trans proline' 0 C--N 1.359 1.101 0 CA-C-N 123.04 2.121 . . . . 0.0 113.058 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -101.39 152.34 20.84 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.953 1.701 . . . . 0.0 113.637 -170.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.85 56.74 4.55 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 125.72 1.629 . . . . 0.0 111.662 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -84.11 -36.98 22.57 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.539 1.536 . . . . 0.0 113.327 -169.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.41 -36.84 83.83 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 122.153 -0.342 . . . . 0.0 110.852 -169.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -49.7 -41.79 44.18 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.196 1.398 . . . . 0.0 111.732 169.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.18 -52.38 28.59 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.055 -1.028 . . . . 0.0 111.498 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.4 m -59.68 -33.17 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.756 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.3 m -75.6 -51.68 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 117.215 -1.374 . . . . 0.0 112.624 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -55.74 -46.87 77.72 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 121.295 1.861 . . . . 0.0 110.175 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.6 t -59.66 -36.13 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.76 -43.37 79.99 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.986 -1.071 . . . . 0.0 112.629 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.85 -42.3 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -172.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . 0.26 21.8 p -83.79 66.48 9.1 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 121.222 1.828 . . . . 0.0 113.516 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.6 mt -43.42 -40.42 3.74 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.63 2.372 . . . . 0.0 111.583 169.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.11 -30.7 56.85 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.647 1.118 . . . . 0.0 114.794 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -104.59 -34.02 8.33 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 117.725 -1.131 . . . . 0.0 113.685 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.1 mm -64.07 -34.83 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 120.874 1.67 . . . . 0.0 110.408 169.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.59 18.31 38.77 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 117.907 -1.496 . . . . 0.0 114.126 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -54.06 147.28 12.93 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.343 1.572 . . . . 0.0 112.979 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . 0.272 0.0 OUTLIER -143.07 172.12 13.14 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.654 1.182 . . . . 0.0 114.015 172.085 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -58.54 24.35 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 121.39 3.848 . . . . 0.0 121.39 -168.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.16 -118.82 1.22 Allowed Glycine 0 CA--C 1.535 1.332 0 CA-C-N 120.912 1.687 . . . . 0.0 109.594 170.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.0 t -130.09 148.77 51.98 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 168.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -123.78 123.42 40.44 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 119.158 -0.449 . . . . 0.0 111.988 -166.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -115.32 103.49 10.86 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -170.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.0 tp -88.62 85.92 6.9 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.779 1.232 . . . . 0.0 109.527 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 66.7 t -77.28 136.85 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.3 tt -127.96 126.27 41.1 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.963 1.256 . . . . 0.0 111.541 169.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.1 t -95.46 128.01 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 126.216 1.806 . . . . 0.0 110.875 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.6 t -156.55 158.26 36.82 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.964 0.506 . . . . 0.0 110.989 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.87 0.59 11.41 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -141.44 -178.9 5.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.678 1.191 . . . . 0.0 111.867 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.95 -168.02 0.18 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.312 1.445 . . . . 0.0 112.137 -175.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -145.5 146.11 31.33 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 120.622 -1.298 . . . . 0.0 111.792 -169.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -80.23 130.02 34.91 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.826 169.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 pp -111.62 174.05 6.06 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.349 1.46 . . . . 0.0 111.344 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.33 130.16 30.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.5 mttm 93.91 -10.85 0.14 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.407 3.083 . . . . 0.0 112.003 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -67.75 -23.89 65.29 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 120.157 1.344 . . . . 0.0 112.706 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -74.65 -11.32 60.16 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.007 -1.058 . . . . 0.0 113.841 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.28 1.1 t -72.15 -21.51 61.44 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 120.458 1.481 . . . . 0.0 113.727 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.96 -37.72 84.79 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.735 1.152 . . . . 0.0 109.689 169.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.31 6.5 15.21 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.071 1.32 . . . . 0.0 113.158 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.277 52.8 m 70.06 37.8 1.64 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.309 2.244 . . . . 0.0 111.463 171.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -121.55 118.5 29.42 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.412 1.085 . . . . 0.0 111.076 169.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -105.12 -26.16 12.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.882 1.273 . . . . 0.0 112.896 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -61.35 116.18 4.44 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.067 0.849 . . . . 0.0 110.29 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 t -65.7 158.4 27.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.664 0.665 . . . . 0.0 110.003 173.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.1 t -67.44 144.61 55.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 122.043 0.925 . . . . 0.0 111.614 174.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.8 p30 -82.56 -10.75 58.85 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.054 1.342 . . . . 0.0 113.193 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.41 26.51 74.05 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.023 -0.876 . . . . 0.0 112.877 -175.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -103.29 172.92 6.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.026 1.73 . . . . 0.0 110.343 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 7.2 t -92.21 148.78 21.89 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.51 -0.744 . . . . 0.0 112.083 170.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -134.62 33.13 3.26 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.705 2.002 . . . . 0.0 112.063 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.75 161.06 13.84 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.197 0.999 . . . . 0.0 111.819 174.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -170.94 -45.26 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.571 1.948 . . . . 0.0 111.016 172.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -80.45 4.79 17.04 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.235 1.414 . . . . 0.0 112.771 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 82.73 -11.21 53.92 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.893 1.711 . . . . 0.0 112.547 -169.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.3 mtt -90.67 143.83 26.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.176 1.39 . . . . 0.0 111.118 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -74.05 95.63 2.56 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 169.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -64.09 -33.43 75.76 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.668 1.187 . . . . 0.0 113.25 -172.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.2 p -81.91 4.66 21.67 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -174.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -37.87 -35.79 0.16 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.799 2.04 . . . . 0.0 115.219 169.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.69 30.07 6.85 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 127.962 2.696 . . . . 0.0 112.521 -172.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.266 43.2 tt0 -139.75 -79.3 0.01 OUTLIER Pre-proline 0 CA--C 1.559 1.293 0 CA-C-O 115.724 -2.084 . . . . 0.0 109.593 169.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -54.18 150.4 32.43 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.574 2.85 . . . . 0.0 117.02 169.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.18 162.52 25.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 128.315 2.646 . . . . 0.0 109.316 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -55.2 140.67 37.94 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.177 -0.952 . . . . 0.0 109.729 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.09 156.91 24.31 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.667 -1.271 . . . . 0.0 112.189 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 27.2 t -81.47 154.9 26.1 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -173.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 20.2 t -59.27 -30.59 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.216 1.006 . . . . 0.0 111.652 -171.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.5 p -66.62 -37.04 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.607 1.163 . . . . 0.0 113.433 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -72.82 -32.58 65.61 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.487 -0.758 . . . . 0.0 110.495 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.1 mt -65.33 -46.54 79.86 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -54.54 -44.78 73.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.104 0.962 . . . . 0.0 112.607 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.8 m -59.43 -53.05 62.57 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.688 0.795 . . . . 0.0 112.119 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -64.57 -43.38 94.06 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.166 -0.959 . . . . 0.0 111.81 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.65 -38.63 81.96 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.178 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.54 -36.18 65.64 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -71.72 -42.33 67.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.869 0.868 . . . . 0.0 111.643 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -80.51 -9.17 59.78 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.615 0.766 . . . . 0.0 112.412 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . 0.402 15.7 p-10 42.02 52.66 4.32 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.831 2.452 . . . . 0.0 113.245 -174.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 79.4 mt -100.49 133.67 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.334 1.854 . . . . 0.0 109.07 174.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -104.33 108.29 59.96 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-N 119.257 0.935 . . . . 0.0 112.362 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.85 140.94 52.28 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.476 2.784 . . . . 0.0 115.754 169.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.1 mm -121.56 100.59 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.519 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -74.06 75.26 1.73 Allowed 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.904 -1.122 . . . . 0.0 112.168 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . 0.255 13.4 m -76.18 110.6 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 120.762 -1.211 . . . . 0.0 112.486 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.23 141.88 17.66 Favored Pre-proline 0 N--CA 1.478 0.97 0 O-C-N 120.997 -1.065 . . . . 0.0 112.389 -171.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -51.32 150.83 14.17 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.43 3.42 . . . . 0.0 115.837 169.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.3 t -47.63 -44.87 27.23 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.374 1.87 . . . . 0.0 113.546 -169.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.8 mtp-105 -42.88 -38.56 2.22 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.614 1.565 . . . . 0.0 113.428 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.51 0.6 16.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.895 1.678 . . . . 0.0 113.322 -170.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 37.5 t -62.6 -38.97 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.615 -1.303 . . . . 0.0 111.141 -175.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -65.23 -27.19 68.49 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.077 0.853 . . . . 0.0 113.025 -174.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.7 t -84.47 -39.94 18.3 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.784 0.434 . . . . 0.0 111.009 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -69.46 -30.32 68.19 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.805 -1.184 . . . . 0.0 110.764 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -60.84 -33.05 72.45 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.158 0.436 . . . . 0.0 110.508 169.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . 0.362 0.0 OUTLIER -87.81 -18.17 29.92 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 119.07 0.85 . . . . 0.0 112.244 -178.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 20.1 mt -72.92 -25.44 61.05 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.528 -1.357 . . . . 0.0 109.812 169.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.45 -10.28 59.28 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.299 1.84 . . . . 0.0 111.518 173.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 90.9 m -89.15 -32.62 17.39 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.363 1.065 . . . . 0.0 109.364 169.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -76.79 -30.11 56.33 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 118.906 -0.568 . . . . 0.0 112.484 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 20.2 mt -118.86 109.66 39.31 Favored Pre-proline 0 N--CA 1.484 1.24 0 CA-C-N 119.114 0.87 . . . . 0.0 110.685 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -55.62 143.21 80.2 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.394 3.396 . . . . 0.0 114.225 174.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt 79.66 -8.35 1.58 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 128.755 2.822 . . . . 0.0 113.452 170.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 10.6 mt -72.9 153.78 40.86 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.286 -0.883 . . . . 0.0 109.954 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.7 p -116.89 -149.04 0.44 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 123.333 1.54 . . . . 0.0 109.432 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.1 tp -177.64 131.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 C-N-CA 127.043 2.137 . . . . 0.0 108.223 -165.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -123.73 150.67 16.96 Favored Glycine 0 N--CA 1.465 0.624 0 C-N-CA 124.37 0.986 . . . . 0.0 110.66 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -94.6 85.1 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.5 tp -59.95 134.88 57.45 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 169.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 99.1 p -153.92 -149.72 0.29 Allowed 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.478 -0.764 . . . . 0.0 110.722 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.36 15.34 0.99 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.522 1.529 . . . . 0.0 113.738 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -132.62 148.75 52.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.075 1.75 . . . . 0.0 111.668 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 12.2 t -92.52 -12.68 31.29 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.54 1.936 . . . . 0.0 112.492 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 74.4 p -57.59 -35.43 70.39 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 119.821 -1.799 . . . . 0.0 112.179 -177.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -65.79 -28.87 69.33 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.753 1.019 . . . . 0.0 113.753 -175.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 3.0 m -77.8 -46.16 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-N 119.438 1.017 . . . . 0.0 111.416 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -75.42 -34.64 61.03 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 31.1 mm100 -80.32 7.38 9.7 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 120.562 1.528 . . . . 0.0 113.108 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.58 -40.06 5.21 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.383 1.873 . . . . 0.0 107.297 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 75.3 mt -74.15 -34.83 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 121.596 -0.69 . . . . 0.0 109.266 172.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 34.4 ttt85 -65.93 -35.45 80.64 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.623 -0.673 . . . . 0.0 110.518 169.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -69.89 -20.33 63.38 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 170.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -76.1 -32.53 59.24 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.932 -1.105 . . . . 0.0 112.307 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -65.51 -33.74 76.64 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.0 p -83.07 -22.46 33.47 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -138.42 -77.16 0.37 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.256 1.411 0 C-N-CA 128.14 2.576 . . . . 0.0 115.038 -168.34 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.992 0.425 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -96.27 145.94 25.14 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.22 1.008 . . . . 0.0 110.583 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.4 t -70.09 123.39 21.47 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.329 -0.857 . . . . 0.0 110.888 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.2 t -128.99 118.7 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-O 121.797 0.808 . . . . 0.0 111.785 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -87.12 127.87 35.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.978 0.911 . . . . 0.0 109.188 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mp -123.44 135.63 54.19 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -117.4 113.29 21.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 123.108 1.432 . . . . 0.0 109.078 172.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -87.46 103.29 15.37 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 126.107 1.763 . . . . 0.0 111.166 174.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.0 tp -102.22 121.59 42.55 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.674 1.19 . . . . 0.0 110.284 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.09 157.89 24.04 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 170.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.02 132.95 11.44 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.409 1.957 . . . . 0.0 110.56 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.15 23.36 13.4 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.612 1.565 . . . . 0.0 114.192 -171.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.7 p -79.28 172.25 14.06 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 119.42 -2.05 . . . . 0.0 114.454 -174.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.06 -23.18 67.59 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.288 -0.882 . . . . 0.0 113.696 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t -68.89 -38.06 79.41 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.591 1.195 . . . . 0.0 111.112 170.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.65 4.82 3.58 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.928 1.291 . . . . 0.0 114.025 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -66.27 -43.34 86.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.643 1.177 . . . . 0.0 112.41 -176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.66 -30.47 64.0 Favored Glycine 0 N--CA 1.471 0.99 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -76.59 -14.05 60.03 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.657 1.183 . . . . 0.0 113.381 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 38.4 tp -58.49 -44.28 89.34 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.812 1.642 . . . . 0.0 111.74 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 t -57.53 -44.72 85.31 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.018 0.826 . . . . 0.0 111.733 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -61.61 -48.42 80.97 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.452 1.501 . . . . 0.0 110.535 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.4 t -60.99 -43.61 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 O-C-N 121.355 -0.841 . . . . 0.0 111.275 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -63.85 -52.28 60.8 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.091 1.356 . . . . 0.0 110.198 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 t -66.93 -35.09 79.2 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.945 -175.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.3 tp -60.44 -31.58 70.55 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.056 1.298 . . . . 0.0 112.886 175.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.26 -40.31 5.81 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -168.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.6 m -65.89 -36.13 82.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.086 -1.057 . . . . 0.0 109.531 169.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -73.69 -35.16 65.13 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.0 175.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.2 tp -62.0 -55.77 25.9 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.34 -53.24 60.53 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.156 0.582 . . . . 0.0 112.188 -174.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -71.44 -26.91 62.94 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -176.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.01 -43.36 71.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.244 0.929 . . . . 0.0 111.576 171.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.8 mt -73.27 -27.66 61.69 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 118.182 -0.913 . . . . 0.0 113.047 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -61.32 -28.87 69.52 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.17 1.35 . . . . 0.0 113.485 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -93.08 -31.96 14.64 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.527 0.331 . . . . 0.0 111.238 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mp -72.5 -31.68 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.884 -0.51 . . . . 0.0 111.067 169.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.7 t -142.17 119.6 11.62 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.84 1.256 . . . . 0.0 111.978 173.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -67.03 -46.9 73.03 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.279 0.631 . . . . 0.0 111.087 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.9 t -90.42 80.81 6.05 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 122.957 1.361 . . . . 0.0 110.219 174.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.53 88.02 0.21 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 106.731 -2.548 . . . . 0.0 106.731 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -98.62 137.69 36.9 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.271 1.028 . . . . 0.0 109.757 -169.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.8 tt -116.93 146.13 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.01 -170.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.77 165.12 19.08 Favored Glycine 0 N--CA 1.464 0.519 0 C-N-CA 125.524 1.535 . . . . 0.0 110.575 171.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -139.76 128.22 22.86 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.863 0.865 . . . . 0.0 113.168 -169.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.35 147.12 19.05 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 123.639 0.638 . . . . 0.0 112.229 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.8 t -114.49 148.25 38.15 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.618 1.567 . . . . 0.0 110.517 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.75 152.27 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.905 1.282 . . . . 0.0 109.462 171.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.7 t -138.0 -70.83 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.779 0.831 . . . . 0.0 108.784 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 t30 174.95 -15.75 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 131.0 3.72 . . . . 0.0 108.622 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.5 ttt -58.58 -60.19 4.21 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.87 1.668 . . . . 0.0 107.111 167.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.302 0.5 OUTLIER -173.87 169.26 4.15 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.264 2.226 . . . . 0.0 114.534 168.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -84.09 120.83 26.62 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 169.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -115.77 117.11 29.33 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 122.234 1.016 . . . . 0.0 110.279 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -74.67 110.56 9.06 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.751 1.62 . . . . 0.0 109.95 170.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.3 mt -94.63 -61.33 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.385 0.674 . . . . 0.0 110.392 -173.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.9 tp -124.99 124.74 42.64 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.034 0.934 . . . . 0.0 110.177 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 166.68 13.46 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.655 -0.653 . . . . 0.0 112.691 169.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 83.9 mt -58.15 116.05 3.31 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.74 -0.6 . . . . 0.0 111.136 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 36.8 p -134.49 154.22 51.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.362 1.465 . . . . 0.0 112.244 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.78 2.08 35.75 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.456 1.502 . . . . 0.0 112.731 171.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -93.07 80.17 4.55 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.861 2.464 . . . . 0.0 107.799 -170.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.9 t -66.64 -46.34 76.1 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 111.425 -2.625 . . . . 0.0 112.067 -169.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.8 p -64.28 -18.81 64.94 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.637 -0.665 . . . . 0.0 112.5 169.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -81.75 -52.93 6.63 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.278 0.944 . . . . 0.0 110.19 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -51.74 -32.98 32.73 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.282 1.033 . . . . 0.0 112.038 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -76.28 -30.53 57.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.781 0.832 . . . . 0.0 110.829 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -74.79 -41.53 59.82 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 123.636 0.774 . . . . 0.0 109.86 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . 0.425 6.9 pt-20 -88.35 -16.7 32.31 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 120.4 -0.52 . . . . 0.0 112.159 -173.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.71 -47.33 48.02 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 166.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -39.76 79.67 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.965 -0.459 . . . . 0.0 111.968 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -67.72 -12.42 60.48 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -66.31 151.51 46.91 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.473 1.488 . . . . 0.0 112.517 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.2 tt -147.66 133.38 18.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.271 1.428 . . . . 0.0 108.683 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.4 m -63.23 158.42 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -173.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.6 p -107.78 -143.78 0.38 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.079 1.352 . . . . 0.0 110.694 169.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.34 143.64 8.83 Favored Glycine 0 N--CA 1.472 1.046 0 O-C-N 120.376 -1.453 . . . . 0.0 114.622 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -160.44 150.47 17.95 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.037 1.735 . . . . 0.0 111.462 170.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.0 tp -73.68 -48.56 31.3 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -169.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.71 119.11 8.65 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 122.945 0.498 . . . . 0.0 109.926 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.9 p -71.16 -35.17 3.85 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 115.686 -2.102 . . . . 0.0 113.976 -174.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -66.0 144.9 77.96 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.375 2.05 . . . . 0.0 110.665 169.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -119.4 161.12 21.04 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -171.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.67 45.03 3.19 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 125.184 1.374 . . . . 0.0 115.598 -169.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -36.96 85.85 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.431 1.892 . . . . 0.0 114.038 -173.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.47 -33.91 76.6 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.547 0.612 . . . . 0.0 111.228 -169.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -58.02 -47.46 83.0 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.347 1.459 . . . . 0.0 111.684 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.86 -56.75 16.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.619 -1.181 . . . . 0.0 109.708 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.294 1.5 p -59.33 -36.83 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-O 117.765 -1.112 . . . . 0.0 113.366 -174.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 38.0 t -74.17 -38.96 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 121.396 1.907 . . . . 0.0 113.572 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -63.91 -40.52 96.69 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.719 1.6 . . . . 0.0 110.344 171.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -49.38 -35.51 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.291 1.037 . . . . 0.0 112.638 169.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.16 -48.21 13.52 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.9 tt -100.42 -4.63 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -171.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 72.2 m -82.5 58.34 4.11 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 119.8 -1.812 . . . . 0.0 110.483 170.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.46 -44.43 55.67 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.235 1.814 . . . . 0.0 111.262 -174.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.62 -24.98 55.05 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.141 -0.811 . . . . 0.0 114.74 -169.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -90.95 -40.59 11.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.267 1.034 . . . . 0.0 111.529 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.9 -38.48 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 118.941 0.791 . . . . 0.0 110.677 171.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.36 27.7 19.54 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.738 -1.034 . . . . 0.0 114.099 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -54.01 125.75 19.99 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.769 1.285 . . . . 0.0 111.63 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -105.06 -170.34 1.74 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.754 2.022 . . . . 0.0 112.059 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -75.13 0.23 16.93 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 118.948 2.944 . . . . 0.0 118.948 -168.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.68 -130.77 3.31 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 121.833 2.106 . . . . 0.0 112.06 -174.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.8 m -100.55 145.8 27.89 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.415 1.886 . . . . 0.0 106.93 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -135.69 128.13 30.43 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 121.395 1.907 . . . . 0.0 108.581 -168.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -133.21 115.73 15.35 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.7 tp -91.2 109.94 21.21 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.975 169.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.63 116.42 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 168.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.7 tp -95.13 134.49 37.79 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 117.276 -1.345 . . . . 0.0 108.094 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.42 124.99 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 O-C-N 123.895 0.747 . . . . 0.0 111.607 168.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.0 t -160.48 141.69 12.13 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.678 0.791 . . . . 0.0 113.067 172.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -103.74 24.41 11.25 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.94 2.096 . . . . 0.0 114.888 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -152.35 -175.69 5.38 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.144 -0.972 . . . . 0.0 112.176 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.51 -175.84 0.41 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.3 1.44 . . . . 0.0 110.806 169.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -137.15 153.84 50.38 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.664 1.185 . . . . 0.0 111.664 -170.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -83.45 132.31 34.97 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.032 0.533 . . . . 0.0 110.817 169.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 pp -117.45 173.94 6.42 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.436 1.494 . . . . 0.0 112.532 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.72 124.99 18.17 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.42 98.7 mttt 80.23 1.84 1.97 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.349 2.259 . . . . 0.0 115.039 -175.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -70.78 -15.24 62.65 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 120.848 -1.157 . . . . 0.0 108.657 166.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -57.46 -29.47 64.25 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 173.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.5 m -60.74 -26.4 67.17 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 118.162 2.653 . . . . 0.0 118.162 -167.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.329 0.0 OUTLIER -69.75 -13.08 62.11 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.894 1.679 . . . . 0.0 113.273 170.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -105.9 150.12 16.84 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 167.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.5 p -75.98 81.89 2.86 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.26 1.53 . . . . 0.0 112.601 -171.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.3 125.19 2.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.172 1.789 . . . . 0.0 110.475 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -119.56 -25.82 5.9 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.579 1.151 . . . . 0.0 113.088 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -51.56 107.23 0.18 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.673 1.589 . . . . 0.0 113.008 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.8 t -68.95 150.83 47.28 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.594 1.088 . . . . 0.0 110.952 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.1 m -55.19 131.7 45.91 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.695 1.198 . . . . 0.0 113.101 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.5 p30 -81.58 -15.28 55.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.338 0.655 . . . . 0.0 112.541 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.94 14.6 81.55 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.903 -1.498 . . . . 0.0 114.26 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -93.16 163.47 13.62 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.872 1.669 . . . . 0.0 112.384 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 20.0 t -62.89 130.85 46.62 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.793 0.837 . . . . 0.0 111.655 172.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -135.75 41.44 2.71 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.745 1.618 . . . . 0.0 112.164 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.1 tp -124.16 140.71 52.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.426 1.491 . . . . 0.0 110.943 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -150.51 -62.1 0.2 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.254 1.021 . . . . 0.0 111.286 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -70.24 -21.81 62.95 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 121.35 -19.4 8.64 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.722 1.629 . . . . 0.0 112.409 -169.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 94.7 mtp -98.31 140.52 32.46 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.628 1.571 . . . . 0.0 112.507 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -77.35 83.04 3.8 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.877 0.871 . . . . 0.0 110.456 169.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -64.36 -30.74 71.78 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.112 -0.993 . . . . 0.0 112.236 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 35.5 m -65.89 -2.12 3.57 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 175.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 40.2 ttt85 -52.37 -37.75 57.04 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.213 -1.554 . . . . 0.0 114.251 172.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.71 -22.24 77.4 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.694 -1.059 . . . . 0.0 114.412 -175.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.317 1.2 pt-20 -112.68 -68.43 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.198 0 CA-C-O 117.133 -1.413 . . . . 0.0 112.059 -173.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -55.36 173.0 0.36 Allowed 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 123.399 2.732 . . . . 0.0 117.265 168.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -100.46 171.51 7.7 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 127.914 2.486 . . . . 0.0 114.048 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -73.7 120.93 19.98 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 166.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.469 ' CD ' ' H ' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -70.78 144.26 50.92 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 120.932 -1.105 . . . . 0.0 110.644 -169.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 39.8 m -68.02 153.92 42.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.468 0.707 . . . . 0.0 111.737 -174.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 82.2 t -60.68 -27.64 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 120.542 -1.349 . . . . 0.0 112.794 -171.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.6 t -81.48 -27.35 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 121.323 -0.861 . . . . 0.0 112.801 171.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -67.0 -38.22 85.59 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.298 0.954 . . . . 0.0 110.253 170.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -55.56 -61.41 2.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.751 0.705 . . . . 0.0 109.19 169.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.75 -48.08 70.04 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.306 1.042 . . . . 0.0 113.569 -170.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 64.7 m -63.82 -45.35 90.01 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -64.14 -47.64 79.14 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.399 -0.813 . . . . 0.0 111.155 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.4 mt -55.58 -40.51 72.08 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.827 0.851 . . . . 0.0 112.68 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.24 -33.26 56.07 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -80.52 -25.55 38.64 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.477 1.035 . . . . 0.0 112.002 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -80.49 -13.91 58.71 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.482 0.713 . . . . 0.0 110.758 168.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 33.4 m120 60.3 36.32 20.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.215 1.806 . . . . 0.0 112.848 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 67.1 mt -95.61 145.13 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.264 1.026 . . . . 0.0 108.929 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -105.13 102.72 37.97 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -77.46 156.29 32.42 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.139 1.226 . . . . 0.0 113.267 169.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -141.42 105.93 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.568 1.547 . . . . 0.0 109.522 -169.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -75.1 73.83 2.26 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.729 -1.232 . . . . 0.0 112.756 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.6 108.87 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 O-C-N 121.235 -0.915 . . . . 0.0 111.233 169.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 34.5 m -146.62 146.64 27.57 Favored Pre-proline 0 N--CA 1.482 1.126 0 O-C-N 120.592 -1.317 . . . . 0.0 112.314 -174.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -67.57 159.75 51.13 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.844 3.03 . . . . 0.0 112.801 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.5 t -41.2 -54.14 2.99 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.453 1.901 . . . . 0.0 114.437 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -57.17 -33.2 67.21 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.69 -17.17 32.37 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.911 1.285 . . . . 0.0 113.966 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.4 t -55.73 -41.12 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 120.15 1.341 . . . . 0.0 112.113 -168.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -62.47 -37.59 86.56 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -172.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 9.6 t -84.27 -30.25 25.78 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.901 0.48 . . . . 0.0 111.3 -173.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -69.14 -32.9 72.58 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.639 -1.288 . . . . 0.0 109.211 169.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -68.37 -7.11 28.46 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.347 -0.845 . . . . 0.0 112.699 169.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -98.91 -6.59 28.59 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.04 -1.038 . . . . 0.0 112.403 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 6.2 mp -104.84 -15.37 15.21 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.546 1.538 . . . . 0.0 111.926 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 6.0 t -79.5 -23.2 43.14 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 118.995 0.816 . . . . 0.0 111.832 169.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 1.7 t -77.85 -23.41 48.93 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.676 -0.64 . . . . 0.0 110.559 172.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -82.45 -34.48 28.14 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 119.375 -0.345 . . . . 0.0 111.102 169.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 13.2 mt -117.66 80.88 14.1 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.985 0.914 . . . . 0.0 109.838 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -62.17 152.34 76.6 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.123 1.882 . . . . 0.0 110.561 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 91.26 -17.31 0.17 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 130.415 3.486 . . . . 0.0 112.505 -176.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.0 tt -74.98 155.62 37.17 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.028 1.331 . . . . 0.0 108.295 168.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.266 48.0 p -127.94 -164.08 1.33 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 169.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 10.8 mt -157.82 145.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 126.823 2.049 . . . . 0.0 109.697 -165.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -131.87 155.34 21.38 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 123.818 0.723 . . . . 0.0 112.284 170.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -85.24 98.74 10.67 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 18.2 tp -59.72 125.69 24.64 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 113.422 -1.717 . . . . 0.0 107.896 168.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 93.4 p -162.51 174.62 12.43 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.974 1.31 . . . . 0.0 109.299 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -60.87 -2.83 0.62 Allowed 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -111.68 130.37 55.79 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.145 1.778 . . . . 0.0 110.402 168.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.6 t -85.92 -17.75 34.59 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.242 1.017 . . . . 0.0 113.591 -172.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 77.9 p -53.77 -44.09 69.75 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.191 1.396 . . . . 0.0 112.562 -168.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -59.83 -31.65 69.93 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 85.5 t -84.0 -48.25 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.131 0.878 . . . . 0.0 110.88 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -60.2 -31.03 69.77 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 118.435 -0.793 . . . . 0.0 111.421 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -65.91 -7.35 16.12 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.062 2.145 . . . . 0.0 114.547 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.9 mp -110.73 -34.8 6.16 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.417 1.487 . . . . 0.0 109.631 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 38.0 mm -75.17 -37.85 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -72.55 -32.22 65.89 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.495 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -75.32 -26.07 58.34 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 118.727 -1.189 . . . . 0.0 114.147 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -72.73 -34.36 67.01 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.236 -0.915 . . . . 0.0 111.166 170.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -67.07 -43.75 81.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.86 0.864 . . . . 0.0 111.904 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 88.4 p -71.06 -12.79 61.71 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -73.48 -23.62 60.08 Favored 'General case' 0 CA--C 1.554 1.107 0 O-C-N 121.231 -0.918 . . . . 0.0 113.335 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 78.3 mt . . . . . 0 C--O 1.259 1.599 0 C-N-CA 125.591 1.556 . . . . 0.0 113.82 -179.466 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 120.831 0.348 . . . . 0.0 111.779 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.88 161.85 22.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.863 1.265 . . . . 0.0 113.622 -174.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 p -66.37 131.99 47.32 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.747 0.819 . . . . 0.0 113.09 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.4 t -133.26 149.21 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.513 1.125 . . . . 0.0 110.007 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -121.62 115.82 23.46 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.353 2.261 . . . . 0.0 109.088 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.51 126.14 53.23 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 120.933 -1.104 . . . . 0.0 111.252 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -112.02 111.98 23.28 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 123.162 1.458 . . . . 0.0 110.227 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -87.57 100.34 12.72 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 126.236 1.814 . . . . 0.0 112.3 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.6 tp -94.84 116.76 29.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.511 0.725 . . . . 0.0 111.104 171.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 28.4 ptm -114.99 144.26 43.88 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.89 123.8 6.33 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.96 1.267 . . . . 0.0 111.655 172.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -107.06 43.7 1.14 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.97 1.708 . . . . 0.0 111.079 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 t -64.81 155.43 33.95 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.106 0.963 . . . . 0.0 112.178 169.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.93 -23.79 64.0 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 121.171 -0.956 . . . . 0.0 112.238 169.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.2 t -63.81 -26.34 68.58 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.625 1.17 . . . . 0.0 112.31 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.5 -3.91 58.72 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 -169.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . 0.288 13.9 pt20 -76.73 142.12 40.59 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 122.022 2.192 . . . . 0.0 109.914 169.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.87 -55.56 1.89 Allowed Glycine 0 N--CA 1.471 1.008 0 N-CA-C 107.036 -2.426 . . . . 0.0 107.036 -167.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -65.15 -22.59 66.94 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.513 1.125 . . . . 0.0 111.279 168.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.8 tp -47.86 -48.87 30.87 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.762 2.025 . . . . 0.0 111.104 176.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -56.92 -47.41 80.67 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.417 0.553 . . . . 0.0 111.382 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -60.07 -42.97 95.7 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.941 -1.1 . . . . 0.0 111.031 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -82.6 3.53 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 124.374 1.07 . . . . 0.0 113.791 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -101.43 -42.33 6.31 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.999 1.32 . . . . 0.0 109.371 169.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 m -52.99 -56.59 14.91 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.888 2.075 . . . . 0.0 108.659 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.6 tp -82.99 86.99 6.89 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 124.13 1.919 . . . . 0.0 106.949 169.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.62 -51.53 0.17 Allowed Glycine 0 C--N 1.307 -1.08 0 CA-C-N 109.757 -3.383 . . . . 0.0 107.434 168.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 t -73.81 -41.7 61.97 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.659 1.184 . . . . 0.0 112.007 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.45 -25.08 62.16 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.309 -0.87 . . . . 0.0 111.914 172.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.1 tp -69.14 -49.57 55.67 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-O 118.6 -0.714 . . . . 0.0 109.635 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.6 mt -47.25 -59.73 2.97 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.362 1.065 . . . . 0.0 113.721 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -68.36 -35.28 77.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.555 0.742 . . . . 0.0 112.928 -168.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.22 -46.36 67.57 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.897 0.479 . . . . 0.0 111.019 172.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tt -58.67 -47.56 84.06 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.939 1.295 . . . . 0.0 110.478 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -65.59 -20.89 66.5 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.192 1.397 . . . . 0.0 113.257 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -89.62 -39.95 12.9 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.076 0.951 . . . . 0.0 110.747 175.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.2 mt -61.14 -44.72 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.067 0.947 . . . . 0.0 110.773 171.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.1 t -132.06 133.96 44.97 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.104 0.962 . . . . 0.0 113.474 -173.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -67.27 -29.17 68.71 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.559 1.144 . . . . 0.0 112.481 173.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.3 m -123.58 83.2 2.1 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.208 1.403 . . . . 0.0 109.231 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.36 85.86 0.28 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 127.669 2.557 . . . . 0.0 107.925 -169.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -80.24 140.39 36.27 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -173.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.4 tp -120.76 136.49 57.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 123.431 0.692 . . . . 0.0 110.389 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.42 147.55 18.86 Favored Glycine 0 N--CA 1.466 0.689 0 C-N-CA 124.221 0.915 . . . . 0.0 110.971 169.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -102.24 164.34 11.74 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.06 147.8 12.74 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 120.713 -1.242 . . . . 0.0 111.718 169.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.5 p -128.33 149.74 50.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.72 151.72 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.923 0.889 . . . . 0.0 111.647 -175.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 50' ' ' ASN 0.273 3.0 p -152.92 -101.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 124.096 0.958 . . . . 0.0 110.362 169.318 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.427 ' H ' HG12 ' A' ' 49' ' ' VAL 0.301 37.1 t30 -136.4 -11.37 1.88 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.084 1.354 . . . . 0.0 109.811 168.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 92.1 mtp -87.28 48.49 1.66 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 102.233 -3.247 . . . . 0.0 102.233 163.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.467 2.1 m 16.23 -116.41 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.506 1 C-N-CA 135.787 5.635 . . . . 0.0 116.145 -167.036 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -113.39 137.97 50.76 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.176 1.39 . . . . 0.0 112.769 -168.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -124.34 122.91 38.99 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -85.6 118.34 25.05 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.087 0.555 . . . . 0.0 109.667 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -125.33 142.19 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 126.163 1.785 . . . . 0.0 107.352 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 39.38 95.63 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 128.963 2.905 . . . . 0.0 117.244 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 161.51 5.84 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.066 0.946 . . . . 0.0 113.101 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.66 124.31 14.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.505 1.122 . . . . 0.0 111.523 -170.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.9 t -147.88 169.64 19.38 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.035 1.334 . . . . 0.0 112.089 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.48 -7.02 51.69 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.644 1.977 . . . . 0.0 113.598 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -90.89 79.52 5.91 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 125.202 2.43 . . . . 0.0 109.486 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 p -63.81 -45.66 88.65 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 129.506 3.123 . . . . 0.0 110.662 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.0 t -55.33 -24.96 31.8 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.48 1.112 . . . . 0.0 111.708 170.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -85.95 -43.89 12.82 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.488 -0.757 . . . . 0.0 110.946 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -55.02 -31.77 61.32 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 121.599 -0.688 . . . . 0.0 111.348 171.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -64.34 -49.22 72.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.435 1.016 . . . . 0.0 108.754 -178.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -64.92 -31.79 73.19 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.087 1.355 . . . . 0.0 110.097 -174.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -94.92 -23.76 17.28 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.683 0.614 . . . . 0.0 111.309 -173.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.13 -50.04 37.7 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 169.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.36 0.0 OUTLIER -75.63 -10.49 59.49 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.555 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -77.92 -20.53 52.67 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 170.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -60.63 131.83 51.96 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.487 1.04 . . . . 0.0 111.186 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.2 mt -128.8 159.02 37.05 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.26 1.424 . . . . 0.0 110.225 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.0 m -82.0 162.41 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.2 p -106.48 -128.55 0.26 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.382 1.473 . . . . 0.0 111.169 171.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 174.76 146.71 5.82 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.359 1.457 . . . . 0.0 113.706 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.58 164.06 32.23 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.098 1.359 . . . . 0.0 112.441 170.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.3 mt -72.23 -48.59 41.67 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -169.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.29 132.97 47.29 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.077 0.551 . . . . 0.0 110.988 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.269 3.7 t -72.58 -37.73 4.58 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-O 116.186 -1.864 . . . . 0.0 113.846 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -69.38 151.83 71.27 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 122.315 2.01 . . . . 0.0 111.269 171.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -122.63 164.29 18.48 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.503 1.121 . . . . 0.0 113.499 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.71 28.64 5.8 Favored Glycine 0 N--CA 1.474 1.211 0 O-C-N 120.369 -1.457 . . . . 0.0 115.663 -170.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -47.04 -40.95 15.89 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.282 1.541 . . . . 0.0 114.747 -168.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . 0.365 5.0 mp -76.88 -19.23 57.7 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 117.98 -1.01 . . . . 0.0 113.463 -172.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.23 -41.31 98.29 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 168.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.29 -54.53 23.69 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 117.133 -1.413 . . . . 0.0 110.668 169.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.5 m -56.76 -33.47 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 120.827 1.649 . . . . 0.0 112.85 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.3 -51.78 44.26 Favored 'Isoleucine or valine' 0 C--N 1.345 0.394 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.387 172.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -60.66 -41.21 94.58 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 120.246 1.385 . . . . 0.0 110.533 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.431 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 64.6 t -56.54 -35.52 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.767 1.227 . . . . 0.0 112.318 175.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.35 -36.34 29.77 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.5 mt -83.5 -30.36 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.838 1.199 . . . . 0.0 112.548 -173.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 88.6 m -83.82 53.69 2.65 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.147 1.379 . . . . 0.0 112.35 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -55.84 -34.2 65.21 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.43 1.092 . . . . 0.0 112.462 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.62 -33.24 48.01 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 119.275 -0.736 . . . . 0.0 114.705 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -95.59 -25.52 16.13 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.045 0.922 . . . . 0.0 112.633 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.431 ' CD1' ' HA ' ' A' ' 92' ' ' VAL . 79.0 mt -82.83 -24.95 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.053 0.842 . . . . 0.0 111.179 169.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.53 24.11 61.33 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.087 -0.84 . . . . 0.0 113.807 171.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -57.87 124.91 20.83 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 118.309 1.055 . . . . 0.0 110.65 173.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -102.69 168.1 9.47 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.865 1.266 . . . . 0.0 111.224 171.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -84.28 54.97 3.15 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -172.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -94.39 -113.43 2.5 Favored Glycine 0 N--CA 1.474 1.213 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 169.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 m -127.41 136.55 51.99 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 128.005 2.522 . . . . 0.0 104.719 169.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.36 136.95 51.63 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 121.344 1.884 . . . . 0.0 110.439 -171.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -126.91 116.26 20.54 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 124.916 1.286 . . . . 0.0 112.761 -172.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.0 tp -94.53 103.2 15.16 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 171.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.68 123.39 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -113.16 128.3 56.44 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -173.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.12 129.14 56.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 124.656 1.223 . . . . 0.0 112.397 -177.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.3 t -155.37 170.97 20.68 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.869 1.268 . . . . 0.0 110.142 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -123.23 -1.3 8.71 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -139.49 175.51 9.5 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.682 -1.261 . . . . 0.0 112.419 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -58.16 -176.25 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.775 1.63 . . . . 0.0 112.39 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -138.01 163.17 32.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 123.086 1.422 . . . . 0.0 114.078 -169.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -78.9 112.15 15.79 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.73 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 mt -80.71 163.29 23.66 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.746 0.818 . . . . 0.0 110.56 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.71 132.72 49.83 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 168.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 90.79 -11.53 0.28 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 130.496 3.519 . . . . 0.0 114.579 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -28.13 69.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 122.186 2.266 . . . . 0.0 111.657 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.1 tppt? -64.4 -7.84 11.22 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.826 1.25 . . . . 0.0 113.038 -176.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.1 t -64.96 -24.34 67.49 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 120.863 -1.148 . . . . 0.0 112.351 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.78 -32.97 74.9 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.321 0.964 . . . . 0.0 112.147 172.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -86.65 4.55 86.12 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.014 1.293 . . . . 0.0 113.854 170.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.336 31.8 p 56.39 41.47 28.91 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 129.069 2.948 . . . . 0.0 114.811 -176.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.83 109.56 21.13 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.409 1.483 . . . . 0.0 108.557 169.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -94.07 -39.26 10.7 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -59.66 129.16 40.53 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.973 0.806 . . . . 0.0 111.666 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.8 t -64.83 163.39 14.33 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.169 0.988 . . . . 0.0 111.286 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.2 p -68.54 140.88 55.64 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.347 0.594 . . . . 0.0 112.087 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.0 p30 -88.93 -14.54 36.47 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.58 25.15 73.12 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.901 -0.944 . . . . 0.0 113.444 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.4 mtp-105 -106.19 166.61 10.39 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.615 1.566 . . . . 0.0 113.121 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 82.4 m -64.34 136.87 57.55 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.191 0.996 . . . . 0.0 111.245 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -142.37 33.85 1.49 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.239 1.416 . . . . 0.0 112.162 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.4 tp -102.81 140.57 36.9 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.637 1.975 . . . . 0.0 109.903 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -146.64 -64.91 0.29 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -87.29 3.23 47.56 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.986 1.315 . . . . 0.0 114.114 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.54 -12.63 43.02 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.857 1.694 . . . . 0.0 114.007 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.5 mtt -95.28 148.58 22.26 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.661 1.731 . . . . 0.0 111.681 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -73.63 90.06 1.77 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 168.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -55.8 -42.19 75.25 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.889 0.876 . . . . 0.0 112.541 -171.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 69.1 m -75.78 2.99 10.75 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -174.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -43.05 -32.87 0.74 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 171.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.94 8.51 63.33 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.502 2.001 . . . . 0.0 115.615 -174.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.265 32.3 tt0 -131.98 -60.13 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.978 0 CA-C-N 120.53 2.165 . . . . 0.0 114.055 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -70.52 146.09 54.52 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 CA-C-N 122.516 1.934 . . . . 0.0 113.029 169.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -65.41 165.52 11.8 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 129.136 2.974 . . . . 0.0 113.136 169.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -62.27 155.28 25.24 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.389 1.09 . . . . 0.0 112.025 169.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -76.86 143.78 39.46 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.61 1.164 . . . . 0.0 110.172 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 44.2 p -73.01 153.79 40.76 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.982 0.42 . . . . 0.0 110.854 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.93 -26.09 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.386 1.075 . . . . 0.0 113.789 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.6 t -81.98 -37.19 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.107 1.363 . . . . 0.0 112.034 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -67.4 -33.3 74.91 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.124 0.875 . . . . 0.0 111.795 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.89 -56.11 17.73 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.656 0.662 . . . . 0.0 110.508 169.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -58.34 -34.47 70.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.966 0.906 . . . . 0.0 112.91 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.3 t -59.27 -65.51 0.66 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.867 0.867 . . . . 0.0 111.3 170.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -67.83 -27.62 66.87 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.187 -1.571 . . . . 0.0 113.853 -174.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -37.3 79.66 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.25 1.386 . . . . 0.0 111.751 169.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.38 -28.45 37.96 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -74.7 -39.85 61.7 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.004 0.82 . . . . 0.0 110.948 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -86.11 -13.67 46.51 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.752 1.221 . . . . 0.0 111.897 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 30.0 m120 58.46 39.92 24.59 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.907 2.083 . . . . 0.0 112.818 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.7 mt -90.99 138.22 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.824 1.65 . . . . 0.0 108.814 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -96.42 107.5 36.21 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 120.354 1.434 . . . . 0.0 110.235 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.77 149.68 43.32 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.126 1.884 . . . . 0.0 113.168 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 30.0 mt -140.97 105.82 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.638 0.775 . . . . 0.0 110.093 176.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -75.82 64.22 1.77 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.425 1.09 . . . . 0.0 113.09 -177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . 0.335 0.5 OUTLIER -60.32 114.01 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 119.952 -1.717 . . . . 0.0 113.38 169.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 35.5 m -151.63 150.47 26.55 Favored Pre-proline 0 N--CA 1.48 1.027 0 O-C-N 120.636 -1.29 . . . . 0.0 112.829 -172.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.41 157.18 59.42 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.325 3.35 . . . . 0.0 113.023 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.5 p -44.66 -51.39 9.22 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.828 2.051 . . . . 0.0 113.968 -170.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -52.21 -27.31 14.23 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -174.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 22.4 ptm -117.13 3.72 12.7 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.323 1.449 . . . . 0.0 114.831 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.11 -39.65 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 CA-C-N 119.994 1.27 . . . . 0.0 110.624 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -67.99 -26.73 66.06 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -170.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.7 -37.6 20.75 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.811 1.245 . . . . 0.0 110.417 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -73.2 -28.44 62.18 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.843 -1.16 . . . . 0.0 111.381 174.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . 0.314 15.0 pt-20 -77.38 0.21 23.28 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.722 1.146 . . . . 0.0 111.995 169.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -99.08 -10.33 22.72 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.201 -0.937 . . . . 0.0 111.349 168.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.86 -31.19 28.13 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.214 1.806 . . . . 0.0 108.551 169.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.2 t -77.89 -5.62 51.61 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.593 1.157 . . . . 0.0 113.387 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 7.5 t -100.91 -17.44 16.82 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.944 0.498 . . . . 0.0 110.336 168.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -82.63 -45.36 14.64 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.258 0.481 . . . . 0.0 111.499 169.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 4.0 mp -97.51 118.11 64.67 Favored Pre-proline 0 N--CA 1.475 0.793 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -76.46 143.64 24.82 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.441 2.094 . . . . 0.0 111.191 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 79.5 tttt 101.46 -22.95 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 130.253 3.421 . . . . 0.0 114.486 169.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . 0.364 0.0 OUTLIER -76.57 168.59 19.81 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 118.897 0.771 . . . . 0.0 111.74 -177.24 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.352 6.9 t -136.86 -163.3 1.4 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 122.983 1.373 . . . . 0.0 107.946 176.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 17.1 tt -157.56 136.98 3.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 126.427 1.891 . . . . 0.0 112.461 -166.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -119.53 155.72 16.02 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.627 0.632 . . . . 0.0 111.905 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -95.34 90.52 5.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 169.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 55.6 tp -58.78 126.91 29.61 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.975 169.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 82.5 p -165.68 -166.12 0.92 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.672 1.189 . . . . 0.0 110.285 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.57 -20.88 23.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.631 1.572 . . . . 0.0 113.892 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -115.46 134.26 55.25 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.609 1.564 . . . . 0.0 111.955 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 10.6 p -90.01 -3.15 58.14 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.678 1.991 . . . . 0.0 113.821 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.7 m -58.0 -42.19 84.67 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.681 1.593 . . . . 0.0 112.072 -169.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -61.75 -42.97 99.66 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.245 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 70.9 t -70.97 -42.88 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.557 -0.715 . . . . 0.0 111.315 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.51 -20.8 66.49 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.558 -0.714 . . . . 0.0 112.198 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -76.47 7.11 4.76 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 127.811 2.444 . . . . 0.0 113.772 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.9 mp -124.04 -40.72 2.26 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.462 1.905 . . . . 0.0 108.581 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 3.3 mp -72.01 -49.39 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 3.2 ptm85 -61.78 -38.73 89.16 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.819 0.736 . . . . 0.0 111.089 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.14 -21.28 50.53 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 118.675 -1.21 . . . . 0.0 114.18 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -74.5 -27.63 60.64 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.109 0.868 . . . . 0.0 112.23 170.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -67.06 -44.73 79.37 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.641 0.655 . . . . 0.0 110.164 169.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.9 m -61.92 -21.51 64.81 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . 0.278 26.0 ttpp -80.91 -17.06 51.83 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -176.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.498 ' O ' HD12 ' A' ' 212' ' ' LEU . 2.2 tm? . . . . . 0 C--O 1.182 -2.483 0 CA-C-O 116.808 -1.568 . . . . 0.0 112.603 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -55.29 147.61 16.45 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.806 1.639 . . . . 0.0 113.399 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -69.71 125.85 27.98 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.892 0.877 . . . . 0.0 112.714 -171.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -112.46 137.83 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.645 1.578 . . . . 0.0 111.145 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -115.3 99.2 7.22 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 168.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -90.81 128.22 36.63 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.604 -0.685 . . . . 0.0 111.248 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -123.78 109.18 13.34 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 123.435 1.588 . . . . 0.0 111.767 172.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -85.63 101.46 12.74 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.261 2.224 . . . . 0.0 113.626 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.5 mt -93.47 119.44 32.56 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.8 ptm -117.75 145.15 44.68 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 169.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.58 136.21 24.38 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.7 mp -109.05 16.27 22.7 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.47 1.508 . . . . 0.0 113.171 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.0 p -67.11 170.52 6.82 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.186 -1.571 . . . . 0.0 113.265 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.66 -22.8 68.37 Favored Glycine 0 N--CA 1.475 1.253 0 O-C-N 120.782 -1.199 . . . . 0.0 114.34 -170.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 p -63.64 -27.54 69.3 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.626 1.17 . . . . 0.0 112.98 170.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.49 2.44 19.0 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.778 1.231 . . . . 0.0 113.957 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -62.91 -38.48 91.12 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.968 -1.082 . . . . 0.0 111.302 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.12 -42.17 91.93 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 170.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -60.86 -39.4 88.98 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.855 1.262 . . . . 0.0 112.8 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.0 tp -61.29 -45.17 95.57 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.184 0.994 . . . . 0.0 112.984 -173.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.3 m -60.44 -40.67 91.94 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -172.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -80.26 -23.73 40.59 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.484 -0.76 . . . . 0.0 112.726 170.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.54 -35.77 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 120.367 1.44 . . . . 0.0 111.994 174.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.17 -38.28 63.73 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.683 1.129 . . . . 0.0 111.94 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.7 p -71.6 -32.34 67.91 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.333 0.653 . . . . 0.0 111.178 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.2 tp -75.87 1.3 15.43 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 124.478 1.111 . . . . 0.0 111.954 169.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.77 -45.66 6.3 Favored Glycine 0 N--CA 1.476 1.303 0 O-C-N 119.197 -2.189 . . . . 0.0 109.23 -170.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.1 p -76.16 -34.13 59.38 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 127.399 2.28 . . . . 0.0 109.756 170.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -78.25 -33.28 49.81 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.369 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.1 tp -66.42 -51.4 57.31 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.199 0.909 . . . . 0.0 109.53 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.64 -47.31 86.82 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.163 0.985 . . . . 0.0 111.069 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -66.62 -42.88 86.13 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.766 -0.584 . . . . 0.0 111.345 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.44 91.08 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.922 0.783 . . . . 0.0 112.484 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.2 tp -61.5 -42.18 98.41 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.3 -0.875 . . . . 0.0 110.863 171.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -69.55 -9.25 53.19 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -86.07 -43.94 12.69 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.15 0.98 . . . . 0.0 111.053 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.4 tp -80.69 -22.95 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.1 t -139.47 129.2 24.63 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.099 -1.0 . . . . 0.0 112.959 176.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -64.02 -30.92 71.96 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.214 1.006 . . . . 0.0 112.335 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.2 m -117.31 90.94 3.44 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.309 1.443 . . . . 0.0 109.165 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.91 81.54 0.31 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 127.023 2.249 . . . . 0.0 108.501 -170.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -80.28 134.87 36.13 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.839 1.256 . . . . 0.0 107.743 -171.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.5 tp -119.61 142.64 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.161 0.585 . . . . 0.0 111.194 -172.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.89 160.26 29.89 Favored Glycine 0 N--CA 1.467 0.736 0 C-N-CA 125.171 1.367 . . . . 0.0 111.435 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -146.34 142.57 28.38 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -169.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.3 142.27 13.25 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.2 p -108.78 142.68 38.98 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.114 0.966 . . . . 0.0 110.615 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . 0.297 0.6 OUTLIER -152.26 137.87 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.943 1.461 . . . . 0.0 114.943 -176.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.05 -137.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 127.577 2.351 . . . . 0.0 105.719 172.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 52' ' ' THR 0.301 10.1 m120 -98.01 -1.6 42.26 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.671 1.578 . . . . 0.0 111.992 168.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 62.9 mtt -85.6 40.93 0.87 Allowed 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 102.079 -3.304 . . . . 0.0 102.079 163.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.496 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.366 68.4 p 14.38 -113.51 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.94 1 C-N-CA 133.925 4.89 . . . . 0.0 113.946 -166.092 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -112.36 130.07 56.09 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 125.089 1.493 . . . . 0.0 111.893 -168.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -122.89 118.75 28.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 168.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -81.39 116.52 21.25 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.039 170.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 mm -89.87 -44.26 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 119.16 -0.448 . . . . 0.0 110.991 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.8 tp -151.53 123.9 8.32 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.793 0.806 . . . . 0.0 112.98 -172.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -54.97 149.34 11.88 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.599 1.96 . . . . 0.0 112.455 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.5 mt -51.15 112.97 0.81 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.048 1.339 . . . . 0.0 110.301 169.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -137.26 158.53 44.22 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.173 0.989 . . . . 0.0 112.152 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.4 -5.6 51.72 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.4 1.88 . . . . 0.0 111.946 169.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -85.98 79.36 9.22 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 125.938 2.78 . . . . 0.0 109.148 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.6 t -64.72 -41.71 95.77 Favored 'General case' 0 C--N 1.314 -0.944 1 C-N-CA 132.018 4.127 . . . . 0.0 110.015 -170.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 m -63.61 -17.02 62.46 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.773 1.229 . . . . 0.0 111.866 175.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . 0.434 26.2 pt20 -102.7 -29.22 11.64 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -57.3 -25.59 59.52 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 120.383 -1.448 . . . . 0.0 112.056 169.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -75.54 -27.87 58.83 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.267 1.427 . . . . 0.0 111.884 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 -78.1 -29.34 48.95 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.965 1.306 . . . . 0.0 109.306 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.04 -34.24 16.87 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.062 0.545 . . . . 0.0 110.01 -174.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.29 -18.24 46.52 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.642 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -82.59 -22.6 34.77 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 171.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -73.06 -17.89 61.38 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -64.1 149.59 47.32 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.696 0.68 . . . . 0.0 112.632 -170.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.05 132.66 19.85 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.704 1.602 . . . . 0.0 108.626 -174.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.4 m -68.39 165.94 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.5 m -131.75 -175.24 3.65 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.729 2.412 . . . . 0.0 110.417 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -137.0 166.77 24.84 Favored Glycine 0 N--CA 1.477 1.374 0 O-C-N 120.664 -1.272 . . . . 0.0 114.649 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -155.7 155.32 32.96 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.442 1.497 . . . . 0.0 113.069 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -56.28 -65.0 0.68 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.417 2.287 . . . . 0.0 111.296 168.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.48 145.17 41.62 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.131 0.972 . . . . 0.0 113.606 -172.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.9 m -70.68 -44.95 17.15 Favored Pre-proline 0 N--CA 1.474 0.761 0 CA-C-O 116.135 -1.888 . . . . 0.0 113.218 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -69.75 141.88 46.46 Favored 'Trans proline' 0 C--N 1.354 0.851 0 CA-C-N 122.225 1.83 . . . . 0.0 112.403 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -92.84 178.88 5.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.378 1.871 . . . . 0.0 112.773 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.43 22.41 26.72 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 125.912 1.72 . . . . 0.0 115.231 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . 0.268 2.8 tt0 -64.02 -29.67 70.8 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 119.353 3.094 . . . . 0.0 119.353 -168.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.22 -20.47 65.69 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 122.255 2.298 . . . . 0.0 112.518 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -65.07 -35.13 80.18 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.651 1.114 . . . . 0.0 111.234 169.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.88 -42.04 73.97 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-O 117.086 -1.435 . . . . 0.0 110.041 168.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.292 2.1 m -61.99 -33.62 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 120.133 1.333 . . . . 0.0 112.764 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.7 p -68.8 -58.06 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 117.732 -1.128 . . . . 0.0 108.607 169.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -52.29 -53.41 44.41 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 121.184 1.811 . . . . 0.0 112.705 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.9 p -54.16 -41.6 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 119.51 1.05 . . . . 0.0 112.137 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.91 -19.25 61.3 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 mp -106.06 -30.01 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 120.081 1.31 . . . . 0.0 113.22 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 84.4 m -78.72 55.97 1.78 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.814 1.646 . . . . 0.0 111.215 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 72.7 mt -51.42 -44.12 62.18 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.148 2.179 . . . . 0.0 111.823 -171.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.3 -17.42 76.32 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.224 0.916 . . . . 0.0 114.264 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -90.76 -54.9 3.78 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.915 1.286 . . . . 0.0 110.19 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.32 -33.13 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 118.562 -0.733 . . . . 0.0 110.59 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.94 25.41 27.13 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.256 0.931 . . . . 0.0 113.432 174.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -57.27 123.95 17.16 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.172 0.986 . . . . 0.0 112.138 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.1 mtp-105 -97.27 -176.57 3.56 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.404 2.282 . . . . 0.0 110.668 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -100.77 39.13 1.41 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.078 1.351 . . . . 0.0 114.446 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -95.11 -122.47 3.83 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 169.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.1 t -113.06 143.62 44.02 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.721 1.608 . . . . 0.0 107.689 169.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -131.68 120.41 22.73 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.152 0.887 . . . . 0.0 110.117 -168.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -120.89 105.64 10.88 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -169.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.41 99.71 12.2 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.5 t -81.06 127.51 39.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.6 tt -110.47 132.43 54.19 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.4 t -119.41 121.88 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.939 0.896 . . . . 0.0 109.944 169.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.3 p -138.97 168.59 19.49 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.599 1.56 . . . . 0.0 110.189 169.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.27 2.28 2.06 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 170.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -142.25 161.22 38.57 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.962 1.705 . . . . 0.0 110.618 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -45.49 173.16 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 128.409 2.684 . . . . 0.0 117.586 -169.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -129.08 137.66 51.39 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.998 -1.064 . . . . 0.0 113.184 178.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -79.02 84.63 5.01 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 125.13 1.372 . . . . 0.0 112.216 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . 0.387 0.0 OUTLIER -73.08 174.65 7.61 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 119.802 -1.811 . . . . 0.0 113.432 174.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.57 134.72 1.72 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 -169.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.311 60.8 mtpt 75.27 -2.25 2.87 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 131.308 3.843 . . . . 0.0 114.898 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.98 -21.18 66.8 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.609 1.095 . . . . 0.0 112.821 169.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.5 mttt -69.72 -7.97 43.88 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.215 -1.553 . . . . 0.0 114.347 172.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.07 -15.55 63.79 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.196 1.362 . . . . 0.0 113.328 175.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -64.15 -21.54 66.59 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 118.802 0.728 . . . . 0.0 112.095 169.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -90.55 -128.32 3.81 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.72 1.629 . . . . 0.0 111.395 170.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.5 t -137.41 52.87 1.88 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.742 1.617 . . . . 0.0 110.132 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -133.7 88.64 2.5 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.854 1.661 . . . . 0.0 110.805 -169.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -102.73 -18.47 15.15 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -68.71 129.6 40.39 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.41 1.005 . . . . 0.0 110.832 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.0 t -69.36 161.38 29.48 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 118.822 0.737 . . . . 0.0 111.319 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.7 m -62.14 133.95 55.92 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.653 -0.654 . . . . 0.0 111.552 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -86.69 -12.58 47.93 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.66 23.99 73.67 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.276 -1.291 . . . . 0.0 114.184 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -103.32 165.13 11.22 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.144 1.472 . . . . 0.0 112.198 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 10.0 t -67.49 126.67 30.03 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.596 1.558 . . . . 0.0 109.382 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -127.34 55.86 1.57 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.637 1.575 . . . . 0.0 110.995 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.13 124.04 22.72 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.005 1.322 . . . . 0.0 109.774 -169.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -125.95 -58.45 1.38 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.34 1.056 . . . . 0.0 111.736 170.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -81.44 -21.38 38.88 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -174.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 121.91 -8.01 10.02 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.062 1.315 . . . . 0.0 114.513 -171.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 94.6 mtp -108.87 142.21 39.8 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.733 1.267 . . . . 0.0 111.364 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -67.69 83.16 0.18 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.272 1.029 . . . . 0.0 110.573 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -72.13 -15.43 61.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -169.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 86.6 p -78.07 -5.34 51.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.71 1.141 . . . . 0.0 113.223 170.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -41.68 -35.03 0.69 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.78 -5.03 81.92 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 117.517 -1.713 . . . . 0.0 114.989 -175.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -120.96 -70.71 0.02 OUTLIER Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 119.791 1.796 . . . . 0.0 112.643 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -61.08 147.18 96.42 Favored 'Trans proline' 0 C--N 1.355 0.891 0 CA-C-N 123.064 2.13 . . . . 0.0 114.919 171.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -62.05 174.87 0.78 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 130.248 3.419 . . . . 0.0 113.397 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -74.17 145.21 44.39 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.487 1.115 . . . . 0.0 112.435 172.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -67.86 131.59 45.81 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.534 0.683 . . . . 0.0 111.971 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 27.0 p -63.11 142.02 58.54 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.055 1.342 . . . . 0.0 113.396 170.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.85 -27.29 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 121.109 -0.994 . . . . 0.0 112.484 -174.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.3 t -65.38 -44.18 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 121.355 -0.84 . . . . 0.0 111.556 172.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -76.1 -20.69 57.43 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.688 -0.633 . . . . 0.0 112.062 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.29 -50.54 63.35 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.265 0.939 . . . . 0.0 108.658 168.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.49 -41.92 73.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.439 0.696 . . . . 0.0 112.615 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.8 p -68.75 -51.42 41.48 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.906 0.775 . . . . 0.0 112.416 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -67.44 -38.31 84.32 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.533 -1.354 . . . . 0.0 113.242 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.9 mp -66.21 -35.05 79.41 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.364 -0.835 . . . . 0.0 111.582 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.71 -28.71 58.71 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 172.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.37 -49.25 64.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.117 1.367 . . . . 0.0 110.026 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -91.09 -0.13 57.66 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.733 0.813 . . . . 0.0 112.907 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.3 m120 47.03 59.61 3.92 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.908 2.083 . . . . 0.0 112.492 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.7 mm -95.71 129.36 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 169.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . 0.345 10.5 pt20 -98.71 110.65 57.99 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 123.3 2.773 . . . . 0.0 108.448 169.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.89 145.44 50.65 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 124.564 3.509 . . . . 0.0 114.06 176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 8.6 mm -127.29 98.69 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.509 1.524 . . . . 0.0 109.338 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -76.89 82.06 3.46 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.22 -1.55 . . . . 0.0 110.453 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 94.2 t -71.95 126.4 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 O-C-N 120.622 -1.299 . . . . 0.0 110.582 168.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 5.1 p -163.11 141.77 6.49 Favored Pre-proline 0 N--CA 1.483 1.221 0 CA-C-O 117.745 -1.122 . . . . 0.0 113.43 -169.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -63.75 157.48 51.74 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 125.033 3.822 . . . . 0.0 116.309 176.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 78.4 p -56.47 -27.0 55.77 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -169.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -56.77 -36.12 69.46 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.664 1.12 . . . . 0.0 112.701 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 52.6 ttp -116.91 -6.12 11.47 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 -169.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 51.6 t -53.99 -32.11 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.718 -1.239 . . . . 0.0 111.286 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -61.79 -34.92 76.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.912 1.285 . . . . 0.0 113.524 -175.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.8 t -92.6 -39.68 11.19 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.848 0.859 . . . . 0.0 110.397 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -69.12 -35.16 76.1 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.318 1.047 . . . . 0.0 110.084 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -68.96 -7.03 31.34 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.549 1.068 . . . . 0.0 112.667 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -99.11 -16.66 18.55 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.826 -1.171 . . . . 0.0 111.536 169.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.05 -21.78 46.33 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.697 -1.252 . . . . 0.0 109.557 169.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.3 p -79.61 -18.76 50.88 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.971 0.908 . . . . 0.0 112.919 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . 0.289 1.7 t -81.25 -17.46 49.39 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.365 0.529 . . . . 0.0 109.909 169.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -89.62 -26.23 20.88 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.826 0.451 . . . . 0.0 111.756 168.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.5 mm -111.86 85.63 6.54 Favored Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 124.984 1.313 . . . . 0.0 110.084 172.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.17 136.94 76.1 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.257 1.971 . . . . 0.0 111.517 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 87.71 -5.7 0.59 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 129.765 3.226 . . . . 0.0 114.335 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.8 tt -72.43 138.84 47.39 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.891 1.276 . . . . 0.0 108.319 169.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 41.5 p -116.92 -164.48 0.98 Allowed 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 120.349 1.431 . . . . 0.0 107.467 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.2 mt -164.53 153.43 2.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 126.052 1.741 . . . . 0.0 110.383 -167.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -140.33 141.22 11.25 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.799 168.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -80.2 82.28 6.29 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 123.628 1.68 . . . . 0.0 108.305 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 17.3 tp -51.19 146.16 6.98 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 112.605 -2.089 . . . . 0.0 110.857 170.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 24.2 p -77.53 162.35 27.19 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.103 -0.998 . . . . 0.0 111.33 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -64.81 -20.9 66.64 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.277 -0.889 . . . . 0.0 112.911 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -88.43 -37.43 15.85 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.35 1.46 . . . . 0.0 112.638 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . 0.312 1.4 p 98.69 -7.52 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 129.863 3.265 . . . . 0.0 115.854 169.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 78.3 p -59.74 -13.7 11.29 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.996 2.118 . . . . 0.0 114.975 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -65.06 -30.61 71.59 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.492 169.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 9.4 p -43.42 -41.49 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 -168.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -62.18 -36.52 82.15 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.513 1.506 . . . . 0.0 112.939 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . 0.263 4.7 pt20 -84.11 19.54 1.79 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.7 mp -120.69 -38.07 2.91 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 128.626 2.77 . . . . 0.0 108.157 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 6.3 mm -59.88 -53.42 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 169.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 41.5 ttt85 -61.75 -41.12 97.26 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.047 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -70.28 -32.98 71.02 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -171.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -72.6 -40.33 66.61 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.784 1.234 . . . . 0.0 111.811 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -73.92 -35.39 64.62 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.872 1.269 . . . . 0.0 113.366 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 23.2 t -43.5 -35.61 1.72 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.182 2.593 . . . . 0.0 116.857 -169.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -64.22 -41.16 97.15 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 118.068 -0.968 . . . . 0.0 113.34 -172.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--O 1.259 1.57 0 C-N-CA 128.385 2.674 . . . . 0.0 114.51 -176.022 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -65.1 137.3 57.58 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 120.709 1.595 . . . . 0.0 111.558 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.5 m -68.27 146.42 53.33 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -170.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.7 t -114.91 141.1 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.769 1.228 . . . . 0.0 110.052 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -114.25 115.74 27.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.551 1.14 . . . . 0.0 109.327 169.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 tp -100.08 129.91 46.17 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.662 0.665 . . . . 0.0 111.874 169.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -120.3 105.26 10.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 123.508 1.623 . . . . 0.0 109.564 169.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -84.0 105.84 15.19 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.54 -1.664 . . . . 0.0 111.286 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -103.3 108.5 19.75 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.726 1.21 . . . . 0.0 109.701 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.2 ptm -113.2 145.54 40.82 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.91 139.58 27.45 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.043 0.83 . . . . 0.0 111.511 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 mp -112.18 25.75 11.25 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.494 1.917 . . . . 0.0 112.529 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.3 t -61.39 160.14 11.39 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.544 0.737 . . . . 0.0 111.345 169.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.59 -25.3 68.69 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 120.903 -1.123 . . . . 0.0 114.341 -170.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 p -74.62 -13.74 60.68 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.414 1.086 . . . . 0.0 113.746 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.91 2.18 18.23 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.431 1.093 . . . . 0.0 113.892 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -54.57 -40.4 68.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.724 0.81 . . . . 0.0 111.708 170.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.48 -27.89 60.6 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 123.594 0.616 . . . . 0.0 113.353 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -67.69 -50.47 57.49 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.283 1.042 . . . . 0.0 111.841 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp -52.56 -41.88 63.95 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.946 1.298 . . . . 0.0 112.847 -169.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.3 m -52.88 -51.73 60.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.712 1.205 . . . . 0.0 113.477 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -87.53 -7.34 57.7 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -174.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.3 m -97.96 13.97 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 119.742 1.156 . . . . 0.0 113.224 170.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -87.15 -32.09 20.04 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.39 -1.444 . . . . 0.0 110.175 177.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.2 t -79.3 -11.88 59.94 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.081 2.152 . . . . 0.0 110.258 168.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.6 tp -85.46 90.28 7.91 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 124.362 2.03 . . . . 0.0 107.035 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.62 -51.13 0.05 OUTLIER Glycine 0 C--N 1.296 -1.686 0 CA-C-N 109.265 -3.607 . . . . 0.0 109.791 167.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.7 m -74.77 -36.57 62.54 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.331 1.852 . . . . 0.0 111.13 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -58.57 -40.56 83.47 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.458 0.703 . . . . 0.0 110.45 169.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -57.42 8.65 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tt -52.69 -40.73 63.22 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 116.988 -1.482 . . . . 0.0 112.902 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -69.62 -32.05 70.53 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 122.027 2.194 . . . . 0.0 112.962 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.18 -37.28 66.58 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.917 0.78 . . . . 0.0 112.842 169.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.8 mt -77.04 -31.61 56.39 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.624 0.77 . . . . 0.0 112.995 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.84 -18.02 62.73 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.329 1.422 . . . . 0.0 113.663 -172.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -81.66 -46.04 14.91 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.798 0.839 . . . . 0.0 109.437 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.83 -23.74 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 38.8 t -151.58 143.86 24.06 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.718 1.145 . . . . 0.0 113.605 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.49 -9.63 59.34 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 174.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.4 t -139.46 120.54 14.65 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.328 1.061 . . . . 0.0 110.74 169.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.94 84.79 0.23 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 -170.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -74.96 146.03 42.07 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.5 tt -133.05 134.45 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.64 0.776 . . . . 0.0 110.585 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.56 152.58 21.66 Favored Glycine 0 N--CA 1.467 0.752 0 C-N-CA 125.907 1.718 . . . . 0.0 111.146 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -124.08 146.98 48.23 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.415 0.686 . . . . 0.0 111.557 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.24 154.14 25.72 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 170.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.6 p -135.24 159.17 42.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.357 1.075 . . . . 0.0 113.185 177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.64 147.77 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 121.347 -0.846 . . . . 0.0 111.986 -169.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . 0.306 12.0 p -154.29 -129.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 116.626 -1.654 . . . . 0.0 109.427 171.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.402 ' C ' ' H ' ' A' ' 52' ' ' THR . 4.5 t30 -95.45 -20.86 18.72 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 123.43 2.832 . . . . 0.0 112.963 169.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 46.2 mtt -80.75 49.13 1.15 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 167.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.402 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.294 12.8 p 25.17 -120.66 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.518 1 C-N-CA 132.157 4.183 . . . . 0.0 114.381 -169.057 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -107.35 133.13 52.34 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 127.483 2.313 . . . . 0.0 112.503 -167.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.2 123.85 48.79 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 169.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -97.43 127.76 43.66 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.609 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -155.67 113.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.929 0.892 . . . . 0.0 109.525 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.9 tp 96.51 83.21 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.868 3.267 . . . . 0.0 107.875 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.15 155.14 21.34 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.797 0.808 . . . . 0.0 111.149 169.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . 0.26 2.2 tm? -54.54 105.03 0.13 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 128.02 2.528 . . . . 0.0 109.689 -170.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.0 t -138.8 174.01 10.98 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.71 1.604 . . . . 0.0 112.635 -169.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.76 -12.32 31.6 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.104 1.362 . . . . 0.0 114.567 -172.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -89.13 85.87 6.76 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 125.364 2.507 . . . . 0.0 108.686 -176.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.6 t -61.7 -39.68 92.34 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 128.077 2.551 . . . . 0.0 110.674 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.7 m -64.54 -15.1 60.37 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.224 -0.923 . . . . 0.0 112.047 169.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -81.03 -38.52 27.31 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.199 -0.938 . . . . 0.0 110.959 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -57.91 -23.6 54.09 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.298 1.039 . . . . 0.0 112.191 170.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -74.91 -43.14 55.91 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.472 -0.768 . . . . 0.0 109.469 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -86.8 -29.68 22.11 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.895 0.878 . . . . 0.0 111.03 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -76.14 -34.32 59.41 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.3 tt -68.97 -37.61 78.89 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.998 -0.525 . . . . 0.0 110.083 170.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -60.44 -38.86 85.45 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.714 0.688 . . . . 0.0 112.191 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -65.01 -20.75 66.65 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -63.47 152.7 37.67 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.566 1.075 . . . . 0.0 111.99 -172.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.1 tp -135.57 127.12 28.82 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.147 1.379 . . . . 0.0 108.736 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.2 m -61.6 163.77 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.828 0.851 . . . . 0.0 112.173 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.9 p -119.56 -157.91 0.72 Allowed 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.761 -0.587 . . . . 0.0 110.333 168.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.66 143.12 9.64 Favored Glycine 0 CA--C 1.524 0.609 0 O-C-N 121.154 -0.967 . . . . 0.0 112.202 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 149.45 28.12 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.659 1.583 . . . . 0.0 110.79 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.01 -57.23 4.18 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -168.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.73 136.76 58.09 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.657 0.662 . . . . 0.0 111.549 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.254 6.4 t -65.84 -39.12 28.34 Favored Pre-proline 0 N--CA 1.476 0.859 0 CA-C-O 116.321 -1.799 . . . . 0.0 114.599 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.71 143.29 50.6 Favored 'Trans proline' 0 C--N 1.359 1.084 0 CA-C-N 122.71 2.003 . . . . 0.0 111.665 173.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.15 162.29 16.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.125 1.77 . . . . 0.0 112.199 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.61 42.27 2.91 Favored Glycine 0 N--CA 1.479 1.525 0 C-N-CA 125.022 1.296 . . . . 0.0 115.264 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -60.74 -29.65 69.52 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.223 1.512 . . . . 0.0 112.891 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.5 tp -65.89 -32.86 74.61 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -169.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -59.7 -54.66 43.84 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.46 -52.31 64.07 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.636 0.774 . . . . 0.0 111.72 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.258 3.1 p -61.3 -36.44 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 119.592 1.087 . . . . 0.0 112.792 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.8 -35.76 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 120.607 1.548 . . . . 0.0 113.23 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -61.91 -46.42 89.44 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.055 1.298 . . . . 0.0 110.741 172.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.9 t -54.79 -36.73 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 122.84 0.456 . . . . 0.0 111.745 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.31 -30.81 62.23 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 20.7 tt -99.01 -25.59 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 61.2 m -82.91 61.31 5.88 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 120.459 1.481 . . . . 0.0 111.512 -171.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.3 mt -49.42 -45.58 46.48 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.909 2.884 . . . . 0.0 110.977 -171.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.59 -23.08 44.32 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 114.14 -1.391 . . . . 0.0 114.135 -173.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -84.66 -46.68 11.25 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.382 1.091 . . . . 0.0 110.938 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.0 mt -79.94 -25.01 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 118.054 -0.974 . . . . 0.0 111.474 177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.06 23.9 36.57 Favored Glycine 0 N--CA 1.471 0.992 0 CA-C-N 119.548 1.067 . . . . 0.0 115.306 169.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -52.62 122.43 8.98 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.92 1.288 . . . . 0.0 112.55 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -93.71 175.03 6.89 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.732 1.213 . . . . 0.0 111.131 170.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -90.49 27.95 1.59 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 116.288 1.958 . . . . 0.0 116.288 -168.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.34 -124.69 3.79 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 120.768 -1.207 . . . . 0.0 110.797 173.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.3 m -97.85 142.5 29.53 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.742 2.017 . . . . 0.0 107.58 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -142.85 119.47 11.08 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 121.076 1.762 . . . . 0.0 110.739 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -113.97 123.28 49.33 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 126.314 1.846 . . . . 0.0 112.99 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 tt -107.87 96.03 6.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 110.112 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 77.5 t -79.93 126.97 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.1 tp -114.25 116.01 28.33 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.66 130.7 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -165.04 151.27 10.14 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 117.615 -1.183 . . . . 0.0 113.062 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -96.82 -13.64 22.43 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.565 1.946 . . . . 0.0 115.45 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -128.51 172.16 11.42 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.124 0.97 . . . . 0.0 113.371 -169.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.52 179.35 0.62 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.569 1.147 . . . . 0.0 111.603 169.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -128.4 156.46 43.13 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.034 -1.666 . . . . 0.0 113.437 -170.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -77.65 117.31 18.94 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.598 169.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.455 HD22 ' H ' ' A' ' 119' ' ' ALA . 2.8 tt -88.61 173.89 8.37 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.287 1.435 . . . . 0.0 110.015 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.455 ' H ' HD22 ' A' ' 118' ' ' LEU . . . -54.99 150.5 10.19 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.99 -1.069 . . . . 0.0 110.5 168.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt 74.06 -21.01 0.29 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.557 1.943 . . . . 0.0 114.826 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -54.01 -56.52 17.12 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.239 -1.538 . . . . 0.0 113.022 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -6.83 0.51 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 119.341 3.089 . . . . 0.0 119.341 -177.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.378 0.5 OUTLIER -64.74 -20.26 66.25 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 122.328 2.331 . . . . 0.0 111.269 174.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -50.48 -44.46 55.87 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.298 1.839 . . . . 0.0 110.241 168.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -87.02 22.3 15.41 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.702 2.096 . . . . 0.0 114.503 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 56.3 m 73.22 20.57 3.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.65 1.98 . . . . 0.0 112.415 170.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 25.2 ttp-105 -116.25 112.59 21.83 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.571 1.548 . . . . 0.0 111.035 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -117.86 -33.76 4.39 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -170.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -63.62 118.21 7.9 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 120.329 1.422 . . . . 0.0 111.304 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . 0.261 3.0 t -67.96 166.36 15.93 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -171.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.8 p -60.85 129.11 39.8 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.708 0.803 . . . . 0.0 112.905 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.7 p30 -82.66 -13.68 56.01 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.458 0.703 . . . . 0.0 112.784 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.86 1.18 66.6 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.433 1.492 . . . . 0.0 114.377 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -79.57 165.69 22.68 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.728 1.611 . . . . 0.0 114.036 -169.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 31.3 t -74.1 126.77 31.27 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.809 0.843 . . . . 0.0 109.489 169.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -141.33 39.83 1.74 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.813 1.645 . . . . 0.0 111.739 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.3 mt -103.56 148.75 25.6 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.166 1.387 . . . . 0.0 109.091 172.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -143.15 -64.5 0.4 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.34 0.656 . . . . 0.0 112.182 175.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -92.11 15.79 12.69 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.387 1.475 . . . . 0.0 113.47 177.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.71 9.4 62.78 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.119 1.342 . . . . 0.0 114.526 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 59.5 ttm -117.61 146.68 43.49 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.115 1.366 . . . . 0.0 111.027 172.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -74.35 87.63 2.02 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.877 0.871 . . . . 0.0 111.942 170.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 62.5 ttt-85 -50.62 -38.15 44.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.206 1.802 . . . . 0.0 112.582 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.0 t -64.12 -17.41 63.42 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.081 1.352 . . . . 0.0 114.632 -176.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -35.95 -50.85 0.7 Allowed 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 120.579 1.536 . . . . 0.0 114.107 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.09 -5.03 84.63 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.168 -1.351 . . . . 0.0 114.747 -172.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.327 3.0 pt-20 -129.09 -64.84 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 115.377 -2.249 . . . . 0.0 113.748 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -68.65 154.81 70.7 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 CA-C-N 124.627 2.688 . . . . 0.0 118.003 169.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . 0.288 26.8 t0 -83.89 141.5 31.25 Favored 'General case' 0 CA--C 1.551 1.01 1 C-N-CA 133.082 4.553 . . . . 0.0 114.828 -176.598 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -50.67 113.99 1.04 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.416 -0.803 . . . . 0.0 111.21 168.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.556 ' CD ' ' H ' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -54.99 153.47 6.35 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 127.469 2.307 . . . . 0.0 114.849 -173.425 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 85.9 p -83.8 153.01 24.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.107 0.963 . . . . 0.0 112.898 -177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.9 m -55.06 -27.39 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.96 -44.6 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.957 0.903 . . . . 0.0 110.929 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -28.25 65.0 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.807 -0.616 . . . . 0.0 111.311 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.8 mt -60.53 -52.55 64.69 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.883 0.765 . . . . 0.0 110.039 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.3 -45.53 84.08 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.431 1.092 . . . . 0.0 111.065 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.2 m -65.91 -47.18 75.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.49 0.716 . . . . 0.0 112.763 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.22 -42.55 98.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.066 1.303 . . . . 0.0 111.974 174.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.49 -44.67 81.98 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.158 0.983 . . . . 0.0 111.784 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.6 -24.77 62.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.413 1.085 . . . . 0.0 113.471 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -75.27 -43.56 50.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.7 0.8 . . . . 0.0 110.724 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -85.08 -13.85 49.05 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.78 39.43 20.77 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.332 1.453 . . . . 0.0 113.541 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.0 mt -82.71 149.4 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 169.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -107.39 111.34 63.11 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 120.152 1.342 . . . . 0.0 109.503 169.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -78.02 149.71 25.87 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.655 3.57 . . . . 0.0 113.346 174.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.9 mp -132.91 107.56 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.875 1.27 . . . . 0.0 109.274 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -74.89 71.29 2.01 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.94 -1.1 . . . . 0.0 112.748 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 95.7 t -75.31 103.39 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 120.421 -1.424 . . . . 0.0 111.742 175.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 22.8 m -145.27 147.73 35.13 Favored Pre-proline 0 N--CA 1.48 1.038 0 O-C-N 120.754 -1.216 . . . . 0.0 112.661 -169.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -55.34 149.99 43.43 Favored 'Trans proline' 0 C--N 1.353 0.791 1 C-N-CA 125.808 4.339 . . . . 0.0 115.744 177.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 36.5 p -46.73 -49.59 19.35 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.746 2.019 . . . . 0.0 113.422 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -43.22 -32.61 0.79 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.607 2.363 . . . . 0.0 115.431 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.8 ptm -118.68 -2.77 10.9 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.6 1.56 . . . . 0.0 114.75 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.78 -29.85 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-N 120.277 1.399 . . . . 0.0 111.05 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -65.11 -21.06 66.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.208 1.003 . . . . 0.0 113.525 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.55 -39.43 11.92 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.161 0.984 . . . . 0.0 111.36 177.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -73.36 -28.87 62.27 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 120.826 -1.171 . . . . 0.0 110.471 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -58.08 -23.77 55.94 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.66 0.784 . . . . 0.0 110.819 168.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -87.52 -29.54 21.26 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.517 -0.74 . . . . 0.0 110.546 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.82 -26.31 61.44 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.302 1.441 . . . . 0.0 110.138 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.295 3.2 t -80.37 -17.36 52.14 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 173.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 28.9 m -82.83 -34.37 26.89 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.637 -0.664 . . . . 0.0 109.402 169.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -78.77 -19.47 52.16 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 20.3 mt -131.74 92.9 29.36 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.504 1.122 . . . . 0.0 108.978 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -60.56 142.34 97.66 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.943 2.429 . . . . 0.0 113.415 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt 93.99 -15.35 0.12 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 130.245 3.418 . . . . 0.0 114.798 169.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.6 pp -84.24 152.3 24.28 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.7 0.682 . . . . 0.0 109.266 168.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 76.3 p -111.0 -146.61 0.41 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -170.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.1 tt 179.75 152.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 128.317 2.647 . . . . 0.0 110.538 -168.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -153.14 151.05 22.89 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 123.912 0.767 . . . . 0.0 111.811 169.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.4 84.21 5.98 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.739 1.216 . . . . 0.0 109.491 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 11.7 tp -51.44 140.2 18.16 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.356 169.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.3 p -166.65 -123.66 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.619 0.768 . . . . 0.0 110.464 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -88.26 5.8 39.99 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.748 2.019 . . . . 0.0 114.353 -174.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -139.47 146.54 40.15 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.293 1.437 . . . . 0.0 112.721 -173.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 10.1 t -89.89 -23.14 21.7 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.12 1.768 . . . . 0.0 112.369 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 57.8 m -58.61 -26.89 64.16 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 119.818 -1.801 . . . . 0.0 112.098 -175.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -60.29 -34.51 73.86 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 12.7 p -78.42 -38.82 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 120.588 1.54 . . . . 0.0 110.816 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -75.95 -37.29 58.8 Favored 'General case' 0 C--O 1.22 -0.491 0 O-C-N 120.935 -1.103 . . . . 0.0 113.757 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -82.55 20.31 1.13 Allowed 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 121.216 1.826 . . . . 0.0 113.966 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.84 -31.23 2.68 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.756 2.022 . . . . 0.0 109.005 169.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 95.8 mt -68.48 -46.7 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 168.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -57.81 -43.68 85.85 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.667 1.187 . . . . 0.0 110.815 174.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -81.32 -23.04 38.07 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -172.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -77.04 -27.84 54.6 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.567 0.747 . . . . 0.0 111.977 169.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -68.98 -46.39 68.22 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.239 0.615 . . . . 0.0 112.241 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 42.8 p -70.13 -9.65 56.26 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.61 -21.0 58.17 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.039 0.935 . . . . 0.0 113.304 170.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 C--O 1.255 1.343 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -174.853 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 57.9 t0 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -114.96 164.56 13.98 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.844 1.257 . . . . 0.0 111.279 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.0 t -66.69 129.31 39.44 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.29 123.45 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 127.071 2.149 . . . . 0.0 108.737 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -108.68 104.79 14.15 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.717 1.207 . . . . 0.0 109.513 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.1 132.17 41.76 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.882 -1.136 . . . . 0.0 112.824 173.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -121.53 110.79 16.45 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 124.426 2.06 . . . . 0.0 110.685 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -88.81 114.13 25.1 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 128.201 2.6 . . . . 0.0 113.111 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.8 mp -108.95 130.96 55.46 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.799 0.84 . . . . 0.0 111.099 169.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . 0.348 0.0 OUTLIER -128.93 151.62 49.46 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 167.299 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.16 129.54 11.68 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.964 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.53 27.63 8.62 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.43 1.892 . . . . 0.0 111.635 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 100.0 p -67.08 164.11 18.6 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.504 -1.372 . . . . 0.0 112.923 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.21 -32.7 85.08 Favored Glycine 0 N--CA 1.471 1.027 0 O-C-N 121.142 -0.974 . . . . 0.0 111.864 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 m -59.75 -31.45 69.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.42 1.088 . . . . 0.0 112.379 172.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.36 -0.54 12.64 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -66.75 138.21 57.22 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 121.06 1.754 . . . . 0.0 110.102 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.67 -44.79 3.16 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.219 0.914 . . . . 0.0 111.281 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -68.53 -25.71 65.07 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.592 1.157 . . . . 0.0 111.789 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.4 tp -49.37 -46.35 47.02 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.943 1.697 . . . . 0.0 110.996 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -53.63 -49.95 66.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.798 0.839 . . . . 0.0 111.724 173.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.269 0.5 OUTLIER -69.14 -25.89 64.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.109 -0.948 . . . . 0.0 113.446 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.281 0.0 OUTLIER -82.42 -33.8 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 169.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . 0.286 3.3 pt20 -71.09 -34.13 70.85 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.263 1.392 . . . . 0.0 111.474 175.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.2 t -66.01 -41.62 90.77 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.174 170.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.0 tp -60.7 -31.6 70.86 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.838 1.199 . . . . 0.0 112.098 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.16 -33.9 6.7 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -168.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.7 t -65.57 -43.29 90.25 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 168.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -78.01 -28.95 49.28 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.38 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.21 -48.05 81.56 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.69 -50.24 58.64 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -57.74 -50.7 72.34 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.781 0.832 . . . . 0.0 111.132 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.71 -40.98 98.12 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.207 0.603 . . . . 0.0 111.564 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.4 mt -79.27 -24.91 42.63 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.114 -0.946 . . . . 0.0 112.926 -176.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.64 -29.17 67.83 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.289 1.404 . . . . 0.0 111.753 169.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.04 -41.5 22.56 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.155 0.982 . . . . 0.0 110.704 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.8 tt -73.29 -28.66 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 118.566 0.621 . . . . 0.0 112.249 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.1 t -145.94 124.56 12.5 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -69.39 -34.25 74.23 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.949 1.299 . . . . 0.0 111.508 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -99.81 78.9 2.17 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.996 1.318 . . . . 0.0 108.964 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.35 74.3 0.42 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 127.198 2.333 . . . . 0.0 108.235 -169.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -81.83 140.02 34.41 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.385 1.093 . . . . 0.0 108.238 -171.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.7 tt -120.32 142.94 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 117.856 0.298 . . . . 0.0 111.795 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.95 157.05 22.46 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.951 1.739 . . . . 0.0 110.1 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -128.26 142.59 51.11 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -169.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.82 141.82 12.01 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 118.729 0.695 . . . . 0.0 112.067 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.0 t -109.7 142.26 41.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.476 1.111 . . . . 0.0 110.447 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -150.48 152.28 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 120.775 -1.203 . . . . 0.0 111.766 170.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.3 t -138.72 -62.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.311 1.045 . . . . 0.0 111.06 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.3 t30 154.35 -24.88 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 1 C-N-CA 132.764 4.426 . . . . 0.0 108.24 -169.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 87.9 mtp -53.72 -50.3 66.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.64 1.176 . . . . 0.0 109.473 168.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.5 p 178.78 179.52 0.39 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 131.09 3.756 . . . . 0.0 108.846 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -98.28 125.75 43.5 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 103.561 -2.755 . . . . 0.0 103.561 166.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 65.3 tp60 -111.9 114.92 28.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 122.337 1.065 . . . . 0.0 109.184 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -82.94 113.21 20.38 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.703 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.5 pt -142.07 115.41 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.967 0.907 . . . . 0.0 109.167 168.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.3 tp 101.72 96.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 130.262 3.425 . . . . 0.0 108.611 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -63.0 163.71 9.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.047 1.339 . . . . 0.0 111.535 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.7 mt -54.37 111.68 0.84 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.373 0.669 . . . . 0.0 110.757 174.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 t -133.74 160.98 35.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.34 1.456 . . . . 0.0 112.472 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.37 -2.23 57.39 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.127 1.771 . . . . 0.0 113.336 170.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -86.28 75.51 9.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 125.037 2.351 . . . . 0.0 108.947 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.1 m -71.59 -45.68 61.47 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 129.26 3.024 . . . . 0.0 112.002 -169.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.3 p -55.88 -26.31 46.55 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.791 -0.568 . . . . 0.0 111.34 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.51 -34.8 15.41 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 122.035 -0.415 . . . . 0.0 110.996 -171.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -54.2 -34.77 61.34 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.268 -0.895 . . . . 0.0 111.869 169.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -75.29 -30.95 60.56 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.511 0.725 . . . . 0.0 110.642 -172.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -75.16 -29.61 60.5 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 124.592 1.157 . . . . 0.0 110.106 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.72 -35.39 22.52 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.336 0.398 . . . . 0.0 110.392 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -39.56 87.84 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -67.08 -47.05 72.45 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -71.4 -29.22 64.67 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 -168.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -76.71 146.2 38.18 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.247 1.385 . . . . 0.0 113.25 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.2 mt -125.17 163.09 23.22 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.048 1.739 . . . . 0.0 111.983 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.35 159.63 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.243 1.417 . . . . 0.0 113.928 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -118.11 -152.59 0.51 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.772 1.629 . . . . 0.0 110.102 169.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -132.79 152.38 20.28 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 124.95 1.262 . . . . 0.0 114.395 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -148.03 152.95 38.29 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.974 1.71 . . . . 0.0 111.154 173.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -70.55 -82.82 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.455 1.502 . . . . 0.0 111.251 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.05 158.93 30.24 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.0 m -65.04 -46.16 73.82 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 115.856 -2.021 . . . . 0.0 115.084 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.29 138.2 65.0 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.609 2.206 . . . . 0.0 112.482 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -101.87 162.55 12.82 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.941 0.897 . . . . 0.0 112.129 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.07 10.18 49.6 Favored Glycine 0 N--CA 1.482 1.706 0 C-N-CA 124.4 1.0 . . . . 0.0 115.098 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -28.21 -46.13 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 131.197 3.799 . . . . 0.0 115.613 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.78 -34.15 52.05 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.922 2.489 . . . . 0.0 114.37 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -68.27 -40.62 81.82 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.596 -1.315 . . . . 0.0 111.81 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.63 -44.79 66.45 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.505 -0.76 . . . . 0.0 111.913 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -54.66 -38.17 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 118.951 0.796 . . . . 0.0 111.755 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.62 -53.62 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 119.139 0.881 . . . . 0.0 111.818 173.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -60.57 -41.35 94.46 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.685 1.13 . . . . 0.0 111.525 -173.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.88 -40.18 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.165 0.586 . . . . 0.0 111.472 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.07 -38.84 89.32 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.038 -1.039 . . . . 0.0 112.193 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.5 mt -81.21 -30.39 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -174.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -84.99 65.64 9.34 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.614 -1.304 . . . . 0.0 112.663 -174.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.4 mt -46.42 -43.59 16.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.781 2.033 . . . . 0.0 111.184 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.28 -31.0 35.47 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.807 1.194 . . . . 0.0 115.136 -174.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -84.95 -43.06 14.36 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.35 1.075 . . . . 0.0 110.514 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.9 mm -72.13 -35.96 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 122.306 -0.246 . . . . 0.0 110.338 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.66 25.91 26.38 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.715 1.15 . . . . 0.0 113.857 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -55.13 122.5 11.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.645 1.178 . . . . 0.0 112.491 -177.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -97.08 168.22 10.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.799 1.24 . . . . 0.0 111.587 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -84.24 57.72 4.4 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.13 -128.05 5.88 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 169.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.9 p -111.34 144.76 40.02 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 168.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 12.1 ptt-85 -146.16 119.79 9.16 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 120.698 1.59 . . . . 0.0 111.181 -170.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -120.68 131.82 54.77 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -172.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.5 tp -89.75 107.97 19.41 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.613 170.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.9 t -90.48 111.96 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 173.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.6 tp -117.09 114.42 23.71 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 119.062 0.846 . . . . 0.0 110.11 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.11 138.18 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.4 t -150.37 170.03 20.01 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 112.439 -2.164 . . . . 0.0 109.465 168.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -130.38 13.88 5.55 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.996 1.718 . . . . 0.0 113.375 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -142.58 179.35 7.02 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.891 1.676 . . . . 0.0 109.825 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -73.3 -170.84 0.85 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.355 0.597 . . . . 0.0 110.437 168.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -143.96 157.25 44.46 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.063 -1.023 . . . . 0.0 113.616 -169.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -73.58 129.94 39.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.331 172.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -105.94 178.32 4.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.832 1.653 . . . . 0.0 109.34 177.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.493 ' H ' HD23 ' A' ' 118' ' ' LEU . . . -53.62 140.68 28.17 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.077 -1.015 . . . . 0.0 112.682 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? 85.52 -26.27 0.1 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 128.883 2.873 . . . . 0.0 114.993 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . 0.256 10.6 p30 -65.36 -22.66 66.83 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 121.944 2.157 . . . . 0.0 114.767 -175.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . 0.253 0.0 OUTLIER -72.12 6.32 2.24 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 120.245 -1.535 . . . . 0.0 114.794 168.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.6 t -61.71 -26.1 67.83 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.755 -1.216 . . . . 0.0 110.155 168.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 57.6 mt -63.7 -35.05 79.29 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.071 1.748 . . . . 0.0 112.96 171.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -88.75 14.36 60.3 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.739 1.638 . . . . 0.0 113.533 172.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.323 25.9 m 41.62 54.81 3.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.375 3.07 . . . . 0.0 114.459 -174.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -100.72 110.45 22.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -85.9 -62.32 1.55 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 121.684 2.038 . . . . 0.0 112.02 -171.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.16 132.77 44.6 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.4 t -49.8 145.02 5.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.767 2.027 . . . . 0.0 111.104 170.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.4 p -65.24 145.27 56.45 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.168 0.985 . . . . 0.0 111.948 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -80.93 -12.54 59.38 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.82 16.73 78.1 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 118.737 -1.035 . . . . 0.0 113.376 -176.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -103.59 159.78 15.3 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.922 1.289 . . . . 0.0 109.018 169.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 4.8 t -85.07 144.65 28.11 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.777 -1.202 . . . . 0.0 112.593 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -132.49 63.78 1.62 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.908 2.083 . . . . 0.0 109.609 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.13 130.04 52.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.199 1.8 . . . . 0.0 108.469 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -133.63 -69.19 0.55 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.226 0.61 . . . . 0.0 112.095 173.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.45 6.64 32.93 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.04 1.336 . . . . 0.0 114.205 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 108.82 -14.49 34.64 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.89 1.71 . . . . 0.0 114.949 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 62.2 mtt -91.54 144.46 25.53 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.285 1.542 . . . . 0.0 110.867 171.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -64.83 98.33 0.27 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 50.9 mmm-85 -56.43 -42.5 78.18 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.304 1.842 . . . . 0.0 112.268 -169.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 70.7 m -95.33 5.06 52.69 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -169.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.9 ttp-105 -47.11 -40.52 15.56 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.504 1.502 . . . . 0.0 112.995 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.73 -3.33 72.83 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 117.953 -1.471 . . . . 0.0 115.208 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.28 45.6 tt0 -120.6 -76.26 0.01 OUTLIER Pre-proline 0 CA--C 1.555 1.161 0 CA-C-O 115.84 -2.028 . . . . 0.0 111.83 176.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -58.89 160.93 16.65 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 123.147 2.565 . . . . 0.0 117.66 175.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -70.12 174.28 5.65 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 129.864 3.266 . . . . 0.0 114.91 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -81.29 123.1 28.23 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.672 1.989 . . . . 0.0 105.893 167.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.599 ' CD ' ' H ' ' A' ' 151' ' ' GLN . 0.2 OUTLIER -64.09 135.5 56.43 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 119.712 -1.868 . . . . 0.0 112.101 -177.634 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 24.6 p -67.44 155.45 38.99 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.387 -1.445 . . . . 0.0 112.087 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.69 -28.42 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 120.625 -1.297 . . . . 0.0 114.282 -169.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 52.0 t -81.54 -22.73 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.448 0.699 . . . . 0.0 112.596 175.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -63.9 -41.67 97.64 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.681 1.128 . . . . 0.0 109.013 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.6 mt -55.7 -56.6 18.51 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.345 0.521 . . . . 0.0 110.857 174.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.36 -30.1 69.34 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.0 t -65.88 -54.07 31.45 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.701 0.682 . . . . 0.0 111.357 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -63.78 -44.39 93.53 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.034 -1.041 . . . . 0.0 113.44 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mt -76.34 -23.88 54.24 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.503 -1.373 . . . . 0.0 112.042 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.99 -37.84 61.78 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 169.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.4 -34.77 63.38 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.235 0.925 . . . . 0.0 110.784 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -85.6 -7.05 59.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.117 0.967 . . . . 0.0 112.594 174.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 58.13 37.56 26.37 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.185 1.794 . . . . 0.0 113.347 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 22.9 mm -88.92 140.62 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.298 1.039 . . . . 0.0 109.193 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -102.92 101.79 23.36 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 120.743 1.611 . . . . 0.0 109.421 169.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -77.63 143.07 21.08 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.299 2.0 . . . . 0.0 112.979 174.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.6 mm -129.31 109.69 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.004 1.722 . . . . 0.0 108.881 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -75.91 71.81 2.74 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 123.648 1.69 . . . . 0.0 112.149 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.93 101.63 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 O-C-N 121.141 -0.974 . . . . 0.0 113.008 169.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 5.6 m -144.4 144.18 24.5 Favored Pre-proline 0 N--CA 1.484 1.225 0 O-C-N 120.175 -1.578 . . . . 0.0 111.707 -174.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -67.15 168.37 17.71 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.762 2.308 . . . . 0.0 115.581 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.1 t -52.13 140.88 19.86 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.499 169.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 103.13 -48.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 130.132 3.373 . . . . 0.0 110.006 -172.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -86.79 -22.45 25.88 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.1 t -50.93 -42.11 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 125.729 1.612 . . . . 0.0 111.89 -169.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -75.28 -15.88 60.48 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -172.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.54 -44.19 21.62 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.984 0.811 . . . . 0.0 109.528 172.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -71.89 -28.03 63.23 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.381 1.473 . . . . 0.0 110.656 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -65.92 -36.01 82.19 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.252 169.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -76.31 -26.71 56.09 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 116.732 -1.987 . . . . 0.0 110.758 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.6 -19.84 58.98 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.776 -1.203 . . . . 0.0 109.746 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.6 t -70.37 -23.84 62.86 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 119.473 1.033 . . . . 0.0 110.908 169.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 11.9 m -75.23 -31.02 60.72 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.389 0.676 . . . . 0.0 109.268 173.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -77.13 -27.64 54.03 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.873 173.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 30.3 pt -119.6 95.92 49.45 Favored Pre-proline 0 N--CA 1.489 1.503 0 CA-C-N 120.182 1.355 . . . . 0.0 113.656 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.87 138.5 51.39 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 124.11 3.207 . . . . 0.0 113.177 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 80.96 -4.1 1.75 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 128.665 2.786 . . . . 0.0 114.065 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.54 154.39 42.07 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.927 1.24 . . . . 0.0 108.583 168.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.554 ' CG2' ' H ' ' A' ' 191' ' ' ILE 0.256 1.9 m -128.11 -177.43 4.14 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 169.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.554 ' H ' ' CG2' ' A' ' 190' ' ' THR . 13.0 tt -146.22 144.49 20.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 129.587 3.155 . . . . 0.0 107.476 -168.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -128.27 146.98 17.18 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -91.1 94.53 9.64 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 60.9 tp -57.14 139.87 51.17 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.277 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 86.7 p -163.85 -176.56 4.64 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.955 1.702 . . . . 0.0 107.697 171.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.59 -6.13 1.52 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 172.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -110.42 133.64 53.09 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.017 1.727 . . . . 0.0 111.728 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 46.8 t -89.72 -17.0 29.12 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.16 1.384 . . . . 0.0 114.053 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 63.2 m -56.67 -40.33 75.33 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.257 -1.527 . . . . 0.0 113.521 -168.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -67.9 -20.31 65.09 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.1 -45.97 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.072 -1.017 . . . . 0.0 110.919 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.9 -34.8 79.26 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 117.625 -1.179 . . . . 0.0 111.512 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -64.57 -6.54 7.79 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.55 1.523 . . . . 0.0 114.17 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 54.3 mt -104.32 -38.8 6.71 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 126.86 2.064 . . . . 0.0 107.425 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 40.4 mm -68.74 -49.53 63.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 169.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . 0.335 21.1 ptt180 -67.28 -26.36 66.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 119.275 -0.97 . . . . 0.0 112.01 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -66.96 -41.56 86.7 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 120.253 1.388 . . . . 0.0 111.161 169.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -75.07 -29.22 60.62 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.769 0.827 . . . . 0.0 112.416 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -66.78 -38.74 87.15 Favored 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 124.28 1.032 . . . . 0.0 111.058 169.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 11.1 t -63.3 -18.74 63.93 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . 0.261 0.0 OUTLIER -103.01 33.71 3.16 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.133 1.373 . . . . 0.0 114.387 -177.013 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 C--O 1.257 1.471 0 N-CA-C 119.165 3.024 . . . . 0.0 119.165 177.71 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.116 0.484 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -95.46 158.51 15.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.959 0.904 . . . . 0.0 111.783 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.1 m -66.32 129.0 38.33 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -174.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 54.8 t -128.29 136.35 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.639 1.976 . . . . 0.0 108.917 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.57 112.03 13.87 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.807 0.843 . . . . 0.0 109.892 -175.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.93 132.13 52.4 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -117.38 103.36 10.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 123.351 1.548 . . . . 0.0 109.836 169.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -79.98 104.51 10.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.367 -1.742 . . . . 0.0 112.169 171.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 tt -103.82 126.69 51.13 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.764 0.826 . . . . 0.0 111.226 171.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.2 ptm -121.32 147.07 46.17 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 174.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.71 136.88 15.04 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.404 1.002 . . . . 0.0 112.22 170.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.55 44.41 2.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.165 1.786 . . . . 0.0 112.41 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.8 p -72.0 165.01 25.12 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.238 -1.539 . . . . 0.0 112.805 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.08 -21.77 71.98 Favored Glycine 0 N--CA 1.474 1.208 0 O-C-N 120.927 -1.108 . . . . 0.0 113.201 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.2 p -75.18 -16.67 60.49 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.162 1.385 . . . . 0.0 113.145 169.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.55 -6.84 59.13 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -75.51 145.07 41.63 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 121.433 1.924 . . . . 0.0 110.005 169.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.91 -54.41 2.59 Favored Glycine 0 N--CA 1.47 0.922 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 -168.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -66.66 -26.18 66.92 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.039 1.336 . . . . 0.0 111.783 169.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.8 tp -45.38 -46.17 13.05 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 127.56 2.344 . . . . 0.0 111.517 172.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.9 t -49.79 -53.08 27.41 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.076 0.95 . . . . 0.0 111.777 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.26 50.6 m-80 -80.6 -25.32 38.53 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 120.132 -1.605 . . . . 0.0 114.485 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.3 12.0 p -74.05 -2.91 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.977 1.262 . . . . 0.0 111.11 168.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . 0.288 16.2 pt20 -103.06 -33.95 9.07 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 119.746 1.157 . . . . 0.0 111.631 168.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.8 m -56.22 -54.86 40.27 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.909 1.284 . . . . 0.0 108.542 168.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.0 tp -81.53 84.23 6.79 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 169.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 177.59 -53.81 0.1 OUTLIER Glycine 0 C--N 1.302 -1.347 0 CA-C-N 110.998 -2.819 . . . . 0.0 107.951 168.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -74.68 -37.99 62.51 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 124.113 0.965 . . . . 0.0 111.297 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -68.83 -36.49 78.25 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.243 0.617 . . . . 0.0 111.064 169.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 tp -63.01 -47.68 82.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -57.38 -61.52 2.43 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.786 1.634 . . . . 0.0 112.344 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -73.43 -35.21 65.76 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.928 1.694 . . . . 0.0 112.927 -171.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.9 -35.93 73.85 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.564 1.074 . . . . 0.0 111.748 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.7 mt -80.82 -30.19 35.86 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -64.56 -17.18 63.71 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 119.324 0.965 . . . . 0.0 112.869 171.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -86.38 -43.89 12.48 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.856 1.263 . . . . 0.0 111.341 174.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 tp -71.69 -26.73 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.013 0.824 . . . . 0.0 112.241 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.7 t -147.02 134.2 20.51 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -72.65 -24.16 61.01 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.479 1.112 . . . . 0.0 112.372 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.3 m -106.26 78.08 1.27 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.281 1.432 . . . . 0.0 109.224 175.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.29 78.75 0.32 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 127.408 2.432 . . . . 0.0 107.817 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -81.56 140.81 34.28 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.05 137.76 56.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.57 155.3 21.67 Favored Glycine 0 N--CA 1.464 0.552 0 C-N-CA 124.45 1.024 . . . . 0.0 111.002 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -107.28 163.52 12.95 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.275 0.63 . . . . 0.0 111.923 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.5 147.99 12.85 Favored Glycine 0 C--N 1.345 1.046 0 O-C-N 120.543 -1.348 . . . . 0.0 112.293 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.7 p -136.66 152.36 50.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.967 1.365 . . . . 0.0 114.403 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -159.78 157.46 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.035 1.334 . . . . 0.0 108.827 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.3 p -146.99 -73.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -164.01 -14.18 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.53 1.532 . . . . 0.0 111.604 169.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -48.16 -41.92 28.22 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.54 1.936 . . . . 0.0 112.903 169.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 p 160.2 -179.95 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.189 1 C-N-CA 133.732 4.813 . . . . 0.0 107.381 -171.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -102.09 135.65 43.31 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 167.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -127.59 127.26 43.57 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 123.306 1.527 . . . . 0.0 110.935 171.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -77.34 129.22 35.54 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.445 171.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.2 mt -137.18 139.35 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 127.406 2.282 . . . . 0.0 105.613 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 44.94 99.47 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.865 2.466 . . . . 0.0 116.529 -169.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -66.91 163.05 20.45 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.154 -0.966 . . . . 0.0 110.983 168.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.4 mt -52.18 117.63 2.94 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.103 0.561 . . . . 0.0 111.583 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -138.31 156.38 47.69 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.326 1.451 . . . . 0.0 111.733 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.64 6.01 50.15 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.286 1.434 . . . . 0.0 112.539 170.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -81.85 79.28 8.43 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 125.359 2.504 . . . . 0.0 108.511 171.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.7 m -67.14 -45.45 77.08 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 129.112 2.965 . . . . 0.0 110.272 -171.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.7 t -63.29 -23.13 67.28 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.849 0.86 . . . . 0.0 111.627 169.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -78.54 -47.16 17.84 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 120.834 -1.166 . . . . 0.0 110.38 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -56.86 -32.9 66.29 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 123.379 0.672 . . . . 0.0 111.585 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -68.44 -38.78 81.49 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.527 -0.733 . . . . 0.0 110.207 -175.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 68.1 mtt-85 -73.54 -38.11 65.36 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.611 1.165 . . . . 0.0 109.144 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -84.13 -25.07 29.96 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.609 -172.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.97 -48.49 53.06 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 168.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -62.03 -33.57 74.62 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -71.76 -14.0 61.87 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -64.59 156.12 30.97 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.371 1.442 . . . . 0.0 113.547 -172.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.28 141.87 37.76 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.324 1.85 . . . . 0.0 110.672 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -79.36 154.0 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-O 121.221 0.534 . . . . 0.0 112.102 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.1 t -109.35 -152.07 0.48 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.604 1.162 . . . . 0.0 109.028 168.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -147.17 151.13 23.45 Favored Glycine 0 N--CA 1.471 1.005 0 O-C-N 120.632 -1.293 . . . . 0.0 114.042 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.53 150.6 21.51 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.254 1.422 . . . . 0.0 111.874 172.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.61 -61.91 1.62 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.288 1.435 . . . . 0.0 112.246 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.3 136.41 51.81 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.021 0.528 . . . . 0.0 111.001 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.324 0.0 OUTLIER -70.35 -38.19 8.11 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-O 116.248 -1.834 . . . . 0.0 113.909 -176.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.51 141.71 81.6 Favored 'Trans proline' 0 C--N 1.355 0.888 0 CA-C-N 122.439 1.907 . . . . 0.0 110.844 169.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -170.83 1.72 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.223 1.009 . . . . 0.0 113.127 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -112.8 30.11 7.68 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 -169.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . 0.285 0.2 OUTLIER -70.33 -29.4 66.09 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 118.526 2.788 . . . . 0.0 118.526 -168.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 mp -66.14 -30.91 71.49 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 123.787 2.994 . . . . 0.0 112.995 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -59.95 -41.76 92.58 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.11 -0.994 . . . . 0.0 110.73 171.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.04 -49.4 72.49 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.024 -0.988 . . . . 0.0 111.379 174.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 m -58.8 -32.88 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 119.701 1.137 . . . . 0.0 112.168 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.0 t -78.02 -40.8 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 117.161 -1.399 . . . . 0.0 112.566 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -56.83 -45.23 82.46 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 121.663 2.029 . . . . 0.0 110.238 171.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.9 t -59.45 -32.37 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.31 -35.32 47.93 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.731 -1.231 . . . . 0.0 113.792 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.1 mm -93.03 -30.85 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 119.721 1.146 . . . . 0.0 113.25 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 78.4 m -79.74 52.27 1.43 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.396 1.478 . . . . 0.0 112.016 -172.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.7 mt -49.86 -41.19 44.73 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.123 2.169 . . . . 0.0 112.207 -169.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.44 -23.63 70.1 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.258 0.932 . . . . 0.0 114.534 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.43 -34.66 8.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.165 0.982 . . . . 0.0 111.531 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.65 -45.97 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 118.976 0.807 . . . . 0.0 110.095 170.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.83 26.04 10.09 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.809 1.195 . . . . 0.0 115.254 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -57.82 125.3 22.42 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.265 1.532 . . . . 0.0 112.268 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -93.02 -158.56 0.61 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.769 1.228 . . . . 0.0 112.139 172.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -90.55 0.33 57.39 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -173.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.9 -127.4 2.28 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 120.586 1.539 . . . . 0.0 111.396 -175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.2 t -114.6 140.72 48.56 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.572 1.549 . . . . 0.0 108.925 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -122.89 134.2 54.38 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 117.32 -1.324 . . . . 0.0 109.887 -168.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -129.91 113.85 15.14 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.49 98.8 9.11 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 170.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 80.4 t -83.69 116.21 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -110.33 108.03 17.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.161 -168.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.2 t -101.74 129.89 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.6 t -161.47 151.43 17.04 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -106.67 -13.5 15.27 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -169.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -137.12 -169.8 2.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.827 1.251 . . . . 0.0 110.553 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.67 -170.71 0.57 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.075 0.95 . . . . 0.0 112.745 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -139.21 149.8 44.8 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.266 1.426 . . . . 0.0 112.546 -172.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -84.68 91.81 8.03 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.031 1.332 . . . . 0.0 113.332 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.24 163.02 4.07 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 120.493 -1.379 . . . . 0.0 112.432 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -46.71 135.1 9.18 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.619 -0.676 . . . . 0.0 111.504 170.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm 97.5 -12.48 0.07 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 130.179 3.391 . . . . 0.0 112.142 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -76.8 -20.09 56.82 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.607 -1.308 . . . . 0.0 113.737 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -71.72 -1.67 14.7 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 120.023 1.283 . . . . 0.0 114.344 170.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -58.41 -36.27 73.34 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.413 1.006 . . . . 0.0 111.453 169.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.6 mt -63.94 -36.27 83.39 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.462 0.705 . . . . 0.0 112.437 173.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -82.39 13.93 37.59 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.778 1.656 . . . . 0.0 114.068 172.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.322 11.6 t 53.04 48.15 22.99 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 128.031 2.532 . . . . 0.0 113.442 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -127.43 113.66 16.48 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.728 1.211 . . . . 0.0 111.41 172.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -94.78 -30.29 14.32 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.304 1.441 . . . . 0.0 113.139 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -60.35 120.32 9.63 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.347 0.659 . . . . 0.0 110.809 -172.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.5 t -61.47 155.95 20.59 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.827 0.739 . . . . 0.0 110.599 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.405 ' HG ' ' NE2' ' A' ' 151' ' ' GLN . 8.6 t -65.01 143.19 58.12 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.655 0.74 . . . . 0.0 112.182 174.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -79.57 -29.27 41.24 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.243 1.017 . . . . 0.0 112.32 -177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.35 18.79 70.56 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.089 0.852 . . . . 0.0 113.044 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -106.88 164.51 12.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.085 1.754 . . . . 0.0 113.386 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 6.3 t -72.05 125.65 27.78 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.142 1.377 . . . . 0.0 109.639 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -134.75 41.17 2.9 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.8 1.64 . . . . 0.0 111.448 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.37 124.42 47.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.287 2.235 . . . . 0.0 109.315 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . 0.257 15.3 p-10 -115.71 -96.72 0.46 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.397 1.079 . . . . 0.0 112.608 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.25 30.25 0.28 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 121.016 1.734 . . . . 0.0 113.679 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.57 -9.32 66.64 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.915 1.721 . . . . 0.0 114.142 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 20.5 ptp -97.02 151.67 19.49 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.597 1.698 . . . . 0.0 113.034 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -84.6 80.58 9.19 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.912 0.885 . . . . 0.0 109.735 169.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.3 ttm-85 -58.63 -32.94 69.51 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 38.9 m -64.87 -8.34 14.99 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -52.94 -29.13 26.9 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 120.649 1.568 . . . . 0.0 114.109 173.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.46 1.4 87.31 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 117.99 -1.45 . . . . 0.0 115.09 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.379 0.7 OUTLIER -121.41 -79.17 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 115.89 -2.005 . . . . 0.0 112.82 178.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.89 154.35 67.14 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 CA-C-N 124.463 2.63 . . . . 0.0 115.65 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -62.02 169.41 2.68 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 129.829 3.252 . . . . 0.0 112.912 170.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -62.83 159.74 15.97 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.489 -0.757 . . . . 0.0 111.812 169.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.405 ' NE2' ' HG ' ' A' ' 131' ' ' SER . 2.5 mt-30 -81.34 140.03 35.01 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.4 -0.812 . . . . 0.0 111.271 -178.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.3 p -80.6 151.48 29.05 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.312 1.045 . . . . 0.0 111.253 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 45.1 t -53.13 -39.09 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -168.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.42 -18.69 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 O-C-N 121.496 -0.753 . . . . 0.0 112.534 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -67.11 -36.31 81.65 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.739 1.154 . . . . 0.0 110.412 170.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -59.05 -58.59 7.98 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 168.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.16 -43.79 78.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.102 0.961 . . . . 0.0 112.976 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.8 m -58.08 -56.13 25.98 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.058 0.943 . . . . 0.0 112.371 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.292 10.6 mptt -86.84 -20.44 27.49 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -174.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.4 mp -67.46 -31.13 71.09 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.382 1.446 . . . . 0.0 109.954 168.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.63 -33.78 58.34 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.657 1.183 . . . . 0.0 114.103 172.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.5 -51.47 59.78 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.4 1.08 . . . . 0.0 110.111 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -77.91 -12.69 60.0 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.69 0.796 . . . . 0.0 111.927 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.79 47.04 18.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.563 2.345 . . . . 0.0 111.991 176.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 28.9 mm -85.43 136.98 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.861 1.264 . . . . 0.0 108.421 174.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -93.82 108.57 35.72 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 120.759 1.618 . . . . 0.0 107.859 168.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -74.0 138.46 25.69 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.412 3.408 . . . . 0.0 113.24 171.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.5 mm -129.31 101.93 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.987 1.315 . . . . 0.0 110.115 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -72.39 72.58 0.96 Allowed 'General case' 0 N--CA 1.476 0.832 0 O-C-N 120.636 -1.29 . . . . 0.0 112.564 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 3.5 p -69.73 106.36 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 O-C-N 120.78 -1.2 . . . . 0.0 113.029 170.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 31.8 m -145.41 147.07 32.29 Favored Pre-proline 0 N--CA 1.482 1.167 0 O-C-N 120.354 -1.466 . . . . 0.0 113.293 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -59.52 155.67 40.65 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 124.855 3.704 . . . . 0.0 114.849 172.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.9 t -41.62 -60.57 1.29 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.447 2.299 . . . . 0.0 114.94 -169.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -64.04 -12.5 39.11 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -171.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 66.8 mmm -99.25 -7.47 26.38 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.6 t -57.34 -36.62 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 120.272 1.396 . . . . 0.0 111.66 -169.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -69.92 -28.31 65.49 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.01 -34.83 24.23 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 118.926 0.785 . . . . 0.0 111.309 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -72.42 -30.72 64.88 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.565 -1.334 . . . . 0.0 110.325 170.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -71.26 -11.79 61.11 Favored 'General case' 0 CA--C 1.553 1.092 0 O-C-N 121.584 -0.697 . . . . 0.0 111.376 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -84.33 -47.11 11.07 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.039 -1.663 . . . . 0.0 109.969 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.81 -21.14 59.47 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 119.966 -1.709 . . . . 0.0 111.051 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.84 -16.7 61.59 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.726 0.81 . . . . 0.0 111.961 171.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.55 -25.57 28.62 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 119.487 -0.292 . . . . 0.0 110.969 170.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -87.99 -18.48 28.93 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 56.9 mt -118.35 96.48 49.85 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.285 1.034 . . . . 0.0 108.837 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -55.42 141.76 81.52 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.688 2.926 . . . . 0.0 114.439 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . 0.325 0.0 OUTLIER 81.55 -15.51 0.71 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 128.618 2.767 . . . . 0.0 113.093 171.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.5 tt -56.76 148.01 21.54 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 127.003 2.121 . . . . 0.0 108.689 169.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 77.2 p -121.41 -150.76 0.46 Allowed 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 120.784 1.629 . . . . 0.0 109.651 170.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -179.34 117.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 119.51 -1.994 . . . . 0.0 109.154 -167.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -110.6 152.68 17.36 Favored Glycine 0 N--CA 1.469 0.875 0 C-N-CA 124.83 1.205 . . . . 0.0 112.242 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -93.8 85.69 4.89 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.866 1.266 . . . . 0.0 109.175 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 47.8 tp -56.79 130.94 47.77 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.977 169.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.7 t -165.7 -159.39 0.4 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.559 1.144 . . . . 0.0 109.278 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -63.79 -11.11 24.0 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.877 1.271 . . . . 0.0 114.205 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -128.95 134.52 48.23 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.773 2.429 . . . . 0.0 111.755 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 24.2 p -95.3 0.04 53.34 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.719 2.008 . . . . 0.0 113.904 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.7 p -56.92 -45.16 82.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.348 1.859 . . . . 0.0 112.722 -169.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -64.0 -39.37 93.97 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 122.719 0.408 . . . . 0.0 111.793 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.5 t -71.45 -42.52 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.639 -0.663 . . . . 0.0 110.12 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.63 -30.94 71.33 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.531 0.732 . . . . 0.0 112.517 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -70.01 -11.9 61.22 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.185 -1.572 . . . . 0.0 113.009 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.53 -35.59 7.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.775 1.63 . . . . 0.0 108.809 -173.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 4.3 mt -77.45 -34.65 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 118.619 -0.705 . . . . 0.0 109.58 169.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -72.84 -29.74 63.46 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.23 0.923 . . . . 0.0 111.25 169.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -64.26 -36.14 83.11 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 119.979 1.263 . . . . 0.0 111.453 169.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -76.11 -24.47 54.96 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.602 0.761 . . . . 0.0 112.638 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -63.68 -50.04 70.79 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.761 0.824 . . . . 0.0 110.592 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 65.5 p -74.94 -7.66 54.24 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.06 -37.09 78.33 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.24 -0.912 . . . . 0.0 111.747 169.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.259 1.582 0 C-N-CA 126.692 1.997 . . . . 0.0 112.856 179.373 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.3 t70 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.158 0.504 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -120.68 147.42 45.29 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.913 1.285 . . . . 0.0 109.056 171.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.9 p -62.02 137.18 58.22 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.621 0.724 . . . . 0.0 111.807 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 t -115.91 145.67 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.947 1.699 . . . . 0.0 106.646 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.3 14.9 p-10 -136.99 111.99 8.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.736 0.779 . . . . 0.0 110.35 171.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.2 tp -96.24 134.35 39.45 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.511 1.124 . . . . 0.0 112.653 -175.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -118.68 103.16 9.42 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 123.204 1.478 . . . . 0.0 109.388 168.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -82.43 93.87 7.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.056 1.742 . . . . 0.0 111.534 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 30.5 tp -92.1 125.53 36.83 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.377 1.071 . . . . 0.0 109.619 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.466 ' CE ' ' CZ ' ' A' ' 45' ' ' PHE 0.306 0.0 OUTLIER -134.24 165.62 24.69 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 172.276 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.46 140.26 15.57 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.677 1.132 . . . . 0.0 112.343 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.59 22.63 13.43 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.15 1.78 . . . . 0.0 112.212 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 p -68.44 160.04 30.47 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.586 -1.321 . . . . 0.0 110.91 169.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -56.46 -21.46 34.47 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 116.443 1.337 . . . . 0.0 116.443 -169.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.4 p -64.23 -27.25 68.92 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.234 1.413 . . . . 0.0 114.264 170.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.35 -10.96 59.9 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.664 1.586 . . . . 0.0 114.813 -172.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -68.12 121.16 15.57 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.63 -39.85 2.76 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.068 1.318 . . . . 0.0 111.805 -169.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -70.79 -44.56 66.38 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 118.339 1.07 . . . . 0.0 110.514 169.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 tt -53.54 -39.74 64.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.112 1.765 . . . . 0.0 112.071 173.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.2 m -62.14 -34.62 76.73 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.324 1.05 . . . . 0.0 113.204 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -81.41 -23.65 37.44 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.8 m -103.5 15.06 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 119.408 1.004 . . . . 0.0 113.496 -173.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -93.53 -36.38 12.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.392 1.077 . . . . 0.0 109.599 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 t -68.81 -14.9 63.32 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 122.026 0.917 . . . . 0.0 109.413 167.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 tp -86.71 102.32 14.12 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 125.133 2.397 . . . . 0.0 107.907 174.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.38 -51.96 0.09 OUTLIER Glycine 0 C--N 1.299 -1.492 0 CA-C-N 108.493 -3.958 . . . . 0.0 110.75 168.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -82.94 -39.61 21.19 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.054 1.342 . . . . 0.0 110.797 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -71.91 -31.36 66.3 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.726 -0.609 . . . . 0.0 111.193 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.13 -44.24 92.82 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-O 119.214 -0.422 . . . . 0.0 109.866 172.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -34.33 75.64 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 116.802 -1.57 . . . . 0.0 112.652 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -31.66 72.78 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 123.165 2.711 . . . . 0.0 112.447 174.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.75 -25.36 53.39 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 171.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 47.8 mt -92.75 -20.93 20.27 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.548 1.067 . . . . 0.0 113.662 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -80.62 -16.43 54.1 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.131 1.332 . . . . 0.0 114.387 -169.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -85.95 -33.27 21.19 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 119.129 -0.463 . . . . 0.0 110.579 169.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . 0.328 0.0 OUTLIER -75.08 -24.88 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 118.979 0.809 . . . . 0.0 112.757 169.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.4 t -154.47 135.37 13.75 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -81.15 1.71 30.72 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 172.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.4 t -141.37 108.08 5.37 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.977 -1.077 . . . . 0.0 109.866 169.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.42 83.69 0.24 Allowed Glycine 0 C--N 1.337 0.625 0 C-N-CA 126.776 2.132 . . . . 0.0 107.929 -169.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -77.25 151.36 35.15 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.28 138.02 53.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 117.754 0.252 . . . . 0.0 111.17 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -135.14 163.77 24.83 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 126.891 2.186 . . . . 0.0 110.9 171.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.466 ' CZ ' ' CE ' ' A' ' 10' ' ' MET . 86.1 t80 -135.5 145.27 46.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.995 0.918 . . . . 0.0 111.831 -169.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.35 147.2 18.47 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 122.568 0.128 . . . . 0.0 112.887 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.6 m -118.7 142.74 47.39 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.503 1.121 . . . . 0.0 112.036 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.79 157.12 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.726 1.21 . . . . 0.0 110.411 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 p -157.83 -52.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 124.405 1.082 . . . . 0.0 109.994 169.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 161.48 -22.9 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 131.302 3.841 . . . . 0.0 110.525 169.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -52.77 -39.93 62.69 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.642 0.777 . . . . 0.0 111.462 170.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.1 p -170.43 168.9 7.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 129.744 3.218 . . . . 0.0 110.723 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -113.11 123.65 50.76 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 101.003 -3.703 . . . . 0.0 101.003 165.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -122.03 114.04 20.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -174.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -81.64 114.63 20.45 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.637 169.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.3 mt -139.44 95.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . 0.262 2.6 tm? 107.43 94.17 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 130.703 3.601 . . . . 0.0 109.139 174.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -52.66 159.42 1.08 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.592 1.557 . . . . 0.0 112.741 170.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.7 mt -53.64 120.47 6.23 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 172.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.8 t -147.0 170.04 17.94 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.511 1.124 . . . . 0.0 112.539 -172.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.35 -22.69 18.79 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.676 1.99 . . . . 0.0 114.397 -175.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -89.92 89.76 7.87 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 125.86 2.743 . . . . 0.0 108.665 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.0 p -60.73 -36.57 79.21 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 131.244 3.818 . . . . 0.0 111.523 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.5 t -65.01 -19.05 65.81 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.06 0.944 . . . . 0.0 110.814 169.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -82.02 -37.25 26.81 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.846 -1.159 . . . . 0.0 111.015 176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -56.88 -32.64 66.06 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.091 -1.006 . . . . 0.0 111.211 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -73.37 -41.68 63.11 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.305 -0.872 . . . . 0.0 110.626 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -27.22 63.34 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -88.46 -30.3 19.52 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.06 -52.56 55.03 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -66.51 -26.96 67.41 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -169.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -69.92 -44.06 70.41 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . 0.267 9.9 pt20 -80.18 167.48 20.29 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -151.54 169.64 21.61 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -167.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.61 154.29 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.648 1.579 . . . . 0.0 113.895 -169.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -120.24 -160.02 0.81 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.285 1.834 . . . . 0.0 111.146 169.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -156.19 155.71 26.52 Favored Glycine 0 N--CA 1.472 1.076 0 O-C-N 120.507 -1.371 . . . . 0.0 113.957 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -152.32 151.96 31.52 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.645 1.178 . . . . 0.0 112.767 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -55.68 -58.99 5.5 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.088 2.155 . . . . 0.0 112.343 174.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.72 143.98 37.63 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.266 15.1 t -70.15 -41.75 15.1 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 115.563 -2.16 . . . . 0.0 114.443 174.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.74 142.87 84.86 Favored 'Trans proline' 0 C--N 1.356 0.972 0 CA-C-N 123.421 2.257 . . . . 0.0 112.319 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -112.78 154.58 26.0 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.912 1.285 . . . . 0.0 113.43 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.04 55.76 4.79 Favored Glycine 0 N--CA 1.479 1.51 0 C-N-CA 125.664 1.602 . . . . 0.0 112.586 -172.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -83.07 -33.82 26.33 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.458 1.903 . . . . 0.0 115.689 -168.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.9 -37.95 79.31 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -171.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -51.46 -46.82 63.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.224 1.01 . . . . 0.0 111.601 169.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.48 -53.63 49.1 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.132 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.25 32.9 m -64.25 -27.41 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 119.476 1.035 . . . . 0.0 112.621 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.496 HG23 HE22 ' A' ' 155' ' ' GLN . 76.7 t -64.04 -63.01 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 119.427 1.012 . . . . 0.0 108.564 168.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -58.43 -42.78 88.04 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.171 0.896 . . . . 0.0 111.174 -173.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.0 t -55.76 -35.4 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.08 0.855 . . . . 0.0 112.428 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.71 -37.14 65.26 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.818 -1.176 . . . . 0.0 113.486 175.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.413 ' HB ' ' SG ' ' A' ' 135' ' ' CYS . 7.9 mm -93.56 -15.8 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.858 0.863 . . . . 0.0 113.017 -172.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.406 ' SG ' ' SG ' ' A' ' 135' ' ' CYS . 1.5 m -79.52 49.01 0.96 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.763 2.025 . . . . 0.0 112.58 177.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -49.95 -40.1 42.65 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.778 -1.201 . . . . 0.0 112.048 -175.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.71 -19.23 54.8 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -91.89 -45.52 8.33 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.917 1.359 . . . . 0.0 110.815 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.5 mm -65.85 -44.35 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.297 0.639 . . . . 0.0 109.351 175.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.33 21.9 21.0 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.998 1.285 . . . . 0.0 114.083 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -49.03 128.36 16.0 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.818 1.247 . . . . 0.0 112.087 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . 0.336 0.6 OUTLIER -113.93 -173.65 2.32 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 175.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -67.65 -2.91 7.61 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 118.792 2.886 . . . . 0.0 118.792 -168.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.29 -125.29 2.63 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 121.091 1.769 . . . . 0.0 112.268 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.4 m -111.83 115.3 28.8 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.145 1.778 . . . . 0.0 107.802 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 -99.54 128.81 45.66 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -168.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -127.19 104.25 7.86 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -168.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.97 89.38 6.05 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.187 -0.946 . . . . 0.0 111.004 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.5 t -72.29 132.57 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 tp -112.62 127.07 56.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.32 124.11 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 123.959 0.787 . . . . 0.0 110.54 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -150.14 164.66 35.05 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.613 0.765 . . . . 0.0 111.465 171.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.46 2.95 6.94 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.721 1.608 . . . . 0.0 114.765 174.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -123.12 173.13 8.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.435 1.094 . . . . 0.0 112.036 171.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -69.98 -169.14 0.24 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.752 0.821 . . . . 0.0 111.542 169.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -142.07 158.71 43.44 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.107 -0.996 . . . . 0.0 112.983 -169.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -84.29 123.84 30.59 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.172 169.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.53 HD23 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -86.43 -177.54 6.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.157 0.983 . . . . 0.0 109.47 170.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.53 ' H ' HD23 ' A' ' 118' ' ' LEU . . . -57.67 163.64 2.42 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.359 -0.838 . . . . 0.0 111.467 169.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.408 0.0 OUTLIER 55.11 -3.68 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.775 2.03 . . . . 0.0 116.162 -169.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -75.16 -28.62 60.18 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 121.313 1.87 . . . . 0.0 113.757 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -73.54 1.88 9.06 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 121.035 1.743 . . . . 0.0 113.424 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.7 t -59.83 -25.36 64.94 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.468 1.031 . . . . 0.0 111.501 169.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.4 mt -61.62 -21.16 64.13 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.405 1.882 . . . . 0.0 113.366 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -91.96 -108.34 1.64 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 169.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.277 7.1 t -152.55 40.3 0.58 Allowed 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 123.429 1.585 . . . . 0.0 111.041 169.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.02 89.64 5.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.942 1.697 . . . . 0.0 109.483 -175.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -86.07 -42.0 14.3 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.746 -0.596 . . . . 0.0 111.333 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -65.67 134.99 54.4 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.246 0.619 . . . . 0.0 109.967 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.3 p -97.19 147.22 24.31 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.548 1.139 . . . . 0.0 109.436 169.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.7 m -58.24 141.85 49.5 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.5 p30 -72.51 -11.38 60.64 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.467 1.507 . . . . 0.0 113.75 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.5 10.07 86.47 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.639 1.114 . . . . 0.0 113.329 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -84.61 176.56 8.52 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.961 1.38 . . . . 0.0 110.276 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . 0.413 ' SG ' ' HB ' ' A' ' 94' ' ' ILE . 0.6 OUTLIER -100.88 144.69 29.52 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 172.301 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -133.8 38.16 3.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.643 1.977 . . . . 0.0 110.868 -170.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 pp -62.53 160.19 14.29 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.112 1.765 . . . . 0.0 111.807 171.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -157.73 -101.46 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.72 1.208 . . . . 0.0 110.298 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.27 35.93 0.82 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.606 1.962 . . . . 0.0 113.062 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.1 18.35 55.96 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.744 1.164 . . . . 0.0 114.476 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.5 ptp -149.01 156.2 41.91 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.962 1.381 . . . . 0.0 113.905 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -68.94 104.37 2.06 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.552 1.141 . . . . 0.0 111.844 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -65.63 -42.05 91.97 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.344 0.658 . . . . 0.0 111.04 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.9 m -74.56 -3.36 30.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -172.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -44.56 -29.65 0.76 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.8 3.64 57.47 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.574 2.035 . . . . 0.0 115.962 -174.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.421 2.3 pt-20 -131.58 -49.58 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.106 0 CA-C-N 120.755 2.277 . . . . 0.0 114.68 170.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -80.02 151.08 20.97 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 CA-C-N 122.479 1.921 . . . . 0.0 113.736 167.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -75.46 165.54 24.96 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 129.155 2.982 . . . . 0.0 112.233 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -57.98 152.93 15.34 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.091 -1.006 . . . . 0.0 109.24 168.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . 0.334 3.0 mm-40 -106.46 165.42 11.29 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.4 p -73.61 161.82 29.9 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -168.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 t -61.96 -28.93 45.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.524 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.8 t -73.49 -42.56 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.265 1.026 . . . . 0.0 111.083 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.496 HE22 HG23 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -64.83 -38.03 89.62 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.489 0.586 . . . . 0.0 110.474 178.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 87.8 mt -57.19 -60.76 3.14 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.028 0.531 . . . . 0.0 110.261 170.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.83 -45.8 85.66 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -172.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.5 m -64.98 -49.59 69.67 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.839 -0.538 . . . . 0.0 112.306 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -74.66 -27.83 60.59 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.067 -1.021 . . . . 0.0 112.384 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 14.8 tp -61.12 -44.47 97.29 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.773 -1.205 . . . . 0.0 111.89 170.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.79 -24.65 61.78 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.04 0.936 . . . . 0.0 113.509 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -72.75 -44.21 61.92 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.098 1.359 . . . . 0.0 110.297 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -80.3 -18.88 47.99 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 56.2 63.74 1.91 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.763 1.625 . . . . 0.0 111.317 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 87.1 mt -113.88 137.66 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.677 1.591 . . . . 0.0 109.274 175.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -91.25 120.71 68.38 Favored Pre-proline 0 N--CA 1.475 0.784 0 CA-C-O 116.703 -1.617 . . . . 0.0 110.488 170.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -88.13 148.66 6.75 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.622 2.881 . . . . 0.0 110.477 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.83 99.17 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -76.48 69.87 2.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 122.285 1.04 . . . . 0.0 111.895 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.49 102.55 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 C-N-CA 126.315 1.846 . . . . 0.0 110.993 169.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.51 147.96 26.93 Favored Pre-proline 0 N--CA 1.481 1.123 0 O-C-N 120.265 -1.522 . . . . 0.0 113.56 -170.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -62.39 148.45 93.26 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 125.199 3.933 . . . . 0.0 115.048 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.5 t -55.16 -28.93 56.41 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -169.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -47.25 -37.12 9.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.989 1.316 . . . . 0.0 113.793 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . 0.257 0.0 OUTLIER -126.64 5.92 6.79 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.064 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.9 t -53.39 -33.63 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 120.331 -1.481 . . . . 0.0 110.969 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -21.68 66.42 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -175.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.2 t -90.81 -38.73 12.79 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.347 0.659 . . . . 0.0 110.534 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -66.66 -36.74 83.26 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.024 1.33 . . . . 0.0 111.228 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -60.0 -19.88 54.78 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.375 1.07 . . . . 0.0 111.56 168.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -110.15 6.41 22.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.843 1.257 . . . . 0.0 113.248 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 62.0 mt -95.4 -25.97 16.05 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 167.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.3 t -77.62 -14.62 59.59 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.18 1.392 . . . . 0.0 112.759 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 3.6 t -84.98 -17.56 37.24 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.712 -0.617 . . . . 0.0 110.965 169.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -92.57 -23.66 18.98 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 118.083 0.401 . . . . 0.0 112.077 169.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 50.9 mt -118.12 91.78 40.97 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 124.38 1.072 . . . . 0.0 109.39 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.54 132.61 52.86 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.778 2.318 . . . . 0.0 112.657 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.5 tttm 105.77 -18.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 130.281 3.432 . . . . 0.0 115.271 169.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . 0.396 0.0 OUTLIER -75.27 164.35 26.54 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 120.568 1.531 . . . . 0.0 112.2 176.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 37.7 p -129.13 176.41 7.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -155.06 127.87 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 128.333 2.653 . . . . 0.0 108.84 -168.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.61 154.29 16.89 Favored Glycine 0 N--CA 1.47 0.965 0 C-N-CA 124.563 1.078 . . . . 0.0 111.518 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -94.89 85.82 4.5 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.125 0.964 . . . . 0.0 109.213 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.0 tp -57.75 138.24 55.73 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 168.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 59.8 p -155.36 -150.84 0.32 Allowed 'General case' 0 CA--C 1.546 0.801 0 O-C-N 120.732 -1.23 . . . . 0.0 113.811 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.6 -32.85 71.82 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.835 1.654 . . . . 0.0 114.032 -169.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -93.08 -168.65 1.98 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.639 1.576 . . . . 0.0 113.274 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 78.4 p -123.82 -16.57 6.61 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 71.1 p -65.49 -28.69 69.38 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 119.855 -1.778 . . . . 0.0 111.668 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -62.15 -37.71 86.23 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 118.123 -0.941 . . . . 0.0 113.433 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . 0.266 14.7 p -69.15 -47.88 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 121.272 1.851 . . . . 0.0 111.12 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -79.86 -43.14 22.83 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.561 -1.337 . . . . 0.0 113.854 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -78.98 6.51 9.12 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 121.584 1.993 . . . . 0.0 113.183 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 92.4 mt -108.0 -26.99 10.42 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.302 1.441 . . . . 0.0 108.751 169.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 57.2 mt -66.02 -42.22 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 166.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -62.39 -48.38 79.97 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.863 169.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -78.03 17.47 0.6 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 122.548 1.166 . . . . 0.0 114.022 -172.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -131.27 -8.3 3.78 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.826 2.05 . . . . 0.0 111.514 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -95.01 -39.64 10.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.558 1.943 . . . . 0.0 106.254 168.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.8 m -24.87 81.48 0.0 OUTLIER 'General case' 0 C--N 1.347 0.476 1 C-N-CA 132.611 4.364 . . . . 0.0 115.667 169.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 6.3 mtmm 171.76 -43.56 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 130.406 3.482 . . . . 0.0 114.174 168.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 C--O 1.267 2.01 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -170.751 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -101.24 157.36 16.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.798 1.639 . . . . 0.0 111.11 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.9 p -71.84 140.29 49.29 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.2 t -137.76 137.28 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.228 1.811 . . . . 0.0 109.297 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -110.71 115.55 29.76 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 168.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -103.32 116.21 32.02 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.065 0.46 . . . . 0.0 110.163 169.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -105.72 103.04 12.46 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 123.919 1.819 . . . . 0.0 109.903 170.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -83.42 114.27 21.34 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 112.515 -2.13 . . . . 0.0 112.044 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 tt -114.42 124.12 51.15 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.795 0.838 . . . . 0.0 111.714 177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.3 mtp -104.2 138.37 40.77 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.58 114.5 3.94 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.488 1.518 . . . . 0.0 109.66 169.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.8 mp -106.96 24.12 13.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.288 2.635 . . . . 0.0 112.705 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 p -68.19 162.57 24.61 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.297 -1.502 . . . . 0.0 113.078 171.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.71 -22.09 63.72 Favored Glycine 0 N--CA 1.476 1.313 0 O-C-N 120.981 -1.074 . . . . 0.0 114.398 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.1 m -59.9 -23.65 63.65 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 118.256 1.028 . . . . 0.0 113.468 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.25 -1.37 57.15 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -169.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -69.56 142.51 53.59 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 122.46 2.391 . . . . 0.0 109.103 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.98 -54.7 4.03 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -169.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -62.74 -24.11 67.52 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.659 0.784 . . . . 0.0 111.149 169.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.0 tp -49.17 -47.27 46.0 Favored 'General case' 0 C--O 1.217 -0.643 0 C-N-CA 125.616 1.566 . . . . 0.0 110.726 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 t -56.02 -47.33 78.03 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.864 0.756 . . . . 0.0 111.882 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -59.97 -42.87 95.09 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.937 -1.102 . . . . 0.0 111.141 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.8 p -86.23 11.93 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.542 1.137 . . . . 0.0 113.129 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -111.05 -47.22 3.23 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.578 1.551 . . . . 0.0 109.4 174.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.2 t -61.0 -44.56 97.25 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.6 tp -76.26 89.91 3.14 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 123.93 1.824 . . . . 0.0 107.591 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.82 -46.02 0.47 Allowed Glycine 0 C--N 1.305 -1.148 0 CA-C-N 110.011 -3.268 . . . . 0.0 110.055 168.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -71.37 -29.51 65.04 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 124.375 1.07 . . . . 0.0 110.65 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.23 -30.41 30.78 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 117.394 -1.288 . . . . 0.0 112.012 169.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -51.63 69.15 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 120.098 1.317 . . . . 0.0 107.933 173.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.0 tp -44.97 -76.41 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.938 2.095 . . . . 0.0 112.944 172.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . 0.291 0.0 OUTLIER -71.9 -21.45 61.63 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -168.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.47 -48.0 36.97 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.377 0.989 . . . . 0.0 111.807 170.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.55 -36.24 81.98 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.536 -0.728 . . . . 0.0 110.812 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -68.19 -16.27 63.92 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -87.01 -38.52 16.5 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.429 0.692 . . . . 0.0 111.734 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.7 tp -77.59 -28.22 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 118.435 0.561 . . . . 0.0 112.202 171.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.1 t -140.98 127.09 19.51 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -86.87 -6.89 58.65 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.277 1.031 . . . . 0.0 112.994 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.9 p -108.78 55.13 0.64 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.187 1.395 . . . . 0.0 110.219 169.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.6 83.52 0.36 Allowed Glycine 0 C--N 1.345 1.035 0 C-N-CA 128.97 3.176 . . . . 0.0 108.866 -171.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -80.78 137.55 36.24 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.692 1.597 . . . . 0.0 108.433 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.33 138.25 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.613 0.765 . . . . 0.0 109.445 -173.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.86 159.2 23.85 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 125.57 1.557 . . . . 0.0 111.739 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -140.56 128.46 21.91 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -169.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -131.92 151.71 19.91 Favored Glycine 0 C--N 1.342 0.868 0 C-N-CA 124.973 1.273 . . . . 0.0 113.493 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.4 t -116.57 140.5 49.31 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.531 1.933 . . . . 0.0 111.071 173.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.17 147.23 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.173 0.989 . . . . 0.0 110.944 169.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -132.83 -60.26 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 118.314 0.506 . . . . 0.0 109.811 167.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 161.78 -34.64 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 1 C-N-CA 131.72 4.008 . . . . 0.0 107.525 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.1 mtt -46.12 -51.68 13.5 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.668 1.587 . . . . 0.0 110.806 169.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.9 p -165.75 178.76 6.38 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 128.067 2.547 . . . . 0.0 110.37 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -111.13 125.08 53.4 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 102.179 -3.267 . . . . 0.0 102.179 165.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -121.01 122.37 39.96 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.991 0.9 . . . . 0.0 110.481 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 46.8 t60 -76.68 126.97 31.9 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.724 168.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.35 -51.86 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 121.703 -0.623 . . . . 0.0 110.896 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.3 tp -129.96 121.0 25.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.719 0.808 . . . . 0.0 111.13 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.89 149.34 36.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.078 0.951 . . . . 0.0 111.707 170.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.3 mt -49.51 112.79 0.7 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.367 1.067 . . . . 0.0 110.795 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 t -143.46 166.42 24.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.576 1.15 . . . . 0.0 112.386 -174.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.05 -7.43 51.84 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.665 1.986 . . . . 0.0 113.244 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -80.34 77.88 7.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 125.466 2.555 . . . . 0.0 108.597 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.3 p -63.46 -47.68 80.82 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 129.549 3.139 . . . . 0.0 110.996 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.1 t -61.26 -15.92 40.09 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.37 1.468 . . . . 0.0 111.713 170.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -89.32 -49.5 6.68 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.454 -0.778 . . . . 0.0 110.667 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -55.31 -35.55 65.24 Favored 'General case' 0 C--O 1.223 -0.334 0 O-C-N 121.301 -0.874 . . . . 0.0 112.017 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -75.82 -23.38 55.78 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.82 -0.55 . . . . 0.0 111.537 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -75.85 -43.02 47.86 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 169.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -71.71 -33.09 68.47 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -169.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.9 -49.08 66.69 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 169.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -70.65 -18.99 62.84 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 -170.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -74.3 -23.38 59.08 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 172.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -63.44 144.94 56.55 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -168.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.7 tp -127.4 138.69 53.06 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.33 2.252 . . . . 0.0 108.69 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.2 m -77.56 154.07 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-O 120.941 0.401 . . . . 0.0 111.881 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.5 p -100.45 -124.88 0.17 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.608 1.563 . . . . 0.0 111.606 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.51 144.54 6.42 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.592 1.092 . . . . 0.0 114.261 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -156.37 153.67 29.31 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.286 1.435 . . . . 0.0 112.221 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.73 -50.19 65.71 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.916 1.686 . . . . 0.0 113.41 -176.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.84 137.7 42.02 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.882 0.873 . . . . 0.0 111.715 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 t -70.24 -30.87 2.05 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-O 115.725 -2.084 . . . . 0.0 115.056 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.95 141.22 26.51 Favored 'Trans proline' 0 C--N 1.358 1.055 0 CA-C-N 123.027 2.117 . . . . 0.0 112.145 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -97.46 158.53 15.43 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.71 1.204 . . . . 0.0 110.803 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.22 28.85 2.89 Favored Glycine 0 N--CA 1.48 1.599 0 O-C-N 120.653 -1.28 . . . . 0.0 114.623 174.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.24 -40.36 70.79 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.244 1.817 . . . . 0.0 111.194 -172.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.08 -25.32 68.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 117.572 -1.204 . . . . 0.0 113.095 -174.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -78.32 -31.27 48.66 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.033 1.288 . . . . 0.0 113.011 171.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.15 -45.89 75.7 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.711 -1.243 . . . . 0.0 111.574 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.71 -29.89 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.61 -60.35 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.125 0.97 . . . . 0.0 109.952 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -67.22 -38.05 84.63 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.698 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.3 t -57.11 -37.41 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 119.606 1.094 . . . . 0.0 112.114 173.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.97 -44.74 65.38 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.636 1.107 . . . . 0.0 113.756 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.3 mt -91.74 -20.22 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 74.4 m -79.74 51.34 1.28 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.404 -1.435 . . . . 0.0 111.407 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -49.47 -42.64 43.8 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.924 1.69 . . . . 0.0 111.177 -174.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -74.66 -22.62 76.88 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.346 0.974 . . . . 0.0 114.39 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -105.69 -34.65 7.65 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.37 1.085 . . . . 0.0 112.594 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.8 mm -70.25 -38.23 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.959 0.8 . . . . 0.0 110.446 169.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.64 27.37 9.78 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.39 1.472 . . . . 0.0 114.591 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -59.93 116.57 4.23 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.959 1.38 . . . . 0.0 112.651 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -90.65 173.96 7.76 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.243 2.617 . . . . 0.0 110.352 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -87.52 20.16 3.03 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -170.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.36 -119.56 0.96 Allowed Glycine 0 C--N 1.346 1.124 0 C-N-CA 124.528 1.061 . . . . 0.0 111.043 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.9 m -116.33 130.46 56.78 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.612 1.565 . . . . 0.0 107.051 170.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.46 132.95 53.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -171.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.36 111.01 9.24 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -167.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -105.85 98.04 7.78 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.082 0.953 . . . . 0.0 109.711 -169.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.3 t -101.81 118.67 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 mp -111.37 131.92 54.82 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 124.245 0.966 . . . . 0.0 109.168 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.1 t -116.53 129.63 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 O-C-N 125.531 1.77 . . . . 0.0 111.159 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 t -152.43 -171.45 3.93 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.347 1.03 . . . . 0.0 109.515 169.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -140.43 2.86 1.88 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.68 -156.43 0.61 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.017 0.927 . . . . 0.0 110.845 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.91 166.53 0.98 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.816 2.046 . . . . 0.0 114.375 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -130.27 146.69 51.9 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.426 1.491 . . . . 0.0 110.507 170.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -76.94 141.77 40.33 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.007 0.432 . . . . 0.0 111.592 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.543 HD21 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -111.74 173.3 6.42 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.625 1.97 . . . . 0.0 109.533 177.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.543 ' H ' HD21 ' A' ' 118' ' ' LEU . . . -48.7 142.59 5.99 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.117 -0.989 . . . . 0.0 111.519 169.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.0 mttm 83.27 -16.52 0.56 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 129.511 3.124 . . . . 0.0 112.875 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.05 -32.08 73.62 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.239 1.381 . . . . 0.0 113.05 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -78.23 6.33 8.41 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.9 t -60.21 -31.19 69.93 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.022 1.283 . . . . 0.0 112.507 170.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.64 -19.26 61.47 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -85.53 15.2 47.55 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.494 1.521 . . . . 0.0 111.916 169.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.348 13.9 t 44.37 54.54 6.18 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 128.869 2.868 . . . . 0.0 112.504 -170.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.1 ttp180 -126.68 106.38 9.35 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.559 1.544 . . . . 0.0 109.907 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -112.66 -25.52 9.07 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -169.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -75.17 129.49 37.6 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.53 1.514 . . . . 0.0 110.829 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.6 t -68.31 167.61 14.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.925 1.29 . . . . 0.0 111.545 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.3 m -66.16 135.72 54.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.579 0.752 . . . . 0.0 112.495 172.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -83.15 -17.72 41.93 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.027 -1.046 . . . . 0.0 113.488 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.91 18.19 77.35 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.304 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.8 mtp-105 -94.49 169.85 9.91 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.842 1.257 . . . . 0.0 112.588 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.21 137.59 43.18 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.409 1.084 . . . . 0.0 110.45 169.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -145.94 44.91 1.26 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.505 1.522 . . . . 0.0 112.237 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.1 tt -118.72 132.23 56.15 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.076 0.95 . . . . 0.0 110.58 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -118.77 -75.61 0.58 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.649 1.179 . . . . 0.0 111.239 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -97.98 28.22 4.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.826 2.05 . . . . 0.0 112.792 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.51 -18.06 58.12 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.627 1.584 . . . . 0.0 113.227 -174.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 14.9 mmt -89.45 143.11 27.08 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.743 1.217 . . . . 0.0 112.495 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -71.94 91.22 1.18 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 168.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -55.92 -43.15 77.07 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.548 1.139 . . . . 0.0 112.304 -171.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.4 p -81.28 7.07 12.31 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -15.42 0.35 Allowed 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 171.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -103.2 -8.64 40.98 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.909 1.719 . . . . 0.0 115.26 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -114.53 -61.95 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 119.876 1.838 . . . . 0.0 111.84 -172.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -77.4 145.66 24.0 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.86 2.373 . . . . 0.0 113.199 168.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -66.28 171.11 5.08 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.305 2.642 . . . . 0.0 111.565 169.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -60.61 156.19 17.14 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 174.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -65.6 163.24 16.61 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.4 p -93.85 152.93 18.54 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 168.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 58.8 t -62.78 -30.6 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 O-C-N 120.621 -1.299 . . . . 0.0 111.231 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.62 -42.69 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.987 0.915 . . . . 0.0 111.061 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -73.47 -26.65 61.01 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.899 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.4 mt -63.74 -54.37 36.5 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 168.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.75 82.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.064 1.346 . . . . 0.0 113.124 -172.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 75.7 m -63.95 -51.15 65.73 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.945 0.498 . . . . 0.0 112.009 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -62.7 -38.66 91.29 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.273 -0.892 . . . . 0.0 112.162 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.8 tp -60.26 -40.33 89.95 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.353 1.061 . . . . 0.0 112.647 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.66 -24.85 63.68 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.098 0.959 . . . . 0.0 113.311 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -75.92 -44.07 42.0 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.184 0.993 . . . . 0.0 110.819 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -78.67 -16.35 57.4 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 60.8 33.26 20.11 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.987 2.115 . . . . 0.0 113.024 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.2 mt -85.59 144.24 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.122 1.369 . . . . 0.0 109.101 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -104.69 106.24 53.93 Favored Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 120.714 1.597 . . . . 0.0 113.791 171.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -75.13 137.62 21.68 Favored 'Trans proline' 0 CA--C 1.537 0.636 1 C-N-CA 125.342 4.028 . . . . 0.0 115.231 169.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.5 mt -130.98 113.44 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -75.62 79.54 2.61 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.893 0.854 . . . . 0.0 111.682 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 39.6 t -66.52 104.51 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-O 122.554 1.169 . . . . 0.0 112.151 169.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 33.3 m -142.32 164.51 32.88 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 120.321 -1.487 . . . . 0.0 110.776 -169.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -85.21 165.74 11.08 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.825 2.35 . . . . 0.0 111.81 -169.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.3 t -50.41 -38.84 45.09 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.772 1.229 . . . . 0.0 113.09 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -63.08 -21.28 66.06 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 3.5 tpt -128.23 5.74 5.83 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -170.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 89.4 t -59.43 -35.96 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 120.015 1.28 . . . . 0.0 111.537 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.27 -0.64 50.51 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -169.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 t -92.82 -36.54 12.8 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.796 0.808 . . . . 0.0 109.46 168.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -74.89 -33.94 62.13 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 124.172 0.989 . . . . 0.0 110.342 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -70.88 -15.0 62.59 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 119.293 0.951 . . . . 0.0 111.96 169.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -84.85 -28.25 26.17 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 120.32 -1.487 . . . . 0.0 111.249 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 43.3 tp -77.27 -27.16 53.06 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.314 2.246 . . . . 0.0 110.074 174.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.48 -7.97 58.02 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.11 1.764 . . . . 0.0 112.531 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 6.7 t -105.79 -15.82 14.84 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.239 0.616 . . . . 0.0 110.685 168.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -80.83 -37.37 30.17 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.313 0.506 . . . . 0.0 111.009 169.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 25.3 mt -104.13 114.9 63.97 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 124.325 1.05 . . . . 0.0 108.779 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.15 140.59 37.82 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.667 2.245 . . . . 0.0 112.432 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 47.2 tptt 82.82 -8.35 1.18 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 129.438 3.095 . . . . 0.0 113.811 170.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.5 mt -67.81 166.14 16.05 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.57 0.748 . . . . 0.0 111.883 170.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.6 p -138.59 -145.51 0.19 Allowed 'General case' 0 C--N 1.344 0.352 0 CA-C-O 122.905 1.336 . . . . 0.0 108.603 168.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.3 pt -157.02 156.86 4.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 128.798 2.839 . . . . 0.0 109.419 -167.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -134.04 153.24 20.84 Favored Glycine 0 N--CA 1.465 0.631 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 169.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -100.63 93.68 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.02 131.97 41.57 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.77 169.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 9.6 t -161.48 -167.81 1.84 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.847 1.259 . . . . 0.0 109.772 170.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.62 -23.95 66.94 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.422 -0.799 . . . . 0.0 112.098 171.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -93.76 141.44 28.5 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.74 1.216 . . . . 0.0 111.418 169.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 27.4 p -103.91 0.7 30.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.186 1.794 . . . . 0.0 113.543 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.4 m -61.14 -48.87 79.63 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.447 1.099 . . . . 0.0 112.009 -168.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -63.73 -46.73 84.05 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 122.099 -0.375 . . . . 0.0 111.514 -172.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.17 -45.7 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 121.231 -0.918 . . . . 0.0 112.139 176.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.32 -29.52 70.27 Favored 'General case' 0 C--O 1.22 -0.48 0 O-C-N 121.23 -0.918 . . . . 0.0 112.32 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -66.59 -6.92 17.04 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.426 -1.421 . . . . 0.0 114.477 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.3 mp -107.81 -28.32 9.73 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.419 1.488 . . . . 0.0 110.035 176.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 18.5 mm -67.25 -43.23 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 168.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -66.38 -42.35 88.07 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.774 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -67.01 -38.34 85.77 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.739 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -71.69 -31.1 66.41 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.658 0.663 . . . . 0.0 112.072 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -62.91 -42.51 99.81 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.179 0.591 . . . . 0.0 111.456 172.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 11.1 t -64.77 -24.89 67.7 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -80.35 -21.48 42.38 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 12.1 tp . . . . . 0 CA--C 1.563 1.474 0 C-N-CA 124.633 1.173 . . . . 0.0 109.871 173.087 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 78.34 149.16 0.1 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 128.471 2.709 . . . . 0.0 112.176 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 p -71.3 117.34 12.71 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.563 1.145 . . . . 0.0 113.527 -173.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.27 127.52 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.969 1.308 . . . . 0.0 108.79 169.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -109.87 116.21 31.24 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -110.37 129.22 55.8 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.671 0.748 . . . . 0.0 111.747 173.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -110.59 113.56 26.27 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 123.418 1.58 . . . . 0.0 109.492 169.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -91.15 104.6 17.15 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 126.482 1.913 . . . . 0.0 112.222 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 tp -101.22 116.72 33.46 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.0 0.92 . . . . 0.0 112.669 177.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 59.4 mtp -97.69 141.17 31.04 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.515 1.526 . . . . 0.0 114.047 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.97 118.43 5.38 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 168.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 mp -106.91 22.99 15.1 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.799 1.64 . . . . 0.0 113.899 -169.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.0 p -78.33 159.49 28.37 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.2 -1.563 . . . . 0.0 113.522 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.68 -26.34 59.92 Favored Glycine 0 N--CA 1.476 1.313 0 N-CA-C 115.918 1.127 . . . . 0.0 115.918 -168.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 t -59.7 -31.25 69.41 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 117.738 0.769 . . . . 0.0 111.969 171.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.97 3.15 8.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.696 1.598 . . . . 0.0 114.577 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -57.37 -47.97 80.26 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 121.128 1.786 . . . . 0.0 112.762 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.26 -32.87 68.65 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -78.55 -13.21 59.94 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.7 tp -59.12 -43.05 91.93 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.724 1.21 . . . . 0.0 111.421 -173.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 t -57.24 -45.57 83.82 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.655 0.782 . . . . 0.0 111.603 171.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -63.91 -47.25 81.31 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.811 -1.181 . . . . 0.0 111.222 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 p -74.22 -32.97 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -72.13 -40.88 67.77 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.839 1.199 . . . . 0.0 111.198 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.7 m -62.55 -42.5 99.58 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.871 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.3 tp -59.3 -26.87 65.34 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.513 1.051 . . . . 0.0 112.714 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.06 -44.86 6.14 Favored Glycine 0 N--CA 1.471 1.015 0 O-C-N 120.824 -1.172 . . . . 0.0 110.74 -168.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 t -70.66 -34.82 72.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.784 -1.208 . . . . 0.0 109.523 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -70.07 -33.16 71.55 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 122.179 -0.326 . . . . 0.0 111.273 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.35 -61.47 2.21 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.17 -31.25 64.12 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.396 1.453 . . . . 0.0 113.844 -169.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . 0.282 0.0 OUTLIER -65.42 -28.91 69.58 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 122.268 2.304 . . . . 0.0 112.23 171.68 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.72 -53.74 10.86 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.725 0.693 . . . . 0.0 111.563 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.4 mt -65.61 -29.46 70.05 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.9 -1.125 . . . . 0.0 111.959 -173.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -66.19 -26.29 67.33 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.874 0.87 . . . . 0.0 113.131 176.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.278 10.2 pt-20 -86.22 -29.67 22.98 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 118.487 -0.768 . . . . 0.0 112.997 -176.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.83 -21.43 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 119.663 1.119 . . . . 0.0 112.12 168.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.6 m -132.41 106.1 7.68 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.826 0.851 . . . . 0.0 113.031 175.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -61.99 -33.23 73.93 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.684 0.793 . . . . 0.0 111.146 169.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -91.82 77.88 5.47 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.051 1.74 . . . . 0.0 109.167 169.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.05 88.11 0.18 Allowed Glycine 0 C--N 1.338 0.67 0 C-N-CA 127.34 2.4 . . . . 0.0 108.185 -169.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -94.68 141.31 28.77 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.54 1.136 . . . . 0.0 109.315 -169.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.9 tt -124.59 137.63 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.92 151.06 17.27 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 171.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -119.52 151.74 38.1 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.236 0.614 . . . . 0.0 111.596 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.18 147.57 17.67 Favored Glycine 0 C--N 1.342 0.913 0 C-N-CA 124.005 0.812 . . . . 0.0 113.45 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.9 t -118.09 150.69 38.92 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.48 1.512 . . . . 0.0 110.95 175.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.15 148.25 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.126 1.371 . . . . 0.0 108.925 172.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.59 -77.04 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.889 0.875 . . . . 0.0 109.429 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -177.83 -23.51 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 130.695 3.598 . . . . 0.0 108.201 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.3 ttt -49.26 -49.04 45.22 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.742 1.617 . . . . 0.0 109.603 167.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 173.4 175.95 0.12 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 130.59 3.556 . . . . 0.0 110.156 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -91.37 130.8 37.17 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 104.721 -2.325 . . . . 0.0 104.721 166.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -121.68 120.33 34.39 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.653 0.781 . . . . 0.0 110.119 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -83.9 117.73 23.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.936 0.894 . . . . 0.0 110.817 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 82.4 mt -130.35 108.73 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.451 1.5 . . . . 0.0 107.0 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.5 tp 87.56 112.37 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 128.26 2.624 . . . . 0.0 111.212 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.55 158.85 30.84 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.397 1.879 . . . . 0.0 109.961 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.8 mt -52.7 112.97 0.93 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.974 1.261 . . . . 0.0 110.858 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.8 t -133.19 162.04 32.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.267 1.427 . . . . 0.0 112.474 -171.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.09 -7.22 33.26 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.169 1.787 . . . . 0.0 114.227 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.286 40.6 p-10 -92.2 84.29 5.21 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 125.921 2.772 . . . . 0.0 110.377 173.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.4 m -59.47 -43.26 93.28 Favored 'General case' 0 C--N 1.316 -0.875 1 C-N-CA 131.961 4.104 . . . . 0.0 109.842 177.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.8 p -60.86 -16.43 41.45 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.968 1.307 . . . . 0.0 112.599 170.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -89.55 -48.53 7.24 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.6 1.091 . . . . 0.0 111.251 175.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -50.39 -35.85 30.08 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.226 1.01 . . . . 0.0 112.059 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -73.03 -23.99 60.66 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.267 1.427 . . . . 0.0 111.508 -171.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.7 mtp85 -91.33 -26.06 19.11 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.538 1.535 . . . . 0.0 109.926 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.81 -37.64 20.52 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.73 -31.29 64.84 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.174 174.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -65.79 -39.83 91.35 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 120.092 1.315 . . . . 0.0 111.32 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -69.52 -12.12 61.39 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -63.45 114.33 3.82 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.479 1.036 . . . . 0.0 110.833 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.4 mt -106.37 161.12 14.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.016 0.927 . . . . 0.0 111.295 170.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.62 160.98 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.787 1.635 . . . . 0.0 114.1 -169.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.2 t -123.08 171.29 9.4 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.381 1.872 . . . . 0.0 111.012 169.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.38 152.5 17.56 Favored Glycine 0 N--CA 1.478 1.496 0 O-C-N 120.588 -1.32 . . . . 0.0 114.907 -173.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -146.3 157.38 43.79 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.925 1.69 . . . . 0.0 113.939 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 tp -83.54 -71.76 0.49 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.458 1.503 . . . . 0.0 109.724 169.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.76 148.04 40.77 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.641 1.176 . . . . 0.0 112.589 -170.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 m -59.45 -46.85 98.87 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-O 116.61 -1.662 . . . . 0.0 113.299 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -66.25 139.51 55.31 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.758 2.306 . . . . 0.0 113.174 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.37 164.52 13.82 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.003 1.321 . . . . 0.0 113.736 175.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.518 ' CA ' ' HH ' ' A' ' 150' ' ' TYR . . . -80.6 38.44 2.3 Favored Glycine 0 N--CA 1.475 1.242 0 C-N-CA 125.249 1.404 . . . . 0.0 116.582 -169.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -63.38 -38.45 91.19 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -168.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -83.92 -10.62 57.83 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -74.12 -46.86 39.99 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.991 1.269 . . . . 0.0 108.625 168.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.69 68.88 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.698 1.599 . . . . 0.0 112.058 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.2 p -54.78 -36.41 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 118.796 -0.621 . . . . 0.0 112.239 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.96 -38.9 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 116.36 -1.781 . . . . 0.0 111.687 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -52.18 -55.3 21.91 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 121.066 1.757 . . . . 0.0 109.001 172.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 73.5 t -52.49 -31.43 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.946 1.298 . . . . 0.0 113.157 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.09 -20.24 52.62 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.78 -31.4 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -174.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.2 p -79.61 67.24 5.32 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 121.846 2.112 . . . . 0.0 112.719 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.9 tp -42.58 -41.08 2.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 128.944 2.898 . . . . 0.0 111.757 172.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.95 -22.02 75.12 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 118.383 -1.231 . . . . 0.0 114.935 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -102.06 -37.15 8.3 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.034 1.417 . . . . 0.0 112.411 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.0 mm -69.39 -39.6 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.37 22.36 29.64 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.233 1.397 . . . . 0.0 113.541 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -59.24 145.58 42.36 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.002 1.401 . . . . 0.0 110.628 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -125.48 -167.22 1.66 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.32 1.048 . . . . 0.0 111.748 171.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -74.49 9.97 1.52 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -168.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.3 -136.62 2.42 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 121.365 1.893 . . . . 0.0 110.518 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -104.03 142.02 35.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.69 1.596 . . . . 0.0 107.792 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -126.22 117.81 23.86 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -167.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -114.5 128.14 56.18 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.168 0.587 . . . . 0.0 111.91 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.3 tt -107.18 95.61 5.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 169.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.1 t -83.74 124.28 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.2 tt -122.92 125.82 46.06 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -170.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 37.3 t -116.16 134.33 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 O-C-N 124.433 1.083 . . . . 0.0 111.697 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.0 t -145.76 -172.42 3.9 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.043 169.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -145.03 5.77 1.14 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.514 1.526 . . . . 0.0 114.872 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -163.01 176.35 10.21 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.764 2.026 . . . . 0.0 109.184 169.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -61.49 -177.91 0.11 Allowed 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 -171.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -127.54 160.2 32.28 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.815 1.646 . . . . 0.0 113.794 -169.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.441 ' CE1' ' HZ2' ' A' ' 122' ' ' LYS . 62.1 m-70 -77.57 128.11 33.6 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.305 0.642 . . . . 0.0 110.836 169.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.2 mp -94.68 165.74 12.35 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.953 1.301 . . . . 0.0 110.119 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.09 146.23 39.36 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.634 -0.666 . . . . 0.0 111.171 169.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 75.05 -11.84 1.02 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 128.83 2.852 . . . . 0.0 114.268 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -66.21 -23.26 66.4 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 120.303 1.41 . . . . 0.0 112.245 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.441 ' HZ2' ' CE1' ' A' ' 117' ' ' HIS . 10.5 mmpt? -70.99 1.48 5.6 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 175.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.1 t -56.78 -32.01 65.22 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.279 1.032 . . . . 0.0 111.815 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.16 -46.99 88.27 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.345 1.058 . . . . 0.0 112.273 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -90.23 21.73 30.01 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.1 1.333 . . . . 0.0 114.03 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.317 5.6 t 56.18 39.79 30.22 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 127.8 2.44 . . . . 0.0 114.444 173.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 59.9 mtt85 -106.49 117.3 33.68 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.459 1.104 . . . . 0.0 109.121 169.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -99.58 -49.68 4.32 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -66.14 119.32 11.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.773 0.715 . . . . 0.0 111.9 -170.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.9 t -74.58 156.51 36.72 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.656 0.782 . . . . 0.0 111.91 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.2 t -62.0 141.24 58.17 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.012 0.911 . . . . 0.0 113.249 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -78.13 -9.83 59.35 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.048 1.739 . . . . 0.0 112.926 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.29 0.64 90.23 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.397 -1.224 . . . . 0.0 115.527 174.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.7 mtt85 -111.12 172.13 7.06 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.216 1.508 . . . . 0.0 112.597 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 34.8 t -75.92 143.48 41.63 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -168.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -132.99 52.74 2.06 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.771 2.028 . . . . 0.0 111.317 175.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.56 132.32 46.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.896 1.678 . . . . 0.0 109.601 -175.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -145.58 -49.35 0.23 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.216 1.007 . . . . 0.0 112.153 172.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -77.79 -8.51 58.11 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.93 -6.58 37.5 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.236 1.398 . . . . 0.0 113.706 -169.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.2 mtt -130.71 143.56 50.82 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.329 1.452 . . . . 0.0 112.657 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -70.4 89.02 0.67 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.823 1.649 . . . . 0.0 112.618 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -16.1 61.05 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -170.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.7 m -89.87 -5.54 56.73 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -28.68 14.16 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.594 1.088 . . . . 0.0 113.761 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.16 -16.87 79.09 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 117.448 -1.751 . . . . 0.0 115.501 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -128.54 -67.84 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.928 0 CA-C-N 120.307 2.053 . . . . 0.0 113.677 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -50.56 141.9 32.49 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 CA-C-N 123.509 2.289 . . . . 0.0 115.536 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -68.42 178.76 1.86 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.117 2.167 . . . . 0.0 112.73 172.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.518 ' HH ' ' CA ' ' A' ' 84' ' ' GLY . 22.0 m-85 -69.58 163.85 24.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.66 1.219 . . . . 0.0 112.116 169.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -88.09 126.55 35.17 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.8 m -63.8 152.61 38.99 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.762 -0.586 . . . . 0.0 110.582 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 72.0 t -53.97 -32.96 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 O-C-N 121.681 -0.637 . . . . 0.0 111.873 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.86 -45.42 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.871 1.269 . . . . 0.0 112.52 173.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -71.61 -35.95 70.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.905 0.882 . . . . 0.0 111.169 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -59.75 -52.99 63.1 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 169.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.17 -43.09 96.09 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.9 p -67.65 -38.79 84.31 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.497 -0.752 . . . . 0.0 112.348 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.96 -35.5 72.2 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.682 -1.261 . . . . 0.0 112.863 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 97.3 mt -60.89 -41.66 96.45 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.805 0.842 . . . . 0.0 111.892 170.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.25 75.91 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.44 1.096 . . . . 0.0 113.17 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -80.91 -39.47 26.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.646 0.778 . . . . 0.0 111.753 -174.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -87.93 -6.23 58.15 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 171.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 31.1 m120 58.19 56.2 4.68 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.865 1.666 . . . . 0.0 111.52 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 51.3 mm -94.55 137.61 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.259 1.424 . . . . 0.0 109.716 171.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -107.21 109.4 62.85 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 119.843 1.201 . . . . 0.0 107.83 168.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -73.06 148.83 45.48 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.205 1.937 . . . . 0.0 112.215 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.5 mp -131.27 99.63 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 170.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -73.78 78.37 1.58 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.498 -0.751 . . . . 0.0 111.937 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . 0.361 3.8 m -79.27 116.15 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 123.431 1.586 . . . . 0.0 113.389 174.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 28.6 m -144.23 155.94 57.86 Favored Pre-proline 0 N--CA 1.478 0.928 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.181 -169.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -78.95 153.25 25.28 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.488 2.792 . . . . 0.0 111.307 -172.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 77.1 p -37.45 -49.34 1.02 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.315 2.246 . . . . 0.0 115.061 -169.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -54.1 -38.32 65.22 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.918 1.287 . . . . 0.0 114.094 -174.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.9 ptm -103.31 -4.47 24.19 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 42.4 t -54.84 -45.26 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.4 1.0 . . . . 0.0 109.85 -171.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . 0.3 0.0 OUTLIER -76.02 -3.89 38.25 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -170.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 82.9 m -92.75 -34.24 13.98 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.33 1.052 . . . . 0.0 110.677 168.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -74.41 -25.83 59.71 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.997 -1.064 . . . . 0.0 110.183 171.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -64.6 -25.34 67.92 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.783 -1.198 . . . . 0.0 110.07 168.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -79.82 -22.84 42.54 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 120.1 -1.625 . . . . 0.0 110.517 176.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 18.4 tp -82.22 -26.13 33.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.308 2.243 . . . . 0.0 109.377 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.7 t -76.11 -13.56 60.2 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.381 -0.825 . . . . 0.0 112.976 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . 0.328 0.0 OUTLIER -99.08 -20.55 16.64 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 118.753 -0.642 . . . . 0.0 111.026 169.549 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -76.91 -31.06 56.44 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.17 0.895 . . . . 0.0 111.481 169.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.92 108.89 45.75 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.046 0.938 . . . . 0.0 109.954 172.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.94 145.41 56.04 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 121.978 1.785 . . . . 0.0 111.255 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt 97.42 -20.58 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 130.557 3.543 . . . . 0.0 114.509 169.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.35 166.84 22.86 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.661 0.664 . . . . 0.0 110.721 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.4 p -125.17 -150.54 0.45 Allowed 'General case' 0 C--N 1.346 0.445 0 CA-C-O 122.926 1.346 . . . . 0.0 109.206 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 11.6 tt 179.08 131.21 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 126.668 1.987 . . . . 0.0 109.843 -167.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -126.2 160.35 20.6 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.592 1.091 . . . . 0.0 112.183 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -89.58 92.16 8.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 122.651 1.215 . . . . 0.0 107.824 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -64.26 123.57 19.47 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.594 -1.639 . . . . 0.0 108.51 169.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 91.1 p -162.64 -162.11 0.77 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.259 1.424 . . . . 0.0 110.437 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.44 -11.47 60.9 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.344 -1.472 . . . . 0.0 114.259 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -124.66 135.21 52.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.982 1.313 . . . . 0.0 111.499 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 34.4 p -89.94 -1.73 58.03 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.978 1.311 . . . . 0.0 113.82 -173.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 33.5 t -56.48 -42.33 78.06 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.335 1.454 . . . . 0.0 111.467 -169.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -57.39 -39.5 76.21 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.304 1.041 . . . . 0.0 111.85 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 88.4 t -78.76 -49.63 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.08 1.352 . . . . 0.0 111.405 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.59 -30.68 71.71 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.162 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -73.93 -1.7 20.8 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.652 1.569 . . . . 0.0 113.079 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 88.4 mt -99.52 -39.7 8.2 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.526 1.531 . . . . 0.0 108.317 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 15.6 mt -74.74 -37.19 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -64.1 -35.75 81.78 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.931 0.492 . . . . 0.0 110.034 169.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -68.66 -36.63 78.81 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.387 173.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -73.11 -24.16 60.59 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.144 0.978 . . . . 0.0 112.167 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -70.27 -39.59 74.86 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.203 1.001 . . . . 0.0 110.365 168.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.5 t -70.35 -26.83 63.93 Favored 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 124.692 1.197 . . . . 0.0 113.545 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -75.04 -17.28 60.52 Favored 'General case' 0 C--O 1.265 1.898 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.5 tt . . . . . 0 CA--C 1.621 3.69 0 C-N-CA 126.217 1.807 . . . . 0.0 114.414 -176.401 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.7 t0 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.986 0.422 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -93.56 159.7 15.11 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.159 0.984 . . . . 0.0 112.075 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.7 t -66.09 124.67 23.21 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.428 -0.795 . . . . 0.0 110.254 169.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.91 147.52 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 126.524 1.93 . . . . 0.0 107.825 172.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.38 124.94 31.38 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.242 0.544 . . . . 0.0 109.93 169.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 mp -115.02 137.88 51.5 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -121.31 107.57 12.68 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 122.8 1.286 . . . . 0.0 110.705 173.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -80.64 103.12 10.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.778 2.031 . . . . 0.0 112.049 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -100.45 113.04 25.48 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.989 1.315 . . . . 0.0 110.588 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 87.3 mtp -97.82 147.05 24.81 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -94.06 124.4 7.86 Favored Glycine 0 CA--C 1.542 1.762 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 168.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.5 mp -115.22 29.39 8.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 125.332 1.453 . . . . 0.0 114.896 -170.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.5 p -88.95 169.96 11.09 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 120.207 -1.558 . . . . 0.0 113.172 -172.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.28 -19.27 63.98 Favored Glycine 0 N--CA 1.479 1.512 0 O-C-N 120.958 -1.089 . . . . 0.0 114.256 -171.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 p -72.26 -28.01 62.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.302 2.241 . . . . 0.0 113.456 169.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.25 -13.59 54.95 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.805 1.642 . . . . 0.0 114.333 -173.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -67.47 133.85 50.28 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 121.209 1.822 . . . . 0.0 108.962 169.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.43 -43.23 2.12 Favored Glycine 0 N--CA 1.474 1.195 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -168.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -76.8 -23.96 52.84 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.665 0.786 . . . . 0.0 111.189 168.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.6 tp -48.75 -50.94 31.52 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 126.028 1.731 . . . . 0.0 110.944 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.1 p -55.14 -41.52 71.89 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.71 1.141 . . . . 0.0 112.609 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -61.04 -45.82 93.24 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.281 -0.887 . . . . 0.0 110.662 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.0 t -66.65 -38.71 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.155 0.582 . . . . 0.0 111.805 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -67.08 -51.26 56.62 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.378 0.671 . . . . 0.0 109.896 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.5 m -64.26 -38.21 90.25 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.181 -177.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.4 tp -59.39 -30.63 68.57 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.05 1.295 . . . . 0.0 111.982 174.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.13 -38.17 6.08 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 -168.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.2 m -67.03 -32.84 74.32 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.84 1.656 . . . . 0.0 110.009 169.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -76.51 -38.41 55.23 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.5 174.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.5 tt -65.4 -47.46 76.23 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -48.55 -56.52 8.15 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 126.922 2.089 . . . . 0.0 113.083 176.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -82.71 -42.32 18.21 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -173.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.3 -34.88 72.83 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.555 1.07 . . . . 0.0 112.106 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 87.4 mt -81.96 -30.41 31.71 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -73.38 -1.63 18.95 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 169.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -91.71 -46.33 7.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.148 0.979 . . . . 0.0 110.718 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.9 tp -69.94 -30.94 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 118.957 0.798 . . . . 0.0 112.117 175.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.3 t -129.66 141.09 50.99 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -83.87 -14.85 50.12 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.884 1.273 . . . . 0.0 111.562 168.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -123.11 81.92 1.94 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.713 1.205 . . . . 0.0 109.822 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.84 79.78 0.28 Allowed Glycine 0 C--N 1.339 0.712 0 C-N-CA 126.874 2.178 . . . . 0.0 109.0 -170.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -82.42 132.14 35.21 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -170.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.9 tp -110.66 138.41 38.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.632 0.773 . . . . 0.0 110.238 -175.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.95 159.21 22.57 Favored Glycine 0 N--CA 1.468 0.768 0 C-N-CA 125.555 1.55 . . . . 0.0 112.088 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -138.08 128.33 26.01 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -169.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.98 159.18 25.99 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 124.688 1.137 . . . . 0.0 113.978 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.6 m -134.15 140.54 46.63 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.425 1.49 . . . . 0.0 111.94 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.18 146.98 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.121 -0.987 . . . . 0.0 112.556 177.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 81.9 t -134.2 -80.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 126.105 1.762 . . . . 0.0 108.319 170.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' A' ' 52' ' ' THR 0.338 0.0 OUTLIER -168.45 -7.1 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.877 1 C-N-CA 132.862 4.465 . . . . 0.0 109.338 168.772 . . . . . . . . 5 4 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 49.6 mtm -77.57 46.27 0.53 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.875 1.67 . . . . 0.0 107.399 166.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.404 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.351 3.2 t 52.12 -164.5 0.07 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 130.617 3.567 . . . . 0.0 114.057 -169.546 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -108.78 130.03 55.38 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.223 2.609 . . . . 0.0 109.33 -175.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -118.07 118.58 32.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.627 0.727 . . . . 0.0 111.142 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -84.62 114.12 21.76 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.075 1.35 . . . . 0.0 109.196 169.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.8 mm -107.67 -24.12 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.7 tp -146.91 120.33 9.03 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.018 1.281 . . . . 0.0 112.161 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.07 152.0 25.19 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.017 1.727 . . . . 0.0 112.566 172.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.81 120.49 4.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.366 1.066 . . . . 0.0 110.506 175.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.2 t -155.12 170.4 21.89 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.41 -5.05 40.68 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.314 2.246 . . . . 0.0 113.697 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -81.89 77.98 8.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 126.178 2.895 . . . . 0.0 108.312 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.5 p -69.69 -43.28 72.78 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 130.129 3.372 . . . . 0.0 111.891 -169.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.1 t -55.65 -33.59 64.22 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.462 1.105 . . . . 0.0 110.214 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . 0.302 6.2 pt20 -88.44 -33.52 17.82 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 118.887 -1.125 . . . . 0.0 112.848 -171.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -53.63 -34.56 58.96 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.601 0.637 . . . . 0.0 110.453 169.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -74.93 -34.42 62.11 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.523 0.729 . . . . 0.0 110.432 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 89.0 mtt-85 -70.69 -38.66 73.72 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.162 0.985 . . . . 0.0 109.229 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.35 -30.21 42.56 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -174.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.95 -40.76 71.83 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 169.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -67.74 -30.87 70.45 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.204 -0.935 . . . . 0.0 112.39 -177.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -65.49 -31.9 73.22 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -55.21 140.85 37.41 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -168.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 mp -120.79 158.73 26.91 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.247 1.819 . . . . 0.0 110.569 -173.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.1 t -100.02 133.89 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.135 0.974 . . . . 0.0 110.881 -176.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.1 m -107.24 -156.97 0.6 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.481 1.512 . . . . 0.0 110.899 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -156.99 153.49 24.74 Favored Glycine 0 N--CA 1.478 1.466 0 O-C-N 119.874 -1.766 . . . . 0.0 116.291 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.8 tptt -157.88 161.95 38.31 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.614 1.566 . . . . 0.0 112.475 169.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.5 mt -70.26 -47.64 60.41 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.941 1.696 . . . . 0.0 114.507 -169.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.84 137.89 42.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.438 0.695 . . . . 0.0 111.926 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.254 13.6 t -67.89 -41.14 26.78 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-O 115.816 -2.04 . . . . 0.0 113.975 173.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.15 150.29 82.06 Favored 'Trans proline' 0 C--N 1.36 1.132 0 CA-C-N 123.09 2.139 . . . . 0.0 111.924 170.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -121.93 160.28 25.14 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -171.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.07 19.07 28.27 Favored Glycine 0 N--CA 1.476 1.304 0 CA-C-O 118.175 -1.347 . . . . 0.0 116.174 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -49.5 -32.45 12.23 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.84 1.82 . . . . 0.0 113.384 -173.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.8 tp -60.16 -41.36 92.64 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.222 1.009 . . . . 0.0 113.441 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.93 -40.03 87.53 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.549 0.339 . . . . 0.0 110.767 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.54 -52.72 50.44 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 117.633 -1.175 . . . . 0.0 112.257 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -54.76 -38.12 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 120.113 1.324 . . . . 0.0 111.306 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.7 t -71.46 -39.79 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 118.943 0.792 . . . . 0.0 112.681 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -67.93 -41.44 82.56 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.514 1.052 . . . . 0.0 112.05 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.7 t -56.4 -40.4 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.194 0.598 . . . . 0.0 110.401 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.62 -40.85 80.19 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.86 -8.65 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -171.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 4.7 t -90.88 67.72 6.18 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.258 -1.526 . . . . 0.0 111.431 172.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -46.98 -42.77 18.48 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.145 1.778 . . . . 0.0 111.171 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.43 -23.54 53.73 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.43 1.014 . . . . 0.0 115.524 -170.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -94.34 -43.45 8.39 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.689 1.245 . . . . 0.0 110.351 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.4 mm -65.36 -39.23 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 118.671 -0.68 . . . . 0.0 110.439 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.43 24.49 23.84 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.44 1.019 . . . . 0.0 114.176 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -55.52 128.06 32.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.224 1.41 . . . . 0.0 113.586 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.86 173.42 6.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.236 1.814 . . . . 0.0 110.29 169.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -89.69 57.01 3.74 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.778 1.231 . . . . 0.0 112.793 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.04 -121.14 4.86 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.335 1.445 . . . . 0.0 110.235 170.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.7 p -119.57 127.91 53.42 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.524 1.93 . . . . 0.0 106.092 169.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -112.1 110.86 21.37 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.918 0.781 . . . . 0.0 110.819 -167.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -111.42 97.72 6.95 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -168.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.1 tp -87.12 94.87 9.76 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.586 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 44.9 t -83.76 116.7 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 37.9 mt -109.31 109.96 21.0 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.165 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.38 125.14 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 O-C-N 123.934 0.771 . . . . 0.0 111.83 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -161.55 150.14 15.69 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.736 0.814 . . . . 0.0 111.229 172.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -105.31 -1.21 25.46 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.338 1.455 . . . . 0.0 114.756 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -121.35 -178.44 3.78 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.496 1.118 . . . . 0.0 111.889 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -77.33 -172.51 2.5 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.648 1.179 . . . . 0.0 111.231 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -139.16 157.17 46.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.075 0.95 . . . . 0.0 112.633 -169.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -79.9 129.75 34.74 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.226 1.01 . . . . 0.0 110.717 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mp -98.99 173.21 6.95 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.851 1.26 . . . . 0.0 109.583 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.65 146.46 10.15 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.776 -0.578 . . . . 0.0 111.59 169.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 90.0 mttt 82.37 -18.98 0.43 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 128.261 2.624 . . . . 0.0 113.269 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.86 -35.71 82.01 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.002 1.273 . . . . 0.0 112.324 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -68.61 -5.28 19.08 Favored 'General case' 0 CA--C 1.551 1.0 0 O-C-N 120.927 -1.108 . . . . 0.0 113.858 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.03 -23.64 65.01 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.906 -1.121 . . . . 0.0 112.849 171.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 mp -63.74 -33.88 76.65 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.212 0.915 . . . . 0.0 110.796 169.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -84.44 16.43 34.92 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 126.127 1.823 . . . . 0.0 113.874 169.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.334 1.3 t 71.08 15.52 6.56 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 129.844 3.258 . . . . 0.0 115.095 176.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.504 ' HA ' ' HE ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -99.96 106.42 18.21 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.963 -1.086 . . . . 0.0 112.244 -177.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -88.51 -48.82 7.31 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.938 1.695 . . . . 0.0 112.411 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 -60.43 131.2 50.01 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -169.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.3 t -63.29 146.07 54.23 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.766 1.227 . . . . 0.0 111.157 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.2 p -53.72 128.95 31.55 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 125.695 1.598 . . . . 0.0 113.879 169.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -72.86 -26.62 61.52 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.422 0.689 . . . . 0.0 112.424 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.4 -25.64 7.91 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 125.697 1.618 . . . . 0.0 112.884 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -61.59 164.91 5.42 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.202 1.801 . . . . 0.0 112.878 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 38.7 t -73.53 136.74 44.1 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.522 0.729 . . . . 0.0 111.231 170.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -137.96 40.75 2.32 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.743 1.617 . . . . 0.0 111.96 172.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.96 156.19 19.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.941 0.896 . . . . 0.0 110.849 171.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.84 -80.16 0.16 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.475 1.11 . . . . 0.0 111.504 171.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.26 28.0 0.76 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.743 1.617 . . . . 0.0 112.771 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.03 -9.73 68.32 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.923 1.725 . . . . 0.0 113.454 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 13.1 mmt -96.74 146.45 24.87 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.777 1.231 . . . . 0.0 112.336 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -77.88 95.12 4.67 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.888 0.851 . . . . 0.0 110.815 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.0 ttp-105 -51.85 -40.15 60.06 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.619 1.968 . . . . 0.0 112.857 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.3 m -87.34 2.75 49.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -169.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.5 ttp85 -56.73 -33.84 66.91 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 121.731 2.06 . . . . 0.0 111.857 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.61 -4.26 87.51 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.29 1.424 . . . . 0.0 115.14 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.298 15.1 tp10 -122.42 -82.3 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.139 0 CA-C-O 115.774 -2.06 . . . . 0.0 111.051 173.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -47.13 146.8 6.0 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 123.341 2.694 . . . . 0.0 116.541 170.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.94 179.55 4.85 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -69.23 147.03 51.83 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.386 -0.822 . . . . 0.0 110.876 170.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -71.4 154.68 41.37 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.527 -0.733 . . . . 0.0 111.964 -177.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.5 p -88.5 155.91 19.39 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.704 -0.623 . . . . 0.0 111.343 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.2 t -59.27 -29.12 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 121.373 -0.829 . . . . 0.0 112.585 -169.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 37.4 t -66.8 -42.46 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.373 1.469 . . . . 0.0 111.59 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -70.49 -29.55 66.11 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.233 1.013 . . . . 0.0 111.715 -174.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.23 -54.72 29.08 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.789 0.836 . . . . 0.0 109.796 170.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.53 -37.7 68.27 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.219 1.008 . . . . 0.0 111.959 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.5 m -60.59 -65.29 0.71 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.312 1.045 . . . . 0.0 112.336 170.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.265 68.9 mmtt -76.25 -17.39 59.5 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.121 -1.612 . . . . 0.0 114.835 -169.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mp -71.72 -41.4 68.6 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.782 0.833 . . . . 0.0 109.493 168.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.32 -35.48 66.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.454 1.102 . . . . 0.0 113.853 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.9 -41.52 78.15 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.942 0.897 . . . . 0.0 110.736 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -87.96 -0.3 56.82 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 65.24 31.01 11.02 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.524 1.129 . . . . 0.0 113.012 170.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 57.2 mt -94.92 134.18 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 120.89 -1.131 . . . . 0.0 108.969 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -107.34 100.51 33.89 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-N 119.078 0.853 . . . . 0.0 111.826 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.02 154.57 74.2 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.746 2.297 . . . . 0.0 115.81 169.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 38.0 mt -132.27 110.77 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.892 1.677 . . . . 0.0 107.775 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -77.58 79.5 4.08 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 123.214 1.483 . . . . 0.0 110.844 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 89.7 t -65.98 109.04 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.583 169.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 27.3 m -148.38 146.52 23.05 Favored Pre-proline 0 N--CA 1.476 0.841 0 O-C-N 120.757 -1.215 . . . . 0.0 112.696 -170.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.36 151.97 27.66 Favored 'Trans proline' 0 C--N 1.351 0.696 1 C-N-CA 125.533 4.155 . . . . 0.0 114.129 169.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 68.3 p -56.81 -29.16 62.47 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -169.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 40.7 tpt85 -58.95 -36.68 75.21 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.927 1.24 . . . . 0.0 112.774 -177.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 34.5 mtt -118.1 12.79 13.7 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.436 1.272 . . . . 0.0 114.436 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 5.4 t -53.39 -34.88 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.646 1.112 . . . . 0.0 111.22 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 45.6 tptt -80.78 -15.04 57.47 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -175.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.12 -34.17 43.61 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.445 1.02 . . . . 0.0 110.383 174.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -80.58 -36.93 32.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.054 1.342 . . . . 0.0 110.342 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -62.7 -13.37 31.62 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.114 0.87 . . . . 0.0 113.072 171.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -105.01 -11.0 16.84 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -80.15 -30.56 38.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.385 1.474 . . . . 0.0 109.154 169.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 58.6 p -77.11 -11.45 59.81 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.144 1.378 . . . . 0.0 112.406 173.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.8 m -78.39 -30.72 47.97 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 168.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -81.42 -28.15 34.4 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 171.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.52 86.09 22.17 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 123.855 0.862 . . . . 0.0 110.711 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.47 149.02 92.17 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.755 2.304 . . . . 0.0 112.196 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt 89.25 -17.08 0.25 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 130.665 3.586 . . . . 0.0 113.017 -175.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.2 mt -76.03 162.39 28.09 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.272 0.629 . . . . 0.0 110.766 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.6 p -129.9 -161.5 1.12 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 48.2 mm -162.13 149.02 4.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 130.332 3.453 . . . . 0.0 109.385 -167.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.06 156.55 26.89 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 168.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -96.81 84.2 3.56 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.644 1.578 . . . . 0.0 108.374 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.0 tt -61.41 138.55 58.26 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.57 1.176 . . . . 0.0 110.572 169.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 90.0 p -159.43 -163.43 1.18 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 128.32 2.648 . . . . 0.0 106.715 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.41 -10.06 47.6 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 120.551 -1.343 . . . . 0.0 112.936 173.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -100.93 128.65 46.87 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.578 1.551 . . . . 0.0 111.28 171.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 44.2 p -92.54 -4.46 53.48 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.141 1.776 . . . . 0.0 114.039 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 79.8 p -58.05 -44.52 87.48 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.408 1.483 . . . . 0.0 112.802 -169.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -62.97 -50.64 69.97 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.753 0.421 . . . . 0.0 111.26 -173.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 17.1 t -72.54 -37.21 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 121.668 -0.645 . . . . 0.0 112.344 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -60.48 -30.12 69.49 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 118.935 0.789 . . . . 0.0 111.486 172.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -69.73 -8.12 45.26 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.606 -1.309 . . . . 0.0 113.769 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.9 mp -105.49 -34.92 7.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.714 1.606 . . . . 0.0 109.326 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 16.3 mm -65.92 -48.38 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -71.7 -31.81 67.13 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 118.651 -0.69 . . . . 0.0 111.658 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -64.92 -43.08 93.94 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.547 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -76.97 -26.66 54.22 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -60.21 -45.5 92.96 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.655 0.782 . . . . 0.0 110.703 171.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 10.8 t -67.12 -20.77 65.83 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.143 0.977 . . . . 0.0 113.475 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -82.36 -15.78 51.54 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--O 1.257 1.452 0 CA-C-O 112.663 -3.541 . . . . 0.0 111.724 176.721 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 35.0 t0 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.198 0.523 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -99.48 142.55 30.82 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.455 1.102 . . . . 0.0 110.3 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.7 p -70.98 134.81 47.46 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.055 -1.028 . . . . 0.0 112.396 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.33 100.97 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-O 122.127 0.965 . . . . 0.0 112.018 -175.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.97 95.93 4.93 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.687 1.195 . . . . 0.0 109.501 171.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.1 tt -90.31 121.38 32.26 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.991 0.516 . . . . 0.0 111.837 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -113.72 109.52 18.71 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 123.728 1.727 . . . . 0.0 109.213 169.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -81.18 104.88 11.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.699 -2.046 . . . . 0.0 111.718 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -108.53 111.31 23.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.618 0.767 . . . . 0.0 109.897 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 28.0 ptm -119.07 149.04 42.35 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.1 134.59 14.58 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.29 1.424 . . . . 0.0 110.892 169.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 mp -102.97 29.64 5.31 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.584 1.954 . . . . 0.0 111.608 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 p -69.7 163.12 26.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.112 1.765 . . . . 0.0 113.505 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.9 -32.3 48.39 Favored Glycine 0 N--CA 1.478 1.484 0 O-C-N 120.654 -1.278 . . . . 0.0 115.047 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 p -80.07 -6.82 58.33 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.239 1.416 . . . . 0.0 114.487 175.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.92 -9.83 59.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.218 1.407 . . . . 0.0 112.257 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -70.54 124.6 24.61 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 168.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.86 -40.98 2.31 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -168.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -67.82 -52.34 38.05 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.3 tp -64.75 -21.44 66.76 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.722 1.209 . . . . 0.0 113.642 -171.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.2 p -79.63 -47.77 14.86 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.549 1.068 . . . . 0.0 112.152 169.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -68.75 -30.29 68.87 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.633 -1.292 . . . . 0.0 112.802 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.0 p -76.03 -2.77 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.563 1.145 . . . . 0.0 113.345 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -69.81 -43.08 72.78 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.804 -1.185 . . . . 0.0 109.373 -175.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.7 m -76.88 -11.53 59.83 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.658 1.983 . . . . 0.0 112.205 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.84 86.59 6.89 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 124.643 2.163 . . . . 0.0 108.604 171.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.27 -54.64 0.02 OUTLIER Glycine 0 N--CA 1.474 1.198 0 CA-C-N 108.851 -3.795 . . . . 0.0 111.088 166.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.3 p -82.35 -41.46 19.98 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.292 1.837 . . . . 0.0 110.64 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.98 -36.07 82.29 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.825 0.85 . . . . 0.0 111.13 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.6 tp -70.88 -40.17 72.4 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.21 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 mt -56.51 -39.44 73.31 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.865 1.211 . . . . 0.0 112.481 171.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -60.8 -34.93 75.26 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.77 1.623 . . . . 0.0 111.798 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.05 -40.72 60.16 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 169.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.9 mt -75.57 -23.46 56.55 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.402 1.001 . . . . 0.0 113.608 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -70.42 -27.1 64.01 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.68 1.582 . . . . 0.0 113.506 -171.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -79.75 -37.92 34.39 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.793 0.437 . . . . 0.0 110.341 173.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.6 mm -63.35 -36.38 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 122.554 0.342 . . . . 0.0 111.869 170.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.7 t -159.06 135.84 9.48 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -169.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -63.78 -31.7 72.97 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.814 1.246 . . . . 0.0 112.832 171.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.7 t -128.75 110.83 12.53 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.998 0.904 . . . . 0.0 111.116 -172.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.68 86.54 0.23 Allowed Glycine 0 C--N 1.337 0.616 0 C-N-CA 125.82 1.676 . . . . 0.0 109.086 -169.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.6 mmt-85 -72.39 138.82 47.47 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.436 1.494 . . . . 0.0 108.672 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 tt -126.6 133.25 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-N 119.062 0.846 . . . . 0.0 111.712 -177.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.89 159.68 26.54 Favored Glycine 0 N--CA 1.475 1.264 0 C-N-CA 126.035 1.778 . . . . 0.0 112.51 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -137.04 133.27 35.29 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -169.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.63 145.94 17.99 Favored Glycine 0 C--N 1.343 0.948 0 C-N-CA 124.827 1.203 . . . . 0.0 111.945 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.7 m -128.49 149.0 50.77 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.084 0.953 . . . . 0.0 112.137 -173.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.1 152.32 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-N 118.99 0.814 . . . . 0.0 113.149 -175.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.4 t -141.5 -84.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 125.152 1.381 . . . . 0.0 109.269 168.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' A' ' 52' ' ' THR . 54.0 t30 -149.54 -20.63 0.28 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.847 2.459 . . . . 0.0 108.269 169.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 76.4 mtm -75.78 50.17 0.56 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 127.514 2.325 . . . . 0.0 106.202 166.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.404 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.342 4.0 t 32.74 -149.56 0.0 OUTLIER 'General case' 0 C--N 1.345 0.375 1 C-N-CA 133.915 4.886 . . . . 0.0 116.71 -168.835 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -106.0 137.35 44.06 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 130.287 3.435 . . . . 0.0 109.343 -174.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -129.37 126.56 39.15 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 122.604 1.192 . . . . 0.0 109.739 168.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -87.35 116.65 25.59 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.851 2.06 . . . . 0.0 109.399 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.7 mt -110.01 -57.46 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.131 -169.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -103.98 117.25 33.84 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.104 0.865 . . . . 0.0 112.907 173.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -64.27 147.45 52.43 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 166.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mp -61.5 126.56 27.8 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 121.072 1.76 . . . . 0.0 110.461 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -149.54 176.83 10.27 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.635 1.174 . . . . 0.0 111.469 -173.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.27 -25.76 23.8 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.432 1.893 . . . . 0.0 113.982 -170.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -87.82 80.63 7.8 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 125.534 2.588 . . . . 0.0 109.653 -176.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.2 m -66.1 -25.77 67.16 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 127.716 2.406 . . . . 0.0 110.09 170.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.5 t -68.14 -23.01 64.84 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.544 -0.722 . . . . 0.0 109.526 168.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -85.69 -34.64 21.22 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.031 -1.043 . . . . 0.0 112.035 173.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -52.87 -26.36 14.49 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 123.962 0.905 . . . . 0.0 110.953 169.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -75.7 -49.98 16.72 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.53 -0.731 . . . . 0.0 109.965 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -79.61 -20.04 47.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 117.887 -1.054 . . . . 0.0 112.38 -169.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -83.28 -35.17 25.5 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 118.06 -1.456 . . . . 0.0 109.131 169.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.25 -29.01 69.76 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.361 0.528 . . . . 0.0 110.588 176.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -65.77 -26.95 67.94 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 170.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -77.96 -26.89 49.07 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 119.483 1.038 . . . . 0.0 113.344 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.77 153.93 23.08 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.327 0.584 . . . . 0.0 110.863 176.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.284 1.0 OUTLIER -148.65 166.25 28.89 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.587 1.155 . . . . 0.0 111.39 170.314 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 t -80.46 147.91 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.151 1.78 . . . . 0.0 114.492 -167.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.6 m -125.82 159.87 31.32 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.268 1.827 . . . . 0.0 113.138 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.63 161.79 13.49 Favored Glycine 0 N--CA 1.476 1.331 0 C-N-CA 125.089 1.328 . . . . 0.0 114.757 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -158.76 147.92 18.89 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.075 2.15 . . . . 0.0 109.654 171.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.08 -74.58 0.06 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.542 1.537 . . . . 0.0 112.193 176.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.81 154.62 41.67 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -173.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.6 m -67.19 -52.42 30.05 Favored Pre-proline 0 N--CA 1.474 0.742 0 CA-C-O 116.372 -1.775 . . . . 0.0 113.913 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -71.08 152.99 62.97 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.107 1.872 . . . . 0.0 111.661 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -133.46 158.99 41.68 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.66 34.13 2.08 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 117.309 1.684 . . . . 0.0 117.309 -168.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -74.02 -21.32 60.02 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -170.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.4 tp -56.96 -53.03 62.65 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.424 0.689 . . . . 0.0 109.79 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -63.57 -31.46 72.64 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.841 -1.162 . . . . 0.0 112.741 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.24 -51.77 68.12 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.86 170.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.64 -26.55 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 119.909 1.232 . . . . 0.0 112.851 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.9 t -70.81 -56.64 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.06 173.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -58.56 -36.78 74.46 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.55 0.614 . . . . 0.0 109.623 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.46 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 52.9 t -60.74 -31.46 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 173.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.78 -51.63 11.04 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.247 -0.908 . . . . 0.0 113.295 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.2 mm -71.28 -23.65 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 119.789 1.177 . . . . 0.0 113.31 -169.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.32 61.09 6.64 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.567 -1.333 . . . . 0.0 112.433 -173.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -46.56 -44.65 18.14 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.448 1.499 . . . . 0.0 110.821 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.97 -24.2 28.01 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.678 1.132 . . . . 0.0 115.207 -171.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -88.4 -40.95 13.13 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.829 1.315 . . . . 0.0 111.042 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 92' ' ' VAL . 27.0 mt -79.64 -31.9 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 121.321 -0.862 . . . . 0.0 110.551 176.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.81 31.76 20.07 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.666 -0.519 . . . . 0.0 113.358 169.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -55.48 120.99 8.02 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.482 1.113 . . . . 0.0 112.414 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -76.45 170.37 16.51 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.716 0.807 . . . . 0.0 111.007 169.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -89.62 52.42 2.32 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.85 0.86 . . . . 0.0 112.095 169.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.7 -119.05 3.87 Favored Glycine 0 N--CA 1.471 0.982 0 N-CA-C 105.867 -2.893 . . . . 0.0 105.867 168.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.6 t -124.76 131.38 53.46 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.23 137.5 41.28 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -168.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -136.42 104.78 5.71 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -167.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 20.9 tp -97.41 101.0 12.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.744 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.6 t -73.81 127.8 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 168.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 21.4 tp -116.26 130.12 56.62 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 169.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.257 6.5 p -141.86 129.97 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.6 t -147.3 -176.46 5.24 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 113.351 -1.75 . . . . 0.0 111.277 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -130.82 -7.98 3.99 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 127.063 2.145 . . . . 0.0 113.607 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -150.14 169.4 21.37 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.917 1.287 . . . . 0.0 112.936 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -53.14 167.52 0.17 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.554 2.342 . . . . 0.0 115.677 -170.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -92.99 163.84 13.51 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -102.59 124.07 47.47 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 165.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.5 mp -104.32 177.21 4.91 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.757 1.223 . . . . 0.0 110.538 -172.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.44 145.46 4.71 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.367 58.6 pttt 56.29 2.79 0.09 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 128.345 2.658 . . . . 0.0 116.891 -170.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -66.34 -28.91 69.03 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 121.475 1.943 . . . . 0.0 112.442 170.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . 0.329 20.1 mttt -75.14 7.61 3.22 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 176.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.6 t -70.92 -18.69 62.65 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.781 1.232 . . . . 0.0 111.209 168.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 mp -65.71 -23.76 66.83 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.196 0.998 . . . . 0.0 112.196 169.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -88.42 -130.72 3.61 Favored Glycine 0 CA--C 1.538 1.482 0 N-CA-C 106.64 -2.584 . . . . 0.0 106.64 168.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.3 m -142.2 68.4 1.32 Allowed 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 118.008 0.904 . . . . 0.0 109.28 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -134.45 81.02 1.88 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.795 1.638 . . . . 0.0 108.665 -175.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -79.49 -45.74 18.76 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.729 0.812 . . . . 0.0 111.726 -176.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -57.99 120.62 8.86 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.049 0.54 . . . . 0.0 111.341 -171.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.4 t -72.13 154.33 41.14 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-O 122.577 1.18 . . . . 0.0 111.246 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.7 p -61.46 138.46 58.27 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 127.425 2.29 . . . . 0.0 115.674 -171.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 54.4 p30 -87.69 -18.15 30.16 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -175.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.28 17.38 78.81 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.988 -0.896 . . . . 0.0 114.017 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 37.5 ttm105 -96.9 158.73 15.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.954 1.702 . . . . 0.0 110.426 174.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.71 146.16 25.81 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.07 -1.019 . . . . 0.0 112.95 169.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -140.7 55.66 1.58 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.273 1.829 . . . . 0.0 110.663 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 tt -130.67 130.13 43.49 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.34 2.256 . . . . 0.0 108.418 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -145.56 -50.07 0.24 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 169.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -72.37 -20.91 61.38 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.905 1.282 . . . . 0.0 114.107 176.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 131.37 -17.88 5.01 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.118 1.818 . . . . 0.0 114.328 -172.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 80.5 mtp -113.52 157.72 21.66 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.989 1.895 . . . . 0.0 114.116 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -73.31 91.98 1.76 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.787 0.835 . . . . 0.0 110.972 171.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -54.62 -38.57 66.98 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.313 1.045 . . . . 0.0 112.535 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 64.8 m -79.58 0.74 28.73 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -41.32 -46.31 3.23 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 120.529 1.513 . . . . 0.0 112.338 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.68 -7.75 88.02 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 117.966 -1.463 . . . . 0.0 115.161 -172.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.276 88.8 tt0 -114.5 -79.39 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.025 0 CA-C-O 115.891 -2.004 . . . . 0.0 112.141 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.92 158.22 48.39 Favored 'Trans proline' 0 C--N 1.356 0.948 0 CA-C-N 123.509 2.289 . . . . 0.0 113.275 170.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -77.27 -168.25 1.08 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.673 1.589 . . . . 0.0 113.514 170.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -69.2 144.83 53.62 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 172.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.53 153.12 43.79 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 54.6 p -85.66 150.97 24.24 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.317 -0.864 . . . . 0.0 112.833 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 70.0 t -56.0 -43.83 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.597 0.759 . . . . 0.0 110.945 -176.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.5 t -75.68 -26.66 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.005 -1.059 . . . . 0.0 112.682 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -61.24 -32.81 72.6 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.869 1.213 . . . . 0.0 110.135 170.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.6 mt -83.69 -33.06 25.24 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.809 -0.557 . . . . 0.0 112.373 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.78 84.47 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.187 0.449 . . . . 0.0 110.331 169.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.1 t -55.29 -51.62 66.08 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.229 1.012 . . . . 0.0 111.193 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -73.57 -48.82 29.94 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.7 mp -73.2 -18.63 61.23 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.701 -1.249 . . . . 0.0 112.169 -173.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.66 -30.54 41.26 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 119.115 0.871 . . . . 0.0 112.586 168.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -68.9 -48.32 63.63 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.322 1.449 . . . . 0.0 109.76 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -79.95 -8.98 59.63 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.042 1.337 . . . . 0.0 111.964 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 59.5 49.13 8.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.769 2.427 . . . . 0.0 112.794 171.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 19.2 mm -96.97 147.21 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.929 1.691 . . . . 0.0 109.671 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -105.96 102.14 37.62 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 120.82 1.645 . . . . 0.0 109.549 168.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -76.23 125.9 8.82 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.977 3.118 . . . . 0.0 113.108 169.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.51 109.49 26.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -77.13 73.31 3.71 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 122.436 1.112 . . . . 0.0 112.371 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 77.4 t -60.0 104.18 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.893 0.877 . . . . 0.0 109.468 167.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 6.3 m -149.42 148.46 26.31 Favored Pre-proline 0 N--CA 1.481 1.122 0 O-C-N 119.871 -1.768 . . . . 0.0 113.2 -173.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -58.8 153.72 48.39 Favored 'Trans proline' 0 C--N 1.354 0.838 1 C-N-CA 125.625 4.217 . . . . 0.0 116.291 178.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 29.2 t -51.74 -54.61 26.57 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -169.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 80.2 mmt-85 -60.42 -13.32 12.81 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 120.549 1.522 . . . . 0.0 114.407 -173.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 14.3 ttp -105.53 -16.52 14.69 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.431 2.293 . . . . 0.0 114.641 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.9 m -62.49 -24.83 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 122.123 2.238 . . . . 0.0 112.344 -170.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -60.27 -28.69 68.27 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.9 t -92.17 -33.56 14.67 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.172 0.589 . . . . 0.0 111.453 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -69.57 -32.25 70.92 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.377 -1.452 . . . . 0.0 109.964 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -68.05 -12.97 61.8 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.453 1.101 . . . . 0.0 112.309 169.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -96.9 -29.21 13.83 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.16 -0.963 . . . . 0.0 111.291 173.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.5 -26.81 63.76 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 119.895 -1.753 . . . . 0.0 109.758 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.4 t -81.15 -15.2 56.49 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.98 -19.44 44.06 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.805 169.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -88.78 -31.58 18.3 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 170.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 14.8 mm -101.78 111.86 64.56 Favored Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 119.547 1.067 . . . . 0.0 109.505 176.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.77 0.65 4.01 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 124.924 3.749 . . . . 0.0 119.779 -168.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -128.68 -2.95 5.36 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 -176.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.2 mt -83.21 172.75 12.29 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.93 1.241 . . . . 0.0 113.299 -169.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.446 0.1 OUTLIER -141.5 -176.42 4.73 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 167.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.9 mp -157.88 136.68 3.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 131.478 3.911 . . . . 0.0 109.354 -166.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -118.38 147.46 18.56 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 172.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -87.43 87.38 7.39 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 122.863 1.316 . . . . 0.0 107.658 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.3 tp -56.35 144.96 28.65 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.494 169.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.3 t -87.47 157.03 19.29 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.387 -0.821 . . . . 0.0 110.356 169.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -60.73 -23.84 65.24 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -171.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -97.45 -8.15 30.0 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.013 1.725 . . . . 0.0 113.956 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.5 p 85.44 -9.31 0.81 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 130.755 3.622 . . . . 0.0 117.378 168.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 82.6 p -67.13 -11.53 57.49 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.225 -1.547 . . . . 0.0 115.04 -169.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -67.8 -17.72 64.61 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.184 0.594 . . . . 0.0 112.229 168.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 4.6 p -46.72 -46.59 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -169.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.21 -33.59 76.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.79 1.177 . . . . 0.0 112.657 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -73.87 -5.26 39.98 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.821 -1.152 . . . . 0.0 113.248 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 61.9 mt -99.59 -34.19 10.33 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.917 2.087 . . . . 0.0 108.4 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 15.4 mm -61.98 -53.87 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 168.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 64.9 ttt-85 -64.49 -39.72 94.32 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.816 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -72.78 -29.37 63.24 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 118.02 -1.472 . . . . 0.0 113.528 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -81.19 -27.25 35.42 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.862 1.21 . . . . 0.0 113.396 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -61.98 -35.57 78.88 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.474 0.579 . . . . 0.0 111.59 171.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 46.3 m -72.17 -23.19 61.24 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 174.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -68.74 -59.08 3.35 Favored 'General case' 0 C--O 1.254 1.315 0 CA-C-N 119.106 0.866 . . . . 0.0 110.254 171.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . 0.287 18.3 tp . . . . . 0 C--O 1.27 2.171 0 C-N-CA 126.88 2.072 . . . . 0.0 115.551 -170.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.9 t0 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.285 0.564 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -132.46 147.1 52.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.468 1.507 . . . . 0.0 109.592 170.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 t -63.39 136.95 57.97 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -170.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 t -110.19 95.66 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.628 1.171 . . . . 0.0 110.125 -171.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -76.39 118.33 18.97 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.544 -0.723 . . . . 0.0 110.352 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.1 mt -107.25 137.79 44.66 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.685 -0.634 . . . . 0.0 110.191 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -122.49 109.48 14.41 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 122.579 1.18 . . . . 0.0 108.986 169.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -83.26 110.64 18.26 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.856 1.262 . . . . 0.0 111.808 173.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 30.3 tp -103.21 124.23 48.22 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.981 0.912 . . . . 0.0 110.62 170.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 40.7 ttp -121.88 138.68 54.3 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -169.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.53 133.58 12.62 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.943 1.259 . . . . 0.0 112.159 172.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tp -119.31 26.53 9.38 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.799 1.639 . . . . 0.0 113.3 -173.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.0 p -66.06 162.8 18.74 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.36 -20.98 68.09 Favored Glycine 0 N--CA 1.475 1.24 0 O-C-N 120.974 -1.079 . . . . 0.0 113.331 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 p -76.44 -18.76 58.64 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.172 1.389 . . . . 0.0 113.174 169.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.05 -6.86 59.49 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.688 1.195 . . . . 0.0 114.167 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -71.79 130.98 42.42 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.6 1.546 . . . . 0.0 108.187 169.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.28 -35.31 4.78 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.662 1.125 . . . . 0.0 110.351 -168.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -82.67 -24.8 33.54 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.43 1.092 . . . . 0.0 111.303 169.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.3 tp -54.94 -39.97 69.45 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.893 1.277 . . . . 0.0 111.468 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.1 p -61.57 -34.36 75.46 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.255 -1.528 . . . . 0.0 113.064 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -69.22 -44.34 72.23 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.906 -1.121 . . . . 0.0 111.013 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.0 m -72.33 -19.98 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 177.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -70.08 -38.21 75.65 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.119 1.767 . . . . 0.0 108.746 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.2 m -77.39 -11.37 59.83 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 127.821 2.448 . . . . 0.0 113.212 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mp -86.47 48.0 1.56 Allowed 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 125.256 1.422 . . . . 0.0 111.661 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.61 -45.1 0.06 OUTLIER Glycine 0 N--CA 1.477 1.376 0 O-C-N 120.698 -1.251 . . . . 0.0 115.656 170.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.2 m -89.54 -21.87 22.68 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.894 0.878 . . . . 0.0 111.008 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.18 -34.42 63.78 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.672 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.3 mp -63.12 -46.62 86.44 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.972 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.3 mt -48.25 -52.93 19.0 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.67 1.123 . . . . 0.0 113.414 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -60.77 -37.12 80.77 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.899 0.772 . . . . 0.0 111.47 -172.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.33 -53.78 32.31 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 169.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 66.7 mt -74.7 -23.41 58.6 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -169.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -61.52 -25.45 67.29 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.288 1.435 . . . . 0.0 112.854 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -85.9 -34.32 20.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.83 0.852 . . . . 0.0 111.305 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.1 mp -65.83 -43.5 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.106 170.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.1 m -153.7 149.12 27.18 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -170.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -62.0 -48.47 80.16 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.734 0.814 . . . . 0.0 112.604 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.8 t -112.92 148.97 33.87 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 123.061 1.41 . . . . 0.0 111.694 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.62 94.66 0.11 Allowed Glycine 0 CA--C 1.517 0.182 0 N-CA-C 105.898 -2.881 . . . . 0.0 105.898 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -92.36 147.47 22.89 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 122.727 0.411 . . . . 0.0 110.402 -168.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.0 tt -122.26 129.27 75.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 124.196 0.998 . . . . 0.0 109.946 -172.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.75 157.84 14.94 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.273 1.416 . . . . 0.0 110.853 172.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -141.58 131.75 24.84 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.24 155.68 24.1 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 124.407 1.004 . . . . 0.0 113.199 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 74.3 m -119.32 139.95 51.12 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.009 1.324 . . . . 0.0 111.316 -177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.3 tt -142.53 157.97 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.787 1.235 . . . . 0.0 111.328 171.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -158.46 -59.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -179.28 -28.97 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 129.861 3.264 . . . . 0.0 107.499 172.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.4 70.98 3.85 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 101.64 -3.467 . . . . 0.0 101.64 165.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.326 14.8 t 19.43 -138.45 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.763 1 C-N-CA 132.129 4.172 . . . . 0.0 116.318 -169.333 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -117.43 146.05 43.73 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 129.335 3.054 . . . . 0.0 109.892 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -134.04 123.28 24.25 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.54 0.736 . . . . 0.0 111.152 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -85.79 98.33 10.68 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.378 1.071 . . . . 0.0 110.08 169.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.5 tt -83.98 -64.24 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.504 0.722 . . . . 0.0 112.258 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 tp -109.27 117.38 33.94 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.605 1.162 . . . . 0.0 110.437 -171.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -60.59 147.76 40.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.498 0.719 . . . . 0.0 112.043 173.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.2 tt -50.41 115.13 1.32 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.554 1.942 . . . . 0.0 110.961 172.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.7 t -155.16 175.71 13.49 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.073 1.349 . . . . 0.0 112.353 -170.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.7 -13.87 41.35 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.289 1.436 . . . . 0.0 114.842 -172.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -88.01 76.19 8.63 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 124.681 2.182 . . . . 0.0 108.793 -175.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.6 m -81.37 -21.26 39.18 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 126.117 1.767 . . . . 0.0 111.549 -175.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.0 t -74.45 -26.17 59.88 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 167.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -80.17 -30.22 38.81 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.754 -1.216 . . . . 0.0 110.326 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -53.66 -34.0 57.18 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.574 -0.704 . . . . 0.0 110.417 169.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -73.0 -36.69 67.09 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -72.84 -33.2 65.99 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.862 1.265 . . . . 0.0 110.267 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.92 -37.36 58.81 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.3 tt -72.42 -27.85 62.59 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.231 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -70.84 -33.88 71.11 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 121.047 -1.033 . . . . 0.0 112.393 171.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -70.54 -27.14 63.93 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -64.73 153.01 41.03 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.713 0.688 . . . . 0.0 112.294 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.28 132.07 37.32 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.712 1.605 . . . . 0.0 108.045 -174.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.13 155.42 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.635 0.774 . . . . 0.0 112.884 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.5 p -103.19 -151.01 0.42 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.511 0.724 . . . . 0.0 111.866 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -142.87 141.53 10.69 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.375 1.464 . . . . 0.0 112.252 173.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.79 144.89 24.57 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.965 1.706 . . . . 0.0 110.652 173.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.56 -38.61 14.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -169.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.43 139.81 42.52 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.8 p -76.0 -38.63 2.51 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-O 115.89 -2.005 . . . . 0.0 114.905 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.99 136.61 53.41 Favored 'Trans proline' 0 C--N 1.355 0.885 0 CA-C-N 122.555 1.948 . . . . 0.0 112.897 171.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.22 160.38 14.57 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.548 1.539 . . . . 0.0 113.402 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.35 22.37 1.66 Allowed Glycine 0 N--CA 1.477 1.426 0 O-C-N 120.883 -1.136 . . . . 0.0 115.147 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -47.16 -34.18 5.94 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.386 2.274 . . . . 0.0 114.573 -169.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.29 -32.92 71.65 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.592 -0.718 . . . . 0.0 112.421 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -57.75 -52.11 66.81 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.307 0.958 . . . . 0.0 110.416 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.29 -49.6 76.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 116.464 -1.731 . . . . 0.0 111.18 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.4 m -55.35 -38.36 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 121.378 1.899 . . . . 0.0 114.423 -169.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 p -86.37 -38.79 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 117.451 -1.262 . . . . 0.0 112.582 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -60.74 -44.42 96.7 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 121.161 1.8 . . . . 0.0 109.776 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.254 6.4 m -65.56 -4.11 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 120.773 1.624 . . . . 0.0 114.239 174.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.77 -18.07 17.39 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.772 1.229 . . . . 0.0 113.222 169.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.4 ' HB ' ' SG ' ' A' ' 135' ' ' CYS . 13.9 mt -104.89 -19.06 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 126.004 1.722 . . . . 0.0 111.735 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 95.3 m -73.16 42.42 0.11 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 127.338 2.255 . . . . 0.0 113.581 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -50.39 -41.41 52.02 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.027 1.331 . . . . 0.0 111.412 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.37 -26.77 46.24 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.24 0.924 . . . . 0.0 115.121 -174.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -88.54 -41.85 12.44 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.161 0.98 . . . . 0.0 110.277 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 74.6 mt -76.03 -38.44 35.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 CA-C-O 117.495 -1.241 . . . . 0.0 110.809 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.19 20.21 31.02 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 119.199 0.909 . . . . 0.0 115.145 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -52.05 125.91 16.94 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.079 1.351 . . . . 0.0 113.063 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -98.12 174.6 6.45 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.356 1.462 . . . . 0.0 113.196 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -71.76 1.55 6.72 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -174.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.25 -134.72 2.01 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 120.666 1.576 . . . . 0.0 110.223 -178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.3 t -97.58 143.29 28.41 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.865 1.266 . . . . 0.0 108.299 175.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -142.0 118.44 10.9 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 119.365 0.984 . . . . 0.0 110.183 -169.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -119.16 109.95 16.47 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -169.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.58 96.77 7.57 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.415 175.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.99 118.49 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 45.8 tp -108.97 128.97 55.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 117.765 -1.112 . . . . 0.0 109.846 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.8 t -120.91 134.79 63.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.6 t -161.24 166.54 27.56 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 112.801 -2.0 . . . . 0.0 109.624 169.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -124.03 7.72 8.61 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.856 2.062 . . . . 0.0 114.214 174.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -141.83 -177.63 5.29 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.573 1.549 . . . . 0.0 111.51 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -55.08 177.87 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.491 2.316 . . . . 0.0 114.696 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -139.34 158.78 43.56 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.82 2.048 . . . . 0.0 110.015 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -85.54 126.67 34.05 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.201 0.6 . . . . 0.0 111.368 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -91.11 176.1 6.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.481 1.512 . . . . 0.0 108.992 172.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.513 ' H ' HD23 ' A' ' 118' ' ' LEU . . . -55.22 148.78 13.73 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.177 -0.952 . . . . 0.0 112.139 169.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.1 mptt 76.55 -13.86 0.88 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.479 2.312 . . . . 0.0 113.589 -176.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -65.62 -19.34 65.87 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.254 -1.529 . . . . 0.0 111.622 169.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -24.08 66.58 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.345 3.0 t -75.66 -11.8 60.07 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 119.216 0.916 . . . . 0.0 112.13 -173.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.4 mt -60.63 -34.84 74.86 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.977 -1.077 . . . . 0.0 110.84 167.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -92.26 15.34 62.36 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.826 1.679 . . . . 0.0 113.711 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.543 0.1 OUTLIER 44.05 54.27 6.0 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 128.672 2.789 . . . . 0.0 113.917 -176.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -104.0 132.14 50.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.017 2.127 . . . . 0.0 105.59 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -113.78 -35.96 4.99 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 120.786 1.63 . . . . 0.0 113.315 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -48.07 116.86 1.67 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.789 1.236 . . . . 0.0 112.037 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.8 t -62.87 157.37 21.66 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.912 0.778 . . . . 0.0 110.164 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -66.53 132.3 47.91 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.838 -0.539 . . . . 0.0 110.622 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.82 -11.15 59.65 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.8 75.14 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 118.65 -1.083 . . . . 0.0 113.793 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -125.79 178.28 5.8 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.243 1.417 . . . . 0.0 112.328 170.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . 0.4 ' SG ' ' HB ' ' A' ' 94' ' ' ILE . 1.2 m -99.39 146.24 26.51 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -169.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -151.55 56.38 0.87 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.568 1.547 . . . . 0.0 113.289 -169.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -134.26 151.43 51.28 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.918 -1.113 . . . . 0.0 111.511 169.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -147.41 -49.95 0.18 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.209 1.004 . . . . 0.0 113.511 -169.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -80.44 -10.16 59.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.242 1.017 . . . . 0.0 112.73 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.07 -9.31 27.17 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.476 1.989 . . . . 0.0 113.928 -171.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 29.9 ttm -99.26 136.13 39.66 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.8 1.8 . . . . 0.0 111.69 174.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -66.66 95.98 0.37 Allowed 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.49 -0.756 . . . . 0.0 111.947 171.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -53.23 -45.33 68.66 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.22 2.208 . . . . 0.0 112.685 -178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 17.2 t -67.79 -19.65 65.12 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -168.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -48.56 -35.32 13.13 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 121.035 1.743 . . . . 0.0 114.064 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.92 -16.82 74.92 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 119.099 -0.834 . . . . 0.0 113.482 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -117.73 -84.49 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.359 0 CA-C-O 115.946 -1.978 . . . . 0.0 109.802 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -51.51 157.64 4.81 Favored 'Trans proline' 0 C--N 1.358 1.03 0 N-CA-C 120.072 3.066 . . . . 0.0 120.072 171.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -77.03 166.77 22.87 Favored 'General case' 0 N--CA 1.468 0.448 1 C-N-CA 131.875 4.07 . . . . 0.0 115.595 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -71.62 123.08 21.71 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 166.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.624 ' CD ' ' H ' ' A' ' 151' ' ' GLN . 1.0 OUTLIER -51.17 147.23 5.66 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 125.875 1.67 . . . . 0.0 112.217 171.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 7.7 t -85.11 166.25 16.8 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.982 0.896 . . . . 0.0 112.561 173.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.46 -27.9 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -168.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.2 p -84.09 -26.39 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 175.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -68.78 -34.16 75.09 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.358 -0.839 . . . . 0.0 110.293 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -58.59 -59.91 4.65 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.037 0.535 . . . . 0.0 110.297 169.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.24 -36.44 66.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.743 0.817 . . . . 0.0 113.069 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.4 t -58.89 -57.55 12.57 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.408 1.083 . . . . 0.0 112.417 175.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -81.37 -22.3 38.48 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.786 -1.196 . . . . 0.0 113.902 -174.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.4 mp -61.08 -48.02 83.63 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.117 0.967 . . . . 0.0 109.869 168.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.88 -28.78 55.51 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -67.91 -50.7 54.66 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.644 0.778 . . . . 0.0 110.179 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -84.16 -1.21 54.62 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.7 t30 64.08 31.86 13.18 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.753 1.161 . . . . 0.0 112.078 169.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.8 mt -97.75 128.61 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -103.87 115.33 63.56 Favored Pre-proline 0 N--CA 1.477 0.891 0 CA-C-N 119.461 1.028 . . . . 0.0 111.954 175.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.31 153.68 35.87 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.482 2.122 . . . . 0.0 115.803 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.04 113.57 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.789 1.636 . . . . 0.0 109.111 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -71.56 68.15 0.56 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 122.248 1.023 . . . . 0.0 112.793 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.1 t -63.85 102.13 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 O-C-N 120.035 -1.665 . . . . 0.0 111.54 170.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 16.3 m -143.45 145.27 31.12 Favored Pre-proline 0 N--CA 1.478 0.934 0 O-C-N 120.074 -1.641 . . . . 0.0 111.174 -174.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -56.96 150.25 56.69 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.79 2.993 . . . . 0.0 112.941 173.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.5 t -46.54 -44.71 18.11 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.705 1.602 . . . . 0.0 114.123 -169.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.4 ptm85 -53.54 -27.95 28.86 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 12.8 tpt -106.02 -4.53 20.39 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.684 1.594 . . . . 0.0 113.917 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.37 -35.52 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 120.239 -1.538 . . . . 0.0 112.807 -169.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -68.53 -20.32 64.55 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.9 m -88.83 -40.22 13.3 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.211 1.404 . . . . 0.0 110.202 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -70.27 -26.42 63.81 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.341 -0.849 . . . . 0.0 111.149 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.75 -16.68 64.24 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.428 1.013 . . . . 0.0 111.844 168.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -82.06 -29.46 31.86 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.742 -1.224 . . . . 0.0 111.35 169.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.55 -26.17 57.75 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.581 -1.325 . . . . 0.0 110.217 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.03 -16.48 53.19 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.612 1.565 . . . . 0.0 111.78 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.77 -28.33 24.62 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.929 0.491 . . . . 0.0 110.286 169.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -78.14 -26.19 47.74 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 62.3 mt -117.3 96.94 50.15 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 123.701 0.801 . . . . 0.0 110.062 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.34 138.98 55.67 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.248 3.299 . . . . 0.0 113.836 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt 76.28 -8.75 1.59 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 129.038 2.935 . . . . 0.0 113.721 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 tt -72.59 150.96 42.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 169.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.3 m -129.53 -139.15 0.23 Allowed 'General case' 0 C--N 1.343 0.294 0 CA-C-O 122.212 1.006 . . . . 0.0 109.549 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.9 tt -173.42 160.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 127.083 2.153 . . . . 0.0 109.807 -168.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -150.69 147.48 17.58 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 169.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.65 89.25 7.44 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.813 1.245 . . . . 0.0 108.42 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.7 tp -58.91 140.86 54.92 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.11 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 84.6 p -164.23 -164.52 0.86 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.572 1.549 . . . . 0.0 108.427 169.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -65.49 -10.14 31.93 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 121.267 -0.896 . . . . 0.0 112.331 169.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -109.58 140.46 43.36 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.149 2.179 . . . . 0.0 111.244 174.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 86.7 p -102.81 6.75 39.44 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.286 1.834 . . . . 0.0 113.795 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.3 p -60.4 -53.17 60.8 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 120.427 -1.421 . . . . 0.0 111.608 -169.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -68.42 -28.88 67.46 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.679 0.791 . . . . 0.0 113.051 -174.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 26.9 m -81.43 -42.36 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.6 1.16 . . . . 0.0 111.158 -177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' A' ' 204' ' ' LEU . . . -69.82 -30.47 67.99 Favored 'General case' 0 C--O 1.219 -0.521 0 O-C-N 121.068 -1.02 . . . . 0.0 111.829 172.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -78.82 33.44 0.21 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 127.38 2.272 . . . . 0.0 112.508 174.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . 0.423 ' H ' ' C ' ' A' ' 202' ' ' ALA . 7.3 tp -142.0 -35.68 0.44 Allowed 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 126.965 2.106 . . . . 0.0 109.126 168.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 32.1 mt -69.93 -43.1 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 119.195 0.907 . . . . 0.0 109.057 170.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -63.37 -24.84 68.02 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.828 1.651 . . . . 0.0 112.831 172.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -91.31 -27.52 18.35 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 170.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -79.57 -19.11 50.19 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.544 -1.347 . . . . 0.0 112.457 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -74.04 -45.62 48.43 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.632 -0.667 . . . . 0.0 111.236 169.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.5 p -71.06 -9.24 57.71 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -174.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -75.92 -13.97 60.26 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.675 1.125 . . . . 0.0 113.699 169.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 C--O 1.256 1.408 0 C-N-CA 125.094 1.358 . . . . 0.0 112.751 174.948 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -98.97 154.66 17.9 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.704 1.201 . . . . 0.0 110.398 173.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -69.88 128.8 37.63 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.091 -1.006 . . . . 0.0 110.364 170.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.3 t -139.62 118.05 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 119.111 0.868 . . . . 0.0 111.883 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -93.74 122.69 36.46 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 122.888 0.475 . . . . 0.0 110.062 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -107.88 120.31 41.91 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.219 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -113.73 104.86 12.63 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 124.783 2.23 . . . . 0.0 110.183 171.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -75.63 117.72 17.7 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 111.52 -2.582 . . . . 0.0 111.761 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.5 tp -118.89 111.06 17.91 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.06 0.944 . . . . 0.0 110.79 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -114.04 137.13 52.13 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 118.821 2.897 . . . . 0.0 118.821 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.24 112.52 4.22 Favored Glycine 0 C--N 1.341 0.819 0 C-N-CA 125.639 1.59 . . . . 0.0 110.268 171.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.3 tp -98.89 28.91 4.05 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.791 1.637 . . . . 0.0 111.456 -172.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.0 p -79.16 164.43 24.24 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.253 -1.529 . . . . 0.0 114.368 -171.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.16 -32.97 85.69 Favored Glycine 0 N--CA 1.472 1.053 0 O-C-N 121.404 -0.81 . . . . 0.0 112.294 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 m -58.3 -40.73 82.79 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.09 0.956 . . . . 0.0 111.243 170.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.11 9.98 2.68 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -68.06 -37.84 81.76 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 121.298 1.863 . . . . 0.0 112.419 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.72 -33.09 66.75 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 172.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -77.1 -10.79 59.62 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 175.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.1 tp -55.23 -51.39 66.73 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.56 1.527 . . . . 0.0 112.56 -175.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.0 m -65.92 -27.7 68.38 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.394 -0.816 . . . . 0.0 112.068 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -75.8 -37.16 59.4 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.838 -1.164 . . . . 0.0 112.702 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.7 p -68.56 -36.03 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 120.426 -1.421 . . . . 0.0 110.858 169.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -72.8 -34.45 66.91 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.105 1.32 . . . . 0.0 112.035 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 t -70.33 -45.27 66.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.055 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.16 -18.09 65.02 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 119.83 1.195 . . . . 0.0 111.06 170.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.08 -51.63 4.12 Favored Glycine 0 C--O 1.218 -0.875 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 -172.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.3 t -67.91 -32.4 72.84 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 127.61 2.364 . . . . 0.0 111.209 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -74.88 -32.35 61.84 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.788 -0.57 . . . . 0.0 110.979 174.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 63.4 tp -65.28 -37.94 88.73 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 123.028 0.205 . . . . 0.0 110.511 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.14 -60.98 2.42 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.693 0.797 . . . . 0.0 111.392 176.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -64.87 -45.25 86.8 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -168.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.31 -36.27 83.54 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 119.082 -0.485 . . . . 0.0 111.81 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.4 ' HA ' HG23 ' A' ' 37' ' ' ILE 0.398 34.2 mt -85.71 -15.34 42.57 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -179.078 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -68.86 -19.81 64.25 Favored 'General case' 0 CA--C 1.553 1.079 0 O-C-N 121.607 -0.683 . . . . 0.0 111.22 168.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -81.75 -45.38 15.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.527 1.131 . . . . 0.0 110.475 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.4 HG23 ' HA ' ' A' ' 34' ' ' LEU . 6.3 tp -72.71 -25.07 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 118.771 -0.633 . . . . 0.0 112.059 173.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.1 t -146.38 134.31 21.37 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.8 ttp85 -70.86 -43.01 69.33 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.351 1.46 . . . . 0.0 111.579 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 t -103.65 94.05 5.24 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 123.403 1.573 . . . . 0.0 109.346 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.11 90.83 0.2 Allowed Glycine 0 C--N 1.332 0.348 0 N-CA-C 105.693 -2.963 . . . . 0.0 105.693 -176.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -76.17 144.13 40.71 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -170.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 mt -136.69 128.18 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 118.078 0.399 . . . . 0.0 110.084 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.91 149.42 19.36 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 126.402 1.953 . . . . 0.0 110.247 -173.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -129.89 131.89 46.21 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.626 1.17 . . . . 0.0 113.926 -169.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.03 152.81 22.95 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 171.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 75.1 p -130.29 154.22 47.85 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.427 0.691 . . . . 0.0 110.796 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.43 140.73 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -169.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.546 ' CG2' ' H ' ' A' ' 50' ' ' ASN 0.308 1.4 m -136.53 -84.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-N 119.735 1.152 . . . . 0.0 111.386 169.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.546 ' H ' ' CG2' ' A' ' 49' ' ' VAL 0.49 4.8 t-20 -156.97 -5.88 0.1 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 129.776 3.23 . . . . 0.0 111.713 169.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.0 ptp -88.99 44.45 1.21 Allowed 'General case' 0 CA--C 1.578 2.044 1 N-CA-C 98.994 -4.447 . . . . 0.0 98.994 160.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.526 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.681 14.6 m 14.23 -113.69 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.179 1 C-N-CA 137.324 6.25 . . . . 0.0 116.135 -164.941 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -112.56 136.83 51.63 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 125.727 1.892 . . . . 0.0 112.513 -168.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -124.43 120.87 33.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.654 1.181 . . . . 0.0 108.028 168.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -84.88 98.6 10.42 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.391 1.477 . . . . 0.0 110.426 169.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -86.88 -33.99 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 121.173 -0.954 . . . . 0.0 113.396 -174.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.4 tt -154.1 129.91 10.12 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.534 1.061 . . . . 0.0 111.375 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -78.79 169.23 18.56 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.4 HD12 ' CE3' ' A' ' 101' ' ' TRP . 73.3 mt -51.86 101.27 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.946 1.698 . . . . 0.0 112.075 176.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.0 t -119.9 167.6 11.97 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.648 1.579 . . . . 0.0 112.32 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.87 -11.82 43.56 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.891 1.676 . . . . 0.0 113.372 172.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -86.42 82.92 7.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 125.355 2.503 . . . . 0.0 109.223 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.9 t -64.61 -51.17 64.08 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 128.459 2.704 . . . . 0.0 110.076 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.4 t -65.12 -15.83 62.83 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.582 -1.324 . . . . 0.0 112.028 174.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -78.72 -45.9 20.21 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.259 -0.901 . . . . 0.0 110.132 173.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -54.45 -34.74 62.05 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.455 -0.778 . . . . 0.0 111.34 173.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -64.75 -39.18 93.19 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 121.19 -0.944 . . . . 0.0 110.199 -176.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 46.4 tpt85 -75.14 -27.75 59.89 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.345 1.458 . . . . 0.0 109.633 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.9 -36.73 19.74 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.595 0.559 . . . . 0.0 109.931 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.46 -47.77 66.25 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -62.31 -32.7 73.48 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -171.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -84.61 -4.19 58.86 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.205 1.402 . . . . 0.0 114.046 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -62.54 125.48 24.09 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.46 -1.4 . . . . 0.0 110.448 174.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -118.59 147.63 43.52 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.252 1.021 . . . . 0.0 110.344 170.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 m -82.5 159.34 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -168.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.2 t -101.93 -150.67 0.41 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 127.715 2.406 . . . . 0.0 112.44 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -159.92 155.89 27.05 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 125.716 1.627 . . . . 0.0 114.573 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -162.12 162.37 28.54 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.999 1.72 . . . . 0.0 112.208 174.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -78.85 -52.64 8.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.073 1.749 . . . . 0.0 111.71 -177.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.31 136.17 46.15 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.931 0.892 . . . . 0.0 111.773 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 80.4 m -72.97 -47.84 8.15 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-O 116.178 -1.867 . . . . 0.0 113.475 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.01 148.67 89.75 Favored 'Trans proline' 0 C--N 1.355 0.89 0 CA-C-N 121.94 1.728 . . . . 0.0 110.992 171.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -123.34 174.93 7.01 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.92 1.288 . . . . 0.0 112.576 -169.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -99.74 23.13 37.32 Favored Glycine 0 N--CA 1.482 1.741 0 O-C-N 119.836 -1.79 . . . . 0.0 115.799 -170.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.13 -17.73 58.73 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 120.359 2.079 . . . . 0.0 116.239 -169.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.9 mp -70.56 -14.09 62.36 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 174.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -72.87 -49.99 26.58 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 167.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.08 -51.11 70.54 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 116.065 -1.922 . . . . 0.0 111.652 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.8 m -52.27 -34.28 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 121.191 1.814 . . . . 0.0 112.135 -177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.4 t -87.6 -37.64 11.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 116.768 -1.587 . . . . 0.0 113.03 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -60.54 -46.6 89.58 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 121.862 2.119 . . . . 0.0 109.203 169.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.1 t -54.68 -40.19 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 125.509 1.524 . . . . 0.0 112.194 175.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.63 -42.32 64.54 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.8 mt -76.52 -38.78 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.455 1.102 . . . . 0.0 113.01 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 66.5 m -81.1 61.27 4.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.829 1.651 . . . . 0.0 110.619 -169.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.4 mt -50.79 -44.51 58.89 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.076 2.55 . . . . 0.0 111.619 -171.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.66 -22.39 66.94 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.691 -176.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -87.49 -47.89 8.38 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.963 0.905 . . . . 0.0 110.416 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.9 mp -70.29 -34.45 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.203 0.601 . . . . 0.0 110.769 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.2 29.41 8.98 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.23 1.395 . . . . 0.0 114.498 172.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.4 ' CE3' HD12 ' A' ' 59' ' ' LEU . 53.1 m95 -57.46 125.31 22.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.707 1.254 . . . . 0.0 112.952 -174.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -86.38 -177.07 6.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.195 2.198 . . . . 0.0 111.223 170.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -97.13 26.16 4.94 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.317 1.447 . . . . 0.0 114.808 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.69 -128.7 1.82 Allowed Glycine 0 CA--C 1.539 1.534 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . 0.308 7.2 t -112.72 152.52 28.98 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.536 -1.332 . . . . 0.0 108.173 167.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -130.16 129.88 44.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 117.439 -1.267 . . . . 0.0 110.362 -167.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -126.62 125.26 41.61 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.88 1.673 . . . . 0.0 115.343 -168.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 48.7 mt -97.7 103.29 15.22 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.676 0.75 . . . . 0.0 112.305 169.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 36.0 t -90.78 95.34 5.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 174.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 37.0 tp -94.8 123.84 38.5 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 170' ' ' VAL 0.273 11.6 p -113.83 139.15 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 170.213 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -164.07 156.39 17.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.24 1.816 . . . . 0.0 109.885 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -106.23 -0.2 24.69 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.58 1.552 . . . . 0.0 114.456 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -144.13 179.47 7.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.195 1.398 . . . . 0.0 111.953 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.28 -174.33 0.12 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 122.992 1.377 . . . . 0.0 113.387 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -135.28 158.57 44.02 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.492 1.917 . . . . 0.0 112.691 -169.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -86.65 130.31 34.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.065 1.346 . . . . 0.0 109.862 169.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.14 170.21 8.23 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.825 1.25 . . . . 0.0 111.634 177.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.82 133.63 42.52 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.911 0.386 . . . . 0.0 111.87 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.4 mttm 91.94 -16.14 0.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 130.596 3.558 . . . . 0.0 113.008 -174.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -63.61 -28.95 70.28 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 121.484 1.947 . . . . 0.0 112.971 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -69.39 -5.54 24.21 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 121.472 -0.768 . . . . 0.0 112.855 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.9 t -62.77 -34.35 77.06 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.445 1.098 . . . . 0.0 112.469 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.66 -28.44 67.71 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.814 0.734 . . . . 0.0 112.373 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -81.05 4.05 73.11 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.109 1.338 . . . . 0.0 113.811 169.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.6 m 75.1 31.73 0.81 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 127.843 2.457 . . . . 0.0 111.6 175.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -115.06 110.87 20.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.553 1.141 . . . . 0.0 111.216 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -96.84 -40.6 8.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.347 1.459 . . . . 0.0 112.303 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -66.35 123.06 18.94 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.992 0.814 . . . . 0.0 110.977 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.9 t -65.93 152.75 43.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.946 0.899 . . . . 0.0 110.605 175.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 t -68.97 138.27 54.43 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.312 1.053 . . . . 0.0 111.963 174.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -82.76 -13.37 56.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.159 1.784 . . . . 0.0 113.911 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.2 31.74 63.56 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.838 -0.979 . . . . 0.0 113.017 -176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -107.61 164.99 11.75 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.213 1.405 . . . . 0.0 112.714 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 26.2 t -67.51 119.45 12.33 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.864 1.265 . . . . 0.0 110.593 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -123.85 40.79 3.64 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.276 1.43 . . . . 0.0 111.838 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.4 tp -122.18 117.95 27.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.755 1.622 . . . . 0.0 108.422 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -120.34 -49.02 2.28 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.463 1.105 . . . . 0.0 108.732 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -86.46 -130.31 0.05 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.727 1.611 . . . . 0.0 108.34 168.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.33 -21.67 7.88 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.089 1.328 . . . . 0.0 113.674 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 21.0 mtt -93.26 142.79 26.92 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.788 1.294 . . . . 0.0 112.78 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -64.56 100.44 0.37 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.721 1.208 . . . . 0.0 110.351 169.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -61.77 -40.32 94.74 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.188 0.995 . . . . 0.0 112.593 -174.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 63.8 m -82.24 6.63 16.11 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 23.2 ttp-105 -47.87 -50.72 25.6 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.698 1.135 . . . . 0.0 111.49 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.39 -31.99 68.38 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-O 118.421 -1.21 . . . . 0.0 113.107 -169.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.291 6.4 tp10 -92.66 -84.57 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.104 0 CA-C-O 115.579 -2.153 . . . . 0.0 112.025 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.31 155.14 71.38 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 CA-C-N 124.646 2.695 . . . . 0.0 116.168 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -72.72 161.56 30.59 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 129.913 3.285 . . . . 0.0 113.847 176.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -52.44 138.4 27.47 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.833 0.853 . . . . 0.0 111.281 172.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.638 ' NE2' ' H ' ' A' ' 151' ' ' GLN 0.271 0.0 OUTLIER -82.18 143.78 31.17 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.094 -1.004 . . . . 0.0 112.014 178.85 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 70.6 m -74.99 148.88 39.54 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.401 1.08 . . . . 0.0 112.769 -174.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.408 ' HA ' ' HG ' ' A' ' 156' ' ' LEU 0.296 33.4 t -58.61 -22.06 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -177.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.4 t -65.33 -44.66 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 118.893 0.769 . . . . 0.0 111.553 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.42 -29.99 59.92 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.552 0.741 . . . . 0.0 110.729 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 153' ' ' VAL . 2.1 mt -63.62 -45.76 88.83 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 172.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.41 -45.89 69.55 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.222 1.009 . . . . 0.0 112.713 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 76.5 p -69.78 -38.84 76.85 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -174.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.34 -45.86 58.05 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.153 -0.967 . . . . 0.0 112.147 173.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.7 mt -53.25 -40.38 64.56 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.923 1.238 . . . . 0.0 113.24 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.73 -28.18 50.72 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -82.7 -34.39 27.33 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.571 1.078 . . . . 0.0 111.536 176.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -72.41 -18.9 61.68 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.843 0.857 . . . . 0.0 111.974 171.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 63.9 39.93 7.81 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.08 1.752 . . . . 0.0 112.314 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.05 143.56 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-O 117.052 -1.451 . . . . 0.0 109.731 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -105.34 115.67 61.64 Favored Pre-proline 0 N--CA 1.481 1.111 0 CA-C-N 121.72 2.055 . . . . 0.0 112.627 170.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -80.38 149.39 19.15 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.635 2.224 . . . . 0.0 113.093 169.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.1 mt -137.22 110.28 7.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.875 1.67 . . . . 0.0 107.107 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -72.45 73.72 1.02 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.933 0.873 . . . . 0.0 112.355 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 88.1 t -65.54 92.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 120.945 -1.097 . . . . 0.0 111.862 172.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 24.4 m -139.2 138.97 21.67 Favored Pre-proline 0 N--CA 1.479 0.993 0 O-C-N 119.729 -1.857 . . . . 0.0 110.513 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -58.53 152.53 54.48 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.558 2.839 . . . . 0.0 114.01 173.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 72.6 p -46.23 -42.72 14.7 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 116.666 2.098 . . . . 0.0 116.666 -168.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -51.37 -40.84 60.03 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 120.214 1.37 . . . . 0.0 113.509 -171.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.6 8.59 33.27 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.5 t -59.85 -42.92 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 121.036 1.744 . . . . 0.0 110.885 -176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -69.58 -13.45 62.33 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -174.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . 0.265 10.1 t -93.03 -27.5 16.95 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 118.86 0.754 . . . . 0.0 112.476 173.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -76.29 -29.76 57.5 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.49 -1.382 . . . . 0.0 109.509 168.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -58.03 -26.54 62.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.168 0.987 . . . . 0.0 110.818 169.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -79.4 -40.28 30.43 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.573 -0.705 . . . . 0.0 109.589 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.6 mp -79.65 -18.66 50.94 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 120.668 -1.27 . . . . 0.0 111.532 -175.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.8 t -74.89 -11.52 60.15 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.066 0.46 . . . . 0.0 110.581 168.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.31 -28.67 23.57 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.177 -0.952 . . . . 0.0 109.434 168.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -76.85 -26.56 54.41 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.27 91.09 50.03 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.536 1.134 . . . . 0.0 110.654 170.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.06 153.45 32.25 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.596 3.531 . . . . 0.0 113.692 173.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 24.9 pttt 88.29 -19.11 0.23 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 131.464 3.906 . . . . 0.0 113.229 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.64 163.91 24.54 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.794 0.838 . . . . 0.0 110.267 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 36.0 p -123.0 -145.42 0.35 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 169.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.2 tt 178.65 138.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 129.055 2.942 . . . . 0.0 107.977 -168.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -133.52 143.5 15.21 Favored Glycine 0 N--CA 1.463 0.479 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -87.87 90.09 8.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.31 133.89 55.73 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.602 169.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 35.2 m -150.74 -158.64 0.94 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.806 1.642 . . . . 0.0 107.703 173.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.34 -24.74 67.51 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 120.882 -1.136 . . . . 0.0 110.522 168.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -85.12 134.96 34.17 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.413 2.285 . . . . 0.0 112.549 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 34.7 p -98.41 -0.7 43.08 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.83 2.052 . . . . 0.0 113.448 174.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.2 p -59.75 -55.79 29.93 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.546 1.938 . . . . 0.0 113.551 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -69.2 -36.98 77.86 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 122.153 -0.342 . . . . 0.0 111.141 -171.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.22 -50.91 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.925 0.89 . . . . 0.0 110.894 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.48 -30.7 71.1 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 118.782 -0.628 . . . . 0.0 111.792 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -74.76 -1.62 22.85 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.246 -1.534 . . . . 0.0 112.912 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.06 -33.47 9.25 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.582 -1.324 . . . . 0.0 109.862 174.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 86.1 mt -73.75 -40.12 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -65.9 -33.78 76.63 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.545 -0.722 . . . . 0.0 111.479 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -69.96 -25.05 63.45 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 119.059 0.845 . . . . 0.0 112.87 172.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -77.26 -37.24 53.45 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.69 -1.256 . . . . 0.0 111.53 173.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -61.14 -32.34 72.04 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.212 0.915 . . . . 0.0 111.69 173.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 54.3 p -75.02 -11.11 60.03 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -71.07 -36.54 72.32 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.487 1.04 . . . . 0.0 110.937 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 1 C--O 1.334 5.501 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -91.98 161.09 14.94 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.012 0.925 . . . . 0.0 111.836 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 t -66.49 127.54 32.71 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.271 -0.893 . . . . 0.0 110.902 169.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.1 t -123.86 135.6 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.394 1.478 . . . . 0.0 109.406 172.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -114.59 113.3 24.2 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 168.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 59.0 tp -101.21 131.89 46.98 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.056 0.455 . . . . 0.0 111.999 171.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -121.09 111.64 17.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 123.631 1.682 . . . . 0.0 109.561 169.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -88.52 107.85 19.1 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.007 -1.906 . . . . 0.0 111.597 175.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.3 tp -100.59 120.14 39.6 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.997 1.319 . . . . 0.0 111.877 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 30.8 mtp -103.97 143.9 32.25 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.88 115.38 4.97 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.701 1.619 . . . . 0.0 109.731 168.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -99.56 35.4 1.99 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.299 1.84 . . . . 0.0 111.951 -174.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 p -75.57 152.85 37.66 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.954 1.302 . . . . 0.0 113.605 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.45 -27.35 60.74 Favored Glycine 0 N--CA 1.478 1.464 0 O-C-N 121.258 -0.901 . . . . 0.0 113.881 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.1 p -65.73 -25.31 67.24 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.396 1.478 . . . . 0.0 113.891 170.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.28 -2.21 48.07 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.659 1.583 . . . . 0.0 114.143 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -70.67 136.62 49.2 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 121.786 2.084 . . . . 0.0 108.136 169.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.76 -50.73 2.01 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -168.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -68.0 -20.29 65.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.817 0.847 . . . . 0.0 111.803 169.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -48.94 -49.31 40.87 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.148 1.779 . . . . 0.0 109.963 175.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.5 m -62.82 -37.77 88.08 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 118.796 0.726 . . . . 0.0 112.793 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -62.41 -41.86 99.0 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.269 -1.519 . . . . 0.0 112.034 172.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.7 p -87.36 20.6 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 125.838 1.655 . . . . 0.0 112.126 174.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -119.7 -49.04 2.35 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.068 1.347 . . . . 0.0 109.097 171.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.1 t -59.33 -37.66 78.37 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.834 -0.541 . . . . 0.0 109.966 169.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.1 tp -96.39 107.01 19.33 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 168.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 146.49 -48.72 0.66 Allowed Glycine 0 C--N 1.303 -1.276 1 C-N-CA 130.817 4.056 . . . . 0.0 106.603 176.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.1 m -76.17 -36.91 58.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.452 1.501 . . . . 0.0 112.355 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.23 -26.29 66.52 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.538 -0.726 . . . . 0.0 112.312 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.97 -57.45 8.69 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.475 172.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.95 -55.56 7.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.163 0.985 . . . . 0.0 112.399 -176.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -69.77 -43.71 71.62 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -169.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.85 -41.23 78.74 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 117.61 0.187 . . . . 0.0 111.435 176.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.48 -36.75 76.82 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.678 -1.264 . . . . 0.0 111.275 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -60.22 -24.83 65.15 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.112 0.965 . . . . 0.0 112.434 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -84.69 -42.02 15.7 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.545 1.138 . . . . 0.0 110.658 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.6 mm -64.78 -34.53 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.285 0.634 . . . . 0.0 111.534 172.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.9 p -155.0 134.3 12.48 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -60.77 -49.51 77.18 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.141 1.776 . . . . 0.0 113.106 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.2 m -95.31 81.36 3.6 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.71 0.767 . . . . 0.0 109.829 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.52 83.03 0.32 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 127.512 2.482 . . . . 0.0 107.492 -177.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -85.47 146.08 27.12 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 125.484 1.514 . . . . 0.0 108.019 -169.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.261 11.9 tt -136.56 141.77 40.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.93 150.77 19.64 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 127.884 2.659 . . . . 0.0 109.816 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -126.79 130.29 49.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.36 146.19 16.63 Favored Glycine 0 C--N 1.343 0.97 0 C-N-CA 124.545 1.069 . . . . 0.0 112.626 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.9 t -119.14 143.5 47.17 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.813 1.645 . . . . 0.0 109.918 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.68 151.04 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.944 1.298 . . . . 0.0 108.581 176.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.94 -18.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 169.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 63.4 t30 117.42 -10.96 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 130.847 3.659 . . . . 0.0 111.597 -171.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 64.9 ttp -62.72 -44.21 96.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.93 -1.106 . . . . 0.0 108.585 169.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.5 p 176.13 -164.35 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.89 1 C-N-CA 135.234 5.413 . . . . 0.0 105.19 169.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -109.11 133.01 53.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 167.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -118.59 121.88 41.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.34 1.067 . . . . 0.0 110.638 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -80.57 111.12 16.69 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.761 169.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.5 mm -93.95 -53.6 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.218 1.007 . . . . 0.0 111.531 -173.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.8 tp -126.15 123.77 39.01 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.163 0.892 . . . . 0.0 111.897 -175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -59.09 154.34 16.01 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.086 1.354 . . . . 0.0 112.15 173.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.5 mt -59.24 111.01 1.19 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.669 1.122 . . . . 0.0 110.884 172.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.1 t -143.49 169.05 18.43 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.371 1.068 . . . . 0.0 112.746 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.33 -10.16 54.99 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.813 2.045 . . . . 0.0 113.841 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -81.47 76.39 8.4 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 124.923 2.297 . . . . 0.0 109.978 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.2 t -56.52 -49.33 75.07 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 129.397 3.079 . . . . 0.0 109.294 173.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.3 m -60.68 -17.61 48.81 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.387 1.075 . . . . 0.0 112.065 173.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -87.7 -42.36 12.7 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 118.604 0.638 . . . . 0.0 111.843 174.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -57.3 -33.72 67.96 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 118.426 0.557 . . . . 0.0 111.467 172.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -62.29 -45.04 95.06 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.443 1.097 . . . . 0.0 109.928 -174.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -76.21 -33.98 59.26 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 124.677 1.191 . . . . 0.0 108.856 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -82.0 -29.6 31.99 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -175.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.8 tp -67.14 -42.65 84.04 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 169.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -67.46 -30.85 70.68 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -72.52 -15.88 61.78 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -60.57 135.85 57.88 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.438 1.017 . . . . 0.0 112.614 -171.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.9 tt -127.59 133.96 49.72 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.697 1.199 . . . . 0.0 110.144 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 t -69.55 145.48 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 127.991 2.516 . . . . 0.0 112.939 -173.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.1 t -92.97 -162.09 0.9 Allowed 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 126.108 1.763 . . . . 0.0 112.133 172.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -159.76 125.15 1.44 Allowed Glycine 0 N--CA 1.481 1.638 0 O-C-N 119.742 -1.849 . . . . 0.0 115.129 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -145.88 167.04 24.21 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.541 1.936 . . . . 0.0 112.836 -173.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.1 mt -95.67 -49.18 5.48 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -169.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.64 136.81 41.93 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.716 0.689 . . . . 0.0 111.033 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.279 13.0 t -64.1 -42.52 69.44 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 114.661 -2.59 . . . . 0.0 115.18 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.66 149.35 73.55 Favored 'Trans proline' 0 C--N 1.359 1.098 0 CA-C-N 123.925 2.437 . . . . 0.0 113.242 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -102.96 165.51 10.98 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.911 0.884 . . . . 0.0 111.994 173.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.45 48.16 3.1 Favored Glycine 0 N--CA 1.48 1.576 0 C-N-CA 125.766 1.651 . . . . 0.0 112.106 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -68.34 -44.14 75.95 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -169.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -72.48 -15.82 61.8 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.814 -1.179 . . . . 0.0 112.848 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -58.29 -49.96 75.31 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.351 1.432 . . . . 0.0 108.398 168.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.32 -45.77 80.16 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.836 -0.54 . . . . 0.0 111.296 171.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.81 -41.33 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 118.178 -0.915 . . . . 0.0 112.294 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.4 t -58.91 -53.19 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 119.922 1.237 . . . . 0.0 109.844 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -62.76 -51.92 65.22 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 122.414 0.286 . . . . 0.0 110.846 -173.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.0 t -56.68 -27.98 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 123.471 0.708 . . . . 0.0 111.874 177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.71 -32.62 23.43 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.83 -31.39 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.485 1.039 . . . . 0.0 112.218 -174.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 60.7 m -82.86 59.47 4.85 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.497 1.919 . . . . 0.0 111.125 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.61 -36.01 75.46 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.266 1.427 . . . . 0.0 113.051 -169.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.62 -32.97 58.82 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.376 0.512 . . . . 0.0 113.312 -174.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -94.77 -38.51 10.74 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.526 1.13 . . . . 0.0 111.354 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.4 mm -63.64 -37.04 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 120.915 1.689 . . . . 0.0 109.537 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.27 28.36 22.87 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.131 1.348 . . . . 0.0 113.818 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -57.44 119.65 6.87 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.191 1.495 . . . . 0.0 110.786 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.4 mmt-85 -83.42 -158.14 0.28 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.755 2.022 . . . . 0.0 108.805 171.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -81.69 -157.58 0.19 Allowed 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.27 -177.91 53.14 Favored Glycine 0 N--CA 1.424 -2.123 0 CA-C-O 125.541 2.745 . . . . 0.0 108.841 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.7 p -67.96 132.84 48.06 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 108.316 -3.942 . . . . 0.0 106.606 168.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.17 135.22 55.19 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 -177.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -138.48 124.62 20.23 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -166.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.4 tp -105.33 98.3 8.02 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.147 0.43 . . . . 0.0 111.011 177.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 39.5 t -80.45 121.68 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 170.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.1 tt -109.41 120.85 43.75 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.7 t -111.59 132.4 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 124.129 0.893 . . . . 0.0 112.001 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.5 t -151.24 179.39 8.34 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.445 1.098 . . . . 0.0 111.283 171.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.57 -13.22 6.57 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.653 1.981 . . . . 0.0 114.097 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -137.09 173.55 11.57 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.49 1.516 . . . . 0.0 112.981 -171.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -60.79 -169.61 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.673 1.589 . . . . 0.0 114.08 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.88 146.37 25.6 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.537 1.681 . . . . 0.0 115.537 -167.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -82.18 93.38 7.06 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.983 1.313 . . . . 0.0 113.458 176.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.478 ' H ' ' CD2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -75.69 173.23 11.35 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.856 -1.152 . . . . 0.0 113.012 170.541 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -47.57 149.07 1.25 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.833 0.853 . . . . 0.0 113.119 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.302 38.6 pttt 76.86 -16.09 0.67 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 131.13 3.772 . . . . 0.0 114.635 -175.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -63.21 -38.26 90.48 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.483 1.038 . . . . 0.0 113.173 -175.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . 0.274 13.7 mttt -86.02 12.87 8.56 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 m -62.36 -26.77 68.64 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 118.975 0.807 . . . . 0.0 108.937 167.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.4 mt -61.65 -36.67 81.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.895 1.278 . . . . 0.0 112.361 169.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -85.62 22.75 10.11 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.596 2.046 . . . . 0.0 113.437 170.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.321 3.9 t 55.52 28.07 11.22 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.669 2.787 . . . . 0.0 114.226 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -101.61 85.86 2.83 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.89 1.676 . . . . 0.0 110.364 -175.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -80.96 -45.65 16.33 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.187 0.995 . . . . 0.0 112.977 -173.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -60.44 121.09 11.22 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.231 1.012 . . . . 0.0 111.239 -169.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.0 t -68.84 143.49 54.54 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 120.184 1.356 . . . . 0.0 111.052 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.0 t -58.33 130.43 46.69 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.319 -0.863 . . . . 0.0 111.933 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.5 p30 -76.72 -9.97 59.05 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.032 1.333 . . . . 0.0 113.816 176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 71.1 23.17 78.36 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 117.797 -1.557 . . . . 0.0 114.124 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -100.16 168.19 9.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.099 1.759 . . . . 0.0 112.524 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 33.4 t -69.96 136.05 50.09 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.272 -0.893 . . . . 0.0 111.637 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -147.78 37.54 0.89 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.495 1.918 . . . . 0.0 112.053 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.7 mt -103.46 136.28 43.5 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.355 1.062 . . . . 0.0 110.768 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -155.29 135.43 13.05 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.338 1.455 . . . . 0.0 110.175 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.3 t0 52.71 27.76 5.59 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.536 1.534 . . . . 0.0 112.951 -169.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.06 -6.92 82.87 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.298 1.904 . . . . 0.0 114.793 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 38.7 mtt -98.78 142.59 30.13 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.829 1.814 . . . . 0.0 113.62 -174.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -76.32 81.13 3.08 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.14 0.976 . . . . 0.0 110.984 169.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -50.89 -44.61 59.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.303 1.441 . . . . 0.0 112.41 -175.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 94.3 p -78.95 -0.19 30.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -170.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -45.12 -39.67 6.23 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 121.125 1.784 . . . . 0.0 113.091 171.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.2 -19.43 79.63 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-O 118.297 -1.279 . . . . 0.0 114.793 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -111.65 -69.18 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 CA-C-O 116.334 -1.793 . . . . 0.0 113.154 -169.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -74.58 146.95 35.19 Favored 'Trans proline' 0 C--N 1.357 1.026 0 CA-C-N 123.697 2.356 . . . . 0.0 114.128 169.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -77.6 167.63 21.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.476 2.711 . . . . 0.0 114.606 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -53.54 148.17 9.82 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.434 1.094 . . . . 0.0 111.947 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.7 157.69 17.19 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.984 0.897 . . . . 0.0 112.38 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 73.6 m -87.36 149.27 24.61 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 168.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -56.8 -30.99 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.618 -1.301 . . . . 0.0 111.343 -175.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.18 -36.18 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.253 1.821 . . . . 0.0 112.964 173.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -75.89 -27.6 57.78 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.332 0.969 . . . . 0.0 111.572 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.52 -47.8 74.7 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.426 168.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.69 -37.33 70.73 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 99.2 p -72.24 -49.94 31.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.279 0.945 . . . . 0.0 113.119 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -70.51 -36.15 73.6 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.391 -1.443 . . . . 0.0 113.817 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.9 mt -68.58 -35.45 77.39 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.927 0.785 . . . . 0.0 112.05 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.05 -33.9 70.73 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -79.22 -44.06 22.57 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.096 0.558 . . . . 0.0 110.897 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -84.02 -0.59 52.27 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 68.96 16.07 8.8 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.676 2.391 . . . . 0.0 115.988 168.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 50.8 mt -75.28 139.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 120.623 -1.298 . . . . 0.0 110.319 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -99.45 95.84 3.91 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.097 173.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -73.82 144.82 35.45 Favored 'Trans proline' 0 C--N 1.352 0.754 0 CA-C-N 121.285 1.495 . . . . 0.0 114.564 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.7 mt -129.89 117.74 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 124.388 1.075 . . . . 0.0 110.754 170.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -78.48 76.09 4.99 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.461 1.124 . . . . 0.0 112.798 178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.8 t -64.38 103.62 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 122.185 0.993 . . . . 0.0 112.483 169.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 17.4 m -144.47 157.97 54.97 Favored Pre-proline 0 N--CA 1.484 1.253 0 CA-C-O 117.573 -1.204 . . . . 0.0 111.239 -169.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -73.87 165.14 32.9 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.603 2.869 . . . . 0.0 111.687 -171.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 73.9 p -52.08 -39.72 60.14 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.334 1.054 . . . . 0.0 113.338 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.7 ptt85 -63.18 -23.3 67.37 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.419 ' CE ' ' CE1' ' A' ' 179' ' ' TYR . 78.3 mtp -103.14 -22.87 13.69 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.3 t -56.47 -26.29 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 120.179 1.354 . . . . 0.0 112.009 -168.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.57 -29.88 70.91 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.918 1.287 . . . . 0.0 114.463 175.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 t -93.83 -37.98 11.47 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.889 0.876 . . . . 0.0 111.575 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.419 ' CE1' ' CE ' ' A' ' 175' ' ' MET . 12.1 m-85 -73.9 -28.5 61.57 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 120.149 -1.594 . . . . 0.0 110.233 175.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . 0.268 17.5 tt0 -66.79 -10.85 51.9 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 119.348 0.976 . . . . 0.0 112.58 172.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -99.3 -7.83 25.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.063 -1.023 . . . . 0.0 113.684 169.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.85 -28.97 22.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.702 1.201 . . . . 0.0 109.406 168.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 15.1 t -85.88 -15.89 40.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 112.784 177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 1.1 t -77.59 -25.86 50.25 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.302 -0.874 . . . . 0.0 108.751 168.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -80.19 -45.25 18.38 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.181 -0.438 . . . . 0.0 111.551 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 19.3 mt -94.81 106.53 25.25 Favored Pre-proline 0 N--CA 1.483 1.218 0 CA-C-O 118.335 -0.841 . . . . 0.0 109.469 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.87 147.17 67.98 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.41 2.073 . . . . 0.0 111.466 -173.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 83.06 -10.21 1.03 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.822 2.849 . . . . 0.0 113.693 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.1 mt -73.37 166.83 22.46 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.48 0.5 OUTLIER -143.47 -161.24 1.23 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 169.431 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.5 mt -160.52 142.7 4.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 C-N-CA 129.769 3.228 . . . . 0.0 111.982 -165.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -124.64 161.55 19.08 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.917 0.77 . . . . 0.0 111.808 169.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -92.37 100.16 12.79 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.888 1.675 . . . . 0.0 108.019 173.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.74 130.28 44.24 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.013 -1.449 . . . . 0.0 108.89 168.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 84.9 p -171.08 -157.49 0.13 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.417 1.487 . . . . 0.0 110.199 170.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.34 -18.62 63.08 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -109.03 133.71 52.63 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.847 1.259 . . . . 0.0 112.204 171.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 73.5 m -91.06 0.02 57.63 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.076 1.35 . . . . 0.0 113.291 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.4 m -59.98 -45.84 91.39 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.052 1.741 . . . . 0.0 112.89 -169.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -63.11 -43.76 97.56 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 118.589 -0.72 . . . . 0.0 112.617 -170.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 8.0 p -82.26 -32.56 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 119.558 1.072 . . . . 0.0 113.161 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -61.48 -30.45 70.61 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 120.366 1.439 . . . . 0.0 110.95 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -65.97 -15.03 62.63 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 119.541 -1.974 . . . . 0.0 114.223 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.1 mt -103.46 -35.45 8.34 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.952 2.101 . . . . 0.0 109.708 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -67.37 -39.16 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.856 1.262 . . . . 0.0 108.116 171.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 29.9 ttp-105 -73.95 -42.21 60.86 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.008 0.923 . . . . 0.0 110.498 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . 0.331 11.5 m-20 -77.86 -12.06 59.95 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 117.619 -1.632 . . . . 0.0 114.294 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.11 -31.92 27.0 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.308 1.043 . . . . 0.0 110.309 168.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -65.74 -45.75 81.44 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.659 -0.65 . . . . 0.0 111.519 170.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 79.8 p -66.83 -9.75 40.72 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.05 -32.01 64.78 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 176.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 13.8 mt . . . . . 0 CA--C 1.571 1.778 0 C-N-CA 125.139 1.375 . . . . 0.0 113.155 172.725 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 120.384 0.135 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -123.52 149.83 44.72 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.115 1.366 . . . . 0.0 110.883 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 m -61.16 111.08 1.58 Allowed 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.137 -0.977 . . . . 0.0 112.059 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 67.1 t -110.97 138.02 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.42 1.088 . . . . 0.0 109.8 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -116.56 117.94 31.25 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.184 1.393 . . . . 0.0 108.834 169.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 tp -110.28 130.52 55.53 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 118.883 0.765 . . . . 0.0 111.78 169.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -115.92 114.47 24.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 123.717 1.722 . . . . 0.0 109.092 168.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -88.46 107.66 18.98 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 127.184 2.194 . . . . 0.0 111.859 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.65 122.02 34.65 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.737 0.815 . . . . 0.0 112.013 170.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.4 mtp -103.41 131.94 50.08 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.15 114.37 3.82 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 167.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.27 21.2 15.42 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.373 1.469 . . . . 0.0 113.989 -172.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.8 p -84.83 168.44 15.11 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 119.679 -1.888 . . . . 0.0 112.699 -169.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.69 -32.16 58.36 Favored Glycine 0 N--CA 1.477 1.369 0 O-C-N 121.401 -0.812 . . . . 0.0 114.045 -170.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -63.45 -35.25 79.82 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.793 1.237 . . . . 0.0 112.698 174.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.55 0.09 18.55 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.712 1.605 . . . . 0.0 114.217 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -53.96 -48.42 70.31 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.712 1.205 . . . . 0.0 112.402 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.32 -26.9 64.86 Favored Glycine 0 N--CA 1.474 1.187 0 CA-C-N 118.282 0.492 . . . . 0.0 113.049 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -82.2 -13.39 57.18 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.322 1.449 . . . . 0.0 113.318 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.8 tp -56.04 -46.37 78.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.051 1.34 . . . . 0.0 112.024 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 t -58.99 -41.03 86.64 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 122.228 1.013 . . . . 0.0 110.819 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -70.47 -19.83 62.92 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.476 -1.39 . . . . 0.0 113.424 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.291 20.1 m -105.97 13.81 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 170.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -108.94 -33.53 6.89 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 167.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.6 t -63.33 -49.51 73.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 169.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.8 tp -85.19 102.47 13.33 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 104.74 -2.319 . . . . 0.0 104.74 168.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 153.32 -39.72 0.7 Allowed Glycine 0 C--N 1.298 -1.558 0 CA-C-N 109.132 -3.667 . . . . 0.0 108.395 168.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.7 m -76.97 -46.4 24.17 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.555 1.542 . . . . 0.0 109.978 172.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.81 -41.25 92.11 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.163 0.985 . . . . 0.0 111.254 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.53 -43.45 76.73 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.556 -176.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.25 -54.05 49.05 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.151 0.98 . . . . 0.0 110.979 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -67.72 -31.9 72.16 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.224 -0.922 . . . . 0.0 113.091 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.53 -49.57 72.97 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.981 0.81 . . . . 0.0 111.516 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.0 mt -83.64 -12.37 56.06 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -60.66 -31.75 70.97 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 120.926 1.694 . . . . 0.0 112.964 170.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -95.52 -27.77 15.21 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 118.96 -0.543 . . . . 0.0 112.06 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.95 -29.09 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 119.334 0.97 . . . . 0.0 109.746 168.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 t -147.12 127.36 13.86 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 169.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -69.48 -27.06 64.89 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.993 1.717 . . . . 0.0 112.359 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.3 t -105.03 92.33 4.18 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.345 1.458 . . . . 0.0 108.736 171.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.46 84.51 0.18 Allowed Glycine 0 C--N 1.338 0.684 0 C-N-CA 127.184 2.326 . . . . 0.0 108.382 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -91.65 135.63 33.73 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -171.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.7 tp -116.61 139.19 44.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 124.83 1.252 . . . . 0.0 110.894 -171.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.5 159.28 24.8 Favored Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.428 1.014 . . . . 0.0 113.036 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -132.27 129.13 39.19 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.37 1.468 . . . . 0.0 113.556 -169.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.72 144.65 16.57 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 124.32 0.962 . . . . 0.0 113.513 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.6 m -114.65 136.31 53.19 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.629 1.572 . . . . 0.0 111.455 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.9 tt -156.46 149.94 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 120.578 -1.327 . . . . 0.0 112.402 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.524 HG21 ' H ' ' A' ' 50' ' ' ASN . 2.3 m -150.52 -66.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 125.586 1.554 . . . . 0.0 111.898 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.524 ' H ' HG21 ' A' ' 49' ' ' VAL 0.424 29.8 t30 168.99 -13.61 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.973 1 C-N-CA 133.251 4.62 . . . . 0.0 111.482 169.278 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.0 ttt -49.32 -38.9 29.44 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 165.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.274 10.6 t 164.13 -163.16 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.967 1 C-N-CA 133.06 4.544 . . . . 0.0 109.623 168.147 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -107.98 132.38 53.57 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.812 2.445 . . . . 0.0 105.805 168.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -127.85 125.79 40.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 122.59 1.186 . . . . 0.0 110.1 169.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.73 132.02 35.5 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.921 1.288 . . . . 0.0 110.576 169.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.54 -17.37 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.39 108.6 5.0 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.84 1.655 . . . . 0.0 112.253 176.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.5 ttpm? -61.39 154.25 24.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.561 1.544 . . . . 0.0 112.607 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.0 mt -50.71 112.54 0.72 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.719 0.69 . . . . 0.0 111.876 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.8 t -143.9 171.13 14.65 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.999 1.32 . . . . 0.0 111.984 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.55 -6.53 16.93 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.745 1.618 . . . . 0.0 114.765 -170.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.25 93.95 9.67 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 125.645 2.641 . . . . 0.0 105.755 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.4 p -76.5 -44.28 35.89 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 131.062 3.745 . . . . 0.0 113.557 -169.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.2 t -59.41 -22.34 61.29 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.758 -0.589 . . . . 0.0 110.662 169.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -71.18 -51.69 23.38 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.183 -0.948 . . . . 0.0 109.971 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -53.77 -37.6 63.6 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 123.365 0.666 . . . . 0.0 111.85 172.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -67.96 -39.14 83.42 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.291 1.036 . . . . 0.0 109.898 -171.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.5 mtp-105 -71.61 -33.88 69.36 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.943 1.297 . . . . 0.0 110.152 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -79.78 -30.56 40.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.409 0.683 . . . . 0.0 109.689 -173.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.12 -54.34 15.46 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.541 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.448 7.7 ptp180 -74.97 -15.04 60.68 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 -169.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.59 2.87 46.69 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 169.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -60.04 155.61 16.58 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.457 1.026 . . . . 0.0 111.742 171.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.97 156.14 46.11 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.401 1.48 . . . . 0.0 111.036 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.84 141.18 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.941 1.296 . . . . 0.0 111.47 -169.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.1 p -94.12 -143.57 0.24 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.426 1.49 . . . . 0.0 112.718 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.75 144.72 9.59 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.561 -1.337 . . . . 0.0 114.262 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -148.65 163.74 36.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.214 1.806 . . . . 0.0 112.84 175.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.9 mt -74.44 -59.85 2.54 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.887 1.275 . . . . 0.0 112.573 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.89 136.98 54.88 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.83 0.852 . . . . 0.0 111.965 -172.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.6 p -75.72 -34.59 1.56 Allowed Pre-proline 0 N--CA 1.475 0.821 0 CA-C-O 115.512 -2.185 . . . . 0.0 113.307 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.39 140.73 44.8 Favored 'Trans proline' 0 C--N 1.354 0.842 0 CA-C-N 123.078 2.135 . . . . 0.0 108.967 169.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -104.44 -177.18 3.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.65 0.78 . . . . 0.0 112.215 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.08 9.49 72.57 Favored Glycine 0 N--CA 1.483 1.777 0 C-N-CA 124.633 1.111 . . . . 0.0 114.829 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -35.45 -55.61 0.66 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 129.192 2.997 . . . . 0.0 118.667 -169.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.7 mp -67.29 -18.5 65.22 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 121.526 1.966 . . . . 0.0 113.134 -174.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.32 -24.08 67.7 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.421 1.464 . . . . 0.0 112.411 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.41 -44.08 25.77 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.311 -1.493 . . . . 0.0 108.129 167.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.6 t -52.5 -42.32 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.277 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.439 HG12 HE21 ' A' ' 91' ' ' GLN . 8.3 p -62.71 -55.81 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.702 1.137 . . . . 0.0 111.783 171.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.439 HE21 HG12 ' A' ' 90' ' ' VAL . 77.1 mm-40 -66.21 -42.33 88.89 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.973 0.806 . . . . 0.0 110.914 -170.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.87 -33.07 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.362 1.065 . . . . 0.0 111.728 171.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.8 68.48 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.671 1.123 . . . . 0.0 111.985 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.289 0.0 OUTLIER -96.38 -14.22 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -169.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.467 ' HG ' HD23 ' A' ' 137' ' ' LEU . 0.1 OUTLIER -79.24 60.52 3.09 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 121.17 1.804 . . . . 0.0 112.351 173.133 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.9 mt -50.95 -40.11 56.64 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.899 1.68 . . . . 0.0 111.74 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.72 -31.02 41.67 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.158 0.885 . . . . 0.0 114.852 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -89.38 -39.74 13.21 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.607 1.203 . . . . 0.0 111.132 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.6 mm -65.73 -38.49 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 120.988 -1.07 . . . . 0.0 110.048 169.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.07 26.3 34.62 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.152 0.882 . . . . 0.0 113.182 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 72.5 m95 -55.97 130.57 44.37 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.229 1.014 . . . . 0.0 112.208 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.5 mtp-105 -104.41 -168.57 1.5 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.407 2.283 . . . . 0.0 111.958 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -86.03 -0.59 55.91 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 117.017 2.229 . . . . 0.0 117.017 -169.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.48 -132.75 3.3 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 120.917 1.69 . . . . 0.0 110.972 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.5 t -99.58 147.58 25.2 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.757 1.223 . . . . 0.0 108.954 174.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -132.15 124.8 29.8 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -125.01 110.15 13.83 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -169.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 25.8 tp -92.59 98.05 11.2 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.283 175.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 t -83.45 124.64 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 174.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 20.2 tp -109.65 112.39 24.43 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 118.81 -0.614 . . . . 0.0 110.214 -175.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.1 t -94.83 133.24 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.297 0.639 . . . . 0.0 111.649 172.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.2 t -166.13 151.01 8.2 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.441 1.088 . . . . 0.0 109.826 167.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -110.27 4.54 20.96 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -177.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -140.98 -177.98 5.35 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.156 1.383 . . . . 0.0 112.857 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -60.72 -177.13 0.07 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.72 1.608 . . . . 0.0 112.882 169.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -140.94 148.15 39.92 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.675 1.19 . . . . 0.0 112.136 -175.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -80.21 88.92 5.45 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.128 1.371 . . . . 0.0 113.182 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.78 165.43 3.98 Favored 'General case' 0 CA--C 1.551 0.99 0 O-C-N 120.395 -1.441 . . . . 0.0 111.83 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -46.91 140.63 4.6 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.684 -0.635 . . . . 0.0 112.387 171.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 89.11 -12.28 0.39 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 129.109 2.964 . . . . 0.0 113.192 -174.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -70.36 -10.53 59.29 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 119.864 1.211 . . . . 0.0 112.759 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -49.41 -28.97 5.72 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.352 1.861 . . . . 0.0 113.96 168.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 84.9 m -66.09 -31.22 71.96 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.763 2.025 . . . . 0.0 112.877 -168.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.2 -34.13 75.7 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.147 0.579 . . . . 0.0 111.571 174.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -84.47 7.77 71.3 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.65 1.595 . . . . 0.0 114.337 170.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.274 1.3 t 61.41 15.61 6.75 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 129.383 3.073 . . . . 0.0 116.057 173.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.1 mtp85 -99.84 144.09 29.31 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.146 -0.971 . . . . 0.0 109.836 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -126.28 -8.7 6.41 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -69.74 118.12 12.2 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.706 1.139 . . . . 0.0 109.371 170.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.7 t -76.92 164.99 25.28 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.758 -0.588 . . . . 0.0 110.647 171.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 96.7 p -64.18 138.85 58.65 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -173.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -82.44 -13.22 57.13 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 174.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.82 9.2 85.06 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.927 1.251 . . . . 0.0 114.199 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -102.12 175.87 5.38 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.669 1.234 . . . . 0.0 111.164 172.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.5 142.91 32.92 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -169.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -142.7 53.82 1.4 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.704 1.602 . . . . 0.0 112.791 -169.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.467 HD23 ' HG ' ' A' ' 95' ' ' CYS 0.273 0.0 OUTLIER -140.29 105.53 5.04 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.056 0.931 . . . . 0.0 111.27 169.946 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -89.26 -45.96 9.13 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.217 1.007 . . . . 0.0 111.328 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -97.05 8.28 44.84 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.444 2.297 . . . . 0.0 113.565 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.76 -12.29 62.7 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 125.747 1.642 . . . . 0.0 114.871 169.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 78.1 mtm -97.05 132.99 42.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.021 1.329 . . . . 0.0 110.375 171.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -64.71 99.03 0.3 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.671 0.748 . . . . 0.0 111.889 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -67.16 -36.34 81.59 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.487 1.515 . . . . 0.0 112.925 -170.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.7 p -85.71 4.47 36.53 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -50.51 -42.29 54.71 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 120.503 1.501 . . . . 0.0 112.278 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.2 -33.86 69.34 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 117.974 -1.459 . . . . 0.0 112.724 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.353 82.5 tt0 -89.28 -90.9 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.415 0 CA-C-O 116.112 -1.899 . . . . 0.0 112.537 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.11 156.94 56.16 Favored 'Trans proline' 0 C--N 1.357 1.01 0 CA-C-N 124.135 2.513 . . . . 0.0 116.052 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -62.95 166.3 5.88 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 129.459 3.104 . . . . 0.0 115.037 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -62.68 132.8 53.52 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 166.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -57.78 154.34 12.11 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.914 -1.117 . . . . 0.0 113.823 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 60.1 p -77.66 162.51 26.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.477 0.711 . . . . 0.0 112.296 174.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 50.9 t -61.36 -39.11 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 121.547 -0.721 . . . . 0.0 111.352 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.2 t -81.59 -19.51 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.48 -37.64 88.08 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.241 1.382 . . . . 0.0 108.623 169.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 28.7 mt -77.25 -31.41 55.02 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 116.153 -1.88 . . . . 0.0 114.595 171.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.01 -42.19 72.24 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 121.268 1.849 . . . . 0.0 110.994 169.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 11.4 t -62.82 -54.16 43.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.595 0.758 . . . . 0.0 111.387 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.4 tppt? -69.58 -38.87 77.53 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -170.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . 0.294 0.0 OUTLIER -68.77 -33.33 73.7 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.537 1.517 . . . . 0.0 111.529 175.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.7 -32.71 64.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -69.29 -46.04 68.15 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.844 1.257 . . . . 0.0 110.056 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -86.26 -8.88 57.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.724 0.81 . . . . 0.0 113.105 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 50.64 49.27 21.2 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.001 1.72 . . . . 0.0 112.456 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.1 mt -102.69 133.58 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-O 116.535 -1.698 . . . . 0.0 106.967 171.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -103.09 113.46 65.84 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 121.439 1.927 . . . . 0.0 110.365 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -67.36 152.79 78.52 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.074 3.183 . . . . 0.0 114.764 173.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.8 mm -134.26 104.29 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.595 1.558 . . . . 0.0 109.371 174.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -73.19 75.98 1.29 Allowed 'General case' 0 N--CA 1.478 0.928 0 O-C-N 119.849 -1.782 . . . . 0.0 112.387 175.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . 0.258 1.9 m -72.13 103.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 123.524 1.63 . . . . 0.0 111.15 169.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 29.0 m -143.05 166.35 20.87 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 120.33 -1.481 . . . . 0.0 110.447 -169.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -80.19 161.8 23.09 Favored 'Trans proline' 0 C--N 1.35 0.619 0 CA-C-N 122.856 2.056 . . . . 0.0 110.036 -172.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.5 t -52.97 -41.97 65.07 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.952 0.501 . . . . 0.0 111.916 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -54.68 -38.67 67.25 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.607 1.163 . . . . 0.0 113.698 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 19.6 mmt -99.75 -9.38 23.1 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.755 1.222 . . . . 0.0 114.175 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -61.89 -29.64 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 120.085 1.311 . . . . 0.0 113.329 -168.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -65.39 -25.07 67.4 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.13 -43.02 20.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.519 0.728 . . . . 0.0 109.955 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -71.02 -30.42 66.62 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.421 1.089 . . . . 0.0 110.535 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -65.81 -14.9 62.29 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.122 0.569 . . . . 0.0 111.829 168.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -96.47 -30.69 13.2 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.393 -0.817 . . . . 0.0 111.599 173.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.61 -25.59 61.37 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 119.979 -1.701 . . . . 0.0 110.03 175.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.1 t -72.49 -21.99 61.13 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.739 -0.601 . . . . 0.0 111.845 173.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 37.7 m -69.71 -29.74 67.2 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -88.46 -14.42 37.92 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 24.0 mt -120.35 87.85 41.11 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.1 0.96 . . . . 0.0 110.421 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.84 134.99 61.54 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.238 2.626 . . . . 0.0 112.903 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 65.2 mttm 85.06 -10.35 0.81 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 129.431 3.092 . . . . 0.0 113.914 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 10.2 tt -65.55 149.4 50.13 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.325 -0.86 . . . . 0.0 109.098 169.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 68.6 p -123.39 -170.22 2.08 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 169.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.0 141.53 2.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 127.083 2.153 . . . . 0.0 108.125 -167.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -132.67 150.86 19.8 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 170.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . 0.262 0.9 OUTLIER -91.44 88.71 6.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 123.128 1.442 . . . . 0.0 109.099 169.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 1.1 tt -57.5 138.63 54.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.654 169.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 95.0 p -160.18 -152.18 0.28 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.387 1.875 . . . . 0.0 109.026 173.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.85 -26.39 64.15 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.741 1.216 . . . . 0.0 113.19 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -100.85 145.09 29.01 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.73 1.212 . . . . 0.0 113.575 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 26.9 t -96.38 -9.55 29.71 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.699 1.6 . . . . 0.0 112.809 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 59.6 m -61.01 -39.77 91.0 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.582 -1.324 . . . . 0.0 113.484 -168.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -66.29 -42.14 88.77 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.321 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 68.5 t -69.25 -49.01 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.324 0.65 . . . . 0.0 111.232 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.07 -23.41 65.86 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 121.391 -0.818 . . . . 0.0 112.34 -177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -73.83 -3.95 31.79 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.676 -1.265 . . . . 0.0 112.702 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 78.0 mt -100.74 -42.16 6.6 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.591 1.556 . . . . 0.0 107.932 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 6.8 mm -70.89 -41.13 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -67.97 -34.62 76.9 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 118.971 -0.538 . . . . 0.0 111.536 172.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -67.33 -35.44 79.42 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 119.786 1.175 . . . . 0.0 112.586 173.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -75.07 -27.87 60.13 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.137 0.975 . . . . 0.0 112.497 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -63.16 -47.28 83.33 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.759 0.824 . . . . 0.0 110.943 173.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 39.2 m -73.19 -13.51 61.17 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -75.23 -11.03 59.98 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.5 mt . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -177.035 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.4 t70 . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -63.05 150.05 43.51 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 121.042 1.747 . . . . 0.0 112.73 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 m -60.01 112.4 1.86 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.666 1.187 . . . . 0.0 112.558 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.03 144.81 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.931 0.892 . . . . 0.0 110.236 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.55 97.88 5.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.063 1.745 . . . . 0.0 108.388 172.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.1 mp -90.9 122.12 33.33 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 121.542 -0.724 . . . . 0.0 112.386 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -119.78 104.2 10.01 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 123.723 1.725 . . . . 0.0 111.13 172.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -85.46 114.72 22.71 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.411 1.885 . . . . 0.0 113.459 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.49 120.0 38.15 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.318 1.447 . . . . 0.0 111.154 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.0 mtp -100.12 144.0 29.66 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 169.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.9 98.19 2.31 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 168.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.69 33.75 0.52 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.201 1.5 . . . . 0.0 114.753 -169.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 p -80.61 169.56 17.49 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 119.889 -1.757 . . . . 0.0 113.408 173.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -50.72 -34.6 29.13 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 125.346 1.45 . . . . 0.0 116.247 -169.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.0 t -61.78 -29.8 70.38 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.195 0.998 . . . . 0.0 113.033 175.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.16 3.46 20.5 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.298 1.439 . . . . 0.0 114.57 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -66.76 -36.22 81.92 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.433 -1.417 . . . . 0.0 110.908 170.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.36 -28.99 71.98 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.426 0.536 . . . . 0.0 112.55 171.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -70.07 -55.04 10.52 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 117.726 0.763 . . . . 0.0 111.842 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.0 tp -55.95 -42.17 75.81 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -168.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.5 t -55.9 -46.59 78.34 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.053 1.297 . . . . 0.0 111.863 176.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -66.39 -28.08 68.36 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.8 -1.187 . . . . 0.0 112.715 173.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.0 t -77.7 -13.45 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 124.904 1.282 . . . . 0.0 112.916 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -91.68 -32.32 15.5 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.889 2.076 . . . . 0.0 113.151 -173.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.4 p -83.57 -18.32 38.72 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 167.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.528 ' C ' ' H ' ' A' ' 28' ' ' SER . 41.3 tp -87.07 -174.41 4.89 Favored 'General case' 0 N--CA 1.417 -2.111 1 N-CA-C 96.996 -5.187 . . . . 0.0 96.996 164.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.47 -42.18 1.94 Allowed Glycine 0 C--N 1.286 -2.227 0 C-N-CA 129.424 3.392 . . . . 0.0 108.497 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.528 ' H ' ' C ' ' A' ' 26' ' ' LEU . 69.8 m -72.74 -39.72 66.66 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.963 2.105 . . . . 0.0 109.109 169.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -80.22 -27.88 38.67 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.003 0.365 . . . . 0.0 110.8 173.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.8 tp -62.42 -54.88 33.66 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.844 0.858 . . . . 0.0 109.664 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -59.69 -58.37 8.89 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.627 0.771 . . . . 0.0 110.484 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -65.61 -36.26 83.2 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.539 1.063 . . . . 0.0 112.434 -169.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.51 -40.13 43.85 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.265 0.6 OUTLIER -75.21 -20.22 59.39 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.263 -1.523 . . . . 0.0 113.112 175.618 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.12 -4.58 33.56 Favored 'General case' 0 CA--C 1.559 1.295 0 O-C-N 120.933 -1.104 . . . . 0.0 111.366 168.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -95.77 -40.25 9.45 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.628 1.571 . . . . 0.0 112.092 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.4 tp -66.22 -26.26 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 120.091 1.314 . . . . 0.0 111.846 171.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.2 t -146.18 138.22 25.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 174.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -55.16 -40.08 70.24 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.301 1.841 . . . . 0.0 112.164 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.1 p -117.27 110.31 17.95 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.395 1.478 . . . . 0.0 109.757 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.57 89.14 0.15 Allowed Glycine 0 C--N 1.339 0.736 0 C-N-CA 126.649 2.071 . . . . 0.0 108.801 -169.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.5 mmm-85 -77.27 138.11 39.2 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 tp -124.08 133.22 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.258 0.623 . . . . 0.0 110.48 -174.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.4 160.54 27.89 Favored Glycine 0 N--CA 1.474 1.202 0 C-N-CA 125.061 1.315 . . . . 0.0 112.722 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -138.69 135.41 34.77 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.006 0.923 . . . . 0.0 112.802 -169.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.39 146.1 18.04 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 124.742 1.163 . . . . 0.0 112.443 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.4 m -118.52 131.5 56.23 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.227 1.011 . . . . 0.0 111.233 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.6 tp -140.09 147.96 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.266 -0.896 . . . . 0.0 111.792 175.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -149.74 -107.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 103.652 -2.721 . . . . 0.0 103.652 168.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.41 ' C ' ' H ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -136.09 -2.1 2.34 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.605 1.162 . . . . 0.0 110.858 168.146 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.7 mtp -78.58 41.09 0.39 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.92 2.088 . . . . 0.0 108.354 168.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.315 1.4 t 53.71 -176.13 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 129.618 3.167 . . . . 0.0 113.261 -168.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -87.24 137.88 31.96 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.363 1.465 . . . . 0.0 109.443 174.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -123.73 121.88 36.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.88 1.324 . . . . 0.0 110.456 169.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -86.69 100.04 12.19 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.487 1.915 . . . . 0.0 110.291 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.0 mm -90.35 -21.22 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 118.164 -0.922 . . . . 0.0 112.887 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.7 tp -157.02 111.72 2.76 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 144.93 43.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.715 1.206 . . . . 0.0 110.939 168.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -61.71 125.26 23.18 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.298 0.953 . . . . 0.0 110.169 -175.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t -135.33 163.37 30.16 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.729 0.811 . . . . 0.0 112.182 -174.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.94 -0.5 55.58 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.995 1.718 . . . . 0.0 111.09 169.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -86.89 82.69 7.72 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 125.659 2.647 . . . . 0.0 109.158 174.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.1 m -61.8 -41.61 97.97 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 131.539 3.936 . . . . 0.0 110.924 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.1 p -63.81 -15.53 59.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.18 1.392 . . . . 0.0 112.323 169.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -86.6 -50.02 7.12 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.01 0.823 . . . . 0.0 110.19 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -55.21 -29.06 57.19 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.308 1.043 . . . . 0.0 112.85 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -86.17 -13.12 47.97 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.918 0.887 . . . . 0.0 112.816 -175.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -88.8 -39.42 13.91 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 168.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -74.5 -43.07 57.62 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -169.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 tt -67.22 -34.39 77.37 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 123.454 0.471 . . . . 0.0 111.333 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.7 mtm105 -75.69 -18.02 59.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 119.613 -0.835 . . . . 0.0 113.069 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -76.72 -45.17 30.43 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -62.34 162.65 9.62 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.928 1.24 . . . . 0.0 113.468 -169.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -152.12 152.0 31.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.853 1.261 . . . . 0.0 110.072 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -73.82 143.89 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 127.925 2.49 . . . . 0.0 113.847 -169.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 71.6 p -108.38 -152.16 0.48 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 126.328 1.851 . . . . 0.0 112.231 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.37 160.4 33.05 Favored Glycine 0 N--CA 1.475 1.247 0 O-C-N 120.196 -1.565 . . . . 0.0 114.13 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -155.89 156.88 35.4 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -56.37 -63.8 1.07 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.681 2.792 . . . . 0.0 113.261 176.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.22 149.21 44.8 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.353 1.061 . . . . 0.0 113.616 -172.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.1 m -72.36 -47.01 10.44 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-O 116.138 -1.886 . . . . 0.0 113.287 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -75.09 154.47 42.08 Favored 'Trans proline' 0 C--N 1.352 0.715 0 CA-C-N 122.302 1.858 . . . . 0.0 112.527 169.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -131.77 179.68 5.92 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.476 1.51 . . . . 0.0 113.455 -178.358 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.94 34.39 4.95 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 119.393 2.517 . . . . 0.0 119.393 -168.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -50.75 -33.53 23.52 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.62 1.71 . . . . 0.0 113.648 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.4 tp -62.69 -44.08 97.16 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -175.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.18 -46.35 82.89 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.252 0.621 . . . . 0.0 109.846 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.08 -58.51 8.34 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 118.496 -0.764 . . . . 0.0 111.034 173.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.4 m -64.99 -25.28 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 119.627 1.103 . . . . 0.0 113.168 -171.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.91 -51.74 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 118.083 -0.961 . . . . 0.0 112.16 169.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -57.03 -42.01 79.64 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.974 1.261 . . . . 0.0 110.41 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.3 t -57.4 -39.16 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.242 0.617 . . . . 0.0 112.238 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.67 -32.22 69.41 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.853 1.056 . . . . 0.0 113.853 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.0 tp -102.13 -15.42 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -170.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.59 ' CB ' ' HG ' ' A' ' 135' ' ' CYS . 0.1 OUTLIER -84.33 56.89 3.98 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.534 -1.354 . . . . 0.0 112.847 179.157 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.2 mt -55.72 -38.97 70.46 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.465 1.506 . . . . 0.0 111.88 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.02 -22.96 47.07 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.524 1.059 . . . . 0.0 114.668 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -92.3 -39.58 11.42 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.465 1.133 . . . . 0.0 111.563 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.7 mt -81.91 -29.18 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 118.822 0.737 . . . . 0.0 111.264 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.34 24.7 39.01 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.027 -0.874 . . . . 0.0 114.891 169.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -49.42 129.26 18.57 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.785 1.234 . . . . 0.0 112.91 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -111.85 173.03 6.55 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.876 1.27 . . . . 0.0 112.434 170.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -81.86 41.58 0.66 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 125.671 1.588 . . . . 0.0 115.107 -170.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.14 -126.45 5.5 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 120.592 -1.318 . . . . 0.0 110.437 170.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.6 t -115.96 134.07 55.36 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.638 1.975 . . . . 0.0 107.704 171.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -124.41 131.51 53.5 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.093 0.86 . . . . 0.0 110.218 -168.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -127.08 98.5 5.33 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -169.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.6 tt -81.9 99.16 8.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.152 172.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.1 t -87.84 124.11 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 174.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 65.4 tp -108.19 117.47 34.23 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.664 1.12 . . . . 0.0 109.267 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.16 128.39 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 124.158 0.911 . . . . 0.0 110.707 170.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.7 t -162.44 163.66 27.54 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.246 1.018 . . . . 0.0 110.882 170.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -121.25 -0.44 9.9 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 116.547 2.055 . . . . 0.0 116.547 -175.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -137.17 172.66 12.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.912 0.885 . . . . 0.0 111.831 172.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -53.43 176.56 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.946 1.699 . . . . 0.0 112.58 174.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -146.04 157.19 43.86 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 120.7 -1.25 . . . . 0.0 112.293 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -79.87 133.28 36.24 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.664 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 46.8 mt -100.74 175.07 5.77 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.189 1.796 . . . . 0.0 110.886 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -47.88 137.09 10.28 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.917 0.865 . . . . 0.0 112.828 172.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 69.5 tttt 83.58 -14.45 0.7 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 130.906 3.682 . . . . 0.0 113.719 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -63.22 -21.95 66.55 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.526 1.512 . . . . 0.0 113.4 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -78.18 -5.91 53.24 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.8 -16.75 63.88 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 120.621 1.555 . . . . 0.0 112.34 171.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 57.3 mt -63.25 -24.71 67.99 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.887 0.875 . . . . 0.0 111.515 169.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -90.35 -123.02 2.53 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 126.198 1.856 . . . . 0.0 109.301 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 p -126.64 0.13 6.8 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.577 1.551 . . . . 0.0 114.319 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -85.56 109.47 18.55 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.789 0.836 . . . . 0.0 111.285 -169.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -94.38 -28.71 15.38 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -87.17 122.23 30.7 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.702 -0.623 . . . . 0.0 112.491 -169.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.3 t -57.93 144.15 40.27 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.888 0.475 . . . . 0.0 110.388 169.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 42.0 t -59.75 140.9 56.16 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.637 0.775 . . . . 0.0 112.614 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.7 p30 -80.74 -13.51 58.93 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.88 14.42 78.47 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.477 1.037 . . . . 0.0 113.423 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -98.94 170.05 9.0 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.259 1.824 . . . . 0.0 110.536 172.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . 0.59 ' HG ' ' CB ' ' A' ' 95' ' ' CYS . 0.5 OUTLIER -100.41 145.35 28.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -139.47 45.6 1.93 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.307 1.843 . . . . 0.0 111.592 -170.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.4 tt -110.08 125.13 52.64 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.68 1.992 . . . . 0.0 108.907 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -131.19 -48.66 1.0 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.613 1.165 . . . . 0.0 112.8 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -84.42 -10.66 57.32 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.493 1.517 . . . . 0.0 113.677 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 108.51 -23.71 23.87 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.199 1.857 . . . . 0.0 111.477 -169.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 80.8 mmm -82.28 145.83 29.78 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.617 1.167 . . . . 0.0 111.259 172.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -77.47 99.04 5.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.174 0.589 . . . . 0.0 109.769 169.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 42.3 ttp-105 -63.28 -38.28 90.56 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.211 1.004 . . . . 0.0 113.563 -170.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.4 p -88.56 7.37 33.55 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -168.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -47.53 -39.7 16.95 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 121.277 1.853 . . . . 0.0 112.461 169.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.13 -0.65 86.49 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 117.8 -1.555 . . . . 0.0 115.789 -174.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -127.35 -65.8 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 119.889 1.845 . . . . 0.0 110.387 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -58.98 147.25 90.86 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.498 2.799 . . . . 0.0 115.625 168.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -69.46 169.34 12.66 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 128.503 2.721 . . . . 0.0 112.87 169.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -69.0 158.06 35.52 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.423 -1.423 . . . . 0.0 108.211 168.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -78.62 157.45 28.68 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.314 -0.866 . . . . 0.0 111.257 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 92.9 p -92.81 156.18 17.16 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.248 -0.907 . . . . 0.0 110.684 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.26 -34.37 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.344 -0.848 . . . . 0.0 112.571 -171.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.9 t -69.93 -33.66 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.412 1.085 . . . . 0.0 111.596 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -68.8 -34.45 75.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.499 0.72 . . . . 0.0 111.144 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.26 -55.95 15.49 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.009 0.924 . . . . 0.0 110.253 174.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.97 76.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.041 0.937 . . . . 0.0 111.448 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.8 t -58.47 -71.43 0.11 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.166 0.986 . . . . 0.0 111.847 172.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -66.85 -34.48 77.89 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.76 -26.58 63.42 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.163 1.347 . . . . 0.0 112.866 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.1 -43.69 64.4 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.768 1.167 . . . . 0.0 113.46 173.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -80.53 -30.67 37.14 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.885 0.766 . . . . 0.0 112.578 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -82.48 -5.56 58.78 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.983 0.81 . . . . 0.0 112.242 168.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 60.64 46.91 8.78 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.007 1.323 . . . . 0.0 111.75 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 29.4 mm -100.36 135.51 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.934 1.293 . . . . 0.0 108.057 174.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -100.64 114.35 65.75 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 120.477 1.49 . . . . 0.0 109.903 170.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -74.74 145.11 32.11 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.035 1.824 . . . . 0.0 110.594 169.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 31.5 mt -128.73 102.08 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 125.126 1.37 . . . . 0.0 107.418 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -74.37 72.8 1.84 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.415 1.102 . . . . 0.0 112.342 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 85.3 t -70.59 97.75 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 O-C-N 120.621 -1.299 . . . . 0.0 111.193 173.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 25.4 m -147.92 145.16 20.23 Favored Pre-proline 0 N--CA 1.484 1.237 0 O-C-N 120.367 -1.458 . . . . 0.0 112.879 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -60.81 156.55 42.66 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 125.111 3.874 . . . . 0.0 116.705 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.5 t -46.62 -58.31 3.95 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.978 1.711 . . . . 0.0 114.471 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -14.67 21.8 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -171.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.0 ptm -109.3 -1.6 18.44 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.308 1.443 . . . . 0.0 114.872 172.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.2 t -65.46 -33.39 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 120.23 -1.544 . . . . 0.0 111.97 -170.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -70.74 -23.68 62.48 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.861 1.21 . . . . 0.0 113.241 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . 0.262 2.4 t -87.18 -13.39 44.1 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.059 -1.026 . . . . 0.0 112.405 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -96.38 -33.72 11.81 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.073 1.349 . . . . 0.0 109.879 168.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.62 -26.7 65.48 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.724 -1.235 . . . . 0.0 111.997 176.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -74.0 -23.48 59.45 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.052 -1.655 . . . . 0.0 110.445 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 35.5 tp -85.02 -19.48 31.93 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.304 1.842 . . . . 0.0 110.824 174.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.6 p -83.65 -6.94 59.57 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.383 0.538 . . . . 0.0 112.019 169.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 6.9 m -88.22 -34.56 17.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.678 1.591 . . . . 0.0 108.865 169.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -79.7 -37.34 35.94 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 174.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 51.0 mt -101.16 113.27 65.82 Favored Pre-proline 0 N--CA 1.478 0.963 0 CA-C-O 118.247 -0.882 . . . . 0.0 108.949 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.7 145.2 40.91 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.577 2.185 . . . . 0.0 111.423 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt 73.55 3.98 4.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 127.117 2.167 . . . . 0.0 113.736 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.69 142.6 46.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.994 1.718 . . . . 0.0 109.052 169.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 76.5 p -108.55 -158.19 0.64 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.8 tt 177.15 136.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 126.983 2.113 . . . . 0.0 110.129 -168.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -129.57 132.45 7.09 Favored Glycine 0 N--CA 1.469 0.892 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -81.99 79.12 8.59 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 124.069 1.89 . . . . 0.0 109.814 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 28.1 tp -53.98 156.85 2.73 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.662 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 57.6 p -85.57 156.0 20.93 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.727 -1.233 . . . . 0.0 110.914 169.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.52 -6.63 37.65 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 120.485 -1.384 . . . . 0.0 113.74 174.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -95.76 -30.94 13.44 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 126.862 2.065 . . . . 0.0 112.395 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . 0.379 35.3 p 75.61 11.79 3.19 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 131.195 3.798 . . . . 0.0 117.94 168.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.2 t -65.09 -11.46 40.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 119.439 -2.038 . . . . 0.0 114.105 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -73.69 -9.66 58.89 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 172.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 38.3 t -49.89 -47.3 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 121.42 1.918 . . . . 0.0 113.67 -174.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -63.84 -32.52 74.06 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.921 -1.112 . . . . 0.0 112.152 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -84.83 20.23 1.87 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 97.5 mt -130.52 -36.93 1.41 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.436 2.294 . . . . 0.0 109.419 176.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 50.0 mt -67.57 -48.48 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.687 1.195 . . . . 0.0 109.188 170.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -63.28 -38.47 91.29 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 119.464 -0.895 . . . . 0.0 110.238 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -67.44 -39.01 85.4 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.998 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.7 70.85 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.935 1.294 . . . . 0.0 112.488 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.34 -35.76 76.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.357 0.663 . . . . 0.0 111.655 173.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.9 t -75.28 -28.59 59.83 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -66.1 -57.19 8.25 Favored 'General case' 0 CA--C 1.551 1.003 0 O-C-N 120.889 -1.132 . . . . 0.0 111.882 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 11.9 tp . . . . . 0 CA--C 1.579 2.06 0 C-N-CA 126.92 2.088 . . . . 0.0 113.535 -174.965 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.178 0.513 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -84.1 130.36 34.86 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.736 -1.228 . . . . 0.0 110.346 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.9 t -56.27 121.51 9.67 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.578 -0.701 . . . . 0.0 110.176 175.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 t -94.3 155.08 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -151.89 101.63 2.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.345 1.069 . . . . 0.0 109.603 169.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.19 142.92 27.06 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.314 1.046 . . . . 0.0 111.717 -171.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -124.45 111.77 16.12 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 123.889 1.804 . . . . 0.0 110.861 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -83.64 101.83 11.78 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.868 -1.969 . . . . 0.0 111.921 175.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.9 tp -102.73 113.28 26.55 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.748 0.819 . . . . 0.0 111.093 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.1 ptm -120.77 151.24 39.82 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.55 141.26 23.56 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.52 1.533 . . . . 0.0 113.348 173.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.43 32.09 5.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.26 1.824 . . . . 0.0 112.255 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.3 p -78.43 163.58 25.51 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 119.91 -1.744 . . . . 0.0 112.194 171.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.81 -19.89 51.06 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 116.484 1.354 . . . . 0.0 116.484 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.5 m -68.58 -28.11 66.65 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.709 1.254 . . . . 0.0 112.84 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.05 1.75 42.43 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -170.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -69.1 -23.09 63.96 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.526 1.512 . . . . 0.0 112.857 171.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.31 -38.25 39.59 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 169.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -43.46 98.84 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.08 1.352 . . . . 0.0 111.091 175.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.5 tp -58.17 -42.54 86.23 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 124.755 1.222 . . . . 0.0 112.55 -177.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -51.57 -43.56 62.47 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.157 0.889 . . . . 0.0 113.283 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -95.12 -0.55 53.31 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -175.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.1 m -99.86 16.01 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 119.758 1.163 . . . . 0.0 112.333 169.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -94.73 -40.97 9.5 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.9 t -74.41 -13.8 60.77 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.71 2.004 . . . . 0.0 110.735 167.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.3 tp -81.26 96.29 7.22 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 124.682 2.182 . . . . 0.0 107.261 172.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.48 -51.24 0.09 OUTLIER Glycine 0 C--N 1.299 -1.514 0 CA-C-N 109.131 -3.668 . . . . 0.0 110.978 168.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.6 m -83.99 -37.27 22.43 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.768 1.227 . . . . 0.0 110.888 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -61.58 -38.65 88.34 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.7 0.8 . . . . 0.0 110.723 169.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.4 tp -63.75 -51.66 63.92 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.5 mt -56.21 -38.91 71.65 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 118.065 -0.969 . . . . 0.0 113.267 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -60.7 -39.74 89.65 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.851 1.66 . . . . 0.0 112.004 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.19 -43.94 60.58 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 171.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.9 mt -73.73 -16.57 61.18 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -69.63 -23.16 63.46 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.879 1.271 . . . . 0.0 113.335 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -73.48 -42.43 61.87 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.116 0.966 . . . . 0.0 109.476 170.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.39 -41.94 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.015 1.326 . . . . 0.0 111.632 174.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 t -166.41 149.89 7.25 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -169.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.5 mmt-85 -76.88 -15.19 59.77 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.2 p -138.43 132.03 30.75 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.486 1.136 . . . . 0.0 111.058 169.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.96 88.34 0.13 Allowed Glycine 0 C--N 1.336 0.529 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -169.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -73.5 148.24 43.3 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -174.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.6 tt -123.17 135.63 62.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -139.99 161.15 26.34 Favored Glycine 0 N--CA 1.464 0.557 0 C-N-CA 125.361 1.458 . . . . 0.0 110.722 172.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -139.17 138.22 36.75 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -169.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.25 145.27 15.92 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 124.491 1.043 . . . . 0.0 112.578 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.3 m -116.13 136.22 53.21 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 125.284 1.434 . . . . 0.0 110.522 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.18 155.31 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.534 1.134 . . . . 0.0 111.197 176.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.1 p -151.93 -65.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 120.656 -1.277 . . . . 0.0 109.02 168.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 177.06 -19.66 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 130.237 3.415 . . . . 0.0 110.081 169.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 54.0 ttm -50.1 -36.84 31.23 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.009 1.324 . . . . 0.0 110.029 167.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t 167.1 -172.39 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 131.465 3.906 . . . . 0.0 109.782 169.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -103.88 131.28 51.25 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 167.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.6 pm0 -130.26 124.38 32.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 123.064 1.411 . . . . 0.0 110.793 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -94.23 104.68 16.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.14 2.176 . . . . 0.0 109.924 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . 0.361 0.0 OUTLIER -91.22 -70.01 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 117.583 -1.199 . . . . 0.0 110.799 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.8 124.49 38.87 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 121.287 1.858 . . . . 0.0 114.74 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -67.08 168.94 9.24 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.558 1.143 . . . . 0.0 110.336 167.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.5 mt -62.1 123.22 17.53 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.276 -0.89 . . . . 0.0 109.349 175.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.8 t -145.14 165.48 28.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.839 1.256 . . . . 0.0 111.291 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -99.69 -7.36 25.74 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.678 1.191 . . . . 0.0 114.009 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -94.52 81.2 3.9 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 124.623 2.154 . . . . 0.0 108.906 173.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.4 m -73.27 -19.34 61.08 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 127.39 2.276 . . . . 0.0 110.869 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.1 t -67.53 -21.16 65.49 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 167.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -82.55 -35.49 27.15 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 120.778 -1.201 . . . . 0.0 111.038 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -55.66 -24.49 34.25 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.221 1.008 . . . . 0.0 111.384 169.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -77.63 -39.68 44.41 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.916 -1.115 . . . . 0.0 109.413 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -66.02 -36.34 82.99 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.425 1.09 . . . . 0.0 109.743 -172.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -90.42 -23.0 21.15 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.24 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -20.61 62.07 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.535 -0.728 . . . . 0.0 109.912 169.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -75.72 -38.09 58.83 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.69 0.796 . . . . 0.0 112.94 170.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.34 -14.64 26.66 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 116.312 1.968 . . . . 0.0 116.312 -175.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -59.3 150.1 26.92 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.64 1.564 . . . . 0.0 110.12 169.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.7 mt -120.53 161.23 21.66 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.832 0.853 . . . . 0.0 111.484 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.0 t -96.51 143.84 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.191 1.397 . . . . 0.0 110.597 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.5 t -113.44 -169.51 1.51 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 127.369 2.268 . . . . 0.0 112.173 -175.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -153.65 153.86 25.12 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.162 1.363 . . . . 0.0 113.661 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -152.49 160.12 43.27 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.186 1.794 . . . . 0.0 111.037 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -87.81 -32.75 18.89 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -174.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.76 143.05 38.29 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.666 0.786 . . . . 0.0 110.026 174.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.319 13.8 t -73.56 -41.37 5.87 Favored Pre-proline 0 N--CA 1.479 0.977 0 CA-C-O 116.341 -1.79 . . . . 0.0 113.969 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.79 137.62 54.54 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.649 2.233 . . . . 0.0 113.852 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -82.67 155.93 24.1 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.932 1.693 . . . . 0.0 113.528 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.77 45.5 3.22 Favored Glycine 0 N--CA 1.485 1.916 0 O-C-N 120.399 -1.438 . . . . 0.0 109.698 168.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -74.71 -39.91 61.63 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -168.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . 0.26 5.9 mp -68.75 -30.21 68.78 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 117.042 -1.456 . . . . 0.0 110.742 -173.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -57.37 -39.53 76.21 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.979 1.718 . . . . 0.0 111.899 169.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.53 -47.38 86.43 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.302 -1.499 . . . . 0.0 111.176 170.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.0 t -54.44 -31.83 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.389 1.076 . . . . 0.0 112.382 172.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.423 ' HA ' HD22 ' A' ' 156' ' ' LEU . 40.9 t -64.75 -65.0 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.592 0.757 . . . . 0.0 111.258 172.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -69.77 -32.62 71.21 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.086 -0.959 . . . . 0.0 112.048 -169.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.53 -20.85 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.922 1.237 . . . . 0.0 113.403 171.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.02 -45.51 16.46 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 120.057 1.299 . . . . 0.0 112.295 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.5 mt -88.19 -19.85 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.45 60.11 5.83 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 119.996 -1.69 . . . . 0.0 111.698 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 mp -48.26 -38.58 19.02 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.185 1.394 . . . . 0.0 111.128 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.83 -29.64 31.39 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.602 1.096 . . . . 0.0 115.497 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -89.65 -46.36 8.69 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 118.94 1.37 . . . . 0.0 110.624 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.9 mm -60.67 -49.54 84.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 172.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.61 29.51 8.19 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.177 0.894 . . . . 0.0 113.815 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.2 m95 -54.84 119.93 6.09 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 118.46 1.13 . . . . 0.0 111.462 174.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -95.82 -144.43 0.27 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.41 1.484 . . . . 0.0 111.96 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -102.1 -10.35 19.75 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 -169.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.16 -126.41 1.6 Allowed Glycine 0 C--N 1.349 1.264 0 CA-C-N 120.895 1.68 . . . . 0.0 112.86 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.4 t -112.26 147.53 36.07 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.311 1.845 . . . . 0.0 110.037 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.73 132.99 29.88 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 119.73 1.15 . . . . 0.0 113.198 -169.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -123.8 104.94 9.26 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -169.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.8 tp -85.6 88.66 7.56 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.847 172.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.3 t -79.13 123.7 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 174.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.5 tp -117.2 111.66 19.75 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 123.814 0.696 . . . . 0.0 109.503 -169.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.34 133.26 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 t -165.62 158.42 15.51 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.683 169.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -106.14 -5.51 19.29 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -174.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -138.57 -179.9 6.08 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.514 1.526 . . . . 0.0 111.423 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.11 -171.33 0.11 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.688 1.595 . . . . 0.0 113.478 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -144.81 150.42 37.13 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.109 1.364 . . . . 0.0 112.499 -170.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -74.16 133.6 42.78 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.859 0.864 . . . . 0.0 110.333 169.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.95 175.22 5.55 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.273 1.429 . . . . 0.0 109.784 170.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.91 142.54 19.07 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.836 -0.54 . . . . 0.0 111.263 169.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt 86.31 -18.06 0.35 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 129.217 3.007 . . . . 0.0 112.667 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -71.58 -19.1 62.19 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 121.061 1.755 . . . . 0.0 113.0 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -74.22 -16.15 60.98 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.499 -1.375 . . . . 0.0 113.876 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.302 9.5 t -74.7 -6.63 49.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 119.556 1.071 . . . . 0.0 113.201 174.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.1 mp -64.93 -24.09 67.42 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.104 -0.998 . . . . 0.0 109.752 167.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -88.65 -123.56 2.14 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 168.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 64.1 p -126.97 16.15 7.35 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.337 1.455 . . . . 0.0 114.1 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.36 125.72 50.84 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.652 1.181 . . . . 0.0 111.932 -169.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -130.43 -20.3 2.98 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -71.52 124.58 24.98 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 121.078 1.763 . . . . 0.0 110.111 170.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.3 t -75.4 147.23 40.16 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.139 0.575 . . . . 0.0 110.722 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.4 t -63.72 135.58 56.8 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.064 1.412 . . . . 0.0 112.602 -175.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -73.94 -10.53 59.74 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.55 2.74 . . . . 0.0 114.832 -170.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.86 15.99 80.63 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.222 -1.321 . . . . 0.0 114.182 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -113.15 170.26 8.34 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.175 1.488 . . . . 0.0 110.632 169.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.3 153.24 18.12 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -169.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -147.88 45.44 1.09 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.027 1.331 . . . . 0.0 113.803 -169.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.41 150.14 20.92 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.342 1.057 . . . . 0.0 109.584 169.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -141.6 -67.79 0.39 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.856 0.862 . . . . 0.0 111.538 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -84.73 -2.64 57.88 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.524 1.53 . . . . 0.0 113.716 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.29 -8.72 38.36 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.217 1.865 . . . . 0.0 114.387 -175.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 92.4 mtp -93.41 148.94 21.62 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.308 2.054 . . . . 0.0 111.088 170.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -70.92 100.7 2.0 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.927 -1.108 . . . . 0.0 110.746 173.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -48.36 80.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.355 1.062 . . . . 0.0 110.821 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 43.5 m -74.44 8.06 2.5 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -175.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.25 -24.61 59.9 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.834 -1.166 . . . . 0.0 111.881 169.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.7 -45.23 7.94 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 118.007 -1.441 . . . . 0.0 113.574 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.303 1.7 pm0 -97.97 -62.78 0.11 Allowed Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -169.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -58.54 149.26 76.65 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.438 2.758 . . . . 0.0 117.625 169.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -74.81 161.15 29.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.87 2.468 . . . . 0.0 111.631 169.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -59.73 131.74 51.82 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 168.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -81.94 157.06 24.43 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 121.153 1.797 . . . . 0.0 112.624 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.3 m -67.8 152.42 45.6 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.111 0.964 . . . . 0.0 113.101 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.15 -26.36 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -169.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.9 m -85.21 -16.17 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -70.03 -27.14 64.42 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.752 1.16 . . . . 0.0 108.494 168.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 90' ' ' VAL . 15.2 mt -84.22 -32.87 24.28 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 117.286 -1.34 . . . . 0.0 114.036 169.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -54.23 -37.37 64.55 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 120.853 1.661 . . . . 0.0 112.398 171.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 89.2 p -68.41 -55.03 13.33 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.835 -0.54 . . . . 0.0 112.119 173.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -66.01 -29.74 70.16 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.6 mp -58.33 -54.58 45.4 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.412 1.085 . . . . 0.0 111.383 170.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.56 -24.63 58.95 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.15 -39.8 63.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.5 1.12 . . . . 0.0 111.022 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -95.52 1.09 53.77 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 174.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 66.89 30.86 7.53 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.314 1.846 . . . . 0.0 113.863 169.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 48.7 mt -89.64 137.86 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 120.705 -1.247 . . . . 0.0 109.603 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -104.59 97.53 12.55 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -74.12 150.37 42.64 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.132 1.888 . . . . 0.0 113.465 173.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 34.9 mm -139.17 106.28 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.715 1.206 . . . . 0.0 109.702 -174.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -73.01 65.62 0.76 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.657 1.183 . . . . 0.0 113.207 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.69 108.6 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 122.401 1.096 . . . . 0.0 111.187 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 28.3 m -146.3 142.01 17.07 Favored Pre-proline 0 N--CA 1.48 1.039 0 O-C-N 119.873 -1.767 . . . . 0.0 110.708 -174.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -54.17 150.78 30.88 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.197 2.598 . . . . 0.0 114.542 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.3 t -44.79 -45.04 9.83 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.347 1.859 . . . . 0.0 114.031 -170.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.33 -36.97 6.84 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.698 1.599 . . . . 0.0 113.782 -172.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.5 mtt -123.62 19.19 9.55 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.741 1.217 . . . . 0.0 114.08 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.2 t -59.52 -37.5 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 O-C-N 120.488 -1.382 . . . . 0.0 110.589 174.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -22.74 66.06 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -170.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.2 t -91.24 -33.21 15.46 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.872 1.269 . . . . 0.0 111.249 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -70.95 -37.02 72.82 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.577 -1.327 . . . . 0.0 110.324 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . 0.353 14.8 pt-20 -73.43 -2.67 23.36 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 169.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -88.63 -43.64 11.2 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.23 -0.919 . . . . 0.0 109.869 169.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . 0.264 4.8 mp -83.84 -10.08 58.3 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 119.288 -2.133 . . . . 0.0 111.93 -174.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 15.1 t -78.16 -19.64 53.57 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 167.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . 0.279 1.3 t -77.41 -19.94 55.38 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 120.881 -1.137 . . . . 0.0 109.655 168.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -83.47 -24.19 31.88 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.345 0.658 . . . . 0.0 111.373 168.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.87 78.71 23.71 Favored Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 124.618 1.167 . . . . 0.0 111.542 170.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.52 142.1 93.85 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.183 1.922 . . . . 0.0 112.122 176.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 62.6 mttm 95.17 -20.34 0.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 131.636 3.975 . . . . 0.0 113.331 -171.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.7 tt -71.03 157.48 38.14 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.495 0.1 OUTLIER -135.36 -160.64 1.07 Allowed 'General case' 0 C--N 1.346 0.416 0 O-C-N 120.009 -1.682 . . . . 0.0 108.169 169.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.97 156.29 10.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 129.025 2.93 . . . . 0.0 108.893 -168.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -137.56 134.76 7.17 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 171.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -83.12 82.21 8.35 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 169.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 20.0 tp -62.34 157.85 18.83 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 113.481 -1.691 . . . . 0.0 110.609 169.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 57.5 p -91.43 168.57 11.45 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.052 -1.03 . . . . 0.0 112.566 173.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.76 -11.42 60.39 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -104.31 -11.99 16.86 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.842 1.657 . . . . 0.0 114.351 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 31.0 m 77.6 -3.85 2.36 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 129.697 3.199 . . . . 0.0 114.657 172.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.4 m -62.75 -14.72 48.01 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.576 1.551 . . . . 0.0 113.935 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -72.73 -11.98 60.84 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 169.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 6.6 p -58.93 -41.38 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -169.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.82 95.84 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 120.08 1.309 . . . . 0.0 111.41 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -66.74 -11.85 56.3 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 10.2 mp -109.86 -25.64 10.21 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 127.256 2.222 . . . . 0.0 109.544 -174.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 48.9 mt -65.79 -52.26 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 166.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . 0.311 30.3 ptt85 -76.34 -21.68 55.85 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 117.513 -1.232 . . . . 0.0 114.22 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -69.78 -13.84 62.48 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 120.427 1.467 . . . . 0.0 114.803 171.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -105.73 -21.89 13.08 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.234 1.414 . . . . 0.0 112.294 -173.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -81.99 -25.04 35.11 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.298 2.239 . . . . 0.0 112.154 170.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -24.09 -44.26 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.881 1 C-N-CA 133.141 4.576 . . . . 0.0 116.745 -168.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -88.92 -44.7 10.25 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 -169.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . 0.256 4.6 mp . . . . . 0 N--CA 1.498 1.971 0 CA-C-N 119.215 0.916 . . . . 0.0 112.5 -169.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.9 t0 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.939 0.4 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -105.41 139.31 40.23 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.806 1.243 . . . . 0.0 110.478 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -66.54 124.59 23.23 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.322 -0.861 . . . . 0.0 111.565 178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.2 t -125.1 140.67 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.328 1.451 . . . . 0.0 109.327 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -124.6 99.39 6.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.296 1.439 . . . . 0.0 109.194 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.0 123.31 40.69 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.181 -0.95 . . . . 0.0 111.128 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -105.45 105.94 16.21 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 123.701 1.715 . . . . 0.0 109.282 169.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -81.83 112.5 19.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.563 173.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 tt -111.34 131.54 55.09 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.372 -0.83 . . . . 0.0 112.841 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 28.4 mtp -110.61 148.49 32.1 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.57 121.35 6.45 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.578 1.561 . . . . 0.0 109.209 168.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.54 36.38 3.11 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.06 1.744 . . . . 0.0 111.697 -175.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.4 p -79.09 163.15 25.35 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.705 1.602 . . . . 0.0 113.479 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -56.69 -32.13 61.3 Favored Glycine 0 N--CA 1.477 1.368 0 O-C-N 121.263 -0.898 . . . . 0.0 114.181 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.6 p -70.2 -19.52 63.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.684 1.193 . . . . 0.0 113.875 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.65 -2.9 48.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.199 1.4 . . . . 0.0 112.774 176.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -66.18 134.39 52.63 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.805 -1.184 . . . . 0.0 109.24 169.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.06 -50.63 3.69 Favored Glycine 0 N--CA 1.471 1.011 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -169.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -65.05 -20.8 66.66 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.025 0.93 . . . . 0.0 112.834 171.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.1 tp -51.64 -32.82 30.8 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.519 1.528 . . . . 0.0 112.157 172.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.4 t -64.16 -56.65 13.32 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.721 -0.612 . . . . 0.0 110.876 169.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.22 -25.69 66.23 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.71 -1.243 . . . . 0.0 113.867 -175.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.2 m -82.52 -2.55 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 119.015 0.825 . . . . 0.0 112.788 172.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.04 -49.05 3.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.192 0.997 . . . . 0.0 110.125 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.8 p -59.15 -20.07 50.49 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.863 1.265 . . . . 0.0 112.421 169.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 tp -110.02 86.55 2.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 127.984 2.514 . . . . 0.0 104.84 169.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 164.3 -43.09 0.31 Allowed Glycine 0 C--N 1.308 -0.977 0 CA-C-N 112.343 -2.208 . . . . 0.0 108.969 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.5 p -66.6 -44.74 81.3 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.43 1.092 . . . . 0.0 110.55 169.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -75.31 -25.38 57.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.697 -1.144 . . . . 0.0 112.68 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 mp -62.87 -50.8 69.47 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 120.103 1.32 . . . . 0.0 108.974 170.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.19 -51.27 69.73 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.081 0.552 . . . . 0.0 111.905 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -63.28 -47.52 81.98 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.739 -0.601 . . . . 0.0 110.8 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.24 -44.19 84.45 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 117.871 0.305 . . . . 0.0 111.583 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.309 2.6 mp -79.9 -11.98 59.77 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -177.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -73.21 -19.3 61.12 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.06 -1.025 . . . . 0.0 111.294 167.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -85.67 -41.06 15.51 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.238 1.015 . . . . 0.0 110.516 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.8 tt -71.45 -26.01 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 175.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 t -149.54 137.3 20.26 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -71.68 -39.84 69.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.874 1.67 . . . . 0.0 111.832 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.7 t -103.21 89.47 3.42 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 122.889 1.328 . . . . 0.0 109.846 172.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.06 84.27 0.31 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 105.627 -2.989 . . . . 0.0 105.627 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 -84.58 133.92 34.41 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.529 1.532 . . . . 0.0 107.774 -169.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.4 tt -125.97 144.41 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 119.545 1.066 . . . . 0.0 112.296 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.27 153.61 21.98 Favored Glycine 0 N--CA 1.461 0.329 0 C-N-CA 125.84 1.686 . . . . 0.0 110.263 -176.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -138.07 130.57 29.32 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -169.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.68 149.69 20.09 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 124.92 1.247 . . . . 0.0 112.901 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.3 p -119.65 144.11 47.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.657 1.183 . . . . 0.0 111.553 174.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.98 150.44 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.518 -1.364 . . . . 0.0 108.961 174.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.1 t -138.36 -68.92 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 170.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.273 1.5 t-20 170.15 -4.05 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.82 1 C-N-CA 134.046 4.938 . . . . 0.0 109.477 169.421 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -54.33 -39.72 67.31 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.118 0.967 . . . . 0.0 109.61 167.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 p 163.74 170.65 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.117 1 C-N-CA 134.355 5.062 . . . . 0.0 108.43 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -89.16 131.21 35.4 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 166.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -123.4 130.31 52.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.677 1.227 . . . . 0.0 110.186 177.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -104.01 104.73 14.73 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.866 2.066 . . . . 0.0 110.429 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -108.96 -9.35 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -173.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.4 tt -157.34 117.22 3.42 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.553 1.069 . . . . 0.0 109.927 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.02 163.74 18.68 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.825 0.85 . . . . 0.0 113.272 172.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.428 HD13 ' CE3' ' A' ' 101' ' ' TRP . 87.4 mt -49.08 104.02 0.06 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.592 1.557 . . . . 0.0 113.334 -169.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.9 p -122.45 161.65 23.15 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.502 1.921 . . . . 0.0 111.221 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.65 6.35 41.95 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 125.722 1.609 . . . . 0.0 112.213 169.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -85.52 76.82 9.99 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.706 2.402 . . . . 0.0 107.22 174.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.4 p -67.3 -45.7 75.75 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 128.771 2.828 . . . . 0.0 111.43 -169.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.6 t -51.98 -34.93 44.57 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.256 1.022 . . . . 0.0 109.96 170.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -83.74 -37.32 22.82 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -172.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -54.64 -33.55 60.81 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.566 1.075 . . . . 0.0 111.089 169.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -72.52 -34.52 67.66 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.643 -0.661 . . . . 0.0 110.036 -176.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -72.35 -35.1 68.46 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.905 0.882 . . . . 0.0 109.241 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.63 -32.16 28.43 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -172.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 tt -73.61 -41.0 63.39 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 171.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -59.71 -33.19 71.3 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.248 -0.908 . . . . 0.0 113.135 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.1 -5.22 55.54 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -64.51 152.56 41.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.771 1.168 . . . . 0.0 112.582 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.7 tt -138.92 137.23 36.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.745 1.218 . . . . 0.0 109.756 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.8 t -74.08 138.09 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 126.474 1.91 . . . . 0.0 112.044 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 t -101.66 -155.9 0.54 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 125.971 1.708 . . . . 0.0 112.17 172.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -146.86 150.33 22.58 Favored Glycine 0 N--CA 1.478 1.483 0 O-C-N 120.048 -1.657 . . . . 0.0 116.019 -173.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -149.75 162.38 40.37 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.918 2.087 . . . . 0.0 113.262 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -32.1 13.0 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 173.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -94.96 132.11 40.16 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.229 0.922 . . . . 0.0 110.318 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.8 p -74.25 -31.46 1.26 Allowed Pre-proline 0 N--CA 1.472 0.675 0 CA-C-O 114.274 -2.774 . . . . 0.0 115.427 -172.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -68.48 144.95 63.08 Favored 'Trans proline' 0 C--N 1.353 0.771 0 CA-C-N 123.893 2.426 . . . . 0.0 112.264 169.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -98.48 -177.3 3.64 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.889 1.276 . . . . 0.0 112.286 -176.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.96 18.28 37.07 Favored Glycine 0 N--CA 1.481 1.652 0 C-N-CA 125.621 1.581 . . . . 0.0 114.327 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -46.72 -39.18 11.11 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -169.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . 0.466 5.1 mp -80.49 7.92 8.84 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 119.899 1.227 . . . . 0.0 113.417 -177.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -80.41 -49.84 10.91 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 165.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.44 -45.23 94.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 116.893 -1.527 . . . . 0.0 112.369 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -49.95 -36.93 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 120.511 1.505 . . . . 0.0 111.653 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 63.1 t -82.59 -45.14 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.172 0.989 . . . . 0.0 111.4 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -59.57 -49.8 76.38 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.524 1.056 . . . . 0.0 109.672 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.2 t -55.97 -42.08 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.203 1.001 . . . . 0.0 111.976 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.69 85.52 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.091 -1.006 . . . . 0.0 112.919 177.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.26 -24.91 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.988 1.315 . . . . 0.0 113.667 -169.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 61.78 3.93 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.812 1.645 . . . . 0.0 110.871 -176.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.4 mt -56.23 -38.63 71.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.072 1.349 . . . . 0.0 112.0 -170.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.01 -34.49 23.98 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.877 0.751 . . . . 0.0 113.47 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -81.66 -45.4 15.81 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 125.334 1.453 . . . . 0.0 110.472 -175.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.8 mm -70.69 -33.31 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 118.915 0.78 . . . . 0.0 110.455 170.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.16 31.5 16.86 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.452 1.025 . . . . 0.0 114.542 174.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.428 ' CE3' HD13 ' A' ' 59' ' ' LEU . 23.1 m95 -56.54 129.45 40.89 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.88 1.272 . . . . 0.0 113.096 -177.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.17 170.66 7.83 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.651 1.18 . . . . 0.0 112.55 169.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -74.42 49.49 0.38 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 127.307 2.243 . . . . 0.0 114.053 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.84 -131.02 6.44 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 170.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.9 m -119.33 132.59 55.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.568 2.347 . . . . 0.0 105.7 177.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -124.61 124.79 42.98 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 119.084 0.856 . . . . 0.0 111.405 -168.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -114.04 112.47 23.31 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 123.977 0.798 . . . . 0.0 110.783 -175.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 14.5 tp -93.44 105.92 17.94 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 170.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.1 t -89.43 125.58 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 172.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -111.03 115.87 30.2 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.72 130.88 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 123.674 0.609 . . . . 0.0 112.611 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.4 t -158.17 164.24 36.77 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.305 1.042 . . . . 0.0 111.453 171.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -112.49 -4.36 14.22 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.85 2.06 . . . . 0.0 114.124 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -137.49 -177.36 4.75 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.476 -1.39 . . . . 0.0 113.439 171.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -61.86 -174.64 0.05 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.333 2.253 . . . . 0.0 112.262 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -140.6 139.46 34.93 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.426 1.09 . . . . 0.0 111.904 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -68.67 108.35 3.34 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.564 1.146 . . . . 0.0 111.721 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.04 177.54 3.68 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.375 0.607 . . . . 0.0 111.527 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.27 148.14 23.5 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.22 -0.925 . . . . 0.0 112.295 172.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? 78.6 -11.19 1.24 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 128.099 2.56 . . . . 0.0 112.668 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.95 -32.5 74.26 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.532 1.133 . . . . 0.0 112.398 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -70.09 0.84 5.41 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 178.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.2 t -58.82 -33.04 69.94 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.052 -1.03 . . . . 0.0 112.417 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 126' ' ' THR . 62.6 tp -65.82 -40.89 92.26 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.635 0.774 . . . . 0.0 111.473 171.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.88 27.03 1.13 Allowed Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.588 1.566 . . . . 0.0 113.392 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.443 ' H ' ' C ' ' A' ' 124' ' ' LEU . 62.7 p 61.94 5.89 1.53 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 131.536 3.935 . . . . 0.0 117.038 169.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . 0.3 48.1 mtt180 -109.99 140.75 43.65 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.939 1.245 . . . . 0.0 114.144 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -109.73 -32.37 7.11 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.14 2.576 . . . . 0.0 114.691 -168.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -71.35 123.41 22.25 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.821 0.737 . . . . 0.0 111.292 -173.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.0 t -57.73 158.25 6.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.489 1.116 . . . . 0.0 110.68 172.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.7 t -70.15 134.43 48.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.977 0.894 . . . . 0.0 111.11 170.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 p30 -78.13 -12.03 59.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.633 1.573 . . . . 0.0 112.647 170.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.19 8.11 73.65 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.876 1.227 . . . . 0.0 114.764 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -78.14 174.02 11.61 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.896 1.348 . . . . 0.0 109.023 168.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -93.13 148.25 22.18 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 171.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -136.2 27.57 3.17 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.886 1.674 . . . . 0.0 112.232 -171.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.3 mt -87.66 153.12 21.62 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.87 0.868 . . . . 0.0 111.008 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -148.0 -67.21 0.24 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.399 1.079 . . . . 0.0 111.44 172.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.22 9.07 27.1 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.721 1.608 . . . . 0.0 113.729 176.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 105.98 -5.47 39.5 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.803 1.668 . . . . 0.0 115.213 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -113.17 149.16 34.03 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.643 1.721 . . . . 0.0 112.277 174.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -70.71 86.61 0.67 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.456 1.102 . . . . 0.0 112.107 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -49.05 -45.11 42.34 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.067 1.347 . . . . 0.0 111.833 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 71.8 m -77.73 -0.14 25.79 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -173.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.4 ttp85 -52.43 -40.33 62.07 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 121.171 1.805 . . . . 0.0 111.658 169.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.7 -25.09 75.92 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 117.617 -1.657 . . . . 0.0 113.156 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.355 42.7 tt0 -96.84 -92.06 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.328 0 CA-C-O 115.465 -2.207 . . . . 0.0 112.041 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.97 152.94 54.71 Favored 'Trans proline' 0 C--N 1.359 1.081 0 CA-C-N 124.241 2.55 . . . . 0.0 116.395 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.01 163.35 7.98 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.819 2.448 . . . . 0.0 114.72 170.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -60.85 139.9 57.82 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 167.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.551 ' NE2' ' H ' ' A' ' 151' ' ' GLN . 0.1 OUTLIER -84.11 150.57 25.46 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.613 -1.305 . . . . 0.0 112.396 -174.55 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.1 t -68.85 148.67 49.91 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.401 0.68 . . . . 0.0 111.805 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.0 t -55.85 -29.47 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.565 1.146 . . . . 0.0 111.802 -177.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.3 -40.66 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.34 1.056 . . . . 0.0 112.138 173.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -65.41 -35.87 82.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.327 0.651 . . . . 0.0 110.141 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 5.2 mt -61.8 -58.12 9.22 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 173.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -54.24 -41.12 68.38 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.486 1.114 . . . . 0.0 112.919 -175.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.8 t -59.65 -54.14 49.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.886 0.874 . . . . 0.0 111.525 173.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -73.64 -33.95 64.75 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.824 -1.173 . . . . 0.0 112.903 -172.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 mt -61.1 -38.23 85.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.401 1.001 . . . . 0.0 111.978 170.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.63 -33.41 64.52 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.114 0.966 . . . . 0.0 113.514 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -68.35 -47.3 67.83 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.641 1.177 . . . . 0.0 110.496 176.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -74.45 -17.37 60.79 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.492 0.717 . . . . 0.0 111.871 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 62.84 49.26 3.71 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.964 1.706 . . . . 0.0 111.514 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.51 125.79 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.82 1.248 . . . . 0.0 108.465 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -91.42 119.79 68.51 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-O 118.38 -0.819 . . . . 0.0 108.805 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.18 152.59 14.09 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.635 2.223 . . . . 0.0 110.603 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.8 mm -138.54 105.4 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.008 1.323 . . . . 0.0 109.379 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -77.96 82.6 4.31 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.428 -1.42 . . . . 0.0 112.46 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 87.9 t -70.28 104.91 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.14 -1.391 . . . . 0.0 112.31 169.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.11 144.79 22.45 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -171.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -63.96 154.17 71.65 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 124.742 3.628 . . . . 0.0 114.912 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.7 m -41.22 -51.04 3.59 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.428 2.291 . . . . 0.0 114.877 -169.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -54.54 -26.37 31.53 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 8.9 ttm -106.02 -8.48 17.52 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.565 1.946 . . . . 0.0 114.073 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 40.1 t -55.56 -47.04 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.902 -1.124 . . . . 0.0 112.148 -168.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . 0.317 11.4 pttm -81.09 -6.18 58.51 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -174.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . 0.255 4.8 t -86.92 -26.87 23.68 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 119.337 0.971 . . . . 0.0 111.129 169.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -83.49 -23.25 32.25 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.694 -1.254 . . . . 0.0 111.471 172.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -34.8 78.49 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.16 -0.963 . . . . 0.0 109.357 167.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . 0.395 0.1 OUTLIER -83.48 1.08 43.47 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 119.915 -1.74 . . . . 0.0 112.893 -178.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -98.56 -25.98 14.56 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.965 2.506 . . . . 0.0 107.407 168.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.23 -18.11 53.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.949 -1.094 . . . . 0.0 113.897 176.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 5.3 t -85.3 -24.14 27.82 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.226 0.61 . . . . 0.0 110.004 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -79.62 -38.09 34.65 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.527 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 35.4 mt -108.66 98.63 29.7 Favored Pre-proline 0 N--CA 1.484 1.227 0 CA-C-N 118.81 0.732 . . . . 0.0 110.037 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -55.06 144.89 66.87 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.215 2.61 . . . . 0.0 112.421 169.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 78.49 -2.47 2.37 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 128.227 2.611 . . . . 0.0 114.849 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 23.2 tp -74.47 152.72 39.39 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.785 1.234 . . . . 0.0 108.464 168.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.3 m -121.12 -153.1 0.53 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 177.83 114.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.427 2.291 . . . . 0.0 108.857 -167.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -109.62 147.1 17.03 Favored Glycine 0 N--CA 1.471 1.001 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 171.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . 0.362 0.9 OUTLIER -95.53 95.66 8.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 124.053 1.882 . . . . 0.0 110.568 177.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 31.1 tp -51.33 134.14 28.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 111.326 -2.67 . . . . 0.0 111.692 172.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 84.0 p -170.03 -166.9 0.59 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.088 1.755 . . . . 0.0 108.901 171.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -58.58 -18.56 30.95 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -97.61 129.28 44.73 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.299 1.439 . . . . 0.0 112.429 173.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 70.7 m -88.95 -3.35 58.76 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.625 1.17 . . . . 0.0 113.586 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 31.0 p -61.74 -47.8 83.58 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.81 1.644 . . . . 0.0 112.901 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -62.55 -51.7 66.34 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.342 0.257 . . . . 0.0 110.819 -178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 88.5 t -62.23 -44.74 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 O-C-N 121.49 -0.756 . . . . 0.0 112.058 -176.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.21 -26.95 68.35 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.186 -0.947 . . . . 0.0 111.92 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -72.31 -10.29 59.59 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.208 -1.558 . . . . 0.0 112.607 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 8.2 mp -96.67 -44.3 7.18 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.507 1.523 . . . . 0.0 107.781 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 26.3 mt -75.6 -35.18 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -71.12 -29.57 65.43 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.34 169.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.38 -31.2 69.44 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 120.177 1.353 . . . . 0.0 113.181 169.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -72.77 -31.51 64.95 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.173 -0.954 . . . . 0.0 111.057 173.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -68.54 -41.46 79.8 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.475 0.71 . . . . 0.0 112.369 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.1 p -68.43 -11.4 59.66 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -89.91 -0.75 57.75 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.261 1.669 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -177.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.88 142.47 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.48 1.512 . . . . 0.0 109.377 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -119.46 113.17 20.36 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.083 1.753 . . . . 0.0 108.327 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.21 126.24 51.98 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.725 -0.609 . . . . 0.0 109.977 177.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -114.62 108.91 17.44 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 123.572 1.653 . . . . 0.0 111.284 174.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -84.01 99.2 10.27 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 112.713 -2.04 . . . . 0.0 113.584 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.4 mt -91.59 129.26 37.59 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.828 0.851 . . . . 0.0 109.675 168.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . 0.253 2.7 ppp? -137.45 156.63 47.95 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 169.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.02 131.81 10.63 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.149 1.833 . . . . 0.0 113.156 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.8 mp -107.42 29.57 7.04 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.917 2.087 . . . . 0.0 111.891 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 CA--C 1.537 0.478 0 O-C-N 120.328 -1.483 . . . . 0.0 113.025 178.743 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.9 t . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 122.383 1.087 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.01 82.22 0.31 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 127.837 2.637 . . . . 0.0 106.605 -172.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -79.37 127.73 32.45 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.9 mt -123.38 130.91 73.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.311 0.577 . . . . 0.0 111.217 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.05 161.51 18.42 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 126.618 2.056 . . . . 0.0 110.278 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -141.28 133.31 27.7 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.82 145.51 16.25 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 121.404 0.446 . . . . 0.0 112.274 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.8 m -114.71 142.08 46.98 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.733 1.213 . . . . 0.0 110.332 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.587 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -152.77 155.04 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 120.913 -1.117 . . . . 0.0 108.984 178.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.587 ' N ' HD13 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -152.47 -62.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.607 1.163 . . . . 0.0 109.426 173.573 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.25 25.5 t30 177.47 -19.43 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 128.917 2.887 . . . . 0.0 111.972 168.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -50.31 -40.91 50.02 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.068 0.849 . . . . 0.0 109.7 168.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.405 ' HA ' ' HD2' ' A' ' 145' ' ' ARG 0.365 3.7 t 163.92 -177.61 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 131.622 3.969 . . . . 0.0 112.158 167.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -85.45 129.8 34.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.344 1.858 . . . . 0.0 108.533 169.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -117.73 112.22 20.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.45 1.1 . . . . 0.0 108.84 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -72.93 122.07 21.07 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.5 mt -103.86 -54.08 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.558 -0.714 . . . . 0.0 111.048 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.1 tp -130.98 120.72 23.91 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.257 0.551 . . . . 0.0 111.669 -175.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -57.85 149.57 22.24 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.705 1.202 . . . . 0.0 111.112 169.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 28.8 mt -48.03 108.8 0.18 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.115 1.366 . . . . 0.0 111.311 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 125.608 1.563 . . . . 0.0 111.823 -174.837 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.0 t -126.8 -140.54 0.27 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.273 1.429 . . . . 0.0 109.323 169.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -147.35 158.56 27.76 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-N 120.562 1.528 . . . . 0.0 115.715 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -160.6 148.41 16.1 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.951 1.7 . . . . 0.0 111.728 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.8 tp -68.06 -55.6 11.97 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.792 1.237 . . . . 0.0 112.223 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.59 136.17 50.92 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.632 0.773 . . . . 0.0 112.069 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.272 7.5 t -70.66 -39.84 9.84 Favored Pre-proline 0 N--CA 1.474 0.762 0 CA-C-O 115.766 -2.064 . . . . 0.0 113.456 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.42 140.07 56.49 Favored 'Trans proline' 0 C--N 1.356 0.939 0 CA-C-N 123.405 2.252 . . . . 0.0 111.693 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -107.4 -179.3 3.88 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.27 1.828 . . . . 0.0 112.738 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -109.18 18.99 30.27 Favored Glycine 0 N--CA 1.479 1.56 0 O-C-N 120.68 -1.262 . . . . 0.0 116.019 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -56.76 -29.22 62.37 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -169.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.34 -28.15 67.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.47 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.72 -34.12 77.46 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 120.126 1.33 . . . . 0.0 112.273 171.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.7 -46.46 78.9 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 118.417 -0.801 . . . . 0.0 109.216 169.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.413 HG22 HD13 ' A' ' 108' ' ' LEU . 1.1 t -53.61 -40.13 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.017 0.826 . . . . 0.0 111.774 174.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.29 -61.9 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.433 1.093 . . . . 0.0 110.852 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.9 -44.8 95.11 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 118.945 -0.55 . . . . 0.0 110.715 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.24 -40.57 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.897 0.879 . . . . 0.0 111.714 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.56 -38.22 86.62 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.436 1.017 . . . . 0.0 112.86 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.6 mt -86.31 -36.8 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.795 0.838 . . . . 0.0 113.181 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 73.6 m -77.53 55.39 1.29 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.823 2.049 . . . . 0.0 112.105 -169.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.3 mt -48.99 -42.59 38.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.453 2.301 . . . . 0.0 111.453 -176.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.98 -19.25 75.45 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.403 1.001 . . . . 0.0 114.719 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -96.58 -47.6 5.86 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.117 0.967 . . . . 0.0 110.79 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.3 mm -66.73 -36.56 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.686 0.795 . . . . 0.0 111.104 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.43 20.93 28.26 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.115 1.341 . . . . 0.0 114.123 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -53.98 121.04 7.2 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.361 1.464 . . . . 0.0 112.212 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ptm85 -107.34 -176.78 3.16 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.015 1.326 . . . . 0.0 112.164 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -73.86 11.08 0.94 Allowed 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 117.851 2.538 . . . . 0.0 117.851 -169.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.61 -129.82 1.97 Allowed Glycine 0 C--N 1.344 1.023 0 CA-C-N 121.215 1.825 . . . . 0.0 110.734 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.9 p -114.33 145.21 42.08 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.494 1.918 . . . . 0.0 107.656 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -129.05 117.87 21.59 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.416 -167.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -122.2 104.45 9.47 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -169.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.413 HD13 HG22 ' A' ' 89' ' ' VAL . 3.1 tt -88.6 94.96 10.06 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.216 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.0 t -77.5 116.01 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.0 tp -105.18 123.06 47.18 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 t -108.27 130.12 61.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 O-C-N 124.595 1.184 . . . . 0.0 112.445 172.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.493 HG22 HG12 ' A' ' 171' ' ' VAL . 7.5 t -140.89 172.91 12.04 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.805 1.642 . . . . 0.0 110.335 173.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -118.96 -14.54 9.38 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 127.164 2.185 . . . . 0.0 111.859 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -133.12 174.82 9.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.789 1.236 . . . . 0.0 113.457 -169.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -61.23 -174.73 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.266 1.427 . . . . 0.0 110.883 168.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -147.12 159.86 43.1 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.655 -1.278 . . . . 0.0 113.36 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -79.22 116.83 19.72 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.27 1.428 . . . . 0.0 111.52 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.9 mp -82.55 -179.23 7.36 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.097 1.359 . . . . 0.0 109.962 173.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.47 160.1 3.35 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.406 -0.809 . . . . 0.0 111.689 169.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.449 0.0 OUTLIER 56.32 -12.68 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.277 0 N-CA-C 117.487 2.402 . . . . 0.0 117.487 -173.624 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.26 -28.21 69.55 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.037 -1.664 . . . . 0.0 111.899 169.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.58 -25.1 67.1 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 116.818 2.155 . . . . 0.0 116.818 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -18.6 63.62 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -167.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 pp -67.05 -19.77 65.73 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 118.68 0.673 . . . . 0.0 112.734 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -96.52 11.94 66.54 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 126.415 1.96 . . . . 0.0 114.11 170.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.334 10.5 t 54.86 53.74 10.03 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 128.078 2.551 . . . . 0.0 113.882 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -116.55 69.69 0.75 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.27 1.828 . . . . 0.0 110.505 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -62.23 -40.21 95.38 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.054 -1.654 . . . . 0.0 113.799 -169.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -60.83 138.92 58.09 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -173.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 t -81.39 148.88 29.1 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.731 0.813 . . . . 0.0 110.624 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 36.4 t -55.35 131.85 46.68 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.605 0.762 . . . . 0.0 111.771 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.7 p30 -89.58 -10.82 44.64 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.697 1.199 . . . . 0.0 113.899 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.93 21.85 78.72 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 117.995 -1.447 . . . . 0.0 114.773 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -112.48 170.39 8.21 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.369 1.584 . . . . 0.0 113.141 169.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 5.5 t -71.1 133.4 46.23 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.586 1.554 . . . . 0.0 112.234 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -138.04 40.45 2.31 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.065 1.746 . . . . 0.0 112.996 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.73 125.35 42.5 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.933 1.693 . . . . 0.0 109.131 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -117.67 -84.66 0.64 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.998 0.919 . . . . 0.0 111.836 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -87.15 20.37 2.76 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.945 1.698 . . . . 0.0 113.39 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.18 -11.87 68.75 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.814 1.674 . . . . 0.0 113.641 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 97.3 mtp -91.14 144.88 25.17 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.64 1.22 . . . . 0.0 111.691 171.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -77.41 83.88 3.84 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.575 0.702 . . . . 0.0 109.231 169.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 42.3 tpt85 -56.02 -32.29 63.86 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.38 1.472 . . . . 0.0 112.942 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.7 m -73.58 -8.54 56.37 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 29.3 ttt85 -56.02 -27.97 55.35 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 121.337 1.881 . . . . 0.0 113.903 176.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.72 -18.39 73.98 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.241 -1.311 . . . . 0.0 114.601 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.265 57.8 tt0 -119.94 -80.03 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.144 0 CA-C-O 115.818 -2.039 . . . . 0.0 112.449 -170.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.88 165.74 24.96 Favored 'Trans proline' 0 C--N 1.36 1.132 0 CA-C-N 123.918 2.435 . . . . 0.0 113.937 170.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -92.4 -179.82 5.32 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -67.52 126.98 31.04 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 167.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -49.7 161.2 0.24 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.505 1.922 . . . . 0.0 115.425 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.1 p -82.84 157.78 23.0 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.099 -1.0 . . . . 0.0 112.141 169.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.05 -34.06 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.645 -1.284 . . . . 0.0 112.001 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.9 t -77.94 -24.5 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.507 0.723 . . . . 0.0 111.682 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -67.17 -34.35 77.36 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.351 -0.843 . . . . 0.0 110.944 172.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.31 -56.12 21.52 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.021 0.828 . . . . 0.0 109.542 168.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.0 -40.49 63.85 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.829 0.852 . . . . 0.0 112.625 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.4 t -62.07 -64.47 0.92 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.966 0.907 . . . . 0.0 112.245 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -73.63 -24.94 60.08 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.085 -1.634 . . . . 0.0 113.878 -169.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.4 mp -63.74 -41.42 98.04 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.269 0.941 . . . . 0.0 110.703 169.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.05 -36.88 61.8 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -69.19 -49.79 53.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.283 1.033 . . . . 0.0 110.493 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -77.42 -15.49 59.32 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.686 0.794 . . . . 0.0 111.278 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 66.96 60.21 0.53 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.189 1.796 . . . . 0.0 110.718 171.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.69 139.69 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.543 1.937 . . . . 0.0 107.988 172.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -107.9 106.16 57.91 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 119.951 1.251 . . . . 0.0 109.432 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.99 151.67 39.86 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.554 2.169 . . . . 0.0 114.005 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 82.5 mt -130.44 109.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.034 1.334 . . . . 0.0 107.801 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -78.89 80.9 5.21 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 122.093 0.949 . . . . 0.0 111.755 -175.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.8 104.81 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.992 0.917 . . . . 0.0 111.978 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.493 HG12 HG22 ' A' ' 112' ' ' THR . 3.0 m -142.61 167.67 15.59 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.078 -1.639 . . . . 0.0 112.064 -169.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -84.4 152.36 12.06 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.41 2.073 . . . . 0.0 110.951 -172.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.3 t -49.51 -43.84 45.81 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -169.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -56.8 -29.28 62.55 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -111.23 -8.2 14.39 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.633 1.973 . . . . 0.0 112.586 -170.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.2 t -54.27 -44.43 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 120.627 -1.296 . . . . 0.0 111.009 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -70.31 -6.08 32.5 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -170.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 18.4 m -87.12 -50.12 6.84 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.967 1.707 . . . . 0.0 110.19 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -73.56 -26.77 60.99 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.974 1.31 . . . . 0.0 110.307 -174.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . 0.353 7.1 pt-20 -65.73 -14.29 61.01 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.001 171.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . 0.379 0.0 OUTLIER -89.0 -22.91 22.76 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-N 120.551 1.523 . . . . 0.0 112.408 167.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.68 -19.78 60.73 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 119.682 -1.886 . . . . 0.0 110.176 169.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 98.7 m -80.28 -18.07 50.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.654 2.382 . . . . 0.0 111.949 169.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.73 -27.6 19.95 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.346 0.521 . . . . 0.0 110.38 169.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -80.26 -32.74 38.25 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 174.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.518 HG22 HD13 ' A' ' 189' ' ' LEU . 27.5 mt -110.21 101.31 47.49 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.46 150.84 64.59 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.857 2.371 . . . . 0.0 111.687 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt 86.36 -11.33 0.64 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 129.265 3.026 . . . . 0.0 113.084 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.518 HD13 HG22 ' A' ' 186' ' ' ILE . 10.2 mp -72.49 166.39 22.73 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.956 0.902 . . . . 0.0 109.817 172.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 69.7 p -125.24 -142.83 0.3 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.096 0.95 . . . . 0.0 109.856 170.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.2 tp -179.04 128.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 128.123 2.569 . . . . 0.0 108.482 -166.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -118.77 155.28 16.13 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . 0.276 11.2 pt-20 -105.2 94.61 5.33 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 122.903 1.335 . . . . 0.0 109.776 173.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 26.2 tp . . . . . 0 CA--C 1.54 0.595 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.981 169.543 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.1 p . . . . . 0 CA--C 1.545 0.783 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.95 108.41 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 121.993 0.901 . . . . 0.0 111.847 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -87.39 114.97 24.48 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 7' ' ' TYR . 1.3 tt -101.82 125.39 48.48 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.866 -0.521 . . . . 0.0 110.025 170.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.47 ' N ' HD23 ' A' ' 6' ' ' LEU . 26.9 t80 -117.42 109.37 16.7 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 123.531 1.634 . . . . 0.0 109.985 169.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -86.35 116.16 24.34 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.668 2.387 . . . . 0.0 112.444 -176.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.519 HD23 ' HB1' ' A' ' 88' ' ' ALA . 6.9 mp -99.25 124.34 44.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.378 1.071 . . . . 0.0 111.061 172.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.1 ttt -114.21 135.5 53.99 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.78 132.21 13.69 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 168.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 47' ' ' SER . 1.4 mp -115.1 15.07 17.16 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.498 1.519 . . . . 0.0 114.197 -170.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.477 0.917 0 O-C-N 121.031 -1.043 . . . . 0.0 112.705 177.946 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 CA--C 1.546 0.794 0 CA-C-O 122.794 1.283 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.9 90.47 0.16 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 106.596 -2.602 . . . . 0.0 106.596 -175.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -78.88 145.66 34.03 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.75 0.82 . . . . 0.0 109.435 -169.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.52 132.61 70.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 124.944 1.298 . . . . 0.0 109.342 -172.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.85 156.98 26.99 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.998 1.761 . . . . 0.0 111.687 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -143.31 136.73 28.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -169.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.35 155.34 23.43 Favored Glycine 0 C--N 1.345 1.033 0 C-N-CA 124.558 1.075 . . . . 0.0 111.194 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.438 ' HB2' HD22 ' A' ' 12' ' ' LEU . 89.3 p -124.66 146.35 49.17 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.842 0.857 . . . . 0.0 111.975 -174.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.584 HG21 ' HB2' ' A' ' 88' ' ' ALA . 1.2 pp -145.42 151.95 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 173.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.0 t -142.86 -126.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 102.6 -3.111 . . . . 0.0 102.6 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -123.69 -0.6 8.57 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 120.406 1.457 . . . . 0.0 109.761 167.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.2 mmt -60.37 -39.08 85.94 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.75 1.62 . . . . 0.0 109.927 169.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.45 ' HB ' ' HD2' ' A' ' 145' ' ' ARG . 5.4 t 147.74 176.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.345 1 C-N-CA 132.399 4.28 . . . . 0.0 112.145 169.56 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -79.85 130.67 35.5 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.519 1.928 . . . . 0.0 109.327 169.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -123.66 128.97 50.42 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.282 1.039 . . . . 0.0 108.714 169.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -92.35 91.67 7.78 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.734 2.014 . . . . 0.0 111.229 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 mp -77.26 -59.87 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.45 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.4 tp -121.15 124.61 45.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.141 0.882 . . . . 0.0 112.114 -172.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.55 161.17 17.9 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 175.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.5 mt -56.29 109.01 0.53 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.129 1.772 . . . . 0.0 111.745 -171.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.6 t . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 125.549 1.54 . . . . 0.0 111.506 -177.447 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.7 t -120.54 -175.17 2.96 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.101 1.76 . . . . 0.0 111.756 171.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -148.46 157.28 27.24 Favored Glycine 0 N--CA 1.474 1.225 0 O-C-N 120.477 -1.389 . . . . 0.0 113.998 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -158.2 167.79 28.82 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.927 1.291 . . . . 0.0 114.232 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -77.57 -62.06 1.79 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.631 1.573 . . . . 0.0 112.952 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.77 151.96 43.89 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.814 0.846 . . . . 0.0 111.673 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.296 5.3 t -82.76 -41.41 0.88 Allowed Pre-proline 0 N--CA 1.479 1.005 0 CA-C-O 116.249 -1.834 . . . . 0.0 115.233 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.23 146.93 77.59 Favored 'Trans proline' 0 C--N 1.359 1.101 0 CA-C-N 123.04 2.121 . . . . 0.0 113.058 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -101.39 152.34 20.84 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.953 1.701 . . . . 0.0 113.637 -170.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.85 56.74 4.55 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 125.72 1.629 . . . . 0.0 111.662 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -84.11 -36.98 22.57 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.539 1.536 . . . . 0.0 113.327 -169.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.41 -36.84 83.83 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 122.153 -0.342 . . . . 0.0 110.852 -169.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -49.7 -41.79 44.18 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.196 1.398 . . . . 0.0 111.732 169.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.584 ' HB2' HG21 ' A' ' 48' ' ' ILE . . . -69.18 -52.38 28.59 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.055 -1.028 . . . . 0.0 111.498 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.4 m -59.68 -33.17 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.756 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.588 ' CG1' HD22 ' A' ' 156' ' ' LEU . 25.3 m -75.6 -51.68 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 117.215 -1.374 . . . . 0.0 112.624 173.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -55.74 -46.87 77.72 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 121.295 1.861 . . . . 0.0 110.175 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.6 t -59.66 -36.13 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.76 -43.37 79.99 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.986 -1.071 . . . . 0.0 112.629 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 90' ' ' VAL . 3.8 mp -78.85 -42.3 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -172.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . 0.26 21.8 p -83.79 66.48 9.1 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 121.222 1.828 . . . . 0.0 113.516 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.6 mt -43.42 -40.42 3.74 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.63 2.372 . . . . 0.0 111.583 169.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.11 -30.7 56.85 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.647 1.118 . . . . 0.0 114.794 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -104.59 -34.02 8.33 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 117.725 -1.131 . . . . 0.0 113.685 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.1 mm -64.07 -34.83 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 120.874 1.67 . . . . 0.0 110.408 169.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.59 18.31 38.77 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 117.907 -1.496 . . . . 0.0 114.126 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -54.06 147.28 12.93 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.343 1.572 . . . . 0.0 112.979 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . 0.272 0.0 OUTLIER -143.07 172.12 13.14 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.654 1.182 . . . . 0.0 114.015 172.085 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -58.54 24.35 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 121.39 3.848 . . . . 0.0 121.39 -168.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.16 -118.82 1.22 Allowed Glycine 0 CA--C 1.535 1.332 0 CA-C-N 120.912 1.687 . . . . 0.0 109.594 170.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.0 t -130.09 148.77 51.98 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 168.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -123.78 123.42 40.44 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 119.158 -0.449 . . . . 0.0 111.988 -166.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -115.32 103.49 10.86 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -170.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.0 tp -88.62 85.92 6.9 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.779 1.232 . . . . 0.0 109.527 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 66.7 t -77.28 136.85 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.3 tt -127.96 126.27 41.1 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.963 1.256 . . . . 0.0 111.541 169.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.1 t -95.46 128.01 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 126.216 1.806 . . . . 0.0 110.875 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.6 t -156.55 158.26 36.82 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.964 0.506 . . . . 0.0 110.989 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.87 0.59 11.41 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -141.44 -178.9 5.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.678 1.191 . . . . 0.0 111.867 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.95 -168.02 0.18 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.312 1.445 . . . . 0.0 112.137 -175.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.502 ' CE1' HD11 ' A' ' 182' ' ' LEU . 17.6 p90 -145.5 146.11 31.33 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 120.622 -1.298 . . . . 0.0 111.792 -169.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -80.23 130.02 34.91 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.826 169.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 pp -111.62 174.05 6.06 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.349 1.46 . . . . 0.0 111.344 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.33 130.16 30.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.5 mttm 93.91 -10.85 0.14 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.407 3.083 . . . . 0.0 112.003 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -67.75 -23.89 65.29 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 120.157 1.344 . . . . 0.0 112.706 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -74.65 -11.32 60.16 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.007 -1.058 . . . . 0.0 113.841 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.28 1.1 t -72.15 -21.51 61.44 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 120.458 1.481 . . . . 0.0 113.727 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.96 -37.72 84.79 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.735 1.152 . . . . 0.0 109.689 169.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.31 6.5 15.21 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.071 1.32 . . . . 0.0 113.158 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.277 52.8 m 70.06 37.8 1.64 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.309 2.244 . . . . 0.0 111.463 171.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -121.55 118.5 29.42 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.412 1.085 . . . . 0.0 111.076 169.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -105.12 -26.16 12.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.882 1.273 . . . . 0.0 112.896 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -61.35 116.18 4.44 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.067 0.849 . . . . 0.0 110.29 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 t -65.7 158.4 27.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.664 0.665 . . . . 0.0 110.003 173.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.1 t -67.44 144.61 55.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 122.043 0.925 . . . . 0.0 111.614 174.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.8 p30 -82.56 -10.75 58.85 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.054 1.342 . . . . 0.0 113.193 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.41 26.51 74.05 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.023 -0.876 . . . . 0.0 112.877 -175.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -103.29 172.92 6.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.026 1.73 . . . . 0.0 110.343 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 7.2 t -92.21 148.78 21.89 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.51 -0.744 . . . . 0.0 112.083 170.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -134.62 33.13 3.26 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.705 2.002 . . . . 0.0 112.063 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.75 161.06 13.84 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.197 0.999 . . . . 0.0 111.819 174.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -170.94 -45.26 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.571 1.948 . . . . 0.0 111.016 172.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -80.45 4.79 17.04 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.235 1.414 . . . . 0.0 112.771 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 82.73 -11.21 53.92 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.893 1.711 . . . . 0.0 112.547 -169.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.3 mtt -90.67 143.83 26.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.176 1.39 . . . . 0.0 111.118 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -74.05 95.63 2.56 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 169.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -64.09 -33.43 75.76 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.668 1.187 . . . . 0.0 113.25 -172.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.41 ' HB2' ' HD2' ' A' ' 148' ' ' PRO . 19.2 p -81.91 4.66 21.67 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -174.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.45 ' HD2' ' HB ' ' A' ' 52' ' ' THR . 40.0 ptt85 -37.87 -35.79 0.16 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.799 2.04 . . . . 0.0 115.219 169.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.69 30.07 6.85 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 127.962 2.696 . . . . 0.0 112.521 -172.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.266 43.2 tt0 -139.75 -79.3 0.01 OUTLIER Pre-proline 0 CA--C 1.559 1.293 0 CA-C-O 115.724 -2.084 . . . . 0.0 109.593 169.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 144' ' ' SER . 33.4 Cg_exo -54.18 150.4 32.43 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.574 2.85 . . . . 0.0 117.02 169.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.18 162.52 25.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 128.315 2.646 . . . . 0.0 109.316 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -55.2 140.67 37.94 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.177 -0.952 . . . . 0.0 109.729 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.09 156.91 24.31 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.667 -1.271 . . . . 0.0 112.189 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 27.2 t -81.47 154.9 26.1 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -173.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 20.2 t -59.27 -30.59 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.216 1.006 . . . . 0.0 111.652 -171.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.5 p -66.62 -37.04 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.607 1.163 . . . . 0.0 113.433 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -72.82 -32.58 65.61 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.487 -0.758 . . . . 0.0 110.495 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.588 HD22 ' CG1' ' A' ' 90' ' ' VAL . 1.1 mt -65.33 -46.54 79.86 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -54.54 -44.78 73.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.104 0.962 . . . . 0.0 112.607 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.8 m -59.43 -53.05 62.57 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.688 0.795 . . . . 0.0 112.119 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -64.57 -43.38 94.06 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.166 -0.959 . . . . 0.0 111.81 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.65 -38.63 81.96 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.178 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.54 -36.18 65.64 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -71.72 -42.33 67.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.869 0.868 . . . . 0.0 111.643 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -80.51 -9.17 59.78 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.615 0.766 . . . . 0.0 112.412 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . 0.402 15.7 p-10 42.02 52.66 4.32 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.831 2.452 . . . . 0.0 113.245 -174.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 79.4 mt -100.49 133.67 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.334 1.854 . . . . 0.0 109.07 174.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -104.33 108.29 59.96 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-N 119.257 0.935 . . . . 0.0 112.362 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.85 140.94 52.28 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.476 2.784 . . . . 0.0 115.754 169.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.1 mm -121.56 100.59 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.519 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -74.06 75.26 1.73 Allowed 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.904 -1.122 . . . . 0.0 112.168 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . 0.255 13.4 m -76.18 110.6 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 120.762 -1.211 . . . . 0.0 112.486 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.23 141.88 17.66 Favored Pre-proline 0 N--CA 1.478 0.97 0 O-C-N 120.997 -1.065 . . . . 0.0 112.389 -171.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -51.32 150.83 14.17 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.43 3.42 . . . . 0.0 115.837 169.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.3 t -47.63 -44.87 27.23 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.374 1.87 . . . . 0.0 113.546 -169.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.8 mtp-105 -42.88 -38.56 2.22 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.614 1.565 . . . . 0.0 113.428 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.51 0.6 16.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.895 1.678 . . . . 0.0 113.322 -170.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 37.5 t -62.6 -38.97 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.615 -1.303 . . . . 0.0 111.141 -175.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -65.23 -27.19 68.49 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.077 0.853 . . . . 0.0 113.025 -174.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.7 t -84.47 -39.94 18.3 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.784 0.434 . . . . 0.0 111.009 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.413 ' CD1' HD12 ' A' ' 182' ' ' LEU . 45.1 m-85 -69.46 -30.32 68.19 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.805 -1.184 . . . . 0.0 110.764 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -60.84 -33.05 72.45 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.158 0.436 . . . . 0.0 110.508 169.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . 0.362 0.0 OUTLIER -87.81 -18.17 29.92 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 119.07 0.85 . . . . 0.0 112.244 -178.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.502 HD11 ' CE1' ' A' ' 116' ' ' PHE . 20.1 mt -72.92 -25.44 61.05 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.528 -1.357 . . . . 0.0 109.812 169.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.45 -10.28 59.28 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.299 1.84 . . . . 0.0 111.518 173.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 90.9 m -89.15 -32.62 17.39 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.363 1.065 . . . . 0.0 109.364 169.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -76.79 -30.11 56.33 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 118.906 -0.568 . . . . 0.0 112.484 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 20.2 mt -118.86 109.66 39.31 Favored Pre-proline 0 N--CA 1.484 1.24 0 CA-C-N 119.114 0.87 . . . . 0.0 110.685 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -55.62 143.21 80.2 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.394 3.396 . . . . 0.0 114.225 174.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt 79.66 -8.35 1.58 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 128.755 2.822 . . . . 0.0 113.452 170.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 10.6 mt -72.9 153.78 40.86 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.286 -0.883 . . . . 0.0 109.954 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.7 p -116.89 -149.04 0.44 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 123.333 1.54 . . . . 0.0 109.432 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.1 tp -177.64 131.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 C-N-CA 127.043 2.137 . . . . 0.0 108.223 -165.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -123.73 150.67 16.96 Favored Glycine 0 N--CA 1.465 0.624 0 C-N-CA 124.37 0.986 . . . . 0.0 110.66 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -94.6 85.1 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.5 tp . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 169.504 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 CA--C 1.543 0.693 0 CA-C-O 119.371 -0.347 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.2 t -128.99 118.7 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-O 121.797 0.808 . . . . 0.0 111.785 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -87.12 127.87 35.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.978 0.911 . . . . 0.0 109.188 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mp -123.44 135.63 54.19 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -117.4 113.29 21.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 123.108 1.432 . . . . 0.0 109.078 172.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -87.46 103.29 15.37 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 126.107 1.763 . . . . 0.0 111.166 174.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.0 tp -102.22 121.59 42.55 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.674 1.19 . . . . 0.0 110.284 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.09 157.89 24.04 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 170.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.02 132.95 11.44 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.409 1.957 . . . . 0.0 110.56 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.15 23.36 13.4 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.612 1.565 . . . . 0.0 114.192 -171.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.7 p . . . . . 0 N--CA 1.479 1.016 0 O-C-N 119.42 -2.05 . . . . 0.0 114.454 -174.817 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.544 0.726 0 CA-C-O 122.957 1.361 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.53 88.02 0.21 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 106.731 -2.548 . . . . 0.0 106.731 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -98.62 137.69 36.9 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.271 1.028 . . . . 0.0 109.757 -169.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.8 tt -116.93 146.13 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.01 -170.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.77 165.12 19.08 Favored Glycine 0 N--CA 1.464 0.519 0 C-N-CA 125.524 1.535 . . . . 0.0 110.575 171.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -139.76 128.22 22.86 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.863 0.865 . . . . 0.0 113.168 -169.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.35 147.12 19.05 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 123.639 0.638 . . . . 0.0 112.229 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.8 t -114.49 148.25 38.15 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.618 1.567 . . . . 0.0 110.517 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.75 152.27 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.905 1.282 . . . . 0.0 109.462 171.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.7 t -138.0 -70.83 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.779 0.831 . . . . 0.0 108.784 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 t30 174.95 -15.75 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 131.0 3.72 . . . . 0.0 108.622 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.5 ttt -58.58 -60.19 4.21 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.87 1.668 . . . . 0.0 107.111 167.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.412 ' HA ' ' HD2' ' A' ' 145' ' ' ARG 0.302 0.5 OUTLIER -173.87 169.26 4.15 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.264 2.226 . . . . 0.0 114.534 168.928 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -84.09 120.83 26.62 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 169.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -115.77 117.11 29.33 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 122.234 1.016 . . . . 0.0 110.279 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -74.67 110.56 9.06 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.751 1.62 . . . . 0.0 109.95 170.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.3 mt -94.63 -61.33 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.385 0.674 . . . . 0.0 110.392 -173.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.9 tp -124.99 124.74 42.64 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.034 0.934 . . . . 0.0 110.177 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 166.68 13.46 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.655 -0.653 . . . . 0.0 112.691 169.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 83.9 mt -58.15 116.05 3.31 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.74 -0.6 . . . . 0.0 111.136 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 36.8 p . . . . . 0 N--CA 1.48 1.074 0 C-N-CA 125.362 1.465 . . . . 0.0 112.244 -179.818 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.6 p -107.78 -143.78 0.38 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.079 1.352 . . . . 0.0 110.694 169.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.34 143.64 8.83 Favored Glycine 0 N--CA 1.472 1.046 0 O-C-N 120.376 -1.453 . . . . 0.0 114.622 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -160.44 150.47 17.95 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.037 1.735 . . . . 0.0 111.462 170.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.0 tp -73.68 -48.56 31.3 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -169.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.71 119.11 8.65 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 122.945 0.498 . . . . 0.0 109.926 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.9 p -71.16 -35.17 3.85 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 115.686 -2.102 . . . . 0.0 113.976 -174.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -66.0 144.9 77.96 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.375 2.05 . . . . 0.0 110.665 169.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -119.4 161.12 21.04 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -171.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.67 45.03 3.19 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 125.184 1.374 . . . . 0.0 115.598 -169.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -36.96 85.85 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.431 1.892 . . . . 0.0 114.038 -173.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.47 -33.91 76.6 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.547 0.612 . . . . 0.0 111.228 -169.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -58.02 -47.46 83.0 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.347 1.459 . . . . 0.0 111.684 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.86 -56.75 16.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.619 -1.181 . . . . 0.0 109.708 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.294 1.5 p -59.33 -36.83 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-O 117.765 -1.112 . . . . 0.0 113.366 -174.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.505 HG21 ' HG3' ' A' ' 151' ' ' GLN . 38.0 t -74.17 -38.96 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 121.396 1.907 . . . . 0.0 113.572 175.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -63.91 -40.52 96.69 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.719 1.6 . . . . 0.0 110.344 171.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.603 HG11 HD13 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -49.38 -35.51 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.291 1.037 . . . . 0.0 112.638 169.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.16 -48.21 13.52 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.9 tt -100.42 -4.63 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -171.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 72.2 m -82.5 58.34 4.11 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 119.8 -1.812 . . . . 0.0 110.483 170.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.46 -44.43 55.67 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.235 1.814 . . . . 0.0 111.262 -174.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.62 -24.98 55.05 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.141 -0.811 . . . . 0.0 114.74 -169.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -90.95 -40.59 11.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.267 1.034 . . . . 0.0 111.529 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.9 -38.48 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 118.941 0.791 . . . . 0.0 110.677 171.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.36 27.7 19.54 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.738 -1.034 . . . . 0.0 114.099 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -54.01 125.75 19.99 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.769 1.285 . . . . 0.0 111.63 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -105.06 -170.34 1.74 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.754 2.022 . . . . 0.0 112.059 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -75.13 0.23 16.93 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 118.948 2.944 . . . . 0.0 118.948 -168.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.68 -130.77 3.31 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 121.833 2.106 . . . . 0.0 112.06 -174.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.8 m -100.55 145.8 27.89 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.415 1.886 . . . . 0.0 106.93 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -135.69 128.13 30.43 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 121.395 1.907 . . . . 0.0 108.581 -168.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -133.21 115.73 15.35 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.603 HD13 HG11 ' A' ' 92' ' ' VAL . 47.7 tp -91.2 109.94 21.21 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.975 169.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.63 116.42 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 168.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.7 tp -95.13 134.49 37.79 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 117.276 -1.345 . . . . 0.0 108.094 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.42 124.99 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 O-C-N 123.895 0.747 . . . . 0.0 111.607 168.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.0 t -160.48 141.69 12.13 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.678 0.791 . . . . 0.0 113.067 172.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -103.74 24.41 11.25 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.94 2.096 . . . . 0.0 114.888 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -152.35 -175.69 5.38 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.144 -0.972 . . . . 0.0 112.176 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.51 -175.84 0.41 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.3 1.44 . . . . 0.0 110.806 169.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -137.15 153.84 50.38 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.664 1.185 . . . . 0.0 111.664 -170.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -83.45 132.31 34.97 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.032 0.533 . . . . 0.0 110.817 169.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 pp -117.45 173.94 6.42 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.436 1.494 . . . . 0.0 112.532 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.72 124.99 18.17 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.42 98.7 mttt 80.23 1.84 1.97 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.349 2.259 . . . . 0.0 115.039 -175.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -70.78 -15.24 62.65 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 120.848 -1.157 . . . . 0.0 108.657 166.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.556 ' HE2' ' CG ' ' A' ' 127' ' ' ARG . 4.9 ptmt -57.46 -29.47 64.25 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 173.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.5 m -60.74 -26.4 67.17 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 118.162 2.653 . . . . 0.0 118.162 -167.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.492 HD13 ' H ' ' A' ' 124' ' ' LEU 0.329 0.0 OUTLIER -69.75 -13.08 62.11 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.894 1.679 . . . . 0.0 113.273 170.607 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -105.9 150.12 16.84 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 167.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.5 p -75.98 81.89 2.86 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.26 1.53 . . . . 0.0 112.601 -171.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.556 ' CG ' ' HE2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -163.3 125.19 2.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.172 1.789 . . . . 0.0 110.475 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -119.56 -25.82 5.9 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.579 1.151 . . . . 0.0 113.088 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -51.56 107.23 0.18 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.673 1.589 . . . . 0.0 113.008 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.8 t -68.95 150.83 47.28 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.594 1.088 . . . . 0.0 110.952 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.1 m -55.19 131.7 45.91 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.695 1.198 . . . . 0.0 113.101 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.5 p30 -81.58 -15.28 55.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.338 0.655 . . . . 0.0 112.541 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.94 14.6 81.55 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.903 -1.498 . . . . 0.0 114.26 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -93.16 163.47 13.62 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.872 1.669 . . . . 0.0 112.384 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 20.0 t -62.89 130.85 46.62 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.793 0.837 . . . . 0.0 111.655 172.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -135.75 41.44 2.71 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.745 1.618 . . . . 0.0 112.164 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.1 tp -124.16 140.71 52.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.426 1.491 . . . . 0.0 110.943 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -150.51 -62.1 0.2 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.254 1.021 . . . . 0.0 111.286 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -70.24 -21.81 62.95 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 121.35 -19.4 8.64 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.722 1.629 . . . . 0.0 112.409 -169.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 94.7 mtp -98.31 140.52 32.46 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.628 1.571 . . . . 0.0 112.507 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -77.35 83.04 3.8 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.877 0.871 . . . . 0.0 110.456 169.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -64.36 -30.74 71.78 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.112 -0.993 . . . . 0.0 112.236 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 35.5 m -65.89 -2.12 3.57 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 175.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.412 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 40.2 ttt85 -52.37 -37.75 57.04 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.213 -1.554 . . . . 0.0 114.251 172.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.71 -22.24 77.4 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.694 -1.059 . . . . 0.0 114.412 -175.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.317 1.2 pt-20 -112.68 -68.43 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.198 0 CA-C-O 117.133 -1.413 . . . . 0.0 112.059 -173.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -55.36 173.0 0.36 Allowed 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 123.399 2.732 . . . . 0.0 117.265 168.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.415 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 45.4 t0 -100.46 171.51 7.7 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 127.914 2.486 . . . . 0.0 114.048 -173.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -73.7 120.93 19.98 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 166.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.505 ' HG3' HG21 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -70.78 144.26 50.92 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 120.932 -1.105 . . . . 0.0 110.644 -169.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 39.8 m -68.02 153.92 42.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.468 0.707 . . . . 0.0 111.737 -174.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 82.2 t -60.68 -27.64 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 120.542 -1.349 . . . . 0.0 112.794 -171.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.6 t -81.48 -27.35 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 121.323 -0.861 . . . . 0.0 112.801 171.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -67.0 -38.22 85.59 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.298 0.954 . . . . 0.0 110.253 170.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.467 HD13 HG23 ' A' ' 90' ' ' VAL . 3.6 mm? -55.56 -61.41 2.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.751 0.705 . . . . 0.0 109.19 169.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.75 -48.08 70.04 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.306 1.042 . . . . 0.0 113.569 -170.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 64.7 m -63.82 -45.35 90.01 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -64.14 -47.64 79.14 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.399 -0.813 . . . . 0.0 111.155 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.4 mt -55.58 -40.51 72.08 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.827 0.851 . . . . 0.0 112.68 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.24 -33.26 56.07 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -80.52 -25.55 38.64 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.477 1.035 . . . . 0.0 112.002 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -80.49 -13.91 58.71 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.482 0.713 . . . . 0.0 110.758 168.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 33.4 m120 60.3 36.32 20.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.215 1.806 . . . . 0.0 112.848 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 67.1 mt -95.61 145.13 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.264 1.026 . . . . 0.0 108.929 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -105.13 102.72 37.97 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -77.46 156.29 32.42 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.139 1.226 . . . . 0.0 113.267 169.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.458 HG22 HG23 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -141.42 105.93 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.568 1.547 . . . . 0.0 109.522 -169.58 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -75.1 73.83 2.26 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.729 -1.232 . . . . 0.0 112.756 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.458 HG23 HG22 ' A' ' 168' ' ' ILE . 76.5 t -66.6 108.87 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 O-C-N 121.235 -0.915 . . . . 0.0 111.233 169.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 34.5 m -146.62 146.64 27.57 Favored Pre-proline 0 N--CA 1.482 1.126 0 O-C-N 120.592 -1.317 . . . . 0.0 112.314 -174.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -67.57 159.75 51.13 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.844 3.03 . . . . 0.0 112.801 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.5 t -41.2 -54.14 2.99 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.453 1.901 . . . . 0.0 114.437 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -57.17 -33.2 67.21 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.69 -17.17 32.37 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.911 1.285 . . . . 0.0 113.966 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.4 t -55.73 -41.12 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 120.15 1.341 . . . . 0.0 112.113 -168.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -62.47 -37.59 86.56 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -172.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 9.6 t -84.27 -30.25 25.78 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.901 0.48 . . . . 0.0 111.3 -173.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -69.14 -32.9 72.58 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.639 -1.288 . . . . 0.0 109.211 169.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -68.37 -7.11 28.46 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.347 -0.845 . . . . 0.0 112.699 169.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -98.91 -6.59 28.59 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.04 -1.038 . . . . 0.0 112.403 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 6.2 mp -104.84 -15.37 15.21 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.546 1.538 . . . . 0.0 111.926 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 6.0 t -79.5 -23.2 43.14 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 118.995 0.816 . . . . 0.0 111.832 169.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 1.7 t -77.85 -23.41 48.93 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.676 -0.64 . . . . 0.0 110.559 172.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -82.45 -34.48 28.14 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 119.375 -0.345 . . . . 0.0 111.102 169.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 13.2 mt -117.66 80.88 14.1 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.985 0.914 . . . . 0.0 109.838 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -62.17 152.34 76.6 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.123 1.882 . . . . 0.0 110.561 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 91.26 -17.31 0.17 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 130.415 3.486 . . . . 0.0 112.505 -176.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.0 tt -74.98 155.62 37.17 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.028 1.331 . . . . 0.0 108.295 168.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.266 48.0 p -127.94 -164.08 1.33 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 169.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 10.8 mt -157.82 145.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 126.823 2.049 . . . . 0.0 109.697 -165.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -131.87 155.34 21.38 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 123.818 0.723 . . . . 0.0 112.284 170.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -85.24 98.74 10.67 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.427 ' HB2' HG12 ' A' ' 170' ' ' VAL . 18.2 tp . . . . . 0 CA--C 1.542 0.641 0 CA-C-N 113.422 -1.717 . . . . 0.0 107.896 168.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 p . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.4 t -133.26 149.21 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.513 1.125 . . . . 0.0 110.007 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -121.62 115.82 23.46 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.353 2.261 . . . . 0.0 109.088 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.51 126.14 53.23 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 120.933 -1.104 . . . . 0.0 111.252 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -112.02 111.98 23.28 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 123.162 1.458 . . . . 0.0 110.227 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -87.57 100.34 12.72 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 126.236 1.814 . . . . 0.0 112.3 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.6 tp -94.84 116.76 29.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.511 0.725 . . . . 0.0 111.104 171.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.407 ' HG3' ' CD2' ' A' ' 12' ' ' LEU . 28.4 ptm -114.99 144.26 43.88 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 175.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.89 123.8 6.33 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.96 1.267 . . . . 0.0 111.655 172.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.407 ' CD2' ' HG3' ' A' ' 10' ' ' MET . 4.0 mm? -107.06 43.7 1.14 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.97 1.708 . . . . 0.0 111.079 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 124.106 0.963 . . . . 0.0 112.178 169.861 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.619 0.723 . . . . 0.0 109.231 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.36 85.86 0.28 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 127.669 2.557 . . . . 0.0 107.925 -169.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -80.24 140.39 36.27 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -173.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.4 tp -120.76 136.49 57.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 123.431 0.692 . . . . 0.0 110.389 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.42 147.55 18.86 Favored Glycine 0 N--CA 1.466 0.689 0 C-N-CA 124.221 0.915 . . . . 0.0 110.971 169.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -102.24 164.34 11.74 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.06 147.8 12.74 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 120.713 -1.242 . . . . 0.0 111.718 169.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.5 p -128.33 149.74 50.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.413 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -145.72 151.72 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.923 0.889 . . . . 0.0 111.647 -175.731 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.423 HG13 ' H ' ' A' ' 50' ' ' ASN 0.273 3.0 p -152.92 -101.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 124.096 0.958 . . . . 0.0 110.362 169.318 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.423 ' H ' HG13 ' A' ' 49' ' ' VAL 0.301 37.1 t30 -136.4 -11.37 1.88 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.084 1.354 . . . . 0.0 109.811 168.094 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 92.1 mtp -87.28 48.49 1.66 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 102.233 -3.247 . . . . 0.0 102.233 163.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.467 2.1 m 16.23 -116.41 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.506 1 C-N-CA 135.787 5.635 . . . . 0.0 116.145 -167.036 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -113.39 137.97 50.76 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.176 1.39 . . . . 0.0 112.769 -168.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -124.34 122.91 38.99 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -85.6 118.34 25.05 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.087 0.555 . . . . 0.0 109.667 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -125.33 142.19 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 126.163 1.785 . . . . 0.0 107.352 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 39.38 95.63 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 128.963 2.905 . . . . 0.0 117.244 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 161.51 5.84 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.066 0.946 . . . . 0.0 113.101 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.66 124.31 14.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.505 1.122 . . . . 0.0 111.523 -170.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.48 1.038 0 C-N-CA 125.035 1.334 . . . . 0.0 112.089 -179.958 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.2 p -106.48 -128.55 0.26 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.382 1.473 . . . . 0.0 111.169 171.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 174.76 146.71 5.82 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.359 1.457 . . . . 0.0 113.706 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.58 164.06 32.23 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.098 1.359 . . . . 0.0 112.441 170.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.3 mt -72.23 -48.59 41.67 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -169.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.29 132.97 47.29 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.077 0.551 . . . . 0.0 110.988 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.269 3.7 t -72.58 -37.73 4.58 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-O 116.186 -1.864 . . . . 0.0 113.846 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -69.38 151.83 71.27 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 122.315 2.01 . . . . 0.0 111.269 171.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -122.63 164.29 18.48 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.503 1.121 . . . . 0.0 113.499 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.71 28.64 5.8 Favored Glycine 0 N--CA 1.474 1.211 0 O-C-N 120.369 -1.457 . . . . 0.0 115.663 -170.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -47.04 -40.95 15.89 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.282 1.541 . . . . 0.0 114.747 -168.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.414 HD13 ' CD2' ' A' ' 116' ' ' PHE 0.365 5.0 mp -76.88 -19.23 57.7 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 117.98 -1.01 . . . . 0.0 113.463 -172.561 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.23 -41.31 98.29 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 168.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.29 -54.53 23.69 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 117.133 -1.413 . . . . 0.0 110.668 169.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.5 m -56.76 -33.47 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 120.827 1.649 . . . . 0.0 112.85 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.541 HG22 HD11 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -68.3 -51.78 44.26 Favored 'Isoleucine or valine' 0 C--N 1.345 0.394 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.387 172.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -60.66 -41.21 94.58 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 120.246 1.385 . . . . 0.0 110.533 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.484 HG11 HD13 ' A' ' 108' ' ' LEU . 64.6 t -56.54 -35.52 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.767 1.227 . . . . 0.0 112.318 175.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.35 -36.34 29.77 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.541 HD11 HG22 ' A' ' 90' ' ' VAL . 7.5 mt -83.5 -30.36 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.838 1.199 . . . . 0.0 112.548 -173.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 88.6 m -83.82 53.69 2.65 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.147 1.379 . . . . 0.0 112.35 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -55.84 -34.2 65.21 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.43 1.092 . . . . 0.0 112.462 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.62 -33.24 48.01 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 119.275 -0.736 . . . . 0.0 114.705 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -95.59 -25.52 16.13 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.045 0.922 . . . . 0.0 112.633 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 92' ' ' VAL . 79.0 mt -82.83 -24.95 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.053 0.842 . . . . 0.0 111.179 169.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.53 24.11 61.33 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.087 -0.84 . . . . 0.0 113.807 171.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -57.87 124.91 20.83 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 118.309 1.055 . . . . 0.0 110.65 173.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -102.69 168.1 9.47 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.865 1.266 . . . . 0.0 111.224 171.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -84.28 54.97 3.15 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -172.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -94.39 -113.43 2.5 Favored Glycine 0 N--CA 1.474 1.213 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 169.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 m -127.41 136.55 51.99 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 128.005 2.522 . . . . 0.0 104.719 169.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.36 136.95 51.63 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 121.344 1.884 . . . . 0.0 110.439 -171.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -126.91 116.26 20.54 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 124.916 1.286 . . . . 0.0 112.761 -172.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.484 HD13 HG11 ' A' ' 92' ' ' VAL . 13.0 tp -94.53 103.2 15.16 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 171.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.68 123.39 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -113.16 128.3 56.44 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -173.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.885 HG12 HG22 ' A' ' 170' ' ' VAL . 4.5 m -133.12 129.14 56.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 124.656 1.223 . . . . 0.0 112.397 -177.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.3 t -155.37 170.97 20.68 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.869 1.268 . . . . 0.0 110.142 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -123.23 -1.3 8.71 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -139.49 175.51 9.5 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.682 -1.261 . . . . 0.0 112.419 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -58.16 -176.25 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.775 1.63 . . . . 0.0 112.39 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.414 ' CD2' HD13 ' A' ' 86' ' ' LEU . 13.0 p90 -138.01 163.17 32.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 123.086 1.422 . . . . 0.0 114.078 -169.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -78.9 112.15 15.79 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.73 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 mt -80.71 163.29 23.66 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.746 0.818 . . . . 0.0 110.56 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.71 132.72 49.83 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 168.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 90.79 -11.53 0.28 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 130.496 3.519 . . . . 0.0 114.579 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -28.13 69.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 122.186 2.266 . . . . 0.0 111.657 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.457 ' HE2' ' CD2' ' A' ' 150' ' ' TYR . 3.1 tppt? -64.4 -7.84 11.22 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.826 1.25 . . . . 0.0 113.038 -176.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.1 t -64.96 -24.34 67.49 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 120.863 -1.148 . . . . 0.0 112.351 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.78 -32.97 74.9 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.321 0.964 . . . . 0.0 112.147 172.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -86.65 4.55 86.12 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.014 1.293 . . . . 0.0 113.854 170.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.336 31.8 p 56.39 41.47 28.91 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 129.069 2.948 . . . . 0.0 114.811 -176.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.83 109.56 21.13 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.409 1.483 . . . . 0.0 108.557 169.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -94.07 -39.26 10.7 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -59.66 129.16 40.53 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.973 0.806 . . . . 0.0 111.666 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.8 t -64.83 163.39 14.33 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.169 0.988 . . . . 0.0 111.286 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.2 p -68.54 140.88 55.64 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.347 0.594 . . . . 0.0 112.087 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.0 p30 -88.93 -14.54 36.47 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.58 25.15 73.12 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.901 -0.944 . . . . 0.0 113.444 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.4 mtp-105 -106.19 166.61 10.39 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.615 1.566 . . . . 0.0 113.121 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 82.4 m -64.34 136.87 57.55 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.191 0.996 . . . . 0.0 111.245 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -142.37 33.85 1.49 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.239 1.416 . . . . 0.0 112.162 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.4 tp -102.81 140.57 36.9 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.637 1.975 . . . . 0.0 109.903 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -146.64 -64.91 0.29 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -87.29 3.23 47.56 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.986 1.315 . . . . 0.0 114.114 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.54 -12.63 43.02 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.857 1.694 . . . . 0.0 114.007 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.5 mtt -95.28 148.58 22.26 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.661 1.731 . . . . 0.0 111.681 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -73.63 90.06 1.77 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 168.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -55.8 -42.19 75.25 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.889 0.876 . . . . 0.0 112.541 -171.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 69.1 m -75.78 2.99 10.75 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -174.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -43.05 -32.87 0.74 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 171.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.94 8.51 63.33 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.502 2.001 . . . . 0.0 115.615 -174.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.265 32.3 tt0 -131.98 -60.13 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.978 0 CA-C-N 120.53 2.165 . . . . 0.0 114.055 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -70.52 146.09 54.52 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 CA-C-N 122.516 1.934 . . . . 0.0 113.029 169.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -65.41 165.52 11.8 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 129.136 2.974 . . . . 0.0 113.136 169.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.457 ' CD2' ' HE2' ' A' ' 122' ' ' LYS . 97.4 m-85 -62.27 155.28 25.24 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.389 1.09 . . . . 0.0 112.025 169.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -76.86 143.78 39.46 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.61 1.164 . . . . 0.0 110.172 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 44.2 p -73.01 153.79 40.76 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.982 0.42 . . . . 0.0 110.854 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.93 -26.09 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.386 1.075 . . . . 0.0 113.789 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.6 t -81.98 -37.19 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.107 1.363 . . . . 0.0 112.034 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -67.4 -33.3 74.91 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.124 0.875 . . . . 0.0 111.795 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.89 -56.11 17.73 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.656 0.662 . . . . 0.0 110.508 169.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -58.34 -34.47 70.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.966 0.906 . . . . 0.0 112.91 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.3 t -59.27 -65.51 0.66 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.867 0.867 . . . . 0.0 111.3 170.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -67.83 -27.62 66.87 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.187 -1.571 . . . . 0.0 113.853 -174.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -37.3 79.66 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.25 1.386 . . . . 0.0 111.751 169.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.38 -28.45 37.96 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -74.7 -39.85 61.7 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.004 0.82 . . . . 0.0 110.948 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -86.11 -13.67 46.51 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.752 1.221 . . . . 0.0 111.897 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 30.0 m120 58.46 39.92 24.59 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.907 2.083 . . . . 0.0 112.818 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.7 mt -90.99 138.22 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.824 1.65 . . . . 0.0 108.814 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -96.42 107.5 36.21 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 120.354 1.434 . . . . 0.0 110.235 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.77 149.68 43.32 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.126 1.884 . . . . 0.0 113.168 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 30.0 mt -140.97 105.82 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.638 0.775 . . . . 0.0 110.093 176.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.53 ' CD2' HD21 ' A' ' 189' ' ' LEU . 22.5 m-85 -75.82 64.22 1.77 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.425 1.09 . . . . 0.0 113.09 -177.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.885 HG22 HG12 ' A' ' 111' ' ' VAL 0.335 0.5 OUTLIER -60.32 114.01 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 119.952 -1.717 . . . . 0.0 113.38 169.917 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 35.5 m -151.63 150.47 26.55 Favored Pre-proline 0 N--CA 1.48 1.027 0 O-C-N 120.636 -1.29 . . . . 0.0 112.829 -172.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.41 157.18 59.42 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.325 3.35 . . . . 0.0 113.023 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.5 p -44.66 -51.39 9.22 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.828 2.051 . . . . 0.0 113.968 -170.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -52.21 -27.31 14.23 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -174.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 22.4 ptm -117.13 3.72 12.7 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.323 1.449 . . . . 0.0 114.831 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.11 -39.65 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 CA-C-N 119.994 1.27 . . . . 0.0 110.624 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -67.99 -26.73 66.06 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -170.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.7 -37.6 20.75 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.811 1.245 . . . . 0.0 110.417 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -73.2 -28.44 62.18 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.843 -1.16 . . . . 0.0 111.381 174.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . 0.314 15.0 pt-20 -77.38 0.21 23.28 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.722 1.146 . . . . 0.0 111.995 169.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -99.08 -10.33 22.72 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.201 -0.937 . . . . 0.0 111.349 168.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.86 -31.19 28.13 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.214 1.806 . . . . 0.0 108.551 169.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.2 t -77.89 -5.62 51.61 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.593 1.157 . . . . 0.0 113.387 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 7.5 t -100.91 -17.44 16.82 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.944 0.498 . . . . 0.0 110.336 168.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -82.63 -45.36 14.64 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.258 0.481 . . . . 0.0 111.499 169.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 4.0 mp -97.51 118.11 64.67 Favored Pre-proline 0 N--CA 1.475 0.793 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -76.46 143.64 24.82 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.441 2.094 . . . . 0.0 111.191 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 79.5 tttt 101.46 -22.95 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 130.253 3.421 . . . . 0.0 114.486 169.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.53 HD21 ' CD2' ' A' ' 169' ' ' PHE 0.364 0.0 OUTLIER -76.57 168.59 19.81 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 118.897 0.771 . . . . 0.0 111.74 -177.24 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.352 6.9 t -136.86 -163.3 1.4 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 122.983 1.373 . . . . 0.0 107.946 176.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 17.1 tt -157.56 136.98 3.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 126.427 1.891 . . . . 0.0 112.461 -166.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -119.53 155.72 16.02 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.627 0.632 . . . . 0.0 111.905 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -95.34 90.52 5.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 169.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.652 ' HB2' HG23 ' A' ' 170' ' ' VAL . 55.6 tp . . . . . 0 N--CA 1.468 0.454 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.975 169.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -112.46 137.83 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.645 1.578 . . . . 0.0 111.145 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -115.3 99.2 7.22 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 168.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -90.81 128.22 36.63 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.604 -0.685 . . . . 0.0 111.248 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.514 ' CD1' HG21 ' A' ' 92' ' ' VAL . 31.3 t80 -123.78 109.18 13.34 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 123.435 1.588 . . . . 0.0 111.767 172.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -85.63 101.46 12.74 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.261 2.224 . . . . 0.0 113.626 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.5 mt -93.47 119.44 32.56 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.8 ptm -117.75 145.15 44.68 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 169.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.58 136.21 24.38 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' A' ' 47' ' ' SER . 3.7 mp -109.05 16.27 22.7 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.47 1.508 . . . . 0.0 113.171 -176.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 CA--C 1.548 0.866 0 O-C-N 120.186 -1.571 . . . . 0.0 113.265 174.325 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.2 m . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.91 81.54 0.31 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 127.023 2.249 . . . . 0.0 108.501 -170.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -80.28 134.87 36.13 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.839 1.256 . . . . 0.0 107.743 -171.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.5 tp -119.61 142.64 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.161 0.585 . . . . 0.0 111.194 -172.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.89 160.26 29.89 Favored Glycine 0 N--CA 1.467 0.736 0 C-N-CA 125.171 1.367 . . . . 0.0 111.435 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -146.34 142.57 28.38 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -169.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.3 142.27 13.25 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.563 ' HB2' HD22 ' A' ' 12' ' ' LEU . 4.2 p -108.78 142.68 38.98 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.114 0.966 . . . . 0.0 110.615 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.566 HD13 ' HB2' ' A' ' 88' ' ' ALA 0.297 0.6 OUTLIER -152.26 137.87 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.943 1.461 . . . . 0.0 114.943 -176.487 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.05 -137.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 127.577 2.351 . . . . 0.0 105.719 172.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' A' ' 52' ' ' THR 0.301 10.1 m120 -98.01 -1.6 42.26 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.671 1.578 . . . . 0.0 111.992 168.388 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 62.9 mtt -85.6 40.93 0.87 Allowed 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 102.079 -3.304 . . . . 0.0 102.079 163.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.366 68.4 p 14.38 -113.51 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.94 1 C-N-CA 133.925 4.89 . . . . 0.0 113.946 -166.092 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -112.36 130.07 56.09 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 125.089 1.493 . . . . 0.0 111.893 -168.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -122.89 118.75 28.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 168.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -81.39 116.52 21.25 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.039 170.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 mm -89.87 -44.26 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 119.16 -0.448 . . . . 0.0 110.991 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.8 tp -151.53 123.9 8.32 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.793 0.806 . . . . 0.0 112.98 -172.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -54.97 149.34 11.88 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.599 1.96 . . . . 0.0 112.455 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.5 mt -51.15 112.97 0.81 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.048 1.339 . . . . 0.0 110.301 169.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.469 0.477 0 C-N-CA 124.173 0.989 . . . . 0.0 112.152 -173.836 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.5 m -131.75 -175.24 3.65 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.729 2.412 . . . . 0.0 110.417 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -137.0 166.77 24.84 Favored Glycine 0 N--CA 1.477 1.374 0 O-C-N 120.664 -1.272 . . . . 0.0 114.649 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -155.7 155.32 32.96 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.442 1.497 . . . . 0.0 113.069 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -56.28 -65.0 0.68 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.417 2.287 . . . . 0.0 111.296 168.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.48 145.17 41.62 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.131 0.972 . . . . 0.0 113.606 -172.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.9 m -70.68 -44.95 17.15 Favored Pre-proline 0 N--CA 1.474 0.761 0 CA-C-O 116.135 -1.888 . . . . 0.0 113.218 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -69.75 141.88 46.46 Favored 'Trans proline' 0 C--N 1.354 0.851 0 CA-C-N 122.225 1.83 . . . . 0.0 112.403 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -92.84 178.88 5.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.378 1.871 . . . . 0.0 112.773 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.43 22.41 26.72 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 125.912 1.72 . . . . 0.0 115.231 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . 0.268 2.8 tt0 -64.02 -29.67 70.8 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 119.353 3.094 . . . . 0.0 119.353 -168.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.534 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 6.3 mp -67.22 -20.47 65.69 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 122.255 2.298 . . . . 0.0 112.518 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -65.07 -35.13 80.18 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.651 1.114 . . . . 0.0 111.234 169.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB2' HD13 ' A' ' 48' ' ' ILE . . . -69.88 -42.04 73.97 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-O 117.086 -1.435 . . . . 0.0 110.041 168.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.292 2.1 m -61.99 -33.62 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 120.133 1.333 . . . . 0.0 112.764 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.7 p -68.8 -58.06 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 117.732 -1.128 . . . . 0.0 108.607 169.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -52.29 -53.41 44.41 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 121.184 1.811 . . . . 0.0 112.705 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.514 HG21 ' CD1' ' A' ' 7' ' ' TYR . 8.9 p -54.16 -41.6 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 119.51 1.05 . . . . 0.0 112.137 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.91 -19.25 61.3 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 159' ' ' LYS . 2.2 mp -106.06 -30.01 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 120.081 1.31 . . . . 0.0 113.22 -176.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 84.4 m -78.72 55.97 1.78 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.814 1.646 . . . . 0.0 111.215 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 72.7 mt -51.42 -44.12 62.18 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.148 2.179 . . . . 0.0 111.823 -171.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.3 -17.42 76.32 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.224 0.916 . . . . 0.0 114.264 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -90.76 -54.9 3.78 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.915 1.286 . . . . 0.0 110.19 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.32 -33.13 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 118.562 -0.733 . . . . 0.0 110.59 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.94 25.41 27.13 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.256 0.931 . . . . 0.0 113.432 174.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -57.27 123.95 17.16 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.172 0.986 . . . . 0.0 112.138 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.1 mtp-105 -97.27 -176.57 3.56 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.404 2.282 . . . . 0.0 110.668 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -100.77 39.13 1.41 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.078 1.351 . . . . 0.0 114.446 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -95.11 -122.47 3.83 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 169.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.1 t -113.06 143.62 44.02 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.721 1.608 . . . . 0.0 107.689 169.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -131.68 120.41 22.73 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.152 0.887 . . . . 0.0 110.117 -168.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.475 ' CE1' ' HG3' ' A' ' 166' ' ' GLN . 51.6 m-85 -120.89 105.64 10.88 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -169.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.41 99.71 12.2 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.5 t -81.06 127.51 39.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.6 tt -110.47 132.43 54.19 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.4 t -119.41 121.88 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.939 0.896 . . . . 0.0 109.944 169.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.3 p -138.97 168.59 19.49 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.599 1.56 . . . . 0.0 110.189 169.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.27 2.28 2.06 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 170.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -142.25 161.22 38.57 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.962 1.705 . . . . 0.0 110.618 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -45.49 173.16 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 128.409 2.684 . . . . 0.0 117.586 -169.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.534 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 49.0 t80 -129.08 137.66 51.39 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.998 -1.064 . . . . 0.0 113.184 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -79.02 84.63 5.01 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 125.13 1.372 . . . . 0.0 112.216 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.59 HD13 ' H ' ' A' ' 118' ' ' LEU 0.387 0.0 OUTLIER -73.08 174.65 7.61 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 119.802 -1.811 . . . . 0.0 113.432 174.833 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.57 134.72 1.72 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 -169.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.311 60.8 mtpt 75.27 -2.25 2.87 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 131.308 3.843 . . . . 0.0 114.898 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.98 -21.18 66.8 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.609 1.095 . . . . 0.0 112.821 169.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.483 ' HE3' ' CZ ' ' A' ' 150' ' ' TYR . 61.5 mttt -69.72 -7.97 43.88 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.215 -1.553 . . . . 0.0 114.347 172.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.07 -15.55 63.79 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.196 1.362 . . . . 0.0 113.328 175.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -64.15 -21.54 66.59 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 118.802 0.728 . . . . 0.0 112.095 169.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -90.55 -128.32 3.81 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.72 1.629 . . . . 0.0 111.395 170.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.5 t -137.41 52.87 1.88 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.742 1.617 . . . . 0.0 110.132 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -133.7 88.64 2.5 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.854 1.661 . . . . 0.0 110.805 -169.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -102.73 -18.47 15.15 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -68.71 129.6 40.39 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.41 1.005 . . . . 0.0 110.832 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.0 t -69.36 161.38 29.48 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 118.822 0.737 . . . . 0.0 111.319 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.7 m -62.14 133.95 55.92 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.653 -0.654 . . . . 0.0 111.552 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -86.69 -12.58 47.93 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.66 23.99 73.67 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.276 -1.291 . . . . 0.0 114.184 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -103.32 165.13 11.22 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.144 1.472 . . . . 0.0 112.198 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 10.0 t -67.49 126.67 30.03 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.596 1.558 . . . . 0.0 109.382 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -127.34 55.86 1.57 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.637 1.575 . . . . 0.0 110.995 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.13 124.04 22.72 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.005 1.322 . . . . 0.0 109.774 -169.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -125.95 -58.45 1.38 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.34 1.056 . . . . 0.0 111.736 170.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -81.44 -21.38 38.88 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -174.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 121.91 -8.01 10.02 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.062 1.315 . . . . 0.0 114.513 -171.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 94.6 mtp -108.87 142.21 39.8 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.733 1.267 . . . . 0.0 111.364 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -67.69 83.16 0.18 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.272 1.029 . . . . 0.0 110.573 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -72.13 -15.43 61.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -169.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 86.6 p -78.07 -5.34 51.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.71 1.141 . . . . 0.0 113.223 170.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -41.68 -35.03 0.69 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.78 -5.03 81.92 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 117.517 -1.713 . . . . 0.0 114.989 -175.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -120.96 -70.71 0.02 OUTLIER Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 119.791 1.796 . . . . 0.0 112.643 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -61.08 147.18 96.42 Favored 'Trans proline' 0 C--N 1.355 0.891 0 CA-C-N 123.064 2.13 . . . . 0.0 114.919 171.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -62.05 174.87 0.78 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 130.248 3.419 . . . . 0.0 113.397 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.483 ' CZ ' ' HE3' ' A' ' 122' ' ' LYS . 59.5 m-85 -74.17 145.21 44.39 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.487 1.115 . . . . 0.0 112.435 172.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -67.86 131.59 45.81 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.534 0.683 . . . . 0.0 111.971 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 27.0 p -63.11 142.02 58.54 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.055 1.342 . . . . 0.0 113.396 170.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.85 -27.29 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 121.109 -0.994 . . . . 0.0 112.484 -174.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.3 t -65.38 -44.18 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 121.355 -0.84 . . . . 0.0 111.556 172.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -76.1 -20.69 57.43 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.688 -0.633 . . . . 0.0 112.062 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.29 -50.54 63.35 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.265 0.939 . . . . 0.0 108.658 168.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.49 -41.92 73.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.439 0.696 . . . . 0.0 112.615 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.8 p -68.75 -51.42 41.48 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.906 0.775 . . . . 0.0 112.416 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.492 ' HB3' HD11 ' A' ' 94' ' ' ILE . 5.5 mptp? -67.44 -38.31 84.32 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.533 -1.354 . . . . 0.0 113.242 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.414 HD23 ' HG3' ' A' ' 167' ' ' PRO . 10.9 mp -66.21 -35.05 79.41 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.364 -0.835 . . . . 0.0 111.582 176.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.71 -28.71 58.71 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 172.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.37 -49.25 64.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.117 1.367 . . . . 0.0 110.026 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -91.09 -0.13 57.66 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.733 0.813 . . . . 0.0 112.907 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.3 m120 47.03 59.61 3.92 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.908 2.083 . . . . 0.0 112.492 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.7 mm -95.71 129.36 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 169.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.475 ' HG3' ' CE1' ' A' ' 107' ' ' PHE 0.345 10.5 pt20 -98.71 110.65 57.99 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 123.3 2.773 . . . . 0.0 108.448 169.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.633 ' HG2' ' HG ' ' A' ' 189' ' ' LEU . 58.2 Cg_endo -70.89 145.44 50.65 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 124.564 3.509 . . . . 0.0 114.06 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 8.6 mm -127.29 98.69 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.509 1.524 . . . . 0.0 109.338 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -76.89 82.06 3.46 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.22 -1.55 . . . . 0.0 110.453 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.469 ' CG1' HD13 ' A' ' 194' ' ' LEU . 94.2 t -71.95 126.4 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 O-C-N 120.622 -1.299 . . . . 0.0 110.582 168.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 5.1 p -163.11 141.77 6.49 Favored Pre-proline 0 N--CA 1.483 1.221 0 CA-C-O 117.745 -1.122 . . . . 0.0 113.43 -169.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -63.75 157.48 51.74 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 125.033 3.822 . . . . 0.0 116.309 176.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 78.4 p -56.47 -27.0 55.77 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -169.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -56.77 -36.12 69.46 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.664 1.12 . . . . 0.0 112.701 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 52.6 ttp -116.91 -6.12 11.47 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 -169.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 51.6 t -53.99 -32.11 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.718 -1.239 . . . . 0.0 111.286 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -61.79 -34.92 76.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.912 1.285 . . . . 0.0 113.524 -175.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.8 t -92.6 -39.68 11.19 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.848 0.859 . . . . 0.0 110.397 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -69.12 -35.16 76.1 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.318 1.047 . . . . 0.0 110.084 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -68.96 -7.03 31.34 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.549 1.068 . . . . 0.0 112.667 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -99.11 -16.66 18.55 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.826 -1.171 . . . . 0.0 111.536 169.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.05 -21.78 46.33 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.697 -1.252 . . . . 0.0 109.557 169.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.504 HG22 HD22 ' A' ' 189' ' ' LEU . 67.3 p -79.61 -18.76 50.88 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.971 0.908 . . . . 0.0 112.919 172.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . 0.289 1.7 t -81.25 -17.46 49.39 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.365 0.529 . . . . 0.0 109.909 169.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -89.62 -26.23 20.88 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.826 0.451 . . . . 0.0 111.756 168.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.5 mm -111.86 85.63 6.54 Favored Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 124.984 1.313 . . . . 0.0 110.084 172.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.17 136.94 76.1 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.257 1.971 . . . . 0.0 111.517 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 87.71 -5.7 0.59 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 129.765 3.226 . . . . 0.0 114.335 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.633 ' HG ' ' HG2' ' A' ' 167' ' ' PRO . 3.8 tt -72.43 138.84 47.39 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.891 1.276 . . . . 0.0 108.319 169.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 41.5 p -116.92 -164.48 0.98 Allowed 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 120.349 1.431 . . . . 0.0 107.467 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.2 mt -164.53 153.43 2.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 126.052 1.741 . . . . 0.0 110.383 -167.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -140.33 141.22 11.25 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.799 168.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -80.2 82.28 6.29 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 123.628 1.68 . . . . 0.0 108.305 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.469 HD13 ' CG1' ' A' ' 170' ' ' VAL . 17.3 tp . . . . . 0 CA--C 1.541 0.626 0 CA-C-N 112.605 -2.089 . . . . 0.0 110.857 170.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.7 t -114.91 141.1 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.769 1.228 . . . . 0.0 110.052 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -114.25 115.74 27.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.551 1.14 . . . . 0.0 109.327 169.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 tp -100.08 129.91 46.17 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.662 0.665 . . . . 0.0 111.874 169.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -120.3 105.26 10.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 123.508 1.623 . . . . 0.0 109.564 169.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -84.0 105.84 15.19 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.54 -1.664 . . . . 0.0 111.286 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -103.3 108.5 19.75 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.726 1.21 . . . . 0.0 109.701 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.2 ptm -113.2 145.54 40.82 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.91 139.58 27.45 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.043 0.83 . . . . 0.0 111.511 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.446 HD13 ' HB2' ' A' ' 47' ' ' SER . 1.4 mp -112.18 25.75 11.25 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.494 1.917 . . . . 0.0 112.529 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.3 t . . . . . 0 CA--C 1.546 0.818 0 C-N-CA 123.544 0.737 . . . . 0.0 111.345 169.61 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 122.328 1.061 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.94 84.79 0.23 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 -170.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -74.96 146.03 42.07 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.5 tt -133.05 134.45 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.64 0.776 . . . . 0.0 110.585 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.56 152.58 21.66 Favored Glycine 0 N--CA 1.467 0.752 0 C-N-CA 125.907 1.718 . . . . 0.0 111.146 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -124.08 146.98 48.23 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.415 0.686 . . . . 0.0 111.557 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.24 154.14 25.72 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 170.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.446 ' HB2' HD13 ' A' ' 12' ' ' LEU . 93.6 p -135.24 159.17 42.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.357 1.075 . . . . 0.0 113.185 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.445 HG21 ' HG2' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -155.64 147.77 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 121.347 -0.846 . . . . 0.0 111.986 -169.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.411 ' N ' HD13 ' A' ' 48' ' ' ILE 0.306 12.0 p -154.29 -129.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 116.626 -1.654 . . . . 0.0 109.427 171.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -95.45 -20.86 18.72 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 123.43 2.832 . . . . 0.0 112.963 169.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 46.2 mtt -80.75 49.13 1.15 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 167.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.294 12.8 p 25.17 -120.66 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.518 1 C-N-CA 132.157 4.183 . . . . 0.0 114.381 -169.057 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -107.35 133.13 52.34 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 127.483 2.313 . . . . 0.0 112.503 -167.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.2 123.85 48.79 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 169.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -97.43 127.76 43.66 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.609 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -155.67 113.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.929 0.892 . . . . 0.0 109.525 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.9 tp 96.51 83.21 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.868 3.267 . . . . 0.0 107.875 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.15 155.14 21.34 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.797 0.808 . . . . 0.0 111.149 169.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . 0.26 2.2 tm? -54.54 105.03 0.13 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 128.02 2.528 . . . . 0.0 109.689 -170.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.487 1.411 0 C-N-CA 125.71 1.604 . . . . 0.0 112.635 -169.525 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 121.084 0.469 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.9 p -119.56 -157.91 0.72 Allowed 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.761 -0.587 . . . . 0.0 110.333 168.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.66 143.12 9.64 Favored Glycine 0 CA--C 1.524 0.609 0 O-C-N 121.154 -0.967 . . . . 0.0 112.202 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 149.45 28.12 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.659 1.583 . . . . 0.0 110.79 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.01 -57.23 4.18 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -168.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.73 136.76 58.09 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.657 0.662 . . . . 0.0 111.549 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.254 6.4 t -65.84 -39.12 28.34 Favored Pre-proline 0 N--CA 1.476 0.859 0 CA-C-O 116.321 -1.799 . . . . 0.0 114.599 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.71 143.29 50.6 Favored 'Trans proline' 0 C--N 1.359 1.084 0 CA-C-N 122.71 2.003 . . . . 0.0 111.665 173.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.557 ' H ' ' HD3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -114.15 162.29 16.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.125 1.77 . . . . 0.0 112.199 176.812 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.61 42.27 2.91 Favored Glycine 0 N--CA 1.479 1.525 0 C-N-CA 125.022 1.296 . . . . 0.0 115.264 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.445 ' HG2' HG21 ' A' ' 48' ' ' ILE . 22.5 mt-30 -60.74 -29.65 69.52 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.223 1.512 . . . . 0.0 112.891 -176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.405 HD11 ' CD1' ' A' ' 156' ' ' LEU . 15.5 tp -65.89 -32.86 74.61 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -169.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -59.7 -54.66 43.84 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.46 -52.31 64.07 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.636 0.774 . . . . 0.0 111.72 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.258 3.1 p -61.3 -36.44 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 119.592 1.087 . . . . 0.0 112.792 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.8 -35.76 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 120.607 1.548 . . . . 0.0 113.23 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -61.91 -46.42 89.44 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.055 1.298 . . . . 0.0 110.741 172.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.9 t -54.79 -36.73 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 122.84 0.456 . . . . 0.0 111.745 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.31 -30.81 62.23 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 20.7 tt -99.01 -25.59 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 61.2 m -82.91 61.31 5.88 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 120.459 1.481 . . . . 0.0 111.512 -171.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.3 mt -49.42 -45.58 46.48 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.909 2.884 . . . . 0.0 110.977 -171.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.59 -23.08 44.32 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 114.14 -1.391 . . . . 0.0 114.135 -173.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -84.66 -46.68 11.25 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.382 1.091 . . . . 0.0 110.938 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.0 mt -79.94 -25.01 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 118.054 -0.974 . . . . 0.0 111.474 177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.06 23.9 36.57 Favored Glycine 0 N--CA 1.471 0.992 0 CA-C-N 119.548 1.067 . . . . 0.0 115.306 169.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -52.62 122.43 8.98 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.92 1.288 . . . . 0.0 112.55 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -93.71 175.03 6.89 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.732 1.213 . . . . 0.0 111.131 170.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -90.49 27.95 1.59 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 116.288 1.958 . . . . 0.0 116.288 -168.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.34 -124.69 3.79 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 120.768 -1.207 . . . . 0.0 110.797 173.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.3 m -97.85 142.5 29.53 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.742 2.017 . . . . 0.0 107.58 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -142.85 119.47 11.08 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 121.076 1.762 . . . . 0.0 110.739 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -113.97 123.28 49.33 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 126.314 1.846 . . . . 0.0 112.99 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 tt -107.87 96.03 6.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 110.112 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 77.5 t -79.93 126.97 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.1 tp -114.25 116.01 28.33 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.66 130.7 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.448 ' O ' ' HD2' ' A' ' 172' ' ' PRO . 3.6 t -165.04 151.27 10.14 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 117.615 -1.183 . . . . 0.0 113.062 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -96.82 -13.64 22.43 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.565 1.946 . . . . 0.0 115.45 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -128.51 172.16 11.42 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.124 0.97 . . . . 0.0 113.371 -169.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.52 179.35 0.62 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.569 1.147 . . . . 0.0 111.603 169.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -128.4 156.46 43.13 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.034 -1.666 . . . . 0.0 113.437 -170.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -77.65 117.31 18.94 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.598 169.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.565 HD23 ' H ' ' A' ' 119' ' ' ALA . 2.8 tt -88.61 173.89 8.37 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.287 1.435 . . . . 0.0 110.015 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.565 ' H ' HD23 ' A' ' 118' ' ' LEU . . . -54.99 150.5 10.19 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.99 -1.069 . . . . 0.0 110.5 168.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt 74.06 -21.01 0.29 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.557 1.943 . . . . 0.0 114.826 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -54.01 -56.52 17.12 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.239 -1.538 . . . . 0.0 113.022 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.516 ' HE2' ' N ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -57.47 -6.83 0.51 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 119.341 3.089 . . . . 0.0 119.341 -177.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.378 0.5 OUTLIER -64.74 -20.26 66.25 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 122.328 2.331 . . . . 0.0 111.269 174.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -50.48 -44.46 55.87 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.298 1.839 . . . . 0.0 110.241 168.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -87.02 22.3 15.41 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.702 2.096 . . . . 0.0 114.503 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 56.3 m 73.22 20.57 3.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.65 1.98 . . . . 0.0 112.415 170.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 25.2 ttp-105 -116.25 112.59 21.83 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.571 1.548 . . . . 0.0 111.035 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -117.86 -33.76 4.39 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -170.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -63.62 118.21 7.9 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 120.329 1.422 . . . . 0.0 111.304 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.424 ' HA ' ' HB3' ' A' ' 149' ' ' ASP 0.261 3.0 t -67.96 166.36 15.93 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -171.466 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.8 p -60.85 129.11 39.8 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.708 0.803 . . . . 0.0 112.905 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.7 p30 -82.66 -13.68 56.01 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.458 0.703 . . . . 0.0 112.784 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.86 1.18 66.6 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.433 1.492 . . . . 0.0 114.377 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -79.57 165.69 22.68 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.728 1.611 . . . . 0.0 114.036 -169.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 31.3 t -74.1 126.77 31.27 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.809 0.843 . . . . 0.0 109.489 169.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -141.33 39.83 1.74 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.813 1.645 . . . . 0.0 111.739 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.3 mt -103.56 148.75 25.6 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.166 1.387 . . . . 0.0 109.091 172.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -143.15 -64.5 0.4 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.34 0.656 . . . . 0.0 112.182 175.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -92.11 15.79 12.69 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.387 1.475 . . . . 0.0 113.47 177.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.71 9.4 62.78 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.119 1.342 . . . . 0.0 114.526 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 59.5 ttm -117.61 146.68 43.49 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.115 1.366 . . . . 0.0 111.027 172.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.452 ' CE1' ' HB3' ' A' ' 144' ' ' SER . 50.7 t80 -74.35 87.63 2.02 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.877 0.871 . . . . 0.0 111.942 170.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 62.5 ttt-85 -50.62 -38.15 44.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.206 1.802 . . . . 0.0 112.582 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.452 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 4.0 t -64.12 -17.41 63.42 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.081 1.352 . . . . 0.0 114.632 -176.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -35.95 -50.85 0.7 Allowed 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 120.579 1.536 . . . . 0.0 114.107 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.09 -5.03 84.63 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.168 -1.351 . . . . 0.0 114.747 -172.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.327 3.0 pt-20 -129.09 -64.84 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 115.377 -2.249 . . . . 0.0 113.748 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -68.65 154.81 70.7 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 CA-C-N 124.627 2.688 . . . . 0.0 118.003 169.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.424 ' HB3' ' HA ' ' A' ' 130' ' ' THR 0.288 26.8 t0 -83.89 141.5 31.25 Favored 'General case' 0 CA--C 1.551 1.01 1 C-N-CA 133.082 4.553 . . . . 0.0 114.828 -176.598 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -50.67 113.99 1.04 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.416 -0.803 . . . . 0.0 111.21 168.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.624 ' CD ' ' H ' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -54.99 153.47 6.35 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 127.469 2.307 . . . . 0.0 114.849 -173.425 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 85.9 p -83.8 153.01 24.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.107 0.963 . . . . 0.0 112.898 -177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.9 m -55.06 -27.39 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.96 -44.6 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.957 0.903 . . . . 0.0 110.929 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -70.34 -28.25 65.0 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.807 -0.616 . . . . 0.0 111.311 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 186' ' ' ILE . 3.8 mt -60.53 -52.55 64.69 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.883 0.765 . . . . 0.0 110.039 172.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.3 -45.53 84.08 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.431 1.092 . . . . 0.0 111.065 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.2 m -65.91 -47.18 75.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.49 0.716 . . . . 0.0 112.763 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -61.22 -42.55 98.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.066 1.303 . . . . 0.0 111.974 174.688 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.49 -44.67 81.98 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.158 0.983 . . . . 0.0 111.784 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.6 -24.77 62.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.413 1.085 . . . . 0.0 113.471 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -75.27 -43.56 50.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.7 0.8 . . . . 0.0 110.724 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -85.08 -13.85 49.05 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.78 39.43 20.77 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.332 1.453 . . . . 0.0 113.541 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.0 mt -82.71 149.4 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 169.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -107.39 111.34 63.11 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 120.152 1.342 . . . . 0.0 109.503 169.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 189' ' ' LEU . 17.3 Cg_exo -78.02 149.71 25.87 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.655 3.57 . . . . 0.0 113.346 174.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.474 HG22 HG23 ' A' ' 170' ' ' VAL . 3.9 mp -132.91 107.56 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.875 1.27 . . . . 0.0 109.274 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -74.89 71.29 2.01 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.94 -1.1 . . . . 0.0 112.748 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.474 HG23 HG22 ' A' ' 168' ' ' ILE . 95.7 t -75.31 103.39 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 120.421 -1.424 . . . . 0.0 111.742 175.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 22.8 m -145.27 147.73 35.13 Favored Pre-proline 0 N--CA 1.48 1.038 0 O-C-N 120.754 -1.216 . . . . 0.0 112.661 -169.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.448 ' HD2' ' O ' ' A' ' 112' ' ' THR . 60.2 Cg_exo -55.34 149.99 43.43 Favored 'Trans proline' 0 C--N 1.353 0.791 1 C-N-CA 125.808 4.339 . . . . 0.0 115.744 177.518 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 36.5 p -46.73 -49.59 19.35 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.746 2.019 . . . . 0.0 113.422 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -43.22 -32.61 0.79 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.607 2.363 . . . . 0.0 115.431 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.8 ptm -118.68 -2.77 10.9 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.6 1.56 . . . . 0.0 114.75 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.78 -29.85 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-N 120.277 1.399 . . . . 0.0 111.05 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -65.11 -21.06 66.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.208 1.003 . . . . 0.0 113.525 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.55 -39.43 11.92 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.161 0.984 . . . . 0.0 111.36 177.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -73.36 -28.87 62.27 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 120.826 -1.171 . . . . 0.0 110.471 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -58.08 -23.77 55.94 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.66 0.784 . . . . 0.0 110.819 168.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -87.52 -29.54 21.26 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.517 -0.74 . . . . 0.0 110.546 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.82 -26.31 61.44 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.302 1.441 . . . . 0.0 110.138 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.295 3.2 t -80.37 -17.36 52.14 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 173.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 28.9 m -82.83 -34.37 26.89 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.637 -0.664 . . . . 0.0 109.402 169.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -78.77 -19.47 52.16 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 156' ' ' LEU . 20.3 mt -131.74 92.9 29.36 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.504 1.122 . . . . 0.0 108.978 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -60.56 142.34 97.66 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.943 2.429 . . . . 0.0 113.415 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt 93.99 -15.35 0.12 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 130.245 3.418 . . . . 0.0 114.798 169.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.41 ' HB3' ' HD2' ' A' ' 167' ' ' PRO . 1.6 pp -84.24 152.3 24.28 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.7 0.682 . . . . 0.0 109.266 168.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 76.3 p -111.0 -146.61 0.41 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -170.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.1 tt 179.75 152.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 128.317 2.647 . . . . 0.0 110.538 -168.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -153.14 151.05 22.89 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 123.912 0.767 . . . . 0.0 111.811 169.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.4 84.21 5.98 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.739 1.216 . . . . 0.0 109.491 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 11.7 tp . . . . . 0 N--CA 1.472 0.629 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.356 169.379 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.0 t . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.29 123.45 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 127.071 2.149 . . . . 0.0 108.737 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -108.68 104.79 14.15 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.717 1.207 . . . . 0.0 109.513 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.512 HD22 ' HB2' ' A' ' 107' ' ' PHE . 1.2 mt -96.1 132.17 41.76 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.882 -1.136 . . . . 0.0 112.824 173.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.442 ' CD2' HG23 ' A' ' 99' ' ' ILE . 26.2 t80 -121.53 110.79 16.45 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 124.426 2.06 . . . . 0.0 110.685 174.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -88.81 114.13 25.1 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 128.201 2.6 . . . . 0.0 113.111 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.448 HD11 HD11 ' A' ' 108' ' ' LEU . 6.8 mp -108.95 130.96 55.46 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.799 0.84 . . . . 0.0 111.099 169.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . 0.348 0.0 OUTLIER -128.93 151.62 49.46 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 167.299 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.16 129.54 11.68 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.964 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.53 27.63 8.62 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.43 1.892 . . . . 0.0 111.635 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 100.0 p . . . . . 0 CA--C 1.541 0.597 0 O-C-N 120.504 -1.372 . . . . 0.0 112.923 174.289 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 122.369 1.081 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.35 74.3 0.42 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 127.198 2.333 . . . . 0.0 108.235 -169.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -81.83 140.02 34.41 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.385 1.093 . . . . 0.0 108.238 -171.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.7 tt -120.32 142.94 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 117.856 0.298 . . . . 0.0 111.795 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.95 157.05 22.46 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.951 1.739 . . . . 0.0 110.1 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -128.26 142.59 51.11 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -169.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.82 141.82 12.01 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 118.729 0.695 . . . . 0.0 112.067 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.0 t -109.7 142.26 41.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.476 1.111 . . . . 0.0 110.447 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -150.48 152.28 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 120.775 -1.203 . . . . 0.0 111.766 170.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.3 t -138.72 -62.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.311 1.045 . . . . 0.0 111.06 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.3 t30 154.35 -24.88 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 1 C-N-CA 132.764 4.426 . . . . 0.0 108.24 -169.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.451 ' O ' HG23 ' A' ' 52' ' ' THR . 87.9 mtp -53.72 -50.3 66.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.64 1.176 . . . . 0.0 109.473 168.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 51' ' ' MET . 4.5 p 178.78 179.52 0.39 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 131.09 3.756 . . . . 0.0 108.846 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -98.28 125.75 43.5 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 103.561 -2.755 . . . . 0.0 103.561 166.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -111.9 114.92 28.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 122.337 1.065 . . . . 0.0 109.184 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -82.94 113.21 20.38 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.703 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.5 pt -142.07 115.41 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.967 0.907 . . . . 0.0 109.167 168.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.3 tp 101.72 96.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 130.262 3.425 . . . . 0.0 108.611 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -63.0 163.71 9.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.047 1.339 . . . . 0.0 111.535 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.7 mt -54.37 111.68 0.84 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.373 0.669 . . . . 0.0 110.757 174.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 125.34 1.456 . . . . 0.0 112.472 -174.684 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -118.11 -152.59 0.51 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.772 1.629 . . . . 0.0 110.102 169.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -132.79 152.38 20.28 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 124.95 1.262 . . . . 0.0 114.395 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -148.03 152.95 38.29 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.974 1.71 . . . . 0.0 111.154 173.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -70.55 -82.82 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.455 1.502 . . . . 0.0 111.251 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.05 158.93 30.24 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.0 m -65.04 -46.16 73.82 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 115.856 -2.021 . . . . 0.0 115.084 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.29 138.2 65.0 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.609 2.206 . . . . 0.0 112.482 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -101.87 162.55 12.82 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.941 0.897 . . . . 0.0 112.129 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.07 10.18 49.6 Favored Glycine 0 N--CA 1.482 1.706 0 C-N-CA 124.4 1.0 . . . . 0.0 115.098 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -28.21 -46.13 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 131.197 3.799 . . . . 0.0 115.613 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.462 ' HA ' HG12 ' A' ' 89' ' ' VAL . 6.3 tp -52.78 -34.15 52.05 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.922 2.489 . . . . 0.0 114.37 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -68.27 -40.62 81.82 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.596 -1.315 . . . . 0.0 111.81 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.63 -44.79 66.45 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.505 -0.76 . . . . 0.0 111.913 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 86' ' ' LEU . 7.7 p -54.66 -38.17 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 118.951 0.796 . . . . 0.0 111.755 174.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.485 HG22 HD11 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -70.62 -53.62 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 119.139 0.881 . . . . 0.0 111.818 173.396 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -60.57 -41.35 94.46 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.685 1.13 . . . . 0.0 111.525 -173.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.88 -40.18 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.165 0.586 . . . . 0.0 111.472 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.07 -38.84 89.32 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.038 -1.039 . . . . 0.0 112.193 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.485 HD11 HG22 ' A' ' 90' ' ' VAL . 16.5 mt -81.21 -30.39 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -174.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -84.99 65.64 9.34 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.614 -1.304 . . . . 0.0 112.663 -174.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.4 mt -46.42 -43.59 16.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.781 2.033 . . . . 0.0 111.184 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.28 -31.0 35.47 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.807 1.194 . . . . 0.0 115.136 -174.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -84.95 -43.06 14.36 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.35 1.075 . . . . 0.0 110.514 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.442 HG23 ' CD2' ' A' ' 7' ' ' TYR . 15.9 mm -72.13 -35.96 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 122.306 -0.246 . . . . 0.0 110.338 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.66 25.91 26.38 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.715 1.15 . . . . 0.0 113.857 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.403 ' CZ3' ' HB2' ' A' ' 106' ' ' ARG . 24.8 m95 -55.13 122.5 11.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.645 1.178 . . . . 0.0 112.491 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -97.08 168.22 10.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.799 1.24 . . . . 0.0 111.587 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -84.24 57.72 4.4 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.13 -128.05 5.88 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 169.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.9 p -111.34 144.76 40.02 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 168.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 12.1 ptt-85 -146.16 119.79 9.16 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 120.698 1.59 . . . . 0.0 111.181 -170.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.512 ' HB2' HD22 ' A' ' 6' ' ' LEU . 11.8 m-85 -120.68 131.82 54.77 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -172.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.448 HD11 HD11 ' A' ' 9' ' ' LEU . 7.5 tp -89.75 107.97 19.41 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.613 170.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.9 t -90.48 111.96 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 173.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.6 tp -117.09 114.42 23.71 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 119.062 0.846 . . . . 0.0 110.11 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.11 138.18 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.403 HG22 HG12 ' A' ' 171' ' ' VAL . 13.4 t -150.37 170.03 20.01 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 112.439 -2.164 . . . . 0.0 109.465 168.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -130.38 13.88 5.55 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.996 1.718 . . . . 0.0 113.375 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -142.58 179.35 7.02 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.891 1.676 . . . . 0.0 109.825 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -73.3 -170.84 0.85 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.355 0.597 . . . . 0.0 110.437 168.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -143.96 157.25 44.46 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.063 -1.023 . . . . 0.0 113.616 -169.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -73.58 129.94 39.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.331 172.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.55 HD22 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -105.94 178.32 4.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.832 1.653 . . . . 0.0 109.34 177.542 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.55 ' H ' HD22 ' A' ' 118' ' ' LEU . . . -53.62 140.68 28.17 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.077 -1.015 . . . . 0.0 112.682 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? 85.52 -26.27 0.1 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 128.883 2.873 . . . . 0.0 114.993 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . 0.256 10.6 p30 -65.36 -22.66 66.83 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 121.944 2.157 . . . . 0.0 114.767 -175.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.444 ' H ' ' HD3' ' A' ' 122' ' ' LYS 0.253 0.0 OUTLIER -72.12 6.32 2.24 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 120.245 -1.535 . . . . 0.0 114.794 168.617 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.6 t -61.71 -26.1 67.83 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.755 -1.216 . . . . 0.0 110.155 168.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 57.6 mt -63.7 -35.05 79.29 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.071 1.748 . . . . 0.0 112.96 171.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -88.75 14.36 60.3 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.739 1.638 . . . . 0.0 113.533 172.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.323 25.9 m 41.62 54.81 3.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.375 3.07 . . . . 0.0 114.459 -174.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -100.72 110.45 22.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -85.9 -62.32 1.55 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 121.684 2.038 . . . . 0.0 112.02 -171.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -72.16 132.77 44.6 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.423 ' HA ' ' CB ' ' A' ' 149' ' ' ASP . 6.4 t -49.8 145.02 5.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.767 2.027 . . . . 0.0 111.104 170.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.4 p -65.24 145.27 56.45 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.168 0.985 . . . . 0.0 111.948 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -80.93 -12.54 59.38 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.476 ' HA3' ' HE3' ' A' ' 159' ' ' LYS . . . 72.82 16.73 78.1 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 118.737 -1.035 . . . . 0.0 113.376 -176.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -103.59 159.78 15.3 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.922 1.289 . . . . 0.0 109.018 169.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 4.8 t -85.07 144.65 28.11 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.777 -1.202 . . . . 0.0 112.593 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -132.49 63.78 1.62 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.908 2.083 . . . . 0.0 109.609 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.13 130.04 52.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.199 1.8 . . . . 0.0 108.469 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -133.63 -69.19 0.55 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.226 0.61 . . . . 0.0 112.095 173.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.45 6.64 32.93 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.04 1.336 . . . . 0.0 114.205 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 108.82 -14.49 34.64 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.89 1.71 . . . . 0.0 114.949 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 62.2 mtt -91.54 144.46 25.53 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.285 1.542 . . . . 0.0 110.867 171.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -64.83 98.33 0.27 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 50.9 mmm-85 -56.43 -42.5 78.18 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.304 1.842 . . . . 0.0 112.268 -169.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 70.7 m -95.33 5.06 52.69 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -169.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.9 ttp-105 -47.11 -40.52 15.56 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.504 1.502 . . . . 0.0 112.995 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.73 -3.33 72.83 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 117.953 -1.471 . . . . 0.0 115.208 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.28 45.6 tt0 -120.6 -76.26 0.01 OUTLIER Pre-proline 0 CA--C 1.555 1.161 0 CA-C-O 115.84 -2.028 . . . . 0.0 111.83 176.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -58.89 160.93 16.65 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 123.147 2.565 . . . . 0.0 117.66 175.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.423 ' CB ' ' HA ' ' A' ' 130' ' ' THR . 6.1 t0 -70.12 174.28 5.65 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 129.864 3.266 . . . . 0.0 114.91 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.433 ' HB3' ' CD2' ' A' ' 86' ' ' LEU . 28.2 m-85 -81.29 123.1 28.23 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.672 1.989 . . . . 0.0 105.893 167.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.651 ' H ' ' CD ' ' A' ' 151' ' ' GLN . 0.2 OUTLIER -64.09 135.5 56.43 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 119.712 -1.868 . . . . 0.0 112.101 -177.634 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 24.6 p -67.44 155.45 38.99 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.387 -1.445 . . . . 0.0 112.087 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.442 HG22 HG23 ' A' ' 186' ' ' ILE . 7.2 p -57.69 -28.42 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 120.625 -1.297 . . . . 0.0 114.282 -169.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 52.0 t -81.54 -22.73 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.448 0.699 . . . . 0.0 112.596 175.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -63.9 -41.67 97.64 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.681 1.128 . . . . 0.0 109.013 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.6 mt -55.7 -56.6 18.51 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.345 0.521 . . . . 0.0 110.857 174.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.48 ' HB2' HG22 ' A' ' 186' ' ' ILE . . . -60.36 -30.1 69.34 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.0 t -65.88 -54.07 31.45 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.701 0.682 . . . . 0.0 111.357 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.476 ' HE3' ' HA3' ' A' ' 133' ' ' GLY . 69.3 mmtt -63.78 -44.39 93.53 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.034 -1.041 . . . . 0.0 113.44 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mt -76.34 -23.88 54.24 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.503 -1.373 . . . . 0.0 112.042 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.99 -37.84 61.78 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 169.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.4 -34.77 63.38 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.235 0.925 . . . . 0.0 110.784 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -85.6 -7.05 59.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.117 0.967 . . . . 0.0 112.594 174.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 58.13 37.56 26.37 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.185 1.794 . . . . 0.0 113.347 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 22.9 mm -88.92 140.62 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.298 1.039 . . . . 0.0 109.193 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.503 ' HB2' ' CD2' ' A' ' 107' ' ' PHE . 20.2 mm100 -102.92 101.79 23.36 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 120.743 1.611 . . . . 0.0 109.421 169.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -77.63 143.07 21.08 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.299 2.0 . . . . 0.0 112.979 174.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.6 mm -129.31 109.69 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.004 1.722 . . . . 0.0 108.881 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -75.91 71.81 2.74 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 123.648 1.69 . . . . 0.0 112.149 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 194' ' ' LEU . 58.1 t -63.93 101.63 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 O-C-N 121.141 -0.974 . . . . 0.0 113.008 169.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.403 HG12 HG22 ' A' ' 112' ' ' THR . 5.6 m -144.4 144.18 24.5 Favored Pre-proline 0 N--CA 1.484 1.225 0 O-C-N 120.175 -1.578 . . . . 0.0 111.707 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -67.15 168.37 17.71 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.762 2.308 . . . . 0.0 115.581 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.1 t -52.13 140.88 19.86 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.499 169.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 103.13 -48.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 130.132 3.373 . . . . 0.0 110.006 -172.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -86.79 -22.45 25.88 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.1 t -50.93 -42.11 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 125.729 1.612 . . . . 0.0 111.89 -169.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -75.28 -15.88 60.48 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -172.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.54 -44.19 21.62 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.984 0.811 . . . . 0.0 109.528 172.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -71.89 -28.03 63.23 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.381 1.473 . . . . 0.0 110.656 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.551 ' O ' HG22 ' A' ' 183' ' ' THR . 13.2 mt-10 -65.92 -36.01 82.19 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.252 169.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -76.31 -26.71 56.09 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 116.732 -1.987 . . . . 0.0 110.758 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.6 -19.84 58.98 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.776 -1.203 . . . . 0.0 109.746 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 180' ' ' GLU . 1.6 t -70.37 -23.84 62.86 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 119.473 1.033 . . . . 0.0 110.908 169.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 11.9 m -75.23 -31.02 60.72 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.389 0.676 . . . . 0.0 109.268 173.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -77.13 -27.64 54.03 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.873 173.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.486 HD11 HD13 ' A' ' 189' ' ' LEU . 30.3 pt -119.6 95.92 49.45 Favored Pre-proline 0 N--CA 1.489 1.503 0 CA-C-N 120.182 1.355 . . . . 0.0 113.656 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.87 138.5 51.39 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 124.11 3.207 . . . . 0.0 113.177 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 80.96 -4.1 1.75 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 128.665 2.786 . . . . 0.0 114.065 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.486 HD13 HD11 ' A' ' 186' ' ' ILE . 0.7 OUTLIER -69.54 154.39 42.07 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.927 1.24 . . . . 0.0 108.583 168.772 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.256 1.9 m -128.11 -177.43 4.14 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 169.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.0 tt -146.22 144.49 20.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 129.587 3.155 . . . . 0.0 107.476 -168.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -128.27 146.98 17.18 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -91.1 94.53 9.64 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.402 ' HB2' HG12 ' A' ' 170' ' ' VAL . 60.9 tp . . . . . 0 CA--C 1.538 0.491 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.277 169.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.1 m . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 54.8 t -128.29 136.35 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.639 1.976 . . . . 0.0 108.917 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.57 112.03 13.87 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.807 0.843 . . . . 0.0 109.892 -175.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.426 HD22 ' HB2' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -105.93 132.13 52.4 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.209 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -117.38 103.36 10.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 123.351 1.548 . . . . 0.0 109.836 169.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -79.98 104.51 10.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.367 -1.742 . . . . 0.0 112.169 171.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 tt -103.82 126.69 51.13 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.764 0.826 . . . . 0.0 111.226 171.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.2 ptm -121.32 147.07 46.17 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 174.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.71 136.88 15.04 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.404 1.002 . . . . 0.0 112.22 170.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.428 HD23 ' HB2' ' A' ' 47' ' ' SER . 0.6 OUTLIER -119.55 44.41 2.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.165 1.786 . . . . 0.0 112.41 -179.646 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 N--CA 1.476 0.831 0 O-C-N 120.238 -1.539 . . . . 0.0 112.805 170.074 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 121.886 0.851 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.29 78.75 0.32 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 127.408 2.432 . . . . 0.0 107.817 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -81.56 140.81 34.28 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.05 137.76 56.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.42 ' HA3' HD23 ' A' ' 59' ' ' LEU . . . -133.57 155.3 21.67 Favored Glycine 0 N--CA 1.464 0.552 0 C-N-CA 124.45 1.024 . . . . 0.0 111.002 171.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -107.28 163.52 12.95 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.275 0.63 . . . . 0.0 111.923 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.5 147.99 12.85 Favored Glycine 0 C--N 1.345 1.046 0 O-C-N 120.543 -1.348 . . . . 0.0 112.293 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.428 ' HB2' HD23 ' A' ' 12' ' ' LEU . 39.7 p -136.66 152.36 50.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.967 1.365 . . . . 0.0 114.403 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -159.78 157.46 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.035 1.334 . . . . 0.0 108.827 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.446 HG13 ' H ' ' A' ' 50' ' ' ASN . 1.3 p -146.99 -73.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.446 ' H ' HG13 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -164.01 -14.18 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.53 1.532 . . . . 0.0 111.604 169.542 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.616 ' O ' HG23 ' A' ' 52' ' ' THR . 23.6 ptt? -48.16 -41.92 28.22 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.54 1.936 . . . . 0.0 112.903 169.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 51' ' ' MET . 19.0 p 160.2 -179.95 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.189 1 C-N-CA 133.732 4.813 . . . . 0.0 107.381 -171.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -102.09 135.65 43.31 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 167.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -127.59 127.26 43.57 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 123.306 1.527 . . . . 0.0 110.935 171.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -77.34 129.22 35.54 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.445 171.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.2 mt -137.18 139.35 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 127.406 2.282 . . . . 0.0 105.613 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER 44.94 99.47 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.865 2.466 . . . . 0.0 116.529 -169.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -66.91 163.05 20.45 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.154 -0.966 . . . . 0.0 110.983 168.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.42 HD23 ' HA3' ' A' ' 44' ' ' GLY . 13.4 mt -52.18 117.63 2.94 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.103 0.561 . . . . 0.0 111.583 -172.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.475 0.776 0 C-N-CA 125.326 1.451 . . . . 0.0 111.733 -174.916 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 121.221 0.534 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.1 t -109.35 -152.07 0.48 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.604 1.162 . . . . 0.0 109.028 168.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -147.17 151.13 23.45 Favored Glycine 0 N--CA 1.471 1.005 0 O-C-N 120.632 -1.293 . . . . 0.0 114.042 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.53 150.6 21.51 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.254 1.422 . . . . 0.0 111.874 172.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.61 -61.91 1.62 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.288 1.435 . . . . 0.0 112.246 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.3 136.41 51.81 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.021 0.528 . . . . 0.0 111.001 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.324 0.0 OUTLIER -70.35 -38.19 8.11 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-O 116.248 -1.834 . . . . 0.0 113.909 -176.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.51 141.71 81.6 Favored 'Trans proline' 0 C--N 1.355 0.888 0 CA-C-N 122.439 1.907 . . . . 0.0 110.844 169.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -170.83 1.72 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.223 1.009 . . . . 0.0 113.127 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.401 ' HA3' ' NH2' ' A' ' 145' ' ' ARG . . . -112.8 30.11 7.68 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 -169.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.506 ' CG ' HD21 ' A' ' 110' ' ' LEU 0.285 0.2 OUTLIER -70.33 -29.4 66.09 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 118.526 2.788 . . . . 0.0 118.526 -168.906 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.83 HD23 HD21 ' A' ' 156' ' ' LEU . 8.4 mp -66.14 -30.91 71.49 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 123.787 2.994 . . . . 0.0 112.995 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -59.95 -41.76 92.58 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.11 -0.994 . . . . 0.0 110.73 171.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.04 -49.4 72.49 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.024 -0.988 . . . . 0.0 111.379 174.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 m -58.8 -32.88 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 119.701 1.137 . . . . 0.0 112.168 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.0 t -78.02 -40.8 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 117.161 -1.399 . . . . 0.0 112.566 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -56.83 -45.23 82.46 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 121.663 2.029 . . . . 0.0 110.238 171.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.578 HG11 HD23 ' A' ' 108' ' ' LEU . 79.9 t -59.45 -32.37 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 174.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.31 -35.32 47.93 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.731 -1.231 . . . . 0.0 113.792 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.1 mm -93.03 -30.85 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 119.721 1.146 . . . . 0.0 113.25 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 78.4 m -79.74 52.27 1.43 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.396 1.478 . . . . 0.0 112.016 -172.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.7 mt -49.86 -41.19 44.73 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.123 2.169 . . . . 0.0 112.207 -169.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.44 -23.63 70.1 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.258 0.932 . . . . 0.0 114.534 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.43 -34.66 8.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.165 0.982 . . . . 0.0 111.531 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.65 -45.97 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 118.976 0.807 . . . . 0.0 110.095 170.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.83 26.04 10.09 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.809 1.195 . . . . 0.0 115.254 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -57.82 125.3 22.42 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.265 1.532 . . . . 0.0 112.268 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -93.02 -158.56 0.61 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.769 1.228 . . . . 0.0 112.139 172.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -90.55 0.33 57.39 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -173.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.9 -127.4 2.28 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 120.586 1.539 . . . . 0.0 111.396 -175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.2 t -114.6 140.72 48.56 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.572 1.549 . . . . 0.0 108.925 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -122.89 134.2 54.38 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 117.32 -1.324 . . . . 0.0 109.887 -168.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.459 ' CD2' ' HB3' ' A' ' 166' ' ' GLN . 15.1 m-85 -129.91 113.85 15.14 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.578 HD23 HG11 ' A' ' 92' ' ' VAL . 3.2 tm? -82.49 98.8 9.11 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 170.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 80.4 t -83.69 116.21 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.506 HD21 ' CG ' ' A' ' 85' ' ' GLN . 3.2 tm? -110.33 108.03 17.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.161 -168.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.413 HG22 HG13 ' A' ' 170' ' ' VAL . 46.2 t -101.74 129.89 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.6 t -161.47 151.43 17.04 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -106.67 -13.5 15.27 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -169.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -137.12 -169.8 2.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.827 1.251 . . . . 0.0 110.553 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.67 -170.71 0.57 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.075 0.95 . . . . 0.0 112.745 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.537 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 48.2 t80 -139.21 149.8 44.8 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.266 1.426 . . . . 0.0 112.546 -172.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -84.68 91.81 8.03 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.031 1.332 . . . . 0.0 113.332 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.24 163.02 4.07 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 120.493 -1.379 . . . . 0.0 112.432 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -46.71 135.1 9.18 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.619 -0.676 . . . . 0.0 111.504 170.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm 97.5 -12.48 0.07 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 130.179 3.391 . . . . 0.0 112.142 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -76.8 -20.09 56.82 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.607 -1.308 . . . . 0.0 113.737 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.42 ' HG3' ' CD2' ' A' ' 150' ' ' TYR . 34.0 mttm -71.72 -1.67 14.7 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 120.023 1.283 . . . . 0.0 114.344 170.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -58.41 -36.27 73.34 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.413 1.006 . . . . 0.0 111.453 169.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.6 mt -63.94 -36.27 83.39 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.462 0.705 . . . . 0.0 112.437 173.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -82.39 13.93 37.59 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.778 1.656 . . . . 0.0 114.068 172.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.322 11.6 t 53.04 48.15 22.99 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 128.031 2.532 . . . . 0.0 113.442 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -127.43 113.66 16.48 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.728 1.211 . . . . 0.0 111.41 172.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -94.78 -30.29 14.32 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.304 1.441 . . . . 0.0 113.139 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -60.35 120.32 9.63 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.347 0.659 . . . . 0.0 110.809 -172.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.5 t -61.47 155.95 20.59 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.827 0.739 . . . . 0.0 110.599 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.6 t -65.01 143.19 58.12 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.655 0.74 . . . . 0.0 112.182 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -79.57 -29.27 41.24 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.243 1.017 . . . . 0.0 112.32 -177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.35 18.79 70.56 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.089 0.852 . . . . 0.0 113.044 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -106.88 164.51 12.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.085 1.754 . . . . 0.0 113.386 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 6.3 t -72.05 125.65 27.78 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.142 1.377 . . . . 0.0 109.639 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -134.75 41.17 2.9 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.8 1.64 . . . . 0.0 111.448 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.37 124.42 47.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.287 2.235 . . . . 0.0 109.315 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . 0.257 15.3 p-10 -115.71 -96.72 0.46 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.397 1.079 . . . . 0.0 112.608 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.25 30.25 0.28 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 121.016 1.734 . . . . 0.0 113.679 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.57 -9.32 66.64 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.915 1.721 . . . . 0.0 114.142 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 20.5 ptp -97.02 151.67 19.49 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.597 1.698 . . . . 0.0 113.034 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -84.6 80.58 9.19 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.912 0.885 . . . . 0.0 109.735 169.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.3 ttm-85 -58.63 -32.94 69.51 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 38.9 m -64.87 -8.34 14.99 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.401 ' NH2' ' HA3' ' A' ' 84' ' ' GLY . 9.2 tpt180 -52.94 -29.13 26.9 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 120.649 1.568 . . . . 0.0 114.109 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.46 1.4 87.31 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 117.99 -1.45 . . . . 0.0 115.09 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.379 0.7 OUTLIER -121.41 -79.17 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 115.89 -2.005 . . . . 0.0 112.82 178.214 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.89 154.35 67.14 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 CA-C-N 124.463 2.63 . . . . 0.0 115.65 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -62.02 169.41 2.68 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 129.829 3.252 . . . . 0.0 112.912 170.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.42 ' CD2' ' HG3' ' A' ' 122' ' ' LYS . 74.8 m-85 -62.83 159.74 15.97 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.489 -0.757 . . . . 0.0 111.812 169.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -81.34 140.03 35.01 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.4 -0.812 . . . . 0.0 111.271 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.3 p -80.6 151.48 29.05 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.312 1.045 . . . . 0.0 111.253 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.525 ' HA ' HD23 ' A' ' 156' ' ' LEU . 45.1 t -53.13 -39.09 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -168.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.42 -18.69 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 O-C-N 121.496 -0.753 . . . . 0.0 112.534 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -67.11 -36.31 81.65 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.739 1.154 . . . . 0.0 110.412 170.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.83 HD21 HD23 ' A' ' 86' ' ' LEU . 1.9 mm? -59.05 -58.59 7.98 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 168.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.16 -43.79 78.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.102 0.961 . . . . 0.0 112.976 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.8 m -58.08 -56.13 25.98 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.058 0.943 . . . . 0.0 112.371 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.292 10.6 mptt -86.84 -20.44 27.49 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -174.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.4 mp -67.46 -31.13 71.09 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.382 1.446 . . . . 0.0 109.954 168.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.63 -33.78 58.34 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.657 1.183 . . . . 0.0 114.103 172.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.5 -51.47 59.78 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.4 1.08 . . . . 0.0 110.111 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -77.91 -12.69 60.0 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.69 0.796 . . . . 0.0 111.927 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.79 47.04 18.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.563 2.345 . . . . 0.0 111.991 176.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 28.9 mm -85.43 136.98 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.861 1.264 . . . . 0.0 108.421 174.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.459 ' HB3' ' CD2' ' A' ' 107' ' ' PHE . 3.7 tp60 -93.82 108.57 35.72 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 120.759 1.618 . . . . 0.0 107.859 168.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.55 ' HG2' ' HG ' ' A' ' 189' ' ' LEU . 83.0 Cg_endo -74.0 138.46 25.69 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.412 3.408 . . . . 0.0 113.24 171.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.5 mm -129.31 101.93 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.987 1.315 . . . . 0.0 110.115 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -72.39 72.58 0.96 Allowed 'General case' 0 N--CA 1.476 0.832 0 O-C-N 120.636 -1.29 . . . . 0.0 112.564 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.417 HG22 ' HB2' ' A' ' 194' ' ' LEU . 3.5 p -69.73 106.36 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 O-C-N 120.78 -1.2 . . . . 0.0 113.029 170.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 31.8 m -145.41 147.07 32.29 Favored Pre-proline 0 N--CA 1.482 1.167 0 O-C-N 120.354 -1.466 . . . . 0.0 113.293 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -59.52 155.67 40.65 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 124.855 3.704 . . . . 0.0 114.849 172.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.9 t -41.62 -60.57 1.29 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.447 2.299 . . . . 0.0 114.94 -169.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -64.04 -12.5 39.11 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -171.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 66.8 mmm -99.25 -7.47 26.38 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.6 t -57.34 -36.62 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 120.272 1.396 . . . . 0.0 111.66 -169.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -69.92 -28.31 65.49 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.01 -34.83 24.23 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 118.926 0.785 . . . . 0.0 111.309 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -72.42 -30.72 64.88 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.565 -1.334 . . . . 0.0 110.325 170.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -71.26 -11.79 61.11 Favored 'General case' 0 CA--C 1.553 1.092 0 O-C-N 121.584 -0.697 . . . . 0.0 111.376 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -84.33 -47.11 11.07 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.039 -1.663 . . . . 0.0 109.969 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.81 -21.14 59.47 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 119.966 -1.709 . . . . 0.0 111.051 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.84 -16.7 61.59 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.726 0.81 . . . . 0.0 111.961 171.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.55 -25.57 28.62 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 119.487 -0.292 . . . . 0.0 110.969 170.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -87.99 -18.48 28.93 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 56.9 mt -118.35 96.48 49.85 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.285 1.034 . . . . 0.0 108.837 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -55.42 141.76 81.52 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.688 2.926 . . . . 0.0 114.439 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . 0.325 0.0 OUTLIER 81.55 -15.51 0.71 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 128.618 2.767 . . . . 0.0 113.093 171.55 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.55 ' HG ' ' HG2' ' A' ' 167' ' ' PRO . 2.5 tt -56.76 148.01 21.54 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 127.003 2.121 . . . . 0.0 108.689 169.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 77.2 p -121.41 -150.76 0.46 Allowed 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 120.784 1.629 . . . . 0.0 109.651 170.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -179.34 117.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 119.51 -1.994 . . . . 0.0 109.154 -167.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -110.6 152.68 17.36 Favored Glycine 0 N--CA 1.469 0.875 0 C-N-CA 124.83 1.205 . . . . 0.0 112.242 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -93.8 85.69 4.89 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.866 1.266 . . . . 0.0 109.175 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.417 ' HB2' HG22 ' A' ' 170' ' ' VAL . 47.8 tp . . . . . 0 N--CA 1.471 0.615 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.977 169.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.9 p . . . . . 0 CA--C 1.545 0.77 0 CA-C-O 121.621 0.724 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 t -115.91 145.67 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.947 1.699 . . . . 0.0 106.646 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.3 14.9 p-10 -136.99 111.99 8.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.736 0.779 . . . . 0.0 110.35 171.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.2 tp -96.24 134.35 39.45 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.511 1.124 . . . . 0.0 112.653 -175.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -118.68 103.16 9.42 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 123.204 1.478 . . . . 0.0 109.388 168.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -82.43 93.87 7.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.056 1.742 . . . . 0.0 111.534 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 30.5 tp -92.1 125.53 36.83 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.377 1.071 . . . . 0.0 109.619 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.466 ' CE ' ' CZ ' ' A' ' 45' ' ' PHE 0.306 0.0 OUTLIER -134.24 165.62 24.69 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 172.276 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.46 140.26 15.57 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.677 1.132 . . . . 0.0 112.343 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.446 HD21 ' CE ' ' A' ' 10' ' ' MET . 3.5 mm? -114.59 22.63 13.43 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.15 1.78 . . . . 0.0 112.212 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 CA--C 1.539 0.528 0 O-C-N 120.586 -1.321 . . . . 0.0 110.91 169.215 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 121.289 0.566 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.42 83.69 0.24 Allowed Glycine 0 C--N 1.337 0.625 0 C-N-CA 126.776 2.132 . . . . 0.0 107.929 -169.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -77.25 151.36 35.15 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.28 138.02 53.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 117.754 0.252 . . . . 0.0 111.17 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.409 ' HA2' HD13 ' A' ' 57' ' ' LEU . . . -135.14 163.77 24.83 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 126.891 2.186 . . . . 0.0 110.9 171.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.466 ' CZ ' ' CE ' ' A' ' 10' ' ' MET . 86.1 t80 -135.5 145.27 46.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.995 0.918 . . . . 0.0 111.831 -169.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.35 147.2 18.47 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 122.568 0.128 . . . . 0.0 112.887 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.6 m -118.7 142.74 47.39 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.503 1.121 . . . . 0.0 112.036 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.79 157.12 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.726 1.21 . . . . 0.0 110.411 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 p -157.83 -52.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 124.405 1.082 . . . . 0.0 109.994 169.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 161.48 -22.9 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 131.302 3.841 . . . . 0.0 110.525 169.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -52.77 -39.93 62.69 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.642 0.777 . . . . 0.0 111.462 170.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.1 p -170.43 168.9 7.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 129.744 3.218 . . . . 0.0 110.723 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -113.11 123.65 50.76 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 101.003 -3.703 . . . . 0.0 101.003 165.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -122.03 114.04 20.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -174.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -81.64 114.63 20.45 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.637 169.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.3 mt -139.44 95.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.409 HD13 ' HA2' ' A' ' 44' ' ' GLY 0.262 2.6 tm? 107.43 94.17 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 130.703 3.601 . . . . 0.0 109.139 174.492 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -52.66 159.42 1.08 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.592 1.557 . . . . 0.0 112.741 170.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.7 mt -53.64 120.47 6.23 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 172.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.475 0.82 0 C-N-CA 124.511 1.124 . . . . 0.0 112.539 -172.625 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -120.24 -160.02 0.81 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.285 1.834 . . . . 0.0 111.146 169.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -156.19 155.71 26.52 Favored Glycine 0 N--CA 1.472 1.076 0 O-C-N 120.507 -1.371 . . . . 0.0 113.957 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -152.32 151.96 31.52 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.645 1.178 . . . . 0.0 112.767 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -55.68 -58.99 5.5 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.088 2.155 . . . . 0.0 112.343 174.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.72 143.98 37.63 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.266 15.1 t -70.15 -41.75 15.1 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 115.563 -2.16 . . . . 0.0 114.443 174.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.74 142.87 84.86 Favored 'Trans proline' 0 C--N 1.356 0.972 0 CA-C-N 123.421 2.257 . . . . 0.0 112.319 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -112.78 154.58 26.0 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.912 1.285 . . . . 0.0 113.43 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.04 55.76 4.79 Favored Glycine 0 N--CA 1.479 1.51 0 C-N-CA 125.664 1.602 . . . . 0.0 112.586 -172.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -83.07 -33.82 26.33 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.458 1.903 . . . . 0.0 115.689 -168.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.9 -37.95 79.31 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -171.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -51.46 -46.82 63.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.224 1.01 . . . . 0.0 111.601 169.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.48 -53.63 49.1 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.132 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.25 32.9 m -64.25 -27.41 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 119.476 1.035 . . . . 0.0 112.621 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.04 -63.01 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 119.427 1.012 . . . . 0.0 108.564 168.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -58.43 -42.78 88.04 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.171 0.896 . . . . 0.0 111.174 -173.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.0 t -55.76 -35.4 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.08 0.855 . . . . 0.0 112.428 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.71 -37.14 65.26 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.818 -1.176 . . . . 0.0 113.486 175.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.433 ' HB ' ' SG ' ' A' ' 135' ' ' CYS . 7.9 mm -93.56 -15.8 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.858 0.863 . . . . 0.0 113.017 -172.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.52 49.01 0.96 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.763 2.025 . . . . 0.0 112.58 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -49.95 -40.1 42.65 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.778 -1.201 . . . . 0.0 112.048 -175.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.71 -19.23 54.8 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -91.89 -45.52 8.33 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.917 1.359 . . . . 0.0 110.815 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.5 mm -65.85 -44.35 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.297 0.639 . . . . 0.0 109.351 175.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.33 21.9 21.0 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.998 1.285 . . . . 0.0 114.083 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -49.03 128.36 16.0 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.818 1.247 . . . . 0.0 112.087 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . 0.336 0.6 OUTLIER -113.93 -173.65 2.32 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 175.376 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -67.65 -2.91 7.61 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 118.792 2.886 . . . . 0.0 118.792 -168.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.29 -125.29 2.63 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 121.091 1.769 . . . . 0.0 112.268 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.4 m -111.83 115.3 28.8 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.145 1.778 . . . . 0.0 107.802 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 -99.54 128.81 45.66 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -168.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -127.19 104.25 7.86 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -168.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.97 89.38 6.05 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.187 -0.946 . . . . 0.0 111.004 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.5 t -72.29 132.57 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 tp -112.62 127.07 56.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.32 124.11 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 123.959 0.787 . . . . 0.0 110.54 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -150.14 164.66 35.05 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.613 0.765 . . . . 0.0 111.465 171.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.46 2.95 6.94 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.721 1.608 . . . . 0.0 114.765 174.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -123.12 173.13 8.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.435 1.094 . . . . 0.0 112.036 171.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -69.98 -169.14 0.24 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.752 0.821 . . . . 0.0 111.542 169.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.437 ' CE1' HD11 ' A' ' 182' ' ' LEU . 29.8 p90 -142.07 158.71 43.44 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.107 -0.996 . . . . 0.0 112.983 -169.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -84.29 123.84 30.59 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.172 169.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.69 HD22 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -86.43 -177.54 6.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.157 0.983 . . . . 0.0 109.47 170.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.69 ' H ' HD22 ' A' ' 118' ' ' LEU . . . -57.67 163.64 2.42 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.359 -0.838 . . . . 0.0 111.467 169.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.408 0.0 OUTLIER 55.11 -3.68 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.775 2.03 . . . . 0.0 116.162 -169.805 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -75.16 -28.62 60.18 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 121.313 1.87 . . . . 0.0 113.757 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -73.54 1.88 9.06 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 121.035 1.743 . . . . 0.0 113.424 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.7 t -59.83 -25.36 64.94 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.468 1.031 . . . . 0.0 111.501 169.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.4 mt -61.62 -21.16 64.13 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.405 1.882 . . . . 0.0 113.366 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -91.96 -108.34 1.64 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 169.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.277 7.1 t -152.55 40.3 0.58 Allowed 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 123.429 1.585 . . . . 0.0 111.041 169.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.02 89.64 5.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.942 1.697 . . . . 0.0 109.483 -175.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -86.07 -42.0 14.3 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.746 -0.596 . . . . 0.0 111.333 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -65.67 134.99 54.4 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.246 0.619 . . . . 0.0 109.967 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.3 p -97.19 147.22 24.31 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.548 1.139 . . . . 0.0 109.436 169.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.7 m -58.24 141.85 49.5 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.5 p30 -72.51 -11.38 60.64 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.467 1.507 . . . . 0.0 113.75 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.5 10.07 86.47 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.639 1.114 . . . . 0.0 113.329 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -84.61 176.56 8.52 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.961 1.38 . . . . 0.0 110.276 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' CYS . . . . . 0.433 ' SG ' ' HB ' ' A' ' 94' ' ' ILE . 0.6 OUTLIER -100.88 144.69 29.52 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 172.301 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -133.8 38.16 3.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.643 1.977 . . . . 0.0 110.868 -170.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 pp -62.53 160.19 14.29 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.112 1.765 . . . . 0.0 111.807 171.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -157.73 -101.46 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.72 1.208 . . . . 0.0 110.298 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.27 35.93 0.82 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.606 1.962 . . . . 0.0 113.062 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.1 18.35 55.96 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.744 1.164 . . . . 0.0 114.476 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.5 ptp -149.01 156.2 41.91 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.962 1.381 . . . . 0.0 113.905 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -68.94 104.37 2.06 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.552 1.141 . . . . 0.0 111.844 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -65.63 -42.05 91.97 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.344 0.658 . . . . 0.0 111.04 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.9 m -74.56 -3.36 30.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -172.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -44.56 -29.65 0.76 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.8 3.64 57.47 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.574 2.035 . . . . 0.0 115.962 -174.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.421 2.3 pt-20 -131.58 -49.58 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.106 0 CA-C-N 120.755 2.277 . . . . 0.0 114.68 170.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -80.02 151.08 20.97 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 CA-C-N 122.479 1.921 . . . . 0.0 113.736 167.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -75.46 165.54 24.96 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 129.155 2.982 . . . . 0.0 112.233 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -57.98 152.93 15.34 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.091 -1.006 . . . . 0.0 109.24 168.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . 0.334 3.0 mm-40 -106.46 165.42 11.29 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.4 p -73.61 161.82 29.9 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -168.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 t -61.96 -28.93 45.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.524 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.8 t -73.49 -42.56 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.265 1.026 . . . . 0.0 111.083 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -64.83 -38.03 89.62 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.489 0.586 . . . . 0.0 110.474 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 87.8 mt -57.19 -60.76 3.14 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.028 0.531 . . . . 0.0 110.261 170.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.83 -45.8 85.66 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -172.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.5 m -64.98 -49.59 69.67 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.839 -0.538 . . . . 0.0 112.306 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -74.66 -27.83 60.59 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.067 -1.021 . . . . 0.0 112.384 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 14.8 tp -61.12 -44.47 97.29 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.773 -1.205 . . . . 0.0 111.89 170.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.79 -24.65 61.78 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.04 0.936 . . . . 0.0 113.509 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -72.75 -44.21 61.92 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.098 1.359 . . . . 0.0 110.297 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -80.3 -18.88 47.99 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 56.2 63.74 1.91 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.763 1.625 . . . . 0.0 111.317 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 87.1 mt -113.88 137.66 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.677 1.591 . . . . 0.0 109.274 175.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -91.25 120.71 68.38 Favored Pre-proline 0 N--CA 1.475 0.784 0 CA-C-O 116.703 -1.617 . . . . 0.0 110.488 170.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -88.13 148.66 6.75 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.622 2.881 . . . . 0.0 110.477 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.83 99.17 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.553 ' HB2' HG22 ' A' ' 191' ' ' ILE . 7.1 m-85 -76.48 69.87 2.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 122.285 1.04 . . . . 0.0 111.895 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.49 102.55 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 C-N-CA 126.315 1.846 . . . . 0.0 110.993 169.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.51 147.96 26.93 Favored Pre-proline 0 N--CA 1.481 1.123 0 O-C-N 120.265 -1.522 . . . . 0.0 113.56 -170.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -62.39 148.45 93.26 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 125.199 3.933 . . . . 0.0 115.048 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.5 t -55.16 -28.93 56.41 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -169.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -47.25 -37.12 9.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.989 1.316 . . . . 0.0 113.793 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . 0.257 0.0 OUTLIER -126.64 5.92 6.79 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.064 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.9 t -53.39 -33.63 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 120.331 -1.481 . . . . 0.0 110.969 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -21.68 66.42 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -175.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.2 t -90.81 -38.73 12.79 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.347 0.659 . . . . 0.0 110.534 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -66.66 -36.74 83.26 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.024 1.33 . . . . 0.0 111.228 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -60.0 -19.88 54.78 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.375 1.07 . . . . 0.0 111.56 168.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -110.15 6.41 22.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.843 1.257 . . . . 0.0 113.248 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.437 HD11 ' CE1' ' A' ' 116' ' ' PHE . 62.0 mt -95.4 -25.97 16.05 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 167.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.3 t -77.62 -14.62 59.59 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.18 1.392 . . . . 0.0 112.759 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 3.6 t -84.98 -17.56 37.24 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.712 -0.617 . . . . 0.0 110.965 169.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -92.57 -23.66 18.98 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 118.083 0.401 . . . . 0.0 112.077 169.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 50.9 mt -118.12 91.78 40.97 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 124.38 1.072 . . . . 0.0 109.39 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.54 132.61 52.86 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.778 2.318 . . . . 0.0 112.657 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.5 tttm 105.77 -18.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 130.281 3.432 . . . . 0.0 115.271 169.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.436 HD21 ' CD2' ' A' ' 169' ' ' PHE 0.396 0.0 OUTLIER -75.27 164.35 26.54 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 120.568 1.531 . . . . 0.0 112.2 176.61 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.435 ' O ' HD23 ' A' ' 189' ' ' LEU . 37.7 p -129.13 176.41 7.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.553 HG22 ' HB2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -155.06 127.87 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 128.333 2.653 . . . . 0.0 108.84 -168.538 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.61 154.29 16.89 Favored Glycine 0 N--CA 1.47 0.965 0 C-N-CA 124.563 1.078 . . . . 0.0 111.518 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -94.89 85.82 4.5 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.125 0.964 . . . . 0.0 109.213 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 168.381 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.9 p . . . . . 0 CA--C 1.547 0.841 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.2 t -137.76 137.28 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.228 1.811 . . . . 0.0 109.297 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -110.71 115.55 29.76 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 168.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -103.32 116.21 32.02 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.065 0.46 . . . . 0.0 110.163 169.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -105.72 103.04 12.46 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 123.919 1.819 . . . . 0.0 109.903 170.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -83.42 114.27 21.34 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 112.515 -2.13 . . . . 0.0 112.044 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.64 HD12 HG21 ' A' ' 92' ' ' VAL . 4.4 tt -114.42 124.12 51.15 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.795 0.838 . . . . 0.0 111.714 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.3 mtp -104.2 138.37 40.77 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.58 114.5 3.94 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.488 1.518 . . . . 0.0 109.66 169.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.8 mp -106.96 24.12 13.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.288 2.635 . . . . 0.0 112.705 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 p . . . . . 0 CA--C 1.543 0.686 0 O-C-N 120.297 -1.502 . . . . 0.0 113.078 171.723 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.9 p . . . . . 0 CA--C 1.552 1.025 0 CA-C-O 122.483 1.135 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.6 83.52 0.36 Allowed Glycine 0 C--N 1.345 1.035 0 C-N-CA 128.97 3.176 . . . . 0.0 108.866 -171.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -80.78 137.55 36.24 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.692 1.597 . . . . 0.0 108.433 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.33 138.25 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.613 0.765 . . . . 0.0 109.445 -173.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.86 159.2 23.85 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 125.57 1.557 . . . . 0.0 111.739 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -140.56 128.46 21.91 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -169.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -131.92 151.71 19.91 Favored Glycine 0 C--N 1.342 0.868 0 C-N-CA 124.973 1.273 . . . . 0.0 113.493 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.4 t -116.57 140.5 49.31 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.531 1.933 . . . . 0.0 111.071 173.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.418 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -138.17 147.23 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.173 0.989 . . . . 0.0 110.944 169.374 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.418 ' N ' HD13 ' A' ' 48' ' ' ILE . 0.7 OUTLIER -132.83 -60.26 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 118.314 0.506 . . . . 0.0 109.811 167.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 161.78 -34.64 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 1 C-N-CA 131.72 4.008 . . . . 0.0 107.525 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.1 mtt -46.12 -51.68 13.5 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.668 1.587 . . . . 0.0 110.806 169.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.9 p -165.75 178.76 6.38 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 128.067 2.547 . . . . 0.0 110.37 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -111.13 125.08 53.4 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 102.179 -3.267 . . . . 0.0 102.179 165.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -121.01 122.37 39.96 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.991 0.9 . . . . 0.0 110.481 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 46.8 t60 -76.68 126.97 31.9 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.724 168.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.35 -51.86 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 121.703 -0.623 . . . . 0.0 110.896 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.3 tp -129.96 121.0 25.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.719 0.808 . . . . 0.0 111.13 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.89 149.34 36.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.078 0.951 . . . . 0.0 111.707 170.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.3 mt -49.51 112.79 0.7 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.367 1.067 . . . . 0.0 110.795 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.475 0.814 0 C-N-CA 124.576 1.15 . . . . 0.0 112.386 -174.17 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.941 0.401 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.5 p -100.45 -124.88 0.17 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.608 1.563 . . . . 0.0 111.606 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.51 144.54 6.42 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.592 1.092 . . . . 0.0 114.261 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -156.37 153.67 29.31 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.286 1.435 . . . . 0.0 112.221 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.73 -50.19 65.71 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.916 1.686 . . . . 0.0 113.41 -176.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.84 137.7 42.02 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.882 0.873 . . . . 0.0 111.715 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 t -70.24 -30.87 2.05 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-O 115.725 -2.084 . . . . 0.0 115.056 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.95 141.22 26.51 Favored 'Trans proline' 0 C--N 1.358 1.055 0 CA-C-N 123.027 2.117 . . . . 0.0 112.145 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -97.46 158.53 15.43 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.71 1.204 . . . . 0.0 110.803 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.22 28.85 2.89 Favored Glycine 0 N--CA 1.48 1.599 0 O-C-N 120.653 -1.28 . . . . 0.0 114.623 174.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.24 -40.36 70.79 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.244 1.817 . . . . 0.0 111.194 -172.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.08 -25.32 68.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 117.572 -1.204 . . . . 0.0 113.095 -174.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -78.32 -31.27 48.66 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.033 1.288 . . . . 0.0 113.011 171.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.582 ' HB1' HD11 ' A' ' 9' ' ' LEU . . . -67.15 -45.89 75.7 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.711 -1.243 . . . . 0.0 111.574 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.531 HG23 HD11 ' A' ' 108' ' ' LEU . 7.3 p -58.71 -29.89 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 177.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.634 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.3 t -61.61 -60.35 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.125 0.97 . . . . 0.0 109.952 174.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -67.22 -38.05 84.63 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.698 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.64 HG21 HD12 ' A' ' 9' ' ' LEU . 77.3 t -57.11 -37.41 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 119.606 1.094 . . . . 0.0 112.114 173.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.97 -44.74 65.38 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.636 1.107 . . . . 0.0 113.756 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 90' ' ' VAL . 3.3 mt -91.74 -20.22 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -169.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 74.4 m -79.74 51.34 1.28 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.404 -1.435 . . . . 0.0 111.407 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -49.47 -42.64 43.8 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.924 1.69 . . . . 0.0 111.177 -174.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -74.66 -22.62 76.88 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.346 0.974 . . . . 0.0 114.39 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -105.69 -34.65 7.65 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.37 1.085 . . . . 0.0 112.594 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.8 mm -70.25 -38.23 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.959 0.8 . . . . 0.0 110.446 169.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.64 27.37 9.78 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.39 1.472 . . . . 0.0 114.591 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -59.93 116.57 4.23 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.959 1.38 . . . . 0.0 112.651 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -90.65 173.96 7.76 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.243 2.617 . . . . 0.0 110.352 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -87.52 20.16 3.03 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -170.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.36 -119.56 0.96 Allowed Glycine 0 C--N 1.346 1.124 0 C-N-CA 124.528 1.061 . . . . 0.0 111.043 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.9 m -116.33 130.46 56.78 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.612 1.565 . . . . 0.0 107.051 170.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.46 132.95 53.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -171.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.36 111.01 9.24 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -167.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.575 HD13 HD13 ' A' ' 110' ' ' LEU . 1.5 tm? -105.85 98.04 7.78 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.082 0.953 . . . . 0.0 109.711 -169.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.3 t -101.81 118.67 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.575 HD13 HD13 ' A' ' 108' ' ' LEU . 6.2 mp -111.37 131.92 54.82 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 124.245 0.966 . . . . 0.0 109.168 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.1 t -116.53 129.63 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 O-C-N 125.531 1.77 . . . . 0.0 111.159 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 t -152.43 -171.45 3.93 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.347 1.03 . . . . 0.0 109.515 169.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -140.43 2.86 1.88 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.68 -156.43 0.61 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.017 0.927 . . . . 0.0 110.845 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.91 166.53 0.98 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.816 2.046 . . . . 0.0 114.375 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -130.27 146.69 51.9 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.426 1.491 . . . . 0.0 110.507 170.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -76.94 141.77 40.33 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.007 0.432 . . . . 0.0 111.592 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.64 HD21 HG23 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -111.74 173.3 6.42 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.625 1.97 . . . . 0.0 109.533 177.322 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.52 ' H ' HD22 ' A' ' 118' ' ' LEU . . . -48.7 142.59 5.99 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.117 -0.989 . . . . 0.0 111.519 169.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.0 mttm 83.27 -16.52 0.56 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 129.511 3.124 . . . . 0.0 112.875 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.05 -32.08 73.62 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.239 1.381 . . . . 0.0 113.05 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -78.23 6.33 8.41 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.9 t -60.21 -31.19 69.93 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.022 1.283 . . . . 0.0 112.507 170.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.64 -19.26 61.47 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -85.53 15.2 47.55 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.494 1.521 . . . . 0.0 111.916 169.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.348 13.9 t 44.37 54.54 6.18 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 128.869 2.868 . . . . 0.0 112.504 -170.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.1 ttp180 -126.68 106.38 9.35 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.559 1.544 . . . . 0.0 109.907 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -112.66 -25.52 9.07 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -169.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -75.17 129.49 37.6 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.53 1.514 . . . . 0.0 110.829 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.6 t -68.31 167.61 14.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.925 1.29 . . . . 0.0 111.545 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.3 m -66.16 135.72 54.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.579 0.752 . . . . 0.0 112.495 172.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -83.15 -17.72 41.93 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.027 -1.046 . . . . 0.0 113.488 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.91 18.19 77.35 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.304 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.8 mtp-105 -94.49 169.85 9.91 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.842 1.257 . . . . 0.0 112.588 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.21 137.59 43.18 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.409 1.084 . . . . 0.0 110.45 169.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -145.94 44.91 1.26 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.505 1.522 . . . . 0.0 112.237 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.1 tt -118.72 132.23 56.15 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.076 0.95 . . . . 0.0 110.58 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -118.77 -75.61 0.58 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.649 1.179 . . . . 0.0 111.239 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -97.98 28.22 4.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.826 2.05 . . . . 0.0 112.792 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.51 -18.06 58.12 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.627 1.584 . . . . 0.0 113.227 -174.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 14.9 mmt -89.45 143.11 27.08 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.743 1.217 . . . . 0.0 112.495 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -71.94 91.22 1.18 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 168.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -55.92 -43.15 77.07 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.548 1.139 . . . . 0.0 112.304 -171.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.4 p -81.28 7.07 12.31 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -15.42 0.35 Allowed 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 171.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -103.2 -8.64 40.98 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.909 1.719 . . . . 0.0 115.26 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -114.53 -61.95 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 119.876 1.838 . . . . 0.0 111.84 -172.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -77.4 145.66 24.0 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.86 2.373 . . . . 0.0 113.199 168.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -66.28 171.11 5.08 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.305 2.642 . . . . 0.0 111.565 169.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -60.61 156.19 17.14 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 174.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -65.6 163.24 16.61 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.4 p -93.85 152.93 18.54 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 168.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.64 HG23 HD21 ' A' ' 118' ' ' LEU . 58.8 t -62.78 -30.6 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 O-C-N 120.621 -1.299 . . . . 0.0 111.231 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.62 -42.69 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.987 0.915 . . . . 0.0 111.061 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -73.47 -26.65 61.01 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.899 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.4 mt -63.74 -54.37 36.5 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 168.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.75 82.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.064 1.346 . . . . 0.0 113.124 -172.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 75.7 m -63.95 -51.15 65.73 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.945 0.498 . . . . 0.0 112.009 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.487 ' HG2' HD11 ' A' ' 94' ' ' ILE . 2.1 tppp? -62.7 -38.66 91.29 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.273 -0.892 . . . . 0.0 112.162 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.8 tp -60.26 -40.33 89.95 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.353 1.061 . . . . 0.0 112.647 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.66 -24.85 63.68 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.098 0.959 . . . . 0.0 113.311 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -75.92 -44.07 42.0 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.184 0.993 . . . . 0.0 110.819 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -78.67 -16.35 57.4 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 60.8 33.26 20.11 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.987 2.115 . . . . 0.0 113.024 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.2 mt -85.59 144.24 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.122 1.369 . . . . 0.0 109.101 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -104.69 106.24 53.93 Favored Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 120.714 1.597 . . . . 0.0 113.791 171.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 31.3 Cg_exo -75.13 137.62 21.68 Favored 'Trans proline' 0 CA--C 1.537 0.636 1 C-N-CA 125.342 4.028 . . . . 0.0 115.231 169.713 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.5 mt -130.98 113.44 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -75.62 79.54 2.61 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.893 0.854 . . . . 0.0 111.682 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 39.6 t -66.52 104.51 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-O 122.554 1.169 . . . . 0.0 112.151 169.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 33.3 m -142.32 164.51 32.88 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 120.321 -1.487 . . . . 0.0 110.776 -169.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -85.21 165.74 11.08 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.825 2.35 . . . . 0.0 111.81 -169.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.3 t -50.41 -38.84 45.09 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.772 1.229 . . . . 0.0 113.09 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -63.08 -21.28 66.06 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 3.5 tpt -128.23 5.74 5.83 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -170.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 89.4 t -59.43 -35.96 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 120.015 1.28 . . . . 0.0 111.537 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.27 -0.64 50.51 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -169.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 t -92.82 -36.54 12.8 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.796 0.808 . . . . 0.0 109.46 168.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -74.89 -33.94 62.13 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 124.172 0.989 . . . . 0.0 110.342 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -70.88 -15.0 62.59 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 119.293 0.951 . . . . 0.0 111.96 169.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -84.85 -28.25 26.17 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 120.32 -1.487 . . . . 0.0 111.249 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 43.3 tp -77.27 -27.16 53.06 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.314 2.246 . . . . 0.0 110.074 174.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.48 -7.97 58.02 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.11 1.764 . . . . 0.0 112.531 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 6.7 t -105.79 -15.82 14.84 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.239 0.616 . . . . 0.0 110.685 168.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -80.83 -37.37 30.17 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.313 0.506 . . . . 0.0 111.009 169.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 25.3 mt -104.13 114.9 63.97 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 124.325 1.05 . . . . 0.0 108.779 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.15 140.59 37.82 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.667 2.245 . . . . 0.0 112.432 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 47.2 tptt 82.82 -8.35 1.18 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 129.438 3.095 . . . . 0.0 113.811 170.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.5 mt -67.81 166.14 16.05 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.57 0.748 . . . . 0.0 111.883 170.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.6 p -138.59 -145.51 0.19 Allowed 'General case' 0 C--N 1.344 0.352 0 CA-C-O 122.905 1.336 . . . . 0.0 108.603 168.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.3 pt -157.02 156.86 4.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 128.798 2.839 . . . . 0.0 109.419 -167.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -134.04 153.24 20.84 Favored Glycine 0 N--CA 1.465 0.631 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 169.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -100.63 93.68 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 CA--C 1.541 0.608 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.77 169.484 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.27 127.52 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.969 1.308 . . . . 0.0 108.79 169.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -109.87 116.21 31.24 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -110.37 129.22 55.8 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.671 0.748 . . . . 0.0 111.747 173.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -110.59 113.56 26.27 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 123.418 1.58 . . . . 0.0 109.492 169.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -91.15 104.6 17.15 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 126.482 1.913 . . . . 0.0 112.222 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 tp -101.22 116.72 33.46 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.0 0.92 . . . . 0.0 112.669 177.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 59.4 mtp -97.69 141.17 31.04 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.515 1.526 . . . . 0.0 114.047 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.97 118.43 5.38 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 168.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 mp -106.91 22.99 15.1 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.799 1.64 . . . . 0.0 113.899 -169.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.0 p . . . . . 0 N--CA 1.475 0.821 0 O-C-N 120.2 -1.563 . . . . 0.0 113.522 176.589 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t . . . . . 0 CA--C 1.547 0.86 0 CA-C-O 121.999 0.904 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.05 88.11 0.18 Allowed Glycine 0 C--N 1.338 0.67 0 C-N-CA 127.34 2.4 . . . . 0.0 108.185 -169.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -94.68 141.31 28.77 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.54 1.136 . . . . 0.0 109.315 -169.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.9 tt -124.59 137.63 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.92 151.06 17.27 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 171.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -119.52 151.74 38.1 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.236 0.614 . . . . 0.0 111.596 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.18 147.57 17.67 Favored Glycine 0 C--N 1.342 0.913 0 C-N-CA 124.005 0.812 . . . . 0.0 113.45 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.9 t -118.09 150.69 38.92 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.48 1.512 . . . . 0.0 110.95 175.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.15 148.25 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.126 1.371 . . . . 0.0 108.925 172.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.59 -77.04 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.889 0.875 . . . . 0.0 109.429 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -177.83 -23.51 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 130.695 3.598 . . . . 0.0 108.201 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.3 ttt -49.26 -49.04 45.22 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.742 1.617 . . . . 0.0 109.603 167.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 173.4 175.95 0.12 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 130.59 3.556 . . . . 0.0 110.156 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -91.37 130.8 37.17 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 104.721 -2.325 . . . . 0.0 104.721 166.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -121.68 120.33 34.39 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.653 0.781 . . . . 0.0 110.119 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -83.9 117.73 23.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.936 0.894 . . . . 0.0 110.817 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 82.4 mt -130.35 108.73 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.451 1.5 . . . . 0.0 107.0 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.5 tp 87.56 112.37 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 128.26 2.624 . . . . 0.0 111.212 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -76.55 158.85 30.84 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.397 1.879 . . . . 0.0 109.961 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.8 mt -52.7 112.97 0.93 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.974 1.261 . . . . 0.0 110.858 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.472 0.659 0 C-N-CA 125.267 1.427 . . . . 0.0 112.474 -171.191 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.2 t -123.08 171.29 9.4 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.381 1.872 . . . . 0.0 111.012 169.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.38 152.5 17.56 Favored Glycine 0 N--CA 1.478 1.496 0 O-C-N 120.588 -1.32 . . . . 0.0 114.907 -173.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -146.3 157.38 43.79 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.925 1.69 . . . . 0.0 113.939 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 tp -83.54 -71.76 0.49 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.458 1.503 . . . . 0.0 109.724 169.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.76 148.04 40.77 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.641 1.176 . . . . 0.0 112.589 -170.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 m -59.45 -46.85 98.87 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-O 116.61 -1.662 . . . . 0.0 113.299 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -66.25 139.51 55.31 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.758 2.306 . . . . 0.0 113.174 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.37 164.52 13.82 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.003 1.321 . . . . 0.0 113.736 175.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.6 38.44 2.3 Favored Glycine 0 N--CA 1.475 1.242 0 C-N-CA 125.249 1.404 . . . . 0.0 116.582 -169.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.67 ' CG ' HD21 ' A' ' 110' ' ' LEU . 8.2 tp-100 -63.38 -38.45 91.19 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -168.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -83.92 -10.62 57.83 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -74.12 -46.86 39.99 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.991 1.269 . . . . 0.0 108.625 168.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.69 68.88 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.698 1.599 . . . . 0.0 112.058 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.2 p -54.78 -36.41 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 118.796 -0.621 . . . . 0.0 112.239 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.96 -38.9 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 116.36 -1.781 . . . . 0.0 111.687 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -52.18 -55.3 21.91 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 121.066 1.757 . . . . 0.0 109.001 172.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 73.5 t -52.49 -31.43 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.946 1.298 . . . . 0.0 113.157 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.09 -20.24 52.62 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.78 -31.4 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -174.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.472 ' HB3' ' SG ' ' A' ' 135' ' ' CYS . 6.2 p -79.61 67.24 5.32 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 121.846 2.112 . . . . 0.0 112.719 176.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.9 tp -42.58 -41.08 2.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 128.944 2.898 . . . . 0.0 111.757 172.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.95 -22.02 75.12 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 118.383 -1.231 . . . . 0.0 114.935 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -102.06 -37.15 8.3 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.034 1.417 . . . . 0.0 112.411 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.0 mm -69.39 -39.6 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.37 22.36 29.64 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.233 1.397 . . . . 0.0 113.541 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -59.24 145.58 42.36 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.002 1.401 . . . . 0.0 110.628 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -125.48 -167.22 1.66 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.32 1.048 . . . . 0.0 111.748 171.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -74.49 9.97 1.52 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -168.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.3 -136.62 2.42 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 121.365 1.893 . . . . 0.0 110.518 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -104.03 142.02 35.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.69 1.596 . . . . 0.0 107.792 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -126.22 117.81 23.86 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -167.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -114.5 128.14 56.18 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.168 0.587 . . . . 0.0 111.91 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.3 tt -107.18 95.61 5.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 169.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.1 t -83.74 124.28 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.67 HD21 ' CG ' ' A' ' 85' ' ' GLN . 10.2 tt -122.92 125.82 46.06 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -170.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.411 HG22 HG23 ' A' ' 170' ' ' VAL . 37.3 t -116.16 134.33 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 O-C-N 124.433 1.083 . . . . 0.0 111.697 -175.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.0 t -145.76 -172.42 3.9 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.043 169.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -145.03 5.77 1.14 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.514 1.526 . . . . 0.0 114.872 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -163.01 176.35 10.21 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.764 2.026 . . . . 0.0 109.184 169.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -61.49 -177.91 0.11 Allowed 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 -171.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -127.54 160.2 32.28 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.815 1.646 . . . . 0.0 113.794 -169.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -77.57 128.11 33.6 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.305 0.642 . . . . 0.0 110.836 169.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.2 mp -94.68 165.74 12.35 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.953 1.301 . . . . 0.0 110.119 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.09 146.23 39.36 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.634 -0.666 . . . . 0.0 111.171 169.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 75.05 -11.84 1.02 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 128.83 2.852 . . . . 0.0 114.268 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -66.21 -23.26 66.4 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 120.303 1.41 . . . . 0.0 112.245 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -70.99 1.48 5.6 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.1 t -56.78 -32.01 65.22 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.279 1.032 . . . . 0.0 111.815 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.16 -46.99 88.27 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.345 1.058 . . . . 0.0 112.273 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -90.23 21.73 30.01 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.1 1.333 . . . . 0.0 114.03 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.317 5.6 t 56.18 39.79 30.22 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 127.8 2.44 . . . . 0.0 114.444 173.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 59.9 mtt85 -106.49 117.3 33.68 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.459 1.104 . . . . 0.0 109.121 169.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -99.58 -49.68 4.32 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -66.14 119.32 11.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.773 0.715 . . . . 0.0 111.9 -170.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.442 ' HA ' ' HB3' ' A' ' 149' ' ' ASP . 8.9 t -74.58 156.51 36.72 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.656 0.782 . . . . 0.0 111.91 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.2 t -62.0 141.24 58.17 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.012 0.911 . . . . 0.0 113.249 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -78.13 -9.83 59.35 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.048 1.739 . . . . 0.0 112.926 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.29 0.64 90.23 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.397 -1.224 . . . . 0.0 115.527 174.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.7 mtt85 -111.12 172.13 7.06 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.216 1.508 . . . . 0.0 112.597 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 95' ' ' CYS . 34.8 t -75.92 143.48 41.63 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -168.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -132.99 52.74 2.06 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.771 2.028 . . . . 0.0 111.317 175.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.56 132.32 46.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.896 1.678 . . . . 0.0 109.601 -175.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -145.58 -49.35 0.23 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.216 1.007 . . . . 0.0 112.153 172.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -77.79 -8.51 58.11 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.93 -6.58 37.5 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.236 1.398 . . . . 0.0 113.706 -169.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.2 mtt -130.71 143.56 50.82 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.329 1.452 . . . . 0.0 112.657 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -70.4 89.02 0.67 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.823 1.649 . . . . 0.0 112.618 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -16.1 61.05 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -170.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.7 m -89.87 -5.54 56.73 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -28.68 14.16 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.594 1.088 . . . . 0.0 113.761 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.16 -16.87 79.09 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 117.448 -1.751 . . . . 0.0 115.501 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -128.54 -67.84 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.928 0 CA-C-N 120.307 2.053 . . . . 0.0 113.677 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -50.56 141.9 32.49 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 CA-C-N 123.509 2.289 . . . . 0.0 115.536 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.442 ' HB3' ' HA ' ' A' ' 130' ' ' THR . 26.0 t0 -68.42 178.76 1.86 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.117 2.167 . . . . 0.0 112.73 172.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -69.58 163.85 24.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.66 1.219 . . . . 0.0 112.116 169.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -88.09 126.55 35.17 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.8 m -63.8 152.61 38.99 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.762 -0.586 . . . . 0.0 110.582 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.523 HG13 HD11 ' A' ' 186' ' ' ILE . 72.0 t -53.97 -32.96 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 O-C-N 121.681 -0.637 . . . . 0.0 111.873 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.86 -45.42 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.871 1.269 . . . . 0.0 112.52 173.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -71.61 -35.95 70.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.905 0.882 . . . . 0.0 111.169 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.431 HD12 HG12 ' A' ' 186' ' ' ILE . 1.5 tm? -59.75 -52.99 63.1 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 169.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.17 -43.09 96.09 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.9 p -67.65 -38.79 84.31 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.497 -0.752 . . . . 0.0 112.348 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.484 ' HA ' ' HE2' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -70.96 -35.5 72.2 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.682 -1.261 . . . . 0.0 112.863 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 97.3 mt -60.89 -41.66 96.45 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.805 0.842 . . . . 0.0 111.892 170.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.25 75.91 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.44 1.096 . . . . 0.0 113.17 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -80.91 -39.47 26.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.646 0.778 . . . . 0.0 111.753 -174.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -87.93 -6.23 58.15 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 171.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 31.1 m120 58.19 56.2 4.68 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.865 1.666 . . . . 0.0 111.52 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 51.3 mm -94.55 137.61 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.259 1.424 . . . . 0.0 109.716 171.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -107.21 109.4 62.85 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 119.843 1.201 . . . . 0.0 107.83 168.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -73.06 148.83 45.48 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.205 1.937 . . . . 0.0 112.215 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.419 HG22 HG13 ' A' ' 170' ' ' VAL . 4.5 mp -131.27 99.63 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 170.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -73.78 78.37 1.58 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.498 -0.751 . . . . 0.0 111.937 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.419 HG13 HG22 ' A' ' 168' ' ' ILE 0.361 3.8 m -79.27 116.15 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 123.431 1.586 . . . . 0.0 113.389 174.863 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 28.6 m -144.23 155.94 57.86 Favored Pre-proline 0 N--CA 1.478 0.928 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.181 -169.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -78.95 153.25 25.28 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.488 2.792 . . . . 0.0 111.307 -172.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 77.1 p -37.45 -49.34 1.02 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.315 2.246 . . . . 0.0 115.061 -169.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -54.1 -38.32 65.22 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.918 1.287 . . . . 0.0 114.094 -174.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.9 ptm -103.31 -4.47 24.19 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 42.4 t -54.84 -45.26 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.4 1.0 . . . . 0.0 109.85 -171.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . 0.3 0.0 OUTLIER -76.02 -3.89 38.25 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -170.788 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 82.9 m -92.75 -34.24 13.98 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.33 1.052 . . . . 0.0 110.677 168.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -74.41 -25.83 59.71 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.997 -1.064 . . . . 0.0 110.183 171.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -64.6 -25.34 67.92 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.783 -1.198 . . . . 0.0 110.07 168.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -79.82 -22.84 42.54 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 120.1 -1.625 . . . . 0.0 110.517 176.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 18.4 tp -82.22 -26.13 33.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.308 2.243 . . . . 0.0 109.377 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.7 t -76.11 -13.56 60.2 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.381 -0.825 . . . . 0.0 112.976 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . 0.328 0.0 OUTLIER -99.08 -20.55 16.64 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 118.753 -0.642 . . . . 0.0 111.026 169.549 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -76.91 -31.06 56.44 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.17 0.895 . . . . 0.0 111.481 169.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.523 HD11 HG13 ' A' ' 153' ' ' VAL . 4.6 mp -115.92 108.89 45.75 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.046 0.938 . . . . 0.0 109.954 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.94 145.41 56.04 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 121.978 1.785 . . . . 0.0 111.255 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt 97.42 -20.58 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 130.557 3.543 . . . . 0.0 114.509 169.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.35 166.84 22.86 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.661 0.664 . . . . 0.0 110.721 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.4 p -125.17 -150.54 0.45 Allowed 'General case' 0 C--N 1.346 0.445 0 CA-C-O 122.926 1.346 . . . . 0.0 109.206 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 11.6 tt 179.08 131.21 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 126.668 1.987 . . . . 0.0 109.843 -167.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -126.2 160.35 20.6 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.592 1.091 . . . . 0.0 112.183 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -89.58 92.16 8.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 122.651 1.215 . . . . 0.0 107.824 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 CA--C 1.538 0.498 0 CA-C-N 113.594 -1.639 . . . . 0.0 108.51 169.155 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.91 147.52 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 126.524 1.93 . . . . 0.0 107.825 172.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.38 124.94 31.38 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.242 0.544 . . . . 0.0 109.93 169.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 mp -115.02 137.88 51.5 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -121.31 107.57 12.68 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 122.8 1.286 . . . . 0.0 110.705 173.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -80.64 103.12 10.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.778 2.031 . . . . 0.0 112.049 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -100.45 113.04 25.48 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.989 1.315 . . . . 0.0 110.588 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 87.3 mtp -97.82 147.05 24.81 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -94.06 124.4 7.86 Favored Glycine 0 CA--C 1.542 1.762 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 168.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.5 mp -115.22 29.39 8.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 125.332 1.453 . . . . 0.0 114.896 -170.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.557 ' HB3' HG13 ' A' ' 49' ' ' VAL . 19.5 p . . . . . 0 N--CA 1.479 1.008 0 O-C-N 120.207 -1.558 . . . . 0.0 113.172 -172.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 122.203 1.002 . . . . 0.0 109.822 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.84 79.78 0.28 Allowed Glycine 0 C--N 1.339 0.712 0 C-N-CA 126.874 2.178 . . . . 0.0 109.0 -170.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -82.42 132.14 35.21 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -170.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.9 tp -110.66 138.41 38.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.632 0.773 . . . . 0.0 110.238 -175.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.95 159.21 22.57 Favored Glycine 0 N--CA 1.468 0.768 0 C-N-CA 125.555 1.55 . . . . 0.0 112.088 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -138.08 128.33 26.01 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -169.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.98 159.18 25.99 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 124.688 1.137 . . . . 0.0 113.978 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.6 m -134.15 140.54 46.63 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.425 1.49 . . . . 0.0 111.94 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.488 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -147.18 146.98 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.121 -0.987 . . . . 0.0 112.556 177.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.557 HG13 ' HB3' ' A' ' 13' ' ' SER . 81.9 t -134.2 -80.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 126.105 1.762 . . . . 0.0 108.319 170.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.409 ' H ' ' H ' ' A' ' 51' ' ' MET 0.338 0.0 OUTLIER -168.45 -7.1 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.877 1 C-N-CA 132.862 4.465 . . . . 0.0 109.338 168.772 . . . . . . . . 5 4 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.409 ' H ' ' H ' ' A' ' 50' ' ' ASN . 49.6 mtm -77.57 46.27 0.53 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.875 1.67 . . . . 0.0 107.399 166.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.351 3.2 t 52.12 -164.5 0.07 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 130.617 3.567 . . . . 0.0 114.057 -169.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -108.78 130.03 55.38 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.223 2.609 . . . . 0.0 109.33 -175.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -118.07 118.58 32.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.627 0.727 . . . . 0.0 111.142 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -84.62 114.12 21.76 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.075 1.35 . . . . 0.0 109.196 169.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.8 mm -107.67 -24.12 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.7 tp -146.91 120.33 9.03 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.018 1.281 . . . . 0.0 112.161 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.07 152.0 25.19 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.017 1.727 . . . . 0.0 112.566 172.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.81 120.49 4.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.366 1.066 . . . . 0.0 110.506 175.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.227 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.1 t . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 120.623 0.249 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.1 m -107.24 -156.97 0.6 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.481 1.512 . . . . 0.0 110.899 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -156.99 153.49 24.74 Favored Glycine 0 N--CA 1.478 1.466 0 O-C-N 119.874 -1.766 . . . . 0.0 116.291 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.8 tptt -157.88 161.95 38.31 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.614 1.566 . . . . 0.0 112.475 169.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.5 mt -70.26 -47.64 60.41 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.941 1.696 . . . . 0.0 114.507 -169.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.84 137.89 42.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.438 0.695 . . . . 0.0 111.926 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.254 13.6 t -67.89 -41.14 26.78 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-O 115.816 -2.04 . . . . 0.0 113.975 173.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.15 150.29 82.06 Favored 'Trans proline' 0 C--N 1.36 1.132 0 CA-C-N 123.09 2.139 . . . . 0.0 111.924 170.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.43 ' H ' ' HA ' ' A' ' 116' ' ' PHE . 52.8 mtpt -121.93 160.28 25.14 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -171.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.07 19.07 28.27 Favored Glycine 0 N--CA 1.476 1.304 0 CA-C-O 118.175 -1.347 . . . . 0.0 116.174 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -49.5 -32.45 12.23 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.84 1.82 . . . . 0.0 113.384 -173.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.416 HD11 ' CD2' ' A' ' 156' ' ' LEU . 11.8 tp -60.16 -41.36 92.64 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.222 1.009 . . . . 0.0 113.441 -176.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.93 -40.03 87.53 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.549 0.339 . . . . 0.0 110.767 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.54 -52.72 50.44 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 117.633 -1.175 . . . . 0.0 112.257 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -54.76 -38.12 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 120.113 1.324 . . . . 0.0 111.306 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.7 t -71.46 -39.79 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 118.943 0.792 . . . . 0.0 112.681 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -67.93 -41.44 82.56 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.514 1.052 . . . . 0.0 112.05 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.467 HG11 HD13 ' A' ' 108' ' ' LEU . 78.7 t -56.4 -40.4 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.194 0.598 . . . . 0.0 110.401 171.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.62 -40.85 80.19 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.86 -8.65 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -171.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 4.7 t -90.88 67.72 6.18 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.258 -1.526 . . . . 0.0 111.431 172.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -46.98 -42.77 18.48 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.145 1.778 . . . . 0.0 111.171 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.43 -23.54 53.73 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.43 1.014 . . . . 0.0 115.524 -170.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -94.34 -43.45 8.39 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.689 1.245 . . . . 0.0 110.351 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.4 mm -65.36 -39.23 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 118.671 -0.68 . . . . 0.0 110.439 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.43 24.49 23.84 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.44 1.019 . . . . 0.0 114.176 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -55.52 128.06 32.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.224 1.41 . . . . 0.0 113.586 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.86 173.42 6.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.236 1.814 . . . . 0.0 110.29 169.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -89.69 57.01 3.74 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.778 1.231 . . . . 0.0 112.793 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.04 -121.14 4.86 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.335 1.445 . . . . 0.0 110.235 170.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.7 p -119.57 127.91 53.42 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.524 1.93 . . . . 0.0 106.092 169.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -112.1 110.86 21.37 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.918 0.781 . . . . 0.0 110.819 -167.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -111.42 97.72 6.95 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -168.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.467 HD13 HG11 ' A' ' 92' ' ' VAL . 11.1 tp -87.12 94.87 9.76 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.586 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.411 HG13 HG21 ' A' ' 170' ' ' VAL . 44.9 t -83.76 116.7 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 37.9 mt -109.31 109.96 21.0 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.165 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.38 125.14 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 O-C-N 123.934 0.771 . . . . 0.0 111.83 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -161.55 150.14 15.69 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.736 0.814 . . . . 0.0 111.229 172.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -105.31 -1.21 25.46 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.338 1.455 . . . . 0.0 114.756 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -121.35 -178.44 3.78 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.496 1.118 . . . . 0.0 111.889 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -77.33 -172.51 2.5 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.648 1.179 . . . . 0.0 111.231 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.43 ' HA ' ' H ' ' A' ' 83' ' ' LYS . 21.5 p90 -139.16 157.17 46.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.075 0.95 . . . . 0.0 112.633 -169.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -79.9 129.75 34.74 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.226 1.01 . . . . 0.0 110.717 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mp -98.99 173.21 6.95 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.851 1.26 . . . . 0.0 109.583 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.65 146.46 10.15 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.776 -0.578 . . . . 0.0 111.59 169.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 90.0 mttt 82.37 -18.98 0.43 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 128.261 2.624 . . . . 0.0 113.269 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.86 -35.71 82.01 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.002 1.273 . . . . 0.0 112.324 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -68.61 -5.28 19.08 Favored 'General case' 0 CA--C 1.551 1.0 0 O-C-N 120.927 -1.108 . . . . 0.0 113.858 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.03 -23.64 65.01 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.906 -1.121 . . . . 0.0 112.849 171.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 mp -63.74 -33.88 76.65 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.212 0.915 . . . . 0.0 110.796 169.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -84.44 16.43 34.92 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 126.127 1.823 . . . . 0.0 113.874 169.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.334 1.3 t 71.08 15.52 6.56 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 129.844 3.258 . . . . 0.0 115.095 176.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.599 ' HA ' ' HE ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -99.96 106.42 18.21 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.963 -1.086 . . . . 0.0 112.244 -177.425 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -88.51 -48.82 7.31 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.938 1.695 . . . . 0.0 112.411 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 -60.43 131.2 50.01 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -169.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.3 t -63.29 146.07 54.23 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.766 1.227 . . . . 0.0 111.157 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.2 p -53.72 128.95 31.55 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 125.695 1.598 . . . . 0.0 113.879 169.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -72.86 -26.62 61.52 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.422 0.689 . . . . 0.0 112.424 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.4 -25.64 7.91 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 125.697 1.618 . . . . 0.0 112.884 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -61.59 164.91 5.42 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.202 1.801 . . . . 0.0 112.878 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 38.7 t -73.53 136.74 44.1 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.522 0.729 . . . . 0.0 111.231 170.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -137.96 40.75 2.32 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.743 1.617 . . . . 0.0 111.96 172.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.96 156.19 19.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.941 0.896 . . . . 0.0 110.849 171.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.84 -80.16 0.16 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.475 1.11 . . . . 0.0 111.504 171.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.26 28.0 0.76 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.743 1.617 . . . . 0.0 112.771 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.03 -9.73 68.32 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.923 1.725 . . . . 0.0 113.454 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 13.1 mmt -96.74 146.45 24.87 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.777 1.231 . . . . 0.0 112.336 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -77.88 95.12 4.67 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.888 0.851 . . . . 0.0 110.815 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.0 ttp-105 -51.85 -40.15 60.06 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.619 1.968 . . . . 0.0 112.857 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.3 m -87.34 2.75 49.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -169.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.5 ttp85 -56.73 -33.84 66.91 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 121.731 2.06 . . . . 0.0 111.857 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.61 -4.26 87.51 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.29 1.424 . . . . 0.0 115.14 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.298 15.1 tp10 -122.42 -82.3 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.139 0 CA-C-O 115.774 -2.06 . . . . 0.0 111.051 173.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -47.13 146.8 6.0 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 123.341 2.694 . . . . 0.0 116.541 170.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.94 179.55 4.85 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -69.23 147.03 51.83 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.386 -0.822 . . . . 0.0 110.876 170.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -71.4 154.68 41.37 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.527 -0.733 . . . . 0.0 111.964 -177.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.5 p -88.5 155.91 19.39 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.704 -0.623 . . . . 0.0 111.343 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.2 t -59.27 -29.12 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 121.373 -0.829 . . . . 0.0 112.585 -169.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 37.4 t -66.8 -42.46 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.373 1.469 . . . . 0.0 111.59 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -70.49 -29.55 66.11 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.233 1.013 . . . . 0.0 111.715 -174.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.517 HD12 HD11 ' A' ' 186' ' ' ILE . 1.0 OUTLIER -64.23 -54.72 29.08 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.789 0.836 . . . . 0.0 109.796 170.514 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.53 -37.7 68.27 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.219 1.008 . . . . 0.0 111.959 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.5 m -60.59 -65.29 0.71 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.312 1.045 . . . . 0.0 112.336 170.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.265 68.9 mmtt -76.25 -17.39 59.5 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.121 -1.612 . . . . 0.0 114.835 -169.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mp -71.72 -41.4 68.6 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.782 0.833 . . . . 0.0 109.493 168.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.32 -35.48 66.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.454 1.102 . . . . 0.0 113.853 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.9 -41.52 78.15 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.942 0.897 . . . . 0.0 110.736 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -87.96 -0.3 56.82 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 65.24 31.01 11.02 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.524 1.129 . . . . 0.0 113.012 170.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 57.2 mt -94.92 134.18 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 120.89 -1.131 . . . . 0.0 108.969 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -107.34 100.51 33.89 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-N 119.078 0.853 . . . . 0.0 111.826 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.02 154.57 74.2 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.746 2.297 . . . . 0.0 115.81 169.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 38.0 mt -132.27 110.77 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.892 1.677 . . . . 0.0 107.775 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -77.58 79.5 4.08 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 123.214 1.483 . . . . 0.0 110.844 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.411 HG21 HG13 ' A' ' 109' ' ' VAL . 89.7 t -65.98 109.04 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.583 169.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 27.3 m -148.38 146.52 23.05 Favored Pre-proline 0 N--CA 1.476 0.841 0 O-C-N 120.757 -1.215 . . . . 0.0 112.696 -170.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.36 151.97 27.66 Favored 'Trans proline' 0 C--N 1.351 0.696 1 C-N-CA 125.533 4.155 . . . . 0.0 114.129 169.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 68.3 p -56.81 -29.16 62.47 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -169.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 40.7 tpt85 -58.95 -36.68 75.21 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.927 1.24 . . . . 0.0 112.774 -177.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 34.5 mtt -118.1 12.79 13.7 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.436 1.272 . . . . 0.0 114.436 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 5.4 t -53.39 -34.88 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.646 1.112 . . . . 0.0 111.22 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.4 ' HA ' ' HB2' ' A' ' 180' ' ' GLU . 45.6 tptt -80.78 -15.04 57.47 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -175.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.12 -34.17 43.61 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.445 1.02 . . . . 0.0 110.383 174.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -80.58 -36.93 32.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.054 1.342 . . . . 0.0 110.342 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 177' ' ' LYS . 9.5 mt-10 -62.7 -13.37 31.62 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.114 0.87 . . . . 0.0 113.072 171.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -105.01 -11.0 16.84 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -80.15 -30.56 38.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.385 1.474 . . . . 0.0 109.154 169.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 58.6 p -77.11 -11.45 59.81 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.144 1.378 . . . . 0.0 112.406 173.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.8 m -78.39 -30.72 47.97 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 168.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -81.42 -28.15 34.4 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 171.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.517 HD11 HD12 ' A' ' 156' ' ' LEU . 6.2 mt -117.52 86.09 22.17 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 123.855 0.862 . . . . 0.0 110.711 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.47 149.02 92.17 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.755 2.304 . . . . 0.0 112.196 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt 89.25 -17.08 0.25 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 130.665 3.586 . . . . 0.0 113.017 -175.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.2 mt -76.03 162.39 28.09 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.272 0.629 . . . . 0.0 110.766 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.6 p -129.9 -161.5 1.12 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 48.2 mm -162.13 149.02 4.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 130.332 3.453 . . . . 0.0 109.385 -167.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.06 156.55 26.89 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 168.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -96.81 84.2 3.56 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.644 1.578 . . . . 0.0 108.374 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.471 0.576 0 CA-C-O 122.57 1.176 . . . . 0.0 110.572 169.795 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.7 p . . . . . 0 CA--C 1.546 0.801 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.33 100.97 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-O 122.127 0.965 . . . . 0.0 112.018 -175.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.97 95.93 4.93 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.687 1.195 . . . . 0.0 109.501 171.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.1 tt -90.31 121.38 32.26 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.991 0.516 . . . . 0.0 111.837 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -113.72 109.52 18.71 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 123.728 1.727 . . . . 0.0 109.213 169.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -81.18 104.88 11.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.699 -2.046 . . . . 0.0 111.718 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -108.53 111.31 23.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.618 0.767 . . . . 0.0 109.897 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 28.0 ptm -119.07 149.04 42.35 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.1 134.59 14.58 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.29 1.424 . . . . 0.0 110.892 169.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 mp -102.97 29.64 5.31 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.584 1.954 . . . . 0.0 111.608 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 p . . . . . 0 CA--C 1.539 0.551 0 C-N-CA 126.112 1.765 . . . . 0.0 113.505 -179.857 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.998 0.904 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.68 86.54 0.23 Allowed Glycine 0 C--N 1.337 0.616 0 C-N-CA 125.82 1.676 . . . . 0.0 109.086 -169.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.6 mmt-85 -72.39 138.82 47.47 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.436 1.494 . . . . 0.0 108.672 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 tt -126.6 133.25 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-N 119.062 0.846 . . . . 0.0 111.712 -177.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.89 159.68 26.54 Favored Glycine 0 N--CA 1.475 1.264 0 C-N-CA 126.035 1.778 . . . . 0.0 112.51 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -137.04 133.27 35.29 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -169.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.63 145.94 17.99 Favored Glycine 0 C--N 1.343 0.948 0 C-N-CA 124.827 1.203 . . . . 0.0 111.945 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.7 m -128.49 149.0 50.77 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.084 0.953 . . . . 0.0 112.137 -173.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.1 152.32 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-N 118.99 0.814 . . . . 0.0 113.149 -175.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.4 t -141.5 -84.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 125.152 1.381 . . . . 0.0 109.269 168.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.428 ' H ' ' H ' ' A' ' 51' ' ' MET . 54.0 t30 -149.54 -20.63 0.28 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.847 2.459 . . . . 0.0 108.269 169.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.428 ' H ' ' H ' ' A' ' 50' ' ' ASN . 76.4 mtm -75.78 50.17 0.56 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 127.514 2.325 . . . . 0.0 106.202 166.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.342 4.0 t 32.74 -149.56 0.0 OUTLIER 'General case' 0 C--N 1.345 0.375 1 C-N-CA 133.915 4.886 . . . . 0.0 116.71 -168.835 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -106.0 137.35 44.06 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 130.287 3.435 . . . . 0.0 109.343 -174.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -129.37 126.56 39.15 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 122.604 1.192 . . . . 0.0 109.739 168.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -87.35 116.65 25.59 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.851 2.06 . . . . 0.0 109.399 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.7 mt -110.01 -57.46 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.131 -169.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -103.98 117.25 33.84 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.104 0.865 . . . . 0.0 112.907 173.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -64.27 147.45 52.43 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 166.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mp -61.5 126.56 27.8 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 121.072 1.76 . . . . 0.0 110.461 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.476 0.83 0 C-N-CA 124.635 1.174 . . . . 0.0 111.469 -173.726 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.6 m -125.82 159.87 31.32 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.268 1.827 . . . . 0.0 113.138 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.63 161.79 13.49 Favored Glycine 0 N--CA 1.476 1.331 0 C-N-CA 125.089 1.328 . . . . 0.0 114.757 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -158.76 147.92 18.89 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.075 2.15 . . . . 0.0 109.654 171.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.08 -74.58 0.06 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.542 1.537 . . . . 0.0 112.193 176.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.81 154.62 41.67 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -173.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.6 m -67.19 -52.42 30.05 Favored Pre-proline 0 N--CA 1.474 0.742 0 CA-C-O 116.372 -1.775 . . . . 0.0 113.913 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -71.08 152.99 62.97 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.107 1.872 . . . . 0.0 111.661 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -133.46 158.99 41.68 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.66 34.13 2.08 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 117.309 1.684 . . . . 0.0 117.309 -168.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -74.02 -21.32 60.02 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -170.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.4 tp -56.96 -53.03 62.65 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.424 0.689 . . . . 0.0 109.79 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -63.57 -31.46 72.64 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.841 -1.162 . . . . 0.0 112.741 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.24 -51.77 68.12 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.86 170.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.494 ' CG1' HD13 ' A' ' 110' ' ' LEU . 27.4 m -59.64 -26.55 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 119.909 1.232 . . . . 0.0 112.851 177.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 156' ' ' LEU . 37.9 t -70.81 -56.64 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.06 173.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -58.56 -36.78 74.46 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.55 0.614 . . . . 0.0 109.623 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.555 HG11 HD13 ' A' ' 108' ' ' LEU . 52.9 t -60.74 -31.46 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 173.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.78 -51.63 11.04 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.247 -0.908 . . . . 0.0 113.295 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.2 mm -71.28 -23.65 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 119.789 1.177 . . . . 0.0 113.31 -169.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.436 ' HG ' ' HG ' ' A' ' 135' ' ' CYS . 0.0 OUTLIER -85.32 61.09 6.64 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.567 -1.333 . . . . 0.0 112.433 -173.012 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -46.56 -44.65 18.14 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.448 1.499 . . . . 0.0 110.821 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.97 -24.2 28.01 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.678 1.132 . . . . 0.0 115.207 -171.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -88.4 -40.95 13.13 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.829 1.315 . . . . 0.0 111.042 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 92' ' ' VAL . 27.0 mt -79.64 -31.9 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 121.321 -0.862 . . . . 0.0 110.551 176.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.81 31.76 20.07 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.666 -0.519 . . . . 0.0 113.358 169.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -55.48 120.99 8.02 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.482 1.113 . . . . 0.0 112.414 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -76.45 170.37 16.51 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.716 0.807 . . . . 0.0 111.007 169.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -89.62 52.42 2.32 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.85 0.86 . . . . 0.0 112.095 169.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.7 -119.05 3.87 Favored Glycine 0 N--CA 1.471 0.982 0 N-CA-C 105.867 -2.893 . . . . 0.0 105.867 168.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.6 t -124.76 131.38 53.46 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.23 137.5 41.28 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -168.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -136.42 104.78 5.71 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -167.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.555 HD13 HG11 ' A' ' 92' ' ' VAL . 20.9 tp -97.41 101.0 12.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.744 -175.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.6 t -73.81 127.8 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 168.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.494 HD13 ' CG1' ' A' ' 89' ' ' VAL . 21.4 tp -116.26 130.12 56.62 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 169.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.422 ' CG2' HD22 ' A' ' 194' ' ' LEU 0.257 6.5 p -141.86 129.97 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.6 t -147.3 -176.46 5.24 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 113.351 -1.75 . . . . 0.0 111.277 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -130.82 -7.98 3.99 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 127.063 2.145 . . . . 0.0 113.607 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -150.14 169.4 21.37 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.917 1.287 . . . . 0.0 112.936 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -53.14 167.52 0.17 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.554 2.342 . . . . 0.0 115.677 -170.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -92.99 163.84 13.51 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . 78.2 m-70 -102.59 124.07 47.47 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 165.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.5 mp -104.32 177.21 4.91 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.757 1.223 . . . . 0.0 110.538 -172.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.44 145.46 4.71 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.367 58.6 pttt 56.29 2.79 0.09 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 128.345 2.658 . . . . 0.0 116.891 -170.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -66.34 -28.91 69.03 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 121.475 1.943 . . . . 0.0 112.442 170.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . 0.329 20.1 mttt -75.14 7.61 3.22 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 176.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.6 t -70.92 -18.69 62.65 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.781 1.232 . . . . 0.0 111.209 168.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 mp -65.71 -23.76 66.83 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.196 0.998 . . . . 0.0 112.196 169.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -88.42 -130.72 3.61 Favored Glycine 0 CA--C 1.538 1.482 0 N-CA-C 106.64 -2.584 . . . . 0.0 106.64 168.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.3 m -142.2 68.4 1.32 Allowed 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 118.008 0.904 . . . . 0.0 109.28 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -134.45 81.02 1.88 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.795 1.638 . . . . 0.0 108.665 -175.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -79.49 -45.74 18.76 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.729 0.812 . . . . 0.0 111.726 -176.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -57.99 120.62 8.86 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.049 0.54 . . . . 0.0 111.341 -171.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.4 t -72.13 154.33 41.14 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-O 122.577 1.18 . . . . 0.0 111.246 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.7 p -61.46 138.46 58.27 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 127.425 2.29 . . . . 0.0 115.674 -171.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 54.4 p30 -87.69 -18.15 30.16 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -175.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.28 17.38 78.81 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.988 -0.896 . . . . 0.0 114.017 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 37.5 ttm105 -96.9 158.73 15.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.954 1.702 . . . . 0.0 110.426 174.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' CYS . . . . . 0.436 ' HG ' ' HG ' ' A' ' 95' ' ' CYS . 0.0 OUTLIER -87.71 146.16 25.81 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.07 -1.019 . . . . 0.0 112.95 169.804 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -140.7 55.66 1.58 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.273 1.829 . . . . 0.0 110.663 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 tt -130.67 130.13 43.49 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.34 2.256 . . . . 0.0 108.418 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -145.56 -50.07 0.24 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 169.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -72.37 -20.91 61.38 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.905 1.282 . . . . 0.0 114.107 176.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 131.37 -17.88 5.01 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.118 1.818 . . . . 0.0 114.328 -172.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 80.5 mtp -113.52 157.72 21.66 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.989 1.895 . . . . 0.0 114.116 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -73.31 91.98 1.76 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.787 0.835 . . . . 0.0 110.972 171.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -54.62 -38.57 66.98 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.313 1.045 . . . . 0.0 112.535 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 64.8 m -79.58 0.74 28.73 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -41.32 -46.31 3.23 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 120.529 1.513 . . . . 0.0 112.338 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.68 -7.75 88.02 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 117.966 -1.463 . . . . 0.0 115.161 -172.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.276 88.8 tt0 -114.5 -79.39 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.025 0 CA-C-O 115.891 -2.004 . . . . 0.0 112.141 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.92 158.22 48.39 Favored 'Trans proline' 0 C--N 1.356 0.948 0 CA-C-N 123.509 2.289 . . . . 0.0 113.275 170.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -77.27 -168.25 1.08 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.673 1.589 . . . . 0.0 113.514 170.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 117' ' ' HIS . 71.2 m-85 -69.2 144.83 53.62 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 172.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.53 153.12 43.79 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 54.6 p -85.66 150.97 24.24 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.317 -0.864 . . . . 0.0 112.833 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 70.0 t -56.0 -43.83 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.597 0.759 . . . . 0.0 110.945 -176.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.5 t -75.68 -26.66 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.005 -1.059 . . . . 0.0 112.682 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -61.24 -32.81 72.6 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.869 1.213 . . . . 0.0 110.135 170.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.42 ' CD2' HG22 ' A' ' 90' ' ' VAL . 5.6 mt -83.69 -33.06 25.24 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.809 -0.557 . . . . 0.0 112.373 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.78 84.47 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.187 0.449 . . . . 0.0 110.331 169.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.1 t -55.29 -51.62 66.08 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.229 1.012 . . . . 0.0 111.193 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -73.57 -48.82 29.94 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.7 mp -73.2 -18.63 61.23 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.701 -1.249 . . . . 0.0 112.169 -173.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.66 -30.54 41.26 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 119.115 0.871 . . . . 0.0 112.586 168.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -68.9 -48.32 63.63 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.322 1.449 . . . . 0.0 109.76 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -79.95 -8.98 59.63 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.042 1.337 . . . . 0.0 111.964 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 59.5 49.13 8.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.769 2.427 . . . . 0.0 112.794 171.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 19.2 mm -96.97 147.21 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.929 1.691 . . . . 0.0 109.671 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -105.96 102.14 37.62 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 120.82 1.645 . . . . 0.0 109.549 168.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.439 ' C ' HD12 ' A' ' 168' ' ' ILE . 37.6 Cg_exo -76.23 125.9 8.82 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.977 3.118 . . . . 0.0 113.108 169.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.485 HG13 HG23 ' A' ' 190' ' ' THR . 1.3 mp -119.51 109.49 26.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -77.13 73.31 3.71 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 122.436 1.112 . . . . 0.0 112.371 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.428 HG23 HG22 ' A' ' 168' ' ' ILE . 77.4 t -60.0 104.18 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.893 0.877 . . . . 0.0 109.468 167.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 6.3 m -149.42 148.46 26.31 Favored Pre-proline 0 N--CA 1.481 1.122 0 O-C-N 119.871 -1.768 . . . . 0.0 113.2 -173.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -58.8 153.72 48.39 Favored 'Trans proline' 0 C--N 1.354 0.838 1 C-N-CA 125.625 4.217 . . . . 0.0 116.291 178.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 29.2 t -51.74 -54.61 26.57 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -169.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 80.2 mmt-85 -60.42 -13.32 12.81 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 120.549 1.522 . . . . 0.0 114.407 -173.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 14.3 ttp -105.53 -16.52 14.69 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.431 2.293 . . . . 0.0 114.641 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.9 m -62.49 -24.83 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 122.123 2.238 . . . . 0.0 112.344 -170.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -60.27 -28.69 68.27 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.9 t -92.17 -33.56 14.67 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.172 0.589 . . . . 0.0 111.453 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -69.57 -32.25 70.92 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.377 -1.452 . . . . 0.0 109.964 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -68.05 -12.97 61.8 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.453 1.101 . . . . 0.0 112.309 169.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -96.9 -29.21 13.83 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.16 -0.963 . . . . 0.0 111.291 173.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.5 -26.81 63.76 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 119.895 -1.753 . . . . 0.0 109.758 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.4 t -81.15 -15.2 56.49 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.98 -19.44 44.06 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.805 169.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -88.78 -31.58 18.3 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 170.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 14.8 mm -101.78 111.86 64.56 Favored Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 119.547 1.067 . . . . 0.0 109.505 176.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.77 0.65 4.01 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 124.924 3.749 . . . . 0.0 119.779 -168.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -128.68 -2.95 5.36 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 -176.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.431 HD22 ' HB2' ' A' ' 167' ' ' PRO . 9.2 mt -83.21 172.75 12.29 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.93 1.241 . . . . 0.0 113.299 -169.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.485 HG23 HG13 ' A' ' 168' ' ' ILE 0.446 0.1 OUTLIER -141.5 -176.42 4.73 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 167.989 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.9 mp -157.88 136.68 3.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 131.478 3.911 . . . . 0.0 109.354 -166.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -118.38 147.46 18.56 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 172.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -87.43 87.38 7.39 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 122.863 1.316 . . . . 0.0 107.658 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.422 HD22 ' CG2' ' A' ' 111' ' ' VAL . 12.3 tp . . . . . 0 CA--C 1.546 0.81 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.494 169.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 t . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 t -110.19 95.66 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.628 1.171 . . . . 0.0 110.125 -171.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -76.39 118.33 18.97 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.544 -0.723 . . . . 0.0 110.352 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.1 mt -107.25 137.79 44.66 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.685 -0.634 . . . . 0.0 110.191 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -122.49 109.48 14.41 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 122.579 1.18 . . . . 0.0 108.986 169.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -83.26 110.64 18.26 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.856 1.262 . . . . 0.0 111.808 173.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' A' ' 88' ' ' ALA . 30.3 tp -103.21 124.23 48.22 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.981 0.912 . . . . 0.0 110.62 170.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 40.7 ttp -121.88 138.68 54.3 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -169.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.53 133.58 12.62 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.943 1.259 . . . . 0.0 112.159 172.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tp -119.31 26.53 9.38 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.799 1.639 . . . . 0.0 113.3 -173.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 179.08 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 123.061 1.41 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.62 94.66 0.11 Allowed Glycine 0 CA--C 1.517 0.182 0 N-CA-C 105.898 -2.881 . . . . 0.0 105.898 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -92.36 147.47 22.89 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 122.727 0.411 . . . . 0.0 110.402 -168.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.0 tt -122.26 129.27 75.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 124.196 0.998 . . . . 0.0 109.946 -172.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.75 157.84 14.94 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.273 1.416 . . . . 0.0 110.853 172.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -141.58 131.75 24.84 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.24 155.68 24.1 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 124.407 1.004 . . . . 0.0 113.199 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 74.3 m -119.32 139.95 51.12 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.009 1.324 . . . . 0.0 111.316 -177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.3 tt -142.53 157.97 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.787 1.235 . . . . 0.0 111.328 171.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -158.46 -59.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -179.28 -28.97 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 129.861 3.264 . . . . 0.0 107.499 172.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.4 70.98 3.85 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 101.64 -3.467 . . . . 0.0 101.64 165.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.326 14.8 t 19.43 -138.45 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.763 1 C-N-CA 132.129 4.172 . . . . 0.0 116.318 -169.333 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -117.43 146.05 43.73 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 129.335 3.054 . . . . 0.0 109.892 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -134.04 123.28 24.25 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.54 0.736 . . . . 0.0 111.152 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -85.79 98.33 10.68 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.378 1.071 . . . . 0.0 110.08 169.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.5 tt -83.98 -64.24 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.504 0.722 . . . . 0.0 112.258 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 tp -109.27 117.38 33.94 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.605 1.162 . . . . 0.0 110.437 -171.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -60.59 147.76 40.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.498 0.719 . . . . 0.0 112.043 173.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.2 tt -50.41 115.13 1.32 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.554 1.942 . . . . 0.0 110.961 172.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.481 1.087 0 C-N-CA 125.073 1.349 . . . . 0.0 112.353 -170.187 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.5 p -103.19 -151.01 0.42 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.511 0.724 . . . . 0.0 111.866 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -142.87 141.53 10.69 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.375 1.464 . . . . 0.0 112.252 173.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -151.79 144.89 24.57 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.965 1.706 . . . . 0.0 110.652 173.431 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.56 -38.61 14.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -169.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.43 139.81 42.52 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.8 p -76.0 -38.63 2.51 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-O 115.89 -2.005 . . . . 0.0 114.905 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.99 136.61 53.41 Favored 'Trans proline' 0 C--N 1.355 0.885 0 CA-C-N 122.555 1.948 . . . . 0.0 112.897 171.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -102.22 160.38 14.57 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.548 1.539 . . . . 0.0 113.402 179.298 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.35 22.37 1.66 Allowed Glycine 0 N--CA 1.477 1.426 0 O-C-N 120.883 -1.136 . . . . 0.0 115.147 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -47.16 -34.18 5.94 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.386 2.274 . . . . 0.0 114.573 -169.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.29 -32.92 71.65 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.592 -0.718 . . . . 0.0 112.421 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -57.75 -52.11 66.81 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.307 0.958 . . . . 0.0 110.416 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.474 ' HB3' HD21 ' A' ' 9' ' ' LEU . . . -60.29 -49.6 76.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 116.464 -1.731 . . . . 0.0 111.18 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.468 HG12 HD13 ' A' ' 110' ' ' LEU . 16.4 m -55.35 -38.36 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 121.378 1.899 . . . . 0.0 114.423 -169.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.5 HG11 ' HG3' ' A' ' 151' ' ' GLN . 1.3 p -86.37 -38.79 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 117.451 -1.262 . . . . 0.0 112.582 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -60.74 -44.42 96.7 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 121.161 1.8 . . . . 0.0 109.776 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.254 6.4 m -65.56 -4.11 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 120.773 1.624 . . . . 0.0 114.239 174.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.77 -18.07 17.39 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.772 1.229 . . . . 0.0 113.222 169.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.9 mt -104.89 -19.06 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 126.004 1.722 . . . . 0.0 111.735 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 95.3 m -73.16 42.42 0.11 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 127.338 2.255 . . . . 0.0 113.581 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -50.39 -41.41 52.02 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.027 1.331 . . . . 0.0 111.412 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.37 -26.77 46.24 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.24 0.924 . . . . 0.0 115.121 -174.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -88.54 -41.85 12.44 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.161 0.98 . . . . 0.0 110.277 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 74.6 mt -76.03 -38.44 35.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 CA-C-O 117.495 -1.241 . . . . 0.0 110.809 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.19 20.21 31.02 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 119.199 0.909 . . . . 0.0 115.145 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -52.05 125.91 16.94 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.079 1.351 . . . . 0.0 113.063 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -98.12 174.6 6.45 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.356 1.462 . . . . 0.0 113.196 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -71.76 1.55 6.72 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -174.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.25 -134.72 2.01 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 120.666 1.576 . . . . 0.0 110.223 -178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.3 t -97.58 143.29 28.41 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.865 1.266 . . . . 0.0 108.299 175.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -142.0 118.44 10.9 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 119.365 0.984 . . . . 0.0 110.183 -169.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -119.16 109.95 16.47 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -169.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.58 96.77 7.57 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.415 175.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.99 118.49 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.468 HD13 HG12 ' A' ' 89' ' ' VAL . 45.8 tp -108.97 128.97 55.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 117.765 -1.112 . . . . 0.0 109.846 -174.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.8 t -120.91 134.79 63.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.6 t -161.24 166.54 27.56 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 112.801 -2.0 . . . . 0.0 109.624 169.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -124.03 7.72 8.61 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.856 2.062 . . . . 0.0 114.214 174.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -141.83 -177.63 5.29 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.573 1.549 . . . . 0.0 111.51 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -55.08 177.87 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.491 2.316 . . . . 0.0 114.696 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -139.34 158.78 43.56 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.82 2.048 . . . . 0.0 110.015 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -85.54 126.67 34.05 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.201 0.6 . . . . 0.0 111.368 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.587 HD22 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -91.11 176.1 6.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.481 1.512 . . . . 0.0 108.992 172.192 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.587 ' H ' HD22 ' A' ' 118' ' ' LEU . . . -55.22 148.78 13.73 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.177 -0.952 . . . . 0.0 112.139 169.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.1 mptt 76.55 -13.86 0.88 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.479 2.312 . . . . 0.0 113.589 -176.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -65.62 -19.34 65.87 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.254 -1.529 . . . . 0.0 111.622 169.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -66.16 -24.08 66.58 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.345 3.0 t -75.66 -11.8 60.07 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 119.216 0.916 . . . . 0.0 112.13 -173.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.4 mt -60.63 -34.84 74.86 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.977 -1.077 . . . . 0.0 110.84 167.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -92.26 15.34 62.36 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.826 1.679 . . . . 0.0 113.711 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.543 0.1 OUTLIER 44.05 54.27 6.0 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 128.672 2.789 . . . . 0.0 113.917 -176.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -104.0 132.14 50.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.017 2.127 . . . . 0.0 105.59 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -113.78 -35.96 4.99 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 120.786 1.63 . . . . 0.0 113.315 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -48.07 116.86 1.67 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.789 1.236 . . . . 0.0 112.037 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.8 t -62.87 157.37 21.66 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.912 0.778 . . . . 0.0 110.164 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -66.53 132.3 47.91 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.838 -0.539 . . . . 0.0 110.622 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.82 -11.15 59.65 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.8 75.14 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 118.65 -1.083 . . . . 0.0 113.793 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -125.79 178.28 5.8 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.243 1.417 . . . . 0.0 112.328 170.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 1.2 m -99.39 146.24 26.51 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -169.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -151.55 56.38 0.87 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.568 1.547 . . . . 0.0 113.289 -169.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -134.26 151.43 51.28 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.918 -1.113 . . . . 0.0 111.511 169.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -147.41 -49.95 0.18 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.209 1.004 . . . . 0.0 113.511 -169.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -80.44 -10.16 59.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.242 1.017 . . . . 0.0 112.73 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.07 -9.31 27.17 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.476 1.989 . . . . 0.0 113.928 -171.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 29.9 ttm -99.26 136.13 39.66 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.8 1.8 . . . . 0.0 111.69 174.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.463 ' CE1' ' HB3' ' A' ' 144' ' ' SER . 30.6 t80 -66.66 95.98 0.37 Allowed 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.49 -0.756 . . . . 0.0 111.947 171.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -53.23 -45.33 68.66 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.22 2.208 . . . . 0.0 112.685 -178.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.463 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 17.2 t -67.79 -19.65 65.12 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -168.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -48.56 -35.32 13.13 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 121.035 1.743 . . . . 0.0 114.064 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.92 -16.82 74.92 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 119.099 -0.834 . . . . 0.0 113.482 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -117.73 -84.49 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.359 0 CA-C-O 115.946 -1.978 . . . . 0.0 109.802 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -51.51 157.64 4.81 Favored 'Trans proline' 0 C--N 1.358 1.03 0 N-CA-C 120.072 3.066 . . . . 0.0 120.072 171.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.446 ' HB2' ' HE3' ' A' ' 122' ' ' LYS . 47.9 t0 -77.03 166.77 22.87 Favored 'General case' 0 N--CA 1.468 0.448 1 C-N-CA 131.875 4.07 . . . . 0.0 115.595 -179.156 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -71.62 123.08 21.71 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 166.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.667 ' CD ' ' H ' ' A' ' 151' ' ' GLN . 1.0 OUTLIER -51.17 147.23 5.66 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 125.875 1.67 . . . . 0.0 112.217 171.192 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 7.7 t -85.11 166.25 16.8 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.982 0.896 . . . . 0.0 112.561 173.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.46 -27.9 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -168.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.2 p -84.09 -26.39 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 175.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -68.78 -34.16 75.09 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.358 -0.839 . . . . 0.0 110.293 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -58.59 -59.91 4.65 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.037 0.535 . . . . 0.0 110.297 169.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.24 -36.44 66.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.743 0.817 . . . . 0.0 113.069 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.4 t -58.89 -57.55 12.57 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.408 1.083 . . . . 0.0 112.417 175.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -81.37 -22.3 38.48 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.786 -1.196 . . . . 0.0 113.902 -174.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.4 mp -61.08 -48.02 83.63 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.117 0.967 . . . . 0.0 109.869 168.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.88 -28.78 55.51 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -67.91 -50.7 54.66 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.644 0.778 . . . . 0.0 110.179 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -84.16 -1.21 54.62 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.7 t30 64.08 31.86 13.18 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.753 1.161 . . . . 0.0 112.078 169.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.8 mt -97.75 128.61 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -103.87 115.33 63.56 Favored Pre-proline 0 N--CA 1.477 0.891 0 CA-C-N 119.461 1.028 . . . . 0.0 111.954 175.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.31 153.68 35.87 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.482 2.122 . . . . 0.0 115.803 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.04 113.57 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.789 1.636 . . . . 0.0 109.111 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.403 ' CD1' HD23 ' A' ' 110' ' ' LEU . 21.7 m-85 -71.56 68.15 0.56 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 122.248 1.023 . . . . 0.0 112.793 176.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.1 t -63.85 102.13 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 O-C-N 120.035 -1.665 . . . . 0.0 111.54 170.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 16.3 m -143.45 145.27 31.12 Favored Pre-proline 0 N--CA 1.478 0.934 0 O-C-N 120.074 -1.641 . . . . 0.0 111.174 -174.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -56.96 150.25 56.69 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.79 2.993 . . . . 0.0 112.941 173.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.5 t -46.54 -44.71 18.11 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.705 1.602 . . . . 0.0 114.123 -169.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.4 ptm85 -53.54 -27.95 28.86 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 12.8 tpt -106.02 -4.53 20.39 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.684 1.594 . . . . 0.0 113.917 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.37 -35.52 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 120.239 -1.538 . . . . 0.0 112.807 -169.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -68.53 -20.32 64.55 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.9 m -88.83 -40.22 13.3 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.211 1.404 . . . . 0.0 110.202 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -70.27 -26.42 63.81 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.341 -0.849 . . . . 0.0 111.149 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.75 -16.68 64.24 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.428 1.013 . . . . 0.0 111.844 168.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -82.06 -29.46 31.86 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.742 -1.224 . . . . 0.0 111.35 169.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.55 -26.17 57.75 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.581 -1.325 . . . . 0.0 110.217 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.03 -16.48 53.19 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.612 1.565 . . . . 0.0 111.78 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.77 -28.33 24.62 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.929 0.491 . . . . 0.0 110.286 169.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -78.14 -26.19 47.74 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 62.3 mt -117.3 96.94 50.15 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 123.701 0.801 . . . . 0.0 110.062 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.34 138.98 55.67 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.248 3.299 . . . . 0.0 113.836 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt 76.28 -8.75 1.59 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 129.038 2.935 . . . . 0.0 113.721 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.439 HD23 ' H ' ' A' ' 190' ' ' THR . 2.9 tt -72.59 150.96 42.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 169.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.439 ' H ' HD23 ' A' ' 189' ' ' LEU . 2.3 m -129.53 -139.15 0.23 Allowed 'General case' 0 C--N 1.343 0.294 0 CA-C-O 122.212 1.006 . . . . 0.0 109.549 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.9 tt -173.42 160.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 127.083 2.153 . . . . 0.0 109.807 -168.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -150.69 147.48 17.58 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 169.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.65 89.25 7.44 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.813 1.245 . . . . 0.0 108.42 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.7 tp . . . . . 0 CA--C 1.537 0.479 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.11 169.156 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.541 0.624 0 CA-C-O 119.009 -0.519 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.575 HG13 HG23 ' A' ' 105' ' ' THR . 51.3 t -139.62 118.05 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 119.111 0.868 . . . . 0.0 111.883 -176.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -93.74 122.69 36.46 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 122.888 0.475 . . . . 0.0 110.062 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -107.88 120.31 41.91 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.219 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -113.73 104.86 12.63 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 124.783 2.23 . . . . 0.0 110.183 171.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -75.63 117.72 17.7 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 111.52 -2.582 . . . . 0.0 111.761 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.5 tp -118.89 111.06 17.91 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.06 0.944 . . . . 0.0 110.79 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -114.04 137.13 52.13 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 118.821 2.897 . . . . 0.0 118.821 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.24 112.52 4.22 Favored Glycine 0 C--N 1.341 0.819 0 C-N-CA 125.639 1.59 . . . . 0.0 110.268 171.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.3 tp -98.89 28.91 4.05 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.791 1.637 . . . . 0.0 111.456 -172.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.0 p . . . . . 0 CA--C 1.543 0.686 0 O-C-N 120.253 -1.529 . . . . 0.0 114.368 -171.581 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 123.403 1.573 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.11 90.83 0.2 Allowed Glycine 0 C--N 1.332 0.348 0 N-CA-C 105.693 -2.963 . . . . 0.0 105.693 -176.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -76.17 144.13 40.71 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -170.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 mt -136.69 128.18 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 118.078 0.399 . . . . 0.0 110.084 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.91 149.42 19.36 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 126.402 1.953 . . . . 0.0 110.247 -173.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -129.89 131.89 46.21 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.626 1.17 . . . . 0.0 113.926 -169.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.03 152.81 22.95 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 171.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 75.1 p -130.29 154.22 47.85 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.427 0.691 . . . . 0.0 110.796 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -151.43 140.73 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -169.697 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.589 ' CG2' ' H ' ' A' ' 50' ' ' ASN 0.308 1.4 m -136.53 -84.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-N 119.735 1.152 . . . . 0.0 111.386 169.207 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.589 ' H ' ' CG2' ' A' ' 49' ' ' VAL 0.49 24.2 t30 -156.97 -5.88 0.1 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 129.776 3.23 . . . . 0.0 111.713 169.227 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.0 ptp -88.99 44.45 1.21 Allowed 'General case' 0 CA--C 1.578 2.044 1 N-CA-C 98.994 -4.447 . . . . 0.0 98.994 160.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.552 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.681 14.6 m 14.23 -113.69 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.179 1 C-N-CA 137.324 6.25 . . . . 0.0 116.135 -164.941 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -112.56 136.83 51.63 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 125.727 1.892 . . . . 0.0 112.513 -168.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -124.43 120.87 33.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.654 1.181 . . . . 0.0 108.028 168.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -84.88 98.6 10.42 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.391 1.477 . . . . 0.0 110.426 169.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -86.88 -33.99 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 121.173 -0.954 . . . . 0.0 113.396 -174.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.4 tt -154.1 129.91 10.12 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.534 1.061 . . . . 0.0 111.375 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -78.79 169.23 18.56 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.407 HD11 ' CE3' ' A' ' 101' ' ' TRP . 73.3 mt -51.86 101.27 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.946 1.698 . . . . 0.0 112.075 176.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.479 1.021 0 C-N-CA 125.648 1.579 . . . . 0.0 112.32 -179.839 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.2 t -101.93 -150.67 0.41 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 127.715 2.406 . . . . 0.0 112.44 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -159.92 155.89 27.05 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 125.716 1.627 . . . . 0.0 114.573 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -162.12 162.37 28.54 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.999 1.72 . . . . 0.0 112.208 174.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -78.85 -52.64 8.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.073 1.749 . . . . 0.0 111.71 -177.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.31 136.17 46.15 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.931 0.892 . . . . 0.0 111.773 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 80.4 m -72.97 -47.84 8.15 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-O 116.178 -1.867 . . . . 0.0 113.475 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.01 148.67 89.75 Favored 'Trans proline' 0 C--N 1.355 0.89 0 CA-C-N 121.94 1.728 . . . . 0.0 110.992 171.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -123.34 174.93 7.01 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.92 1.288 . . . . 0.0 112.576 -169.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -99.74 23.13 37.32 Favored Glycine 0 N--CA 1.482 1.741 0 O-C-N 119.836 -1.79 . . . . 0.0 115.799 -170.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.515 ' NE2' ' H ' ' A' ' 85' ' ' GLN . 1.9 pm0 -62.13 -17.73 58.73 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 120.359 2.079 . . . . 0.0 116.239 -169.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.496 ' HA ' HG22 ' A' ' 89' ' ' VAL . 4.9 mp -70.56 -14.09 62.36 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -72.87 -49.99 26.58 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 167.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.08 -51.11 70.54 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 116.065 -1.922 . . . . 0.0 111.652 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.496 HG22 ' HA ' ' A' ' 86' ' ' LEU . 28.8 m -52.27 -34.28 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 121.191 1.814 . . . . 0.0 112.135 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.868 HG21 HD22 ' A' ' 156' ' ' LEU . 12.4 t -87.6 -37.64 11.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 116.768 -1.587 . . . . 0.0 113.03 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -60.54 -46.6 89.58 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 121.862 2.119 . . . . 0.0 109.203 169.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.1 t -54.68 -40.19 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 125.509 1.524 . . . . 0.0 112.194 175.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.63 -42.32 64.54 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.8 mt -76.52 -38.78 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.455 1.102 . . . . 0.0 113.01 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 66.5 m -81.1 61.27 4.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.829 1.651 . . . . 0.0 110.619 -169.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.4 mt -50.79 -44.51 58.89 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.076 2.55 . . . . 0.0 111.619 -171.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.66 -22.39 66.94 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.691 -176.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -87.49 -47.89 8.38 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.963 0.905 . . . . 0.0 110.416 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.9 mp -70.29 -34.45 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.203 0.601 . . . . 0.0 110.769 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.2 29.41 8.98 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.23 1.395 . . . . 0.0 114.498 172.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.407 ' CE3' HD11 ' A' ' 59' ' ' LEU . 53.1 m95 -57.46 125.31 22.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.707 1.254 . . . . 0.0 112.952 -174.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -86.38 -177.07 6.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.195 2.198 . . . . 0.0 111.223 170.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -97.13 26.16 4.94 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.317 1.447 . . . . 0.0 114.808 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.69 -128.7 1.82 Allowed Glycine 0 CA--C 1.539 1.534 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.575 HG23 HG13 ' A' ' 4' ' ' VAL 0.308 7.2 t -112.72 152.52 28.98 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.536 -1.332 . . . . 0.0 108.173 167.171 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -130.16 129.88 44.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 117.439 -1.267 . . . . 0.0 110.362 -167.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -126.62 125.26 41.61 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.88 1.673 . . . . 0.0 115.343 -168.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 108' ' ' LEU . 48.7 mt -97.7 103.29 15.22 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.676 0.75 . . . . 0.0 112.305 169.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.536 HG13 HG21 ' A' ' 170' ' ' VAL . 36.0 t -90.78 95.34 5.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 174.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 37.0 tp -94.8 123.84 38.5 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 170' ' ' VAL 0.273 11.6 p -113.83 139.15 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 170.213 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -164.07 156.39 17.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.24 1.816 . . . . 0.0 109.885 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -106.23 -0.2 24.69 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.58 1.552 . . . . 0.0 114.456 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -144.13 179.47 7.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.195 1.398 . . . . 0.0 111.953 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.28 -174.33 0.12 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 122.992 1.377 . . . . 0.0 113.387 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -135.28 158.57 44.02 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.492 1.917 . . . . 0.0 112.691 -169.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -86.65 130.31 34.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.065 1.346 . . . . 0.0 109.862 169.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.474 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -110.14 170.21 8.23 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.825 1.25 . . . . 0.0 111.634 177.221 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.82 133.63 42.52 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.911 0.386 . . . . 0.0 111.87 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.4 mttm 91.94 -16.14 0.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 130.596 3.558 . . . . 0.0 113.008 -174.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -63.61 -28.95 70.28 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 121.484 1.947 . . . . 0.0 112.971 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -69.39 -5.54 24.21 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 121.472 -0.768 . . . . 0.0 112.855 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.9 t -62.77 -34.35 77.06 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.445 1.098 . . . . 0.0 112.469 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.66 -28.44 67.71 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.814 0.734 . . . . 0.0 112.373 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -81.05 4.05 73.11 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.109 1.338 . . . . 0.0 113.811 169.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.6 m 75.1 31.73 0.81 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 127.843 2.457 . . . . 0.0 111.6 175.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -115.06 110.87 20.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.553 1.141 . . . . 0.0 111.216 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -96.84 -40.6 8.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.347 1.459 . . . . 0.0 112.303 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -66.35 123.06 18.94 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.992 0.814 . . . . 0.0 110.977 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.9 t -65.93 152.75 43.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.946 0.899 . . . . 0.0 110.605 175.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 t -68.97 138.27 54.43 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.312 1.053 . . . . 0.0 111.963 174.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -82.76 -13.37 56.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.159 1.784 . . . . 0.0 113.911 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.2 31.74 63.56 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.838 -0.979 . . . . 0.0 113.017 -176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -107.61 164.99 11.75 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.213 1.405 . . . . 0.0 112.714 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 26.2 t -67.51 119.45 12.33 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.864 1.265 . . . . 0.0 110.593 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -123.85 40.79 3.64 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.276 1.43 . . . . 0.0 111.838 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.4 tp -122.18 117.95 27.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.755 1.622 . . . . 0.0 108.422 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -120.34 -49.02 2.28 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.463 1.105 . . . . 0.0 108.732 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -86.46 -130.31 0.05 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.727 1.611 . . . . 0.0 108.34 168.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.33 -21.67 7.88 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.089 1.328 . . . . 0.0 113.674 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 21.0 mtt -93.26 142.79 26.92 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.788 1.294 . . . . 0.0 112.78 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -64.56 100.44 0.37 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.721 1.208 . . . . 0.0 110.351 169.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -61.77 -40.32 94.74 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.188 0.995 . . . . 0.0 112.593 -174.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 63.8 m -82.24 6.63 16.11 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 23.2 ttp-105 -47.87 -50.72 25.6 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.698 1.135 . . . . 0.0 111.49 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.39 -31.99 68.38 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-O 118.421 -1.21 . . . . 0.0 113.107 -169.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.291 6.4 tp10 -92.66 -84.57 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.104 0 CA-C-O 115.579 -2.153 . . . . 0.0 112.025 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.31 155.14 71.38 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 CA-C-N 124.646 2.695 . . . . 0.0 116.168 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -72.72 161.56 30.59 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 129.913 3.285 . . . . 0.0 113.847 176.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -52.44 138.4 27.47 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.833 0.853 . . . . 0.0 111.281 172.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.473 ' CD ' ' H ' ' A' ' 151' ' ' GLN 0.271 0.0 OUTLIER -82.18 143.78 31.17 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.094 -1.004 . . . . 0.0 112.014 178.85 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 70.6 m -74.99 148.88 39.54 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.401 1.08 . . . . 0.0 112.769 -174.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.442 ' HA ' ' HG ' ' A' ' 156' ' ' LEU 0.296 33.4 t -58.61 -22.06 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -177.695 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.4 t -65.33 -44.66 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 118.893 0.769 . . . . 0.0 111.553 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.42 -29.99 59.92 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.552 0.741 . . . . 0.0 110.729 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.868 HD22 HG21 ' A' ' 90' ' ' VAL . 2.1 mt -63.62 -45.76 88.83 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 172.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.41 -45.89 69.55 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.222 1.009 . . . . 0.0 112.713 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 76.5 p -69.78 -38.84 76.85 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -174.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.34 -45.86 58.05 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.153 -0.967 . . . . 0.0 112.147 173.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.7 mt -53.25 -40.38 64.56 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.923 1.238 . . . . 0.0 113.24 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.73 -28.18 50.72 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -82.7 -34.39 27.33 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.571 1.078 . . . . 0.0 111.536 176.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -72.41 -18.9 61.68 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.843 0.857 . . . . 0.0 111.974 171.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 63.9 39.93 7.81 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.08 1.752 . . . . 0.0 112.314 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.05 143.56 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-O 117.052 -1.451 . . . . 0.0 109.731 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -105.34 115.67 61.64 Favored Pre-proline 0 N--CA 1.481 1.111 0 CA-C-N 121.72 2.055 . . . . 0.0 112.627 170.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -80.38 149.39 19.15 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.635 2.224 . . . . 0.0 113.093 169.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.1 mt -137.22 110.28 7.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.875 1.67 . . . . 0.0 107.107 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -72.45 73.72 1.02 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.933 0.873 . . . . 0.0 112.355 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.536 HG21 HG13 ' A' ' 109' ' ' VAL . 88.1 t -65.54 92.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 120.945 -1.097 . . . . 0.0 111.862 172.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 24.4 m -139.2 138.97 21.67 Favored Pre-proline 0 N--CA 1.479 0.993 0 O-C-N 119.729 -1.857 . . . . 0.0 110.513 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -58.53 152.53 54.48 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.558 2.839 . . . . 0.0 114.01 173.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 72.6 p -46.23 -42.72 14.7 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 116.666 2.098 . . . . 0.0 116.666 -168.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -51.37 -40.84 60.03 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 120.214 1.37 . . . . 0.0 113.509 -171.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.6 8.59 33.27 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.5 t -59.85 -42.92 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 121.036 1.744 . . . . 0.0 110.885 -176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -69.58 -13.45 62.33 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -174.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' THR . . . . . 0.443 ' HA ' ' HE2' ' A' ' 181' ' ' LYS 0.265 10.1 t -93.03 -27.5 16.95 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 118.86 0.754 . . . . 0.0 112.476 173.319 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -76.29 -29.76 57.5 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.49 -1.382 . . . . 0.0 109.509 168.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -58.03 -26.54 62.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.168 0.987 . . . . 0.0 110.818 169.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 178' ' ' THR . 55.3 mtmt -79.4 -40.28 30.43 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.573 -0.705 . . . . 0.0 109.589 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.6 mp -79.65 -18.66 50.94 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 120.668 -1.27 . . . . 0.0 111.532 -175.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.8 t -74.89 -11.52 60.15 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.066 0.46 . . . . 0.0 110.581 168.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.31 -28.67 23.57 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.177 -0.952 . . . . 0.0 109.434 168.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -76.85 -26.56 54.41 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.27 91.09 50.03 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.536 1.134 . . . . 0.0 110.654 170.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.06 153.45 32.25 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.596 3.531 . . . . 0.0 113.692 173.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 24.9 pttt 88.29 -19.11 0.23 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 131.464 3.906 . . . . 0.0 113.229 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.64 163.91 24.54 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.794 0.838 . . . . 0.0 110.267 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 36.0 p -123.0 -145.42 0.35 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 169.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.2 tt 178.65 138.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 129.055 2.942 . . . . 0.0 107.977 -168.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -133.52 143.5 15.21 Favored Glycine 0 N--CA 1.463 0.479 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -87.87 90.09 8.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 56.1 tp . . . . . 0 CA--C 1.539 0.545 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.602 169.736 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 119.989 -0.053 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.1 t -123.86 135.6 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.394 1.478 . . . . 0.0 109.406 172.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -114.59 113.3 24.2 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 168.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.522 HD23 HD12 ' A' ' 43' ' ' ILE . 59.0 tp -101.21 131.89 46.98 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.056 0.455 . . . . 0.0 111.999 171.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -121.09 111.64 17.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 123.631 1.682 . . . . 0.0 109.561 169.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -88.52 107.85 19.1 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.007 -1.906 . . . . 0.0 111.597 175.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.3 tp -100.59 120.14 39.6 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.997 1.319 . . . . 0.0 111.877 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 30.8 mtp -103.97 143.9 32.25 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.88 115.38 4.97 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.701 1.619 . . . . 0.0 109.731 168.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -99.56 35.4 1.99 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.299 1.84 . . . . 0.0 111.951 -174.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 p . . . . . 0 N--CA 1.471 0.589 0 C-N-CA 124.954 1.302 . . . . 0.0 113.605 -179.512 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 121.71 0.767 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.52 83.03 0.32 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 127.512 2.482 . . . . 0.0 107.492 -177.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -85.47 146.08 27.12 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 125.484 1.514 . . . . 0.0 108.019 -169.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.522 HD12 HD23 ' A' ' 6' ' ' LEU 0.261 11.9 tt -136.56 141.77 40.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 178.759 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.93 150.77 19.64 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 127.884 2.659 . . . . 0.0 109.816 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -126.79 130.29 49.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.36 146.19 16.63 Favored Glycine 0 C--N 1.343 0.97 0 C-N-CA 124.545 1.069 . . . . 0.0 112.626 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.9 t -119.14 143.5 47.17 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.813 1.645 . . . . 0.0 109.918 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.68 151.04 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.944 1.298 . . . . 0.0 108.581 176.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.94 -18.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 169.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 63.4 t30 117.42 -10.96 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 130.847 3.659 . . . . 0.0 111.597 -171.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.51 ' O ' HG23 ' A' ' 52' ' ' THR . 64.9 ttp -62.72 -44.21 96.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.93 -1.106 . . . . 0.0 108.585 169.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 51' ' ' MET . 55.5 p 176.13 -164.35 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.89 1 C-N-CA 135.234 5.413 . . . . 0.0 105.19 169.287 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -109.11 133.01 53.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 167.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -118.59 121.88 41.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.34 1.067 . . . . 0.0 110.638 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -80.57 111.12 16.69 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.761 169.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.5 mm -93.95 -53.6 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.218 1.007 . . . . 0.0 111.531 -173.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.8 tp -126.15 123.77 39.01 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.163 0.892 . . . . 0.0 111.897 -175.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -59.09 154.34 16.01 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.086 1.354 . . . . 0.0 112.15 173.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.5 mt -59.24 111.01 1.19 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.669 1.122 . . . . 0.0 110.884 172.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 124.371 1.068 . . . . 0.0 112.746 -177.064 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 CA--C 1.547 0.865 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.1 t -92.97 -162.09 0.9 Allowed 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 126.108 1.763 . . . . 0.0 112.133 172.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -159.76 125.15 1.44 Allowed Glycine 0 N--CA 1.481 1.638 0 O-C-N 119.742 -1.849 . . . . 0.0 115.129 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -145.88 167.04 24.21 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.541 1.936 . . . . 0.0 112.836 -173.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.1 mt -95.67 -49.18 5.48 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -169.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.64 136.81 41.93 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.716 0.689 . . . . 0.0 111.033 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.279 13.0 t -64.1 -42.52 69.44 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 114.661 -2.59 . . . . 0.0 115.18 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.66 149.35 73.55 Favored 'Trans proline' 0 C--N 1.359 1.098 0 CA-C-N 123.925 2.437 . . . . 0.0 113.242 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -102.96 165.51 10.98 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.911 0.884 . . . . 0.0 111.994 173.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.45 48.16 3.1 Favored Glycine 0 N--CA 1.48 1.576 0 C-N-CA 125.766 1.651 . . . . 0.0 112.106 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -68.34 -44.14 75.95 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -169.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -72.48 -15.82 61.8 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.814 -1.179 . . . . 0.0 112.848 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -58.29 -49.96 75.31 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.351 1.432 . . . . 0.0 108.398 168.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.32 -45.77 80.16 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.836 -0.54 . . . . 0.0 111.296 171.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.81 -41.33 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 118.178 -0.915 . . . . 0.0 112.294 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.4 t -58.91 -53.19 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 119.922 1.237 . . . . 0.0 109.844 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -62.76 -51.92 65.22 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 122.414 0.286 . . . . 0.0 110.846 -173.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.537 HG11 HD13 ' A' ' 108' ' ' LEU . 88.0 t -56.68 -27.98 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 123.471 0.708 . . . . 0.0 111.874 177.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.71 -32.62 23.43 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.83 -31.39 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.485 1.039 . . . . 0.0 112.218 -174.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 60.7 m -82.86 59.47 4.85 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.497 1.919 . . . . 0.0 111.125 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.61 -36.01 75.46 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.266 1.427 . . . . 0.0 113.051 -169.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.62 -32.97 58.82 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.376 0.512 . . . . 0.0 113.312 -174.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -94.77 -38.51 10.74 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.526 1.13 . . . . 0.0 111.354 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.4 mm -63.64 -37.04 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 120.915 1.689 . . . . 0.0 109.537 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.27 28.36 22.87 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.131 1.348 . . . . 0.0 113.818 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -57.44 119.65 6.87 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.191 1.495 . . . . 0.0 110.786 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.4 mmt-85 -83.42 -158.14 0.28 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.755 2.022 . . . . 0.0 108.805 171.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -81.69 -157.58 0.19 Allowed 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.27 -177.91 53.14 Favored Glycine 0 N--CA 1.424 -2.123 0 CA-C-O 125.541 2.745 . . . . 0.0 108.841 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.7 p -67.96 132.84 48.06 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 108.316 -3.942 . . . . 0.0 106.606 168.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.17 135.22 55.19 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 -177.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.414 ' CD2' ' HB2' ' A' ' 166' ' ' GLN . 1.8 t80 -138.48 124.62 20.23 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -166.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.537 HD13 HG11 ' A' ' 92' ' ' VAL . 52.4 tp -105.33 98.3 8.02 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.147 0.43 . . . . 0.0 111.011 177.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 39.5 t -80.45 121.68 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 170.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.412 HD23 ' C ' ' A' ' 110' ' ' LEU . 7.1 tt -109.41 120.85 43.75 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.7 t -111.59 132.4 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 124.129 0.893 . . . . 0.0 112.001 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.5 t -151.24 179.39 8.34 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.445 1.098 . . . . 0.0 111.283 171.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.57 -13.22 6.57 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.653 1.981 . . . . 0.0 114.097 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -137.09 173.55 11.57 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.49 1.516 . . . . 0.0 112.981 -171.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -60.79 -169.61 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.673 1.589 . . . . 0.0 114.08 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.88 146.37 25.6 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.537 1.681 . . . . 0.0 115.537 -167.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.506 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . 37.9 m80 -82.18 93.38 7.06 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.983 1.313 . . . . 0.0 113.458 176.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.626 ' H ' HD23 ' A' ' 118' ' ' LEU . 0.4 OUTLIER -75.69 173.23 11.35 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.856 -1.152 . . . . 0.0 113.012 170.541 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -47.57 149.07 1.25 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.833 0.853 . . . . 0.0 113.119 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.302 38.6 pttt 76.86 -16.09 0.67 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 131.13 3.772 . . . . 0.0 114.635 -175.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -63.21 -38.26 90.48 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.483 1.038 . . . . 0.0 113.173 -175.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . 0.274 13.7 mttt -86.02 12.87 8.56 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 m -62.36 -26.77 68.64 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 118.975 0.807 . . . . 0.0 108.937 167.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.4 mt -61.65 -36.67 81.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.895 1.278 . . . . 0.0 112.361 169.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -85.62 22.75 10.11 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.596 2.046 . . . . 0.0 113.437 170.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.321 3.9 t 55.52 28.07 11.22 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.669 2.787 . . . . 0.0 114.226 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 149' ' ' ASP . 20.1 ttp180 -101.61 85.86 2.83 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.89 1.676 . . . . 0.0 110.364 -175.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -80.96 -45.65 16.33 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.187 0.995 . . . . 0.0 112.977 -173.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -60.44 121.09 11.22 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.231 1.012 . . . . 0.0 111.239 -169.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.0 t -68.84 143.49 54.54 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 120.184 1.356 . . . . 0.0 111.052 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.0 t -58.33 130.43 46.69 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.319 -0.863 . . . . 0.0 111.933 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.5 p30 -76.72 -9.97 59.05 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.032 1.333 . . . . 0.0 113.816 176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 71.1 23.17 78.36 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 117.797 -1.557 . . . . 0.0 114.124 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -100.16 168.19 9.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.099 1.759 . . . . 0.0 112.524 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 33.4 t -69.96 136.05 50.09 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.272 -0.893 . . . . 0.0 111.637 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -147.78 37.54 0.89 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.495 1.918 . . . . 0.0 112.053 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.7 mt -103.46 136.28 43.5 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.355 1.062 . . . . 0.0 110.768 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -155.29 135.43 13.05 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.338 1.455 . . . . 0.0 110.175 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.3 t0 52.71 27.76 5.59 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.536 1.534 . . . . 0.0 112.951 -169.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.06 -6.92 82.87 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.298 1.904 . . . . 0.0 114.793 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 38.7 mtt -98.78 142.59 30.13 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.829 1.814 . . . . 0.0 113.62 -174.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -76.32 81.13 3.08 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.14 0.976 . . . . 0.0 110.984 169.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -50.89 -44.61 59.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.303 1.441 . . . . 0.0 112.41 -175.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 94.3 p -78.95 -0.19 30.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -170.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 52' ' ' THR . 1.3 ttp180 -45.12 -39.67 6.23 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 121.125 1.784 . . . . 0.0 113.091 171.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.2 -19.43 79.63 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-O 118.297 -1.279 . . . . 0.0 114.793 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -111.65 -69.18 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 CA-C-O 116.334 -1.793 . . . . 0.0 113.154 -169.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -74.58 146.95 35.19 Favored 'Trans proline' 0 C--N 1.357 1.026 0 CA-C-N 123.697 2.356 . . . . 0.0 114.128 169.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 127' ' ' ARG . 24.3 t0 -77.6 167.63 21.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.476 2.711 . . . . 0.0 114.606 176.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.506 ' CE2' ' HB3' ' A' ' 117' ' ' HIS . 64.0 m-85 -53.54 148.17 9.82 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.434 1.094 . . . . 0.0 111.947 178.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.7 157.69 17.19 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.984 0.897 . . . . 0.0 112.38 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 73.6 m -87.36 149.27 24.61 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 168.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -56.8 -30.99 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.618 -1.301 . . . . 0.0 111.343 -175.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.18 -36.18 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.253 1.821 . . . . 0.0 112.964 173.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -75.89 -27.6 57.78 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.332 0.969 . . . . 0.0 111.572 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.52 -47.8 74.7 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.426 168.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.69 -37.33 70.73 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 99.2 p -72.24 -49.94 31.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.279 0.945 . . . . 0.0 113.119 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.572 ' HA ' ' HE2' ' A' ' 159' ' ' LYS . 8.7 mmpt? -70.51 -36.15 73.6 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.391 -1.443 . . . . 0.0 113.817 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.9 mt -68.58 -35.45 77.39 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.927 0.785 . . . . 0.0 112.05 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.05 -33.9 70.73 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -79.22 -44.06 22.57 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.096 0.558 . . . . 0.0 110.897 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -84.02 -0.59 52.27 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 68.96 16.07 8.8 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.676 2.391 . . . . 0.0 115.988 168.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 50.8 mt -75.28 139.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 120.623 -1.298 . . . . 0.0 110.319 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.414 ' HB2' ' CD2' ' A' ' 107' ' ' PHE . 11.3 mm-40 -99.45 95.84 3.91 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.097 173.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -73.82 144.82 35.45 Favored 'Trans proline' 0 C--N 1.352 0.754 0 CA-C-N 121.285 1.495 . . . . 0.0 114.564 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.7 mt -129.89 117.74 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 124.388 1.075 . . . . 0.0 110.754 170.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -78.48 76.09 4.99 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.461 1.124 . . . . 0.0 112.798 178.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.8 t -64.38 103.62 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 122.185 0.993 . . . . 0.0 112.483 169.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.407 ' HB ' ' HD2' ' A' ' 172' ' ' PRO . 17.4 m -144.47 157.97 54.97 Favored Pre-proline 0 N--CA 1.484 1.253 0 CA-C-O 117.573 -1.204 . . . . 0.0 111.239 -169.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.407 ' HD2' ' HB ' ' A' ' 171' ' ' VAL . 57.2 Cg_endo -73.87 165.14 32.9 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.603 2.869 . . . . 0.0 111.687 -171.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 73.9 p -52.08 -39.72 60.14 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.334 1.054 . . . . 0.0 113.338 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.7 ptt85 -63.18 -23.3 67.37 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.419 ' CE ' ' CE1' ' A' ' 179' ' ' TYR . 78.3 mtp -103.14 -22.87 13.69 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.3 t -56.47 -26.29 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 120.179 1.354 . . . . 0.0 112.009 -168.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.57 -29.88 70.91 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.918 1.287 . . . . 0.0 114.463 175.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 t -93.83 -37.98 11.47 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.889 0.876 . . . . 0.0 111.575 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.419 ' CE1' ' CE ' ' A' ' 175' ' ' MET . 12.1 m-85 -73.9 -28.5 61.57 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 120.149 -1.594 . . . . 0.0 110.233 175.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.525 ' HA ' HG22 ' A' ' 183' ' ' THR 0.268 17.5 tt0 -66.79 -10.85 51.9 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 119.348 0.976 . . . . 0.0 112.58 172.147 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -99.3 -7.83 25.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.063 -1.023 . . . . 0.0 113.684 169.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.85 -28.97 22.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.702 1.201 . . . . 0.0 109.406 168.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.525 HG22 ' HA ' ' A' ' 180' ' ' GLU . 15.1 t -85.88 -15.89 40.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 112.784 177.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 1.1 t -77.59 -25.86 50.25 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.302 -0.874 . . . . 0.0 108.751 168.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -80.19 -45.25 18.38 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.181 -0.438 . . . . 0.0 111.551 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 19.3 mt -94.81 106.53 25.25 Favored Pre-proline 0 N--CA 1.483 1.218 0 CA-C-O 118.335 -0.841 . . . . 0.0 109.469 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.87 147.17 67.98 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.41 2.073 . . . . 0.0 111.466 -173.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 83.06 -10.21 1.03 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.822 2.849 . . . . 0.0 113.693 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.1 mt -73.37 166.83 22.46 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.48 0.5 OUTLIER -143.47 -161.24 1.23 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 169.431 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.5 mt -160.52 142.7 4.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 C-N-CA 129.769 3.228 . . . . 0.0 111.982 -165.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -124.64 161.55 19.08 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.917 0.77 . . . . 0.0 111.808 169.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -92.37 100.16 12.79 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.888 1.675 . . . . 0.0 108.019 173.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 13.8 tp . . . . . 0 CA--C 1.541 0.608 0 CA-C-N 114.013 -1.449 . . . . 0.0 108.89 168.813 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 67.1 t -110.97 138.02 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.42 1.088 . . . . 0.0 109.8 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -116.56 117.94 31.25 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.184 1.393 . . . . 0.0 108.834 169.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.428 HD12 ' CB ' ' A' ' 107' ' ' PHE . 2.4 tp -110.28 130.52 55.53 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 118.883 0.765 . . . . 0.0 111.78 169.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.402 ' CD2' HG23 ' A' ' 99' ' ' ILE . 28.8 t80 -115.92 114.47 24.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 123.717 1.722 . . . . 0.0 109.092 168.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -88.46 107.66 18.98 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 127.184 2.194 . . . . 0.0 111.859 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.65 122.02 34.65 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.737 0.815 . . . . 0.0 112.013 170.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.44 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 24.4 mtp -103.41 131.94 50.08 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 174.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.15 114.37 3.82 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 167.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.27 21.2 15.42 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.373 1.469 . . . . 0.0 113.989 -172.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.8 p . . . . . 0 N--CA 1.474 0.748 0 O-C-N 119.679 -1.888 . . . . 0.0 112.699 -169.866 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.3 t . . . . . 0 CA--C 1.542 0.649 0 CA-C-O 122.148 0.975 . . . . 0.0 108.736 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.46 84.51 0.18 Allowed Glycine 0 C--N 1.338 0.684 0 C-N-CA 127.184 2.326 . . . . 0.0 108.382 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -91.65 135.63 33.73 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -171.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.7 tp -116.61 139.19 44.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 124.83 1.252 . . . . 0.0 110.894 -171.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.5 159.28 24.8 Favored Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.428 1.014 . . . . 0.0 113.036 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -132.27 129.13 39.19 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.37 1.468 . . . . 0.0 113.556 -169.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.72 144.65 16.57 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 124.32 0.962 . . . . 0.0 113.513 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.6 m -114.65 136.31 53.19 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.629 1.572 . . . . 0.0 111.455 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.9 tt -156.46 149.94 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 120.578 -1.327 . . . . 0.0 112.402 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.522 HG23 ' H ' ' A' ' 50' ' ' ASN . 2.3 m -150.52 -66.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 125.586 1.554 . . . . 0.0 111.898 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.522 ' H ' HG23 ' A' ' 49' ' ' VAL 0.424 29.8 t30 168.99 -13.61 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.973 1 C-N-CA 133.251 4.62 . . . . 0.0 111.482 169.278 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.0 ttt -49.32 -38.9 29.44 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 165.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.274 10.6 t 164.13 -163.16 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.967 1 C-N-CA 133.06 4.544 . . . . 0.0 109.623 168.147 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -107.98 132.38 53.57 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.812 2.445 . . . . 0.0 105.805 168.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -127.85 125.79 40.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 122.59 1.186 . . . . 0.0 110.1 169.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.73 132.02 35.5 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.921 1.288 . . . . 0.0 110.576 169.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.54 -17.37 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.39 108.6 5.0 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.84 1.655 . . . . 0.0 112.253 176.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.5 ttpm? -61.39 154.25 24.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.561 1.544 . . . . 0.0 112.607 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.0 mt -50.71 112.54 0.72 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.719 0.69 . . . . 0.0 111.876 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.479 0.989 0 C-N-CA 124.999 1.32 . . . . 0.0 111.984 178.259 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 120.539 0.209 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.1 p -94.12 -143.57 0.24 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.426 1.49 . . . . 0.0 112.718 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.75 144.72 9.59 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.561 -1.337 . . . . 0.0 114.262 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -148.65 163.74 36.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.214 1.806 . . . . 0.0 112.84 175.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.9 mt -74.44 -59.85 2.54 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.887 1.275 . . . . 0.0 112.573 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.89 136.98 54.88 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.83 0.852 . . . . 0.0 111.965 -172.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.6 p -75.72 -34.59 1.56 Allowed Pre-proline 0 N--CA 1.475 0.821 0 CA-C-O 115.512 -2.185 . . . . 0.0 113.307 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.39 140.73 44.8 Favored 'Trans proline' 0 C--N 1.354 0.842 0 CA-C-N 123.078 2.135 . . . . 0.0 108.967 169.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -104.44 -177.18 3.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.65 0.78 . . . . 0.0 112.215 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.08 9.49 72.57 Favored Glycine 0 N--CA 1.483 1.777 0 C-N-CA 124.633 1.111 . . . . 0.0 114.829 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -35.45 -55.61 0.66 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 129.192 2.997 . . . . 0.0 118.667 -169.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 7.7 mp -67.29 -18.5 65.22 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 121.526 1.966 . . . . 0.0 113.134 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.32 -24.08 67.7 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.421 1.464 . . . . 0.0 112.411 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.41 -44.08 25.77 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.311 -1.493 . . . . 0.0 108.129 167.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.443 HG22 HD13 ' A' ' 110' ' ' LEU . 31.6 t -52.5 -42.32 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.277 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.427 HG13 HE21 ' A' ' 91' ' ' GLN . 8.3 p -62.71 -55.81 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.702 1.137 . . . . 0.0 111.783 171.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.427 HE21 HG13 ' A' ' 90' ' ' VAL . 77.1 mm-40 -66.21 -42.33 88.89 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.973 0.806 . . . . 0.0 110.914 -170.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.535 HG11 HD13 ' A' ' 108' ' ' LEU . 78.2 t -60.87 -33.07 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.362 1.065 . . . . 0.0 111.728 171.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.8 68.48 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.671 1.123 . . . . 0.0 111.985 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.289 0.0 OUTLIER -96.38 -14.22 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -169.859 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.24 60.52 3.09 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 121.17 1.804 . . . . 0.0 112.351 173.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.9 mt -50.95 -40.11 56.64 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.899 1.68 . . . . 0.0 111.74 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.72 -31.02 41.67 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.158 0.885 . . . . 0.0 114.852 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -89.38 -39.74 13.21 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.607 1.203 . . . . 0.0 111.132 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.454 HG21 ' CE2' ' A' ' 101' ' ' TRP . 33.6 mm -65.73 -38.49 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 120.988 -1.07 . . . . 0.0 110.048 169.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.07 26.3 34.62 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.152 0.882 . . . . 0.0 113.182 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.454 ' CE2' HG21 ' A' ' 99' ' ' ILE . 72.5 m95 -55.97 130.57 44.37 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.229 1.014 . . . . 0.0 112.208 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.5 mtp-105 -104.41 -168.57 1.5 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.407 2.283 . . . . 0.0 111.958 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -86.03 -0.59 55.91 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 117.017 2.229 . . . . 0.0 117.017 -169.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.48 -132.75 3.3 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 120.917 1.69 . . . . 0.0 110.972 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.5 t -99.58 147.58 25.2 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.757 1.223 . . . . 0.0 108.954 174.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.407 ' HB2' ' HA ' ' A' ' 165' ' ' ILE . 97.3 mtt180 -132.15 124.8 29.8 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -168.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.428 ' CB ' HD12 ' A' ' 6' ' ' LEU . 64.5 m-85 -125.01 110.15 13.83 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -169.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.535 HD13 HG11 ' A' ' 92' ' ' VAL . 25.8 tp -92.59 98.05 11.2 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.283 175.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 t -83.45 124.64 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 174.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.443 HD13 HG22 ' A' ' 89' ' ' VAL . 20.2 tp -109.65 112.39 24.43 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 118.81 -0.614 . . . . 0.0 110.214 -175.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 10' ' ' MET . 17.1 t -94.83 133.24 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.297 0.639 . . . . 0.0 111.649 172.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.2 t -166.13 151.01 8.2 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.441 1.088 . . . . 0.0 109.826 167.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -110.27 4.54 20.96 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -177.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -140.98 -177.98 5.35 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.156 1.383 . . . . 0.0 112.857 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -60.72 -177.13 0.07 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.72 1.608 . . . . 0.0 112.882 169.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 31.3 t80 -140.94 148.15 39.92 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.675 1.19 . . . . 0.0 112.136 -175.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -80.21 88.92 5.45 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.128 1.371 . . . . 0.0 113.182 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.78 165.43 3.98 Favored 'General case' 0 CA--C 1.551 0.99 0 O-C-N 120.395 -1.441 . . . . 0.0 111.83 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -46.91 140.63 4.6 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.684 -0.635 . . . . 0.0 112.387 171.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 89.11 -12.28 0.39 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 129.109 2.964 . . . . 0.0 113.192 -174.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -70.36 -10.53 59.29 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 119.864 1.211 . . . . 0.0 112.759 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -49.41 -28.97 5.72 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.352 1.861 . . . . 0.0 113.96 168.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 84.9 m -66.09 -31.22 71.96 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.763 2.025 . . . . 0.0 112.877 -168.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.2 -34.13 75.7 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.147 0.579 . . . . 0.0 111.571 174.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -84.47 7.77 71.3 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.65 1.595 . . . . 0.0 114.337 170.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.274 1.3 t 61.41 15.61 6.75 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 129.383 3.073 . . . . 0.0 116.057 173.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.1 mtp85 -99.84 144.09 29.31 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.146 -0.971 . . . . 0.0 109.836 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -126.28 -8.7 6.41 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -69.74 118.12 12.2 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.706 1.139 . . . . 0.0 109.371 170.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.7 t -76.92 164.99 25.28 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.758 -0.588 . . . . 0.0 110.647 171.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 96.7 p -64.18 138.85 58.65 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -173.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -82.44 -13.22 57.13 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 174.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.82 9.2 85.06 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.927 1.251 . . . . 0.0 114.199 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -102.12 175.87 5.38 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.669 1.234 . . . . 0.0 111.164 172.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.5 142.91 32.92 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -169.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -142.7 53.82 1.4 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.704 1.602 . . . . 0.0 112.791 -169.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . 0.273 0.0 OUTLIER -140.29 105.53 5.04 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.056 0.931 . . . . 0.0 111.27 169.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -89.26 -45.96 9.13 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.217 1.007 . . . . 0.0 111.328 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -97.05 8.28 44.84 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.444 2.297 . . . . 0.0 113.565 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.76 -12.29 62.7 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 125.747 1.642 . . . . 0.0 114.871 169.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 78.1 mtm -97.05 132.99 42.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.021 1.329 . . . . 0.0 110.375 171.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -64.71 99.03 0.3 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.671 0.748 . . . . 0.0 111.889 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -67.16 -36.34 81.59 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.487 1.515 . . . . 0.0 112.925 -170.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.7 p -85.71 4.47 36.53 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -50.51 -42.29 54.71 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 120.503 1.501 . . . . 0.0 112.278 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.2 -33.86 69.34 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 117.974 -1.459 . . . . 0.0 112.724 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.353 82.5 tt0 -89.28 -90.9 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.415 0 CA-C-O 116.112 -1.899 . . . . 0.0 112.537 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.11 156.94 56.16 Favored 'Trans proline' 0 C--N 1.357 1.01 0 CA-C-N 124.135 2.513 . . . . 0.0 116.052 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -62.95 166.3 5.88 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 129.459 3.104 . . . . 0.0 115.037 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -62.68 132.8 53.52 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 166.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -57.78 154.34 12.11 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.914 -1.117 . . . . 0.0 113.823 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 60.1 p -77.66 162.51 26.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.477 0.711 . . . . 0.0 112.296 174.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 50.9 t -61.36 -39.11 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 121.547 -0.721 . . . . 0.0 111.352 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.2 t -81.59 -19.51 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.48 -37.64 88.08 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.241 1.382 . . . . 0.0 108.623 169.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 28.7 mt -77.25 -31.41 55.02 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 116.153 -1.88 . . . . 0.0 114.595 171.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.01 -42.19 72.24 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 121.268 1.849 . . . . 0.0 110.994 169.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 11.4 t -62.82 -54.16 43.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.595 0.758 . . . . 0.0 111.387 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.4 tppt? -69.58 -38.87 77.53 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -170.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . 0.294 0.0 OUTLIER -68.77 -33.33 73.7 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.537 1.517 . . . . 0.0 111.529 175.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.7 -32.71 64.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -69.29 -46.04 68.15 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.844 1.257 . . . . 0.0 110.056 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -86.26 -8.88 57.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.724 0.81 . . . . 0.0 113.105 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 50.64 49.27 21.2 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.001 1.72 . . . . 0.0 112.456 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.407 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 68.1 mt -102.69 133.58 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-O 116.535 -1.698 . . . . 0.0 106.967 171.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -103.09 113.46 65.84 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 121.439 1.927 . . . . 0.0 110.365 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -67.36 152.79 78.52 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.074 3.183 . . . . 0.0 114.764 173.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.8 mm -134.26 104.29 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.595 1.558 . . . . 0.0 109.371 174.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.55 ' CD2' HD21 ' A' ' 189' ' ' LEU . 23.3 m-85 -73.19 75.98 1.29 Allowed 'General case' 0 N--CA 1.478 0.928 0 O-C-N 119.849 -1.782 . . . . 0.0 112.387 175.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . 0.258 1.9 m -72.13 103.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 123.524 1.63 . . . . 0.0 111.15 169.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 29.0 m -143.05 166.35 20.87 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 120.33 -1.481 . . . . 0.0 110.447 -169.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -80.19 161.8 23.09 Favored 'Trans proline' 0 C--N 1.35 0.619 0 CA-C-N 122.856 2.056 . . . . 0.0 110.036 -172.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.5 t -52.97 -41.97 65.07 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.952 0.501 . . . . 0.0 111.916 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -54.68 -38.67 67.25 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.607 1.163 . . . . 0.0 113.698 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 19.6 mmt -99.75 -9.38 23.1 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.755 1.222 . . . . 0.0 114.175 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -61.89 -29.64 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 120.085 1.311 . . . . 0.0 113.329 -168.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -65.39 -25.07 67.4 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.13 -43.02 20.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.519 0.728 . . . . 0.0 109.955 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -71.02 -30.42 66.62 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.421 1.089 . . . . 0.0 110.535 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -65.81 -14.9 62.29 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.122 0.569 . . . . 0.0 111.829 168.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -96.47 -30.69 13.2 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.393 -0.817 . . . . 0.0 111.599 173.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.61 -25.59 61.37 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 119.979 -1.701 . . . . 0.0 110.03 175.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.1 t -72.49 -21.99 61.13 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.739 -0.601 . . . . 0.0 111.845 173.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 37.7 m -69.71 -29.74 67.2 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -88.46 -14.42 37.92 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 24.0 mt -120.35 87.85 41.11 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.1 0.96 . . . . 0.0 110.421 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.84 134.99 61.54 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.238 2.626 . . . . 0.0 112.903 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 65.2 mttm 85.06 -10.35 0.81 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 129.431 3.092 . . . . 0.0 113.914 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.55 HD21 ' CD2' ' A' ' 169' ' ' PHE . 10.2 tt -65.55 149.4 50.13 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.325 -0.86 . . . . 0.0 109.098 169.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 68.6 p -123.39 -170.22 2.08 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 169.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.0 141.53 2.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 127.083 2.153 . . . . 0.0 108.125 -167.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -132.67 150.86 19.8 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 170.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . 0.262 0.9 OUTLIER -91.44 88.71 6.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 123.128 1.442 . . . . 0.0 109.099 169.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 CA--C 1.539 0.531 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.654 169.602 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.03 144.81 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.931 0.892 . . . . 0.0 110.236 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.55 97.88 5.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.063 1.745 . . . . 0.0 108.388 172.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.1 mp -90.9 122.12 33.33 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 121.542 -0.724 . . . . 0.0 112.386 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -119.78 104.2 10.01 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 123.723 1.725 . . . . 0.0 111.13 172.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -85.46 114.72 22.71 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.411 1.885 . . . . 0.0 113.459 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.49 120.0 38.15 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.318 1.447 . . . . 0.0 111.154 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.0 mtp -100.12 144.0 29.66 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 169.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.9 98.19 2.31 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 168.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.69 33.75 0.52 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.201 1.5 . . . . 0.0 114.753 -169.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.477 0.901 0 O-C-N 119.889 -1.757 . . . . 0.0 113.408 173.113 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.1 p . . . . . 0 CA--C 1.546 0.821 0 CA-C-O 122.23 1.014 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.57 89.14 0.15 Allowed Glycine 0 C--N 1.339 0.736 0 C-N-CA 126.649 2.071 . . . . 0.0 108.801 -169.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.5 mmm-85 -77.27 138.11 39.2 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 tp -124.08 133.22 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.258 0.623 . . . . 0.0 110.48 -174.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.4 160.54 27.89 Favored Glycine 0 N--CA 1.474 1.202 0 C-N-CA 125.061 1.315 . . . . 0.0 112.722 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -138.69 135.41 34.77 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.006 0.923 . . . . 0.0 112.802 -169.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.39 146.1 18.04 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 124.742 1.163 . . . . 0.0 112.443 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.4 m -118.52 131.5 56.23 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.227 1.011 . . . . 0.0 111.233 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.6 tp -140.09 147.96 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.266 -0.896 . . . . 0.0 111.792 175.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -149.74 -107.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 103.652 -2.721 . . . . 0.0 103.652 168.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -136.09 -2.1 2.34 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.605 1.162 . . . . 0.0 110.858 168.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.7 mtp -78.58 41.09 0.39 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.92 2.088 . . . . 0.0 108.354 168.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.315 1.4 t 53.71 -176.13 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 129.618 3.167 . . . . 0.0 113.261 -168.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -87.24 137.88 31.96 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.363 1.465 . . . . 0.0 109.443 174.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -123.73 121.88 36.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.88 1.324 . . . . 0.0 110.456 169.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -86.69 100.04 12.19 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.487 1.915 . . . . 0.0 110.291 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.0 mm -90.35 -21.22 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 118.164 -0.922 . . . . 0.0 112.887 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.7 tp -157.02 111.72 2.76 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 144.93 43.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.715 1.206 . . . . 0.0 110.939 168.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -61.71 125.26 23.18 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.298 0.953 . . . . 0.0 110.169 -175.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.47 0.542 0 C-N-CA 123.729 0.811 . . . . 0.0 112.182 -174.645 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 71.6 p -108.38 -152.16 0.48 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 126.328 1.851 . . . . 0.0 112.231 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.37 160.4 33.05 Favored Glycine 0 N--CA 1.475 1.247 0 O-C-N 120.196 -1.565 . . . . 0.0 114.13 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -155.89 156.88 35.4 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -56.37 -63.8 1.07 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.681 2.792 . . . . 0.0 113.261 176.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.22 149.21 44.8 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.353 1.061 . . . . 0.0 113.616 -172.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.1 m -72.36 -47.01 10.44 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-O 116.138 -1.886 . . . . 0.0 113.287 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -75.09 154.47 42.08 Favored 'Trans proline' 0 C--N 1.352 0.715 0 CA-C-N 122.302 1.858 . . . . 0.0 112.527 169.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -131.77 179.68 5.92 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.476 1.51 . . . . 0.0 113.455 -178.358 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.94 34.39 4.95 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 119.393 2.517 . . . . 0.0 119.393 -168.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -50.75 -33.53 23.52 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.62 1.71 . . . . 0.0 113.648 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.511 HD13 ' CE2' ' A' ' 116' ' ' PHE . 7.4 tp -62.69 -44.08 97.16 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -175.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.18 -46.35 82.89 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.252 0.621 . . . . 0.0 109.846 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.08 -58.51 8.34 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 118.496 -0.764 . . . . 0.0 111.034 173.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.536 HG12 HD21 ' A' ' 108' ' ' LEU . 13.4 m -64.99 -25.28 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 119.627 1.103 . . . . 0.0 113.168 -171.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.91 -51.74 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 118.083 -0.961 . . . . 0.0 112.16 169.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -57.03 -42.01 79.64 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.974 1.261 . . . . 0.0 110.41 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.482 ' HA ' HD12 ' A' ' 99' ' ' ILE . 38.3 t -57.4 -39.16 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.242 0.617 . . . . 0.0 112.238 176.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.67 -32.22 69.41 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.853 1.056 . . . . 0.0 113.853 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.445 HG23 ' SG ' ' A' ' 135' ' ' CYS . 10.0 tp -102.13 -15.42 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -170.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.33 56.89 3.98 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.534 -1.354 . . . . 0.0 112.847 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.2 mt -55.72 -38.97 70.46 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.465 1.506 . . . . 0.0 111.88 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.02 -22.96 47.07 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.524 1.059 . . . . 0.0 114.668 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -92.3 -39.58 11.42 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.465 1.133 . . . . 0.0 111.563 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 92' ' ' VAL . 9.7 mt -81.91 -29.18 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 118.822 0.737 . . . . 0.0 111.264 175.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.34 24.7 39.01 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.027 -0.874 . . . . 0.0 114.891 169.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -49.42 129.26 18.57 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.785 1.234 . . . . 0.0 112.91 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -111.85 173.03 6.55 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.876 1.27 . . . . 0.0 112.434 170.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -81.86 41.58 0.66 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 125.671 1.588 . . . . 0.0 115.107 -170.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.14 -126.45 5.5 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 120.592 -1.318 . . . . 0.0 110.437 170.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.6 t -115.96 134.07 55.36 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.638 1.975 . . . . 0.0 107.704 171.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -124.41 131.51 53.5 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.093 0.86 . . . . 0.0 110.218 -168.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -127.08 98.5 5.33 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -169.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.536 HD21 HG12 ' A' ' 89' ' ' VAL . 5.6 tt -81.9 99.16 8.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.152 172.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.1 t -87.84 124.11 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 174.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 65.4 tp -108.19 117.47 34.23 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.664 1.12 . . . . 0.0 109.267 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.16 128.39 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 124.158 0.911 . . . . 0.0 110.707 170.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.7 t -162.44 163.66 27.54 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.246 1.018 . . . . 0.0 110.882 170.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -121.25 -0.44 9.9 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 116.547 2.055 . . . . 0.0 116.547 -175.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -137.17 172.66 12.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.912 0.885 . . . . 0.0 111.831 172.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -53.43 176.56 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.946 1.699 . . . . 0.0 112.58 174.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.511 ' CE2' HD13 ' A' ' 86' ' ' LEU . 7.2 p90 -146.04 157.19 43.86 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 120.7 -1.25 . . . . 0.0 112.293 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -79.87 133.28 36.24 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.664 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 46.8 mt -100.74 175.07 5.77 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.189 1.796 . . . . 0.0 110.886 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -47.88 137.09 10.28 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.917 0.865 . . . . 0.0 112.828 172.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 69.5 tttt 83.58 -14.45 0.7 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 130.906 3.682 . . . . 0.0 113.719 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -63.22 -21.95 66.55 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.526 1.512 . . . . 0.0 113.4 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.559 ' HE3' ' CZ ' ' A' ' 150' ' ' TYR . 90.1 mttt -78.18 -5.91 53.24 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 172.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.8 -16.75 63.88 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 120.621 1.555 . . . . 0.0 112.34 171.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 57.3 mt -63.25 -24.71 67.99 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.887 0.875 . . . . 0.0 111.515 169.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -90.35 -123.02 2.53 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 126.198 1.856 . . . . 0.0 109.301 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 p -126.64 0.13 6.8 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.577 1.551 . . . . 0.0 114.319 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -85.56 109.47 18.55 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.789 0.836 . . . . 0.0 111.285 -169.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -94.38 -28.71 15.38 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -87.17 122.23 30.7 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.702 -0.623 . . . . 0.0 112.491 -169.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.3 t -57.93 144.15 40.27 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.888 0.475 . . . . 0.0 110.388 169.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 42.0 t -59.75 140.9 56.16 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.637 0.775 . . . . 0.0 112.614 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.7 p30 -80.74 -13.51 58.93 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.88 14.42 78.47 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.477 1.037 . . . . 0.0 113.423 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -98.94 170.05 9.0 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.259 1.824 . . . . 0.0 110.536 172.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' CYS . . . . . 0.445 ' SG ' HG23 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -100.41 145.35 28.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -139.47 45.6 1.93 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.307 1.843 . . . . 0.0 111.592 -170.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.4 tt -110.08 125.13 52.64 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.68 1.992 . . . . 0.0 108.907 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -131.19 -48.66 1.0 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.613 1.165 . . . . 0.0 112.8 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -84.42 -10.66 57.32 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.493 1.517 . . . . 0.0 113.677 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 108.51 -23.71 23.87 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.199 1.857 . . . . 0.0 111.477 -169.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 80.8 mmm -82.28 145.83 29.78 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.617 1.167 . . . . 0.0 111.259 172.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -77.47 99.04 5.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.174 0.589 . . . . 0.0 109.769 169.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 42.3 ttp-105 -63.28 -38.28 90.56 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.211 1.004 . . . . 0.0 113.563 -170.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.4 p -88.56 7.37 33.55 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -168.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -47.53 -39.7 16.95 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 121.277 1.853 . . . . 0.0 112.461 169.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.13 -0.65 86.49 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 117.8 -1.555 . . . . 0.0 115.789 -174.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -127.35 -65.8 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 119.889 1.845 . . . . 0.0 110.387 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -58.98 147.25 90.86 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.498 2.799 . . . . 0.0 115.625 168.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.527 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 39.8 t0 -69.46 169.34 12.66 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 128.503 2.721 . . . . 0.0 112.87 169.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.559 ' CZ ' ' HE3' ' A' ' 122' ' ' LYS . 75.6 m-85 -69.0 158.06 35.52 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.423 -1.423 . . . . 0.0 108.211 168.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -78.62 157.45 28.68 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.314 -0.866 . . . . 0.0 111.257 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 92.9 p -92.81 156.18 17.16 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.248 -0.907 . . . . 0.0 110.684 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.26 -34.37 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.344 -0.848 . . . . 0.0 112.571 -171.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.9 t -69.93 -33.66 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.412 1.085 . . . . 0.0 111.596 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -68.8 -34.45 75.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.499 0.72 . . . . 0.0 111.144 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.507 ' CD1' HD11 ' A' ' 86' ' ' LEU . 4.5 mt -65.26 -55.95 15.49 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.009 0.924 . . . . 0.0 110.253 174.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.97 76.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.041 0.937 . . . . 0.0 111.448 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.8 t -58.47 -71.43 0.11 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.166 0.986 . . . . 0.0 111.847 172.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -66.85 -34.48 77.89 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.721 HD22 ' HG3' ' A' ' 167' ' ' PRO . 0.7 OUTLIER -70.76 -26.58 63.42 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.163 1.347 . . . . 0.0 112.866 176.745 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.1 -43.69 64.4 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.768 1.167 . . . . 0.0 113.46 173.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -80.53 -30.67 37.14 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.885 0.766 . . . . 0.0 112.578 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -82.48 -5.56 58.78 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.983 0.81 . . . . 0.0 112.242 168.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 60.64 46.91 8.78 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.007 1.323 . . . . 0.0 111.75 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.567 ' HB ' HD23 ' A' ' 160' ' ' LEU . 29.4 mm -100.36 135.51 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.934 1.293 . . . . 0.0 108.057 174.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -100.64 114.35 65.75 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 120.477 1.49 . . . . 0.0 109.903 170.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.721 ' HG3' HD22 ' A' ' 160' ' ' LEU . 4.8 Cg_exo -74.74 145.11 32.11 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.035 1.824 . . . . 0.0 110.594 169.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.417 HG22 HG23 ' A' ' 170' ' ' VAL . 31.5 mt -128.73 102.08 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 125.126 1.37 . . . . 0.0 107.418 177.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -74.37 72.8 1.84 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.415 1.102 . . . . 0.0 112.342 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.417 HG23 HG22 ' A' ' 168' ' ' ILE . 85.3 t -70.59 97.75 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 O-C-N 120.621 -1.299 . . . . 0.0 111.193 173.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 25.4 m -147.92 145.16 20.23 Favored Pre-proline 0 N--CA 1.484 1.237 0 O-C-N 120.367 -1.458 . . . . 0.0 112.879 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -60.81 156.55 42.66 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 125.111 3.874 . . . . 0.0 116.705 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.5 t -46.62 -58.31 3.95 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.978 1.711 . . . . 0.0 114.471 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -14.67 21.8 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -171.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.0 ptm -109.3 -1.6 18.44 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.308 1.443 . . . . 0.0 114.872 172.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.2 t -65.46 -33.39 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 120.23 -1.544 . . . . 0.0 111.97 -170.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -70.74 -23.68 62.48 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.861 1.21 . . . . 0.0 113.241 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . 0.262 2.4 t -87.18 -13.39 44.1 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.059 -1.026 . . . . 0.0 112.405 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -96.38 -33.72 11.81 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.073 1.349 . . . . 0.0 109.879 168.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.62 -26.7 65.48 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.724 -1.235 . . . . 0.0 111.997 176.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -74.0 -23.48 59.45 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.052 -1.655 . . . . 0.0 110.445 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 35.5 tp -85.02 -19.48 31.93 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.304 1.842 . . . . 0.0 110.824 174.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.6 p -83.65 -6.94 59.57 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.383 0.538 . . . . 0.0 112.019 169.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 6.9 m -88.22 -34.56 17.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.678 1.591 . . . . 0.0 108.865 169.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -79.7 -37.34 35.94 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 174.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 51.0 mt -101.16 113.27 65.82 Favored Pre-proline 0 N--CA 1.478 0.963 0 CA-C-O 118.247 -0.882 . . . . 0.0 108.949 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.7 145.2 40.91 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.577 2.185 . . . . 0.0 111.423 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt 73.55 3.98 4.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 127.117 2.167 . . . . 0.0 113.736 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.69 142.6 46.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.994 1.718 . . . . 0.0 109.052 169.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 76.5 p -108.55 -158.19 0.64 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.8 tt 177.15 136.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 126.983 2.113 . . . . 0.0 110.129 -168.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -129.57 132.45 7.09 Favored Glycine 0 N--CA 1.469 0.892 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -81.99 79.12 8.59 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 124.069 1.89 . . . . 0.0 109.814 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 28.1 tp . . . . . 0 CA--C 1.546 0.826 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.662 174.734 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 t -94.3 155.08 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.648 ' HB2' HD13 ' A' ' 59' ' ' LEU . 3.7 p-10 -151.89 101.63 2.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.345 1.069 . . . . 0.0 109.603 169.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.19 142.92 27.06 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.314 1.046 . . . . 0.0 111.717 -171.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -124.45 111.77 16.12 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 123.889 1.804 . . . . 0.0 110.861 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -83.64 101.83 11.78 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.868 -1.969 . . . . 0.0 111.921 175.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.489 HD23 HD13 ' A' ' 110' ' ' LEU . 33.9 tp -102.73 113.28 26.55 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.748 0.819 . . . . 0.0 111.093 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.1 ptm -120.77 151.24 39.82 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.55 141.26 23.56 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.52 1.533 . . . . 0.0 113.348 173.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.43 32.09 5.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.26 1.824 . . . . 0.0 112.255 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.3 p . . . . . 0 N--CA 1.474 0.773 0 O-C-N 119.91 -1.744 . . . . 0.0 112.194 171.289 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 122.486 1.136 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.96 88.34 0.13 Allowed Glycine 0 C--N 1.336 0.529 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -169.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -73.5 148.24 43.3 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -174.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.6 tt -123.17 135.63 62.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.434 ' HA3' HD23 ' A' ' 59' ' ' LEU . . . -139.99 161.15 26.34 Favored Glycine 0 N--CA 1.464 0.557 0 C-N-CA 125.361 1.458 . . . . 0.0 110.722 172.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -139.17 138.22 36.75 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -169.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.25 145.27 15.92 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 124.491 1.043 . . . . 0.0 112.578 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.3 m -116.13 136.22 53.21 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 125.284 1.434 . . . . 0.0 110.522 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.18 155.31 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.534 1.134 . . . . 0.0 111.197 176.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.1 p -151.93 -65.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 120.656 -1.277 . . . . 0.0 109.02 168.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.6 t30 177.06 -19.66 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 130.237 3.415 . . . . 0.0 110.081 169.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 54.0 ttm -50.1 -36.84 31.23 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.009 1.324 . . . . 0.0 110.029 167.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t 167.1 -172.39 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 131.465 3.906 . . . . 0.0 109.782 169.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -103.88 131.28 51.25 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 167.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.6 pm0 -130.26 124.38 32.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 123.064 1.411 . . . . 0.0 110.793 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -94.23 104.68 16.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.14 2.176 . . . . 0.0 109.924 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . 0.361 0.0 OUTLIER -91.22 -70.01 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 117.583 -1.199 . . . . 0.0 110.799 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.8 124.49 38.87 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 121.287 1.858 . . . . 0.0 114.74 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -67.08 168.94 9.24 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.558 1.143 . . . . 0.0 110.336 167.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.648 HD13 ' HB2' ' A' ' 5' ' ' ASP . 13.5 mt -62.1 123.22 17.53 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.276 -0.89 . . . . 0.0 109.349 175.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 124.839 1.256 . . . . 0.0 111.291 -176.556 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.0 t . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 121.208 0.528 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.5 t -113.44 -169.51 1.51 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 127.369 2.268 . . . . 0.0 112.173 -175.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -153.65 153.86 25.12 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.162 1.363 . . . . 0.0 113.661 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -152.49 160.12 43.27 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.186 1.794 . . . . 0.0 111.037 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -87.81 -32.75 18.89 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -174.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.76 143.05 38.29 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.666 0.786 . . . . 0.0 110.026 174.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.319 13.8 t -73.56 -41.37 5.87 Favored Pre-proline 0 N--CA 1.479 0.977 0 CA-C-O 116.341 -1.79 . . . . 0.0 113.969 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.79 137.62 54.54 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.649 2.233 . . . . 0.0 113.852 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -82.67 155.93 24.1 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.932 1.693 . . . . 0.0 113.528 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.77 45.5 3.22 Favored Glycine 0 N--CA 1.485 1.916 0 O-C-N 120.399 -1.438 . . . . 0.0 109.698 168.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -74.71 -39.91 61.63 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -168.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . 0.26 5.9 mp -68.75 -30.21 68.78 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 117.042 -1.456 . . . . 0.0 110.742 -173.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -57.37 -39.53 76.21 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.979 1.718 . . . . 0.0 111.899 169.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.53 -47.38 86.43 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.302 -1.499 . . . . 0.0 111.176 170.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.0 t -54.44 -31.83 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.389 1.076 . . . . 0.0 112.382 172.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.581 ' HA ' HD21 ' A' ' 156' ' ' LEU . 40.9 t -64.75 -65.0 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.592 0.757 . . . . 0.0 111.258 172.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -69.77 -32.62 71.21 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.086 -0.959 . . . . 0.0 112.048 -169.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 108' ' ' LEU . 33.0 m -62.53 -20.85 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.922 1.237 . . . . 0.0 113.403 171.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.02 -45.51 16.46 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 120.057 1.299 . . . . 0.0 112.295 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.5 mt -88.19 -19.85 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.45 60.11 5.83 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 119.996 -1.69 . . . . 0.0 111.698 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.421 HD12 ' H ' ' A' ' 96' ' ' LEU . 6.6 mp -48.26 -38.58 19.02 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.185 1.394 . . . . 0.0 111.128 176.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.83 -29.64 31.39 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.602 1.096 . . . . 0.0 115.497 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -89.65 -46.36 8.69 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 118.94 1.37 . . . . 0.0 110.624 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.9 mm -60.67 -49.54 84.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 172.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.61 29.51 8.19 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.177 0.894 . . . . 0.0 113.815 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.558 ' CE3' HD11 ' A' ' 59' ' ' LEU . 14.2 m95 -54.84 119.93 6.09 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 118.46 1.13 . . . . 0.0 111.462 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -95.82 -144.43 0.27 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.41 1.484 . . . . 0.0 111.96 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -102.1 -10.35 19.75 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 -169.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.16 -126.41 1.6 Allowed Glycine 0 C--N 1.349 1.264 0 CA-C-N 120.895 1.68 . . . . 0.0 112.86 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.4 t -112.26 147.53 36.07 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.311 1.845 . . . . 0.0 110.037 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.73 132.99 29.88 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 119.73 1.15 . . . . 0.0 113.198 -169.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -123.8 104.94 9.26 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -169.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 92' ' ' VAL . 16.8 tp -85.6 88.66 7.56 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.847 172.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.3 t -79.13 123.7 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 174.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.489 HD13 HD23 ' A' ' 9' ' ' LEU . 47.5 tp -117.2 111.66 19.75 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 123.814 0.696 . . . . 0.0 109.503 -169.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.34 133.26 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 t -165.62 158.42 15.51 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.683 169.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -106.14 -5.51 19.29 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -174.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -138.57 -179.9 6.08 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.514 1.526 . . . . 0.0 111.423 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.11 -171.33 0.11 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.688 1.595 . . . . 0.0 113.478 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -144.81 150.42 37.13 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.109 1.364 . . . . 0.0 112.499 -170.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -74.16 133.6 42.78 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.859 0.864 . . . . 0.0 110.333 169.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.95 175.22 5.55 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.273 1.429 . . . . 0.0 109.784 170.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.91 142.54 19.07 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.836 -0.54 . . . . 0.0 111.263 169.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.533 ' O ' HG22 ' A' ' 123' ' ' THR . 72.5 mmtt 86.31 -18.06 0.35 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 129.217 3.007 . . . . 0.0 112.667 -173.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -71.58 -19.1 62.19 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 121.061 1.755 . . . . 0.0 113.0 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -74.22 -16.15 60.98 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.499 -1.375 . . . . 0.0 113.876 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 120' ' ' LYS 0.302 9.5 t -74.7 -6.63 49.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 119.556 1.071 . . . . 0.0 113.201 174.162 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.1 mp -64.93 -24.09 67.42 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.104 -0.998 . . . . 0.0 109.752 167.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -88.65 -123.56 2.14 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 168.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 64.1 p -126.97 16.15 7.35 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.337 1.455 . . . . 0.0 114.1 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.36 125.72 50.84 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.652 1.181 . . . . 0.0 111.932 -169.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -130.43 -20.3 2.98 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -71.52 124.58 24.98 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 121.078 1.763 . . . . 0.0 110.111 170.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.441 ' HA ' ' HB3' ' A' ' 149' ' ' ASP . 15.3 t -75.4 147.23 40.16 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.139 0.575 . . . . 0.0 110.722 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.4 t -63.72 135.58 56.8 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.064 1.412 . . . . 0.0 112.602 -175.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -73.94 -10.53 59.74 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.55 2.74 . . . . 0.0 114.832 -170.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.86 15.99 80.63 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.222 -1.321 . . . . 0.0 114.182 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -113.15 170.26 8.34 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.175 1.488 . . . . 0.0 110.632 169.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.3 153.24 18.12 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -169.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -147.88 45.44 1.09 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.027 1.331 . . . . 0.0 113.803 -169.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.41 150.14 20.92 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.342 1.057 . . . . 0.0 109.584 169.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -141.6 -67.79 0.39 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.856 0.862 . . . . 0.0 111.538 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -84.73 -2.64 57.88 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.524 1.53 . . . . 0.0 113.716 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.29 -8.72 38.36 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.217 1.865 . . . . 0.0 114.387 -175.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 92.4 mtp -93.41 148.94 21.62 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.308 2.054 . . . . 0.0 111.088 170.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -70.92 100.7 2.0 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.927 -1.108 . . . . 0.0 110.746 173.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -48.36 80.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.355 1.062 . . . . 0.0 110.821 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 43.5 m -74.44 8.06 2.5 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -175.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.25 -24.61 59.9 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.834 -1.166 . . . . 0.0 111.881 169.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.7 -45.23 7.94 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 118.007 -1.441 . . . . 0.0 113.574 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.303 1.7 pm0 -97.97 -62.78 0.11 Allowed Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -169.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -58.54 149.26 76.65 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.438 2.758 . . . . 0.0 117.625 169.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' A' ' 130' ' ' THR . 56.0 t0 -74.81 161.15 29.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.87 2.468 . . . . 0.0 111.631 169.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -59.73 131.74 51.82 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 168.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -81.94 157.06 24.43 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 121.153 1.797 . . . . 0.0 112.624 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.3 m -67.8 152.42 45.6 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.111 0.964 . . . . 0.0 113.101 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.15 -26.36 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -169.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.9 m -85.21 -16.17 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -70.03 -27.14 64.42 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.752 1.16 . . . . 0.0 108.494 168.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.581 HD21 ' HA ' ' A' ' 90' ' ' VAL . 15.2 mt -84.22 -32.87 24.28 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 117.286 -1.34 . . . . 0.0 114.036 169.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -54.23 -37.37 64.55 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 120.853 1.661 . . . . 0.0 112.398 171.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 89.2 p -68.41 -55.03 13.33 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.835 -0.54 . . . . 0.0 112.119 173.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -66.01 -29.74 70.16 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.6 mp -58.33 -54.58 45.4 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.412 1.085 . . . . 0.0 111.383 170.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.56 -24.63 58.95 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.15 -39.8 63.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.5 1.12 . . . . 0.0 111.022 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -95.52 1.09 53.77 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 174.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 66.89 30.86 7.53 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.314 1.846 . . . . 0.0 113.863 169.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 48.7 mt -89.64 137.86 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 120.705 -1.247 . . . . 0.0 109.603 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -104.59 97.53 12.55 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -74.12 150.37 42.64 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.132 1.888 . . . . 0.0 113.465 173.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.495 ' CD1' HG23 ' A' ' 190' ' ' THR . 34.9 mm -139.17 106.28 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.715 1.206 . . . . 0.0 109.702 -174.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.478 ' HB2' HG22 ' A' ' 191' ' ' ILE . 21.2 m-85 -73.01 65.62 0.76 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.657 1.183 . . . . 0.0 113.207 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.69 108.6 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 122.401 1.096 . . . . 0.0 111.187 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 28.3 m -146.3 142.01 17.07 Favored Pre-proline 0 N--CA 1.48 1.039 0 O-C-N 119.873 -1.767 . . . . 0.0 110.708 -174.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -54.17 150.78 30.88 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.197 2.598 . . . . 0.0 114.542 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.3 t -44.79 -45.04 9.83 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.347 1.859 . . . . 0.0 114.031 -170.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.33 -36.97 6.84 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.698 1.599 . . . . 0.0 113.782 -172.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.5 mtt -123.62 19.19 9.55 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.741 1.217 . . . . 0.0 114.08 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.2 t -59.52 -37.5 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 O-C-N 120.488 -1.382 . . . . 0.0 110.589 174.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 180' ' ' GLU . 0.0 OUTLIER -66.71 -22.74 66.06 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -170.435 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.2 t -91.24 -33.21 15.46 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.872 1.269 . . . . 0.0 111.249 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -70.95 -37.02 72.82 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.577 -1.327 . . . . 0.0 110.324 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.534 ' HA ' HG22 ' A' ' 183' ' ' THR 0.353 14.8 pt-20 -73.43 -2.67 23.36 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 169.662 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.646 ' O ' HG22 ' A' ' 184' ' ' THR . 87.1 tttt -88.63 -43.64 11.2 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.23 -0.919 . . . . 0.0 109.869 169.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . 0.264 4.8 mp -83.84 -10.08 58.3 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 119.288 -2.133 . . . . 0.0 111.93 -174.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 180' ' ' GLU . 15.1 t -78.16 -19.64 53.57 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 167.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 181' ' ' LYS 0.279 1.3 t -77.41 -19.94 55.38 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 120.881 -1.137 . . . . 0.0 109.655 168.587 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -83.47 -24.19 31.88 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.345 0.658 . . . . 0.0 111.373 168.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.87 78.71 23.71 Favored Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 124.618 1.167 . . . . 0.0 111.542 170.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.52 142.1 93.85 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.183 1.922 . . . . 0.0 112.122 176.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 62.6 mttm 95.17 -20.34 0.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 131.636 3.975 . . . . 0.0 113.331 -171.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.7 tt -71.03 157.48 38.14 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.495 HG23 ' CD1' ' A' ' 168' ' ' ILE 0.495 0.1 OUTLIER -135.36 -160.64 1.07 Allowed 'General case' 0 C--N 1.346 0.416 0 O-C-N 120.009 -1.682 . . . . 0.0 108.169 169.871 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.478 HG22 ' HB2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -146.97 156.29 10.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 129.025 2.93 . . . . 0.0 108.893 -168.193 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -137.56 134.76 7.17 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 171.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -83.12 82.21 8.35 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 169.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 20.0 tp . . . . . 0 CA--C 1.544 0.73 0 CA-C-N 113.481 -1.691 . . . . 0.0 110.609 169.865 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.543 0.703 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.2 t -125.1 140.67 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.328 1.451 . . . . 0.0 109.327 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -124.6 99.39 6.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.296 1.439 . . . . 0.0 109.194 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.0 123.31 40.69 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.181 -0.95 . . . . 0.0 111.128 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -105.45 105.94 16.21 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 123.701 1.715 . . . . 0.0 109.282 169.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -81.83 112.5 19.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.563 173.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 tt -111.34 131.54 55.09 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.372 -0.83 . . . . 0.0 112.841 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 28.4 mtp -110.61 148.49 32.1 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.57 121.35 6.45 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.578 1.561 . . . . 0.0 109.209 168.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.54 36.38 3.11 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.06 1.744 . . . . 0.0 111.697 -175.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.504 ' OG ' ' HE2' ' A' ' 83' ' ' LYS . 24.4 p . . . . . 0 C--N 1.324 -0.515 0 C-N-CA 125.705 1.602 . . . . 0.0 113.479 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 CA--C 1.545 0.773 0 CA-C-O 122.889 1.328 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.06 84.27 0.31 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 105.627 -2.989 . . . . 0.0 105.627 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 -84.58 133.92 34.41 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.529 1.532 . . . . 0.0 107.774 -169.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.4 tt -125.97 144.41 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 119.545 1.066 . . . . 0.0 112.296 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.27 153.61 21.98 Favored Glycine 0 N--CA 1.461 0.329 0 C-N-CA 125.84 1.686 . . . . 0.0 110.263 -176.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -138.07 130.57 29.32 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -169.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.68 149.69 20.09 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 124.92 1.247 . . . . 0.0 112.901 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.3 p -119.65 144.11 47.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.657 1.183 . . . . 0.0 111.553 174.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -140.98 150.44 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.518 -1.364 . . . . 0.0 108.961 174.705 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.419 ' N ' HD13 ' A' ' 48' ' ' ILE . 38.1 t -138.36 -68.92 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 170.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.425 ' H ' ' H ' ' A' ' 51' ' ' MET 0.273 1.5 t-20 170.15 -4.05 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.82 1 C-N-CA 134.046 4.938 . . . . 0.0 109.477 169.421 . . . . . . . . 4 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.425 ' H ' ' H ' ' A' ' 50' ' ' ASN . 26.7 ptt? -54.33 -39.72 67.31 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.118 0.967 . . . . 0.0 109.61 167.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.486 ' HA ' ' HD3' ' A' ' 145' ' ' ARG . 1.2 p 163.74 170.65 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.117 1 C-N-CA 134.355 5.062 . . . . 0.0 108.43 -178.845 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -89.16 131.21 35.4 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 166.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -123.4 130.31 52.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.677 1.227 . . . . 0.0 110.186 177.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -104.01 104.73 14.73 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.866 2.066 . . . . 0.0 110.429 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.437 HD13 ' H ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -108.96 -9.35 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -173.497 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.4 tt -157.34 117.22 3.42 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.553 1.069 . . . . 0.0 109.927 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.02 163.74 18.68 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.825 0.85 . . . . 0.0 113.272 172.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.458 HD11 ' CE3' ' A' ' 101' ' ' TRP . 87.4 mt -49.08 104.02 0.06 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.592 1.557 . . . . 0.0 113.334 -169.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.483 1.213 0 C-N-CA 126.502 1.921 . . . . 0.0 111.221 179.458 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.8 t . . . . . 0 CA--C 1.545 0.764 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 t -101.66 -155.9 0.54 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 125.971 1.708 . . . . 0.0 112.17 172.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -146.86 150.33 22.58 Favored Glycine 0 N--CA 1.478 1.483 0 O-C-N 120.048 -1.657 . . . . 0.0 116.019 -173.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -149.75 162.38 40.37 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.918 2.087 . . . . 0.0 113.262 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -32.1 13.0 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 173.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -94.96 132.11 40.16 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.229 0.922 . . . . 0.0 110.318 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.8 p -74.25 -31.46 1.26 Allowed Pre-proline 0 N--CA 1.472 0.675 0 CA-C-O 114.274 -2.774 . . . . 0.0 115.427 -172.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -68.48 144.95 63.08 Favored 'Trans proline' 0 C--N 1.353 0.771 0 CA-C-N 123.893 2.426 . . . . 0.0 112.264 169.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HE2' ' OG ' ' A' ' 13' ' ' SER . 12.1 mptt -98.48 -177.3 3.64 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.889 1.276 . . . . 0.0 112.286 -176.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.96 18.28 37.07 Favored Glycine 0 N--CA 1.481 1.652 0 C-N-CA 125.621 1.581 . . . . 0.0 114.327 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -46.72 -39.18 11.11 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -169.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.55 HD23 HD13 ' A' ' 156' ' ' LEU 0.466 5.1 mp -80.49 7.92 8.84 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 119.899 1.227 . . . . 0.0 113.417 -177.63 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -80.41 -49.84 10.91 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 165.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.44 -45.23 94.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 116.893 -1.527 . . . . 0.0 112.369 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -49.95 -36.93 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 120.511 1.505 . . . . 0.0 111.653 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.579 HG21 ' HG3' ' A' ' 151' ' ' GLN . 63.1 t -82.59 -45.14 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.172 0.989 . . . . 0.0 111.4 -178.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -59.57 -49.8 76.38 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.524 1.056 . . . . 0.0 109.672 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.437 HG11 HD13 ' A' ' 108' ' ' LEU . 82.2 t -55.97 -42.08 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.203 1.001 . . . . 0.0 111.976 176.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.69 85.52 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.091 -1.006 . . . . 0.0 112.919 177.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.26 -24.91 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.988 1.315 . . . . 0.0 113.667 -169.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 61.78 3.93 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.812 1.645 . . . . 0.0 110.871 -176.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.4 mt -56.23 -38.63 71.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.072 1.349 . . . . 0.0 112.0 -170.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.01 -34.49 23.98 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.877 0.751 . . . . 0.0 113.47 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -81.66 -45.4 15.81 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 125.334 1.453 . . . . 0.0 110.472 -175.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.8 mm -70.69 -33.31 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 118.915 0.78 . . . . 0.0 110.455 170.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.16 31.5 16.86 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.452 1.025 . . . . 0.0 114.542 174.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.458 ' CE3' HD11 ' A' ' 59' ' ' LEU . 23.1 m95 -56.54 129.45 40.89 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.88 1.272 . . . . 0.0 113.096 -177.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.17 170.66 7.83 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.651 1.18 . . . . 0.0 112.55 169.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -74.42 49.49 0.38 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 127.307 2.243 . . . . 0.0 114.053 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.84 -131.02 6.44 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 170.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.9 m -119.33 132.59 55.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.568 2.347 . . . . 0.0 105.7 177.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -124.61 124.79 42.98 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 119.084 0.856 . . . . 0.0 111.405 -168.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -114.04 112.47 23.31 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 123.977 0.798 . . . . 0.0 110.783 -175.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.437 HD13 HG11 ' A' ' 92' ' ' VAL . 14.5 tp -93.44 105.92 17.94 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 170.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.1 t -89.43 125.58 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 172.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -111.03 115.87 30.2 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.525 HG13 HD22 ' A' ' 194' ' ' LEU . 60.0 t -108.72 130.88 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 123.674 0.609 . . . . 0.0 112.611 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.4 t -158.17 164.24 36.77 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.305 1.042 . . . . 0.0 111.453 171.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -112.49 -4.36 14.22 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.85 2.06 . . . . 0.0 114.124 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -137.49 -177.36 4.75 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.476 -1.39 . . . . 0.0 113.439 171.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -61.86 -174.64 0.05 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.333 2.253 . . . . 0.0 112.262 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 20.8 t80 -140.6 139.46 34.93 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.426 1.09 . . . . 0.0 111.904 -174.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -68.67 108.35 3.34 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.564 1.146 . . . . 0.0 111.721 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.04 177.54 3.68 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.375 0.607 . . . . 0.0 111.527 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.27 148.14 23.5 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.22 -0.925 . . . . 0.0 112.295 172.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? 78.6 -11.19 1.24 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 128.099 2.56 . . . . 0.0 112.668 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.95 -32.5 74.26 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.532 1.133 . . . . 0.0 112.398 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -70.09 0.84 5.41 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 178.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.2 t -58.82 -33.04 69.94 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.052 -1.03 . . . . 0.0 112.417 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.6 tp -65.82 -40.89 92.26 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.635 0.774 . . . . 0.0 111.473 171.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.88 27.03 1.13 Allowed Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.588 1.566 . . . . 0.0 113.392 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 62.7 p 61.94 5.89 1.53 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 131.536 3.935 . . . . 0.0 117.038 169.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . 0.3 48.1 mtt180 -109.99 140.75 43.65 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.939 1.245 . . . . 0.0 114.144 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -109.73 -32.37 7.11 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.14 2.576 . . . . 0.0 114.691 -168.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -71.35 123.41 22.25 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.821 0.737 . . . . 0.0 111.292 -173.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.0 t -57.73 158.25 6.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.489 1.116 . . . . 0.0 110.68 172.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 151' ' ' GLN . 20.7 t -70.15 134.43 48.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.977 0.894 . . . . 0.0 111.11 170.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 p30 -78.13 -12.03 59.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.633 1.573 . . . . 0.0 112.647 170.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.19 8.11 73.65 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.876 1.227 . . . . 0.0 114.764 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -78.14 174.02 11.61 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.896 1.348 . . . . 0.0 109.023 168.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -93.13 148.25 22.18 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 171.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -136.2 27.57 3.17 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.886 1.674 . . . . 0.0 112.232 -171.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.3 mt -87.66 153.12 21.62 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.87 0.868 . . . . 0.0 111.008 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -148.0 -67.21 0.24 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.399 1.079 . . . . 0.0 111.44 172.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.22 9.07 27.1 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.721 1.608 . . . . 0.0 113.729 176.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 105.98 -5.47 39.5 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.803 1.668 . . . . 0.0 115.213 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -113.17 149.16 34.03 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.643 1.721 . . . . 0.0 112.277 174.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -70.71 86.61 0.67 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.456 1.102 . . . . 0.0 112.107 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -49.05 -45.11 42.34 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.067 1.347 . . . . 0.0 111.833 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 71.8 m -77.73 -0.14 25.79 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -173.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.486 ' HD3' ' HA ' ' A' ' 52' ' ' THR . 9.4 ttp85 -52.43 -40.33 62.07 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 121.171 1.805 . . . . 0.0 111.658 169.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.7 -25.09 75.92 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 117.617 -1.657 . . . . 0.0 113.156 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.355 42.7 tt0 -96.84 -92.06 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.328 0 CA-C-O 115.465 -2.207 . . . . 0.0 112.041 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.97 152.94 54.71 Favored 'Trans proline' 0 C--N 1.359 1.081 0 CA-C-N 124.241 2.55 . . . . 0.0 116.395 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.01 163.35 7.98 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.819 2.448 . . . . 0.0 114.72 170.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -60.85 139.9 57.82 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 167.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.579 ' HG3' HG21 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -84.11 150.57 25.46 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.613 -1.305 . . . . 0.0 112.396 -174.55 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.1 t -68.85 148.67 49.91 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.401 0.68 . . . . 0.0 111.805 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.0 t -55.85 -29.47 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.565 1.146 . . . . 0.0 111.802 -177.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.3 -40.66 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.34 1.056 . . . . 0.0 112.138 173.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -65.41 -35.87 82.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.327 0.651 . . . . 0.0 110.141 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.55 HD13 HD23 ' A' ' 86' ' ' LEU . 5.2 mt -61.8 -58.12 9.22 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 173.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -54.24 -41.12 68.38 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.486 1.114 . . . . 0.0 112.919 -175.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.8 t -59.65 -54.14 49.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.886 0.874 . . . . 0.0 111.525 173.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -73.64 -33.95 64.75 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.824 -1.173 . . . . 0.0 112.903 -172.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 mt -61.1 -38.23 85.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.401 1.001 . . . . 0.0 111.978 170.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.63 -33.41 64.52 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.114 0.966 . . . . 0.0 113.514 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -68.35 -47.3 67.83 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.641 1.177 . . . . 0.0 110.496 176.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -74.45 -17.37 60.79 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.492 0.717 . . . . 0.0 111.871 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 62.84 49.26 3.71 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.964 1.706 . . . . 0.0 111.514 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.51 125.79 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.82 1.248 . . . . 0.0 108.465 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -91.42 119.79 68.51 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-O 118.38 -0.819 . . . . 0.0 108.805 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.18 152.59 14.09 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.635 2.223 . . . . 0.0 110.603 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.8 mm -138.54 105.4 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.008 1.323 . . . . 0.0 109.379 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.553 ' CD2' HD11 ' A' ' 189' ' ' LEU . 28.2 m-85 -77.96 82.6 4.31 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.428 -1.42 . . . . 0.0 112.46 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 87.9 t -70.28 104.91 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.14 -1.391 . . . . 0.0 112.31 169.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.11 144.79 22.45 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -171.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -63.96 154.17 71.65 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 124.742 3.628 . . . . 0.0 114.912 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.7 m -41.22 -51.04 3.59 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.428 2.291 . . . . 0.0 114.877 -169.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -54.54 -26.37 31.53 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 8.9 ttm -106.02 -8.48 17.52 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.565 1.946 . . . . 0.0 114.073 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 40.1 t -55.56 -47.04 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.902 -1.124 . . . . 0.0 112.148 -168.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . 0.317 11.4 pttm -81.09 -6.18 58.51 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -174.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . 0.255 4.8 t -86.92 -26.87 23.68 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 119.337 0.971 . . . . 0.0 111.129 169.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -83.49 -23.25 32.25 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.694 -1.254 . . . . 0.0 111.471 172.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -34.8 78.49 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.16 -0.963 . . . . 0.0 109.357 167.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . 0.395 0.1 OUTLIER -83.48 1.08 43.47 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 119.915 -1.74 . . . . 0.0 112.893 -178.24 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -98.56 -25.98 14.56 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.965 2.506 . . . . 0.0 107.407 168.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.517 ' HA ' HD23 ' A' ' 189' ' ' LEU . 0.6 OUTLIER -79.23 -18.11 53.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.949 -1.094 . . . . 0.0 113.897 176.276 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 5.3 t -85.3 -24.14 27.82 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.226 0.61 . . . . 0.0 110.004 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -79.62 -38.09 34.65 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.527 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 35.4 mt -108.66 98.63 29.7 Favored Pre-proline 0 N--CA 1.484 1.227 0 CA-C-N 118.81 0.732 . . . . 0.0 110.037 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -55.06 144.89 66.87 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.215 2.61 . . . . 0.0 112.421 169.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 78.49 -2.47 2.37 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 128.227 2.611 . . . . 0.0 114.849 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.553 HD11 ' CD2' ' A' ' 169' ' ' PHE . 23.2 tp -74.47 152.72 39.39 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.785 1.234 . . . . 0.0 108.464 168.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.3 m -121.12 -153.1 0.53 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 177.83 114.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.427 2.291 . . . . 0.0 108.857 -167.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -109.62 147.1 17.03 Favored Glycine 0 N--CA 1.471 1.001 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 171.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . 0.362 0.9 OUTLIER -95.53 95.66 8.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 124.053 1.882 . . . . 0.0 110.568 177.943 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.525 HD22 HG13 ' A' ' 111' ' ' VAL . 31.1 tp . . . . . 0 CA--C 1.539 0.547 0 CA-C-N 111.326 -2.67 . . . . 0.0 111.692 172.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -72.95 159.24 34.01 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.186 -1.571 . . . . 0.0 113.217 -176.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.4 m -62.42 131.94 50.9 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.291 -0.881 . . . . 0.0 113.16 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.88 142.47 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.48 1.512 . . . . 0.0 109.377 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -119.46 113.17 20.36 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.083 1.753 . . . . 0.0 108.327 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.21 126.24 51.98 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.725 -0.609 . . . . 0.0 109.977 177.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -114.62 108.91 17.44 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 123.572 1.653 . . . . 0.0 111.284 174.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -84.01 99.2 10.27 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 112.713 -2.04 . . . . 0.0 113.584 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.4 mt -91.59 129.26 37.59 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.828 0.851 . . . . 0.0 109.675 168.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . 0.253 2.7 ppp? -137.45 156.63 47.95 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 169.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.02 131.81 10.63 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.149 1.833 . . . . 0.0 113.156 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.8 mp -107.42 29.57 7.04 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.917 2.087 . . . . 0.0 111.891 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.6 p -74.31 159.91 31.79 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.328 -1.483 . . . . 0.0 113.025 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.97 -33.08 82.42 Favored Glycine 0 N--CA 1.473 1.128 0 O-C-N 120.892 -1.13 . . . . 0.0 111.607 173.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.1 m -65.91 -26.24 67.52 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.258 1.423 . . . . 0.0 113.127 172.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.83 -7.62 53.98 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 137.79 51.75 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 120.891 1.678 . . . . 0.0 108.717 169.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.5 -41.06 3.05 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.334 0.969 . . . . 0.0 110.971 -169.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -80.29 -10.87 59.76 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.468 1.107 . . . . 0.0 111.191 168.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.3 tp -58.12 -52.86 63.77 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.364 1.066 . . . . 0.0 109.819 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.1 p -49.7 -45.38 48.93 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.088 0.955 . . . . 0.0 112.326 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -64.6 -35.14 80.04 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.993 0.917 . . . . 0.0 111.637 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 p -89.96 3.3 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -93.64 -51.66 4.83 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 169.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.5 t -59.95 -45.29 93.11 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.633 1.173 . . . . 0.0 110.318 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.5 tp -79.87 83.71 5.76 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.55 -47.09 0.24 Allowed Glycine 0 C--N 1.304 -1.243 0 CA-C-N 110.59 -3.005 . . . . 0.0 109.372 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.4 p -73.51 -43.15 60.73 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.46 0.704 . . . . 0.0 111.675 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -75.97 -21.62 56.79 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.5 tt -67.33 -61.23 2.01 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 169.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 43' ' ' ILE . 9.6 tt -47.24 -55.9 7.75 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.482 1.113 . . . . 0.0 112.931 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -75.11 -28.27 60.16 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.089 0.859 . . . . 0.0 113.24 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.63 -41.27 96.27 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.094 0.861 . . . . 0.0 111.355 169.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.537 HD11 HG21 ' A' ' 205' ' ' ILE . 16.1 mt -74.83 -30.7 61.46 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.408 -0.807 . . . . 0.0 112.904 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -64.19 -21.0 66.4 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.69 1.132 . . . . 0.0 113.156 172.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -81.46 -49.54 10.5 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.743 0.817 . . . . 0.0 109.474 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.71 -28.02 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.5 t -129.03 130.34 46.47 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -69.94 -22.07 63.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.462 1.105 . . . . 0.0 113.232 169.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.9 t -129.85 88.69 2.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.772 1.229 . . . . 0.0 109.272 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.01 82.22 0.31 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 127.837 2.637 . . . . 0.0 106.605 -172.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -79.37 127.73 32.45 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.476 HG21 HD12 ' A' ' 31' ' ' LEU . 2.9 mt -123.38 130.91 73.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.311 0.577 . . . . 0.0 111.217 -177.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.05 161.51 18.42 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 126.618 2.056 . . . . 0.0 110.278 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -141.28 133.31 27.7 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.82 145.51 16.25 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 121.404 0.446 . . . . 0.0 112.274 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.8 m -114.71 142.08 46.98 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.733 1.213 . . . . 0.0 110.332 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.587 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -152.77 155.04 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 120.913 -1.117 . . . . 0.0 108.984 178.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.587 ' N ' HD13 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -152.47 -62.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.607 1.163 . . . . 0.0 109.426 173.573 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.25 25.5 t30 177.47 -19.43 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 128.917 2.887 . . . . 0.0 111.972 168.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -50.31 -40.91 50.02 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.068 0.849 . . . . 0.0 109.7 168.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.405 ' HA ' ' HD2' ' A' ' 145' ' ' ARG 0.365 3.7 t 163.92 -177.61 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 131.622 3.969 . . . . 0.0 112.158 167.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -85.45 129.8 34.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.344 1.858 . . . . 0.0 108.533 169.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -117.73 112.22 20.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.45 1.1 . . . . 0.0 108.84 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -72.93 122.07 21.07 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.5 mt -103.86 -54.08 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.558 -0.714 . . . . 0.0 111.048 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.1 tp -130.98 120.72 23.91 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.257 0.551 . . . . 0.0 111.669 -175.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -57.85 149.57 22.24 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.705 1.202 . . . . 0.0 111.112 169.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 28.8 mt -48.03 108.8 0.18 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.115 1.366 . . . . 0.0 111.311 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t -129.57 162.27 28.6 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.608 1.563 . . . . 0.0 111.823 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.36 -4.28 42.24 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.071 1.748 . . . . 0.0 113.646 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.47 102.82 15.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 127.106 3.336 . . . . 0.0 108.222 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.6 t -66.2 -53.47 36.95 Favored 'General case' 0 C--N 1.304 -1.402 2 C-N-CA 132.152 4.181 . . . . 0.0 110.434 -174.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.3 p -64.66 -19.28 65.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.335 1.054 . . . . 0.0 112.321 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . 0.303 5.1 pt20 -83.82 -47.51 11.04 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.578 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -57.96 -33.82 69.27 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.175 -0.953 . . . . 0.0 111.918 174.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -70.78 -33.36 70.68 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.356 -0.84 . . . . 0.0 111.2 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 -79.77 -31.03 40.85 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.895 1.278 . . . . 0.0 109.621 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -80.95 -32.38 34.52 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -175.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 32.4 tp -73.23 -47.95 38.98 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.717 170.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -70.07 -25.66 63.64 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.683 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -57.87 -29.84 65.34 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.587 1.155 . . . . 0.0 114.049 170.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -61.73 150.37 36.97 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -170.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.3 tp -141.37 149.7 41.46 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.173 1.389 . . . . 0.0 109.196 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.85 169.43 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.988 1.315 . . . . 0.0 112.837 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.0 t -126.8 -140.54 0.27 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.273 1.429 . . . . 0.0 109.323 169.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -147.35 158.56 27.76 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-N 120.562 1.528 . . . . 0.0 115.715 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -160.6 148.41 16.1 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.951 1.7 . . . . 0.0 111.728 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.8 tp -68.06 -55.6 11.97 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.792 1.237 . . . . 0.0 112.223 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.59 136.17 50.92 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.632 0.773 . . . . 0.0 112.069 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.272 7.5 t -70.66 -39.84 9.84 Favored Pre-proline 0 N--CA 1.474 0.762 0 CA-C-O 115.766 -2.064 . . . . 0.0 113.456 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.42 140.07 56.49 Favored 'Trans proline' 0 C--N 1.356 0.939 0 CA-C-N 123.405 2.252 . . . . 0.0 111.693 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -107.4 -179.3 3.88 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.27 1.828 . . . . 0.0 112.738 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -109.18 18.99 30.27 Favored Glycine 0 N--CA 1.479 1.56 0 O-C-N 120.68 -1.262 . . . . 0.0 116.019 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -56.76 -29.22 62.37 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -169.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.34 -28.15 67.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.47 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.72 -34.12 77.46 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 120.126 1.33 . . . . 0.0 112.273 171.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.7 -46.46 78.9 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 118.417 -0.801 . . . . 0.0 109.216 169.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.413 HG22 HD13 ' A' ' 108' ' ' LEU . 1.1 t -53.61 -40.13 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.017 0.826 . . . . 0.0 111.774 174.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.29 -61.9 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.433 1.093 . . . . 0.0 110.852 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.9 -44.8 95.11 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 118.945 -0.55 . . . . 0.0 110.715 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.24 -40.57 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.897 0.879 . . . . 0.0 111.714 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.56 -38.22 86.62 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.436 1.017 . . . . 0.0 112.86 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.6 mt -86.31 -36.8 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.795 0.838 . . . . 0.0 113.181 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 73.6 m -77.53 55.39 1.29 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.823 2.049 . . . . 0.0 112.105 -169.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 62.3 mt -48.99 -42.59 38.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.453 2.301 . . . . 0.0 111.453 -176.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.98 -19.25 75.45 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.403 1.001 . . . . 0.0 114.719 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -96.58 -47.6 5.86 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.117 0.967 . . . . 0.0 110.79 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.3 mm -66.73 -36.56 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.686 0.795 . . . . 0.0 111.104 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.43 20.93 28.26 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.115 1.341 . . . . 0.0 114.123 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -53.98 121.04 7.2 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.361 1.464 . . . . 0.0 112.212 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ptm85 -107.34 -176.78 3.16 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.015 1.326 . . . . 0.0 112.164 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -73.86 11.08 0.94 Allowed 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 117.851 2.538 . . . . 0.0 117.851 -169.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.61 -129.82 1.97 Allowed Glycine 0 C--N 1.344 1.023 0 CA-C-N 121.215 1.825 . . . . 0.0 110.734 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.9 p -114.33 145.21 42.08 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.494 1.918 . . . . 0.0 107.656 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -129.05 117.87 21.59 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.416 -167.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -122.2 104.45 9.47 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -169.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.413 HD13 HG22 ' A' ' 89' ' ' VAL . 3.1 tt -88.6 94.96 10.06 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.216 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.0 t -77.5 116.01 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.0 tp -105.18 123.06 47.18 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 t -108.27 130.12 61.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 O-C-N 124.595 1.184 . . . . 0.0 112.445 172.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.493 HG22 HG12 ' A' ' 171' ' ' VAL . 7.5 t -140.89 172.91 12.04 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.805 1.642 . . . . 0.0 110.335 173.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -118.96 -14.54 9.38 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 127.164 2.185 . . . . 0.0 111.859 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -133.12 174.82 9.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.789 1.236 . . . . 0.0 113.457 -169.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -61.23 -174.73 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.266 1.427 . . . . 0.0 110.883 168.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -147.12 159.86 43.1 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.655 -1.278 . . . . 0.0 113.36 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -79.22 116.83 19.72 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.27 1.428 . . . . 0.0 111.52 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.9 mp -82.55 -179.23 7.36 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.097 1.359 . . . . 0.0 109.962 173.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.47 160.1 3.35 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.406 -0.809 . . . . 0.0 111.689 169.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.449 0.0 OUTLIER 56.32 -12.68 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.277 0 N-CA-C 117.487 2.402 . . . . 0.0 117.487 -173.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.26 -28.21 69.55 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.037 -1.664 . . . . 0.0 111.899 169.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.58 -25.1 67.1 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 116.818 2.155 . . . . 0.0 116.818 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -18.6 63.62 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -167.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 pp -67.05 -19.77 65.73 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 118.68 0.673 . . . . 0.0 112.734 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -96.52 11.94 66.54 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 126.415 1.96 . . . . 0.0 114.11 170.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.334 10.5 t 54.86 53.74 10.03 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 128.078 2.551 . . . . 0.0 113.882 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -116.55 69.69 0.75 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.27 1.828 . . . . 0.0 110.505 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -62.23 -40.21 95.38 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.054 -1.654 . . . . 0.0 113.799 -169.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -60.83 138.92 58.09 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -173.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 t -81.39 148.88 29.1 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.731 0.813 . . . . 0.0 110.624 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 36.4 t -55.35 131.85 46.68 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.605 0.762 . . . . 0.0 111.771 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.7 p30 -89.58 -10.82 44.64 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.697 1.199 . . . . 0.0 113.899 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.93 21.85 78.72 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 117.995 -1.447 . . . . 0.0 114.773 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -112.48 170.39 8.21 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.369 1.584 . . . . 0.0 113.141 169.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 5.5 t -71.1 133.4 46.23 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.586 1.554 . . . . 0.0 112.234 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -138.04 40.45 2.31 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.065 1.746 . . . . 0.0 112.996 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.73 125.35 42.5 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.933 1.693 . . . . 0.0 109.131 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -117.67 -84.66 0.64 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.998 0.919 . . . . 0.0 111.836 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -87.15 20.37 2.76 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.945 1.698 . . . . 0.0 113.39 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.18 -11.87 68.75 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.814 1.674 . . . . 0.0 113.641 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 97.3 mtp -91.14 144.88 25.17 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.64 1.22 . . . . 0.0 111.691 171.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -77.41 83.88 3.84 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.575 0.702 . . . . 0.0 109.231 169.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 42.3 tpt85 -56.02 -32.29 63.86 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.38 1.472 . . . . 0.0 112.942 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.7 m -73.58 -8.54 56.37 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 29.3 ttt85 -56.02 -27.97 55.35 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 121.337 1.881 . . . . 0.0 113.903 176.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.72 -18.39 73.98 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.241 -1.311 . . . . 0.0 114.601 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.265 57.8 tt0 -119.94 -80.03 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.144 0 CA-C-O 115.818 -2.039 . . . . 0.0 112.449 -170.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.88 165.74 24.96 Favored 'Trans proline' 0 C--N 1.36 1.132 0 CA-C-N 123.918 2.435 . . . . 0.0 113.937 170.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -92.4 -179.82 5.32 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -67.52 126.98 31.04 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 167.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -49.7 161.2 0.24 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.505 1.922 . . . . 0.0 115.425 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.1 p -82.84 157.78 23.0 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.099 -1.0 . . . . 0.0 112.141 169.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.05 -34.06 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.645 -1.284 . . . . 0.0 112.001 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.9 t -77.94 -24.5 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.507 0.723 . . . . 0.0 111.682 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -67.17 -34.35 77.36 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.351 -0.843 . . . . 0.0 110.944 172.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.31 -56.12 21.52 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.021 0.828 . . . . 0.0 109.542 168.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.0 -40.49 63.85 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.829 0.852 . . . . 0.0 112.625 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.4 t -62.07 -64.47 0.92 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.966 0.907 . . . . 0.0 112.245 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -73.63 -24.94 60.08 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.085 -1.634 . . . . 0.0 113.878 -169.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.4 mp -63.74 -41.42 98.04 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.269 0.941 . . . . 0.0 110.703 169.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.05 -36.88 61.8 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -69.19 -49.79 53.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.283 1.033 . . . . 0.0 110.493 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -77.42 -15.49 59.32 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.686 0.794 . . . . 0.0 111.278 178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 66.96 60.21 0.53 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.189 1.796 . . . . 0.0 110.718 171.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.69 139.69 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.543 1.937 . . . . 0.0 107.988 172.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -107.9 106.16 57.91 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 119.951 1.251 . . . . 0.0 109.432 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.99 151.67 39.86 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.554 2.169 . . . . 0.0 114.005 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 82.5 mt -130.44 109.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.034 1.334 . . . . 0.0 107.801 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -78.89 80.9 5.21 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 122.093 0.949 . . . . 0.0 111.755 -175.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.8 104.81 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.992 0.917 . . . . 0.0 111.978 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.493 HG12 HG22 ' A' ' 112' ' ' THR . 3.0 m -142.61 167.67 15.59 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.078 -1.639 . . . . 0.0 112.064 -169.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -84.4 152.36 12.06 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.41 2.073 . . . . 0.0 110.951 -172.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.3 t -49.51 -43.84 45.81 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -169.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -56.8 -29.28 62.55 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -111.23 -8.2 14.39 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.633 1.973 . . . . 0.0 112.586 -170.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.2 t -54.27 -44.43 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 120.627 -1.296 . . . . 0.0 111.009 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -70.31 -6.08 32.5 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -170.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 18.4 m -87.12 -50.12 6.84 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.967 1.707 . . . . 0.0 110.19 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -73.56 -26.77 60.99 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.974 1.31 . . . . 0.0 110.307 -174.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . 0.353 7.1 pt-20 -65.73 -14.29 61.01 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.001 171.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . 0.379 0.0 OUTLIER -89.0 -22.91 22.76 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-N 120.551 1.523 . . . . 0.0 112.408 167.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.68 -19.78 60.73 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 119.682 -1.886 . . . . 0.0 110.176 169.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 98.7 m -80.28 -18.07 50.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.654 2.382 . . . . 0.0 111.949 169.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.73 -27.6 19.95 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.346 0.521 . . . . 0.0 110.38 169.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -80.26 -32.74 38.25 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 174.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.518 HG22 HD13 ' A' ' 189' ' ' LEU . 27.5 mt -110.21 101.31 47.49 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.46 150.84 64.59 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.857 2.371 . . . . 0.0 111.687 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt 86.36 -11.33 0.64 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 129.265 3.026 . . . . 0.0 113.084 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.518 HD13 HG22 ' A' ' 186' ' ' ILE . 10.2 mp -72.49 166.39 22.73 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.956 0.902 . . . . 0.0 109.817 172.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 69.7 p -125.24 -142.83 0.3 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.096 0.95 . . . . 0.0 109.856 170.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.2 tp -179.04 128.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 128.123 2.569 . . . . 0.0 108.482 -166.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -118.77 155.28 16.13 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . 0.276 11.2 pt-20 -105.2 94.61 5.33 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 122.903 1.335 . . . . 0.0 109.776 173.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 26.2 tp -50.79 134.38 25.23 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.981 169.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 66.0 p -161.95 -161.71 0.79 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.058 1.343 . . . . 0.0 110.115 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.21 -16.09 63.15 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.108 0.963 . . . . 0.0 112.866 172.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -110.05 150.78 28.05 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.441 1.497 . . . . 0.0 112.931 172.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 36.4 p -106.83 -5.72 18.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.732 1.613 . . . . 0.0 113.588 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 59.9 p -60.38 -36.71 78.7 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.732 1.213 . . . . 0.0 111.957 -169.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -58.38 -52.2 66.6 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.565 0.746 . . . . 0.0 111.012 171.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.65 -45.28 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.145 0.978 . . . . 0.0 111.682 -175.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.79 -27.84 67.09 Favored 'General case' 0 C--O 1.219 -0.501 0 O-C-N 121.7 -0.625 . . . . 0.0 112.396 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -70.32 -10.33 58.69 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.623 -1.298 . . . . 0.0 112.394 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.29 -40.23 6.85 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.112 1.365 . . . . 0.0 108.866 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.537 HG21 HD11 ' A' ' 34' ' ' LEU . 10.1 mm -60.78 -49.48 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 169.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 5.0 mtm105 -76.95 -23.95 52.38 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 118.296 -0.859 . . . . 0.0 112.699 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -66.66 -41.04 88.82 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 120.034 1.288 . . . . 0.0 111.14 169.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -70.46 -25.86 63.37 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.665 0.786 . . . . 0.0 112.277 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -66.35 -40.15 89.62 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.163 0.985 . . . . 0.0 112.411 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.8 t -77.12 -15.26 59.61 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -71.39 -18.24 62.36 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 121.328 -0.857 . . . . 0.0 113.227 173.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.907 1.683 . . . . 0.0 113.465 -169.145 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 110.692 -0.114 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -86.51 147.1 26.11 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.445 0.698 . . . . 0.0 110.306 172.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.1 p -76.55 143.57 40.24 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.991 -1.068 . . . . 0.0 111.903 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.95 108.41 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 121.993 0.901 . . . . 0.0 111.847 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -87.39 114.97 24.48 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 7' ' ' TYR . 1.3 tt -101.82 125.39 48.48 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.866 -0.521 . . . . 0.0 110.025 170.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.47 ' N ' HD23 ' A' ' 6' ' ' LEU . 26.9 t80 -117.42 109.37 16.7 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 123.531 1.634 . . . . 0.0 109.985 169.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -86.35 116.16 24.34 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.668 2.387 . . . . 0.0 112.444 -176.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.519 HD23 ' HB1' ' A' ' 88' ' ' ALA . 6.9 mp -99.25 124.34 44.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.378 1.071 . . . . 0.0 111.061 172.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.1 ttt -114.21 135.5 53.99 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.78 132.21 13.69 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 168.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 47' ' ' SER . 1.4 mp -115.1 15.07 17.16 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.498 1.519 . . . . 0.0 114.197 -170.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 p -74.66 174.49 9.01 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.031 -1.043 . . . . 0.0 112.705 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.47 -29.09 52.76 Favored Glycine 0 N--CA 1.477 1.397 0 O-C-N 121.102 -0.999 . . . . 0.0 115.487 -169.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 p -65.24 -25.14 67.54 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.073 1.749 . . . . 0.0 114.241 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.27 -10.42 59.74 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.502 1.521 . . . . 0.0 113.948 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -70.37 115.5 9.63 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.24 -38.6 3.24 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.097 1.332 . . . . 0.0 111.794 -169.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -65.7 -42.71 90.85 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.592 1.196 . . . . 0.0 110.309 169.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.3 tp -60.39 -31.96 70.86 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.952 0.901 . . . . 0.0 113.361 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.2 m -63.82 -44.46 93.18 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.223 0.609 . . . . 0.0 112.279 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -81.52 -15.62 54.32 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -175.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.0 m -93.26 1.34 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 119.207 0.912 . . . . 0.0 113.444 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -84.38 -35.62 23.03 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.815 1.643 . . . . 0.0 108.759 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 t -71.46 -14.76 62.24 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.997 1.319 . . . . 0.0 110.147 167.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.6 tp -80.61 95.72 6.63 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 125.584 2.612 . . . . 0.0 106.797 170.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.74 -46.32 0.08 OUTLIER Glycine 0 C--N 1.298 -1.576 1 CA-C-N 108.244 -4.071 . . . . 0.0 110.957 167.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.4 p -92.9 -34.76 13.67 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.77 1.628 . . . . 0.0 111.535 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.14 -40.33 97.28 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.629 -0.67 . . . . 0.0 110.111 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.9 tp -66.36 -49.24 67.57 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.427 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.47 -45.35 69.52 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.041 0.837 . . . . 0.0 110.602 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.4 tmmm? -65.45 -38.33 89.53 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 120.111 1.323 . . . . 0.0 111.362 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.48 -38.38 74.39 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 172.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.6 mt -80.55 -18.36 48.64 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 119.838 1.199 . . . . 0.0 113.482 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.54 -29.19 63.35 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.474 1.488 . . . . 0.0 113.785 -170.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -83.7 -31.78 25.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.086 0.554 . . . . 0.0 110.421 172.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.57 -33.55 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-O 119.046 -0.502 . . . . 0.0 111.566 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 99.6 p -160.5 148.25 16.18 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 116.885 2.179 . . . . 0.0 116.885 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -66.75 -48.42 69.17 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.088 1.355 . . . . 0.0 112.376 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.4 p -112.26 124.47 52.52 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 122.794 1.283 . . . . 0.0 111.889 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.9 90.47 0.16 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 106.596 -2.602 . . . . 0.0 106.596 -175.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -78.88 145.66 34.03 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.75 0.82 . . . . 0.0 109.435 -169.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.52 132.61 70.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 124.944 1.298 . . . . 0.0 109.342 -172.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.85 156.98 26.99 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.998 1.761 . . . . 0.0 111.687 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.43 ' CD1' HD21 ' A' ' 70' ' ' LEU . 63.7 t80 -143.31 136.73 28.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -169.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.35 155.34 23.43 Favored Glycine 0 C--N 1.345 1.033 0 C-N-CA 124.558 1.075 . . . . 0.0 111.194 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.438 ' HB2' HD22 ' A' ' 12' ' ' LEU . 89.3 p -124.66 146.35 49.17 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.842 0.857 . . . . 0.0 111.975 -174.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.584 HG21 ' HB2' ' A' ' 88' ' ' ALA . 1.2 pp -145.42 151.95 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 173.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.0 t -142.86 -126.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 102.6 -3.111 . . . . 0.0 102.6 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -123.69 -0.6 8.57 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 120.406 1.457 . . . . 0.0 109.761 167.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.2 mmt -60.37 -39.08 85.94 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.75 1.62 . . . . 0.0 109.927 169.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.45 ' HB ' ' HD2' ' A' ' 145' ' ' ARG . 5.4 t 147.74 176.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.345 1 C-N-CA 132.399 4.28 . . . . 0.0 112.145 169.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -79.85 130.67 35.5 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.519 1.928 . . . . 0.0 109.327 169.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -123.66 128.97 50.42 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.282 1.039 . . . . 0.0 108.714 169.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -92.35 91.67 7.78 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.734 2.014 . . . . 0.0 111.229 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 mp -77.26 -59.87 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.45 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.4 tp -121.15 124.61 45.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.141 0.882 . . . . 0.0 112.114 -172.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.55 161.17 17.9 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 175.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.5 mt -56.29 109.01 0.53 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.129 1.772 . . . . 0.0 111.745 -171.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.6 t -143.02 171.3 14.25 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.549 1.54 . . . . 0.0 111.506 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.07 -5.09 56.94 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.023 1.729 . . . . 0.0 113.99 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -95.61 75.04 3.23 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 125.733 2.682 . . . . 0.0 108.992 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 p -69.31 -19.59 63.88 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 128.412 2.685 . . . . 0.0 110.973 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.3 p -76.5 -15.71 59.82 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.787 1.235 . . . . 0.0 110.58 168.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . 0.328 1.4 pt20 -91.52 -26.88 18.56 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 119.229 0.922 . . . . 0.0 112.183 173.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -60.99 -23.68 65.56 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.343 1.057 . . . . 0.0 111.241 168.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -71.5 -44.25 65.03 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.239 -0.913 . . . . 0.0 109.173 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -68.04 -39.96 82.94 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 125.074 1.35 . . . . 0.0 108.988 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . 0.265 59.9 mt-10 -86.91 -19.42 28.87 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.18 -175.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 45' ' ' PHE . 14.2 mt -75.39 -33.14 60.97 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 167.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.0 ttp-105 -70.83 -36.8 73.09 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 118.705 0.684 . . . . 0.0 112.352 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -73.2 -16.0 61.43 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 175.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -64.74 150.48 47.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.747 0.819 . . . . 0.0 110.479 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.75 168.4 19.9 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.789 0.835 . . . . 0.0 111.927 172.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.6 t -94.71 146.69 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.667 1.987 . . . . 0.0 111.87 -169.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.7 t -120.54 -175.17 2.96 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.101 1.76 . . . . 0.0 111.756 171.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -148.46 157.28 27.24 Favored Glycine 0 N--CA 1.474 1.225 0 O-C-N 120.477 -1.389 . . . . 0.0 113.998 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -158.2 167.79 28.82 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.927 1.291 . . . . 0.0 114.232 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -77.57 -62.06 1.79 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.631 1.573 . . . . 0.0 112.952 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.77 151.96 43.89 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.814 0.846 . . . . 0.0 111.673 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.296 5.3 t -82.76 -41.41 0.88 Allowed Pre-proline 0 N--CA 1.479 1.005 0 CA-C-O 116.249 -1.834 . . . . 0.0 115.233 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.23 146.93 77.59 Favored 'Trans proline' 0 C--N 1.359 1.101 0 CA-C-N 123.04 2.121 . . . . 0.0 113.058 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -101.39 152.34 20.84 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.953 1.701 . . . . 0.0 113.637 -170.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.85 56.74 4.55 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 125.72 1.629 . . . . 0.0 111.662 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -84.11 -36.98 22.57 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.539 1.536 . . . . 0.0 113.327 -169.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.41 -36.84 83.83 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 122.153 -0.342 . . . . 0.0 110.852 -169.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -49.7 -41.79 44.18 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.196 1.398 . . . . 0.0 111.732 169.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.584 ' HB2' HG21 ' A' ' 48' ' ' ILE . . . -69.18 -52.38 28.59 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.055 -1.028 . . . . 0.0 111.498 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.4 m -59.68 -33.17 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.756 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.588 ' CG1' HD22 ' A' ' 156' ' ' LEU . 25.3 m -75.6 -51.68 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 117.215 -1.374 . . . . 0.0 112.624 173.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -55.74 -46.87 77.72 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 121.295 1.861 . . . . 0.0 110.175 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.6 t -59.66 -36.13 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.76 -43.37 79.99 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.986 -1.071 . . . . 0.0 112.629 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 90' ' ' VAL . 3.8 mp -78.85 -42.3 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -172.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . 0.26 21.8 p -83.79 66.48 9.1 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 121.222 1.828 . . . . 0.0 113.516 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.6 mt -43.42 -40.42 3.74 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.63 2.372 . . . . 0.0 111.583 169.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.11 -30.7 56.85 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.647 1.118 . . . . 0.0 114.794 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -104.59 -34.02 8.33 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 117.725 -1.131 . . . . 0.0 113.685 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.1 mm -64.07 -34.83 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 120.874 1.67 . . . . 0.0 110.408 169.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.59 18.31 38.77 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 117.907 -1.496 . . . . 0.0 114.126 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -54.06 147.28 12.93 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.343 1.572 . . . . 0.0 112.979 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . 0.272 0.0 OUTLIER -143.07 172.12 13.14 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.654 1.182 . . . . 0.0 114.015 172.085 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -58.54 24.35 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 121.39 3.848 . . . . 0.0 121.39 -168.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.16 -118.82 1.22 Allowed Glycine 0 CA--C 1.535 1.332 0 CA-C-N 120.912 1.687 . . . . 0.0 109.594 170.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.0 t -130.09 148.77 51.98 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 168.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -123.78 123.42 40.44 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 119.158 -0.449 . . . . 0.0 111.988 -166.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -115.32 103.49 10.86 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -170.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.0 tp -88.62 85.92 6.9 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.779 1.232 . . . . 0.0 109.527 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 66.7 t -77.28 136.85 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.3 tt -127.96 126.27 41.1 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.963 1.256 . . . . 0.0 111.541 169.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.1 t -95.46 128.01 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 126.216 1.806 . . . . 0.0 110.875 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.6 t -156.55 158.26 36.82 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.964 0.506 . . . . 0.0 110.989 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.87 0.59 11.41 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -141.44 -178.9 5.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.678 1.191 . . . . 0.0 111.867 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.95 -168.02 0.18 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.312 1.445 . . . . 0.0 112.137 -175.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.502 ' CE1' HD11 ' A' ' 182' ' ' LEU . 17.6 p90 -145.5 146.11 31.33 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 120.622 -1.298 . . . . 0.0 111.792 -169.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -80.23 130.02 34.91 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.826 169.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 pp -111.62 174.05 6.06 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.349 1.46 . . . . 0.0 111.344 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.33 130.16 30.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.5 mttm 93.91 -10.85 0.14 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.407 3.083 . . . . 0.0 112.003 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -67.75 -23.89 65.29 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 120.157 1.344 . . . . 0.0 112.706 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -74.65 -11.32 60.16 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.007 -1.058 . . . . 0.0 113.841 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.28 1.1 t -72.15 -21.51 61.44 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 120.458 1.481 . . . . 0.0 113.727 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.96 -37.72 84.79 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.735 1.152 . . . . 0.0 109.689 169.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.31 6.5 15.21 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.071 1.32 . . . . 0.0 113.158 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.277 52.8 m 70.06 37.8 1.64 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.309 2.244 . . . . 0.0 111.463 171.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -121.55 118.5 29.42 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.412 1.085 . . . . 0.0 111.076 169.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -105.12 -26.16 12.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.882 1.273 . . . . 0.0 112.896 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -61.35 116.18 4.44 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.067 0.849 . . . . 0.0 110.29 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 t -65.7 158.4 27.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.664 0.665 . . . . 0.0 110.003 173.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.1 t -67.44 144.61 55.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 122.043 0.925 . . . . 0.0 111.614 174.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.8 p30 -82.56 -10.75 58.85 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.054 1.342 . . . . 0.0 113.193 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.41 26.51 74.05 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.023 -0.876 . . . . 0.0 112.877 -175.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -103.29 172.92 6.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.026 1.73 . . . . 0.0 110.343 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 7.2 t -92.21 148.78 21.89 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.51 -0.744 . . . . 0.0 112.083 170.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -134.62 33.13 3.26 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.705 2.002 . . . . 0.0 112.063 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.75 161.06 13.84 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.197 0.999 . . . . 0.0 111.819 174.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -170.94 -45.26 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.571 1.948 . . . . 0.0 111.016 172.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -80.45 4.79 17.04 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.235 1.414 . . . . 0.0 112.771 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 82.73 -11.21 53.92 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.893 1.711 . . . . 0.0 112.547 -169.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.3 mtt -90.67 143.83 26.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.176 1.39 . . . . 0.0 111.118 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -74.05 95.63 2.56 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 169.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -64.09 -33.43 75.76 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.668 1.187 . . . . 0.0 113.25 -172.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.41 ' HB2' ' HD2' ' A' ' 148' ' ' PRO . 19.2 p -81.91 4.66 21.67 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -174.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.45 ' HD2' ' HB ' ' A' ' 52' ' ' THR . 40.0 ptt85 -37.87 -35.79 0.16 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.799 2.04 . . . . 0.0 115.219 169.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.69 30.07 6.85 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 127.962 2.696 . . . . 0.0 112.521 -172.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.266 43.2 tt0 -139.75 -79.3 0.01 OUTLIER Pre-proline 0 CA--C 1.559 1.293 0 CA-C-O 115.724 -2.084 . . . . 0.0 109.593 169.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 144' ' ' SER . 33.4 Cg_exo -54.18 150.4 32.43 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.574 2.85 . . . . 0.0 117.02 169.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.18 162.52 25.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 128.315 2.646 . . . . 0.0 109.316 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -55.2 140.67 37.94 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.177 -0.952 . . . . 0.0 109.729 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.09 156.91 24.31 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.667 -1.271 . . . . 0.0 112.189 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 27.2 t -81.47 154.9 26.1 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -173.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 20.2 t -59.27 -30.59 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.216 1.006 . . . . 0.0 111.652 -171.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.5 p -66.62 -37.04 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.607 1.163 . . . . 0.0 113.433 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -72.82 -32.58 65.61 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.487 -0.758 . . . . 0.0 110.495 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.588 HD22 ' CG1' ' A' ' 90' ' ' VAL . 1.1 mt -65.33 -46.54 79.86 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -54.54 -44.78 73.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.104 0.962 . . . . 0.0 112.607 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.8 m -59.43 -53.05 62.57 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.688 0.795 . . . . 0.0 112.119 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -64.57 -43.38 94.06 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.166 -0.959 . . . . 0.0 111.81 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.65 -38.63 81.96 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.178 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.54 -36.18 65.64 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -71.72 -42.33 67.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.869 0.868 . . . . 0.0 111.643 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -80.51 -9.17 59.78 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.615 0.766 . . . . 0.0 112.412 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . 0.402 15.7 p-10 42.02 52.66 4.32 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.831 2.452 . . . . 0.0 113.245 -174.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 79.4 mt -100.49 133.67 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.334 1.854 . . . . 0.0 109.07 174.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -104.33 108.29 59.96 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-N 119.257 0.935 . . . . 0.0 112.362 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.85 140.94 52.28 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.476 2.784 . . . . 0.0 115.754 169.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.1 mm -121.56 100.59 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.519 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -74.06 75.26 1.73 Allowed 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.904 -1.122 . . . . 0.0 112.168 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.489 HG11 HG12 ' A' ' 201' ' ' VAL 0.255 13.4 m -76.18 110.6 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 120.762 -1.211 . . . . 0.0 112.486 173.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.23 141.88 17.66 Favored Pre-proline 0 N--CA 1.478 0.97 0 O-C-N 120.997 -1.065 . . . . 0.0 112.389 -171.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -51.32 150.83 14.17 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.43 3.42 . . . . 0.0 115.837 169.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.3 t -47.63 -44.87 27.23 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.374 1.87 . . . . 0.0 113.546 -169.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.8 mtp-105 -42.88 -38.56 2.22 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.614 1.565 . . . . 0.0 113.428 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.51 0.6 16.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.895 1.678 . . . . 0.0 113.322 -170.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 37.5 t -62.6 -38.97 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.615 -1.303 . . . . 0.0 111.141 -175.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -65.23 -27.19 68.49 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.077 0.853 . . . . 0.0 113.025 -174.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.7 t -84.47 -39.94 18.3 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.784 0.434 . . . . 0.0 111.009 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.413 ' CD1' HD12 ' A' ' 182' ' ' LEU . 45.1 m-85 -69.46 -30.32 68.19 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.805 -1.184 . . . . 0.0 110.764 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -60.84 -33.05 72.45 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.158 0.436 . . . . 0.0 110.508 169.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . 0.362 0.0 OUTLIER -87.81 -18.17 29.92 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 119.07 0.85 . . . . 0.0 112.244 -178.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.502 HD11 ' CE1' ' A' ' 116' ' ' PHE . 20.1 mt -72.92 -25.44 61.05 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.528 -1.357 . . . . 0.0 109.812 169.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.45 -10.28 59.28 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.299 1.84 . . . . 0.0 111.518 173.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 90.9 m -89.15 -32.62 17.39 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.363 1.065 . . . . 0.0 109.364 169.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -76.79 -30.11 56.33 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 118.906 -0.568 . . . . 0.0 112.484 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 20.2 mt -118.86 109.66 39.31 Favored Pre-proline 0 N--CA 1.484 1.24 0 CA-C-N 119.114 0.87 . . . . 0.0 110.685 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -55.62 143.21 80.2 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.394 3.396 . . . . 0.0 114.225 174.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt 79.66 -8.35 1.58 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 128.755 2.822 . . . . 0.0 113.452 170.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 10.6 mt -72.9 153.78 40.86 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.286 -0.883 . . . . 0.0 109.954 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.7 p -116.89 -149.04 0.44 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 123.333 1.54 . . . . 0.0 109.432 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.1 tp -177.64 131.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 C-N-CA 127.043 2.137 . . . . 0.0 108.223 -165.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -123.73 150.67 16.96 Favored Glycine 0 N--CA 1.465 0.624 0 C-N-CA 124.37 0.986 . . . . 0.0 110.66 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -94.6 85.1 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.5 tp -59.95 134.88 57.45 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 169.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 99.1 p -153.92 -149.72 0.29 Allowed 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.478 -0.764 . . . . 0.0 110.722 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.36 15.34 0.99 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.522 1.529 . . . . 0.0 113.738 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -132.62 148.75 52.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.075 1.75 . . . . 0.0 111.668 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 12.2 t -92.52 -12.68 31.29 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.54 1.936 . . . . 0.0 112.492 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 74.4 p -57.59 -35.43 70.39 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 119.821 -1.799 . . . . 0.0 112.179 -177.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -65.79 -28.87 69.33 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.753 1.019 . . . . 0.0 113.753 -175.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.489 HG12 HG11 ' A' ' 170' ' ' VAL . 3.0 m -77.8 -46.16 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-N 119.438 1.017 . . . . 0.0 111.416 174.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -75.42 -34.64 61.03 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 31.1 mm100 -80.32 7.38 9.7 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 120.562 1.528 . . . . 0.0 113.108 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.58 -40.06 5.21 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.383 1.873 . . . . 0.0 107.297 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 75.3 mt -74.15 -34.83 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 121.596 -0.69 . . . . 0.0 109.266 172.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 34.4 ttt85 -65.93 -35.45 80.64 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.623 -0.673 . . . . 0.0 110.518 169.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -69.89 -20.33 63.38 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 170.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -76.1 -32.53 59.24 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.932 -1.105 . . . . 0.0 112.307 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -65.51 -33.74 76.64 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.0 p -83.07 -22.46 33.47 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -138.42 -77.16 0.37 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.256 1.411 0 C-N-CA 128.14 2.576 . . . . 0.0 115.038 -168.34 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.992 0.425 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -96.27 145.94 25.14 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.22 1.008 . . . . 0.0 110.583 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.4 t -70.09 123.39 21.47 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.329 -0.857 . . . . 0.0 110.888 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.2 t -128.99 118.7 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-O 121.797 0.808 . . . . 0.0 111.785 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -87.12 127.87 35.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.978 0.911 . . . . 0.0 109.188 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mp -123.44 135.63 54.19 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -117.4 113.29 21.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 123.108 1.432 . . . . 0.0 109.078 172.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -87.46 103.29 15.37 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 126.107 1.763 . . . . 0.0 111.166 174.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.0 tp -102.22 121.59 42.55 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.674 1.19 . . . . 0.0 110.284 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.09 157.89 24.04 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 170.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.02 132.95 11.44 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.409 1.957 . . . . 0.0 110.56 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.15 23.36 13.4 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.612 1.565 . . . . 0.0 114.192 -171.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.7 p -79.28 172.25 14.06 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 119.42 -2.05 . . . . 0.0 114.454 -174.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.06 -23.18 67.59 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.288 -0.882 . . . . 0.0 113.696 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t -68.89 -38.06 79.41 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.591 1.195 . . . . 0.0 111.112 170.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.65 4.82 3.58 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.928 1.291 . . . . 0.0 114.025 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -66.27 -43.34 86.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.643 1.177 . . . . 0.0 112.41 -176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.66 -30.47 64.0 Favored Glycine 0 N--CA 1.471 0.99 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -76.59 -14.05 60.03 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.657 1.183 . . . . 0.0 113.381 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 38.4 tp -58.49 -44.28 89.34 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.812 1.642 . . . . 0.0 111.74 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 t -57.53 -44.72 85.31 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.018 0.826 . . . . 0.0 111.733 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -61.61 -48.42 80.97 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.452 1.501 . . . . 0.0 110.535 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.631 HG22 HG11 ' A' ' 111' ' ' VAL . 59.4 t -60.99 -43.61 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 O-C-N 121.355 -0.841 . . . . 0.0 111.275 175.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -63.85 -52.28 60.8 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.091 1.356 . . . . 0.0 110.198 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 t -66.93 -35.09 79.2 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.945 -175.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.3 tp -60.44 -31.58 70.55 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.056 1.298 . . . . 0.0 112.886 175.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.26 -40.31 5.81 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -168.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.6 m -65.89 -36.13 82.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.086 -1.057 . . . . 0.0 109.531 169.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -73.69 -35.16 65.13 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.0 175.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.2 tp -62.0 -55.77 25.9 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.4 HD12 ' CD1' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -58.34 -53.24 60.53 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.156 0.582 . . . . 0.0 112.188 -174.301 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -71.44 -26.91 62.94 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -176.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.01 -43.36 71.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.244 0.929 . . . . 0.0 111.576 171.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.8 mt -73.27 -27.66 61.69 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 118.182 -0.913 . . . . 0.0 113.047 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -61.32 -28.87 69.52 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.17 1.35 . . . . 0.0 113.485 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -93.08 -31.96 14.64 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.527 0.331 . . . . 0.0 111.238 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mp -72.5 -31.68 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.884 -0.51 . . . . 0.0 111.067 169.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.7 t -142.17 119.6 11.62 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.84 1.256 . . . . 0.0 111.978 173.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -67.03 -46.9 73.03 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.279 0.631 . . . . 0.0 111.087 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.9 t -90.42 80.81 6.05 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 122.957 1.361 . . . . 0.0 110.219 174.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.53 88.02 0.21 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 106.731 -2.548 . . . . 0.0 106.731 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -98.62 137.69 36.9 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.271 1.028 . . . . 0.0 109.757 -169.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.8 tt -116.93 146.13 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.01 -170.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.77 165.12 19.08 Favored Glycine 0 N--CA 1.464 0.519 0 C-N-CA 125.524 1.535 . . . . 0.0 110.575 171.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -139.76 128.22 22.86 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.863 0.865 . . . . 0.0 113.168 -169.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.35 147.12 19.05 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 123.639 0.638 . . . . 0.0 112.229 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.8 t -114.49 148.25 38.15 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.618 1.567 . . . . 0.0 110.517 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.75 152.27 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.905 1.282 . . . . 0.0 109.462 171.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.7 t -138.0 -70.83 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.779 0.831 . . . . 0.0 108.784 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 t30 174.95 -15.75 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 131.0 3.72 . . . . 0.0 108.622 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.5 ttt -58.58 -60.19 4.21 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.87 1.668 . . . . 0.0 107.111 167.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.412 ' HA ' ' HD2' ' A' ' 145' ' ' ARG 0.302 0.5 OUTLIER -173.87 169.26 4.15 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.264 2.226 . . . . 0.0 114.534 168.928 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -84.09 120.83 26.62 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 169.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -115.77 117.11 29.33 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 122.234 1.016 . . . . 0.0 110.279 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -74.67 110.56 9.06 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.751 1.62 . . . . 0.0 109.95 170.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.3 mt -94.63 -61.33 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.385 0.674 . . . . 0.0 110.392 -173.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.9 tp -124.99 124.74 42.64 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.034 0.934 . . . . 0.0 110.177 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 166.68 13.46 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.655 -0.653 . . . . 0.0 112.691 169.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 83.9 mt -58.15 116.05 3.31 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.74 -0.6 . . . . 0.0 111.136 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 36.8 p -134.49 154.22 51.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.362 1.465 . . . . 0.0 112.244 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.78 2.08 35.75 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.456 1.502 . . . . 0.0 112.731 171.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -93.07 80.17 4.55 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.861 2.464 . . . . 0.0 107.799 -170.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.9 t -66.64 -46.34 76.1 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 111.425 -2.625 . . . . 0.0 112.067 -169.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.8 p -64.28 -18.81 64.94 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.637 -0.665 . . . . 0.0 112.5 169.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -81.75 -52.93 6.63 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.278 0.944 . . . . 0.0 110.19 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.4 ' CD1' HD12 ' A' ' 31' ' ' LEU . 16.0 t80 -51.74 -32.98 32.73 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.282 1.033 . . . . 0.0 112.038 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -76.28 -30.53 57.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.781 0.832 . . . . 0.0 110.829 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -74.79 -41.53 59.82 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 123.636 0.774 . . . . 0.0 109.86 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . 0.425 6.9 pt-20 -88.35 -16.7 32.31 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 120.4 -0.52 . . . . 0.0 112.159 -173.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.71 -47.33 48.02 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 166.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -39.76 79.67 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.965 -0.459 . . . . 0.0 111.968 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -67.72 -12.42 60.48 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -66.31 151.51 46.91 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.473 1.488 . . . . 0.0 112.517 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.2 tt -147.66 133.38 18.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.271 1.428 . . . . 0.0 108.683 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.4 m -63.23 158.42 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -173.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.6 p -107.78 -143.78 0.38 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.079 1.352 . . . . 0.0 110.694 169.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.34 143.64 8.83 Favored Glycine 0 N--CA 1.472 1.046 0 O-C-N 120.376 -1.453 . . . . 0.0 114.622 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -160.44 150.47 17.95 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.037 1.735 . . . . 0.0 111.462 170.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.0 tp -73.68 -48.56 31.3 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -169.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.71 119.11 8.65 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 122.945 0.498 . . . . 0.0 109.926 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.9 p -71.16 -35.17 3.85 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 115.686 -2.102 . . . . 0.0 113.976 -174.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -66.0 144.9 77.96 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.375 2.05 . . . . 0.0 110.665 169.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -119.4 161.12 21.04 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -171.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.67 45.03 3.19 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 125.184 1.374 . . . . 0.0 115.598 -169.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -36.96 85.85 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.431 1.892 . . . . 0.0 114.038 -173.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.47 -33.91 76.6 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.547 0.612 . . . . 0.0 111.228 -169.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -58.02 -47.46 83.0 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.347 1.459 . . . . 0.0 111.684 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.86 -56.75 16.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.619 -1.181 . . . . 0.0 109.708 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.294 1.5 p -59.33 -36.83 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-O 117.765 -1.112 . . . . 0.0 113.366 -174.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.505 HG21 ' HG3' ' A' ' 151' ' ' GLN . 38.0 t -74.17 -38.96 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 121.396 1.907 . . . . 0.0 113.572 175.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -63.91 -40.52 96.69 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.719 1.6 . . . . 0.0 110.344 171.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.603 HG11 HD13 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -49.38 -35.51 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.291 1.037 . . . . 0.0 112.638 169.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.16 -48.21 13.52 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.9 tt -100.42 -4.63 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -171.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 72.2 m -82.5 58.34 4.11 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 119.8 -1.812 . . . . 0.0 110.483 170.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.46 -44.43 55.67 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.235 1.814 . . . . 0.0 111.262 -174.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.62 -24.98 55.05 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.141 -0.811 . . . . 0.0 114.74 -169.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -90.95 -40.59 11.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.267 1.034 . . . . 0.0 111.529 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.9 -38.48 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 118.941 0.791 . . . . 0.0 110.677 171.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.36 27.7 19.54 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.738 -1.034 . . . . 0.0 114.099 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -54.01 125.75 19.99 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.769 1.285 . . . . 0.0 111.63 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -105.06 -170.34 1.74 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.754 2.022 . . . . 0.0 112.059 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -75.13 0.23 16.93 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 118.948 2.944 . . . . 0.0 118.948 -168.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.68 -130.77 3.31 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 121.833 2.106 . . . . 0.0 112.06 -174.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.8 m -100.55 145.8 27.89 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.415 1.886 . . . . 0.0 106.93 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -135.69 128.13 30.43 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 121.395 1.907 . . . . 0.0 108.581 -168.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -133.21 115.73 15.35 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.603 HD13 HG11 ' A' ' 92' ' ' VAL . 47.7 tp -91.2 109.94 21.21 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.975 169.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.63 116.42 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 168.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.7 tp -95.13 134.49 37.79 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 117.276 -1.345 . . . . 0.0 108.094 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.631 HG11 HG22 ' A' ' 23' ' ' VAL . 21.6 t -121.42 124.99 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 O-C-N 123.895 0.747 . . . . 0.0 111.607 168.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.0 t -160.48 141.69 12.13 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.678 0.791 . . . . 0.0 113.067 172.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -103.74 24.41 11.25 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.94 2.096 . . . . 0.0 114.888 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -152.35 -175.69 5.38 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.144 -0.972 . . . . 0.0 112.176 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.51 -175.84 0.41 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.3 1.44 . . . . 0.0 110.806 169.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -137.15 153.84 50.38 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.664 1.185 . . . . 0.0 111.664 -170.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -83.45 132.31 34.97 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.032 0.533 . . . . 0.0 110.817 169.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 pp -117.45 173.94 6.42 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.436 1.494 . . . . 0.0 112.532 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.72 124.99 18.17 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.42 98.7 mttt 80.23 1.84 1.97 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.349 2.259 . . . . 0.0 115.039 -175.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -70.78 -15.24 62.65 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 120.848 -1.157 . . . . 0.0 108.657 166.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.556 ' HE2' ' CG ' ' A' ' 127' ' ' ARG . 4.9 ptmt -57.46 -29.47 64.25 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 173.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.5 m -60.74 -26.4 67.17 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 118.162 2.653 . . . . 0.0 118.162 -167.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.492 HD13 ' H ' ' A' ' 124' ' ' LEU 0.329 0.0 OUTLIER -69.75 -13.08 62.11 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.894 1.679 . . . . 0.0 113.273 170.607 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -105.9 150.12 16.84 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 167.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.5 p -75.98 81.89 2.86 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.26 1.53 . . . . 0.0 112.601 -171.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.556 ' CG ' ' HE2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -163.3 125.19 2.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.172 1.789 . . . . 0.0 110.475 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -119.56 -25.82 5.9 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.579 1.151 . . . . 0.0 113.088 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -51.56 107.23 0.18 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.673 1.589 . . . . 0.0 113.008 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.8 t -68.95 150.83 47.28 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.594 1.088 . . . . 0.0 110.952 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.1 m -55.19 131.7 45.91 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.695 1.198 . . . . 0.0 113.101 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.5 p30 -81.58 -15.28 55.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.338 0.655 . . . . 0.0 112.541 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.94 14.6 81.55 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.903 -1.498 . . . . 0.0 114.26 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -93.16 163.47 13.62 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.872 1.669 . . . . 0.0 112.384 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 20.0 t -62.89 130.85 46.62 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.793 0.837 . . . . 0.0 111.655 172.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -135.75 41.44 2.71 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.745 1.618 . . . . 0.0 112.164 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.1 tp -124.16 140.71 52.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.426 1.491 . . . . 0.0 110.943 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -150.51 -62.1 0.2 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.254 1.021 . . . . 0.0 111.286 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -70.24 -21.81 62.95 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 121.35 -19.4 8.64 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.722 1.629 . . . . 0.0 112.409 -169.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 94.7 mtp -98.31 140.52 32.46 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.628 1.571 . . . . 0.0 112.507 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -77.35 83.04 3.8 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.877 0.871 . . . . 0.0 110.456 169.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -64.36 -30.74 71.78 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.112 -0.993 . . . . 0.0 112.236 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 35.5 m -65.89 -2.12 3.57 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 175.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.412 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 40.2 ttt85 -52.37 -37.75 57.04 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.213 -1.554 . . . . 0.0 114.251 172.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.71 -22.24 77.4 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.694 -1.059 . . . . 0.0 114.412 -175.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.317 1.2 pt-20 -112.68 -68.43 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.198 0 CA-C-O 117.133 -1.413 . . . . 0.0 112.059 -173.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -55.36 173.0 0.36 Allowed 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 123.399 2.732 . . . . 0.0 117.265 168.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.415 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 45.4 t0 -100.46 171.51 7.7 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 127.914 2.486 . . . . 0.0 114.048 -173.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -73.7 120.93 19.98 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 166.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.505 ' HG3' HG21 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -70.78 144.26 50.92 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 120.932 -1.105 . . . . 0.0 110.644 -169.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 39.8 m -68.02 153.92 42.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.468 0.707 . . . . 0.0 111.737 -174.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 82.2 t -60.68 -27.64 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 120.542 -1.349 . . . . 0.0 112.794 -171.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.6 t -81.48 -27.35 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 121.323 -0.861 . . . . 0.0 112.801 171.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -67.0 -38.22 85.59 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.298 0.954 . . . . 0.0 110.253 170.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.467 HD13 HG23 ' A' ' 90' ' ' VAL . 3.6 mm? -55.56 -61.41 2.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.751 0.705 . . . . 0.0 109.19 169.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.75 -48.08 70.04 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.306 1.042 . . . . 0.0 113.569 -170.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 64.7 m -63.82 -45.35 90.01 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -64.14 -47.64 79.14 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.399 -0.813 . . . . 0.0 111.155 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.4 mt -55.58 -40.51 72.08 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.827 0.851 . . . . 0.0 112.68 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.24 -33.26 56.07 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -80.52 -25.55 38.64 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.477 1.035 . . . . 0.0 112.002 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -80.49 -13.91 58.71 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.482 0.713 . . . . 0.0 110.758 168.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 33.4 m120 60.3 36.32 20.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.215 1.806 . . . . 0.0 112.848 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 67.1 mt -95.61 145.13 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.264 1.026 . . . . 0.0 108.929 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -105.13 102.72 37.97 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -77.46 156.29 32.42 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.139 1.226 . . . . 0.0 113.267 169.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.458 HG22 HG23 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -141.42 105.93 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.568 1.547 . . . . 0.0 109.522 -169.58 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -75.1 73.83 2.26 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.729 -1.232 . . . . 0.0 112.756 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.458 HG23 HG22 ' A' ' 168' ' ' ILE . 76.5 t -66.6 108.87 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 O-C-N 121.235 -0.915 . . . . 0.0 111.233 169.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 34.5 m -146.62 146.64 27.57 Favored Pre-proline 0 N--CA 1.482 1.126 0 O-C-N 120.592 -1.317 . . . . 0.0 112.314 -174.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -67.57 159.75 51.13 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.844 3.03 . . . . 0.0 112.801 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.5 t -41.2 -54.14 2.99 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.453 1.901 . . . . 0.0 114.437 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -57.17 -33.2 67.21 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.69 -17.17 32.37 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.911 1.285 . . . . 0.0 113.966 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.4 t -55.73 -41.12 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 120.15 1.341 . . . . 0.0 112.113 -168.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -62.47 -37.59 86.56 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -172.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 9.6 t -84.27 -30.25 25.78 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.901 0.48 . . . . 0.0 111.3 -173.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -69.14 -32.9 72.58 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.639 -1.288 . . . . 0.0 109.211 169.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -68.37 -7.11 28.46 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.347 -0.845 . . . . 0.0 112.699 169.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -98.91 -6.59 28.59 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.04 -1.038 . . . . 0.0 112.403 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 6.2 mp -104.84 -15.37 15.21 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.546 1.538 . . . . 0.0 111.926 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 6.0 t -79.5 -23.2 43.14 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 118.995 0.816 . . . . 0.0 111.832 169.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 1.7 t -77.85 -23.41 48.93 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.676 -0.64 . . . . 0.0 110.559 172.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -82.45 -34.48 28.14 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 119.375 -0.345 . . . . 0.0 111.102 169.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 13.2 mt -117.66 80.88 14.1 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.985 0.914 . . . . 0.0 109.838 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -62.17 152.34 76.6 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.123 1.882 . . . . 0.0 110.561 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 91.26 -17.31 0.17 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 130.415 3.486 . . . . 0.0 112.505 -176.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.0 tt -74.98 155.62 37.17 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.028 1.331 . . . . 0.0 108.295 168.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.266 48.0 p -127.94 -164.08 1.33 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 169.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 10.8 mt -157.82 145.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 126.823 2.049 . . . . 0.0 109.697 -165.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -131.87 155.34 21.38 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 123.818 0.723 . . . . 0.0 112.284 170.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -85.24 98.74 10.67 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.427 ' HB2' HG12 ' A' ' 170' ' ' VAL . 18.2 tp -59.72 125.69 24.64 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 113.422 -1.717 . . . . 0.0 107.896 168.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 93.4 p -162.51 174.62 12.43 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.974 1.31 . . . . 0.0 109.299 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -60.87 -2.83 0.62 Allowed 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -111.68 130.37 55.79 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.145 1.778 . . . . 0.0 110.402 168.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.6 t -85.92 -17.75 34.59 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.242 1.017 . . . . 0.0 113.591 -172.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 77.9 p -53.77 -44.09 69.75 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.191 1.396 . . . . 0.0 112.562 -168.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -59.83 -31.65 69.93 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 85.5 t -84.0 -48.25 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.131 0.878 . . . . 0.0 110.88 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -60.2 -31.03 69.77 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 118.435 -0.793 . . . . 0.0 111.421 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -65.91 -7.35 16.12 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.062 2.145 . . . . 0.0 114.547 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.9 mp -110.73 -34.8 6.16 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.417 1.487 . . . . 0.0 109.631 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 38.0 mm -75.17 -37.85 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -72.55 -32.22 65.89 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.495 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -75.32 -26.07 58.34 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 118.727 -1.189 . . . . 0.0 114.147 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -72.73 -34.36 67.01 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.236 -0.915 . . . . 0.0 111.166 170.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -67.07 -43.75 81.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.86 0.864 . . . . 0.0 111.904 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 88.4 p -71.06 -12.79 61.71 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -73.48 -23.62 60.08 Favored 'General case' 0 CA--C 1.554 1.107 0 O-C-N 121.231 -0.918 . . . . 0.0 113.335 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 78.3 mt . . . . . 0 C--O 1.259 1.599 0 C-N-CA 125.591 1.556 . . . . 0.0 113.82 -179.466 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 120.831 0.348 . . . . 0.0 111.779 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.88 161.85 22.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.863 1.265 . . . . 0.0 113.622 -174.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 p -66.37 131.99 47.32 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.747 0.819 . . . . 0.0 113.09 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.4 t -133.26 149.21 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.513 1.125 . . . . 0.0 110.007 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -121.62 115.82 23.46 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.353 2.261 . . . . 0.0 109.088 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.51 126.14 53.23 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 120.933 -1.104 . . . . 0.0 111.252 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -112.02 111.98 23.28 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 123.162 1.458 . . . . 0.0 110.227 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -87.57 100.34 12.72 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 126.236 1.814 . . . . 0.0 112.3 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.6 tp -94.84 116.76 29.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.511 0.725 . . . . 0.0 111.104 171.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.407 ' HG3' ' CD2' ' A' ' 12' ' ' LEU . 28.4 ptm -114.99 144.26 43.88 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 175.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.89 123.8 6.33 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.96 1.267 . . . . 0.0 111.655 172.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.407 ' CD2' ' HG3' ' A' ' 10' ' ' MET . 4.0 mm? -107.06 43.7 1.14 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.97 1.708 . . . . 0.0 111.079 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 t -64.81 155.43 33.95 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.106 0.963 . . . . 0.0 112.178 169.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.93 -23.79 64.0 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 121.171 -0.956 . . . . 0.0 112.238 169.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.2 t -63.81 -26.34 68.58 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.625 1.17 . . . . 0.0 112.31 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.5 -3.91 58.72 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 -169.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . 0.288 13.9 pt20 -76.73 142.12 40.59 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 122.022 2.192 . . . . 0.0 109.914 169.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.87 -55.56 1.89 Allowed Glycine 0 N--CA 1.471 1.008 0 N-CA-C 107.036 -2.426 . . . . 0.0 107.036 -167.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -65.15 -22.59 66.94 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.513 1.125 . . . . 0.0 111.279 168.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.483 ' HA ' HG12 ' A' ' 23' ' ' VAL . 20.8 tp -47.86 -48.87 30.87 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.762 2.025 . . . . 0.0 111.104 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -56.92 -47.41 80.67 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.417 0.553 . . . . 0.0 111.382 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -60.07 -42.97 95.7 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.941 -1.1 . . . . 0.0 111.031 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 20' ' ' LEU . 8.6 p -82.6 3.53 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 124.374 1.07 . . . . 0.0 113.791 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -101.43 -42.33 6.31 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.999 1.32 . . . . 0.0 109.371 169.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 m -52.99 -56.59 14.91 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.888 2.075 . . . . 0.0 108.659 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.537 ' CD2' HG21 ' A' ' 170' ' ' VAL . 13.6 tp -82.99 86.99 6.89 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 124.13 1.919 . . . . 0.0 106.949 169.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.62 -51.53 0.17 Allowed Glycine 0 C--N 1.307 -1.08 0 CA-C-N 109.757 -3.383 . . . . 0.0 107.434 168.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 t -73.81 -41.7 61.97 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.659 1.184 . . . . 0.0 112.007 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.45 -25.08 62.16 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.309 -0.87 . . . . 0.0 111.914 172.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.1 tp -69.14 -49.57 55.67 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-O 118.6 -0.714 . . . . 0.0 109.635 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.6 mt -47.25 -59.73 2.97 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.362 1.065 . . . . 0.0 113.721 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -68.36 -35.28 77.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.555 0.742 . . . . 0.0 112.928 -168.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.22 -46.36 67.57 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.897 0.479 . . . . 0.0 111.019 172.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tt -58.67 -47.56 84.06 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.939 1.295 . . . . 0.0 110.478 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -65.59 -20.89 66.5 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.192 1.397 . . . . 0.0 113.257 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -89.62 -39.95 12.9 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.076 0.951 . . . . 0.0 110.747 175.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.2 mt -61.14 -44.72 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.067 0.947 . . . . 0.0 110.773 171.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.1 t -132.06 133.96 44.97 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.104 0.962 . . . . 0.0 113.474 -173.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -67.27 -29.17 68.71 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.559 1.144 . . . . 0.0 112.481 173.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.3 m -123.58 83.2 2.1 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.208 1.403 . . . . 0.0 109.231 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.36 85.86 0.28 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 127.669 2.557 . . . . 0.0 107.925 -169.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -80.24 140.39 36.27 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -173.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.4 tp -120.76 136.49 57.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 123.431 0.692 . . . . 0.0 110.389 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.42 147.55 18.86 Favored Glycine 0 N--CA 1.466 0.689 0 C-N-CA 124.221 0.915 . . . . 0.0 110.971 169.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -102.24 164.34 11.74 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.06 147.8 12.74 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 120.713 -1.242 . . . . 0.0 111.718 169.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.5 p -128.33 149.74 50.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.413 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -145.72 151.72 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.923 0.889 . . . . 0.0 111.647 -175.731 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.423 HG13 ' H ' ' A' ' 50' ' ' ASN 0.273 3.0 p -152.92 -101.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 124.096 0.958 . . . . 0.0 110.362 169.318 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.423 ' H ' HG13 ' A' ' 49' ' ' VAL 0.301 37.1 t30 -136.4 -11.37 1.88 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.084 1.354 . . . . 0.0 109.811 168.094 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 92.1 mtp -87.28 48.49 1.66 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 102.233 -3.247 . . . . 0.0 102.233 163.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.467 2.1 m 16.23 -116.41 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.506 1 C-N-CA 135.787 5.635 . . . . 0.0 116.145 -167.036 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -113.39 137.97 50.76 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.176 1.39 . . . . 0.0 112.769 -168.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -124.34 122.91 38.99 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -85.6 118.34 25.05 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.087 0.555 . . . . 0.0 109.667 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -125.33 142.19 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 126.163 1.785 . . . . 0.0 107.352 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 39.38 95.63 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 128.963 2.905 . . . . 0.0 117.244 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 161.51 5.84 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.066 0.946 . . . . 0.0 113.101 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.66 124.31 14.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.505 1.122 . . . . 0.0 111.523 -170.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.9 t -147.88 169.64 19.38 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.035 1.334 . . . . 0.0 112.089 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.48 -7.02 51.69 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.644 1.977 . . . . 0.0 113.598 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -90.89 79.52 5.91 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 125.202 2.43 . . . . 0.0 109.486 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 p -63.81 -45.66 88.65 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 129.506 3.123 . . . . 0.0 110.662 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.0 t -55.33 -24.96 31.8 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.48 1.112 . . . . 0.0 111.708 170.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -85.95 -43.89 12.82 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.488 -0.757 . . . . 0.0 110.946 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -55.02 -31.77 61.32 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 121.599 -0.688 . . . . 0.0 111.348 171.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -64.34 -49.22 72.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.435 1.016 . . . . 0.0 108.754 -178.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -64.92 -31.79 73.19 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.087 1.355 . . . . 0.0 110.097 -174.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -94.92 -23.76 17.28 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.683 0.614 . . . . 0.0 111.309 -173.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.13 -50.04 37.7 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 169.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.36 0.0 OUTLIER -75.63 -10.49 59.49 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.555 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -77.92 -20.53 52.67 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 170.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -60.63 131.83 51.96 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.487 1.04 . . . . 0.0 111.186 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.2 mt -128.8 159.02 37.05 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.26 1.424 . . . . 0.0 110.225 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.0 m -82.0 162.41 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.2 p -106.48 -128.55 0.26 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.382 1.473 . . . . 0.0 111.169 171.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 174.76 146.71 5.82 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.359 1.457 . . . . 0.0 113.706 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.58 164.06 32.23 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.098 1.359 . . . . 0.0 112.441 170.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.3 mt -72.23 -48.59 41.67 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -169.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.29 132.97 47.29 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.077 0.551 . . . . 0.0 110.988 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.269 3.7 t -72.58 -37.73 4.58 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-O 116.186 -1.864 . . . . 0.0 113.846 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -69.38 151.83 71.27 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 122.315 2.01 . . . . 0.0 111.269 171.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -122.63 164.29 18.48 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.503 1.121 . . . . 0.0 113.499 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.71 28.64 5.8 Favored Glycine 0 N--CA 1.474 1.211 0 O-C-N 120.369 -1.457 . . . . 0.0 115.663 -170.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -47.04 -40.95 15.89 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.282 1.541 . . . . 0.0 114.747 -168.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.414 HD13 ' CD2' ' A' ' 116' ' ' PHE 0.365 5.0 mp -76.88 -19.23 57.7 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 117.98 -1.01 . . . . 0.0 113.463 -172.561 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.23 -41.31 98.29 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 168.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.29 -54.53 23.69 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 117.133 -1.413 . . . . 0.0 110.668 169.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.5 m -56.76 -33.47 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 120.827 1.649 . . . . 0.0 112.85 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.541 HG22 HD11 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -68.3 -51.78 44.26 Favored 'Isoleucine or valine' 0 C--N 1.345 0.394 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.387 172.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -60.66 -41.21 94.58 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 120.246 1.385 . . . . 0.0 110.533 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.484 HG11 HD13 ' A' ' 108' ' ' LEU . 64.6 t -56.54 -35.52 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.767 1.227 . . . . 0.0 112.318 175.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.35 -36.34 29.77 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.541 HD11 HG22 ' A' ' 90' ' ' VAL . 7.5 mt -83.5 -30.36 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.838 1.199 . . . . 0.0 112.548 -173.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 88.6 m -83.82 53.69 2.65 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.147 1.379 . . . . 0.0 112.35 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -55.84 -34.2 65.21 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.43 1.092 . . . . 0.0 112.462 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.62 -33.24 48.01 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 119.275 -0.736 . . . . 0.0 114.705 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -95.59 -25.52 16.13 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.045 0.922 . . . . 0.0 112.633 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 92' ' ' VAL . 79.0 mt -82.83 -24.95 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.053 0.842 . . . . 0.0 111.179 169.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.53 24.11 61.33 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.087 -0.84 . . . . 0.0 113.807 171.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -57.87 124.91 20.83 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 118.309 1.055 . . . . 0.0 110.65 173.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -102.69 168.1 9.47 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.865 1.266 . . . . 0.0 111.224 171.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -84.28 54.97 3.15 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -172.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -94.39 -113.43 2.5 Favored Glycine 0 N--CA 1.474 1.213 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 169.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 m -127.41 136.55 51.99 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 128.005 2.522 . . . . 0.0 104.719 169.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.36 136.95 51.63 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 121.344 1.884 . . . . 0.0 110.439 -171.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -126.91 116.26 20.54 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 124.916 1.286 . . . . 0.0 112.761 -172.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.484 HD13 HG11 ' A' ' 92' ' ' VAL . 13.0 tp -94.53 103.2 15.16 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 171.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.68 123.39 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -113.16 128.3 56.44 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -173.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.885 HG12 HG22 ' A' ' 170' ' ' VAL . 4.5 m -133.12 129.14 56.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 124.656 1.223 . . . . 0.0 112.397 -177.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.3 t -155.37 170.97 20.68 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.869 1.268 . . . . 0.0 110.142 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -123.23 -1.3 8.71 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -139.49 175.51 9.5 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.682 -1.261 . . . . 0.0 112.419 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -58.16 -176.25 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.775 1.63 . . . . 0.0 112.39 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.414 ' CD2' HD13 ' A' ' 86' ' ' LEU . 13.0 p90 -138.01 163.17 32.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 123.086 1.422 . . . . 0.0 114.078 -169.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -78.9 112.15 15.79 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.73 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 mt -80.71 163.29 23.66 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.746 0.818 . . . . 0.0 110.56 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.71 132.72 49.83 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 168.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 90.79 -11.53 0.28 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 130.496 3.519 . . . . 0.0 114.579 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -28.13 69.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 122.186 2.266 . . . . 0.0 111.657 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.457 ' HE2' ' CD2' ' A' ' 150' ' ' TYR . 3.1 tppt? -64.4 -7.84 11.22 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.826 1.25 . . . . 0.0 113.038 -176.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.1 t -64.96 -24.34 67.49 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 120.863 -1.148 . . . . 0.0 112.351 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.78 -32.97 74.9 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.321 0.964 . . . . 0.0 112.147 172.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -86.65 4.55 86.12 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.014 1.293 . . . . 0.0 113.854 170.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.336 31.8 p 56.39 41.47 28.91 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 129.069 2.948 . . . . 0.0 114.811 -176.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.83 109.56 21.13 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.409 1.483 . . . . 0.0 108.557 169.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -94.07 -39.26 10.7 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -59.66 129.16 40.53 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.973 0.806 . . . . 0.0 111.666 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.8 t -64.83 163.39 14.33 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.169 0.988 . . . . 0.0 111.286 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.2 p -68.54 140.88 55.64 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.347 0.594 . . . . 0.0 112.087 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.0 p30 -88.93 -14.54 36.47 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.58 25.15 73.12 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.901 -0.944 . . . . 0.0 113.444 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.4 mtp-105 -106.19 166.61 10.39 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.615 1.566 . . . . 0.0 113.121 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 82.4 m -64.34 136.87 57.55 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.191 0.996 . . . . 0.0 111.245 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -142.37 33.85 1.49 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.239 1.416 . . . . 0.0 112.162 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.4 tp -102.81 140.57 36.9 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.637 1.975 . . . . 0.0 109.903 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -146.64 -64.91 0.29 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -87.29 3.23 47.56 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.986 1.315 . . . . 0.0 114.114 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.54 -12.63 43.02 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.857 1.694 . . . . 0.0 114.007 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.5 mtt -95.28 148.58 22.26 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.661 1.731 . . . . 0.0 111.681 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -73.63 90.06 1.77 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 168.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -55.8 -42.19 75.25 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.889 0.876 . . . . 0.0 112.541 -171.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 69.1 m -75.78 2.99 10.75 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -174.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -43.05 -32.87 0.74 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 171.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.94 8.51 63.33 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.502 2.001 . . . . 0.0 115.615 -174.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.265 32.3 tt0 -131.98 -60.13 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.978 0 CA-C-N 120.53 2.165 . . . . 0.0 114.055 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -70.52 146.09 54.52 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 CA-C-N 122.516 1.934 . . . . 0.0 113.029 169.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -65.41 165.52 11.8 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 129.136 2.974 . . . . 0.0 113.136 169.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.457 ' CD2' ' HE2' ' A' ' 122' ' ' LYS . 97.4 m-85 -62.27 155.28 25.24 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.389 1.09 . . . . 0.0 112.025 169.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -76.86 143.78 39.46 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.61 1.164 . . . . 0.0 110.172 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 44.2 p -73.01 153.79 40.76 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.982 0.42 . . . . 0.0 110.854 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.93 -26.09 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.386 1.075 . . . . 0.0 113.789 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.6 t -81.98 -37.19 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.107 1.363 . . . . 0.0 112.034 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -67.4 -33.3 74.91 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.124 0.875 . . . . 0.0 111.795 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.89 -56.11 17.73 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.656 0.662 . . . . 0.0 110.508 169.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -58.34 -34.47 70.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.966 0.906 . . . . 0.0 112.91 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.3 t -59.27 -65.51 0.66 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.867 0.867 . . . . 0.0 111.3 170.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -67.83 -27.62 66.87 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.187 -1.571 . . . . 0.0 113.853 -174.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -37.3 79.66 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.25 1.386 . . . . 0.0 111.751 169.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.38 -28.45 37.96 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -74.7 -39.85 61.7 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.004 0.82 . . . . 0.0 110.948 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -86.11 -13.67 46.51 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.752 1.221 . . . . 0.0 111.897 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 30.0 m120 58.46 39.92 24.59 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.907 2.083 . . . . 0.0 112.818 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.7 mt -90.99 138.22 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.824 1.65 . . . . 0.0 108.814 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -96.42 107.5 36.21 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 120.354 1.434 . . . . 0.0 110.235 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.77 149.68 43.32 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.126 1.884 . . . . 0.0 113.168 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 30.0 mt -140.97 105.82 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.638 0.775 . . . . 0.0 110.093 176.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.53 ' CD2' HD21 ' A' ' 189' ' ' LEU . 22.5 m-85 -75.82 64.22 1.77 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.425 1.09 . . . . 0.0 113.09 -177.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.885 HG22 HG12 ' A' ' 111' ' ' VAL 0.335 0.5 OUTLIER -60.32 114.01 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 119.952 -1.717 . . . . 0.0 113.38 169.917 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 35.5 m -151.63 150.47 26.55 Favored Pre-proline 0 N--CA 1.48 1.027 0 O-C-N 120.636 -1.29 . . . . 0.0 112.829 -172.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.41 157.18 59.42 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.325 3.35 . . . . 0.0 113.023 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.5 p -44.66 -51.39 9.22 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.828 2.051 . . . . 0.0 113.968 -170.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -52.21 -27.31 14.23 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -174.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 22.4 ptm -117.13 3.72 12.7 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.323 1.449 . . . . 0.0 114.831 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.11 -39.65 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 CA-C-N 119.994 1.27 . . . . 0.0 110.624 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -67.99 -26.73 66.06 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -170.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.7 -37.6 20.75 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.811 1.245 . . . . 0.0 110.417 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -73.2 -28.44 62.18 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.843 -1.16 . . . . 0.0 111.381 174.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . 0.314 15.0 pt-20 -77.38 0.21 23.28 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.722 1.146 . . . . 0.0 111.995 169.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -99.08 -10.33 22.72 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.201 -0.937 . . . . 0.0 111.349 168.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.86 -31.19 28.13 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.214 1.806 . . . . 0.0 108.551 169.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.2 t -77.89 -5.62 51.61 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.593 1.157 . . . . 0.0 113.387 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 7.5 t -100.91 -17.44 16.82 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.944 0.498 . . . . 0.0 110.336 168.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -82.63 -45.36 14.64 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.258 0.481 . . . . 0.0 111.499 169.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 4.0 mp -97.51 118.11 64.67 Favored Pre-proline 0 N--CA 1.475 0.793 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -76.46 143.64 24.82 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.441 2.094 . . . . 0.0 111.191 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 79.5 tttt 101.46 -22.95 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 130.253 3.421 . . . . 0.0 114.486 169.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.53 HD21 ' CD2' ' A' ' 169' ' ' PHE 0.364 0.0 OUTLIER -76.57 168.59 19.81 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 118.897 0.771 . . . . 0.0 111.74 -177.24 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.352 6.9 t -136.86 -163.3 1.4 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 122.983 1.373 . . . . 0.0 107.946 176.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 17.1 tt -157.56 136.98 3.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 126.427 1.891 . . . . 0.0 112.461 -166.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -119.53 155.72 16.02 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.627 0.632 . . . . 0.0 111.905 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -95.34 90.52 5.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 169.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.652 ' HB2' HG23 ' A' ' 170' ' ' VAL . 55.6 tp -58.78 126.91 29.61 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.975 169.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 82.5 p -165.68 -166.12 0.92 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.672 1.189 . . . . 0.0 110.285 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.57 -20.88 23.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.631 1.572 . . . . 0.0 113.892 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -115.46 134.26 55.25 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.609 1.564 . . . . 0.0 111.955 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 10.6 p -90.01 -3.15 58.14 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.678 1.991 . . . . 0.0 113.821 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.7 m -58.0 -42.19 84.67 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.681 1.593 . . . . 0.0 112.072 -169.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -61.75 -42.97 99.66 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.245 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 70.9 t -70.97 -42.88 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.557 -0.715 . . . . 0.0 111.315 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.51 -20.8 66.49 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.558 -0.714 . . . . 0.0 112.198 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -76.47 7.11 4.76 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 127.811 2.444 . . . . 0.0 113.772 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.9 mp -124.04 -40.72 2.26 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.462 1.905 . . . . 0.0 108.581 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 3.3 mp -72.01 -49.39 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 3.2 ptm85 -61.78 -38.73 89.16 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.819 0.736 . . . . 0.0 111.089 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.14 -21.28 50.53 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 118.675 -1.21 . . . . 0.0 114.18 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -74.5 -27.63 60.64 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.109 0.868 . . . . 0.0 112.23 170.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -67.06 -44.73 79.37 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.641 0.655 . . . . 0.0 110.164 169.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.9 m -61.92 -21.51 64.81 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . 0.278 26.0 ttpp -80.91 -17.06 51.83 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -176.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.731 HD13 ' O ' ' A' ' 212' ' ' LEU . 2.2 tm? . . . . . 0 C--O 1.182 -2.483 0 CA-C-O 116.808 -1.568 . . . . 0.0 112.603 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -55.29 147.61 16.45 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.806 1.639 . . . . 0.0 113.399 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -69.71 125.85 27.98 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.892 0.877 . . . . 0.0 112.714 -171.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -112.46 137.83 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.645 1.578 . . . . 0.0 111.145 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -115.3 99.2 7.22 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 168.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -90.81 128.22 36.63 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.604 -0.685 . . . . 0.0 111.248 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.514 ' CD1' HG21 ' A' ' 92' ' ' VAL . 31.3 t80 -123.78 109.18 13.34 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 123.435 1.588 . . . . 0.0 111.767 172.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -85.63 101.46 12.74 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.261 2.224 . . . . 0.0 113.626 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.5 mt -93.47 119.44 32.56 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.8 ptm -117.75 145.15 44.68 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 169.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.58 136.21 24.38 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' A' ' 47' ' ' SER . 3.7 mp -109.05 16.27 22.7 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.47 1.508 . . . . 0.0 113.171 -176.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.0 p -67.11 170.52 6.82 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.186 -1.571 . . . . 0.0 113.265 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.66 -22.8 68.37 Favored Glycine 0 N--CA 1.475 1.253 0 O-C-N 120.782 -1.199 . . . . 0.0 114.34 -170.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 p -63.64 -27.54 69.3 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.626 1.17 . . . . 0.0 112.98 170.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.49 2.44 19.0 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.778 1.231 . . . . 0.0 113.957 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -62.91 -38.48 91.12 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.968 -1.082 . . . . 0.0 111.302 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.12 -42.17 91.93 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 170.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -60.86 -39.4 88.98 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.855 1.262 . . . . 0.0 112.8 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.0 tp -61.29 -45.17 95.57 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.184 0.994 . . . . 0.0 112.984 -173.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.3 m -60.44 -40.67 91.94 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -172.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -80.26 -23.73 40.59 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.484 -0.76 . . . . 0.0 112.726 170.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.54 -35.77 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 120.367 1.44 . . . . 0.0 111.994 174.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.17 -38.28 63.73 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.683 1.129 . . . . 0.0 111.94 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.7 p -71.6 -32.34 67.91 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.333 0.653 . . . . 0.0 111.178 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 202' ' ' ALA . 39.2 tp -75.87 1.3 15.43 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 124.478 1.111 . . . . 0.0 111.954 169.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.77 -45.66 6.3 Favored Glycine 0 N--CA 1.476 1.303 0 O-C-N 119.197 -2.189 . . . . 0.0 109.23 -170.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.1 p -76.16 -34.13 59.38 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 127.399 2.28 . . . . 0.0 109.756 170.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -78.25 -33.28 49.81 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.369 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.1 tp -66.42 -51.4 57.31 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.199 0.909 . . . . 0.0 109.53 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 63' ' ' SER . 1.2 tt -60.64 -47.31 86.82 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.163 0.985 . . . . 0.0 111.069 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -66.62 -42.88 86.13 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.766 -0.584 . . . . 0.0 111.345 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.44 91.08 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.922 0.783 . . . . 0.0 112.484 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.2 tp -61.5 -42.18 98.41 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.3 -0.875 . . . . 0.0 110.863 171.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -69.55 -9.25 53.19 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -86.07 -43.94 12.69 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.15 0.98 . . . . 0.0 111.053 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.4 tp -80.69 -22.95 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.1 t -139.47 129.2 24.63 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.099 -1.0 . . . . 0.0 112.959 176.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -64.02 -30.92 71.96 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.214 1.006 . . . . 0.0 112.335 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.2 m -117.31 90.94 3.44 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.309 1.443 . . . . 0.0 109.165 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.91 81.54 0.31 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 127.023 2.249 . . . . 0.0 108.501 -170.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -80.28 134.87 36.13 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.839 1.256 . . . . 0.0 107.743 -171.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.5 tp -119.61 142.64 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.161 0.585 . . . . 0.0 111.194 -172.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.89 160.26 29.89 Favored Glycine 0 N--CA 1.467 0.736 0 C-N-CA 125.171 1.367 . . . . 0.0 111.435 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -146.34 142.57 28.38 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -169.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.3 142.27 13.25 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.563 ' HB2' HD22 ' A' ' 12' ' ' LEU . 4.2 p -108.78 142.68 38.98 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.114 0.966 . . . . 0.0 110.615 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.566 HD13 ' HB2' ' A' ' 88' ' ' ALA 0.297 0.6 OUTLIER -152.26 137.87 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.943 1.461 . . . . 0.0 114.943 -176.487 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.05 -137.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 127.577 2.351 . . . . 0.0 105.719 172.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' A' ' 52' ' ' THR 0.301 10.1 m120 -98.01 -1.6 42.26 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.671 1.578 . . . . 0.0 111.992 168.388 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 62.9 mtt -85.6 40.93 0.87 Allowed 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 102.079 -3.304 . . . . 0.0 102.079 163.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.366 68.4 p 14.38 -113.51 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.94 1 C-N-CA 133.925 4.89 . . . . 0.0 113.946 -166.092 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -112.36 130.07 56.09 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 125.089 1.493 . . . . 0.0 111.893 -168.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -122.89 118.75 28.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 168.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -81.39 116.52 21.25 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.039 170.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 mm -89.87 -44.26 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 119.16 -0.448 . . . . 0.0 110.991 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.8 tp -151.53 123.9 8.32 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.793 0.806 . . . . 0.0 112.98 -172.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -54.97 149.34 11.88 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.599 1.96 . . . . 0.0 112.455 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.5 mt -51.15 112.97 0.81 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.048 1.339 . . . . 0.0 110.301 169.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -137.26 158.53 44.22 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.173 0.989 . . . . 0.0 112.152 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.4 -5.6 51.72 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.4 1.88 . . . . 0.0 111.946 169.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -85.98 79.36 9.22 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 125.938 2.78 . . . . 0.0 109.148 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.524 ' HA ' HD11 ' A' ' 31' ' ' LEU . 29.6 t -64.72 -41.71 95.77 Favored 'General case' 0 C--N 1.314 -0.944 1 C-N-CA 132.018 4.127 . . . . 0.0 110.015 -170.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 m -63.61 -17.02 62.46 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.773 1.229 . . . . 0.0 111.866 175.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . 0.434 26.2 pt20 -102.7 -29.22 11.64 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -57.3 -25.59 59.52 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 120.383 -1.448 . . . . 0.0 112.056 169.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -75.54 -27.87 58.83 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.267 1.427 . . . . 0.0 111.884 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 -78.1 -29.34 48.95 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.965 1.306 . . . . 0.0 109.306 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.04 -34.24 16.87 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.062 0.545 . . . . 0.0 110.01 -174.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.29 -18.24 46.52 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.642 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -82.59 -22.6 34.77 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 171.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -73.06 -17.89 61.38 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -64.1 149.59 47.32 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.696 0.68 . . . . 0.0 112.632 -170.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.05 132.66 19.85 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.704 1.602 . . . . 0.0 108.626 -174.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.4 m -68.39 165.94 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.5 m -131.75 -175.24 3.65 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.729 2.412 . . . . 0.0 110.417 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -137.0 166.77 24.84 Favored Glycine 0 N--CA 1.477 1.374 0 O-C-N 120.664 -1.272 . . . . 0.0 114.649 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -155.7 155.32 32.96 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.442 1.497 . . . . 0.0 113.069 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -56.28 -65.0 0.68 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.417 2.287 . . . . 0.0 111.296 168.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.48 145.17 41.62 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.131 0.972 . . . . 0.0 113.606 -172.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.9 m -70.68 -44.95 17.15 Favored Pre-proline 0 N--CA 1.474 0.761 0 CA-C-O 116.135 -1.888 . . . . 0.0 113.218 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -69.75 141.88 46.46 Favored 'Trans proline' 0 C--N 1.354 0.851 0 CA-C-N 122.225 1.83 . . . . 0.0 112.403 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -92.84 178.88 5.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.378 1.871 . . . . 0.0 112.773 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.43 22.41 26.72 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 125.912 1.72 . . . . 0.0 115.231 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . 0.268 2.8 tt0 -64.02 -29.67 70.8 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 119.353 3.094 . . . . 0.0 119.353 -168.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.534 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 6.3 mp -67.22 -20.47 65.69 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 122.255 2.298 . . . . 0.0 112.518 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -65.07 -35.13 80.18 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.651 1.114 . . . . 0.0 111.234 169.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB2' HD13 ' A' ' 48' ' ' ILE . . . -69.88 -42.04 73.97 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-O 117.086 -1.435 . . . . 0.0 110.041 168.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.292 2.1 m -61.99 -33.62 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 120.133 1.333 . . . . 0.0 112.764 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.7 p -68.8 -58.06 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 117.732 -1.128 . . . . 0.0 108.607 169.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -52.29 -53.41 44.41 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 121.184 1.811 . . . . 0.0 112.705 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.514 HG21 ' CD1' ' A' ' 7' ' ' TYR . 8.9 p -54.16 -41.6 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 119.51 1.05 . . . . 0.0 112.137 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.91 -19.25 61.3 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 159' ' ' LYS . 2.2 mp -106.06 -30.01 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 120.081 1.31 . . . . 0.0 113.22 -176.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 84.4 m -78.72 55.97 1.78 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.814 1.646 . . . . 0.0 111.215 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 72.7 mt -51.42 -44.12 62.18 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.148 2.179 . . . . 0.0 111.823 -171.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.3 -17.42 76.32 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.224 0.916 . . . . 0.0 114.264 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -90.76 -54.9 3.78 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.915 1.286 . . . . 0.0 110.19 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.32 -33.13 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 118.562 -0.733 . . . . 0.0 110.59 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.94 25.41 27.13 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.256 0.931 . . . . 0.0 113.432 174.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -57.27 123.95 17.16 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.172 0.986 . . . . 0.0 112.138 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.1 mtp-105 -97.27 -176.57 3.56 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.404 2.282 . . . . 0.0 110.668 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -100.77 39.13 1.41 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.078 1.351 . . . . 0.0 114.446 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -95.11 -122.47 3.83 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 169.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.1 t -113.06 143.62 44.02 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.721 1.608 . . . . 0.0 107.689 169.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -131.68 120.41 22.73 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.152 0.887 . . . . 0.0 110.117 -168.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.475 ' CE1' ' HG3' ' A' ' 166' ' ' GLN . 51.6 m-85 -120.89 105.64 10.88 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -169.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.41 99.71 12.2 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.43 HG21 HD12 ' A' ' 205' ' ' ILE . 59.5 t -81.06 127.51 39.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 171.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.6 tt -110.47 132.43 54.19 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.4 t -119.41 121.88 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.939 0.896 . . . . 0.0 109.944 169.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.3 p -138.97 168.59 19.49 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.599 1.56 . . . . 0.0 110.189 169.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.27 2.28 2.06 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 170.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -142.25 161.22 38.57 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.962 1.705 . . . . 0.0 110.618 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -45.49 173.16 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 128.409 2.684 . . . . 0.0 117.586 -169.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.534 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 49.0 t80 -129.08 137.66 51.39 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.998 -1.064 . . . . 0.0 113.184 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -79.02 84.63 5.01 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 125.13 1.372 . . . . 0.0 112.216 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.59 HD13 ' H ' ' A' ' 118' ' ' LEU 0.387 0.0 OUTLIER -73.08 174.65 7.61 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 119.802 -1.811 . . . . 0.0 113.432 174.833 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.57 134.72 1.72 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 -169.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.311 60.8 mtpt 75.27 -2.25 2.87 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 131.308 3.843 . . . . 0.0 114.898 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.98 -21.18 66.8 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.609 1.095 . . . . 0.0 112.821 169.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.483 ' HE3' ' CZ ' ' A' ' 150' ' ' TYR . 61.5 mttt -69.72 -7.97 43.88 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.215 -1.553 . . . . 0.0 114.347 172.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.07 -15.55 63.79 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.196 1.362 . . . . 0.0 113.328 175.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -64.15 -21.54 66.59 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 118.802 0.728 . . . . 0.0 112.095 169.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -90.55 -128.32 3.81 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.72 1.629 . . . . 0.0 111.395 170.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.5 t -137.41 52.87 1.88 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.742 1.617 . . . . 0.0 110.132 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -133.7 88.64 2.5 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.854 1.661 . . . . 0.0 110.805 -169.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -102.73 -18.47 15.15 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -68.71 129.6 40.39 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.41 1.005 . . . . 0.0 110.832 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.0 t -69.36 161.38 29.48 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 118.822 0.737 . . . . 0.0 111.319 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.7 m -62.14 133.95 55.92 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.653 -0.654 . . . . 0.0 111.552 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -86.69 -12.58 47.93 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.66 23.99 73.67 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.276 -1.291 . . . . 0.0 114.184 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -103.32 165.13 11.22 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.144 1.472 . . . . 0.0 112.198 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 10.0 t -67.49 126.67 30.03 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.596 1.558 . . . . 0.0 109.382 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -127.34 55.86 1.57 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.637 1.575 . . . . 0.0 110.995 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.13 124.04 22.72 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.005 1.322 . . . . 0.0 109.774 -169.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -125.95 -58.45 1.38 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.34 1.056 . . . . 0.0 111.736 170.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -81.44 -21.38 38.88 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -174.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 121.91 -8.01 10.02 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.062 1.315 . . . . 0.0 114.513 -171.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 94.6 mtp -108.87 142.21 39.8 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.733 1.267 . . . . 0.0 111.364 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -67.69 83.16 0.18 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.272 1.029 . . . . 0.0 110.573 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -72.13 -15.43 61.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -169.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 86.6 p -78.07 -5.34 51.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.71 1.141 . . . . 0.0 113.223 170.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -41.68 -35.03 0.69 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.78 -5.03 81.92 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 117.517 -1.713 . . . . 0.0 114.989 -175.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -120.96 -70.71 0.02 OUTLIER Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 119.791 1.796 . . . . 0.0 112.643 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -61.08 147.18 96.42 Favored 'Trans proline' 0 C--N 1.355 0.891 0 CA-C-N 123.064 2.13 . . . . 0.0 114.919 171.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -62.05 174.87 0.78 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 130.248 3.419 . . . . 0.0 113.397 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.483 ' CZ ' ' HE3' ' A' ' 122' ' ' LYS . 59.5 m-85 -74.17 145.21 44.39 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.487 1.115 . . . . 0.0 112.435 172.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -67.86 131.59 45.81 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.534 0.683 . . . . 0.0 111.971 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 27.0 p -63.11 142.02 58.54 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.055 1.342 . . . . 0.0 113.396 170.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.85 -27.29 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 121.109 -0.994 . . . . 0.0 112.484 -174.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.3 t -65.38 -44.18 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 121.355 -0.84 . . . . 0.0 111.556 172.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -76.1 -20.69 57.43 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.688 -0.633 . . . . 0.0 112.062 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.29 -50.54 63.35 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.265 0.939 . . . . 0.0 108.658 168.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.49 -41.92 73.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.439 0.696 . . . . 0.0 112.615 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.8 p -68.75 -51.42 41.48 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.906 0.775 . . . . 0.0 112.416 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.492 ' HB3' HD11 ' A' ' 94' ' ' ILE . 5.5 mptp? -67.44 -38.31 84.32 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.533 -1.354 . . . . 0.0 113.242 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.414 HD23 ' HG3' ' A' ' 167' ' ' PRO . 10.9 mp -66.21 -35.05 79.41 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.364 -0.835 . . . . 0.0 111.582 176.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.71 -28.71 58.71 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 172.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.37 -49.25 64.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.117 1.367 . . . . 0.0 110.026 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -91.09 -0.13 57.66 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.733 0.813 . . . . 0.0 112.907 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.3 m120 47.03 59.61 3.92 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.908 2.083 . . . . 0.0 112.492 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.7 mm -95.71 129.36 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 169.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.475 ' HG3' ' CE1' ' A' ' 107' ' ' PHE 0.345 10.5 pt20 -98.71 110.65 57.99 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 123.3 2.773 . . . . 0.0 108.448 169.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.633 ' HG2' ' HG ' ' A' ' 189' ' ' LEU . 58.2 Cg_endo -70.89 145.44 50.65 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 124.564 3.509 . . . . 0.0 114.06 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 8.6 mm -127.29 98.69 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.509 1.524 . . . . 0.0 109.338 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -76.89 82.06 3.46 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.22 -1.55 . . . . 0.0 110.453 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.469 ' CG1' HD13 ' A' ' 194' ' ' LEU . 94.2 t -71.95 126.4 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 O-C-N 120.622 -1.299 . . . . 0.0 110.582 168.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 5.1 p -163.11 141.77 6.49 Favored Pre-proline 0 N--CA 1.483 1.221 0 CA-C-O 117.745 -1.122 . . . . 0.0 113.43 -169.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -63.75 157.48 51.74 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 125.033 3.822 . . . . 0.0 116.309 176.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 78.4 p -56.47 -27.0 55.77 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -169.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -56.77 -36.12 69.46 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.664 1.12 . . . . 0.0 112.701 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 52.6 ttp -116.91 -6.12 11.47 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 -169.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 51.6 t -53.99 -32.11 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.718 -1.239 . . . . 0.0 111.286 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -61.79 -34.92 76.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.912 1.285 . . . . 0.0 113.524 -175.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.8 t -92.6 -39.68 11.19 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.848 0.859 . . . . 0.0 110.397 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -69.12 -35.16 76.1 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.318 1.047 . . . . 0.0 110.084 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -68.96 -7.03 31.34 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.549 1.068 . . . . 0.0 112.667 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -99.11 -16.66 18.55 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.826 -1.171 . . . . 0.0 111.536 169.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.05 -21.78 46.33 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.697 -1.252 . . . . 0.0 109.557 169.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.504 HG22 HD22 ' A' ' 189' ' ' LEU . 67.3 p -79.61 -18.76 50.88 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.971 0.908 . . . . 0.0 112.919 172.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . 0.289 1.7 t -81.25 -17.46 49.39 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.365 0.529 . . . . 0.0 109.909 169.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -89.62 -26.23 20.88 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.826 0.451 . . . . 0.0 111.756 168.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.5 mm -111.86 85.63 6.54 Favored Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 124.984 1.313 . . . . 0.0 110.084 172.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.17 136.94 76.1 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.257 1.971 . . . . 0.0 111.517 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 87.71 -5.7 0.59 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 129.765 3.226 . . . . 0.0 114.335 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.633 ' HG ' ' HG2' ' A' ' 167' ' ' PRO . 3.8 tt -72.43 138.84 47.39 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.891 1.276 . . . . 0.0 108.319 169.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 41.5 p -116.92 -164.48 0.98 Allowed 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 120.349 1.431 . . . . 0.0 107.467 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.2 mt -164.53 153.43 2.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 126.052 1.741 . . . . 0.0 110.383 -167.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.458 ' HA3' HD23 ' A' ' 204' ' ' LEU . . . -140.33 141.22 11.25 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.799 168.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -80.2 82.28 6.29 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 123.628 1.68 . . . . 0.0 108.305 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.469 HD13 ' CG1' ' A' ' 170' ' ' VAL . 17.3 tp -51.19 146.16 6.98 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 112.605 -2.089 . . . . 0.0 110.857 170.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 24.2 p -77.53 162.35 27.19 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.103 -0.998 . . . . 0.0 111.33 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -64.81 -20.9 66.64 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.277 -0.889 . . . . 0.0 112.911 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -88.43 -37.43 15.85 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.35 1.46 . . . . 0.0 112.638 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . 0.312 1.4 p 98.69 -7.52 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 129.863 3.265 . . . . 0.0 115.854 169.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 78.3 p -59.74 -13.7 11.29 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.996 2.118 . . . . 0.0 114.975 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -65.06 -30.61 71.59 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.492 169.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 9.4 p -43.42 -41.49 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 -168.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.476 ' HB2' HD11 ' A' ' 26' ' ' LEU . . . -62.18 -36.52 82.15 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.513 1.506 . . . . 0.0 112.939 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . 0.263 4.7 pt20 -84.11 19.54 1.79 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.458 HD23 ' HA3' ' A' ' 192' ' ' GLY . 7.7 mp -120.69 -38.07 2.91 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 128.626 2.77 . . . . 0.0 108.157 172.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.43 HD12 HG21 ' A' ' 109' ' ' VAL . 6.3 mm -59.88 -53.42 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 169.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 41.5 ttt85 -61.75 -41.12 97.26 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.047 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -70.28 -32.98 71.02 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -171.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -72.6 -40.33 66.61 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.784 1.234 . . . . 0.0 111.811 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -73.92 -35.39 64.62 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.872 1.269 . . . . 0.0 113.366 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 23.2 t -43.5 -35.61 1.72 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.182 2.593 . . . . 0.0 116.857 -169.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -64.22 -41.16 97.15 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 118.068 -0.968 . . . . 0.0 113.34 -172.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--O 1.259 1.57 0 C-N-CA 128.385 2.674 . . . . 0.0 114.51 -176.022 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -65.1 137.3 57.58 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 120.709 1.595 . . . . 0.0 111.558 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.5 m -68.27 146.42 53.33 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -170.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.7 t -114.91 141.1 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.769 1.228 . . . . 0.0 110.052 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -114.25 115.74 27.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.551 1.14 . . . . 0.0 109.327 169.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 tp -100.08 129.91 46.17 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.662 0.665 . . . . 0.0 111.874 169.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -120.3 105.26 10.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 123.508 1.623 . . . . 0.0 109.564 169.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -84.0 105.84 15.19 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.54 -1.664 . . . . 0.0 111.286 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -103.3 108.5 19.75 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.726 1.21 . . . . 0.0 109.701 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.2 ptm -113.2 145.54 40.82 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.91 139.58 27.45 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.043 0.83 . . . . 0.0 111.511 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.446 HD13 ' HB2' ' A' ' 47' ' ' SER . 1.4 mp -112.18 25.75 11.25 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.494 1.917 . . . . 0.0 112.529 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.3 t -61.39 160.14 11.39 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.544 0.737 . . . . 0.0 111.345 169.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.59 -25.3 68.69 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 120.903 -1.123 . . . . 0.0 114.341 -170.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 p -74.62 -13.74 60.68 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.414 1.086 . . . . 0.0 113.746 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.91 2.18 18.23 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.431 1.093 . . . . 0.0 113.892 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -54.57 -40.4 68.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.724 0.81 . . . . 0.0 111.708 170.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.48 -27.89 60.6 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 123.594 0.616 . . . . 0.0 113.353 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -67.69 -50.47 57.49 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.283 1.042 . . . . 0.0 111.841 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp -52.56 -41.88 63.95 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.946 1.298 . . . . 0.0 112.847 -169.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.3 m -52.88 -51.73 60.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.712 1.205 . . . . 0.0 113.477 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -87.53 -7.34 57.7 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -174.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.3 m -97.96 13.97 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 119.742 1.156 . . . . 0.0 113.224 170.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.481 ' HA ' HD22 ' A' ' 70' ' ' LEU . 9.8 pt20 -87.15 -32.09 20.04 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.39 -1.444 . . . . 0.0 110.175 177.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.2 t -79.3 -11.88 59.94 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.081 2.152 . . . . 0.0 110.258 168.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.6 tp -85.46 90.28 7.91 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 124.362 2.03 . . . . 0.0 107.035 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.62 -51.13 0.05 OUTLIER Glycine 0 C--N 1.296 -1.686 0 CA-C-N 109.265 -3.607 . . . . 0.0 109.791 167.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.7 m -74.77 -36.57 62.54 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.331 1.852 . . . . 0.0 111.13 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -58.57 -40.56 83.47 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.458 0.703 . . . . 0.0 110.45 169.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -57.42 8.65 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tt -52.69 -40.73 63.22 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 116.988 -1.482 . . . . 0.0 112.902 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -69.62 -32.05 70.53 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 122.027 2.194 . . . . 0.0 112.962 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.18 -37.28 66.58 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.917 0.78 . . . . 0.0 112.842 169.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.8 mt -77.04 -31.61 56.39 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.624 0.77 . . . . 0.0 112.995 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.84 -18.02 62.73 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.329 1.422 . . . . 0.0 113.663 -172.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -81.66 -46.04 14.91 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.798 0.839 . . . . 0.0 109.437 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.83 -23.74 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 38.8 t -151.58 143.86 24.06 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.718 1.145 . . . . 0.0 113.605 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.49 -9.63 59.34 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 174.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.4 t -139.46 120.54 14.65 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.328 1.061 . . . . 0.0 110.74 169.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.94 84.79 0.23 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 -170.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -74.96 146.03 42.07 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.5 tt -133.05 134.45 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.64 0.776 . . . . 0.0 110.585 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.56 152.58 21.66 Favored Glycine 0 N--CA 1.467 0.752 0 C-N-CA 125.907 1.718 . . . . 0.0 111.146 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -124.08 146.98 48.23 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.415 0.686 . . . . 0.0 111.557 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.24 154.14 25.72 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 170.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.446 ' HB2' HD13 ' A' ' 12' ' ' LEU . 93.6 p -135.24 159.17 42.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.357 1.075 . . . . 0.0 113.185 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.445 HG21 ' HG2' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -155.64 147.77 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 121.347 -0.846 . . . . 0.0 111.986 -169.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.411 ' N ' HD13 ' A' ' 48' ' ' ILE 0.306 12.0 p -154.29 -129.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 116.626 -1.654 . . . . 0.0 109.427 171.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -95.45 -20.86 18.72 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 123.43 2.832 . . . . 0.0 112.963 169.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 46.2 mtt -80.75 49.13 1.15 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 167.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.294 12.8 p 25.17 -120.66 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.518 1 C-N-CA 132.157 4.183 . . . . 0.0 114.381 -169.057 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -107.35 133.13 52.34 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 127.483 2.313 . . . . 0.0 112.503 -167.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.2 123.85 48.79 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 169.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -97.43 127.76 43.66 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.609 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -155.67 113.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.929 0.892 . . . . 0.0 109.525 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.9 tp 96.51 83.21 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.868 3.267 . . . . 0.0 107.875 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.15 155.14 21.34 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.797 0.808 . . . . 0.0 111.149 169.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . 0.26 2.2 tm? -54.54 105.03 0.13 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 128.02 2.528 . . . . 0.0 109.689 -170.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.0 t -138.8 174.01 10.98 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.71 1.604 . . . . 0.0 112.635 -169.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.76 -12.32 31.6 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.104 1.362 . . . . 0.0 114.567 -172.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -89.13 85.87 6.76 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 125.364 2.507 . . . . 0.0 108.686 -176.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.6 t -61.7 -39.68 92.34 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 128.077 2.551 . . . . 0.0 110.674 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.7 m -64.54 -15.1 60.37 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.224 -0.923 . . . . 0.0 112.047 169.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -81.03 -38.52 27.31 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.199 -0.938 . . . . 0.0 110.959 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -57.91 -23.6 54.09 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.298 1.039 . . . . 0.0 112.191 170.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -74.91 -43.14 55.91 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.472 -0.768 . . . . 0.0 109.469 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -86.8 -29.68 22.11 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.895 0.878 . . . . 0.0 111.03 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -76.14 -34.32 59.41 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.481 HD22 ' HA ' ' A' ' 24' ' ' GLN . 8.3 tt -68.97 -37.61 78.89 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.998 -0.525 . . . . 0.0 110.083 170.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -60.44 -38.86 85.45 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.714 0.688 . . . . 0.0 112.191 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -65.01 -20.75 66.65 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -63.47 152.7 37.67 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.566 1.075 . . . . 0.0 111.99 -172.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.1 tp -135.57 127.12 28.82 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.147 1.379 . . . . 0.0 108.736 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.2 m -61.6 163.77 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.828 0.851 . . . . 0.0 112.173 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.9 p -119.56 -157.91 0.72 Allowed 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.761 -0.587 . . . . 0.0 110.333 168.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.66 143.12 9.64 Favored Glycine 0 CA--C 1.524 0.609 0 O-C-N 121.154 -0.967 . . . . 0.0 112.202 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 149.45 28.12 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.659 1.583 . . . . 0.0 110.79 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.01 -57.23 4.18 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -168.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.73 136.76 58.09 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.657 0.662 . . . . 0.0 111.549 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.254 6.4 t -65.84 -39.12 28.34 Favored Pre-proline 0 N--CA 1.476 0.859 0 CA-C-O 116.321 -1.799 . . . . 0.0 114.599 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.71 143.29 50.6 Favored 'Trans proline' 0 C--N 1.359 1.084 0 CA-C-N 122.71 2.003 . . . . 0.0 111.665 173.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.557 ' H ' ' HD3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -114.15 162.29 16.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.125 1.77 . . . . 0.0 112.199 176.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.61 42.27 2.91 Favored Glycine 0 N--CA 1.479 1.525 0 C-N-CA 125.022 1.296 . . . . 0.0 115.264 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.445 ' HG2' HG21 ' A' ' 48' ' ' ILE . 22.5 mt-30 -60.74 -29.65 69.52 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.223 1.512 . . . . 0.0 112.891 -176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.405 HD11 ' CD1' ' A' ' 156' ' ' LEU . 15.5 tp -65.89 -32.86 74.61 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -169.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -59.7 -54.66 43.84 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.46 -52.31 64.07 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.636 0.774 . . . . 0.0 111.72 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.258 3.1 p -61.3 -36.44 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 119.592 1.087 . . . . 0.0 112.792 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.8 -35.76 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 120.607 1.548 . . . . 0.0 113.23 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -61.91 -46.42 89.44 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.055 1.298 . . . . 0.0 110.741 172.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.9 t -54.79 -36.73 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 122.84 0.456 . . . . 0.0 111.745 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.31 -30.81 62.23 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 20.7 tt -99.01 -25.59 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 61.2 m -82.91 61.31 5.88 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 120.459 1.481 . . . . 0.0 111.512 -171.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.3 mt -49.42 -45.58 46.48 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.909 2.884 . . . . 0.0 110.977 -171.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.59 -23.08 44.32 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 114.14 -1.391 . . . . 0.0 114.135 -173.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -84.66 -46.68 11.25 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.382 1.091 . . . . 0.0 110.938 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.0 mt -79.94 -25.01 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 118.054 -0.974 . . . . 0.0 111.474 177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.06 23.9 36.57 Favored Glycine 0 N--CA 1.471 0.992 0 CA-C-N 119.548 1.067 . . . . 0.0 115.306 169.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -52.62 122.43 8.98 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.92 1.288 . . . . 0.0 112.55 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -93.71 175.03 6.89 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.732 1.213 . . . . 0.0 111.131 170.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -90.49 27.95 1.59 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 116.288 1.958 . . . . 0.0 116.288 -168.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.34 -124.69 3.79 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 120.768 -1.207 . . . . 0.0 110.797 173.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.3 m -97.85 142.5 29.53 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.742 2.017 . . . . 0.0 107.58 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -142.85 119.47 11.08 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 121.076 1.762 . . . . 0.0 110.739 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -113.97 123.28 49.33 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 126.314 1.846 . . . . 0.0 112.99 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 tt -107.87 96.03 6.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 110.112 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 77.5 t -79.93 126.97 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.1 tp -114.25 116.01 28.33 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.66 130.7 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.448 ' O ' ' HD2' ' A' ' 172' ' ' PRO . 3.6 t -165.04 151.27 10.14 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 117.615 -1.183 . . . . 0.0 113.062 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -96.82 -13.64 22.43 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.565 1.946 . . . . 0.0 115.45 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -128.51 172.16 11.42 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.124 0.97 . . . . 0.0 113.371 -169.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.52 179.35 0.62 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.569 1.147 . . . . 0.0 111.603 169.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -128.4 156.46 43.13 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.034 -1.666 . . . . 0.0 113.437 -170.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -77.65 117.31 18.94 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.598 169.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.565 HD23 ' H ' ' A' ' 119' ' ' ALA . 2.8 tt -88.61 173.89 8.37 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.287 1.435 . . . . 0.0 110.015 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.565 ' H ' HD23 ' A' ' 118' ' ' LEU . . . -54.99 150.5 10.19 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.99 -1.069 . . . . 0.0 110.5 168.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt 74.06 -21.01 0.29 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.557 1.943 . . . . 0.0 114.826 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -54.01 -56.52 17.12 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.239 -1.538 . . . . 0.0 113.022 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.516 ' HE2' ' N ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -57.47 -6.83 0.51 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 119.341 3.089 . . . . 0.0 119.341 -177.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.378 0.5 OUTLIER -64.74 -20.26 66.25 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 122.328 2.331 . . . . 0.0 111.269 174.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -50.48 -44.46 55.87 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.298 1.839 . . . . 0.0 110.241 168.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -87.02 22.3 15.41 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.702 2.096 . . . . 0.0 114.503 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 56.3 m 73.22 20.57 3.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.65 1.98 . . . . 0.0 112.415 170.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 25.2 ttp-105 -116.25 112.59 21.83 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.571 1.548 . . . . 0.0 111.035 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -117.86 -33.76 4.39 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -170.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -63.62 118.21 7.9 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 120.329 1.422 . . . . 0.0 111.304 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.424 ' HA ' ' HB3' ' A' ' 149' ' ' ASP 0.261 3.0 t -67.96 166.36 15.93 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -171.466 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.8 p -60.85 129.11 39.8 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.708 0.803 . . . . 0.0 112.905 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.7 p30 -82.66 -13.68 56.01 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.458 0.703 . . . . 0.0 112.784 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.86 1.18 66.6 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.433 1.492 . . . . 0.0 114.377 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -79.57 165.69 22.68 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.728 1.611 . . . . 0.0 114.036 -169.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 31.3 t -74.1 126.77 31.27 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.809 0.843 . . . . 0.0 109.489 169.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -141.33 39.83 1.74 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.813 1.645 . . . . 0.0 111.739 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.3 mt -103.56 148.75 25.6 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.166 1.387 . . . . 0.0 109.091 172.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -143.15 -64.5 0.4 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.34 0.656 . . . . 0.0 112.182 175.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -92.11 15.79 12.69 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.387 1.475 . . . . 0.0 113.47 177.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.71 9.4 62.78 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.119 1.342 . . . . 0.0 114.526 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 59.5 ttm -117.61 146.68 43.49 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.115 1.366 . . . . 0.0 111.027 172.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.452 ' CE1' ' HB3' ' A' ' 144' ' ' SER . 50.7 t80 -74.35 87.63 2.02 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.877 0.871 . . . . 0.0 111.942 170.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 62.5 ttt-85 -50.62 -38.15 44.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.206 1.802 . . . . 0.0 112.582 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.452 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 4.0 t -64.12 -17.41 63.42 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.081 1.352 . . . . 0.0 114.632 -176.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -35.95 -50.85 0.7 Allowed 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 120.579 1.536 . . . . 0.0 114.107 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.09 -5.03 84.63 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.168 -1.351 . . . . 0.0 114.747 -172.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.327 3.0 pt-20 -129.09 -64.84 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 115.377 -2.249 . . . . 0.0 113.748 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -68.65 154.81 70.7 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 CA-C-N 124.627 2.688 . . . . 0.0 118.003 169.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.424 ' HB3' ' HA ' ' A' ' 130' ' ' THR 0.288 26.8 t0 -83.89 141.5 31.25 Favored 'General case' 0 CA--C 1.551 1.01 1 C-N-CA 133.082 4.553 . . . . 0.0 114.828 -176.598 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -50.67 113.99 1.04 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.416 -0.803 . . . . 0.0 111.21 168.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.624 ' CD ' ' H ' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -54.99 153.47 6.35 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 127.469 2.307 . . . . 0.0 114.849 -173.425 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 85.9 p -83.8 153.01 24.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.107 0.963 . . . . 0.0 112.898 -177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.9 m -55.06 -27.39 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.96 -44.6 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.957 0.903 . . . . 0.0 110.929 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -70.34 -28.25 65.0 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.807 -0.616 . . . . 0.0 111.311 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 186' ' ' ILE . 3.8 mt -60.53 -52.55 64.69 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.883 0.765 . . . . 0.0 110.039 172.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.3 -45.53 84.08 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.431 1.092 . . . . 0.0 111.065 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.2 m -65.91 -47.18 75.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.49 0.716 . . . . 0.0 112.763 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -61.22 -42.55 98.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.066 1.303 . . . . 0.0 111.974 174.688 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.49 -44.67 81.98 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.158 0.983 . . . . 0.0 111.784 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.6 -24.77 62.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.413 1.085 . . . . 0.0 113.471 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -75.27 -43.56 50.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.7 0.8 . . . . 0.0 110.724 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -85.08 -13.85 49.05 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.78 39.43 20.77 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.332 1.453 . . . . 0.0 113.541 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.0 mt -82.71 149.4 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 169.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -107.39 111.34 63.11 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 120.152 1.342 . . . . 0.0 109.503 169.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 189' ' ' LEU . 17.3 Cg_exo -78.02 149.71 25.87 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.655 3.57 . . . . 0.0 113.346 174.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.474 HG22 HG23 ' A' ' 170' ' ' VAL . 3.9 mp -132.91 107.56 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.875 1.27 . . . . 0.0 109.274 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -74.89 71.29 2.01 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.94 -1.1 . . . . 0.0 112.748 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.474 HG23 HG22 ' A' ' 168' ' ' ILE . 95.7 t -75.31 103.39 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 120.421 -1.424 . . . . 0.0 111.742 175.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 22.8 m -145.27 147.73 35.13 Favored Pre-proline 0 N--CA 1.48 1.038 0 O-C-N 120.754 -1.216 . . . . 0.0 112.661 -169.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.448 ' HD2' ' O ' ' A' ' 112' ' ' THR . 60.2 Cg_exo -55.34 149.99 43.43 Favored 'Trans proline' 0 C--N 1.353 0.791 1 C-N-CA 125.808 4.339 . . . . 0.0 115.744 177.518 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 36.5 p -46.73 -49.59 19.35 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.746 2.019 . . . . 0.0 113.422 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -43.22 -32.61 0.79 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.607 2.363 . . . . 0.0 115.431 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.8 ptm -118.68 -2.77 10.9 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.6 1.56 . . . . 0.0 114.75 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.78 -29.85 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-N 120.277 1.399 . . . . 0.0 111.05 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -65.11 -21.06 66.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.208 1.003 . . . . 0.0 113.525 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.55 -39.43 11.92 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.161 0.984 . . . . 0.0 111.36 177.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -73.36 -28.87 62.27 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 120.826 -1.171 . . . . 0.0 110.471 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -58.08 -23.77 55.94 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.66 0.784 . . . . 0.0 110.819 168.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -87.52 -29.54 21.26 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.517 -0.74 . . . . 0.0 110.546 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.82 -26.31 61.44 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.302 1.441 . . . . 0.0 110.138 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.295 3.2 t -80.37 -17.36 52.14 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 173.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 28.9 m -82.83 -34.37 26.89 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.637 -0.664 . . . . 0.0 109.402 169.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -78.77 -19.47 52.16 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 156' ' ' LEU . 20.3 mt -131.74 92.9 29.36 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.504 1.122 . . . . 0.0 108.978 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -60.56 142.34 97.66 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.943 2.429 . . . . 0.0 113.415 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt 93.99 -15.35 0.12 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 130.245 3.418 . . . . 0.0 114.798 169.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.41 ' HB3' ' HD2' ' A' ' 167' ' ' PRO . 1.6 pp -84.24 152.3 24.28 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.7 0.682 . . . . 0.0 109.266 168.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 76.3 p -111.0 -146.61 0.41 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -170.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.1 tt 179.75 152.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 128.317 2.647 . . . . 0.0 110.538 -168.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -153.14 151.05 22.89 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 123.912 0.767 . . . . 0.0 111.811 169.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.4 84.21 5.98 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.739 1.216 . . . . 0.0 109.491 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 11.7 tp -51.44 140.2 18.16 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.356 169.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.3 p -166.65 -123.66 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.619 0.768 . . . . 0.0 110.464 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -88.26 5.8 39.99 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.748 2.019 . . . . 0.0 114.353 -174.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -139.47 146.54 40.15 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.293 1.437 . . . . 0.0 112.721 -173.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 10.1 t -89.89 -23.14 21.7 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.12 1.768 . . . . 0.0 112.369 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 57.8 m -58.61 -26.89 64.16 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 119.818 -1.801 . . . . 0.0 112.098 -175.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -60.29 -34.51 73.86 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 12.7 p -78.42 -38.82 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 120.588 1.54 . . . . 0.0 110.816 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -75.95 -37.29 58.8 Favored 'General case' 0 C--O 1.22 -0.491 0 O-C-N 120.935 -1.103 . . . . 0.0 113.757 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -82.55 20.31 1.13 Allowed 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 121.216 1.826 . . . . 0.0 113.966 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.84 -31.23 2.68 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.756 2.022 . . . . 0.0 109.005 169.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 95.8 mt -68.48 -46.7 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 168.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -57.81 -43.68 85.85 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.667 1.187 . . . . 0.0 110.815 174.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -81.32 -23.04 38.07 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -172.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -77.04 -27.84 54.6 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.567 0.747 . . . . 0.0 111.977 169.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -68.98 -46.39 68.22 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.239 0.615 . . . . 0.0 112.241 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 42.8 p -70.13 -9.65 56.26 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.61 -21.0 58.17 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.039 0.935 . . . . 0.0 113.304 170.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 C--O 1.255 1.343 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -174.853 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 57.9 t0 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -114.96 164.56 13.98 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.844 1.257 . . . . 0.0 111.279 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.0 t -66.69 129.31 39.44 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.29 123.45 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 127.071 2.149 . . . . 0.0 108.737 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -108.68 104.79 14.15 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.717 1.207 . . . . 0.0 109.513 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.512 HD22 ' HB2' ' A' ' 107' ' ' PHE . 1.2 mt -96.1 132.17 41.76 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.882 -1.136 . . . . 0.0 112.824 173.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.442 ' CD2' HG23 ' A' ' 99' ' ' ILE . 26.2 t80 -121.53 110.79 16.45 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 124.426 2.06 . . . . 0.0 110.685 174.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -88.81 114.13 25.1 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 128.201 2.6 . . . . 0.0 113.111 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.448 HD11 HD11 ' A' ' 108' ' ' LEU . 6.8 mp -108.95 130.96 55.46 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.799 0.84 . . . . 0.0 111.099 169.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . 0.348 0.0 OUTLIER -128.93 151.62 49.46 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 167.299 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.16 129.54 11.68 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.964 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.53 27.63 8.62 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.43 1.892 . . . . 0.0 111.635 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 100.0 p -67.08 164.11 18.6 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.504 -1.372 . . . . 0.0 112.923 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.21 -32.7 85.08 Favored Glycine 0 N--CA 1.471 1.027 0 O-C-N 121.142 -0.974 . . . . 0.0 111.864 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 m -59.75 -31.45 69.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.42 1.088 . . . . 0.0 112.379 172.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.36 -0.54 12.64 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -66.75 138.21 57.22 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 121.06 1.754 . . . . 0.0 110.102 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.67 -44.79 3.16 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.219 0.914 . . . . 0.0 111.281 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -68.53 -25.71 65.07 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.592 1.157 . . . . 0.0 111.789 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.4 tp -49.37 -46.35 47.02 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.943 1.697 . . . . 0.0 110.996 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -53.63 -49.95 66.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.798 0.839 . . . . 0.0 111.724 173.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.269 0.5 OUTLIER -69.14 -25.89 64.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.109 -0.948 . . . . 0.0 113.446 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.441 HG11 HG11 ' A' ' 111' ' ' VAL 0.281 0.0 OUTLIER -82.42 -33.8 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 169.881 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . 0.286 3.3 pt20 -71.09 -34.13 70.85 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.263 1.392 . . . . 0.0 111.474 175.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.2 t -66.01 -41.62 90.77 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.174 170.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.46 HD22 HD13 ' A' ' 194' ' ' LEU . 36.0 tp -60.7 -31.6 70.86 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.838 1.199 . . . . 0.0 112.098 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.16 -33.9 6.7 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -168.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.7 t -65.57 -43.29 90.25 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 168.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -78.01 -28.95 49.28 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.38 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.21 -48.05 81.56 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.69 -50.24 58.64 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -57.74 -50.7 72.34 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.781 0.832 . . . . 0.0 111.132 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.71 -40.98 98.12 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.207 0.603 . . . . 0.0 111.564 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.4 mt -79.27 -24.91 42.63 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.114 -0.946 . . . . 0.0 112.926 -176.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.64 -29.17 67.83 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.289 1.404 . . . . 0.0 111.753 169.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.04 -41.5 22.56 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.155 0.982 . . . . 0.0 110.704 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.8 tt -73.29 -28.66 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 118.566 0.621 . . . . 0.0 112.249 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.1 t -145.94 124.56 12.5 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -69.39 -34.25 74.23 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.949 1.299 . . . . 0.0 111.508 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -99.81 78.9 2.17 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.996 1.318 . . . . 0.0 108.964 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.35 74.3 0.42 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 127.198 2.333 . . . . 0.0 108.235 -169.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -81.83 140.02 34.41 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.385 1.093 . . . . 0.0 108.238 -171.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.429 HG23 ' CD2' ' A' ' 66' ' ' PHE . 11.7 tt -120.32 142.94 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 117.856 0.298 . . . . 0.0 111.795 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.95 157.05 22.46 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.951 1.739 . . . . 0.0 110.1 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -128.26 142.59 51.11 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -169.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.82 141.82 12.01 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 118.729 0.695 . . . . 0.0 112.067 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.0 t -109.7 142.26 41.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.476 1.111 . . . . 0.0 110.447 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -150.48 152.28 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 120.775 -1.203 . . . . 0.0 111.766 170.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.3 t -138.72 -62.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.311 1.045 . . . . 0.0 111.06 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.3 t30 154.35 -24.88 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 1 C-N-CA 132.764 4.426 . . . . 0.0 108.24 -169.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.451 ' O ' HG23 ' A' ' 52' ' ' THR . 87.9 mtp -53.72 -50.3 66.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.64 1.176 . . . . 0.0 109.473 168.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 51' ' ' MET . 4.5 p 178.78 179.52 0.39 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 131.09 3.756 . . . . 0.0 108.846 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -98.28 125.75 43.5 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 103.561 -2.755 . . . . 0.0 103.561 166.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -111.9 114.92 28.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 122.337 1.065 . . . . 0.0 109.184 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -82.94 113.21 20.38 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.703 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 41.5 pt -142.07 115.41 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.967 0.907 . . . . 0.0 109.167 168.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.3 tp 101.72 96.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 130.262 3.425 . . . . 0.0 108.611 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -63.0 163.71 9.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.047 1.339 . . . . 0.0 111.535 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.7 mt -54.37 111.68 0.84 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.373 0.669 . . . . 0.0 110.757 174.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 t -133.74 160.98 35.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.34 1.456 . . . . 0.0 112.472 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.37 -2.23 57.39 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.127 1.771 . . . . 0.0 113.336 170.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -86.28 75.51 9.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 125.037 2.351 . . . . 0.0 108.947 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.1 m -71.59 -45.68 61.47 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 129.26 3.024 . . . . 0.0 112.002 -169.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.3 p -55.88 -26.31 46.55 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.791 -0.568 . . . . 0.0 111.34 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.51 -34.8 15.41 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 122.035 -0.415 . . . . 0.0 110.996 -171.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.429 ' CD2' HG23 ' A' ' 43' ' ' ILE . 20.4 t80 -54.2 -34.77 61.34 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.268 -0.895 . . . . 0.0 111.869 169.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -75.29 -30.95 60.56 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.511 0.725 . . . . 0.0 110.642 -172.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -75.16 -29.61 60.5 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 124.592 1.157 . . . . 0.0 110.106 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.72 -35.39 22.52 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.336 0.398 . . . . 0.0 110.392 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -39.56 87.84 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -67.08 -47.05 72.45 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -71.4 -29.22 64.67 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 -168.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -76.71 146.2 38.18 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.247 1.385 . . . . 0.0 113.25 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.2 mt -125.17 163.09 23.22 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.048 1.739 . . . . 0.0 111.983 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.35 159.63 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.243 1.417 . . . . 0.0 113.928 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -118.11 -152.59 0.51 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.772 1.629 . . . . 0.0 110.102 169.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -132.79 152.38 20.28 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 124.95 1.262 . . . . 0.0 114.395 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -148.03 152.95 38.29 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.974 1.71 . . . . 0.0 111.154 173.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -70.55 -82.82 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.455 1.502 . . . . 0.0 111.251 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.05 158.93 30.24 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.0 m -65.04 -46.16 73.82 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 115.856 -2.021 . . . . 0.0 115.084 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.29 138.2 65.0 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.609 2.206 . . . . 0.0 112.482 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -101.87 162.55 12.82 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.941 0.897 . . . . 0.0 112.129 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.07 10.18 49.6 Favored Glycine 0 N--CA 1.482 1.706 0 C-N-CA 124.4 1.0 . . . . 0.0 115.098 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -28.21 -46.13 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 131.197 3.799 . . . . 0.0 115.613 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.462 ' HA ' HG12 ' A' ' 89' ' ' VAL . 6.3 tp -52.78 -34.15 52.05 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.922 2.489 . . . . 0.0 114.37 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -68.27 -40.62 81.82 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.596 -1.315 . . . . 0.0 111.81 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.63 -44.79 66.45 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.505 -0.76 . . . . 0.0 111.913 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 86' ' ' LEU . 7.7 p -54.66 -38.17 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 118.951 0.796 . . . . 0.0 111.755 174.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.485 HG22 HD11 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -70.62 -53.62 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 119.139 0.881 . . . . 0.0 111.818 173.396 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -60.57 -41.35 94.46 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.685 1.13 . . . . 0.0 111.525 -173.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.88 -40.18 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.165 0.586 . . . . 0.0 111.472 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.07 -38.84 89.32 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.038 -1.039 . . . . 0.0 112.193 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.485 HD11 HG22 ' A' ' 90' ' ' VAL . 16.5 mt -81.21 -30.39 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -174.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -84.99 65.64 9.34 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.614 -1.304 . . . . 0.0 112.663 -174.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.4 mt -46.42 -43.59 16.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.781 2.033 . . . . 0.0 111.184 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.28 -31.0 35.47 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.807 1.194 . . . . 0.0 115.136 -174.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -84.95 -43.06 14.36 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.35 1.075 . . . . 0.0 110.514 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.442 HG23 ' CD2' ' A' ' 7' ' ' TYR . 15.9 mm -72.13 -35.96 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 122.306 -0.246 . . . . 0.0 110.338 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.66 25.91 26.38 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.715 1.15 . . . . 0.0 113.857 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.403 ' CZ3' ' HB2' ' A' ' 106' ' ' ARG . 24.8 m95 -55.13 122.5 11.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.645 1.178 . . . . 0.0 112.491 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -97.08 168.22 10.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.799 1.24 . . . . 0.0 111.587 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -84.24 57.72 4.4 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.13 -128.05 5.88 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 169.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.9 p -111.34 144.76 40.02 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 168.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 12.1 ptt-85 -146.16 119.79 9.16 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 120.698 1.59 . . . . 0.0 111.181 -170.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.512 ' HB2' HD22 ' A' ' 6' ' ' LEU . 11.8 m-85 -120.68 131.82 54.77 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -172.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.448 HD11 HD11 ' A' ' 9' ' ' LEU . 7.5 tp -89.75 107.97 19.41 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.613 170.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.9 t -90.48 111.96 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 173.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.6 tp -117.09 114.42 23.71 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 119.062 0.846 . . . . 0.0 110.11 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.441 HG11 HG11 ' A' ' 23' ' ' VAL . 98.0 t -106.11 138.18 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.403 HG22 HG12 ' A' ' 171' ' ' VAL . 13.4 t -150.37 170.03 20.01 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 112.439 -2.164 . . . . 0.0 109.465 168.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -130.38 13.88 5.55 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.996 1.718 . . . . 0.0 113.375 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -142.58 179.35 7.02 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.891 1.676 . . . . 0.0 109.825 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -73.3 -170.84 0.85 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.355 0.597 . . . . 0.0 110.437 168.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -143.96 157.25 44.46 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.063 -1.023 . . . . 0.0 113.616 -169.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -73.58 129.94 39.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.331 172.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.55 HD22 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -105.94 178.32 4.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.832 1.653 . . . . 0.0 109.34 177.542 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.55 ' H ' HD22 ' A' ' 118' ' ' LEU . . . -53.62 140.68 28.17 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.077 -1.015 . . . . 0.0 112.682 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? 85.52 -26.27 0.1 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 128.883 2.873 . . . . 0.0 114.993 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . 0.256 10.6 p30 -65.36 -22.66 66.83 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 121.944 2.157 . . . . 0.0 114.767 -175.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.444 ' H ' ' HD3' ' A' ' 122' ' ' LYS 0.253 0.0 OUTLIER -72.12 6.32 2.24 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 120.245 -1.535 . . . . 0.0 114.794 168.617 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.6 t -61.71 -26.1 67.83 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.755 -1.216 . . . . 0.0 110.155 168.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 57.6 mt -63.7 -35.05 79.29 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.071 1.748 . . . . 0.0 112.96 171.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -88.75 14.36 60.3 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.739 1.638 . . . . 0.0 113.533 172.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.323 25.9 m 41.62 54.81 3.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.375 3.07 . . . . 0.0 114.459 -174.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -100.72 110.45 22.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -85.9 -62.32 1.55 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 121.684 2.038 . . . . 0.0 112.02 -171.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -72.16 132.77 44.6 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.423 ' HA ' ' CB ' ' A' ' 149' ' ' ASP . 6.4 t -49.8 145.02 5.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.767 2.027 . . . . 0.0 111.104 170.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.4 p -65.24 145.27 56.45 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.168 0.985 . . . . 0.0 111.948 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -80.93 -12.54 59.38 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.476 ' HA3' ' HE3' ' A' ' 159' ' ' LYS . . . 72.82 16.73 78.1 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 118.737 -1.035 . . . . 0.0 113.376 -176.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -103.59 159.78 15.3 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.922 1.289 . . . . 0.0 109.018 169.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 4.8 t -85.07 144.65 28.11 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.777 -1.202 . . . . 0.0 112.593 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -132.49 63.78 1.62 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.908 2.083 . . . . 0.0 109.609 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.13 130.04 52.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.199 1.8 . . . . 0.0 108.469 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -133.63 -69.19 0.55 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.226 0.61 . . . . 0.0 112.095 173.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.45 6.64 32.93 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.04 1.336 . . . . 0.0 114.205 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 108.82 -14.49 34.64 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.89 1.71 . . . . 0.0 114.949 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 62.2 mtt -91.54 144.46 25.53 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.285 1.542 . . . . 0.0 110.867 171.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -64.83 98.33 0.27 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 50.9 mmm-85 -56.43 -42.5 78.18 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.304 1.842 . . . . 0.0 112.268 -169.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 70.7 m -95.33 5.06 52.69 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -169.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.9 ttp-105 -47.11 -40.52 15.56 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.504 1.502 . . . . 0.0 112.995 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.73 -3.33 72.83 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 117.953 -1.471 . . . . 0.0 115.208 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.28 45.6 tt0 -120.6 -76.26 0.01 OUTLIER Pre-proline 0 CA--C 1.555 1.161 0 CA-C-O 115.84 -2.028 . . . . 0.0 111.83 176.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -58.89 160.93 16.65 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 123.147 2.565 . . . . 0.0 117.66 175.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.423 ' CB ' ' HA ' ' A' ' 130' ' ' THR . 6.1 t0 -70.12 174.28 5.65 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 129.864 3.266 . . . . 0.0 114.91 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.433 ' HB3' ' CD2' ' A' ' 86' ' ' LEU . 28.2 m-85 -81.29 123.1 28.23 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.672 1.989 . . . . 0.0 105.893 167.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.651 ' H ' ' CD ' ' A' ' 151' ' ' GLN . 0.2 OUTLIER -64.09 135.5 56.43 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 119.712 -1.868 . . . . 0.0 112.101 -177.634 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 24.6 p -67.44 155.45 38.99 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.387 -1.445 . . . . 0.0 112.087 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.442 HG22 HG23 ' A' ' 186' ' ' ILE . 7.2 p -57.69 -28.42 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 120.625 -1.297 . . . . 0.0 114.282 -169.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 52.0 t -81.54 -22.73 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.448 0.699 . . . . 0.0 112.596 175.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -63.9 -41.67 97.64 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.681 1.128 . . . . 0.0 109.013 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.6 mt -55.7 -56.6 18.51 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.345 0.521 . . . . 0.0 110.857 174.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.48 ' HB2' HG22 ' A' ' 186' ' ' ILE . . . -60.36 -30.1 69.34 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.0 t -65.88 -54.07 31.45 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.701 0.682 . . . . 0.0 111.357 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.476 ' HE3' ' HA3' ' A' ' 133' ' ' GLY . 69.3 mmtt -63.78 -44.39 93.53 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.034 -1.041 . . . . 0.0 113.44 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mt -76.34 -23.88 54.24 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.503 -1.373 . . . . 0.0 112.042 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.99 -37.84 61.78 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 169.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.4 -34.77 63.38 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.235 0.925 . . . . 0.0 110.784 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -85.6 -7.05 59.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.117 0.967 . . . . 0.0 112.594 174.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 58.13 37.56 26.37 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.185 1.794 . . . . 0.0 113.347 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 22.9 mm -88.92 140.62 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.298 1.039 . . . . 0.0 109.193 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.503 ' HB2' ' CD2' ' A' ' 107' ' ' PHE . 20.2 mm100 -102.92 101.79 23.36 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 120.743 1.611 . . . . 0.0 109.421 169.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -77.63 143.07 21.08 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.299 2.0 . . . . 0.0 112.979 174.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.6 mm -129.31 109.69 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.004 1.722 . . . . 0.0 108.881 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -75.91 71.81 2.74 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 123.648 1.69 . . . . 0.0 112.149 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 194' ' ' LEU . 58.1 t -63.93 101.63 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 O-C-N 121.141 -0.974 . . . . 0.0 113.008 169.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.403 HG12 HG22 ' A' ' 112' ' ' THR . 5.6 m -144.4 144.18 24.5 Favored Pre-proline 0 N--CA 1.484 1.225 0 O-C-N 120.175 -1.578 . . . . 0.0 111.707 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -67.15 168.37 17.71 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.762 2.308 . . . . 0.0 115.581 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.1 t -52.13 140.88 19.86 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.499 169.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 103.13 -48.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 130.132 3.373 . . . . 0.0 110.006 -172.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -86.79 -22.45 25.88 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.1 t -50.93 -42.11 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 125.729 1.612 . . . . 0.0 111.89 -169.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -75.28 -15.88 60.48 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -172.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.54 -44.19 21.62 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.984 0.811 . . . . 0.0 109.528 172.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -71.89 -28.03 63.23 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.381 1.473 . . . . 0.0 110.656 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.551 ' O ' HG22 ' A' ' 183' ' ' THR . 13.2 mt-10 -65.92 -36.01 82.19 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.252 169.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -76.31 -26.71 56.09 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 116.732 -1.987 . . . . 0.0 110.758 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.6 -19.84 58.98 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.776 -1.203 . . . . 0.0 109.746 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 180' ' ' GLU . 1.6 t -70.37 -23.84 62.86 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 119.473 1.033 . . . . 0.0 110.908 169.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 11.9 m -75.23 -31.02 60.72 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.389 0.676 . . . . 0.0 109.268 173.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -77.13 -27.64 54.03 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.873 173.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.486 HD11 HD13 ' A' ' 189' ' ' LEU . 30.3 pt -119.6 95.92 49.45 Favored Pre-proline 0 N--CA 1.489 1.503 0 CA-C-N 120.182 1.355 . . . . 0.0 113.656 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.87 138.5 51.39 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 124.11 3.207 . . . . 0.0 113.177 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 80.96 -4.1 1.75 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 128.665 2.786 . . . . 0.0 114.065 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.486 HD13 HD11 ' A' ' 186' ' ' ILE . 0.7 OUTLIER -69.54 154.39 42.07 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.927 1.24 . . . . 0.0 108.583 168.772 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.256 1.9 m -128.11 -177.43 4.14 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 169.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.0 tt -146.22 144.49 20.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 129.587 3.155 . . . . 0.0 107.476 -168.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -128.27 146.98 17.18 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -91.1 94.53 9.64 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.46 HD13 HD22 ' A' ' 26' ' ' LEU . 60.9 tp -57.14 139.87 51.17 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.277 169.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 86.7 p -163.85 -176.56 4.64 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.955 1.702 . . . . 0.0 107.697 171.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.59 -6.13 1.52 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 172.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -110.42 133.64 53.09 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.017 1.727 . . . . 0.0 111.728 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 46.8 t -89.72 -17.0 29.12 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.16 1.384 . . . . 0.0 114.053 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 63.2 m -56.67 -40.33 75.33 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.257 -1.527 . . . . 0.0 113.521 -168.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -67.9 -20.31 65.09 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.1 -45.97 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.072 -1.017 . . . . 0.0 110.919 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.9 -34.8 79.26 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 117.625 -1.179 . . . . 0.0 111.512 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -64.57 -6.54 7.79 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.55 1.523 . . . . 0.0 114.17 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 54.3 mt -104.32 -38.8 6.71 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 126.86 2.064 . . . . 0.0 107.425 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 40.4 mm -68.74 -49.53 63.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 169.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . 0.335 21.1 ptt180 -67.28 -26.36 66.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 119.275 -0.97 . . . . 0.0 112.01 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -66.96 -41.56 86.7 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 120.253 1.388 . . . . 0.0 111.161 169.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -75.07 -29.22 60.62 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.769 0.827 . . . . 0.0 112.416 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -66.78 -38.74 87.15 Favored 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 124.28 1.032 . . . . 0.0 111.058 169.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 11.1 t -63.3 -18.74 63.93 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . 0.261 0.0 OUTLIER -103.01 33.71 3.16 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.133 1.373 . . . . 0.0 114.387 -177.013 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 C--O 1.257 1.471 0 N-CA-C 119.165 3.024 . . . . 0.0 119.165 177.71 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.116 0.484 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -95.46 158.51 15.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.959 0.904 . . . . 0.0 111.783 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.1 m -66.32 129.0 38.33 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -174.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 54.8 t -128.29 136.35 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.639 1.976 . . . . 0.0 108.917 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.57 112.03 13.87 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.807 0.843 . . . . 0.0 109.892 -175.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.426 HD22 ' HB2' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -105.93 132.13 52.4 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.209 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -117.38 103.36 10.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 123.351 1.548 . . . . 0.0 109.836 169.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -79.98 104.51 10.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.367 -1.742 . . . . 0.0 112.169 171.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 tt -103.82 126.69 51.13 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.764 0.826 . . . . 0.0 111.226 171.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.2 ptm -121.32 147.07 46.17 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 174.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.71 136.88 15.04 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.404 1.002 . . . . 0.0 112.22 170.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.428 HD23 ' HB2' ' A' ' 47' ' ' SER . 0.6 OUTLIER -119.55 44.41 2.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.165 1.786 . . . . 0.0 112.41 -179.646 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.8 p -72.0 165.01 25.12 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.238 -1.539 . . . . 0.0 112.805 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.08 -21.77 71.98 Favored Glycine 0 N--CA 1.474 1.208 0 O-C-N 120.927 -1.108 . . . . 0.0 113.201 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.2 p -75.18 -16.67 60.49 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.162 1.385 . . . . 0.0 113.145 169.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.55 -6.84 59.13 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -75.51 145.07 41.63 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 121.433 1.924 . . . . 0.0 110.005 169.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.91 -54.41 2.59 Favored Glycine 0 N--CA 1.47 0.922 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 -168.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -66.66 -26.18 66.92 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.039 1.336 . . . . 0.0 111.783 169.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.44 ' HA ' HG12 ' A' ' 23' ' ' VAL . 46.8 tp -45.38 -46.17 13.05 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 127.56 2.344 . . . . 0.0 111.517 172.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.9 t -49.79 -53.08 27.41 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.076 0.95 . . . . 0.0 111.777 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.26 50.6 m-80 -80.6 -25.32 38.53 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 120.132 -1.605 . . . . 0.0 114.485 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 20' ' ' LEU 0.3 12.0 p -74.05 -2.91 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.977 1.262 . . . . 0.0 111.11 168.464 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . 0.288 16.2 pt20 -103.06 -33.95 9.07 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 119.746 1.157 . . . . 0.0 111.631 168.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.8 m -56.22 -54.86 40.27 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.909 1.284 . . . . 0.0 108.542 168.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.444 ' CD2' HG21 ' A' ' 170' ' ' VAL . 13.0 tp -81.53 84.23 6.79 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 169.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 177.59 -53.81 0.1 OUTLIER Glycine 0 C--N 1.302 -1.347 0 CA-C-N 110.998 -2.819 . . . . 0.0 107.951 168.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -74.68 -37.99 62.51 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 124.113 0.965 . . . . 0.0 111.297 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -68.83 -36.49 78.25 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.243 0.617 . . . . 0.0 111.064 169.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 tp -63.01 -47.68 82.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.653 HD11 ' HB3' ' A' ' 63' ' ' SER . 1.7 tm? -57.38 -61.52 2.43 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.786 1.634 . . . . 0.0 112.344 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -73.43 -35.21 65.76 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.928 1.694 . . . . 0.0 112.927 -171.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.9 -35.93 73.85 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.564 1.074 . . . . 0.0 111.748 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.7 mt -80.82 -30.19 35.86 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -64.56 -17.18 63.71 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 119.324 0.965 . . . . 0.0 112.869 171.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -86.38 -43.89 12.48 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.856 1.263 . . . . 0.0 111.341 174.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 tp -71.69 -26.73 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.013 0.824 . . . . 0.0 112.241 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.7 t -147.02 134.2 20.51 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 176.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -72.65 -24.16 61.01 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.479 1.112 . . . . 0.0 112.372 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.3 m -106.26 78.08 1.27 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.281 1.432 . . . . 0.0 109.224 175.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.29 78.75 0.32 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 127.408 2.432 . . . . 0.0 107.817 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -81.56 140.81 34.28 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.451 HD12 ' CE1' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -125.05 137.76 56.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -177.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.42 ' HA3' HD23 ' A' ' 59' ' ' LEU . . . -133.57 155.3 21.67 Favored Glycine 0 N--CA 1.464 0.552 0 C-N-CA 124.45 1.024 . . . . 0.0 111.002 171.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -107.28 163.52 12.95 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.275 0.63 . . . . 0.0 111.923 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.5 147.99 12.85 Favored Glycine 0 C--N 1.345 1.046 0 O-C-N 120.543 -1.348 . . . . 0.0 112.293 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.428 ' HB2' HD23 ' A' ' 12' ' ' LEU . 39.7 p -136.66 152.36 50.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.967 1.365 . . . . 0.0 114.403 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -159.78 157.46 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.035 1.334 . . . . 0.0 108.827 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.446 HG13 ' H ' ' A' ' 50' ' ' ASN . 1.3 p -146.99 -73.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.446 ' H ' HG13 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -164.01 -14.18 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.53 1.532 . . . . 0.0 111.604 169.542 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.616 ' O ' HG23 ' A' ' 52' ' ' THR . 23.6 ptt? -48.16 -41.92 28.22 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.54 1.936 . . . . 0.0 112.903 169.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 51' ' ' MET . 19.0 p 160.2 -179.95 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.189 1 C-N-CA 133.732 4.813 . . . . 0.0 107.381 -171.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -102.09 135.65 43.31 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 167.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -127.59 127.26 43.57 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 123.306 1.527 . . . . 0.0 110.935 171.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -77.34 129.22 35.54 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.445 171.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.2 mt -137.18 139.35 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 127.406 2.282 . . . . 0.0 105.613 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER 44.94 99.47 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.865 2.466 . . . . 0.0 116.529 -169.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -66.91 163.05 20.45 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.154 -0.966 . . . . 0.0 110.983 168.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.42 HD23 ' HA3' ' A' ' 44' ' ' GLY . 13.4 mt -52.18 117.63 2.94 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.103 0.561 . . . . 0.0 111.583 -172.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -138.31 156.38 47.69 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.326 1.451 . . . . 0.0 111.733 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.64 6.01 50.15 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.286 1.434 . . . . 0.0 112.539 170.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -81.85 79.28 8.43 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 125.359 2.504 . . . . 0.0 108.511 171.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.653 ' HB3' HD11 ' A' ' 31' ' ' LEU . 67.7 m -67.14 -45.45 77.08 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 129.112 2.965 . . . . 0.0 110.272 -171.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.7 t -63.29 -23.13 67.28 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.849 0.86 . . . . 0.0 111.627 169.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -78.54 -47.16 17.84 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 120.834 -1.166 . . . . 0.0 110.38 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.451 ' CE1' HD12 ' A' ' 43' ' ' ILE . 55.2 t80 -56.86 -32.9 66.29 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 123.379 0.672 . . . . 0.0 111.585 176.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -68.44 -38.78 81.49 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.527 -0.733 . . . . 0.0 110.207 -175.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 68.1 mtt-85 -73.54 -38.11 65.36 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.611 1.165 . . . . 0.0 109.144 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -84.13 -25.07 29.96 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.609 -172.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.97 -48.49 53.06 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 168.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -62.03 -33.57 74.62 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -71.76 -14.0 61.87 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -64.59 156.12 30.97 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.371 1.442 . . . . 0.0 113.547 -172.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.28 141.87 37.76 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.324 1.85 . . . . 0.0 110.672 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -79.36 154.0 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-O 121.221 0.534 . . . . 0.0 112.102 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.1 t -109.35 -152.07 0.48 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.604 1.162 . . . . 0.0 109.028 168.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -147.17 151.13 23.45 Favored Glycine 0 N--CA 1.471 1.005 0 O-C-N 120.632 -1.293 . . . . 0.0 114.042 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.53 150.6 21.51 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.254 1.422 . . . . 0.0 111.874 172.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.61 -61.91 1.62 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.288 1.435 . . . . 0.0 112.246 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.3 136.41 51.81 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.021 0.528 . . . . 0.0 111.001 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.324 0.0 OUTLIER -70.35 -38.19 8.11 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-O 116.248 -1.834 . . . . 0.0 113.909 -176.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.51 141.71 81.6 Favored 'Trans proline' 0 C--N 1.355 0.888 0 CA-C-N 122.439 1.907 . . . . 0.0 110.844 169.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -170.83 1.72 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.223 1.009 . . . . 0.0 113.127 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.401 ' HA3' ' NH2' ' A' ' 145' ' ' ARG . . . -112.8 30.11 7.68 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 -169.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.506 ' CG ' HD21 ' A' ' 110' ' ' LEU 0.285 0.2 OUTLIER -70.33 -29.4 66.09 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 118.526 2.788 . . . . 0.0 118.526 -168.906 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.83 HD23 HD21 ' A' ' 156' ' ' LEU . 8.4 mp -66.14 -30.91 71.49 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 123.787 2.994 . . . . 0.0 112.995 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -59.95 -41.76 92.58 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.11 -0.994 . . . . 0.0 110.73 171.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.04 -49.4 72.49 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.024 -0.988 . . . . 0.0 111.379 174.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 m -58.8 -32.88 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 119.701 1.137 . . . . 0.0 112.168 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.0 t -78.02 -40.8 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 117.161 -1.399 . . . . 0.0 112.566 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -56.83 -45.23 82.46 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 121.663 2.029 . . . . 0.0 110.238 171.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.578 HG11 HD23 ' A' ' 108' ' ' LEU . 79.9 t -59.45 -32.37 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 174.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.31 -35.32 47.93 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.731 -1.231 . . . . 0.0 113.792 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.1 mm -93.03 -30.85 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 119.721 1.146 . . . . 0.0 113.25 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 78.4 m -79.74 52.27 1.43 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.396 1.478 . . . . 0.0 112.016 -172.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.7 mt -49.86 -41.19 44.73 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.123 2.169 . . . . 0.0 112.207 -169.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.44 -23.63 70.1 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.258 0.932 . . . . 0.0 114.534 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.43 -34.66 8.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.165 0.982 . . . . 0.0 111.531 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.65 -45.97 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 118.976 0.807 . . . . 0.0 110.095 170.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.83 26.04 10.09 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.809 1.195 . . . . 0.0 115.254 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -57.82 125.3 22.42 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.265 1.532 . . . . 0.0 112.268 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -93.02 -158.56 0.61 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.769 1.228 . . . . 0.0 112.139 172.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -90.55 0.33 57.39 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -173.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.9 -127.4 2.28 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 120.586 1.539 . . . . 0.0 111.396 -175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.2 t -114.6 140.72 48.56 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.572 1.549 . . . . 0.0 108.925 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -122.89 134.2 54.38 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 117.32 -1.324 . . . . 0.0 109.887 -168.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.459 ' CD2' ' HB3' ' A' ' 166' ' ' GLN . 15.1 m-85 -129.91 113.85 15.14 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.578 HD23 HG11 ' A' ' 92' ' ' VAL . 3.2 tm? -82.49 98.8 9.11 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 170.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 80.4 t -83.69 116.21 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.506 HD21 ' CG ' ' A' ' 85' ' ' GLN . 3.2 tm? -110.33 108.03 17.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.161 -168.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.413 HG22 HG13 ' A' ' 170' ' ' VAL . 46.2 t -101.74 129.89 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.6 t -161.47 151.43 17.04 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -106.67 -13.5 15.27 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -169.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -137.12 -169.8 2.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.827 1.251 . . . . 0.0 110.553 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.67 -170.71 0.57 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.075 0.95 . . . . 0.0 112.745 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.537 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 48.2 t80 -139.21 149.8 44.8 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.266 1.426 . . . . 0.0 112.546 -172.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -84.68 91.81 8.03 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.031 1.332 . . . . 0.0 113.332 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.24 163.02 4.07 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 120.493 -1.379 . . . . 0.0 112.432 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -46.71 135.1 9.18 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.619 -0.676 . . . . 0.0 111.504 170.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm 97.5 -12.48 0.07 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 130.179 3.391 . . . . 0.0 112.142 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -76.8 -20.09 56.82 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.607 -1.308 . . . . 0.0 113.737 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.42 ' HG3' ' CD2' ' A' ' 150' ' ' TYR . 34.0 mttm -71.72 -1.67 14.7 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 120.023 1.283 . . . . 0.0 114.344 170.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -58.41 -36.27 73.34 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.413 1.006 . . . . 0.0 111.453 169.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.6 mt -63.94 -36.27 83.39 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.462 0.705 . . . . 0.0 112.437 173.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -82.39 13.93 37.59 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.778 1.656 . . . . 0.0 114.068 172.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.322 11.6 t 53.04 48.15 22.99 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 128.031 2.532 . . . . 0.0 113.442 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -127.43 113.66 16.48 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.728 1.211 . . . . 0.0 111.41 172.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -94.78 -30.29 14.32 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.304 1.441 . . . . 0.0 113.139 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -60.35 120.32 9.63 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.347 0.659 . . . . 0.0 110.809 -172.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.5 t -61.47 155.95 20.59 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.827 0.739 . . . . 0.0 110.599 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.6 t -65.01 143.19 58.12 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.655 0.74 . . . . 0.0 112.182 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -79.57 -29.27 41.24 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.243 1.017 . . . . 0.0 112.32 -177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.35 18.79 70.56 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.089 0.852 . . . . 0.0 113.044 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -106.88 164.51 12.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.085 1.754 . . . . 0.0 113.386 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 6.3 t -72.05 125.65 27.78 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.142 1.377 . . . . 0.0 109.639 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -134.75 41.17 2.9 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.8 1.64 . . . . 0.0 111.448 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.37 124.42 47.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.287 2.235 . . . . 0.0 109.315 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . 0.257 15.3 p-10 -115.71 -96.72 0.46 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.397 1.079 . . . . 0.0 112.608 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.25 30.25 0.28 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 121.016 1.734 . . . . 0.0 113.679 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.57 -9.32 66.64 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.915 1.721 . . . . 0.0 114.142 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 20.5 ptp -97.02 151.67 19.49 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.597 1.698 . . . . 0.0 113.034 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -84.6 80.58 9.19 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.912 0.885 . . . . 0.0 109.735 169.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.3 ttm-85 -58.63 -32.94 69.51 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 38.9 m -64.87 -8.34 14.99 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.401 ' NH2' ' HA3' ' A' ' 84' ' ' GLY . 9.2 tpt180 -52.94 -29.13 26.9 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 120.649 1.568 . . . . 0.0 114.109 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.46 1.4 87.31 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 117.99 -1.45 . . . . 0.0 115.09 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.379 0.7 OUTLIER -121.41 -79.17 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 115.89 -2.005 . . . . 0.0 112.82 178.214 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.89 154.35 67.14 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 CA-C-N 124.463 2.63 . . . . 0.0 115.65 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -62.02 169.41 2.68 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 129.829 3.252 . . . . 0.0 112.912 170.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.42 ' CD2' ' HG3' ' A' ' 122' ' ' LYS . 74.8 m-85 -62.83 159.74 15.97 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.489 -0.757 . . . . 0.0 111.812 169.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -81.34 140.03 35.01 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.4 -0.812 . . . . 0.0 111.271 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.3 p -80.6 151.48 29.05 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.312 1.045 . . . . 0.0 111.253 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.525 ' HA ' HD23 ' A' ' 156' ' ' LEU . 45.1 t -53.13 -39.09 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -168.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.42 -18.69 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 O-C-N 121.496 -0.753 . . . . 0.0 112.534 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -67.11 -36.31 81.65 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.739 1.154 . . . . 0.0 110.412 170.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.83 HD21 HD23 ' A' ' 86' ' ' LEU . 1.9 mm? -59.05 -58.59 7.98 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 168.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.16 -43.79 78.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.102 0.961 . . . . 0.0 112.976 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.8 m -58.08 -56.13 25.98 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.058 0.943 . . . . 0.0 112.371 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.292 10.6 mptt -86.84 -20.44 27.49 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -174.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.4 mp -67.46 -31.13 71.09 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.382 1.446 . . . . 0.0 109.954 168.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.63 -33.78 58.34 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.657 1.183 . . . . 0.0 114.103 172.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.5 -51.47 59.78 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.4 1.08 . . . . 0.0 110.111 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -77.91 -12.69 60.0 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.69 0.796 . . . . 0.0 111.927 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.79 47.04 18.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.563 2.345 . . . . 0.0 111.991 176.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 28.9 mm -85.43 136.98 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.861 1.264 . . . . 0.0 108.421 174.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.459 ' HB3' ' CD2' ' A' ' 107' ' ' PHE . 3.7 tp60 -93.82 108.57 35.72 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 120.759 1.618 . . . . 0.0 107.859 168.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.55 ' HG2' ' HG ' ' A' ' 189' ' ' LEU . 83.0 Cg_endo -74.0 138.46 25.69 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.412 3.408 . . . . 0.0 113.24 171.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.5 mm -129.31 101.93 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.987 1.315 . . . . 0.0 110.115 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -72.39 72.58 0.96 Allowed 'General case' 0 N--CA 1.476 0.832 0 O-C-N 120.636 -1.29 . . . . 0.0 112.564 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.444 HG21 ' CD2' ' A' ' 26' ' ' LEU . 3.5 p -69.73 106.36 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 O-C-N 120.78 -1.2 . . . . 0.0 113.029 170.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 31.8 m -145.41 147.07 32.29 Favored Pre-proline 0 N--CA 1.482 1.167 0 O-C-N 120.354 -1.466 . . . . 0.0 113.293 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -59.52 155.67 40.65 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 124.855 3.704 . . . . 0.0 114.849 172.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.9 t -41.62 -60.57 1.29 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.447 2.299 . . . . 0.0 114.94 -169.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -64.04 -12.5 39.11 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -171.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 66.8 mmm -99.25 -7.47 26.38 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.6 t -57.34 -36.62 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 120.272 1.396 . . . . 0.0 111.66 -169.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -69.92 -28.31 65.49 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.01 -34.83 24.23 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 118.926 0.785 . . . . 0.0 111.309 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -72.42 -30.72 64.88 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.565 -1.334 . . . . 0.0 110.325 170.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -71.26 -11.79 61.11 Favored 'General case' 0 CA--C 1.553 1.092 0 O-C-N 121.584 -0.697 . . . . 0.0 111.376 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -84.33 -47.11 11.07 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.039 -1.663 . . . . 0.0 109.969 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.81 -21.14 59.47 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 119.966 -1.709 . . . . 0.0 111.051 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.84 -16.7 61.59 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.726 0.81 . . . . 0.0 111.961 171.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.55 -25.57 28.62 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 119.487 -0.292 . . . . 0.0 110.969 170.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -87.99 -18.48 28.93 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 56.9 mt -118.35 96.48 49.85 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.285 1.034 . . . . 0.0 108.837 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -55.42 141.76 81.52 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.688 2.926 . . . . 0.0 114.439 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . 0.325 0.0 OUTLIER 81.55 -15.51 0.71 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 128.618 2.767 . . . . 0.0 113.093 171.55 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.55 ' HG ' ' HG2' ' A' ' 167' ' ' PRO . 2.5 tt -56.76 148.01 21.54 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 127.003 2.121 . . . . 0.0 108.689 169.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 77.2 p -121.41 -150.76 0.46 Allowed 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 120.784 1.629 . . . . 0.0 109.651 170.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -179.34 117.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 119.51 -1.994 . . . . 0.0 109.154 -167.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -110.6 152.68 17.36 Favored Glycine 0 N--CA 1.469 0.875 0 C-N-CA 124.83 1.205 . . . . 0.0 112.242 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -93.8 85.69 4.89 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.866 1.266 . . . . 0.0 109.175 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.417 ' HB2' HG22 ' A' ' 170' ' ' VAL . 47.8 tp -56.79 130.94 47.77 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.977 169.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.7 t -165.7 -159.39 0.4 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.559 1.144 . . . . 0.0 109.278 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -63.79 -11.11 24.0 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.877 1.271 . . . . 0.0 114.205 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -128.95 134.52 48.23 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.773 2.429 . . . . 0.0 111.755 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 24.2 p -95.3 0.04 53.34 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.719 2.008 . . . . 0.0 113.904 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.7 p -56.92 -45.16 82.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.348 1.859 . . . . 0.0 112.722 -169.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -64.0 -39.37 93.97 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 122.719 0.408 . . . . 0.0 111.793 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.5 t -71.45 -42.52 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.639 -0.663 . . . . 0.0 110.12 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.63 -30.94 71.33 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.531 0.732 . . . . 0.0 112.517 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -70.01 -11.9 61.22 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.185 -1.572 . . . . 0.0 113.009 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.53 -35.59 7.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.775 1.63 . . . . 0.0 108.809 -173.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 4.3 mt -77.45 -34.65 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 118.619 -0.705 . . . . 0.0 109.58 169.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -72.84 -29.74 63.46 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.23 0.923 . . . . 0.0 111.25 169.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -64.26 -36.14 83.11 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 119.979 1.263 . . . . 0.0 111.453 169.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -76.11 -24.47 54.96 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.602 0.761 . . . . 0.0 112.638 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -63.68 -50.04 70.79 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.761 0.824 . . . . 0.0 110.592 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 65.5 p -74.94 -7.66 54.24 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.06 -37.09 78.33 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.24 -0.912 . . . . 0.0 111.747 169.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.259 1.582 0 C-N-CA 126.692 1.997 . . . . 0.0 112.856 179.373 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.3 t70 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.158 0.504 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -120.68 147.42 45.29 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.913 1.285 . . . . 0.0 109.056 171.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.9 p -62.02 137.18 58.22 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.621 0.724 . . . . 0.0 111.807 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 t -115.91 145.67 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.947 1.699 . . . . 0.0 106.646 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.3 14.9 p-10 -136.99 111.99 8.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.736 0.779 . . . . 0.0 110.35 171.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.2 tp -96.24 134.35 39.45 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.511 1.124 . . . . 0.0 112.653 -175.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -118.68 103.16 9.42 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 123.204 1.478 . . . . 0.0 109.388 168.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -82.43 93.87 7.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.056 1.742 . . . . 0.0 111.534 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 30.5 tp -92.1 125.53 36.83 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.377 1.071 . . . . 0.0 109.619 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.466 ' CE ' ' CZ ' ' A' ' 45' ' ' PHE 0.306 0.0 OUTLIER -134.24 165.62 24.69 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 172.276 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.46 140.26 15.57 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.677 1.132 . . . . 0.0 112.343 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.446 HD21 ' CE ' ' A' ' 10' ' ' MET . 3.5 mm? -114.59 22.63 13.43 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.15 1.78 . . . . 0.0 112.212 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 p -68.44 160.04 30.47 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.586 -1.321 . . . . 0.0 110.91 169.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -56.46 -21.46 34.47 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 116.443 1.337 . . . . 0.0 116.443 -169.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.4 p -64.23 -27.25 68.92 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.234 1.413 . . . . 0.0 114.264 170.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.35 -10.96 59.9 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.664 1.586 . . . . 0.0 114.813 -172.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -68.12 121.16 15.57 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.63 -39.85 2.76 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.068 1.318 . . . . 0.0 111.805 -169.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -70.79 -44.56 66.38 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 118.339 1.07 . . . . 0.0 110.514 169.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 tt -53.54 -39.74 64.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.112 1.765 . . . . 0.0 112.071 173.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.2 m -62.14 -34.62 76.73 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.324 1.05 . . . . 0.0 113.204 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -81.41 -23.65 37.44 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.8 m -103.5 15.06 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 119.408 1.004 . . . . 0.0 113.496 -173.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -93.53 -36.38 12.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.392 1.077 . . . . 0.0 109.599 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 t -68.81 -14.9 63.32 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 122.026 0.917 . . . . 0.0 109.413 167.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 tp -86.71 102.32 14.12 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 125.133 2.397 . . . . 0.0 107.907 174.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.38 -51.96 0.09 OUTLIER Glycine 0 C--N 1.299 -1.492 0 CA-C-N 108.493 -3.958 . . . . 0.0 110.75 168.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -82.94 -39.61 21.19 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.054 1.342 . . . . 0.0 110.797 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -71.91 -31.36 66.3 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.726 -0.609 . . . . 0.0 111.193 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.13 -44.24 92.82 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-O 119.214 -0.422 . . . . 0.0 109.866 172.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -34.33 75.64 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 116.802 -1.57 . . . . 0.0 112.652 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -31.66 72.78 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 123.165 2.711 . . . . 0.0 112.447 174.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.75 -25.36 53.39 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 171.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 47.8 mt -92.75 -20.93 20.27 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.548 1.067 . . . . 0.0 113.662 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -80.62 -16.43 54.1 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.131 1.332 . . . . 0.0 114.387 -169.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -85.95 -33.27 21.19 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 119.129 -0.463 . . . . 0.0 110.579 169.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . 0.328 0.0 OUTLIER -75.08 -24.88 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 118.979 0.809 . . . . 0.0 112.757 169.46 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.4 t -154.47 135.37 13.75 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -81.15 1.71 30.72 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 172.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.4 t -141.37 108.08 5.37 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.977 -1.077 . . . . 0.0 109.866 169.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.42 83.69 0.24 Allowed Glycine 0 C--N 1.337 0.625 0 C-N-CA 126.776 2.132 . . . . 0.0 107.929 -169.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -77.25 151.36 35.15 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.28 138.02 53.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 117.754 0.252 . . . . 0.0 111.17 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.409 ' HA2' HD13 ' A' ' 57' ' ' LEU . . . -135.14 163.77 24.83 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 126.891 2.186 . . . . 0.0 110.9 171.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.466 ' CZ ' ' CE ' ' A' ' 10' ' ' MET . 86.1 t80 -135.5 145.27 46.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.995 0.918 . . . . 0.0 111.831 -169.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.35 147.2 18.47 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 122.568 0.128 . . . . 0.0 112.887 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.6 m -118.7 142.74 47.39 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.503 1.121 . . . . 0.0 112.036 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.79 157.12 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.726 1.21 . . . . 0.0 110.411 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 p -157.83 -52.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 124.405 1.082 . . . . 0.0 109.994 169.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 161.48 -22.9 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 131.302 3.841 . . . . 0.0 110.525 169.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -52.77 -39.93 62.69 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.642 0.777 . . . . 0.0 111.462 170.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.1 p -170.43 168.9 7.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 129.744 3.218 . . . . 0.0 110.723 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -113.11 123.65 50.76 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 101.003 -3.703 . . . . 0.0 101.003 165.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -122.03 114.04 20.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -174.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -81.64 114.63 20.45 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.637 169.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.3 mt -139.44 95.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.409 HD13 ' HA2' ' A' ' 44' ' ' GLY 0.262 2.6 tm? 107.43 94.17 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 130.703 3.601 . . . . 0.0 109.139 174.492 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -52.66 159.42 1.08 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.592 1.557 . . . . 0.0 112.741 170.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.7 mt -53.64 120.47 6.23 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 172.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.8 t -147.0 170.04 17.94 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.511 1.124 . . . . 0.0 112.539 -172.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.35 -22.69 18.79 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.676 1.99 . . . . 0.0 114.397 -175.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -89.92 89.76 7.87 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 125.86 2.743 . . . . 0.0 108.665 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.0 p -60.73 -36.57 79.21 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 131.244 3.818 . . . . 0.0 111.523 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.5 t -65.01 -19.05 65.81 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.06 0.944 . . . . 0.0 110.814 169.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -82.02 -37.25 26.81 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.846 -1.159 . . . . 0.0 111.015 176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -56.88 -32.64 66.06 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.091 -1.006 . . . . 0.0 111.211 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -73.37 -41.68 63.11 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.305 -0.872 . . . . 0.0 110.626 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -27.22 63.34 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -88.46 -30.3 19.52 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.06 -52.56 55.03 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -66.51 -26.96 67.41 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -169.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -69.92 -44.06 70.41 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . 0.267 9.9 pt20 -80.18 167.48 20.29 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -151.54 169.64 21.61 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -167.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.61 154.29 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.648 1.579 . . . . 0.0 113.895 -169.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -120.24 -160.02 0.81 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.285 1.834 . . . . 0.0 111.146 169.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -156.19 155.71 26.52 Favored Glycine 0 N--CA 1.472 1.076 0 O-C-N 120.507 -1.371 . . . . 0.0 113.957 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -152.32 151.96 31.52 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.645 1.178 . . . . 0.0 112.767 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -55.68 -58.99 5.5 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.088 2.155 . . . . 0.0 112.343 174.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.72 143.98 37.63 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.266 15.1 t -70.15 -41.75 15.1 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 115.563 -2.16 . . . . 0.0 114.443 174.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.74 142.87 84.86 Favored 'Trans proline' 0 C--N 1.356 0.972 0 CA-C-N 123.421 2.257 . . . . 0.0 112.319 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -112.78 154.58 26.0 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.912 1.285 . . . . 0.0 113.43 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.04 55.76 4.79 Favored Glycine 0 N--CA 1.479 1.51 0 C-N-CA 125.664 1.602 . . . . 0.0 112.586 -172.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -83.07 -33.82 26.33 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.458 1.903 . . . . 0.0 115.689 -168.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.9 -37.95 79.31 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -171.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -51.46 -46.82 63.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.224 1.01 . . . . 0.0 111.601 169.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.48 -53.63 49.1 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.132 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.25 32.9 m -64.25 -27.41 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 119.476 1.035 . . . . 0.0 112.621 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.04 -63.01 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 119.427 1.012 . . . . 0.0 108.564 168.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -58.43 -42.78 88.04 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.171 0.896 . . . . 0.0 111.174 -173.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.0 t -55.76 -35.4 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.08 0.855 . . . . 0.0 112.428 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.71 -37.14 65.26 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.818 -1.176 . . . . 0.0 113.486 175.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.433 ' HB ' ' SG ' ' A' ' 135' ' ' CYS . 7.9 mm -93.56 -15.8 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.858 0.863 . . . . 0.0 113.017 -172.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.52 49.01 0.96 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.763 2.025 . . . . 0.0 112.58 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -49.95 -40.1 42.65 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.778 -1.201 . . . . 0.0 112.048 -175.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.71 -19.23 54.8 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -91.89 -45.52 8.33 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.917 1.359 . . . . 0.0 110.815 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.5 mm -65.85 -44.35 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.297 0.639 . . . . 0.0 109.351 175.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.33 21.9 21.0 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.998 1.285 . . . . 0.0 114.083 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -49.03 128.36 16.0 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.818 1.247 . . . . 0.0 112.087 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . 0.336 0.6 OUTLIER -113.93 -173.65 2.32 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 175.376 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -67.65 -2.91 7.61 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 118.792 2.886 . . . . 0.0 118.792 -168.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.29 -125.29 2.63 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 121.091 1.769 . . . . 0.0 112.268 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.4 m -111.83 115.3 28.8 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.145 1.778 . . . . 0.0 107.802 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 -99.54 128.81 45.66 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -168.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -127.19 104.25 7.86 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -168.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.97 89.38 6.05 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.187 -0.946 . . . . 0.0 111.004 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.5 t -72.29 132.57 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 tp -112.62 127.07 56.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.32 124.11 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 123.959 0.787 . . . . 0.0 110.54 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -150.14 164.66 35.05 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.613 0.765 . . . . 0.0 111.465 171.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.46 2.95 6.94 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.721 1.608 . . . . 0.0 114.765 174.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -123.12 173.13 8.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.435 1.094 . . . . 0.0 112.036 171.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -69.98 -169.14 0.24 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.752 0.821 . . . . 0.0 111.542 169.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.437 ' CE1' HD11 ' A' ' 182' ' ' LEU . 29.8 p90 -142.07 158.71 43.44 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.107 -0.996 . . . . 0.0 112.983 -169.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -84.29 123.84 30.59 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.172 169.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.69 HD22 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -86.43 -177.54 6.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.157 0.983 . . . . 0.0 109.47 170.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.69 ' H ' HD22 ' A' ' 118' ' ' LEU . . . -57.67 163.64 2.42 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.359 -0.838 . . . . 0.0 111.467 169.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.408 0.0 OUTLIER 55.11 -3.68 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.775 2.03 . . . . 0.0 116.162 -169.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -75.16 -28.62 60.18 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 121.313 1.87 . . . . 0.0 113.757 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -73.54 1.88 9.06 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 121.035 1.743 . . . . 0.0 113.424 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.7 t -59.83 -25.36 64.94 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.468 1.031 . . . . 0.0 111.501 169.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.4 mt -61.62 -21.16 64.13 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.405 1.882 . . . . 0.0 113.366 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -91.96 -108.34 1.64 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 169.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.277 7.1 t -152.55 40.3 0.58 Allowed 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 123.429 1.585 . . . . 0.0 111.041 169.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.02 89.64 5.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.942 1.697 . . . . 0.0 109.483 -175.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -86.07 -42.0 14.3 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.746 -0.596 . . . . 0.0 111.333 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -65.67 134.99 54.4 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.246 0.619 . . . . 0.0 109.967 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.3 p -97.19 147.22 24.31 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.548 1.139 . . . . 0.0 109.436 169.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.7 m -58.24 141.85 49.5 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.5 p30 -72.51 -11.38 60.64 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.467 1.507 . . . . 0.0 113.75 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.5 10.07 86.47 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.639 1.114 . . . . 0.0 113.329 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -84.61 176.56 8.52 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.961 1.38 . . . . 0.0 110.276 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' CYS . . . . . 0.433 ' SG ' ' HB ' ' A' ' 94' ' ' ILE . 0.6 OUTLIER -100.88 144.69 29.52 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 172.301 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -133.8 38.16 3.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.643 1.977 . . . . 0.0 110.868 -170.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 pp -62.53 160.19 14.29 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.112 1.765 . . . . 0.0 111.807 171.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -157.73 -101.46 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.72 1.208 . . . . 0.0 110.298 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.27 35.93 0.82 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.606 1.962 . . . . 0.0 113.062 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.1 18.35 55.96 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.744 1.164 . . . . 0.0 114.476 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.5 ptp -149.01 156.2 41.91 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.962 1.381 . . . . 0.0 113.905 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -68.94 104.37 2.06 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.552 1.141 . . . . 0.0 111.844 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -65.63 -42.05 91.97 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.344 0.658 . . . . 0.0 111.04 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.9 m -74.56 -3.36 30.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -172.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -44.56 -29.65 0.76 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.8 3.64 57.47 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.574 2.035 . . . . 0.0 115.962 -174.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.421 2.3 pt-20 -131.58 -49.58 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.106 0 CA-C-N 120.755 2.277 . . . . 0.0 114.68 170.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -80.02 151.08 20.97 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 CA-C-N 122.479 1.921 . . . . 0.0 113.736 167.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -75.46 165.54 24.96 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 129.155 2.982 . . . . 0.0 112.233 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -57.98 152.93 15.34 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.091 -1.006 . . . . 0.0 109.24 168.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . 0.334 3.0 mm-40 -106.46 165.42 11.29 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.4 p -73.61 161.82 29.9 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -168.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 t -61.96 -28.93 45.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.524 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.8 t -73.49 -42.56 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.265 1.026 . . . . 0.0 111.083 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -64.83 -38.03 89.62 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.489 0.586 . . . . 0.0 110.474 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 87.8 mt -57.19 -60.76 3.14 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.028 0.531 . . . . 0.0 110.261 170.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.83 -45.8 85.66 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -172.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.5 m -64.98 -49.59 69.67 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.839 -0.538 . . . . 0.0 112.306 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -74.66 -27.83 60.59 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.067 -1.021 . . . . 0.0 112.384 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 14.8 tp -61.12 -44.47 97.29 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.773 -1.205 . . . . 0.0 111.89 170.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.79 -24.65 61.78 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.04 0.936 . . . . 0.0 113.509 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -72.75 -44.21 61.92 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.098 1.359 . . . . 0.0 110.297 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -80.3 -18.88 47.99 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 56.2 63.74 1.91 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.763 1.625 . . . . 0.0 111.317 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 87.1 mt -113.88 137.66 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.677 1.591 . . . . 0.0 109.274 175.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -91.25 120.71 68.38 Favored Pre-proline 0 N--CA 1.475 0.784 0 CA-C-O 116.703 -1.617 . . . . 0.0 110.488 170.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -88.13 148.66 6.75 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.622 2.881 . . . . 0.0 110.477 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.83 99.17 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.553 ' HB2' HG22 ' A' ' 191' ' ' ILE . 7.1 m-85 -76.48 69.87 2.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 122.285 1.04 . . . . 0.0 111.895 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.49 102.55 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 C-N-CA 126.315 1.846 . . . . 0.0 110.993 169.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.51 147.96 26.93 Favored Pre-proline 0 N--CA 1.481 1.123 0 O-C-N 120.265 -1.522 . . . . 0.0 113.56 -170.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -62.39 148.45 93.26 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 125.199 3.933 . . . . 0.0 115.048 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.5 t -55.16 -28.93 56.41 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -169.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -47.25 -37.12 9.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.989 1.316 . . . . 0.0 113.793 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . 0.257 0.0 OUTLIER -126.64 5.92 6.79 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.064 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.9 t -53.39 -33.63 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 120.331 -1.481 . . . . 0.0 110.969 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -21.68 66.42 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -175.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.2 t -90.81 -38.73 12.79 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.347 0.659 . . . . 0.0 110.534 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -66.66 -36.74 83.26 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.024 1.33 . . . . 0.0 111.228 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -60.0 -19.88 54.78 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.375 1.07 . . . . 0.0 111.56 168.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -110.15 6.41 22.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.843 1.257 . . . . 0.0 113.248 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.437 HD11 ' CE1' ' A' ' 116' ' ' PHE . 62.0 mt -95.4 -25.97 16.05 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 167.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.3 t -77.62 -14.62 59.59 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.18 1.392 . . . . 0.0 112.759 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 3.6 t -84.98 -17.56 37.24 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.712 -0.617 . . . . 0.0 110.965 169.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -92.57 -23.66 18.98 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 118.083 0.401 . . . . 0.0 112.077 169.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 50.9 mt -118.12 91.78 40.97 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 124.38 1.072 . . . . 0.0 109.39 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.54 132.61 52.86 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.778 2.318 . . . . 0.0 112.657 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.5 tttm 105.77 -18.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 130.281 3.432 . . . . 0.0 115.271 169.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.436 HD21 ' CD2' ' A' ' 169' ' ' PHE 0.396 0.0 OUTLIER -75.27 164.35 26.54 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 120.568 1.531 . . . . 0.0 112.2 176.61 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.435 ' O ' HD23 ' A' ' 189' ' ' LEU . 37.7 p -129.13 176.41 7.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.553 HG22 ' HB2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -155.06 127.87 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 128.333 2.653 . . . . 0.0 108.84 -168.538 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.61 154.29 16.89 Favored Glycine 0 N--CA 1.47 0.965 0 C-N-CA 124.563 1.078 . . . . 0.0 111.518 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -94.89 85.82 4.5 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.125 0.964 . . . . 0.0 109.213 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.0 tp -57.75 138.24 55.73 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 168.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 59.8 p -155.36 -150.84 0.32 Allowed 'General case' 0 CA--C 1.546 0.801 0 O-C-N 120.732 -1.23 . . . . 0.0 113.811 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.6 -32.85 71.82 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.835 1.654 . . . . 0.0 114.032 -169.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -93.08 -168.65 1.98 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.639 1.576 . . . . 0.0 113.274 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 78.4 p -123.82 -16.57 6.61 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 71.1 p -65.49 -28.69 69.38 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 119.855 -1.778 . . . . 0.0 111.668 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -62.15 -37.71 86.23 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 118.123 -0.941 . . . . 0.0 113.433 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . 0.266 14.7 p -69.15 -47.88 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 121.272 1.851 . . . . 0.0 111.12 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -79.86 -43.14 22.83 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.561 -1.337 . . . . 0.0 113.854 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -78.98 6.51 9.12 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 121.584 1.993 . . . . 0.0 113.183 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 92.4 mt -108.0 -26.99 10.42 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.302 1.441 . . . . 0.0 108.751 169.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 57.2 mt -66.02 -42.22 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 166.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -62.39 -48.38 79.97 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.863 169.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -78.03 17.47 0.6 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 122.548 1.166 . . . . 0.0 114.022 -172.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -131.27 -8.3 3.78 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.826 2.05 . . . . 0.0 111.514 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -95.01 -39.64 10.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.558 1.943 . . . . 0.0 106.254 168.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.8 m -24.87 81.48 0.0 OUTLIER 'General case' 0 C--N 1.347 0.476 1 C-N-CA 132.611 4.364 . . . . 0.0 115.667 169.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 6.3 mtmm 171.76 -43.56 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 130.406 3.482 . . . . 0.0 114.174 168.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 C--O 1.267 2.01 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -170.751 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -101.24 157.36 16.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.798 1.639 . . . . 0.0 111.11 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.9 p -71.84 140.29 49.29 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.2 t -137.76 137.28 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.228 1.811 . . . . 0.0 109.297 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -110.71 115.55 29.76 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 168.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -103.32 116.21 32.02 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.065 0.46 . . . . 0.0 110.163 169.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -105.72 103.04 12.46 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 123.919 1.819 . . . . 0.0 109.903 170.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -83.42 114.27 21.34 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 112.515 -2.13 . . . . 0.0 112.044 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.64 HD12 HG21 ' A' ' 92' ' ' VAL . 4.4 tt -114.42 124.12 51.15 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.795 0.838 . . . . 0.0 111.714 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.3 mtp -104.2 138.37 40.77 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.58 114.5 3.94 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.488 1.518 . . . . 0.0 109.66 169.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.8 mp -106.96 24.12 13.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.288 2.635 . . . . 0.0 112.705 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 p -68.19 162.57 24.61 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.297 -1.502 . . . . 0.0 113.078 171.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.71 -22.09 63.72 Favored Glycine 0 N--CA 1.476 1.313 0 O-C-N 120.981 -1.074 . . . . 0.0 114.398 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.1 m -59.9 -23.65 63.65 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 118.256 1.028 . . . . 0.0 113.468 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.25 -1.37 57.15 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -169.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -69.56 142.51 53.59 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 122.46 2.391 . . . . 0.0 109.103 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.98 -54.7 4.03 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -169.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -62.74 -24.11 67.52 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.659 0.784 . . . . 0.0 111.149 169.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.0 tp -49.17 -47.27 46.0 Favored 'General case' 0 C--O 1.217 -0.643 0 C-N-CA 125.616 1.566 . . . . 0.0 110.726 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 t -56.02 -47.33 78.03 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.864 0.756 . . . . 0.0 111.882 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -59.97 -42.87 95.09 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.937 -1.102 . . . . 0.0 111.141 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.8 p -86.23 11.93 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.542 1.137 . . . . 0.0 113.129 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -111.05 -47.22 3.23 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.578 1.551 . . . . 0.0 109.4 174.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.2 t -61.0 -44.56 97.25 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.407 ' CD2' HG11 ' A' ' 170' ' ' VAL . 25.6 tp -76.26 89.91 3.14 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 123.93 1.824 . . . . 0.0 107.591 169.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.82 -46.02 0.47 Allowed Glycine 0 C--N 1.305 -1.148 0 CA-C-N 110.011 -3.268 . . . . 0.0 110.055 168.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -71.37 -29.51 65.04 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 124.375 1.07 . . . . 0.0 110.65 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.23 -30.41 30.78 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 117.394 -1.288 . . . . 0.0 112.012 169.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -51.63 69.15 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 120.098 1.317 . . . . 0.0 107.933 173.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 63' ' ' SER . 13.0 tp -44.97 -76.41 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.938 2.095 . . . . 0.0 112.944 172.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . 0.291 0.0 OUTLIER -71.9 -21.45 61.63 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -168.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.47 -48.0 36.97 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.377 0.989 . . . . 0.0 111.807 170.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.55 -36.24 81.98 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.536 -0.728 . . . . 0.0 110.812 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -68.19 -16.27 63.92 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -87.01 -38.52 16.5 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.429 0.692 . . . . 0.0 111.734 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.7 tp -77.59 -28.22 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 118.435 0.561 . . . . 0.0 112.202 171.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.1 t -140.98 127.09 19.51 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -86.87 -6.89 58.65 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.277 1.031 . . . . 0.0 112.994 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.9 p -108.78 55.13 0.64 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.187 1.395 . . . . 0.0 110.219 169.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.6 83.52 0.36 Allowed Glycine 0 C--N 1.345 1.035 0 C-N-CA 128.97 3.176 . . . . 0.0 108.866 -171.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -80.78 137.55 36.24 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.692 1.597 . . . . 0.0 108.433 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.49 HD12 ' CE1' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -120.33 138.25 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.613 0.765 . . . . 0.0 109.445 -173.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.86 159.2 23.85 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 125.57 1.557 . . . . 0.0 111.739 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -140.56 128.46 21.91 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -169.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -131.92 151.71 19.91 Favored Glycine 0 C--N 1.342 0.868 0 C-N-CA 124.973 1.273 . . . . 0.0 113.493 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.4 t -116.57 140.5 49.31 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.531 1.933 . . . . 0.0 111.071 173.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.418 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -138.17 147.23 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.173 0.989 . . . . 0.0 110.944 169.374 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.418 ' N ' HD13 ' A' ' 48' ' ' ILE . 0.7 OUTLIER -132.83 -60.26 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 118.314 0.506 . . . . 0.0 109.811 167.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 161.78 -34.64 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 1 C-N-CA 131.72 4.008 . . . . 0.0 107.525 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.1 mtt -46.12 -51.68 13.5 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.668 1.587 . . . . 0.0 110.806 169.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.9 p -165.75 178.76 6.38 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 128.067 2.547 . . . . 0.0 110.37 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -111.13 125.08 53.4 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 102.179 -3.267 . . . . 0.0 102.179 165.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -121.01 122.37 39.96 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.991 0.9 . . . . 0.0 110.481 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 46.8 t60 -76.68 126.97 31.9 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.724 168.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.35 -51.86 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 121.703 -0.623 . . . . 0.0 110.896 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.3 tp -129.96 121.0 25.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.719 0.808 . . . . 0.0 111.13 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.89 149.34 36.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.078 0.951 . . . . 0.0 111.707 170.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.3 mt -49.51 112.79 0.7 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.367 1.067 . . . . 0.0 110.795 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 t -143.46 166.42 24.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.576 1.15 . . . . 0.0 112.386 -174.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.05 -7.43 51.84 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.665 1.986 . . . . 0.0 113.244 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -80.34 77.88 7.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 125.466 2.555 . . . . 0.0 108.597 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.489 ' HA ' HD11 ' A' ' 31' ' ' LEU . 30.3 p -63.46 -47.68 80.82 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 129.549 3.139 . . . . 0.0 110.996 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.1 t -61.26 -15.92 40.09 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.37 1.468 . . . . 0.0 111.713 170.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -89.32 -49.5 6.68 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.454 -0.778 . . . . 0.0 110.667 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.49 ' CE1' HD12 ' A' ' 43' ' ' ILE . 42.6 t80 -55.31 -35.55 65.24 Favored 'General case' 0 C--O 1.223 -0.334 0 O-C-N 121.301 -0.874 . . . . 0.0 112.017 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -75.82 -23.38 55.78 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.82 -0.55 . . . . 0.0 111.537 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -75.85 -43.02 47.86 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 169.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -71.71 -33.09 68.47 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -169.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.9 -49.08 66.69 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 169.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -70.65 -18.99 62.84 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 -170.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -74.3 -23.38 59.08 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 172.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -63.44 144.94 56.55 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -168.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.7 tp -127.4 138.69 53.06 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.33 2.252 . . . . 0.0 108.69 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.2 m -77.56 154.07 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-O 120.941 0.401 . . . . 0.0 111.881 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.5 p -100.45 -124.88 0.17 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.608 1.563 . . . . 0.0 111.606 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.51 144.54 6.42 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.592 1.092 . . . . 0.0 114.261 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -156.37 153.67 29.31 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.286 1.435 . . . . 0.0 112.221 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.73 -50.19 65.71 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.916 1.686 . . . . 0.0 113.41 -176.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.84 137.7 42.02 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.882 0.873 . . . . 0.0 111.715 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 t -70.24 -30.87 2.05 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-O 115.725 -2.084 . . . . 0.0 115.056 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.95 141.22 26.51 Favored 'Trans proline' 0 C--N 1.358 1.055 0 CA-C-N 123.027 2.117 . . . . 0.0 112.145 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -97.46 158.53 15.43 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.71 1.204 . . . . 0.0 110.803 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.22 28.85 2.89 Favored Glycine 0 N--CA 1.48 1.599 0 O-C-N 120.653 -1.28 . . . . 0.0 114.623 174.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.24 -40.36 70.79 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.244 1.817 . . . . 0.0 111.194 -172.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.08 -25.32 68.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 117.572 -1.204 . . . . 0.0 113.095 -174.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -78.32 -31.27 48.66 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.033 1.288 . . . . 0.0 113.011 171.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.582 ' HB1' HD11 ' A' ' 9' ' ' LEU . . . -67.15 -45.89 75.7 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.711 -1.243 . . . . 0.0 111.574 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.531 HG23 HD11 ' A' ' 108' ' ' LEU . 7.3 p -58.71 -29.89 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 177.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.634 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.3 t -61.61 -60.35 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.125 0.97 . . . . 0.0 109.952 174.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -67.22 -38.05 84.63 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.698 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.64 HG21 HD12 ' A' ' 9' ' ' LEU . 77.3 t -57.11 -37.41 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 119.606 1.094 . . . . 0.0 112.114 173.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.97 -44.74 65.38 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.636 1.107 . . . . 0.0 113.756 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 90' ' ' VAL . 3.3 mt -91.74 -20.22 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -169.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 74.4 m -79.74 51.34 1.28 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.404 -1.435 . . . . 0.0 111.407 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -49.47 -42.64 43.8 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.924 1.69 . . . . 0.0 111.177 -174.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -74.66 -22.62 76.88 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.346 0.974 . . . . 0.0 114.39 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -105.69 -34.65 7.65 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.37 1.085 . . . . 0.0 112.594 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.8 mm -70.25 -38.23 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.959 0.8 . . . . 0.0 110.446 169.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.64 27.37 9.78 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.39 1.472 . . . . 0.0 114.591 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -59.93 116.57 4.23 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.959 1.38 . . . . 0.0 112.651 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -90.65 173.96 7.76 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.243 2.617 . . . . 0.0 110.352 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -87.52 20.16 3.03 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -170.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.36 -119.56 0.96 Allowed Glycine 0 C--N 1.346 1.124 0 C-N-CA 124.528 1.061 . . . . 0.0 111.043 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.9 m -116.33 130.46 56.78 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.612 1.565 . . . . 0.0 107.051 170.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.46 132.95 53.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -171.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.36 111.01 9.24 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -167.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.575 HD13 HD13 ' A' ' 110' ' ' LEU . 1.5 tm? -105.85 98.04 7.78 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.082 0.953 . . . . 0.0 109.711 -169.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.3 t -101.81 118.67 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.575 HD13 HD13 ' A' ' 108' ' ' LEU . 6.2 mp -111.37 131.92 54.82 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 124.245 0.966 . . . . 0.0 109.168 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.1 t -116.53 129.63 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 O-C-N 125.531 1.77 . . . . 0.0 111.159 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 t -152.43 -171.45 3.93 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.347 1.03 . . . . 0.0 109.515 169.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -140.43 2.86 1.88 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.68 -156.43 0.61 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.017 0.927 . . . . 0.0 110.845 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.91 166.53 0.98 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.816 2.046 . . . . 0.0 114.375 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -130.27 146.69 51.9 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.426 1.491 . . . . 0.0 110.507 170.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -76.94 141.77 40.33 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.007 0.432 . . . . 0.0 111.592 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.64 HD21 HG23 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -111.74 173.3 6.42 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.625 1.97 . . . . 0.0 109.533 177.322 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.52 ' H ' HD22 ' A' ' 118' ' ' LEU . . . -48.7 142.59 5.99 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.117 -0.989 . . . . 0.0 111.519 169.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.0 mttm 83.27 -16.52 0.56 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 129.511 3.124 . . . . 0.0 112.875 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.05 -32.08 73.62 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.239 1.381 . . . . 0.0 113.05 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -78.23 6.33 8.41 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.9 t -60.21 -31.19 69.93 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.022 1.283 . . . . 0.0 112.507 170.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.64 -19.26 61.47 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -85.53 15.2 47.55 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.494 1.521 . . . . 0.0 111.916 169.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.348 13.9 t 44.37 54.54 6.18 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 128.869 2.868 . . . . 0.0 112.504 -170.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.1 ttp180 -126.68 106.38 9.35 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.559 1.544 . . . . 0.0 109.907 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -112.66 -25.52 9.07 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -169.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -75.17 129.49 37.6 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.53 1.514 . . . . 0.0 110.829 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.6 t -68.31 167.61 14.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.925 1.29 . . . . 0.0 111.545 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.3 m -66.16 135.72 54.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.579 0.752 . . . . 0.0 112.495 172.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -83.15 -17.72 41.93 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.027 -1.046 . . . . 0.0 113.488 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.91 18.19 77.35 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.304 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.8 mtp-105 -94.49 169.85 9.91 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.842 1.257 . . . . 0.0 112.588 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.21 137.59 43.18 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.409 1.084 . . . . 0.0 110.45 169.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -145.94 44.91 1.26 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.505 1.522 . . . . 0.0 112.237 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.1 tt -118.72 132.23 56.15 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.076 0.95 . . . . 0.0 110.58 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -118.77 -75.61 0.58 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.649 1.179 . . . . 0.0 111.239 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -97.98 28.22 4.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.826 2.05 . . . . 0.0 112.792 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.51 -18.06 58.12 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.627 1.584 . . . . 0.0 113.227 -174.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 14.9 mmt -89.45 143.11 27.08 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.743 1.217 . . . . 0.0 112.495 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -71.94 91.22 1.18 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 168.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -55.92 -43.15 77.07 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.548 1.139 . . . . 0.0 112.304 -171.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.4 p -81.28 7.07 12.31 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -15.42 0.35 Allowed 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 171.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -103.2 -8.64 40.98 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.909 1.719 . . . . 0.0 115.26 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -114.53 -61.95 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 119.876 1.838 . . . . 0.0 111.84 -172.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -77.4 145.66 24.0 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.86 2.373 . . . . 0.0 113.199 168.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -66.28 171.11 5.08 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.305 2.642 . . . . 0.0 111.565 169.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -60.61 156.19 17.14 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 174.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -65.6 163.24 16.61 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.4 p -93.85 152.93 18.54 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 168.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.64 HG23 HD21 ' A' ' 118' ' ' LEU . 58.8 t -62.78 -30.6 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 O-C-N 120.621 -1.299 . . . . 0.0 111.231 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.62 -42.69 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.987 0.915 . . . . 0.0 111.061 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -73.47 -26.65 61.01 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.899 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.4 mt -63.74 -54.37 36.5 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 168.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.75 82.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.064 1.346 . . . . 0.0 113.124 -172.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 75.7 m -63.95 -51.15 65.73 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.945 0.498 . . . . 0.0 112.009 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.487 ' HG2' HD11 ' A' ' 94' ' ' ILE . 2.1 tppp? -62.7 -38.66 91.29 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.273 -0.892 . . . . 0.0 112.162 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.8 tp -60.26 -40.33 89.95 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.353 1.061 . . . . 0.0 112.647 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.66 -24.85 63.68 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.098 0.959 . . . . 0.0 113.311 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -75.92 -44.07 42.0 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.184 0.993 . . . . 0.0 110.819 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -78.67 -16.35 57.4 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 60.8 33.26 20.11 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.987 2.115 . . . . 0.0 113.024 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.2 mt -85.59 144.24 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.122 1.369 . . . . 0.0 109.101 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -104.69 106.24 53.93 Favored Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 120.714 1.597 . . . . 0.0 113.791 171.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 31.3 Cg_exo -75.13 137.62 21.68 Favored 'Trans proline' 0 CA--C 1.537 0.636 1 C-N-CA 125.342 4.028 . . . . 0.0 115.231 169.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.5 mt -130.98 113.44 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -75.62 79.54 2.61 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.893 0.854 . . . . 0.0 111.682 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.407 HG11 ' CD2' ' A' ' 26' ' ' LEU . 39.6 t -66.52 104.51 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-O 122.554 1.169 . . . . 0.0 112.151 169.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 33.3 m -142.32 164.51 32.88 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 120.321 -1.487 . . . . 0.0 110.776 -169.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -85.21 165.74 11.08 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.825 2.35 . . . . 0.0 111.81 -169.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.3 t -50.41 -38.84 45.09 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.772 1.229 . . . . 0.0 113.09 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -63.08 -21.28 66.06 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 3.5 tpt -128.23 5.74 5.83 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -170.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 89.4 t -59.43 -35.96 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 120.015 1.28 . . . . 0.0 111.537 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.27 -0.64 50.51 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -169.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 t -92.82 -36.54 12.8 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.796 0.808 . . . . 0.0 109.46 168.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -74.89 -33.94 62.13 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 124.172 0.989 . . . . 0.0 110.342 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -70.88 -15.0 62.59 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 119.293 0.951 . . . . 0.0 111.96 169.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -84.85 -28.25 26.17 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 120.32 -1.487 . . . . 0.0 111.249 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 43.3 tp -77.27 -27.16 53.06 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.314 2.246 . . . . 0.0 110.074 174.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.48 -7.97 58.02 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.11 1.764 . . . . 0.0 112.531 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 6.7 t -105.79 -15.82 14.84 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.239 0.616 . . . . 0.0 110.685 168.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -80.83 -37.37 30.17 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.313 0.506 . . . . 0.0 111.009 169.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 25.3 mt -104.13 114.9 63.97 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 124.325 1.05 . . . . 0.0 108.779 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.15 140.59 37.82 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.667 2.245 . . . . 0.0 112.432 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 47.2 tptt 82.82 -8.35 1.18 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 129.438 3.095 . . . . 0.0 113.811 170.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.5 mt -67.81 166.14 16.05 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.57 0.748 . . . . 0.0 111.883 170.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.6 p -138.59 -145.51 0.19 Allowed 'General case' 0 C--N 1.344 0.352 0 CA-C-O 122.905 1.336 . . . . 0.0 108.603 168.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.3 pt -157.02 156.86 4.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 128.798 2.839 . . . . 0.0 109.419 -167.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -134.04 153.24 20.84 Favored Glycine 0 N--CA 1.465 0.631 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 169.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -100.63 93.68 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.02 131.97 41.57 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.77 169.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 9.6 t -161.48 -167.81 1.84 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.847 1.259 . . . . 0.0 109.772 170.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.62 -23.95 66.94 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.422 -0.799 . . . . 0.0 112.098 171.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -93.76 141.44 28.5 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.74 1.216 . . . . 0.0 111.418 169.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 27.4 p -103.91 0.7 30.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.186 1.794 . . . . 0.0 113.543 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.4 m -61.14 -48.87 79.63 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.447 1.099 . . . . 0.0 112.009 -168.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -63.73 -46.73 84.05 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 122.099 -0.375 . . . . 0.0 111.514 -172.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.17 -45.7 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 121.231 -0.918 . . . . 0.0 112.139 176.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.32 -29.52 70.27 Favored 'General case' 0 C--O 1.22 -0.48 0 O-C-N 121.23 -0.918 . . . . 0.0 112.32 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -66.59 -6.92 17.04 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.426 -1.421 . . . . 0.0 114.477 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.3 mp -107.81 -28.32 9.73 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.419 1.488 . . . . 0.0 110.035 176.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 18.5 mm -67.25 -43.23 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 168.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -66.38 -42.35 88.07 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.774 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -67.01 -38.34 85.77 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.739 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -71.69 -31.1 66.41 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.658 0.663 . . . . 0.0 112.072 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -62.91 -42.51 99.81 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.179 0.591 . . . . 0.0 111.456 172.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 11.1 t -64.77 -24.89 67.7 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -80.35 -21.48 42.38 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 12.1 tp . . . . . 0 CA--C 1.563 1.474 0 C-N-CA 124.633 1.173 . . . . 0.0 109.871 173.087 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 78.34 149.16 0.1 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 128.471 2.709 . . . . 0.0 112.176 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 p -71.3 117.34 12.71 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.563 1.145 . . . . 0.0 113.527 -173.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.27 127.52 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.969 1.308 . . . . 0.0 108.79 169.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -109.87 116.21 31.24 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -110.37 129.22 55.8 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.671 0.748 . . . . 0.0 111.747 173.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -110.59 113.56 26.27 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 123.418 1.58 . . . . 0.0 109.492 169.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -91.15 104.6 17.15 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 126.482 1.913 . . . . 0.0 112.222 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 tp -101.22 116.72 33.46 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.0 0.92 . . . . 0.0 112.669 177.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 59.4 mtp -97.69 141.17 31.04 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.515 1.526 . . . . 0.0 114.047 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.97 118.43 5.38 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 168.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 mp -106.91 22.99 15.1 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.799 1.64 . . . . 0.0 113.899 -169.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.0 p -78.33 159.49 28.37 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.2 -1.563 . . . . 0.0 113.522 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.68 -26.34 59.92 Favored Glycine 0 N--CA 1.476 1.313 0 N-CA-C 115.918 1.127 . . . . 0.0 115.918 -168.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 t -59.7 -31.25 69.41 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 117.738 0.769 . . . . 0.0 111.969 171.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.97 3.15 8.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.696 1.598 . . . . 0.0 114.577 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -57.37 -47.97 80.26 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 121.128 1.786 . . . . 0.0 112.762 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.26 -32.87 68.65 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -78.55 -13.21 59.94 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.7 tp -59.12 -43.05 91.93 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.724 1.21 . . . . 0.0 111.421 -173.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 t -57.24 -45.57 83.82 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.655 0.782 . . . . 0.0 111.603 171.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -63.91 -47.25 81.31 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.811 -1.181 . . . . 0.0 111.222 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 p -74.22 -32.97 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -72.13 -40.88 67.77 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.839 1.199 . . . . 0.0 111.198 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.7 m -62.55 -42.5 99.58 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.871 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.458 HD22 HD23 ' A' ' 194' ' ' LEU . 27.3 tp -59.3 -26.87 65.34 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.513 1.051 . . . . 0.0 112.714 174.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.06 -44.86 6.14 Favored Glycine 0 N--CA 1.471 1.015 0 O-C-N 120.824 -1.172 . . . . 0.0 110.74 -168.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 t -70.66 -34.82 72.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.784 -1.208 . . . . 0.0 109.523 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -70.07 -33.16 71.55 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 122.179 -0.326 . . . . 0.0 111.273 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.35 -61.47 2.21 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.17 -31.25 64.12 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.396 1.453 . . . . 0.0 113.844 -169.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . 0.282 0.0 OUTLIER -65.42 -28.91 69.58 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 122.268 2.304 . . . . 0.0 112.23 171.68 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.72 -53.74 10.86 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.725 0.693 . . . . 0.0 111.563 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.4 mt -65.61 -29.46 70.05 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.9 -1.125 . . . . 0.0 111.959 -173.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -66.19 -26.29 67.33 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.874 0.87 . . . . 0.0 113.131 176.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.278 10.2 pt-20 -86.22 -29.67 22.98 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 118.487 -0.768 . . . . 0.0 112.997 -176.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.83 -21.43 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 119.663 1.119 . . . . 0.0 112.12 168.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.6 m -132.41 106.1 7.68 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.826 0.851 . . . . 0.0 113.031 175.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -61.99 -33.23 73.93 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.684 0.793 . . . . 0.0 111.146 169.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -91.82 77.88 5.47 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.051 1.74 . . . . 0.0 109.167 169.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.05 88.11 0.18 Allowed Glycine 0 C--N 1.338 0.67 0 C-N-CA 127.34 2.4 . . . . 0.0 108.185 -169.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -94.68 141.31 28.77 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.54 1.136 . . . . 0.0 109.315 -169.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.9 tt -124.59 137.63 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.92 151.06 17.27 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 171.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -119.52 151.74 38.1 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.236 0.614 . . . . 0.0 111.596 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.18 147.57 17.67 Favored Glycine 0 C--N 1.342 0.913 0 C-N-CA 124.005 0.812 . . . . 0.0 113.45 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.9 t -118.09 150.69 38.92 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.48 1.512 . . . . 0.0 110.95 175.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.15 148.25 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.126 1.371 . . . . 0.0 108.925 172.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.59 -77.04 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.889 0.875 . . . . 0.0 109.429 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -177.83 -23.51 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 130.695 3.598 . . . . 0.0 108.201 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.3 ttt -49.26 -49.04 45.22 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.742 1.617 . . . . 0.0 109.603 167.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 173.4 175.95 0.12 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 130.59 3.556 . . . . 0.0 110.156 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -91.37 130.8 37.17 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 104.721 -2.325 . . . . 0.0 104.721 166.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -121.68 120.33 34.39 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.653 0.781 . . . . 0.0 110.119 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -83.9 117.73 23.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.936 0.894 . . . . 0.0 110.817 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 82.4 mt -130.35 108.73 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.451 1.5 . . . . 0.0 107.0 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.5 tp 87.56 112.37 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 128.26 2.624 . . . . 0.0 111.212 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -76.55 158.85 30.84 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.397 1.879 . . . . 0.0 109.961 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.8 mt -52.7 112.97 0.93 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.974 1.261 . . . . 0.0 110.858 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.8 t -133.19 162.04 32.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.267 1.427 . . . . 0.0 112.474 -171.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.09 -7.22 33.26 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.169 1.787 . . . . 0.0 114.227 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.286 40.6 p-10 -92.2 84.29 5.21 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 125.921 2.772 . . . . 0.0 110.377 173.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.4 m -59.47 -43.26 93.28 Favored 'General case' 0 C--N 1.316 -0.875 1 C-N-CA 131.961 4.104 . . . . 0.0 109.842 177.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.8 p -60.86 -16.43 41.45 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.968 1.307 . . . . 0.0 112.599 170.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -89.55 -48.53 7.24 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.6 1.091 . . . . 0.0 111.251 175.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -50.39 -35.85 30.08 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.226 1.01 . . . . 0.0 112.059 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -73.03 -23.99 60.66 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.267 1.427 . . . . 0.0 111.508 -171.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.7 mtp85 -91.33 -26.06 19.11 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.538 1.535 . . . . 0.0 109.926 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.81 -37.64 20.52 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.73 -31.29 64.84 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.174 174.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -65.79 -39.83 91.35 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 120.092 1.315 . . . . 0.0 111.32 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -69.52 -12.12 61.39 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -63.45 114.33 3.82 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.479 1.036 . . . . 0.0 110.833 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.4 mt -106.37 161.12 14.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.016 0.927 . . . . 0.0 111.295 170.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.62 160.98 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.787 1.635 . . . . 0.0 114.1 -169.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.2 t -123.08 171.29 9.4 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.381 1.872 . . . . 0.0 111.012 169.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.38 152.5 17.56 Favored Glycine 0 N--CA 1.478 1.496 0 O-C-N 120.588 -1.32 . . . . 0.0 114.907 -173.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -146.3 157.38 43.79 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.925 1.69 . . . . 0.0 113.939 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 tp -83.54 -71.76 0.49 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.458 1.503 . . . . 0.0 109.724 169.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.76 148.04 40.77 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.641 1.176 . . . . 0.0 112.589 -170.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 m -59.45 -46.85 98.87 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-O 116.61 -1.662 . . . . 0.0 113.299 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -66.25 139.51 55.31 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.758 2.306 . . . . 0.0 113.174 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.37 164.52 13.82 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.003 1.321 . . . . 0.0 113.736 175.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.6 38.44 2.3 Favored Glycine 0 N--CA 1.475 1.242 0 C-N-CA 125.249 1.404 . . . . 0.0 116.582 -169.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.67 ' CG ' HD21 ' A' ' 110' ' ' LEU . 8.2 tp-100 -63.38 -38.45 91.19 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -168.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -83.92 -10.62 57.83 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -74.12 -46.86 39.99 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.991 1.269 . . . . 0.0 108.625 168.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.69 68.88 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.698 1.599 . . . . 0.0 112.058 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.2 p -54.78 -36.41 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 118.796 -0.621 . . . . 0.0 112.239 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.96 -38.9 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 116.36 -1.781 . . . . 0.0 111.687 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -52.18 -55.3 21.91 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 121.066 1.757 . . . . 0.0 109.001 172.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 73.5 t -52.49 -31.43 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.946 1.298 . . . . 0.0 113.157 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.09 -20.24 52.62 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.78 -31.4 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -174.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.472 ' HB3' ' SG ' ' A' ' 135' ' ' CYS . 6.2 p -79.61 67.24 5.32 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 121.846 2.112 . . . . 0.0 112.719 176.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.9 tp -42.58 -41.08 2.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 128.944 2.898 . . . . 0.0 111.757 172.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.95 -22.02 75.12 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 118.383 -1.231 . . . . 0.0 114.935 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -102.06 -37.15 8.3 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.034 1.417 . . . . 0.0 112.411 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.0 mm -69.39 -39.6 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.37 22.36 29.64 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.233 1.397 . . . . 0.0 113.541 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -59.24 145.58 42.36 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.002 1.401 . . . . 0.0 110.628 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -125.48 -167.22 1.66 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.32 1.048 . . . . 0.0 111.748 171.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -74.49 9.97 1.52 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -168.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.3 -136.62 2.42 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 121.365 1.893 . . . . 0.0 110.518 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -104.03 142.02 35.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.69 1.596 . . . . 0.0 107.792 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -126.22 117.81 23.86 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -167.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -114.5 128.14 56.18 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.168 0.587 . . . . 0.0 111.91 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.3 tt -107.18 95.61 5.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 169.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.43 HG21 HD11 ' A' ' 205' ' ' ILE . 35.1 t -83.74 124.28 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 173.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.67 HD21 ' CG ' ' A' ' 85' ' ' GLN . 10.2 tt -122.92 125.82 46.06 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -170.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.411 HG22 HG23 ' A' ' 170' ' ' VAL . 37.3 t -116.16 134.33 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 O-C-N 124.433 1.083 . . . . 0.0 111.697 -175.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.0 t -145.76 -172.42 3.9 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.043 169.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -145.03 5.77 1.14 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.514 1.526 . . . . 0.0 114.872 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -163.01 176.35 10.21 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.764 2.026 . . . . 0.0 109.184 169.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -61.49 -177.91 0.11 Allowed 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 -171.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -127.54 160.2 32.28 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.815 1.646 . . . . 0.0 113.794 -169.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -77.57 128.11 33.6 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.305 0.642 . . . . 0.0 110.836 169.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.2 mp -94.68 165.74 12.35 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.953 1.301 . . . . 0.0 110.119 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.09 146.23 39.36 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.634 -0.666 . . . . 0.0 111.171 169.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 75.05 -11.84 1.02 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 128.83 2.852 . . . . 0.0 114.268 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -66.21 -23.26 66.4 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 120.303 1.41 . . . . 0.0 112.245 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -70.99 1.48 5.6 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.1 t -56.78 -32.01 65.22 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.279 1.032 . . . . 0.0 111.815 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.16 -46.99 88.27 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.345 1.058 . . . . 0.0 112.273 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -90.23 21.73 30.01 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.1 1.333 . . . . 0.0 114.03 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.317 5.6 t 56.18 39.79 30.22 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 127.8 2.44 . . . . 0.0 114.444 173.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 59.9 mtt85 -106.49 117.3 33.68 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.459 1.104 . . . . 0.0 109.121 169.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -99.58 -49.68 4.32 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -66.14 119.32 11.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.773 0.715 . . . . 0.0 111.9 -170.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.442 ' HA ' ' HB3' ' A' ' 149' ' ' ASP . 8.9 t -74.58 156.51 36.72 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.656 0.782 . . . . 0.0 111.91 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.2 t -62.0 141.24 58.17 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.012 0.911 . . . . 0.0 113.249 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -78.13 -9.83 59.35 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.048 1.739 . . . . 0.0 112.926 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.29 0.64 90.23 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.397 -1.224 . . . . 0.0 115.527 174.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.7 mtt85 -111.12 172.13 7.06 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.216 1.508 . . . . 0.0 112.597 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 95' ' ' CYS . 34.8 t -75.92 143.48 41.63 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -168.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -132.99 52.74 2.06 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.771 2.028 . . . . 0.0 111.317 175.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.56 132.32 46.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.896 1.678 . . . . 0.0 109.601 -175.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -145.58 -49.35 0.23 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.216 1.007 . . . . 0.0 112.153 172.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -77.79 -8.51 58.11 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.93 -6.58 37.5 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.236 1.398 . . . . 0.0 113.706 -169.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.2 mtt -130.71 143.56 50.82 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.329 1.452 . . . . 0.0 112.657 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -70.4 89.02 0.67 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.823 1.649 . . . . 0.0 112.618 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -16.1 61.05 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -170.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.7 m -89.87 -5.54 56.73 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -28.68 14.16 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.594 1.088 . . . . 0.0 113.761 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.16 -16.87 79.09 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 117.448 -1.751 . . . . 0.0 115.501 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -128.54 -67.84 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.928 0 CA-C-N 120.307 2.053 . . . . 0.0 113.677 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -50.56 141.9 32.49 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 CA-C-N 123.509 2.289 . . . . 0.0 115.536 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.442 ' HB3' ' HA ' ' A' ' 130' ' ' THR . 26.0 t0 -68.42 178.76 1.86 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.117 2.167 . . . . 0.0 112.73 172.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -69.58 163.85 24.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.66 1.219 . . . . 0.0 112.116 169.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -88.09 126.55 35.17 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.8 m -63.8 152.61 38.99 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.762 -0.586 . . . . 0.0 110.582 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.523 HG13 HD11 ' A' ' 186' ' ' ILE . 72.0 t -53.97 -32.96 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 O-C-N 121.681 -0.637 . . . . 0.0 111.873 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.86 -45.42 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.871 1.269 . . . . 0.0 112.52 173.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -71.61 -35.95 70.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.905 0.882 . . . . 0.0 111.169 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.431 HD12 HG12 ' A' ' 186' ' ' ILE . 1.5 tm? -59.75 -52.99 63.1 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 169.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.17 -43.09 96.09 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.9 p -67.65 -38.79 84.31 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.497 -0.752 . . . . 0.0 112.348 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.484 ' HA ' ' HE2' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -70.96 -35.5 72.2 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.682 -1.261 . . . . 0.0 112.863 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 97.3 mt -60.89 -41.66 96.45 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.805 0.842 . . . . 0.0 111.892 170.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.25 75.91 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.44 1.096 . . . . 0.0 113.17 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -80.91 -39.47 26.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.646 0.778 . . . . 0.0 111.753 -174.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -87.93 -6.23 58.15 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 171.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 31.1 m120 58.19 56.2 4.68 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.865 1.666 . . . . 0.0 111.52 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 51.3 mm -94.55 137.61 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.259 1.424 . . . . 0.0 109.716 171.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -107.21 109.4 62.85 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 119.843 1.201 . . . . 0.0 107.83 168.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -73.06 148.83 45.48 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.205 1.937 . . . . 0.0 112.215 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.419 HG22 HG13 ' A' ' 170' ' ' VAL . 4.5 mp -131.27 99.63 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 170.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -73.78 78.37 1.58 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.498 -0.751 . . . . 0.0 111.937 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.702 HG11 HG13 ' A' ' 201' ' ' VAL 0.361 3.8 m -79.27 116.15 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 123.431 1.586 . . . . 0.0 113.389 174.863 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 28.6 m -144.23 155.94 57.86 Favored Pre-proline 0 N--CA 1.478 0.928 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.181 -169.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -78.95 153.25 25.28 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.488 2.792 . . . . 0.0 111.307 -172.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 77.1 p -37.45 -49.34 1.02 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.315 2.246 . . . . 0.0 115.061 -169.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -54.1 -38.32 65.22 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.918 1.287 . . . . 0.0 114.094 -174.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.9 ptm -103.31 -4.47 24.19 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 42.4 t -54.84 -45.26 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.4 1.0 . . . . 0.0 109.85 -171.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . 0.3 0.0 OUTLIER -76.02 -3.89 38.25 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -170.788 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 82.9 m -92.75 -34.24 13.98 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.33 1.052 . . . . 0.0 110.677 168.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -74.41 -25.83 59.71 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.997 -1.064 . . . . 0.0 110.183 171.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -64.6 -25.34 67.92 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.783 -1.198 . . . . 0.0 110.07 168.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -79.82 -22.84 42.54 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 120.1 -1.625 . . . . 0.0 110.517 176.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 18.4 tp -82.22 -26.13 33.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.308 2.243 . . . . 0.0 109.377 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.7 t -76.11 -13.56 60.2 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.381 -0.825 . . . . 0.0 112.976 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . 0.328 0.0 OUTLIER -99.08 -20.55 16.64 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 118.753 -0.642 . . . . 0.0 111.026 169.549 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -76.91 -31.06 56.44 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.17 0.895 . . . . 0.0 111.481 169.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.523 HD11 HG13 ' A' ' 153' ' ' VAL . 4.6 mp -115.92 108.89 45.75 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.046 0.938 . . . . 0.0 109.954 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.94 145.41 56.04 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 121.978 1.785 . . . . 0.0 111.255 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt 97.42 -20.58 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 130.557 3.543 . . . . 0.0 114.509 169.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.35 166.84 22.86 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.661 0.664 . . . . 0.0 110.721 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.4 p -125.17 -150.54 0.45 Allowed 'General case' 0 C--N 1.346 0.445 0 CA-C-O 122.926 1.346 . . . . 0.0 109.206 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 11.6 tt 179.08 131.21 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 126.668 1.987 . . . . 0.0 109.843 -167.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -126.2 160.35 20.6 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.592 1.091 . . . . 0.0 112.183 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -89.58 92.16 8.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 122.651 1.215 . . . . 0.0 107.824 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.458 HD23 HD22 ' A' ' 26' ' ' LEU . 2.6 tm? -64.26 123.57 19.47 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.594 -1.639 . . . . 0.0 108.51 169.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 91.1 p -162.64 -162.11 0.77 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.259 1.424 . . . . 0.0 110.437 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.44 -11.47 60.9 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.344 -1.472 . . . . 0.0 114.259 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -124.66 135.21 52.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.982 1.313 . . . . 0.0 111.499 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 34.4 p -89.94 -1.73 58.03 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.978 1.311 . . . . 0.0 113.82 -173.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 33.5 t -56.48 -42.33 78.06 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.335 1.454 . . . . 0.0 111.467 -169.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -57.39 -39.5 76.21 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.304 1.041 . . . . 0.0 111.85 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.702 HG13 HG11 ' A' ' 170' ' ' VAL . 88.4 t -78.76 -49.63 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.08 1.352 . . . . 0.0 111.405 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.59 -30.68 71.71 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.162 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -73.93 -1.7 20.8 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.652 1.569 . . . . 0.0 113.079 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 88.4 mt -99.52 -39.7 8.2 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.526 1.531 . . . . 0.0 108.317 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.43 HD11 HG21 ' A' ' 109' ' ' VAL . 15.6 mt -74.74 -37.19 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -64.1 -35.75 81.78 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.931 0.492 . . . . 0.0 110.034 169.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -68.66 -36.63 78.81 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.387 173.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -73.11 -24.16 60.59 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.144 0.978 . . . . 0.0 112.167 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -70.27 -39.59 74.86 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.203 1.001 . . . . 0.0 110.365 168.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.5 t -70.35 -26.83 63.93 Favored 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 124.692 1.197 . . . . 0.0 113.545 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -75.04 -17.28 60.52 Favored 'General case' 0 C--O 1.265 1.898 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.5 tt . . . . . 0 CA--C 1.621 3.69 0 C-N-CA 126.217 1.807 . . . . 0.0 114.414 -176.401 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.7 t0 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.986 0.422 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -93.56 159.7 15.11 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.159 0.984 . . . . 0.0 112.075 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.7 t -66.09 124.67 23.21 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.428 -0.795 . . . . 0.0 110.254 169.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.91 147.52 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 126.524 1.93 . . . . 0.0 107.825 172.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.38 124.94 31.38 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.242 0.544 . . . . 0.0 109.93 169.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 mp -115.02 137.88 51.5 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -121.31 107.57 12.68 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 122.8 1.286 . . . . 0.0 110.705 173.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -80.64 103.12 10.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.778 2.031 . . . . 0.0 112.049 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -100.45 113.04 25.48 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.989 1.315 . . . . 0.0 110.588 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 87.3 mtp -97.82 147.05 24.81 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -94.06 124.4 7.86 Favored Glycine 0 CA--C 1.542 1.762 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 168.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.5 mp -115.22 29.39 8.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 125.332 1.453 . . . . 0.0 114.896 -170.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.557 ' HB3' HG13 ' A' ' 49' ' ' VAL . 19.5 p -88.95 169.96 11.09 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 120.207 -1.558 . . . . 0.0 113.172 -172.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.28 -19.27 63.98 Favored Glycine 0 N--CA 1.479 1.512 0 O-C-N 120.958 -1.089 . . . . 0.0 114.256 -171.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 p -72.26 -28.01 62.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.302 2.241 . . . . 0.0 113.456 169.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.25 -13.59 54.95 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.805 1.642 . . . . 0.0 114.333 -173.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -67.47 133.85 50.28 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 121.209 1.822 . . . . 0.0 108.962 169.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.43 -43.23 2.12 Favored Glycine 0 N--CA 1.474 1.195 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -168.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -76.8 -23.96 52.84 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.665 0.786 . . . . 0.0 111.189 168.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.6 tp -48.75 -50.94 31.52 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 126.028 1.731 . . . . 0.0 110.944 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.1 p -55.14 -41.52 71.89 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.71 1.141 . . . . 0.0 112.609 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 -61.04 -45.82 93.24 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.281 -0.887 . . . . 0.0 110.662 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.428 HG22 HG11 ' A' ' 111' ' ' VAL . 15.0 t -66.65 -38.71 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.155 0.582 . . . . 0.0 111.805 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -67.08 -51.26 56.62 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.378 0.671 . . . . 0.0 109.896 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.5 m -64.26 -38.21 90.25 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.181 -177.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.462 HD22 HD12 ' A' ' 194' ' ' LEU . 52.4 tp -59.39 -30.63 68.57 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.05 1.295 . . . . 0.0 111.982 174.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.13 -38.17 6.08 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 -168.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.2 m -67.03 -32.84 74.32 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.84 1.656 . . . . 0.0 110.009 169.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -76.51 -38.41 55.23 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.5 174.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.5 tt -65.4 -47.46 76.23 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.469 HD21 ' HA ' ' A' ' 63' ' ' SER . 2.6 tm? -48.55 -56.52 8.15 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 126.922 2.089 . . . . 0.0 113.083 176.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -82.71 -42.32 18.21 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -173.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.3 -34.88 72.83 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.555 1.07 . . . . 0.0 112.106 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.401 ' HA ' HG22 ' A' ' 37' ' ' ILE . 87.4 mt -81.96 -30.41 31.71 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -73.38 -1.63 18.95 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 169.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -91.71 -46.33 7.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.148 0.979 . . . . 0.0 110.718 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.401 HG22 ' HA ' ' A' ' 34' ' ' LEU . 10.9 tp -69.94 -30.94 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 118.957 0.798 . . . . 0.0 112.117 175.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.3 t -129.66 141.09 50.99 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -83.87 -14.85 50.12 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.884 1.273 . . . . 0.0 111.562 168.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -123.11 81.92 1.94 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.713 1.205 . . . . 0.0 109.822 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.84 79.78 0.28 Allowed Glycine 0 C--N 1.339 0.712 0 C-N-CA 126.874 2.178 . . . . 0.0 109.0 -170.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -82.42 132.14 35.21 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -170.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.404 HG21 HD23 ' A' ' 31' ' ' LEU . 10.9 tp -110.66 138.41 38.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.632 0.773 . . . . 0.0 110.238 -175.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.95 159.21 22.57 Favored Glycine 0 N--CA 1.468 0.768 0 C-N-CA 125.555 1.55 . . . . 0.0 112.088 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -138.08 128.33 26.01 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -169.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.98 159.18 25.99 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 124.688 1.137 . . . . 0.0 113.978 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.6 m -134.15 140.54 46.63 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.425 1.49 . . . . 0.0 111.94 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.488 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -147.18 146.98 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.121 -0.987 . . . . 0.0 112.556 177.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.557 HG13 ' HB3' ' A' ' 13' ' ' SER . 81.9 t -134.2 -80.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 126.105 1.762 . . . . 0.0 108.319 170.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.409 ' H ' ' H ' ' A' ' 51' ' ' MET 0.338 0.0 OUTLIER -168.45 -7.1 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.877 1 C-N-CA 132.862 4.465 . . . . 0.0 109.338 168.772 . . . . . . . . 5 4 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.409 ' H ' ' H ' ' A' ' 50' ' ' ASN . 49.6 mtm -77.57 46.27 0.53 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.875 1.67 . . . . 0.0 107.399 166.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.351 3.2 t 52.12 -164.5 0.07 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 130.617 3.567 . . . . 0.0 114.057 -169.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -108.78 130.03 55.38 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.223 2.609 . . . . 0.0 109.33 -175.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -118.07 118.58 32.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.627 0.727 . . . . 0.0 111.142 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -84.62 114.12 21.76 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.075 1.35 . . . . 0.0 109.196 169.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.8 mm -107.67 -24.12 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.7 tp -146.91 120.33 9.03 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.018 1.281 . . . . 0.0 112.161 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.07 152.0 25.19 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.017 1.727 . . . . 0.0 112.566 172.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.81 120.49 4.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.366 1.066 . . . . 0.0 110.506 175.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.2 t -155.12 170.4 21.89 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.41 -5.05 40.68 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.314 2.246 . . . . 0.0 113.697 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -81.89 77.98 8.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 126.178 2.895 . . . . 0.0 108.312 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.469 ' HA ' HD21 ' A' ' 31' ' ' LEU . 34.5 p -69.69 -43.28 72.78 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 130.129 3.372 . . . . 0.0 111.891 -169.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.1 t -55.65 -33.59 64.22 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.462 1.105 . . . . 0.0 110.214 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . 0.302 6.2 pt20 -88.44 -33.52 17.82 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 118.887 -1.125 . . . . 0.0 112.848 -171.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -53.63 -34.56 58.96 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.601 0.637 . . . . 0.0 110.453 169.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -74.93 -34.42 62.11 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.523 0.729 . . . . 0.0 110.432 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 89.0 mtt-85 -70.69 -38.66 73.72 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.162 0.985 . . . . 0.0 109.229 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.35 -30.21 42.56 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -174.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.95 -40.76 71.83 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 169.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -67.74 -30.87 70.45 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.204 -0.935 . . . . 0.0 112.39 -177.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -65.49 -31.9 73.22 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -55.21 140.85 37.41 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -168.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 mp -120.79 158.73 26.91 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.247 1.819 . . . . 0.0 110.569 -173.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.1 t -100.02 133.89 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.135 0.974 . . . . 0.0 110.881 -176.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.1 m -107.24 -156.97 0.6 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.481 1.512 . . . . 0.0 110.899 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -156.99 153.49 24.74 Favored Glycine 0 N--CA 1.478 1.466 0 O-C-N 119.874 -1.766 . . . . 0.0 116.291 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.8 tptt -157.88 161.95 38.31 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.614 1.566 . . . . 0.0 112.475 169.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.5 mt -70.26 -47.64 60.41 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.941 1.696 . . . . 0.0 114.507 -169.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.84 137.89 42.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.438 0.695 . . . . 0.0 111.926 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.254 13.6 t -67.89 -41.14 26.78 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-O 115.816 -2.04 . . . . 0.0 113.975 173.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.15 150.29 82.06 Favored 'Trans proline' 0 C--N 1.36 1.132 0 CA-C-N 123.09 2.139 . . . . 0.0 111.924 170.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.43 ' H ' ' HA ' ' A' ' 116' ' ' PHE . 52.8 mtpt -121.93 160.28 25.14 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -171.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.07 19.07 28.27 Favored Glycine 0 N--CA 1.476 1.304 0 CA-C-O 118.175 -1.347 . . . . 0.0 116.174 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -49.5 -32.45 12.23 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.84 1.82 . . . . 0.0 113.384 -173.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.416 HD11 ' CD2' ' A' ' 156' ' ' LEU . 11.8 tp -60.16 -41.36 92.64 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.222 1.009 . . . . 0.0 113.441 -176.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.93 -40.03 87.53 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.549 0.339 . . . . 0.0 110.767 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.54 -52.72 50.44 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 117.633 -1.175 . . . . 0.0 112.257 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -54.76 -38.12 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 120.113 1.324 . . . . 0.0 111.306 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.7 t -71.46 -39.79 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 118.943 0.792 . . . . 0.0 112.681 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -67.93 -41.44 82.56 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.514 1.052 . . . . 0.0 112.05 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.467 HG11 HD13 ' A' ' 108' ' ' LEU . 78.7 t -56.4 -40.4 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.194 0.598 . . . . 0.0 110.401 171.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.62 -40.85 80.19 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.86 -8.65 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -171.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 4.7 t -90.88 67.72 6.18 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.258 -1.526 . . . . 0.0 111.431 172.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -46.98 -42.77 18.48 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.145 1.778 . . . . 0.0 111.171 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.43 -23.54 53.73 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.43 1.014 . . . . 0.0 115.524 -170.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -94.34 -43.45 8.39 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.689 1.245 . . . . 0.0 110.351 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.4 mm -65.36 -39.23 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 118.671 -0.68 . . . . 0.0 110.439 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.43 24.49 23.84 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.44 1.019 . . . . 0.0 114.176 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -55.52 128.06 32.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.224 1.41 . . . . 0.0 113.586 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.86 173.42 6.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.236 1.814 . . . . 0.0 110.29 169.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -89.69 57.01 3.74 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.778 1.231 . . . . 0.0 112.793 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.04 -121.14 4.86 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.335 1.445 . . . . 0.0 110.235 170.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.7 p -119.57 127.91 53.42 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.524 1.93 . . . . 0.0 106.092 169.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -112.1 110.86 21.37 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.918 0.781 . . . . 0.0 110.819 -167.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -111.42 97.72 6.95 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -168.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.467 HD13 HG11 ' A' ' 92' ' ' VAL . 11.1 tp -87.12 94.87 9.76 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.586 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.411 HG13 HG21 ' A' ' 170' ' ' VAL . 44.9 t -83.76 116.7 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 37.9 mt -109.31 109.96 21.0 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.165 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.428 HG11 HG22 ' A' ' 23' ' ' VAL . 40.6 t -104.38 125.14 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 O-C-N 123.934 0.771 . . . . 0.0 111.83 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -161.55 150.14 15.69 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.736 0.814 . . . . 0.0 111.229 172.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -105.31 -1.21 25.46 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.338 1.455 . . . . 0.0 114.756 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -121.35 -178.44 3.78 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.496 1.118 . . . . 0.0 111.889 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -77.33 -172.51 2.5 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.648 1.179 . . . . 0.0 111.231 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.43 ' HA ' ' H ' ' A' ' 83' ' ' LYS . 21.5 p90 -139.16 157.17 46.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.075 0.95 . . . . 0.0 112.633 -169.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -79.9 129.75 34.74 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.226 1.01 . . . . 0.0 110.717 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mp -98.99 173.21 6.95 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.851 1.26 . . . . 0.0 109.583 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.65 146.46 10.15 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.776 -0.578 . . . . 0.0 111.59 169.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 90.0 mttt 82.37 -18.98 0.43 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 128.261 2.624 . . . . 0.0 113.269 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.86 -35.71 82.01 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.002 1.273 . . . . 0.0 112.324 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -68.61 -5.28 19.08 Favored 'General case' 0 CA--C 1.551 1.0 0 O-C-N 120.927 -1.108 . . . . 0.0 113.858 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.03 -23.64 65.01 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.906 -1.121 . . . . 0.0 112.849 171.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 mp -63.74 -33.88 76.65 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.212 0.915 . . . . 0.0 110.796 169.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -84.44 16.43 34.92 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 126.127 1.823 . . . . 0.0 113.874 169.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.334 1.3 t 71.08 15.52 6.56 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 129.844 3.258 . . . . 0.0 115.095 176.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.599 ' HA ' ' HE ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -99.96 106.42 18.21 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.963 -1.086 . . . . 0.0 112.244 -177.425 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -88.51 -48.82 7.31 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.938 1.695 . . . . 0.0 112.411 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 -60.43 131.2 50.01 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -169.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.3 t -63.29 146.07 54.23 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.766 1.227 . . . . 0.0 111.157 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.2 p -53.72 128.95 31.55 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 125.695 1.598 . . . . 0.0 113.879 169.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -72.86 -26.62 61.52 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.422 0.689 . . . . 0.0 112.424 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.4 -25.64 7.91 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 125.697 1.618 . . . . 0.0 112.884 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -61.59 164.91 5.42 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.202 1.801 . . . . 0.0 112.878 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 38.7 t -73.53 136.74 44.1 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.522 0.729 . . . . 0.0 111.231 170.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -137.96 40.75 2.32 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.743 1.617 . . . . 0.0 111.96 172.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.96 156.19 19.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.941 0.896 . . . . 0.0 110.849 171.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.84 -80.16 0.16 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.475 1.11 . . . . 0.0 111.504 171.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.26 28.0 0.76 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.743 1.617 . . . . 0.0 112.771 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.03 -9.73 68.32 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.923 1.725 . . . . 0.0 113.454 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 13.1 mmt -96.74 146.45 24.87 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.777 1.231 . . . . 0.0 112.336 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -77.88 95.12 4.67 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.888 0.851 . . . . 0.0 110.815 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.0 ttp-105 -51.85 -40.15 60.06 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.619 1.968 . . . . 0.0 112.857 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.3 m -87.34 2.75 49.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -169.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.5 ttp85 -56.73 -33.84 66.91 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 121.731 2.06 . . . . 0.0 111.857 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.61 -4.26 87.51 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.29 1.424 . . . . 0.0 115.14 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.298 15.1 tp10 -122.42 -82.3 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.139 0 CA-C-O 115.774 -2.06 . . . . 0.0 111.051 173.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -47.13 146.8 6.0 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 123.341 2.694 . . . . 0.0 116.541 170.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.94 179.55 4.85 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -69.23 147.03 51.83 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.386 -0.822 . . . . 0.0 110.876 170.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -71.4 154.68 41.37 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.527 -0.733 . . . . 0.0 111.964 -177.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.5 p -88.5 155.91 19.39 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.704 -0.623 . . . . 0.0 111.343 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.2 t -59.27 -29.12 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 121.373 -0.829 . . . . 0.0 112.585 -169.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 37.4 t -66.8 -42.46 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.373 1.469 . . . . 0.0 111.59 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -70.49 -29.55 66.11 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.233 1.013 . . . . 0.0 111.715 -174.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.517 HD12 HD11 ' A' ' 186' ' ' ILE . 1.0 OUTLIER -64.23 -54.72 29.08 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.789 0.836 . . . . 0.0 109.796 170.514 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.53 -37.7 68.27 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.219 1.008 . . . . 0.0 111.959 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.5 m -60.59 -65.29 0.71 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.312 1.045 . . . . 0.0 112.336 170.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.265 68.9 mmtt -76.25 -17.39 59.5 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.121 -1.612 . . . . 0.0 114.835 -169.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mp -71.72 -41.4 68.6 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.782 0.833 . . . . 0.0 109.493 168.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.32 -35.48 66.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.454 1.102 . . . . 0.0 113.853 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.9 -41.52 78.15 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.942 0.897 . . . . 0.0 110.736 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -87.96 -0.3 56.82 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 65.24 31.01 11.02 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.524 1.129 . . . . 0.0 113.012 170.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 57.2 mt -94.92 134.18 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 120.89 -1.131 . . . . 0.0 108.969 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -107.34 100.51 33.89 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-N 119.078 0.853 . . . . 0.0 111.826 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.02 154.57 74.2 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.746 2.297 . . . . 0.0 115.81 169.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 38.0 mt -132.27 110.77 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.892 1.677 . . . . 0.0 107.775 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -77.58 79.5 4.08 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 123.214 1.483 . . . . 0.0 110.844 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.541 HG13 HG21 ' A' ' 201' ' ' VAL . 89.7 t -65.98 109.04 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.583 169.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 27.3 m -148.38 146.52 23.05 Favored Pre-proline 0 N--CA 1.476 0.841 0 O-C-N 120.757 -1.215 . . . . 0.0 112.696 -170.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.36 151.97 27.66 Favored 'Trans proline' 0 C--N 1.351 0.696 1 C-N-CA 125.533 4.155 . . . . 0.0 114.129 169.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 68.3 p -56.81 -29.16 62.47 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -169.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 40.7 tpt85 -58.95 -36.68 75.21 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.927 1.24 . . . . 0.0 112.774 -177.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 34.5 mtt -118.1 12.79 13.7 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.436 1.272 . . . . 0.0 114.436 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 5.4 t -53.39 -34.88 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.646 1.112 . . . . 0.0 111.22 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.4 ' HA ' ' HB2' ' A' ' 180' ' ' GLU . 45.6 tptt -80.78 -15.04 57.47 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -175.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.12 -34.17 43.61 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.445 1.02 . . . . 0.0 110.383 174.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -80.58 -36.93 32.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.054 1.342 . . . . 0.0 110.342 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 177' ' ' LYS . 9.5 mt-10 -62.7 -13.37 31.62 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.114 0.87 . . . . 0.0 113.072 171.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -105.01 -11.0 16.84 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -80.15 -30.56 38.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.385 1.474 . . . . 0.0 109.154 169.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 58.6 p -77.11 -11.45 59.81 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.144 1.378 . . . . 0.0 112.406 173.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.8 m -78.39 -30.72 47.97 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 168.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -81.42 -28.15 34.4 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 171.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.517 HD11 HD12 ' A' ' 156' ' ' LEU . 6.2 mt -117.52 86.09 22.17 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 123.855 0.862 . . . . 0.0 110.711 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.47 149.02 92.17 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.755 2.304 . . . . 0.0 112.196 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt 89.25 -17.08 0.25 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 130.665 3.586 . . . . 0.0 113.017 -175.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.2 mt -76.03 162.39 28.09 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.272 0.629 . . . . 0.0 110.766 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.6 p -129.9 -161.5 1.12 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 48.2 mm -162.13 149.02 4.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 130.332 3.453 . . . . 0.0 109.385 -167.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.06 156.55 26.89 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 168.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -96.81 84.2 3.56 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.644 1.578 . . . . 0.0 108.374 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.462 HD12 HD22 ' A' ' 26' ' ' LEU . 2.0 tt -61.41 138.55 58.26 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.57 1.176 . . . . 0.0 110.572 169.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 90.0 p -159.43 -163.43 1.18 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 128.32 2.648 . . . . 0.0 106.715 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.41 -10.06 47.6 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 120.551 -1.343 . . . . 0.0 112.936 173.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -100.93 128.65 46.87 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.578 1.551 . . . . 0.0 111.28 171.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 44.2 p -92.54 -4.46 53.48 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.141 1.776 . . . . 0.0 114.039 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 79.8 p -58.05 -44.52 87.48 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.408 1.483 . . . . 0.0 112.802 -169.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -62.97 -50.64 69.97 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.753 0.421 . . . . 0.0 111.26 -173.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.541 HG21 HG13 ' A' ' 170' ' ' VAL . 17.1 t -72.54 -37.21 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 121.668 -0.645 . . . . 0.0 112.344 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -60.48 -30.12 69.49 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 118.935 0.789 . . . . 0.0 111.486 172.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -69.73 -8.12 45.26 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.606 -1.309 . . . . 0.0 113.769 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.9 mp -105.49 -34.92 7.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.714 1.606 . . . . 0.0 109.326 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 16.3 mm -65.92 -48.38 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -71.7 -31.81 67.13 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 118.651 -0.69 . . . . 0.0 111.658 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -64.92 -43.08 93.94 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.547 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -76.97 -26.66 54.22 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -60.21 -45.5 92.96 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.655 0.782 . . . . 0.0 110.703 171.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 10.8 t -67.12 -20.77 65.83 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.143 0.977 . . . . 0.0 113.475 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -82.36 -15.78 51.54 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -175.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--O 1.257 1.452 0 CA-C-O 112.663 -3.541 . . . . 0.0 111.724 176.721 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 35.0 t0 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.198 0.523 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -99.48 142.55 30.82 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.455 1.102 . . . . 0.0 110.3 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.7 p -70.98 134.81 47.46 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.055 -1.028 . . . . 0.0 112.396 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.33 100.97 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-O 122.127 0.965 . . . . 0.0 112.018 -175.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.97 95.93 4.93 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.687 1.195 . . . . 0.0 109.501 171.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.1 tt -90.31 121.38 32.26 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.991 0.516 . . . . 0.0 111.837 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -113.72 109.52 18.71 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 123.728 1.727 . . . . 0.0 109.213 169.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -81.18 104.88 11.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.699 -2.046 . . . . 0.0 111.718 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -108.53 111.31 23.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.618 0.767 . . . . 0.0 109.897 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 28.0 ptm -119.07 149.04 42.35 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.1 134.59 14.58 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.29 1.424 . . . . 0.0 110.892 169.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 mp -102.97 29.64 5.31 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.584 1.954 . . . . 0.0 111.608 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 p -69.7 163.12 26.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.112 1.765 . . . . 0.0 113.505 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.9 -32.3 48.39 Favored Glycine 0 N--CA 1.478 1.484 0 O-C-N 120.654 -1.278 . . . . 0.0 115.047 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 p -80.07 -6.82 58.33 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.239 1.416 . . . . 0.0 114.487 175.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.92 -9.83 59.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.218 1.407 . . . . 0.0 112.257 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -70.54 124.6 24.61 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 168.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.86 -40.98 2.31 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -168.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -67.82 -52.34 38.05 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.3 tp -64.75 -21.44 66.76 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.722 1.209 . . . . 0.0 113.642 -171.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.2 p -79.63 -47.77 14.86 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.549 1.068 . . . . 0.0 112.152 169.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -68.75 -30.29 68.87 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.633 -1.292 . . . . 0.0 112.802 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.0 p -76.03 -2.77 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.563 1.145 . . . . 0.0 113.345 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -69.81 -43.08 72.78 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.804 -1.185 . . . . 0.0 109.373 -175.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.7 m -76.88 -11.53 59.83 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.658 1.983 . . . . 0.0 112.205 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.84 86.59 6.89 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 124.643 2.163 . . . . 0.0 108.604 171.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.27 -54.64 0.02 OUTLIER Glycine 0 N--CA 1.474 1.198 0 CA-C-N 108.851 -3.795 . . . . 0.0 111.088 166.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.3 p -82.35 -41.46 19.98 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.292 1.837 . . . . 0.0 110.64 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.98 -36.07 82.29 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.825 0.85 . . . . 0.0 111.13 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.6 tp -70.88 -40.17 72.4 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.21 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 mt -56.51 -39.44 73.31 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.865 1.211 . . . . 0.0 112.481 171.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -60.8 -34.93 75.26 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.77 1.623 . . . . 0.0 111.798 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.05 -40.72 60.16 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 169.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.9 mt -75.57 -23.46 56.55 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.402 1.001 . . . . 0.0 113.608 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -70.42 -27.1 64.01 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.68 1.582 . . . . 0.0 113.506 -171.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -79.75 -37.92 34.39 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.793 0.437 . . . . 0.0 110.341 173.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.6 mm -63.35 -36.38 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 122.554 0.342 . . . . 0.0 111.869 170.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.7 t -159.06 135.84 9.48 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -169.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -63.78 -31.7 72.97 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.814 1.246 . . . . 0.0 112.832 171.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.7 t -128.75 110.83 12.53 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.998 0.904 . . . . 0.0 111.116 -172.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.68 86.54 0.23 Allowed Glycine 0 C--N 1.337 0.616 0 C-N-CA 125.82 1.676 . . . . 0.0 109.086 -169.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.6 mmt-85 -72.39 138.82 47.47 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.436 1.494 . . . . 0.0 108.672 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 tt -126.6 133.25 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-N 119.062 0.846 . . . . 0.0 111.712 -177.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.89 159.68 26.54 Favored Glycine 0 N--CA 1.475 1.264 0 C-N-CA 126.035 1.778 . . . . 0.0 112.51 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -137.04 133.27 35.29 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -169.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.63 145.94 17.99 Favored Glycine 0 C--N 1.343 0.948 0 C-N-CA 124.827 1.203 . . . . 0.0 111.945 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.7 m -128.49 149.0 50.77 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.084 0.953 . . . . 0.0 112.137 -173.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.1 152.32 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-N 118.99 0.814 . . . . 0.0 113.149 -175.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.4 t -141.5 -84.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 125.152 1.381 . . . . 0.0 109.269 168.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.428 ' H ' ' H ' ' A' ' 51' ' ' MET . 54.0 t30 -149.54 -20.63 0.28 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.847 2.459 . . . . 0.0 108.269 169.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.428 ' H ' ' H ' ' A' ' 50' ' ' ASN . 76.4 mtm -75.78 50.17 0.56 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 127.514 2.325 . . . . 0.0 106.202 166.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.342 4.0 t 32.74 -149.56 0.0 OUTLIER 'General case' 0 C--N 1.345 0.375 1 C-N-CA 133.915 4.886 . . . . 0.0 116.71 -168.835 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -106.0 137.35 44.06 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 130.287 3.435 . . . . 0.0 109.343 -174.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -129.37 126.56 39.15 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 122.604 1.192 . . . . 0.0 109.739 168.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -87.35 116.65 25.59 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.851 2.06 . . . . 0.0 109.399 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.7 mt -110.01 -57.46 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.131 -169.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -103.98 117.25 33.84 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.104 0.865 . . . . 0.0 112.907 173.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -64.27 147.45 52.43 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 166.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mp -61.5 126.56 27.8 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 121.072 1.76 . . . . 0.0 110.461 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -149.54 176.83 10.27 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.635 1.174 . . . . 0.0 111.469 -173.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.27 -25.76 23.8 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.432 1.893 . . . . 0.0 113.982 -170.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -87.82 80.63 7.8 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 125.534 2.588 . . . . 0.0 109.653 -176.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.2 m -66.1 -25.77 67.16 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 127.716 2.406 . . . . 0.0 110.09 170.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.5 t -68.14 -23.01 64.84 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.544 -0.722 . . . . 0.0 109.526 168.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -85.69 -34.64 21.22 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.031 -1.043 . . . . 0.0 112.035 173.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 44.9 t80 -52.87 -26.36 14.49 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 123.962 0.905 . . . . 0.0 110.953 169.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -75.7 -49.98 16.72 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.53 -0.731 . . . . 0.0 109.965 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -79.61 -20.04 47.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 117.887 -1.054 . . . . 0.0 112.38 -169.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -83.28 -35.17 25.5 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 118.06 -1.456 . . . . 0.0 109.131 169.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -65.25 -29.01 69.76 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.361 0.528 . . . . 0.0 110.588 176.162 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -65.77 -26.95 67.94 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 170.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -77.96 -26.89 49.07 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 119.483 1.038 . . . . 0.0 113.344 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.77 153.93 23.08 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.327 0.584 . . . . 0.0 110.863 176.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.284 1.0 OUTLIER -148.65 166.25 28.89 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.587 1.155 . . . . 0.0 111.39 170.314 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 t -80.46 147.91 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.151 1.78 . . . . 0.0 114.492 -167.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.6 m -125.82 159.87 31.32 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.268 1.827 . . . . 0.0 113.138 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.63 161.79 13.49 Favored Glycine 0 N--CA 1.476 1.331 0 C-N-CA 125.089 1.328 . . . . 0.0 114.757 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -158.76 147.92 18.89 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.075 2.15 . . . . 0.0 109.654 171.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.08 -74.58 0.06 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.542 1.537 . . . . 0.0 112.193 176.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.81 154.62 41.67 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -173.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.6 m -67.19 -52.42 30.05 Favored Pre-proline 0 N--CA 1.474 0.742 0 CA-C-O 116.372 -1.775 . . . . 0.0 113.913 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -71.08 152.99 62.97 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.107 1.872 . . . . 0.0 111.661 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -133.46 158.99 41.68 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.66 34.13 2.08 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 117.309 1.684 . . . . 0.0 117.309 -168.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -74.02 -21.32 60.02 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -170.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.4 tp -56.96 -53.03 62.65 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.424 0.689 . . . . 0.0 109.79 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -63.57 -31.46 72.64 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.841 -1.162 . . . . 0.0 112.741 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.24 -51.77 68.12 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.86 170.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.494 ' CG1' HD13 ' A' ' 110' ' ' LEU . 27.4 m -59.64 -26.55 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 119.909 1.232 . . . . 0.0 112.851 177.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 156' ' ' LEU . 37.9 t -70.81 -56.64 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.06 173.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -58.56 -36.78 74.46 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.55 0.614 . . . . 0.0 109.623 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.555 HG11 HD13 ' A' ' 108' ' ' LEU . 52.9 t -60.74 -31.46 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 173.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.78 -51.63 11.04 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.247 -0.908 . . . . 0.0 113.295 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.2 mm -71.28 -23.65 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 119.789 1.177 . . . . 0.0 113.31 -169.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.436 ' HG ' ' HG ' ' A' ' 135' ' ' CYS . 0.0 OUTLIER -85.32 61.09 6.64 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.567 -1.333 . . . . 0.0 112.433 -173.012 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -46.56 -44.65 18.14 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.448 1.499 . . . . 0.0 110.821 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.97 -24.2 28.01 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.678 1.132 . . . . 0.0 115.207 -171.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -88.4 -40.95 13.13 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.829 1.315 . . . . 0.0 111.042 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 92' ' ' VAL . 27.0 mt -79.64 -31.9 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 121.321 -0.862 . . . . 0.0 110.551 176.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.81 31.76 20.07 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.666 -0.519 . . . . 0.0 113.358 169.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -55.48 120.99 8.02 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.482 1.113 . . . . 0.0 112.414 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -76.45 170.37 16.51 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.716 0.807 . . . . 0.0 111.007 169.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -89.62 52.42 2.32 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.85 0.86 . . . . 0.0 112.095 169.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.7 -119.05 3.87 Favored Glycine 0 N--CA 1.471 0.982 0 N-CA-C 105.867 -2.893 . . . . 0.0 105.867 168.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.6 t -124.76 131.38 53.46 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.23 137.5 41.28 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -168.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -136.42 104.78 5.71 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -167.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.555 HD13 HG11 ' A' ' 92' ' ' VAL . 20.9 tp -97.41 101.0 12.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.744 -175.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.6 t -73.81 127.8 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 168.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.494 HD13 ' CG1' ' A' ' 89' ' ' VAL . 21.4 tp -116.26 130.12 56.62 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 169.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.422 ' CG2' HD22 ' A' ' 194' ' ' LEU 0.257 6.5 p -141.86 129.97 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.6 t -147.3 -176.46 5.24 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 113.351 -1.75 . . . . 0.0 111.277 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -130.82 -7.98 3.99 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 127.063 2.145 . . . . 0.0 113.607 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -150.14 169.4 21.37 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.917 1.287 . . . . 0.0 112.936 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -53.14 167.52 0.17 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.554 2.342 . . . . 0.0 115.677 -170.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -92.99 163.84 13.51 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . 78.2 m-70 -102.59 124.07 47.47 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 165.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.5 mp -104.32 177.21 4.91 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.757 1.223 . . . . 0.0 110.538 -172.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.44 145.46 4.71 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.367 58.6 pttt 56.29 2.79 0.09 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 128.345 2.658 . . . . 0.0 116.891 -170.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -66.34 -28.91 69.03 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 121.475 1.943 . . . . 0.0 112.442 170.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . 0.329 20.1 mttt -75.14 7.61 3.22 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 176.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.6 t -70.92 -18.69 62.65 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.781 1.232 . . . . 0.0 111.209 168.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 mp -65.71 -23.76 66.83 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.196 0.998 . . . . 0.0 112.196 169.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -88.42 -130.72 3.61 Favored Glycine 0 CA--C 1.538 1.482 0 N-CA-C 106.64 -2.584 . . . . 0.0 106.64 168.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.3 m -142.2 68.4 1.32 Allowed 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 118.008 0.904 . . . . 0.0 109.28 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -134.45 81.02 1.88 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.795 1.638 . . . . 0.0 108.665 -175.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -79.49 -45.74 18.76 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.729 0.812 . . . . 0.0 111.726 -176.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -57.99 120.62 8.86 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.049 0.54 . . . . 0.0 111.341 -171.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.4 t -72.13 154.33 41.14 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-O 122.577 1.18 . . . . 0.0 111.246 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.7 p -61.46 138.46 58.27 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 127.425 2.29 . . . . 0.0 115.674 -171.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 54.4 p30 -87.69 -18.15 30.16 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -175.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.28 17.38 78.81 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.988 -0.896 . . . . 0.0 114.017 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 37.5 ttm105 -96.9 158.73 15.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.954 1.702 . . . . 0.0 110.426 174.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' CYS . . . . . 0.436 ' HG ' ' HG ' ' A' ' 95' ' ' CYS . 0.0 OUTLIER -87.71 146.16 25.81 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.07 -1.019 . . . . 0.0 112.95 169.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -140.7 55.66 1.58 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.273 1.829 . . . . 0.0 110.663 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 tt -130.67 130.13 43.49 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.34 2.256 . . . . 0.0 108.418 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -145.56 -50.07 0.24 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 169.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -72.37 -20.91 61.38 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.905 1.282 . . . . 0.0 114.107 176.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 131.37 -17.88 5.01 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.118 1.818 . . . . 0.0 114.328 -172.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 80.5 mtp -113.52 157.72 21.66 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.989 1.895 . . . . 0.0 114.116 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -73.31 91.98 1.76 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.787 0.835 . . . . 0.0 110.972 171.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -54.62 -38.57 66.98 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.313 1.045 . . . . 0.0 112.535 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 64.8 m -79.58 0.74 28.73 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -41.32 -46.31 3.23 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 120.529 1.513 . . . . 0.0 112.338 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.68 -7.75 88.02 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 117.966 -1.463 . . . . 0.0 115.161 -172.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.276 88.8 tt0 -114.5 -79.39 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.025 0 CA-C-O 115.891 -2.004 . . . . 0.0 112.141 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.92 158.22 48.39 Favored 'Trans proline' 0 C--N 1.356 0.948 0 CA-C-N 123.509 2.289 . . . . 0.0 113.275 170.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -77.27 -168.25 1.08 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.673 1.589 . . . . 0.0 113.514 170.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 117' ' ' HIS . 71.2 m-85 -69.2 144.83 53.62 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 172.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.53 153.12 43.79 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 54.6 p -85.66 150.97 24.24 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.317 -0.864 . . . . 0.0 112.833 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 70.0 t -56.0 -43.83 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.597 0.759 . . . . 0.0 110.945 -176.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.5 t -75.68 -26.66 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.005 -1.059 . . . . 0.0 112.682 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -61.24 -32.81 72.6 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.869 1.213 . . . . 0.0 110.135 170.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.42 ' CD2' HG22 ' A' ' 90' ' ' VAL . 5.6 mt -83.69 -33.06 25.24 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.809 -0.557 . . . . 0.0 112.373 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.78 84.47 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.187 0.449 . . . . 0.0 110.331 169.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.1 t -55.29 -51.62 66.08 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.229 1.012 . . . . 0.0 111.193 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -73.57 -48.82 29.94 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.7 mp -73.2 -18.63 61.23 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.701 -1.249 . . . . 0.0 112.169 -173.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.66 -30.54 41.26 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 119.115 0.871 . . . . 0.0 112.586 168.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -68.9 -48.32 63.63 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.322 1.449 . . . . 0.0 109.76 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -79.95 -8.98 59.63 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.042 1.337 . . . . 0.0 111.964 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 59.5 49.13 8.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.769 2.427 . . . . 0.0 112.794 171.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 19.2 mm -96.97 147.21 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.929 1.691 . . . . 0.0 109.671 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -105.96 102.14 37.62 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 120.82 1.645 . . . . 0.0 109.549 168.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.439 ' C ' HD12 ' A' ' 168' ' ' ILE . 37.6 Cg_exo -76.23 125.9 8.82 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.977 3.118 . . . . 0.0 113.108 169.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.485 HG13 HG23 ' A' ' 190' ' ' THR . 1.3 mp -119.51 109.49 26.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -77.13 73.31 3.71 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 122.436 1.112 . . . . 0.0 112.371 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.428 HG23 HG22 ' A' ' 168' ' ' ILE . 77.4 t -60.0 104.18 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.893 0.877 . . . . 0.0 109.468 167.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 6.3 m -149.42 148.46 26.31 Favored Pre-proline 0 N--CA 1.481 1.122 0 O-C-N 119.871 -1.768 . . . . 0.0 113.2 -173.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -58.8 153.72 48.39 Favored 'Trans proline' 0 C--N 1.354 0.838 1 C-N-CA 125.625 4.217 . . . . 0.0 116.291 178.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 29.2 t -51.74 -54.61 26.57 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -169.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 80.2 mmt-85 -60.42 -13.32 12.81 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 120.549 1.522 . . . . 0.0 114.407 -173.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 14.3 ttp -105.53 -16.52 14.69 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.431 2.293 . . . . 0.0 114.641 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.9 m -62.49 -24.83 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 122.123 2.238 . . . . 0.0 112.344 -170.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -60.27 -28.69 68.27 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.9 t -92.17 -33.56 14.67 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.172 0.589 . . . . 0.0 111.453 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -69.57 -32.25 70.92 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.377 -1.452 . . . . 0.0 109.964 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -68.05 -12.97 61.8 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.453 1.101 . . . . 0.0 112.309 169.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -96.9 -29.21 13.83 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.16 -0.963 . . . . 0.0 111.291 173.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.5 -26.81 63.76 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 119.895 -1.753 . . . . 0.0 109.758 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.4 t -81.15 -15.2 56.49 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.98 -19.44 44.06 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.805 169.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -88.78 -31.58 18.3 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 170.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 14.8 mm -101.78 111.86 64.56 Favored Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 119.547 1.067 . . . . 0.0 109.505 176.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.77 0.65 4.01 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 124.924 3.749 . . . . 0.0 119.779 -168.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -128.68 -2.95 5.36 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 -176.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.431 HD22 ' HB2' ' A' ' 167' ' ' PRO . 9.2 mt -83.21 172.75 12.29 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.93 1.241 . . . . 0.0 113.299 -169.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.485 HG23 HG13 ' A' ' 168' ' ' ILE 0.446 0.1 OUTLIER -141.5 -176.42 4.73 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 167.989 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.9 mp -157.88 136.68 3.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 131.478 3.911 . . . . 0.0 109.354 -166.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -118.38 147.46 18.56 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 172.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -87.43 87.38 7.39 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 122.863 1.316 . . . . 0.0 107.658 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.422 HD22 ' CG2' ' A' ' 111' ' ' VAL . 12.3 tp -56.35 144.96 28.65 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.494 169.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.3 t -87.47 157.03 19.29 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.387 -0.821 . . . . 0.0 110.356 169.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -60.73 -23.84 65.24 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -171.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -97.45 -8.15 30.0 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.013 1.725 . . . . 0.0 113.956 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.5 p 85.44 -9.31 0.81 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 130.755 3.622 . . . . 0.0 117.378 168.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 82.6 p -67.13 -11.53 57.49 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.225 -1.547 . . . . 0.0 115.04 -169.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -67.8 -17.72 64.61 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.184 0.594 . . . . 0.0 112.229 168.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 4.6 p -46.72 -46.59 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -169.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.21 -33.59 76.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.79 1.177 . . . . 0.0 112.657 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -73.87 -5.26 39.98 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.821 -1.152 . . . . 0.0 113.248 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 61.9 mt -99.59 -34.19 10.33 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.917 2.087 . . . . 0.0 108.4 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 15.4 mm -61.98 -53.87 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 168.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 64.9 ttt-85 -64.49 -39.72 94.32 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.816 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -72.78 -29.37 63.24 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 118.02 -1.472 . . . . 0.0 113.528 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -81.19 -27.25 35.42 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.862 1.21 . . . . 0.0 113.396 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -61.98 -35.57 78.88 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.474 0.579 . . . . 0.0 111.59 171.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 46.3 m -72.17 -23.19 61.24 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 174.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -68.74 -59.08 3.35 Favored 'General case' 0 C--O 1.254 1.315 0 CA-C-N 119.106 0.866 . . . . 0.0 110.254 171.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . 0.287 18.3 tp . . . . . 0 C--O 1.27 2.171 0 C-N-CA 126.88 2.072 . . . . 0.0 115.551 -170.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.9 t0 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.285 0.564 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -132.46 147.1 52.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.468 1.507 . . . . 0.0 109.592 170.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 t -63.39 136.95 57.97 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -170.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 t -110.19 95.66 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.628 1.171 . . . . 0.0 110.125 -171.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -76.39 118.33 18.97 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.544 -0.723 . . . . 0.0 110.352 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.1 mt -107.25 137.79 44.66 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.685 -0.634 . . . . 0.0 110.191 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -122.49 109.48 14.41 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 122.579 1.18 . . . . 0.0 108.986 169.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -83.26 110.64 18.26 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.856 1.262 . . . . 0.0 111.808 173.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' A' ' 88' ' ' ALA . 30.3 tp -103.21 124.23 48.22 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.981 0.912 . . . . 0.0 110.62 170.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.424 ' SD ' HD21 ' A' ' 70' ' ' LEU . 40.7 ttp -121.88 138.68 54.3 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -169.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.53 133.58 12.62 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.943 1.259 . . . . 0.0 112.159 172.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tp -119.31 26.53 9.38 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.799 1.639 . . . . 0.0 113.3 -173.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.0 p -66.06 162.8 18.74 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.36 -20.98 68.09 Favored Glycine 0 N--CA 1.475 1.24 0 O-C-N 120.974 -1.079 . . . . 0.0 113.331 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 p -76.44 -18.76 58.64 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.172 1.389 . . . . 0.0 113.174 169.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.05 -6.86 59.49 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.688 1.195 . . . . 0.0 114.167 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -71.79 130.98 42.42 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.6 1.546 . . . . 0.0 108.187 169.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.28 -35.31 4.78 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.662 1.125 . . . . 0.0 110.351 -168.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -82.67 -24.8 33.54 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.43 1.092 . . . . 0.0 111.303 169.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.3 tp -54.94 -39.97 69.45 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.893 1.277 . . . . 0.0 111.468 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.1 p -61.57 -34.36 75.46 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.255 -1.528 . . . . 0.0 113.064 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -69.22 -44.34 72.23 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.906 -1.121 . . . . 0.0 111.013 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.464 ' CG1' HG11 ' A' ' 111' ' ' VAL . 5.0 m -72.33 -19.98 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.473 ' HA ' HD22 ' A' ' 70' ' ' LEU . 59.7 mt-30 -70.08 -38.21 75.65 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.119 1.767 . . . . 0.0 108.746 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.2 m -77.39 -11.37 59.83 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 127.821 2.448 . . . . 0.0 113.212 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.484 HD21 HG21 ' A' ' 201' ' ' VAL . 1.8 mp -86.47 48.0 1.56 Allowed 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 125.256 1.422 . . . . 0.0 111.661 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.61 -45.1 0.06 OUTLIER Glycine 0 N--CA 1.477 1.376 0 O-C-N 120.698 -1.251 . . . . 0.0 115.656 170.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.2 m -89.54 -21.87 22.68 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.894 0.878 . . . . 0.0 111.008 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.18 -34.42 63.78 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.672 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.3 mp -63.12 -46.62 86.44 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.972 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 63' ' ' SER . 18.3 mt -48.25 -52.93 19.0 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.67 1.123 . . . . 0.0 113.414 174.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -60.77 -37.12 80.77 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.899 0.772 . . . . 0.0 111.47 -172.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.33 -53.78 32.31 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 169.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 66.7 mt -74.7 -23.41 58.6 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -169.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -61.52 -25.45 67.29 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.288 1.435 . . . . 0.0 112.854 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -85.9 -34.32 20.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.83 0.852 . . . . 0.0 111.305 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.1 mp -65.83 -43.5 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.106 170.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.1 m -153.7 149.12 27.18 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -170.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -62.0 -48.47 80.16 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.734 0.814 . . . . 0.0 112.604 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.8 t -112.92 148.97 33.87 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 123.061 1.41 . . . . 0.0 111.694 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.62 94.66 0.11 Allowed Glycine 0 CA--C 1.517 0.182 0 N-CA-C 105.898 -2.881 . . . . 0.0 105.898 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -92.36 147.47 22.89 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 122.727 0.411 . . . . 0.0 110.402 -168.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.0 tt -122.26 129.27 75.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 124.196 0.998 . . . . 0.0 109.946 -172.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.75 157.84 14.94 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.273 1.416 . . . . 0.0 110.853 172.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -141.58 131.75 24.84 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.24 155.68 24.1 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 124.407 1.004 . . . . 0.0 113.199 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 74.3 m -119.32 139.95 51.12 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.009 1.324 . . . . 0.0 111.316 -177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.3 tt -142.53 157.97 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.787 1.235 . . . . 0.0 111.328 171.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -158.46 -59.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -179.28 -28.97 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 129.861 3.264 . . . . 0.0 107.499 172.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.4 70.98 3.85 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 101.64 -3.467 . . . . 0.0 101.64 165.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.326 14.8 t 19.43 -138.45 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.763 1 C-N-CA 132.129 4.172 . . . . 0.0 116.318 -169.333 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -117.43 146.05 43.73 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 129.335 3.054 . . . . 0.0 109.892 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -134.04 123.28 24.25 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.54 0.736 . . . . 0.0 111.152 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -85.79 98.33 10.68 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.378 1.071 . . . . 0.0 110.08 169.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.5 tt -83.98 -64.24 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.504 0.722 . . . . 0.0 112.258 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 tp -109.27 117.38 33.94 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.605 1.162 . . . . 0.0 110.437 -171.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -60.59 147.76 40.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.498 0.719 . . . . 0.0 112.043 173.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.2 tt -50.41 115.13 1.32 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.554 1.942 . . . . 0.0 110.961 172.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.7 t -155.16 175.71 13.49 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.073 1.349 . . . . 0.0 112.353 -170.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.7 -13.87 41.35 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.289 1.436 . . . . 0.0 114.842 -172.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -88.01 76.19 8.63 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 124.681 2.182 . . . . 0.0 108.793 -175.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.464 ' HB2' HD11 ' A' ' 31' ' ' LEU . 53.6 m -81.37 -21.26 39.18 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 126.117 1.767 . . . . 0.0 111.549 -175.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.0 t -74.45 -26.17 59.88 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 167.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -80.17 -30.22 38.81 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.754 -1.216 . . . . 0.0 110.326 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -53.66 -34.0 57.18 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.574 -0.704 . . . . 0.0 110.417 169.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -73.0 -36.69 67.09 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -72.84 -33.2 65.99 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.862 1.265 . . . . 0.0 110.267 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.92 -37.36 58.81 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 24' ' ' GLN . 4.3 tt -72.42 -27.85 62.59 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.231 175.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -70.84 -33.88 71.11 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 121.047 -1.033 . . . . 0.0 112.393 171.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -70.54 -27.14 63.93 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -64.73 153.01 41.03 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.713 0.688 . . . . 0.0 112.294 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.28 132.07 37.32 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.712 1.605 . . . . 0.0 108.045 -174.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.13 155.42 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.635 0.774 . . . . 0.0 112.884 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.5 p -103.19 -151.01 0.42 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.511 0.724 . . . . 0.0 111.866 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -142.87 141.53 10.69 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.375 1.464 . . . . 0.0 112.252 173.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -151.79 144.89 24.57 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.965 1.706 . . . . 0.0 110.652 173.431 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.56 -38.61 14.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -169.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.43 139.81 42.52 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.8 p -76.0 -38.63 2.51 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-O 115.89 -2.005 . . . . 0.0 114.905 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.99 136.61 53.41 Favored 'Trans proline' 0 C--N 1.355 0.885 0 CA-C-N 122.555 1.948 . . . . 0.0 112.897 171.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -102.22 160.38 14.57 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.548 1.539 . . . . 0.0 113.402 179.298 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.35 22.37 1.66 Allowed Glycine 0 N--CA 1.477 1.426 0 O-C-N 120.883 -1.136 . . . . 0.0 115.147 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -47.16 -34.18 5.94 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.386 2.274 . . . . 0.0 114.573 -169.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.29 -32.92 71.65 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.592 -0.718 . . . . 0.0 112.421 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -57.75 -52.11 66.81 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.307 0.958 . . . . 0.0 110.416 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.474 ' HB3' HD21 ' A' ' 9' ' ' LEU . . . -60.29 -49.6 76.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 116.464 -1.731 . . . . 0.0 111.18 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.468 HG12 HD13 ' A' ' 110' ' ' LEU . 16.4 m -55.35 -38.36 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 121.378 1.899 . . . . 0.0 114.423 -169.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.5 HG11 ' HG3' ' A' ' 151' ' ' GLN . 1.3 p -86.37 -38.79 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 117.451 -1.262 . . . . 0.0 112.582 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -60.74 -44.42 96.7 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 121.161 1.8 . . . . 0.0 109.776 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.254 6.4 m -65.56 -4.11 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 120.773 1.624 . . . . 0.0 114.239 174.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.77 -18.07 17.39 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.772 1.229 . . . . 0.0 113.222 169.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.9 mt -104.89 -19.06 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 126.004 1.722 . . . . 0.0 111.735 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 95.3 m -73.16 42.42 0.11 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 127.338 2.255 . . . . 0.0 113.581 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -50.39 -41.41 52.02 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.027 1.331 . . . . 0.0 111.412 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.37 -26.77 46.24 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.24 0.924 . . . . 0.0 115.121 -174.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -88.54 -41.85 12.44 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.161 0.98 . . . . 0.0 110.277 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 74.6 mt -76.03 -38.44 35.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 CA-C-O 117.495 -1.241 . . . . 0.0 110.809 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.19 20.21 31.02 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 119.199 0.909 . . . . 0.0 115.145 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -52.05 125.91 16.94 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.079 1.351 . . . . 0.0 113.063 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -98.12 174.6 6.45 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.356 1.462 . . . . 0.0 113.196 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -71.76 1.55 6.72 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -174.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.25 -134.72 2.01 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 120.666 1.576 . . . . 0.0 110.223 -178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.3 t -97.58 143.29 28.41 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.865 1.266 . . . . 0.0 108.299 175.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -142.0 118.44 10.9 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 119.365 0.984 . . . . 0.0 110.183 -169.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -119.16 109.95 16.47 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -169.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.58 96.77 7.57 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.415 175.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.99 118.49 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.468 HD13 HG12 ' A' ' 89' ' ' VAL . 45.8 tp -108.97 128.97 55.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 117.765 -1.112 . . . . 0.0 109.846 -174.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.464 HG11 ' CG1' ' A' ' 23' ' ' VAL . 48.8 t -120.91 134.79 63.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.6 t -161.24 166.54 27.56 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 112.801 -2.0 . . . . 0.0 109.624 169.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -124.03 7.72 8.61 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.856 2.062 . . . . 0.0 114.214 174.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -141.83 -177.63 5.29 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.573 1.549 . . . . 0.0 111.51 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -55.08 177.87 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.491 2.316 . . . . 0.0 114.696 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -139.34 158.78 43.56 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.82 2.048 . . . . 0.0 110.015 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -85.54 126.67 34.05 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.201 0.6 . . . . 0.0 111.368 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.587 HD22 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -91.11 176.1 6.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.481 1.512 . . . . 0.0 108.992 172.192 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.587 ' H ' HD22 ' A' ' 118' ' ' LEU . . . -55.22 148.78 13.73 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.177 -0.952 . . . . 0.0 112.139 169.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.1 mptt 76.55 -13.86 0.88 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.479 2.312 . . . . 0.0 113.589 -176.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -65.62 -19.34 65.87 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.254 -1.529 . . . . 0.0 111.622 169.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -66.16 -24.08 66.58 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.345 3.0 t -75.66 -11.8 60.07 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 119.216 0.916 . . . . 0.0 112.13 -173.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.4 mt -60.63 -34.84 74.86 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.977 -1.077 . . . . 0.0 110.84 167.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -92.26 15.34 62.36 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.826 1.679 . . . . 0.0 113.711 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.543 0.1 OUTLIER 44.05 54.27 6.0 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 128.672 2.789 . . . . 0.0 113.917 -176.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -104.0 132.14 50.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.017 2.127 . . . . 0.0 105.59 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -113.78 -35.96 4.99 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 120.786 1.63 . . . . 0.0 113.315 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -48.07 116.86 1.67 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.789 1.236 . . . . 0.0 112.037 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.8 t -62.87 157.37 21.66 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.912 0.778 . . . . 0.0 110.164 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -66.53 132.3 47.91 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.838 -0.539 . . . . 0.0 110.622 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.82 -11.15 59.65 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.8 75.14 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 118.65 -1.083 . . . . 0.0 113.793 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -125.79 178.28 5.8 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.243 1.417 . . . . 0.0 112.328 170.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 1.2 m -99.39 146.24 26.51 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -169.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -151.55 56.38 0.87 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.568 1.547 . . . . 0.0 113.289 -169.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -134.26 151.43 51.28 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.918 -1.113 . . . . 0.0 111.511 169.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -147.41 -49.95 0.18 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.209 1.004 . . . . 0.0 113.511 -169.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -80.44 -10.16 59.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.242 1.017 . . . . 0.0 112.73 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.07 -9.31 27.17 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.476 1.989 . . . . 0.0 113.928 -171.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 29.9 ttm -99.26 136.13 39.66 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.8 1.8 . . . . 0.0 111.69 174.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.463 ' CE1' ' HB3' ' A' ' 144' ' ' SER . 30.6 t80 -66.66 95.98 0.37 Allowed 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.49 -0.756 . . . . 0.0 111.947 171.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -53.23 -45.33 68.66 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.22 2.208 . . . . 0.0 112.685 -178.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.463 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 17.2 t -67.79 -19.65 65.12 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -168.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -48.56 -35.32 13.13 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 121.035 1.743 . . . . 0.0 114.064 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.92 -16.82 74.92 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 119.099 -0.834 . . . . 0.0 113.482 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -117.73 -84.49 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.359 0 CA-C-O 115.946 -1.978 . . . . 0.0 109.802 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -51.51 157.64 4.81 Favored 'Trans proline' 0 C--N 1.358 1.03 0 N-CA-C 120.072 3.066 . . . . 0.0 120.072 171.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.446 ' HB2' ' HE3' ' A' ' 122' ' ' LYS . 47.9 t0 -77.03 166.77 22.87 Favored 'General case' 0 N--CA 1.468 0.448 1 C-N-CA 131.875 4.07 . . . . 0.0 115.595 -179.156 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -71.62 123.08 21.71 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 166.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.667 ' H ' ' CD ' ' A' ' 151' ' ' GLN . 1.0 OUTLIER -51.17 147.23 5.66 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 125.875 1.67 . . . . 0.0 112.217 171.192 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 7.7 t -85.11 166.25 16.8 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.982 0.896 . . . . 0.0 112.561 173.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.46 -27.9 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -168.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.2 p -84.09 -26.39 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 175.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -68.78 -34.16 75.09 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.358 -0.839 . . . . 0.0 110.293 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -58.59 -59.91 4.65 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.037 0.535 . . . . 0.0 110.297 169.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.24 -36.44 66.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.743 0.817 . . . . 0.0 113.069 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.4 t -58.89 -57.55 12.57 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.408 1.083 . . . . 0.0 112.417 175.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -81.37 -22.3 38.48 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.786 -1.196 . . . . 0.0 113.902 -174.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.4 mp -61.08 -48.02 83.63 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.117 0.967 . . . . 0.0 109.869 168.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.88 -28.78 55.51 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -67.91 -50.7 54.66 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.644 0.778 . . . . 0.0 110.179 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -84.16 -1.21 54.62 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.7 t30 64.08 31.86 13.18 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.753 1.161 . . . . 0.0 112.078 169.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.8 mt -97.75 128.61 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -103.87 115.33 63.56 Favored Pre-proline 0 N--CA 1.477 0.891 0 CA-C-N 119.461 1.028 . . . . 0.0 111.954 175.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.31 153.68 35.87 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.482 2.122 . . . . 0.0 115.803 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.04 113.57 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.789 1.636 . . . . 0.0 109.111 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.403 ' CD1' HD23 ' A' ' 110' ' ' LEU . 21.7 m-85 -71.56 68.15 0.56 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 122.248 1.023 . . . . 0.0 112.793 176.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.1 t -63.85 102.13 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 O-C-N 120.035 -1.665 . . . . 0.0 111.54 170.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 16.3 m -143.45 145.27 31.12 Favored Pre-proline 0 N--CA 1.478 0.934 0 O-C-N 120.074 -1.641 . . . . 0.0 111.174 -174.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -56.96 150.25 56.69 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.79 2.993 . . . . 0.0 112.941 173.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.5 t -46.54 -44.71 18.11 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.705 1.602 . . . . 0.0 114.123 -169.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.4 ptm85 -53.54 -27.95 28.86 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 12.8 tpt -106.02 -4.53 20.39 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.684 1.594 . . . . 0.0 113.917 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.37 -35.52 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 120.239 -1.538 . . . . 0.0 112.807 -169.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -68.53 -20.32 64.55 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.9 m -88.83 -40.22 13.3 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.211 1.404 . . . . 0.0 110.202 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -70.27 -26.42 63.81 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.341 -0.849 . . . . 0.0 111.149 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.75 -16.68 64.24 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.428 1.013 . . . . 0.0 111.844 168.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -82.06 -29.46 31.86 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.742 -1.224 . . . . 0.0 111.35 169.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.55 -26.17 57.75 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.581 -1.325 . . . . 0.0 110.217 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.03 -16.48 53.19 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.612 1.565 . . . . 0.0 111.78 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.77 -28.33 24.62 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.929 0.491 . . . . 0.0 110.286 169.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -78.14 -26.19 47.74 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 62.3 mt -117.3 96.94 50.15 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 123.701 0.801 . . . . 0.0 110.062 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.34 138.98 55.67 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.248 3.299 . . . . 0.0 113.836 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt 76.28 -8.75 1.59 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 129.038 2.935 . . . . 0.0 113.721 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.439 HD23 ' H ' ' A' ' 190' ' ' THR . 2.9 tt -72.59 150.96 42.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 169.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.439 ' H ' HD23 ' A' ' 189' ' ' LEU . 2.3 m -129.53 -139.15 0.23 Allowed 'General case' 0 C--N 1.343 0.294 0 CA-C-O 122.212 1.006 . . . . 0.0 109.549 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.9 tt -173.42 160.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 127.083 2.153 . . . . 0.0 109.807 -168.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -150.69 147.48 17.58 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 169.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.65 89.25 7.44 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.813 1.245 . . . . 0.0 108.42 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.7 tp -58.91 140.86 54.92 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.11 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 84.6 p -164.23 -164.52 0.86 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.572 1.549 . . . . 0.0 108.427 169.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -65.49 -10.14 31.93 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 121.267 -0.896 . . . . 0.0 112.331 169.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -109.58 140.46 43.36 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.149 2.179 . . . . 0.0 111.244 174.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 86.7 p -102.81 6.75 39.44 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.286 1.834 . . . . 0.0 113.795 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.3 p -60.4 -53.17 60.8 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 120.427 -1.421 . . . . 0.0 111.608 -169.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -68.42 -28.88 67.46 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.679 0.791 . . . . 0.0 113.051 -174.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.484 HG21 HD21 ' A' ' 26' ' ' LEU . 26.9 m -81.43 -42.36 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.6 1.16 . . . . 0.0 111.158 -177.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -69.82 -30.47 67.99 Favored 'General case' 0 C--O 1.219 -0.521 0 O-C-N 121.068 -1.02 . . . . 0.0 111.829 172.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -78.82 33.44 0.21 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 127.38 2.272 . . . . 0.0 112.508 174.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.413 HD21 ' HB ' ' A' ' 190' ' ' THR . 7.3 tp -142.0 -35.68 0.44 Allowed 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 126.965 2.106 . . . . 0.0 109.126 168.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 32.1 mt -69.93 -43.1 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 119.195 0.907 . . . . 0.0 109.057 170.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -63.37 -24.84 68.02 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.828 1.651 . . . . 0.0 112.831 172.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -91.31 -27.52 18.35 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 170.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -79.57 -19.11 50.19 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.544 -1.347 . . . . 0.0 112.457 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -74.04 -45.62 48.43 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.632 -0.667 . . . . 0.0 111.236 169.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.5 p -71.06 -9.24 57.71 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -174.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -75.92 -13.97 60.26 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.675 1.125 . . . . 0.0 113.699 169.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 C--O 1.256 1.408 0 C-N-CA 125.094 1.358 . . . . 0.0 112.751 174.948 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -98.97 154.66 17.9 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.704 1.201 . . . . 0.0 110.398 173.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -69.88 128.8 37.63 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.091 -1.006 . . . . 0.0 110.364 170.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.575 HG13 HG23 ' A' ' 105' ' ' THR . 51.3 t -139.62 118.05 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 119.111 0.868 . . . . 0.0 111.883 -176.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -93.74 122.69 36.46 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 122.888 0.475 . . . . 0.0 110.062 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -107.88 120.31 41.91 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.219 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -113.73 104.86 12.63 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 124.783 2.23 . . . . 0.0 110.183 171.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -75.63 117.72 17.7 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 111.52 -2.582 . . . . 0.0 111.761 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.5 tp -118.89 111.06 17.91 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.06 0.944 . . . . 0.0 110.79 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -114.04 137.13 52.13 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 118.821 2.897 . . . . 0.0 118.821 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.24 112.52 4.22 Favored Glycine 0 C--N 1.341 0.819 0 C-N-CA 125.639 1.59 . . . . 0.0 110.268 171.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.3 tp -98.89 28.91 4.05 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.791 1.637 . . . . 0.0 111.456 -172.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.0 p -79.16 164.43 24.24 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.253 -1.529 . . . . 0.0 114.368 -171.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.16 -32.97 85.69 Favored Glycine 0 N--CA 1.472 1.053 0 O-C-N 121.404 -0.81 . . . . 0.0 112.294 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 m -58.3 -40.73 82.79 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.09 0.956 . . . . 0.0 111.243 170.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.11 9.98 2.68 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -68.06 -37.84 81.76 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 121.298 1.863 . . . . 0.0 112.419 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.72 -33.09 66.75 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 172.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -77.1 -10.79 59.62 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 175.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.416 ' HA ' HG12 ' A' ' 23' ' ' VAL . 33.1 tp -55.23 -51.39 66.73 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.56 1.527 . . . . 0.0 112.56 -175.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.0 m -65.92 -27.7 68.38 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.394 -0.816 . . . . 0.0 112.068 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -75.8 -37.16 59.4 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.838 -1.164 . . . . 0.0 112.702 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 20' ' ' LEU . 3.7 p -68.56 -36.03 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 120.426 -1.421 . . . . 0.0 110.858 169.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -72.8 -34.45 66.91 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.105 1.32 . . . . 0.0 112.035 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 t -70.33 -45.27 66.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.055 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.16 -18.09 65.02 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 119.83 1.195 . . . . 0.0 111.06 170.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.08 -51.63 4.12 Favored Glycine 0 C--O 1.218 -0.875 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 -172.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.3 t -67.91 -32.4 72.84 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 127.61 2.364 . . . . 0.0 111.209 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -74.88 -32.35 61.84 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.788 -0.57 . . . . 0.0 110.979 174.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 63.4 tp -65.28 -37.94 88.73 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 123.028 0.205 . . . . 0.0 110.511 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.473 HD21 ' CE1' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -65.14 -60.98 2.42 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.693 0.797 . . . . 0.0 111.392 176.049 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -64.87 -45.25 86.8 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -168.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.31 -36.27 83.54 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 119.082 -0.485 . . . . 0.0 111.81 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.496 ' HA ' HG22 ' A' ' 37' ' ' ILE 0.398 34.2 mt -85.71 -15.34 42.57 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -179.078 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -68.86 -19.81 64.25 Favored 'General case' 0 CA--C 1.553 1.079 0 O-C-N 121.607 -0.683 . . . . 0.0 111.22 168.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -81.75 -45.38 15.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.527 1.131 . . . . 0.0 110.475 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.496 HG22 ' HA ' ' A' ' 34' ' ' LEU . 6.3 tp -72.71 -25.07 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 118.771 -0.633 . . . . 0.0 112.059 173.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.1 t -146.38 134.31 21.37 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.8 ttp85 -70.86 -43.01 69.33 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.351 1.46 . . . . 0.0 111.579 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 t -103.65 94.05 5.24 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 123.403 1.573 . . . . 0.0 109.346 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.11 90.83 0.2 Allowed Glycine 0 C--N 1.332 0.348 0 N-CA-C 105.693 -2.963 . . . . 0.0 105.693 -176.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -76.17 144.13 40.71 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -170.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 mt -136.69 128.18 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 118.078 0.399 . . . . 0.0 110.084 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.91 149.42 19.36 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 126.402 1.953 . . . . 0.0 110.247 -173.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -129.89 131.89 46.21 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.626 1.17 . . . . 0.0 113.926 -169.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.03 152.81 22.95 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 171.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 75.1 p -130.29 154.22 47.85 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.427 0.691 . . . . 0.0 110.796 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -151.43 140.73 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -169.697 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.589 ' CG2' ' H ' ' A' ' 50' ' ' ASN 0.308 1.4 m -136.53 -84.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-N 119.735 1.152 . . . . 0.0 111.386 169.207 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.589 ' H ' ' CG2' ' A' ' 49' ' ' VAL 0.49 24.2 t30 -156.97 -5.88 0.1 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 129.776 3.23 . . . . 0.0 111.713 169.227 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.0 ptp -88.99 44.45 1.21 Allowed 'General case' 0 CA--C 1.578 2.044 1 N-CA-C 98.994 -4.447 . . . . 0.0 98.994 160.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.552 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.681 14.6 m 14.23 -113.69 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.179 1 C-N-CA 137.324 6.25 . . . . 0.0 116.135 -164.941 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -112.56 136.83 51.63 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 125.727 1.892 . . . . 0.0 112.513 -168.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -124.43 120.87 33.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.654 1.181 . . . . 0.0 108.028 168.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -84.88 98.6 10.42 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.391 1.477 . . . . 0.0 110.426 169.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -86.88 -33.99 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 121.173 -0.954 . . . . 0.0 113.396 -174.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.4 tt -154.1 129.91 10.12 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.534 1.061 . . . . 0.0 111.375 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -78.79 169.23 18.56 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.407 HD11 ' CE3' ' A' ' 101' ' ' TRP . 73.3 mt -51.86 101.27 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.946 1.698 . . . . 0.0 112.075 176.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.0 t -119.9 167.6 11.97 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.648 1.579 . . . . 0.0 112.32 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.87 -11.82 43.56 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.891 1.676 . . . . 0.0 113.372 172.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -86.42 82.92 7.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 125.355 2.503 . . . . 0.0 109.223 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.9 t -64.61 -51.17 64.08 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 128.459 2.704 . . . . 0.0 110.076 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.4 t -65.12 -15.83 62.83 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.582 -1.324 . . . . 0.0 112.028 174.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -78.72 -45.9 20.21 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.259 -0.901 . . . . 0.0 110.132 173.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.473 ' CE1' HD21 ' A' ' 31' ' ' LEU . 6.9 t80 -54.45 -34.74 62.05 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.455 -0.778 . . . . 0.0 111.34 173.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -64.75 -39.18 93.19 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 121.19 -0.944 . . . . 0.0 110.199 -176.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 46.4 tpt85 -75.14 -27.75 59.89 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.345 1.458 . . . . 0.0 109.633 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.9 -36.73 19.74 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.595 0.559 . . . . 0.0 109.931 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.46 -47.77 66.25 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -62.31 -32.7 73.48 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -171.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -84.61 -4.19 58.86 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.205 1.402 . . . . 0.0 114.046 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -62.54 125.48 24.09 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.46 -1.4 . . . . 0.0 110.448 174.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -118.59 147.63 43.52 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.252 1.021 . . . . 0.0 110.344 170.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 m -82.5 159.34 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -168.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.2 t -101.93 -150.67 0.41 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 127.715 2.406 . . . . 0.0 112.44 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -159.92 155.89 27.05 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 125.716 1.627 . . . . 0.0 114.573 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -162.12 162.37 28.54 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.999 1.72 . . . . 0.0 112.208 174.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -78.85 -52.64 8.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.073 1.749 . . . . 0.0 111.71 -177.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.31 136.17 46.15 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.931 0.892 . . . . 0.0 111.773 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 80.4 m -72.97 -47.84 8.15 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-O 116.178 -1.867 . . . . 0.0 113.475 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.01 148.67 89.75 Favored 'Trans proline' 0 C--N 1.355 0.89 0 CA-C-N 121.94 1.728 . . . . 0.0 110.992 171.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -123.34 174.93 7.01 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.92 1.288 . . . . 0.0 112.576 -169.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -99.74 23.13 37.32 Favored Glycine 0 N--CA 1.482 1.741 0 O-C-N 119.836 -1.79 . . . . 0.0 115.799 -170.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.515 ' NE2' ' H ' ' A' ' 85' ' ' GLN . 1.9 pm0 -62.13 -17.73 58.73 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 120.359 2.079 . . . . 0.0 116.239 -169.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.496 ' HA ' HG22 ' A' ' 89' ' ' VAL . 4.9 mp -70.56 -14.09 62.36 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -72.87 -49.99 26.58 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 167.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.08 -51.11 70.54 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 116.065 -1.922 . . . . 0.0 111.652 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.496 HG22 ' HA ' ' A' ' 86' ' ' LEU . 28.8 m -52.27 -34.28 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 121.191 1.814 . . . . 0.0 112.135 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.868 HG21 HD22 ' A' ' 156' ' ' LEU . 12.4 t -87.6 -37.64 11.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 116.768 -1.587 . . . . 0.0 113.03 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -60.54 -46.6 89.58 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 121.862 2.119 . . . . 0.0 109.203 169.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.1 t -54.68 -40.19 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 125.509 1.524 . . . . 0.0 112.194 175.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.63 -42.32 64.54 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.8 mt -76.52 -38.78 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.455 1.102 . . . . 0.0 113.01 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 66.5 m -81.1 61.27 4.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.829 1.651 . . . . 0.0 110.619 -169.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.4 mt -50.79 -44.51 58.89 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.076 2.55 . . . . 0.0 111.619 -171.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.66 -22.39 66.94 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.691 -176.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -87.49 -47.89 8.38 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.963 0.905 . . . . 0.0 110.416 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.9 mp -70.29 -34.45 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.203 0.601 . . . . 0.0 110.769 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.2 29.41 8.98 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.23 1.395 . . . . 0.0 114.498 172.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.407 ' CE3' HD11 ' A' ' 59' ' ' LEU . 53.1 m95 -57.46 125.31 22.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.707 1.254 . . . . 0.0 112.952 -174.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -86.38 -177.07 6.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.195 2.198 . . . . 0.0 111.223 170.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -97.13 26.16 4.94 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.317 1.447 . . . . 0.0 114.808 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.69 -128.7 1.82 Allowed Glycine 0 CA--C 1.539 1.534 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.575 HG23 HG13 ' A' ' 4' ' ' VAL 0.308 7.2 t -112.72 152.52 28.98 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.536 -1.332 . . . . 0.0 108.173 167.171 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -130.16 129.88 44.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 117.439 -1.267 . . . . 0.0 110.362 -167.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -126.62 125.26 41.61 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.88 1.673 . . . . 0.0 115.343 -168.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 108' ' ' LEU . 48.7 mt -97.7 103.29 15.22 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.676 0.75 . . . . 0.0 112.305 169.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.536 HG13 HG21 ' A' ' 170' ' ' VAL . 36.0 t -90.78 95.34 5.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 174.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 37.0 tp -94.8 123.84 38.5 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 170' ' ' VAL 0.273 11.6 p -113.83 139.15 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 170.213 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -164.07 156.39 17.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.24 1.816 . . . . 0.0 109.885 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -106.23 -0.2 24.69 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.58 1.552 . . . . 0.0 114.456 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -144.13 179.47 7.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.195 1.398 . . . . 0.0 111.953 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.28 -174.33 0.12 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 122.992 1.377 . . . . 0.0 113.387 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -135.28 158.57 44.02 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.492 1.917 . . . . 0.0 112.691 -169.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -86.65 130.31 34.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.065 1.346 . . . . 0.0 109.862 169.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.474 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -110.14 170.21 8.23 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.825 1.25 . . . . 0.0 111.634 177.221 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.82 133.63 42.52 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.911 0.386 . . . . 0.0 111.87 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.4 mttm 91.94 -16.14 0.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 130.596 3.558 . . . . 0.0 113.008 -174.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -63.61 -28.95 70.28 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 121.484 1.947 . . . . 0.0 112.971 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -69.39 -5.54 24.21 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 121.472 -0.768 . . . . 0.0 112.855 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.9 t -62.77 -34.35 77.06 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.445 1.098 . . . . 0.0 112.469 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.66 -28.44 67.71 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.814 0.734 . . . . 0.0 112.373 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -81.05 4.05 73.11 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.109 1.338 . . . . 0.0 113.811 169.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.6 m 75.1 31.73 0.81 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 127.843 2.457 . . . . 0.0 111.6 175.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -115.06 110.87 20.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.553 1.141 . . . . 0.0 111.216 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -96.84 -40.6 8.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.347 1.459 . . . . 0.0 112.303 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -66.35 123.06 18.94 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.992 0.814 . . . . 0.0 110.977 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.9 t -65.93 152.75 43.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.946 0.899 . . . . 0.0 110.605 175.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 t -68.97 138.27 54.43 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.312 1.053 . . . . 0.0 111.963 174.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -82.76 -13.37 56.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.159 1.784 . . . . 0.0 113.911 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.2 31.74 63.56 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.838 -0.979 . . . . 0.0 113.017 -176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -107.61 164.99 11.75 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.213 1.405 . . . . 0.0 112.714 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 26.2 t -67.51 119.45 12.33 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.864 1.265 . . . . 0.0 110.593 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -123.85 40.79 3.64 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.276 1.43 . . . . 0.0 111.838 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.4 tp -122.18 117.95 27.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.755 1.622 . . . . 0.0 108.422 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -120.34 -49.02 2.28 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.463 1.105 . . . . 0.0 108.732 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -86.46 -130.31 0.05 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.727 1.611 . . . . 0.0 108.34 168.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.33 -21.67 7.88 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.089 1.328 . . . . 0.0 113.674 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 21.0 mtt -93.26 142.79 26.92 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.788 1.294 . . . . 0.0 112.78 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -64.56 100.44 0.37 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.721 1.208 . . . . 0.0 110.351 169.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -61.77 -40.32 94.74 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.188 0.995 . . . . 0.0 112.593 -174.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 63.8 m -82.24 6.63 16.11 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 23.2 ttp-105 -47.87 -50.72 25.6 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.698 1.135 . . . . 0.0 111.49 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.39 -31.99 68.38 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-O 118.421 -1.21 . . . . 0.0 113.107 -169.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.291 6.4 tp10 -92.66 -84.57 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.104 0 CA-C-O 115.579 -2.153 . . . . 0.0 112.025 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.31 155.14 71.38 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 CA-C-N 124.646 2.695 . . . . 0.0 116.168 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -72.72 161.56 30.59 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 129.913 3.285 . . . . 0.0 113.847 176.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -52.44 138.4 27.47 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.833 0.853 . . . . 0.0 111.281 172.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.473 ' H ' ' CD ' ' A' ' 151' ' ' GLN 0.271 0.0 OUTLIER -82.18 143.78 31.17 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.094 -1.004 . . . . 0.0 112.014 178.85 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 70.6 m -74.99 148.88 39.54 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.401 1.08 . . . . 0.0 112.769 -174.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.442 ' HA ' ' HG ' ' A' ' 156' ' ' LEU 0.296 33.4 t -58.61 -22.06 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -177.695 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.4 t -65.33 -44.66 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 118.893 0.769 . . . . 0.0 111.553 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.42 -29.99 59.92 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.552 0.741 . . . . 0.0 110.729 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.868 HD22 HG21 ' A' ' 90' ' ' VAL . 2.1 mt -63.62 -45.76 88.83 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 172.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.41 -45.89 69.55 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.222 1.009 . . . . 0.0 112.713 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 76.5 p -69.78 -38.84 76.85 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -174.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.34 -45.86 58.05 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.153 -0.967 . . . . 0.0 112.147 173.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.7 mt -53.25 -40.38 64.56 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.923 1.238 . . . . 0.0 113.24 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.73 -28.18 50.72 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -82.7 -34.39 27.33 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.571 1.078 . . . . 0.0 111.536 176.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -72.41 -18.9 61.68 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.843 0.857 . . . . 0.0 111.974 171.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 63.9 39.93 7.81 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.08 1.752 . . . . 0.0 112.314 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.05 143.56 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-O 117.052 -1.451 . . . . 0.0 109.731 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -105.34 115.67 61.64 Favored Pre-proline 0 N--CA 1.481 1.111 0 CA-C-N 121.72 2.055 . . . . 0.0 112.627 170.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -80.38 149.39 19.15 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.635 2.224 . . . . 0.0 113.093 169.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.1 mt -137.22 110.28 7.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.875 1.67 . . . . 0.0 107.107 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -72.45 73.72 1.02 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.933 0.873 . . . . 0.0 112.355 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.536 HG21 HG13 ' A' ' 109' ' ' VAL . 88.1 t -65.54 92.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 120.945 -1.097 . . . . 0.0 111.862 172.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 24.4 m -139.2 138.97 21.67 Favored Pre-proline 0 N--CA 1.479 0.993 0 O-C-N 119.729 -1.857 . . . . 0.0 110.513 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -58.53 152.53 54.48 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.558 2.839 . . . . 0.0 114.01 173.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 72.6 p -46.23 -42.72 14.7 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 116.666 2.098 . . . . 0.0 116.666 -168.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -51.37 -40.84 60.03 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 120.214 1.37 . . . . 0.0 113.509 -171.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.6 8.59 33.27 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.5 t -59.85 -42.92 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 121.036 1.744 . . . . 0.0 110.885 -176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -69.58 -13.45 62.33 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -174.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.443 ' HA ' ' HE2' ' A' ' 181' ' ' LYS 0.265 10.1 t -93.03 -27.5 16.95 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 118.86 0.754 . . . . 0.0 112.476 173.319 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -76.29 -29.76 57.5 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.49 -1.382 . . . . 0.0 109.509 168.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -58.03 -26.54 62.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.168 0.987 . . . . 0.0 110.818 169.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 178' ' ' THR . 55.3 mtmt -79.4 -40.28 30.43 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.573 -0.705 . . . . 0.0 109.589 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.6 mp -79.65 -18.66 50.94 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 120.668 -1.27 . . . . 0.0 111.532 -175.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.8 t -74.89 -11.52 60.15 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.066 0.46 . . . . 0.0 110.581 168.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.31 -28.67 23.57 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.177 -0.952 . . . . 0.0 109.434 168.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -76.85 -26.56 54.41 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.27 91.09 50.03 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.536 1.134 . . . . 0.0 110.654 170.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.06 153.45 32.25 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.596 3.531 . . . . 0.0 113.692 173.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 24.9 pttt 88.29 -19.11 0.23 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 131.464 3.906 . . . . 0.0 113.229 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.64 163.91 24.54 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.794 0.838 . . . . 0.0 110.267 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 36.0 p -123.0 -145.42 0.35 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 169.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.2 tt 178.65 138.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 129.055 2.942 . . . . 0.0 107.977 -168.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -133.52 143.5 15.21 Favored Glycine 0 N--CA 1.463 0.479 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -87.87 90.09 8.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.31 133.89 55.73 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.602 169.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 35.2 m -150.74 -158.64 0.94 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.806 1.642 . . . . 0.0 107.703 173.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.34 -24.74 67.51 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 120.882 -1.136 . . . . 0.0 110.522 168.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -85.12 134.96 34.17 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.413 2.285 . . . . 0.0 112.549 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 34.7 p -98.41 -0.7 43.08 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.83 2.052 . . . . 0.0 113.448 174.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.2 p -59.75 -55.79 29.93 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.546 1.938 . . . . 0.0 113.551 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -69.2 -36.98 77.86 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 122.153 -0.342 . . . . 0.0 111.141 -171.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.22 -50.91 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.925 0.89 . . . . 0.0 110.894 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.48 -30.7 71.1 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 118.782 -0.628 . . . . 0.0 111.792 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -74.76 -1.62 22.85 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.246 -1.534 . . . . 0.0 112.912 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.06 -33.47 9.25 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.582 -1.324 . . . . 0.0 109.862 174.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 86.1 mt -73.75 -40.12 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -65.9 -33.78 76.63 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.545 -0.722 . . . . 0.0 111.479 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -69.96 -25.05 63.45 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 119.059 0.845 . . . . 0.0 112.87 172.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -77.26 -37.24 53.45 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.69 -1.256 . . . . 0.0 111.53 173.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -61.14 -32.34 72.04 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.212 0.915 . . . . 0.0 111.69 173.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 54.3 p -75.02 -11.11 60.03 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -71.07 -36.54 72.32 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.487 1.04 . . . . 0.0 110.937 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 1 C--O 1.334 5.501 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -91.98 161.09 14.94 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.012 0.925 . . . . 0.0 111.836 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 t -66.49 127.54 32.71 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.271 -0.893 . . . . 0.0 110.902 169.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.1 t -123.86 135.6 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.394 1.478 . . . . 0.0 109.406 172.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -114.59 113.3 24.2 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 168.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.522 HD23 HD12 ' A' ' 43' ' ' ILE . 59.0 tp -101.21 131.89 46.98 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.056 0.455 . . . . 0.0 111.999 171.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -121.09 111.64 17.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 123.631 1.682 . . . . 0.0 109.561 169.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -88.52 107.85 19.1 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.007 -1.906 . . . . 0.0 111.597 175.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.3 tp -100.59 120.14 39.6 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.997 1.319 . . . . 0.0 111.877 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 30.8 mtp -103.97 143.9 32.25 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.88 115.38 4.97 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.701 1.619 . . . . 0.0 109.731 168.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -99.56 35.4 1.99 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.299 1.84 . . . . 0.0 111.951 -174.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 p -75.57 152.85 37.66 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.954 1.302 . . . . 0.0 113.605 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.45 -27.35 60.74 Favored Glycine 0 N--CA 1.478 1.464 0 O-C-N 121.258 -0.901 . . . . 0.0 113.881 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.1 p -65.73 -25.31 67.24 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.396 1.478 . . . . 0.0 113.891 170.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.28 -2.21 48.07 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.659 1.583 . . . . 0.0 114.143 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -70.67 136.62 49.2 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 121.786 2.084 . . . . 0.0 108.136 169.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.76 -50.73 2.01 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -168.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -68.0 -20.29 65.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.817 0.847 . . . . 0.0 111.803 169.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -48.94 -49.31 40.87 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.148 1.779 . . . . 0.0 109.963 175.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.5 m -62.82 -37.77 88.08 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 118.796 0.726 . . . . 0.0 112.793 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -62.41 -41.86 99.0 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.269 -1.519 . . . . 0.0 112.034 172.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.7 p -87.36 20.6 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 125.838 1.655 . . . . 0.0 112.126 174.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -119.7 -49.04 2.35 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.068 1.347 . . . . 0.0 109.097 171.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.1 t -59.33 -37.66 78.37 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.834 -0.541 . . . . 0.0 109.966 169.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.1 tp -96.39 107.01 19.33 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 168.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 146.49 -48.72 0.66 Allowed Glycine 0 C--N 1.303 -1.276 1 C-N-CA 130.817 4.056 . . . . 0.0 106.603 176.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.1 m -76.17 -36.91 58.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.452 1.501 . . . . 0.0 112.355 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.23 -26.29 66.52 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.538 -0.726 . . . . 0.0 112.312 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.97 -57.45 8.69 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.475 172.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.632 HD22 HG21 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -46.95 -55.56 7.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.163 0.985 . . . . 0.0 112.399 -176.71 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -69.77 -43.71 71.62 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -169.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.85 -41.23 78.74 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 117.61 0.187 . . . . 0.0 111.435 176.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.466 HD21 ' CG2' ' A' ' 205' ' ' ILE . 1.0 OUTLIER -69.48 -36.75 76.82 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.678 -1.264 . . . . 0.0 111.275 -177.831 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -60.22 -24.83 65.15 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.112 0.965 . . . . 0.0 112.434 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -84.69 -42.02 15.7 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.545 1.138 . . . . 0.0 110.658 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.6 mm -64.78 -34.53 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.285 0.634 . . . . 0.0 111.534 172.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.9 p -155.0 134.3 12.48 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -60.77 -49.51 77.18 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.141 1.776 . . . . 0.0 113.106 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.2 m -95.31 81.36 3.6 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.71 0.767 . . . . 0.0 109.829 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.52 83.03 0.32 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 127.512 2.482 . . . . 0.0 107.492 -177.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -85.47 146.08 27.12 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 125.484 1.514 . . . . 0.0 108.019 -169.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.632 HG21 HD22 ' A' ' 31' ' ' LEU 0.261 11.9 tt -136.56 141.77 40.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 178.759 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.93 150.77 19.64 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 127.884 2.659 . . . . 0.0 109.816 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -126.79 130.29 49.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.36 146.19 16.63 Favored Glycine 0 C--N 1.343 0.97 0 C-N-CA 124.545 1.069 . . . . 0.0 112.626 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.9 t -119.14 143.5 47.17 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.813 1.645 . . . . 0.0 109.918 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.68 151.04 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.944 1.298 . . . . 0.0 108.581 176.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.94 -18.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 169.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 63.4 t30 117.42 -10.96 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 130.847 3.659 . . . . 0.0 111.597 -171.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.51 ' O ' HG23 ' A' ' 52' ' ' THR . 64.9 ttp -62.72 -44.21 96.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.93 -1.106 . . . . 0.0 108.585 169.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 51' ' ' MET . 55.5 p 176.13 -164.35 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.89 1 C-N-CA 135.234 5.413 . . . . 0.0 105.19 169.287 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -109.11 133.01 53.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 167.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -118.59 121.88 41.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.34 1.067 . . . . 0.0 110.638 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -80.57 111.12 16.69 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.761 169.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.5 mm -93.95 -53.6 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.218 1.007 . . . . 0.0 111.531 -173.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.8 tp -126.15 123.77 39.01 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.163 0.892 . . . . 0.0 111.897 -175.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -59.09 154.34 16.01 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.086 1.354 . . . . 0.0 112.15 173.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.5 mt -59.24 111.01 1.19 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.669 1.122 . . . . 0.0 110.884 172.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.1 t -143.49 169.05 18.43 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.371 1.068 . . . . 0.0 112.746 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.33 -10.16 54.99 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.813 2.045 . . . . 0.0 113.841 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -81.47 76.39 8.4 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 124.923 2.297 . . . . 0.0 109.978 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.2 t -56.52 -49.33 75.07 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 129.397 3.079 . . . . 0.0 109.294 173.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.3 m -60.68 -17.61 48.81 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.387 1.075 . . . . 0.0 112.065 173.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -87.7 -42.36 12.7 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 118.604 0.638 . . . . 0.0 111.843 174.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.597 ' CD1' HD21 ' A' ' 31' ' ' LEU . 8.3 t80 -57.3 -33.72 67.96 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 118.426 0.557 . . . . 0.0 111.467 172.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -62.29 -45.04 95.06 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.443 1.097 . . . . 0.0 109.928 -174.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -76.21 -33.98 59.26 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 124.677 1.191 . . . . 0.0 108.856 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -82.0 -29.6 31.99 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -175.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.8 tp -67.14 -42.65 84.04 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 169.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -67.46 -30.85 70.68 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -72.52 -15.88 61.78 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -60.57 135.85 57.88 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.438 1.017 . . . . 0.0 112.614 -171.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 75' ' ' VAL . 2.9 tt -127.59 133.96 49.72 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.697 1.199 . . . . 0.0 110.144 -175.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.419 ' N ' HD23 ' A' ' 74' ' ' LEU . 4.2 t -69.55 145.48 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 127.991 2.516 . . . . 0.0 112.939 -173.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.1 t -92.97 -162.09 0.9 Allowed 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 126.108 1.763 . . . . 0.0 112.133 172.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -159.76 125.15 1.44 Allowed Glycine 0 N--CA 1.481 1.638 0 O-C-N 119.742 -1.849 . . . . 0.0 115.129 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -145.88 167.04 24.21 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.541 1.936 . . . . 0.0 112.836 -173.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.1 mt -95.67 -49.18 5.48 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -169.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.64 136.81 41.93 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.716 0.689 . . . . 0.0 111.033 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.279 13.0 t -64.1 -42.52 69.44 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 114.661 -2.59 . . . . 0.0 115.18 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.66 149.35 73.55 Favored 'Trans proline' 0 C--N 1.359 1.098 0 CA-C-N 123.925 2.437 . . . . 0.0 113.242 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -102.96 165.51 10.98 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.911 0.884 . . . . 0.0 111.994 173.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.45 48.16 3.1 Favored Glycine 0 N--CA 1.48 1.576 0 C-N-CA 125.766 1.651 . . . . 0.0 112.106 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -68.34 -44.14 75.95 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -169.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -72.48 -15.82 61.8 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.814 -1.179 . . . . 0.0 112.848 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -58.29 -49.96 75.31 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.351 1.432 . . . . 0.0 108.398 168.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.32 -45.77 80.16 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.836 -0.54 . . . . 0.0 111.296 171.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.81 -41.33 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 118.178 -0.915 . . . . 0.0 112.294 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.4 t -58.91 -53.19 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 119.922 1.237 . . . . 0.0 109.844 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -62.76 -51.92 65.22 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 122.414 0.286 . . . . 0.0 110.846 -173.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.537 HG11 HD13 ' A' ' 108' ' ' LEU . 88.0 t -56.68 -27.98 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 123.471 0.708 . . . . 0.0 111.874 177.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.71 -32.62 23.43 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.83 -31.39 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.485 1.039 . . . . 0.0 112.218 -174.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 60.7 m -82.86 59.47 4.85 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.497 1.919 . . . . 0.0 111.125 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.61 -36.01 75.46 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.266 1.427 . . . . 0.0 113.051 -169.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.62 -32.97 58.82 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.376 0.512 . . . . 0.0 113.312 -174.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -94.77 -38.51 10.74 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.526 1.13 . . . . 0.0 111.354 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.4 mm -63.64 -37.04 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 120.915 1.689 . . . . 0.0 109.537 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.27 28.36 22.87 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.131 1.348 . . . . 0.0 113.818 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -57.44 119.65 6.87 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.191 1.495 . . . . 0.0 110.786 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.4 mmt-85 -83.42 -158.14 0.28 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.755 2.022 . . . . 0.0 108.805 171.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -81.69 -157.58 0.19 Allowed 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.27 -177.91 53.14 Favored Glycine 0 N--CA 1.424 -2.123 0 CA-C-O 125.541 2.745 . . . . 0.0 108.841 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.7 p -67.96 132.84 48.06 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 108.316 -3.942 . . . . 0.0 106.606 168.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.17 135.22 55.19 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 -177.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.437 ' CE1' HG13 ' A' ' 205' ' ' ILE . 1.8 t80 -138.48 124.62 20.23 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -166.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.537 HD13 HG11 ' A' ' 92' ' ' VAL . 52.4 tp -105.33 98.3 8.02 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.147 0.43 . . . . 0.0 111.011 177.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 39.5 t -80.45 121.68 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 170.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.412 HD23 ' C ' ' A' ' 110' ' ' LEU . 7.1 tt -109.41 120.85 43.75 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.7 t -111.59 132.4 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 124.129 0.893 . . . . 0.0 112.001 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.5 t -151.24 179.39 8.34 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.445 1.098 . . . . 0.0 111.283 171.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.57 -13.22 6.57 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.653 1.981 . . . . 0.0 114.097 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -137.09 173.55 11.57 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.49 1.516 . . . . 0.0 112.981 -171.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -60.79 -169.61 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.673 1.589 . . . . 0.0 114.08 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.88 146.37 25.6 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.537 1.681 . . . . 0.0 115.537 -167.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.506 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . 37.9 m80 -82.18 93.38 7.06 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.983 1.313 . . . . 0.0 113.458 176.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.626 HD23 ' H ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -75.69 173.23 11.35 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.856 -1.152 . . . . 0.0 113.012 170.541 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -47.57 149.07 1.25 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.833 0.853 . . . . 0.0 113.119 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.302 38.6 pttt 76.86 -16.09 0.67 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 131.13 3.772 . . . . 0.0 114.635 -175.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -63.21 -38.26 90.48 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.483 1.038 . . . . 0.0 113.173 -175.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . 0.274 13.7 mttt -86.02 12.87 8.56 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 m -62.36 -26.77 68.64 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 118.975 0.807 . . . . 0.0 108.937 167.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.4 mt -61.65 -36.67 81.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.895 1.278 . . . . 0.0 112.361 169.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -85.62 22.75 10.11 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.596 2.046 . . . . 0.0 113.437 170.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.321 3.9 t 55.52 28.07 11.22 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.669 2.787 . . . . 0.0 114.226 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 149' ' ' ASP . 20.1 ttp180 -101.61 85.86 2.83 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.89 1.676 . . . . 0.0 110.364 -175.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -80.96 -45.65 16.33 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.187 0.995 . . . . 0.0 112.977 -173.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -60.44 121.09 11.22 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.231 1.012 . . . . 0.0 111.239 -169.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.0 t -68.84 143.49 54.54 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 120.184 1.356 . . . . 0.0 111.052 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.0 t -58.33 130.43 46.69 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.319 -0.863 . . . . 0.0 111.933 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.5 p30 -76.72 -9.97 59.05 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.032 1.333 . . . . 0.0 113.816 176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 71.1 23.17 78.36 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 117.797 -1.557 . . . . 0.0 114.124 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -100.16 168.19 9.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.099 1.759 . . . . 0.0 112.524 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 33.4 t -69.96 136.05 50.09 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.272 -0.893 . . . . 0.0 111.637 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -147.78 37.54 0.89 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.495 1.918 . . . . 0.0 112.053 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.7 mt -103.46 136.28 43.5 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.355 1.062 . . . . 0.0 110.768 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -155.29 135.43 13.05 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.338 1.455 . . . . 0.0 110.175 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.3 t0 52.71 27.76 5.59 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.536 1.534 . . . . 0.0 112.951 -169.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.06 -6.92 82.87 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.298 1.904 . . . . 0.0 114.793 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 38.7 mtt -98.78 142.59 30.13 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.829 1.814 . . . . 0.0 113.62 -174.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -76.32 81.13 3.08 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.14 0.976 . . . . 0.0 110.984 169.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -50.89 -44.61 59.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.303 1.441 . . . . 0.0 112.41 -175.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 94.3 p -78.95 -0.19 30.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -170.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 52' ' ' THR . 1.3 ttp180 -45.12 -39.67 6.23 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 121.125 1.784 . . . . 0.0 113.091 171.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.2 -19.43 79.63 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-O 118.297 -1.279 . . . . 0.0 114.793 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -111.65 -69.18 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 CA-C-O 116.334 -1.793 . . . . 0.0 113.154 -169.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -74.58 146.95 35.19 Favored 'Trans proline' 0 C--N 1.357 1.026 0 CA-C-N 123.697 2.356 . . . . 0.0 114.128 169.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 127' ' ' ARG . 24.3 t0 -77.6 167.63 21.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.476 2.711 . . . . 0.0 114.606 176.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.506 ' CE2' ' HB3' ' A' ' 117' ' ' HIS . 64.0 m-85 -53.54 148.17 9.82 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.434 1.094 . . . . 0.0 111.947 178.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.7 157.69 17.19 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.984 0.897 . . . . 0.0 112.38 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 73.6 m -87.36 149.27 24.61 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 168.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -56.8 -30.99 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.618 -1.301 . . . . 0.0 111.343 -175.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.18 -36.18 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.253 1.821 . . . . 0.0 112.964 173.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -75.89 -27.6 57.78 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.332 0.969 . . . . 0.0 111.572 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.52 -47.8 74.7 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.426 168.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.69 -37.33 70.73 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 99.2 p -72.24 -49.94 31.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.279 0.945 . . . . 0.0 113.119 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 159' ' ' LYS . 8.7 mmpt? -70.51 -36.15 73.6 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.391 -1.443 . . . . 0.0 113.817 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.9 mt -68.58 -35.45 77.39 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.927 0.785 . . . . 0.0 112.05 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.05 -33.9 70.73 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -79.22 -44.06 22.57 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.096 0.558 . . . . 0.0 110.897 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -84.02 -0.59 52.27 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 68.96 16.07 8.8 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.676 2.391 . . . . 0.0 115.988 168.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 50.8 mt -75.28 139.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 120.623 -1.298 . . . . 0.0 110.319 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.414 ' HB2' ' CD2' ' A' ' 107' ' ' PHE . 11.3 mm-40 -99.45 95.84 3.91 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.097 173.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -73.82 144.82 35.45 Favored 'Trans proline' 0 C--N 1.352 0.754 0 CA-C-N 121.285 1.495 . . . . 0.0 114.564 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.7 mt -129.89 117.74 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 124.388 1.075 . . . . 0.0 110.754 170.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -78.48 76.09 4.99 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.461 1.124 . . . . 0.0 112.798 178.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.409 ' CG2' HG21 ' A' ' 201' ' ' VAL . 10.8 t -64.38 103.62 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 122.185 0.993 . . . . 0.0 112.483 169.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.407 ' HB ' ' HD2' ' A' ' 172' ' ' PRO . 17.4 m -144.47 157.97 54.97 Favored Pre-proline 0 N--CA 1.484 1.253 0 CA-C-O 117.573 -1.204 . . . . 0.0 111.239 -169.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.407 ' HD2' ' HB ' ' A' ' 171' ' ' VAL . 57.2 Cg_endo -73.87 165.14 32.9 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.603 2.869 . . . . 0.0 111.687 -171.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 73.9 p -52.08 -39.72 60.14 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.334 1.054 . . . . 0.0 113.338 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.7 ptt85 -63.18 -23.3 67.37 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.419 ' CE ' ' CE1' ' A' ' 179' ' ' TYR . 78.3 mtp -103.14 -22.87 13.69 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.3 t -56.47 -26.29 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 120.179 1.354 . . . . 0.0 112.009 -168.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.57 -29.88 70.91 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.918 1.287 . . . . 0.0 114.463 175.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 t -93.83 -37.98 11.47 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.889 0.876 . . . . 0.0 111.575 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.419 ' CE1' ' CE ' ' A' ' 175' ' ' MET . 12.1 m-85 -73.9 -28.5 61.57 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 120.149 -1.594 . . . . 0.0 110.233 175.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.525 ' HA ' HG22 ' A' ' 183' ' ' THR 0.268 17.5 tt0 -66.79 -10.85 51.9 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 119.348 0.976 . . . . 0.0 112.58 172.147 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -99.3 -7.83 25.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.063 -1.023 . . . . 0.0 113.684 169.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.85 -28.97 22.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.702 1.201 . . . . 0.0 109.406 168.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.525 HG22 ' HA ' ' A' ' 180' ' ' GLU . 15.1 t -85.88 -15.89 40.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 112.784 177.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 1.1 t -77.59 -25.86 50.25 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.302 -0.874 . . . . 0.0 108.751 168.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -80.19 -45.25 18.38 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.181 -0.438 . . . . 0.0 111.551 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 19.3 mt -94.81 106.53 25.25 Favored Pre-proline 0 N--CA 1.483 1.218 0 CA-C-O 118.335 -0.841 . . . . 0.0 109.469 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.87 147.17 67.98 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.41 2.073 . . . . 0.0 111.466 -173.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 83.06 -10.21 1.03 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.822 2.849 . . . . 0.0 113.693 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.1 mt -73.37 166.83 22.46 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.48 0.5 OUTLIER -143.47 -161.24 1.23 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 169.431 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.5 mt -160.52 142.7 4.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 C-N-CA 129.769 3.228 . . . . 0.0 111.982 -165.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -124.64 161.55 19.08 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.917 0.77 . . . . 0.0 111.808 169.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -92.37 100.16 12.79 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.888 1.675 . . . . 0.0 108.019 173.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.74 130.28 44.24 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.013 -1.449 . . . . 0.0 108.89 168.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 84.9 p -171.08 -157.49 0.13 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.417 1.487 . . . . 0.0 110.199 170.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.34 -18.62 63.08 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -109.03 133.71 52.63 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.847 1.259 . . . . 0.0 112.204 171.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 73.5 m -91.06 0.02 57.63 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.076 1.35 . . . . 0.0 113.291 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.4 m -59.98 -45.84 91.39 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.052 1.741 . . . . 0.0 112.89 -169.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -63.11 -43.76 97.56 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 118.589 -0.72 . . . . 0.0 112.617 -170.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.409 HG21 ' CG2' ' A' ' 170' ' ' VAL . 8.0 p -82.26 -32.56 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 119.558 1.072 . . . . 0.0 113.161 175.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -61.48 -30.45 70.61 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 120.366 1.439 . . . . 0.0 110.95 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -65.97 -15.03 62.63 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 119.541 -1.974 . . . . 0.0 114.223 172.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.1 mt -103.46 -35.45 8.34 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.952 2.101 . . . . 0.0 109.708 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.466 ' CG2' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -67.37 -39.16 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.856 1.262 . . . . 0.0 108.116 171.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 29.9 ttp-105 -73.95 -42.21 60.86 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.008 0.923 . . . . 0.0 110.498 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . 0.331 11.5 m-20 -77.86 -12.06 59.95 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 117.619 -1.632 . . . . 0.0 114.294 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.11 -31.92 27.0 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.308 1.043 . . . . 0.0 110.309 168.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -65.74 -45.75 81.44 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.659 -0.65 . . . . 0.0 111.519 170.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 79.8 p -66.83 -9.75 40.72 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.494 ' HA ' ' HE3' ' A' ' 211' ' ' LYS . 0.5 OUTLIER -73.05 -32.01 64.78 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 176.471 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 13.8 mt . . . . . 0 CA--C 1.571 1.778 0 C-N-CA 125.139 1.375 . . . . 0.0 113.155 172.725 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 120.384 0.135 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -123.52 149.83 44.72 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.115 1.366 . . . . 0.0 110.883 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 m -61.16 111.08 1.58 Allowed 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.137 -0.977 . . . . 0.0 112.059 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 67.1 t -110.97 138.02 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.42 1.088 . . . . 0.0 109.8 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -116.56 117.94 31.25 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.184 1.393 . . . . 0.0 108.834 169.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.428 HD12 ' CB ' ' A' ' 107' ' ' PHE . 2.4 tp -110.28 130.52 55.53 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 118.883 0.765 . . . . 0.0 111.78 169.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.402 ' CD2' HG23 ' A' ' 99' ' ' ILE . 28.8 t80 -115.92 114.47 24.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 123.717 1.722 . . . . 0.0 109.092 168.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -88.46 107.66 18.98 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 127.184 2.194 . . . . 0.0 111.859 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.65 122.02 34.65 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.737 0.815 . . . . 0.0 112.013 170.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.44 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 24.4 mtp -103.41 131.94 50.08 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 174.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.15 114.37 3.82 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 167.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.27 21.2 15.42 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.373 1.469 . . . . 0.0 113.989 -172.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.8 p -84.83 168.44 15.11 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 119.679 -1.888 . . . . 0.0 112.699 -169.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.69 -32.16 58.36 Favored Glycine 0 N--CA 1.477 1.369 0 O-C-N 121.401 -0.812 . . . . 0.0 114.045 -170.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -63.45 -35.25 79.82 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.793 1.237 . . . . 0.0 112.698 174.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.55 0.09 18.55 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.712 1.605 . . . . 0.0 114.217 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -53.96 -48.42 70.31 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.712 1.205 . . . . 0.0 112.402 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.32 -26.9 64.86 Favored Glycine 0 N--CA 1.474 1.187 0 CA-C-N 118.282 0.492 . . . . 0.0 113.049 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -82.2 -13.39 57.18 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.322 1.449 . . . . 0.0 113.318 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.8 tp -56.04 -46.37 78.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.051 1.34 . . . . 0.0 112.024 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 t -58.99 -41.03 86.64 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 122.228 1.013 . . . . 0.0 110.819 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -70.47 -19.83 62.92 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.476 -1.39 . . . . 0.0 113.424 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.291 20.1 m -105.97 13.81 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 170.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -108.94 -33.53 6.89 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 167.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.6 t -63.33 -49.51 73.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 169.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.401 HD22 HD12 ' A' ' 194' ' ' LEU . 20.8 tp -85.19 102.47 13.33 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 104.74 -2.319 . . . . 0.0 104.74 168.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 153.32 -39.72 0.7 Allowed Glycine 0 C--N 1.298 -1.558 0 CA-C-N 109.132 -3.667 . . . . 0.0 108.395 168.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.7 m -76.97 -46.4 24.17 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.555 1.542 . . . . 0.0 109.978 172.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.81 -41.25 92.11 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.163 0.985 . . . . 0.0 111.254 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.53 -43.45 76.73 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.556 -176.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.25 -54.05 49.05 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.151 0.98 . . . . 0.0 110.979 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -67.72 -31.9 72.16 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.224 -0.922 . . . . 0.0 113.091 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.53 -49.57 72.97 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.981 0.81 . . . . 0.0 111.516 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.0 mt -83.64 -12.37 56.06 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -60.66 -31.75 70.97 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 120.926 1.694 . . . . 0.0 112.964 170.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -95.52 -27.77 15.21 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 118.96 -0.543 . . . . 0.0 112.06 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.95 -29.09 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 119.334 0.97 . . . . 0.0 109.746 168.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 t -147.12 127.36 13.86 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 169.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -69.48 -27.06 64.89 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.993 1.717 . . . . 0.0 112.359 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.3 t -105.03 92.33 4.18 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.345 1.458 . . . . 0.0 108.736 171.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.46 84.51 0.18 Allowed Glycine 0 C--N 1.338 0.684 0 C-N-CA 127.184 2.326 . . . . 0.0 108.382 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -91.65 135.63 33.73 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -171.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.7 tp -116.61 139.19 44.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 124.83 1.252 . . . . 0.0 110.894 -171.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.5 159.28 24.8 Favored Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.428 1.014 . . . . 0.0 113.036 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -132.27 129.13 39.19 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.37 1.468 . . . . 0.0 113.556 -169.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.72 144.65 16.57 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 124.32 0.962 . . . . 0.0 113.513 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.6 m -114.65 136.31 53.19 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.629 1.572 . . . . 0.0 111.455 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.9 tt -156.46 149.94 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 120.578 -1.327 . . . . 0.0 112.402 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.522 HG23 ' H ' ' A' ' 50' ' ' ASN . 2.3 m -150.52 -66.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 125.586 1.554 . . . . 0.0 111.898 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.522 ' H ' HG23 ' A' ' 49' ' ' VAL 0.424 29.8 t30 168.99 -13.61 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.973 1 C-N-CA 133.251 4.62 . . . . 0.0 111.482 169.278 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.0 ttt -49.32 -38.9 29.44 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 165.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.274 10.6 t 164.13 -163.16 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.967 1 C-N-CA 133.06 4.544 . . . . 0.0 109.623 168.147 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -107.98 132.38 53.57 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.812 2.445 . . . . 0.0 105.805 168.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -127.85 125.79 40.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 122.59 1.186 . . . . 0.0 110.1 169.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.73 132.02 35.5 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.921 1.288 . . . . 0.0 110.576 169.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.54 -17.37 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.39 108.6 5.0 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.84 1.655 . . . . 0.0 112.253 176.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.5 ttpm? -61.39 154.25 24.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.561 1.544 . . . . 0.0 112.607 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.0 mt -50.71 112.54 0.72 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.719 0.69 . . . . 0.0 111.876 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.8 t -143.9 171.13 14.65 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.999 1.32 . . . . 0.0 111.984 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.55 -6.53 16.93 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.745 1.618 . . . . 0.0 114.765 -170.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.25 93.95 9.67 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 125.645 2.641 . . . . 0.0 105.755 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.4 p -76.5 -44.28 35.89 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 131.062 3.745 . . . . 0.0 113.557 -169.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.2 t -59.41 -22.34 61.29 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.758 -0.589 . . . . 0.0 110.662 169.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -71.18 -51.69 23.38 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.183 -0.948 . . . . 0.0 109.971 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -53.77 -37.6 63.6 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 123.365 0.666 . . . . 0.0 111.85 172.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -67.96 -39.14 83.42 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.291 1.036 . . . . 0.0 109.898 -171.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.5 mtp-105 -71.61 -33.88 69.36 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.943 1.297 . . . . 0.0 110.152 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -79.78 -30.56 40.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.409 0.683 . . . . 0.0 109.689 -173.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.12 -54.34 15.46 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.541 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.448 7.7 ptp180 -74.97 -15.04 60.68 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 -169.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.59 2.87 46.69 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 169.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -60.04 155.61 16.58 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.457 1.026 . . . . 0.0 111.742 171.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.97 156.14 46.11 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.401 1.48 . . . . 0.0 111.036 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.84 141.18 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.941 1.296 . . . . 0.0 111.47 -169.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.1 p -94.12 -143.57 0.24 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.426 1.49 . . . . 0.0 112.718 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.75 144.72 9.59 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.561 -1.337 . . . . 0.0 114.262 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -148.65 163.74 36.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.214 1.806 . . . . 0.0 112.84 175.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.9 mt -74.44 -59.85 2.54 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.887 1.275 . . . . 0.0 112.573 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.89 136.98 54.88 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.83 0.852 . . . . 0.0 111.965 -172.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.6 p -75.72 -34.59 1.56 Allowed Pre-proline 0 N--CA 1.475 0.821 0 CA-C-O 115.512 -2.185 . . . . 0.0 113.307 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.39 140.73 44.8 Favored 'Trans proline' 0 C--N 1.354 0.842 0 CA-C-N 123.078 2.135 . . . . 0.0 108.967 169.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -104.44 -177.18 3.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.65 0.78 . . . . 0.0 112.215 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.08 9.49 72.57 Favored Glycine 0 N--CA 1.483 1.777 0 C-N-CA 124.633 1.111 . . . . 0.0 114.829 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -35.45 -55.61 0.66 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 129.192 2.997 . . . . 0.0 118.667 -169.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 7.7 mp -67.29 -18.5 65.22 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 121.526 1.966 . . . . 0.0 113.134 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.32 -24.08 67.7 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.421 1.464 . . . . 0.0 112.411 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.41 -44.08 25.77 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.311 -1.493 . . . . 0.0 108.129 167.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.443 HG22 HD13 ' A' ' 110' ' ' LEU . 31.6 t -52.5 -42.32 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.277 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.427 HG13 HE21 ' A' ' 91' ' ' GLN . 8.3 p -62.71 -55.81 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.702 1.137 . . . . 0.0 111.783 171.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.427 HE21 HG13 ' A' ' 90' ' ' VAL . 77.1 mm-40 -66.21 -42.33 88.89 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.973 0.806 . . . . 0.0 110.914 -170.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.535 HG11 HD13 ' A' ' 108' ' ' LEU . 78.2 t -60.87 -33.07 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.362 1.065 . . . . 0.0 111.728 171.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.8 68.48 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.671 1.123 . . . . 0.0 111.985 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.289 0.0 OUTLIER -96.38 -14.22 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -169.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.24 60.52 3.09 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 121.17 1.804 . . . . 0.0 112.351 173.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.9 mt -50.95 -40.11 56.64 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.899 1.68 . . . . 0.0 111.74 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.72 -31.02 41.67 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.158 0.885 . . . . 0.0 114.852 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -89.38 -39.74 13.21 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.607 1.203 . . . . 0.0 111.132 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.454 HG21 ' CE2' ' A' ' 101' ' ' TRP . 33.6 mm -65.73 -38.49 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 120.988 -1.07 . . . . 0.0 110.048 169.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.07 26.3 34.62 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.152 0.882 . . . . 0.0 113.182 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.454 ' CE2' HG21 ' A' ' 99' ' ' ILE . 72.5 m95 -55.97 130.57 44.37 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.229 1.014 . . . . 0.0 112.208 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.5 mtp-105 -104.41 -168.57 1.5 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.407 2.283 . . . . 0.0 111.958 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -86.03 -0.59 55.91 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 117.017 2.229 . . . . 0.0 117.017 -169.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.48 -132.75 3.3 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 120.917 1.69 . . . . 0.0 110.972 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.5 t -99.58 147.58 25.2 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.757 1.223 . . . . 0.0 108.954 174.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.407 ' HB2' ' HA ' ' A' ' 165' ' ' ILE . 97.3 mtt180 -132.15 124.8 29.8 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -168.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.428 ' CB ' HD12 ' A' ' 6' ' ' LEU . 64.5 m-85 -125.01 110.15 13.83 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -169.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.535 HD13 HG11 ' A' ' 92' ' ' VAL . 25.8 tp -92.59 98.05 11.2 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.283 175.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 t -83.45 124.64 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 174.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.443 HD13 HG22 ' A' ' 89' ' ' VAL . 20.2 tp -109.65 112.39 24.43 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 118.81 -0.614 . . . . 0.0 110.214 -175.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 10' ' ' MET . 17.1 t -94.83 133.24 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.297 0.639 . . . . 0.0 111.649 172.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.2 t -166.13 151.01 8.2 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.441 1.088 . . . . 0.0 109.826 167.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -110.27 4.54 20.96 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -177.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -140.98 -177.98 5.35 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.156 1.383 . . . . 0.0 112.857 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -60.72 -177.13 0.07 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.72 1.608 . . . . 0.0 112.882 169.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 31.3 t80 -140.94 148.15 39.92 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.675 1.19 . . . . 0.0 112.136 -175.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -80.21 88.92 5.45 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.128 1.371 . . . . 0.0 113.182 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.78 165.43 3.98 Favored 'General case' 0 CA--C 1.551 0.99 0 O-C-N 120.395 -1.441 . . . . 0.0 111.83 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -46.91 140.63 4.6 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.684 -0.635 . . . . 0.0 112.387 171.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 89.11 -12.28 0.39 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 129.109 2.964 . . . . 0.0 113.192 -174.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -70.36 -10.53 59.29 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 119.864 1.211 . . . . 0.0 112.759 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -49.41 -28.97 5.72 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.352 1.861 . . . . 0.0 113.96 168.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 84.9 m -66.09 -31.22 71.96 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.763 2.025 . . . . 0.0 112.877 -168.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.2 -34.13 75.7 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.147 0.579 . . . . 0.0 111.571 174.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -84.47 7.77 71.3 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.65 1.595 . . . . 0.0 114.337 170.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.274 1.3 t 61.41 15.61 6.75 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 129.383 3.073 . . . . 0.0 116.057 173.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.1 mtp85 -99.84 144.09 29.31 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.146 -0.971 . . . . 0.0 109.836 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -126.28 -8.7 6.41 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -69.74 118.12 12.2 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.706 1.139 . . . . 0.0 109.371 170.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.7 t -76.92 164.99 25.28 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.758 -0.588 . . . . 0.0 110.647 171.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 96.7 p -64.18 138.85 58.65 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -173.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -82.44 -13.22 57.13 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 174.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.82 9.2 85.06 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.927 1.251 . . . . 0.0 114.199 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -102.12 175.87 5.38 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.669 1.234 . . . . 0.0 111.164 172.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.5 142.91 32.92 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -169.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -142.7 53.82 1.4 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.704 1.602 . . . . 0.0 112.791 -169.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . 0.273 0.0 OUTLIER -140.29 105.53 5.04 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.056 0.931 . . . . 0.0 111.27 169.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -89.26 -45.96 9.13 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.217 1.007 . . . . 0.0 111.328 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -97.05 8.28 44.84 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.444 2.297 . . . . 0.0 113.565 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.76 -12.29 62.7 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 125.747 1.642 . . . . 0.0 114.871 169.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 78.1 mtm -97.05 132.99 42.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.021 1.329 . . . . 0.0 110.375 171.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -64.71 99.03 0.3 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.671 0.748 . . . . 0.0 111.889 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -67.16 -36.34 81.59 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.487 1.515 . . . . 0.0 112.925 -170.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.7 p -85.71 4.47 36.53 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -50.51 -42.29 54.71 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 120.503 1.501 . . . . 0.0 112.278 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.2 -33.86 69.34 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 117.974 -1.459 . . . . 0.0 112.724 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.353 82.5 tt0 -89.28 -90.9 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.415 0 CA-C-O 116.112 -1.899 . . . . 0.0 112.537 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.11 156.94 56.16 Favored 'Trans proline' 0 C--N 1.357 1.01 0 CA-C-N 124.135 2.513 . . . . 0.0 116.052 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -62.95 166.3 5.88 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 129.459 3.104 . . . . 0.0 115.037 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -62.68 132.8 53.52 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 166.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -57.78 154.34 12.11 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.914 -1.117 . . . . 0.0 113.823 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 60.1 p -77.66 162.51 26.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.477 0.711 . . . . 0.0 112.296 174.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 50.9 t -61.36 -39.11 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 121.547 -0.721 . . . . 0.0 111.352 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.2 t -81.59 -19.51 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.48 -37.64 88.08 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.241 1.382 . . . . 0.0 108.623 169.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 28.7 mt -77.25 -31.41 55.02 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 116.153 -1.88 . . . . 0.0 114.595 171.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.01 -42.19 72.24 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 121.268 1.849 . . . . 0.0 110.994 169.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 11.4 t -62.82 -54.16 43.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.595 0.758 . . . . 0.0 111.387 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.4 tppt? -69.58 -38.87 77.53 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -170.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . 0.294 0.0 OUTLIER -68.77 -33.33 73.7 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.537 1.517 . . . . 0.0 111.529 175.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.7 -32.71 64.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -69.29 -46.04 68.15 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.844 1.257 . . . . 0.0 110.056 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -86.26 -8.88 57.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.724 0.81 . . . . 0.0 113.105 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 50.64 49.27 21.2 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.001 1.72 . . . . 0.0 112.456 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.407 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 68.1 mt -102.69 133.58 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-O 116.535 -1.698 . . . . 0.0 106.967 171.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -103.09 113.46 65.84 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 121.439 1.927 . . . . 0.0 110.365 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -67.36 152.79 78.52 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.074 3.183 . . . . 0.0 114.764 173.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.8 mm -134.26 104.29 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.595 1.558 . . . . 0.0 109.371 174.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.55 ' CD2' HD21 ' A' ' 189' ' ' LEU . 23.3 m-85 -73.19 75.98 1.29 Allowed 'General case' 0 N--CA 1.478 0.928 0 O-C-N 119.849 -1.782 . . . . 0.0 112.387 175.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . 0.258 1.9 m -72.13 103.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 123.524 1.63 . . . . 0.0 111.15 169.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 29.0 m -143.05 166.35 20.87 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 120.33 -1.481 . . . . 0.0 110.447 -169.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -80.19 161.8 23.09 Favored 'Trans proline' 0 C--N 1.35 0.619 0 CA-C-N 122.856 2.056 . . . . 0.0 110.036 -172.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.5 t -52.97 -41.97 65.07 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.952 0.501 . . . . 0.0 111.916 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -54.68 -38.67 67.25 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.607 1.163 . . . . 0.0 113.698 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 19.6 mmt -99.75 -9.38 23.1 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.755 1.222 . . . . 0.0 114.175 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -61.89 -29.64 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 120.085 1.311 . . . . 0.0 113.329 -168.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -65.39 -25.07 67.4 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.13 -43.02 20.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.519 0.728 . . . . 0.0 109.955 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -71.02 -30.42 66.62 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.421 1.089 . . . . 0.0 110.535 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -65.81 -14.9 62.29 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.122 0.569 . . . . 0.0 111.829 168.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -96.47 -30.69 13.2 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.393 -0.817 . . . . 0.0 111.599 173.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.61 -25.59 61.37 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 119.979 -1.701 . . . . 0.0 110.03 175.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.1 t -72.49 -21.99 61.13 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.739 -0.601 . . . . 0.0 111.845 173.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 37.7 m -69.71 -29.74 67.2 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -88.46 -14.42 37.92 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 24.0 mt -120.35 87.85 41.11 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.1 0.96 . . . . 0.0 110.421 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.84 134.99 61.54 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.238 2.626 . . . . 0.0 112.903 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 65.2 mttm 85.06 -10.35 0.81 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 129.431 3.092 . . . . 0.0 113.914 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.55 HD21 ' CD2' ' A' ' 169' ' ' PHE . 10.2 tt -65.55 149.4 50.13 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.325 -0.86 . . . . 0.0 109.098 169.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 68.6 p -123.39 -170.22 2.08 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 169.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.0 141.53 2.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 127.083 2.153 . . . . 0.0 108.125 -167.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -132.67 150.86 19.8 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 170.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . 0.262 0.9 OUTLIER -91.44 88.71 6.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 123.128 1.442 . . . . 0.0 109.099 169.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.401 HD12 HD22 ' A' ' 26' ' ' LEU . 1.1 tt -57.5 138.63 54.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.654 169.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 95.0 p -160.18 -152.18 0.28 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.387 1.875 . . . . 0.0 109.026 173.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.85 -26.39 64.15 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.741 1.216 . . . . 0.0 113.19 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -100.85 145.09 29.01 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.73 1.212 . . . . 0.0 113.575 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 26.9 t -96.38 -9.55 29.71 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.699 1.6 . . . . 0.0 112.809 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 59.6 m -61.01 -39.77 91.0 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.582 -1.324 . . . . 0.0 113.484 -168.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -66.29 -42.14 88.77 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.321 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 68.5 t -69.25 -49.01 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.324 0.65 . . . . 0.0 111.232 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.07 -23.41 65.86 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 121.391 -0.818 . . . . 0.0 112.34 -177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -73.83 -3.95 31.79 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.676 -1.265 . . . . 0.0 112.702 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 78.0 mt -100.74 -42.16 6.6 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.591 1.556 . . . . 0.0 107.932 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 6.8 mm -70.89 -41.13 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -67.97 -34.62 76.9 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 118.971 -0.538 . . . . 0.0 111.536 172.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -67.33 -35.44 79.42 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 119.786 1.175 . . . . 0.0 112.586 173.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -75.07 -27.87 60.13 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.137 0.975 . . . . 0.0 112.497 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -63.16 -47.28 83.33 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.759 0.824 . . . . 0.0 110.943 173.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 39.2 m -73.19 -13.51 61.17 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -75.23 -11.03 59.98 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.5 mt . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -177.035 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.4 t70 . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -63.05 150.05 43.51 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 121.042 1.747 . . . . 0.0 112.73 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 m -60.01 112.4 1.86 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.666 1.187 . . . . 0.0 112.558 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.03 144.81 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.931 0.892 . . . . 0.0 110.236 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.55 97.88 5.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.063 1.745 . . . . 0.0 108.388 172.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.1 mp -90.9 122.12 33.33 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 121.542 -0.724 . . . . 0.0 112.386 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -119.78 104.2 10.01 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 123.723 1.725 . . . . 0.0 111.13 172.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -85.46 114.72 22.71 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.411 1.885 . . . . 0.0 113.459 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.49 120.0 38.15 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.318 1.447 . . . . 0.0 111.154 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.0 mtp -100.12 144.0 29.66 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 169.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.9 98.19 2.31 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 168.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.69 33.75 0.52 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.201 1.5 . . . . 0.0 114.753 -169.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 p -80.61 169.56 17.49 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 119.889 -1.757 . . . . 0.0 113.408 173.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -50.72 -34.6 29.13 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 125.346 1.45 . . . . 0.0 116.247 -169.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.0 t -61.78 -29.8 70.38 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.195 0.998 . . . . 0.0 113.033 175.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.16 3.46 20.5 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.298 1.439 . . . . 0.0 114.57 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -66.76 -36.22 81.92 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.433 -1.417 . . . . 0.0 110.908 170.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.36 -28.99 71.98 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.426 0.536 . . . . 0.0 112.55 171.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -70.07 -55.04 10.52 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 117.726 0.763 . . . . 0.0 111.842 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.0 tp -55.95 -42.17 75.81 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -168.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.5 t -55.9 -46.59 78.34 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.053 1.297 . . . . 0.0 111.863 176.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -66.39 -28.08 68.36 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.8 -1.187 . . . . 0.0 112.715 173.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.0 t -77.7 -13.45 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 124.904 1.282 . . . . 0.0 112.916 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -91.68 -32.32 15.5 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.889 2.076 . . . . 0.0 113.151 -173.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.4 p -83.57 -18.32 38.72 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 167.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.593 ' HG ' ' H ' ' A' ' 27' ' ' GLY . 41.3 tp -87.07 -174.41 4.89 Favored 'General case' 0 N--CA 1.417 -2.111 1 N-CA-C 96.996 -5.187 . . . . 0.0 96.996 164.868 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.593 ' H ' ' HG ' ' A' ' 26' ' ' LEU . . . 77.47 -42.18 1.94 Allowed Glycine 0 C--N 1.286 -2.227 0 C-N-CA 129.424 3.392 . . . . 0.0 108.497 -169.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.8 m -72.74 -39.72 66.66 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.963 2.105 . . . . 0.0 109.109 169.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -80.22 -27.88 38.67 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.003 0.365 . . . . 0.0 110.8 173.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.8 tp -62.42 -54.88 33.66 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.844 0.858 . . . . 0.0 109.664 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.484 HD13 ' C ' ' A' ' 31' ' ' LEU . 2.4 tm? -59.69 -58.37 8.89 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.627 0.771 . . . . 0.0 110.484 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -65.61 -36.26 83.2 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.539 1.063 . . . . 0.0 112.434 -169.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.51 -40.13 43.85 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.265 0.6 OUTLIER -75.21 -20.22 59.39 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.263 -1.523 . . . . 0.0 113.112 175.618 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.12 -4.58 33.56 Favored 'General case' 0 CA--C 1.559 1.295 0 O-C-N 120.933 -1.104 . . . . 0.0 111.366 168.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -95.77 -40.25 9.45 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.628 1.571 . . . . 0.0 112.092 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.4 tp -66.22 -26.26 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 120.091 1.314 . . . . 0.0 111.846 171.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.2 t -146.18 138.22 25.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 174.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -55.16 -40.08 70.24 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.301 1.841 . . . . 0.0 112.164 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.1 p -117.27 110.31 17.95 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.395 1.478 . . . . 0.0 109.757 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.57 89.14 0.15 Allowed Glycine 0 C--N 1.339 0.736 0 C-N-CA 126.649 2.071 . . . . 0.0 108.801 -169.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.5 mmm-85 -77.27 138.11 39.2 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.402 HG21 HD23 ' A' ' 31' ' ' LEU . 2.5 tp -124.08 133.22 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.258 0.623 . . . . 0.0 110.48 -174.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.4 160.54 27.89 Favored Glycine 0 N--CA 1.474 1.202 0 C-N-CA 125.061 1.315 . . . . 0.0 112.722 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -138.69 135.41 34.77 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.006 0.923 . . . . 0.0 112.802 -169.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.39 146.1 18.04 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 124.742 1.163 . . . . 0.0 112.443 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.4 m -118.52 131.5 56.23 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.227 1.011 . . . . 0.0 111.233 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.6 tp -140.09 147.96 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.266 -0.896 . . . . 0.0 111.792 175.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -149.74 -107.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 103.652 -2.721 . . . . 0.0 103.652 168.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -136.09 -2.1 2.34 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.605 1.162 . . . . 0.0 110.858 168.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.7 mtp -78.58 41.09 0.39 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.92 2.088 . . . . 0.0 108.354 168.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.315 1.4 t 53.71 -176.13 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 129.618 3.167 . . . . 0.0 113.261 -168.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -87.24 137.88 31.96 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.363 1.465 . . . . 0.0 109.443 174.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -123.73 121.88 36.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.88 1.324 . . . . 0.0 110.456 169.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -86.69 100.04 12.19 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.487 1.915 . . . . 0.0 110.291 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.0 mm -90.35 -21.22 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 118.164 -0.922 . . . . 0.0 112.887 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.7 tp -157.02 111.72 2.76 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 144.93 43.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.715 1.206 . . . . 0.0 110.939 168.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -61.71 125.26 23.18 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.298 0.953 . . . . 0.0 110.169 -175.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t -135.33 163.37 30.16 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.729 0.811 . . . . 0.0 112.182 -174.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.94 -0.5 55.58 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.995 1.718 . . . . 0.0 111.09 169.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -86.89 82.69 7.72 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 125.659 2.647 . . . . 0.0 109.158 174.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.1 m -61.8 -41.61 97.97 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 131.539 3.936 . . . . 0.0 110.924 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.1 p -63.81 -15.53 59.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.18 1.392 . . . . 0.0 112.323 169.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -86.6 -50.02 7.12 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.01 0.823 . . . . 0.0 110.19 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -55.21 -29.06 57.19 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.308 1.043 . . . . 0.0 112.85 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -86.17 -13.12 47.97 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.918 0.887 . . . . 0.0 112.816 -175.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -88.8 -39.42 13.91 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 168.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -74.5 -43.07 57.62 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -169.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 tt -67.22 -34.39 77.37 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 123.454 0.471 . . . . 0.0 111.333 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.7 mtm105 -75.69 -18.02 59.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 119.613 -0.835 . . . . 0.0 113.069 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -76.72 -45.17 30.43 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -62.34 162.65 9.62 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.928 1.24 . . . . 0.0 113.468 -169.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -152.12 152.0 31.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.853 1.261 . . . . 0.0 110.072 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -73.82 143.89 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 127.925 2.49 . . . . 0.0 113.847 -169.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 71.6 p -108.38 -152.16 0.48 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 126.328 1.851 . . . . 0.0 112.231 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.37 160.4 33.05 Favored Glycine 0 N--CA 1.475 1.247 0 O-C-N 120.196 -1.565 . . . . 0.0 114.13 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -155.89 156.88 35.4 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -56.37 -63.8 1.07 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.681 2.792 . . . . 0.0 113.261 176.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.22 149.21 44.8 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.353 1.061 . . . . 0.0 113.616 -172.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.1 m -72.36 -47.01 10.44 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-O 116.138 -1.886 . . . . 0.0 113.287 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -75.09 154.47 42.08 Favored 'Trans proline' 0 C--N 1.352 0.715 0 CA-C-N 122.302 1.858 . . . . 0.0 112.527 169.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -131.77 179.68 5.92 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.476 1.51 . . . . 0.0 113.455 -178.358 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.94 34.39 4.95 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 119.393 2.517 . . . . 0.0 119.393 -168.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -50.75 -33.53 23.52 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.62 1.71 . . . . 0.0 113.648 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.511 HD13 ' CE2' ' A' ' 116' ' ' PHE . 7.4 tp -62.69 -44.08 97.16 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -175.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.18 -46.35 82.89 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.252 0.621 . . . . 0.0 109.846 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.08 -58.51 8.34 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 118.496 -0.764 . . . . 0.0 111.034 173.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.536 HG12 HD21 ' A' ' 108' ' ' LEU . 13.4 m -64.99 -25.28 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 119.627 1.103 . . . . 0.0 113.168 -171.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.91 -51.74 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 118.083 -0.961 . . . . 0.0 112.16 169.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -57.03 -42.01 79.64 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.974 1.261 . . . . 0.0 110.41 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.482 ' HA ' HD12 ' A' ' 99' ' ' ILE . 38.3 t -57.4 -39.16 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.242 0.617 . . . . 0.0 112.238 176.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.67 -32.22 69.41 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.853 1.056 . . . . 0.0 113.853 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.445 HG23 ' SG ' ' A' ' 135' ' ' CYS . 10.0 tp -102.13 -15.42 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -170.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.33 56.89 3.98 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.534 -1.354 . . . . 0.0 112.847 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.2 mt -55.72 -38.97 70.46 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.465 1.506 . . . . 0.0 111.88 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.02 -22.96 47.07 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.524 1.059 . . . . 0.0 114.668 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -92.3 -39.58 11.42 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.465 1.133 . . . . 0.0 111.563 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 92' ' ' VAL . 9.7 mt -81.91 -29.18 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 118.822 0.737 . . . . 0.0 111.264 175.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.34 24.7 39.01 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.027 -0.874 . . . . 0.0 114.891 169.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -49.42 129.26 18.57 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.785 1.234 . . . . 0.0 112.91 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -111.85 173.03 6.55 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.876 1.27 . . . . 0.0 112.434 170.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -81.86 41.58 0.66 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 125.671 1.588 . . . . 0.0 115.107 -170.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.14 -126.45 5.5 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 120.592 -1.318 . . . . 0.0 110.437 170.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.6 t -115.96 134.07 55.36 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.638 1.975 . . . . 0.0 107.704 171.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -124.41 131.51 53.5 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.093 0.86 . . . . 0.0 110.218 -168.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -127.08 98.5 5.33 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -169.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.536 HD21 HG12 ' A' ' 89' ' ' VAL . 5.6 tt -81.9 99.16 8.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.152 172.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.1 t -87.84 124.11 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 174.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 65.4 tp -108.19 117.47 34.23 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.664 1.12 . . . . 0.0 109.267 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.16 128.39 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 124.158 0.911 . . . . 0.0 110.707 170.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.7 t -162.44 163.66 27.54 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.246 1.018 . . . . 0.0 110.882 170.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -121.25 -0.44 9.9 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 116.547 2.055 . . . . 0.0 116.547 -175.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -137.17 172.66 12.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.912 0.885 . . . . 0.0 111.831 172.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -53.43 176.56 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.946 1.699 . . . . 0.0 112.58 174.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.511 ' CE2' HD13 ' A' ' 86' ' ' LEU . 7.2 p90 -146.04 157.19 43.86 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 120.7 -1.25 . . . . 0.0 112.293 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -79.87 133.28 36.24 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.664 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 46.8 mt -100.74 175.07 5.77 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.189 1.796 . . . . 0.0 110.886 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -47.88 137.09 10.28 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.917 0.865 . . . . 0.0 112.828 172.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 69.5 tttt 83.58 -14.45 0.7 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 130.906 3.682 . . . . 0.0 113.719 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -63.22 -21.95 66.55 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.526 1.512 . . . . 0.0 113.4 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.559 ' HE3' ' CZ ' ' A' ' 150' ' ' TYR . 90.1 mttt -78.18 -5.91 53.24 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 172.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.8 -16.75 63.88 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 120.621 1.555 . . . . 0.0 112.34 171.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 57.3 mt -63.25 -24.71 67.99 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.887 0.875 . . . . 0.0 111.515 169.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -90.35 -123.02 2.53 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 126.198 1.856 . . . . 0.0 109.301 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 p -126.64 0.13 6.8 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.577 1.551 . . . . 0.0 114.319 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -85.56 109.47 18.55 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.789 0.836 . . . . 0.0 111.285 -169.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -94.38 -28.71 15.38 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -87.17 122.23 30.7 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.702 -0.623 . . . . 0.0 112.491 -169.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.3 t -57.93 144.15 40.27 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.888 0.475 . . . . 0.0 110.388 169.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 42.0 t -59.75 140.9 56.16 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.637 0.775 . . . . 0.0 112.614 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.7 p30 -80.74 -13.51 58.93 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.88 14.42 78.47 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.477 1.037 . . . . 0.0 113.423 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -98.94 170.05 9.0 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.259 1.824 . . . . 0.0 110.536 172.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' CYS . . . . . 0.445 ' SG ' HG23 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -100.41 145.35 28.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -139.47 45.6 1.93 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.307 1.843 . . . . 0.0 111.592 -170.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.4 tt -110.08 125.13 52.64 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.68 1.992 . . . . 0.0 108.907 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -131.19 -48.66 1.0 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.613 1.165 . . . . 0.0 112.8 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -84.42 -10.66 57.32 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.493 1.517 . . . . 0.0 113.677 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 108.51 -23.71 23.87 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.199 1.857 . . . . 0.0 111.477 -169.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 80.8 mmm -82.28 145.83 29.78 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.617 1.167 . . . . 0.0 111.259 172.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -77.47 99.04 5.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.174 0.589 . . . . 0.0 109.769 169.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 42.3 ttp-105 -63.28 -38.28 90.56 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.211 1.004 . . . . 0.0 113.563 -170.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.4 p -88.56 7.37 33.55 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -168.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -47.53 -39.7 16.95 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 121.277 1.853 . . . . 0.0 112.461 169.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.13 -0.65 86.49 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 117.8 -1.555 . . . . 0.0 115.789 -174.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -127.35 -65.8 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 119.889 1.845 . . . . 0.0 110.387 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -58.98 147.25 90.86 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.498 2.799 . . . . 0.0 115.625 168.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.527 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 39.8 t0 -69.46 169.34 12.66 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 128.503 2.721 . . . . 0.0 112.87 169.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.559 ' CZ ' ' HE3' ' A' ' 122' ' ' LYS . 75.6 m-85 -69.0 158.06 35.52 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.423 -1.423 . . . . 0.0 108.211 168.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -78.62 157.45 28.68 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.314 -0.866 . . . . 0.0 111.257 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 92.9 p -92.81 156.18 17.16 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.248 -0.907 . . . . 0.0 110.684 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.26 -34.37 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.344 -0.848 . . . . 0.0 112.571 -171.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.9 t -69.93 -33.66 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.412 1.085 . . . . 0.0 111.596 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -68.8 -34.45 75.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.499 0.72 . . . . 0.0 111.144 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.507 ' CD1' HD11 ' A' ' 86' ' ' LEU . 4.5 mt -65.26 -55.95 15.49 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.009 0.924 . . . . 0.0 110.253 174.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.97 76.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.041 0.937 . . . . 0.0 111.448 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.8 t -58.47 -71.43 0.11 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.166 0.986 . . . . 0.0 111.847 172.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -66.85 -34.48 77.89 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.721 HD22 ' HG3' ' A' ' 167' ' ' PRO . 0.7 OUTLIER -70.76 -26.58 63.42 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.163 1.347 . . . . 0.0 112.866 176.745 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.1 -43.69 64.4 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.768 1.167 . . . . 0.0 113.46 173.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -80.53 -30.67 37.14 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.885 0.766 . . . . 0.0 112.578 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -82.48 -5.56 58.78 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.983 0.81 . . . . 0.0 112.242 168.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 60.64 46.91 8.78 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.007 1.323 . . . . 0.0 111.75 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.567 ' HB ' HD23 ' A' ' 160' ' ' LEU . 29.4 mm -100.36 135.51 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.934 1.293 . . . . 0.0 108.057 174.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -100.64 114.35 65.75 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 120.477 1.49 . . . . 0.0 109.903 170.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.721 ' HG3' HD22 ' A' ' 160' ' ' LEU . 4.8 Cg_exo -74.74 145.11 32.11 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.035 1.824 . . . . 0.0 110.594 169.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.417 HG22 HG23 ' A' ' 170' ' ' VAL . 31.5 mt -128.73 102.08 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 125.126 1.37 . . . . 0.0 107.418 177.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -74.37 72.8 1.84 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.415 1.102 . . . . 0.0 112.342 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.417 HG23 HG22 ' A' ' 168' ' ' ILE . 85.3 t -70.59 97.75 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 O-C-N 120.621 -1.299 . . . . 0.0 111.193 173.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 25.4 m -147.92 145.16 20.23 Favored Pre-proline 0 N--CA 1.484 1.237 0 O-C-N 120.367 -1.458 . . . . 0.0 112.879 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -60.81 156.55 42.66 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 125.111 3.874 . . . . 0.0 116.705 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.5 t -46.62 -58.31 3.95 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.978 1.711 . . . . 0.0 114.471 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -14.67 21.8 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -171.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.0 ptm -109.3 -1.6 18.44 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.308 1.443 . . . . 0.0 114.872 172.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.2 t -65.46 -33.39 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 120.23 -1.544 . . . . 0.0 111.97 -170.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -70.74 -23.68 62.48 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.861 1.21 . . . . 0.0 113.241 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . 0.262 2.4 t -87.18 -13.39 44.1 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.059 -1.026 . . . . 0.0 112.405 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -96.38 -33.72 11.81 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.073 1.349 . . . . 0.0 109.879 168.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.62 -26.7 65.48 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.724 -1.235 . . . . 0.0 111.997 176.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -74.0 -23.48 59.45 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.052 -1.655 . . . . 0.0 110.445 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 35.5 tp -85.02 -19.48 31.93 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.304 1.842 . . . . 0.0 110.824 174.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.6 p -83.65 -6.94 59.57 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.383 0.538 . . . . 0.0 112.019 169.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 6.9 m -88.22 -34.56 17.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.678 1.591 . . . . 0.0 108.865 169.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -79.7 -37.34 35.94 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 174.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 51.0 mt -101.16 113.27 65.82 Favored Pre-proline 0 N--CA 1.478 0.963 0 CA-C-O 118.247 -0.882 . . . . 0.0 108.949 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.7 145.2 40.91 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.577 2.185 . . . . 0.0 111.423 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt 73.55 3.98 4.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 127.117 2.167 . . . . 0.0 113.736 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.69 142.6 46.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.994 1.718 . . . . 0.0 109.052 169.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 76.5 p -108.55 -158.19 0.64 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.8 tt 177.15 136.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 126.983 2.113 . . . . 0.0 110.129 -168.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -129.57 132.45 7.09 Favored Glycine 0 N--CA 1.469 0.892 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -81.99 79.12 8.59 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 124.069 1.89 . . . . 0.0 109.814 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 28.1 tp -53.98 156.85 2.73 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.662 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 57.6 p -85.57 156.0 20.93 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.727 -1.233 . . . . 0.0 110.914 169.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.52 -6.63 37.65 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 120.485 -1.384 . . . . 0.0 113.74 174.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -95.76 -30.94 13.44 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 126.862 2.065 . . . . 0.0 112.395 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . 0.379 35.3 p 75.61 11.79 3.19 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 131.195 3.798 . . . . 0.0 117.94 168.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.2 t -65.09 -11.46 40.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 119.439 -2.038 . . . . 0.0 114.105 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -73.69 -9.66 58.89 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 172.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 38.3 t -49.89 -47.3 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 121.42 1.918 . . . . 0.0 113.67 -174.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -63.84 -32.52 74.06 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.921 -1.112 . . . . 0.0 112.152 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -84.83 20.23 1.87 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 97.5 mt -130.52 -36.93 1.41 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.436 2.294 . . . . 0.0 109.419 176.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 50.0 mt -67.57 -48.48 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.687 1.195 . . . . 0.0 109.188 170.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -63.28 -38.47 91.29 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 119.464 -0.895 . . . . 0.0 110.238 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -67.44 -39.01 85.4 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.998 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.7 70.85 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.935 1.294 . . . . 0.0 112.488 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.34 -35.76 76.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.357 0.663 . . . . 0.0 111.655 173.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.9 t -75.28 -28.59 59.83 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 175.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -66.1 -57.19 8.25 Favored 'General case' 0 CA--C 1.551 1.003 0 O-C-N 120.889 -1.132 . . . . 0.0 111.882 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 11.9 tp . . . . . 0 CA--C 1.579 2.06 0 C-N-CA 126.92 2.088 . . . . 0.0 113.535 -174.965 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.178 0.513 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -84.1 130.36 34.86 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.736 -1.228 . . . . 0.0 110.346 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.9 t -56.27 121.51 9.67 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.578 -0.701 . . . . 0.0 110.176 175.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 t -94.3 155.08 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.648 ' HB2' HD13 ' A' ' 59' ' ' LEU . 3.7 p-10 -151.89 101.63 2.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.345 1.069 . . . . 0.0 109.603 169.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.19 142.92 27.06 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.314 1.046 . . . . 0.0 111.717 -171.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -124.45 111.77 16.12 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 123.889 1.804 . . . . 0.0 110.861 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -83.64 101.83 11.78 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.868 -1.969 . . . . 0.0 111.921 175.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.489 HD23 HD13 ' A' ' 110' ' ' LEU . 33.9 tp -102.73 113.28 26.55 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.748 0.819 . . . . 0.0 111.093 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.1 ptm -120.77 151.24 39.82 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.55 141.26 23.56 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.52 1.533 . . . . 0.0 113.348 173.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.43 32.09 5.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.26 1.824 . . . . 0.0 112.255 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.3 p -78.43 163.58 25.51 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 119.91 -1.744 . . . . 0.0 112.194 171.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.81 -19.89 51.06 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 116.484 1.354 . . . . 0.0 116.484 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.5 m -68.58 -28.11 66.65 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.709 1.254 . . . . 0.0 112.84 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.05 1.75 42.43 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -170.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -69.1 -23.09 63.96 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.526 1.512 . . . . 0.0 112.857 171.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.31 -38.25 39.59 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 169.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -43.46 98.84 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.08 1.352 . . . . 0.0 111.091 175.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.409 ' HA ' HG22 ' A' ' 23' ' ' VAL . 27.5 tp -58.17 -42.54 86.23 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 124.755 1.222 . . . . 0.0 112.55 -177.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -51.57 -43.56 62.47 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.157 0.889 . . . . 0.0 113.283 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -95.12 -0.55 53.31 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -175.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 20' ' ' LEU . 20.1 m -99.86 16.01 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 119.758 1.163 . . . . 0.0 112.333 169.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -94.73 -40.97 9.5 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.9 t -74.41 -13.8 60.77 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.71 2.004 . . . . 0.0 110.735 167.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.3 tp -81.26 96.29 7.22 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 124.682 2.182 . . . . 0.0 107.261 172.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.48 -51.24 0.09 OUTLIER Glycine 0 C--N 1.299 -1.514 0 CA-C-N 109.131 -3.668 . . . . 0.0 110.978 168.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.6 m -83.99 -37.27 22.43 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.768 1.227 . . . . 0.0 110.888 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -61.58 -38.65 88.34 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.7 0.8 . . . . 0.0 110.723 169.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.4 tp -63.75 -51.66 63.92 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.5 mt -56.21 -38.91 71.65 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 118.065 -0.969 . . . . 0.0 113.267 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -60.7 -39.74 89.65 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.851 1.66 . . . . 0.0 112.004 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.19 -43.94 60.58 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 171.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.9 mt -73.73 -16.57 61.18 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -69.63 -23.16 63.46 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.879 1.271 . . . . 0.0 113.335 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -73.48 -42.43 61.87 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.116 0.966 . . . . 0.0 109.476 170.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.473 HG23 ' CE1' ' A' ' 209' ' ' TYR . 1.4 mp -63.39 -41.94 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.015 1.326 . . . . 0.0 111.632 174.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 t -166.41 149.89 7.25 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -169.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.5 mmt-85 -76.88 -15.19 59.77 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.2 p -138.43 132.03 30.75 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.486 1.136 . . . . 0.0 111.058 169.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.96 88.34 0.13 Allowed Glycine 0 C--N 1.336 0.529 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -169.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -73.5 148.24 43.3 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -174.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.6 tt -123.17 135.63 62.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.434 ' HA3' HD23 ' A' ' 59' ' ' LEU . . . -139.99 161.15 26.34 Favored Glycine 0 N--CA 1.464 0.557 0 C-N-CA 125.361 1.458 . . . . 0.0 110.722 172.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.41 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 91.1 t80 -139.17 138.22 36.75 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -169.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.25 145.27 15.92 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 124.491 1.043 . . . . 0.0 112.578 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.3 m -116.13 136.22 53.21 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 125.284 1.434 . . . . 0.0 110.522 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.18 155.31 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.534 1.134 . . . . 0.0 111.197 176.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.1 p -151.93 -65.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 120.656 -1.277 . . . . 0.0 109.02 168.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 65.6 t30 177.06 -19.66 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 130.237 3.415 . . . . 0.0 110.081 169.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 54.0 ttm -50.1 -36.84 31.23 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.009 1.324 . . . . 0.0 110.029 167.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t 167.1 -172.39 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 131.465 3.906 . . . . 0.0 109.782 169.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -103.88 131.28 51.25 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 167.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.6 pm0 -130.26 124.38 32.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 123.064 1.411 . . . . 0.0 110.793 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -94.23 104.68 16.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.14 2.176 . . . . 0.0 109.924 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . 0.361 0.0 OUTLIER -91.22 -70.01 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 117.583 -1.199 . . . . 0.0 110.799 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.8 124.49 38.87 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 121.287 1.858 . . . . 0.0 114.74 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -67.08 168.94 9.24 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.558 1.143 . . . . 0.0 110.336 167.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.648 HD13 ' HB2' ' A' ' 5' ' ' ASP . 13.5 mt -62.1 123.22 17.53 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.276 -0.89 . . . . 0.0 109.349 175.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.8 t -145.14 165.48 28.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.839 1.256 . . . . 0.0 111.291 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -99.69 -7.36 25.74 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.678 1.191 . . . . 0.0 114.009 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -94.52 81.2 3.9 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 124.623 2.154 . . . . 0.0 108.906 173.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.4 m -73.27 -19.34 61.08 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 127.39 2.276 . . . . 0.0 110.869 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.1 t -67.53 -21.16 65.49 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 167.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -82.55 -35.49 27.15 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 120.778 -1.201 . . . . 0.0 111.038 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.41 ' CE2' ' HB2' ' A' ' 45' ' ' PHE . 33.4 t80 -55.66 -24.49 34.25 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.221 1.008 . . . . 0.0 111.384 169.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -77.63 -39.68 44.41 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.916 -1.115 . . . . 0.0 109.413 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -66.02 -36.34 82.99 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.425 1.09 . . . . 0.0 109.743 -172.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -90.42 -23.0 21.15 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.24 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.422 ' HA ' HE21 ' A' ' 73' ' ' GLN . 0.1 OUTLIER -71.46 -20.61 62.07 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.535 -0.728 . . . . 0.0 109.912 169.311 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -75.72 -38.09 58.83 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.69 0.796 . . . . 0.0 112.94 170.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.34 -14.64 26.66 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 116.312 1.968 . . . . 0.0 116.312 -175.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.422 HE21 ' HA ' ' A' ' 70' ' ' LEU . 4.2 pt20 -59.3 150.1 26.92 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.64 1.564 . . . . 0.0 110.12 169.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.7 mt -120.53 161.23 21.66 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.832 0.853 . . . . 0.0 111.484 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.0 t -96.51 143.84 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.191 1.397 . . . . 0.0 110.597 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.5 t -113.44 -169.51 1.51 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 127.369 2.268 . . . . 0.0 112.173 -175.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -153.65 153.86 25.12 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.162 1.363 . . . . 0.0 113.661 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -152.49 160.12 43.27 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.186 1.794 . . . . 0.0 111.037 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -87.81 -32.75 18.89 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -174.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.76 143.05 38.29 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.666 0.786 . . . . 0.0 110.026 174.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.319 13.8 t -73.56 -41.37 5.87 Favored Pre-proline 0 N--CA 1.479 0.977 0 CA-C-O 116.341 -1.79 . . . . 0.0 113.969 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.79 137.62 54.54 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.649 2.233 . . . . 0.0 113.852 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -82.67 155.93 24.1 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.932 1.693 . . . . 0.0 113.528 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.77 45.5 3.22 Favored Glycine 0 N--CA 1.485 1.916 0 O-C-N 120.399 -1.438 . . . . 0.0 109.698 168.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -74.71 -39.91 61.63 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -168.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . 0.26 5.9 mp -68.75 -30.21 68.78 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 117.042 -1.456 . . . . 0.0 110.742 -173.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -57.37 -39.53 76.21 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.979 1.718 . . . . 0.0 111.899 169.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.53 -47.38 86.43 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.302 -1.499 . . . . 0.0 111.176 170.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.0 t -54.44 -31.83 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.389 1.076 . . . . 0.0 112.382 172.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.581 ' HA ' HD21 ' A' ' 156' ' ' LEU . 40.9 t -64.75 -65.0 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.592 0.757 . . . . 0.0 111.258 172.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -69.77 -32.62 71.21 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.086 -0.959 . . . . 0.0 112.048 -169.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 108' ' ' LEU . 33.0 m -62.53 -20.85 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.922 1.237 . . . . 0.0 113.403 171.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.02 -45.51 16.46 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 120.057 1.299 . . . . 0.0 112.295 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.5 mt -88.19 -19.85 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.45 60.11 5.83 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 119.996 -1.69 . . . . 0.0 111.698 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.421 ' H ' HD12 ' A' ' 96' ' ' LEU . 6.6 mp -48.26 -38.58 19.02 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.185 1.394 . . . . 0.0 111.128 176.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.83 -29.64 31.39 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.602 1.096 . . . . 0.0 115.497 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -89.65 -46.36 8.69 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 118.94 1.37 . . . . 0.0 110.624 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.9 mm -60.67 -49.54 84.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 172.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.61 29.51 8.19 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.177 0.894 . . . . 0.0 113.815 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.558 ' CE3' HD11 ' A' ' 59' ' ' LEU . 14.2 m95 -54.84 119.93 6.09 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 118.46 1.13 . . . . 0.0 111.462 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -95.82 -144.43 0.27 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.41 1.484 . . . . 0.0 111.96 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -102.1 -10.35 19.75 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 -169.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.16 -126.41 1.6 Allowed Glycine 0 C--N 1.349 1.264 0 CA-C-N 120.895 1.68 . . . . 0.0 112.86 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.4 t -112.26 147.53 36.07 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.311 1.845 . . . . 0.0 110.037 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.73 132.99 29.88 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 119.73 1.15 . . . . 0.0 113.198 -169.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -123.8 104.94 9.26 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -169.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 92' ' ' VAL . 16.8 tp -85.6 88.66 7.56 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.847 172.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.686 HG21 HG12 ' A' ' 205' ' ' ILE . 54.3 t -79.13 123.7 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 174.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.489 HD13 HD23 ' A' ' 9' ' ' LEU . 47.5 tp -117.2 111.66 19.75 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 123.814 0.696 . . . . 0.0 109.503 -169.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.34 133.26 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 t -165.62 158.42 15.51 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.683 169.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -106.14 -5.51 19.29 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -174.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -138.57 -179.9 6.08 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.514 1.526 . . . . 0.0 111.423 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.11 -171.33 0.11 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.688 1.595 . . . . 0.0 113.478 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -144.81 150.42 37.13 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.109 1.364 . . . . 0.0 112.499 -170.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -74.16 133.6 42.78 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.859 0.864 . . . . 0.0 110.333 169.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.95 175.22 5.55 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.273 1.429 . . . . 0.0 109.784 170.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.91 142.54 19.07 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.836 -0.54 . . . . 0.0 111.263 169.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.533 ' O ' HG22 ' A' ' 123' ' ' THR . 72.5 mmtt 86.31 -18.06 0.35 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 129.217 3.007 . . . . 0.0 112.667 -173.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -71.58 -19.1 62.19 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 121.061 1.755 . . . . 0.0 113.0 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -74.22 -16.15 60.98 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.499 -1.375 . . . . 0.0 113.876 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 120' ' ' LYS 0.302 9.5 t -74.7 -6.63 49.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 119.556 1.071 . . . . 0.0 113.201 174.162 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.1 mp -64.93 -24.09 67.42 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.104 -0.998 . . . . 0.0 109.752 167.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -88.65 -123.56 2.14 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 168.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 64.1 p -126.97 16.15 7.35 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.337 1.455 . . . . 0.0 114.1 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.36 125.72 50.84 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.652 1.181 . . . . 0.0 111.932 -169.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -130.43 -20.3 2.98 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -71.52 124.58 24.98 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 121.078 1.763 . . . . 0.0 110.111 170.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.441 ' HA ' ' HB3' ' A' ' 149' ' ' ASP . 15.3 t -75.4 147.23 40.16 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.139 0.575 . . . . 0.0 110.722 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.4 t -63.72 135.58 56.8 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.064 1.412 . . . . 0.0 112.602 -175.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -73.94 -10.53 59.74 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.55 2.74 . . . . 0.0 114.832 -170.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.86 15.99 80.63 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.222 -1.321 . . . . 0.0 114.182 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -113.15 170.26 8.34 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.175 1.488 . . . . 0.0 110.632 169.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.3 153.24 18.12 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -169.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -147.88 45.44 1.09 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.027 1.331 . . . . 0.0 113.803 -169.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.41 150.14 20.92 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.342 1.057 . . . . 0.0 109.584 169.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -141.6 -67.79 0.39 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.856 0.862 . . . . 0.0 111.538 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -84.73 -2.64 57.88 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.524 1.53 . . . . 0.0 113.716 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.29 -8.72 38.36 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.217 1.865 . . . . 0.0 114.387 -175.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 92.4 mtp -93.41 148.94 21.62 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.308 2.054 . . . . 0.0 111.088 170.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -70.92 100.7 2.0 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.927 -1.108 . . . . 0.0 110.746 173.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -48.36 80.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.355 1.062 . . . . 0.0 110.821 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 43.5 m -74.44 8.06 2.5 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -175.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.25 -24.61 59.9 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.834 -1.166 . . . . 0.0 111.881 169.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.7 -45.23 7.94 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 118.007 -1.441 . . . . 0.0 113.574 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.303 1.7 pm0 -97.97 -62.78 0.11 Allowed Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -169.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -58.54 149.26 76.65 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.438 2.758 . . . . 0.0 117.625 169.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' A' ' 130' ' ' THR . 56.0 t0 -74.81 161.15 29.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.87 2.468 . . . . 0.0 111.631 169.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -59.73 131.74 51.82 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 168.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -81.94 157.06 24.43 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 121.153 1.797 . . . . 0.0 112.624 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.3 m -67.8 152.42 45.6 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.111 0.964 . . . . 0.0 113.101 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.15 -26.36 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -169.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.9 m -85.21 -16.17 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -70.03 -27.14 64.42 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.752 1.16 . . . . 0.0 108.494 168.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.581 HD21 ' HA ' ' A' ' 90' ' ' VAL . 15.2 mt -84.22 -32.87 24.28 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 117.286 -1.34 . . . . 0.0 114.036 169.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -54.23 -37.37 64.55 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 120.853 1.661 . . . . 0.0 112.398 171.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 89.2 p -68.41 -55.03 13.33 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.835 -0.54 . . . . 0.0 112.119 173.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -66.01 -29.74 70.16 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.6 mp -58.33 -54.58 45.4 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.412 1.085 . . . . 0.0 111.383 170.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.56 -24.63 58.95 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.15 -39.8 63.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.5 1.12 . . . . 0.0 111.022 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -95.52 1.09 53.77 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 174.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 66.89 30.86 7.53 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.314 1.846 . . . . 0.0 113.863 169.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 48.7 mt -89.64 137.86 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 120.705 -1.247 . . . . 0.0 109.603 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -104.59 97.53 12.55 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -74.12 150.37 42.64 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.132 1.888 . . . . 0.0 113.465 173.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.495 ' CD1' HG23 ' A' ' 190' ' ' THR . 34.9 mm -139.17 106.28 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.715 1.206 . . . . 0.0 109.702 -174.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.478 ' HB2' HG22 ' A' ' 191' ' ' ILE . 21.2 m-85 -73.01 65.62 0.76 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.657 1.183 . . . . 0.0 113.207 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.69 108.6 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 122.401 1.096 . . . . 0.0 111.187 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 28.3 m -146.3 142.01 17.07 Favored Pre-proline 0 N--CA 1.48 1.039 0 O-C-N 119.873 -1.767 . . . . 0.0 110.708 -174.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -54.17 150.78 30.88 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.197 2.598 . . . . 0.0 114.542 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.3 t -44.79 -45.04 9.83 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.347 1.859 . . . . 0.0 114.031 -170.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.33 -36.97 6.84 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.698 1.599 . . . . 0.0 113.782 -172.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.5 mtt -123.62 19.19 9.55 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.741 1.217 . . . . 0.0 114.08 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.2 t -59.52 -37.5 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 O-C-N 120.488 -1.382 . . . . 0.0 110.589 174.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 180' ' ' GLU . 0.0 OUTLIER -66.71 -22.74 66.06 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -170.435 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.2 t -91.24 -33.21 15.46 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.872 1.269 . . . . 0.0 111.249 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -70.95 -37.02 72.82 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.577 -1.327 . . . . 0.0 110.324 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.534 ' HA ' HG22 ' A' ' 183' ' ' THR 0.353 14.8 pt-20 -73.43 -2.67 23.36 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 169.662 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.646 ' O ' HG22 ' A' ' 184' ' ' THR . 87.1 tttt -88.63 -43.64 11.2 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.23 -0.919 . . . . 0.0 109.869 169.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . 0.264 4.8 mp -83.84 -10.08 58.3 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 119.288 -2.133 . . . . 0.0 111.93 -174.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 180' ' ' GLU . 15.1 t -78.16 -19.64 53.57 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 167.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 181' ' ' LYS 0.279 1.3 t -77.41 -19.94 55.38 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 120.881 -1.137 . . . . 0.0 109.655 168.587 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -83.47 -24.19 31.88 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.345 0.658 . . . . 0.0 111.373 168.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.87 78.71 23.71 Favored Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 124.618 1.167 . . . . 0.0 111.542 170.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.52 142.1 93.85 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.183 1.922 . . . . 0.0 112.122 176.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 62.6 mttm 95.17 -20.34 0.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 131.636 3.975 . . . . 0.0 113.331 -171.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.7 tt -71.03 157.48 38.14 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.495 HG23 ' CD1' ' A' ' 168' ' ' ILE 0.495 0.1 OUTLIER -135.36 -160.64 1.07 Allowed 'General case' 0 C--N 1.346 0.416 0 O-C-N 120.009 -1.682 . . . . 0.0 108.169 169.871 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.478 HG22 ' HB2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -146.97 156.29 10.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 129.025 2.93 . . . . 0.0 108.893 -168.193 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -137.56 134.76 7.17 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 171.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -83.12 82.21 8.35 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 169.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 20.0 tp -62.34 157.85 18.83 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 113.481 -1.691 . . . . 0.0 110.609 169.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 57.5 p -91.43 168.57 11.45 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.052 -1.03 . . . . 0.0 112.566 173.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.76 -11.42 60.39 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -104.31 -11.99 16.86 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.842 1.657 . . . . 0.0 114.351 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 31.0 m 77.6 -3.85 2.36 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 129.697 3.199 . . . . 0.0 114.657 172.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.4 m -62.75 -14.72 48.01 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.576 1.551 . . . . 0.0 113.935 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -72.73 -11.98 60.84 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 169.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 6.6 p -58.93 -41.38 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -169.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.82 95.84 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 120.08 1.309 . . . . 0.0 111.41 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -66.74 -11.85 56.3 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 10.2 mp -109.86 -25.64 10.21 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 127.256 2.222 . . . . 0.0 109.544 -174.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.686 HG12 HG21 ' A' ' 109' ' ' VAL . 48.9 mt -65.79 -52.26 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 166.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . 0.311 30.3 ptt85 -76.34 -21.68 55.85 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 117.513 -1.232 . . . . 0.0 114.22 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -69.78 -13.84 62.48 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 120.427 1.467 . . . . 0.0 114.803 171.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -105.73 -21.89 13.08 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.234 1.414 . . . . 0.0 112.294 -173.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.473 ' CE1' HG23 ' A' ' 37' ' ' ILE . 18.2 t80 -81.99 -25.04 35.11 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.298 2.239 . . . . 0.0 112.154 170.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -24.09 -44.26 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.881 1 C-N-CA 133.141 4.576 . . . . 0.0 116.745 -168.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -88.92 -44.7 10.25 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 -169.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . 0.256 4.6 mp . . . . . 0 N--CA 1.498 1.971 0 CA-C-N 119.215 0.916 . . . . 0.0 112.5 -169.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.9 t0 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.939 0.4 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -105.41 139.31 40.23 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.806 1.243 . . . . 0.0 110.478 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -66.54 124.59 23.23 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.322 -0.861 . . . . 0.0 111.565 178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.2 t -125.1 140.67 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.328 1.451 . . . . 0.0 109.327 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -124.6 99.39 6.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.296 1.439 . . . . 0.0 109.194 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.0 123.31 40.69 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.181 -0.95 . . . . 0.0 111.128 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -105.45 105.94 16.21 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 123.701 1.715 . . . . 0.0 109.282 169.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -81.83 112.5 19.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.563 173.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 tt -111.34 131.54 55.09 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.372 -0.83 . . . . 0.0 112.841 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.472 ' SD ' HD21 ' A' ' 70' ' ' LEU . 28.4 mtp -110.61 148.49 32.1 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 177.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.57 121.35 6.45 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.578 1.561 . . . . 0.0 109.209 168.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.54 36.38 3.11 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.06 1.744 . . . . 0.0 111.697 -175.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.504 ' OG ' ' HE2' ' A' ' 83' ' ' LYS . 24.4 p -79.09 163.15 25.35 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.705 1.602 . . . . 0.0 113.479 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -56.69 -32.13 61.3 Favored Glycine 0 N--CA 1.477 1.368 0 O-C-N 121.263 -0.898 . . . . 0.0 114.181 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.6 p -70.2 -19.52 63.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.684 1.193 . . . . 0.0 113.875 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.65 -2.9 48.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.199 1.4 . . . . 0.0 112.774 176.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -66.18 134.39 52.63 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.805 -1.184 . . . . 0.0 109.24 169.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.06 -50.63 3.69 Favored Glycine 0 N--CA 1.471 1.011 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -169.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -65.05 -20.8 66.66 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.025 0.93 . . . . 0.0 112.834 171.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.522 ' HA ' HG22 ' A' ' 23' ' ' VAL . 42.1 tp -51.64 -32.82 30.8 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.519 1.528 . . . . 0.0 112.157 172.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.4 t -64.16 -56.65 13.32 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.721 -0.612 . . . . 0.0 110.876 169.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -67.22 -25.69 66.23 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.71 -1.243 . . . . 0.0 113.867 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 20' ' ' LEU . 10.2 m -82.52 -2.55 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 119.015 0.825 . . . . 0.0 112.788 172.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.04 -49.05 3.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.192 0.997 . . . . 0.0 110.125 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.8 p -59.15 -20.07 50.49 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.863 1.265 . . . . 0.0 112.421 169.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 tp -110.02 86.55 2.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 127.984 2.514 . . . . 0.0 104.84 169.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 164.3 -43.09 0.31 Allowed Glycine 0 C--N 1.308 -0.977 0 CA-C-N 112.343 -2.208 . . . . 0.0 108.969 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.5 p -66.6 -44.74 81.3 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.43 1.092 . . . . 0.0 110.55 169.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -75.31 -25.38 57.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.697 -1.144 . . . . 0.0 112.68 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 mp -62.87 -50.8 69.47 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 120.103 1.32 . . . . 0.0 108.974 170.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.546 HD11 ' HA ' ' A' ' 63' ' ' SER . 0.4 OUTLIER -61.19 -51.27 69.73 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.081 0.552 . . . . 0.0 111.905 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -63.28 -47.52 81.98 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.739 -0.601 . . . . 0.0 110.8 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.24 -44.19 84.45 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 117.871 0.305 . . . . 0.0 111.583 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.471 ' HA ' HG22 ' A' ' 37' ' ' ILE 0.309 2.6 mp -79.9 -11.98 59.77 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -177.732 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -73.21 -19.3 61.12 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.06 -1.025 . . . . 0.0 111.294 167.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -85.67 -41.06 15.51 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.238 1.015 . . . . 0.0 110.516 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.471 HG22 ' HA ' ' A' ' 34' ' ' LEU . 8.8 tt -71.45 -26.01 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 175.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 t -149.54 137.3 20.26 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -71.68 -39.84 69.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.874 1.67 . . . . 0.0 111.832 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.7 t -103.21 89.47 3.42 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 122.889 1.328 . . . . 0.0 109.846 172.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.06 84.27 0.31 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 105.627 -2.989 . . . . 0.0 105.627 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 -84.58 133.92 34.41 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.529 1.532 . . . . 0.0 107.774 -169.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.4 tt -125.97 144.41 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 119.545 1.066 . . . . 0.0 112.296 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.27 153.61 21.98 Favored Glycine 0 N--CA 1.461 0.329 0 C-N-CA 125.84 1.686 . . . . 0.0 110.263 -176.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -138.07 130.57 29.32 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -169.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.68 149.69 20.09 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 124.92 1.247 . . . . 0.0 112.901 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.3 p -119.65 144.11 47.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.657 1.183 . . . . 0.0 111.553 174.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -140.98 150.44 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.518 -1.364 . . . . 0.0 108.961 174.705 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.419 ' N ' HD13 ' A' ' 48' ' ' ILE . 38.1 t -138.36 -68.92 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 170.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.425 ' H ' ' H ' ' A' ' 51' ' ' MET 0.273 1.5 t-20 170.15 -4.05 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.82 1 C-N-CA 134.046 4.938 . . . . 0.0 109.477 169.421 . . . . . . . . 4 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.425 ' H ' ' H ' ' A' ' 50' ' ' ASN . 26.7 ptt? -54.33 -39.72 67.31 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.118 0.967 . . . . 0.0 109.61 167.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.486 ' HA ' ' HD3' ' A' ' 145' ' ' ARG . 1.2 p 163.74 170.65 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.117 1 C-N-CA 134.355 5.062 . . . . 0.0 108.43 -178.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -89.16 131.21 35.4 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 166.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -123.4 130.31 52.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.677 1.227 . . . . 0.0 110.186 177.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -104.01 104.73 14.73 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.866 2.066 . . . . 0.0 110.429 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.437 ' H ' HD13 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -108.96 -9.35 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -173.497 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.4 tt -157.34 117.22 3.42 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.553 1.069 . . . . 0.0 109.927 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.02 163.74 18.68 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.825 0.85 . . . . 0.0 113.272 172.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.458 HD11 ' CE3' ' A' ' 101' ' ' TRP . 87.4 mt -49.08 104.02 0.06 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.592 1.557 . . . . 0.0 113.334 -169.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.9 p -122.45 161.65 23.15 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.502 1.921 . . . . 0.0 111.221 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.65 6.35 41.95 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 125.722 1.609 . . . . 0.0 112.213 169.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -85.52 76.82 9.99 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.706 2.402 . . . . 0.0 107.22 174.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.546 ' HA ' HD11 ' A' ' 31' ' ' LEU . 24.4 p -67.3 -45.7 75.75 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 128.771 2.828 . . . . 0.0 111.43 -169.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.6 t -51.98 -34.93 44.57 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.256 1.022 . . . . 0.0 109.96 170.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -83.74 -37.32 22.82 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -172.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -54.64 -33.55 60.81 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.566 1.075 . . . . 0.0 111.089 169.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -72.52 -34.52 67.66 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.643 -0.661 . . . . 0.0 110.036 -176.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -72.35 -35.1 68.46 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.905 0.882 . . . . 0.0 109.241 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.63 -32.16 28.43 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -172.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.472 HD21 ' SD ' ' A' ' 10' ' ' MET . 3.4 tt -73.61 -41.0 63.39 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 171.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -59.71 -33.19 71.3 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.248 -0.908 . . . . 0.0 113.135 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.1 -5.22 55.54 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -64.51 152.56 41.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.771 1.168 . . . . 0.0 112.582 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.7 tt -138.92 137.23 36.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.745 1.218 . . . . 0.0 109.756 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.8 t -74.08 138.09 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 126.474 1.91 . . . . 0.0 112.044 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 t -101.66 -155.9 0.54 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 125.971 1.708 . . . . 0.0 112.17 172.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -146.86 150.33 22.58 Favored Glycine 0 N--CA 1.478 1.483 0 O-C-N 120.048 -1.657 . . . . 0.0 116.019 -173.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -149.75 162.38 40.37 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.918 2.087 . . . . 0.0 113.262 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -32.1 13.0 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 173.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -94.96 132.11 40.16 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.229 0.922 . . . . 0.0 110.318 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.8 p -74.25 -31.46 1.26 Allowed Pre-proline 0 N--CA 1.472 0.675 0 CA-C-O 114.274 -2.774 . . . . 0.0 115.427 -172.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -68.48 144.95 63.08 Favored 'Trans proline' 0 C--N 1.353 0.771 0 CA-C-N 123.893 2.426 . . . . 0.0 112.264 169.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HE2' ' OG ' ' A' ' 13' ' ' SER . 12.1 mptt -98.48 -177.3 3.64 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.889 1.276 . . . . 0.0 112.286 -176.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.96 18.28 37.07 Favored Glycine 0 N--CA 1.481 1.652 0 C-N-CA 125.621 1.581 . . . . 0.0 114.327 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -46.72 -39.18 11.11 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -169.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.55 HD23 HD13 ' A' ' 156' ' ' LEU 0.466 5.1 mp -80.49 7.92 8.84 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 119.899 1.227 . . . . 0.0 113.417 -177.63 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -80.41 -49.84 10.91 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 165.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.44 -45.23 94.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 116.893 -1.527 . . . . 0.0 112.369 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -49.95 -36.93 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 120.511 1.505 . . . . 0.0 111.653 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.579 HG21 ' HG3' ' A' ' 151' ' ' GLN . 63.1 t -82.59 -45.14 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.172 0.989 . . . . 0.0 111.4 -178.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -59.57 -49.8 76.38 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.524 1.056 . . . . 0.0 109.672 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.437 HG11 HD13 ' A' ' 108' ' ' LEU . 82.2 t -55.97 -42.08 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.203 1.001 . . . . 0.0 111.976 176.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.69 85.52 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.091 -1.006 . . . . 0.0 112.919 177.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.26 -24.91 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.988 1.315 . . . . 0.0 113.667 -169.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 61.78 3.93 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.812 1.645 . . . . 0.0 110.871 -176.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.4 mt -56.23 -38.63 71.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.072 1.349 . . . . 0.0 112.0 -170.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.01 -34.49 23.98 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.877 0.751 . . . . 0.0 113.47 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -81.66 -45.4 15.81 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 125.334 1.453 . . . . 0.0 110.472 -175.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.8 mm -70.69 -33.31 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 118.915 0.78 . . . . 0.0 110.455 170.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.16 31.5 16.86 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.452 1.025 . . . . 0.0 114.542 174.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.458 ' CE3' HD11 ' A' ' 59' ' ' LEU . 23.1 m95 -56.54 129.45 40.89 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.88 1.272 . . . . 0.0 113.096 -177.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.17 170.66 7.83 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.651 1.18 . . . . 0.0 112.55 169.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -74.42 49.49 0.38 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 127.307 2.243 . . . . 0.0 114.053 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.84 -131.02 6.44 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 170.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.9 m -119.33 132.59 55.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.568 2.347 . . . . 0.0 105.7 177.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -124.61 124.79 42.98 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 119.084 0.856 . . . . 0.0 111.405 -168.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -114.04 112.47 23.31 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 123.977 0.798 . . . . 0.0 110.783 -175.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.437 HD13 HG11 ' A' ' 92' ' ' VAL . 14.5 tp -93.44 105.92 17.94 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 170.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.1 t -89.43 125.58 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 172.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -111.03 115.87 30.2 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.525 HG13 HD22 ' A' ' 194' ' ' LEU . 60.0 t -108.72 130.88 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 123.674 0.609 . . . . 0.0 112.611 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.4 t -158.17 164.24 36.77 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.305 1.042 . . . . 0.0 111.453 171.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -112.49 -4.36 14.22 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.85 2.06 . . . . 0.0 114.124 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -137.49 -177.36 4.75 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.476 -1.39 . . . . 0.0 113.439 171.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -61.86 -174.64 0.05 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.333 2.253 . . . . 0.0 112.262 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 20.8 t80 -140.6 139.46 34.93 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.426 1.09 . . . . 0.0 111.904 -174.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -68.67 108.35 3.34 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.564 1.146 . . . . 0.0 111.721 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.04 177.54 3.68 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.375 0.607 . . . . 0.0 111.527 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.27 148.14 23.5 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.22 -0.925 . . . . 0.0 112.295 172.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? 78.6 -11.19 1.24 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 128.099 2.56 . . . . 0.0 112.668 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.95 -32.5 74.26 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.532 1.133 . . . . 0.0 112.398 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -70.09 0.84 5.41 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 178.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.2 t -58.82 -33.04 69.94 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.052 -1.03 . . . . 0.0 112.417 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.6 tp -65.82 -40.89 92.26 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.635 0.774 . . . . 0.0 111.473 171.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.88 27.03 1.13 Allowed Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.588 1.566 . . . . 0.0 113.392 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 62.7 p 61.94 5.89 1.53 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 131.536 3.935 . . . . 0.0 117.038 169.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . 0.3 48.1 mtt180 -109.99 140.75 43.65 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.939 1.245 . . . . 0.0 114.144 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -109.73 -32.37 7.11 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.14 2.576 . . . . 0.0 114.691 -168.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -71.35 123.41 22.25 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.821 0.737 . . . . 0.0 111.292 -173.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.0 t -57.73 158.25 6.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.489 1.116 . . . . 0.0 110.68 172.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 151' ' ' GLN . 20.7 t -70.15 134.43 48.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.977 0.894 . . . . 0.0 111.11 170.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 p30 -78.13 -12.03 59.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.633 1.573 . . . . 0.0 112.647 170.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.19 8.11 73.65 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.876 1.227 . . . . 0.0 114.764 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -78.14 174.02 11.61 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.896 1.348 . . . . 0.0 109.023 168.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -93.13 148.25 22.18 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 171.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -136.2 27.57 3.17 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.886 1.674 . . . . 0.0 112.232 -171.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.3 mt -87.66 153.12 21.62 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.87 0.868 . . . . 0.0 111.008 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -148.0 -67.21 0.24 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.399 1.079 . . . . 0.0 111.44 172.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.22 9.07 27.1 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.721 1.608 . . . . 0.0 113.729 176.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 105.98 -5.47 39.5 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.803 1.668 . . . . 0.0 115.213 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -113.17 149.16 34.03 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.643 1.721 . . . . 0.0 112.277 174.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -70.71 86.61 0.67 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.456 1.102 . . . . 0.0 112.107 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -49.05 -45.11 42.34 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.067 1.347 . . . . 0.0 111.833 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 71.8 m -77.73 -0.14 25.79 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -173.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.486 ' HD3' ' HA ' ' A' ' 52' ' ' THR . 9.4 ttp85 -52.43 -40.33 62.07 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 121.171 1.805 . . . . 0.0 111.658 169.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.7 -25.09 75.92 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 117.617 -1.657 . . . . 0.0 113.156 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.355 42.7 tt0 -96.84 -92.06 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.328 0 CA-C-O 115.465 -2.207 . . . . 0.0 112.041 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.97 152.94 54.71 Favored 'Trans proline' 0 C--N 1.359 1.081 0 CA-C-N 124.241 2.55 . . . . 0.0 116.395 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.01 163.35 7.98 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.819 2.448 . . . . 0.0 114.72 170.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -60.85 139.9 57.82 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 167.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.579 ' HG3' HG21 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -84.11 150.57 25.46 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.613 -1.305 . . . . 0.0 112.396 -174.55 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.1 t -68.85 148.67 49.91 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.401 0.68 . . . . 0.0 111.805 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.0 t -55.85 -29.47 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.565 1.146 . . . . 0.0 111.802 -177.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.3 -40.66 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.34 1.056 . . . . 0.0 112.138 173.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -65.41 -35.87 82.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.327 0.651 . . . . 0.0 110.141 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.55 HD13 HD23 ' A' ' 86' ' ' LEU . 5.2 mt -61.8 -58.12 9.22 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 173.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -54.24 -41.12 68.38 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.486 1.114 . . . . 0.0 112.919 -175.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.8 t -59.65 -54.14 49.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.886 0.874 . . . . 0.0 111.525 173.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -73.64 -33.95 64.75 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.824 -1.173 . . . . 0.0 112.903 -172.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 mt -61.1 -38.23 85.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.401 1.001 . . . . 0.0 111.978 170.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.63 -33.41 64.52 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.114 0.966 . . . . 0.0 113.514 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -68.35 -47.3 67.83 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.641 1.177 . . . . 0.0 110.496 176.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -74.45 -17.37 60.79 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.492 0.717 . . . . 0.0 111.871 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 62.84 49.26 3.71 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.964 1.706 . . . . 0.0 111.514 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.51 125.79 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.82 1.248 . . . . 0.0 108.465 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -91.42 119.79 68.51 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-O 118.38 -0.819 . . . . 0.0 108.805 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.18 152.59 14.09 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.635 2.223 . . . . 0.0 110.603 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.8 mm -138.54 105.4 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.008 1.323 . . . . 0.0 109.379 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.553 ' CD2' HD11 ' A' ' 189' ' ' LEU . 28.2 m-85 -77.96 82.6 4.31 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.428 -1.42 . . . . 0.0 112.46 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 87.9 t -70.28 104.91 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.14 -1.391 . . . . 0.0 112.31 169.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.11 144.79 22.45 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -171.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -63.96 154.17 71.65 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 124.742 3.628 . . . . 0.0 114.912 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.7 m -41.22 -51.04 3.59 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.428 2.291 . . . . 0.0 114.877 -169.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -54.54 -26.37 31.53 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 8.9 ttm -106.02 -8.48 17.52 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.565 1.946 . . . . 0.0 114.073 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 40.1 t -55.56 -47.04 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.902 -1.124 . . . . 0.0 112.148 -168.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . 0.317 11.4 pttm -81.09 -6.18 58.51 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -174.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . 0.255 4.8 t -86.92 -26.87 23.68 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 119.337 0.971 . . . . 0.0 111.129 169.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -83.49 -23.25 32.25 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.694 -1.254 . . . . 0.0 111.471 172.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -34.8 78.49 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.16 -0.963 . . . . 0.0 109.357 167.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . 0.395 0.1 OUTLIER -83.48 1.08 43.47 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 119.915 -1.74 . . . . 0.0 112.893 -178.24 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -98.56 -25.98 14.56 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.965 2.506 . . . . 0.0 107.407 168.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.517 ' HA ' HD23 ' A' ' 189' ' ' LEU . 0.6 OUTLIER -79.23 -18.11 53.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.949 -1.094 . . . . 0.0 113.897 176.276 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 5.3 t -85.3 -24.14 27.82 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.226 0.61 . . . . 0.0 110.004 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -79.62 -38.09 34.65 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.527 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 35.4 mt -108.66 98.63 29.7 Favored Pre-proline 0 N--CA 1.484 1.227 0 CA-C-N 118.81 0.732 . . . . 0.0 110.037 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -55.06 144.89 66.87 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.215 2.61 . . . . 0.0 112.421 169.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 78.49 -2.47 2.37 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 128.227 2.611 . . . . 0.0 114.849 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.553 HD11 ' CD2' ' A' ' 169' ' ' PHE . 23.2 tp -74.47 152.72 39.39 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.785 1.234 . . . . 0.0 108.464 168.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.3 m -121.12 -153.1 0.53 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 177.83 114.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.427 2.291 . . . . 0.0 108.857 -167.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -109.62 147.1 17.03 Favored Glycine 0 N--CA 1.471 1.001 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 171.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . 0.362 0.9 OUTLIER -95.53 95.66 8.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 124.053 1.882 . . . . 0.0 110.568 177.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.525 HD22 HG13 ' A' ' 111' ' ' VAL . 31.1 tp -51.33 134.14 28.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 111.326 -2.67 . . . . 0.0 111.692 172.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 84.0 p -170.03 -166.9 0.59 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.088 1.755 . . . . 0.0 108.901 171.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -58.58 -18.56 30.95 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -97.61 129.28 44.73 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.299 1.439 . . . . 0.0 112.429 173.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 70.7 m -88.95 -3.35 58.76 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.625 1.17 . . . . 0.0 113.586 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 31.0 p -61.74 -47.8 83.58 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.81 1.644 . . . . 0.0 112.901 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -62.55 -51.7 66.34 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.342 0.257 . . . . 0.0 110.819 -178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 88.5 t -62.23 -44.74 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 O-C-N 121.49 -0.756 . . . . 0.0 112.058 -176.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.21 -26.95 68.35 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.186 -0.947 . . . . 0.0 111.92 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -72.31 -10.29 59.59 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.208 -1.558 . . . . 0.0 112.607 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 8.2 mp -96.67 -44.3 7.18 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.507 1.523 . . . . 0.0 107.781 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 26.3 mt -75.6 -35.18 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -71.12 -29.57 65.43 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.34 169.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -69.38 -31.2 69.44 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 120.177 1.353 . . . . 0.0 113.181 169.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -72.77 -31.51 64.95 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.173 -0.954 . . . . 0.0 111.057 173.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -68.54 -41.46 79.8 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.475 0.71 . . . . 0.0 112.369 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.1 p -68.43 -11.4 59.66 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -89.91 -0.75 57.75 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.261 1.669 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -177.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.88 142.47 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.48 1.512 . . . . 0.0 109.377 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -119.46 113.17 20.36 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.083 1.753 . . . . 0.0 108.327 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.21 126.24 51.98 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.725 -0.609 . . . . 0.0 109.977 177.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -114.62 108.91 17.44 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 123.572 1.653 . . . . 0.0 111.284 174.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -84.01 99.2 10.27 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 112.713 -2.04 . . . . 0.0 113.584 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.4 mt -91.59 129.26 37.59 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.828 0.851 . . . . 0.0 109.675 168.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . 0.253 2.7 ppp? -137.45 156.63 47.95 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 169.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.02 131.81 10.63 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.149 1.833 . . . . 0.0 113.156 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.8 mp -107.42 29.57 7.04 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.917 2.087 . . . . 0.0 111.891 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.6 p . . . . . 0 CA--C 1.537 0.478 0 O-C-N 120.328 -1.483 . . . . 0.0 113.025 178.743 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.9 t . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 122.383 1.087 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.01 82.22 0.31 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 127.837 2.637 . . . . 0.0 106.605 -172.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -79.37 127.73 32.45 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.9 mt -123.38 130.91 73.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.311 0.577 . . . . 0.0 111.217 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.05 161.51 18.42 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 126.618 2.056 . . . . 0.0 110.278 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -141.28 133.31 27.7 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.82 145.51 16.25 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 121.404 0.446 . . . . 0.0 112.274 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.8 m -114.71 142.08 46.98 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.733 1.213 . . . . 0.0 110.332 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.587 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -152.77 155.04 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 120.913 -1.117 . . . . 0.0 108.984 178.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.587 ' N ' HD13 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -152.47 -62.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.607 1.163 . . . . 0.0 109.426 173.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.25 25.5 t30 177.47 -19.43 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 128.917 2.887 . . . . 0.0 111.972 168.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -50.31 -40.91 50.02 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.068 0.849 . . . . 0.0 109.7 168.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.405 ' HA ' ' HD2' ' A' ' 145' ' ' ARG 0.365 3.7 t 163.92 -177.61 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 131.622 3.969 . . . . 0.0 112.158 167.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -85.45 129.8 34.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.344 1.858 . . . . 0.0 108.533 169.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -117.73 112.22 20.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.45 1.1 . . . . 0.0 108.84 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -72.93 122.07 21.07 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.5 mt -103.86 -54.08 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.558 -0.714 . . . . 0.0 111.048 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.1 tp -130.98 120.72 23.91 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.257 0.551 . . . . 0.0 111.669 -175.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -57.85 149.57 22.24 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.705 1.202 . . . . 0.0 111.112 169.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 28.8 mt -48.03 108.8 0.18 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.115 1.366 . . . . 0.0 111.311 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 125.608 1.563 . . . . 0.0 111.823 -174.837 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.0 t -126.8 -140.54 0.27 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.273 1.429 . . . . 0.0 109.323 169.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -147.35 158.56 27.76 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-N 120.562 1.528 . . . . 0.0 115.715 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -160.6 148.41 16.1 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.951 1.7 . . . . 0.0 111.728 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.8 tp -68.06 -55.6 11.97 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.792 1.237 . . . . 0.0 112.223 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.59 136.17 50.92 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.632 0.773 . . . . 0.0 112.069 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.272 7.5 t -70.66 -39.84 9.84 Favored Pre-proline 0 N--CA 1.474 0.762 0 CA-C-O 115.766 -2.064 . . . . 0.0 113.456 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.42 140.07 56.49 Favored 'Trans proline' 0 C--N 1.356 0.939 0 CA-C-N 123.405 2.252 . . . . 0.0 111.693 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -107.4 -179.3 3.88 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.27 1.828 . . . . 0.0 112.738 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -109.18 18.99 30.27 Favored Glycine 0 N--CA 1.479 1.56 0 O-C-N 120.68 -1.262 . . . . 0.0 116.019 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -29.22 62.37 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -169.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.34 -28.15 67.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.47 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.72 -34.12 77.46 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 120.126 1.33 . . . . 0.0 112.273 171.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.7 -46.46 78.9 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 118.417 -0.801 . . . . 0.0 109.216 169.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.413 HG22 HD13 ' A' ' 108' ' ' LEU . 1.1 t -53.61 -40.13 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.017 0.826 . . . . 0.0 111.774 174.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.29 -61.9 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.433 1.093 . . . . 0.0 110.852 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.9 -44.8 95.11 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 118.945 -0.55 . . . . 0.0 110.715 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.24 -40.57 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.897 0.879 . . . . 0.0 111.714 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.56 -38.22 86.62 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.436 1.017 . . . . 0.0 112.86 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.6 mt -86.31 -36.8 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.795 0.838 . . . . 0.0 113.181 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 73.6 m -77.53 55.39 1.29 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.823 2.049 . . . . 0.0 112.105 -169.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.456 HD21 HD22 ' A' ' 163' ' ' ASN . 62.3 mt -48.99 -42.59 38.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.453 2.301 . . . . 0.0 111.453 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.98 -19.25 75.45 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.403 1.001 . . . . 0.0 114.719 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -96.58 -47.6 5.86 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.117 0.967 . . . . 0.0 110.79 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.3 mm -66.73 -36.56 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.686 0.795 . . . . 0.0 111.104 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.43 20.93 28.26 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.115 1.341 . . . . 0.0 114.123 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -53.98 121.04 7.2 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.361 1.464 . . . . 0.0 112.212 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ptm85 -107.34 -176.78 3.16 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.015 1.326 . . . . 0.0 112.164 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -73.86 11.08 0.94 Allowed 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 117.851 2.538 . . . . 0.0 117.851 -169.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.61 -129.82 1.97 Allowed Glycine 0 C--N 1.344 1.023 0 CA-C-N 121.215 1.825 . . . . 0.0 110.734 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.9 p -114.33 145.21 42.08 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.494 1.918 . . . . 0.0 107.656 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -129.05 117.87 21.59 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.416 -167.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -122.2 104.45 9.47 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -169.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.413 HD13 HG22 ' A' ' 89' ' ' VAL . 3.1 tt -88.6 94.96 10.06 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.216 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.0 t -77.5 116.01 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.0 tp -105.18 123.06 47.18 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 t -108.27 130.12 61.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 O-C-N 124.595 1.184 . . . . 0.0 112.445 172.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.493 HG22 HG12 ' A' ' 171' ' ' VAL . 7.5 t -140.89 172.91 12.04 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.805 1.642 . . . . 0.0 110.335 173.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -118.96 -14.54 9.38 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 127.164 2.185 . . . . 0.0 111.859 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -133.12 174.82 9.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.789 1.236 . . . . 0.0 113.457 -169.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -61.23 -174.73 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.266 1.427 . . . . 0.0 110.883 168.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -147.12 159.86 43.1 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.655 -1.278 . . . . 0.0 113.36 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -79.22 116.83 19.72 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.27 1.428 . . . . 0.0 111.52 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.9 mp -82.55 -179.23 7.36 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.097 1.359 . . . . 0.0 109.962 173.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.47 160.1 3.35 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.406 -0.809 . . . . 0.0 111.689 169.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.449 0.0 OUTLIER 56.32 -12.68 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.277 0 N-CA-C 117.487 2.402 . . . . 0.0 117.487 -173.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.26 -28.21 69.55 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.037 -1.664 . . . . 0.0 111.899 169.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.58 -25.1 67.1 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 116.818 2.155 . . . . 0.0 116.818 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -18.6 63.62 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -167.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 pp -67.05 -19.77 65.73 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 118.68 0.673 . . . . 0.0 112.734 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -96.52 11.94 66.54 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 126.415 1.96 . . . . 0.0 114.11 170.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.334 10.5 t 54.86 53.74 10.03 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 128.078 2.551 . . . . 0.0 113.882 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -116.55 69.69 0.75 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.27 1.828 . . . . 0.0 110.505 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -62.23 -40.21 95.38 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.054 -1.654 . . . . 0.0 113.799 -169.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -60.83 138.92 58.09 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -173.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 t -81.39 148.88 29.1 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.731 0.813 . . . . 0.0 110.624 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 36.4 t -55.35 131.85 46.68 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.605 0.762 . . . . 0.0 111.771 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.7 p30 -89.58 -10.82 44.64 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.697 1.199 . . . . 0.0 113.899 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.93 21.85 78.72 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 117.995 -1.447 . . . . 0.0 114.773 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -112.48 170.39 8.21 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.369 1.584 . . . . 0.0 113.141 169.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 5.5 t -71.1 133.4 46.23 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.586 1.554 . . . . 0.0 112.234 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -138.04 40.45 2.31 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.065 1.746 . . . . 0.0 112.996 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.73 125.35 42.5 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.933 1.693 . . . . 0.0 109.131 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -117.67 -84.66 0.64 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.998 0.919 . . . . 0.0 111.836 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -87.15 20.37 2.76 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.945 1.698 . . . . 0.0 113.39 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.18 -11.87 68.75 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.814 1.674 . . . . 0.0 113.641 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 97.3 mtp -91.14 144.88 25.17 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.64 1.22 . . . . 0.0 111.691 171.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -77.41 83.88 3.84 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.575 0.702 . . . . 0.0 109.231 169.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 42.3 tpt85 -56.02 -32.29 63.86 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.38 1.472 . . . . 0.0 112.942 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.7 m -73.58 -8.54 56.37 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 29.3 ttt85 -56.02 -27.97 55.35 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 121.337 1.881 . . . . 0.0 113.903 176.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.72 -18.39 73.98 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.241 -1.311 . . . . 0.0 114.601 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.265 57.8 tt0 -119.94 -80.03 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.144 0 CA-C-O 115.818 -2.039 . . . . 0.0 112.449 -170.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.88 165.74 24.96 Favored 'Trans proline' 0 C--N 1.36 1.132 0 CA-C-N 123.918 2.435 . . . . 0.0 113.937 170.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -92.4 -179.82 5.32 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -67.52 126.98 31.04 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 167.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -49.7 161.2 0.24 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.505 1.922 . . . . 0.0 115.425 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.1 p -82.84 157.78 23.0 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.099 -1.0 . . . . 0.0 112.141 169.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.05 -34.06 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.645 -1.284 . . . . 0.0 112.001 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.9 t -77.94 -24.5 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.507 0.723 . . . . 0.0 111.682 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -67.17 -34.35 77.36 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.351 -0.843 . . . . 0.0 110.944 172.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.31 -56.12 21.52 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.021 0.828 . . . . 0.0 109.542 168.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.0 -40.49 63.85 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.829 0.852 . . . . 0.0 112.625 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.4 t -62.07 -64.47 0.92 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.966 0.907 . . . . 0.0 112.245 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -73.63 -24.94 60.08 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.085 -1.634 . . . . 0.0 113.878 -169.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.4 mp -63.74 -41.42 98.04 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.269 0.941 . . . . 0.0 110.703 169.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.05 -36.88 61.8 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -69.19 -49.79 53.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.283 1.033 . . . . 0.0 110.493 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.456 HD22 HD21 ' A' ' 96' ' ' LEU . 4.7 m120 -77.42 -15.49 59.32 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.686 0.794 . . . . 0.0 111.278 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 66.96 60.21 0.53 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.189 1.796 . . . . 0.0 110.718 171.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.69 139.69 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.543 1.937 . . . . 0.0 107.988 172.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -107.9 106.16 57.91 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 119.951 1.251 . . . . 0.0 109.432 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.99 151.67 39.86 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.554 2.169 . . . . 0.0 114.005 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 82.5 mt -130.44 109.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.034 1.334 . . . . 0.0 107.801 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -78.89 80.9 5.21 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 122.093 0.949 . . . . 0.0 111.755 -175.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.8 104.81 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.992 0.917 . . . . 0.0 111.978 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.493 HG12 HG22 ' A' ' 112' ' ' THR . 3.0 m -142.61 167.67 15.59 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.078 -1.639 . . . . 0.0 112.064 -169.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -84.4 152.36 12.06 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.41 2.073 . . . . 0.0 110.951 -172.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.3 t -49.51 -43.84 45.81 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -169.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -56.8 -29.28 62.55 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -111.23 -8.2 14.39 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.633 1.973 . . . . 0.0 112.586 -170.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.2 t -54.27 -44.43 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 120.627 -1.296 . . . . 0.0 111.009 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -70.31 -6.08 32.5 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -170.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 18.4 m -87.12 -50.12 6.84 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.967 1.707 . . . . 0.0 110.19 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -73.56 -26.77 60.99 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.974 1.31 . . . . 0.0 110.307 -174.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . 0.353 7.1 pt-20 -65.73 -14.29 61.01 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.001 171.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . 0.379 0.0 OUTLIER -89.0 -22.91 22.76 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-N 120.551 1.523 . . . . 0.0 112.408 167.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.68 -19.78 60.73 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 119.682 -1.886 . . . . 0.0 110.176 169.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 98.7 m -80.28 -18.07 50.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.654 2.382 . . . . 0.0 111.949 169.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.73 -27.6 19.95 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.346 0.521 . . . . 0.0 110.38 169.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -80.26 -32.74 38.25 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 174.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.518 HG22 HD13 ' A' ' 189' ' ' LEU . 27.5 mt -110.21 101.31 47.49 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.46 150.84 64.59 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.857 2.371 . . . . 0.0 111.687 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt 86.36 -11.33 0.64 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 129.265 3.026 . . . . 0.0 113.084 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.518 HD13 HG22 ' A' ' 186' ' ' ILE . 10.2 mp -72.49 166.39 22.73 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.956 0.902 . . . . 0.0 109.817 172.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 69.7 p -125.24 -142.83 0.3 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.096 0.95 . . . . 0.0 109.856 170.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.2 tp -179.04 128.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 128.123 2.569 . . . . 0.0 108.482 -166.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -118.77 155.28 16.13 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . 0.276 11.2 pt-20 -105.2 94.61 5.33 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 122.903 1.335 . . . . 0.0 109.776 173.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 26.2 tp . . . . . 0 CA--C 1.54 0.595 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.981 169.543 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.1 p . . . . . 0 CA--C 1.545 0.783 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.95 108.41 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 121.993 0.901 . . . . 0.0 111.847 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -87.39 114.97 24.48 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 7' ' ' TYR . 1.3 tt -101.82 125.39 48.48 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.866 -0.521 . . . . 0.0 110.025 170.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.47 ' N ' HD23 ' A' ' 6' ' ' LEU . 26.9 t80 -117.42 109.37 16.7 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 123.531 1.634 . . . . 0.0 109.985 169.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -86.35 116.16 24.34 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.668 2.387 . . . . 0.0 112.444 -176.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.519 HD23 ' HB1' ' A' ' 88' ' ' ALA . 6.9 mp -99.25 124.34 44.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.378 1.071 . . . . 0.0 111.061 172.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.1 ttt -114.21 135.5 53.99 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.78 132.21 13.69 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 168.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 47' ' ' SER . 1.4 mp -115.1 15.07 17.16 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.498 1.519 . . . . 0.0 114.197 -170.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.477 0.917 0 O-C-N 121.031 -1.043 . . . . 0.0 112.705 177.946 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.4 p . . . . . 0 CA--C 1.546 0.794 0 CA-C-O 122.794 1.283 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.9 90.47 0.16 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 106.596 -2.602 . . . . 0.0 106.596 -175.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -78.88 145.66 34.03 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.75 0.82 . . . . 0.0 109.435 -169.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.52 132.61 70.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 124.944 1.298 . . . . 0.0 109.342 -172.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.85 156.98 26.99 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.998 1.761 . . . . 0.0 111.687 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -143.31 136.73 28.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -169.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.35 155.34 23.43 Favored Glycine 0 C--N 1.345 1.033 0 C-N-CA 124.558 1.075 . . . . 0.0 111.194 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.438 ' HB2' HD22 ' A' ' 12' ' ' LEU . 89.3 p -124.66 146.35 49.17 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.842 0.857 . . . . 0.0 111.975 -174.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.584 HG21 ' HB2' ' A' ' 88' ' ' ALA . 1.2 pp -145.42 151.95 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 173.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.0 t -142.86 -126.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 102.6 -3.111 . . . . 0.0 102.6 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -123.69 -0.6 8.57 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 120.406 1.457 . . . . 0.0 109.761 167.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.2 mmt -60.37 -39.08 85.94 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.75 1.62 . . . . 0.0 109.927 169.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.45 ' HB ' ' HD2' ' A' ' 145' ' ' ARG . 5.4 t 147.74 176.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.345 1 C-N-CA 132.399 4.28 . . . . 0.0 112.145 169.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -79.85 130.67 35.5 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.519 1.928 . . . . 0.0 109.327 169.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -123.66 128.97 50.42 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.282 1.039 . . . . 0.0 108.714 169.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -92.35 91.67 7.78 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.734 2.014 . . . . 0.0 111.229 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 mp -77.26 -59.87 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.45 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.4 tp -121.15 124.61 45.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.141 0.882 . . . . 0.0 112.114 -172.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.55 161.17 17.9 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 175.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.5 mt -56.29 109.01 0.53 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.129 1.772 . . . . 0.0 111.745 -171.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.6 t . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 125.549 1.54 . . . . 0.0 111.506 -177.447 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.7 t -120.54 -175.17 2.96 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.101 1.76 . . . . 0.0 111.756 171.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -148.46 157.28 27.24 Favored Glycine 0 N--CA 1.474 1.225 0 O-C-N 120.477 -1.389 . . . . 0.0 113.998 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -158.2 167.79 28.82 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.927 1.291 . . . . 0.0 114.232 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -77.57 -62.06 1.79 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.631 1.573 . . . . 0.0 112.952 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.77 151.96 43.89 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.814 0.846 . . . . 0.0 111.673 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.296 5.3 t -82.76 -41.41 0.88 Allowed Pre-proline 0 N--CA 1.479 1.005 0 CA-C-O 116.249 -1.834 . . . . 0.0 115.233 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.23 146.93 77.59 Favored 'Trans proline' 0 C--N 1.359 1.101 0 CA-C-N 123.04 2.121 . . . . 0.0 113.058 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -101.39 152.34 20.84 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.953 1.701 . . . . 0.0 113.637 -170.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.85 56.74 4.55 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 125.72 1.629 . . . . 0.0 111.662 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -84.11 -36.98 22.57 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.539 1.536 . . . . 0.0 113.327 -169.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.41 -36.84 83.83 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 122.153 -0.342 . . . . 0.0 110.852 -169.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -49.7 -41.79 44.18 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.196 1.398 . . . . 0.0 111.732 169.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.584 ' HB2' HG21 ' A' ' 48' ' ' ILE . . . -69.18 -52.38 28.59 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.055 -1.028 . . . . 0.0 111.498 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.4 m -59.68 -33.17 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.756 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.588 ' CG1' HD22 ' A' ' 156' ' ' LEU . 25.3 m -75.6 -51.68 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 117.215 -1.374 . . . . 0.0 112.624 173.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -55.74 -46.87 77.72 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 121.295 1.861 . . . . 0.0 110.175 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.6 t -59.66 -36.13 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.76 -43.37 79.99 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.986 -1.071 . . . . 0.0 112.629 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 90' ' ' VAL . 3.8 mp -78.85 -42.3 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -172.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . 0.26 21.8 p -83.79 66.48 9.1 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 121.222 1.828 . . . . 0.0 113.516 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.6 mt -43.42 -40.42 3.74 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.63 2.372 . . . . 0.0 111.583 169.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.11 -30.7 56.85 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.647 1.118 . . . . 0.0 114.794 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -104.59 -34.02 8.33 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 117.725 -1.131 . . . . 0.0 113.685 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.1 mm -64.07 -34.83 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 120.874 1.67 . . . . 0.0 110.408 169.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.59 18.31 38.77 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 117.907 -1.496 . . . . 0.0 114.126 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -54.06 147.28 12.93 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.343 1.572 . . . . 0.0 112.979 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . 0.272 0.0 OUTLIER -143.07 172.12 13.14 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.654 1.182 . . . . 0.0 114.015 172.085 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -58.54 24.35 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 121.39 3.848 . . . . 0.0 121.39 -168.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.16 -118.82 1.22 Allowed Glycine 0 CA--C 1.535 1.332 0 CA-C-N 120.912 1.687 . . . . 0.0 109.594 170.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.0 t -130.09 148.77 51.98 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 168.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -123.78 123.42 40.44 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 119.158 -0.449 . . . . 0.0 111.988 -166.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -115.32 103.49 10.86 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -170.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.0 tp -88.62 85.92 6.9 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.779 1.232 . . . . 0.0 109.527 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 66.7 t -77.28 136.85 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.3 tt -127.96 126.27 41.1 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.963 1.256 . . . . 0.0 111.541 169.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.1 t -95.46 128.01 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 126.216 1.806 . . . . 0.0 110.875 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.6 t -156.55 158.26 36.82 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.964 0.506 . . . . 0.0 110.989 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.87 0.59 11.41 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -141.44 -178.9 5.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.678 1.191 . . . . 0.0 111.867 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.95 -168.02 0.18 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.312 1.445 . . . . 0.0 112.137 -175.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.502 ' CE1' HD11 ' A' ' 182' ' ' LEU . 17.6 p90 -145.5 146.11 31.33 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 120.622 -1.298 . . . . 0.0 111.792 -169.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -80.23 130.02 34.91 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.826 169.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 pp -111.62 174.05 6.06 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.349 1.46 . . . . 0.0 111.344 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.33 130.16 30.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.5 mttm 93.91 -10.85 0.14 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.407 3.083 . . . . 0.0 112.003 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -67.75 -23.89 65.29 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 120.157 1.344 . . . . 0.0 112.706 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -74.65 -11.32 60.16 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.007 -1.058 . . . . 0.0 113.841 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.28 1.1 t -72.15 -21.51 61.44 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 120.458 1.481 . . . . 0.0 113.727 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.96 -37.72 84.79 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.735 1.152 . . . . 0.0 109.689 169.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.31 6.5 15.21 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.071 1.32 . . . . 0.0 113.158 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.277 52.8 m 70.06 37.8 1.64 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.309 2.244 . . . . 0.0 111.463 171.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -121.55 118.5 29.42 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.412 1.085 . . . . 0.0 111.076 169.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -105.12 -26.16 12.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.882 1.273 . . . . 0.0 112.896 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -61.35 116.18 4.44 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.067 0.849 . . . . 0.0 110.29 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 t -65.7 158.4 27.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.664 0.665 . . . . 0.0 110.003 173.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.1 t -67.44 144.61 55.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 122.043 0.925 . . . . 0.0 111.614 174.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.8 p30 -82.56 -10.75 58.85 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.054 1.342 . . . . 0.0 113.193 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.41 26.51 74.05 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.023 -0.876 . . . . 0.0 112.877 -175.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -103.29 172.92 6.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.026 1.73 . . . . 0.0 110.343 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 7.2 t -92.21 148.78 21.89 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.51 -0.744 . . . . 0.0 112.083 170.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -134.62 33.13 3.26 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.705 2.002 . . . . 0.0 112.063 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.75 161.06 13.84 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.197 0.999 . . . . 0.0 111.819 174.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -170.94 -45.26 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.571 1.948 . . . . 0.0 111.016 172.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -80.45 4.79 17.04 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.235 1.414 . . . . 0.0 112.771 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 82.73 -11.21 53.92 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.893 1.711 . . . . 0.0 112.547 -169.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.3 mtt -90.67 143.83 26.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.176 1.39 . . . . 0.0 111.118 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -74.05 95.63 2.56 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 169.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -64.09 -33.43 75.76 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.668 1.187 . . . . 0.0 113.25 -172.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.41 ' HB2' ' HD2' ' A' ' 148' ' ' PRO . 19.2 p -81.91 4.66 21.67 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -174.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.45 ' HD2' ' HB ' ' A' ' 52' ' ' THR . 40.0 ptt85 -37.87 -35.79 0.16 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.799 2.04 . . . . 0.0 115.219 169.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.69 30.07 6.85 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 127.962 2.696 . . . . 0.0 112.521 -172.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.266 43.2 tt0 -139.75 -79.3 0.01 OUTLIER Pre-proline 0 CA--C 1.559 1.293 0 CA-C-O 115.724 -2.084 . . . . 0.0 109.593 169.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 144' ' ' SER . 33.4 Cg_exo -54.18 150.4 32.43 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.574 2.85 . . . . 0.0 117.02 169.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.18 162.52 25.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 128.315 2.646 . . . . 0.0 109.316 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -55.2 140.67 37.94 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.177 -0.952 . . . . 0.0 109.729 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.09 156.91 24.31 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.667 -1.271 . . . . 0.0 112.189 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 27.2 t -81.47 154.9 26.1 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -173.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 20.2 t -59.27 -30.59 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.216 1.006 . . . . 0.0 111.652 -171.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.5 p -66.62 -37.04 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.607 1.163 . . . . 0.0 113.433 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -72.82 -32.58 65.61 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.487 -0.758 . . . . 0.0 110.495 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.588 HD22 ' CG1' ' A' ' 90' ' ' VAL . 1.1 mt -65.33 -46.54 79.86 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -54.54 -44.78 73.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.104 0.962 . . . . 0.0 112.607 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.8 m -59.43 -53.05 62.57 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.688 0.795 . . . . 0.0 112.119 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -64.57 -43.38 94.06 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.166 -0.959 . . . . 0.0 111.81 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.65 -38.63 81.96 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.178 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.54 -36.18 65.64 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -71.72 -42.33 67.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.869 0.868 . . . . 0.0 111.643 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -80.51 -9.17 59.78 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.615 0.766 . . . . 0.0 112.412 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . 0.402 15.7 p-10 42.02 52.66 4.32 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.831 2.452 . . . . 0.0 113.245 -174.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 79.4 mt -100.49 133.67 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.334 1.854 . . . . 0.0 109.07 174.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -104.33 108.29 59.96 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-N 119.257 0.935 . . . . 0.0 112.362 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.85 140.94 52.28 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.476 2.784 . . . . 0.0 115.754 169.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.1 mm -121.56 100.59 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.519 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -74.06 75.26 1.73 Allowed 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.904 -1.122 . . . . 0.0 112.168 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . 0.255 13.4 m -76.18 110.6 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 120.762 -1.211 . . . . 0.0 112.486 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.23 141.88 17.66 Favored Pre-proline 0 N--CA 1.478 0.97 0 O-C-N 120.997 -1.065 . . . . 0.0 112.389 -171.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -51.32 150.83 14.17 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.43 3.42 . . . . 0.0 115.837 169.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.3 t -47.63 -44.87 27.23 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.374 1.87 . . . . 0.0 113.546 -169.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.8 mtp-105 -42.88 -38.56 2.22 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.614 1.565 . . . . 0.0 113.428 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.51 0.6 16.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.895 1.678 . . . . 0.0 113.322 -170.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 37.5 t -62.6 -38.97 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.615 -1.303 . . . . 0.0 111.141 -175.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -65.23 -27.19 68.49 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.077 0.853 . . . . 0.0 113.025 -174.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.7 t -84.47 -39.94 18.3 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.784 0.434 . . . . 0.0 111.009 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.413 ' CD1' HD12 ' A' ' 182' ' ' LEU . 45.1 m-85 -69.46 -30.32 68.19 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.805 -1.184 . . . . 0.0 110.764 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -60.84 -33.05 72.45 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.158 0.436 . . . . 0.0 110.508 169.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . 0.362 0.0 OUTLIER -87.81 -18.17 29.92 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 119.07 0.85 . . . . 0.0 112.244 -178.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.502 HD11 ' CE1' ' A' ' 116' ' ' PHE . 20.1 mt -72.92 -25.44 61.05 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.528 -1.357 . . . . 0.0 109.812 169.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.45 -10.28 59.28 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.299 1.84 . . . . 0.0 111.518 173.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 90.9 m -89.15 -32.62 17.39 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.363 1.065 . . . . 0.0 109.364 169.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -76.79 -30.11 56.33 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 118.906 -0.568 . . . . 0.0 112.484 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 20.2 mt -118.86 109.66 39.31 Favored Pre-proline 0 N--CA 1.484 1.24 0 CA-C-N 119.114 0.87 . . . . 0.0 110.685 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -55.62 143.21 80.2 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.394 3.396 . . . . 0.0 114.225 174.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt 79.66 -8.35 1.58 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 128.755 2.822 . . . . 0.0 113.452 170.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 10.6 mt -72.9 153.78 40.86 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.286 -0.883 . . . . 0.0 109.954 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.7 p -116.89 -149.04 0.44 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 123.333 1.54 . . . . 0.0 109.432 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.1 tp -177.64 131.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 C-N-CA 127.043 2.137 . . . . 0.0 108.223 -165.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -123.73 150.67 16.96 Favored Glycine 0 N--CA 1.465 0.624 0 C-N-CA 124.37 0.986 . . . . 0.0 110.66 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -94.6 85.1 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.5 tp . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 169.504 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 CA--C 1.543 0.693 0 CA-C-O 119.371 -0.347 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.2 t -128.99 118.7 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-O 121.797 0.808 . . . . 0.0 111.785 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -87.12 127.87 35.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.978 0.911 . . . . 0.0 109.188 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mp -123.44 135.63 54.19 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -117.4 113.29 21.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 123.108 1.432 . . . . 0.0 109.078 172.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -87.46 103.29 15.37 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 126.107 1.763 . . . . 0.0 111.166 174.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.0 tp -102.22 121.59 42.55 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.674 1.19 . . . . 0.0 110.284 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.09 157.89 24.04 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 170.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.02 132.95 11.44 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.409 1.957 . . . . 0.0 110.56 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.15 23.36 13.4 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.612 1.565 . . . . 0.0 114.192 -171.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.7 p . . . . . 0 N--CA 1.479 1.016 0 O-C-N 119.42 -2.05 . . . . 0.0 114.454 -174.817 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.544 0.726 0 CA-C-O 122.957 1.361 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.53 88.02 0.21 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 106.731 -2.548 . . . . 0.0 106.731 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -98.62 137.69 36.9 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.271 1.028 . . . . 0.0 109.757 -169.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.8 tt -116.93 146.13 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.01 -170.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.77 165.12 19.08 Favored Glycine 0 N--CA 1.464 0.519 0 C-N-CA 125.524 1.535 . . . . 0.0 110.575 171.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -139.76 128.22 22.86 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.863 0.865 . . . . 0.0 113.168 -169.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.35 147.12 19.05 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 123.639 0.638 . . . . 0.0 112.229 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.8 t -114.49 148.25 38.15 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.618 1.567 . . . . 0.0 110.517 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.75 152.27 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.905 1.282 . . . . 0.0 109.462 171.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.7 t -138.0 -70.83 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.779 0.831 . . . . 0.0 108.784 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 t30 174.95 -15.75 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 131.0 3.72 . . . . 0.0 108.622 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.5 ttt -58.58 -60.19 4.21 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.87 1.668 . . . . 0.0 107.111 167.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.412 ' HA ' ' HD2' ' A' ' 145' ' ' ARG 0.302 0.5 OUTLIER -173.87 169.26 4.15 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.264 2.226 . . . . 0.0 114.534 168.928 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -84.09 120.83 26.62 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 169.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -115.77 117.11 29.33 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 122.234 1.016 . . . . 0.0 110.279 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -74.67 110.56 9.06 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.751 1.62 . . . . 0.0 109.95 170.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.3 mt -94.63 -61.33 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.385 0.674 . . . . 0.0 110.392 -173.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.9 tp -124.99 124.74 42.64 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.034 0.934 . . . . 0.0 110.177 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 166.68 13.46 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.655 -0.653 . . . . 0.0 112.691 169.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 83.9 mt -58.15 116.05 3.31 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.74 -0.6 . . . . 0.0 111.136 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 36.8 p . . . . . 0 N--CA 1.48 1.074 0 C-N-CA 125.362 1.465 . . . . 0.0 112.244 -179.818 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.6 p -107.78 -143.78 0.38 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.079 1.352 . . . . 0.0 110.694 169.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.34 143.64 8.83 Favored Glycine 0 N--CA 1.472 1.046 0 O-C-N 120.376 -1.453 . . . . 0.0 114.622 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -160.44 150.47 17.95 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.037 1.735 . . . . 0.0 111.462 170.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.0 tp -73.68 -48.56 31.3 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -169.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.71 119.11 8.65 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 122.945 0.498 . . . . 0.0 109.926 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.9 p -71.16 -35.17 3.85 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 115.686 -2.102 . . . . 0.0 113.976 -174.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -66.0 144.9 77.96 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.375 2.05 . . . . 0.0 110.665 169.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -119.4 161.12 21.04 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -171.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.67 45.03 3.19 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 125.184 1.374 . . . . 0.0 115.598 -169.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -36.96 85.85 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.431 1.892 . . . . 0.0 114.038 -173.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.47 -33.91 76.6 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.547 0.612 . . . . 0.0 111.228 -169.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -58.02 -47.46 83.0 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.347 1.459 . . . . 0.0 111.684 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.86 -56.75 16.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.619 -1.181 . . . . 0.0 109.708 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.294 1.5 p -59.33 -36.83 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-O 117.765 -1.112 . . . . 0.0 113.366 -174.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.505 HG21 ' HG3' ' A' ' 151' ' ' GLN . 38.0 t -74.17 -38.96 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 121.396 1.907 . . . . 0.0 113.572 175.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -63.91 -40.52 96.69 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.719 1.6 . . . . 0.0 110.344 171.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.603 HG11 HD13 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -49.38 -35.51 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.291 1.037 . . . . 0.0 112.638 169.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.16 -48.21 13.52 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.9 tt -100.42 -4.63 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -171.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 72.2 m -82.5 58.34 4.11 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 119.8 -1.812 . . . . 0.0 110.483 170.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.46 -44.43 55.67 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.235 1.814 . . . . 0.0 111.262 -174.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.62 -24.98 55.05 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.141 -0.811 . . . . 0.0 114.74 -169.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -90.95 -40.59 11.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.267 1.034 . . . . 0.0 111.529 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.9 -38.48 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 118.941 0.791 . . . . 0.0 110.677 171.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.36 27.7 19.54 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.738 -1.034 . . . . 0.0 114.099 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -54.01 125.75 19.99 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.769 1.285 . . . . 0.0 111.63 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -105.06 -170.34 1.74 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.754 2.022 . . . . 0.0 112.059 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -75.13 0.23 16.93 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 118.948 2.944 . . . . 0.0 118.948 -168.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.68 -130.77 3.31 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 121.833 2.106 . . . . 0.0 112.06 -174.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.8 m -100.55 145.8 27.89 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.415 1.886 . . . . 0.0 106.93 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -135.69 128.13 30.43 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 121.395 1.907 . . . . 0.0 108.581 -168.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -133.21 115.73 15.35 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.603 HD13 HG11 ' A' ' 92' ' ' VAL . 47.7 tp -91.2 109.94 21.21 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.975 169.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.63 116.42 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 168.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.7 tp -95.13 134.49 37.79 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 117.276 -1.345 . . . . 0.0 108.094 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.42 124.99 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 O-C-N 123.895 0.747 . . . . 0.0 111.607 168.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.0 t -160.48 141.69 12.13 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.678 0.791 . . . . 0.0 113.067 172.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -103.74 24.41 11.25 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.94 2.096 . . . . 0.0 114.888 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -152.35 -175.69 5.38 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.144 -0.972 . . . . 0.0 112.176 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.51 -175.84 0.41 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.3 1.44 . . . . 0.0 110.806 169.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -137.15 153.84 50.38 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.664 1.185 . . . . 0.0 111.664 -170.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -83.45 132.31 34.97 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.032 0.533 . . . . 0.0 110.817 169.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 pp -117.45 173.94 6.42 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.436 1.494 . . . . 0.0 112.532 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.72 124.99 18.17 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.42 98.7 mttt 80.23 1.84 1.97 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.349 2.259 . . . . 0.0 115.039 -175.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -70.78 -15.24 62.65 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 120.848 -1.157 . . . . 0.0 108.657 166.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.556 ' HE2' ' CG ' ' A' ' 127' ' ' ARG . 4.9 ptmt -57.46 -29.47 64.25 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 173.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.5 m -60.74 -26.4 67.17 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 118.162 2.653 . . . . 0.0 118.162 -167.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.492 HD13 ' H ' ' A' ' 124' ' ' LEU 0.329 0.0 OUTLIER -69.75 -13.08 62.11 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.894 1.679 . . . . 0.0 113.273 170.607 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -105.9 150.12 16.84 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 167.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.5 p -75.98 81.89 2.86 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.26 1.53 . . . . 0.0 112.601 -171.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.556 ' CG ' ' HE2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -163.3 125.19 2.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.172 1.789 . . . . 0.0 110.475 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -119.56 -25.82 5.9 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.579 1.151 . . . . 0.0 113.088 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -51.56 107.23 0.18 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.673 1.589 . . . . 0.0 113.008 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.8 t -68.95 150.83 47.28 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.594 1.088 . . . . 0.0 110.952 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.1 m -55.19 131.7 45.91 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.695 1.198 . . . . 0.0 113.101 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.5 p30 -81.58 -15.28 55.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.338 0.655 . . . . 0.0 112.541 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.94 14.6 81.55 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.903 -1.498 . . . . 0.0 114.26 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -93.16 163.47 13.62 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.872 1.669 . . . . 0.0 112.384 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 20.0 t -62.89 130.85 46.62 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.793 0.837 . . . . 0.0 111.655 172.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -135.75 41.44 2.71 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.745 1.618 . . . . 0.0 112.164 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.1 tp -124.16 140.71 52.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.426 1.491 . . . . 0.0 110.943 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -150.51 -62.1 0.2 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.254 1.021 . . . . 0.0 111.286 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -70.24 -21.81 62.95 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 121.35 -19.4 8.64 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.722 1.629 . . . . 0.0 112.409 -169.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 94.7 mtp -98.31 140.52 32.46 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.628 1.571 . . . . 0.0 112.507 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -77.35 83.04 3.8 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.877 0.871 . . . . 0.0 110.456 169.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -64.36 -30.74 71.78 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.112 -0.993 . . . . 0.0 112.236 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 35.5 m -65.89 -2.12 3.57 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 175.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.412 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 40.2 ttt85 -52.37 -37.75 57.04 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.213 -1.554 . . . . 0.0 114.251 172.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.71 -22.24 77.4 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.694 -1.059 . . . . 0.0 114.412 -175.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.317 1.2 pt-20 -112.68 -68.43 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.198 0 CA-C-O 117.133 -1.413 . . . . 0.0 112.059 -173.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -55.36 173.0 0.36 Allowed 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 123.399 2.732 . . . . 0.0 117.265 168.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.415 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 45.4 t0 -100.46 171.51 7.7 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 127.914 2.486 . . . . 0.0 114.048 -173.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -73.7 120.93 19.98 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 166.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.505 ' HG3' HG21 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -70.78 144.26 50.92 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 120.932 -1.105 . . . . 0.0 110.644 -169.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 39.8 m -68.02 153.92 42.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.468 0.707 . . . . 0.0 111.737 -174.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 82.2 t -60.68 -27.64 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 120.542 -1.349 . . . . 0.0 112.794 -171.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.6 t -81.48 -27.35 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 121.323 -0.861 . . . . 0.0 112.801 171.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -67.0 -38.22 85.59 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.298 0.954 . . . . 0.0 110.253 170.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.467 HD13 HG23 ' A' ' 90' ' ' VAL . 3.6 mm? -55.56 -61.41 2.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.751 0.705 . . . . 0.0 109.19 169.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.75 -48.08 70.04 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.306 1.042 . . . . 0.0 113.569 -170.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 64.7 m -63.82 -45.35 90.01 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -64.14 -47.64 79.14 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.399 -0.813 . . . . 0.0 111.155 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.4 mt -55.58 -40.51 72.08 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.827 0.851 . . . . 0.0 112.68 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.24 -33.26 56.07 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -80.52 -25.55 38.64 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.477 1.035 . . . . 0.0 112.002 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -80.49 -13.91 58.71 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.482 0.713 . . . . 0.0 110.758 168.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 33.4 m120 60.3 36.32 20.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.215 1.806 . . . . 0.0 112.848 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 67.1 mt -95.61 145.13 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.264 1.026 . . . . 0.0 108.929 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -105.13 102.72 37.97 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -77.46 156.29 32.42 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.139 1.226 . . . . 0.0 113.267 169.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.458 HG22 HG23 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -141.42 105.93 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.568 1.547 . . . . 0.0 109.522 -169.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -75.1 73.83 2.26 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.729 -1.232 . . . . 0.0 112.756 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.458 HG23 HG22 ' A' ' 168' ' ' ILE . 76.5 t -66.6 108.87 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 O-C-N 121.235 -0.915 . . . . 0.0 111.233 169.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 34.5 m -146.62 146.64 27.57 Favored Pre-proline 0 N--CA 1.482 1.126 0 O-C-N 120.592 -1.317 . . . . 0.0 112.314 -174.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -67.57 159.75 51.13 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.844 3.03 . . . . 0.0 112.801 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.5 t -41.2 -54.14 2.99 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.453 1.901 . . . . 0.0 114.437 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -57.17 -33.2 67.21 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.69 -17.17 32.37 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.911 1.285 . . . . 0.0 113.966 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.4 t -55.73 -41.12 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 120.15 1.341 . . . . 0.0 112.113 -168.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -62.47 -37.59 86.56 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -172.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 9.6 t -84.27 -30.25 25.78 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.901 0.48 . . . . 0.0 111.3 -173.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -69.14 -32.9 72.58 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.639 -1.288 . . . . 0.0 109.211 169.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -68.37 -7.11 28.46 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.347 -0.845 . . . . 0.0 112.699 169.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -98.91 -6.59 28.59 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.04 -1.038 . . . . 0.0 112.403 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 6.2 mp -104.84 -15.37 15.21 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.546 1.538 . . . . 0.0 111.926 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 6.0 t -79.5 -23.2 43.14 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 118.995 0.816 . . . . 0.0 111.832 169.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 1.7 t -77.85 -23.41 48.93 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.676 -0.64 . . . . 0.0 110.559 172.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -82.45 -34.48 28.14 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 119.375 -0.345 . . . . 0.0 111.102 169.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 13.2 mt -117.66 80.88 14.1 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.985 0.914 . . . . 0.0 109.838 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -62.17 152.34 76.6 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.123 1.882 . . . . 0.0 110.561 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 91.26 -17.31 0.17 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 130.415 3.486 . . . . 0.0 112.505 -176.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.0 tt -74.98 155.62 37.17 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.028 1.331 . . . . 0.0 108.295 168.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.266 48.0 p -127.94 -164.08 1.33 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 169.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 10.8 mt -157.82 145.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 126.823 2.049 . . . . 0.0 109.697 -165.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -131.87 155.34 21.38 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 123.818 0.723 . . . . 0.0 112.284 170.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -85.24 98.74 10.67 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.427 ' HB2' HG12 ' A' ' 170' ' ' VAL . 18.2 tp . . . . . 0 CA--C 1.542 0.641 0 CA-C-N 113.422 -1.717 . . . . 0.0 107.896 168.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 p . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.4 t -133.26 149.21 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.513 1.125 . . . . 0.0 110.007 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -121.62 115.82 23.46 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.353 2.261 . . . . 0.0 109.088 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.51 126.14 53.23 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 120.933 -1.104 . . . . 0.0 111.252 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -112.02 111.98 23.28 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 123.162 1.458 . . . . 0.0 110.227 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -87.57 100.34 12.72 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 126.236 1.814 . . . . 0.0 112.3 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.6 tp -94.84 116.76 29.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.511 0.725 . . . . 0.0 111.104 171.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.407 ' HG3' ' CD2' ' A' ' 12' ' ' LEU . 28.4 ptm -114.99 144.26 43.88 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 175.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.89 123.8 6.33 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.96 1.267 . . . . 0.0 111.655 172.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.407 ' CD2' ' HG3' ' A' ' 10' ' ' MET . 4.0 mm? -107.06 43.7 1.14 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.97 1.708 . . . . 0.0 111.079 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 124.106 0.963 . . . . 0.0 112.178 169.861 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.619 0.723 . . . . 0.0 109.231 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.36 85.86 0.28 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 127.669 2.557 . . . . 0.0 107.925 -169.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -80.24 140.39 36.27 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -173.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.4 tp -120.76 136.49 57.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 123.431 0.692 . . . . 0.0 110.389 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.42 147.55 18.86 Favored Glycine 0 N--CA 1.466 0.689 0 C-N-CA 124.221 0.915 . . . . 0.0 110.971 169.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -102.24 164.34 11.74 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.06 147.8 12.74 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 120.713 -1.242 . . . . 0.0 111.718 169.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.5 p -128.33 149.74 50.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.413 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -145.72 151.72 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.923 0.889 . . . . 0.0 111.647 -175.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.423 HG13 ' H ' ' A' ' 50' ' ' ASN 0.273 3.0 p -152.92 -101.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 124.096 0.958 . . . . 0.0 110.362 169.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.423 ' H ' HG13 ' A' ' 49' ' ' VAL 0.301 37.1 t30 -136.4 -11.37 1.88 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.084 1.354 . . . . 0.0 109.811 168.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 92.1 mtp -87.28 48.49 1.66 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 102.233 -3.247 . . . . 0.0 102.233 163.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.467 2.1 m 16.23 -116.41 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.506 1 C-N-CA 135.787 5.635 . . . . 0.0 116.145 -167.036 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -113.39 137.97 50.76 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.176 1.39 . . . . 0.0 112.769 -168.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -124.34 122.91 38.99 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -85.6 118.34 25.05 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.087 0.555 . . . . 0.0 109.667 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -125.33 142.19 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 126.163 1.785 . . . . 0.0 107.352 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 39.38 95.63 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 128.963 2.905 . . . . 0.0 117.244 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 161.51 5.84 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.066 0.946 . . . . 0.0 113.101 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.66 124.31 14.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.505 1.122 . . . . 0.0 111.523 -170.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.48 1.038 0 C-N-CA 125.035 1.334 . . . . 0.0 112.089 -179.958 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.2 p -106.48 -128.55 0.26 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.382 1.473 . . . . 0.0 111.169 171.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 174.76 146.71 5.82 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.359 1.457 . . . . 0.0 113.706 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.58 164.06 32.23 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.098 1.359 . . . . 0.0 112.441 170.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.3 mt -72.23 -48.59 41.67 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -169.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.29 132.97 47.29 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.077 0.551 . . . . 0.0 110.988 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.269 3.7 t -72.58 -37.73 4.58 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-O 116.186 -1.864 . . . . 0.0 113.846 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -69.38 151.83 71.27 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 122.315 2.01 . . . . 0.0 111.269 171.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -122.63 164.29 18.48 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.503 1.121 . . . . 0.0 113.499 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.71 28.64 5.8 Favored Glycine 0 N--CA 1.474 1.211 0 O-C-N 120.369 -1.457 . . . . 0.0 115.663 -170.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -47.04 -40.95 15.89 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.282 1.541 . . . . 0.0 114.747 -168.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.414 HD13 ' CD2' ' A' ' 116' ' ' PHE 0.365 5.0 mp -76.88 -19.23 57.7 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 117.98 -1.01 . . . . 0.0 113.463 -172.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.23 -41.31 98.29 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 168.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.29 -54.53 23.69 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 117.133 -1.413 . . . . 0.0 110.668 169.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.5 m -56.76 -33.47 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 120.827 1.649 . . . . 0.0 112.85 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.541 HG22 HD11 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -68.3 -51.78 44.26 Favored 'Isoleucine or valine' 0 C--N 1.345 0.394 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.387 172.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -60.66 -41.21 94.58 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 120.246 1.385 . . . . 0.0 110.533 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.484 HG11 HD13 ' A' ' 108' ' ' LEU . 64.6 t -56.54 -35.52 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.767 1.227 . . . . 0.0 112.318 175.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.35 -36.34 29.77 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.541 HD11 HG22 ' A' ' 90' ' ' VAL . 7.5 mt -83.5 -30.36 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.838 1.199 . . . . 0.0 112.548 -173.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 88.6 m -83.82 53.69 2.65 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.147 1.379 . . . . 0.0 112.35 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -55.84 -34.2 65.21 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.43 1.092 . . . . 0.0 112.462 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.62 -33.24 48.01 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 119.275 -0.736 . . . . 0.0 114.705 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -95.59 -25.52 16.13 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.045 0.922 . . . . 0.0 112.633 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 92' ' ' VAL . 79.0 mt -82.83 -24.95 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.053 0.842 . . . . 0.0 111.179 169.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.53 24.11 61.33 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.087 -0.84 . . . . 0.0 113.807 171.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -57.87 124.91 20.83 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 118.309 1.055 . . . . 0.0 110.65 173.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -102.69 168.1 9.47 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.865 1.266 . . . . 0.0 111.224 171.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -84.28 54.97 3.15 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -172.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -94.39 -113.43 2.5 Favored Glycine 0 N--CA 1.474 1.213 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 169.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 m -127.41 136.55 51.99 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 128.005 2.522 . . . . 0.0 104.719 169.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.36 136.95 51.63 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 121.344 1.884 . . . . 0.0 110.439 -171.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -126.91 116.26 20.54 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 124.916 1.286 . . . . 0.0 112.761 -172.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.484 HD13 HG11 ' A' ' 92' ' ' VAL . 13.0 tp -94.53 103.2 15.16 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 171.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.68 123.39 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -113.16 128.3 56.44 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -173.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.885 HG12 HG22 ' A' ' 170' ' ' VAL . 4.5 m -133.12 129.14 56.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 124.656 1.223 . . . . 0.0 112.397 -177.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.3 t -155.37 170.97 20.68 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.869 1.268 . . . . 0.0 110.142 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -123.23 -1.3 8.71 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -139.49 175.51 9.5 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.682 -1.261 . . . . 0.0 112.419 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -58.16 -176.25 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.775 1.63 . . . . 0.0 112.39 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.414 ' CD2' HD13 ' A' ' 86' ' ' LEU . 13.0 p90 -138.01 163.17 32.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 123.086 1.422 . . . . 0.0 114.078 -169.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -78.9 112.15 15.79 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.73 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 mt -80.71 163.29 23.66 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.746 0.818 . . . . 0.0 110.56 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.71 132.72 49.83 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 168.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 90.79 -11.53 0.28 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 130.496 3.519 . . . . 0.0 114.579 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -28.13 69.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 122.186 2.266 . . . . 0.0 111.657 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.457 ' HE2' ' CD2' ' A' ' 150' ' ' TYR . 3.1 tppt? -64.4 -7.84 11.22 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.826 1.25 . . . . 0.0 113.038 -176.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.1 t -64.96 -24.34 67.49 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 120.863 -1.148 . . . . 0.0 112.351 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.78 -32.97 74.9 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.321 0.964 . . . . 0.0 112.147 172.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -86.65 4.55 86.12 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.014 1.293 . . . . 0.0 113.854 170.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.336 31.8 p 56.39 41.47 28.91 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 129.069 2.948 . . . . 0.0 114.811 -176.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.83 109.56 21.13 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.409 1.483 . . . . 0.0 108.557 169.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -94.07 -39.26 10.7 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -59.66 129.16 40.53 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.973 0.806 . . . . 0.0 111.666 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.8 t -64.83 163.39 14.33 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.169 0.988 . . . . 0.0 111.286 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.2 p -68.54 140.88 55.64 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.347 0.594 . . . . 0.0 112.087 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.0 p30 -88.93 -14.54 36.47 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.58 25.15 73.12 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.901 -0.944 . . . . 0.0 113.444 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.4 mtp-105 -106.19 166.61 10.39 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.615 1.566 . . . . 0.0 113.121 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 82.4 m -64.34 136.87 57.55 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.191 0.996 . . . . 0.0 111.245 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -142.37 33.85 1.49 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.239 1.416 . . . . 0.0 112.162 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.4 tp -102.81 140.57 36.9 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.637 1.975 . . . . 0.0 109.903 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -146.64 -64.91 0.29 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -87.29 3.23 47.56 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.986 1.315 . . . . 0.0 114.114 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.54 -12.63 43.02 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.857 1.694 . . . . 0.0 114.007 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.5 mtt -95.28 148.58 22.26 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.661 1.731 . . . . 0.0 111.681 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -73.63 90.06 1.77 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 168.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -55.8 -42.19 75.25 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.889 0.876 . . . . 0.0 112.541 -171.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 69.1 m -75.78 2.99 10.75 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -174.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -43.05 -32.87 0.74 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 171.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.94 8.51 63.33 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.502 2.001 . . . . 0.0 115.615 -174.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.265 32.3 tt0 -131.98 -60.13 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.978 0 CA-C-N 120.53 2.165 . . . . 0.0 114.055 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -70.52 146.09 54.52 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 CA-C-N 122.516 1.934 . . . . 0.0 113.029 169.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -65.41 165.52 11.8 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 129.136 2.974 . . . . 0.0 113.136 169.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.457 ' CD2' ' HE2' ' A' ' 122' ' ' LYS . 97.4 m-85 -62.27 155.28 25.24 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.389 1.09 . . . . 0.0 112.025 169.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -76.86 143.78 39.46 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.61 1.164 . . . . 0.0 110.172 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 44.2 p -73.01 153.79 40.76 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.982 0.42 . . . . 0.0 110.854 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.93 -26.09 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.386 1.075 . . . . 0.0 113.789 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.6 t -81.98 -37.19 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.107 1.363 . . . . 0.0 112.034 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -67.4 -33.3 74.91 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.124 0.875 . . . . 0.0 111.795 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.89 -56.11 17.73 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.656 0.662 . . . . 0.0 110.508 169.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -58.34 -34.47 70.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.966 0.906 . . . . 0.0 112.91 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.3 t -59.27 -65.51 0.66 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.867 0.867 . . . . 0.0 111.3 170.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -67.83 -27.62 66.87 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.187 -1.571 . . . . 0.0 113.853 -174.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -37.3 79.66 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.25 1.386 . . . . 0.0 111.751 169.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.38 -28.45 37.96 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -74.7 -39.85 61.7 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.004 0.82 . . . . 0.0 110.948 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -86.11 -13.67 46.51 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.752 1.221 . . . . 0.0 111.897 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 30.0 m120 58.46 39.92 24.59 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.907 2.083 . . . . 0.0 112.818 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.7 mt -90.99 138.22 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.824 1.65 . . . . 0.0 108.814 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -96.42 107.5 36.21 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 120.354 1.434 . . . . 0.0 110.235 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.77 149.68 43.32 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.126 1.884 . . . . 0.0 113.168 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 30.0 mt -140.97 105.82 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.638 0.775 . . . . 0.0 110.093 176.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.53 ' CD2' HD21 ' A' ' 189' ' ' LEU . 22.5 m-85 -75.82 64.22 1.77 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.425 1.09 . . . . 0.0 113.09 -177.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.885 HG22 HG12 ' A' ' 111' ' ' VAL 0.335 0.5 OUTLIER -60.32 114.01 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 119.952 -1.717 . . . . 0.0 113.38 169.917 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 35.5 m -151.63 150.47 26.55 Favored Pre-proline 0 N--CA 1.48 1.027 0 O-C-N 120.636 -1.29 . . . . 0.0 112.829 -172.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.41 157.18 59.42 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.325 3.35 . . . . 0.0 113.023 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.5 p -44.66 -51.39 9.22 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.828 2.051 . . . . 0.0 113.968 -170.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -52.21 -27.31 14.23 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -174.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 22.4 ptm -117.13 3.72 12.7 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.323 1.449 . . . . 0.0 114.831 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.11 -39.65 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 CA-C-N 119.994 1.27 . . . . 0.0 110.624 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -67.99 -26.73 66.06 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -170.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.7 -37.6 20.75 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.811 1.245 . . . . 0.0 110.417 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -73.2 -28.44 62.18 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.843 -1.16 . . . . 0.0 111.381 174.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . 0.314 15.0 pt-20 -77.38 0.21 23.28 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.722 1.146 . . . . 0.0 111.995 169.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -99.08 -10.33 22.72 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.201 -0.937 . . . . 0.0 111.349 168.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.86 -31.19 28.13 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.214 1.806 . . . . 0.0 108.551 169.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.2 t -77.89 -5.62 51.61 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.593 1.157 . . . . 0.0 113.387 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 7.5 t -100.91 -17.44 16.82 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.944 0.498 . . . . 0.0 110.336 168.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -82.63 -45.36 14.64 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.258 0.481 . . . . 0.0 111.499 169.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 4.0 mp -97.51 118.11 64.67 Favored Pre-proline 0 N--CA 1.475 0.793 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -76.46 143.64 24.82 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.441 2.094 . . . . 0.0 111.191 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 79.5 tttt 101.46 -22.95 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 130.253 3.421 . . . . 0.0 114.486 169.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.53 HD21 ' CD2' ' A' ' 169' ' ' PHE 0.364 0.0 OUTLIER -76.57 168.59 19.81 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 118.897 0.771 . . . . 0.0 111.74 -177.24 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.352 6.9 t -136.86 -163.3 1.4 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 122.983 1.373 . . . . 0.0 107.946 176.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 17.1 tt -157.56 136.98 3.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 126.427 1.891 . . . . 0.0 112.461 -166.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -119.53 155.72 16.02 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.627 0.632 . . . . 0.0 111.905 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -95.34 90.52 5.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 169.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.652 ' HB2' HG23 ' A' ' 170' ' ' VAL . 55.6 tp . . . . . 0 N--CA 1.468 0.454 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.975 169.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -112.46 137.83 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.645 1.578 . . . . 0.0 111.145 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -115.3 99.2 7.22 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 168.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -90.81 128.22 36.63 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.604 -0.685 . . . . 0.0 111.248 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.514 ' CD1' HG21 ' A' ' 92' ' ' VAL . 31.3 t80 -123.78 109.18 13.34 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 123.435 1.588 . . . . 0.0 111.767 172.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -85.63 101.46 12.74 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.261 2.224 . . . . 0.0 113.626 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.5 mt -93.47 119.44 32.56 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.8 ptm -117.75 145.15 44.68 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 169.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.58 136.21 24.38 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' A' ' 47' ' ' SER . 3.7 mp -109.05 16.27 22.7 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.47 1.508 . . . . 0.0 113.171 -176.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 CA--C 1.548 0.866 0 O-C-N 120.186 -1.571 . . . . 0.0 113.265 174.325 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.2 m . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.91 81.54 0.31 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 127.023 2.249 . . . . 0.0 108.501 -170.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -80.28 134.87 36.13 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.839 1.256 . . . . 0.0 107.743 -171.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.5 tp -119.61 142.64 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.161 0.585 . . . . 0.0 111.194 -172.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.89 160.26 29.89 Favored Glycine 0 N--CA 1.467 0.736 0 C-N-CA 125.171 1.367 . . . . 0.0 111.435 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -146.34 142.57 28.38 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -169.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.3 142.27 13.25 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.563 ' HB2' HD22 ' A' ' 12' ' ' LEU . 4.2 p -108.78 142.68 38.98 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.114 0.966 . . . . 0.0 110.615 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.566 HD13 ' HB2' ' A' ' 88' ' ' ALA 0.297 0.6 OUTLIER -152.26 137.87 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.943 1.461 . . . . 0.0 114.943 -176.487 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.05 -137.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 127.577 2.351 . . . . 0.0 105.719 172.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' A' ' 52' ' ' THR 0.301 10.1 m120 -98.01 -1.6 42.26 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.671 1.578 . . . . 0.0 111.992 168.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 62.9 mtt -85.6 40.93 0.87 Allowed 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 102.079 -3.304 . . . . 0.0 102.079 163.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.366 68.4 p 14.38 -113.51 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.94 1 C-N-CA 133.925 4.89 . . . . 0.0 113.946 -166.092 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -112.36 130.07 56.09 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 125.089 1.493 . . . . 0.0 111.893 -168.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -122.89 118.75 28.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 168.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -81.39 116.52 21.25 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.039 170.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 mm -89.87 -44.26 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 119.16 -0.448 . . . . 0.0 110.991 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.8 tp -151.53 123.9 8.32 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.793 0.806 . . . . 0.0 112.98 -172.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -54.97 149.34 11.88 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.599 1.96 . . . . 0.0 112.455 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.5 mt -51.15 112.97 0.81 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.048 1.339 . . . . 0.0 110.301 169.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.469 0.477 0 C-N-CA 124.173 0.989 . . . . 0.0 112.152 -173.836 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.5 m -131.75 -175.24 3.65 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.729 2.412 . . . . 0.0 110.417 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -137.0 166.77 24.84 Favored Glycine 0 N--CA 1.477 1.374 0 O-C-N 120.664 -1.272 . . . . 0.0 114.649 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -155.7 155.32 32.96 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.442 1.497 . . . . 0.0 113.069 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -56.28 -65.0 0.68 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.417 2.287 . . . . 0.0 111.296 168.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.48 145.17 41.62 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.131 0.972 . . . . 0.0 113.606 -172.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.9 m -70.68 -44.95 17.15 Favored Pre-proline 0 N--CA 1.474 0.761 0 CA-C-O 116.135 -1.888 . . . . 0.0 113.218 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -69.75 141.88 46.46 Favored 'Trans proline' 0 C--N 1.354 0.851 0 CA-C-N 122.225 1.83 . . . . 0.0 112.403 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -92.84 178.88 5.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.378 1.871 . . . . 0.0 112.773 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.43 22.41 26.72 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 125.912 1.72 . . . . 0.0 115.231 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . 0.268 2.8 tt0 -64.02 -29.67 70.8 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 119.353 3.094 . . . . 0.0 119.353 -168.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.534 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 6.3 mp -67.22 -20.47 65.69 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 122.255 2.298 . . . . 0.0 112.518 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -65.07 -35.13 80.18 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.651 1.114 . . . . 0.0 111.234 169.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB2' HD13 ' A' ' 48' ' ' ILE . . . -69.88 -42.04 73.97 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-O 117.086 -1.435 . . . . 0.0 110.041 168.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.292 2.1 m -61.99 -33.62 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 120.133 1.333 . . . . 0.0 112.764 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.7 p -68.8 -58.06 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 117.732 -1.128 . . . . 0.0 108.607 169.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -52.29 -53.41 44.41 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 121.184 1.811 . . . . 0.0 112.705 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.514 HG21 ' CD1' ' A' ' 7' ' ' TYR . 8.9 p -54.16 -41.6 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 119.51 1.05 . . . . 0.0 112.137 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.91 -19.25 61.3 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 159' ' ' LYS . 2.2 mp -106.06 -30.01 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 120.081 1.31 . . . . 0.0 113.22 -176.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 84.4 m -78.72 55.97 1.78 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.814 1.646 . . . . 0.0 111.215 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 72.7 mt -51.42 -44.12 62.18 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.148 2.179 . . . . 0.0 111.823 -171.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.3 -17.42 76.32 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.224 0.916 . . . . 0.0 114.264 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -90.76 -54.9 3.78 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.915 1.286 . . . . 0.0 110.19 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.32 -33.13 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 118.562 -0.733 . . . . 0.0 110.59 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.94 25.41 27.13 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.256 0.931 . . . . 0.0 113.432 174.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -57.27 123.95 17.16 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.172 0.986 . . . . 0.0 112.138 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.1 mtp-105 -97.27 -176.57 3.56 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.404 2.282 . . . . 0.0 110.668 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -100.77 39.13 1.41 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.078 1.351 . . . . 0.0 114.446 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -95.11 -122.47 3.83 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 169.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.1 t -113.06 143.62 44.02 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.721 1.608 . . . . 0.0 107.689 169.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -131.68 120.41 22.73 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.152 0.887 . . . . 0.0 110.117 -168.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.475 ' CE1' ' HG3' ' A' ' 166' ' ' GLN . 51.6 m-85 -120.89 105.64 10.88 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -169.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.41 99.71 12.2 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.5 t -81.06 127.51 39.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.6 tt -110.47 132.43 54.19 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.4 t -119.41 121.88 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.939 0.896 . . . . 0.0 109.944 169.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.3 p -138.97 168.59 19.49 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.599 1.56 . . . . 0.0 110.189 169.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.27 2.28 2.06 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 170.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -142.25 161.22 38.57 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.962 1.705 . . . . 0.0 110.618 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -45.49 173.16 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 128.409 2.684 . . . . 0.0 117.586 -169.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.534 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 49.0 t80 -129.08 137.66 51.39 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.998 -1.064 . . . . 0.0 113.184 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -79.02 84.63 5.01 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 125.13 1.372 . . . . 0.0 112.216 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.59 HD13 ' H ' ' A' ' 118' ' ' LEU 0.387 0.0 OUTLIER -73.08 174.65 7.61 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 119.802 -1.811 . . . . 0.0 113.432 174.833 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.57 134.72 1.72 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 -169.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.311 60.8 mtpt 75.27 -2.25 2.87 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 131.308 3.843 . . . . 0.0 114.898 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.98 -21.18 66.8 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.609 1.095 . . . . 0.0 112.821 169.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.483 ' HE3' ' CZ ' ' A' ' 150' ' ' TYR . 61.5 mttt -69.72 -7.97 43.88 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.215 -1.553 . . . . 0.0 114.347 172.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.07 -15.55 63.79 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.196 1.362 . . . . 0.0 113.328 175.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -64.15 -21.54 66.59 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 118.802 0.728 . . . . 0.0 112.095 169.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -90.55 -128.32 3.81 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.72 1.629 . . . . 0.0 111.395 170.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.5 t -137.41 52.87 1.88 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.742 1.617 . . . . 0.0 110.132 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -133.7 88.64 2.5 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.854 1.661 . . . . 0.0 110.805 -169.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -102.73 -18.47 15.15 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -68.71 129.6 40.39 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.41 1.005 . . . . 0.0 110.832 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.0 t -69.36 161.38 29.48 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 118.822 0.737 . . . . 0.0 111.319 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.7 m -62.14 133.95 55.92 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.653 -0.654 . . . . 0.0 111.552 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -86.69 -12.58 47.93 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.66 23.99 73.67 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.276 -1.291 . . . . 0.0 114.184 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -103.32 165.13 11.22 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.144 1.472 . . . . 0.0 112.198 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 10.0 t -67.49 126.67 30.03 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.596 1.558 . . . . 0.0 109.382 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -127.34 55.86 1.57 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.637 1.575 . . . . 0.0 110.995 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.13 124.04 22.72 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.005 1.322 . . . . 0.0 109.774 -169.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -125.95 -58.45 1.38 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.34 1.056 . . . . 0.0 111.736 170.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -81.44 -21.38 38.88 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -174.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 121.91 -8.01 10.02 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.062 1.315 . . . . 0.0 114.513 -171.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 94.6 mtp -108.87 142.21 39.8 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.733 1.267 . . . . 0.0 111.364 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -67.69 83.16 0.18 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.272 1.029 . . . . 0.0 110.573 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -72.13 -15.43 61.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -169.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 86.6 p -78.07 -5.34 51.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.71 1.141 . . . . 0.0 113.223 170.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -41.68 -35.03 0.69 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.78 -5.03 81.92 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 117.517 -1.713 . . . . 0.0 114.989 -175.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -120.96 -70.71 0.02 OUTLIER Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 119.791 1.796 . . . . 0.0 112.643 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -61.08 147.18 96.42 Favored 'Trans proline' 0 C--N 1.355 0.891 0 CA-C-N 123.064 2.13 . . . . 0.0 114.919 171.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -62.05 174.87 0.78 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 130.248 3.419 . . . . 0.0 113.397 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.483 ' CZ ' ' HE3' ' A' ' 122' ' ' LYS . 59.5 m-85 -74.17 145.21 44.39 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.487 1.115 . . . . 0.0 112.435 172.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -67.86 131.59 45.81 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.534 0.683 . . . . 0.0 111.971 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 27.0 p -63.11 142.02 58.54 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.055 1.342 . . . . 0.0 113.396 170.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.85 -27.29 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 121.109 -0.994 . . . . 0.0 112.484 -174.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.3 t -65.38 -44.18 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 121.355 -0.84 . . . . 0.0 111.556 172.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -76.1 -20.69 57.43 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.688 -0.633 . . . . 0.0 112.062 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.29 -50.54 63.35 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.265 0.939 . . . . 0.0 108.658 168.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.49 -41.92 73.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.439 0.696 . . . . 0.0 112.615 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.8 p -68.75 -51.42 41.48 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.906 0.775 . . . . 0.0 112.416 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.492 ' HB3' HD11 ' A' ' 94' ' ' ILE . 5.5 mptp? -67.44 -38.31 84.32 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.533 -1.354 . . . . 0.0 113.242 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.414 HD23 ' HG3' ' A' ' 167' ' ' PRO . 10.9 mp -66.21 -35.05 79.41 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.364 -0.835 . . . . 0.0 111.582 176.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.71 -28.71 58.71 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 172.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.37 -49.25 64.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.117 1.367 . . . . 0.0 110.026 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -91.09 -0.13 57.66 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.733 0.813 . . . . 0.0 112.907 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.3 m120 47.03 59.61 3.92 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.908 2.083 . . . . 0.0 112.492 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.7 mm -95.71 129.36 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 169.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.475 ' HG3' ' CE1' ' A' ' 107' ' ' PHE 0.345 10.5 pt20 -98.71 110.65 57.99 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 123.3 2.773 . . . . 0.0 108.448 169.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.633 ' HG2' ' HG ' ' A' ' 189' ' ' LEU . 58.2 Cg_endo -70.89 145.44 50.65 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 124.564 3.509 . . . . 0.0 114.06 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 8.6 mm -127.29 98.69 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.509 1.524 . . . . 0.0 109.338 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -76.89 82.06 3.46 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.22 -1.55 . . . . 0.0 110.453 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.469 ' CG1' HD13 ' A' ' 194' ' ' LEU . 94.2 t -71.95 126.4 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 O-C-N 120.622 -1.299 . . . . 0.0 110.582 168.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 5.1 p -163.11 141.77 6.49 Favored Pre-proline 0 N--CA 1.483 1.221 0 CA-C-O 117.745 -1.122 . . . . 0.0 113.43 -169.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -63.75 157.48 51.74 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 125.033 3.822 . . . . 0.0 116.309 176.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 78.4 p -56.47 -27.0 55.77 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -169.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -56.77 -36.12 69.46 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.664 1.12 . . . . 0.0 112.701 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 52.6 ttp -116.91 -6.12 11.47 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 -169.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 51.6 t -53.99 -32.11 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.718 -1.239 . . . . 0.0 111.286 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -61.79 -34.92 76.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.912 1.285 . . . . 0.0 113.524 -175.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.8 t -92.6 -39.68 11.19 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.848 0.859 . . . . 0.0 110.397 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -69.12 -35.16 76.1 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.318 1.047 . . . . 0.0 110.084 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -68.96 -7.03 31.34 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.549 1.068 . . . . 0.0 112.667 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -99.11 -16.66 18.55 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.826 -1.171 . . . . 0.0 111.536 169.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.05 -21.78 46.33 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.697 -1.252 . . . . 0.0 109.557 169.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.504 HG22 HD22 ' A' ' 189' ' ' LEU . 67.3 p -79.61 -18.76 50.88 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.971 0.908 . . . . 0.0 112.919 172.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . 0.289 1.7 t -81.25 -17.46 49.39 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.365 0.529 . . . . 0.0 109.909 169.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -89.62 -26.23 20.88 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.826 0.451 . . . . 0.0 111.756 168.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.5 mm -111.86 85.63 6.54 Favored Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 124.984 1.313 . . . . 0.0 110.084 172.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.17 136.94 76.1 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.257 1.971 . . . . 0.0 111.517 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 87.71 -5.7 0.59 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 129.765 3.226 . . . . 0.0 114.335 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.633 ' HG ' ' HG2' ' A' ' 167' ' ' PRO . 3.8 tt -72.43 138.84 47.39 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.891 1.276 . . . . 0.0 108.319 169.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 41.5 p -116.92 -164.48 0.98 Allowed 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 120.349 1.431 . . . . 0.0 107.467 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.2 mt -164.53 153.43 2.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 126.052 1.741 . . . . 0.0 110.383 -167.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -140.33 141.22 11.25 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.799 168.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -80.2 82.28 6.29 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 123.628 1.68 . . . . 0.0 108.305 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.469 HD13 ' CG1' ' A' ' 170' ' ' VAL . 17.3 tp . . . . . 0 CA--C 1.541 0.626 0 CA-C-N 112.605 -2.089 . . . . 0.0 110.857 170.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.7 t -114.91 141.1 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.769 1.228 . . . . 0.0 110.052 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -114.25 115.74 27.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.551 1.14 . . . . 0.0 109.327 169.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 tp -100.08 129.91 46.17 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.662 0.665 . . . . 0.0 111.874 169.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -120.3 105.26 10.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 123.508 1.623 . . . . 0.0 109.564 169.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -84.0 105.84 15.19 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.54 -1.664 . . . . 0.0 111.286 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -103.3 108.5 19.75 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.726 1.21 . . . . 0.0 109.701 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.2 ptm -113.2 145.54 40.82 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.91 139.58 27.45 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.043 0.83 . . . . 0.0 111.511 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.446 HD13 ' HB2' ' A' ' 47' ' ' SER . 1.4 mp -112.18 25.75 11.25 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.494 1.917 . . . . 0.0 112.529 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.3 t . . . . . 0 CA--C 1.546 0.818 0 C-N-CA 123.544 0.737 . . . . 0.0 111.345 169.61 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 122.328 1.061 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.94 84.79 0.23 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 -170.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -74.96 146.03 42.07 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.5 tt -133.05 134.45 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.64 0.776 . . . . 0.0 110.585 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.56 152.58 21.66 Favored Glycine 0 N--CA 1.467 0.752 0 C-N-CA 125.907 1.718 . . . . 0.0 111.146 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -124.08 146.98 48.23 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.415 0.686 . . . . 0.0 111.557 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.24 154.14 25.72 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 170.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.446 ' HB2' HD13 ' A' ' 12' ' ' LEU . 93.6 p -135.24 159.17 42.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.357 1.075 . . . . 0.0 113.185 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.445 HG21 ' HG2' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -155.64 147.77 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 121.347 -0.846 . . . . 0.0 111.986 -169.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.411 ' N ' HD13 ' A' ' 48' ' ' ILE 0.306 12.0 p -154.29 -129.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 116.626 -1.654 . . . . 0.0 109.427 171.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -95.45 -20.86 18.72 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 123.43 2.832 . . . . 0.0 112.963 169.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 46.2 mtt -80.75 49.13 1.15 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 167.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.294 12.8 p 25.17 -120.66 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.518 1 C-N-CA 132.157 4.183 . . . . 0.0 114.381 -169.057 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -107.35 133.13 52.34 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 127.483 2.313 . . . . 0.0 112.503 -167.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.2 123.85 48.79 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 169.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -97.43 127.76 43.66 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.609 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -155.67 113.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.929 0.892 . . . . 0.0 109.525 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.9 tp 96.51 83.21 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.868 3.267 . . . . 0.0 107.875 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.15 155.14 21.34 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.797 0.808 . . . . 0.0 111.149 169.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . 0.26 2.2 tm? -54.54 105.03 0.13 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 128.02 2.528 . . . . 0.0 109.689 -170.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.487 1.411 0 C-N-CA 125.71 1.604 . . . . 0.0 112.635 -169.525 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 121.084 0.469 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.9 p -119.56 -157.91 0.72 Allowed 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.761 -0.587 . . . . 0.0 110.333 168.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.66 143.12 9.64 Favored Glycine 0 CA--C 1.524 0.609 0 O-C-N 121.154 -0.967 . . . . 0.0 112.202 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 149.45 28.12 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.659 1.583 . . . . 0.0 110.79 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.01 -57.23 4.18 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -168.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.73 136.76 58.09 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.657 0.662 . . . . 0.0 111.549 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.254 6.4 t -65.84 -39.12 28.34 Favored Pre-proline 0 N--CA 1.476 0.859 0 CA-C-O 116.321 -1.799 . . . . 0.0 114.599 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.71 143.29 50.6 Favored 'Trans proline' 0 C--N 1.359 1.084 0 CA-C-N 122.71 2.003 . . . . 0.0 111.665 173.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.557 ' H ' ' HD3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -114.15 162.29 16.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.125 1.77 . . . . 0.0 112.199 176.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.61 42.27 2.91 Favored Glycine 0 N--CA 1.479 1.525 0 C-N-CA 125.022 1.296 . . . . 0.0 115.264 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.445 ' HG2' HG21 ' A' ' 48' ' ' ILE . 22.5 mt-30 -60.74 -29.65 69.52 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.223 1.512 . . . . 0.0 112.891 -176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.405 HD11 ' CD1' ' A' ' 156' ' ' LEU . 15.5 tp -65.89 -32.86 74.61 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -169.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -59.7 -54.66 43.84 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.46 -52.31 64.07 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.636 0.774 . . . . 0.0 111.72 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.258 3.1 p -61.3 -36.44 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 119.592 1.087 . . . . 0.0 112.792 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.8 -35.76 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 120.607 1.548 . . . . 0.0 113.23 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -61.91 -46.42 89.44 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.055 1.298 . . . . 0.0 110.741 172.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.9 t -54.79 -36.73 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 122.84 0.456 . . . . 0.0 111.745 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.31 -30.81 62.23 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 20.7 tt -99.01 -25.59 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 61.2 m -82.91 61.31 5.88 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 120.459 1.481 . . . . 0.0 111.512 -171.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.3 mt -49.42 -45.58 46.48 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.909 2.884 . . . . 0.0 110.977 -171.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.59 -23.08 44.32 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 114.14 -1.391 . . . . 0.0 114.135 -173.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -84.66 -46.68 11.25 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.382 1.091 . . . . 0.0 110.938 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.0 mt -79.94 -25.01 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 118.054 -0.974 . . . . 0.0 111.474 177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.06 23.9 36.57 Favored Glycine 0 N--CA 1.471 0.992 0 CA-C-N 119.548 1.067 . . . . 0.0 115.306 169.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -52.62 122.43 8.98 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.92 1.288 . . . . 0.0 112.55 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -93.71 175.03 6.89 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.732 1.213 . . . . 0.0 111.131 170.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -90.49 27.95 1.59 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 116.288 1.958 . . . . 0.0 116.288 -168.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.34 -124.69 3.79 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 120.768 -1.207 . . . . 0.0 110.797 173.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.3 m -97.85 142.5 29.53 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.742 2.017 . . . . 0.0 107.58 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -142.85 119.47 11.08 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 121.076 1.762 . . . . 0.0 110.739 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -113.97 123.28 49.33 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 126.314 1.846 . . . . 0.0 112.99 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 tt -107.87 96.03 6.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 110.112 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 77.5 t -79.93 126.97 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.1 tp -114.25 116.01 28.33 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.66 130.7 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.448 ' O ' ' HD2' ' A' ' 172' ' ' PRO . 3.6 t -165.04 151.27 10.14 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 117.615 -1.183 . . . . 0.0 113.062 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -96.82 -13.64 22.43 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.565 1.946 . . . . 0.0 115.45 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -128.51 172.16 11.42 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.124 0.97 . . . . 0.0 113.371 -169.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.52 179.35 0.62 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.569 1.147 . . . . 0.0 111.603 169.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -128.4 156.46 43.13 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.034 -1.666 . . . . 0.0 113.437 -170.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -77.65 117.31 18.94 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.598 169.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.565 HD23 ' H ' ' A' ' 119' ' ' ALA . 2.8 tt -88.61 173.89 8.37 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.287 1.435 . . . . 0.0 110.015 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.565 ' H ' HD23 ' A' ' 118' ' ' LEU . . . -54.99 150.5 10.19 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.99 -1.069 . . . . 0.0 110.5 168.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt 74.06 -21.01 0.29 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.557 1.943 . . . . 0.0 114.826 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -54.01 -56.52 17.12 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.239 -1.538 . . . . 0.0 113.022 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.516 ' HE2' ' N ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -57.47 -6.83 0.51 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 119.341 3.089 . . . . 0.0 119.341 -177.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.378 0.5 OUTLIER -64.74 -20.26 66.25 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 122.328 2.331 . . . . 0.0 111.269 174.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -50.48 -44.46 55.87 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.298 1.839 . . . . 0.0 110.241 168.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -87.02 22.3 15.41 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.702 2.096 . . . . 0.0 114.503 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 56.3 m 73.22 20.57 3.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.65 1.98 . . . . 0.0 112.415 170.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 25.2 ttp-105 -116.25 112.59 21.83 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.571 1.548 . . . . 0.0 111.035 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -117.86 -33.76 4.39 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -170.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -63.62 118.21 7.9 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 120.329 1.422 . . . . 0.0 111.304 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.424 ' HA ' ' HB3' ' A' ' 149' ' ' ASP 0.261 3.0 t -67.96 166.36 15.93 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -171.466 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.8 p -60.85 129.11 39.8 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.708 0.803 . . . . 0.0 112.905 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.7 p30 -82.66 -13.68 56.01 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.458 0.703 . . . . 0.0 112.784 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.86 1.18 66.6 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.433 1.492 . . . . 0.0 114.377 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -79.57 165.69 22.68 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.728 1.611 . . . . 0.0 114.036 -169.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 31.3 t -74.1 126.77 31.27 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.809 0.843 . . . . 0.0 109.489 169.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -141.33 39.83 1.74 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.813 1.645 . . . . 0.0 111.739 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.3 mt -103.56 148.75 25.6 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.166 1.387 . . . . 0.0 109.091 172.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -143.15 -64.5 0.4 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.34 0.656 . . . . 0.0 112.182 175.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -92.11 15.79 12.69 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.387 1.475 . . . . 0.0 113.47 177.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.71 9.4 62.78 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.119 1.342 . . . . 0.0 114.526 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 59.5 ttm -117.61 146.68 43.49 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.115 1.366 . . . . 0.0 111.027 172.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.452 ' CE1' ' HB3' ' A' ' 144' ' ' SER . 50.7 t80 -74.35 87.63 2.02 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.877 0.871 . . . . 0.0 111.942 170.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 62.5 ttt-85 -50.62 -38.15 44.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.206 1.802 . . . . 0.0 112.582 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.452 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 4.0 t -64.12 -17.41 63.42 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.081 1.352 . . . . 0.0 114.632 -176.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -35.95 -50.85 0.7 Allowed 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 120.579 1.536 . . . . 0.0 114.107 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.09 -5.03 84.63 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.168 -1.351 . . . . 0.0 114.747 -172.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.327 3.0 pt-20 -129.09 -64.84 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 115.377 -2.249 . . . . 0.0 113.748 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -68.65 154.81 70.7 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 CA-C-N 124.627 2.688 . . . . 0.0 118.003 169.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.424 ' HB3' ' HA ' ' A' ' 130' ' ' THR 0.288 26.8 t0 -83.89 141.5 31.25 Favored 'General case' 0 CA--C 1.551 1.01 1 C-N-CA 133.082 4.553 . . . . 0.0 114.828 -176.598 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -50.67 113.99 1.04 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.416 -0.803 . . . . 0.0 111.21 168.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.624 ' CD ' ' H ' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -54.99 153.47 6.35 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 127.469 2.307 . . . . 0.0 114.849 -173.425 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 85.9 p -83.8 153.01 24.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.107 0.963 . . . . 0.0 112.898 -177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.9 m -55.06 -27.39 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.96 -44.6 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.957 0.903 . . . . 0.0 110.929 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -28.25 65.0 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.807 -0.616 . . . . 0.0 111.311 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 186' ' ' ILE . 3.8 mt -60.53 -52.55 64.69 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.883 0.765 . . . . 0.0 110.039 172.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.3 -45.53 84.08 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.431 1.092 . . . . 0.0 111.065 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.2 m -65.91 -47.18 75.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.49 0.716 . . . . 0.0 112.763 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -61.22 -42.55 98.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.066 1.303 . . . . 0.0 111.974 174.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.49 -44.67 81.98 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.158 0.983 . . . . 0.0 111.784 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.6 -24.77 62.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.413 1.085 . . . . 0.0 113.471 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -75.27 -43.56 50.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.7 0.8 . . . . 0.0 110.724 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -85.08 -13.85 49.05 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.78 39.43 20.77 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.332 1.453 . . . . 0.0 113.541 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.0 mt -82.71 149.4 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 169.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -107.39 111.34 63.11 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 120.152 1.342 . . . . 0.0 109.503 169.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 189' ' ' LEU . 17.3 Cg_exo -78.02 149.71 25.87 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.655 3.57 . . . . 0.0 113.346 174.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.474 HG22 HG23 ' A' ' 170' ' ' VAL . 3.9 mp -132.91 107.56 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.875 1.27 . . . . 0.0 109.274 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -74.89 71.29 2.01 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.94 -1.1 . . . . 0.0 112.748 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.474 HG23 HG22 ' A' ' 168' ' ' ILE . 95.7 t -75.31 103.39 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 120.421 -1.424 . . . . 0.0 111.742 175.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 22.8 m -145.27 147.73 35.13 Favored Pre-proline 0 N--CA 1.48 1.038 0 O-C-N 120.754 -1.216 . . . . 0.0 112.661 -169.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.448 ' HD2' ' O ' ' A' ' 112' ' ' THR . 60.2 Cg_exo -55.34 149.99 43.43 Favored 'Trans proline' 0 C--N 1.353 0.791 1 C-N-CA 125.808 4.339 . . . . 0.0 115.744 177.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 36.5 p -46.73 -49.59 19.35 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.746 2.019 . . . . 0.0 113.422 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -43.22 -32.61 0.79 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.607 2.363 . . . . 0.0 115.431 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.8 ptm -118.68 -2.77 10.9 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.6 1.56 . . . . 0.0 114.75 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.78 -29.85 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-N 120.277 1.399 . . . . 0.0 111.05 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -65.11 -21.06 66.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.208 1.003 . . . . 0.0 113.525 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.55 -39.43 11.92 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.161 0.984 . . . . 0.0 111.36 177.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -73.36 -28.87 62.27 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 120.826 -1.171 . . . . 0.0 110.471 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -58.08 -23.77 55.94 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.66 0.784 . . . . 0.0 110.819 168.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -87.52 -29.54 21.26 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.517 -0.74 . . . . 0.0 110.546 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.82 -26.31 61.44 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.302 1.441 . . . . 0.0 110.138 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.295 3.2 t -80.37 -17.36 52.14 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 173.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 28.9 m -82.83 -34.37 26.89 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.637 -0.664 . . . . 0.0 109.402 169.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -78.77 -19.47 52.16 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 156' ' ' LEU . 20.3 mt -131.74 92.9 29.36 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.504 1.122 . . . . 0.0 108.978 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -60.56 142.34 97.66 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.943 2.429 . . . . 0.0 113.415 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt 93.99 -15.35 0.12 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 130.245 3.418 . . . . 0.0 114.798 169.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.41 ' HB3' ' HD2' ' A' ' 167' ' ' PRO . 1.6 pp -84.24 152.3 24.28 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.7 0.682 . . . . 0.0 109.266 168.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 76.3 p -111.0 -146.61 0.41 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -170.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.1 tt 179.75 152.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 128.317 2.647 . . . . 0.0 110.538 -168.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -153.14 151.05 22.89 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 123.912 0.767 . . . . 0.0 111.811 169.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.4 84.21 5.98 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.739 1.216 . . . . 0.0 109.491 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 11.7 tp . . . . . 0 N--CA 1.472 0.629 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.356 169.379 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.0 t . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.29 123.45 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 127.071 2.149 . . . . 0.0 108.737 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -108.68 104.79 14.15 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.717 1.207 . . . . 0.0 109.513 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.512 HD22 ' HB2' ' A' ' 107' ' ' PHE . 1.2 mt -96.1 132.17 41.76 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.882 -1.136 . . . . 0.0 112.824 173.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.442 ' CD2' HG23 ' A' ' 99' ' ' ILE . 26.2 t80 -121.53 110.79 16.45 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 124.426 2.06 . . . . 0.0 110.685 174.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -88.81 114.13 25.1 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 128.201 2.6 . . . . 0.0 113.111 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.448 HD11 HD11 ' A' ' 108' ' ' LEU . 6.8 mp -108.95 130.96 55.46 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.799 0.84 . . . . 0.0 111.099 169.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . 0.348 0.0 OUTLIER -128.93 151.62 49.46 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 167.299 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.16 129.54 11.68 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.964 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.53 27.63 8.62 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.43 1.892 . . . . 0.0 111.635 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 100.0 p . . . . . 0 CA--C 1.541 0.597 0 O-C-N 120.504 -1.372 . . . . 0.0 112.923 174.289 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 122.369 1.081 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.35 74.3 0.42 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 127.198 2.333 . . . . 0.0 108.235 -169.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -81.83 140.02 34.41 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.385 1.093 . . . . 0.0 108.238 -171.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.7 tt -120.32 142.94 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 117.856 0.298 . . . . 0.0 111.795 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.95 157.05 22.46 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.951 1.739 . . . . 0.0 110.1 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -128.26 142.59 51.11 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -169.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.82 141.82 12.01 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 118.729 0.695 . . . . 0.0 112.067 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.0 t -109.7 142.26 41.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.476 1.111 . . . . 0.0 110.447 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -150.48 152.28 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 120.775 -1.203 . . . . 0.0 111.766 170.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.3 t -138.72 -62.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.311 1.045 . . . . 0.0 111.06 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.3 t30 154.35 -24.88 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 1 C-N-CA 132.764 4.426 . . . . 0.0 108.24 -169.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.451 ' O ' HG23 ' A' ' 52' ' ' THR . 87.9 mtp -53.72 -50.3 66.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.64 1.176 . . . . 0.0 109.473 168.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 51' ' ' MET . 4.5 p 178.78 179.52 0.39 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 131.09 3.756 . . . . 0.0 108.846 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -98.28 125.75 43.5 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 103.561 -2.755 . . . . 0.0 103.561 166.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.408 HE21 HG23 ' A' ' 56' ' ' ILE . 65.3 tp60 -111.9 114.92 28.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 122.337 1.065 . . . . 0.0 109.184 174.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -82.94 113.21 20.38 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.703 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.408 HG23 HE21 ' A' ' 54' ' ' GLN . 41.5 pt -142.07 115.41 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.967 0.907 . . . . 0.0 109.167 168.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.3 tp 101.72 96.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 130.262 3.425 . . . . 0.0 108.611 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -63.0 163.71 9.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.047 1.339 . . . . 0.0 111.535 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.7 mt -54.37 111.68 0.84 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.373 0.669 . . . . 0.0 110.757 174.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 125.34 1.456 . . . . 0.0 112.472 -174.684 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -118.11 -152.59 0.51 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.772 1.629 . . . . 0.0 110.102 169.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -132.79 152.38 20.28 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 124.95 1.262 . . . . 0.0 114.395 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -148.03 152.95 38.29 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.974 1.71 . . . . 0.0 111.154 173.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -70.55 -82.82 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.455 1.502 . . . . 0.0 111.251 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.05 158.93 30.24 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.0 m -65.04 -46.16 73.82 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 115.856 -2.021 . . . . 0.0 115.084 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.29 138.2 65.0 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.609 2.206 . . . . 0.0 112.482 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -101.87 162.55 12.82 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.941 0.897 . . . . 0.0 112.129 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.07 10.18 49.6 Favored Glycine 0 N--CA 1.482 1.706 0 C-N-CA 124.4 1.0 . . . . 0.0 115.098 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -28.21 -46.13 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 131.197 3.799 . . . . 0.0 115.613 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.462 ' HA ' HG12 ' A' ' 89' ' ' VAL . 6.3 tp -52.78 -34.15 52.05 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.922 2.489 . . . . 0.0 114.37 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -68.27 -40.62 81.82 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.596 -1.315 . . . . 0.0 111.81 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.63 -44.79 66.45 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.505 -0.76 . . . . 0.0 111.913 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 86' ' ' LEU . 7.7 p -54.66 -38.17 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 118.951 0.796 . . . . 0.0 111.755 174.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.485 HG22 HD11 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -70.62 -53.62 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 119.139 0.881 . . . . 0.0 111.818 173.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -60.57 -41.35 94.46 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.685 1.13 . . . . 0.0 111.525 -173.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.88 -40.18 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.165 0.586 . . . . 0.0 111.472 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.07 -38.84 89.32 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.038 -1.039 . . . . 0.0 112.193 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.485 HD11 HG22 ' A' ' 90' ' ' VAL . 16.5 mt -81.21 -30.39 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -174.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -84.99 65.64 9.34 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.614 -1.304 . . . . 0.0 112.663 -174.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.4 mt -46.42 -43.59 16.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.781 2.033 . . . . 0.0 111.184 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.28 -31.0 35.47 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.807 1.194 . . . . 0.0 115.136 -174.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -84.95 -43.06 14.36 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.35 1.075 . . . . 0.0 110.514 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.442 HG23 ' CD2' ' A' ' 7' ' ' TYR . 15.9 mm -72.13 -35.96 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 122.306 -0.246 . . . . 0.0 110.338 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.66 25.91 26.38 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.715 1.15 . . . . 0.0 113.857 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.403 ' CZ3' ' HB2' ' A' ' 106' ' ' ARG . 24.8 m95 -55.13 122.5 11.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.645 1.178 . . . . 0.0 112.491 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -97.08 168.22 10.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.799 1.24 . . . . 0.0 111.587 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -84.24 57.72 4.4 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.13 -128.05 5.88 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 169.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.9 p -111.34 144.76 40.02 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 168.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 12.1 ptt-85 -146.16 119.79 9.16 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 120.698 1.59 . . . . 0.0 111.181 -170.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.512 ' HB2' HD22 ' A' ' 6' ' ' LEU . 11.8 m-85 -120.68 131.82 54.77 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -172.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.448 HD11 HD11 ' A' ' 9' ' ' LEU . 7.5 tp -89.75 107.97 19.41 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.613 170.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.9 t -90.48 111.96 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 173.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.6 tp -117.09 114.42 23.71 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 119.062 0.846 . . . . 0.0 110.11 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.0 t -106.11 138.18 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.403 HG22 HG12 ' A' ' 171' ' ' VAL . 13.4 t -150.37 170.03 20.01 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 112.439 -2.164 . . . . 0.0 109.465 168.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -130.38 13.88 5.55 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.996 1.718 . . . . 0.0 113.375 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -142.58 179.35 7.02 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.891 1.676 . . . . 0.0 109.825 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -73.3 -170.84 0.85 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.355 0.597 . . . . 0.0 110.437 168.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -143.96 157.25 44.46 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.063 -1.023 . . . . 0.0 113.616 -169.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -73.58 129.94 39.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.331 172.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.55 HD22 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -105.94 178.32 4.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.832 1.653 . . . . 0.0 109.34 177.542 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.55 ' H ' HD22 ' A' ' 118' ' ' LEU . . . -53.62 140.68 28.17 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.077 -1.015 . . . . 0.0 112.682 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? 85.52 -26.27 0.1 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 128.883 2.873 . . . . 0.0 114.993 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . 0.256 10.6 p30 -65.36 -22.66 66.83 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 121.944 2.157 . . . . 0.0 114.767 -175.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.444 ' H ' ' HD3' ' A' ' 122' ' ' LYS 0.253 0.0 OUTLIER -72.12 6.32 2.24 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 120.245 -1.535 . . . . 0.0 114.794 168.617 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.6 t -61.71 -26.1 67.83 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.755 -1.216 . . . . 0.0 110.155 168.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 57.6 mt -63.7 -35.05 79.29 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.071 1.748 . . . . 0.0 112.96 171.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -88.75 14.36 60.3 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.739 1.638 . . . . 0.0 113.533 172.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.323 25.9 m 41.62 54.81 3.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.375 3.07 . . . . 0.0 114.459 -174.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -100.72 110.45 22.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -85.9 -62.32 1.55 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 121.684 2.038 . . . . 0.0 112.02 -171.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.16 132.77 44.6 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.423 ' HA ' ' CB ' ' A' ' 149' ' ' ASP . 6.4 t -49.8 145.02 5.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.767 2.027 . . . . 0.0 111.104 170.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.4 p -65.24 145.27 56.45 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.168 0.985 . . . . 0.0 111.948 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -80.93 -12.54 59.38 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.476 ' HA3' ' HE3' ' A' ' 159' ' ' LYS . . . 72.82 16.73 78.1 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 118.737 -1.035 . . . . 0.0 113.376 -176.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -103.59 159.78 15.3 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.922 1.289 . . . . 0.0 109.018 169.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 4.8 t -85.07 144.65 28.11 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.777 -1.202 . . . . 0.0 112.593 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -132.49 63.78 1.62 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.908 2.083 . . . . 0.0 109.609 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.13 130.04 52.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.199 1.8 . . . . 0.0 108.469 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -133.63 -69.19 0.55 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.226 0.61 . . . . 0.0 112.095 173.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.45 6.64 32.93 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.04 1.336 . . . . 0.0 114.205 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 108.82 -14.49 34.64 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.89 1.71 . . . . 0.0 114.949 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 62.2 mtt -91.54 144.46 25.53 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.285 1.542 . . . . 0.0 110.867 171.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -64.83 98.33 0.27 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 50.9 mmm-85 -56.43 -42.5 78.18 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.304 1.842 . . . . 0.0 112.268 -169.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 70.7 m -95.33 5.06 52.69 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -169.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.9 ttp-105 -47.11 -40.52 15.56 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.504 1.502 . . . . 0.0 112.995 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.73 -3.33 72.83 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 117.953 -1.471 . . . . 0.0 115.208 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.28 45.6 tt0 -120.6 -76.26 0.01 OUTLIER Pre-proline 0 CA--C 1.555 1.161 0 CA-C-O 115.84 -2.028 . . . . 0.0 111.83 176.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -58.89 160.93 16.65 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 123.147 2.565 . . . . 0.0 117.66 175.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.423 ' CB ' ' HA ' ' A' ' 130' ' ' THR . 6.1 t0 -70.12 174.28 5.65 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 129.864 3.266 . . . . 0.0 114.91 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.433 ' HB3' ' CD2' ' A' ' 86' ' ' LEU . 28.2 m-85 -81.29 123.1 28.23 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.672 1.989 . . . . 0.0 105.893 167.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.651 ' H ' ' CD ' ' A' ' 151' ' ' GLN . 0.2 OUTLIER -64.09 135.5 56.43 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 119.712 -1.868 . . . . 0.0 112.101 -177.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 24.6 p -67.44 155.45 38.99 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.387 -1.445 . . . . 0.0 112.087 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.442 HG22 HG23 ' A' ' 186' ' ' ILE . 7.2 p -57.69 -28.42 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 120.625 -1.297 . . . . 0.0 114.282 -169.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 52.0 t -81.54 -22.73 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.448 0.699 . . . . 0.0 112.596 175.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -63.9 -41.67 97.64 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.681 1.128 . . . . 0.0 109.013 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.6 mt -55.7 -56.6 18.51 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.345 0.521 . . . . 0.0 110.857 174.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.48 ' HB2' HG22 ' A' ' 186' ' ' ILE . . . -60.36 -30.1 69.34 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.0 t -65.88 -54.07 31.45 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.701 0.682 . . . . 0.0 111.357 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.476 ' HE3' ' HA3' ' A' ' 133' ' ' GLY . 69.3 mmtt -63.78 -44.39 93.53 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.034 -1.041 . . . . 0.0 113.44 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mt -76.34 -23.88 54.24 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.503 -1.373 . . . . 0.0 112.042 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.99 -37.84 61.78 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 169.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.4 -34.77 63.38 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.235 0.925 . . . . 0.0 110.784 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -85.6 -7.05 59.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.117 0.967 . . . . 0.0 112.594 174.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 58.13 37.56 26.37 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.185 1.794 . . . . 0.0 113.347 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 22.9 mm -88.92 140.62 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.298 1.039 . . . . 0.0 109.193 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.503 ' HB2' ' CD2' ' A' ' 107' ' ' PHE . 20.2 mm100 -102.92 101.79 23.36 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 120.743 1.611 . . . . 0.0 109.421 169.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -77.63 143.07 21.08 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.299 2.0 . . . . 0.0 112.979 174.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.6 mm -129.31 109.69 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.004 1.722 . . . . 0.0 108.881 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -75.91 71.81 2.74 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 123.648 1.69 . . . . 0.0 112.149 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 194' ' ' LEU . 58.1 t -63.93 101.63 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 O-C-N 121.141 -0.974 . . . . 0.0 113.008 169.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.403 HG12 HG22 ' A' ' 112' ' ' THR . 5.6 m -144.4 144.18 24.5 Favored Pre-proline 0 N--CA 1.484 1.225 0 O-C-N 120.175 -1.578 . . . . 0.0 111.707 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -67.15 168.37 17.71 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.762 2.308 . . . . 0.0 115.581 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.1 t -52.13 140.88 19.86 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.499 169.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 103.13 -48.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 130.132 3.373 . . . . 0.0 110.006 -172.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -86.79 -22.45 25.88 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.1 t -50.93 -42.11 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 125.729 1.612 . . . . 0.0 111.89 -169.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -75.28 -15.88 60.48 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -172.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.54 -44.19 21.62 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.984 0.811 . . . . 0.0 109.528 172.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -71.89 -28.03 63.23 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.381 1.473 . . . . 0.0 110.656 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.551 ' O ' HG22 ' A' ' 183' ' ' THR . 13.2 mt-10 -65.92 -36.01 82.19 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.252 169.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -76.31 -26.71 56.09 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 116.732 -1.987 . . . . 0.0 110.758 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.6 -19.84 58.98 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.776 -1.203 . . . . 0.0 109.746 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 180' ' ' GLU . 1.6 t -70.37 -23.84 62.86 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 119.473 1.033 . . . . 0.0 110.908 169.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 11.9 m -75.23 -31.02 60.72 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.389 0.676 . . . . 0.0 109.268 173.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -77.13 -27.64 54.03 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.873 173.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.486 HD11 HD13 ' A' ' 189' ' ' LEU . 30.3 pt -119.6 95.92 49.45 Favored Pre-proline 0 N--CA 1.489 1.503 0 CA-C-N 120.182 1.355 . . . . 0.0 113.656 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.87 138.5 51.39 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 124.11 3.207 . . . . 0.0 113.177 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 80.96 -4.1 1.75 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 128.665 2.786 . . . . 0.0 114.065 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.486 HD13 HD11 ' A' ' 186' ' ' ILE . 0.7 OUTLIER -69.54 154.39 42.07 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.927 1.24 . . . . 0.0 108.583 168.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.256 1.9 m -128.11 -177.43 4.14 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 169.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.0 tt -146.22 144.49 20.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 129.587 3.155 . . . . 0.0 107.476 -168.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -128.27 146.98 17.18 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -91.1 94.53 9.64 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.402 ' HB2' HG12 ' A' ' 170' ' ' VAL . 60.9 tp . . . . . 0 CA--C 1.538 0.491 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.277 169.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.1 m . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 54.8 t -128.29 136.35 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.639 1.976 . . . . 0.0 108.917 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.57 112.03 13.87 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.807 0.843 . . . . 0.0 109.892 -175.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.426 HD22 ' HB2' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -105.93 132.13 52.4 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -117.38 103.36 10.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 123.351 1.548 . . . . 0.0 109.836 169.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -79.98 104.51 10.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.367 -1.742 . . . . 0.0 112.169 171.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 tt -103.82 126.69 51.13 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.764 0.826 . . . . 0.0 111.226 171.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.2 ptm -121.32 147.07 46.17 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 174.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.71 136.88 15.04 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.404 1.002 . . . . 0.0 112.22 170.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.428 HD23 ' HB2' ' A' ' 47' ' ' SER . 0.6 OUTLIER -119.55 44.41 2.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.165 1.786 . . . . 0.0 112.41 -179.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 N--CA 1.476 0.831 0 O-C-N 120.238 -1.539 . . . . 0.0 112.805 170.074 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 121.886 0.851 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.29 78.75 0.32 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 127.408 2.432 . . . . 0.0 107.817 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -81.56 140.81 34.28 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.05 137.76 56.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.42 ' HA3' HD23 ' A' ' 59' ' ' LEU . . . -133.57 155.3 21.67 Favored Glycine 0 N--CA 1.464 0.552 0 C-N-CA 124.45 1.024 . . . . 0.0 111.002 171.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -107.28 163.52 12.95 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.275 0.63 . . . . 0.0 111.923 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.5 147.99 12.85 Favored Glycine 0 C--N 1.345 1.046 0 O-C-N 120.543 -1.348 . . . . 0.0 112.293 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.428 ' HB2' HD23 ' A' ' 12' ' ' LEU . 39.7 p -136.66 152.36 50.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.967 1.365 . . . . 0.0 114.403 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -159.78 157.46 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.035 1.334 . . . . 0.0 108.827 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.446 HG13 ' H ' ' A' ' 50' ' ' ASN . 1.3 p -146.99 -73.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.446 ' H ' HG13 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -164.01 -14.18 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.53 1.532 . . . . 0.0 111.604 169.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.616 ' O ' HG23 ' A' ' 52' ' ' THR . 23.6 ptt? -48.16 -41.92 28.22 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.54 1.936 . . . . 0.0 112.903 169.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 51' ' ' MET . 19.0 p 160.2 -179.95 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.189 1 C-N-CA 133.732 4.813 . . . . 0.0 107.381 -171.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -102.09 135.65 43.31 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 167.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -127.59 127.26 43.57 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 123.306 1.527 . . . . 0.0 110.935 171.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -77.34 129.22 35.54 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.445 171.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.2 mt -137.18 139.35 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 127.406 2.282 . . . . 0.0 105.613 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER 44.94 99.47 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.865 2.466 . . . . 0.0 116.529 -169.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -66.91 163.05 20.45 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.154 -0.966 . . . . 0.0 110.983 168.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.42 HD23 ' HA3' ' A' ' 44' ' ' GLY . 13.4 mt -52.18 117.63 2.94 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.103 0.561 . . . . 0.0 111.583 -172.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.475 0.776 0 C-N-CA 125.326 1.451 . . . . 0.0 111.733 -174.916 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 N--CA 1.478 0.95 0 CA-C-O 121.221 0.534 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.1 t -109.35 -152.07 0.48 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.604 1.162 . . . . 0.0 109.028 168.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -147.17 151.13 23.45 Favored Glycine 0 N--CA 1.471 1.005 0 O-C-N 120.632 -1.293 . . . . 0.0 114.042 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.53 150.6 21.51 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.254 1.422 . . . . 0.0 111.874 172.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.61 -61.91 1.62 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.288 1.435 . . . . 0.0 112.246 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.3 136.41 51.81 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.021 0.528 . . . . 0.0 111.001 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.324 0.0 OUTLIER -70.35 -38.19 8.11 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-O 116.248 -1.834 . . . . 0.0 113.909 -176.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.51 141.71 81.6 Favored 'Trans proline' 0 C--N 1.355 0.888 0 CA-C-N 122.439 1.907 . . . . 0.0 110.844 169.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -170.83 1.72 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.223 1.009 . . . . 0.0 113.127 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.401 ' HA3' ' NH2' ' A' ' 145' ' ' ARG . . . -112.8 30.11 7.68 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 -169.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.506 ' CG ' HD21 ' A' ' 110' ' ' LEU 0.285 0.2 OUTLIER -70.33 -29.4 66.09 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 118.526 2.788 . . . . 0.0 118.526 -168.906 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.83 HD23 HD21 ' A' ' 156' ' ' LEU . 8.4 mp -66.14 -30.91 71.49 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 123.787 2.994 . . . . 0.0 112.995 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -59.95 -41.76 92.58 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.11 -0.994 . . . . 0.0 110.73 171.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.04 -49.4 72.49 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.024 -0.988 . . . . 0.0 111.379 174.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 m -58.8 -32.88 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 119.701 1.137 . . . . 0.0 112.168 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.0 t -78.02 -40.8 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 117.161 -1.399 . . . . 0.0 112.566 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -56.83 -45.23 82.46 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 121.663 2.029 . . . . 0.0 110.238 171.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.578 HG11 HD23 ' A' ' 108' ' ' LEU . 79.9 t -59.45 -32.37 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 174.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.31 -35.32 47.93 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.731 -1.231 . . . . 0.0 113.792 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.1 mm -93.03 -30.85 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 119.721 1.146 . . . . 0.0 113.25 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 78.4 m -79.74 52.27 1.43 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.396 1.478 . . . . 0.0 112.016 -172.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.7 mt -49.86 -41.19 44.73 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.123 2.169 . . . . 0.0 112.207 -169.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.44 -23.63 70.1 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.258 0.932 . . . . 0.0 114.534 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.43 -34.66 8.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.165 0.982 . . . . 0.0 111.531 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.65 -45.97 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 118.976 0.807 . . . . 0.0 110.095 170.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.83 26.04 10.09 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.809 1.195 . . . . 0.0 115.254 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -57.82 125.3 22.42 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.265 1.532 . . . . 0.0 112.268 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -93.02 -158.56 0.61 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.769 1.228 . . . . 0.0 112.139 172.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -90.55 0.33 57.39 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -173.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.9 -127.4 2.28 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 120.586 1.539 . . . . 0.0 111.396 -175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.2 t -114.6 140.72 48.56 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.572 1.549 . . . . 0.0 108.925 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -122.89 134.2 54.38 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 117.32 -1.324 . . . . 0.0 109.887 -168.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.459 ' CD2' ' HB3' ' A' ' 166' ' ' GLN . 15.1 m-85 -129.91 113.85 15.14 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.578 HD23 HG11 ' A' ' 92' ' ' VAL . 3.2 tm? -82.49 98.8 9.11 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 170.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 80.4 t -83.69 116.21 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.506 HD21 ' CG ' ' A' ' 85' ' ' GLN . 3.2 tm? -110.33 108.03 17.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.161 -168.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.413 HG22 HG13 ' A' ' 170' ' ' VAL . 46.2 t -101.74 129.89 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.6 t -161.47 151.43 17.04 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -106.67 -13.5 15.27 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -169.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -137.12 -169.8 2.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.827 1.251 . . . . 0.0 110.553 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.67 -170.71 0.57 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.075 0.95 . . . . 0.0 112.745 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.537 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 48.2 t80 -139.21 149.8 44.8 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.266 1.426 . . . . 0.0 112.546 -172.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -84.68 91.81 8.03 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.031 1.332 . . . . 0.0 113.332 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.24 163.02 4.07 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 120.493 -1.379 . . . . 0.0 112.432 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -46.71 135.1 9.18 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.619 -0.676 . . . . 0.0 111.504 170.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm 97.5 -12.48 0.07 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 130.179 3.391 . . . . 0.0 112.142 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -76.8 -20.09 56.82 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.607 -1.308 . . . . 0.0 113.737 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.42 ' HG3' ' CD2' ' A' ' 150' ' ' TYR . 34.0 mttm -71.72 -1.67 14.7 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 120.023 1.283 . . . . 0.0 114.344 170.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -58.41 -36.27 73.34 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.413 1.006 . . . . 0.0 111.453 169.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.6 mt -63.94 -36.27 83.39 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.462 0.705 . . . . 0.0 112.437 173.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -82.39 13.93 37.59 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.778 1.656 . . . . 0.0 114.068 172.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.322 11.6 t 53.04 48.15 22.99 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 128.031 2.532 . . . . 0.0 113.442 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -127.43 113.66 16.48 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.728 1.211 . . . . 0.0 111.41 172.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -94.78 -30.29 14.32 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.304 1.441 . . . . 0.0 113.139 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -60.35 120.32 9.63 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.347 0.659 . . . . 0.0 110.809 -172.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.5 t -61.47 155.95 20.59 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.827 0.739 . . . . 0.0 110.599 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.6 t -65.01 143.19 58.12 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.655 0.74 . . . . 0.0 112.182 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -79.57 -29.27 41.24 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.243 1.017 . . . . 0.0 112.32 -177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.35 18.79 70.56 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.089 0.852 . . . . 0.0 113.044 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -106.88 164.51 12.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.085 1.754 . . . . 0.0 113.386 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 6.3 t -72.05 125.65 27.78 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.142 1.377 . . . . 0.0 109.639 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -134.75 41.17 2.9 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.8 1.64 . . . . 0.0 111.448 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.37 124.42 47.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.287 2.235 . . . . 0.0 109.315 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . 0.257 15.3 p-10 -115.71 -96.72 0.46 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.397 1.079 . . . . 0.0 112.608 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.25 30.25 0.28 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 121.016 1.734 . . . . 0.0 113.679 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.57 -9.32 66.64 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.915 1.721 . . . . 0.0 114.142 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 20.5 ptp -97.02 151.67 19.49 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.597 1.698 . . . . 0.0 113.034 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -84.6 80.58 9.19 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.912 0.885 . . . . 0.0 109.735 169.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.3 ttm-85 -58.63 -32.94 69.51 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 38.9 m -64.87 -8.34 14.99 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.401 ' NH2' ' HA3' ' A' ' 84' ' ' GLY . 9.2 tpt180 -52.94 -29.13 26.9 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 120.649 1.568 . . . . 0.0 114.109 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.46 1.4 87.31 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 117.99 -1.45 . . . . 0.0 115.09 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.379 0.7 OUTLIER -121.41 -79.17 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 115.89 -2.005 . . . . 0.0 112.82 178.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.89 154.35 67.14 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 CA-C-N 124.463 2.63 . . . . 0.0 115.65 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -62.02 169.41 2.68 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 129.829 3.252 . . . . 0.0 112.912 170.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.42 ' CD2' ' HG3' ' A' ' 122' ' ' LYS . 74.8 m-85 -62.83 159.74 15.97 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.489 -0.757 . . . . 0.0 111.812 169.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -81.34 140.03 35.01 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.4 -0.812 . . . . 0.0 111.271 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.3 p -80.6 151.48 29.05 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.312 1.045 . . . . 0.0 111.253 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.525 ' HA ' HD23 ' A' ' 156' ' ' LEU . 45.1 t -53.13 -39.09 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -168.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.42 -18.69 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 O-C-N 121.496 -0.753 . . . . 0.0 112.534 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -67.11 -36.31 81.65 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.739 1.154 . . . . 0.0 110.412 170.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.83 HD21 HD23 ' A' ' 86' ' ' LEU . 1.9 mm? -59.05 -58.59 7.98 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 168.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.16 -43.79 78.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.102 0.961 . . . . 0.0 112.976 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.8 m -58.08 -56.13 25.98 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.058 0.943 . . . . 0.0 112.371 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.292 10.6 mptt -86.84 -20.44 27.49 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -174.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.4 mp -67.46 -31.13 71.09 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.382 1.446 . . . . 0.0 109.954 168.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.63 -33.78 58.34 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.657 1.183 . . . . 0.0 114.103 172.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.5 -51.47 59.78 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.4 1.08 . . . . 0.0 110.111 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -77.91 -12.69 60.0 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.69 0.796 . . . . 0.0 111.927 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.79 47.04 18.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.563 2.345 . . . . 0.0 111.991 176.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 28.9 mm -85.43 136.98 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.861 1.264 . . . . 0.0 108.421 174.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.459 ' HB3' ' CD2' ' A' ' 107' ' ' PHE . 3.7 tp60 -93.82 108.57 35.72 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 120.759 1.618 . . . . 0.0 107.859 168.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.55 ' HG2' ' HG ' ' A' ' 189' ' ' LEU . 83.0 Cg_endo -74.0 138.46 25.69 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.412 3.408 . . . . 0.0 113.24 171.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.5 mm -129.31 101.93 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.987 1.315 . . . . 0.0 110.115 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -72.39 72.58 0.96 Allowed 'General case' 0 N--CA 1.476 0.832 0 O-C-N 120.636 -1.29 . . . . 0.0 112.564 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.417 HG22 ' HB2' ' A' ' 194' ' ' LEU . 3.5 p -69.73 106.36 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 O-C-N 120.78 -1.2 . . . . 0.0 113.029 170.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 31.8 m -145.41 147.07 32.29 Favored Pre-proline 0 N--CA 1.482 1.167 0 O-C-N 120.354 -1.466 . . . . 0.0 113.293 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -59.52 155.67 40.65 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 124.855 3.704 . . . . 0.0 114.849 172.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.9 t -41.62 -60.57 1.29 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.447 2.299 . . . . 0.0 114.94 -169.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -64.04 -12.5 39.11 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -171.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 66.8 mmm -99.25 -7.47 26.38 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.6 t -57.34 -36.62 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 120.272 1.396 . . . . 0.0 111.66 -169.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -69.92 -28.31 65.49 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.01 -34.83 24.23 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 118.926 0.785 . . . . 0.0 111.309 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -72.42 -30.72 64.88 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.565 -1.334 . . . . 0.0 110.325 170.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -71.26 -11.79 61.11 Favored 'General case' 0 CA--C 1.553 1.092 0 O-C-N 121.584 -0.697 . . . . 0.0 111.376 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -84.33 -47.11 11.07 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.039 -1.663 . . . . 0.0 109.969 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.81 -21.14 59.47 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 119.966 -1.709 . . . . 0.0 111.051 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.84 -16.7 61.59 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.726 0.81 . . . . 0.0 111.961 171.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.55 -25.57 28.62 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 119.487 -0.292 . . . . 0.0 110.969 170.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -87.99 -18.48 28.93 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 56.9 mt -118.35 96.48 49.85 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.285 1.034 . . . . 0.0 108.837 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -55.42 141.76 81.52 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.688 2.926 . . . . 0.0 114.439 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . 0.325 0.0 OUTLIER 81.55 -15.51 0.71 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 128.618 2.767 . . . . 0.0 113.093 171.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.55 ' HG ' ' HG2' ' A' ' 167' ' ' PRO . 2.5 tt -56.76 148.01 21.54 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 127.003 2.121 . . . . 0.0 108.689 169.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 77.2 p -121.41 -150.76 0.46 Allowed 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 120.784 1.629 . . . . 0.0 109.651 170.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -179.34 117.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 119.51 -1.994 . . . . 0.0 109.154 -167.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -110.6 152.68 17.36 Favored Glycine 0 N--CA 1.469 0.875 0 C-N-CA 124.83 1.205 . . . . 0.0 112.242 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -93.8 85.69 4.89 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.866 1.266 . . . . 0.0 109.175 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.417 ' HB2' HG22 ' A' ' 170' ' ' VAL . 47.8 tp . . . . . 0 N--CA 1.471 0.615 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.977 169.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.9 p . . . . . 0 CA--C 1.545 0.77 0 CA-C-O 121.621 0.724 . . . . 0.0 111.807 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 t -115.91 145.67 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.947 1.699 . . . . 0.0 106.646 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.3 14.9 p-10 -136.99 111.99 8.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.736 0.779 . . . . 0.0 110.35 171.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.2 tp -96.24 134.35 39.45 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.511 1.124 . . . . 0.0 112.653 -175.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -118.68 103.16 9.42 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 123.204 1.478 . . . . 0.0 109.388 168.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -82.43 93.87 7.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.056 1.742 . . . . 0.0 111.534 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 30.5 tp -92.1 125.53 36.83 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.377 1.071 . . . . 0.0 109.619 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.466 ' CE ' ' CZ ' ' A' ' 45' ' ' PHE 0.306 0.0 OUTLIER -134.24 165.62 24.69 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 172.276 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.46 140.26 15.57 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.677 1.132 . . . . 0.0 112.343 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.446 HD21 ' CE ' ' A' ' 10' ' ' MET . 3.5 mm? -114.59 22.63 13.43 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.15 1.78 . . . . 0.0 112.212 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 CA--C 1.539 0.528 0 O-C-N 120.586 -1.321 . . . . 0.0 110.91 169.215 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 121.289 0.566 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.42 83.69 0.24 Allowed Glycine 0 C--N 1.337 0.625 0 C-N-CA 126.776 2.132 . . . . 0.0 107.929 -169.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -77.25 151.36 35.15 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.28 138.02 53.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 117.754 0.252 . . . . 0.0 111.17 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.409 ' HA2' HD13 ' A' ' 57' ' ' LEU . . . -135.14 163.77 24.83 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 126.891 2.186 . . . . 0.0 110.9 171.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.466 ' CZ ' ' CE ' ' A' ' 10' ' ' MET . 86.1 t80 -135.5 145.27 46.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.995 0.918 . . . . 0.0 111.831 -169.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.35 147.2 18.47 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 122.568 0.128 . . . . 0.0 112.887 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.6 m -118.7 142.74 47.39 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.503 1.121 . . . . 0.0 112.036 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.79 157.12 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.726 1.21 . . . . 0.0 110.411 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 p -157.83 -52.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 124.405 1.082 . . . . 0.0 109.994 169.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 161.48 -22.9 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 131.302 3.841 . . . . 0.0 110.525 169.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -52.77 -39.93 62.69 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.642 0.777 . . . . 0.0 111.462 170.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.1 p -170.43 168.9 7.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 129.744 3.218 . . . . 0.0 110.723 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -113.11 123.65 50.76 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 101.003 -3.703 . . . . 0.0 101.003 165.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -122.03 114.04 20.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -174.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -81.64 114.63 20.45 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.637 169.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.3 mt -139.44 95.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.409 HD13 ' HA2' ' A' ' 44' ' ' GLY 0.262 2.6 tm? 107.43 94.17 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 130.703 3.601 . . . . 0.0 109.139 174.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -52.66 159.42 1.08 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.592 1.557 . . . . 0.0 112.741 170.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.7 mt -53.64 120.47 6.23 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 172.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.475 0.82 0 C-N-CA 124.511 1.124 . . . . 0.0 112.539 -172.625 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -120.24 -160.02 0.81 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.285 1.834 . . . . 0.0 111.146 169.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -156.19 155.71 26.52 Favored Glycine 0 N--CA 1.472 1.076 0 O-C-N 120.507 -1.371 . . . . 0.0 113.957 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -152.32 151.96 31.52 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.645 1.178 . . . . 0.0 112.767 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -55.68 -58.99 5.5 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.088 2.155 . . . . 0.0 112.343 174.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.72 143.98 37.63 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.266 15.1 t -70.15 -41.75 15.1 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 115.563 -2.16 . . . . 0.0 114.443 174.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.74 142.87 84.86 Favored 'Trans proline' 0 C--N 1.356 0.972 0 CA-C-N 123.421 2.257 . . . . 0.0 112.319 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -112.78 154.58 26.0 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.912 1.285 . . . . 0.0 113.43 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.04 55.76 4.79 Favored Glycine 0 N--CA 1.479 1.51 0 C-N-CA 125.664 1.602 . . . . 0.0 112.586 -172.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.613 HE22 HG21 ' A' ' 112' ' ' THR . 32.5 tt0 -83.07 -33.82 26.33 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.458 1.903 . . . . 0.0 115.689 -168.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.9 -37.95 79.31 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -171.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -51.46 -46.82 63.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.224 1.01 . . . . 0.0 111.601 169.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.48 -53.63 49.1 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.132 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.25 32.9 m -64.25 -27.41 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 119.476 1.035 . . . . 0.0 112.621 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.503 HG22 HE22 ' A' ' 155' ' ' GLN . 76.7 t -64.04 -63.01 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 119.427 1.012 . . . . 0.0 108.564 168.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -58.43 -42.78 88.04 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.171 0.896 . . . . 0.0 111.174 -173.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.0 t -55.76 -35.4 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.08 0.855 . . . . 0.0 112.428 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.71 -37.14 65.26 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.818 -1.176 . . . . 0.0 113.486 175.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.433 ' HB ' ' SG ' ' A' ' 135' ' ' CYS . 7.9 mm -93.56 -15.8 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.858 0.863 . . . . 0.0 113.017 -172.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.52 49.01 0.96 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.763 2.025 . . . . 0.0 112.58 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -49.95 -40.1 42.65 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.778 -1.201 . . . . 0.0 112.048 -175.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.71 -19.23 54.8 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -91.89 -45.52 8.33 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.917 1.359 . . . . 0.0 110.815 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.5 mm -65.85 -44.35 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.297 0.639 . . . . 0.0 109.351 175.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.33 21.9 21.0 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.998 1.285 . . . . 0.0 114.083 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -49.03 128.36 16.0 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.818 1.247 . . . . 0.0 112.087 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . 0.336 0.6 OUTLIER -113.93 -173.65 2.32 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 175.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -67.65 -2.91 7.61 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 118.792 2.886 . . . . 0.0 118.792 -168.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.29 -125.29 2.63 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 121.091 1.769 . . . . 0.0 112.268 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.4 m -111.83 115.3 28.8 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.145 1.778 . . . . 0.0 107.802 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 -99.54 128.81 45.66 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -168.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -127.19 104.25 7.86 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -168.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.97 89.38 6.05 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.187 -0.946 . . . . 0.0 111.004 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.5 t -72.29 132.57 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 tp -112.62 127.07 56.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.32 124.11 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 123.959 0.787 . . . . 0.0 110.54 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.613 HG21 HE22 ' A' ' 85' ' ' GLN . 9.5 t -150.14 164.66 35.05 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.613 0.765 . . . . 0.0 111.465 171.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.46 2.95 6.94 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.721 1.608 . . . . 0.0 114.765 174.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -123.12 173.13 8.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.435 1.094 . . . . 0.0 112.036 171.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -69.98 -169.14 0.24 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.752 0.821 . . . . 0.0 111.542 169.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.437 ' CE1' HD11 ' A' ' 182' ' ' LEU . 29.8 p90 -142.07 158.71 43.44 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.107 -0.996 . . . . 0.0 112.983 -169.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -84.29 123.84 30.59 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.172 169.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.69 HD22 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -86.43 -177.54 6.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.157 0.983 . . . . 0.0 109.47 170.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.69 ' H ' HD22 ' A' ' 118' ' ' LEU . . . -57.67 163.64 2.42 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.359 -0.838 . . . . 0.0 111.467 169.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.408 0.0 OUTLIER 55.11 -3.68 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.775 2.03 . . . . 0.0 116.162 -169.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -75.16 -28.62 60.18 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 121.313 1.87 . . . . 0.0 113.757 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -73.54 1.88 9.06 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 121.035 1.743 . . . . 0.0 113.424 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.7 t -59.83 -25.36 64.94 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.468 1.031 . . . . 0.0 111.501 169.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.4 mt -61.62 -21.16 64.13 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.405 1.882 . . . . 0.0 113.366 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -91.96 -108.34 1.64 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 169.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.277 7.1 t -152.55 40.3 0.58 Allowed 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 123.429 1.585 . . . . 0.0 111.041 169.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.02 89.64 5.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.942 1.697 . . . . 0.0 109.483 -175.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -86.07 -42.0 14.3 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.746 -0.596 . . . . 0.0 111.333 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -65.67 134.99 54.4 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.246 0.619 . . . . 0.0 109.967 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.3 p -97.19 147.22 24.31 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.548 1.139 . . . . 0.0 109.436 169.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.7 m -58.24 141.85 49.5 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.5 p30 -72.51 -11.38 60.64 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.467 1.507 . . . . 0.0 113.75 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.5 10.07 86.47 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.639 1.114 . . . . 0.0 113.329 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -84.61 176.56 8.52 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.961 1.38 . . . . 0.0 110.276 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . 0.433 ' SG ' ' HB ' ' A' ' 94' ' ' ILE . 0.6 OUTLIER -100.88 144.69 29.52 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 172.301 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -133.8 38.16 3.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.643 1.977 . . . . 0.0 110.868 -170.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 pp -62.53 160.19 14.29 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.112 1.765 . . . . 0.0 111.807 171.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -157.73 -101.46 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.72 1.208 . . . . 0.0 110.298 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.27 35.93 0.82 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.606 1.962 . . . . 0.0 113.062 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.1 18.35 55.96 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.744 1.164 . . . . 0.0 114.476 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.5 ptp -149.01 156.2 41.91 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.962 1.381 . . . . 0.0 113.905 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -68.94 104.37 2.06 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.552 1.141 . . . . 0.0 111.844 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -65.63 -42.05 91.97 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.344 0.658 . . . . 0.0 111.04 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.9 m -74.56 -3.36 30.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -172.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -44.56 -29.65 0.76 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.8 3.64 57.47 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.574 2.035 . . . . 0.0 115.962 -174.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.421 2.3 pt-20 -131.58 -49.58 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.106 0 CA-C-N 120.755 2.277 . . . . 0.0 114.68 170.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -80.02 151.08 20.97 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 CA-C-N 122.479 1.921 . . . . 0.0 113.736 167.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -75.46 165.54 24.96 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 129.155 2.982 . . . . 0.0 112.233 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -57.98 152.93 15.34 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.091 -1.006 . . . . 0.0 109.24 168.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . 0.334 3.0 mm-40 -106.46 165.42 11.29 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.4 p -73.61 161.82 29.9 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -168.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 t -61.96 -28.93 45.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.524 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.8 t -73.49 -42.56 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.265 1.026 . . . . 0.0 111.083 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.503 HE22 HG22 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -64.83 -38.03 89.62 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.489 0.586 . . . . 0.0 110.474 178.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 87.8 mt -57.19 -60.76 3.14 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.028 0.531 . . . . 0.0 110.261 170.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.83 -45.8 85.66 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -172.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.5 m -64.98 -49.59 69.67 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.839 -0.538 . . . . 0.0 112.306 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -74.66 -27.83 60.59 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.067 -1.021 . . . . 0.0 112.384 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 14.8 tp -61.12 -44.47 97.29 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.773 -1.205 . . . . 0.0 111.89 170.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.79 -24.65 61.78 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.04 0.936 . . . . 0.0 113.509 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -72.75 -44.21 61.92 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.098 1.359 . . . . 0.0 110.297 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -80.3 -18.88 47.99 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 56.2 63.74 1.91 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.763 1.625 . . . . 0.0 111.317 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 87.1 mt -113.88 137.66 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.677 1.591 . . . . 0.0 109.274 175.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -91.25 120.71 68.38 Favored Pre-proline 0 N--CA 1.475 0.784 0 CA-C-O 116.703 -1.617 . . . . 0.0 110.488 170.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -88.13 148.66 6.75 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.622 2.881 . . . . 0.0 110.477 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.83 99.17 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.553 ' HB2' HG22 ' A' ' 191' ' ' ILE . 7.1 m-85 -76.48 69.87 2.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 122.285 1.04 . . . . 0.0 111.895 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.49 102.55 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 C-N-CA 126.315 1.846 . . . . 0.0 110.993 169.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.51 147.96 26.93 Favored Pre-proline 0 N--CA 1.481 1.123 0 O-C-N 120.265 -1.522 . . . . 0.0 113.56 -170.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -62.39 148.45 93.26 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 125.199 3.933 . . . . 0.0 115.048 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.5 t -55.16 -28.93 56.41 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -169.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -47.25 -37.12 9.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.989 1.316 . . . . 0.0 113.793 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . 0.257 0.0 OUTLIER -126.64 5.92 6.79 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.064 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.9 t -53.39 -33.63 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 120.331 -1.481 . . . . 0.0 110.969 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -21.68 66.42 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -175.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.2 t -90.81 -38.73 12.79 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.347 0.659 . . . . 0.0 110.534 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -66.66 -36.74 83.26 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.024 1.33 . . . . 0.0 111.228 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -60.0 -19.88 54.78 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.375 1.07 . . . . 0.0 111.56 168.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -110.15 6.41 22.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.843 1.257 . . . . 0.0 113.248 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.437 HD11 ' CE1' ' A' ' 116' ' ' PHE . 62.0 mt -95.4 -25.97 16.05 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 167.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.3 t -77.62 -14.62 59.59 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.18 1.392 . . . . 0.0 112.759 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 3.6 t -84.98 -17.56 37.24 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.712 -0.617 . . . . 0.0 110.965 169.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -92.57 -23.66 18.98 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 118.083 0.401 . . . . 0.0 112.077 169.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 50.9 mt -118.12 91.78 40.97 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 124.38 1.072 . . . . 0.0 109.39 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.54 132.61 52.86 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.778 2.318 . . . . 0.0 112.657 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.5 tttm 105.77 -18.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 130.281 3.432 . . . . 0.0 115.271 169.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.436 HD21 ' CD2' ' A' ' 169' ' ' PHE 0.396 0.0 OUTLIER -75.27 164.35 26.54 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 120.568 1.531 . . . . 0.0 112.2 176.61 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.435 ' O ' HD23 ' A' ' 189' ' ' LEU . 37.7 p -129.13 176.41 7.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.553 HG22 ' HB2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -155.06 127.87 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 128.333 2.653 . . . . 0.0 108.84 -168.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.61 154.29 16.89 Favored Glycine 0 N--CA 1.47 0.965 0 C-N-CA 124.563 1.078 . . . . 0.0 111.518 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -94.89 85.82 4.5 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.125 0.964 . . . . 0.0 109.213 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 CA--C 1.541 0.621 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 168.381 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.9 p . . . . . 0 CA--C 1.547 0.841 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.2 t -137.76 137.28 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.228 1.811 . . . . 0.0 109.297 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -110.71 115.55 29.76 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 168.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -103.32 116.21 32.02 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.065 0.46 . . . . 0.0 110.163 169.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -105.72 103.04 12.46 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 123.919 1.819 . . . . 0.0 109.903 170.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -83.42 114.27 21.34 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 112.515 -2.13 . . . . 0.0 112.044 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.64 HD12 HG21 ' A' ' 92' ' ' VAL . 4.4 tt -114.42 124.12 51.15 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.795 0.838 . . . . 0.0 111.714 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.3 mtp -104.2 138.37 40.77 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.58 114.5 3.94 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.488 1.518 . . . . 0.0 109.66 169.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.8 mp -106.96 24.12 13.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.288 2.635 . . . . 0.0 112.705 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 p . . . . . 0 CA--C 1.543 0.686 0 O-C-N 120.297 -1.502 . . . . 0.0 113.078 171.723 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.9 p . . . . . 0 CA--C 1.552 1.025 0 CA-C-O 122.483 1.135 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.6 83.52 0.36 Allowed Glycine 0 C--N 1.345 1.035 0 C-N-CA 128.97 3.176 . . . . 0.0 108.866 -171.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -80.78 137.55 36.24 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.692 1.597 . . . . 0.0 108.433 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -120.33 138.25 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.613 0.765 . . . . 0.0 109.445 -173.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.86 159.2 23.85 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 125.57 1.557 . . . . 0.0 111.739 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -140.56 128.46 21.91 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -169.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -131.92 151.71 19.91 Favored Glycine 0 C--N 1.342 0.868 0 C-N-CA 124.973 1.273 . . . . 0.0 113.493 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.4 t -116.57 140.5 49.31 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.531 1.933 . . . . 0.0 111.071 173.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.418 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -138.17 147.23 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.173 0.989 . . . . 0.0 110.944 169.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.418 ' N ' HD13 ' A' ' 48' ' ' ILE . 0.7 OUTLIER -132.83 -60.26 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 118.314 0.506 . . . . 0.0 109.811 167.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 161.78 -34.64 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 1 C-N-CA 131.72 4.008 . . . . 0.0 107.525 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.1 mtt -46.12 -51.68 13.5 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.668 1.587 . . . . 0.0 110.806 169.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.9 p -165.75 178.76 6.38 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 128.067 2.547 . . . . 0.0 110.37 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -111.13 125.08 53.4 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 102.179 -3.267 . . . . 0.0 102.179 165.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -121.01 122.37 39.96 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.991 0.9 . . . . 0.0 110.481 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 46.8 t60 -76.68 126.97 31.9 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.724 168.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.35 -51.86 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 121.703 -0.623 . . . . 0.0 110.896 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.3 tp -129.96 121.0 25.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.719 0.808 . . . . 0.0 111.13 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.89 149.34 36.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.078 0.951 . . . . 0.0 111.707 170.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.3 mt -49.51 112.79 0.7 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.367 1.067 . . . . 0.0 110.795 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.475 0.814 0 C-N-CA 124.576 1.15 . . . . 0.0 112.386 -174.17 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.941 0.401 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.5 p -100.45 -124.88 0.17 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.608 1.563 . . . . 0.0 111.606 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.51 144.54 6.42 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.592 1.092 . . . . 0.0 114.261 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -156.37 153.67 29.31 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.286 1.435 . . . . 0.0 112.221 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.73 -50.19 65.71 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.916 1.686 . . . . 0.0 113.41 -176.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.84 137.7 42.02 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.882 0.873 . . . . 0.0 111.715 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 t -70.24 -30.87 2.05 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-O 115.725 -2.084 . . . . 0.0 115.056 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.95 141.22 26.51 Favored 'Trans proline' 0 C--N 1.358 1.055 0 CA-C-N 123.027 2.117 . . . . 0.0 112.145 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -97.46 158.53 15.43 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.71 1.204 . . . . 0.0 110.803 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.22 28.85 2.89 Favored Glycine 0 N--CA 1.48 1.599 0 O-C-N 120.653 -1.28 . . . . 0.0 114.623 174.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.24 -40.36 70.79 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.244 1.817 . . . . 0.0 111.194 -172.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.08 -25.32 68.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 117.572 -1.204 . . . . 0.0 113.095 -174.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -78.32 -31.27 48.66 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.033 1.288 . . . . 0.0 113.011 171.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.582 ' HB1' HD11 ' A' ' 9' ' ' LEU . . . -67.15 -45.89 75.7 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.711 -1.243 . . . . 0.0 111.574 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.531 HG23 HD11 ' A' ' 108' ' ' LEU . 7.3 p -58.71 -29.89 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 177.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.634 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.3 t -61.61 -60.35 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.125 0.97 . . . . 0.0 109.952 174.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -67.22 -38.05 84.63 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.698 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.64 HG21 HD12 ' A' ' 9' ' ' LEU . 77.3 t -57.11 -37.41 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 119.606 1.094 . . . . 0.0 112.114 173.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.97 -44.74 65.38 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.636 1.107 . . . . 0.0 113.756 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 90' ' ' VAL . 3.3 mt -91.74 -20.22 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -169.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 74.4 m -79.74 51.34 1.28 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.404 -1.435 . . . . 0.0 111.407 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -49.47 -42.64 43.8 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.924 1.69 . . . . 0.0 111.177 -174.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -74.66 -22.62 76.88 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.346 0.974 . . . . 0.0 114.39 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -105.69 -34.65 7.65 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.37 1.085 . . . . 0.0 112.594 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.8 mm -70.25 -38.23 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.959 0.8 . . . . 0.0 110.446 169.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.64 27.37 9.78 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.39 1.472 . . . . 0.0 114.591 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -59.93 116.57 4.23 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.959 1.38 . . . . 0.0 112.651 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -90.65 173.96 7.76 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.243 2.617 . . . . 0.0 110.352 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -87.52 20.16 3.03 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -170.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.36 -119.56 0.96 Allowed Glycine 0 C--N 1.346 1.124 0 C-N-CA 124.528 1.061 . . . . 0.0 111.043 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.9 m -116.33 130.46 56.78 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.612 1.565 . . . . 0.0 107.051 170.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.46 132.95 53.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -171.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.36 111.01 9.24 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -167.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.575 HD13 HD13 ' A' ' 110' ' ' LEU . 1.5 tm? -105.85 98.04 7.78 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.082 0.953 . . . . 0.0 109.711 -169.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.3 t -101.81 118.67 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.575 HD13 HD13 ' A' ' 108' ' ' LEU . 6.2 mp -111.37 131.92 54.82 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 124.245 0.966 . . . . 0.0 109.168 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.1 t -116.53 129.63 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 O-C-N 125.531 1.77 . . . . 0.0 111.159 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 t -152.43 -171.45 3.93 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.347 1.03 . . . . 0.0 109.515 169.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -140.43 2.86 1.88 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.68 -156.43 0.61 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.017 0.927 . . . . 0.0 110.845 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.91 166.53 0.98 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.816 2.046 . . . . 0.0 114.375 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -130.27 146.69 51.9 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.426 1.491 . . . . 0.0 110.507 170.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -76.94 141.77 40.33 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.007 0.432 . . . . 0.0 111.592 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.64 HD21 HG23 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -111.74 173.3 6.42 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.625 1.97 . . . . 0.0 109.533 177.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.52 ' H ' HD22 ' A' ' 118' ' ' LEU . . . -48.7 142.59 5.99 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.117 -0.989 . . . . 0.0 111.519 169.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.0 mttm 83.27 -16.52 0.56 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 129.511 3.124 . . . . 0.0 112.875 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.05 -32.08 73.62 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.239 1.381 . . . . 0.0 113.05 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -78.23 6.33 8.41 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.9 t -60.21 -31.19 69.93 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.022 1.283 . . . . 0.0 112.507 170.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.64 -19.26 61.47 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -85.53 15.2 47.55 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.494 1.521 . . . . 0.0 111.916 169.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.348 13.9 t 44.37 54.54 6.18 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 128.869 2.868 . . . . 0.0 112.504 -170.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.1 ttp180 -126.68 106.38 9.35 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.559 1.544 . . . . 0.0 109.907 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -112.66 -25.52 9.07 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -169.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -75.17 129.49 37.6 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.53 1.514 . . . . 0.0 110.829 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.6 t -68.31 167.61 14.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.925 1.29 . . . . 0.0 111.545 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.3 m -66.16 135.72 54.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.579 0.752 . . . . 0.0 112.495 172.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -83.15 -17.72 41.93 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.027 -1.046 . . . . 0.0 113.488 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.91 18.19 77.35 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.304 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.8 mtp-105 -94.49 169.85 9.91 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.842 1.257 . . . . 0.0 112.588 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.21 137.59 43.18 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.409 1.084 . . . . 0.0 110.45 169.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -145.94 44.91 1.26 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.505 1.522 . . . . 0.0 112.237 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.1 tt -118.72 132.23 56.15 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.076 0.95 . . . . 0.0 110.58 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -118.77 -75.61 0.58 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.649 1.179 . . . . 0.0 111.239 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -97.98 28.22 4.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.826 2.05 . . . . 0.0 112.792 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.51 -18.06 58.12 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.627 1.584 . . . . 0.0 113.227 -174.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 14.9 mmt -89.45 143.11 27.08 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.743 1.217 . . . . 0.0 112.495 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -71.94 91.22 1.18 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 168.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -55.92 -43.15 77.07 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.548 1.139 . . . . 0.0 112.304 -171.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.4 p -81.28 7.07 12.31 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -15.42 0.35 Allowed 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 171.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -103.2 -8.64 40.98 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.909 1.719 . . . . 0.0 115.26 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -114.53 -61.95 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 119.876 1.838 . . . . 0.0 111.84 -172.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -77.4 145.66 24.0 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.86 2.373 . . . . 0.0 113.199 168.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -66.28 171.11 5.08 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.305 2.642 . . . . 0.0 111.565 169.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -60.61 156.19 17.14 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 174.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -65.6 163.24 16.61 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.4 p -93.85 152.93 18.54 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 168.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.64 HG23 HD21 ' A' ' 118' ' ' LEU . 58.8 t -62.78 -30.6 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 O-C-N 120.621 -1.299 . . . . 0.0 111.231 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.62 -42.69 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.987 0.915 . . . . 0.0 111.061 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -73.47 -26.65 61.01 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.899 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.4 mt -63.74 -54.37 36.5 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 168.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.75 82.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.064 1.346 . . . . 0.0 113.124 -172.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 75.7 m -63.95 -51.15 65.73 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.945 0.498 . . . . 0.0 112.009 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.487 ' HG2' HD11 ' A' ' 94' ' ' ILE . 2.1 tppp? -62.7 -38.66 91.29 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.273 -0.892 . . . . 0.0 112.162 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.8 tp -60.26 -40.33 89.95 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.353 1.061 . . . . 0.0 112.647 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.66 -24.85 63.68 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.098 0.959 . . . . 0.0 113.311 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -75.92 -44.07 42.0 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.184 0.993 . . . . 0.0 110.819 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -78.67 -16.35 57.4 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 60.8 33.26 20.11 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.987 2.115 . . . . 0.0 113.024 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.2 mt -85.59 144.24 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.122 1.369 . . . . 0.0 109.101 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -104.69 106.24 53.93 Favored Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 120.714 1.597 . . . . 0.0 113.791 171.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 31.3 Cg_exo -75.13 137.62 21.68 Favored 'Trans proline' 0 CA--C 1.537 0.636 1 C-N-CA 125.342 4.028 . . . . 0.0 115.231 169.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.5 mt -130.98 113.44 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -75.62 79.54 2.61 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.893 0.854 . . . . 0.0 111.682 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 39.6 t -66.52 104.51 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-O 122.554 1.169 . . . . 0.0 112.151 169.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 33.3 m -142.32 164.51 32.88 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 120.321 -1.487 . . . . 0.0 110.776 -169.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -85.21 165.74 11.08 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.825 2.35 . . . . 0.0 111.81 -169.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.3 t -50.41 -38.84 45.09 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.772 1.229 . . . . 0.0 113.09 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -63.08 -21.28 66.06 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 3.5 tpt -128.23 5.74 5.83 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -170.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 89.4 t -59.43 -35.96 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 120.015 1.28 . . . . 0.0 111.537 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.27 -0.64 50.51 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -169.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 t -92.82 -36.54 12.8 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.796 0.808 . . . . 0.0 109.46 168.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -74.89 -33.94 62.13 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 124.172 0.989 . . . . 0.0 110.342 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -70.88 -15.0 62.59 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 119.293 0.951 . . . . 0.0 111.96 169.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -84.85 -28.25 26.17 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 120.32 -1.487 . . . . 0.0 111.249 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 43.3 tp -77.27 -27.16 53.06 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.314 2.246 . . . . 0.0 110.074 174.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.48 -7.97 58.02 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.11 1.764 . . . . 0.0 112.531 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 6.7 t -105.79 -15.82 14.84 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.239 0.616 . . . . 0.0 110.685 168.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -80.83 -37.37 30.17 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.313 0.506 . . . . 0.0 111.009 169.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 25.3 mt -104.13 114.9 63.97 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 124.325 1.05 . . . . 0.0 108.779 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.15 140.59 37.82 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.667 2.245 . . . . 0.0 112.432 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 47.2 tptt 82.82 -8.35 1.18 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 129.438 3.095 . . . . 0.0 113.811 170.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.5 mt -67.81 166.14 16.05 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.57 0.748 . . . . 0.0 111.883 170.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.6 p -138.59 -145.51 0.19 Allowed 'General case' 0 C--N 1.344 0.352 0 CA-C-O 122.905 1.336 . . . . 0.0 108.603 168.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.3 pt -157.02 156.86 4.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 128.798 2.839 . . . . 0.0 109.419 -167.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -134.04 153.24 20.84 Favored Glycine 0 N--CA 1.465 0.631 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 169.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -100.63 93.68 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 CA--C 1.541 0.608 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.77 169.484 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 p . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.27 127.52 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.969 1.308 . . . . 0.0 108.79 169.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -109.87 116.21 31.24 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -110.37 129.22 55.8 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.671 0.748 . . . . 0.0 111.747 173.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -110.59 113.56 26.27 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 123.418 1.58 . . . . 0.0 109.492 169.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -91.15 104.6 17.15 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 126.482 1.913 . . . . 0.0 112.222 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 tp -101.22 116.72 33.46 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.0 0.92 . . . . 0.0 112.669 177.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 59.4 mtp -97.69 141.17 31.04 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.515 1.526 . . . . 0.0 114.047 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.97 118.43 5.38 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 168.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 mp -106.91 22.99 15.1 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.799 1.64 . . . . 0.0 113.899 -169.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.0 p . . . . . 0 N--CA 1.475 0.821 0 O-C-N 120.2 -1.563 . . . . 0.0 113.522 176.589 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t . . . . . 0 CA--C 1.547 0.86 0 CA-C-O 121.999 0.904 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.05 88.11 0.18 Allowed Glycine 0 C--N 1.338 0.67 0 C-N-CA 127.34 2.4 . . . . 0.0 108.185 -169.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -94.68 141.31 28.77 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.54 1.136 . . . . 0.0 109.315 -169.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.9 tt -124.59 137.63 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.92 151.06 17.27 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 171.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -119.52 151.74 38.1 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.236 0.614 . . . . 0.0 111.596 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.18 147.57 17.67 Favored Glycine 0 C--N 1.342 0.913 0 C-N-CA 124.005 0.812 . . . . 0.0 113.45 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.9 t -118.09 150.69 38.92 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.48 1.512 . . . . 0.0 110.95 175.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.15 148.25 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.126 1.371 . . . . 0.0 108.925 172.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.59 -77.04 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.889 0.875 . . . . 0.0 109.429 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -177.83 -23.51 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 130.695 3.598 . . . . 0.0 108.201 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.3 ttt -49.26 -49.04 45.22 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.742 1.617 . . . . 0.0 109.603 167.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 173.4 175.95 0.12 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 130.59 3.556 . . . . 0.0 110.156 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -91.37 130.8 37.17 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 104.721 -2.325 . . . . 0.0 104.721 166.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -121.68 120.33 34.39 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.653 0.781 . . . . 0.0 110.119 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -83.9 117.73 23.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.936 0.894 . . . . 0.0 110.817 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 82.4 mt -130.35 108.73 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.451 1.5 . . . . 0.0 107.0 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.5 tp 87.56 112.37 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 128.26 2.624 . . . . 0.0 111.212 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -76.55 158.85 30.84 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.397 1.879 . . . . 0.0 109.961 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.8 mt -52.7 112.97 0.93 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.974 1.261 . . . . 0.0 110.858 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.472 0.659 0 C-N-CA 125.267 1.427 . . . . 0.0 112.474 -171.191 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.2 t -123.08 171.29 9.4 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.381 1.872 . . . . 0.0 111.012 169.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.38 152.5 17.56 Favored Glycine 0 N--CA 1.478 1.496 0 O-C-N 120.588 -1.32 . . . . 0.0 114.907 -173.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -146.3 157.38 43.79 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.925 1.69 . . . . 0.0 113.939 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 tp -83.54 -71.76 0.49 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.458 1.503 . . . . 0.0 109.724 169.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.76 148.04 40.77 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.641 1.176 . . . . 0.0 112.589 -170.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 m -59.45 -46.85 98.87 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-O 116.61 -1.662 . . . . 0.0 113.299 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -66.25 139.51 55.31 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.758 2.306 . . . . 0.0 113.174 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.37 164.52 13.82 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.003 1.321 . . . . 0.0 113.736 175.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.6 38.44 2.3 Favored Glycine 0 N--CA 1.475 1.242 0 C-N-CA 125.249 1.404 . . . . 0.0 116.582 -169.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.67 ' CG ' HD21 ' A' ' 110' ' ' LEU . 8.2 tp-100 -63.38 -38.45 91.19 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -168.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -83.92 -10.62 57.83 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -74.12 -46.86 39.99 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.991 1.269 . . . . 0.0 108.625 168.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.69 68.88 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.698 1.599 . . . . 0.0 112.058 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.2 p -54.78 -36.41 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 118.796 -0.621 . . . . 0.0 112.239 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.96 -38.9 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 116.36 -1.781 . . . . 0.0 111.687 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -52.18 -55.3 21.91 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 121.066 1.757 . . . . 0.0 109.001 172.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 73.5 t -52.49 -31.43 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.946 1.298 . . . . 0.0 113.157 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.09 -20.24 52.62 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.78 -31.4 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -174.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.472 ' HB3' ' SG ' ' A' ' 135' ' ' CYS . 6.2 p -79.61 67.24 5.32 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 121.846 2.112 . . . . 0.0 112.719 176.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.9 tp -42.58 -41.08 2.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 128.944 2.898 . . . . 0.0 111.757 172.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.95 -22.02 75.12 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 118.383 -1.231 . . . . 0.0 114.935 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -102.06 -37.15 8.3 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.034 1.417 . . . . 0.0 112.411 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.0 mm -69.39 -39.6 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.37 22.36 29.64 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.233 1.397 . . . . 0.0 113.541 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -59.24 145.58 42.36 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.002 1.401 . . . . 0.0 110.628 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -125.48 -167.22 1.66 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.32 1.048 . . . . 0.0 111.748 171.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -74.49 9.97 1.52 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -168.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.3 -136.62 2.42 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 121.365 1.893 . . . . 0.0 110.518 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -104.03 142.02 35.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.69 1.596 . . . . 0.0 107.792 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -126.22 117.81 23.86 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -167.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -114.5 128.14 56.18 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.168 0.587 . . . . 0.0 111.91 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.3 tt -107.18 95.61 5.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 169.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.1 t -83.74 124.28 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 173.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.67 HD21 ' CG ' ' A' ' 85' ' ' GLN . 10.2 tt -122.92 125.82 46.06 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -170.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.411 HG22 HG23 ' A' ' 170' ' ' VAL . 37.3 t -116.16 134.33 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 O-C-N 124.433 1.083 . . . . 0.0 111.697 -175.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.0 t -145.76 -172.42 3.9 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.043 169.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -145.03 5.77 1.14 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.514 1.526 . . . . 0.0 114.872 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -163.01 176.35 10.21 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.764 2.026 . . . . 0.0 109.184 169.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -61.49 -177.91 0.11 Allowed 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 -171.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -127.54 160.2 32.28 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.815 1.646 . . . . 0.0 113.794 -169.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -77.57 128.11 33.6 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.305 0.642 . . . . 0.0 110.836 169.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.2 mp -94.68 165.74 12.35 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.953 1.301 . . . . 0.0 110.119 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.09 146.23 39.36 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.634 -0.666 . . . . 0.0 111.171 169.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 75.05 -11.84 1.02 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 128.83 2.852 . . . . 0.0 114.268 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -66.21 -23.26 66.4 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 120.303 1.41 . . . . 0.0 112.245 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -70.99 1.48 5.6 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.1 t -56.78 -32.01 65.22 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.279 1.032 . . . . 0.0 111.815 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.16 -46.99 88.27 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.345 1.058 . . . . 0.0 112.273 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -90.23 21.73 30.01 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.1 1.333 . . . . 0.0 114.03 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.317 5.6 t 56.18 39.79 30.22 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 127.8 2.44 . . . . 0.0 114.444 173.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 59.9 mtt85 -106.49 117.3 33.68 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.459 1.104 . . . . 0.0 109.121 169.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -99.58 -49.68 4.32 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -66.14 119.32 11.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.773 0.715 . . . . 0.0 111.9 -170.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.442 ' HA ' ' HB3' ' A' ' 149' ' ' ASP . 8.9 t -74.58 156.51 36.72 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.656 0.782 . . . . 0.0 111.91 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.2 t -62.0 141.24 58.17 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.012 0.911 . . . . 0.0 113.249 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -78.13 -9.83 59.35 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.048 1.739 . . . . 0.0 112.926 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.29 0.64 90.23 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.397 -1.224 . . . . 0.0 115.527 174.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.7 mtt85 -111.12 172.13 7.06 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.216 1.508 . . . . 0.0 112.597 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 95' ' ' CYS . 34.8 t -75.92 143.48 41.63 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -168.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -132.99 52.74 2.06 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.771 2.028 . . . . 0.0 111.317 175.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.56 132.32 46.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.896 1.678 . . . . 0.0 109.601 -175.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -145.58 -49.35 0.23 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.216 1.007 . . . . 0.0 112.153 172.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -77.79 -8.51 58.11 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.93 -6.58 37.5 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.236 1.398 . . . . 0.0 113.706 -169.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.2 mtt -130.71 143.56 50.82 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.329 1.452 . . . . 0.0 112.657 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -70.4 89.02 0.67 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.823 1.649 . . . . 0.0 112.618 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -16.1 61.05 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -170.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.7 m -89.87 -5.54 56.73 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -28.68 14.16 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.594 1.088 . . . . 0.0 113.761 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.16 -16.87 79.09 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 117.448 -1.751 . . . . 0.0 115.501 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -128.54 -67.84 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.928 0 CA-C-N 120.307 2.053 . . . . 0.0 113.677 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -50.56 141.9 32.49 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 CA-C-N 123.509 2.289 . . . . 0.0 115.536 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.442 ' HB3' ' HA ' ' A' ' 130' ' ' THR . 26.0 t0 -68.42 178.76 1.86 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.117 2.167 . . . . 0.0 112.73 172.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -69.58 163.85 24.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.66 1.219 . . . . 0.0 112.116 169.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -88.09 126.55 35.17 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.8 m -63.8 152.61 38.99 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.762 -0.586 . . . . 0.0 110.582 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.523 HG13 HD11 ' A' ' 186' ' ' ILE . 72.0 t -53.97 -32.96 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 O-C-N 121.681 -0.637 . . . . 0.0 111.873 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.86 -45.42 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.871 1.269 . . . . 0.0 112.52 173.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -71.61 -35.95 70.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.905 0.882 . . . . 0.0 111.169 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.431 HD12 HG12 ' A' ' 186' ' ' ILE . 1.5 tm? -59.75 -52.99 63.1 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 169.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.17 -43.09 96.09 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.9 p -67.65 -38.79 84.31 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.497 -0.752 . . . . 0.0 112.348 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.484 ' HA ' ' HE2' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -70.96 -35.5 72.2 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.682 -1.261 . . . . 0.0 112.863 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 97.3 mt -60.89 -41.66 96.45 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.805 0.842 . . . . 0.0 111.892 170.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.25 75.91 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.44 1.096 . . . . 0.0 113.17 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -80.91 -39.47 26.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.646 0.778 . . . . 0.0 111.753 -174.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -87.93 -6.23 58.15 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 171.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 31.1 m120 58.19 56.2 4.68 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.865 1.666 . . . . 0.0 111.52 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 51.3 mm -94.55 137.61 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.259 1.424 . . . . 0.0 109.716 171.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -107.21 109.4 62.85 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 119.843 1.201 . . . . 0.0 107.83 168.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -73.06 148.83 45.48 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.205 1.937 . . . . 0.0 112.215 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.419 HG22 HG13 ' A' ' 170' ' ' VAL . 4.5 mp -131.27 99.63 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 170.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -73.78 78.37 1.58 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.498 -0.751 . . . . 0.0 111.937 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.419 HG13 HG22 ' A' ' 168' ' ' ILE 0.361 3.8 m -79.27 116.15 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 123.431 1.586 . . . . 0.0 113.389 174.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 28.6 m -144.23 155.94 57.86 Favored Pre-proline 0 N--CA 1.478 0.928 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.181 -169.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -78.95 153.25 25.28 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.488 2.792 . . . . 0.0 111.307 -172.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 77.1 p -37.45 -49.34 1.02 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.315 2.246 . . . . 0.0 115.061 -169.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -54.1 -38.32 65.22 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.918 1.287 . . . . 0.0 114.094 -174.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.9 ptm -103.31 -4.47 24.19 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 42.4 t -54.84 -45.26 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.4 1.0 . . . . 0.0 109.85 -171.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . 0.3 0.0 OUTLIER -76.02 -3.89 38.25 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -170.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 82.9 m -92.75 -34.24 13.98 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.33 1.052 . . . . 0.0 110.677 168.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -74.41 -25.83 59.71 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.997 -1.064 . . . . 0.0 110.183 171.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -64.6 -25.34 67.92 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.783 -1.198 . . . . 0.0 110.07 168.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -79.82 -22.84 42.54 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 120.1 -1.625 . . . . 0.0 110.517 176.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 18.4 tp -82.22 -26.13 33.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.308 2.243 . . . . 0.0 109.377 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.7 t -76.11 -13.56 60.2 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.381 -0.825 . . . . 0.0 112.976 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . 0.328 0.0 OUTLIER -99.08 -20.55 16.64 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 118.753 -0.642 . . . . 0.0 111.026 169.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -76.91 -31.06 56.44 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.17 0.895 . . . . 0.0 111.481 169.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.523 HD11 HG13 ' A' ' 153' ' ' VAL . 4.6 mp -115.92 108.89 45.75 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.046 0.938 . . . . 0.0 109.954 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.94 145.41 56.04 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 121.978 1.785 . . . . 0.0 111.255 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt 97.42 -20.58 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 130.557 3.543 . . . . 0.0 114.509 169.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.35 166.84 22.86 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.661 0.664 . . . . 0.0 110.721 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.4 p -125.17 -150.54 0.45 Allowed 'General case' 0 C--N 1.346 0.445 0 CA-C-O 122.926 1.346 . . . . 0.0 109.206 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 11.6 tt 179.08 131.21 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 126.668 1.987 . . . . 0.0 109.843 -167.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -126.2 160.35 20.6 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.592 1.091 . . . . 0.0 112.183 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -89.58 92.16 8.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 122.651 1.215 . . . . 0.0 107.824 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.6 tm? . . . . . 0 CA--C 1.538 0.498 0 CA-C-N 113.594 -1.639 . . . . 0.0 108.51 169.155 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.91 147.52 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 126.524 1.93 . . . . 0.0 107.825 172.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.38 124.94 31.38 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.242 0.544 . . . . 0.0 109.93 169.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 mp -115.02 137.88 51.5 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -121.31 107.57 12.68 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 122.8 1.286 . . . . 0.0 110.705 173.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -80.64 103.12 10.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.778 2.031 . . . . 0.0 112.049 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -100.45 113.04 25.48 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.989 1.315 . . . . 0.0 110.588 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 87.3 mtp -97.82 147.05 24.81 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -94.06 124.4 7.86 Favored Glycine 0 CA--C 1.542 1.762 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 168.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.5 mp -115.22 29.39 8.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 125.332 1.453 . . . . 0.0 114.896 -170.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.557 ' HB3' HG13 ' A' ' 49' ' ' VAL . 19.5 p . . . . . 0 N--CA 1.479 1.008 0 O-C-N 120.207 -1.558 . . . . 0.0 113.172 -172.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 122.203 1.002 . . . . 0.0 109.822 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.84 79.78 0.28 Allowed Glycine 0 C--N 1.339 0.712 0 C-N-CA 126.874 2.178 . . . . 0.0 109.0 -170.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -82.42 132.14 35.21 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -170.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.9 tp -110.66 138.41 38.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.632 0.773 . . . . 0.0 110.238 -175.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.95 159.21 22.57 Favored Glycine 0 N--CA 1.468 0.768 0 C-N-CA 125.555 1.55 . . . . 0.0 112.088 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -138.08 128.33 26.01 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -169.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.98 159.18 25.99 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 124.688 1.137 . . . . 0.0 113.978 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.6 m -134.15 140.54 46.63 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.425 1.49 . . . . 0.0 111.94 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.488 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -147.18 146.98 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.121 -0.987 . . . . 0.0 112.556 177.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.557 HG13 ' HB3' ' A' ' 13' ' ' SER . 81.9 t -134.2 -80.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 126.105 1.762 . . . . 0.0 108.319 170.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.409 ' H ' ' H ' ' A' ' 51' ' ' MET 0.338 0.0 OUTLIER -168.45 -7.1 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.877 1 C-N-CA 132.862 4.465 . . . . 0.0 109.338 168.772 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.409 ' H ' ' H ' ' A' ' 50' ' ' ASN . 49.6 mtm -77.57 46.27 0.53 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.875 1.67 . . . . 0.0 107.399 166.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.351 3.2 t 52.12 -164.5 0.07 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 130.617 3.567 . . . . 0.0 114.057 -169.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -108.78 130.03 55.38 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.223 2.609 . . . . 0.0 109.33 -175.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -118.07 118.58 32.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.627 0.727 . . . . 0.0 111.142 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -84.62 114.12 21.76 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.075 1.35 . . . . 0.0 109.196 169.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.8 mm -107.67 -24.12 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.7 tp -146.91 120.33 9.03 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.018 1.281 . . . . 0.0 112.161 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.07 152.0 25.19 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.017 1.727 . . . . 0.0 112.566 172.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.81 120.49 4.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.366 1.066 . . . . 0.0 110.506 175.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.227 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.1 t . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 120.623 0.249 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.1 m -107.24 -156.97 0.6 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.481 1.512 . . . . 0.0 110.899 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -156.99 153.49 24.74 Favored Glycine 0 N--CA 1.478 1.466 0 O-C-N 119.874 -1.766 . . . . 0.0 116.291 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.8 tptt -157.88 161.95 38.31 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.614 1.566 . . . . 0.0 112.475 169.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.5 mt -70.26 -47.64 60.41 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.941 1.696 . . . . 0.0 114.507 -169.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.84 137.89 42.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.438 0.695 . . . . 0.0 111.926 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.254 13.6 t -67.89 -41.14 26.78 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-O 115.816 -2.04 . . . . 0.0 113.975 173.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.15 150.29 82.06 Favored 'Trans proline' 0 C--N 1.36 1.132 0 CA-C-N 123.09 2.139 . . . . 0.0 111.924 170.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.43 ' H ' ' HA ' ' A' ' 116' ' ' PHE . 52.8 mtpt -121.93 160.28 25.14 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -171.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.07 19.07 28.27 Favored Glycine 0 N--CA 1.476 1.304 0 CA-C-O 118.175 -1.347 . . . . 0.0 116.174 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -49.5 -32.45 12.23 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.84 1.82 . . . . 0.0 113.384 -173.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.416 HD11 ' CD2' ' A' ' 156' ' ' LEU . 11.8 tp -60.16 -41.36 92.64 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.222 1.009 . . . . 0.0 113.441 -176.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.93 -40.03 87.53 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.549 0.339 . . . . 0.0 110.767 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.54 -52.72 50.44 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 117.633 -1.175 . . . . 0.0 112.257 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -54.76 -38.12 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 120.113 1.324 . . . . 0.0 111.306 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.7 t -71.46 -39.79 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 118.943 0.792 . . . . 0.0 112.681 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -67.93 -41.44 82.56 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.514 1.052 . . . . 0.0 112.05 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.467 HG11 HD13 ' A' ' 108' ' ' LEU . 78.7 t -56.4 -40.4 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.194 0.598 . . . . 0.0 110.401 171.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.62 -40.85 80.19 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.86 -8.65 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -171.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 4.7 t -90.88 67.72 6.18 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.258 -1.526 . . . . 0.0 111.431 172.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -46.98 -42.77 18.48 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.145 1.778 . . . . 0.0 111.171 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.43 -23.54 53.73 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.43 1.014 . . . . 0.0 115.524 -170.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -94.34 -43.45 8.39 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.689 1.245 . . . . 0.0 110.351 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.4 mm -65.36 -39.23 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 118.671 -0.68 . . . . 0.0 110.439 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.43 24.49 23.84 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.44 1.019 . . . . 0.0 114.176 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -55.52 128.06 32.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.224 1.41 . . . . 0.0 113.586 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.86 173.42 6.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.236 1.814 . . . . 0.0 110.29 169.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -89.69 57.01 3.74 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.778 1.231 . . . . 0.0 112.793 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.04 -121.14 4.86 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.335 1.445 . . . . 0.0 110.235 170.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.7 p -119.57 127.91 53.42 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.524 1.93 . . . . 0.0 106.092 169.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -112.1 110.86 21.37 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.918 0.781 . . . . 0.0 110.819 -167.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -111.42 97.72 6.95 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -168.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.467 HD13 HG11 ' A' ' 92' ' ' VAL . 11.1 tp -87.12 94.87 9.76 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.586 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.411 HG13 HG21 ' A' ' 170' ' ' VAL . 44.9 t -83.76 116.7 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 37.9 mt -109.31 109.96 21.0 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.165 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.38 125.14 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 O-C-N 123.934 0.771 . . . . 0.0 111.83 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -161.55 150.14 15.69 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.736 0.814 . . . . 0.0 111.229 172.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -105.31 -1.21 25.46 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.338 1.455 . . . . 0.0 114.756 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -121.35 -178.44 3.78 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.496 1.118 . . . . 0.0 111.889 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -77.33 -172.51 2.5 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.648 1.179 . . . . 0.0 111.231 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.43 ' HA ' ' H ' ' A' ' 83' ' ' LYS . 21.5 p90 -139.16 157.17 46.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.075 0.95 . . . . 0.0 112.633 -169.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -79.9 129.75 34.74 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.226 1.01 . . . . 0.0 110.717 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mp -98.99 173.21 6.95 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.851 1.26 . . . . 0.0 109.583 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.65 146.46 10.15 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.776 -0.578 . . . . 0.0 111.59 169.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 90.0 mttt 82.37 -18.98 0.43 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 128.261 2.624 . . . . 0.0 113.269 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.86 -35.71 82.01 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.002 1.273 . . . . 0.0 112.324 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -68.61 -5.28 19.08 Favored 'General case' 0 CA--C 1.551 1.0 0 O-C-N 120.927 -1.108 . . . . 0.0 113.858 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.03 -23.64 65.01 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.906 -1.121 . . . . 0.0 112.849 171.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 mp -63.74 -33.88 76.65 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.212 0.915 . . . . 0.0 110.796 169.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -84.44 16.43 34.92 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 126.127 1.823 . . . . 0.0 113.874 169.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.334 1.3 t 71.08 15.52 6.56 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 129.844 3.258 . . . . 0.0 115.095 176.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.599 ' HA ' ' HE ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -99.96 106.42 18.21 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.963 -1.086 . . . . 0.0 112.244 -177.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -88.51 -48.82 7.31 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.938 1.695 . . . . 0.0 112.411 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 -60.43 131.2 50.01 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -169.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.3 t -63.29 146.07 54.23 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.766 1.227 . . . . 0.0 111.157 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.2 p -53.72 128.95 31.55 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 125.695 1.598 . . . . 0.0 113.879 169.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -72.86 -26.62 61.52 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.422 0.689 . . . . 0.0 112.424 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.4 -25.64 7.91 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 125.697 1.618 . . . . 0.0 112.884 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -61.59 164.91 5.42 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.202 1.801 . . . . 0.0 112.878 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 38.7 t -73.53 136.74 44.1 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.522 0.729 . . . . 0.0 111.231 170.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -137.96 40.75 2.32 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.743 1.617 . . . . 0.0 111.96 172.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.96 156.19 19.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.941 0.896 . . . . 0.0 110.849 171.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.84 -80.16 0.16 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.475 1.11 . . . . 0.0 111.504 171.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.26 28.0 0.76 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.743 1.617 . . . . 0.0 112.771 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.03 -9.73 68.32 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.923 1.725 . . . . 0.0 113.454 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 13.1 mmt -96.74 146.45 24.87 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.777 1.231 . . . . 0.0 112.336 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -77.88 95.12 4.67 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.888 0.851 . . . . 0.0 110.815 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.0 ttp-105 -51.85 -40.15 60.06 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.619 1.968 . . . . 0.0 112.857 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.3 m -87.34 2.75 49.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -169.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.5 ttp85 -56.73 -33.84 66.91 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 121.731 2.06 . . . . 0.0 111.857 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.61 -4.26 87.51 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.29 1.424 . . . . 0.0 115.14 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.298 15.1 tp10 -122.42 -82.3 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.139 0 CA-C-O 115.774 -2.06 . . . . 0.0 111.051 173.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -47.13 146.8 6.0 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 123.341 2.694 . . . . 0.0 116.541 170.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.94 179.55 4.85 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -69.23 147.03 51.83 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.386 -0.822 . . . . 0.0 110.876 170.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -71.4 154.68 41.37 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.527 -0.733 . . . . 0.0 111.964 -177.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.5 p -88.5 155.91 19.39 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.704 -0.623 . . . . 0.0 111.343 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.2 t -59.27 -29.12 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 121.373 -0.829 . . . . 0.0 112.585 -169.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 37.4 t -66.8 -42.46 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.373 1.469 . . . . 0.0 111.59 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -70.49 -29.55 66.11 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.233 1.013 . . . . 0.0 111.715 -174.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.517 HD12 HD11 ' A' ' 186' ' ' ILE . 1.0 OUTLIER -64.23 -54.72 29.08 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.789 0.836 . . . . 0.0 109.796 170.514 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.53 -37.7 68.27 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.219 1.008 . . . . 0.0 111.959 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.5 m -60.59 -65.29 0.71 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.312 1.045 . . . . 0.0 112.336 170.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.265 68.9 mmtt -76.25 -17.39 59.5 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.121 -1.612 . . . . 0.0 114.835 -169.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mp -71.72 -41.4 68.6 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.782 0.833 . . . . 0.0 109.493 168.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.32 -35.48 66.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.454 1.102 . . . . 0.0 113.853 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.9 -41.52 78.15 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.942 0.897 . . . . 0.0 110.736 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -87.96 -0.3 56.82 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 65.24 31.01 11.02 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.524 1.129 . . . . 0.0 113.012 170.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 57.2 mt -94.92 134.18 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 120.89 -1.131 . . . . 0.0 108.969 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -107.34 100.51 33.89 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-N 119.078 0.853 . . . . 0.0 111.826 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.02 154.57 74.2 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.746 2.297 . . . . 0.0 115.81 169.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 38.0 mt -132.27 110.77 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.892 1.677 . . . . 0.0 107.775 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -77.58 79.5 4.08 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 123.214 1.483 . . . . 0.0 110.844 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.411 HG21 HG13 ' A' ' 109' ' ' VAL . 89.7 t -65.98 109.04 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.583 169.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 27.3 m -148.38 146.52 23.05 Favored Pre-proline 0 N--CA 1.476 0.841 0 O-C-N 120.757 -1.215 . . . . 0.0 112.696 -170.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.36 151.97 27.66 Favored 'Trans proline' 0 C--N 1.351 0.696 1 C-N-CA 125.533 4.155 . . . . 0.0 114.129 169.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 68.3 p -56.81 -29.16 62.47 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -169.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 40.7 tpt85 -58.95 -36.68 75.21 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.927 1.24 . . . . 0.0 112.774 -177.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 34.5 mtt -118.1 12.79 13.7 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.436 1.272 . . . . 0.0 114.436 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 5.4 t -53.39 -34.88 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.646 1.112 . . . . 0.0 111.22 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.4 ' HA ' ' HB2' ' A' ' 180' ' ' GLU . 45.6 tptt -80.78 -15.04 57.47 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -175.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.12 -34.17 43.61 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.445 1.02 . . . . 0.0 110.383 174.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -80.58 -36.93 32.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.054 1.342 . . . . 0.0 110.342 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 177' ' ' LYS . 9.5 mt-10 -62.7 -13.37 31.62 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.114 0.87 . . . . 0.0 113.072 171.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -105.01 -11.0 16.84 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -80.15 -30.56 38.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.385 1.474 . . . . 0.0 109.154 169.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 58.6 p -77.11 -11.45 59.81 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.144 1.378 . . . . 0.0 112.406 173.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.8 m -78.39 -30.72 47.97 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 168.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -81.42 -28.15 34.4 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 171.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.517 HD11 HD12 ' A' ' 156' ' ' LEU . 6.2 mt -117.52 86.09 22.17 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 123.855 0.862 . . . . 0.0 110.711 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.47 149.02 92.17 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.755 2.304 . . . . 0.0 112.196 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt 89.25 -17.08 0.25 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 130.665 3.586 . . . . 0.0 113.017 -175.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.2 mt -76.03 162.39 28.09 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.272 0.629 . . . . 0.0 110.766 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.6 p -129.9 -161.5 1.12 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 48.2 mm -162.13 149.02 4.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 130.332 3.453 . . . . 0.0 109.385 -167.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.06 156.55 26.89 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 168.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -96.81 84.2 3.56 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.644 1.578 . . . . 0.0 108.374 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.471 0.576 0 CA-C-O 122.57 1.176 . . . . 0.0 110.572 169.795 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.7 p . . . . . 0 CA--C 1.546 0.801 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.33 100.97 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-O 122.127 0.965 . . . . 0.0 112.018 -175.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.97 95.93 4.93 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.687 1.195 . . . . 0.0 109.501 171.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.1 tt -90.31 121.38 32.26 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.991 0.516 . . . . 0.0 111.837 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -113.72 109.52 18.71 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 123.728 1.727 . . . . 0.0 109.213 169.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -81.18 104.88 11.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.699 -2.046 . . . . 0.0 111.718 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -108.53 111.31 23.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.618 0.767 . . . . 0.0 109.897 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 28.0 ptm -119.07 149.04 42.35 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.1 134.59 14.58 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.29 1.424 . . . . 0.0 110.892 169.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 mp -102.97 29.64 5.31 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.584 1.954 . . . . 0.0 111.608 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 p . . . . . 0 CA--C 1.539 0.551 0 C-N-CA 126.112 1.765 . . . . 0.0 113.505 -179.857 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.998 0.904 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.68 86.54 0.23 Allowed Glycine 0 C--N 1.337 0.616 0 C-N-CA 125.82 1.676 . . . . 0.0 109.086 -169.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.6 mmt-85 -72.39 138.82 47.47 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.436 1.494 . . . . 0.0 108.672 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 tt -126.6 133.25 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-N 119.062 0.846 . . . . 0.0 111.712 -177.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.89 159.68 26.54 Favored Glycine 0 N--CA 1.475 1.264 0 C-N-CA 126.035 1.778 . . . . 0.0 112.51 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -137.04 133.27 35.29 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -169.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.63 145.94 17.99 Favored Glycine 0 C--N 1.343 0.948 0 C-N-CA 124.827 1.203 . . . . 0.0 111.945 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.7 m -128.49 149.0 50.77 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.084 0.953 . . . . 0.0 112.137 -173.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.1 152.32 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-N 118.99 0.814 . . . . 0.0 113.149 -175.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.4 t -141.5 -84.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 125.152 1.381 . . . . 0.0 109.269 168.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.428 ' H ' ' H ' ' A' ' 51' ' ' MET . 54.0 t30 -149.54 -20.63 0.28 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.847 2.459 . . . . 0.0 108.269 169.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.428 ' H ' ' H ' ' A' ' 50' ' ' ASN . 76.4 mtm -75.78 50.17 0.56 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 127.514 2.325 . . . . 0.0 106.202 166.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.342 4.0 t 32.74 -149.56 0.0 OUTLIER 'General case' 0 C--N 1.345 0.375 1 C-N-CA 133.915 4.886 . . . . 0.0 116.71 -168.835 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -106.0 137.35 44.06 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 130.287 3.435 . . . . 0.0 109.343 -174.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -129.37 126.56 39.15 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 122.604 1.192 . . . . 0.0 109.739 168.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -87.35 116.65 25.59 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.851 2.06 . . . . 0.0 109.399 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.7 mt -110.01 -57.46 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.131 -169.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -103.98 117.25 33.84 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.104 0.865 . . . . 0.0 112.907 173.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -64.27 147.45 52.43 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 166.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mp -61.5 126.56 27.8 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 121.072 1.76 . . . . 0.0 110.461 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.476 0.83 0 C-N-CA 124.635 1.174 . . . . 0.0 111.469 -173.726 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.6 m -125.82 159.87 31.32 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.268 1.827 . . . . 0.0 113.138 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.63 161.79 13.49 Favored Glycine 0 N--CA 1.476 1.331 0 C-N-CA 125.089 1.328 . . . . 0.0 114.757 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -158.76 147.92 18.89 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.075 2.15 . . . . 0.0 109.654 171.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.08 -74.58 0.06 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.542 1.537 . . . . 0.0 112.193 176.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.81 154.62 41.67 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -173.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.6 m -67.19 -52.42 30.05 Favored Pre-proline 0 N--CA 1.474 0.742 0 CA-C-O 116.372 -1.775 . . . . 0.0 113.913 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -71.08 152.99 62.97 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.107 1.872 . . . . 0.0 111.661 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -133.46 158.99 41.68 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.66 34.13 2.08 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 117.309 1.684 . . . . 0.0 117.309 -168.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -74.02 -21.32 60.02 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -170.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.4 tp -56.96 -53.03 62.65 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.424 0.689 . . . . 0.0 109.79 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -63.57 -31.46 72.64 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.841 -1.162 . . . . 0.0 112.741 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.24 -51.77 68.12 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.86 170.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.494 ' CG1' HD13 ' A' ' 110' ' ' LEU . 27.4 m -59.64 -26.55 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 119.909 1.232 . . . . 0.0 112.851 177.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 156' ' ' LEU . 37.9 t -70.81 -56.64 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.06 173.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -58.56 -36.78 74.46 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.55 0.614 . . . . 0.0 109.623 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.555 HG11 HD13 ' A' ' 108' ' ' LEU . 52.9 t -60.74 -31.46 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 173.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.78 -51.63 11.04 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.247 -0.908 . . . . 0.0 113.295 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.2 mm -71.28 -23.65 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 119.789 1.177 . . . . 0.0 113.31 -169.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.436 ' HG ' ' HG ' ' A' ' 135' ' ' CYS . 0.0 OUTLIER -85.32 61.09 6.64 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.567 -1.333 . . . . 0.0 112.433 -173.012 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -46.56 -44.65 18.14 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.448 1.499 . . . . 0.0 110.821 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.97 -24.2 28.01 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.678 1.132 . . . . 0.0 115.207 -171.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -88.4 -40.95 13.13 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.829 1.315 . . . . 0.0 111.042 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 92' ' ' VAL . 27.0 mt -79.64 -31.9 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 121.321 -0.862 . . . . 0.0 110.551 176.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.81 31.76 20.07 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.666 -0.519 . . . . 0.0 113.358 169.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -55.48 120.99 8.02 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.482 1.113 . . . . 0.0 112.414 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -76.45 170.37 16.51 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.716 0.807 . . . . 0.0 111.007 169.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -89.62 52.42 2.32 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.85 0.86 . . . . 0.0 112.095 169.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.7 -119.05 3.87 Favored Glycine 0 N--CA 1.471 0.982 0 N-CA-C 105.867 -2.893 . . . . 0.0 105.867 168.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.6 t -124.76 131.38 53.46 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.23 137.5 41.28 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -168.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -136.42 104.78 5.71 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -167.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.555 HD13 HG11 ' A' ' 92' ' ' VAL . 20.9 tp -97.41 101.0 12.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.744 -175.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.6 t -73.81 127.8 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 168.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.494 HD13 ' CG1' ' A' ' 89' ' ' VAL . 21.4 tp -116.26 130.12 56.62 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 169.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.422 ' CG2' HD22 ' A' ' 194' ' ' LEU 0.257 6.5 p -141.86 129.97 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.6 t -147.3 -176.46 5.24 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 113.351 -1.75 . . . . 0.0 111.277 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -130.82 -7.98 3.99 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 127.063 2.145 . . . . 0.0 113.607 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -150.14 169.4 21.37 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.917 1.287 . . . . 0.0 112.936 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -53.14 167.52 0.17 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.554 2.342 . . . . 0.0 115.677 -170.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -92.99 163.84 13.51 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . 78.2 m-70 -102.59 124.07 47.47 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 165.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.5 mp -104.32 177.21 4.91 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.757 1.223 . . . . 0.0 110.538 -172.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.44 145.46 4.71 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.367 58.6 pttt 56.29 2.79 0.09 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 128.345 2.658 . . . . 0.0 116.891 -170.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -66.34 -28.91 69.03 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 121.475 1.943 . . . . 0.0 112.442 170.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . 0.329 20.1 mttt -75.14 7.61 3.22 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 176.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.6 t -70.92 -18.69 62.65 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.781 1.232 . . . . 0.0 111.209 168.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 mp -65.71 -23.76 66.83 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.196 0.998 . . . . 0.0 112.196 169.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -88.42 -130.72 3.61 Favored Glycine 0 CA--C 1.538 1.482 0 N-CA-C 106.64 -2.584 . . . . 0.0 106.64 168.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.3 m -142.2 68.4 1.32 Allowed 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 118.008 0.904 . . . . 0.0 109.28 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -134.45 81.02 1.88 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.795 1.638 . . . . 0.0 108.665 -175.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -79.49 -45.74 18.76 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.729 0.812 . . . . 0.0 111.726 -176.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -57.99 120.62 8.86 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.049 0.54 . . . . 0.0 111.341 -171.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.4 t -72.13 154.33 41.14 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-O 122.577 1.18 . . . . 0.0 111.246 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.7 p -61.46 138.46 58.27 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 127.425 2.29 . . . . 0.0 115.674 -171.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 54.4 p30 -87.69 -18.15 30.16 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -175.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.28 17.38 78.81 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.988 -0.896 . . . . 0.0 114.017 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 37.5 ttm105 -96.9 158.73 15.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.954 1.702 . . . . 0.0 110.426 174.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . 0.436 ' HG ' ' HG ' ' A' ' 95' ' ' CYS . 0.0 OUTLIER -87.71 146.16 25.81 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.07 -1.019 . . . . 0.0 112.95 169.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -140.7 55.66 1.58 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.273 1.829 . . . . 0.0 110.663 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 tt -130.67 130.13 43.49 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.34 2.256 . . . . 0.0 108.418 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -145.56 -50.07 0.24 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 169.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -72.37 -20.91 61.38 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.905 1.282 . . . . 0.0 114.107 176.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 131.37 -17.88 5.01 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.118 1.818 . . . . 0.0 114.328 -172.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 80.5 mtp -113.52 157.72 21.66 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.989 1.895 . . . . 0.0 114.116 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -73.31 91.98 1.76 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.787 0.835 . . . . 0.0 110.972 171.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -54.62 -38.57 66.98 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.313 1.045 . . . . 0.0 112.535 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 64.8 m -79.58 0.74 28.73 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -41.32 -46.31 3.23 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 120.529 1.513 . . . . 0.0 112.338 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.68 -7.75 88.02 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 117.966 -1.463 . . . . 0.0 115.161 -172.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.276 88.8 tt0 -114.5 -79.39 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.025 0 CA-C-O 115.891 -2.004 . . . . 0.0 112.141 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.92 158.22 48.39 Favored 'Trans proline' 0 C--N 1.356 0.948 0 CA-C-N 123.509 2.289 . . . . 0.0 113.275 170.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -77.27 -168.25 1.08 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.673 1.589 . . . . 0.0 113.514 170.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 117' ' ' HIS . 71.2 m-85 -69.2 144.83 53.62 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 172.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.53 153.12 43.79 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 54.6 p -85.66 150.97 24.24 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.317 -0.864 . . . . 0.0 112.833 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 70.0 t -56.0 -43.83 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.597 0.759 . . . . 0.0 110.945 -176.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.5 t -75.68 -26.66 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.005 -1.059 . . . . 0.0 112.682 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -61.24 -32.81 72.6 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.869 1.213 . . . . 0.0 110.135 170.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.42 ' CD2' HG22 ' A' ' 90' ' ' VAL . 5.6 mt -83.69 -33.06 25.24 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.809 -0.557 . . . . 0.0 112.373 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.78 84.47 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.187 0.449 . . . . 0.0 110.331 169.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.1 t -55.29 -51.62 66.08 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.229 1.012 . . . . 0.0 111.193 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -73.57 -48.82 29.94 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.7 mp -73.2 -18.63 61.23 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.701 -1.249 . . . . 0.0 112.169 -173.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.66 -30.54 41.26 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 119.115 0.871 . . . . 0.0 112.586 168.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -68.9 -48.32 63.63 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.322 1.449 . . . . 0.0 109.76 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -79.95 -8.98 59.63 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.042 1.337 . . . . 0.0 111.964 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 59.5 49.13 8.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.769 2.427 . . . . 0.0 112.794 171.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 19.2 mm -96.97 147.21 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.929 1.691 . . . . 0.0 109.671 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -105.96 102.14 37.62 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 120.82 1.645 . . . . 0.0 109.549 168.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.439 ' C ' HD12 ' A' ' 168' ' ' ILE . 37.6 Cg_exo -76.23 125.9 8.82 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.977 3.118 . . . . 0.0 113.108 169.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.485 HG13 HG23 ' A' ' 190' ' ' THR . 1.3 mp -119.51 109.49 26.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -77.13 73.31 3.71 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 122.436 1.112 . . . . 0.0 112.371 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.428 HG23 HG22 ' A' ' 168' ' ' ILE . 77.4 t -60.0 104.18 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.893 0.877 . . . . 0.0 109.468 167.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 6.3 m -149.42 148.46 26.31 Favored Pre-proline 0 N--CA 1.481 1.122 0 O-C-N 119.871 -1.768 . . . . 0.0 113.2 -173.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -58.8 153.72 48.39 Favored 'Trans proline' 0 C--N 1.354 0.838 1 C-N-CA 125.625 4.217 . . . . 0.0 116.291 178.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 29.2 t -51.74 -54.61 26.57 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -169.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 80.2 mmt-85 -60.42 -13.32 12.81 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 120.549 1.522 . . . . 0.0 114.407 -173.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 14.3 ttp -105.53 -16.52 14.69 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.431 2.293 . . . . 0.0 114.641 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.9 m -62.49 -24.83 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 122.123 2.238 . . . . 0.0 112.344 -170.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -60.27 -28.69 68.27 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.9 t -92.17 -33.56 14.67 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.172 0.589 . . . . 0.0 111.453 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -69.57 -32.25 70.92 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.377 -1.452 . . . . 0.0 109.964 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -68.05 -12.97 61.8 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.453 1.101 . . . . 0.0 112.309 169.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -96.9 -29.21 13.83 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.16 -0.963 . . . . 0.0 111.291 173.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.5 -26.81 63.76 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 119.895 -1.753 . . . . 0.0 109.758 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.4 t -81.15 -15.2 56.49 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.98 -19.44 44.06 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.805 169.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -88.78 -31.58 18.3 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 170.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 14.8 mm -101.78 111.86 64.56 Favored Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 119.547 1.067 . . . . 0.0 109.505 176.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.77 0.65 4.01 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 124.924 3.749 . . . . 0.0 119.779 -168.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -128.68 -2.95 5.36 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 -176.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.431 HD22 ' HB2' ' A' ' 167' ' ' PRO . 9.2 mt -83.21 172.75 12.29 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.93 1.241 . . . . 0.0 113.299 -169.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.485 HG23 HG13 ' A' ' 168' ' ' ILE 0.446 0.1 OUTLIER -141.5 -176.42 4.73 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 167.989 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.9 mp -157.88 136.68 3.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 131.478 3.911 . . . . 0.0 109.354 -166.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -118.38 147.46 18.56 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 172.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -87.43 87.38 7.39 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 122.863 1.316 . . . . 0.0 107.658 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.422 HD22 ' CG2' ' A' ' 111' ' ' VAL . 12.3 tp . . . . . 0 CA--C 1.546 0.81 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.494 169.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 t . . . . . 0 CA--C 1.543 0.694 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 t -110.19 95.66 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.628 1.171 . . . . 0.0 110.125 -171.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -76.39 118.33 18.97 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.544 -0.723 . . . . 0.0 110.352 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.1 mt -107.25 137.79 44.66 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.685 -0.634 . . . . 0.0 110.191 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -122.49 109.48 14.41 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 122.579 1.18 . . . . 0.0 108.986 169.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -83.26 110.64 18.26 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.856 1.262 . . . . 0.0 111.808 173.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' A' ' 88' ' ' ALA . 30.3 tp -103.21 124.23 48.22 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.981 0.912 . . . . 0.0 110.62 170.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 40.7 ttp -121.88 138.68 54.3 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -169.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.53 133.58 12.62 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.943 1.259 . . . . 0.0 112.159 172.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tp -119.31 26.53 9.38 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.799 1.639 . . . . 0.0 113.3 -173.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 179.08 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 123.061 1.41 . . . . 0.0 111.694 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.62 94.66 0.11 Allowed Glycine 0 CA--C 1.517 0.182 0 N-CA-C 105.898 -2.881 . . . . 0.0 105.898 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -92.36 147.47 22.89 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 122.727 0.411 . . . . 0.0 110.402 -168.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.0 tt -122.26 129.27 75.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 124.196 0.998 . . . . 0.0 109.946 -172.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.75 157.84 14.94 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.273 1.416 . . . . 0.0 110.853 172.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -141.58 131.75 24.84 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.24 155.68 24.1 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 124.407 1.004 . . . . 0.0 113.199 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 74.3 m -119.32 139.95 51.12 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.009 1.324 . . . . 0.0 111.316 -177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.3 tt -142.53 157.97 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.787 1.235 . . . . 0.0 111.328 171.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -158.46 -59.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -179.28 -28.97 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 129.861 3.264 . . . . 0.0 107.499 172.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.4 70.98 3.85 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 101.64 -3.467 . . . . 0.0 101.64 165.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.326 14.8 t 19.43 -138.45 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.763 1 C-N-CA 132.129 4.172 . . . . 0.0 116.318 -169.333 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -117.43 146.05 43.73 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 129.335 3.054 . . . . 0.0 109.892 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -134.04 123.28 24.25 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.54 0.736 . . . . 0.0 111.152 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -85.79 98.33 10.68 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.378 1.071 . . . . 0.0 110.08 169.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.5 tt -83.98 -64.24 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.504 0.722 . . . . 0.0 112.258 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 tp -109.27 117.38 33.94 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.605 1.162 . . . . 0.0 110.437 -171.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -60.59 147.76 40.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.498 0.719 . . . . 0.0 112.043 173.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.2 tt -50.41 115.13 1.32 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.554 1.942 . . . . 0.0 110.961 172.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.481 1.087 0 C-N-CA 125.073 1.349 . . . . 0.0 112.353 -170.187 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.5 p -103.19 -151.01 0.42 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.511 0.724 . . . . 0.0 111.866 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -142.87 141.53 10.69 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.375 1.464 . . . . 0.0 112.252 173.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -151.79 144.89 24.57 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.965 1.706 . . . . 0.0 110.652 173.431 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.56 -38.61 14.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -169.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.43 139.81 42.52 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.8 p -76.0 -38.63 2.51 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-O 115.89 -2.005 . . . . 0.0 114.905 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.99 136.61 53.41 Favored 'Trans proline' 0 C--N 1.355 0.885 0 CA-C-N 122.555 1.948 . . . . 0.0 112.897 171.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -102.22 160.38 14.57 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.548 1.539 . . . . 0.0 113.402 179.298 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.35 22.37 1.66 Allowed Glycine 0 N--CA 1.477 1.426 0 O-C-N 120.883 -1.136 . . . . 0.0 115.147 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -47.16 -34.18 5.94 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.386 2.274 . . . . 0.0 114.573 -169.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.29 -32.92 71.65 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.592 -0.718 . . . . 0.0 112.421 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -57.75 -52.11 66.81 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.307 0.958 . . . . 0.0 110.416 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.474 ' HB3' HD21 ' A' ' 9' ' ' LEU . . . -60.29 -49.6 76.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 116.464 -1.731 . . . . 0.0 111.18 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.468 HG12 HD13 ' A' ' 110' ' ' LEU . 16.4 m -55.35 -38.36 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 121.378 1.899 . . . . 0.0 114.423 -169.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.5 HG11 ' HG3' ' A' ' 151' ' ' GLN . 1.3 p -86.37 -38.79 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 117.451 -1.262 . . . . 0.0 112.582 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -60.74 -44.42 96.7 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 121.161 1.8 . . . . 0.0 109.776 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.254 6.4 m -65.56 -4.11 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 120.773 1.624 . . . . 0.0 114.239 174.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.77 -18.07 17.39 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.772 1.229 . . . . 0.0 113.222 169.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.9 mt -104.89 -19.06 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 126.004 1.722 . . . . 0.0 111.735 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 95.3 m -73.16 42.42 0.11 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 127.338 2.255 . . . . 0.0 113.581 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -50.39 -41.41 52.02 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.027 1.331 . . . . 0.0 111.412 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.37 -26.77 46.24 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.24 0.924 . . . . 0.0 115.121 -174.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -88.54 -41.85 12.44 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.161 0.98 . . . . 0.0 110.277 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 74.6 mt -76.03 -38.44 35.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 CA-C-O 117.495 -1.241 . . . . 0.0 110.809 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.19 20.21 31.02 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 119.199 0.909 . . . . 0.0 115.145 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -52.05 125.91 16.94 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.079 1.351 . . . . 0.0 113.063 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -98.12 174.6 6.45 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.356 1.462 . . . . 0.0 113.196 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -71.76 1.55 6.72 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -174.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.25 -134.72 2.01 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 120.666 1.576 . . . . 0.0 110.223 -178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.3 t -97.58 143.29 28.41 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.865 1.266 . . . . 0.0 108.299 175.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -142.0 118.44 10.9 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 119.365 0.984 . . . . 0.0 110.183 -169.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -119.16 109.95 16.47 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -169.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.58 96.77 7.57 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.415 175.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.99 118.49 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.468 HD13 HG12 ' A' ' 89' ' ' VAL . 45.8 tp -108.97 128.97 55.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 117.765 -1.112 . . . . 0.0 109.846 -174.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.8 t -120.91 134.79 63.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.6 t -161.24 166.54 27.56 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 112.801 -2.0 . . . . 0.0 109.624 169.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -124.03 7.72 8.61 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.856 2.062 . . . . 0.0 114.214 174.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -141.83 -177.63 5.29 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.573 1.549 . . . . 0.0 111.51 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -55.08 177.87 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.491 2.316 . . . . 0.0 114.696 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -139.34 158.78 43.56 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.82 2.048 . . . . 0.0 110.015 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -85.54 126.67 34.05 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.201 0.6 . . . . 0.0 111.368 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.587 HD22 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -91.11 176.1 6.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.481 1.512 . . . . 0.0 108.992 172.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.587 ' H ' HD22 ' A' ' 118' ' ' LEU . . . -55.22 148.78 13.73 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.177 -0.952 . . . . 0.0 112.139 169.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.1 mptt 76.55 -13.86 0.88 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.479 2.312 . . . . 0.0 113.589 -176.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -65.62 -19.34 65.87 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.254 -1.529 . . . . 0.0 111.622 169.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -66.16 -24.08 66.58 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.345 3.0 t -75.66 -11.8 60.07 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 119.216 0.916 . . . . 0.0 112.13 -173.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.4 mt -60.63 -34.84 74.86 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.977 -1.077 . . . . 0.0 110.84 167.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -92.26 15.34 62.36 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.826 1.679 . . . . 0.0 113.711 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.543 0.1 OUTLIER 44.05 54.27 6.0 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 128.672 2.789 . . . . 0.0 113.917 -176.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -104.0 132.14 50.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.017 2.127 . . . . 0.0 105.59 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -113.78 -35.96 4.99 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 120.786 1.63 . . . . 0.0 113.315 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -48.07 116.86 1.67 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.789 1.236 . . . . 0.0 112.037 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.8 t -62.87 157.37 21.66 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.912 0.778 . . . . 0.0 110.164 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -66.53 132.3 47.91 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.838 -0.539 . . . . 0.0 110.622 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.82 -11.15 59.65 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.8 75.14 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 118.65 -1.083 . . . . 0.0 113.793 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -125.79 178.28 5.8 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.243 1.417 . . . . 0.0 112.328 170.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 1.2 m -99.39 146.24 26.51 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -169.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -151.55 56.38 0.87 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.568 1.547 . . . . 0.0 113.289 -169.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -134.26 151.43 51.28 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.918 -1.113 . . . . 0.0 111.511 169.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -147.41 -49.95 0.18 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.209 1.004 . . . . 0.0 113.511 -169.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -80.44 -10.16 59.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.242 1.017 . . . . 0.0 112.73 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.07 -9.31 27.17 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.476 1.989 . . . . 0.0 113.928 -171.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 29.9 ttm -99.26 136.13 39.66 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.8 1.8 . . . . 0.0 111.69 174.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.463 ' CE1' ' HB3' ' A' ' 144' ' ' SER . 30.6 t80 -66.66 95.98 0.37 Allowed 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.49 -0.756 . . . . 0.0 111.947 171.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -53.23 -45.33 68.66 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.22 2.208 . . . . 0.0 112.685 -178.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.463 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 17.2 t -67.79 -19.65 65.12 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -168.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -48.56 -35.32 13.13 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 121.035 1.743 . . . . 0.0 114.064 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.92 -16.82 74.92 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 119.099 -0.834 . . . . 0.0 113.482 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -117.73 -84.49 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.359 0 CA-C-O 115.946 -1.978 . . . . 0.0 109.802 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -51.51 157.64 4.81 Favored 'Trans proline' 0 C--N 1.358 1.03 0 N-CA-C 120.072 3.066 . . . . 0.0 120.072 171.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.446 ' HB2' ' HE3' ' A' ' 122' ' ' LYS . 47.9 t0 -77.03 166.77 22.87 Favored 'General case' 0 N--CA 1.468 0.448 1 C-N-CA 131.875 4.07 . . . . 0.0 115.595 -179.156 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -71.62 123.08 21.71 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 166.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.667 ' CD ' ' H ' ' A' ' 151' ' ' GLN . 1.0 OUTLIER -51.17 147.23 5.66 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 125.875 1.67 . . . . 0.0 112.217 171.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 7.7 t -85.11 166.25 16.8 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.982 0.896 . . . . 0.0 112.561 173.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.46 -27.9 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -168.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.2 p -84.09 -26.39 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 175.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -68.78 -34.16 75.09 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.358 -0.839 . . . . 0.0 110.293 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -58.59 -59.91 4.65 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.037 0.535 . . . . 0.0 110.297 169.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.24 -36.44 66.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.743 0.817 . . . . 0.0 113.069 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.4 t -58.89 -57.55 12.57 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.408 1.083 . . . . 0.0 112.417 175.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -81.37 -22.3 38.48 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.786 -1.196 . . . . 0.0 113.902 -174.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.4 mp -61.08 -48.02 83.63 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.117 0.967 . . . . 0.0 109.869 168.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.88 -28.78 55.51 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -67.91 -50.7 54.66 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.644 0.778 . . . . 0.0 110.179 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -84.16 -1.21 54.62 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.7 t30 64.08 31.86 13.18 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.753 1.161 . . . . 0.0 112.078 169.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.8 mt -97.75 128.61 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -103.87 115.33 63.56 Favored Pre-proline 0 N--CA 1.477 0.891 0 CA-C-N 119.461 1.028 . . . . 0.0 111.954 175.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.31 153.68 35.87 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.482 2.122 . . . . 0.0 115.803 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.04 113.57 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.789 1.636 . . . . 0.0 109.111 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.403 ' CD1' HD23 ' A' ' 110' ' ' LEU . 21.7 m-85 -71.56 68.15 0.56 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 122.248 1.023 . . . . 0.0 112.793 176.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.1 t -63.85 102.13 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 O-C-N 120.035 -1.665 . . . . 0.0 111.54 170.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 16.3 m -143.45 145.27 31.12 Favored Pre-proline 0 N--CA 1.478 0.934 0 O-C-N 120.074 -1.641 . . . . 0.0 111.174 -174.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -56.96 150.25 56.69 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.79 2.993 . . . . 0.0 112.941 173.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.5 t -46.54 -44.71 18.11 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.705 1.602 . . . . 0.0 114.123 -169.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.4 ptm85 -53.54 -27.95 28.86 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 12.8 tpt -106.02 -4.53 20.39 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.684 1.594 . . . . 0.0 113.917 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.37 -35.52 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 120.239 -1.538 . . . . 0.0 112.807 -169.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -68.53 -20.32 64.55 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.9 m -88.83 -40.22 13.3 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.211 1.404 . . . . 0.0 110.202 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -70.27 -26.42 63.81 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.341 -0.849 . . . . 0.0 111.149 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.75 -16.68 64.24 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.428 1.013 . . . . 0.0 111.844 168.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -82.06 -29.46 31.86 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.742 -1.224 . . . . 0.0 111.35 169.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.55 -26.17 57.75 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.581 -1.325 . . . . 0.0 110.217 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.03 -16.48 53.19 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.612 1.565 . . . . 0.0 111.78 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.77 -28.33 24.62 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.929 0.491 . . . . 0.0 110.286 169.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -78.14 -26.19 47.74 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 62.3 mt -117.3 96.94 50.15 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 123.701 0.801 . . . . 0.0 110.062 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.34 138.98 55.67 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.248 3.299 . . . . 0.0 113.836 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt 76.28 -8.75 1.59 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 129.038 2.935 . . . . 0.0 113.721 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.439 HD23 ' H ' ' A' ' 190' ' ' THR . 2.9 tt -72.59 150.96 42.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 169.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.439 ' H ' HD23 ' A' ' 189' ' ' LEU . 2.3 m -129.53 -139.15 0.23 Allowed 'General case' 0 C--N 1.343 0.294 0 CA-C-O 122.212 1.006 . . . . 0.0 109.549 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.9 tt -173.42 160.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 127.083 2.153 . . . . 0.0 109.807 -168.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -150.69 147.48 17.58 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 169.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.65 89.25 7.44 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.813 1.245 . . . . 0.0 108.42 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.7 tp . . . . . 0 CA--C 1.537 0.479 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.11 169.156 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.541 0.624 0 CA-C-O 119.009 -0.519 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.575 HG13 HG23 ' A' ' 105' ' ' THR . 51.3 t -139.62 118.05 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 119.111 0.868 . . . . 0.0 111.883 -176.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -93.74 122.69 36.46 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 122.888 0.475 . . . . 0.0 110.062 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -107.88 120.31 41.91 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.219 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -113.73 104.86 12.63 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 124.783 2.23 . . . . 0.0 110.183 171.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -75.63 117.72 17.7 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 111.52 -2.582 . . . . 0.0 111.761 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.5 tp -118.89 111.06 17.91 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.06 0.944 . . . . 0.0 110.79 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -114.04 137.13 52.13 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 118.821 2.897 . . . . 0.0 118.821 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.24 112.52 4.22 Favored Glycine 0 C--N 1.341 0.819 0 C-N-CA 125.639 1.59 . . . . 0.0 110.268 171.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.3 tp -98.89 28.91 4.05 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.791 1.637 . . . . 0.0 111.456 -172.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.0 p . . . . . 0 CA--C 1.543 0.686 0 O-C-N 120.253 -1.529 . . . . 0.0 114.368 -171.581 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 123.403 1.573 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.11 90.83 0.2 Allowed Glycine 0 C--N 1.332 0.348 0 N-CA-C 105.693 -2.963 . . . . 0.0 105.693 -176.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -76.17 144.13 40.71 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -170.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 mt -136.69 128.18 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 118.078 0.399 . . . . 0.0 110.084 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.91 149.42 19.36 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 126.402 1.953 . . . . 0.0 110.247 -173.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -129.89 131.89 46.21 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.626 1.17 . . . . 0.0 113.926 -169.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.03 152.81 22.95 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 171.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 75.1 p -130.29 154.22 47.85 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.427 0.691 . . . . 0.0 110.796 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -151.43 140.73 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -169.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.589 ' CG2' ' H ' ' A' ' 50' ' ' ASN 0.308 1.4 m -136.53 -84.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-N 119.735 1.152 . . . . 0.0 111.386 169.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.589 ' H ' ' CG2' ' A' ' 49' ' ' VAL 0.49 4.8 t-20 -156.97 -5.88 0.1 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 129.776 3.23 . . . . 0.0 111.713 169.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.0 ptp -88.99 44.45 1.21 Allowed 'General case' 0 CA--C 1.578 2.044 1 N-CA-C 98.994 -4.447 . . . . 0.0 98.994 160.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.552 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.681 14.6 m 14.23 -113.69 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.179 1 C-N-CA 137.324 6.25 . . . . 0.0 116.135 -164.941 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -112.56 136.83 51.63 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 125.727 1.892 . . . . 0.0 112.513 -168.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -124.43 120.87 33.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.654 1.181 . . . . 0.0 108.028 168.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -84.88 98.6 10.42 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.391 1.477 . . . . 0.0 110.426 169.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -86.88 -33.99 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 121.173 -0.954 . . . . 0.0 113.396 -174.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.4 tt -154.1 129.91 10.12 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.534 1.061 . . . . 0.0 111.375 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -78.79 169.23 18.56 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.407 HD11 ' CE3' ' A' ' 101' ' ' TRP . 73.3 mt -51.86 101.27 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.946 1.698 . . . . 0.0 112.075 176.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.479 1.021 0 C-N-CA 125.648 1.579 . . . . 0.0 112.32 -179.839 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.2 t -101.93 -150.67 0.41 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 127.715 2.406 . . . . 0.0 112.44 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -159.92 155.89 27.05 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 125.716 1.627 . . . . 0.0 114.573 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -162.12 162.37 28.54 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.999 1.72 . . . . 0.0 112.208 174.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -78.85 -52.64 8.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.073 1.749 . . . . 0.0 111.71 -177.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.31 136.17 46.15 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.931 0.892 . . . . 0.0 111.773 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 80.4 m -72.97 -47.84 8.15 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-O 116.178 -1.867 . . . . 0.0 113.475 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.01 148.67 89.75 Favored 'Trans proline' 0 C--N 1.355 0.89 0 CA-C-N 121.94 1.728 . . . . 0.0 110.992 171.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.523 ' HB2' HE22 ' A' ' 85' ' ' GLN . 29.4 mmmt -123.34 174.93 7.01 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.92 1.288 . . . . 0.0 112.576 -169.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -99.74 23.13 37.32 Favored Glycine 0 N--CA 1.482 1.741 0 O-C-N 119.836 -1.79 . . . . 0.0 115.799 -170.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.523 HE22 ' HB2' ' A' ' 83' ' ' LYS . 0.4 OUTLIER -62.13 -17.73 58.73 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 120.359 2.079 . . . . 0.0 116.239 -169.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.496 ' HA ' HG22 ' A' ' 89' ' ' VAL . 4.9 mp -70.56 -14.09 62.36 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.413 ' HA ' HE22 ' A' ' 151' ' ' GLN . 93.4 m-20 -72.87 -49.99 26.58 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 167.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.08 -51.11 70.54 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 116.065 -1.922 . . . . 0.0 111.652 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.496 HG22 ' HA ' ' A' ' 86' ' ' LEU . 28.8 m -52.27 -34.28 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 121.191 1.814 . . . . 0.0 112.135 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.868 HG21 HD22 ' A' ' 156' ' ' LEU . 12.4 t -87.6 -37.64 11.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 116.768 -1.587 . . . . 0.0 113.03 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -60.54 -46.6 89.58 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 121.862 2.119 . . . . 0.0 109.203 169.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.1 t -54.68 -40.19 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 125.509 1.524 . . . . 0.0 112.194 175.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.63 -42.32 64.54 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.8 mt -76.52 -38.78 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.455 1.102 . . . . 0.0 113.01 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 66.5 m -81.1 61.27 4.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.829 1.651 . . . . 0.0 110.619 -169.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.4 mt -50.79 -44.51 58.89 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.076 2.55 . . . . 0.0 111.619 -171.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.66 -22.39 66.94 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.691 -176.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -87.49 -47.89 8.38 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.963 0.905 . . . . 0.0 110.416 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.9 mp -70.29 -34.45 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.203 0.601 . . . . 0.0 110.769 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.2 29.41 8.98 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.23 1.395 . . . . 0.0 114.498 172.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.407 ' CE3' HD11 ' A' ' 59' ' ' LEU . 53.1 m95 -57.46 125.31 22.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.707 1.254 . . . . 0.0 112.952 -174.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -86.38 -177.07 6.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.195 2.198 . . . . 0.0 111.223 170.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -97.13 26.16 4.94 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.317 1.447 . . . . 0.0 114.808 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.69 -128.7 1.82 Allowed Glycine 0 CA--C 1.539 1.534 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.575 HG23 HG13 ' A' ' 4' ' ' VAL 0.308 7.2 t -112.72 152.52 28.98 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.536 -1.332 . . . . 0.0 108.173 167.171 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -130.16 129.88 44.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 117.439 -1.267 . . . . 0.0 110.362 -167.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -126.62 125.26 41.61 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.88 1.673 . . . . 0.0 115.343 -168.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 108' ' ' LEU . 48.7 mt -97.7 103.29 15.22 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.676 0.75 . . . . 0.0 112.305 169.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.536 HG13 HG21 ' A' ' 170' ' ' VAL . 36.0 t -90.78 95.34 5.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 174.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 37.0 tp -94.8 123.84 38.5 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 170' ' ' VAL 0.273 11.6 p -113.83 139.15 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 170.213 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -164.07 156.39 17.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.24 1.816 . . . . 0.0 109.885 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -106.23 -0.2 24.69 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.58 1.552 . . . . 0.0 114.456 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -144.13 179.47 7.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.195 1.398 . . . . 0.0 111.953 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.28 -174.33 0.12 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 122.992 1.377 . . . . 0.0 113.387 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -135.28 158.57 44.02 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.492 1.917 . . . . 0.0 112.691 -169.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -86.65 130.31 34.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.065 1.346 . . . . 0.0 109.862 169.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.474 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -110.14 170.21 8.23 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.825 1.25 . . . . 0.0 111.634 177.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.82 133.63 42.52 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.911 0.386 . . . . 0.0 111.87 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.4 mttm 91.94 -16.14 0.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 130.596 3.558 . . . . 0.0 113.008 -174.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -63.61 -28.95 70.28 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 121.484 1.947 . . . . 0.0 112.971 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -69.39 -5.54 24.21 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 121.472 -0.768 . . . . 0.0 112.855 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.9 t -62.77 -34.35 77.06 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.445 1.098 . . . . 0.0 112.469 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.66 -28.44 67.71 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.814 0.734 . . . . 0.0 112.373 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -81.05 4.05 73.11 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.109 1.338 . . . . 0.0 113.811 169.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.6 m 75.1 31.73 0.81 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 127.843 2.457 . . . . 0.0 111.6 175.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -115.06 110.87 20.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.553 1.141 . . . . 0.0 111.216 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -96.84 -40.6 8.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.347 1.459 . . . . 0.0 112.303 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -66.35 123.06 18.94 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.992 0.814 . . . . 0.0 110.977 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.9 t -65.93 152.75 43.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.946 0.899 . . . . 0.0 110.605 175.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 t -68.97 138.27 54.43 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.312 1.053 . . . . 0.0 111.963 174.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -82.76 -13.37 56.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.159 1.784 . . . . 0.0 113.911 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.2 31.74 63.56 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.838 -0.979 . . . . 0.0 113.017 -176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -107.61 164.99 11.75 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.213 1.405 . . . . 0.0 112.714 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 26.2 t -67.51 119.45 12.33 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.864 1.265 . . . . 0.0 110.593 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -123.85 40.79 3.64 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.276 1.43 . . . . 0.0 111.838 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.4 tp -122.18 117.95 27.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.755 1.622 . . . . 0.0 108.422 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -120.34 -49.02 2.28 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.463 1.105 . . . . 0.0 108.732 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -86.46 -130.31 0.05 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.727 1.611 . . . . 0.0 108.34 168.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.33 -21.67 7.88 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.089 1.328 . . . . 0.0 113.674 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 21.0 mtt -93.26 142.79 26.92 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.788 1.294 . . . . 0.0 112.78 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -64.56 100.44 0.37 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.721 1.208 . . . . 0.0 110.351 169.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -61.77 -40.32 94.74 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.188 0.995 . . . . 0.0 112.593 -174.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 63.8 m -82.24 6.63 16.11 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 23.2 ttp-105 -47.87 -50.72 25.6 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.698 1.135 . . . . 0.0 111.49 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.39 -31.99 68.38 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-O 118.421 -1.21 . . . . 0.0 113.107 -169.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.291 6.4 tp10 -92.66 -84.57 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.104 0 CA-C-O 115.579 -2.153 . . . . 0.0 112.025 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.31 155.14 71.38 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 CA-C-N 124.646 2.695 . . . . 0.0 116.168 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -72.72 161.56 30.59 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 129.913 3.285 . . . . 0.0 113.847 176.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -52.44 138.4 27.47 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.833 0.853 . . . . 0.0 111.281 172.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.665 ' NE2' ' H ' ' A' ' 151' ' ' GLN 0.271 0.0 OUTLIER -82.18 143.78 31.17 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.094 -1.004 . . . . 0.0 112.014 178.85 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 70.6 m -74.99 148.88 39.54 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.401 1.08 . . . . 0.0 112.769 -174.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.442 ' HA ' ' HG ' ' A' ' 156' ' ' LEU 0.296 33.4 t -58.61 -22.06 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -177.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.4 t -65.33 -44.66 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 118.893 0.769 . . . . 0.0 111.553 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.42 -29.99 59.92 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.552 0.741 . . . . 0.0 110.729 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.868 HD22 HG21 ' A' ' 90' ' ' VAL . 2.1 mt -63.62 -45.76 88.83 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 172.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.41 -45.89 69.55 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.222 1.009 . . . . 0.0 112.713 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 76.5 p -69.78 -38.84 76.85 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -174.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.34 -45.86 58.05 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.153 -0.967 . . . . 0.0 112.147 173.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.7 mt -53.25 -40.38 64.56 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.923 1.238 . . . . 0.0 113.24 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.73 -28.18 50.72 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -82.7 -34.39 27.33 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.571 1.078 . . . . 0.0 111.536 176.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -72.41 -18.9 61.68 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.843 0.857 . . . . 0.0 111.974 171.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 63.9 39.93 7.81 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.08 1.752 . . . . 0.0 112.314 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.05 143.56 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-O 117.052 -1.451 . . . . 0.0 109.731 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -105.34 115.67 61.64 Favored Pre-proline 0 N--CA 1.481 1.111 0 CA-C-N 121.72 2.055 . . . . 0.0 112.627 170.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -80.38 149.39 19.15 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.635 2.224 . . . . 0.0 113.093 169.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.1 mt -137.22 110.28 7.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.875 1.67 . . . . 0.0 107.107 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -72.45 73.72 1.02 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.933 0.873 . . . . 0.0 112.355 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.536 HG21 HG13 ' A' ' 109' ' ' VAL . 88.1 t -65.54 92.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 120.945 -1.097 . . . . 0.0 111.862 172.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 24.4 m -139.2 138.97 21.67 Favored Pre-proline 0 N--CA 1.479 0.993 0 O-C-N 119.729 -1.857 . . . . 0.0 110.513 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -58.53 152.53 54.48 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.558 2.839 . . . . 0.0 114.01 173.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 72.6 p -46.23 -42.72 14.7 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 116.666 2.098 . . . . 0.0 116.666 -168.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -51.37 -40.84 60.03 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 120.214 1.37 . . . . 0.0 113.509 -171.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.6 8.59 33.27 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.5 t -59.85 -42.92 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 121.036 1.744 . . . . 0.0 110.885 -176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -69.58 -13.45 62.33 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -174.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . 0.443 ' HA ' ' HE2' ' A' ' 181' ' ' LYS 0.265 10.1 t -93.03 -27.5 16.95 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 118.86 0.754 . . . . 0.0 112.476 173.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -76.29 -29.76 57.5 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.49 -1.382 . . . . 0.0 109.509 168.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -58.03 -26.54 62.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.168 0.987 . . . . 0.0 110.818 169.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 178' ' ' THR . 55.3 mtmt -79.4 -40.28 30.43 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.573 -0.705 . . . . 0.0 109.589 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.6 mp -79.65 -18.66 50.94 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 120.668 -1.27 . . . . 0.0 111.532 -175.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.8 t -74.89 -11.52 60.15 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.066 0.46 . . . . 0.0 110.581 168.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.31 -28.67 23.57 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.177 -0.952 . . . . 0.0 109.434 168.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -76.85 -26.56 54.41 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.27 91.09 50.03 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.536 1.134 . . . . 0.0 110.654 170.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.06 153.45 32.25 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.596 3.531 . . . . 0.0 113.692 173.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 24.9 pttt 88.29 -19.11 0.23 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 131.464 3.906 . . . . 0.0 113.229 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.64 163.91 24.54 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.794 0.838 . . . . 0.0 110.267 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 36.0 p -123.0 -145.42 0.35 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 169.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.2 tt 178.65 138.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 129.055 2.942 . . . . 0.0 107.977 -168.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -133.52 143.5 15.21 Favored Glycine 0 N--CA 1.463 0.479 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -87.87 90.09 8.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 56.1 tp . . . . . 0 CA--C 1.539 0.545 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.602 169.736 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 119.989 -0.053 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.1 t -123.86 135.6 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.394 1.478 . . . . 0.0 109.406 172.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -114.59 113.3 24.2 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 168.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.522 HD23 HD12 ' A' ' 43' ' ' ILE . 59.0 tp -101.21 131.89 46.98 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.056 0.455 . . . . 0.0 111.999 171.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -121.09 111.64 17.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 123.631 1.682 . . . . 0.0 109.561 169.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -88.52 107.85 19.1 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.007 -1.906 . . . . 0.0 111.597 175.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.3 tp -100.59 120.14 39.6 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.997 1.319 . . . . 0.0 111.877 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 30.8 mtp -103.97 143.9 32.25 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.88 115.38 4.97 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.701 1.619 . . . . 0.0 109.731 168.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -99.56 35.4 1.99 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.299 1.84 . . . . 0.0 111.951 -174.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 p . . . . . 0 N--CA 1.471 0.589 0 C-N-CA 124.954 1.302 . . . . 0.0 113.605 -179.512 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 121.71 0.767 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.52 83.03 0.32 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 127.512 2.482 . . . . 0.0 107.492 -177.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -85.47 146.08 27.12 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 125.484 1.514 . . . . 0.0 108.019 -169.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.522 HD12 HD23 ' A' ' 6' ' ' LEU 0.261 11.9 tt -136.56 141.77 40.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 178.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.93 150.77 19.64 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 127.884 2.659 . . . . 0.0 109.816 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -126.79 130.29 49.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.36 146.19 16.63 Favored Glycine 0 C--N 1.343 0.97 0 C-N-CA 124.545 1.069 . . . . 0.0 112.626 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.9 t -119.14 143.5 47.17 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.813 1.645 . . . . 0.0 109.918 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.68 151.04 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.944 1.298 . . . . 0.0 108.581 176.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.94 -18.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 169.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 63.4 t30 117.42 -10.96 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 130.847 3.659 . . . . 0.0 111.597 -171.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.51 ' O ' HG23 ' A' ' 52' ' ' THR . 64.9 ttp -62.72 -44.21 96.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.93 -1.106 . . . . 0.0 108.585 169.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 51' ' ' MET . 55.5 p 176.13 -164.35 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.89 1 C-N-CA 135.234 5.413 . . . . 0.0 105.19 169.287 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -109.11 133.01 53.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 167.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -118.59 121.88 41.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.34 1.067 . . . . 0.0 110.638 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -80.57 111.12 16.69 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.761 169.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.5 mm -93.95 -53.6 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.218 1.007 . . . . 0.0 111.531 -173.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.8 tp -126.15 123.77 39.01 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.163 0.892 . . . . 0.0 111.897 -175.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -59.09 154.34 16.01 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.086 1.354 . . . . 0.0 112.15 173.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.5 mt -59.24 111.01 1.19 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.669 1.122 . . . . 0.0 110.884 172.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.478 0.957 0 C-N-CA 124.371 1.068 . . . . 0.0 112.746 -177.064 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 t . . . . . 0 CA--C 1.547 0.865 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.1 t -92.97 -162.09 0.9 Allowed 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 126.108 1.763 . . . . 0.0 112.133 172.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -159.76 125.15 1.44 Allowed Glycine 0 N--CA 1.481 1.638 0 O-C-N 119.742 -1.849 . . . . 0.0 115.129 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -145.88 167.04 24.21 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.541 1.936 . . . . 0.0 112.836 -173.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.1 mt -95.67 -49.18 5.48 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -169.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.64 136.81 41.93 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.716 0.689 . . . . 0.0 111.033 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.279 13.0 t -64.1 -42.52 69.44 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 114.661 -2.59 . . . . 0.0 115.18 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.66 149.35 73.55 Favored 'Trans proline' 0 C--N 1.359 1.098 0 CA-C-N 123.925 2.437 . . . . 0.0 113.242 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -102.96 165.51 10.98 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.911 0.884 . . . . 0.0 111.994 173.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.45 48.16 3.1 Favored Glycine 0 N--CA 1.48 1.576 0 C-N-CA 125.766 1.651 . . . . 0.0 112.106 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -68.34 -44.14 75.95 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -169.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -72.48 -15.82 61.8 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.814 -1.179 . . . . 0.0 112.848 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -58.29 -49.96 75.31 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.351 1.432 . . . . 0.0 108.398 168.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.32 -45.77 80.16 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.836 -0.54 . . . . 0.0 111.296 171.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.81 -41.33 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 118.178 -0.915 . . . . 0.0 112.294 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.4 t -58.91 -53.19 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 119.922 1.237 . . . . 0.0 109.844 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -62.76 -51.92 65.22 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 122.414 0.286 . . . . 0.0 110.846 -173.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.537 HG11 HD13 ' A' ' 108' ' ' LEU . 88.0 t -56.68 -27.98 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 123.471 0.708 . . . . 0.0 111.874 177.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.71 -32.62 23.43 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.83 -31.39 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.485 1.039 . . . . 0.0 112.218 -174.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 60.7 m -82.86 59.47 4.85 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.497 1.919 . . . . 0.0 111.125 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.61 -36.01 75.46 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.266 1.427 . . . . 0.0 113.051 -169.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.62 -32.97 58.82 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.376 0.512 . . . . 0.0 113.312 -174.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -94.77 -38.51 10.74 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.526 1.13 . . . . 0.0 111.354 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.4 mm -63.64 -37.04 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 120.915 1.689 . . . . 0.0 109.537 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.27 28.36 22.87 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.131 1.348 . . . . 0.0 113.818 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -57.44 119.65 6.87 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.191 1.495 . . . . 0.0 110.786 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.4 mmt-85 -83.42 -158.14 0.28 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.755 2.022 . . . . 0.0 108.805 171.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -81.69 -157.58 0.19 Allowed 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.27 -177.91 53.14 Favored Glycine 0 N--CA 1.424 -2.123 0 CA-C-O 125.541 2.745 . . . . 0.0 108.841 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.7 p -67.96 132.84 48.06 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 108.316 -3.942 . . . . 0.0 106.606 168.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.17 135.22 55.19 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 -177.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.414 ' CD2' ' HB2' ' A' ' 166' ' ' GLN . 1.8 t80 -138.48 124.62 20.23 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -166.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.537 HD13 HG11 ' A' ' 92' ' ' VAL . 52.4 tp -105.33 98.3 8.02 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.147 0.43 . . . . 0.0 111.011 177.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 39.5 t -80.45 121.68 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 170.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.412 HD23 ' C ' ' A' ' 110' ' ' LEU . 7.1 tt -109.41 120.85 43.75 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.7 t -111.59 132.4 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 124.129 0.893 . . . . 0.0 112.001 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.5 t -151.24 179.39 8.34 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.445 1.098 . . . . 0.0 111.283 171.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.57 -13.22 6.57 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.653 1.981 . . . . 0.0 114.097 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -137.09 173.55 11.57 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.49 1.516 . . . . 0.0 112.981 -171.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -60.79 -169.61 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.673 1.589 . . . . 0.0 114.08 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.88 146.37 25.6 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.537 1.681 . . . . 0.0 115.537 -167.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.506 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . 97.1 m-70 -82.18 93.38 7.06 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.983 1.313 . . . . 0.0 113.458 176.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.626 ' H ' HD23 ' A' ' 118' ' ' LEU . 0.4 OUTLIER -75.69 173.23 11.35 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.856 -1.152 . . . . 0.0 113.012 170.541 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -47.57 149.07 1.25 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.833 0.853 . . . . 0.0 113.119 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.302 38.6 pttt 76.86 -16.09 0.67 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 131.13 3.772 . . . . 0.0 114.635 -175.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -63.21 -38.26 90.48 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.483 1.038 . . . . 0.0 113.173 -175.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . 0.274 13.7 mttt -86.02 12.87 8.56 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 m -62.36 -26.77 68.64 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 118.975 0.807 . . . . 0.0 108.937 167.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.4 mt -61.65 -36.67 81.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.895 1.278 . . . . 0.0 112.361 169.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -85.62 22.75 10.11 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.596 2.046 . . . . 0.0 113.437 170.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.321 3.9 t 55.52 28.07 11.22 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.669 2.787 . . . . 0.0 114.226 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 149' ' ' ASP . 20.1 ttp180 -101.61 85.86 2.83 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.89 1.676 . . . . 0.0 110.364 -175.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -80.96 -45.65 16.33 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.187 0.995 . . . . 0.0 112.977 -173.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -60.44 121.09 11.22 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.231 1.012 . . . . 0.0 111.239 -169.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.0 t -68.84 143.49 54.54 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 120.184 1.356 . . . . 0.0 111.052 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.0 t -58.33 130.43 46.69 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.319 -0.863 . . . . 0.0 111.933 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.5 p30 -76.72 -9.97 59.05 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.032 1.333 . . . . 0.0 113.816 176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 71.1 23.17 78.36 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 117.797 -1.557 . . . . 0.0 114.124 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -100.16 168.19 9.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.099 1.759 . . . . 0.0 112.524 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 33.4 t -69.96 136.05 50.09 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.272 -0.893 . . . . 0.0 111.637 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -147.78 37.54 0.89 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.495 1.918 . . . . 0.0 112.053 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.7 mt -103.46 136.28 43.5 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.355 1.062 . . . . 0.0 110.768 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -155.29 135.43 13.05 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.338 1.455 . . . . 0.0 110.175 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.3 t0 52.71 27.76 5.59 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.536 1.534 . . . . 0.0 112.951 -169.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.06 -6.92 82.87 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.298 1.904 . . . . 0.0 114.793 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 38.7 mtt -98.78 142.59 30.13 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.829 1.814 . . . . 0.0 113.62 -174.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -76.32 81.13 3.08 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.14 0.976 . . . . 0.0 110.984 169.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -50.89 -44.61 59.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.303 1.441 . . . . 0.0 112.41 -175.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 94.3 p -78.95 -0.19 30.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -170.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 52' ' ' THR . 1.3 ttp180 -45.12 -39.67 6.23 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 121.125 1.784 . . . . 0.0 113.091 171.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.2 -19.43 79.63 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-O 118.297 -1.279 . . . . 0.0 114.793 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -111.65 -69.18 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 CA-C-O 116.334 -1.793 . . . . 0.0 113.154 -169.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -74.58 146.95 35.19 Favored 'Trans proline' 0 C--N 1.357 1.026 0 CA-C-N 123.697 2.356 . . . . 0.0 114.128 169.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 127' ' ' ARG . 24.3 t0 -77.6 167.63 21.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.476 2.711 . . . . 0.0 114.606 176.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.506 ' CE2' ' HB3' ' A' ' 117' ' ' HIS . 64.0 m-85 -53.54 148.17 9.82 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.434 1.094 . . . . 0.0 111.947 178.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.7 157.69 17.19 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.984 0.897 . . . . 0.0 112.38 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 73.6 m -87.36 149.27 24.61 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 168.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -56.8 -30.99 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.618 -1.301 . . . . 0.0 111.343 -175.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.18 -36.18 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.253 1.821 . . . . 0.0 112.964 173.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -75.89 -27.6 57.78 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.332 0.969 . . . . 0.0 111.572 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.52 -47.8 74.7 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.426 168.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.69 -37.33 70.73 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 99.2 p -72.24 -49.94 31.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.279 0.945 . . . . 0.0 113.119 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.572 ' HA ' ' HE2' ' A' ' 159' ' ' LYS . 8.7 mmpt? -70.51 -36.15 73.6 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.391 -1.443 . . . . 0.0 113.817 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.9 mt -68.58 -35.45 77.39 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.927 0.785 . . . . 0.0 112.05 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.05 -33.9 70.73 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -79.22 -44.06 22.57 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.096 0.558 . . . . 0.0 110.897 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -84.02 -0.59 52.27 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 68.96 16.07 8.8 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.676 2.391 . . . . 0.0 115.988 168.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 50.8 mt -75.28 139.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 120.623 -1.298 . . . . 0.0 110.319 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.414 ' HB2' ' CD2' ' A' ' 107' ' ' PHE . 11.3 mm-40 -99.45 95.84 3.91 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.097 173.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -73.82 144.82 35.45 Favored 'Trans proline' 0 C--N 1.352 0.754 0 CA-C-N 121.285 1.495 . . . . 0.0 114.564 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.7 mt -129.89 117.74 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 124.388 1.075 . . . . 0.0 110.754 170.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -78.48 76.09 4.99 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.461 1.124 . . . . 0.0 112.798 178.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.8 t -64.38 103.62 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 122.185 0.993 . . . . 0.0 112.483 169.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.407 ' HB ' ' HD2' ' A' ' 172' ' ' PRO . 17.4 m -144.47 157.97 54.97 Favored Pre-proline 0 N--CA 1.484 1.253 0 CA-C-O 117.573 -1.204 . . . . 0.0 111.239 -169.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.407 ' HD2' ' HB ' ' A' ' 171' ' ' VAL . 57.2 Cg_endo -73.87 165.14 32.9 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.603 2.869 . . . . 0.0 111.687 -171.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 73.9 p -52.08 -39.72 60.14 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.334 1.054 . . . . 0.0 113.338 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.7 ptt85 -63.18 -23.3 67.37 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.419 ' CE ' ' CE1' ' A' ' 179' ' ' TYR . 78.3 mtp -103.14 -22.87 13.69 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.3 t -56.47 -26.29 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 120.179 1.354 . . . . 0.0 112.009 -168.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.57 -29.88 70.91 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.918 1.287 . . . . 0.0 114.463 175.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 t -93.83 -37.98 11.47 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.889 0.876 . . . . 0.0 111.575 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.419 ' CE1' ' CE ' ' A' ' 175' ' ' MET . 12.1 m-85 -73.9 -28.5 61.57 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 120.149 -1.594 . . . . 0.0 110.233 175.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.525 ' HA ' HG22 ' A' ' 183' ' ' THR 0.268 17.5 tt0 -66.79 -10.85 51.9 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 119.348 0.976 . . . . 0.0 112.58 172.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -99.3 -7.83 25.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.063 -1.023 . . . . 0.0 113.684 169.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.85 -28.97 22.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.702 1.201 . . . . 0.0 109.406 168.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.525 HG22 ' HA ' ' A' ' 180' ' ' GLU . 15.1 t -85.88 -15.89 40.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 112.784 177.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 1.1 t -77.59 -25.86 50.25 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.302 -0.874 . . . . 0.0 108.751 168.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -80.19 -45.25 18.38 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.181 -0.438 . . . . 0.0 111.551 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 19.3 mt -94.81 106.53 25.25 Favored Pre-proline 0 N--CA 1.483 1.218 0 CA-C-O 118.335 -0.841 . . . . 0.0 109.469 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.87 147.17 67.98 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.41 2.073 . . . . 0.0 111.466 -173.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 83.06 -10.21 1.03 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.822 2.849 . . . . 0.0 113.693 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.1 mt -73.37 166.83 22.46 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.48 0.5 OUTLIER -143.47 -161.24 1.23 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 169.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.5 mt -160.52 142.7 4.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 C-N-CA 129.769 3.228 . . . . 0.0 111.982 -165.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -124.64 161.55 19.08 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.917 0.77 . . . . 0.0 111.808 169.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -92.37 100.16 12.79 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.888 1.675 . . . . 0.0 108.019 173.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 13.8 tp . . . . . 0 CA--C 1.541 0.608 0 CA-C-N 114.013 -1.449 . . . . 0.0 108.89 168.813 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 67.1 t -110.97 138.02 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.42 1.088 . . . . 0.0 109.8 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -116.56 117.94 31.25 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.184 1.393 . . . . 0.0 108.834 169.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.428 HD12 ' CB ' ' A' ' 107' ' ' PHE . 2.4 tp -110.28 130.52 55.53 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 118.883 0.765 . . . . 0.0 111.78 169.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.402 ' CD2' HG23 ' A' ' 99' ' ' ILE . 28.8 t80 -115.92 114.47 24.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 123.717 1.722 . . . . 0.0 109.092 168.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -88.46 107.66 18.98 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 127.184 2.194 . . . . 0.0 111.859 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.65 122.02 34.65 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.737 0.815 . . . . 0.0 112.013 170.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.44 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 24.4 mtp -103.41 131.94 50.08 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 174.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.15 114.37 3.82 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 167.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.27 21.2 15.42 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.373 1.469 . . . . 0.0 113.989 -172.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.8 p . . . . . 0 N--CA 1.474 0.748 0 O-C-N 119.679 -1.888 . . . . 0.0 112.699 -169.866 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.3 t . . . . . 0 CA--C 1.542 0.649 0 CA-C-O 122.148 0.975 . . . . 0.0 108.736 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.46 84.51 0.18 Allowed Glycine 0 C--N 1.338 0.684 0 C-N-CA 127.184 2.326 . . . . 0.0 108.382 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -91.65 135.63 33.73 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -171.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.7 tp -116.61 139.19 44.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 124.83 1.252 . . . . 0.0 110.894 -171.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.5 159.28 24.8 Favored Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.428 1.014 . . . . 0.0 113.036 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -132.27 129.13 39.19 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.37 1.468 . . . . 0.0 113.556 -169.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.72 144.65 16.57 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 124.32 0.962 . . . . 0.0 113.513 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.6 m -114.65 136.31 53.19 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.629 1.572 . . . . 0.0 111.455 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.9 tt -156.46 149.94 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 120.578 -1.327 . . . . 0.0 112.402 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.522 HG23 ' H ' ' A' ' 50' ' ' ASN . 2.3 m -150.52 -66.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 125.586 1.554 . . . . 0.0 111.898 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.522 ' H ' HG23 ' A' ' 49' ' ' VAL 0.424 29.8 t30 168.99 -13.61 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.973 1 C-N-CA 133.251 4.62 . . . . 0.0 111.482 169.278 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.0 ttt -49.32 -38.9 29.44 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 165.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.274 10.6 t 164.13 -163.16 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.967 1 C-N-CA 133.06 4.544 . . . . 0.0 109.623 168.147 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -107.98 132.38 53.57 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.812 2.445 . . . . 0.0 105.805 168.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -127.85 125.79 40.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 122.59 1.186 . . . . 0.0 110.1 169.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.73 132.02 35.5 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.921 1.288 . . . . 0.0 110.576 169.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.54 -17.37 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.39 108.6 5.0 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.84 1.655 . . . . 0.0 112.253 176.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.5 ttpm? -61.39 154.25 24.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.561 1.544 . . . . 0.0 112.607 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.0 mt -50.71 112.54 0.72 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.719 0.69 . . . . 0.0 111.876 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.479 0.989 0 C-N-CA 124.999 1.32 . . . . 0.0 111.984 178.259 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 120.539 0.209 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.1 p -94.12 -143.57 0.24 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.426 1.49 . . . . 0.0 112.718 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.75 144.72 9.59 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.561 -1.337 . . . . 0.0 114.262 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -148.65 163.74 36.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.214 1.806 . . . . 0.0 112.84 175.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.9 mt -74.44 -59.85 2.54 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.887 1.275 . . . . 0.0 112.573 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.89 136.98 54.88 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.83 0.852 . . . . 0.0 111.965 -172.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.6 p -75.72 -34.59 1.56 Allowed Pre-proline 0 N--CA 1.475 0.821 0 CA-C-O 115.512 -2.185 . . . . 0.0 113.307 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.39 140.73 44.8 Favored 'Trans proline' 0 C--N 1.354 0.842 0 CA-C-N 123.078 2.135 . . . . 0.0 108.967 169.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -104.44 -177.18 3.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.65 0.78 . . . . 0.0 112.215 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.08 9.49 72.57 Favored Glycine 0 N--CA 1.483 1.777 0 C-N-CA 124.633 1.111 . . . . 0.0 114.829 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -35.45 -55.61 0.66 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 129.192 2.997 . . . . 0.0 118.667 -169.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 7.7 mp -67.29 -18.5 65.22 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 121.526 1.966 . . . . 0.0 113.134 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.32 -24.08 67.7 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.421 1.464 . . . . 0.0 112.411 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.41 -44.08 25.77 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.311 -1.493 . . . . 0.0 108.129 167.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.443 HG22 HD13 ' A' ' 110' ' ' LEU . 31.6 t -52.5 -42.32 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.277 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.427 HG13 HE21 ' A' ' 91' ' ' GLN . 8.3 p -62.71 -55.81 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.702 1.137 . . . . 0.0 111.783 171.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.427 HE21 HG13 ' A' ' 90' ' ' VAL . 77.1 mm-40 -66.21 -42.33 88.89 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.973 0.806 . . . . 0.0 110.914 -170.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.535 HG11 HD13 ' A' ' 108' ' ' LEU . 78.2 t -60.87 -33.07 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.362 1.065 . . . . 0.0 111.728 171.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.8 68.48 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.671 1.123 . . . . 0.0 111.985 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.289 0.0 OUTLIER -96.38 -14.22 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -169.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.24 60.52 3.09 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 121.17 1.804 . . . . 0.0 112.351 173.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.9 mt -50.95 -40.11 56.64 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.899 1.68 . . . . 0.0 111.74 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.72 -31.02 41.67 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.158 0.885 . . . . 0.0 114.852 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -89.38 -39.74 13.21 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.607 1.203 . . . . 0.0 111.132 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.454 HG21 ' CE2' ' A' ' 101' ' ' TRP . 33.6 mm -65.73 -38.49 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 120.988 -1.07 . . . . 0.0 110.048 169.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.07 26.3 34.62 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.152 0.882 . . . . 0.0 113.182 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.454 ' CE2' HG21 ' A' ' 99' ' ' ILE . 72.5 m95 -55.97 130.57 44.37 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.229 1.014 . . . . 0.0 112.208 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.5 mtp-105 -104.41 -168.57 1.5 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.407 2.283 . . . . 0.0 111.958 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -86.03 -0.59 55.91 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 117.017 2.229 . . . . 0.0 117.017 -169.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.48 -132.75 3.3 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 120.917 1.69 . . . . 0.0 110.972 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.5 t -99.58 147.58 25.2 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.757 1.223 . . . . 0.0 108.954 174.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.407 ' HB2' ' HA ' ' A' ' 165' ' ' ILE . 97.3 mtt180 -132.15 124.8 29.8 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -168.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.428 ' CB ' HD12 ' A' ' 6' ' ' LEU . 64.5 m-85 -125.01 110.15 13.83 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -169.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.535 HD13 HG11 ' A' ' 92' ' ' VAL . 25.8 tp -92.59 98.05 11.2 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.283 175.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 t -83.45 124.64 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 174.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.443 HD13 HG22 ' A' ' 89' ' ' VAL . 20.2 tp -109.65 112.39 24.43 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 118.81 -0.614 . . . . 0.0 110.214 -175.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 10' ' ' MET . 17.1 t -94.83 133.24 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.297 0.639 . . . . 0.0 111.649 172.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.2 t -166.13 151.01 8.2 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.441 1.088 . . . . 0.0 109.826 167.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -110.27 4.54 20.96 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -177.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -140.98 -177.98 5.35 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.156 1.383 . . . . 0.0 112.857 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -60.72 -177.13 0.07 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.72 1.608 . . . . 0.0 112.882 169.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 31.3 t80 -140.94 148.15 39.92 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.675 1.19 . . . . 0.0 112.136 -175.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -80.21 88.92 5.45 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.128 1.371 . . . . 0.0 113.182 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.78 165.43 3.98 Favored 'General case' 0 CA--C 1.551 0.99 0 O-C-N 120.395 -1.441 . . . . 0.0 111.83 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -46.91 140.63 4.6 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.684 -0.635 . . . . 0.0 112.387 171.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 89.11 -12.28 0.39 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 129.109 2.964 . . . . 0.0 113.192 -174.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -70.36 -10.53 59.29 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 119.864 1.211 . . . . 0.0 112.759 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -49.41 -28.97 5.72 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.352 1.861 . . . . 0.0 113.96 168.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 84.9 m -66.09 -31.22 71.96 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.763 2.025 . . . . 0.0 112.877 -168.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.2 -34.13 75.7 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.147 0.579 . . . . 0.0 111.571 174.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -84.47 7.77 71.3 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.65 1.595 . . . . 0.0 114.337 170.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.274 1.3 t 61.41 15.61 6.75 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 129.383 3.073 . . . . 0.0 116.057 173.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.1 mtp85 -99.84 144.09 29.31 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.146 -0.971 . . . . 0.0 109.836 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -126.28 -8.7 6.41 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -69.74 118.12 12.2 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.706 1.139 . . . . 0.0 109.371 170.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.7 t -76.92 164.99 25.28 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.758 -0.588 . . . . 0.0 110.647 171.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 96.7 p -64.18 138.85 58.65 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -173.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -82.44 -13.22 57.13 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 174.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.82 9.2 85.06 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.927 1.251 . . . . 0.0 114.199 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -102.12 175.87 5.38 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.669 1.234 . . . . 0.0 111.164 172.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.5 142.91 32.92 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -169.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -142.7 53.82 1.4 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.704 1.602 . . . . 0.0 112.791 -169.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . 0.273 0.0 OUTLIER -140.29 105.53 5.04 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.056 0.931 . . . . 0.0 111.27 169.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -89.26 -45.96 9.13 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.217 1.007 . . . . 0.0 111.328 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -97.05 8.28 44.84 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.444 2.297 . . . . 0.0 113.565 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.76 -12.29 62.7 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 125.747 1.642 . . . . 0.0 114.871 169.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 78.1 mtm -97.05 132.99 42.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.021 1.329 . . . . 0.0 110.375 171.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -64.71 99.03 0.3 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.671 0.748 . . . . 0.0 111.889 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -67.16 -36.34 81.59 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.487 1.515 . . . . 0.0 112.925 -170.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.7 p -85.71 4.47 36.53 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -50.51 -42.29 54.71 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 120.503 1.501 . . . . 0.0 112.278 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.2 -33.86 69.34 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 117.974 -1.459 . . . . 0.0 112.724 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.353 82.5 tt0 -89.28 -90.9 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.415 0 CA-C-O 116.112 -1.899 . . . . 0.0 112.537 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.11 156.94 56.16 Favored 'Trans proline' 0 C--N 1.357 1.01 0 CA-C-N 124.135 2.513 . . . . 0.0 116.052 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -62.95 166.3 5.88 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 129.459 3.104 . . . . 0.0 115.037 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -62.68 132.8 53.52 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 166.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -57.78 154.34 12.11 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.914 -1.117 . . . . 0.0 113.823 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 60.1 p -77.66 162.51 26.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.477 0.711 . . . . 0.0 112.296 174.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 50.9 t -61.36 -39.11 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 121.547 -0.721 . . . . 0.0 111.352 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.2 t -81.59 -19.51 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.48 -37.64 88.08 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.241 1.382 . . . . 0.0 108.623 169.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 28.7 mt -77.25 -31.41 55.02 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 116.153 -1.88 . . . . 0.0 114.595 171.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.01 -42.19 72.24 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 121.268 1.849 . . . . 0.0 110.994 169.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 11.4 t -62.82 -54.16 43.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.595 0.758 . . . . 0.0 111.387 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.4 tppt? -69.58 -38.87 77.53 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -170.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . 0.294 0.0 OUTLIER -68.77 -33.33 73.7 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.537 1.517 . . . . 0.0 111.529 175.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.7 -32.71 64.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -69.29 -46.04 68.15 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.844 1.257 . . . . 0.0 110.056 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -86.26 -8.88 57.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.724 0.81 . . . . 0.0 113.105 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 50.64 49.27 21.2 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.001 1.72 . . . . 0.0 112.456 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.407 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 68.1 mt -102.69 133.58 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-O 116.535 -1.698 . . . . 0.0 106.967 171.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -103.09 113.46 65.84 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 121.439 1.927 . . . . 0.0 110.365 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -67.36 152.79 78.52 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.074 3.183 . . . . 0.0 114.764 173.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.8 mm -134.26 104.29 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.595 1.558 . . . . 0.0 109.371 174.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.55 ' CD2' HD21 ' A' ' 189' ' ' LEU . 23.3 m-85 -73.19 75.98 1.29 Allowed 'General case' 0 N--CA 1.478 0.928 0 O-C-N 119.849 -1.782 . . . . 0.0 112.387 175.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . 0.258 1.9 m -72.13 103.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 123.524 1.63 . . . . 0.0 111.15 169.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 29.0 m -143.05 166.35 20.87 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 120.33 -1.481 . . . . 0.0 110.447 -169.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -80.19 161.8 23.09 Favored 'Trans proline' 0 C--N 1.35 0.619 0 CA-C-N 122.856 2.056 . . . . 0.0 110.036 -172.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.5 t -52.97 -41.97 65.07 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.952 0.501 . . . . 0.0 111.916 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -54.68 -38.67 67.25 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.607 1.163 . . . . 0.0 113.698 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 19.6 mmt -99.75 -9.38 23.1 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.755 1.222 . . . . 0.0 114.175 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -61.89 -29.64 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 120.085 1.311 . . . . 0.0 113.329 -168.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -65.39 -25.07 67.4 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.13 -43.02 20.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.519 0.728 . . . . 0.0 109.955 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -71.02 -30.42 66.62 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.421 1.089 . . . . 0.0 110.535 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -65.81 -14.9 62.29 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.122 0.569 . . . . 0.0 111.829 168.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -96.47 -30.69 13.2 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.393 -0.817 . . . . 0.0 111.599 173.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.61 -25.59 61.37 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 119.979 -1.701 . . . . 0.0 110.03 175.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.1 t -72.49 -21.99 61.13 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.739 -0.601 . . . . 0.0 111.845 173.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 37.7 m -69.71 -29.74 67.2 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -88.46 -14.42 37.92 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 24.0 mt -120.35 87.85 41.11 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.1 0.96 . . . . 0.0 110.421 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.84 134.99 61.54 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.238 2.626 . . . . 0.0 112.903 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 65.2 mttm 85.06 -10.35 0.81 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 129.431 3.092 . . . . 0.0 113.914 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.55 HD21 ' CD2' ' A' ' 169' ' ' PHE . 10.2 tt -65.55 149.4 50.13 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.325 -0.86 . . . . 0.0 109.098 169.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 68.6 p -123.39 -170.22 2.08 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 169.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.0 141.53 2.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 127.083 2.153 . . . . 0.0 108.125 -167.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -132.67 150.86 19.8 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 170.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . 0.262 0.9 OUTLIER -91.44 88.71 6.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 123.128 1.442 . . . . 0.0 109.099 169.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 CA--C 1.539 0.531 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.654 169.602 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 m . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.03 144.81 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.931 0.892 . . . . 0.0 110.236 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.55 97.88 5.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.063 1.745 . . . . 0.0 108.388 172.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.1 mp -90.9 122.12 33.33 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 121.542 -0.724 . . . . 0.0 112.386 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -119.78 104.2 10.01 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 123.723 1.725 . . . . 0.0 111.13 172.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -85.46 114.72 22.71 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.411 1.885 . . . . 0.0 113.459 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.49 120.0 38.15 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.318 1.447 . . . . 0.0 111.154 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.0 mtp -100.12 144.0 29.66 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 169.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.9 98.19 2.31 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 168.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.69 33.75 0.52 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.201 1.5 . . . . 0.0 114.753 -169.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.477 0.901 0 O-C-N 119.889 -1.757 . . . . 0.0 113.408 173.113 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.1 p . . . . . 0 CA--C 1.546 0.821 0 CA-C-O 122.23 1.014 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.57 89.14 0.15 Allowed Glycine 0 C--N 1.339 0.736 0 C-N-CA 126.649 2.071 . . . . 0.0 108.801 -169.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.5 mmm-85 -77.27 138.11 39.2 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 tp -124.08 133.22 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.258 0.623 . . . . 0.0 110.48 -174.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.4 160.54 27.89 Favored Glycine 0 N--CA 1.474 1.202 0 C-N-CA 125.061 1.315 . . . . 0.0 112.722 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -138.69 135.41 34.77 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.006 0.923 . . . . 0.0 112.802 -169.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.39 146.1 18.04 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 124.742 1.163 . . . . 0.0 112.443 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.4 m -118.52 131.5 56.23 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.227 1.011 . . . . 0.0 111.233 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.6 tp -140.09 147.96 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.266 -0.896 . . . . 0.0 111.792 175.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -149.74 -107.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 103.652 -2.721 . . . . 0.0 103.652 168.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.09 -2.1 2.34 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.605 1.162 . . . . 0.0 110.858 168.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.7 mtp -78.58 41.09 0.39 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.92 2.088 . . . . 0.0 108.354 168.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.315 1.4 t 53.71 -176.13 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 129.618 3.167 . . . . 0.0 113.261 -168.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -87.24 137.88 31.96 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.363 1.465 . . . . 0.0 109.443 174.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -123.73 121.88 36.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.88 1.324 . . . . 0.0 110.456 169.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -86.69 100.04 12.19 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.487 1.915 . . . . 0.0 110.291 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.0 mm -90.35 -21.22 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 118.164 -0.922 . . . . 0.0 112.887 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.7 tp -157.02 111.72 2.76 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 144.93 43.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.715 1.206 . . . . 0.0 110.939 168.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -61.71 125.26 23.18 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.298 0.953 . . . . 0.0 110.169 -175.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t . . . . . 0 N--CA 1.47 0.542 0 C-N-CA 123.729 0.811 . . . . 0.0 112.182 -174.645 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 71.6 p -108.38 -152.16 0.48 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 126.328 1.851 . . . . 0.0 112.231 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.37 160.4 33.05 Favored Glycine 0 N--CA 1.475 1.247 0 O-C-N 120.196 -1.565 . . . . 0.0 114.13 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -155.89 156.88 35.4 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -56.37 -63.8 1.07 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.681 2.792 . . . . 0.0 113.261 176.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.22 149.21 44.8 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.353 1.061 . . . . 0.0 113.616 -172.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.1 m -72.36 -47.01 10.44 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-O 116.138 -1.886 . . . . 0.0 113.287 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -75.09 154.47 42.08 Favored 'Trans proline' 0 C--N 1.352 0.715 0 CA-C-N 122.302 1.858 . . . . 0.0 112.527 169.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -131.77 179.68 5.92 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.476 1.51 . . . . 0.0 113.455 -178.358 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.94 34.39 4.95 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 119.393 2.517 . . . . 0.0 119.393 -168.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -50.75 -33.53 23.52 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.62 1.71 . . . . 0.0 113.648 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.511 HD13 ' CE2' ' A' ' 116' ' ' PHE . 7.4 tp -62.69 -44.08 97.16 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -175.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.18 -46.35 82.89 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.252 0.621 . . . . 0.0 109.846 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.08 -58.51 8.34 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 118.496 -0.764 . . . . 0.0 111.034 173.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.536 HG12 HD21 ' A' ' 108' ' ' LEU . 13.4 m -64.99 -25.28 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 119.627 1.103 . . . . 0.0 113.168 -171.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.91 -51.74 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 118.083 -0.961 . . . . 0.0 112.16 169.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -57.03 -42.01 79.64 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.974 1.261 . . . . 0.0 110.41 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.482 ' HA ' HD12 ' A' ' 99' ' ' ILE . 38.3 t -57.4 -39.16 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.242 0.617 . . . . 0.0 112.238 176.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.67 -32.22 69.41 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.853 1.056 . . . . 0.0 113.853 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.445 HG23 ' SG ' ' A' ' 135' ' ' CYS . 10.0 tp -102.13 -15.42 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -170.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.33 56.89 3.98 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.534 -1.354 . . . . 0.0 112.847 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.2 mt -55.72 -38.97 70.46 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.465 1.506 . . . . 0.0 111.88 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.02 -22.96 47.07 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.524 1.059 . . . . 0.0 114.668 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -92.3 -39.58 11.42 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.465 1.133 . . . . 0.0 111.563 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 92' ' ' VAL . 9.7 mt -81.91 -29.18 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 118.822 0.737 . . . . 0.0 111.264 175.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.34 24.7 39.01 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.027 -0.874 . . . . 0.0 114.891 169.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -49.42 129.26 18.57 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.785 1.234 . . . . 0.0 112.91 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -111.85 173.03 6.55 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.876 1.27 . . . . 0.0 112.434 170.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -81.86 41.58 0.66 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 125.671 1.588 . . . . 0.0 115.107 -170.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.14 -126.45 5.5 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 120.592 -1.318 . . . . 0.0 110.437 170.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.6 t -115.96 134.07 55.36 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.638 1.975 . . . . 0.0 107.704 171.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -124.41 131.51 53.5 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.093 0.86 . . . . 0.0 110.218 -168.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -127.08 98.5 5.33 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -169.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.536 HD21 HG12 ' A' ' 89' ' ' VAL . 5.6 tt -81.9 99.16 8.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.152 172.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.1 t -87.84 124.11 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 174.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 65.4 tp -108.19 117.47 34.23 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.664 1.12 . . . . 0.0 109.267 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.16 128.39 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 124.158 0.911 . . . . 0.0 110.707 170.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.7 t -162.44 163.66 27.54 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.246 1.018 . . . . 0.0 110.882 170.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -121.25 -0.44 9.9 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 116.547 2.055 . . . . 0.0 116.547 -175.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -137.17 172.66 12.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.912 0.885 . . . . 0.0 111.831 172.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -53.43 176.56 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.946 1.699 . . . . 0.0 112.58 174.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.511 ' CE2' HD13 ' A' ' 86' ' ' LEU . 7.2 p90 -146.04 157.19 43.86 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 120.7 -1.25 . . . . 0.0 112.293 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -79.87 133.28 36.24 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.664 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 46.8 mt -100.74 175.07 5.77 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.189 1.796 . . . . 0.0 110.886 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -47.88 137.09 10.28 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.917 0.865 . . . . 0.0 112.828 172.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 69.5 tttt 83.58 -14.45 0.7 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 130.906 3.682 . . . . 0.0 113.719 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -63.22 -21.95 66.55 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.526 1.512 . . . . 0.0 113.4 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.559 ' HE3' ' CZ ' ' A' ' 150' ' ' TYR . 90.1 mttt -78.18 -5.91 53.24 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 172.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.8 -16.75 63.88 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 120.621 1.555 . . . . 0.0 112.34 171.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 57.3 mt -63.25 -24.71 67.99 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.887 0.875 . . . . 0.0 111.515 169.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -90.35 -123.02 2.53 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 126.198 1.856 . . . . 0.0 109.301 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 p -126.64 0.13 6.8 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.577 1.551 . . . . 0.0 114.319 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -85.56 109.47 18.55 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.789 0.836 . . . . 0.0 111.285 -169.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -94.38 -28.71 15.38 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -87.17 122.23 30.7 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.702 -0.623 . . . . 0.0 112.491 -169.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.3 t -57.93 144.15 40.27 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.888 0.475 . . . . 0.0 110.388 169.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 42.0 t -59.75 140.9 56.16 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.637 0.775 . . . . 0.0 112.614 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.7 p30 -80.74 -13.51 58.93 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.88 14.42 78.47 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.477 1.037 . . . . 0.0 113.423 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -98.94 170.05 9.0 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.259 1.824 . . . . 0.0 110.536 172.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . 0.445 ' SG ' HG23 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -100.41 145.35 28.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -139.47 45.6 1.93 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.307 1.843 . . . . 0.0 111.592 -170.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.4 tt -110.08 125.13 52.64 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.68 1.992 . . . . 0.0 108.907 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -131.19 -48.66 1.0 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.613 1.165 . . . . 0.0 112.8 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -84.42 -10.66 57.32 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.493 1.517 . . . . 0.0 113.677 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 108.51 -23.71 23.87 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.199 1.857 . . . . 0.0 111.477 -169.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 80.8 mmm -82.28 145.83 29.78 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.617 1.167 . . . . 0.0 111.259 172.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -77.47 99.04 5.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.174 0.589 . . . . 0.0 109.769 169.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 42.3 ttp-105 -63.28 -38.28 90.56 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.211 1.004 . . . . 0.0 113.563 -170.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.4 p -88.56 7.37 33.55 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -168.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -47.53 -39.7 16.95 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 121.277 1.853 . . . . 0.0 112.461 169.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.13 -0.65 86.49 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 117.8 -1.555 . . . . 0.0 115.789 -174.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -127.35 -65.8 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 119.889 1.845 . . . . 0.0 110.387 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -58.98 147.25 90.86 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.498 2.799 . . . . 0.0 115.625 168.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.527 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 39.8 t0 -69.46 169.34 12.66 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 128.503 2.721 . . . . 0.0 112.87 169.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.559 ' CZ ' ' HE3' ' A' ' 122' ' ' LYS . 75.6 m-85 -69.0 158.06 35.52 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.423 -1.423 . . . . 0.0 108.211 168.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -78.62 157.45 28.68 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.314 -0.866 . . . . 0.0 111.257 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 92.9 p -92.81 156.18 17.16 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.248 -0.907 . . . . 0.0 110.684 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.26 -34.37 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.344 -0.848 . . . . 0.0 112.571 -171.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.9 t -69.93 -33.66 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.412 1.085 . . . . 0.0 111.596 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -68.8 -34.45 75.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.499 0.72 . . . . 0.0 111.144 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.507 ' CD1' HD11 ' A' ' 86' ' ' LEU . 4.5 mt -65.26 -55.95 15.49 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.009 0.924 . . . . 0.0 110.253 174.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.97 76.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.041 0.937 . . . . 0.0 111.448 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.8 t -58.47 -71.43 0.11 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.166 0.986 . . . . 0.0 111.847 172.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -66.85 -34.48 77.89 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.721 HD22 ' HG3' ' A' ' 167' ' ' PRO . 0.7 OUTLIER -70.76 -26.58 63.42 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.163 1.347 . . . . 0.0 112.866 176.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.1 -43.69 64.4 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.768 1.167 . . . . 0.0 113.46 173.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -80.53 -30.67 37.14 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.885 0.766 . . . . 0.0 112.578 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -82.48 -5.56 58.78 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.983 0.81 . . . . 0.0 112.242 168.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 60.64 46.91 8.78 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.007 1.323 . . . . 0.0 111.75 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.567 ' HB ' HD23 ' A' ' 160' ' ' LEU . 29.4 mm -100.36 135.51 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.934 1.293 . . . . 0.0 108.057 174.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -100.64 114.35 65.75 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 120.477 1.49 . . . . 0.0 109.903 170.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.721 ' HG3' HD22 ' A' ' 160' ' ' LEU . 4.8 Cg_exo -74.74 145.11 32.11 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.035 1.824 . . . . 0.0 110.594 169.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.417 HG22 HG23 ' A' ' 170' ' ' VAL . 31.5 mt -128.73 102.08 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 125.126 1.37 . . . . 0.0 107.418 177.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -74.37 72.8 1.84 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.415 1.102 . . . . 0.0 112.342 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.417 HG23 HG22 ' A' ' 168' ' ' ILE . 85.3 t -70.59 97.75 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 O-C-N 120.621 -1.299 . . . . 0.0 111.193 173.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 25.4 m -147.92 145.16 20.23 Favored Pre-proline 0 N--CA 1.484 1.237 0 O-C-N 120.367 -1.458 . . . . 0.0 112.879 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -60.81 156.55 42.66 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 125.111 3.874 . . . . 0.0 116.705 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.5 t -46.62 -58.31 3.95 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.978 1.711 . . . . 0.0 114.471 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -14.67 21.8 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -171.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.0 ptm -109.3 -1.6 18.44 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.308 1.443 . . . . 0.0 114.872 172.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.2 t -65.46 -33.39 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 120.23 -1.544 . . . . 0.0 111.97 -170.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -70.74 -23.68 62.48 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.861 1.21 . . . . 0.0 113.241 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . 0.262 2.4 t -87.18 -13.39 44.1 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.059 -1.026 . . . . 0.0 112.405 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -96.38 -33.72 11.81 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.073 1.349 . . . . 0.0 109.879 168.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.62 -26.7 65.48 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.724 -1.235 . . . . 0.0 111.997 176.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -74.0 -23.48 59.45 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.052 -1.655 . . . . 0.0 110.445 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 35.5 tp -85.02 -19.48 31.93 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.304 1.842 . . . . 0.0 110.824 174.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.6 p -83.65 -6.94 59.57 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.383 0.538 . . . . 0.0 112.019 169.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 6.9 m -88.22 -34.56 17.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.678 1.591 . . . . 0.0 108.865 169.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -79.7 -37.34 35.94 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 174.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 51.0 mt -101.16 113.27 65.82 Favored Pre-proline 0 N--CA 1.478 0.963 0 CA-C-O 118.247 -0.882 . . . . 0.0 108.949 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.7 145.2 40.91 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.577 2.185 . . . . 0.0 111.423 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt 73.55 3.98 4.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 127.117 2.167 . . . . 0.0 113.736 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.69 142.6 46.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.994 1.718 . . . . 0.0 109.052 169.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 76.5 p -108.55 -158.19 0.64 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.8 tt 177.15 136.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 126.983 2.113 . . . . 0.0 110.129 -168.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -129.57 132.45 7.09 Favored Glycine 0 N--CA 1.469 0.892 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -81.99 79.12 8.59 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 124.069 1.89 . . . . 0.0 109.814 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 28.1 tp . . . . . 0 CA--C 1.546 0.826 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.662 174.734 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 t -94.3 155.08 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.648 ' HB2' HD13 ' A' ' 59' ' ' LEU . 3.7 p-10 -151.89 101.63 2.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.345 1.069 . . . . 0.0 109.603 169.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.19 142.92 27.06 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.314 1.046 . . . . 0.0 111.717 -171.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -124.45 111.77 16.12 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 123.889 1.804 . . . . 0.0 110.861 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -83.64 101.83 11.78 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.868 -1.969 . . . . 0.0 111.921 175.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.489 HD23 HD13 ' A' ' 110' ' ' LEU . 33.9 tp -102.73 113.28 26.55 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.748 0.819 . . . . 0.0 111.093 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.1 ptm -120.77 151.24 39.82 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.55 141.26 23.56 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.52 1.533 . . . . 0.0 113.348 173.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.43 32.09 5.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.26 1.824 . . . . 0.0 112.255 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.3 p . . . . . 0 N--CA 1.474 0.773 0 O-C-N 119.91 -1.744 . . . . 0.0 112.194 171.289 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 122.486 1.136 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.96 88.34 0.13 Allowed Glycine 0 C--N 1.336 0.529 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -169.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -73.5 148.24 43.3 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -174.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.6 tt -123.17 135.63 62.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.434 ' HA3' HD23 ' A' ' 59' ' ' LEU . . . -139.99 161.15 26.34 Favored Glycine 0 N--CA 1.464 0.557 0 C-N-CA 125.361 1.458 . . . . 0.0 110.722 172.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -139.17 138.22 36.75 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -169.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.25 145.27 15.92 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 124.491 1.043 . . . . 0.0 112.578 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.3 m -116.13 136.22 53.21 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 125.284 1.434 . . . . 0.0 110.522 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.18 155.31 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.534 1.134 . . . . 0.0 111.197 176.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.1 p -151.93 -65.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 120.656 -1.277 . . . . 0.0 109.02 168.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 177.06 -19.66 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 130.237 3.415 . . . . 0.0 110.081 169.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 54.0 ttm -50.1 -36.84 31.23 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.009 1.324 . . . . 0.0 110.029 167.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t 167.1 -172.39 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 131.465 3.906 . . . . 0.0 109.782 169.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -103.88 131.28 51.25 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 167.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.6 pm0 -130.26 124.38 32.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 123.064 1.411 . . . . 0.0 110.793 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -94.23 104.68 16.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.14 2.176 . . . . 0.0 109.924 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . 0.361 0.0 OUTLIER -91.22 -70.01 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 117.583 -1.199 . . . . 0.0 110.799 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.8 124.49 38.87 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 121.287 1.858 . . . . 0.0 114.74 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -67.08 168.94 9.24 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.558 1.143 . . . . 0.0 110.336 167.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.648 HD13 ' HB2' ' A' ' 5' ' ' ASP . 13.5 mt -62.1 123.22 17.53 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.276 -0.89 . . . . 0.0 109.349 175.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 124.839 1.256 . . . . 0.0 111.291 -176.556 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.0 t . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 121.208 0.528 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.5 t -113.44 -169.51 1.51 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 127.369 2.268 . . . . 0.0 112.173 -175.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -153.65 153.86 25.12 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.162 1.363 . . . . 0.0 113.661 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -152.49 160.12 43.27 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.186 1.794 . . . . 0.0 111.037 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -87.81 -32.75 18.89 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -174.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.76 143.05 38.29 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.666 0.786 . . . . 0.0 110.026 174.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.319 13.8 t -73.56 -41.37 5.87 Favored Pre-proline 0 N--CA 1.479 0.977 0 CA-C-O 116.341 -1.79 . . . . 0.0 113.969 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.79 137.62 54.54 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.649 2.233 . . . . 0.0 113.852 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -82.67 155.93 24.1 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.932 1.693 . . . . 0.0 113.528 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.77 45.5 3.22 Favored Glycine 0 N--CA 1.485 1.916 0 O-C-N 120.399 -1.438 . . . . 0.0 109.698 168.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -74.71 -39.91 61.63 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -168.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . 0.26 5.9 mp -68.75 -30.21 68.78 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 117.042 -1.456 . . . . 0.0 110.742 -173.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -57.37 -39.53 76.21 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.979 1.718 . . . . 0.0 111.899 169.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.53 -47.38 86.43 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.302 -1.499 . . . . 0.0 111.176 170.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.0 t -54.44 -31.83 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.389 1.076 . . . . 0.0 112.382 172.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.581 ' HA ' HD21 ' A' ' 156' ' ' LEU . 40.9 t -64.75 -65.0 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.592 0.757 . . . . 0.0 111.258 172.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -69.77 -32.62 71.21 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.086 -0.959 . . . . 0.0 112.048 -169.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 108' ' ' LEU . 33.0 m -62.53 -20.85 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.922 1.237 . . . . 0.0 113.403 171.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.02 -45.51 16.46 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 120.057 1.299 . . . . 0.0 112.295 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.5 mt -88.19 -19.85 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.45 60.11 5.83 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 119.996 -1.69 . . . . 0.0 111.698 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.421 HD12 ' H ' ' A' ' 96' ' ' LEU . 6.6 mp -48.26 -38.58 19.02 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.185 1.394 . . . . 0.0 111.128 176.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.83 -29.64 31.39 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.602 1.096 . . . . 0.0 115.497 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -89.65 -46.36 8.69 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 118.94 1.37 . . . . 0.0 110.624 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.9 mm -60.67 -49.54 84.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 172.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.61 29.51 8.19 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.177 0.894 . . . . 0.0 113.815 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.558 ' CE3' HD11 ' A' ' 59' ' ' LEU . 14.2 m95 -54.84 119.93 6.09 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 118.46 1.13 . . . . 0.0 111.462 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -95.82 -144.43 0.27 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.41 1.484 . . . . 0.0 111.96 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -102.1 -10.35 19.75 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 -169.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.16 -126.41 1.6 Allowed Glycine 0 C--N 1.349 1.264 0 CA-C-N 120.895 1.68 . . . . 0.0 112.86 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.4 t -112.26 147.53 36.07 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.311 1.845 . . . . 0.0 110.037 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.73 132.99 29.88 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 119.73 1.15 . . . . 0.0 113.198 -169.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -123.8 104.94 9.26 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -169.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 92' ' ' VAL . 16.8 tp -85.6 88.66 7.56 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.847 172.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.3 t -79.13 123.7 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 174.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.489 HD13 HD23 ' A' ' 9' ' ' LEU . 47.5 tp -117.2 111.66 19.75 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 123.814 0.696 . . . . 0.0 109.503 -169.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.34 133.26 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 t -165.62 158.42 15.51 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.683 169.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -106.14 -5.51 19.29 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -174.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -138.57 -179.9 6.08 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.514 1.526 . . . . 0.0 111.423 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.11 -171.33 0.11 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.688 1.595 . . . . 0.0 113.478 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -144.81 150.42 37.13 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.109 1.364 . . . . 0.0 112.499 -170.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -74.16 133.6 42.78 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.859 0.864 . . . . 0.0 110.333 169.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.95 175.22 5.55 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.273 1.429 . . . . 0.0 109.784 170.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.91 142.54 19.07 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.836 -0.54 . . . . 0.0 111.263 169.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.533 ' O ' HG22 ' A' ' 123' ' ' THR . 72.5 mmtt 86.31 -18.06 0.35 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 129.217 3.007 . . . . 0.0 112.667 -173.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -71.58 -19.1 62.19 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 121.061 1.755 . . . . 0.0 113.0 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -74.22 -16.15 60.98 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.499 -1.375 . . . . 0.0 113.876 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 120' ' ' LYS 0.302 9.5 t -74.7 -6.63 49.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 119.556 1.071 . . . . 0.0 113.201 174.162 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.1 mp -64.93 -24.09 67.42 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.104 -0.998 . . . . 0.0 109.752 167.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -88.65 -123.56 2.14 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 168.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 64.1 p -126.97 16.15 7.35 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.337 1.455 . . . . 0.0 114.1 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.36 125.72 50.84 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.652 1.181 . . . . 0.0 111.932 -169.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -130.43 -20.3 2.98 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -71.52 124.58 24.98 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 121.078 1.763 . . . . 0.0 110.111 170.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.441 ' HA ' ' HB3' ' A' ' 149' ' ' ASP . 15.3 t -75.4 147.23 40.16 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.139 0.575 . . . . 0.0 110.722 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.4 t -63.72 135.58 56.8 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.064 1.412 . . . . 0.0 112.602 -175.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -73.94 -10.53 59.74 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.55 2.74 . . . . 0.0 114.832 -170.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.86 15.99 80.63 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.222 -1.321 . . . . 0.0 114.182 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -113.15 170.26 8.34 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.175 1.488 . . . . 0.0 110.632 169.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.3 153.24 18.12 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -169.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -147.88 45.44 1.09 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.027 1.331 . . . . 0.0 113.803 -169.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.41 150.14 20.92 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.342 1.057 . . . . 0.0 109.584 169.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -141.6 -67.79 0.39 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.856 0.862 . . . . 0.0 111.538 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -84.73 -2.64 57.88 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.524 1.53 . . . . 0.0 113.716 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.29 -8.72 38.36 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.217 1.865 . . . . 0.0 114.387 -175.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 92.4 mtp -93.41 148.94 21.62 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.308 2.054 . . . . 0.0 111.088 170.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -70.92 100.7 2.0 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.927 -1.108 . . . . 0.0 110.746 173.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -48.36 80.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.355 1.062 . . . . 0.0 110.821 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 43.5 m -74.44 8.06 2.5 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -175.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.25 -24.61 59.9 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.834 -1.166 . . . . 0.0 111.881 169.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.7 -45.23 7.94 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 118.007 -1.441 . . . . 0.0 113.574 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.303 1.7 pm0 -97.97 -62.78 0.11 Allowed Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -169.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -58.54 149.26 76.65 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.438 2.758 . . . . 0.0 117.625 169.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' A' ' 130' ' ' THR . 56.0 t0 -74.81 161.15 29.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.87 2.468 . . . . 0.0 111.631 169.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -59.73 131.74 51.82 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 168.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -81.94 157.06 24.43 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 121.153 1.797 . . . . 0.0 112.624 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.3 m -67.8 152.42 45.6 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.111 0.964 . . . . 0.0 113.101 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.15 -26.36 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -169.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.9 m -85.21 -16.17 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -70.03 -27.14 64.42 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.752 1.16 . . . . 0.0 108.494 168.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.581 HD21 ' HA ' ' A' ' 90' ' ' VAL . 15.2 mt -84.22 -32.87 24.28 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 117.286 -1.34 . . . . 0.0 114.036 169.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -54.23 -37.37 64.55 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 120.853 1.661 . . . . 0.0 112.398 171.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 89.2 p -68.41 -55.03 13.33 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.835 -0.54 . . . . 0.0 112.119 173.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -66.01 -29.74 70.16 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.6 mp -58.33 -54.58 45.4 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.412 1.085 . . . . 0.0 111.383 170.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.56 -24.63 58.95 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.15 -39.8 63.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.5 1.12 . . . . 0.0 111.022 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -95.52 1.09 53.77 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 174.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 66.89 30.86 7.53 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.314 1.846 . . . . 0.0 113.863 169.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 48.7 mt -89.64 137.86 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 120.705 -1.247 . . . . 0.0 109.603 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -104.59 97.53 12.55 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -74.12 150.37 42.64 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.132 1.888 . . . . 0.0 113.465 173.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.495 ' CD1' HG23 ' A' ' 190' ' ' THR . 34.9 mm -139.17 106.28 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.715 1.206 . . . . 0.0 109.702 -174.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.478 ' HB2' HG22 ' A' ' 191' ' ' ILE . 21.2 m-85 -73.01 65.62 0.76 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.657 1.183 . . . . 0.0 113.207 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.69 108.6 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 122.401 1.096 . . . . 0.0 111.187 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 28.3 m -146.3 142.01 17.07 Favored Pre-proline 0 N--CA 1.48 1.039 0 O-C-N 119.873 -1.767 . . . . 0.0 110.708 -174.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -54.17 150.78 30.88 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.197 2.598 . . . . 0.0 114.542 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.3 t -44.79 -45.04 9.83 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.347 1.859 . . . . 0.0 114.031 -170.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.33 -36.97 6.84 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.698 1.599 . . . . 0.0 113.782 -172.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.5 mtt -123.62 19.19 9.55 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.741 1.217 . . . . 0.0 114.08 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.2 t -59.52 -37.5 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 O-C-N 120.488 -1.382 . . . . 0.0 110.589 174.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 180' ' ' GLU . 0.0 OUTLIER -66.71 -22.74 66.06 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -170.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.2 t -91.24 -33.21 15.46 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.872 1.269 . . . . 0.0 111.249 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -70.95 -37.02 72.82 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.577 -1.327 . . . . 0.0 110.324 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.534 ' HA ' HG22 ' A' ' 183' ' ' THR 0.353 14.8 pt-20 -73.43 -2.67 23.36 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 169.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.646 ' O ' HG22 ' A' ' 184' ' ' THR . 87.1 tttt -88.63 -43.64 11.2 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.23 -0.919 . . . . 0.0 109.869 169.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . 0.264 4.8 mp -83.84 -10.08 58.3 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 119.288 -2.133 . . . . 0.0 111.93 -174.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 180' ' ' GLU . 15.1 t -78.16 -19.64 53.57 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 167.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 181' ' ' LYS 0.279 1.3 t -77.41 -19.94 55.38 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 120.881 -1.137 . . . . 0.0 109.655 168.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -83.47 -24.19 31.88 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.345 0.658 . . . . 0.0 111.373 168.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.87 78.71 23.71 Favored Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 124.618 1.167 . . . . 0.0 111.542 170.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.52 142.1 93.85 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.183 1.922 . . . . 0.0 112.122 176.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 62.6 mttm 95.17 -20.34 0.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 131.636 3.975 . . . . 0.0 113.331 -171.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.7 tt -71.03 157.48 38.14 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.495 HG23 ' CD1' ' A' ' 168' ' ' ILE 0.495 0.1 OUTLIER -135.36 -160.64 1.07 Allowed 'General case' 0 C--N 1.346 0.416 0 O-C-N 120.009 -1.682 . . . . 0.0 108.169 169.871 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.478 HG22 ' HB2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -146.97 156.29 10.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 129.025 2.93 . . . . 0.0 108.893 -168.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -137.56 134.76 7.17 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 171.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -83.12 82.21 8.35 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 169.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 20.0 tp . . . . . 0 CA--C 1.544 0.73 0 CA-C-N 113.481 -1.691 . . . . 0.0 110.609 169.865 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.543 0.703 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.2 t -125.1 140.67 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.328 1.451 . . . . 0.0 109.327 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -124.6 99.39 6.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.296 1.439 . . . . 0.0 109.194 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.0 123.31 40.69 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.181 -0.95 . . . . 0.0 111.128 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -105.45 105.94 16.21 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 123.701 1.715 . . . . 0.0 109.282 169.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -81.83 112.5 19.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.563 173.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 tt -111.34 131.54 55.09 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.372 -0.83 . . . . 0.0 112.841 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 28.4 mtp -110.61 148.49 32.1 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.57 121.35 6.45 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.578 1.561 . . . . 0.0 109.209 168.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.54 36.38 3.11 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.06 1.744 . . . . 0.0 111.697 -175.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.504 ' OG ' ' HE2' ' A' ' 83' ' ' LYS . 24.4 p . . . . . 0 C--N 1.324 -0.515 0 C-N-CA 125.705 1.602 . . . . 0.0 113.479 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 CA--C 1.545 0.773 0 CA-C-O 122.889 1.328 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.06 84.27 0.31 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 105.627 -2.989 . . . . 0.0 105.627 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 -84.58 133.92 34.41 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.529 1.532 . . . . 0.0 107.774 -169.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.4 tt -125.97 144.41 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 119.545 1.066 . . . . 0.0 112.296 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.27 153.61 21.98 Favored Glycine 0 N--CA 1.461 0.329 0 C-N-CA 125.84 1.686 . . . . 0.0 110.263 -176.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -138.07 130.57 29.32 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -169.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.68 149.69 20.09 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 124.92 1.247 . . . . 0.0 112.901 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.3 p -119.65 144.11 47.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.657 1.183 . . . . 0.0 111.553 174.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -140.98 150.44 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.518 -1.364 . . . . 0.0 108.961 174.705 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.419 ' N ' HD13 ' A' ' 48' ' ' ILE . 38.1 t -138.36 -68.92 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 170.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.425 ' H ' ' H ' ' A' ' 51' ' ' MET 0.273 1.5 t-20 170.15 -4.05 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.82 1 C-N-CA 134.046 4.938 . . . . 0.0 109.477 169.421 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.425 ' H ' ' H ' ' A' ' 50' ' ' ASN . 26.7 ptt? -54.33 -39.72 67.31 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.118 0.967 . . . . 0.0 109.61 167.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.486 ' HA ' ' HD3' ' A' ' 145' ' ' ARG . 1.2 p 163.74 170.65 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.117 1 C-N-CA 134.355 5.062 . . . . 0.0 108.43 -178.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -89.16 131.21 35.4 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 166.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -123.4 130.31 52.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.677 1.227 . . . . 0.0 110.186 177.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -104.01 104.73 14.73 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.866 2.066 . . . . 0.0 110.429 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.437 HD13 ' H ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -108.96 -9.35 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -173.497 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.4 tt -157.34 117.22 3.42 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.553 1.069 . . . . 0.0 109.927 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.02 163.74 18.68 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.825 0.85 . . . . 0.0 113.272 172.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.458 HD11 ' CE3' ' A' ' 101' ' ' TRP . 87.4 mt -49.08 104.02 0.06 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.592 1.557 . . . . 0.0 113.334 -169.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.483 1.213 0 C-N-CA 126.502 1.921 . . . . 0.0 111.221 179.458 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.8 t . . . . . 0 CA--C 1.545 0.764 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 t -101.66 -155.9 0.54 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 125.971 1.708 . . . . 0.0 112.17 172.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -146.86 150.33 22.58 Favored Glycine 0 N--CA 1.478 1.483 0 O-C-N 120.048 -1.657 . . . . 0.0 116.019 -173.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -149.75 162.38 40.37 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.918 2.087 . . . . 0.0 113.262 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -32.1 13.0 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 173.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -94.96 132.11 40.16 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.229 0.922 . . . . 0.0 110.318 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.8 p -74.25 -31.46 1.26 Allowed Pre-proline 0 N--CA 1.472 0.675 0 CA-C-O 114.274 -2.774 . . . . 0.0 115.427 -172.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -68.48 144.95 63.08 Favored 'Trans proline' 0 C--N 1.353 0.771 0 CA-C-N 123.893 2.426 . . . . 0.0 112.264 169.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HE2' ' OG ' ' A' ' 13' ' ' SER . 12.1 mptt -98.48 -177.3 3.64 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.889 1.276 . . . . 0.0 112.286 -176.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.96 18.28 37.07 Favored Glycine 0 N--CA 1.481 1.652 0 C-N-CA 125.621 1.581 . . . . 0.0 114.327 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -46.72 -39.18 11.11 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -169.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.55 HD23 HD13 ' A' ' 156' ' ' LEU 0.466 5.1 mp -80.49 7.92 8.84 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 119.899 1.227 . . . . 0.0 113.417 -177.63 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -80.41 -49.84 10.91 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 165.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.44 -45.23 94.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 116.893 -1.527 . . . . 0.0 112.369 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -49.95 -36.93 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 120.511 1.505 . . . . 0.0 111.653 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.579 HG21 ' HG3' ' A' ' 151' ' ' GLN . 63.1 t -82.59 -45.14 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.172 0.989 . . . . 0.0 111.4 -178.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -59.57 -49.8 76.38 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.524 1.056 . . . . 0.0 109.672 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.437 HG11 HD13 ' A' ' 108' ' ' LEU . 82.2 t -55.97 -42.08 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.203 1.001 . . . . 0.0 111.976 176.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.69 85.52 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.091 -1.006 . . . . 0.0 112.919 177.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.26 -24.91 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.988 1.315 . . . . 0.0 113.667 -169.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 61.78 3.93 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.812 1.645 . . . . 0.0 110.871 -176.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.4 mt -56.23 -38.63 71.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.072 1.349 . . . . 0.0 112.0 -170.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.01 -34.49 23.98 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.877 0.751 . . . . 0.0 113.47 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -81.66 -45.4 15.81 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 125.334 1.453 . . . . 0.0 110.472 -175.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.8 mm -70.69 -33.31 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 118.915 0.78 . . . . 0.0 110.455 170.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.16 31.5 16.86 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.452 1.025 . . . . 0.0 114.542 174.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.458 ' CE3' HD11 ' A' ' 59' ' ' LEU . 23.1 m95 -56.54 129.45 40.89 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.88 1.272 . . . . 0.0 113.096 -177.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.17 170.66 7.83 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.651 1.18 . . . . 0.0 112.55 169.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -74.42 49.49 0.38 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 127.307 2.243 . . . . 0.0 114.053 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.84 -131.02 6.44 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 170.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.9 m -119.33 132.59 55.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.568 2.347 . . . . 0.0 105.7 177.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -124.61 124.79 42.98 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 119.084 0.856 . . . . 0.0 111.405 -168.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -114.04 112.47 23.31 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 123.977 0.798 . . . . 0.0 110.783 -175.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.437 HD13 HG11 ' A' ' 92' ' ' VAL . 14.5 tp -93.44 105.92 17.94 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 170.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.1 t -89.43 125.58 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 172.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -111.03 115.87 30.2 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.525 HG13 HD22 ' A' ' 194' ' ' LEU . 60.0 t -108.72 130.88 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 123.674 0.609 . . . . 0.0 112.611 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.4 t -158.17 164.24 36.77 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.305 1.042 . . . . 0.0 111.453 171.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -112.49 -4.36 14.22 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.85 2.06 . . . . 0.0 114.124 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -137.49 -177.36 4.75 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.476 -1.39 . . . . 0.0 113.439 171.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -61.86 -174.64 0.05 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.333 2.253 . . . . 0.0 112.262 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 20.8 t80 -140.6 139.46 34.93 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.426 1.09 . . . . 0.0 111.904 -174.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -68.67 108.35 3.34 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.564 1.146 . . . . 0.0 111.721 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.04 177.54 3.68 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.375 0.607 . . . . 0.0 111.527 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.27 148.14 23.5 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.22 -0.925 . . . . 0.0 112.295 172.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? 78.6 -11.19 1.24 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 128.099 2.56 . . . . 0.0 112.668 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.95 -32.5 74.26 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.532 1.133 . . . . 0.0 112.398 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -70.09 0.84 5.41 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 178.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.2 t -58.82 -33.04 69.94 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.052 -1.03 . . . . 0.0 112.417 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.6 tp -65.82 -40.89 92.26 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.635 0.774 . . . . 0.0 111.473 171.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.88 27.03 1.13 Allowed Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.588 1.566 . . . . 0.0 113.392 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 62.7 p 61.94 5.89 1.53 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 131.536 3.935 . . . . 0.0 117.038 169.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . 0.3 48.1 mtt180 -109.99 140.75 43.65 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.939 1.245 . . . . 0.0 114.144 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -109.73 -32.37 7.11 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.14 2.576 . . . . 0.0 114.691 -168.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -71.35 123.41 22.25 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.821 0.737 . . . . 0.0 111.292 -173.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.0 t -57.73 158.25 6.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.489 1.116 . . . . 0.0 110.68 172.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 151' ' ' GLN . 20.7 t -70.15 134.43 48.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.977 0.894 . . . . 0.0 111.11 170.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 p30 -78.13 -12.03 59.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.633 1.573 . . . . 0.0 112.647 170.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.19 8.11 73.65 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.876 1.227 . . . . 0.0 114.764 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -78.14 174.02 11.61 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.896 1.348 . . . . 0.0 109.023 168.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -93.13 148.25 22.18 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 171.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -136.2 27.57 3.17 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.886 1.674 . . . . 0.0 112.232 -171.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.3 mt -87.66 153.12 21.62 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.87 0.868 . . . . 0.0 111.008 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -148.0 -67.21 0.24 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.399 1.079 . . . . 0.0 111.44 172.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.22 9.07 27.1 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.721 1.608 . . . . 0.0 113.729 176.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 105.98 -5.47 39.5 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.803 1.668 . . . . 0.0 115.213 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -113.17 149.16 34.03 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.643 1.721 . . . . 0.0 112.277 174.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -70.71 86.61 0.67 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.456 1.102 . . . . 0.0 112.107 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -49.05 -45.11 42.34 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.067 1.347 . . . . 0.0 111.833 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 71.8 m -77.73 -0.14 25.79 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -173.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.486 ' HD3' ' HA ' ' A' ' 52' ' ' THR . 9.4 ttp85 -52.43 -40.33 62.07 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 121.171 1.805 . . . . 0.0 111.658 169.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.7 -25.09 75.92 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 117.617 -1.657 . . . . 0.0 113.156 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.355 42.7 tt0 -96.84 -92.06 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.328 0 CA-C-O 115.465 -2.207 . . . . 0.0 112.041 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.97 152.94 54.71 Favored 'Trans proline' 0 C--N 1.359 1.081 0 CA-C-N 124.241 2.55 . . . . 0.0 116.395 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.01 163.35 7.98 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.819 2.448 . . . . 0.0 114.72 170.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -60.85 139.9 57.82 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 167.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.579 ' HG3' HG21 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -84.11 150.57 25.46 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.613 -1.305 . . . . 0.0 112.396 -174.55 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.1 t -68.85 148.67 49.91 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.401 0.68 . . . . 0.0 111.805 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.0 t -55.85 -29.47 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.565 1.146 . . . . 0.0 111.802 -177.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.3 -40.66 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.34 1.056 . . . . 0.0 112.138 173.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -65.41 -35.87 82.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.327 0.651 . . . . 0.0 110.141 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.55 HD13 HD23 ' A' ' 86' ' ' LEU . 5.2 mt -61.8 -58.12 9.22 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 173.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -54.24 -41.12 68.38 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.486 1.114 . . . . 0.0 112.919 -175.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.8 t -59.65 -54.14 49.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.886 0.874 . . . . 0.0 111.525 173.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -73.64 -33.95 64.75 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.824 -1.173 . . . . 0.0 112.903 -172.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 mt -61.1 -38.23 85.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.401 1.001 . . . . 0.0 111.978 170.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.63 -33.41 64.52 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.114 0.966 . . . . 0.0 113.514 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -68.35 -47.3 67.83 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.641 1.177 . . . . 0.0 110.496 176.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -74.45 -17.37 60.79 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.492 0.717 . . . . 0.0 111.871 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 62.84 49.26 3.71 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.964 1.706 . . . . 0.0 111.514 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.51 125.79 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.82 1.248 . . . . 0.0 108.465 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -91.42 119.79 68.51 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-O 118.38 -0.819 . . . . 0.0 108.805 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.18 152.59 14.09 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.635 2.223 . . . . 0.0 110.603 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.8 mm -138.54 105.4 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.008 1.323 . . . . 0.0 109.379 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.553 ' CD2' HD11 ' A' ' 189' ' ' LEU . 28.2 m-85 -77.96 82.6 4.31 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.428 -1.42 . . . . 0.0 112.46 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 87.9 t -70.28 104.91 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.14 -1.391 . . . . 0.0 112.31 169.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.11 144.79 22.45 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -171.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -63.96 154.17 71.65 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 124.742 3.628 . . . . 0.0 114.912 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.7 m -41.22 -51.04 3.59 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.428 2.291 . . . . 0.0 114.877 -169.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -54.54 -26.37 31.53 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 8.9 ttm -106.02 -8.48 17.52 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.565 1.946 . . . . 0.0 114.073 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 40.1 t -55.56 -47.04 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.902 -1.124 . . . . 0.0 112.148 -168.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . 0.317 11.4 pttm -81.09 -6.18 58.51 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -174.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . 0.255 4.8 t -86.92 -26.87 23.68 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 119.337 0.971 . . . . 0.0 111.129 169.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -83.49 -23.25 32.25 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.694 -1.254 . . . . 0.0 111.471 172.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -34.8 78.49 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.16 -0.963 . . . . 0.0 109.357 167.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . 0.395 0.1 OUTLIER -83.48 1.08 43.47 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 119.915 -1.74 . . . . 0.0 112.893 -178.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -98.56 -25.98 14.56 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.965 2.506 . . . . 0.0 107.407 168.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.517 ' HA ' HD23 ' A' ' 189' ' ' LEU . 0.6 OUTLIER -79.23 -18.11 53.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.949 -1.094 . . . . 0.0 113.897 176.276 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 5.3 t -85.3 -24.14 27.82 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.226 0.61 . . . . 0.0 110.004 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -79.62 -38.09 34.65 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.527 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 35.4 mt -108.66 98.63 29.7 Favored Pre-proline 0 N--CA 1.484 1.227 0 CA-C-N 118.81 0.732 . . . . 0.0 110.037 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -55.06 144.89 66.87 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.215 2.61 . . . . 0.0 112.421 169.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 78.49 -2.47 2.37 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 128.227 2.611 . . . . 0.0 114.849 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.553 HD11 ' CD2' ' A' ' 169' ' ' PHE . 23.2 tp -74.47 152.72 39.39 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.785 1.234 . . . . 0.0 108.464 168.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.3 m -121.12 -153.1 0.53 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 177.83 114.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.427 2.291 . . . . 0.0 108.857 -167.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -109.62 147.1 17.03 Favored Glycine 0 N--CA 1.471 1.001 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 171.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . 0.362 0.9 OUTLIER -95.53 95.66 8.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 124.053 1.882 . . . . 0.0 110.568 177.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.525 HD22 HG13 ' A' ' 111' ' ' VAL . 31.1 tp . . . . . 0 CA--C 1.539 0.547 0 CA-C-N 111.326 -2.67 . . . . 0.0 111.692 172.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -72.95 159.24 34.01 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.186 -1.571 . . . . 0.0 113.217 -176.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.4 m -62.42 131.94 50.9 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.291 -0.881 . . . . 0.0 113.16 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.9 t -128.88 142.47 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.48 1.512 . . . . 0.0 109.377 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -119.46 113.17 20.36 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.083 1.753 . . . . 0.0 108.327 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.21 126.24 51.98 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.725 -0.609 . . . . 0.0 109.977 177.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -114.62 108.91 17.44 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 123.572 1.653 . . . . 0.0 111.284 174.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -84.01 99.2 10.27 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 112.713 -2.04 . . . . 0.0 113.584 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.4 mt -91.59 129.26 37.59 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.828 0.851 . . . . 0.0 109.675 168.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . 0.253 2.7 ppp? -137.45 156.63 47.95 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 169.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.02 131.81 10.63 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 126.149 1.833 . . . . 0.0 113.156 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.8 mp -107.42 29.57 7.04 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.917 2.087 . . . . 0.0 111.891 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.6 p -74.31 159.91 31.79 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.328 -1.483 . . . . 0.0 113.025 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.97 -33.08 82.42 Favored Glycine 0 N--CA 1.473 1.128 0 O-C-N 120.892 -1.13 . . . . 0.0 111.607 173.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.1 m -65.91 -26.24 67.52 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.258 1.423 . . . . 0.0 113.127 172.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.83 -7.62 53.98 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 137.79 51.75 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 120.891 1.678 . . . . 0.0 108.717 169.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.5 -41.06 3.05 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.334 0.969 . . . . 0.0 110.971 -169.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -80.29 -10.87 59.76 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.468 1.107 . . . . 0.0 111.191 168.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.3 tp -58.12 -52.86 63.77 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 124.364 1.066 . . . . 0.0 109.819 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.1 p -49.7 -45.38 48.93 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.088 0.955 . . . . 0.0 112.326 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -64.6 -35.14 80.04 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.993 0.917 . . . . 0.0 111.637 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.5 p -89.96 3.3 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -93.64 -51.66 4.83 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 169.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.5 t -59.95 -45.29 93.11 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.633 1.173 . . . . 0.0 110.318 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.5 tp -79.87 83.71 5.76 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 168.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.55 -47.09 0.24 Allowed Glycine 0 C--N 1.304 -1.243 0 CA-C-N 110.59 -3.005 . . . . 0.0 109.372 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.4 p -73.51 -43.15 60.73 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 123.46 0.704 . . . . 0.0 111.675 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -75.97 -21.62 56.79 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.5 tt -67.33 -61.23 2.01 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 169.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 43' ' ' ILE . 9.6 tt -47.24 -55.9 7.75 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.482 1.113 . . . . 0.0 112.931 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -75.11 -28.27 60.16 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 119.089 0.859 . . . . 0.0 113.24 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.63 -41.27 96.27 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.094 0.861 . . . . 0.0 111.355 169.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.537 HD11 HG21 ' A' ' 205' ' ' ILE . 16.1 mt -74.83 -30.7 61.46 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.408 -0.807 . . . . 0.0 112.904 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -64.19 -21.0 66.4 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.69 1.132 . . . . 0.0 113.156 172.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -81.46 -49.54 10.5 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.743 0.817 . . . . 0.0 109.474 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -72.71 -28.02 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.5 t -129.03 130.34 46.47 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -69.94 -22.07 63.21 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.462 1.105 . . . . 0.0 113.232 169.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.9 t -129.85 88.69 2.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.772 1.229 . . . . 0.0 109.272 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.01 82.22 0.31 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 127.837 2.637 . . . . 0.0 106.605 -172.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -79.37 127.73 32.45 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.476 HG21 HD12 ' A' ' 31' ' ' LEU . 2.9 mt -123.38 130.91 73.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.311 0.577 . . . . 0.0 111.217 -177.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.05 161.51 18.42 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 126.618 2.056 . . . . 0.0 110.278 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -141.28 133.31 27.7 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -169.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.82 145.51 16.25 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 121.404 0.446 . . . . 0.0 112.274 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.8 m -114.71 142.08 46.98 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.733 1.213 . . . . 0.0 110.332 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.587 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -152.77 155.04 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 120.913 -1.117 . . . . 0.0 108.984 178.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.587 ' N ' HD13 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -152.47 -62.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.607 1.163 . . . . 0.0 109.426 173.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.25 25.5 t30 177.47 -19.43 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 128.917 2.887 . . . . 0.0 111.972 168.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -50.31 -40.91 50.02 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 119.068 0.849 . . . . 0.0 109.7 168.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.405 ' HA ' ' HD2' ' A' ' 145' ' ' ARG 0.365 3.7 t 163.92 -177.61 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 131.622 3.969 . . . . 0.0 112.158 167.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -85.45 129.8 34.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.344 1.858 . . . . 0.0 108.533 169.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -117.73 112.22 20.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.45 1.1 . . . . 0.0 108.84 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -72.93 122.07 21.07 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.5 mt -103.86 -54.08 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.558 -0.714 . . . . 0.0 111.048 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.1 tp -130.98 120.72 23.91 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.257 0.551 . . . . 0.0 111.669 -175.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -57.85 149.57 22.24 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.705 1.202 . . . . 0.0 111.112 169.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 28.8 mt -48.03 108.8 0.18 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.115 1.366 . . . . 0.0 111.311 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t -129.57 162.27 28.6 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.608 1.563 . . . . 0.0 111.823 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.36 -4.28 42.24 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.071 1.748 . . . . 0.0 113.646 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.47 102.82 15.55 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 127.106 3.336 . . . . 0.0 108.222 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 9.6 t -66.2 -53.47 36.95 Favored 'General case' 0 C--N 1.304 -1.402 2 C-N-CA 132.152 4.181 . . . . 0.0 110.434 -174.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.3 p -64.66 -19.28 65.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.335 1.054 . . . . 0.0 112.321 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . 0.303 5.1 pt20 -83.82 -47.51 11.04 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.578 -177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -57.96 -33.82 69.27 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 121.175 -0.953 . . . . 0.0 111.918 174.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -70.78 -33.36 70.68 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.356 -0.84 . . . . 0.0 111.2 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttm-85 -79.77 -31.03 40.85 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.895 1.278 . . . . 0.0 109.621 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -80.95 -32.38 34.52 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -175.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 32.4 tp -73.23 -47.95 38.98 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.717 170.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -70.07 -25.66 63.64 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.019 -1.072 . . . . 0.0 112.683 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -57.87 -29.84 65.34 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.587 1.155 . . . . 0.0 114.049 170.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -61.73 150.37 36.97 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -170.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.3 tp -141.37 149.7 41.46 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.173 1.389 . . . . 0.0 109.196 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.85 169.43 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.988 1.315 . . . . 0.0 112.837 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.0 t -126.8 -140.54 0.27 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.273 1.429 . . . . 0.0 109.323 169.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -147.35 158.56 27.76 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-N 120.562 1.528 . . . . 0.0 115.715 -175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -160.6 148.41 16.1 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.951 1.7 . . . . 0.0 111.728 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.8 tp -68.06 -55.6 11.97 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.792 1.237 . . . . 0.0 112.223 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.59 136.17 50.92 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.632 0.773 . . . . 0.0 112.069 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.272 7.5 t -70.66 -39.84 9.84 Favored Pre-proline 0 N--CA 1.474 0.762 0 CA-C-O 115.766 -2.064 . . . . 0.0 113.456 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.42 140.07 56.49 Favored 'Trans proline' 0 C--N 1.356 0.939 0 CA-C-N 123.405 2.252 . . . . 0.0 111.693 169.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -107.4 -179.3 3.88 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.27 1.828 . . . . 0.0 112.738 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -109.18 18.99 30.27 Favored Glycine 0 N--CA 1.479 1.56 0 O-C-N 120.68 -1.262 . . . . 0.0 116.019 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -29.22 62.37 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -169.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.34 -28.15 67.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.144 -0.931 . . . . 0.0 111.47 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -65.72 -34.12 77.46 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 120.126 1.33 . . . . 0.0 112.273 171.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.7 -46.46 78.9 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 118.417 -0.801 . . . . 0.0 109.216 169.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.413 HG22 HD13 ' A' ' 108' ' ' LEU . 1.1 t -53.61 -40.13 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-N 119.017 0.826 . . . . 0.0 111.774 174.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.29 -61.9 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.433 1.093 . . . . 0.0 110.852 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -62.9 -44.8 95.11 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 118.945 -0.55 . . . . 0.0 110.715 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.24 -40.57 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.897 0.879 . . . . 0.0 111.714 174.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.56 -38.22 86.62 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.436 1.017 . . . . 0.0 112.86 176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 18.6 mt -86.31 -36.8 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.795 0.838 . . . . 0.0 113.181 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 73.6 m -77.53 55.39 1.29 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.823 2.049 . . . . 0.0 112.105 -169.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.456 HD21 HD22 ' A' ' 163' ' ' ASN . 62.3 mt -48.99 -42.59 38.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.453 2.301 . . . . 0.0 111.453 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -77.98 -19.25 75.45 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.403 1.001 . . . . 0.0 114.719 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -96.58 -47.6 5.86 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.117 0.967 . . . . 0.0 110.79 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.3 mm -66.73 -36.56 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.686 0.795 . . . . 0.0 111.104 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.43 20.93 28.26 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.115 1.341 . . . . 0.0 114.123 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -53.98 121.04 7.2 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.361 1.464 . . . . 0.0 112.212 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.2 ptm85 -107.34 -176.78 3.16 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.015 1.326 . . . . 0.0 112.164 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -73.86 11.08 0.94 Allowed 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 117.851 2.538 . . . . 0.0 117.851 -169.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.61 -129.82 1.97 Allowed Glycine 0 C--N 1.344 1.023 0 CA-C-N 121.215 1.825 . . . . 0.0 110.734 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.9 p -114.33 145.21 42.08 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.494 1.918 . . . . 0.0 107.656 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -129.05 117.87 21.59 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 118.879 -0.581 . . . . 0.0 110.416 -167.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -122.2 104.45 9.47 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -169.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.413 HD13 HG22 ' A' ' 89' ' ' VAL . 3.1 tt -88.6 94.96 10.06 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.216 -177.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.0 t -77.5 116.01 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 47.0 tp -105.18 123.06 47.18 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 t -108.27 130.12 61.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 O-C-N 124.595 1.184 . . . . 0.0 112.445 172.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.493 HG22 HG12 ' A' ' 171' ' ' VAL . 7.5 t -140.89 172.91 12.04 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.805 1.642 . . . . 0.0 110.335 173.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -118.96 -14.54 9.38 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 127.164 2.185 . . . . 0.0 111.859 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -133.12 174.82 9.96 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.789 1.236 . . . . 0.0 113.457 -169.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -61.23 -174.73 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.266 1.427 . . . . 0.0 110.883 168.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -147.12 159.86 43.1 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 120.655 -1.278 . . . . 0.0 113.36 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -79.22 116.83 19.72 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.27 1.428 . . . . 0.0 111.52 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.9 mp -82.55 -179.23 7.36 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.097 1.359 . . . . 0.0 109.962 173.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.47 160.1 3.35 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.406 -0.809 . . . . 0.0 111.689 169.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.449 0.0 OUTLIER 56.32 -12.68 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.277 0 N-CA-C 117.487 2.402 . . . . 0.0 117.487 -173.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.26 -28.21 69.55 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.037 -1.664 . . . . 0.0 111.899 169.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.58 -25.1 67.1 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 116.818 2.155 . . . . 0.0 116.818 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -18.6 63.62 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -167.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 pp -67.05 -19.77 65.73 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 118.68 0.673 . . . . 0.0 112.734 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -96.52 11.94 66.54 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 126.415 1.96 . . . . 0.0 114.11 170.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.334 10.5 t 54.86 53.74 10.03 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 128.078 2.551 . . . . 0.0 113.882 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -116.55 69.69 0.75 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.27 1.828 . . . . 0.0 110.505 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -62.23 -40.21 95.38 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 120.054 -1.654 . . . . 0.0 113.799 -169.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -60.83 138.92 58.09 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -173.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 t -81.39 148.88 29.1 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.731 0.813 . . . . 0.0 110.624 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 36.4 t -55.35 131.85 46.68 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.605 0.762 . . . . 0.0 111.771 170.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.7 p30 -89.58 -10.82 44.64 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.697 1.199 . . . . 0.0 113.899 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.93 21.85 78.72 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 117.995 -1.447 . . . . 0.0 114.773 177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -112.48 170.39 8.21 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 119.369 1.584 . . . . 0.0 113.141 169.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 5.5 t -71.1 133.4 46.23 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.586 1.554 . . . . 0.0 112.234 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -138.04 40.45 2.31 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.065 1.746 . . . . 0.0 112.996 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.73 125.35 42.5 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.933 1.693 . . . . 0.0 109.131 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -117.67 -84.66 0.64 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.998 0.919 . . . . 0.0 111.836 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -87.15 20.37 2.76 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.945 1.698 . . . . 0.0 113.39 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.18 -11.87 68.75 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.814 1.674 . . . . 0.0 113.641 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 97.3 mtp -91.14 144.88 25.17 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.64 1.22 . . . . 0.0 111.691 171.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -77.41 83.88 3.84 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.575 0.702 . . . . 0.0 109.231 169.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 42.3 tpt85 -56.02 -32.29 63.86 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.38 1.472 . . . . 0.0 112.942 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.7 m -73.58 -8.54 56.37 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 29.3 ttt85 -56.02 -27.97 55.35 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 121.337 1.881 . . . . 0.0 113.903 176.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.72 -18.39 73.98 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.241 -1.311 . . . . 0.0 114.601 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.265 57.8 tt0 -119.94 -80.03 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.144 0 CA-C-O 115.818 -2.039 . . . . 0.0 112.449 -170.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.88 165.74 24.96 Favored 'Trans proline' 0 C--N 1.36 1.132 0 CA-C-N 123.918 2.435 . . . . 0.0 113.937 170.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 25.2 p-10 -92.4 -179.82 5.32 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 -172.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -67.52 126.98 31.04 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 167.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -49.7 161.2 0.24 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.505 1.922 . . . . 0.0 115.425 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.1 p -82.84 157.78 23.0 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 121.099 -1.0 . . . . 0.0 112.141 169.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.05 -34.06 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 120.645 -1.284 . . . . 0.0 112.001 -176.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.9 t -77.94 -24.5 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.507 0.723 . . . . 0.0 111.682 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -67.17 -34.35 77.36 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.351 -0.843 . . . . 0.0 110.944 172.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.31 -56.12 21.52 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.021 0.828 . . . . 0.0 109.542 168.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.0 -40.49 63.85 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.829 0.852 . . . . 0.0 112.625 -173.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 30.4 t -62.07 -64.47 0.92 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.966 0.907 . . . . 0.0 112.245 172.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -73.63 -24.94 60.08 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.085 -1.634 . . . . 0.0 113.878 -169.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.4 mp -63.74 -41.42 98.04 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.269 0.941 . . . . 0.0 110.703 169.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.05 -36.88 61.8 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -69.19 -49.79 53.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.283 1.033 . . . . 0.0 110.493 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.456 HD22 HD21 ' A' ' 96' ' ' LEU . 4.7 m120 -77.42 -15.49 59.32 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.686 0.794 . . . . 0.0 111.278 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 66.96 60.21 0.53 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.189 1.796 . . . . 0.0 110.718 171.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.69 139.69 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 126.543 1.937 . . . . 0.0 107.988 172.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -107.9 106.16 57.91 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 119.951 1.251 . . . . 0.0 109.432 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.99 151.67 39.86 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.554 2.169 . . . . 0.0 114.005 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 82.5 mt -130.44 109.28 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.034 1.334 . . . . 0.0 107.801 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -78.89 80.9 5.21 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 122.093 0.949 . . . . 0.0 111.755 -175.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.8 104.81 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 123.992 0.917 . . . . 0.0 111.978 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.493 HG12 HG22 ' A' ' 112' ' ' THR . 3.0 m -142.61 167.67 15.59 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 120.078 -1.639 . . . . 0.0 112.064 -169.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -84.4 152.36 12.06 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.41 2.073 . . . . 0.0 110.951 -172.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.3 t -49.51 -43.84 45.81 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -169.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -56.8 -29.28 62.55 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -111.23 -8.2 14.39 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 126.633 1.973 . . . . 0.0 112.586 -170.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.2 t -54.27 -44.43 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 120.627 -1.296 . . . . 0.0 111.009 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -70.31 -6.08 32.5 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -170.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 18.4 m -87.12 -50.12 6.84 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.967 1.707 . . . . 0.0 110.19 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -73.56 -26.77 60.99 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.974 1.31 . . . . 0.0 110.307 -174.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . 0.353 7.1 pt-20 -65.73 -14.29 61.01 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.001 171.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . 0.379 0.0 OUTLIER -89.0 -22.91 22.76 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-N 120.551 1.523 . . . . 0.0 112.408 167.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.68 -19.78 60.73 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 119.682 -1.886 . . . . 0.0 110.176 169.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 98.7 m -80.28 -18.07 50.37 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.654 2.382 . . . . 0.0 111.949 169.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.73 -27.6 19.95 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 118.346 0.521 . . . . 0.0 110.38 169.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -80.26 -32.74 38.25 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 174.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.518 HG22 HD13 ' A' ' 189' ' ' LEU . 27.5 mt -110.21 101.31 47.49 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.46 150.84 64.59 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.857 2.371 . . . . 0.0 111.687 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt 86.36 -11.33 0.64 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 129.265 3.026 . . . . 0.0 113.084 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.518 HD13 HG22 ' A' ' 186' ' ' ILE . 10.2 mp -72.49 166.39 22.73 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.956 0.902 . . . . 0.0 109.817 172.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 69.7 p -125.24 -142.83 0.3 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.096 0.95 . . . . 0.0 109.856 170.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.2 tp -179.04 128.07 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 128.123 2.569 . . . . 0.0 108.482 -166.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -118.77 155.28 16.13 Favored Glycine 0 N--CA 1.467 0.746 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . 0.276 11.2 pt-20 -105.2 94.61 5.33 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 122.903 1.335 . . . . 0.0 109.776 173.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 26.2 tp -50.79 134.38 25.23 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.981 169.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 66.0 p -161.95 -161.71 0.79 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.058 1.343 . . . . 0.0 110.115 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.21 -16.09 63.15 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.108 0.963 . . . . 0.0 112.866 172.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -110.05 150.78 28.05 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.441 1.497 . . . . 0.0 112.931 172.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 36.4 p -106.83 -5.72 18.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.732 1.613 . . . . 0.0 113.588 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 59.9 p -60.38 -36.71 78.7 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.732 1.213 . . . . 0.0 111.957 -169.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -58.38 -52.2 66.6 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.565 0.746 . . . . 0.0 111.012 171.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.65 -45.28 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.145 0.978 . . . . 0.0 111.682 -175.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.79 -27.84 67.09 Favored 'General case' 0 C--O 1.219 -0.501 0 O-C-N 121.7 -0.625 . . . . 0.0 112.396 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -70.32 -10.33 58.69 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.623 -1.298 . . . . 0.0 112.394 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.29 -40.23 6.85 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.112 1.365 . . . . 0.0 108.866 -177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.537 HG21 HD11 ' A' ' 34' ' ' LEU . 10.1 mm -60.78 -49.48 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 169.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 5.0 mtm105 -76.95 -23.95 52.38 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 118.296 -0.859 . . . . 0.0 112.699 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -66.66 -41.04 88.82 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 120.034 1.288 . . . . 0.0 111.14 169.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -70.46 -25.86 63.37 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.665 0.786 . . . . 0.0 112.277 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -66.35 -40.15 89.62 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.163 0.985 . . . . 0.0 112.411 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.8 t -77.12 -15.26 59.61 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -71.39 -18.24 62.36 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 121.328 -0.857 . . . . 0.0 113.227 173.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 C--O 1.253 1.261 0 C-N-CA 125.907 1.683 . . . . 0.0 113.465 -169.145 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 110.692 -0.114 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -86.51 147.1 26.11 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.445 0.698 . . . . 0.0 110.306 172.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.1 p -76.55 143.57 40.24 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.991 -1.068 . . . . 0.0 111.903 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.95 108.41 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 121.993 0.901 . . . . 0.0 111.847 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -87.39 114.97 24.48 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 7' ' ' TYR . 1.3 tt -101.82 125.39 48.48 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.866 -0.521 . . . . 0.0 110.025 170.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.47 ' N ' HD23 ' A' ' 6' ' ' LEU . 26.9 t80 -117.42 109.37 16.7 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 123.531 1.634 . . . . 0.0 109.985 169.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -86.35 116.16 24.34 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.668 2.387 . . . . 0.0 112.444 -176.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.519 HD23 ' HB1' ' A' ' 88' ' ' ALA . 6.9 mp -99.25 124.34 44.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.378 1.071 . . . . 0.0 111.061 172.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.1 ttt -114.21 135.5 53.99 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.78 132.21 13.69 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 168.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 47' ' ' SER . 1.4 mp -115.1 15.07 17.16 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.498 1.519 . . . . 0.0 114.197 -170.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.3 p -74.66 174.49 9.01 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 121.031 -1.043 . . . . 0.0 112.705 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.47 -29.09 52.76 Favored Glycine 0 N--CA 1.477 1.397 0 O-C-N 121.102 -0.999 . . . . 0.0 115.487 -169.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.0 p -65.24 -25.14 67.54 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.073 1.749 . . . . 0.0 114.241 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.27 -10.42 59.74 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.502 1.521 . . . . 0.0 113.948 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -70.37 115.5 9.63 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 169.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.24 -38.6 3.24 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.097 1.332 . . . . 0.0 111.794 -169.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -65.7 -42.71 90.85 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 118.592 1.196 . . . . 0.0 110.309 169.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.3 tp -60.39 -31.96 70.86 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.952 0.901 . . . . 0.0 113.361 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.2 m -63.82 -44.46 93.18 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.223 0.609 . . . . 0.0 112.279 174.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -81.52 -15.62 54.32 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 -175.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.0 m -93.26 1.34 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 119.207 0.912 . . . . 0.0 113.444 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -84.38 -35.62 23.03 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.815 1.643 . . . . 0.0 108.759 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.4 t -71.46 -14.76 62.24 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.997 1.319 . . . . 0.0 110.147 167.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 13.6 tp -80.61 95.72 6.63 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-O 125.584 2.612 . . . . 0.0 106.797 170.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.74 -46.32 0.08 OUTLIER Glycine 0 C--N 1.298 -1.576 1 CA-C-N 108.244 -4.071 . . . . 0.0 110.957 167.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.4 p -92.9 -34.76 13.67 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 125.77 1.628 . . . . 0.0 111.535 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -63.14 -40.33 97.28 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.629 -0.67 . . . . 0.0 110.111 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 13.9 tp -66.36 -49.24 67.57 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.427 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.47 -45.35 69.52 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.041 0.837 . . . . 0.0 110.602 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.4 tmmm? -65.45 -38.33 89.53 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 120.111 1.323 . . . . 0.0 111.362 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.48 -38.38 74.39 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 172.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.6 mt -80.55 -18.36 48.64 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 119.838 1.199 . . . . 0.0 113.482 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.54 -29.19 63.35 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.474 1.488 . . . . 0.0 113.785 -170.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -83.7 -31.78 25.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.086 0.554 . . . . 0.0 110.421 172.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.7 mp -67.57 -33.55 62.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-O 119.046 -0.502 . . . . 0.0 111.566 169.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 99.6 p -160.5 148.25 16.18 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 116.885 2.179 . . . . 0.0 116.885 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -66.75 -48.42 69.17 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.088 1.355 . . . . 0.0 112.376 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.4 p -112.26 124.47 52.52 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 122.794 1.283 . . . . 0.0 111.889 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.9 90.47 0.16 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 106.596 -2.602 . . . . 0.0 106.596 -175.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -78.88 145.66 34.03 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.75 0.82 . . . . 0.0 109.435 -169.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.52 132.61 70.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 124.944 1.298 . . . . 0.0 109.342 -172.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.85 156.98 26.99 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.998 1.761 . . . . 0.0 111.687 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.43 ' CD1' HD21 ' A' ' 70' ' ' LEU . 63.7 t80 -143.31 136.73 28.23 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -169.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.35 155.34 23.43 Favored Glycine 0 C--N 1.345 1.033 0 C-N-CA 124.558 1.075 . . . . 0.0 111.194 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.438 ' HB2' HD22 ' A' ' 12' ' ' LEU . 89.3 p -124.66 146.35 49.17 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.842 0.857 . . . . 0.0 111.975 -174.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.584 HG21 ' HB2' ' A' ' 88' ' ' ALA . 1.2 pp -145.42 151.95 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 173.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.0 t -142.86 -126.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 102.6 -3.111 . . . . 0.0 102.6 169.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -123.69 -0.6 8.57 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 120.406 1.457 . . . . 0.0 109.761 167.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 25.2 mmt -60.37 -39.08 85.94 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.75 1.62 . . . . 0.0 109.927 169.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.45 ' HB ' ' HD2' ' A' ' 145' ' ' ARG . 5.4 t 147.74 176.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.345 1 C-N-CA 132.399 4.28 . . . . 0.0 112.145 169.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -79.85 130.67 35.5 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.519 1.928 . . . . 0.0 109.327 169.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -123.66 128.97 50.42 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.282 1.039 . . . . 0.0 108.714 169.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -92.35 91.67 7.78 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.734 2.014 . . . . 0.0 111.229 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.406 HG12 HE22 ' A' ' 73' ' ' GLN . 2.8 mp -77.26 -59.87 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.45 -178.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.4 tp -121.15 124.61 45.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.141 0.882 . . . . 0.0 112.114 -172.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.55 161.17 17.9 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 175.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.5 mt -56.29 109.01 0.53 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 126.129 1.772 . . . . 0.0 111.745 -171.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.6 t -143.02 171.3 14.25 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.549 1.54 . . . . 0.0 111.506 -177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.07 -5.09 56.94 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.023 1.729 . . . . 0.0 113.99 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -95.61 75.04 3.23 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 125.733 2.682 . . . . 0.0 108.992 -179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.8 p -69.31 -19.59 63.88 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 128.412 2.685 . . . . 0.0 110.973 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 61.3 p -76.5 -15.71 59.82 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.787 1.235 . . . . 0.0 110.58 168.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . 0.328 1.4 pt20 -91.52 -26.88 18.56 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 119.229 0.922 . . . . 0.0 112.183 173.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -60.99 -23.68 65.56 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.343 1.057 . . . . 0.0 111.241 168.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -71.5 -44.25 65.03 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.239 -0.913 . . . . 0.0 109.173 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -68.04 -39.96 82.94 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 125.074 1.35 . . . . 0.0 108.988 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . 0.265 59.9 mt-10 -86.91 -19.42 28.87 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.18 -175.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 45' ' ' PHE . 14.2 mt -75.39 -33.14 60.97 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 167.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.0 ttp-105 -70.83 -36.8 73.09 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 118.705 0.684 . . . . 0.0 112.352 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -73.2 -16.0 61.43 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 175.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.406 HE22 HG12 ' A' ' 56' ' ' ILE . 4.7 tp-100 -64.74 150.48 47.26 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.747 0.819 . . . . 0.0 110.479 173.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.75 168.4 19.9 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.789 0.835 . . . . 0.0 111.927 172.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 44.6 t -94.71 146.69 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.667 1.987 . . . . 0.0 111.87 -169.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.7 t -120.54 -175.17 2.96 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.101 1.76 . . . . 0.0 111.756 171.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -148.46 157.28 27.24 Favored Glycine 0 N--CA 1.474 1.225 0 O-C-N 120.477 -1.389 . . . . 0.0 113.998 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.1 ptmm? -158.2 167.79 28.82 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.927 1.291 . . . . 0.0 114.232 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -77.57 -62.06 1.79 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.631 1.573 . . . . 0.0 112.952 -169.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.77 151.96 43.89 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.814 0.846 . . . . 0.0 111.673 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.296 5.3 t -82.76 -41.41 0.88 Allowed Pre-proline 0 N--CA 1.479 1.005 0 CA-C-O 116.249 -1.834 . . . . 0.0 115.233 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.23 146.93 77.59 Favored 'Trans proline' 0 C--N 1.359 1.101 0 CA-C-N 123.04 2.121 . . . . 0.0 113.058 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -101.39 152.34 20.84 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.953 1.701 . . . . 0.0 113.637 -170.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.85 56.74 4.55 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 125.72 1.629 . . . . 0.0 111.662 171.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -84.11 -36.98 22.57 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.539 1.536 . . . . 0.0 113.327 -169.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.41 -36.84 83.83 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 122.153 -0.342 . . . . 0.0 110.852 -169.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -49.7 -41.79 44.18 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.196 1.398 . . . . 0.0 111.732 169.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.584 ' HB2' HG21 ' A' ' 48' ' ' ILE . . . -69.18 -52.38 28.59 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.055 -1.028 . . . . 0.0 111.498 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.4 m -59.68 -33.17 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-O 119.062 -0.494 . . . . 0.0 110.756 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.588 ' CG1' HD22 ' A' ' 156' ' ' LEU . 25.3 m -75.6 -51.68 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 117.215 -1.374 . . . . 0.0 112.624 173.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -55.74 -46.87 77.72 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 121.295 1.861 . . . . 0.0 110.175 -177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.6 t -59.66 -36.13 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.76 -43.37 79.99 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.986 -1.071 . . . . 0.0 112.629 176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 90' ' ' VAL . 3.8 mp -78.85 -42.3 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -172.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . 0.26 21.8 p -83.79 66.48 9.1 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 121.222 1.828 . . . . 0.0 113.516 -174.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.6 mt -43.42 -40.42 3.74 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 127.63 2.372 . . . . 0.0 111.583 169.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.11 -30.7 56.85 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.647 1.118 . . . . 0.0 114.794 -172.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -104.59 -34.02 8.33 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 117.725 -1.131 . . . . 0.0 113.685 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.1 mm -64.07 -34.83 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 120.874 1.67 . . . . 0.0 110.408 169.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 93.59 18.31 38.77 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 117.907 -1.496 . . . . 0.0 114.126 172.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -54.06 147.28 12.93 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 119.343 1.572 . . . . 0.0 112.979 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . 0.272 0.0 OUTLIER -143.07 172.12 13.14 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.654 1.182 . . . . 0.0 114.015 172.085 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -58.54 24.35 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 121.39 3.848 . . . . 0.0 121.39 -168.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.16 -118.82 1.22 Allowed Glycine 0 CA--C 1.535 1.332 0 CA-C-N 120.912 1.687 . . . . 0.0 109.594 170.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.0 t -130.09 148.77 51.98 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 168.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 66.6 mtt85 -123.78 123.42 40.44 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 119.158 -0.449 . . . . 0.0 111.988 -166.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -115.32 103.49 10.86 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -170.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 12.0 tp -88.62 85.92 6.9 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.779 1.232 . . . . 0.0 109.527 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 66.7 t -77.28 136.85 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.3 tt -127.96 126.27 41.1 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.963 1.256 . . . . 0.0 111.541 169.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.1 t -95.46 128.01 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 126.216 1.806 . . . . 0.0 110.875 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.6 t -156.55 158.26 36.82 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.964 0.506 . . . . 0.0 110.989 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.87 0.59 11.41 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -141.44 -178.9 5.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.678 1.191 . . . . 0.0 111.867 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.95 -168.02 0.18 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.312 1.445 . . . . 0.0 112.137 -175.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.502 ' CE1' HD11 ' A' ' 182' ' ' LEU . 17.6 p90 -145.5 146.11 31.33 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 120.622 -1.298 . . . . 0.0 111.792 -169.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -80.23 130.02 34.91 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.826 169.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 pp -111.62 174.05 6.06 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.349 1.46 . . . . 0.0 111.344 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.33 130.16 30.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.5 mttm 93.91 -10.85 0.14 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 129.407 3.083 . . . . 0.0 112.003 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -67.75 -23.89 65.29 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 120.157 1.344 . . . . 0.0 112.706 174.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 27.5 tptt -74.65 -11.32 60.16 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.007 -1.058 . . . . 0.0 113.841 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.28 1.1 t -72.15 -21.51 61.44 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 120.458 1.481 . . . . 0.0 113.727 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.96 -37.72 84.79 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.735 1.152 . . . . 0.0 109.689 169.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -73.31 6.5 15.21 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.071 1.32 . . . . 0.0 113.158 169.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.277 52.8 m 70.06 37.8 1.64 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.309 2.244 . . . . 0.0 111.463 171.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -121.55 118.5 29.42 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.412 1.085 . . . . 0.0 111.076 169.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -105.12 -26.16 12.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.882 1.273 . . . . 0.0 112.896 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -61.35 116.18 4.44 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.067 0.849 . . . . 0.0 110.29 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 t -65.7 158.4 27.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.664 0.665 . . . . 0.0 110.003 173.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.1 t -67.44 144.61 55.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 122.043 0.925 . . . . 0.0 111.614 174.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.8 p30 -82.56 -10.75 58.85 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.054 1.342 . . . . 0.0 113.193 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.41 26.51 74.05 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.023 -0.876 . . . . 0.0 112.877 -175.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -103.29 172.92 6.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.026 1.73 . . . . 0.0 110.343 171.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 7.2 t -92.21 148.78 21.89 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.51 -0.744 . . . . 0.0 112.083 170.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -134.62 33.13 3.26 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.705 2.002 . . . . 0.0 112.063 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.75 161.06 13.84 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.197 0.999 . . . . 0.0 111.819 174.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -170.94 -45.26 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.571 1.948 . . . . 0.0 111.016 172.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -80.45 4.79 17.04 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.235 1.414 . . . . 0.0 112.771 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 82.73 -11.21 53.92 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.893 1.711 . . . . 0.0 112.547 -169.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.3 mtt -90.67 143.83 26.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.176 1.39 . . . . 0.0 111.118 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -74.05 95.63 2.56 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 169.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 48.3 mtp180 -64.09 -33.43 75.76 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.668 1.187 . . . . 0.0 113.25 -172.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.41 ' HB2' ' HD2' ' A' ' 148' ' ' PRO . 19.2 p -81.91 4.66 21.67 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -174.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.45 ' HD2' ' HB ' ' A' ' 52' ' ' THR . 40.0 ptt85 -37.87 -35.79 0.16 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 126.799 2.04 . . . . 0.0 115.219 169.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.69 30.07 6.85 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 127.962 2.696 . . . . 0.0 112.521 -172.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.266 43.2 tt0 -139.75 -79.3 0.01 OUTLIER Pre-proline 0 CA--C 1.559 1.293 0 CA-C-O 115.724 -2.084 . . . . 0.0 109.593 169.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 144' ' ' SER . 33.4 Cg_exo -54.18 150.4 32.43 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 123.574 2.85 . . . . 0.0 117.02 169.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.18 162.52 25.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 128.315 2.646 . . . . 0.0 109.316 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -55.2 140.67 37.94 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.177 -0.952 . . . . 0.0 109.729 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.09 156.91 24.31 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.667 -1.271 . . . . 0.0 112.189 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 27.2 t -81.47 154.9 26.1 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -173.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 20.2 t -59.27 -30.59 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 124.216 1.006 . . . . 0.0 111.652 -171.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.5 p -66.62 -37.04 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.607 1.163 . . . . 0.0 113.433 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -72.82 -32.58 65.61 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.487 -0.758 . . . . 0.0 110.495 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.588 HD22 ' CG1' ' A' ' 90' ' ' VAL . 1.1 mt -65.33 -46.54 79.86 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 176.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -54.54 -44.78 73.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.104 0.962 . . . . 0.0 112.607 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 51.8 m -59.43 -53.05 62.57 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.688 0.795 . . . . 0.0 112.119 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -64.57 -43.38 94.06 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.166 -0.959 . . . . 0.0 111.81 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.65 -38.63 81.96 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 118.355 -0.831 . . . . 0.0 112.178 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.54 -36.18 65.64 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -71.72 -42.33 67.44 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.869 0.868 . . . . 0.0 111.643 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -80.51 -9.17 59.78 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.615 0.766 . . . . 0.0 112.412 171.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . 0.402 15.7 p-10 42.02 52.66 4.32 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.831 2.452 . . . . 0.0 113.245 -174.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 79.4 mt -100.49 133.67 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.334 1.854 . . . . 0.0 109.07 174.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -104.33 108.29 59.96 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-N 119.257 0.935 . . . . 0.0 112.362 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.85 140.94 52.28 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.476 2.784 . . . . 0.0 115.754 169.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.1 mm -121.56 100.59 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.519 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -74.06 75.26 1.73 Allowed 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.904 -1.122 . . . . 0.0 112.168 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.489 HG11 HG12 ' A' ' 201' ' ' VAL 0.255 13.4 m -76.18 110.6 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 120.762 -1.211 . . . . 0.0 112.486 173.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.23 141.88 17.66 Favored Pre-proline 0 N--CA 1.478 0.97 0 O-C-N 120.997 -1.065 . . . . 0.0 112.389 -171.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -51.32 150.83 14.17 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.43 3.42 . . . . 0.0 115.837 169.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.3 t -47.63 -44.87 27.23 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.374 1.87 . . . . 0.0 113.546 -169.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.8 mtp-105 -42.88 -38.56 2.22 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.614 1.565 . . . . 0.0 113.428 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.51 0.6 16.55 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.895 1.678 . . . . 0.0 113.322 -170.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 37.5 t -62.6 -38.97 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 120.615 -1.303 . . . . 0.0 111.141 -175.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -65.23 -27.19 68.49 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.077 0.853 . . . . 0.0 113.025 -174.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.7 t -84.47 -39.94 18.3 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.784 0.434 . . . . 0.0 111.009 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.413 ' CD1' HD12 ' A' ' 182' ' ' LEU . 45.1 m-85 -69.46 -30.32 68.19 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.805 -1.184 . . . . 0.0 110.764 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -60.84 -33.05 72.45 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.158 0.436 . . . . 0.0 110.508 169.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . 0.362 0.0 OUTLIER -87.81 -18.17 29.92 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 119.07 0.85 . . . . 0.0 112.244 -178.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.502 HD11 ' CE1' ' A' ' 116' ' ' PHE . 20.1 mt -72.92 -25.44 61.05 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 120.528 -1.357 . . . . 0.0 109.812 169.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.45 -10.28 59.28 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.299 1.84 . . . . 0.0 111.518 173.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 90.9 m -89.15 -32.62 17.39 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.363 1.065 . . . . 0.0 109.364 169.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -76.79 -30.11 56.33 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 118.906 -0.568 . . . . 0.0 112.484 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 20.2 mt -118.86 109.66 39.31 Favored Pre-proline 0 N--CA 1.484 1.24 0 CA-C-N 119.114 0.87 . . . . 0.0 110.685 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -55.62 143.21 80.2 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.394 3.396 . . . . 0.0 114.225 174.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt 79.66 -8.35 1.58 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 128.755 2.822 . . . . 0.0 113.452 170.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 10.6 mt -72.9 153.78 40.86 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.286 -0.883 . . . . 0.0 109.954 171.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 19.7 p -116.89 -149.04 0.44 Allowed 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 123.333 1.54 . . . . 0.0 109.432 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.1 tp -177.64 131.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 C-N-CA 127.043 2.137 . . . . 0.0 108.223 -165.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -123.73 150.67 16.96 Favored Glycine 0 N--CA 1.465 0.624 0 C-N-CA 124.37 0.986 . . . . 0.0 110.66 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -94.6 85.1 4.41 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 170.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.5 tp -59.95 134.88 57.45 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 169.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 99.1 p -153.92 -149.72 0.29 Allowed 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.478 -0.764 . . . . 0.0 110.722 -176.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.36 15.34 0.99 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.522 1.529 . . . . 0.0 113.738 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -132.62 148.75 52.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.075 1.75 . . . . 0.0 111.668 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 12.2 t -92.52 -12.68 31.29 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.54 1.936 . . . . 0.0 112.492 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 74.4 p -57.59 -35.43 70.39 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 119.821 -1.799 . . . . 0.0 112.179 -177.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -65.79 -28.87 69.33 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.753 1.019 . . . . 0.0 113.753 -175.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.489 HG12 HG11 ' A' ' 170' ' ' VAL . 3.0 m -77.8 -46.16 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-N 119.438 1.017 . . . . 0.0 111.416 174.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -75.42 -34.64 61.03 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -176.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 31.1 mm100 -80.32 7.38 9.7 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 120.562 1.528 . . . . 0.0 113.108 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.58 -40.06 5.21 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.383 1.873 . . . . 0.0 107.297 176.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 75.3 mt -74.15 -34.83 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 121.596 -0.69 . . . . 0.0 109.266 172.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 34.4 ttt85 -65.93 -35.45 80.64 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.623 -0.673 . . . . 0.0 110.518 169.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -69.89 -20.33 63.38 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 170.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -76.1 -32.53 59.24 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 120.932 -1.105 . . . . 0.0 112.307 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -65.51 -33.74 76.64 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.0 p -83.07 -22.46 33.47 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -138.42 -77.16 0.37 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.256 1.411 0 C-N-CA 128.14 2.576 . . . . 0.0 115.038 -168.34 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.992 0.425 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -96.27 145.94 25.14 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.22 1.008 . . . . 0.0 110.583 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.4 t -70.09 123.39 21.47 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.329 -0.857 . . . . 0.0 110.888 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.2 t -128.99 118.7 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-O 121.797 0.808 . . . . 0.0 111.785 -175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -87.12 127.87 35.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.978 0.911 . . . . 0.0 109.188 173.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mp -123.44 135.63 54.19 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 169.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -117.4 113.29 21.87 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 123.108 1.432 . . . . 0.0 109.078 172.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -87.46 103.29 15.37 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 126.107 1.763 . . . . 0.0 111.166 174.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.0 tp -102.22 121.59 42.55 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.674 1.19 . . . . 0.0 110.284 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.09 157.89 24.04 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 170.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.02 132.95 11.44 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 126.409 1.957 . . . . 0.0 110.56 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.15 23.36 13.4 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.612 1.565 . . . . 0.0 114.192 -171.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.7 p -79.28 172.25 14.06 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 119.42 -2.05 . . . . 0.0 114.454 -174.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.06 -23.18 67.59 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.288 -0.882 . . . . 0.0 113.696 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.9 t -68.89 -38.06 79.41 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.591 1.195 . . . . 0.0 111.112 170.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.65 4.82 3.58 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.928 1.291 . . . . 0.0 114.025 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -66.27 -43.34 86.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.643 1.177 . . . . 0.0 112.41 -176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.66 -30.47 64.0 Favored Glycine 0 N--CA 1.471 0.99 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -76.59 -14.05 60.03 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.657 1.183 . . . . 0.0 113.381 177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 38.4 tp -58.49 -44.28 89.34 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.812 1.642 . . . . 0.0 111.74 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 t -57.53 -44.72 85.31 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.018 0.826 . . . . 0.0 111.733 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -61.61 -48.42 80.97 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.452 1.501 . . . . 0.0 110.535 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.631 HG22 HG11 ' A' ' 111' ' ' VAL . 59.4 t -60.99 -43.61 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 O-C-N 121.355 -0.841 . . . . 0.0 111.275 175.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -63.85 -52.28 60.8 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.091 1.356 . . . . 0.0 110.198 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 t -66.93 -35.09 79.2 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.945 -175.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.3 tp -60.44 -31.58 70.55 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.056 1.298 . . . . 0.0 112.886 175.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.26 -40.31 5.81 Favored Glycine 0 N--CA 1.473 1.121 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -168.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.6 m -65.89 -36.13 82.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.086 -1.057 . . . . 0.0 109.531 169.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -73.69 -35.16 65.13 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.0 175.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 16.2 tp -62.0 -55.77 25.9 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.4 HD12 ' CD1' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -58.34 -53.24 60.53 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.156 0.582 . . . . 0.0 112.188 -174.301 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -71.44 -26.91 62.94 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -176.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.01 -43.36 71.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.244 0.929 . . . . 0.0 111.576 171.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.8 mt -73.27 -27.66 61.69 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 118.182 -0.913 . . . . 0.0 113.047 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -61.32 -28.87 69.52 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 120.17 1.35 . . . . 0.0 113.485 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -93.08 -31.96 14.64 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.527 0.331 . . . . 0.0 111.238 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mp -72.5 -31.68 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 121.884 -0.51 . . . . 0.0 111.067 169.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.7 t -142.17 119.6 11.62 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.84 1.256 . . . . 0.0 111.978 173.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -67.03 -46.9 73.03 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.279 0.631 . . . . 0.0 111.087 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.9 t -90.42 80.81 6.05 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 122.957 1.361 . . . . 0.0 110.219 174.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.53 88.02 0.21 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 106.731 -2.548 . . . . 0.0 106.731 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -98.62 137.69 36.9 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 124.271 1.028 . . . . 0.0 109.757 -169.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.8 tt -116.93 146.13 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.01 -170.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.77 165.12 19.08 Favored Glycine 0 N--CA 1.464 0.519 0 C-N-CA 125.524 1.535 . . . . 0.0 110.575 171.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -139.76 128.22 22.86 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.863 0.865 . . . . 0.0 113.168 -169.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.35 147.12 19.05 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 123.639 0.638 . . . . 0.0 112.229 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.8 t -114.49 148.25 38.15 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 125.618 1.567 . . . . 0.0 110.517 177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.75 152.27 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.905 1.282 . . . . 0.0 109.462 171.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.7 t -138.0 -70.83 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.779 0.831 . . . . 0.0 108.784 169.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 t30 174.95 -15.75 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 131.0 3.72 . . . . 0.0 108.622 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.5 ttt -58.58 -60.19 4.21 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.87 1.668 . . . . 0.0 107.111 167.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.412 ' HA ' ' HD2' ' A' ' 145' ' ' ARG 0.302 0.5 OUTLIER -173.87 169.26 4.15 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.264 2.226 . . . . 0.0 114.534 168.928 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -84.09 120.83 26.62 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 169.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -115.77 117.11 29.33 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 122.234 1.016 . . . . 0.0 110.279 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -74.67 110.56 9.06 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.751 1.62 . . . . 0.0 109.95 170.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.3 mt -94.63 -61.33 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.385 0.674 . . . . 0.0 110.392 -173.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.9 tp -124.99 124.74 42.64 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.034 0.934 . . . . 0.0 110.177 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.13 166.68 13.46 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.655 -0.653 . . . . 0.0 112.691 169.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 83.9 mt -58.15 116.05 3.31 Favored 'General case' 0 CA--C 1.546 0.79 0 O-C-N 121.74 -0.6 . . . . 0.0 111.136 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 36.8 p -134.49 154.22 51.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.362 1.465 . . . . 0.0 112.244 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.78 2.08 35.75 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.456 1.502 . . . . 0.0 112.731 171.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -93.07 80.17 4.55 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.861 2.464 . . . . 0.0 107.799 -170.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 28.9 t -66.64 -46.34 76.1 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 111.425 -2.625 . . . . 0.0 112.067 -169.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.8 p -64.28 -18.81 64.94 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.637 -0.665 . . . . 0.0 112.5 169.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -81.75 -52.93 6.63 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.278 0.944 . . . . 0.0 110.19 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.4 ' CD1' HD12 ' A' ' 31' ' ' LEU . 16.0 t80 -51.74 -32.98 32.73 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.282 1.033 . . . . 0.0 112.038 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -76.28 -30.53 57.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.781 0.832 . . . . 0.0 110.829 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -74.79 -41.53 59.82 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 123.636 0.774 . . . . 0.0 109.86 175.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . 0.425 6.9 pt-20 -88.35 -16.7 32.31 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 120.4 -0.52 . . . . 0.0 112.159 -173.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.5 tt -72.71 -47.33 48.02 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 166.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -39.76 79.67 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 121.965 -0.459 . . . . 0.0 111.968 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -67.72 -12.42 60.48 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -66.31 151.51 46.91 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 120.473 1.488 . . . . 0.0 112.517 -177.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.2 tt -147.66 133.38 18.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.271 1.428 . . . . 0.0 108.683 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.4 m -63.23 158.42 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 -173.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.6 p -107.78 -143.78 0.38 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.079 1.352 . . . . 0.0 110.694 169.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.34 143.64 8.83 Favored Glycine 0 N--CA 1.472 1.046 0 O-C-N 120.376 -1.453 . . . . 0.0 114.622 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -160.44 150.47 17.95 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.037 1.735 . . . . 0.0 111.462 170.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.0 tp -73.68 -48.56 31.3 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -169.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.71 119.11 8.65 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 122.945 0.498 . . . . 0.0 109.926 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.9 p -71.16 -35.17 3.85 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-O 115.686 -2.102 . . . . 0.0 113.976 -174.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -66.0 144.9 77.96 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.375 2.05 . . . . 0.0 110.665 169.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -119.4 161.12 21.04 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -171.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.67 45.03 3.19 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 125.184 1.374 . . . . 0.0 115.598 -169.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -36.96 85.85 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.431 1.892 . . . . 0.0 114.038 -173.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.0 mp -63.47 -33.91 76.6 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.547 0.612 . . . . 0.0 111.228 -169.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -58.02 -47.46 83.0 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.347 1.459 . . . . 0.0 111.684 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.86 -56.75 16.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.619 -1.181 . . . . 0.0 109.708 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.294 1.5 p -59.33 -36.83 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-O 117.765 -1.112 . . . . 0.0 113.366 -174.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.505 HG21 ' HG3' ' A' ' 151' ' ' GLN . 38.0 t -74.17 -38.96 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 121.396 1.907 . . . . 0.0 113.572 175.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -63.91 -40.52 96.69 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 120.719 1.6 . . . . 0.0 110.344 171.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.603 HG11 HD13 ' A' ' 108' ' ' LEU . 1.0 OUTLIER -49.38 -35.51 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 124.291 1.037 . . . . 0.0 112.638 169.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.16 -48.21 13.52 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.9 tt -100.42 -4.63 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -171.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 72.2 m -82.5 58.34 4.11 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 119.8 -1.812 . . . . 0.0 110.483 170.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.46 -44.43 55.67 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.235 1.814 . . . . 0.0 111.262 -174.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.62 -24.98 55.05 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.141 -0.811 . . . . 0.0 114.74 -169.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -90.95 -40.59 11.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.267 1.034 . . . . 0.0 111.529 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.9 -38.48 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 118.941 0.791 . . . . 0.0 110.677 171.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.36 27.7 19.54 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.738 -1.034 . . . . 0.0 114.099 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -54.01 125.75 19.99 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.769 1.285 . . . . 0.0 111.63 177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -105.06 -170.34 1.74 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.754 2.022 . . . . 0.0 112.059 176.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -75.13 0.23 16.93 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 118.948 2.944 . . . . 0.0 118.948 -168.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.68 -130.77 3.31 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 121.833 2.106 . . . . 0.0 112.06 -174.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.8 m -100.55 145.8 27.89 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 126.415 1.886 . . . . 0.0 106.93 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -135.69 128.13 30.43 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 121.395 1.907 . . . . 0.0 108.581 -168.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -133.21 115.73 15.35 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.603 HD13 HG11 ' A' ' 92' ' ' VAL . 47.7 tp -91.2 109.94 21.21 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.975 169.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.63 116.42 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 168.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.7 tp -95.13 134.49 37.79 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 117.276 -1.345 . . . . 0.0 108.094 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.631 HG11 HG22 ' A' ' 23' ' ' VAL . 21.6 t -121.42 124.99 73.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 O-C-N 123.895 0.747 . . . . 0.0 111.607 168.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.0 t -160.48 141.69 12.13 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.678 0.791 . . . . 0.0 113.067 172.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -103.74 24.41 11.25 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.94 2.096 . . . . 0.0 114.888 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -152.35 -175.69 5.38 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.144 -0.972 . . . . 0.0 112.176 171.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.51 -175.84 0.41 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.3 1.44 . . . . 0.0 110.806 169.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -137.15 153.84 50.38 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.664 1.185 . . . . 0.0 111.664 -170.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -83.45 132.31 34.97 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.032 0.533 . . . . 0.0 110.817 169.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 pp -117.45 173.94 6.42 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.436 1.494 . . . . 0.0 112.532 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.72 124.99 18.17 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.42 98.7 mttt 80.23 1.84 1.97 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.349 2.259 . . . . 0.0 115.039 -175.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -70.78 -15.24 62.65 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 120.848 -1.157 . . . . 0.0 108.657 166.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.556 ' HE2' ' CG ' ' A' ' 127' ' ' ARG . 4.9 ptmt -57.46 -29.47 64.25 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 173.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.5 m -60.74 -26.4 67.17 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 118.162 2.653 . . . . 0.0 118.162 -167.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.492 HD13 ' H ' ' A' ' 124' ' ' LEU 0.329 0.0 OUTLIER -69.75 -13.08 62.11 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 120.894 1.679 . . . . 0.0 113.273 170.607 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -105.9 150.12 16.84 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 107.468 -2.253 . . . . 0.0 107.468 167.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 11.5 p -75.98 81.89 2.86 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 119.26 1.53 . . . . 0.0 112.601 -171.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.556 ' CG ' ' HE2' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -163.3 125.19 2.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.172 1.789 . . . . 0.0 110.475 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -119.56 -25.82 5.9 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.579 1.151 . . . . 0.0 113.088 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -51.56 107.23 0.18 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.673 1.589 . . . . 0.0 113.008 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.8 t -68.95 150.83 47.28 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.594 1.088 . . . . 0.0 110.952 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.1 m -55.19 131.7 45.91 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.695 1.198 . . . . 0.0 113.101 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.5 p30 -81.58 -15.28 55.25 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.338 0.655 . . . . 0.0 112.541 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.94 14.6 81.55 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.903 -1.498 . . . . 0.0 114.26 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 90.8 mtt180 -93.16 163.47 13.62 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.872 1.669 . . . . 0.0 112.384 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 20.0 t -62.89 130.85 46.62 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.793 0.837 . . . . 0.0 111.655 172.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -135.75 41.44 2.71 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.745 1.618 . . . . 0.0 112.164 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.1 tp -124.16 140.71 52.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.426 1.491 . . . . 0.0 110.943 -175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -150.51 -62.1 0.2 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.254 1.021 . . . . 0.0 111.286 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -70.24 -21.81 62.95 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 121.35 -19.4 8.64 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.722 1.629 . . . . 0.0 112.409 -169.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 94.7 mtp -98.31 140.52 32.46 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.628 1.571 . . . . 0.0 112.507 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -77.35 83.04 3.8 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.877 0.871 . . . . 0.0 110.456 169.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -64.36 -30.74 71.78 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.112 -0.993 . . . . 0.0 112.236 -173.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 35.5 m -65.89 -2.12 3.57 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 175.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.412 ' HD2' ' HA ' ' A' ' 52' ' ' THR . 40.2 ttt85 -52.37 -37.75 57.04 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 120.213 -1.554 . . . . 0.0 114.251 172.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.71 -22.24 77.4 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.694 -1.059 . . . . 0.0 114.412 -175.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.317 1.2 pt-20 -112.68 -68.43 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.198 0 CA-C-O 117.133 -1.413 . . . . 0.0 112.059 -173.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -55.36 173.0 0.36 Allowed 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 123.399 2.732 . . . . 0.0 117.265 168.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.415 ' HA ' ' HE3' ' A' ' 122' ' ' LYS . 45.4 t0 -100.46 171.51 7.7 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 127.914 2.486 . . . . 0.0 114.048 -173.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -73.7 120.93 19.98 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 166.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.505 ' HG3' HG21 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -70.78 144.26 50.92 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 120.932 -1.105 . . . . 0.0 110.644 -169.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 39.8 m -68.02 153.92 42.73 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.468 0.707 . . . . 0.0 111.737 -174.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 82.2 t -60.68 -27.64 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 O-C-N 120.542 -1.349 . . . . 0.0 112.794 -171.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 55.6 t -81.48 -27.35 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 121.323 -0.861 . . . . 0.0 112.801 171.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -67.0 -38.22 85.59 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.298 0.954 . . . . 0.0 110.253 170.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.467 HD13 HG23 ' A' ' 90' ' ' VAL . 3.6 mm? -55.56 -61.41 2.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 118.751 0.705 . . . . 0.0 109.19 169.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.75 -48.08 70.04 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.306 1.042 . . . . 0.0 113.569 -170.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 64.7 m -63.82 -45.35 90.01 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -64.14 -47.64 79.14 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.399 -0.813 . . . . 0.0 111.155 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 90.4 mt -55.58 -40.51 72.08 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.827 0.851 . . . . 0.0 112.68 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.24 -33.26 56.07 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -80.52 -25.55 38.64 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 119.477 1.035 . . . . 0.0 112.002 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -80.49 -13.91 58.71 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.482 0.713 . . . . 0.0 110.758 168.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 33.4 m120 60.3 36.32 20.65 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.215 1.806 . . . . 0.0 112.848 177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 67.1 mt -95.61 145.13 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.264 1.026 . . . . 0.0 108.929 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -105.13 102.72 37.97 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -77.46 156.29 32.42 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.139 1.226 . . . . 0.0 113.267 169.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.458 HG22 HG23 ' A' ' 170' ' ' VAL . 0.7 OUTLIER -141.42 105.93 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.568 1.547 . . . . 0.0 109.522 -169.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -75.1 73.83 2.26 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.729 -1.232 . . . . 0.0 112.756 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.458 HG23 HG22 ' A' ' 168' ' ' ILE . 76.5 t -66.6 108.87 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 O-C-N 121.235 -0.915 . . . . 0.0 111.233 169.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 34.5 m -146.62 146.64 27.57 Favored Pre-proline 0 N--CA 1.482 1.126 0 O-C-N 120.592 -1.317 . . . . 0.0 112.314 -174.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -67.57 159.75 51.13 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.844 3.03 . . . . 0.0 112.801 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.5 t -41.2 -54.14 2.99 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.453 1.901 . . . . 0.0 114.437 -169.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -57.17 -33.2 67.21 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.69 -17.17 32.37 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.911 1.285 . . . . 0.0 113.966 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.4 t -55.73 -41.12 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 120.15 1.341 . . . . 0.0 112.113 -168.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -62.47 -37.59 86.56 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -172.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 9.6 t -84.27 -30.25 25.78 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.901 0.48 . . . . 0.0 111.3 -173.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -69.14 -32.9 72.58 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.639 -1.288 . . . . 0.0 109.211 169.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -68.37 -7.11 28.46 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.347 -0.845 . . . . 0.0 112.699 169.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -98.91 -6.59 28.59 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 121.04 -1.038 . . . . 0.0 112.403 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 6.2 mp -104.84 -15.37 15.21 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.546 1.538 . . . . 0.0 111.926 173.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 6.0 t -79.5 -23.2 43.14 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 118.995 0.816 . . . . 0.0 111.832 169.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 1.7 t -77.85 -23.41 48.93 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.676 -0.64 . . . . 0.0 110.559 172.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -82.45 -34.48 28.14 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 119.375 -0.345 . . . . 0.0 111.102 169.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 13.2 mt -117.66 80.88 14.1 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 123.985 0.914 . . . . 0.0 109.838 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -62.17 152.34 76.6 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.123 1.882 . . . . 0.0 110.561 173.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 91.26 -17.31 0.17 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 130.415 3.486 . . . . 0.0 112.505 -176.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.0 tt -74.98 155.62 37.17 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.028 1.331 . . . . 0.0 108.295 168.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.266 48.0 p -127.94 -164.08 1.33 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 169.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 10.8 mt -157.82 145.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 126.823 2.049 . . . . 0.0 109.697 -165.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -131.87 155.34 21.38 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 123.818 0.723 . . . . 0.0 112.284 170.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -85.24 98.74 10.67 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.427 ' HB2' HG12 ' A' ' 170' ' ' VAL . 18.2 tp -59.72 125.69 24.64 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 113.422 -1.717 . . . . 0.0 107.896 168.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 93.4 p -162.51 174.62 12.43 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 124.974 1.31 . . . . 0.0 109.299 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -60.87 -2.83 0.62 Allowed 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -111.68 130.37 55.79 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.145 1.778 . . . . 0.0 110.402 168.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.6 t -85.92 -17.75 34.59 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.242 1.017 . . . . 0.0 113.591 -172.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 77.9 p -53.77 -44.09 69.75 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.191 1.396 . . . . 0.0 112.562 -168.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -59.83 -31.65 69.93 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 85.5 t -84.0 -48.25 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.131 0.878 . . . . 0.0 110.88 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -60.2 -31.03 69.77 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 118.435 -0.793 . . . . 0.0 111.421 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -65.91 -7.35 16.12 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 127.062 2.145 . . . . 0.0 114.547 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.9 mp -110.73 -34.8 6.16 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.417 1.487 . . . . 0.0 109.631 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 38.0 mm -75.17 -37.85 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -72.55 -32.22 65.89 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 118.64 -0.695 . . . . 0.0 111.495 172.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -75.32 -26.07 58.34 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 118.727 -1.189 . . . . 0.0 114.147 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -72.73 -34.36 67.01 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.236 -0.915 . . . . 0.0 111.166 170.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -67.07 -43.75 81.85 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.86 0.864 . . . . 0.0 111.904 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 88.4 p -71.06 -12.79 61.71 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -73.48 -23.62 60.08 Favored 'General case' 0 CA--C 1.554 1.107 0 O-C-N 121.231 -0.918 . . . . 0.0 113.335 172.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 78.3 mt . . . . . 0 C--O 1.259 1.599 0 C-N-CA 125.591 1.556 . . . . 0.0 113.82 -179.466 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 120.831 0.348 . . . . 0.0 111.779 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -81.88 161.85 22.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.863 1.265 . . . . 0.0 113.622 -174.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.1 p -66.37 131.99 47.32 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.747 0.819 . . . . 0.0 113.09 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.4 t -133.26 149.21 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.513 1.125 . . . . 0.0 110.007 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -121.62 115.82 23.46 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.353 2.261 . . . . 0.0 109.088 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.51 126.14 53.23 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 120.933 -1.104 . . . . 0.0 111.252 176.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -112.02 111.98 23.28 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 123.162 1.458 . . . . 0.0 110.227 169.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -87.57 100.34 12.72 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 126.236 1.814 . . . . 0.0 112.3 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.6 tp -94.84 116.76 29.12 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.511 0.725 . . . . 0.0 111.104 171.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.407 ' HG3' ' CD2' ' A' ' 12' ' ' LEU . 28.4 ptm -114.99 144.26 43.88 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 175.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.89 123.8 6.33 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.96 1.267 . . . . 0.0 111.655 172.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.407 ' CD2' ' HG3' ' A' ' 10' ' ' MET . 4.0 mm? -107.06 43.7 1.14 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.97 1.708 . . . . 0.0 111.079 174.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.2 t -64.81 155.43 33.95 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.106 0.963 . . . . 0.0 112.178 169.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.93 -23.79 64.0 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 121.171 -0.956 . . . . 0.0 112.238 169.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.2 t -63.81 -26.34 68.58 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.625 1.17 . . . . 0.0 112.31 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.5 -3.91 58.72 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 -169.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . 0.288 13.9 pt20 -76.73 142.12 40.59 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 122.022 2.192 . . . . 0.0 109.914 169.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.87 -55.56 1.89 Allowed Glycine 0 N--CA 1.471 1.008 0 N-CA-C 107.036 -2.426 . . . . 0.0 107.036 -167.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -65.15 -22.59 66.94 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.513 1.125 . . . . 0.0 111.279 168.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.483 ' HA ' HG12 ' A' ' 23' ' ' VAL . 20.8 tp -47.86 -48.87 30.87 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.762 2.025 . . . . 0.0 111.104 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -56.92 -47.41 80.67 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.417 0.553 . . . . 0.0 111.382 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -60.07 -42.97 95.7 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 120.941 -1.1 . . . . 0.0 111.031 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 20' ' ' LEU . 8.6 p -82.6 3.53 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 124.374 1.07 . . . . 0.0 113.791 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -101.43 -42.33 6.31 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.999 1.32 . . . . 0.0 109.371 169.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 m -52.99 -56.59 14.91 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.888 2.075 . . . . 0.0 108.659 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.537 ' CD2' HG21 ' A' ' 170' ' ' VAL . 13.6 tp -82.99 86.99 6.89 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 124.13 1.919 . . . . 0.0 106.949 169.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.62 -51.53 0.17 Allowed Glycine 0 C--N 1.307 -1.08 0 CA-C-N 109.757 -3.383 . . . . 0.0 107.434 168.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 t -73.81 -41.7 61.97 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.659 1.184 . . . . 0.0 112.007 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.45 -25.08 62.16 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.309 -0.87 . . . . 0.0 111.914 172.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.1 tp -69.14 -49.57 55.67 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-O 118.6 -0.714 . . . . 0.0 109.635 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.6 mt -47.25 -59.73 2.97 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.362 1.065 . . . . 0.0 113.721 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -68.36 -35.28 77.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.555 0.742 . . . . 0.0 112.928 -168.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.22 -46.36 67.57 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.897 0.479 . . . . 0.0 111.019 172.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tt -58.67 -47.56 84.06 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.939 1.295 . . . . 0.0 110.478 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -65.59 -20.89 66.5 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.192 1.397 . . . . 0.0 113.257 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -89.62 -39.95 12.9 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.076 0.951 . . . . 0.0 110.747 175.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.2 mt -61.14 -44.72 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.067 0.947 . . . . 0.0 110.773 171.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.1 t -132.06 133.96 44.97 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.104 0.962 . . . . 0.0 113.474 -173.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -67.27 -29.17 68.71 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.559 1.144 . . . . 0.0 112.481 173.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.3 m -123.58 83.2 2.1 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.208 1.403 . . . . 0.0 109.231 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.36 85.86 0.28 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 127.669 2.557 . . . . 0.0 107.925 -169.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -80.24 140.39 36.27 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -173.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.4 tp -120.76 136.49 57.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 123.431 0.692 . . . . 0.0 110.389 177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.42 147.55 18.86 Favored Glycine 0 N--CA 1.466 0.689 0 C-N-CA 124.221 0.915 . . . . 0.0 110.971 169.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -102.24 164.34 11.74 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.06 147.8 12.74 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 120.713 -1.242 . . . . 0.0 111.718 169.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.5 p -128.33 149.74 50.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.413 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -145.72 151.72 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.923 0.889 . . . . 0.0 111.647 -175.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.423 HG13 ' H ' ' A' ' 50' ' ' ASN 0.273 3.0 p -152.92 -101.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 124.096 0.958 . . . . 0.0 110.362 169.318 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.423 ' H ' HG13 ' A' ' 49' ' ' VAL 0.301 37.1 t30 -136.4 -11.37 1.88 Allowed 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.084 1.354 . . . . 0.0 109.811 168.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 92.1 mtp -87.28 48.49 1.66 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 102.233 -3.247 . . . . 0.0 102.233 163.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.467 2.1 m 16.23 -116.41 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.506 1 C-N-CA 135.787 5.635 . . . . 0.0 116.145 -167.036 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -113.39 137.97 50.76 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.176 1.39 . . . . 0.0 112.769 -168.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -124.34 122.91 38.99 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -85.6 118.34 25.05 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.087 0.555 . . . . 0.0 109.667 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mp -125.33 142.19 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 126.163 1.785 . . . . 0.0 107.352 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 39.38 95.63 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 128.963 2.905 . . . . 0.0 117.244 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.53 161.51 5.84 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.066 0.946 . . . . 0.0 113.101 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.66 124.31 14.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.505 1.122 . . . . 0.0 111.523 -170.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.9 t -147.88 169.64 19.38 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.035 1.334 . . . . 0.0 112.089 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.48 -7.02 51.69 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.644 1.977 . . . . 0.0 113.598 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -90.89 79.52 5.91 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 125.202 2.43 . . . . 0.0 109.486 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 p -63.81 -45.66 88.65 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 129.506 3.123 . . . . 0.0 110.662 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.0 t -55.33 -24.96 31.8 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.48 1.112 . . . . 0.0 111.708 170.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -85.95 -43.89 12.82 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.488 -0.757 . . . . 0.0 110.946 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -55.02 -31.77 61.32 Favored 'General case' 0 C--O 1.219 -0.524 0 O-C-N 121.599 -0.688 . . . . 0.0 111.348 171.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -64.34 -49.22 72.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.435 1.016 . . . . 0.0 108.754 -178.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 68.9 mtt-85 -64.92 -31.79 73.19 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.087 1.355 . . . . 0.0 110.097 -174.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -94.92 -23.76 17.28 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 123.683 0.614 . . . . 0.0 111.309 -173.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.13 -50.04 37.7 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 169.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.36 0.0 OUTLIER -75.63 -10.49 59.49 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.555 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -77.92 -20.53 52.67 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 170.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -60.63 131.83 51.96 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.487 1.04 . . . . 0.0 111.186 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.2 mt -128.8 159.02 37.05 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.26 1.424 . . . . 0.0 110.225 169.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.0 m -82.0 162.41 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -169.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.2 p -106.48 -128.55 0.26 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.382 1.473 . . . . 0.0 111.169 171.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 174.76 146.71 5.82 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.359 1.457 . . . . 0.0 113.706 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.58 164.06 32.23 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.098 1.359 . . . . 0.0 112.441 170.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.3 mt -72.23 -48.59 41.67 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 -169.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.29 132.97 47.29 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.077 0.551 . . . . 0.0 110.988 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.269 3.7 t -72.58 -37.73 4.58 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-O 116.186 -1.864 . . . . 0.0 113.846 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -69.38 151.83 71.27 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 122.315 2.01 . . . . 0.0 111.269 171.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -122.63 164.29 18.48 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.503 1.121 . . . . 0.0 113.499 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.71 28.64 5.8 Favored Glycine 0 N--CA 1.474 1.211 0 O-C-N 120.369 -1.457 . . . . 0.0 115.663 -170.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -47.04 -40.95 15.89 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.282 1.541 . . . . 0.0 114.747 -168.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.414 HD13 ' CD2' ' A' ' 116' ' ' PHE 0.365 5.0 mp -76.88 -19.23 57.7 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 117.98 -1.01 . . . . 0.0 113.463 -172.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.23 -41.31 98.29 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 168.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.29 -54.53 23.69 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-O 117.133 -1.413 . . . . 0.0 110.668 169.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.5 m -56.76 -33.47 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 120.827 1.649 . . . . 0.0 112.85 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.541 HG22 HD11 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -68.3 -51.78 44.26 Favored 'Isoleucine or valine' 0 C--N 1.345 0.394 0 CA-C-O 118.239 -0.886 . . . . 0.0 111.387 172.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -60.66 -41.21 94.58 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 120.246 1.385 . . . . 0.0 110.533 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.484 HG11 HD13 ' A' ' 108' ' ' LEU . 64.6 t -56.54 -35.52 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.767 1.227 . . . . 0.0 112.318 175.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.35 -36.34 29.77 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.541 HD11 HG22 ' A' ' 90' ' ' VAL . 7.5 mt -83.5 -30.36 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.838 1.199 . . . . 0.0 112.548 -173.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 88.6 m -83.82 53.69 2.65 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.147 1.379 . . . . 0.0 112.35 -176.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -55.84 -34.2 65.21 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.43 1.092 . . . . 0.0 112.462 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.62 -33.24 48.01 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 119.275 -0.736 . . . . 0.0 114.705 -175.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -95.59 -25.52 16.13 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.045 0.922 . . . . 0.0 112.633 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.453 ' CD1' ' HA ' ' A' ' 92' ' ' VAL . 79.0 mt -82.83 -24.95 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 119.053 0.842 . . . . 0.0 111.179 169.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.53 24.11 61.33 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.087 -0.84 . . . . 0.0 113.807 171.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -57.87 124.91 20.83 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 118.309 1.055 . . . . 0.0 110.65 173.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -102.69 168.1 9.47 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.865 1.266 . . . . 0.0 111.224 171.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -84.28 54.97 3.15 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -172.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -94.39 -113.43 2.5 Favored Glycine 0 N--CA 1.474 1.213 0 N-CA-C 108.058 -2.017 . . . . 0.0 108.058 169.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 m -127.41 136.55 51.99 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 128.005 2.522 . . . . 0.0 104.719 169.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.36 136.95 51.63 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 121.344 1.884 . . . . 0.0 110.439 -171.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -126.91 116.26 20.54 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 124.916 1.286 . . . . 0.0 112.761 -172.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.484 HD13 HG11 ' A' ' 92' ' ' VAL . 13.0 tp -94.53 103.2 15.16 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 171.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.68 123.39 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -113.16 128.3 56.44 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -173.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.885 HG12 HG22 ' A' ' 170' ' ' VAL . 4.5 m -133.12 129.14 56.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 124.656 1.223 . . . . 0.0 112.397 -177.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.3 t -155.37 170.97 20.68 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.869 1.268 . . . . 0.0 110.142 -175.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -123.23 -1.3 8.71 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -139.49 175.51 9.5 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.682 -1.261 . . . . 0.0 112.419 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -58.16 -176.25 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.775 1.63 . . . . 0.0 112.39 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.414 ' CD2' HD13 ' A' ' 86' ' ' LEU . 13.0 p90 -138.01 163.17 32.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 123.086 1.422 . . . . 0.0 114.078 -169.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -78.9 112.15 15.79 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.73 174.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 mt -80.71 163.29 23.66 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.746 0.818 . . . . 0.0 110.56 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.71 132.72 49.83 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 168.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 90.79 -11.53 0.28 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 130.496 3.519 . . . . 0.0 114.579 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -28.13 69.83 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 122.186 2.266 . . . . 0.0 111.657 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.457 ' HE2' ' CD2' ' A' ' 150' ' ' TYR . 3.1 tppt? -64.4 -7.84 11.22 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.826 1.25 . . . . 0.0 113.038 -176.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.1 t -64.96 -24.34 67.49 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 120.863 -1.148 . . . . 0.0 112.351 169.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 25.5 mt -64.78 -32.97 74.9 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.321 0.964 . . . . 0.0 112.147 172.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -86.65 4.55 86.12 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.014 1.293 . . . . 0.0 113.854 170.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.336 31.8 p 56.39 41.47 28.91 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 129.069 2.948 . . . . 0.0 114.811 -176.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.83 109.56 21.13 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.409 1.483 . . . . 0.0 108.557 169.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -94.07 -39.26 10.7 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -59.66 129.16 40.53 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.973 0.806 . . . . 0.0 111.666 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.8 t -64.83 163.39 14.33 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.169 0.988 . . . . 0.0 111.286 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.2 p -68.54 140.88 55.64 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.347 0.594 . . . . 0.0 112.087 172.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.0 p30 -88.93 -14.54 36.47 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.58 25.15 73.12 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.901 -0.944 . . . . 0.0 113.444 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.4 mtp-105 -106.19 166.61 10.39 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.615 1.566 . . . . 0.0 113.121 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 82.4 m -64.34 136.87 57.55 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.191 0.996 . . . . 0.0 111.245 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -142.37 33.85 1.49 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.239 1.416 . . . . 0.0 112.162 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.4 tp -102.81 140.57 36.9 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.637 1.975 . . . . 0.0 109.903 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -146.64 -64.91 0.29 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -87.29 3.23 47.56 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.986 1.315 . . . . 0.0 114.114 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.54 -12.63 43.02 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.857 1.694 . . . . 0.0 114.007 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.5 mtt -95.28 148.58 22.26 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.661 1.731 . . . . 0.0 111.681 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -73.63 90.06 1.77 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 168.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -55.8 -42.19 75.25 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.889 0.876 . . . . 0.0 112.541 -171.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 69.1 m -75.78 2.99 10.75 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -174.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -43.05 -32.87 0.74 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 171.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.94 8.51 63.33 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.502 2.001 . . . . 0.0 115.615 -174.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.265 32.3 tt0 -131.98 -60.13 0.02 OUTLIER Pre-proline 0 N--CA 1.479 0.978 0 CA-C-N 120.53 2.165 . . . . 0.0 114.055 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -70.52 146.09 54.52 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 CA-C-N 122.516 1.934 . . . . 0.0 113.029 169.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -65.41 165.52 11.8 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 129.136 2.974 . . . . 0.0 113.136 169.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.457 ' CD2' ' HE2' ' A' ' 122' ' ' LYS . 97.4 m-85 -62.27 155.28 25.24 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 122.389 1.09 . . . . 0.0 112.025 169.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -76.86 143.78 39.46 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.61 1.164 . . . . 0.0 110.172 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 44.2 p -73.01 153.79 40.76 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.982 0.42 . . . . 0.0 110.854 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.3 p -51.93 -26.09 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.386 1.075 . . . . 0.0 113.789 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.6 t -81.98 -37.19 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.107 1.363 . . . . 0.0 112.034 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -67.4 -33.3 74.91 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.124 0.875 . . . . 0.0 111.795 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.89 -56.11 17.73 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.656 0.662 . . . . 0.0 110.508 169.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -58.34 -34.47 70.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.966 0.906 . . . . 0.0 112.91 -173.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 37.3 t -59.27 -65.51 0.66 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.867 0.867 . . . . 0.0 111.3 170.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -67.83 -27.62 66.87 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.187 -1.571 . . . . 0.0 113.853 -174.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -37.3 79.66 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.25 1.386 . . . . 0.0 111.751 169.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.38 -28.45 37.96 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 176.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -74.7 -39.85 61.7 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.004 0.82 . . . . 0.0 110.948 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -86.11 -13.67 46.51 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.752 1.221 . . . . 0.0 111.897 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 30.0 m120 58.46 39.92 24.59 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.907 2.083 . . . . 0.0 112.818 175.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.7 mt -90.99 138.22 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.824 1.65 . . . . 0.0 108.814 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -96.42 107.5 36.21 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 120.354 1.434 . . . . 0.0 110.235 172.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -73.77 149.68 43.32 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.126 1.884 . . . . 0.0 113.168 172.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 30.0 mt -140.97 105.82 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.638 0.775 . . . . 0.0 110.093 176.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.53 ' CD2' HD21 ' A' ' 189' ' ' LEU . 22.5 m-85 -75.82 64.22 1.77 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.425 1.09 . . . . 0.0 113.09 -177.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.885 HG22 HG12 ' A' ' 111' ' ' VAL 0.335 0.5 OUTLIER -60.32 114.01 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 119.952 -1.717 . . . . 0.0 113.38 169.917 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 35.5 m -151.63 150.47 26.55 Favored Pre-proline 0 N--CA 1.48 1.027 0 O-C-N 120.636 -1.29 . . . . 0.0 112.829 -172.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -65.41 157.18 59.42 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 124.325 3.35 . . . . 0.0 113.023 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.5 p -44.66 -51.39 9.22 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.828 2.051 . . . . 0.0 113.968 -170.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -52.21 -27.31 14.23 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -174.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 22.4 ptm -117.13 3.72 12.7 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.323 1.449 . . . . 0.0 114.831 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.11 -39.65 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 CA-C-N 119.994 1.27 . . . . 0.0 110.624 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -67.99 -26.73 66.06 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -170.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.7 -37.6 20.75 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.811 1.245 . . . . 0.0 110.417 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -73.2 -28.44 62.18 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 120.843 -1.16 . . . . 0.0 111.381 174.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . 0.314 15.0 pt-20 -77.38 0.21 23.28 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.722 1.146 . . . . 0.0 111.995 169.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -99.08 -10.33 22.72 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.201 -0.937 . . . . 0.0 111.349 168.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.86 -31.19 28.13 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.214 1.806 . . . . 0.0 108.551 169.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.2 t -77.89 -5.62 51.61 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.593 1.157 . . . . 0.0 113.387 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 7.5 t -100.91 -17.44 16.82 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.944 0.498 . . . . 0.0 110.336 168.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -82.63 -45.36 14.64 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.258 0.481 . . . . 0.0 111.499 169.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 4.0 mp -97.51 118.11 64.67 Favored Pre-proline 0 N--CA 1.475 0.793 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -76.46 143.64 24.82 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.441 2.094 . . . . 0.0 111.191 175.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 79.5 tttt 101.46 -22.95 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 130.253 3.421 . . . . 0.0 114.486 169.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.53 HD21 ' CD2' ' A' ' 169' ' ' PHE 0.364 0.0 OUTLIER -76.57 168.59 19.81 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 118.897 0.771 . . . . 0.0 111.74 -177.24 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.352 6.9 t -136.86 -163.3 1.4 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 122.983 1.373 . . . . 0.0 107.946 176.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 17.1 tt -157.56 136.98 3.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 126.427 1.891 . . . . 0.0 112.461 -166.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -119.53 155.72 16.02 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 123.627 0.632 . . . . 0.0 111.905 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -95.34 90.52 5.85 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 169.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.652 ' HB2' HG23 ' A' ' 170' ' ' VAL . 55.6 tp -58.78 126.91 29.61 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.975 169.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 82.5 p -165.68 -166.12 0.92 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.672 1.189 . . . . 0.0 110.285 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.57 -20.88 23.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.631 1.572 . . . . 0.0 113.892 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -115.46 134.26 55.25 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.609 1.564 . . . . 0.0 111.955 171.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 10.6 p -90.01 -3.15 58.14 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.678 1.991 . . . . 0.0 113.821 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.7 m -58.0 -42.19 84.67 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.681 1.593 . . . . 0.0 112.072 -169.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -61.75 -42.97 99.66 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.245 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 70.9 t -70.97 -42.88 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.557 -0.715 . . . . 0.0 111.315 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.51 -20.8 66.49 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.558 -0.714 . . . . 0.0 112.198 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -76.47 7.11 4.76 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 127.811 2.444 . . . . 0.0 113.772 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.9 mp -124.04 -40.72 2.26 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.462 1.905 . . . . 0.0 108.581 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 3.3 mp -72.01 -49.39 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 3.2 ptm85 -61.78 -38.73 89.16 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 118.819 0.736 . . . . 0.0 111.089 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.14 -21.28 50.53 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 118.675 -1.21 . . . . 0.0 114.18 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -74.5 -27.63 60.64 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.109 0.868 . . . . 0.0 112.23 170.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -67.06 -44.73 79.37 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 118.641 0.655 . . . . 0.0 110.164 169.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.9 m -61.92 -21.51 64.81 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . 0.278 26.0 ttpp -80.91 -17.06 51.83 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -176.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.731 HD13 ' O ' ' A' ' 212' ' ' LEU . 2.2 tm? . . . . . 0 C--O 1.182 -2.483 0 CA-C-O 116.808 -1.568 . . . . 0.0 112.603 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -55.29 147.61 16.45 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.806 1.639 . . . . 0.0 113.399 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -69.71 125.85 27.98 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.892 0.877 . . . . 0.0 112.714 -171.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.9 t -112.46 137.83 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.645 1.578 . . . . 0.0 111.145 -171.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -115.3 99.2 7.22 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 168.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -90.81 128.22 36.63 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.604 -0.685 . . . . 0.0 111.248 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.514 ' CD1' HG21 ' A' ' 92' ' ' VAL . 31.3 t80 -123.78 109.18 13.34 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 123.435 1.588 . . . . 0.0 111.767 172.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -85.63 101.46 12.74 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 127.261 2.224 . . . . 0.0 113.626 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.5 mt -93.47 119.44 32.56 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 27.8 ptm -117.75 145.15 44.68 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.309 1.225 . . . . 0.0 114.309 169.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.58 136.21 24.38 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' A' ' 47' ' ' SER . 3.7 mp -109.05 16.27 22.7 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.47 1.508 . . . . 0.0 113.171 -176.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.0 p -67.11 170.52 6.82 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 120.186 -1.571 . . . . 0.0 113.265 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.66 -22.8 68.37 Favored Glycine 0 N--CA 1.475 1.253 0 O-C-N 120.782 -1.199 . . . . 0.0 114.34 -170.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 p -63.64 -27.54 69.3 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.626 1.17 . . . . 0.0 112.98 170.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.49 2.44 19.0 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.778 1.231 . . . . 0.0 113.957 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -62.91 -38.48 91.12 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.968 -1.082 . . . . 0.0 111.302 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.12 -42.17 91.93 Favored Glycine 0 CA--C 1.532 1.109 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 170.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -60.86 -39.4 88.98 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.855 1.262 . . . . 0.0 112.8 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.0 tp -61.29 -45.17 95.57 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.184 0.994 . . . . 0.0 112.984 -173.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.3 m -60.44 -40.67 91.94 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -172.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -80.26 -23.73 40.59 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.484 -0.76 . . . . 0.0 112.726 170.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.54 -35.77 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 120.367 1.44 . . . . 0.0 111.994 174.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -74.17 -38.28 63.73 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.683 1.129 . . . . 0.0 111.94 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.7 p -71.6 -32.34 67.91 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.333 0.653 . . . . 0.0 111.178 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 202' ' ' ALA . 39.2 tp -75.87 1.3 15.43 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 124.478 1.111 . . . . 0.0 111.954 169.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.77 -45.66 6.3 Favored Glycine 0 N--CA 1.476 1.303 0 O-C-N 119.197 -2.189 . . . . 0.0 109.23 -170.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.1 p -76.16 -34.13 59.38 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 127.399 2.28 . . . . 0.0 109.756 170.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -78.25 -33.28 49.81 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 119.363 -0.935 . . . . 0.0 112.369 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 50.1 tp -66.42 -51.4 57.31 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.199 0.909 . . . . 0.0 109.53 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 63' ' ' SER . 1.2 tt -60.64 -47.31 86.82 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.163 0.985 . . . . 0.0 111.069 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -66.62 -42.88 86.13 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.766 -0.584 . . . . 0.0 111.345 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.44 91.08 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.922 0.783 . . . . 0.0 112.484 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.2 tp -61.5 -42.18 98.41 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.3 -0.875 . . . . 0.0 110.863 171.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -69.55 -9.25 53.19 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -86.07 -43.94 12.69 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.15 0.98 . . . . 0.0 111.053 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.4 tp -80.69 -22.95 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.1 t -139.47 129.2 24.63 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.099 -1.0 . . . . 0.0 112.959 176.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -64.02 -30.92 71.96 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.214 1.006 . . . . 0.0 112.335 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 65.2 m -117.31 90.94 3.44 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.309 1.443 . . . . 0.0 109.165 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.91 81.54 0.31 Allowed Glycine 0 C--N 1.339 0.742 0 C-N-CA 127.023 2.249 . . . . 0.0 108.501 -170.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -80.28 134.87 36.13 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.839 1.256 . . . . 0.0 107.743 -171.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.5 tp -119.61 142.64 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.161 0.585 . . . . 0.0 111.194 -172.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.89 160.26 29.89 Favored Glycine 0 N--CA 1.467 0.736 0 C-N-CA 125.171 1.367 . . . . 0.0 111.435 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -146.34 142.57 28.38 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -169.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.3 142.27 13.25 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.563 ' HB2' HD22 ' A' ' 12' ' ' LEU . 4.2 p -108.78 142.68 38.98 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 124.114 0.966 . . . . 0.0 110.615 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.566 HD13 ' HB2' ' A' ' 88' ' ' ALA 0.297 0.6 OUTLIER -152.26 137.87 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 114.943 1.461 . . . . 0.0 114.943 -176.487 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -141.05 -137.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 127.577 2.351 . . . . 0.0 105.719 172.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' A' ' 52' ' ' THR 0.301 10.1 m120 -98.01 -1.6 42.26 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.671 1.578 . . . . 0.0 111.992 168.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 62.9 mtt -85.6 40.93 0.87 Allowed 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 102.079 -3.304 . . . . 0.0 102.079 163.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.366 68.4 p 14.38 -113.51 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.94 1 C-N-CA 133.925 4.89 . . . . 0.0 113.946 -166.092 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -112.36 130.07 56.09 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 125.089 1.493 . . . . 0.0 111.893 -168.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -122.89 118.75 28.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 168.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -81.39 116.52 21.25 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.039 170.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 42.7 mm -89.87 -44.26 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 119.16 -0.448 . . . . 0.0 110.991 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 55.8 tp -151.53 123.9 8.32 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.793 0.806 . . . . 0.0 112.98 -172.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -54.97 149.34 11.88 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.599 1.96 . . . . 0.0 112.455 169.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 82.5 mt -51.15 112.97 0.81 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.048 1.339 . . . . 0.0 110.301 169.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.6 t -137.26 158.53 44.22 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.173 0.989 . . . . 0.0 112.152 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.4 -5.6 51.72 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.4 1.88 . . . . 0.0 111.946 169.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -85.98 79.36 9.22 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 125.938 2.78 . . . . 0.0 109.148 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.524 ' HA ' HD11 ' A' ' 31' ' ' LEU . 29.6 t -64.72 -41.71 95.77 Favored 'General case' 0 C--N 1.314 -0.944 1 C-N-CA 132.018 4.127 . . . . 0.0 110.015 -170.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 m -63.61 -17.02 62.46 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.773 1.229 . . . . 0.0 111.866 175.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . 0.434 26.2 pt20 -102.7 -29.22 11.64 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -57.3 -25.59 59.52 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 120.383 -1.448 . . . . 0.0 112.056 169.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -75.54 -27.87 58.83 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.267 1.427 . . . . 0.0 111.884 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 -78.1 -29.34 48.95 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.965 1.306 . . . . 0.0 109.306 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.04 -34.24 16.87 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.062 0.545 . . . . 0.0 110.01 -174.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.29 -18.24 46.52 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 118.468 -0.777 . . . . 0.0 112.642 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -82.59 -22.6 34.77 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 171.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -73.06 -17.89 61.38 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -64.1 149.59 47.32 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.696 0.68 . . . . 0.0 112.632 -170.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.05 132.66 19.85 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.704 1.602 . . . . 0.0 108.626 -174.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.4 m -68.39 165.94 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.5 m -131.75 -175.24 3.65 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.729 2.412 . . . . 0.0 110.417 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -137.0 166.77 24.84 Favored Glycine 0 N--CA 1.477 1.374 0 O-C-N 120.664 -1.272 . . . . 0.0 114.649 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.9 tttp -155.7 155.32 32.96 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.442 1.497 . . . . 0.0 113.069 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -56.28 -65.0 0.68 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.417 2.287 . . . . 0.0 111.296 168.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.48 145.17 41.62 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.131 0.972 . . . . 0.0 113.606 -172.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.9 m -70.68 -44.95 17.15 Favored Pre-proline 0 N--CA 1.474 0.761 0 CA-C-O 116.135 -1.888 . . . . 0.0 113.218 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -69.75 141.88 46.46 Favored 'Trans proline' 0 C--N 1.354 0.851 0 CA-C-N 122.225 1.83 . . . . 0.0 112.403 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -92.84 178.88 5.63 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.378 1.871 . . . . 0.0 112.773 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.43 22.41 26.72 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 125.912 1.72 . . . . 0.0 115.231 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . 0.268 2.8 tt0 -64.02 -29.67 70.8 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 119.353 3.094 . . . . 0.0 119.353 -168.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.534 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 6.3 mp -67.22 -20.47 65.69 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 122.255 2.298 . . . . 0.0 112.518 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -65.07 -35.13 80.18 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.651 1.114 . . . . 0.0 111.234 169.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB2' HD13 ' A' ' 48' ' ' ILE . . . -69.88 -42.04 73.97 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-O 117.086 -1.435 . . . . 0.0 110.041 168.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.292 2.1 m -61.99 -33.62 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 CA-C-N 120.133 1.333 . . . . 0.0 112.764 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.7 p -68.8 -58.06 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 117.732 -1.128 . . . . 0.0 108.607 169.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 -52.29 -53.41 44.41 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 121.184 1.811 . . . . 0.0 112.705 -175.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.514 HG21 ' CD1' ' A' ' 7' ' ' TYR . 8.9 p -54.16 -41.6 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 119.51 1.05 . . . . 0.0 112.137 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.91 -19.25 61.3 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.492 HD11 ' HB3' ' A' ' 159' ' ' LYS . 2.2 mp -106.06 -30.01 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 120.081 1.31 . . . . 0.0 113.22 -176.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 84.4 m -78.72 55.97 1.78 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.814 1.646 . . . . 0.0 111.215 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 72.7 mt -51.42 -44.12 62.18 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.148 2.179 . . . . 0.0 111.823 -171.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.3 -17.42 76.32 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.224 0.916 . . . . 0.0 114.264 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -90.76 -54.9 3.78 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.915 1.286 . . . . 0.0 110.19 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.32 -33.13 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 118.562 -0.733 . . . . 0.0 110.59 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.94 25.41 27.13 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.256 0.931 . . . . 0.0 113.432 174.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -57.27 123.95 17.16 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.172 0.986 . . . . 0.0 112.138 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.1 mtp-105 -97.27 -176.57 3.56 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.404 2.282 . . . . 0.0 110.668 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -100.77 39.13 1.41 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.078 1.351 . . . . 0.0 114.446 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -95.11 -122.47 3.83 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 169.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.1 t -113.06 143.62 44.02 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.721 1.608 . . . . 0.0 107.689 169.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -131.68 120.41 22.73 Favored 'General case' 0 C--N 1.344 0.369 0 CA-C-N 119.152 0.887 . . . . 0.0 110.117 -168.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.475 ' CE1' ' HG3' ' A' ' 166' ' ' GLN . 51.6 m-85 -120.89 105.64 10.88 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -169.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.41 99.71 12.2 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.43 HG21 HD12 ' A' ' 205' ' ' ILE . 59.5 t -81.06 127.51 39.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 171.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.6 tt -110.47 132.43 54.19 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 38.4 t -119.41 121.88 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.939 0.896 . . . . 0.0 109.944 169.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.3 p -138.97 168.59 19.49 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.599 1.56 . . . . 0.0 110.189 169.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.27 2.28 2.06 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 170.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -142.25 161.22 38.57 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.962 1.705 . . . . 0.0 110.618 172.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -45.49 173.16 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 128.409 2.684 . . . . 0.0 117.586 -169.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.534 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 49.0 t80 -129.08 137.66 51.39 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 120.998 -1.064 . . . . 0.0 113.184 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -79.02 84.63 5.01 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 125.13 1.372 . . . . 0.0 112.216 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.59 HD13 ' H ' ' A' ' 118' ' ' LEU 0.387 0.0 OUTLIER -73.08 174.65 7.61 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 119.802 -1.811 . . . . 0.0 113.432 174.833 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -40.57 134.72 1.72 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 -169.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.311 60.8 mtpt 75.27 -2.25 2.87 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 131.308 3.843 . . . . 0.0 114.898 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -64.98 -21.18 66.8 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.609 1.095 . . . . 0.0 112.821 169.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.483 ' HE3' ' CZ ' ' A' ' 150' ' ' TYR . 61.5 mttt -69.72 -7.97 43.88 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 120.215 -1.553 . . . . 0.0 114.347 172.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.07 -15.55 63.79 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 120.196 1.362 . . . . 0.0 113.328 175.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -64.15 -21.54 66.59 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 118.802 0.728 . . . . 0.0 112.095 169.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -90.55 -128.32 3.81 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.72 1.629 . . . . 0.0 111.395 170.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.5 t -137.41 52.87 1.88 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.742 1.617 . . . . 0.0 110.132 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -133.7 88.64 2.5 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.854 1.661 . . . . 0.0 110.805 -169.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -102.73 -18.47 15.15 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -68.71 129.6 40.39 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 119.41 1.005 . . . . 0.0 110.832 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.0 t -69.36 161.38 29.48 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 118.822 0.737 . . . . 0.0 111.319 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.7 m -62.14 133.95 55.92 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.653 -0.654 . . . . 0.0 111.552 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -86.69 -12.58 47.93 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.66 23.99 73.67 Favored Glycine 0 CA--C 1.535 1.298 0 CA-C-O 118.276 -1.291 . . . . 0.0 114.184 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -103.32 165.13 11.22 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.144 1.472 . . . . 0.0 112.198 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 10.0 t -67.49 126.67 30.03 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.596 1.558 . . . . 0.0 109.382 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -127.34 55.86 1.57 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.637 1.575 . . . . 0.0 110.995 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.13 124.04 22.72 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.005 1.322 . . . . 0.0 109.774 -169.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -125.95 -58.45 1.38 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.34 1.056 . . . . 0.0 111.736 170.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -81.44 -21.38 38.88 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -174.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 121.91 -8.01 10.02 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.062 1.315 . . . . 0.0 114.513 -171.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 94.6 mtp -108.87 142.21 39.8 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 118.733 1.267 . . . . 0.0 111.364 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -67.69 83.16 0.18 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.272 1.029 . . . . 0.0 110.573 171.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -72.13 -15.43 61.98 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -169.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 86.6 p -78.07 -5.34 51.16 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.71 1.141 . . . . 0.0 113.223 170.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -41.68 -35.03 0.69 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.78 -5.03 81.92 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 117.517 -1.713 . . . . 0.0 114.989 -175.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -120.96 -70.71 0.02 OUTLIER Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 119.791 1.796 . . . . 0.0 112.643 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -61.08 147.18 96.42 Favored 'Trans proline' 0 C--N 1.355 0.891 0 CA-C-N 123.064 2.13 . . . . 0.0 114.919 171.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -62.05 174.87 0.78 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 130.248 3.419 . . . . 0.0 113.397 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.483 ' CZ ' ' HE3' ' A' ' 122' ' ' LYS . 59.5 m-85 -74.17 145.21 44.39 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.487 1.115 . . . . 0.0 112.435 172.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -67.86 131.59 45.81 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.534 0.683 . . . . 0.0 111.971 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 27.0 p -63.11 142.02 58.54 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.055 1.342 . . . . 0.0 113.396 170.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 25.2 t -62.85 -27.29 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 121.109 -0.994 . . . . 0.0 112.484 -174.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 71.3 t -65.38 -44.18 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 O-C-N 121.355 -0.84 . . . . 0.0 111.556 172.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -76.1 -20.69 57.43 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.688 -0.633 . . . . 0.0 112.062 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 66.3 mt -66.29 -50.54 63.35 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.265 0.939 . . . . 0.0 108.658 168.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.49 -41.92 73.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.439 0.696 . . . . 0.0 112.615 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 88.8 p -68.75 -51.42 41.48 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.906 0.775 . . . . 0.0 112.416 178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.492 ' HB3' HD11 ' A' ' 94' ' ' ILE . 5.5 mptp? -67.44 -38.31 84.32 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 120.533 -1.354 . . . . 0.0 113.242 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.414 HD23 ' HG3' ' A' ' 167' ' ' PRO . 10.9 mp -66.21 -35.05 79.41 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.364 -0.835 . . . . 0.0 111.582 176.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -75.71 -28.71 58.71 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 172.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.37 -49.25 64.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.117 1.367 . . . . 0.0 110.026 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -91.09 -0.13 57.66 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.733 0.813 . . . . 0.0 112.907 177.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.3 m120 47.03 59.61 3.92 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.908 2.083 . . . . 0.0 112.492 175.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.7 mm -95.71 129.36 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 169.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.475 ' HG3' ' CE1' ' A' ' 107' ' ' PHE 0.345 10.5 pt20 -98.71 110.65 57.99 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 123.3 2.773 . . . . 0.0 108.448 169.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.633 ' HG2' ' HG ' ' A' ' 189' ' ' LEU . 58.2 Cg_endo -70.89 145.44 50.65 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 124.564 3.509 . . . . 0.0 114.06 176.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 8.6 mm -127.29 98.69 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.509 1.524 . . . . 0.0 109.338 176.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -76.89 82.06 3.46 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.22 -1.55 . . . . 0.0 110.453 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.469 ' CG1' HD13 ' A' ' 194' ' ' LEU . 94.2 t -71.95 126.4 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.158 0 O-C-N 120.622 -1.299 . . . . 0.0 110.582 168.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 5.1 p -163.11 141.77 6.49 Favored Pre-proline 0 N--CA 1.483 1.221 0 CA-C-O 117.745 -1.122 . . . . 0.0 113.43 -169.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -63.75 157.48 51.74 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 125.033 3.822 . . . . 0.0 116.309 176.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 78.4 p -56.47 -27.0 55.77 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -169.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.4 mtp180 -56.77 -36.12 69.46 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.664 1.12 . . . . 0.0 112.701 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 52.6 ttp -116.91 -6.12 11.47 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 -169.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 51.6 t -53.99 -32.11 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.718 -1.239 . . . . 0.0 111.286 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -61.79 -34.92 76.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.912 1.285 . . . . 0.0 113.524 -175.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.8 t -92.6 -39.68 11.19 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.848 0.859 . . . . 0.0 110.397 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -69.12 -35.16 76.1 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.318 1.047 . . . . 0.0 110.084 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -68.96 -7.03 31.34 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.549 1.068 . . . . 0.0 112.667 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -99.11 -16.66 18.55 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 120.826 -1.171 . . . . 0.0 111.536 169.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 8.1 mp -79.05 -21.78 46.33 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.697 -1.252 . . . . 0.0 109.557 169.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.504 HG22 HD22 ' A' ' 189' ' ' LEU . 67.3 p -79.61 -18.76 50.88 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.971 0.908 . . . . 0.0 112.919 172.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . 0.289 1.7 t -81.25 -17.46 49.39 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.365 0.529 . . . . 0.0 109.909 169.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -89.62 -26.23 20.88 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.826 0.451 . . . . 0.0 111.756 168.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.5 mm -111.86 85.63 6.54 Favored Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 124.984 1.313 . . . . 0.0 110.084 172.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.17 136.94 76.1 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.257 1.971 . . . . 0.0 111.517 176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt 87.71 -5.7 0.59 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 129.765 3.226 . . . . 0.0 114.335 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.633 ' HG ' ' HG2' ' A' ' 167' ' ' PRO . 3.8 tt -72.43 138.84 47.39 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.891 1.276 . . . . 0.0 108.319 169.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 41.5 p -116.92 -164.48 0.98 Allowed 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 120.349 1.431 . . . . 0.0 107.467 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.2 mt -164.53 153.43 2.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 126.052 1.741 . . . . 0.0 110.383 -167.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.458 ' HA3' HD23 ' A' ' 204' ' ' LEU . . . -140.33 141.22 11.25 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.799 168.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -80.2 82.28 6.29 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 123.628 1.68 . . . . 0.0 108.305 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.469 HD13 ' CG1' ' A' ' 170' ' ' VAL . 17.3 tp -51.19 146.16 6.98 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 112.605 -2.089 . . . . 0.0 110.857 170.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 24.2 p -77.53 162.35 27.19 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.103 -0.998 . . . . 0.0 111.33 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -64.81 -20.9 66.64 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.277 -0.889 . . . . 0.0 112.911 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -88.43 -37.43 15.85 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.35 1.46 . . . . 0.0 112.638 171.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . 0.312 1.4 p 98.69 -7.52 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 129.863 3.265 . . . . 0.0 115.854 169.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 78.3 p -59.74 -13.7 11.29 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.996 2.118 . . . . 0.0 114.975 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -65.06 -30.61 71.59 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 118.828 -0.606 . . . . 0.0 111.492 169.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 9.4 p -43.42 -41.49 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 116.915 2.191 . . . . 0.0 116.915 -168.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.476 ' HB2' HD11 ' A' ' 26' ' ' LEU . . . -62.18 -36.52 82.15 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.513 1.506 . . . . 0.0 112.939 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . 0.263 4.7 pt20 -84.11 19.54 1.79 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.458 HD23 ' HA3' ' A' ' 192' ' ' GLY . 7.7 mp -120.69 -38.07 2.91 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 128.626 2.77 . . . . 0.0 108.157 172.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.43 HD12 HG21 ' A' ' 109' ' ' VAL . 6.3 mm -59.88 -53.42 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 169.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 41.5 ttt85 -61.75 -41.12 97.26 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.047 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -70.28 -32.98 71.02 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -171.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -72.6 -40.33 66.61 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.784 1.234 . . . . 0.0 111.811 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -73.92 -35.39 64.62 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.872 1.269 . . . . 0.0 113.366 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 23.2 t -43.5 -35.61 1.72 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.182 2.593 . . . . 0.0 116.857 -169.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -64.22 -41.16 97.15 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 118.068 -0.968 . . . . 0.0 113.34 -172.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--O 1.259 1.57 0 C-N-CA 128.385 2.674 . . . . 0.0 114.51 -176.022 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -65.1 137.3 57.58 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 120.709 1.595 . . . . 0.0 111.558 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.5 m -68.27 146.42 53.33 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.766 1.025 . . . . 0.0 113.766 -170.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.7 t -114.91 141.1 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.769 1.228 . . . . 0.0 110.052 -175.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -114.25 115.74 27.91 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.551 1.14 . . . . 0.0 109.327 169.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 tp -100.08 129.91 46.17 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.662 0.665 . . . . 0.0 111.874 169.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -120.3 105.26 10.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 123.508 1.623 . . . . 0.0 109.564 169.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -84.0 105.84 15.19 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.54 -1.664 . . . . 0.0 111.286 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -103.3 108.5 19.75 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.726 1.21 . . . . 0.0 109.701 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.2 ptm -113.2 145.54 40.82 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.91 139.58 27.45 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 124.043 0.83 . . . . 0.0 111.511 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.446 HD13 ' HB2' ' A' ' 47' ' ' SER . 1.4 mp -112.18 25.75 11.25 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.494 1.917 . . . . 0.0 112.529 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.3 t -61.39 160.14 11.39 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.544 0.737 . . . . 0.0 111.345 169.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.59 -25.3 68.69 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 120.903 -1.123 . . . . 0.0 114.341 -170.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 p -74.62 -13.74 60.68 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.414 1.086 . . . . 0.0 113.746 174.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.91 2.18 18.23 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.431 1.093 . . . . 0.0 113.892 174.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.6 mm-40 -54.57 -40.4 68.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.724 0.81 . . . . 0.0 111.708 170.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -76.48 -27.89 60.6 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 123.594 0.616 . . . . 0.0 113.353 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 26.9 m170 -67.69 -50.47 57.49 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.283 1.042 . . . . 0.0 111.841 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp -52.56 -41.88 63.95 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.946 1.298 . . . . 0.0 112.847 -169.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.3 m -52.88 -51.73 60.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.712 1.205 . . . . 0.0 113.477 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -87.53 -7.34 57.7 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -174.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.3 m -97.96 13.97 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 119.742 1.156 . . . . 0.0 113.224 170.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.481 ' HA ' HD22 ' A' ' 70' ' ' LEU . 9.8 pt20 -87.15 -32.09 20.04 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.39 -1.444 . . . . 0.0 110.175 177.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.2 t -79.3 -11.88 59.94 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.081 2.152 . . . . 0.0 110.258 168.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 53.6 tp -85.46 90.28 7.91 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 124.362 2.03 . . . . 0.0 107.035 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.62 -51.13 0.05 OUTLIER Glycine 0 C--N 1.296 -1.686 0 CA-C-N 109.265 -3.607 . . . . 0.0 109.791 167.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.7 m -74.77 -36.57 62.54 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.331 1.852 . . . . 0.0 111.13 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -58.57 -40.56 83.47 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.458 0.703 . . . . 0.0 110.45 169.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -57.42 8.65 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.7 tt -52.69 -40.73 63.22 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 116.988 -1.482 . . . . 0.0 112.902 -176.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -69.62 -32.05 70.53 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 122.027 2.194 . . . . 0.0 112.962 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.18 -37.28 66.58 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.917 0.78 . . . . 0.0 112.842 169.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 31.8 mt -77.04 -31.61 56.39 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.624 0.77 . . . . 0.0 112.995 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.84 -18.02 62.73 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.329 1.422 . . . . 0.0 113.663 -172.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -81.66 -46.04 14.91 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.798 0.839 . . . . 0.0 109.437 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.83 -23.74 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 38.8 t -151.58 143.86 24.06 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 119.718 1.145 . . . . 0.0 113.605 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.49 -9.63 59.34 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 174.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.4 t -139.46 120.54 14.65 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.328 1.061 . . . . 0.0 110.74 169.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.94 84.79 0.23 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 106.088 -2.805 . . . . 0.0 106.088 -170.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -74.96 146.03 42.07 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.5 tt -133.05 134.45 57.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 123.64 0.776 . . . . 0.0 110.585 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.56 152.58 21.66 Favored Glycine 0 N--CA 1.467 0.752 0 C-N-CA 125.907 1.718 . . . . 0.0 111.146 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -124.08 146.98 48.23 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.415 0.686 . . . . 0.0 111.557 -174.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.24 154.14 25.72 Favored Glycine 0 C--N 1.339 0.695 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 170.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.446 ' HB2' HD13 ' A' ' 12' ' ' LEU . 93.6 p -135.24 159.17 42.4 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.357 1.075 . . . . 0.0 113.185 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.445 HG21 ' HG2' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -155.64 147.77 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 O-C-N 121.347 -0.846 . . . . 0.0 111.986 -169.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.411 ' N ' HD13 ' A' ' 48' ' ' ILE 0.306 12.0 p -154.29 -129.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 116.626 -1.654 . . . . 0.0 109.427 171.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -95.45 -20.86 18.72 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 123.43 2.832 . . . . 0.0 112.963 169.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 46.2 mtt -80.75 49.13 1.15 Allowed 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 167.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.294 12.8 p 25.17 -120.66 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.518 1 C-N-CA 132.157 4.183 . . . . 0.0 114.381 -169.057 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -107.35 133.13 52.34 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 127.483 2.313 . . . . 0.0 112.503 -167.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -116.2 123.85 48.79 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 169.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -97.43 127.76 43.66 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.609 169.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -155.67 113.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.929 0.892 . . . . 0.0 109.525 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 42.9 tp 96.51 83.21 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.868 3.267 . . . . 0.0 107.875 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.15 155.14 21.34 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.797 0.808 . . . . 0.0 111.149 169.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . 0.26 2.2 tm? -54.54 105.03 0.13 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 128.02 2.528 . . . . 0.0 109.689 -170.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.0 t -138.8 174.01 10.98 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.71 1.604 . . . . 0.0 112.635 -169.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.76 -12.32 31.6 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.104 1.362 . . . . 0.0 114.567 -172.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -89.13 85.87 6.76 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 125.364 2.507 . . . . 0.0 108.686 -176.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.6 t -61.7 -39.68 92.34 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 128.077 2.551 . . . . 0.0 110.674 175.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.7 m -64.54 -15.1 60.37 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.224 -0.923 . . . . 0.0 112.047 169.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -81.03 -38.52 27.31 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.199 -0.938 . . . . 0.0 110.959 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -57.91 -23.6 54.09 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.298 1.039 . . . . 0.0 112.191 170.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -74.91 -43.14 55.91 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.472 -0.768 . . . . 0.0 109.469 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -86.8 -29.68 22.11 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.895 0.878 . . . . 0.0 111.03 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -76.14 -34.32 59.41 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.481 HD22 ' HA ' ' A' ' 24' ' ' GLN . 8.3 tt -68.97 -37.61 78.89 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.998 -0.525 . . . . 0.0 110.083 170.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 -60.44 -38.86 85.45 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.714 0.688 . . . . 0.0 112.191 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -65.01 -20.75 66.65 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -63.47 152.7 37.67 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.566 1.075 . . . . 0.0 111.99 -172.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 62.1 tp -135.57 127.12 28.82 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.147 1.379 . . . . 0.0 108.736 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.2 m -61.6 163.77 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.828 0.851 . . . . 0.0 112.173 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.9 p -119.56 -157.91 0.72 Allowed 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.761 -0.587 . . . . 0.0 110.333 168.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.66 143.12 9.64 Favored Glycine 0 CA--C 1.524 0.609 0 O-C-N 121.154 -0.967 . . . . 0.0 112.202 174.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 149.45 28.12 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.659 1.583 . . . . 0.0 110.79 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.01 -57.23 4.18 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 -168.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.73 136.76 58.09 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.657 0.662 . . . . 0.0 111.549 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.254 6.4 t -65.84 -39.12 28.34 Favored Pre-proline 0 N--CA 1.476 0.859 0 CA-C-O 116.321 -1.799 . . . . 0.0 114.599 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.71 143.29 50.6 Favored 'Trans proline' 0 C--N 1.359 1.084 0 CA-C-N 122.71 2.003 . . . . 0.0 111.665 173.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.557 ' H ' ' HD3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -114.15 162.29 16.7 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.125 1.77 . . . . 0.0 112.199 176.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.61 42.27 2.91 Favored Glycine 0 N--CA 1.479 1.525 0 C-N-CA 125.022 1.296 . . . . 0.0 115.264 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.445 ' HG2' HG21 ' A' ' 48' ' ' ILE . 22.5 mt-30 -60.74 -29.65 69.52 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 119.223 1.512 . . . . 0.0 112.891 -176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.405 HD11 ' CD1' ' A' ' 156' ' ' LEU . 15.5 tp -65.89 -32.86 74.61 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -169.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -59.7 -54.66 43.84 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.46 -52.31 64.07 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.636 0.774 . . . . 0.0 111.72 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.258 3.1 p -61.3 -36.44 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 119.592 1.087 . . . . 0.0 112.792 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.8 -35.76 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 120.607 1.548 . . . . 0.0 113.23 173.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -61.91 -46.42 89.44 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.055 1.298 . . . . 0.0 110.741 172.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 77.9 t -54.79 -36.73 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 122.84 0.456 . . . . 0.0 111.745 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.31 -30.81 62.23 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 20.7 tt -99.01 -25.59 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 61.2 m -82.91 61.31 5.88 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 120.459 1.481 . . . . 0.0 111.512 -171.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.3 mt -49.42 -45.58 46.48 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 128.909 2.884 . . . . 0.0 110.977 -171.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.59 -23.08 44.32 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 114.14 -1.391 . . . . 0.0 114.135 -173.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -84.66 -46.68 11.25 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.382 1.091 . . . . 0.0 110.938 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.0 mt -79.94 -25.01 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 118.054 -0.974 . . . . 0.0 111.474 177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.06 23.9 36.57 Favored Glycine 0 N--CA 1.471 0.992 0 CA-C-N 119.548 1.067 . . . . 0.0 115.306 169.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -52.62 122.43 8.98 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.92 1.288 . . . . 0.0 112.55 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -93.71 175.03 6.89 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.732 1.213 . . . . 0.0 111.131 170.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -90.49 27.95 1.59 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 116.288 1.958 . . . . 0.0 116.288 -168.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.34 -124.69 3.79 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 120.768 -1.207 . . . . 0.0 110.797 173.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.3 m -97.85 142.5 29.53 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.742 2.017 . . . . 0.0 107.58 173.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -142.85 119.47 11.08 Favored 'General case' 0 C--N 1.348 0.529 0 CA-C-N 121.076 1.762 . . . . 0.0 110.739 -176.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -113.97 123.28 49.33 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 126.314 1.846 . . . . 0.0 112.99 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 tt -107.87 96.03 6.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.829 0.347 . . . . 0.0 110.112 175.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 77.5 t -79.93 126.97 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 36.1 tp -114.25 116.01 28.33 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.66 130.7 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.448 ' O ' ' HD2' ' A' ' 172' ' ' PRO . 3.6 t -165.04 151.27 10.14 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 117.615 -1.183 . . . . 0.0 113.062 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -96.82 -13.64 22.43 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.565 1.946 . . . . 0.0 115.45 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -128.51 172.16 11.42 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.124 0.97 . . . . 0.0 113.371 -169.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.52 179.35 0.62 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.569 1.147 . . . . 0.0 111.603 169.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -128.4 156.46 43.13 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.034 -1.666 . . . . 0.0 113.437 -170.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -77.65 117.31 18.94 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.598 169.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.565 HD23 ' H ' ' A' ' 119' ' ' ALA . 2.8 tt -88.61 173.89 8.37 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.287 1.435 . . . . 0.0 110.015 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.565 ' H ' HD23 ' A' ' 118' ' ' LEU . . . -54.99 150.5 10.19 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.99 -1.069 . . . . 0.0 110.5 168.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt 74.06 -21.01 0.29 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.557 1.943 . . . . 0.0 114.826 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -54.01 -56.52 17.12 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 120.239 -1.538 . . . . 0.0 113.022 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.516 ' HE2' ' N ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -57.47 -6.83 0.51 Allowed 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 119.341 3.089 . . . . 0.0 119.341 -177.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.378 0.5 OUTLIER -64.74 -20.26 66.25 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 122.328 2.331 . . . . 0.0 111.269 174.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -50.48 -44.46 55.87 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.298 1.839 . . . . 0.0 110.241 168.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -87.02 22.3 15.41 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.702 2.096 . . . . 0.0 114.503 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 56.3 m 73.22 20.57 3.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.65 1.98 . . . . 0.0 112.415 170.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 25.2 ttp-105 -116.25 112.59 21.83 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.571 1.548 . . . . 0.0 111.035 -172.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -117.86 -33.76 4.39 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -170.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -63.62 118.21 7.9 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 120.329 1.422 . . . . 0.0 111.304 -174.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.424 ' HA ' ' HB3' ' A' ' 149' ' ' ASP 0.261 3.0 t -67.96 166.36 15.93 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -171.466 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.8 p -60.85 129.11 39.8 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.708 0.803 . . . . 0.0 112.905 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.7 p30 -82.66 -13.68 56.01 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.458 0.703 . . . . 0.0 112.784 169.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.86 1.18 66.6 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.433 1.492 . . . . 0.0 114.377 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -79.57 165.69 22.68 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.728 1.611 . . . . 0.0 114.036 -169.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 31.3 t -74.1 126.77 31.27 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.809 0.843 . . . . 0.0 109.489 169.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -141.33 39.83 1.74 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.813 1.645 . . . . 0.0 111.739 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.3 mt -103.56 148.75 25.6 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.166 1.387 . . . . 0.0 109.091 172.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -143.15 -64.5 0.4 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.34 0.656 . . . . 0.0 112.182 175.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -92.11 15.79 12.69 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.387 1.475 . . . . 0.0 113.47 177.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.71 9.4 62.78 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.119 1.342 . . . . 0.0 114.526 -177.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 59.5 ttm -117.61 146.68 43.49 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.115 1.366 . . . . 0.0 111.027 172.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.452 ' CE1' ' HB3' ' A' ' 144' ' ' SER . 50.7 t80 -74.35 87.63 2.02 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.877 0.871 . . . . 0.0 111.942 170.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 62.5 ttt-85 -50.62 -38.15 44.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.206 1.802 . . . . 0.0 112.582 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.452 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 4.0 t -64.12 -17.41 63.42 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.081 1.352 . . . . 0.0 114.632 -176.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 37.5 ttp-105 -35.95 -50.85 0.7 Allowed 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 120.579 1.536 . . . . 0.0 114.107 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.09 -5.03 84.63 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.168 -1.351 . . . . 0.0 114.747 -172.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.327 3.0 pt-20 -129.09 -64.84 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 115.377 -2.249 . . . . 0.0 113.748 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -68.65 154.81 70.7 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 CA-C-N 124.627 2.688 . . . . 0.0 118.003 169.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.424 ' HB3' ' HA ' ' A' ' 130' ' ' THR 0.288 26.8 t0 -83.89 141.5 31.25 Favored 'General case' 0 CA--C 1.551 1.01 1 C-N-CA 133.082 4.553 . . . . 0.0 114.828 -176.598 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -50.67 113.99 1.04 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.416 -0.803 . . . . 0.0 111.21 168.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.624 ' CD ' ' H ' ' A' ' 151' ' ' GLN . 0.0 OUTLIER -54.99 153.47 6.35 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 127.469 2.307 . . . . 0.0 114.849 -173.425 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 85.9 p -83.8 153.01 24.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.107 0.963 . . . . 0.0 112.898 -177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 17.9 m -55.06 -27.39 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.96 -44.6 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.957 0.903 . . . . 0.0 110.929 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.34 -28.25 65.0 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.807 -0.616 . . . . 0.0 111.311 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 186' ' ' ILE . 3.8 mt -60.53 -52.55 64.69 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.883 0.765 . . . . 0.0 110.039 172.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.3 -45.53 84.08 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.431 1.092 . . . . 0.0 111.065 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.2 m -65.91 -47.18 75.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.49 0.716 . . . . 0.0 112.763 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 159' ' ' LYS . 0.3 OUTLIER -61.22 -42.55 98.8 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.066 1.303 . . . . 0.0 111.974 174.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.49 -44.67 81.98 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.158 0.983 . . . . 0.0 111.784 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.6 -24.77 62.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.413 1.085 . . . . 0.0 113.471 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -75.27 -43.56 50.62 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.7 0.8 . . . . 0.0 110.724 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -85.08 -13.85 49.05 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 18.4 m120 59.78 39.43 20.77 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.332 1.453 . . . . 0.0 113.541 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.0 mt -82.71 149.4 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 169.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -107.39 111.34 63.11 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 120.152 1.342 . . . . 0.0 109.503 169.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 189' ' ' LEU . 17.3 Cg_exo -78.02 149.71 25.87 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 124.655 3.57 . . . . 0.0 113.346 174.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.474 HG22 HG23 ' A' ' 170' ' ' VAL . 3.9 mp -132.91 107.56 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.875 1.27 . . . . 0.0 109.274 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -74.89 71.29 2.01 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.94 -1.1 . . . . 0.0 112.748 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.474 HG23 HG22 ' A' ' 168' ' ' ILE . 95.7 t -75.31 103.39 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 120.421 -1.424 . . . . 0.0 111.742 175.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 22.8 m -145.27 147.73 35.13 Favored Pre-proline 0 N--CA 1.48 1.038 0 O-C-N 120.754 -1.216 . . . . 0.0 112.661 -169.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.448 ' HD2' ' O ' ' A' ' 112' ' ' THR . 60.2 Cg_exo -55.34 149.99 43.43 Favored 'Trans proline' 0 C--N 1.353 0.791 1 C-N-CA 125.808 4.339 . . . . 0.0 115.744 177.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 36.5 p -46.73 -49.59 19.35 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.746 2.019 . . . . 0.0 113.422 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -43.22 -32.61 0.79 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.607 2.363 . . . . 0.0 115.431 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.8 ptm -118.68 -2.77 10.9 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.6 1.56 . . . . 0.0 114.75 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.78 -29.85 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 CA-C-N 120.277 1.399 . . . . 0.0 111.05 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -65.11 -21.06 66.75 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.208 1.003 . . . . 0.0 113.525 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.55 -39.43 11.92 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.161 0.984 . . . . 0.0 111.36 177.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -73.36 -28.87 62.27 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 120.826 -1.171 . . . . 0.0 110.471 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -58.08 -23.77 55.94 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.66 0.784 . . . . 0.0 110.819 168.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -87.52 -29.54 21.26 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.517 -0.74 . . . . 0.0 110.546 179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 8.7 mp -72.82 -26.31 61.44 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.302 1.441 . . . . 0.0 110.138 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . 0.295 3.2 t -80.37 -17.36 52.14 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 173.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 28.9 m -82.83 -34.37 26.89 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.637 -0.664 . . . . 0.0 109.402 169.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -78.77 -19.47 52.16 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 156' ' ' LEU . 20.3 mt -131.74 92.9 29.36 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.504 1.122 . . . . 0.0 108.978 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -60.56 142.34 97.66 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.943 2.429 . . . . 0.0 113.415 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt 93.99 -15.35 0.12 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 130.245 3.418 . . . . 0.0 114.798 169.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.41 ' HB3' ' HD2' ' A' ' 167' ' ' PRO . 1.6 pp -84.24 152.3 24.28 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 118.7 0.682 . . . . 0.0 109.266 168.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 76.3 p -111.0 -146.61 0.41 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -170.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 18.1 tt 179.75 152.49 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 128.317 2.647 . . . . 0.0 110.538 -168.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -153.14 151.05 22.89 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 123.912 0.767 . . . . 0.0 111.811 169.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.4 84.21 5.98 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.739 1.216 . . . . 0.0 109.491 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 11.7 tp -51.44 140.2 18.16 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.176 -1.375 . . . . 0.0 109.356 169.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.3 p -166.65 -123.66 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.619 0.768 . . . . 0.0 110.464 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -88.26 5.8 39.99 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.748 2.019 . . . . 0.0 114.353 -174.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -139.47 146.54 40.15 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.293 1.437 . . . . 0.0 112.721 -173.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 10.1 t -89.89 -23.14 21.7 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.12 1.768 . . . . 0.0 112.369 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 57.8 m -58.61 -26.89 64.16 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 119.818 -1.801 . . . . 0.0 112.098 -175.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -60.29 -34.51 73.86 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 12.7 p -78.42 -38.82 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 120.588 1.54 . . . . 0.0 110.816 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -75.95 -37.29 58.8 Favored 'General case' 0 C--O 1.22 -0.491 0 O-C-N 120.935 -1.103 . . . . 0.0 113.757 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -82.55 20.31 1.13 Allowed 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 121.216 1.826 . . . . 0.0 113.966 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.84 -31.23 2.68 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.756 2.022 . . . . 0.0 109.005 169.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 95.8 mt -68.48 -46.7 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 168.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -57.81 -43.68 85.85 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.667 1.187 . . . . 0.0 110.815 174.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -81.32 -23.04 38.07 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -172.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -77.04 -27.84 54.6 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.567 0.747 . . . . 0.0 111.977 169.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -68.98 -46.39 68.22 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.239 0.615 . . . . 0.0 112.241 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 42.8 p -70.13 -9.65 56.26 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.61 -21.0 58.17 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.039 0.935 . . . . 0.0 113.304 170.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 C--O 1.255 1.343 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -174.853 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 57.9 t0 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -114.96 164.56 13.98 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.844 1.257 . . . . 0.0 111.279 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.0 t -66.69 129.31 39.44 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.29 123.45 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 127.071 2.149 . . . . 0.0 108.737 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -108.68 104.79 14.15 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.717 1.207 . . . . 0.0 109.513 171.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.512 HD22 ' HB2' ' A' ' 107' ' ' PHE . 1.2 mt -96.1 132.17 41.76 Favored 'General case' 0 N--CA 1.48 1.05 0 O-C-N 120.882 -1.136 . . . . 0.0 112.824 173.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.442 ' CD2' HG23 ' A' ' 99' ' ' ILE . 26.2 t80 -121.53 110.79 16.45 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 124.426 2.06 . . . . 0.0 110.685 174.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -88.81 114.13 25.1 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 128.201 2.6 . . . . 0.0 113.111 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.448 HD11 HD11 ' A' ' 108' ' ' LEU . 6.8 mp -108.95 130.96 55.46 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.799 0.84 . . . . 0.0 111.099 169.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . 0.348 0.0 OUTLIER -128.93 151.62 49.46 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 167.299 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.16 129.54 11.68 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.964 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -106.53 27.63 8.62 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.43 1.892 . . . . 0.0 111.635 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 100.0 p -67.08 164.11 18.6 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.504 -1.372 . . . . 0.0 112.923 174.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.21 -32.7 85.08 Favored Glycine 0 N--CA 1.471 1.027 0 O-C-N 121.142 -0.974 . . . . 0.0 111.864 174.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.0 m -59.75 -31.45 69.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.42 1.088 . . . . 0.0 112.379 172.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.36 -0.54 12.64 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -66.75 138.21 57.22 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 121.06 1.754 . . . . 0.0 110.102 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.67 -44.79 3.16 Favored Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.219 0.914 . . . . 0.0 111.281 -171.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -68.53 -25.71 65.07 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.592 1.157 . . . . 0.0 111.789 172.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.4 tp -49.37 -46.35 47.02 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.943 1.697 . . . . 0.0 110.996 174.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -53.63 -49.95 66.76 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.798 0.839 . . . . 0.0 111.724 173.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.269 0.5 OUTLIER -69.14 -25.89 64.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.109 -0.948 . . . . 0.0 113.446 -179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.441 HG11 HG11 ' A' ' 111' ' ' VAL 0.281 0.0 OUTLIER -82.42 -33.8 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 169.881 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . 0.286 3.3 pt20 -71.09 -34.13 70.85 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 120.263 1.392 . . . . 0.0 111.474 175.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.2 t -66.01 -41.62 90.77 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.174 170.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.46 HD22 HD13 ' A' ' 194' ' ' LEU . 36.0 tp -60.7 -31.6 70.86 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.838 1.199 . . . . 0.0 112.098 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.16 -33.9 6.7 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 110.641 -0.983 . . . . 0.0 110.641 -168.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.7 t -65.57 -43.29 90.25 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 168.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -78.01 -28.95 49.28 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.38 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.21 -48.05 81.56 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.69 -50.24 58.64 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -57.74 -50.7 72.34 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.781 0.832 . . . . 0.0 111.132 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.71 -40.98 98.12 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.207 0.603 . . . . 0.0 111.564 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 80.4 mt -79.27 -24.91 42.63 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.114 -0.946 . . . . 0.0 112.926 -176.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.64 -29.17 67.83 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 120.289 1.404 . . . . 0.0 111.753 169.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -81.04 -41.5 22.56 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.155 0.982 . . . . 0.0 110.704 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.8 tt -73.29 -28.66 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 118.566 0.621 . . . . 0.0 112.249 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.1 t -145.94 124.56 12.5 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -69.39 -34.25 74.23 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.949 1.299 . . . . 0.0 111.508 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -99.81 78.9 2.17 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.996 1.318 . . . . 0.0 108.964 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.35 74.3 0.42 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 127.198 2.333 . . . . 0.0 108.235 -169.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -81.83 140.02 34.41 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.385 1.093 . . . . 0.0 108.238 -171.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.429 HG23 ' CD2' ' A' ' 66' ' ' PHE . 11.7 tt -120.32 142.94 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 117.856 0.298 . . . . 0.0 111.795 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.95 157.05 22.46 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.951 1.739 . . . . 0.0 110.1 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -128.26 142.59 51.11 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -169.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.82 141.82 12.01 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 118.729 0.695 . . . . 0.0 112.067 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.0 t -109.7 142.26 41.14 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.476 1.111 . . . . 0.0 110.447 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -150.48 152.28 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 120.775 -1.203 . . . . 0.0 111.766 170.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.3 t -138.72 -62.52 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.311 1.045 . . . . 0.0 111.06 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.3 t30 154.35 -24.88 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 1 C-N-CA 132.764 4.426 . . . . 0.0 108.24 -169.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.451 ' O ' HG23 ' A' ' 52' ' ' THR . 87.9 mtp -53.72 -50.3 66.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.64 1.176 . . . . 0.0 109.473 168.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 51' ' ' MET . 4.5 p 178.78 179.52 0.39 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 131.09 3.756 . . . . 0.0 108.846 177.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -98.28 125.75 43.5 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 103.561 -2.755 . . . . 0.0 103.561 166.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.408 HE21 HG23 ' A' ' 56' ' ' ILE . 65.3 tp60 -111.9 114.92 28.15 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 122.337 1.065 . . . . 0.0 109.184 174.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -82.94 113.21 20.38 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.703 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.408 HG23 HE21 ' A' ' 54' ' ' GLN . 41.5 pt -142.07 115.41 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.967 0.907 . . . . 0.0 109.167 168.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 57.3 tp 101.72 96.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 130.262 3.425 . . . . 0.0 108.611 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -63.0 163.71 9.38 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.047 1.339 . . . . 0.0 111.535 174.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.7 mt -54.37 111.68 0.84 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.373 0.669 . . . . 0.0 110.757 174.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 t -133.74 160.98 35.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.34 1.456 . . . . 0.0 112.472 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.37 -2.23 57.39 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 126.127 1.771 . . . . 0.0 113.336 170.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -86.28 75.51 9.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 125.037 2.351 . . . . 0.0 108.947 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 68.1 m -71.59 -45.68 61.47 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 129.26 3.024 . . . . 0.0 112.002 -169.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.3 p -55.88 -26.31 46.55 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.791 -0.568 . . . . 0.0 111.34 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.51 -34.8 15.41 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 122.035 -0.415 . . . . 0.0 110.996 -171.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.429 ' CD2' HG23 ' A' ' 43' ' ' ILE . 20.4 t80 -54.2 -34.77 61.34 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.268 -0.895 . . . . 0.0 111.869 169.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -75.29 -30.95 60.56 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.511 0.725 . . . . 0.0 110.642 -172.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -75.16 -29.61 60.5 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 124.592 1.157 . . . . 0.0 110.106 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.72 -35.39 22.52 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.336 0.398 . . . . 0.0 110.392 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.78 -39.56 87.84 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -67.08 -47.05 72.45 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -71.4 -29.22 64.67 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 -168.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -76.71 146.2 38.18 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 120.247 1.385 . . . . 0.0 113.25 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.2 mt -125.17 163.09 23.22 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.048 1.739 . . . . 0.0 111.983 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.35 159.63 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.243 1.417 . . . . 0.0 113.928 -177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -118.11 -152.59 0.51 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.772 1.629 . . . . 0.0 110.102 169.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -132.79 152.38 20.28 Favored Glycine 0 N--CA 1.473 1.14 0 C-N-CA 124.95 1.262 . . . . 0.0 114.395 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -148.03 152.95 38.29 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.974 1.71 . . . . 0.0 111.154 173.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -70.55 -82.82 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.455 1.502 . . . . 0.0 111.251 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.05 158.93 30.24 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.0 m -65.04 -46.16 73.82 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-O 115.856 -2.021 . . . . 0.0 115.084 -172.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.29 138.2 65.0 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.609 2.206 . . . . 0.0 112.482 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -101.87 162.55 12.82 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.941 0.897 . . . . 0.0 112.129 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.07 10.18 49.6 Favored Glycine 0 N--CA 1.482 1.706 0 C-N-CA 124.4 1.0 . . . . 0.0 115.098 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -28.21 -46.13 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 131.197 3.799 . . . . 0.0 115.613 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.462 ' HA ' HG12 ' A' ' 89' ' ' VAL . 6.3 tp -52.78 -34.15 52.05 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.922 2.489 . . . . 0.0 114.37 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -68.27 -40.62 81.82 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.596 -1.315 . . . . 0.0 111.81 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.63 -44.79 66.45 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.505 -0.76 . . . . 0.0 111.913 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 86' ' ' LEU . 7.7 p -54.66 -38.17 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 118.951 0.796 . . . . 0.0 111.755 174.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.485 HG22 HD11 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -70.62 -53.62 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 119.139 0.881 . . . . 0.0 111.818 173.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -60.57 -41.35 94.46 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.685 1.13 . . . . 0.0 111.525 -173.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.9 t -65.88 -40.18 86.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.165 0.586 . . . . 0.0 111.472 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.07 -38.84 89.32 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.038 -1.039 . . . . 0.0 112.193 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.485 HD11 HG22 ' A' ' 90' ' ' VAL . 16.5 mt -81.21 -30.39 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -174.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -84.99 65.64 9.34 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.614 -1.304 . . . . 0.0 112.663 -174.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.4 mt -46.42 -43.59 16.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.781 2.033 . . . . 0.0 111.184 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -81.28 -31.0 35.47 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.807 1.194 . . . . 0.0 115.136 -174.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -84.95 -43.06 14.36 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.35 1.075 . . . . 0.0 110.514 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.442 HG23 ' CD2' ' A' ' 7' ' ' TYR . 15.9 mm -72.13 -35.96 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 122.306 -0.246 . . . . 0.0 110.338 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.66 25.91 26.38 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.715 1.15 . . . . 0.0 113.857 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.403 ' CZ3' ' HB2' ' A' ' 106' ' ' ARG . 24.8 m95 -55.13 122.5 11.14 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.645 1.178 . . . . 0.0 112.491 -177.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -97.08 168.22 10.58 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.799 1.24 . . . . 0.0 111.587 169.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -84.24 57.72 4.4 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.13 -128.05 5.88 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 169.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.9 p -111.34 144.76 40.02 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 168.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 101' ' ' TRP . 12.1 ptt-85 -146.16 119.79 9.16 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 120.698 1.59 . . . . 0.0 111.181 -170.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.512 ' HB2' HD22 ' A' ' 6' ' ' LEU . 11.8 m-85 -120.68 131.82 54.77 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -172.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.448 HD11 HD11 ' A' ' 9' ' ' LEU . 7.5 tp -89.75 107.97 19.41 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.613 170.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.9 t -90.48 111.96 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 173.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 43.6 tp -117.09 114.42 23.71 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 119.062 0.846 . . . . 0.0 110.11 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.441 HG11 HG11 ' A' ' 23' ' ' VAL . 98.0 t -106.11 138.18 32.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.403 HG22 HG12 ' A' ' 171' ' ' VAL . 13.4 t -150.37 170.03 20.01 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 112.439 -2.164 . . . . 0.0 109.465 168.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -130.38 13.88 5.55 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.996 1.718 . . . . 0.0 113.375 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -142.58 179.35 7.02 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.891 1.676 . . . . 0.0 109.825 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -73.3 -170.84 0.85 Allowed 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.355 0.597 . . . . 0.0 110.437 168.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -143.96 157.25 44.46 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.063 -1.023 . . . . 0.0 113.616 -169.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -73.58 129.94 39.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.331 172.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.55 HD22 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -105.94 178.32 4.6 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.832 1.653 . . . . 0.0 109.34 177.542 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.55 ' H ' HD22 ' A' ' 118' ' ' LEU . . . -53.62 140.68 28.17 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.077 -1.015 . . . . 0.0 112.682 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? 85.52 -26.27 0.1 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 128.883 2.873 . . . . 0.0 114.993 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . 0.256 10.6 p30 -65.36 -22.66 66.83 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 121.944 2.157 . . . . 0.0 114.767 -175.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.444 ' H ' ' HD3' ' A' ' 122' ' ' LYS 0.253 0.0 OUTLIER -72.12 6.32 2.24 Favored 'General case' 0 N--CA 1.48 1.044 0 O-C-N 120.245 -1.535 . . . . 0.0 114.794 168.617 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 6.6 t -61.71 -26.1 67.83 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 120.755 -1.216 . . . . 0.0 110.155 168.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 57.6 mt -63.7 -35.05 79.29 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.071 1.748 . . . . 0.0 112.96 171.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -88.75 14.36 60.3 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.739 1.638 . . . . 0.0 113.533 172.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.323 25.9 m 41.62 54.81 3.68 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 129.375 3.07 . . . . 0.0 114.459 -174.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -100.72 110.45 22.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -85.9 -62.32 1.55 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 121.684 2.038 . . . . 0.0 112.02 -171.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.16 132.77 44.6 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.423 ' HA ' ' CB ' ' A' ' 149' ' ' ASP . 6.4 t -49.8 145.02 5.71 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.767 2.027 . . . . 0.0 111.104 170.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.4 p -65.24 145.27 56.45 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.168 0.985 . . . . 0.0 111.948 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.5 p-10 -80.93 -12.54 59.38 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.476 ' HA3' ' HE3' ' A' ' 159' ' ' LYS . . . 72.82 16.73 78.1 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 118.737 -1.035 . . . . 0.0 113.376 -176.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -103.59 159.78 15.3 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.922 1.289 . . . . 0.0 109.018 169.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 4.8 t -85.07 144.65 28.11 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.777 -1.202 . . . . 0.0 112.593 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -132.49 63.78 1.62 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.908 2.083 . . . . 0.0 109.609 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.13 130.04 52.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.199 1.8 . . . . 0.0 108.469 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -133.63 -69.19 0.55 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.226 0.61 . . . . 0.0 112.095 173.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.45 6.64 32.93 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.04 1.336 . . . . 0.0 114.205 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 108.82 -14.49 34.64 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.89 1.71 . . . . 0.0 114.949 174.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 62.2 mtt -91.54 144.46 25.53 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.285 1.542 . . . . 0.0 110.867 171.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -64.83 98.33 0.27 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 50.9 mmm-85 -56.43 -42.5 78.18 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.304 1.842 . . . . 0.0 112.268 -169.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 70.7 m -95.33 5.06 52.69 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -169.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.9 ttp-105 -47.11 -40.52 15.56 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 120.504 1.502 . . . . 0.0 112.995 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.73 -3.33 72.83 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 117.953 -1.471 . . . . 0.0 115.208 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.28 45.6 tt0 -120.6 -76.26 0.01 OUTLIER Pre-proline 0 CA--C 1.555 1.161 0 CA-C-O 115.84 -2.028 . . . . 0.0 111.83 176.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -58.89 160.93 16.65 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 123.147 2.565 . . . . 0.0 117.66 175.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.423 ' CB ' ' HA ' ' A' ' 130' ' ' THR . 6.1 t0 -70.12 174.28 5.65 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 129.864 3.266 . . . . 0.0 114.91 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.433 ' HB3' ' CD2' ' A' ' 86' ' ' LEU . 28.2 m-85 -81.29 123.1 28.23 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.672 1.989 . . . . 0.0 105.893 167.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.651 ' H ' ' CD ' ' A' ' 151' ' ' GLN . 0.2 OUTLIER -64.09 135.5 56.43 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 119.712 -1.868 . . . . 0.0 112.101 -177.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 24.6 p -67.44 155.45 38.99 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.387 -1.445 . . . . 0.0 112.087 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.442 HG22 HG23 ' A' ' 186' ' ' ILE . 7.2 p -57.69 -28.42 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 120.625 -1.297 . . . . 0.0 114.282 -169.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 52.0 t -81.54 -22.73 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.448 0.699 . . . . 0.0 112.596 175.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -63.9 -41.67 97.64 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.681 1.128 . . . . 0.0 109.013 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.6 mt -55.7 -56.6 18.51 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.345 0.521 . . . . 0.0 110.857 174.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.48 ' HB2' HG22 ' A' ' 186' ' ' ILE . . . -60.36 -30.1 69.34 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.0 t -65.88 -54.07 31.45 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.701 0.682 . . . . 0.0 111.357 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.476 ' HE3' ' HA3' ' A' ' 133' ' ' GLY . 69.3 mmtt -63.78 -44.39 93.53 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.034 -1.041 . . . . 0.0 113.44 -178.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mt -76.34 -23.88 54.24 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.503 -1.373 . . . . 0.0 112.042 -176.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.99 -37.84 61.78 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 169.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.4 -34.77 63.38 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.235 0.925 . . . . 0.0 110.784 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -85.6 -7.05 59.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.117 0.967 . . . . 0.0 112.594 174.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 58.13 37.56 26.37 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.185 1.794 . . . . 0.0 113.347 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 22.9 mm -88.92 140.62 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.298 1.039 . . . . 0.0 109.193 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.503 ' HB2' ' CD2' ' A' ' 107' ' ' PHE . 20.2 mm100 -102.92 101.79 23.36 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 120.743 1.611 . . . . 0.0 109.421 169.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -77.63 143.07 21.08 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.299 2.0 . . . . 0.0 112.979 174.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 18.6 mm -129.31 109.69 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.004 1.722 . . . . 0.0 108.881 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -75.91 71.81 2.74 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 123.648 1.69 . . . . 0.0 112.149 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 194' ' ' LEU . 58.1 t -63.93 101.63 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 O-C-N 121.141 -0.974 . . . . 0.0 113.008 169.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.403 HG12 HG22 ' A' ' 112' ' ' THR . 5.6 m -144.4 144.18 24.5 Favored Pre-proline 0 N--CA 1.484 1.225 0 O-C-N 120.175 -1.578 . . . . 0.0 111.707 -174.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -67.15 168.37 17.71 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.762 2.308 . . . . 0.0 115.581 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.1 t -52.13 140.88 19.86 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.499 169.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 103.13 -48.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 130.132 3.373 . . . . 0.0 110.006 -172.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -86.79 -22.45 25.88 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.1 t -50.93 -42.11 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 125.729 1.612 . . . . 0.0 111.89 -169.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -75.28 -15.88 60.48 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -172.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.54 -44.19 21.62 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.984 0.811 . . . . 0.0 109.528 172.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -71.89 -28.03 63.23 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.381 1.473 . . . . 0.0 110.656 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.551 ' O ' HG22 ' A' ' 183' ' ' THR . 13.2 mt-10 -65.92 -36.01 82.19 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.252 169.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -76.31 -26.71 56.09 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 116.732 -1.987 . . . . 0.0 110.758 -178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.6 -19.84 58.98 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.776 -1.203 . . . . 0.0 109.746 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 180' ' ' GLU . 1.6 t -70.37 -23.84 62.86 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 119.473 1.033 . . . . 0.0 110.908 169.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 11.9 m -75.23 -31.02 60.72 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.389 0.676 . . . . 0.0 109.268 173.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -77.13 -27.64 54.03 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 117.948 -1.025 . . . . 0.0 112.873 173.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.486 HD11 HD13 ' A' ' 189' ' ' LEU . 30.3 pt -119.6 95.92 49.45 Favored Pre-proline 0 N--CA 1.489 1.503 0 CA-C-N 120.182 1.355 . . . . 0.0 113.656 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.87 138.5 51.39 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 124.11 3.207 . . . . 0.0 113.177 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 80.96 -4.1 1.75 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 128.665 2.786 . . . . 0.0 114.065 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.486 HD13 HD11 ' A' ' 186' ' ' ILE . 0.7 OUTLIER -69.54 154.39 42.07 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.927 1.24 . . . . 0.0 108.583 168.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.256 1.9 m -128.11 -177.43 4.14 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 169.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.0 tt -146.22 144.49 20.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 C-N-CA 129.587 3.155 . . . . 0.0 107.476 -168.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -128.27 146.98 17.18 Favored Glycine 0 N--CA 1.466 0.682 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -91.1 94.53 9.64 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.46 HD13 HD22 ' A' ' 26' ' ' LEU . 60.9 tp -57.14 139.87 51.17 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.277 169.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 86.7 p -163.85 -176.56 4.64 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.955 1.702 . . . . 0.0 107.697 171.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -60.59 -6.13 1.52 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 172.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -110.42 133.64 53.09 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.017 1.727 . . . . 0.0 111.728 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 46.8 t -89.72 -17.0 29.12 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.16 1.384 . . . . 0.0 114.053 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 63.2 m -56.67 -40.33 75.33 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.257 -1.527 . . . . 0.0 113.521 -168.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -67.9 -20.31 65.09 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.1 -45.97 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.072 -1.017 . . . . 0.0 110.919 176.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.9 -34.8 79.26 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 117.625 -1.179 . . . . 0.0 111.512 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -64.57 -6.54 7.79 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.55 1.523 . . . . 0.0 114.17 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 54.3 mt -104.32 -38.8 6.71 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 126.86 2.064 . . . . 0.0 107.425 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 40.4 mm -68.74 -49.53 63.46 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 169.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . 0.335 21.1 ptt180 -67.28 -26.36 66.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 119.275 -0.97 . . . . 0.0 112.01 175.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -66.96 -41.56 86.7 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 120.253 1.388 . . . . 0.0 111.161 169.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -75.07 -29.22 60.62 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.769 0.827 . . . . 0.0 112.416 -177.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -66.78 -38.74 87.15 Favored 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 124.28 1.032 . . . . 0.0 111.058 169.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 11.1 t -63.3 -18.74 63.93 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . 0.261 0.0 OUTLIER -103.01 33.71 3.16 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 125.133 1.373 . . . . 0.0 114.387 -177.013 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 C--O 1.257 1.471 0 N-CA-C 119.165 3.024 . . . . 0.0 119.165 177.71 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.116 0.484 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -95.46 158.51 15.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.959 0.904 . . . . 0.0 111.783 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.1 m -66.32 129.0 38.33 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -174.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 54.8 t -128.29 136.35 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.639 1.976 . . . . 0.0 108.917 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.57 112.03 13.87 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.807 0.843 . . . . 0.0 109.892 -175.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.426 HD22 ' HB2' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -105.93 132.13 52.4 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -176.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -117.38 103.36 10.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 123.351 1.548 . . . . 0.0 109.836 169.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -79.98 104.51 10.6 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 113.367 -1.742 . . . . 0.0 112.169 171.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.0 tt -103.82 126.69 51.13 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.764 0.826 . . . . 0.0 111.226 171.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.2 ptm -121.32 147.07 46.17 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 174.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.71 136.88 15.04 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 124.404 1.002 . . . . 0.0 112.22 170.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.428 HD23 ' HB2' ' A' ' 47' ' ' SER . 0.6 OUTLIER -119.55 44.41 2.38 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.165 1.786 . . . . 0.0 112.41 -179.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 56.8 p -72.0 165.01 25.12 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 120.238 -1.539 . . . . 0.0 112.805 170.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.08 -21.77 71.98 Favored Glycine 0 N--CA 1.474 1.208 0 O-C-N 120.927 -1.108 . . . . 0.0 113.201 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.2 p -75.18 -16.67 60.49 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.162 1.385 . . . . 0.0 113.145 169.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.55 -6.84 59.13 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -75.51 145.07 41.63 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 121.433 1.924 . . . . 0.0 110.005 169.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.91 -54.41 2.59 Favored Glycine 0 N--CA 1.47 0.922 0 N-CA-C 107.702 -2.159 . . . . 0.0 107.702 -168.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -66.66 -26.18 66.92 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.039 1.336 . . . . 0.0 111.783 169.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.44 ' HA ' HG12 ' A' ' 23' ' ' VAL . 46.8 tp -45.38 -46.17 13.05 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 127.56 2.344 . . . . 0.0 111.517 172.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.9 t -49.79 -53.08 27.41 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.076 0.95 . . . . 0.0 111.777 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.26 50.6 m-80 -80.6 -25.32 38.53 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 120.132 -1.605 . . . . 0.0 114.485 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 20' ' ' LEU 0.3 12.0 p -74.05 -2.91 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 119.977 1.262 . . . . 0.0 111.11 168.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . 0.288 16.2 pt20 -103.06 -33.95 9.07 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 119.746 1.157 . . . . 0.0 111.631 168.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.8 m -56.22 -54.86 40.27 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.909 1.284 . . . . 0.0 108.542 168.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.444 ' CD2' HG21 ' A' ' 170' ' ' VAL . 13.0 tp -81.53 84.23 6.79 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 169.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 177.59 -53.81 0.1 OUTLIER Glycine 0 C--N 1.302 -1.347 0 CA-C-N 110.998 -2.819 . . . . 0.0 107.951 168.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -74.68 -37.99 62.51 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 124.113 0.965 . . . . 0.0 111.297 176.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -68.83 -36.49 78.25 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.243 0.617 . . . . 0.0 111.064 169.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.7 tp -63.01 -47.68 82.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.653 HD11 ' HB3' ' A' ' 63' ' ' SER . 1.7 tm? -57.38 -61.52 2.43 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.786 1.634 . . . . 0.0 112.344 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -73.43 -35.21 65.76 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 120.928 1.694 . . . . 0.0 112.927 -171.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.9 -35.93 73.85 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.564 1.074 . . . . 0.0 111.748 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.7 mt -80.82 -30.19 35.86 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -64.56 -17.18 63.71 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 119.324 0.965 . . . . 0.0 112.869 171.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -86.38 -43.89 12.48 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.856 1.263 . . . . 0.0 111.341 174.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 tp -71.69 -26.73 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.013 0.824 . . . . 0.0 112.241 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.7 t -147.02 134.2 20.51 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 176.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -72.65 -24.16 61.01 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.479 1.112 . . . . 0.0 112.372 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.3 m -106.26 78.08 1.27 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.281 1.432 . . . . 0.0 109.224 175.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.29 78.75 0.32 Allowed Glycine 0 C--N 1.335 0.502 0 C-N-CA 127.408 2.432 . . . . 0.0 107.817 -170.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -81.56 140.81 34.28 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.451 HD12 ' CE1' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -125.05 137.76 56.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -177.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.42 ' HA3' HD23 ' A' ' 59' ' ' LEU . . . -133.57 155.3 21.67 Favored Glycine 0 N--CA 1.464 0.552 0 C-N-CA 124.45 1.024 . . . . 0.0 111.002 171.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -107.28 163.52 12.95 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.275 0.63 . . . . 0.0 111.923 -175.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.5 147.99 12.85 Favored Glycine 0 C--N 1.345 1.046 0 O-C-N 120.543 -1.348 . . . . 0.0 112.293 170.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.428 ' HB2' HD23 ' A' ' 12' ' ' LEU . 39.7 p -136.66 152.36 50.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.967 1.365 . . . . 0.0 114.403 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -159.78 157.46 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.035 1.334 . . . . 0.0 108.827 -175.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.446 HG13 ' H ' ' A' ' 50' ' ' ASN . 1.3 p -146.99 -73.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.446 ' H ' HG13 ' A' ' 49' ' ' VAL . 0.9 OUTLIER -164.01 -14.18 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.53 1.532 . . . . 0.0 111.604 169.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.616 ' O ' HG23 ' A' ' 52' ' ' THR . 23.6 ptt? -48.16 -41.92 28.22 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.54 1.936 . . . . 0.0 112.903 169.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 51' ' ' MET . 19.0 p 160.2 -179.95 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.189 1 C-N-CA 133.732 4.813 . . . . 0.0 107.381 -171.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -102.09 135.65 43.31 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 167.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -127.59 127.26 43.57 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 123.306 1.527 . . . . 0.0 110.935 171.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -77.34 129.22 35.54 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.445 171.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.2 mt -137.18 139.35 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 127.406 2.282 . . . . 0.0 105.613 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 57' ' ' LEU . 0.9 OUTLIER 44.94 99.47 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.865 2.466 . . . . 0.0 116.529 -169.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -66.91 163.05 20.45 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.154 -0.966 . . . . 0.0 110.983 168.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.42 HD23 ' HA3' ' A' ' 44' ' ' GLY . 13.4 mt -52.18 117.63 2.94 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.103 0.561 . . . . 0.0 111.583 -172.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -138.31 156.38 47.69 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.326 1.451 . . . . 0.0 111.733 -174.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.64 6.01 50.15 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.286 1.434 . . . . 0.0 112.539 170.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -81.85 79.28 8.43 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 125.359 2.504 . . . . 0.0 108.511 171.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.653 ' HB3' HD11 ' A' ' 31' ' ' LEU . 67.7 m -67.14 -45.45 77.08 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 129.112 2.965 . . . . 0.0 110.272 -171.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.7 t -63.29 -23.13 67.28 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.849 0.86 . . . . 0.0 111.627 169.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -78.54 -47.16 17.84 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 120.834 -1.166 . . . . 0.0 110.38 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.451 ' CE1' HD12 ' A' ' 43' ' ' ILE . 55.2 t80 -56.86 -32.9 66.29 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 123.379 0.672 . . . . 0.0 111.585 176.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.474 HE21 HD12 ' A' ' 31' ' ' LEU . 74.2 mt-30 -68.44 -38.78 81.49 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.527 -0.733 . . . . 0.0 110.207 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 68.1 mtt-85 -73.54 -38.11 65.36 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.611 1.165 . . . . 0.0 109.144 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -84.13 -25.07 29.96 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.609 -172.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.97 -48.49 53.06 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 168.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -62.03 -33.57 74.62 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -71.76 -14.0 61.87 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -64.59 156.12 30.97 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.371 1.442 . . . . 0.0 113.547 -172.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 pp -139.28 141.87 37.76 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.324 1.85 . . . . 0.0 110.672 -169.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.1 m -79.36 154.0 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 CA-C-O 121.221 0.534 . . . . 0.0 112.102 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.1 t -109.35 -152.07 0.48 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.604 1.162 . . . . 0.0 109.028 168.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -147.17 151.13 23.45 Favored Glycine 0 N--CA 1.471 1.005 0 O-C-N 120.632 -1.293 . . . . 0.0 114.042 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.53 150.6 21.51 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.254 1.422 . . . . 0.0 111.874 172.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.61 -61.91 1.62 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.288 1.435 . . . . 0.0 112.246 -173.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.3 136.41 51.81 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.021 0.528 . . . . 0.0 111.001 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.324 0.0 OUTLIER -70.35 -38.19 8.11 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-O 116.248 -1.834 . . . . 0.0 113.909 -176.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.51 141.71 81.6 Favored 'Trans proline' 0 C--N 1.355 0.888 0 CA-C-N 122.439 1.907 . . . . 0.0 110.844 169.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -170.83 1.72 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.223 1.009 . . . . 0.0 113.127 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.401 ' HA3' ' NH2' ' A' ' 145' ' ' ARG . . . -112.8 30.11 7.68 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 -169.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.506 ' CG ' HD21 ' A' ' 110' ' ' LEU 0.285 0.2 OUTLIER -70.33 -29.4 66.09 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 118.526 2.788 . . . . 0.0 118.526 -168.906 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.83 HD23 HD21 ' A' ' 156' ' ' LEU . 8.4 mp -66.14 -30.91 71.49 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 123.787 2.994 . . . . 0.0 112.995 178.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -59.95 -41.76 92.58 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.11 -0.994 . . . . 0.0 110.73 171.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.04 -49.4 72.49 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.024 -0.988 . . . . 0.0 111.379 174.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.1 m -58.8 -32.88 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 119.701 1.137 . . . . 0.0 112.168 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.0 t -78.02 -40.8 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 117.161 -1.399 . . . . 0.0 112.566 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -56.83 -45.23 82.46 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 121.663 2.029 . . . . 0.0 110.238 171.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.578 HG11 HD23 ' A' ' 108' ' ' LEU . 79.9 t -59.45 -32.37 48.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 174.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.31 -35.32 47.93 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.731 -1.231 . . . . 0.0 113.792 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 19.1 mm -93.03 -30.85 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 119.721 1.146 . . . . 0.0 113.25 -172.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 78.4 m -79.74 52.27 1.43 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.396 1.478 . . . . 0.0 112.016 -172.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.7 mt -49.86 -41.19 44.73 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.123 2.169 . . . . 0.0 112.207 -169.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.44 -23.63 70.1 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.258 0.932 . . . . 0.0 114.534 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.43 -34.66 8.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.165 0.982 . . . . 0.0 111.531 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.65 -45.97 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 118.976 0.807 . . . . 0.0 110.095 170.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 97.83 26.04 10.09 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.809 1.195 . . . . 0.0 115.254 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -57.82 125.3 22.42 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.265 1.532 . . . . 0.0 112.268 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -93.02 -158.56 0.61 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.769 1.228 . . . . 0.0 112.139 172.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -90.55 0.33 57.39 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 116.277 1.954 . . . . 0.0 116.277 -173.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.9 -127.4 2.28 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 120.586 1.539 . . . . 0.0 111.396 -175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.2 t -114.6 140.72 48.56 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.572 1.549 . . . . 0.0 108.925 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -122.89 134.2 54.38 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 117.32 -1.324 . . . . 0.0 109.887 -168.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.459 ' CD2' ' HB3' ' A' ' 166' ' ' GLN . 15.1 m-85 -129.91 113.85 15.14 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.578 HD23 HG11 ' A' ' 92' ' ' VAL . 3.2 tm? -82.49 98.8 9.11 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 170.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 80.4 t -83.69 116.21 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.506 HD21 ' CG ' ' A' ' 85' ' ' GLN . 3.2 tm? -110.33 108.03 17.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.202 -0.904 . . . . 0.0 112.161 -168.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.413 HG22 HG13 ' A' ' 170' ' ' VAL . 46.2 t -101.74 129.89 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.6 t -161.47 151.43 17.04 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 169.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -106.67 -13.5 15.27 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -169.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 58.3 m-80 -137.12 -169.8 2.57 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.827 1.251 . . . . 0.0 110.553 176.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.67 -170.71 0.57 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.075 0.95 . . . . 0.0 112.745 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.537 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 48.2 t80 -139.21 149.8 44.8 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.266 1.426 . . . . 0.0 112.546 -172.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -84.68 91.81 8.03 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.031 1.332 . . . . 0.0 113.332 175.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -59.24 163.02 4.07 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 120.493 -1.379 . . . . 0.0 112.432 177.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -46.71 135.1 9.18 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.619 -0.676 . . . . 0.0 111.504 170.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm 97.5 -12.48 0.07 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 130.179 3.391 . . . . 0.0 112.142 -175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -76.8 -20.09 56.82 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.607 -1.308 . . . . 0.0 113.737 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.42 ' HG3' ' CD2' ' A' ' 150' ' ' TYR . 34.0 mttm -71.72 -1.67 14.7 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 120.023 1.283 . . . . 0.0 114.344 170.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 87.7 m -58.41 -36.27 73.34 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 119.413 1.006 . . . . 0.0 111.453 169.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.6 mt -63.94 -36.27 83.39 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.462 0.705 . . . . 0.0 112.437 173.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -82.39 13.93 37.59 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.778 1.656 . . . . 0.0 114.068 172.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.322 11.6 t 53.04 48.15 22.99 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 128.031 2.532 . . . . 0.0 113.442 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -127.43 113.66 16.48 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.728 1.211 . . . . 0.0 111.41 172.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -94.78 -30.29 14.32 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.304 1.441 . . . . 0.0 113.139 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -60.35 120.32 9.63 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.347 0.659 . . . . 0.0 110.809 -172.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.5 t -61.47 155.95 20.59 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 118.827 0.739 . . . . 0.0 110.599 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.6 t -65.01 143.19 58.12 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.655 0.74 . . . . 0.0 112.182 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -79.57 -29.27 41.24 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.243 1.017 . . . . 0.0 112.32 -177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.35 18.79 70.56 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.089 0.852 . . . . 0.0 113.044 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -106.88 164.51 12.06 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.085 1.754 . . . . 0.0 113.386 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 6.3 t -72.05 125.65 27.78 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.142 1.377 . . . . 0.0 109.639 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -134.75 41.17 2.9 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.8 1.64 . . . . 0.0 111.448 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -101.37 124.42 47.03 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.287 2.235 . . . . 0.0 109.315 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . 0.257 15.3 p-10 -115.71 -96.72 0.46 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.397 1.079 . . . . 0.0 112.608 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.25 30.25 0.28 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 121.016 1.734 . . . . 0.0 113.679 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 96.57 -9.32 66.64 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.915 1.721 . . . . 0.0 114.142 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 20.5 ptp -97.02 151.67 19.49 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.597 1.698 . . . . 0.0 113.034 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -84.6 80.58 9.19 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.912 0.885 . . . . 0.0 109.735 169.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.3 ttm-85 -58.63 -32.94 69.51 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 38.9 m -64.87 -8.34 14.99 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.401 ' NH2' ' HA3' ' A' ' 84' ' ' GLY . 9.2 tpt180 -52.94 -29.13 26.9 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 120.649 1.568 . . . . 0.0 114.109 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.46 1.4 87.31 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 117.99 -1.45 . . . . 0.0 115.09 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.379 0.7 OUTLIER -121.41 -79.17 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.005 0 CA-C-O 115.89 -2.005 . . . . 0.0 112.82 178.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.89 154.35 67.14 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 CA-C-N 124.463 2.63 . . . . 0.0 115.65 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -62.02 169.41 2.68 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 129.829 3.252 . . . . 0.0 112.912 170.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.42 ' CD2' ' HG3' ' A' ' 122' ' ' LYS . 74.8 m-85 -62.83 159.74 15.97 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.489 -0.757 . . . . 0.0 111.812 169.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -81.34 140.03 35.01 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.4 -0.812 . . . . 0.0 111.271 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.3 p -80.6 151.48 29.05 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.312 1.045 . . . . 0.0 111.253 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.525 ' HA ' HD23 ' A' ' 156' ' ' LEU . 45.1 t -53.13 -39.09 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -168.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.42 -18.69 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 O-C-N 121.496 -0.753 . . . . 0.0 112.534 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -67.11 -36.31 81.65 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.739 1.154 . . . . 0.0 110.412 170.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.83 HD21 HD23 ' A' ' 86' ' ' LEU . 1.9 mm? -59.05 -58.59 7.98 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 168.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.16 -43.79 78.69 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.102 0.961 . . . . 0.0 112.976 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 57.8 m -58.08 -56.13 25.98 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.058 0.943 . . . . 0.0 112.371 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.292 10.6 mptt -86.84 -20.44 27.49 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -174.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.4 mp -67.46 -31.13 71.09 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.382 1.446 . . . . 0.0 109.954 168.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.63 -33.78 58.34 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.657 1.183 . . . . 0.0 114.103 172.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.5 -51.47 59.78 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.4 1.08 . . . . 0.0 110.111 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -77.91 -12.69 60.0 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.69 0.796 . . . . 0.0 111.927 176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.79 47.04 18.83 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.563 2.345 . . . . 0.0 111.991 176.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 28.9 mm -85.43 136.98 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.861 1.264 . . . . 0.0 108.421 174.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.459 ' HB3' ' CD2' ' A' ' 107' ' ' PHE . 3.7 tp60 -93.82 108.57 35.72 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 120.759 1.618 . . . . 0.0 107.859 168.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.55 ' HG2' ' HG ' ' A' ' 189' ' ' LEU . 83.0 Cg_endo -74.0 138.46 25.69 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.412 3.408 . . . . 0.0 113.24 171.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 20.5 mm -129.31 101.93 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.987 1.315 . . . . 0.0 110.115 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -72.39 72.58 0.96 Allowed 'General case' 0 N--CA 1.476 0.832 0 O-C-N 120.636 -1.29 . . . . 0.0 112.564 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.444 HG21 ' CD2' ' A' ' 26' ' ' LEU . 3.5 p -69.73 106.36 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 O-C-N 120.78 -1.2 . . . . 0.0 113.029 170.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 31.8 m -145.41 147.07 32.29 Favored Pre-proline 0 N--CA 1.482 1.167 0 O-C-N 120.354 -1.466 . . . . 0.0 113.293 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -59.52 155.67 40.65 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 124.855 3.704 . . . . 0.0 114.849 172.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.9 t -41.62 -60.57 1.29 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.447 2.299 . . . . 0.0 114.94 -169.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -64.04 -12.5 39.11 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -171.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 66.8 mmm -99.25 -7.47 26.38 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 170.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.6 t -57.34 -36.62 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 120.272 1.396 . . . . 0.0 111.66 -169.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -69.92 -28.31 65.49 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.01 -34.83 24.23 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 118.926 0.785 . . . . 0.0 111.309 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -72.42 -30.72 64.88 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.565 -1.334 . . . . 0.0 110.325 170.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -71.26 -11.79 61.11 Favored 'General case' 0 CA--C 1.553 1.092 0 O-C-N 121.584 -0.697 . . . . 0.0 111.376 168.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -84.33 -47.11 11.07 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 120.039 -1.663 . . . . 0.0 109.969 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -74.81 -21.14 59.47 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 119.966 -1.709 . . . . 0.0 111.051 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.84 -16.7 61.59 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.726 0.81 . . . . 0.0 111.961 171.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.55 -25.57 28.62 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 119.487 -0.292 . . . . 0.0 110.969 170.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -87.99 -18.48 28.93 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 56.9 mt -118.35 96.48 49.85 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.285 1.034 . . . . 0.0 108.837 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -55.42 141.76 81.52 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.688 2.926 . . . . 0.0 114.439 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . 0.325 0.0 OUTLIER 81.55 -15.51 0.71 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 128.618 2.767 . . . . 0.0 113.093 171.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.55 ' HG ' ' HG2' ' A' ' 167' ' ' PRO . 2.5 tt -56.76 148.01 21.54 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 127.003 2.121 . . . . 0.0 108.689 169.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 77.2 p -121.41 -150.76 0.46 Allowed 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 120.784 1.629 . . . . 0.0 109.651 170.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -179.34 117.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 O-C-N 119.51 -1.994 . . . . 0.0 109.154 -167.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -110.6 152.68 17.36 Favored Glycine 0 N--CA 1.469 0.875 0 C-N-CA 124.83 1.205 . . . . 0.0 112.242 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -93.8 85.69 4.89 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.866 1.266 . . . . 0.0 109.175 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.417 ' HB2' HG22 ' A' ' 170' ' ' VAL . 47.8 tp -56.79 130.94 47.77 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.977 169.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.7 t -165.7 -159.39 0.4 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.559 1.144 . . . . 0.0 109.278 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -63.79 -11.11 24.0 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.877 1.271 . . . . 0.0 114.205 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -128.95 134.52 48.23 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 127.773 2.429 . . . . 0.0 111.755 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 24.2 p -95.3 0.04 53.34 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.719 2.008 . . . . 0.0 113.904 -174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 50.7 p -56.92 -45.16 82.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.348 1.859 . . . . 0.0 112.722 -169.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -64.0 -39.37 93.97 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 122.719 0.408 . . . . 0.0 111.793 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 47.5 t -71.45 -42.52 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 121.639 -0.663 . . . . 0.0 110.12 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.63 -30.94 71.33 Favored 'General case' 0 C--O 1.216 -0.669 0 C-N-CA 123.531 0.732 . . . . 0.0 112.517 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -70.01 -11.9 61.22 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.185 -1.572 . . . . 0.0 113.009 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.53 -35.59 7.81 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.775 1.63 . . . . 0.0 108.809 -173.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 4.3 mt -77.45 -34.65 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 118.619 -0.705 . . . . 0.0 109.58 169.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -72.84 -29.74 63.46 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.23 0.923 . . . . 0.0 111.25 169.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -64.26 -36.14 83.11 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 119.979 1.263 . . . . 0.0 111.453 169.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -76.11 -24.47 54.96 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.602 0.761 . . . . 0.0 112.638 175.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -63.68 -50.04 70.79 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.761 0.824 . . . . 0.0 110.592 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 65.5 p -74.94 -7.66 54.24 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -69.06 -37.09 78.33 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.24 -0.912 . . . . 0.0 111.747 169.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.259 1.582 0 C-N-CA 126.692 1.997 . . . . 0.0 112.856 179.373 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.3 t70 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.158 0.504 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -120.68 147.42 45.29 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.913 1.285 . . . . 0.0 109.056 171.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.9 p -62.02 137.18 58.22 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 121.621 0.724 . . . . 0.0 111.807 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 t -115.91 145.67 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 125.947 1.699 . . . . 0.0 106.646 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.3 14.9 p-10 -136.99 111.99 8.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.736 0.779 . . . . 0.0 110.35 171.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 24.2 tp -96.24 134.35 39.45 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.511 1.124 . . . . 0.0 112.653 -175.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -118.68 103.16 9.42 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 123.204 1.478 . . . . 0.0 109.388 168.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -82.43 93.87 7.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.056 1.742 . . . . 0.0 111.534 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 30.5 tp -92.1 125.53 36.83 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.377 1.071 . . . . 0.0 109.619 173.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.466 ' CE ' ' CZ ' ' A' ' 45' ' ' PHE 0.306 0.0 OUTLIER -134.24 165.62 24.69 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 172.276 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.46 140.26 15.57 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.677 1.132 . . . . 0.0 112.343 -177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.446 HD21 ' CE ' ' A' ' 10' ' ' MET . 3.5 mm? -114.59 22.63 13.43 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.15 1.78 . . . . 0.0 112.212 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 p -68.44 160.04 30.47 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.586 -1.321 . . . . 0.0 110.91 169.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -56.46 -21.46 34.47 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 116.443 1.337 . . . . 0.0 116.443 -169.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 23.4 p -64.23 -27.25 68.92 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.234 1.413 . . . . 0.0 114.264 170.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.35 -10.96 59.9 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.664 1.586 . . . . 0.0 114.813 -172.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -68.12 121.16 15.57 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.63 -39.85 2.76 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.068 1.318 . . . . 0.0 111.805 -169.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -70.79 -44.56 66.38 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 118.339 1.07 . . . . 0.0 110.514 169.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.0 tt -53.54 -39.74 64.94 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.112 1.765 . . . . 0.0 112.071 173.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.2 m -62.14 -34.62 76.73 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.324 1.05 . . . . 0.0 113.204 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -81.41 -23.65 37.44 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.8 m -103.5 15.06 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 119.408 1.004 . . . . 0.0 113.496 -173.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -93.53 -36.38 12.45 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.392 1.077 . . . . 0.0 109.599 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 t -68.81 -14.9 63.32 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 122.026 0.917 . . . . 0.0 109.413 167.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.9 tp -86.71 102.32 14.12 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 125.133 2.397 . . . . 0.0 107.907 174.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.38 -51.96 0.09 OUTLIER Glycine 0 C--N 1.299 -1.492 0 CA-C-N 108.493 -3.958 . . . . 0.0 110.75 168.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -82.94 -39.61 21.19 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.054 1.342 . . . . 0.0 110.797 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -71.91 -31.36 66.3 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.726 -0.609 . . . . 0.0 111.193 176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.13 -44.24 92.82 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-O 119.214 -0.422 . . . . 0.0 109.866 172.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -34.33 75.64 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 116.802 -1.57 . . . . 0.0 112.652 178.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -31.66 72.78 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 123.165 2.711 . . . . 0.0 112.447 174.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.75 -25.36 53.39 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 171.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 47.8 mt -92.75 -20.93 20.27 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.548 1.067 . . . . 0.0 113.662 175.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -80.62 -16.43 54.1 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 120.131 1.332 . . . . 0.0 114.387 -169.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -85.95 -33.27 21.19 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 119.129 -0.463 . . . . 0.0 110.579 169.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . 0.328 0.0 OUTLIER -75.08 -24.88 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-N 118.979 0.809 . . . . 0.0 112.757 169.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.4 t -154.47 135.37 13.75 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -81.15 1.71 30.72 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 172.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.4 t -141.37 108.08 5.37 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 120.977 -1.077 . . . . 0.0 109.866 169.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.42 83.69 0.24 Allowed Glycine 0 C--N 1.337 0.625 0 C-N-CA 126.776 2.132 . . . . 0.0 107.929 -169.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -77.25 151.36 35.15 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -175.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 12.0 tt -132.28 138.02 53.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 117.754 0.252 . . . . 0.0 111.17 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.409 ' HA2' HD13 ' A' ' 57' ' ' LEU . . . -135.14 163.77 24.83 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 126.891 2.186 . . . . 0.0 110.9 171.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.466 ' CZ ' ' CE ' ' A' ' 10' ' ' MET . 86.1 t80 -135.5 145.27 46.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.995 0.918 . . . . 0.0 111.831 -169.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.35 147.2 18.47 Favored Glycine 0 C--N 1.343 0.938 0 C-N-CA 122.568 0.128 . . . . 0.0 112.887 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 63.6 m -118.7 142.74 47.39 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.503 1.121 . . . . 0.0 112.036 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.79 157.12 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.726 1.21 . . . . 0.0 110.411 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.4 p -157.83 -52.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 124.405 1.082 . . . . 0.0 109.994 169.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 161.48 -22.9 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 131.302 3.841 . . . . 0.0 110.525 169.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -52.77 -39.93 62.69 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.642 0.777 . . . . 0.0 111.462 170.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.1 p -170.43 168.9 7.71 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 129.744 3.218 . . . . 0.0 110.723 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -113.11 123.65 50.76 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 101.003 -3.703 . . . . 0.0 101.003 165.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -122.03 114.04 20.4 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -174.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -81.64 114.63 20.45 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.637 169.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.3 mt -139.44 95.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.409 HD13 ' HA2' ' A' ' 44' ' ' GLY 0.262 2.6 tm? 107.43 94.17 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 130.703 3.601 . . . . 0.0 109.139 174.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -52.66 159.42 1.08 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.592 1.557 . . . . 0.0 112.741 170.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.7 mt -53.64 120.47 6.23 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 172.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.8 t -147.0 170.04 17.94 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.511 1.124 . . . . 0.0 112.539 -172.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.35 -22.69 18.79 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.676 1.99 . . . . 0.0 114.397 -175.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -89.92 89.76 7.87 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 125.86 2.743 . . . . 0.0 108.665 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.0 p -60.73 -36.57 79.21 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 131.244 3.818 . . . . 0.0 111.523 173.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.5 t -65.01 -19.05 65.81 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.06 0.944 . . . . 0.0 110.814 169.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -82.02 -37.25 26.81 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.846 -1.159 . . . . 0.0 111.015 176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -56.88 -32.64 66.06 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.091 -1.006 . . . . 0.0 111.211 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -73.37 -41.68 63.11 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.305 -0.872 . . . . 0.0 110.626 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -27.22 63.34 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -88.46 -30.3 19.52 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.06 -52.56 55.03 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -66.51 -26.96 67.41 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -169.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -69.92 -44.06 70.41 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -177.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . 0.267 9.9 pt20 -80.18 167.48 20.29 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -151.54 169.64 21.61 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -167.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -73.61 154.29 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.648 1.579 . . . . 0.0 113.895 -169.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -120.24 -160.02 0.81 Allowed 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.285 1.834 . . . . 0.0 111.146 169.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -156.19 155.71 26.52 Favored Glycine 0 N--CA 1.472 1.076 0 O-C-N 120.507 -1.371 . . . . 0.0 113.957 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -152.32 151.96 31.52 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.645 1.178 . . . . 0.0 112.767 174.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -55.68 -58.99 5.5 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.088 2.155 . . . . 0.0 112.343 174.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.72 143.98 37.63 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.266 15.1 t -70.15 -41.75 15.1 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 115.563 -2.16 . . . . 0.0 114.443 174.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -63.74 142.87 84.86 Favored 'Trans proline' 0 C--N 1.356 0.972 0 CA-C-N 123.421 2.257 . . . . 0.0 112.319 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -112.78 154.58 26.0 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.912 1.285 . . . . 0.0 113.43 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.04 55.76 4.79 Favored Glycine 0 N--CA 1.479 1.51 0 C-N-CA 125.664 1.602 . . . . 0.0 112.586 -172.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.613 HE22 HG21 ' A' ' 112' ' ' THR . 32.5 tt0 -83.07 -33.82 26.33 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.458 1.903 . . . . 0.0 115.689 -168.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.9 -37.95 79.31 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -171.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -51.46 -46.82 63.2 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.224 1.01 . . . . 0.0 111.601 169.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.48 -53.63 49.1 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.132 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . 0.25 32.9 m -64.25 -27.41 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 119.476 1.035 . . . . 0.0 112.621 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.503 HG22 HE22 ' A' ' 155' ' ' GLN . 76.7 t -64.04 -63.01 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 119.427 1.012 . . . . 0.0 108.564 168.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -58.43 -42.78 88.04 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.171 0.896 . . . . 0.0 111.174 -173.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.0 t -55.76 -35.4 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.08 0.855 . . . . 0.0 112.428 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.71 -37.14 65.26 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.818 -1.176 . . . . 0.0 113.486 175.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.433 ' HB ' ' SG ' ' A' ' 135' ' ' CYS . 7.9 mm -93.56 -15.8 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.858 0.863 . . . . 0.0 113.017 -172.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.5 m -79.52 49.01 0.96 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.763 2.025 . . . . 0.0 112.58 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -49.95 -40.1 42.65 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.778 -1.201 . . . . 0.0 112.048 -175.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -87.71 -19.23 54.8 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 115.738 1.055 . . . . 0.0 115.738 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -91.89 -45.52 8.33 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.917 1.359 . . . . 0.0 110.815 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.5 mm -65.85 -44.35 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 123.297 0.639 . . . . 0.0 109.351 175.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.33 21.9 21.0 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.998 1.285 . . . . 0.0 114.083 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 57.3 m95 -49.03 128.36 16.0 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.818 1.247 . . . . 0.0 112.087 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . 0.336 0.6 OUTLIER -113.93 -173.65 2.32 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 175.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -67.65 -2.91 7.61 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 118.792 2.886 . . . . 0.0 118.792 -168.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.29 -125.29 2.63 Favored Glycine 0 C--N 1.343 0.955 0 CA-C-N 121.091 1.769 . . . . 0.0 112.268 -174.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 98.4 m -111.83 115.3 28.8 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.145 1.778 . . . . 0.0 107.802 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 -99.54 128.81 45.66 Favored 'General case' 0 C--N 1.344 0.333 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -168.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -127.19 104.25 7.86 Favored 'General case' 0 C--O 1.215 -0.734 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 -168.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.97 89.38 6.05 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.187 -0.946 . . . . 0.0 111.004 177.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.5 t -72.29 132.57 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 tp -112.62 127.07 56.0 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.1 t -113.32 124.11 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 O-C-N 123.959 0.787 . . . . 0.0 110.54 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.613 HG21 HE22 ' A' ' 85' ' ' GLN . 9.5 t -150.14 164.66 35.05 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.613 0.765 . . . . 0.0 111.465 171.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.46 2.95 6.94 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.721 1.608 . . . . 0.0 114.765 174.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -123.12 173.13 8.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.435 1.094 . . . . 0.0 112.036 171.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -69.98 -169.14 0.24 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.752 0.821 . . . . 0.0 111.542 169.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.437 ' CE1' HD11 ' A' ' 182' ' ' LEU . 29.8 p90 -142.07 158.71 43.44 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.107 -0.996 . . . . 0.0 112.983 -169.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -84.29 123.84 30.59 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.172 169.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.69 HD22 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -86.43 -177.54 6.22 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.157 0.983 . . . . 0.0 109.47 170.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.69 ' H ' HD22 ' A' ' 118' ' ' LEU . . . -57.67 163.64 2.42 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.359 -0.838 . . . . 0.0 111.467 169.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.408 0.0 OUTLIER 55.11 -3.68 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.775 2.03 . . . . 0.0 116.162 -169.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -75.16 -28.62 60.18 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 121.313 1.87 . . . . 0.0 113.757 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -73.54 1.88 9.06 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 121.035 1.743 . . . . 0.0 113.424 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.7 t -59.83 -25.36 64.94 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.468 1.031 . . . . 0.0 111.501 169.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.4 mt -61.62 -21.16 64.13 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.405 1.882 . . . . 0.0 113.366 174.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -91.96 -108.34 1.64 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 169.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.277 7.1 t -152.55 40.3 0.58 Allowed 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 123.429 1.585 . . . . 0.0 111.041 169.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.02 89.64 5.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.942 1.697 . . . . 0.0 109.483 -175.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -86.07 -42.0 14.3 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.746 -0.596 . . . . 0.0 111.333 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -65.67 134.99 54.4 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.246 0.619 . . . . 0.0 109.967 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.3 p -97.19 147.22 24.31 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.548 1.139 . . . . 0.0 109.436 169.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.7 m -58.24 141.85 49.5 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.5 p30 -72.51 -11.38 60.64 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.467 1.507 . . . . 0.0 113.75 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.5 10.07 86.47 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.639 1.114 . . . . 0.0 113.329 -175.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -84.61 176.56 8.52 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.961 1.38 . . . . 0.0 110.276 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . 0.433 ' SG ' ' HB ' ' A' ' 94' ' ' ILE . 0.6 OUTLIER -100.88 144.69 29.52 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 172.301 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -133.8 38.16 3.23 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.643 1.977 . . . . 0.0 110.868 -170.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.4 pp -62.53 160.19 14.29 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.112 1.765 . . . . 0.0 111.807 171.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -157.73 -101.46 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.72 1.208 . . . . 0.0 110.298 176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -89.27 35.93 0.82 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.606 1.962 . . . . 0.0 113.062 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.1 18.35 55.96 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.744 1.164 . . . . 0.0 114.476 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 22.5 ptp -149.01 156.2 41.91 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.962 1.381 . . . . 0.0 113.905 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -68.94 104.37 2.06 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.552 1.141 . . . . 0.0 111.844 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -65.63 -42.05 91.97 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.344 0.658 . . . . 0.0 111.04 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.9 m -74.56 -3.36 30.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -172.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -44.56 -29.65 0.76 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.8 3.64 57.47 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.574 2.035 . . . . 0.0 115.962 -174.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.421 2.3 pt-20 -131.58 -49.58 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.106 0 CA-C-N 120.755 2.277 . . . . 0.0 114.68 170.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -80.02 151.08 20.97 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 CA-C-N 122.479 1.921 . . . . 0.0 113.736 167.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -75.46 165.54 24.96 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 129.155 2.982 . . . . 0.0 112.233 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -57.98 152.93 15.34 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.091 -1.006 . . . . 0.0 109.24 168.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . 0.334 3.0 mm-40 -106.46 165.42 11.29 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 53.4 p -73.61 161.82 29.9 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -168.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.1 t -61.96 -28.93 45.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.524 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.8 t -73.49 -42.56 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.265 1.026 . . . . 0.0 111.083 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.503 HE22 HG22 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -64.83 -38.03 89.62 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.489 0.586 . . . . 0.0 110.474 178.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 87.8 mt -57.19 -60.76 3.14 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 123.028 0.531 . . . . 0.0 110.261 170.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.83 -45.8 85.66 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -172.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.5 m -64.98 -49.59 69.67 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.839 -0.538 . . . . 0.0 112.306 -177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -74.66 -27.83 60.59 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.067 -1.021 . . . . 0.0 112.384 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 14.8 tp -61.12 -44.47 97.29 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.773 -1.205 . . . . 0.0 111.89 170.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.79 -24.65 61.78 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.04 0.936 . . . . 0.0 113.509 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -72.75 -44.21 61.92 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.098 1.359 . . . . 0.0 110.297 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -80.3 -18.88 47.99 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 56.2 63.74 1.91 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.763 1.625 . . . . 0.0 111.317 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 87.1 mt -113.88 137.66 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.677 1.591 . . . . 0.0 109.274 175.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -91.25 120.71 68.38 Favored Pre-proline 0 N--CA 1.475 0.784 0 CA-C-O 116.703 -1.617 . . . . 0.0 110.488 170.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -88.13 148.66 6.75 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.622 2.881 . . . . 0.0 110.477 168.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.0 mp -137.83 99.17 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.553 ' HB2' HG22 ' A' ' 191' ' ' ILE . 7.1 m-85 -76.48 69.87 2.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 122.285 1.04 . . . . 0.0 111.895 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 92.9 t -61.49 102.55 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 C-N-CA 126.315 1.846 . . . . 0.0 110.993 169.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 30.7 m -148.51 147.96 26.93 Favored Pre-proline 0 N--CA 1.481 1.123 0 O-C-N 120.265 -1.522 . . . . 0.0 113.56 -170.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -62.39 148.45 93.26 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 125.199 3.933 . . . . 0.0 115.048 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.5 t -55.16 -28.93 56.41 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -169.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -47.25 -37.12 9.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.989 1.316 . . . . 0.0 113.793 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . 0.257 0.0 OUTLIER -126.64 5.92 6.79 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -178.064 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.9 t -53.39 -33.63 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 120.331 -1.481 . . . . 0.0 110.969 176.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -21.68 66.42 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -175.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.2 t -90.81 -38.73 12.79 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.347 0.659 . . . . 0.0 110.534 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -66.66 -36.74 83.26 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.024 1.33 . . . . 0.0 111.228 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -60.0 -19.88 54.78 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.375 1.07 . . . . 0.0 111.56 168.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -110.15 6.41 22.73 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.843 1.257 . . . . 0.0 113.248 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.437 HD11 ' CE1' ' A' ' 116' ' ' PHE . 62.0 mt -95.4 -25.97 16.05 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 167.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.3 t -77.62 -14.62 59.59 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.18 1.392 . . . . 0.0 112.759 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 3.6 t -84.98 -17.56 37.24 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.712 -0.617 . . . . 0.0 110.965 169.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -92.57 -23.66 18.98 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 118.083 0.401 . . . . 0.0 112.077 169.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 50.9 mt -118.12 91.78 40.97 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 124.38 1.072 . . . . 0.0 109.39 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.54 132.61 52.86 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.778 2.318 . . . . 0.0 112.657 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.5 tttm 105.77 -18.05 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 130.281 3.432 . . . . 0.0 115.271 169.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.436 HD21 ' CD2' ' A' ' 169' ' ' PHE 0.396 0.0 OUTLIER -75.27 164.35 26.54 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 120.568 1.531 . . . . 0.0 112.2 176.61 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.435 ' O ' HD23 ' A' ' 189' ' ' LEU . 37.7 p -129.13 176.41 7.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 104.301 -2.481 . . . . 0.0 104.301 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.553 HG22 ' HB2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -155.06 127.87 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 128.333 2.653 . . . . 0.0 108.84 -168.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.61 154.29 16.89 Favored Glycine 0 N--CA 1.47 0.965 0 C-N-CA 124.563 1.078 . . . . 0.0 111.518 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -94.89 85.82 4.5 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.125 0.964 . . . . 0.0 109.213 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 12.0 tp -57.75 138.24 55.73 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 168.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 59.8 p -155.36 -150.84 0.32 Allowed 'General case' 0 CA--C 1.546 0.801 0 O-C-N 120.732 -1.23 . . . . 0.0 113.811 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.6 -32.85 71.82 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.835 1.654 . . . . 0.0 114.032 -169.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -93.08 -168.65 1.98 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.639 1.576 . . . . 0.0 113.274 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 78.4 p -123.82 -16.57 6.61 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -175.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 71.1 p -65.49 -28.69 69.38 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 119.855 -1.778 . . . . 0.0 111.668 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -62.15 -37.71 86.23 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 118.123 -0.941 . . . . 0.0 113.433 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . 0.266 14.7 p -69.15 -47.88 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 121.272 1.851 . . . . 0.0 111.12 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -79.86 -43.14 22.83 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.561 -1.337 . . . . 0.0 113.854 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -78.98 6.51 9.12 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 121.584 1.993 . . . . 0.0 113.183 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 92.4 mt -108.0 -26.99 10.42 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.302 1.441 . . . . 0.0 108.751 169.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 57.2 mt -66.02 -42.22 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 166.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -62.39 -48.38 79.97 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.863 169.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -78.03 17.47 0.6 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 122.548 1.166 . . . . 0.0 114.022 -172.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -131.27 -8.3 3.78 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.826 2.05 . . . . 0.0 111.514 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -95.01 -39.64 10.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.558 1.943 . . . . 0.0 106.254 168.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 4.8 m -24.87 81.48 0.0 OUTLIER 'General case' 0 C--N 1.347 0.476 1 C-N-CA 132.611 4.364 . . . . 0.0 115.667 169.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 6.3 mtmm 171.76 -43.56 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 130.406 3.482 . . . . 0.0 114.174 168.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 C--O 1.267 2.01 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -170.751 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -101.24 157.36 16.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.798 1.639 . . . . 0.0 111.11 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.9 p -71.84 140.29 49.29 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.2 t -137.76 137.28 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 126.228 1.811 . . . . 0.0 109.297 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -110.71 115.55 29.76 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 168.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -103.32 116.21 32.02 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.065 0.46 . . . . 0.0 110.163 169.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -105.72 103.04 12.46 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 123.919 1.819 . . . . 0.0 109.903 170.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -83.42 114.27 21.34 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 112.515 -2.13 . . . . 0.0 112.044 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.64 HD12 HG21 ' A' ' 92' ' ' VAL . 4.4 tt -114.42 124.12 51.15 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.795 0.838 . . . . 0.0 111.714 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.3 mtp -104.2 138.37 40.77 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 115.352 1.612 . . . . 0.0 115.352 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.58 114.5 3.94 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.488 1.518 . . . . 0.0 109.66 169.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.8 mp -106.96 24.12 13.29 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 128.288 2.635 . . . . 0.0 112.705 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.0 p -68.19 162.57 24.61 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.297 -1.502 . . . . 0.0 113.078 171.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.71 -22.09 63.72 Favored Glycine 0 N--CA 1.476 1.313 0 O-C-N 120.981 -1.074 . . . . 0.0 114.398 -177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.1 m -59.9 -23.65 63.65 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 118.256 1.028 . . . . 0.0 113.468 169.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.25 -1.37 57.15 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -169.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -69.56 142.51 53.59 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 122.46 2.391 . . . . 0.0 109.103 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.98 -54.7 4.03 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -169.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -62.74 -24.11 67.52 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.659 0.784 . . . . 0.0 111.149 169.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.0 tp -49.17 -47.27 46.0 Favored 'General case' 0 C--O 1.217 -0.643 0 C-N-CA 125.616 1.566 . . . . 0.0 110.726 176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 t -56.02 -47.33 78.03 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.864 0.756 . . . . 0.0 111.882 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -59.97 -42.87 95.09 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 120.937 -1.102 . . . . 0.0 111.141 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.8 p -86.23 11.93 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.542 1.137 . . . . 0.0 113.129 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -111.05 -47.22 3.23 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.578 1.551 . . . . 0.0 109.4 174.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.2 t -61.0 -44.56 97.25 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 169.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.407 ' CD2' HG11 ' A' ' 170' ' ' VAL . 25.6 tp -76.26 89.91 3.14 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 123.93 1.824 . . . . 0.0 107.591 169.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 157.82 -46.02 0.47 Allowed Glycine 0 C--N 1.305 -1.148 0 CA-C-N 110.011 -3.268 . . . . 0.0 110.055 168.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -71.37 -29.51 65.04 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 124.375 1.07 . . . . 0.0 110.65 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.23 -30.41 30.78 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 117.394 -1.288 . . . . 0.0 112.012 169.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -51.63 69.15 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 120.098 1.317 . . . . 0.0 107.933 173.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 63' ' ' SER . 13.0 tp -44.97 -76.41 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.938 2.095 . . . . 0.0 112.944 172.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . 0.291 0.0 OUTLIER -71.9 -21.45 61.63 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -168.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.47 -48.0 36.97 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.377 0.989 . . . . 0.0 111.807 170.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.55 -36.24 81.98 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 121.536 -0.728 . . . . 0.0 110.812 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -68.19 -16.27 63.92 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -87.01 -38.52 16.5 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.429 0.692 . . . . 0.0 111.734 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.7 tp -77.59 -28.22 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 118.435 0.561 . . . . 0.0 112.202 171.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.1 t -140.98 127.09 19.51 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -86.87 -6.89 58.65 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.277 1.031 . . . . 0.0 112.994 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.9 p -108.78 55.13 0.64 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.187 1.395 . . . . 0.0 110.219 169.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.6 83.52 0.36 Allowed Glycine 0 C--N 1.345 1.035 0 C-N-CA 128.97 3.176 . . . . 0.0 108.866 -171.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -80.78 137.55 36.24 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.692 1.597 . . . . 0.0 108.433 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.49 HD12 ' CE1' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -120.33 138.25 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.613 0.765 . . . . 0.0 109.445 -173.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -134.86 159.2 23.85 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 125.57 1.557 . . . . 0.0 111.739 -178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -140.56 128.46 21.91 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -169.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -131.92 151.71 19.91 Favored Glycine 0 C--N 1.342 0.868 0 C-N-CA 124.973 1.273 . . . . 0.0 113.493 176.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.4 t -116.57 140.5 49.31 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.531 1.933 . . . . 0.0 111.071 173.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.418 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -138.17 147.23 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.173 0.989 . . . . 0.0 110.944 169.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.418 ' N ' HD13 ' A' ' 48' ' ' ILE . 0.7 OUTLIER -132.83 -60.26 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 118.314 0.506 . . . . 0.0 109.811 167.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 161.78 -34.64 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 1 C-N-CA 131.72 4.008 . . . . 0.0 107.525 -176.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 61.1 mtt -46.12 -51.68 13.5 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.668 1.587 . . . . 0.0 110.806 169.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.9 p -165.75 178.76 6.38 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 128.067 2.547 . . . . 0.0 110.37 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -111.13 125.08 53.4 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 102.179 -3.267 . . . . 0.0 102.179 165.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -121.01 122.37 39.96 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.991 0.9 . . . . 0.0 110.481 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 46.8 t60 -76.68 126.97 31.9 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.724 168.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.35 -51.86 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 121.703 -0.623 . . . . 0.0 110.896 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 33.3 tp -129.96 121.0 25.71 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.719 0.808 . . . . 0.0 111.13 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.89 149.34 36.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.078 0.951 . . . . 0.0 111.707 170.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.3 mt -49.51 112.79 0.7 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.367 1.067 . . . . 0.0 110.795 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 t -143.46 166.42 24.82 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.576 1.15 . . . . 0.0 112.386 -174.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.05 -7.43 51.84 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.665 1.986 . . . . 0.0 113.244 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -80.34 77.88 7.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 125.466 2.555 . . . . 0.0 108.597 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.489 ' HA ' HD11 ' A' ' 31' ' ' LEU . 30.3 p -63.46 -47.68 80.82 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 129.549 3.139 . . . . 0.0 110.996 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.1 t -61.26 -15.92 40.09 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.37 1.468 . . . . 0.0 111.713 170.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -89.32 -49.5 6.68 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.454 -0.778 . . . . 0.0 110.667 174.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.49 ' CE1' HD12 ' A' ' 43' ' ' ILE . 42.6 t80 -55.31 -35.55 65.24 Favored 'General case' 0 C--O 1.223 -0.334 0 O-C-N 121.301 -0.874 . . . . 0.0 112.017 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -75.82 -23.38 55.78 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.82 -0.55 . . . . 0.0 111.537 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -75.85 -43.02 47.86 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 169.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -71.71 -33.09 68.47 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -169.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.9 -49.08 66.69 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 169.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.7 mtp180 -70.65 -18.99 62.84 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.503 1.298 . . . . 0.0 114.503 -170.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -74.3 -23.38 59.08 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 172.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -63.44 144.94 56.55 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -168.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.7 tp -127.4 138.69 53.06 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.33 2.252 . . . . 0.0 108.69 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.2 m -77.56 154.07 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-O 120.941 0.401 . . . . 0.0 111.881 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.5 p -100.45 -124.88 0.17 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.608 1.563 . . . . 0.0 111.606 175.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.51 144.54 6.42 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.592 1.092 . . . . 0.0 114.261 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -156.37 153.67 29.31 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.286 1.435 . . . . 0.0 112.221 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.73 -50.19 65.71 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.916 1.686 . . . . 0.0 113.41 -176.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.84 137.7 42.02 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.882 0.873 . . . . 0.0 111.715 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 t -70.24 -30.87 2.05 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-O 115.725 -2.084 . . . . 0.0 115.056 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.95 141.22 26.51 Favored 'Trans proline' 0 C--N 1.358 1.055 0 CA-C-N 123.027 2.117 . . . . 0.0 112.145 174.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -97.46 158.53 15.43 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.71 1.204 . . . . 0.0 110.803 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.22 28.85 2.89 Favored Glycine 0 N--CA 1.48 1.599 0 O-C-N 120.653 -1.28 . . . . 0.0 114.623 174.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.24 -40.36 70.79 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.244 1.817 . . . . 0.0 111.194 -172.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.08 -25.32 68.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 117.572 -1.204 . . . . 0.0 113.095 -174.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -78.32 -31.27 48.66 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.033 1.288 . . . . 0.0 113.011 171.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.582 ' HB1' HD11 ' A' ' 9' ' ' LEU . . . -67.15 -45.89 75.7 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.711 -1.243 . . . . 0.0 111.574 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.531 HG23 HD11 ' A' ' 108' ' ' LEU . 7.3 p -58.71 -29.89 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 112.727 0.639 . . . . 0.0 112.727 177.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.634 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.3 t -61.61 -60.35 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.125 0.97 . . . . 0.0 109.952 174.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -67.22 -38.05 84.63 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.698 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.64 HG21 HD12 ' A' ' 9' ' ' LEU . 77.3 t -57.11 -37.41 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 119.606 1.094 . . . . 0.0 112.114 173.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.97 -44.74 65.38 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.636 1.107 . . . . 0.0 113.756 176.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.634 HD12 ' O ' ' A' ' 90' ' ' VAL . 3.3 mt -91.74 -20.22 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -169.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 74.4 m -79.74 51.34 1.28 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 120.404 -1.435 . . . . 0.0 111.407 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 7.6 mp -49.47 -42.64 43.8 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.924 1.69 . . . . 0.0 111.177 -174.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -74.66 -22.62 76.88 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.346 0.974 . . . . 0.0 114.39 -174.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -105.69 -34.65 7.65 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.37 1.085 . . . . 0.0 112.594 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 21.8 mm -70.25 -38.23 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.959 0.8 . . . . 0.0 110.446 169.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.64 27.37 9.78 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.39 1.472 . . . . 0.0 114.591 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 43.2 m95 -59.93 116.57 4.23 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.959 1.38 . . . . 0.0 112.651 -175.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -90.65 173.96 7.76 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.243 2.617 . . . . 0.0 110.352 174.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -87.52 20.16 3.03 Favored 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -170.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.36 -119.56 0.96 Allowed Glycine 0 C--N 1.346 1.124 0 C-N-CA 124.528 1.061 . . . . 0.0 111.043 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.9 m -116.33 130.46 56.78 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.612 1.565 . . . . 0.0 107.051 170.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.46 132.95 53.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -171.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.36 111.01 9.24 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -167.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.575 HD13 HD13 ' A' ' 110' ' ' LEU . 1.5 tm? -105.85 98.04 7.78 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.082 0.953 . . . . 0.0 109.711 -169.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.3 t -101.81 118.67 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.575 HD13 HD13 ' A' ' 108' ' ' LEU . 6.2 mp -111.37 131.92 54.82 Favored 'General case' 0 CA--C 1.502 -0.9 0 O-C-N 124.245 0.966 . . . . 0.0 109.168 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 26.1 t -116.53 129.63 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 O-C-N 125.531 1.77 . . . . 0.0 111.159 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.7 t -152.43 -171.45 3.93 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 124.347 1.03 . . . . 0.0 109.515 169.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -140.43 2.86 1.88 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.68 -156.43 0.61 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.017 0.927 . . . . 0.0 110.845 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.91 166.53 0.98 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.816 2.046 . . . . 0.0 114.375 -176.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -130.27 146.69 51.9 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.426 1.491 . . . . 0.0 110.507 170.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -76.94 141.77 40.33 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.007 0.432 . . . . 0.0 111.592 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.64 HD21 HG23 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -111.74 173.3 6.42 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.625 1.97 . . . . 0.0 109.533 177.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.52 ' H ' HD22 ' A' ' 118' ' ' LEU . . . -48.7 142.59 5.99 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.117 -0.989 . . . . 0.0 111.519 169.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.0 mttm 83.27 -16.52 0.56 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 129.511 3.124 . . . . 0.0 112.875 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.05 -32.08 73.62 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.239 1.381 . . . . 0.0 113.05 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -78.23 6.33 8.41 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 175.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.9 t -60.21 -31.19 69.93 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 120.022 1.283 . . . . 0.0 112.507 170.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.64 -19.26 61.47 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 171.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -85.53 15.2 47.55 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 125.494 1.521 . . . . 0.0 111.916 169.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.348 13.9 t 44.37 54.54 6.18 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 128.869 2.868 . . . . 0.0 112.504 -170.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.1 ttp180 -126.68 106.38 9.35 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.559 1.544 . . . . 0.0 109.907 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -112.66 -25.52 9.07 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 115.891 1.812 . . . . 0.0 115.891 -169.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -75.17 129.49 37.6 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.53 1.514 . . . . 0.0 110.829 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.6 t -68.31 167.61 14.11 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.925 1.29 . . . . 0.0 111.545 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.3 m -66.16 135.72 54.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.579 0.752 . . . . 0.0 112.495 172.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -83.15 -17.72 41.93 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 121.027 -1.046 . . . . 0.0 113.488 172.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.91 18.19 77.35 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.6 -1.111 . . . . 0.0 114.304 -178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 20.8 mtp-105 -94.49 169.85 9.91 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.842 1.257 . . . . 0.0 112.588 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.21 137.59 43.18 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.409 1.084 . . . . 0.0 110.45 169.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -145.94 44.91 1.26 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.505 1.522 . . . . 0.0 112.237 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.1 tt -118.72 132.23 56.15 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.076 0.95 . . . . 0.0 110.58 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -118.77 -75.61 0.58 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.649 1.179 . . . . 0.0 111.239 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -97.98 28.22 4.08 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.826 2.05 . . . . 0.0 112.792 -177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 95.51 -18.06 58.12 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.627 1.584 . . . . 0.0 113.227 -174.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 14.9 mmt -89.45 143.11 27.08 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.743 1.217 . . . . 0.0 112.495 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -71.94 91.22 1.18 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 168.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -55.92 -43.15 77.07 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.548 1.139 . . . . 0.0 112.304 -171.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.4 p -81.28 7.07 12.31 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -174.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.16 -15.42 0.35 Allowed 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 171.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -103.2 -8.64 40.98 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.909 1.719 . . . . 0.0 115.26 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -114.53 -61.95 0.03 OUTLIER Pre-proline 0 CA--C 1.55 0.964 0 CA-C-N 119.876 1.838 . . . . 0.0 111.84 -172.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -77.4 145.66 24.0 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.86 2.373 . . . . 0.0 113.199 168.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -66.28 171.11 5.08 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 128.305 2.642 . . . . 0.0 111.565 169.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -60.61 156.19 17.14 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 174.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -65.6 163.24 16.61 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 25.4 p -93.85 152.93 18.54 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 168.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.64 HG23 HD21 ' A' ' 118' ' ' LEU . 58.8 t -62.78 -30.6 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 O-C-N 120.621 -1.299 . . . . 0.0 111.231 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.62 -42.69 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.987 0.915 . . . . 0.0 111.061 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -73.47 -26.65 61.01 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.557 -0.735 . . . . 0.0 110.899 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 17.4 mt -63.74 -54.37 36.5 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 168.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.82 -45.75 82.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.064 1.346 . . . . 0.0 113.124 -172.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 75.7 m -63.95 -51.15 65.73 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.945 0.498 . . . . 0.0 112.009 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.487 ' HG2' HD11 ' A' ' 94' ' ' ILE . 2.1 tppp? -62.7 -38.66 91.29 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.273 -0.892 . . . . 0.0 112.162 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.8 tp -60.26 -40.33 89.95 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.353 1.061 . . . . 0.0 112.647 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.66 -24.85 63.68 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.098 0.959 . . . . 0.0 113.311 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -75.92 -44.07 42.0 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.184 0.993 . . . . 0.0 110.819 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -78.67 -16.35 57.4 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 175.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 60.8 33.26 20.11 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.987 2.115 . . . . 0.0 113.024 176.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 89.2 mt -85.59 144.24 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.122 1.369 . . . . 0.0 109.101 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -104.69 106.24 53.93 Favored Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 120.714 1.597 . . . . 0.0 113.791 171.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 31.3 Cg_exo -75.13 137.62 21.68 Favored 'Trans proline' 0 CA--C 1.537 0.636 1 C-N-CA 125.342 4.028 . . . . 0.0 115.231 169.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.5 mt -130.98 113.44 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -75.62 79.54 2.61 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.893 0.854 . . . . 0.0 111.682 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.407 HG11 ' CD2' ' A' ' 26' ' ' LEU . 39.6 t -66.52 104.51 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-O 122.554 1.169 . . . . 0.0 112.151 169.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 33.3 m -142.32 164.51 32.88 Favored Pre-proline 0 N--CA 1.488 1.44 0 O-C-N 120.321 -1.487 . . . . 0.0 110.776 -169.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -85.21 165.74 11.08 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.825 2.35 . . . . 0.0 111.81 -169.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.3 t -50.41 -38.84 45.09 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.772 1.229 . . . . 0.0 113.09 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -63.08 -21.28 66.06 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 3.5 tpt -128.23 5.74 5.83 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -170.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 89.4 t -59.43 -35.96 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 120.015 1.28 . . . . 0.0 111.537 -173.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.27 -0.64 50.51 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -169.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 t -92.82 -36.54 12.8 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.796 0.808 . . . . 0.0 109.46 168.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -74.89 -33.94 62.13 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 124.172 0.989 . . . . 0.0 110.342 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -70.88 -15.0 62.59 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 119.293 0.951 . . . . 0.0 111.96 169.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -84.85 -28.25 26.17 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 120.32 -1.487 . . . . 0.0 111.249 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 43.3 tp -77.27 -27.16 53.06 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.314 2.246 . . . . 0.0 110.074 174.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.48 -7.97 58.02 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.11 1.764 . . . . 0.0 112.531 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 6.7 t -105.79 -15.82 14.84 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.239 0.616 . . . . 0.0 110.685 168.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -80.83 -37.37 30.17 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 118.313 0.506 . . . . 0.0 111.009 169.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 25.3 mt -104.13 114.9 63.97 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 124.325 1.05 . . . . 0.0 108.779 175.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.15 140.59 37.82 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.667 2.245 . . . . 0.0 112.432 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 47.2 tptt 82.82 -8.35 1.18 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 129.438 3.095 . . . . 0.0 113.811 170.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.5 mt -67.81 166.14 16.05 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.57 0.748 . . . . 0.0 111.883 170.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.6 p -138.59 -145.51 0.19 Allowed 'General case' 0 C--N 1.344 0.352 0 CA-C-O 122.905 1.336 . . . . 0.0 108.603 168.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.3 pt -157.02 156.86 4.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 128.798 2.839 . . . . 0.0 109.419 -167.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -134.04 153.24 20.84 Favored Glycine 0 N--CA 1.465 0.631 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 169.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -100.63 93.68 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 172.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 15.3 tp -54.02 131.97 41.57 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.77 169.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 9.6 t -161.48 -167.81 1.84 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.847 1.259 . . . . 0.0 109.772 170.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -65.62 -23.95 66.94 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.422 -0.799 . . . . 0.0 112.098 171.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -93.76 141.44 28.5 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.74 1.216 . . . . 0.0 111.418 169.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 27.4 p -103.91 0.7 30.44 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.186 1.794 . . . . 0.0 113.543 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.4 m -61.14 -48.87 79.63 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.447 1.099 . . . . 0.0 112.009 -168.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -63.73 -46.73 84.05 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 122.099 -0.375 . . . . 0.0 111.514 -172.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.17 -45.7 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 121.231 -0.918 . . . . 0.0 112.139 176.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.32 -29.52 70.27 Favored 'General case' 0 C--O 1.22 -0.48 0 O-C-N 121.23 -0.918 . . . . 0.0 112.32 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 27.0 mm100 -66.59 -6.92 17.04 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.426 -1.421 . . . . 0.0 114.477 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.3 mp -107.81 -28.32 9.73 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.419 1.488 . . . . 0.0 110.035 176.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 18.5 mm -67.25 -43.23 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 168.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -66.38 -42.35 88.07 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.774 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -67.01 -38.34 85.77 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.739 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -71.69 -31.1 66.41 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.658 0.663 . . . . 0.0 112.072 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -62.91 -42.51 99.81 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.179 0.591 . . . . 0.0 111.456 172.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 11.1 t -64.77 -24.89 67.7 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -80.35 -21.48 42.38 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 12.1 tp . . . . . 0 CA--C 1.563 1.474 0 C-N-CA 124.633 1.173 . . . . 0.0 109.871 173.087 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 78.34 149.16 0.1 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 128.471 2.709 . . . . 0.0 112.176 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 p -71.3 117.34 12.71 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.563 1.145 . . . . 0.0 113.527 -173.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.27 127.52 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.969 1.308 . . . . 0.0 108.79 169.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -109.87 116.21 31.24 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -110.37 129.22 55.8 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.671 0.748 . . . . 0.0 111.747 173.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -110.59 113.56 26.27 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 123.418 1.58 . . . . 0.0 109.492 169.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -91.15 104.6 17.15 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 126.482 1.913 . . . . 0.0 112.222 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.9 tp -101.22 116.72 33.46 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.0 0.92 . . . . 0.0 112.669 177.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 59.4 mtp -97.69 141.17 31.04 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.515 1.526 . . . . 0.0 114.047 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.97 118.43 5.38 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 168.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 mp -106.91 22.99 15.1 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.799 1.64 . . . . 0.0 113.899 -169.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.0 p -78.33 159.49 28.37 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 120.2 -1.563 . . . . 0.0 113.522 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.68 -26.34 59.92 Favored Glycine 0 N--CA 1.476 1.313 0 N-CA-C 115.918 1.127 . . . . 0.0 115.918 -168.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 t -59.7 -31.25 69.41 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 117.738 0.769 . . . . 0.0 111.969 171.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.97 3.15 8.81 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.696 1.598 . . . . 0.0 114.577 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -57.37 -47.97 80.26 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 121.128 1.786 . . . . 0.0 112.762 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.26 -32.87 68.65 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -78.55 -13.21 59.94 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.7 tp -59.12 -43.05 91.93 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.724 1.21 . . . . 0.0 111.421 -173.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 t -57.24 -45.57 83.82 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.655 0.782 . . . . 0.0 111.603 171.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -63.91 -47.25 81.31 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.811 -1.181 . . . . 0.0 111.222 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 p -74.22 -32.97 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -72.13 -40.88 67.77 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.839 1.199 . . . . 0.0 111.198 173.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.7 m -62.55 -42.5 99.58 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.871 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.458 HD22 HD23 ' A' ' 194' ' ' LEU . 27.3 tp -59.3 -26.87 65.34 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.513 1.051 . . . . 0.0 112.714 174.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.06 -44.86 6.14 Favored Glycine 0 N--CA 1.471 1.015 0 O-C-N 120.824 -1.172 . . . . 0.0 110.74 -168.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 t -70.66 -34.82 72.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.784 -1.208 . . . . 0.0 109.523 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -70.07 -33.16 71.55 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 122.179 -0.326 . . . . 0.0 111.273 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.35 -61.47 2.21 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.17 -31.25 64.12 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.396 1.453 . . . . 0.0 113.844 -169.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . 0.282 0.0 OUTLIER -65.42 -28.91 69.58 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 122.268 2.304 . . . . 0.0 112.23 171.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.72 -53.74 10.86 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.725 0.693 . . . . 0.0 111.563 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.4 mt -65.61 -29.46 70.05 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.9 -1.125 . . . . 0.0 111.959 -173.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -66.19 -26.29 67.33 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.874 0.87 . . . . 0.0 113.131 176.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . 0.278 10.2 pt-20 -86.22 -29.67 22.98 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 118.487 -0.768 . . . . 0.0 112.997 -176.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.83 -21.43 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-N 119.663 1.119 . . . . 0.0 112.12 168.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 74.6 m -132.41 106.1 7.68 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.826 0.851 . . . . 0.0 113.031 175.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -61.99 -33.23 73.93 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.684 0.793 . . . . 0.0 111.146 169.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -91.82 77.88 5.47 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.051 1.74 . . . . 0.0 109.167 169.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.05 88.11 0.18 Allowed Glycine 0 C--N 1.338 0.67 0 C-N-CA 127.34 2.4 . . . . 0.0 108.185 -169.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -94.68 141.31 28.77 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.54 1.136 . . . . 0.0 109.315 -169.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.9 tt -124.59 137.63 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.92 151.06 17.27 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 171.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -119.52 151.74 38.1 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.236 0.614 . . . . 0.0 111.596 -173.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -151.18 147.57 17.67 Favored Glycine 0 C--N 1.342 0.913 0 C-N-CA 124.005 0.812 . . . . 0.0 113.45 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.9 t -118.09 150.69 38.92 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.48 1.512 . . . . 0.0 110.95 175.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.15 148.25 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.126 1.371 . . . . 0.0 108.925 172.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.8 t -137.59 -77.04 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.889 0.875 . . . . 0.0 109.429 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -177.83 -23.51 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 130.695 3.598 . . . . 0.0 108.201 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 18.3 ttt -49.26 -49.04 45.22 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.742 1.617 . . . . 0.0 109.603 167.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 173.4 175.95 0.12 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 130.59 3.556 . . . . 0.0 110.156 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -91.37 130.8 37.17 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 104.721 -2.325 . . . . 0.0 104.721 166.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -121.68 120.33 34.39 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.653 0.781 . . . . 0.0 110.119 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -83.9 117.73 23.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.936 0.894 . . . . 0.0 110.817 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 82.4 mt -130.35 108.73 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.451 1.5 . . . . 0.0 107.0 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 58.5 tp 87.56 112.37 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 128.26 2.624 . . . . 0.0 111.212 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -76.55 158.85 30.84 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.397 1.879 . . . . 0.0 109.961 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.8 mt -52.7 112.97 0.93 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.974 1.261 . . . . 0.0 110.858 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.8 t -133.19 162.04 32.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.267 1.427 . . . . 0.0 112.474 -171.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.09 -7.22 33.26 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.169 1.787 . . . . 0.0 114.227 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.286 40.6 p-10 -92.2 84.29 5.21 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 125.921 2.772 . . . . 0.0 110.377 173.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.4 m -59.47 -43.26 93.28 Favored 'General case' 0 C--N 1.316 -0.875 1 C-N-CA 131.961 4.104 . . . . 0.0 109.842 177.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 63.8 p -60.86 -16.43 41.45 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.968 1.307 . . . . 0.0 112.599 170.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -89.55 -48.53 7.24 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.6 1.091 . . . . 0.0 111.251 175.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -50.39 -35.85 30.08 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.226 1.01 . . . . 0.0 112.059 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -73.03 -23.99 60.66 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.267 1.427 . . . . 0.0 111.508 -171.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.7 mtp85 -91.33 -26.06 19.11 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.538 1.535 . . . . 0.0 109.926 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.81 -37.64 20.52 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.73 -31.29 64.84 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.174 174.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -65.79 -39.83 91.35 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 120.092 1.315 . . . . 0.0 111.32 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -69.52 -12.12 61.39 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -63.45 114.33 3.82 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.479 1.036 . . . . 0.0 110.833 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.4 mt -106.37 161.12 14.85 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.016 0.927 . . . . 0.0 111.295 170.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.62 160.98 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.787 1.635 . . . . 0.0 114.1 -169.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.2 t -123.08 171.29 9.4 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.381 1.872 . . . . 0.0 111.012 169.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.38 152.5 17.56 Favored Glycine 0 N--CA 1.478 1.496 0 O-C-N 120.588 -1.32 . . . . 0.0 114.907 -173.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -146.3 157.38 43.79 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.925 1.69 . . . . 0.0 113.939 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 tp -83.54 -71.76 0.49 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.458 1.503 . . . . 0.0 109.724 169.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.76 148.04 40.77 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.641 1.176 . . . . 0.0 112.589 -170.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 m -59.45 -46.85 98.87 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-O 116.61 -1.662 . . . . 0.0 113.299 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -66.25 139.51 55.31 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.758 2.306 . . . . 0.0 113.174 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.37 164.52 13.82 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.003 1.321 . . . . 0.0 113.736 175.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.6 38.44 2.3 Favored Glycine 0 N--CA 1.475 1.242 0 C-N-CA 125.249 1.404 . . . . 0.0 116.582 -169.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.67 ' CG ' HD21 ' A' ' 110' ' ' LEU . 8.2 tp-100 -63.38 -38.45 91.19 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -168.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -83.92 -10.62 57.83 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -74.12 -46.86 39.99 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.991 1.269 . . . . 0.0 108.625 168.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.69 68.88 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.698 1.599 . . . . 0.0 112.058 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.2 p -54.78 -36.41 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 118.796 -0.621 . . . . 0.0 112.239 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.0 t -79.96 -38.9 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-O 116.36 -1.781 . . . . 0.0 111.687 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -52.18 -55.3 21.91 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 121.066 1.757 . . . . 0.0 109.001 172.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 73.5 t -52.49 -31.43 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.946 1.298 . . . . 0.0 113.157 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.09 -20.24 52.62 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.957 1.465 . . . . 0.0 114.957 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.78 -31.4 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -174.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.472 ' HB3' ' SG ' ' A' ' 135' ' ' CYS . 6.2 p -79.61 67.24 5.32 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 121.846 2.112 . . . . 0.0 112.719 176.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.9 tp -42.58 -41.08 2.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 128.944 2.898 . . . . 0.0 111.757 172.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.95 -22.02 75.12 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 118.383 -1.231 . . . . 0.0 114.935 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -102.06 -37.15 8.3 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.034 1.417 . . . . 0.0 112.411 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.0 mm -69.39 -39.6 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.37 22.36 29.64 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.233 1.397 . . . . 0.0 113.541 174.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -59.24 145.58 42.36 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.002 1.401 . . . . 0.0 110.628 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -125.48 -167.22 1.66 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.32 1.048 . . . . 0.0 111.748 171.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -74.49 9.97 1.52 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -168.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.3 -136.62 2.42 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-N 121.365 1.893 . . . . 0.0 110.518 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -104.03 142.02 35.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.69 1.596 . . . . 0.0 107.792 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -126.22 117.81 23.86 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -167.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -114.5 128.14 56.18 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 123.168 0.587 . . . . 0.0 111.91 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.3 tt -107.18 95.61 5.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 169.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.43 HG21 HD11 ' A' ' 205' ' ' ILE . 35.1 t -83.74 124.28 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 173.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.67 HD21 ' CG ' ' A' ' 85' ' ' GLN . 10.2 tt -122.92 125.82 46.06 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -170.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.411 HG22 HG23 ' A' ' 170' ' ' VAL . 37.3 t -116.16 134.33 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 O-C-N 124.433 1.083 . . . . 0.0 111.697 -175.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.0 t -145.76 -172.42 3.9 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.043 169.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -145.03 5.77 1.14 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.514 1.526 . . . . 0.0 114.872 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -163.01 176.35 10.21 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.764 2.026 . . . . 0.0 109.184 169.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -61.49 -177.91 0.11 Allowed 'General case' 0 CA--C 1.551 0.992 0 N-CA-C 115.456 1.651 . . . . 0.0 115.456 -171.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -127.54 160.2 32.28 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.815 1.646 . . . . 0.0 113.794 -169.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -77.57 128.11 33.6 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.305 0.642 . . . . 0.0 110.836 169.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.2 mp -94.68 165.74 12.35 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.953 1.301 . . . . 0.0 110.119 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.09 146.23 39.36 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.634 -0.666 . . . . 0.0 111.171 169.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 75.05 -11.84 1.02 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 128.83 2.852 . . . . 0.0 114.268 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -66.21 -23.26 66.4 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 120.303 1.41 . . . . 0.0 112.245 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -70.99 1.48 5.6 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 175.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.1 t -56.78 -32.01 65.22 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.279 1.032 . . . . 0.0 111.815 169.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -61.16 -46.99 88.27 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.345 1.058 . . . . 0.0 112.273 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -90.23 21.73 30.01 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.1 1.333 . . . . 0.0 114.03 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.317 5.6 t 56.18 39.79 30.22 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 127.8 2.44 . . . . 0.0 114.444 173.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 59.9 mtt85 -106.49 117.3 33.68 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.459 1.104 . . . . 0.0 109.121 169.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -99.58 -49.68 4.32 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -66.14 119.32 11.23 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.773 0.715 . . . . 0.0 111.9 -170.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.442 ' HA ' ' HB3' ' A' ' 149' ' ' ASP . 8.9 t -74.58 156.51 36.72 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.656 0.782 . . . . 0.0 111.91 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.2 t -62.0 141.24 58.17 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 122.012 0.911 . . . . 0.0 113.249 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -78.13 -9.83 59.35 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.048 1.739 . . . . 0.0 112.926 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.29 0.64 90.23 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.397 -1.224 . . . . 0.0 115.527 174.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.7 mtt85 -111.12 172.13 7.06 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.216 1.508 . . . . 0.0 112.597 175.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 95' ' ' CYS . 34.8 t -75.92 143.48 41.63 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -168.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -132.99 52.74 2.06 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.771 2.028 . . . . 0.0 111.317 175.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.56 132.32 46.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.896 1.678 . . . . 0.0 109.601 -175.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -145.58 -49.35 0.23 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.216 1.007 . . . . 0.0 112.153 172.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -77.79 -8.51 58.11 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 106.93 -6.58 37.5 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.236 1.398 . . . . 0.0 113.706 -169.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.2 mtt -130.71 143.56 50.82 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.329 1.452 . . . . 0.0 112.657 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -70.4 89.02 0.67 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.823 1.649 . . . . 0.0 112.618 -173.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -16.1 61.05 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -170.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.7 m -89.87 -5.54 56.73 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -28.68 14.16 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.594 1.088 . . . . 0.0 113.761 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.16 -16.87 79.09 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 117.448 -1.751 . . . . 0.0 115.501 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -128.54 -67.84 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.928 0 CA-C-N 120.307 2.053 . . . . 0.0 113.677 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -50.56 141.9 32.49 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 CA-C-N 123.509 2.289 . . . . 0.0 115.536 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.442 ' HB3' ' HA ' ' A' ' 130' ' ' THR . 26.0 t0 -68.42 178.76 1.86 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.117 2.167 . . . . 0.0 112.73 172.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -69.58 163.85 24.56 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.66 1.219 . . . . 0.0 112.116 169.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -88.09 126.55 35.17 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 -176.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 68.8 m -63.8 152.61 38.99 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.762 -0.586 . . . . 0.0 110.582 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.523 HG13 HD11 ' A' ' 186' ' ' ILE . 72.0 t -53.97 -32.96 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 O-C-N 121.681 -0.637 . . . . 0.0 111.873 -177.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.86 -45.42 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.871 1.269 . . . . 0.0 112.52 173.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 12.6 tp-100 -71.61 -35.95 70.63 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.905 0.882 . . . . 0.0 111.169 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.431 HD12 HG12 ' A' ' 186' ' ' ILE . 1.5 tm? -59.75 -52.99 63.1 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 169.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.17 -43.09 96.09 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.9 p -67.65 -38.79 84.31 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.497 -0.752 . . . . 0.0 112.348 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.484 ' HA ' ' HE2' ' A' ' 159' ' ' LYS . 0.2 OUTLIER -70.96 -35.5 72.2 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.682 -1.261 . . . . 0.0 112.863 -179.348 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 97.3 mt -60.89 -41.66 96.45 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.805 0.842 . . . . 0.0 111.892 170.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.21 -34.25 75.91 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.44 1.096 . . . . 0.0 113.17 -177.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -80.91 -39.47 26.21 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.646 0.778 . . . . 0.0 111.753 -174.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -87.93 -6.23 58.15 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 171.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 31.1 m120 58.19 56.2 4.68 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.865 1.666 . . . . 0.0 111.52 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 51.3 mm -94.55 137.61 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.259 1.424 . . . . 0.0 109.716 171.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -107.21 109.4 62.85 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 119.843 1.201 . . . . 0.0 107.83 168.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -73.06 148.83 45.48 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.205 1.937 . . . . 0.0 112.215 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.419 HG22 HG13 ' A' ' 170' ' ' VAL . 4.5 mp -131.27 99.63 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 170.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -73.78 78.37 1.58 Allowed 'General case' 0 N--CA 1.465 0.303 0 O-C-N 121.498 -0.751 . . . . 0.0 111.937 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.702 HG11 HG13 ' A' ' 201' ' ' VAL 0.361 3.8 m -79.27 116.15 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 123.431 1.586 . . . . 0.0 113.389 174.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 28.6 m -144.23 155.94 57.86 Favored Pre-proline 0 N--CA 1.478 0.928 0 CA-C-N 114.4 -1.273 . . . . 0.0 111.181 -169.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -78.95 153.25 25.28 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.488 2.792 . . . . 0.0 111.307 -172.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 77.1 p -37.45 -49.34 1.02 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.315 2.246 . . . . 0.0 115.061 -169.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -54.1 -38.32 65.22 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.918 1.287 . . . . 0.0 114.094 -174.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.9 ptm -103.31 -4.47 24.19 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 42.4 t -54.84 -45.26 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.4 1.0 . . . . 0.0 109.85 -171.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . 0.3 0.0 OUTLIER -76.02 -3.89 38.25 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 -170.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 82.9 m -92.75 -34.24 13.98 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.33 1.052 . . . . 0.0 110.677 168.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -74.41 -25.83 59.71 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.997 -1.064 . . . . 0.0 110.183 171.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -64.6 -25.34 67.92 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.783 -1.198 . . . . 0.0 110.07 168.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -79.82 -22.84 42.54 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 120.1 -1.625 . . . . 0.0 110.517 176.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 18.4 tp -82.22 -26.13 33.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.308 2.243 . . . . 0.0 109.377 176.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 1.7 t -76.11 -13.56 60.2 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.381 -0.825 . . . . 0.0 112.976 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . 0.328 0.0 OUTLIER -99.08 -20.55 16.64 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 118.753 -0.642 . . . . 0.0 111.026 169.549 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -76.91 -31.06 56.44 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.17 0.895 . . . . 0.0 111.481 169.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.523 HD11 HG13 ' A' ' 153' ' ' VAL . 4.6 mp -115.92 108.89 45.75 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.046 0.938 . . . . 0.0 109.954 172.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.94 145.41 56.04 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 121.978 1.785 . . . . 0.0 111.255 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt 97.42 -20.58 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 130.557 3.543 . . . . 0.0 114.509 169.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.35 166.84 22.86 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.661 0.664 . . . . 0.0 110.721 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.4 p -125.17 -150.54 0.45 Allowed 'General case' 0 C--N 1.346 0.445 0 CA-C-O 122.926 1.346 . . . . 0.0 109.206 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 11.6 tt 179.08 131.21 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 126.668 1.987 . . . . 0.0 109.843 -167.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -126.2 160.35 20.6 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.592 1.091 . . . . 0.0 112.183 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -89.58 92.16 8.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 122.651 1.215 . . . . 0.0 107.824 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.458 HD23 HD22 ' A' ' 26' ' ' LEU . 2.6 tm? -64.26 123.57 19.47 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 113.594 -1.639 . . . . 0.0 108.51 169.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 91.1 p -162.64 -162.11 0.77 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.259 1.424 . . . . 0.0 110.437 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.44 -11.47 60.9 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 120.344 -1.472 . . . . 0.0 114.259 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -124.66 135.21 52.88 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.982 1.313 . . . . 0.0 111.499 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 34.4 p -89.94 -1.73 58.03 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.978 1.311 . . . . 0.0 113.82 -173.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 33.5 t -56.48 -42.33 78.06 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.335 1.454 . . . . 0.0 111.467 -169.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -57.39 -39.5 76.21 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.304 1.041 . . . . 0.0 111.85 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.702 HG13 HG11 ' A' ' 170' ' ' VAL . 88.4 t -78.76 -49.63 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.08 1.352 . . . . 0.0 111.405 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.59 -30.68 71.71 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 118.264 -0.874 . . . . 0.0 111.162 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -73.93 -1.7 20.8 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.652 1.569 . . . . 0.0 113.079 178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 88.4 mt -99.52 -39.7 8.2 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.526 1.531 . . . . 0.0 108.317 176.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.43 HD11 HG21 ' A' ' 109' ' ' VAL . 15.6 mt -74.74 -37.19 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -64.1 -35.75 81.78 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.931 0.492 . . . . 0.0 110.034 169.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -68.66 -36.63 78.81 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.387 173.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -73.11 -24.16 60.59 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.144 0.978 . . . . 0.0 112.167 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -70.27 -39.59 74.86 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.203 1.001 . . . . 0.0 110.365 168.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.5 t -70.35 -26.83 63.93 Favored 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 124.692 1.197 . . . . 0.0 113.545 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -75.04 -17.28 60.52 Favored 'General case' 0 C--O 1.265 1.898 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.5 tt . . . . . 0 CA--C 1.621 3.69 0 C-N-CA 126.217 1.807 . . . . 0.0 114.414 -176.401 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.7 t0 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.986 0.422 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -93.56 159.7 15.11 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.159 0.984 . . . . 0.0 112.075 174.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.7 t -66.09 124.67 23.21 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.428 -0.795 . . . . 0.0 110.254 169.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -122.91 147.52 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 126.524 1.93 . . . . 0.0 107.825 172.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -131.38 124.94 31.38 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.242 0.544 . . . . 0.0 109.93 169.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 mp -115.02 137.88 51.5 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -121.31 107.57 12.68 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 122.8 1.286 . . . . 0.0 110.705 173.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -80.64 103.12 10.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.778 2.031 . . . . 0.0 112.049 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -100.45 113.04 25.48 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.989 1.315 . . . . 0.0 110.588 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 87.3 mtp -97.82 147.05 24.81 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -94.06 124.4 7.86 Favored Glycine 0 CA--C 1.542 1.762 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 168.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.5 mp -115.22 29.39 8.05 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 125.332 1.453 . . . . 0.0 114.896 -170.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.557 ' HB3' HG13 ' A' ' 49' ' ' VAL . 19.5 p -88.95 169.96 11.09 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 120.207 -1.558 . . . . 0.0 113.172 -172.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.28 -19.27 63.98 Favored Glycine 0 N--CA 1.479 1.512 0 O-C-N 120.958 -1.089 . . . . 0.0 114.256 -171.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.5 p -72.26 -28.01 62.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.302 2.241 . . . . 0.0 113.456 169.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.25 -13.59 54.95 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.805 1.642 . . . . 0.0 114.333 -173.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -67.47 133.85 50.28 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 121.209 1.822 . . . . 0.0 108.962 169.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.43 -43.23 2.12 Favored Glycine 0 N--CA 1.474 1.195 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -168.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -76.8 -23.96 52.84 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.665 0.786 . . . . 0.0 111.189 168.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.6 tp -48.75 -50.94 31.52 Favored 'General case' 0 C--O 1.219 -0.541 0 C-N-CA 126.028 1.731 . . . . 0.0 110.944 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.1 p -55.14 -41.52 71.89 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.71 1.141 . . . . 0.0 112.609 177.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -61.04 -45.82 93.24 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.281 -0.887 . . . . 0.0 110.662 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.428 HG22 HG11 ' A' ' 111' ' ' VAL . 15.0 t -66.65 -38.71 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.155 0.582 . . . . 0.0 111.805 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -67.08 -51.26 56.62 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.378 0.671 . . . . 0.0 109.896 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.5 m -64.26 -38.21 90.25 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.181 -177.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.462 HD22 HD12 ' A' ' 194' ' ' LEU . 52.4 tp -59.39 -30.63 68.57 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.05 1.295 . . . . 0.0 111.982 174.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.13 -38.17 6.08 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 -168.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.2 m -67.03 -32.84 74.32 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.84 1.656 . . . . 0.0 110.009 169.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -76.51 -38.41 55.23 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.5 174.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.5 tt -65.4 -47.46 76.23 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.469 HD21 ' HA ' ' A' ' 63' ' ' SER . 2.6 tm? -48.55 -56.52 8.15 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 126.922 2.089 . . . . 0.0 113.083 176.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -82.71 -42.32 18.21 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -173.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.3 -34.88 72.83 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.555 1.07 . . . . 0.0 112.106 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.401 ' HA ' HG22 ' A' ' 37' ' ' ILE . 87.4 mt -81.96 -30.41 31.71 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -73.38 -1.63 18.95 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 169.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -91.71 -46.33 7.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.148 0.979 . . . . 0.0 110.718 169.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.401 HG22 ' HA ' ' A' ' 34' ' ' LEU . 10.9 tp -69.94 -30.94 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 118.957 0.798 . . . . 0.0 112.117 175.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.3 t -129.66 141.09 50.99 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -83.87 -14.85 50.12 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.884 1.273 . . . . 0.0 111.562 168.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 t -123.11 81.92 1.94 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.713 1.205 . . . . 0.0 109.822 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.84 79.78 0.28 Allowed Glycine 0 C--N 1.339 0.712 0 C-N-CA 126.874 2.178 . . . . 0.0 109.0 -170.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -82.42 132.14 35.21 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -170.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.404 HG21 HD23 ' A' ' 31' ' ' LEU . 10.9 tp -110.66 138.41 38.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.632 0.773 . . . . 0.0 110.238 -175.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.95 159.21 22.57 Favored Glycine 0 N--CA 1.468 0.768 0 C-N-CA 125.555 1.55 . . . . 0.0 112.088 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -138.08 128.33 26.01 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -169.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.98 159.18 25.99 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 124.688 1.137 . . . . 0.0 113.978 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.6 m -134.15 140.54 46.63 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.425 1.49 . . . . 0.0 111.94 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.488 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -147.18 146.98 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 121.121 -0.987 . . . . 0.0 112.556 177.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.557 HG13 ' HB3' ' A' ' 13' ' ' SER . 81.9 t -134.2 -80.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 126.105 1.762 . . . . 0.0 108.319 170.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.409 ' H ' ' H ' ' A' ' 51' ' ' MET 0.338 0.0 OUTLIER -168.45 -7.1 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.877 1 C-N-CA 132.862 4.465 . . . . 0.0 109.338 168.772 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.409 ' H ' ' H ' ' A' ' 50' ' ' ASN . 49.6 mtm -77.57 46.27 0.53 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.875 1.67 . . . . 0.0 107.399 166.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.351 3.2 t 52.12 -164.5 0.07 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 130.617 3.567 . . . . 0.0 114.057 -169.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -108.78 130.03 55.38 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.223 2.609 . . . . 0.0 109.33 -175.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -118.07 118.58 32.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.627 0.727 . . . . 0.0 111.142 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -84.62 114.12 21.76 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.075 1.35 . . . . 0.0 109.196 169.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.8 mm -107.67 -24.12 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.7 tp -146.91 120.33 9.03 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 120.018 1.281 . . . . 0.0 112.161 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -60.07 152.0 25.19 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.017 1.727 . . . . 0.0 112.566 172.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.81 120.49 4.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.366 1.066 . . . . 0.0 110.506 175.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.2 t -155.12 170.4 21.89 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.41 -5.05 40.68 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.314 2.246 . . . . 0.0 113.697 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -81.89 77.98 8.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 126.178 2.895 . . . . 0.0 108.312 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.469 ' HA ' HD21 ' A' ' 31' ' ' LEU . 34.5 p -69.69 -43.28 72.78 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 130.129 3.372 . . . . 0.0 111.891 -169.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.1 t -55.65 -33.59 64.22 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.462 1.105 . . . . 0.0 110.214 169.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . 0.302 6.2 pt20 -88.44 -33.52 17.82 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 118.887 -1.125 . . . . 0.0 112.848 -171.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -53.63 -34.56 58.96 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.601 0.637 . . . . 0.0 110.453 169.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -74.93 -34.42 62.11 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.523 0.729 . . . . 0.0 110.432 -176.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 89.0 mtt-85 -70.69 -38.66 73.72 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.162 0.985 . . . . 0.0 109.229 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.35 -30.21 42.56 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -174.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.95 -40.76 71.83 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 169.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -67.74 -30.87 70.45 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.204 -0.935 . . . . 0.0 112.39 -177.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -65.49 -31.9 73.22 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -55.21 140.85 37.41 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -168.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 mp -120.79 158.73 26.91 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.247 1.819 . . . . 0.0 110.569 -173.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.1 t -100.02 133.89 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.135 0.974 . . . . 0.0 110.881 -176.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.1 m -107.24 -156.97 0.6 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.481 1.512 . . . . 0.0 110.899 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -156.99 153.49 24.74 Favored Glycine 0 N--CA 1.478 1.466 0 O-C-N 119.874 -1.766 . . . . 0.0 116.291 -174.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.8 tptt -157.88 161.95 38.31 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.614 1.566 . . . . 0.0 112.475 169.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.5 mt -70.26 -47.64 60.41 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.941 1.696 . . . . 0.0 114.507 -169.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.84 137.89 42.15 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.438 0.695 . . . . 0.0 111.926 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.254 13.6 t -67.89 -41.14 26.78 Favored Pre-proline 0 CA--C 1.545 0.788 0 CA-C-O 115.816 -2.04 . . . . 0.0 113.975 173.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.15 150.29 82.06 Favored 'Trans proline' 0 C--N 1.36 1.132 0 CA-C-N 123.09 2.139 . . . . 0.0 111.924 170.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.43 ' H ' ' HA ' ' A' ' 116' ' ' PHE . 52.8 mtpt -121.93 160.28 25.14 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -171.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.07 19.07 28.27 Favored Glycine 0 N--CA 1.476 1.304 0 CA-C-O 118.175 -1.347 . . . . 0.0 116.174 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -49.5 -32.45 12.23 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.84 1.82 . . . . 0.0 113.384 -173.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.416 HD11 ' CD2' ' A' ' 156' ' ' LEU . 11.8 tp -60.16 -41.36 92.64 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.222 1.009 . . . . 0.0 113.441 -176.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.93 -40.03 87.53 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.549 0.339 . . . . 0.0 110.767 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.54 -52.72 50.44 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 117.633 -1.175 . . . . 0.0 112.257 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -54.76 -38.12 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 120.113 1.324 . . . . 0.0 111.306 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.7 t -71.46 -39.79 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 118.943 0.792 . . . . 0.0 112.681 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -67.93 -41.44 82.56 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.514 1.052 . . . . 0.0 112.05 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.467 HG11 HD13 ' A' ' 108' ' ' LEU . 78.7 t -56.4 -40.4 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 123.194 0.598 . . . . 0.0 110.401 171.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.62 -40.85 80.19 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.86 -8.65 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -171.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 4.7 t -90.88 67.72 6.18 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.258 -1.526 . . . . 0.0 111.431 172.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -46.98 -42.77 18.48 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.145 1.778 . . . . 0.0 111.171 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.43 -23.54 53.73 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.43 1.014 . . . . 0.0 115.524 -170.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -94.34 -43.45 8.39 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.689 1.245 . . . . 0.0 110.351 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 20.4 mm -65.36 -39.23 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 118.671 -0.68 . . . . 0.0 110.439 175.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 92.43 24.49 23.84 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.44 1.019 . . . . 0.0 114.176 178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -55.52 128.06 32.7 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.224 1.41 . . . . 0.0 113.586 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.86 173.42 6.68 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.236 1.814 . . . . 0.0 110.29 169.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -89.69 57.01 3.74 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.778 1.231 . . . . 0.0 112.793 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -105.04 -121.14 4.86 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.335 1.445 . . . . 0.0 110.235 170.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.7 p -119.57 127.91 53.42 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.524 1.93 . . . . 0.0 106.092 169.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -112.1 110.86 21.37 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.918 0.781 . . . . 0.0 110.819 -167.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -111.42 97.72 6.95 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -168.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.467 HD13 HG11 ' A' ' 92' ' ' VAL . 11.1 tp -87.12 94.87 9.76 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.586 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.411 HG13 HG21 ' A' ' 170' ' ' VAL . 44.9 t -83.76 116.7 28.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 37.9 mt -109.31 109.96 21.0 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.165 -174.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.428 HG11 HG22 ' A' ' 23' ' ' VAL . 40.6 t -104.38 125.14 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 O-C-N 123.934 0.771 . . . . 0.0 111.83 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -161.55 150.14 15.69 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.736 0.814 . . . . 0.0 111.229 172.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -105.31 -1.21 25.46 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.338 1.455 . . . . 0.0 114.756 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -121.35 -178.44 3.78 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.496 1.118 . . . . 0.0 111.889 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -77.33 -172.51 2.5 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.648 1.179 . . . . 0.0 111.231 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.43 ' HA ' ' H ' ' A' ' 83' ' ' LYS . 21.5 p90 -139.16 157.17 46.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.075 0.95 . . . . 0.0 112.633 -169.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -79.9 129.75 34.74 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.226 1.01 . . . . 0.0 110.717 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mp -98.99 173.21 6.95 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.851 1.26 . . . . 0.0 109.583 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.65 146.46 10.15 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.776 -0.578 . . . . 0.0 111.59 169.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 90.0 mttt 82.37 -18.98 0.43 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 128.261 2.624 . . . . 0.0 113.269 -178.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.86 -35.71 82.01 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.002 1.273 . . . . 0.0 112.324 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -68.61 -5.28 19.08 Favored 'General case' 0 CA--C 1.551 1.0 0 O-C-N 120.927 -1.108 . . . . 0.0 113.858 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.03 -23.64 65.01 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.906 -1.121 . . . . 0.0 112.849 171.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.4 mp -63.74 -33.88 76.65 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 119.212 0.915 . . . . 0.0 110.796 169.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -84.44 16.43 34.92 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 126.127 1.823 . . . . 0.0 113.874 169.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.334 1.3 t 71.08 15.52 6.56 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 129.844 3.258 . . . . 0.0 115.095 176.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.599 ' HA ' ' HE ' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -99.96 106.42 18.21 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 120.963 -1.086 . . . . 0.0 112.244 -177.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -88.51 -48.82 7.31 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.938 1.695 . . . . 0.0 112.411 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 42.0 m-20 -60.43 131.2 50.01 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -169.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.3 t -63.29 146.07 54.23 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.766 1.227 . . . . 0.0 111.157 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.2 p -53.72 128.95 31.55 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 125.695 1.598 . . . . 0.0 113.879 169.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -72.86 -26.62 61.52 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.422 0.689 . . . . 0.0 112.424 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 87.4 -25.64 7.91 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 125.697 1.618 . . . . 0.0 112.884 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -61.59 164.91 5.42 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.202 1.801 . . . . 0.0 112.878 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 38.7 t -73.53 136.74 44.1 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.522 0.729 . . . . 0.0 111.231 170.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -137.96 40.75 2.32 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.743 1.617 . . . . 0.0 111.96 172.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 23.7 mt -86.96 156.19 19.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.941 0.896 . . . . 0.0 110.849 171.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.84 -80.16 0.16 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.475 1.11 . . . . 0.0 111.504 171.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.26 28.0 0.76 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.743 1.617 . . . . 0.0 112.771 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 86.03 -9.73 68.32 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.923 1.725 . . . . 0.0 113.454 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 13.1 mmt -96.74 146.45 24.87 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.777 1.231 . . . . 0.0 112.336 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -77.88 95.12 4.67 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.888 0.851 . . . . 0.0 110.815 169.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.0 ttp-105 -51.85 -40.15 60.06 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.619 1.968 . . . . 0.0 112.857 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.3 m -87.34 2.75 49.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -169.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.5 ttp85 -56.73 -33.84 66.91 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 121.731 2.06 . . . . 0.0 111.857 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.61 -4.26 87.51 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.29 1.424 . . . . 0.0 115.14 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.298 15.1 tp10 -122.42 -82.3 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.139 0 CA-C-O 115.774 -2.06 . . . . 0.0 111.051 173.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -47.13 146.8 6.0 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 123.341 2.694 . . . . 0.0 116.541 170.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -74.94 179.55 4.85 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -69.23 147.03 51.83 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.386 -0.822 . . . . 0.0 110.876 170.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -71.4 154.68 41.37 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.527 -0.733 . . . . 0.0 111.964 -177.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 59.5 p -88.5 155.91 19.39 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.704 -0.623 . . . . 0.0 111.343 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.2 t -59.27 -29.12 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 O-C-N 121.373 -0.829 . . . . 0.0 112.585 -169.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 37.4 t -66.8 -42.46 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.373 1.469 . . . . 0.0 111.59 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -70.49 -29.55 66.11 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.233 1.013 . . . . 0.0 111.715 -174.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.517 HD12 HD11 ' A' ' 186' ' ' ILE . 1.0 OUTLIER -64.23 -54.72 29.08 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.789 0.836 . . . . 0.0 109.796 170.514 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.53 -37.7 68.27 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.219 1.008 . . . . 0.0 111.959 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.5 m -60.59 -65.29 0.71 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.312 1.045 . . . . 0.0 112.336 170.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . 0.265 68.9 mmtt -76.25 -17.39 59.5 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.121 -1.612 . . . . 0.0 114.835 -169.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mp -71.72 -41.4 68.6 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.782 0.833 . . . . 0.0 109.493 168.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.32 -35.48 66.06 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.454 1.102 . . . . 0.0 113.853 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.9 -41.52 78.15 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.942 0.897 . . . . 0.0 110.736 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -87.96 -0.3 56.82 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 173.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 65.24 31.01 11.02 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.524 1.129 . . . . 0.0 113.012 170.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 57.2 mt -94.92 134.18 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 120.89 -1.131 . . . . 0.0 108.969 -177.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -107.34 100.51 33.89 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-N 119.078 0.853 . . . . 0.0 111.826 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.02 154.57 74.2 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.746 2.297 . . . . 0.0 115.81 169.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 38.0 mt -132.27 110.77 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.892 1.677 . . . . 0.0 107.775 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -77.58 79.5 4.08 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 123.214 1.483 . . . . 0.0 110.844 173.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.541 HG13 HG21 ' A' ' 201' ' ' VAL . 89.7 t -65.98 109.04 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 113.566 -1.652 . . . . 0.0 111.583 169.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 27.3 m -148.38 146.52 23.05 Favored Pre-proline 0 N--CA 1.476 0.841 0 O-C-N 120.757 -1.215 . . . . 0.0 112.696 -170.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.36 151.97 27.66 Favored 'Trans proline' 0 C--N 1.351 0.696 1 C-N-CA 125.533 4.155 . . . . 0.0 114.129 169.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 68.3 p -56.81 -29.16 62.47 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -169.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 40.7 tpt85 -58.95 -36.68 75.21 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.927 1.24 . . . . 0.0 112.774 -177.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 34.5 mtt -118.1 12.79 13.7 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.436 1.272 . . . . 0.0 114.436 -175.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 5.4 t -53.39 -34.88 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.646 1.112 . . . . 0.0 111.22 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.4 ' HA ' ' HB2' ' A' ' 180' ' ' GLU . 45.6 tptt -80.78 -15.04 57.47 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -175.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.12 -34.17 43.61 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 119.445 1.02 . . . . 0.0 110.383 174.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -80.58 -36.93 32.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.054 1.342 . . . . 0.0 110.342 176.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 177' ' ' LYS . 9.5 mt-10 -62.7 -13.37 31.62 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.114 0.87 . . . . 0.0 113.072 171.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -105.01 -11.0 16.84 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -80.15 -30.56 38.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.385 1.474 . . . . 0.0 109.154 169.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 58.6 p -77.11 -11.45 59.81 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.144 1.378 . . . . 0.0 112.406 173.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 54.8 m -78.39 -30.72 47.97 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 168.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -81.42 -28.15 34.4 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 171.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.517 HD11 HD12 ' A' ' 156' ' ' LEU . 6.2 mt -117.52 86.09 22.17 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 123.855 0.862 . . . . 0.0 110.711 175.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -63.47 149.02 92.17 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.755 2.304 . . . . 0.0 112.196 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt 89.25 -17.08 0.25 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 130.665 3.586 . . . . 0.0 113.017 -175.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.2 mt -76.03 162.39 28.09 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.272 0.629 . . . . 0.0 110.766 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.6 p -129.9 -161.5 1.12 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 48.2 mm -162.13 149.02 4.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 130.332 3.453 . . . . 0.0 109.385 -167.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.06 156.55 26.89 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.991 -0.444 . . . . 0.0 111.991 168.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -96.81 84.2 3.56 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.644 1.578 . . . . 0.0 108.374 -173.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.462 HD12 HD22 ' A' ' 26' ' ' LEU . 2.0 tt -61.41 138.55 58.26 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.57 1.176 . . . . 0.0 110.572 169.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 90.0 p -159.43 -163.43 1.18 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 128.32 2.648 . . . . 0.0 106.715 173.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.41 -10.06 47.6 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 120.551 -1.343 . . . . 0.0 112.936 173.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -100.93 128.65 46.87 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.578 1.551 . . . . 0.0 111.28 171.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 44.2 p -92.54 -4.46 53.48 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.141 1.776 . . . . 0.0 114.039 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 79.8 p -58.05 -44.52 87.48 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.408 1.483 . . . . 0.0 112.802 -169.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -62.97 -50.64 69.97 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.753 0.421 . . . . 0.0 111.26 -173.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.541 HG21 HG13 ' A' ' 170' ' ' VAL . 17.1 t -72.54 -37.21 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 O-C-N 121.668 -0.645 . . . . 0.0 112.344 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -60.48 -30.12 69.49 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 118.935 0.789 . . . . 0.0 111.486 172.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -69.73 -8.12 45.26 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.606 -1.309 . . . . 0.0 113.769 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.9 mp -105.49 -34.92 7.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.714 1.606 . . . . 0.0 109.326 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 16.3 mm -65.92 -48.38 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 169.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -71.7 -31.81 67.13 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 118.651 -0.69 . . . . 0.0 111.658 -177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -64.92 -43.08 93.94 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.547 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -76.97 -26.66 54.22 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -60.21 -45.5 92.96 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.655 0.782 . . . . 0.0 110.703 171.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 10.8 t -67.12 -20.77 65.83 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.143 0.977 . . . . 0.0 113.475 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -82.36 -15.78 51.54 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -175.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--O 1.257 1.452 0 CA-C-O 112.663 -3.541 . . . . 0.0 111.724 176.721 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 35.0 t0 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.198 0.523 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -99.48 142.55 30.82 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.455 1.102 . . . . 0.0 110.3 176.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.7 p -70.98 134.81 47.46 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 121.055 -1.028 . . . . 0.0 112.396 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.33 100.97 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-O 122.127 0.965 . . . . 0.0 112.018 -175.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.97 95.93 4.93 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.687 1.195 . . . . 0.0 109.501 171.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.1 tt -90.31 121.38 32.26 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.991 0.516 . . . . 0.0 111.837 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -113.72 109.52 18.71 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 123.728 1.727 . . . . 0.0 109.213 169.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -81.18 104.88 11.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.699 -2.046 . . . . 0.0 111.718 174.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.1 tt -108.53 111.31 23.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.618 0.767 . . . . 0.0 109.897 177.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 28.0 ptm -119.07 149.04 42.35 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.1 134.59 14.58 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.29 1.424 . . . . 0.0 110.892 169.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.4 mp -102.97 29.64 5.31 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.584 1.954 . . . . 0.0 111.608 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.8 p -69.7 163.12 26.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.112 1.765 . . . . 0.0 113.505 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.9 -32.3 48.39 Favored Glycine 0 N--CA 1.478 1.484 0 O-C-N 120.654 -1.278 . . . . 0.0 115.047 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.0 p -80.07 -6.82 58.33 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.239 1.416 . . . . 0.0 114.487 175.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.92 -9.83 59.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.218 1.407 . . . . 0.0 112.257 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -70.54 124.6 24.61 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 168.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.86 -40.98 2.31 Favored Glycine 0 CA--C 1.532 1.125 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -168.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -67.82 -52.34 38.05 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 168.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.3 tp -64.75 -21.44 66.76 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.722 1.209 . . . . 0.0 113.642 -171.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.2 p -79.63 -47.77 14.86 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.549 1.068 . . . . 0.0 112.152 169.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -68.75 -30.29 68.87 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.633 -1.292 . . . . 0.0 112.802 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.0 p -76.03 -2.77 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.563 1.145 . . . . 0.0 113.345 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -69.81 -43.08 72.78 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.804 -1.185 . . . . 0.0 109.373 -175.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 19.7 m -76.88 -11.53 59.83 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.658 1.983 . . . . 0.0 112.205 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.84 86.59 6.89 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 124.643 2.163 . . . . 0.0 108.604 171.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.27 -54.64 0.02 OUTLIER Glycine 0 N--CA 1.474 1.198 0 CA-C-N 108.851 -3.795 . . . . 0.0 111.088 166.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.3 p -82.35 -41.46 19.98 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.292 1.837 . . . . 0.0 110.64 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -62.98 -36.07 82.29 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.825 0.85 . . . . 0.0 111.13 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.6 tp -70.88 -40.17 72.4 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.21 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.0 mt -56.51 -39.44 73.31 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.865 1.211 . . . . 0.0 112.481 171.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -60.8 -34.93 75.26 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.77 1.623 . . . . 0.0 111.798 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.05 -40.72 60.16 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 169.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.9 mt -75.57 -23.46 56.55 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.402 1.001 . . . . 0.0 113.608 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -70.42 -27.1 64.01 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 120.68 1.582 . . . . 0.0 113.506 -171.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -79.75 -37.92 34.39 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.793 0.437 . . . . 0.0 110.341 173.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.6 mm -63.35 -36.38 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 122.554 0.342 . . . . 0.0 111.869 170.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.7 t -159.06 135.84 9.48 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 -169.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -63.78 -31.7 72.97 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.814 1.246 . . . . 0.0 112.832 171.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.7 t -128.75 110.83 12.53 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.998 0.904 . . . . 0.0 111.116 -172.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.68 86.54 0.23 Allowed Glycine 0 C--N 1.337 0.616 0 C-N-CA 125.82 1.676 . . . . 0.0 109.086 -169.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.6 mmt-85 -72.39 138.82 47.47 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.436 1.494 . . . . 0.0 108.672 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 tt -126.6 133.25 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-N 119.062 0.846 . . . . 0.0 111.712 -177.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.89 159.68 26.54 Favored Glycine 0 N--CA 1.475 1.264 0 C-N-CA 126.035 1.778 . . . . 0.0 112.51 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -137.04 133.27 35.29 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -169.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.63 145.94 17.99 Favored Glycine 0 C--N 1.343 0.948 0 C-N-CA 124.827 1.203 . . . . 0.0 111.945 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.7 m -128.49 149.0 50.77 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.084 0.953 . . . . 0.0 112.137 -173.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.1 152.32 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-N 118.99 0.814 . . . . 0.0 113.149 -175.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.4 t -141.5 -84.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 125.152 1.381 . . . . 0.0 109.269 168.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.428 ' H ' ' H ' ' A' ' 51' ' ' MET . 54.0 t30 -149.54 -20.63 0.28 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.847 2.459 . . . . 0.0 108.269 169.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.428 ' H ' ' H ' ' A' ' 50' ' ' ASN . 76.4 mtm -75.78 50.17 0.56 Allowed 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 127.514 2.325 . . . . 0.0 106.202 166.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.342 4.0 t 32.74 -149.56 0.0 OUTLIER 'General case' 0 C--N 1.345 0.375 1 C-N-CA 133.915 4.886 . . . . 0.0 116.71 -168.835 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -106.0 137.35 44.06 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 130.287 3.435 . . . . 0.0 109.343 -174.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -129.37 126.56 39.15 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 122.604 1.192 . . . . 0.0 109.739 168.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -87.35 116.65 25.59 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.851 2.06 . . . . 0.0 109.399 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.7 mt -110.01 -57.46 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.131 -169.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -103.98 117.25 33.84 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.104 0.865 . . . . 0.0 112.907 173.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -64.27 147.45 52.43 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 166.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mp -61.5 126.56 27.8 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 121.072 1.76 . . . . 0.0 110.461 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -149.54 176.83 10.27 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.635 1.174 . . . . 0.0 111.469 -173.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.27 -25.76 23.8 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.432 1.893 . . . . 0.0 113.982 -170.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -87.82 80.63 7.8 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 125.534 2.588 . . . . 0.0 109.653 -176.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.2 m -66.1 -25.77 67.16 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 127.716 2.406 . . . . 0.0 110.09 170.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.5 t -68.14 -23.01 64.84 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.544 -0.722 . . . . 0.0 109.526 168.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -85.69 -34.64 21.22 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.031 -1.043 . . . . 0.0 112.035 173.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 70' ' ' LEU . 44.9 t80 -52.87 -26.36 14.49 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 123.962 0.905 . . . . 0.0 110.953 169.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -75.7 -49.98 16.72 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.53 -0.731 . . . . 0.0 109.965 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -79.61 -20.04 47.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 117.887 -1.054 . . . . 0.0 112.38 -169.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -83.28 -35.17 25.5 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 118.06 -1.456 . . . . 0.0 109.131 169.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 66' ' ' PHE . 0.3 OUTLIER -65.25 -29.01 69.76 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 118.361 0.528 . . . . 0.0 110.588 176.162 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 73.1 mtp180 -65.77 -26.95 67.94 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 170.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -77.96 -26.89 49.07 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 119.483 1.038 . . . . 0.0 113.344 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.77 153.93 23.08 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.327 0.584 . . . . 0.0 110.863 176.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.284 1.0 OUTLIER -148.65 166.25 28.89 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.587 1.155 . . . . 0.0 111.39 170.314 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.2 t -80.46 147.91 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.151 1.78 . . . . 0.0 114.492 -167.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 74.6 m -125.82 159.87 31.32 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.268 1.827 . . . . 0.0 113.138 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.63 161.79 13.49 Favored Glycine 0 N--CA 1.476 1.331 0 C-N-CA 125.089 1.328 . . . . 0.0 114.757 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -158.76 147.92 18.89 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.075 2.15 . . . . 0.0 109.654 171.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.08 -74.58 0.06 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.542 1.537 . . . . 0.0 112.193 176.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.81 154.62 41.67 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -173.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.6 m -67.19 -52.42 30.05 Favored Pre-proline 0 N--CA 1.474 0.742 0 CA-C-O 116.372 -1.775 . . . . 0.0 113.913 -176.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -71.08 152.99 62.97 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.107 1.872 . . . . 0.0 111.661 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -133.46 158.99 41.68 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.66 34.13 2.08 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 117.309 1.684 . . . . 0.0 117.309 -168.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -74.02 -21.32 60.02 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -170.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.4 tp -56.96 -53.03 62.65 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.424 0.689 . . . . 0.0 109.79 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -63.57 -31.46 72.64 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 120.841 -1.162 . . . . 0.0 112.741 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.24 -51.77 68.12 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 118.111 -0.947 . . . . 0.0 110.86 170.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.494 ' CG1' HD13 ' A' ' 110' ' ' LEU . 27.4 m -59.64 -26.55 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-N 119.909 1.232 . . . . 0.0 112.851 177.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' A' ' 156' ' ' LEU . 37.9 t -70.81 -56.64 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-O 118.429 -0.796 . . . . 0.0 112.06 173.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -58.56 -36.78 74.46 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.55 0.614 . . . . 0.0 109.623 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.555 HG11 HD13 ' A' ' 108' ' ' LEU . 52.9 t -60.74 -31.46 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 173.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.78 -51.63 11.04 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.247 -0.908 . . . . 0.0 113.295 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.2 mm -71.28 -23.65 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 119.789 1.177 . . . . 0.0 113.31 -169.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.436 ' HG ' ' HG ' ' A' ' 135' ' ' CYS . 0.0 OUTLIER -85.32 61.09 6.64 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.567 -1.333 . . . . 0.0 112.433 -173.012 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -46.56 -44.65 18.14 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.448 1.499 . . . . 0.0 110.821 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -90.97 -24.2 28.01 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 124.678 1.132 . . . . 0.0 115.207 -171.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -88.4 -40.95 13.13 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.829 1.315 . . . . 0.0 111.042 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 92' ' ' VAL . 27.0 mt -79.64 -31.9 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 121.321 -0.862 . . . . 0.0 110.551 176.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.81 31.76 20.07 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.666 -0.519 . . . . 0.0 113.358 169.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -55.48 120.99 8.02 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.482 1.113 . . . . 0.0 112.414 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -76.45 170.37 16.51 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.716 0.807 . . . . 0.0 111.007 169.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -89.62 52.42 2.32 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.85 0.86 . . . . 0.0 112.095 169.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.7 -119.05 3.87 Favored Glycine 0 N--CA 1.471 0.982 0 N-CA-C 105.867 -2.893 . . . . 0.0 105.867 168.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.6 t -124.76 131.38 53.46 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.23 137.5 41.28 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -168.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -136.42 104.78 5.71 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 -167.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.555 HD13 HG11 ' A' ' 92' ' ' VAL . 20.9 tp -97.41 101.0 12.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.744 -175.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.6 t -73.81 127.8 35.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 168.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.494 HD13 ' CG1' ' A' ' 89' ' ' VAL . 21.4 tp -116.26 130.12 56.62 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 169.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.422 ' CG2' HD22 ' A' ' 194' ' ' LEU 0.257 6.5 p -141.86 129.97 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.6 t -147.3 -176.46 5.24 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 113.351 -1.75 . . . . 0.0 111.277 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -130.82 -7.98 3.99 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 127.063 2.145 . . . . 0.0 113.607 177.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -150.14 169.4 21.37 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.917 1.287 . . . . 0.0 112.936 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -53.14 167.52 0.17 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.554 2.342 . . . . 0.0 115.677 -170.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -92.99 163.84 13.51 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 174.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.406 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . 78.2 m-70 -102.59 124.07 47.47 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 165.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.5 mp -104.32 177.21 4.91 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.757 1.223 . . . . 0.0 110.538 -172.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -49.44 145.46 4.71 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.367 58.6 pttt 56.29 2.79 0.09 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 128.345 2.658 . . . . 0.0 116.891 -170.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -66.34 -28.91 69.03 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 121.475 1.943 . . . . 0.0 112.442 170.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . 0.329 20.1 mttt -75.14 7.61 3.22 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 176.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.6 t -70.92 -18.69 62.65 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.781 1.232 . . . . 0.0 111.209 168.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 mp -65.71 -23.76 66.83 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.196 0.998 . . . . 0.0 112.196 169.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -88.42 -130.72 3.61 Favored Glycine 0 CA--C 1.538 1.482 0 N-CA-C 106.64 -2.584 . . . . 0.0 106.64 168.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 14.3 m -142.2 68.4 1.32 Allowed 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 118.008 0.904 . . . . 0.0 109.28 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -134.45 81.02 1.88 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.795 1.638 . . . . 0.0 108.665 -175.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -79.49 -45.74 18.76 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.729 0.812 . . . . 0.0 111.726 -176.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -57.99 120.62 8.86 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.049 0.54 . . . . 0.0 111.341 -171.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.4 t -72.13 154.33 41.14 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-O 122.577 1.18 . . . . 0.0 111.246 177.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.7 p -61.46 138.46 58.27 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 127.425 2.29 . . . . 0.0 115.674 -171.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 54.4 p30 -87.69 -18.15 30.16 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -175.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.28 17.38 78.81 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.988 -0.896 . . . . 0.0 114.017 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 37.5 ttm105 -96.9 158.73 15.29 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.954 1.702 . . . . 0.0 110.426 174.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . 0.436 ' HG ' ' HG ' ' A' ' 95' ' ' CYS . 0.0 OUTLIER -87.71 146.16 25.81 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.07 -1.019 . . . . 0.0 112.95 169.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -140.7 55.66 1.58 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.273 1.829 . . . . 0.0 110.663 -173.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 tt -130.67 130.13 43.49 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.34 2.256 . . . . 0.0 108.418 -173.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -145.56 -50.07 0.24 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 169.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -72.37 -20.91 61.38 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.905 1.282 . . . . 0.0 114.107 176.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 131.37 -17.88 5.01 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.118 1.818 . . . . 0.0 114.328 -172.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 80.5 mtp -113.52 157.72 21.66 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 119.989 1.895 . . . . 0.0 114.116 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -73.31 91.98 1.76 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.787 0.835 . . . . 0.0 110.972 171.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -54.62 -38.57 66.98 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.313 1.045 . . . . 0.0 112.535 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 64.8 m -79.58 0.74 28.73 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -172.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -41.32 -46.31 3.23 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 120.529 1.513 . . . . 0.0 112.338 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.68 -7.75 88.02 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 117.966 -1.463 . . . . 0.0 115.161 -172.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.276 88.8 tt0 -114.5 -79.39 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.025 0 CA-C-O 115.891 -2.004 . . . . 0.0 112.141 -175.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.92 158.22 48.39 Favored 'Trans proline' 0 C--N 1.356 0.948 0 CA-C-N 123.509 2.289 . . . . 0.0 113.275 170.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -77.27 -168.25 1.08 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.673 1.589 . . . . 0.0 113.514 170.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.406 ' CE2' ' HB3' ' A' ' 117' ' ' HIS . 71.2 m-85 -69.2 144.83 53.62 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 172.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.53 153.12 43.79 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 176.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 54.6 p -85.66 150.97 24.24 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.317 -0.864 . . . . 0.0 112.833 176.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 70.0 t -56.0 -43.83 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.597 0.759 . . . . 0.0 110.945 -176.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.5 t -75.68 -26.66 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.005 -1.059 . . . . 0.0 112.682 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -61.24 -32.81 72.6 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 119.869 1.213 . . . . 0.0 110.135 170.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.42 ' CD2' HG22 ' A' ' 90' ' ' VAL . 5.6 mt -83.69 -33.06 25.24 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.809 -0.557 . . . . 0.0 112.373 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.78 84.47 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.187 0.449 . . . . 0.0 110.331 169.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.1 t -55.29 -51.62 66.08 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.229 1.012 . . . . 0.0 111.193 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -73.57 -48.82 29.94 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.287 1.218 . . . . 0.0 114.287 -172.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.7 mp -73.2 -18.63 61.23 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.701 -1.249 . . . . 0.0 112.169 -173.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.66 -30.54 41.26 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 119.115 0.871 . . . . 0.0 112.586 168.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -68.9 -48.32 63.63 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.322 1.449 . . . . 0.0 109.76 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -79.95 -8.98 59.63 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.042 1.337 . . . . 0.0 111.964 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 59.5 49.13 8.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.769 2.427 . . . . 0.0 112.794 171.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 19.2 mm -96.97 147.21 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.929 1.691 . . . . 0.0 109.671 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -105.96 102.14 37.62 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 120.82 1.645 . . . . 0.0 109.549 168.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.439 ' C ' HD12 ' A' ' 168' ' ' ILE . 37.6 Cg_exo -76.23 125.9 8.82 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 123.977 3.118 . . . . 0.0 113.108 169.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.485 HG13 HG23 ' A' ' 190' ' ' THR . 1.3 mp -119.51 109.49 26.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -77.13 73.31 3.71 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 122.436 1.112 . . . . 0.0 112.371 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.428 HG23 HG22 ' A' ' 168' ' ' ILE . 77.4 t -60.0 104.18 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 C-N-CA 123.893 0.877 . . . . 0.0 109.468 167.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 6.3 m -149.42 148.46 26.31 Favored Pre-proline 0 N--CA 1.481 1.122 0 O-C-N 119.871 -1.768 . . . . 0.0 113.2 -173.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -58.8 153.72 48.39 Favored 'Trans proline' 0 C--N 1.354 0.838 1 C-N-CA 125.625 4.217 . . . . 0.0 116.291 178.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 29.2 t -51.74 -54.61 26.57 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -169.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 80.2 mmt-85 -60.42 -13.32 12.81 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 120.549 1.522 . . . . 0.0 114.407 -173.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 14.3 ttp -105.53 -16.52 14.69 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.431 2.293 . . . . 0.0 114.641 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.9 m -62.49 -24.83 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-N 122.123 2.238 . . . . 0.0 112.344 -170.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -60.27 -28.69 68.27 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.9 t -92.17 -33.56 14.67 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.172 0.589 . . . . 0.0 111.453 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -69.57 -32.25 70.92 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.377 -1.452 . . . . 0.0 109.964 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -68.05 -12.97 61.8 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.453 1.101 . . . . 0.0 112.309 169.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -96.9 -29.21 13.83 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.16 -0.963 . . . . 0.0 111.291 173.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.5 -26.81 63.76 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 119.895 -1.753 . . . . 0.0 109.758 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.4 t -81.15 -15.2 56.49 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 174.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.98 -19.44 44.06 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.805 169.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -88.78 -31.58 18.3 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 170.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 14.8 mm -101.78 111.86 64.56 Favored Pre-proline 0 N--CA 1.485 1.311 0 CA-C-N 119.547 1.067 . . . . 0.0 109.505 176.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.77 0.65 4.01 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 124.924 3.749 . . . . 0.0 119.779 -168.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -128.68 -2.95 5.36 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 -176.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.431 HD22 ' HB2' ' A' ' 167' ' ' PRO . 9.2 mt -83.21 172.75 12.29 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.93 1.241 . . . . 0.0 113.299 -169.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.485 HG23 HG13 ' A' ' 168' ' ' ILE 0.446 0.1 OUTLIER -141.5 -176.42 4.73 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 103.771 -2.677 . . . . 0.0 103.771 167.989 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.9 mp -157.88 136.68 3.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 C-N-CA 131.478 3.911 . . . . 0.0 109.354 -166.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -118.38 147.46 18.56 Favored Glycine 0 N--CA 1.467 0.759 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 172.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -87.43 87.38 7.39 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 122.863 1.316 . . . . 0.0 107.658 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.422 HD22 ' CG2' ' A' ' 111' ' ' VAL . 12.3 tp -56.35 144.96 28.65 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.494 169.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.3 t -87.47 157.03 19.29 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.387 -0.821 . . . . 0.0 110.356 169.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -60.73 -23.84 65.24 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -171.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -97.45 -8.15 30.0 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.013 1.725 . . . . 0.0 113.956 175.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 1.5 p 85.44 -9.31 0.81 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 130.755 3.622 . . . . 0.0 117.378 168.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 82.6 p -67.13 -11.53 57.49 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.225 -1.547 . . . . 0.0 115.04 -169.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -67.8 -17.72 64.61 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.184 0.594 . . . . 0.0 112.229 168.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 4.6 p -46.72 -46.59 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -169.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.21 -33.59 76.11 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.79 1.177 . . . . 0.0 112.657 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -73.87 -5.26 39.98 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.821 -1.152 . . . . 0.0 113.248 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 61.9 mt -99.59 -34.19 10.33 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.917 2.087 . . . . 0.0 108.4 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 15.4 mm -61.98 -53.87 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 168.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 64.9 ttt-85 -64.49 -39.72 94.32 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.816 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -72.78 -29.37 63.24 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 118.02 -1.472 . . . . 0.0 113.528 -178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -81.19 -27.25 35.42 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.862 1.21 . . . . 0.0 113.396 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -61.98 -35.57 78.88 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.474 0.579 . . . . 0.0 111.59 171.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 46.3 m -72.17 -23.19 61.24 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 174.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -68.74 -59.08 3.35 Favored 'General case' 0 C--O 1.254 1.315 0 CA-C-N 119.106 0.866 . . . . 0.0 110.254 171.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . 0.287 18.3 tp . . . . . 0 C--O 1.27 2.171 0 C-N-CA 126.88 2.072 . . . . 0.0 115.551 -170.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.9 t0 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.285 0.564 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -132.46 147.1 52.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.468 1.507 . . . . 0.0 109.592 170.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 t -63.39 136.95 57.97 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -170.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 16.2 t -110.19 95.66 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.628 1.171 . . . . 0.0 110.125 -171.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -76.39 118.33 18.97 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.544 -0.723 . . . . 0.0 110.352 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.1 mt -107.25 137.79 44.66 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.685 -0.634 . . . . 0.0 110.191 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -122.49 109.48 14.41 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 122.579 1.18 . . . . 0.0 108.986 169.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -83.26 110.64 18.26 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.856 1.262 . . . . 0.0 111.808 173.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' A' ' 88' ' ' ALA . 30.3 tp -103.21 124.23 48.22 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.981 0.912 . . . . 0.0 110.62 170.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.424 ' SD ' HD21 ' A' ' 70' ' ' LEU . 40.7 ttp -121.88 138.68 54.3 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 -169.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.53 133.58 12.62 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.943 1.259 . . . . 0.0 112.159 172.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tp -119.31 26.53 9.38 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.799 1.639 . . . . 0.0 113.3 -173.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.0 p -66.06 162.8 18.74 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.36 -20.98 68.09 Favored Glycine 0 N--CA 1.475 1.24 0 O-C-N 120.974 -1.079 . . . . 0.0 113.331 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 p -76.44 -18.76 58.64 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.172 1.389 . . . . 0.0 113.174 169.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.05 -6.86 59.49 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.688 1.195 . . . . 0.0 114.167 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -71.79 130.98 42.42 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.6 1.546 . . . . 0.0 108.187 169.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.28 -35.31 4.78 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.662 1.125 . . . . 0.0 110.351 -168.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -82.67 -24.8 33.54 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.43 1.092 . . . . 0.0 111.303 169.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.3 tp -54.94 -39.97 69.45 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.893 1.277 . . . . 0.0 111.468 176.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 93.1 p -61.57 -34.36 75.46 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.255 -1.528 . . . . 0.0 113.064 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -69.22 -44.34 72.23 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 120.906 -1.121 . . . . 0.0 111.013 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.464 ' CG1' HG11 ' A' ' 111' ' ' VAL . 5.0 m -72.33 -19.98 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 177.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.473 ' HA ' HD22 ' A' ' 70' ' ' LEU . 59.7 mt-30 -70.08 -38.21 75.65 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.119 1.767 . . . . 0.0 108.746 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.2 m -77.39 -11.37 59.83 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 127.821 2.448 . . . . 0.0 113.212 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.484 HD21 HG21 ' A' ' 201' ' ' VAL . 1.8 mp -86.47 48.0 1.56 Allowed 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 125.256 1.422 . . . . 0.0 111.661 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -140.61 -45.1 0.06 OUTLIER Glycine 0 N--CA 1.477 1.376 0 O-C-N 120.698 -1.251 . . . . 0.0 115.656 170.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.2 m -89.54 -21.87 22.68 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.894 0.878 . . . . 0.0 111.008 -176.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.18 -34.42 63.78 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.672 173.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.3 mp -63.12 -46.62 86.44 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.972 173.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 63' ' ' SER . 18.3 mt -48.25 -52.93 19.0 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.67 1.123 . . . . 0.0 113.414 174.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -60.77 -37.12 80.77 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.899 0.772 . . . . 0.0 111.47 -172.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.33 -53.78 32.31 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 169.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 66.7 mt -74.7 -23.41 58.6 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -169.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -61.52 -25.45 67.29 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.288 1.435 . . . . 0.0 112.854 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -85.9 -34.32 20.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.83 0.852 . . . . 0.0 111.305 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.1 mp -65.83 -43.5 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.106 170.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.1 m -153.7 149.12 27.18 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -170.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 58.7 mtm180 -62.0 -48.47 80.16 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.734 0.814 . . . . 0.0 112.604 178.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.8 t -112.92 148.97 33.87 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 123.061 1.41 . . . . 0.0 111.694 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.62 94.66 0.11 Allowed Glycine 0 CA--C 1.517 0.182 0 N-CA-C 105.898 -2.881 . . . . 0.0 105.898 -176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -92.36 147.47 22.89 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 122.727 0.411 . . . . 0.0 110.402 -168.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.0 tt -122.26 129.27 75.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 124.196 0.998 . . . . 0.0 109.946 -172.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.75 157.84 14.94 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.273 1.416 . . . . 0.0 110.853 172.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -141.58 131.75 24.84 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.24 155.68 24.1 Favored Glycine 0 C--N 1.341 0.838 0 C-N-CA 124.407 1.004 . . . . 0.0 113.199 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 74.3 m -119.32 139.95 51.12 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.009 1.324 . . . . 0.0 111.316 -177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 2.3 tt -142.53 157.97 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.787 1.235 . . . . 0.0 111.328 171.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 p -158.46 -59.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 176.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -179.28 -28.97 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 129.861 3.264 . . . . 0.0 107.499 172.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.4 70.98 3.85 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 101.64 -3.467 . . . . 0.0 101.64 165.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.326 14.8 t 19.43 -138.45 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.763 1 C-N-CA 132.129 4.172 . . . . 0.0 116.318 -169.333 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -117.43 146.05 43.73 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 129.335 3.054 . . . . 0.0 109.892 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -134.04 123.28 24.25 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.54 0.736 . . . . 0.0 111.152 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -85.79 98.33 10.68 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.378 1.071 . . . . 0.0 110.08 169.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.5 tt -83.98 -64.24 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.504 0.722 . . . . 0.0 112.258 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.7 tp -109.27 117.38 33.94 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.605 1.162 . . . . 0.0 110.437 -171.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -60.59 147.76 40.56 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.498 0.719 . . . . 0.0 112.043 173.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.2 tt -50.41 115.13 1.32 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.554 1.942 . . . . 0.0 110.961 172.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.7 t -155.16 175.71 13.49 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.073 1.349 . . . . 0.0 112.353 -170.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.7 -13.87 41.35 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.289 1.436 . . . . 0.0 114.842 -172.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -88.01 76.19 8.63 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 124.681 2.182 . . . . 0.0 108.793 -175.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.464 ' HB2' HD11 ' A' ' 31' ' ' LEU . 53.6 m -81.37 -21.26 39.18 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 126.117 1.767 . . . . 0.0 111.549 -175.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.0 t -74.45 -26.17 59.88 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 167.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -80.17 -30.22 38.81 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.754 -1.216 . . . . 0.0 110.326 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -53.66 -34.0 57.18 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.574 -0.704 . . . . 0.0 110.417 169.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -73.0 -36.69 67.09 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -72.84 -33.2 65.99 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 124.862 1.265 . . . . 0.0 110.267 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.92 -37.36 58.81 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 24' ' ' GLN . 4.3 tt -72.42 -27.85 62.59 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.231 175.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -70.84 -33.88 71.11 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 121.047 -1.033 . . . . 0.0 112.393 171.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.1 mttm -70.54 -27.14 63.93 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.7 mm-40 -64.73 153.01 41.03 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.713 0.688 . . . . 0.0 112.294 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.28 132.07 37.32 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.712 1.605 . . . . 0.0 108.045 -174.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.13 155.42 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.635 0.774 . . . . 0.0 112.884 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.5 p -103.19 -151.01 0.42 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.511 0.724 . . . . 0.0 111.866 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -142.87 141.53 10.69 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 125.375 1.464 . . . . 0.0 112.252 173.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.421 ' HE2' ' HA ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -151.79 144.89 24.57 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.965 1.706 . . . . 0.0 110.652 173.431 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -88.56 -38.61 14.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -169.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -75.43 139.81 42.52 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.8 p -76.0 -38.63 2.51 Favored Pre-proline 0 N--CA 1.478 0.94 0 CA-C-O 115.89 -2.005 . . . . 0.0 114.905 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.99 136.61 53.41 Favored 'Trans proline' 0 C--N 1.355 0.885 0 CA-C-N 122.555 1.948 . . . . 0.0 112.897 171.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -102.22 160.38 14.57 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.548 1.539 . . . . 0.0 113.402 179.298 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.35 22.37 1.66 Allowed Glycine 0 N--CA 1.477 1.426 0 O-C-N 120.883 -1.136 . . . . 0.0 115.147 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -47.16 -34.18 5.94 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.386 2.274 . . . . 0.0 114.573 -169.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.29 -32.92 71.65 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.592 -0.718 . . . . 0.0 112.421 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -57.75 -52.11 66.81 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.307 0.958 . . . . 0.0 110.416 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.474 ' HB3' HD21 ' A' ' 9' ' ' LEU . . . -60.29 -49.6 76.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 116.464 -1.731 . . . . 0.0 111.18 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.468 HG12 HD13 ' A' ' 110' ' ' LEU . 16.4 m -55.35 -38.36 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 121.378 1.899 . . . . 0.0 114.423 -169.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.5 HG11 ' HG3' ' A' ' 151' ' ' GLN . 1.3 p -86.37 -38.79 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 117.451 -1.262 . . . . 0.0 112.582 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.9 mp0 -60.74 -44.42 96.7 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 121.161 1.8 . . . . 0.0 109.776 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.254 6.4 m -65.56 -4.11 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 120.773 1.624 . . . . 0.0 114.239 174.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.77 -18.07 17.39 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.772 1.229 . . . . 0.0 113.222 169.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 13.9 mt -104.89 -19.06 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 126.004 1.722 . . . . 0.0 111.735 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 95.3 m -73.16 42.42 0.11 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 127.338 2.255 . . . . 0.0 113.581 177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -50.39 -41.41 52.02 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.027 1.331 . . . . 0.0 111.412 -174.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.37 -26.77 46.24 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.24 0.924 . . . . 0.0 115.121 -174.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -88.54 -41.85 12.44 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.161 0.98 . . . . 0.0 110.277 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 74.6 mt -76.03 -38.44 35.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 CA-C-O 117.495 -1.241 . . . . 0.0 110.809 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 94.19 20.21 31.02 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 119.199 0.909 . . . . 0.0 115.145 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -52.05 125.91 16.94 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.079 1.351 . . . . 0.0 113.063 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -98.12 174.6 6.45 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.356 1.462 . . . . 0.0 113.196 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -71.76 1.55 6.72 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.099 2.259 . . . . 0.0 117.099 -174.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -82.25 -134.72 2.01 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 120.666 1.576 . . . . 0.0 110.223 -178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.3 t -97.58 143.29 28.41 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.865 1.266 . . . . 0.0 108.299 175.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.3 ptt180 -142.0 118.44 10.9 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-N 119.365 0.984 . . . . 0.0 110.183 -169.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -119.16 109.95 16.47 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 -169.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.58 96.77 7.57 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.415 175.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.99 118.49 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.468 HD13 HG12 ' A' ' 89' ' ' VAL . 45.8 tp -108.97 128.97 55.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 117.765 -1.112 . . . . 0.0 109.846 -174.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.464 HG11 ' CG1' ' A' ' 23' ' ' VAL . 48.8 t -120.91 134.79 63.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.6 t -161.24 166.54 27.56 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 112.801 -2.0 . . . . 0.0 109.624 169.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -124.03 7.72 8.61 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.856 2.062 . . . . 0.0 114.214 174.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -141.83 -177.63 5.29 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.573 1.549 . . . . 0.0 111.51 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -55.08 177.87 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.491 2.316 . . . . 0.0 114.696 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -139.34 158.78 43.56 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.82 2.048 . . . . 0.0 110.015 -177.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -85.54 126.67 34.05 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.201 0.6 . . . . 0.0 111.368 169.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.587 HD22 ' H ' ' A' ' 119' ' ' ALA . 0.0 OUTLIER -91.11 176.1 6.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.481 1.512 . . . . 0.0 108.992 172.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.587 ' H ' HD22 ' A' ' 118' ' ' LEU . . . -55.22 148.78 13.73 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.177 -0.952 . . . . 0.0 112.139 169.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 11.1 mptt 76.55 -13.86 0.88 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.479 2.312 . . . . 0.0 113.589 -176.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -65.62 -19.34 65.87 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.254 -1.529 . . . . 0.0 111.622 169.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -66.16 -24.08 66.58 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.345 3.0 t -75.66 -11.8 60.07 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 119.216 0.916 . . . . 0.0 112.13 -173.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 58.4 mt -60.63 -34.84 74.86 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.977 -1.077 . . . . 0.0 110.84 167.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -92.26 15.34 62.36 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.826 1.679 . . . . 0.0 113.711 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.543 0.1 OUTLIER 44.05 54.27 6.0 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 128.672 2.789 . . . . 0.0 113.917 -176.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -104.0 132.14 50.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.017 2.127 . . . . 0.0 105.59 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -113.78 -35.96 4.99 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 120.786 1.63 . . . . 0.0 113.315 176.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -48.07 116.86 1.67 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.789 1.236 . . . . 0.0 112.037 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.8 t -62.87 157.37 21.66 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 118.912 0.778 . . . . 0.0 110.164 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -66.53 132.3 47.91 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.838 -0.539 . . . . 0.0 110.622 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.82 -11.15 59.65 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 69.8 25.8 75.14 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 118.65 -1.083 . . . . 0.0 113.793 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -125.79 178.28 5.8 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.243 1.417 . . . . 0.0 112.328 170.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 1.2 m -99.39 146.24 26.51 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -169.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -151.55 56.38 0.87 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.568 1.547 . . . . 0.0 113.289 -169.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -134.26 151.43 51.28 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 120.918 -1.113 . . . . 0.0 111.511 169.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -147.41 -49.95 0.18 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.209 1.004 . . . . 0.0 113.511 -169.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -80.44 -10.16 59.75 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.242 1.017 . . . . 0.0 112.73 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 112.07 -9.31 27.17 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.476 1.989 . . . . 0.0 113.928 -171.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 29.9 ttm -99.26 136.13 39.66 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.8 1.8 . . . . 0.0 111.69 174.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.463 ' CE1' ' HB3' ' A' ' 144' ' ' SER . 30.6 t80 -66.66 95.98 0.37 Allowed 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.49 -0.756 . . . . 0.0 111.947 171.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -53.23 -45.33 68.66 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 127.22 2.208 . . . . 0.0 112.685 -178.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.463 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 17.2 t -67.79 -19.65 65.12 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 116.704 2.113 . . . . 0.0 116.704 -168.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -48.56 -35.32 13.13 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 121.035 1.743 . . . . 0.0 114.064 176.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.92 -16.82 74.92 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 119.099 -0.834 . . . . 0.0 113.482 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -117.73 -84.49 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.359 0 CA-C-O 115.946 -1.978 . . . . 0.0 109.802 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -51.51 157.64 4.81 Favored 'Trans proline' 0 C--N 1.358 1.03 0 N-CA-C 120.072 3.066 . . . . 0.0 120.072 171.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.446 ' HB2' ' HE3' ' A' ' 122' ' ' LYS . 47.9 t0 -77.03 166.77 22.87 Favored 'General case' 0 N--CA 1.468 0.448 1 C-N-CA 131.875 4.07 . . . . 0.0 115.595 -179.156 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -71.62 123.08 21.71 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 166.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.667 ' H ' ' CD ' ' A' ' 151' ' ' GLN . 1.0 OUTLIER -51.17 147.23 5.66 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 125.875 1.67 . . . . 0.0 112.217 171.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 7.7 t -85.11 166.25 16.8 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.982 0.896 . . . . 0.0 112.561 173.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.46 -27.9 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -168.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.2 p -84.09 -26.39 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 175.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -68.78 -34.16 75.09 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.358 -0.839 . . . . 0.0 110.293 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -58.59 -59.91 4.65 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.037 0.535 . . . . 0.0 110.297 169.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.24 -36.44 66.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.743 0.817 . . . . 0.0 113.069 -175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.4 t -58.89 -57.55 12.57 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.408 1.083 . . . . 0.0 112.417 175.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -81.37 -22.3 38.48 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.786 -1.196 . . . . 0.0 113.902 -174.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.4 mp -61.08 -48.02 83.63 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.117 0.967 . . . . 0.0 109.869 168.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.88 -28.78 55.51 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -67.91 -50.7 54.66 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.644 0.778 . . . . 0.0 110.179 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -84.16 -1.21 54.62 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.7 t30 64.08 31.86 13.18 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.753 1.161 . . . . 0.0 112.078 169.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.8 mt -97.75 128.61 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -103.87 115.33 63.56 Favored Pre-proline 0 N--CA 1.477 0.891 0 CA-C-N 119.461 1.028 . . . . 0.0 111.954 175.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.31 153.68 35.87 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.482 2.122 . . . . 0.0 115.803 173.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.04 113.57 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 125.789 1.636 . . . . 0.0 109.111 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.403 ' CD1' HD23 ' A' ' 110' ' ' LEU . 21.7 m-85 -71.56 68.15 0.56 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 122.248 1.023 . . . . 0.0 112.793 176.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.1 t -63.85 102.13 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 O-C-N 120.035 -1.665 . . . . 0.0 111.54 170.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 16.3 m -143.45 145.27 31.12 Favored Pre-proline 0 N--CA 1.478 0.934 0 O-C-N 120.074 -1.641 . . . . 0.0 111.174 -174.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -56.96 150.25 56.69 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.79 2.993 . . . . 0.0 112.941 173.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 21.5 t -46.54 -44.71 18.11 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.705 1.602 . . . . 0.0 114.123 -169.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.4 ptm85 -53.54 -27.95 28.86 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 12.8 tpt -106.02 -4.53 20.39 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.684 1.594 . . . . 0.0 113.917 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.37 -35.52 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 120.239 -1.538 . . . . 0.0 112.807 -169.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -68.53 -20.32 64.55 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -175.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 93.9 m -88.83 -40.22 13.3 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.211 1.404 . . . . 0.0 110.202 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -70.27 -26.42 63.81 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.341 -0.849 . . . . 0.0 111.149 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.75 -16.68 64.24 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.428 1.013 . . . . 0.0 111.844 168.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -82.06 -29.46 31.86 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.742 -1.224 . . . . 0.0 111.35 169.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.55 -26.17 57.75 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 120.581 -1.325 . . . . 0.0 110.217 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.03 -16.48 53.19 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.612 1.565 . . . . 0.0 111.78 177.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.77 -28.33 24.62 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.929 0.491 . . . . 0.0 110.286 169.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -78.14 -26.19 47.74 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 62.3 mt -117.3 96.94 50.15 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 123.701 0.801 . . . . 0.0 110.062 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.34 138.98 55.67 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 124.248 3.299 . . . . 0.0 113.836 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt 76.28 -8.75 1.59 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 129.038 2.935 . . . . 0.0 113.721 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.439 HD23 ' H ' ' A' ' 190' ' ' THR . 2.9 tt -72.59 150.96 42.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 169.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.439 ' H ' HD23 ' A' ' 189' ' ' LEU . 2.3 m -129.53 -139.15 0.23 Allowed 'General case' 0 C--N 1.343 0.294 0 CA-C-O 122.212 1.006 . . . . 0.0 109.549 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 13.9 tt -173.42 160.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 127.083 2.153 . . . . 0.0 109.807 -168.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -150.69 147.48 17.58 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 169.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.65 89.25 7.44 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.813 1.245 . . . . 0.0 108.42 174.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 34.7 tp -58.91 140.86 54.92 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.11 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 84.6 p -164.23 -164.52 0.86 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.572 1.549 . . . . 0.0 108.427 169.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -65.49 -10.14 31.93 Favored 'General case' 0 CA--C 1.552 1.038 0 O-C-N 121.267 -0.896 . . . . 0.0 112.331 169.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -109.58 140.46 43.36 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.149 2.179 . . . . 0.0 111.244 174.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 86.7 p -102.81 6.75 39.44 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.286 1.834 . . . . 0.0 113.795 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 39.3 p -60.4 -53.17 60.8 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 120.427 -1.421 . . . . 0.0 111.608 -169.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -68.42 -28.88 67.46 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.679 0.791 . . . . 0.0 113.051 -174.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.484 HG21 HD21 ' A' ' 26' ' ' LEU . 26.9 m -81.43 -42.36 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.6 1.16 . . . . 0.0 111.158 -177.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -69.82 -30.47 67.99 Favored 'General case' 0 C--O 1.219 -0.521 0 O-C-N 121.068 -1.02 . . . . 0.0 111.829 172.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -78.82 33.44 0.21 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 127.38 2.272 . . . . 0.0 112.508 174.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.413 HD21 ' HB ' ' A' ' 190' ' ' THR . 7.3 tp -142.0 -35.68 0.44 Allowed 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 126.965 2.106 . . . . 0.0 109.126 168.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 32.1 mt -69.93 -43.1 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 119.195 0.907 . . . . 0.0 109.057 170.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -63.37 -24.84 68.02 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.828 1.651 . . . . 0.0 112.831 172.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -91.31 -27.52 18.35 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 170.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -79.57 -19.11 50.19 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.544 -1.347 . . . . 0.0 112.457 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -74.04 -45.62 48.43 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.632 -0.667 . . . . 0.0 111.236 169.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.5 p -71.06 -9.24 57.71 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -174.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -75.92 -13.97 60.26 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.675 1.125 . . . . 0.0 113.699 169.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 C--O 1.256 1.408 0 C-N-CA 125.094 1.358 . . . . 0.0 112.751 174.948 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -98.97 154.66 17.9 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.704 1.201 . . . . 0.0 110.398 173.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -69.88 128.8 37.63 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.091 -1.006 . . . . 0.0 110.364 170.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.575 HG13 HG23 ' A' ' 105' ' ' THR . 51.3 t -139.62 118.05 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 119.111 0.868 . . . . 0.0 111.883 -176.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -93.74 122.69 36.46 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 122.888 0.475 . . . . 0.0 110.062 -174.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mt -107.88 120.31 41.91 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.219 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -113.73 104.86 12.63 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 124.783 2.23 . . . . 0.0 110.183 171.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -75.63 117.72 17.7 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 111.52 -2.582 . . . . 0.0 111.761 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.5 tp -118.89 111.06 17.91 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.06 0.944 . . . . 0.0 110.79 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -114.04 137.13 52.13 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 118.821 2.897 . . . . 0.0 118.821 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.24 112.52 4.22 Favored Glycine 0 C--N 1.341 0.819 0 C-N-CA 125.639 1.59 . . . . 0.0 110.268 171.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 23.3 tp -98.89 28.91 4.05 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.791 1.637 . . . . 0.0 111.456 -172.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.0 p -79.16 164.43 24.24 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.253 -1.529 . . . . 0.0 114.368 -171.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.16 -32.97 85.69 Favored Glycine 0 N--CA 1.472 1.053 0 O-C-N 121.404 -0.81 . . . . 0.0 112.294 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 m -58.3 -40.73 82.79 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.09 0.956 . . . . 0.0 111.243 170.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.11 9.98 2.68 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.97 1.47 . . . . 0.0 114.97 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -68.06 -37.84 81.76 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 121.298 1.863 . . . . 0.0 112.419 176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.72 -33.09 66.75 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 172.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -77.1 -10.79 59.62 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 175.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.416 ' HA ' HG12 ' A' ' 23' ' ' VAL . 33.1 tp -55.23 -51.39 66.73 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.56 1.527 . . . . 0.0 112.56 -175.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 74.0 m -65.92 -27.7 68.38 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.394 -0.816 . . . . 0.0 112.068 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -75.8 -37.16 59.4 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.838 -1.164 . . . . 0.0 112.702 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 20' ' ' LEU . 3.7 p -68.56 -36.03 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 O-C-N 120.426 -1.421 . . . . 0.0 110.858 169.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -72.8 -34.45 66.91 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.105 1.32 . . . . 0.0 112.035 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 t -70.33 -45.27 66.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.055 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -65.16 -18.09 65.02 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 119.83 1.195 . . . . 0.0 111.06 170.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.08 -51.63 4.12 Favored Glycine 0 C--O 1.218 -0.875 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 -172.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.3 t -67.91 -32.4 72.84 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 127.61 2.364 . . . . 0.0 111.209 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -74.88 -32.35 61.84 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.788 -0.57 . . . . 0.0 110.979 174.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 63.4 tp -65.28 -37.94 88.73 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 123.028 0.205 . . . . 0.0 110.511 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.473 HD21 ' CE1' ' A' ' 66' ' ' PHE . 0.2 OUTLIER -65.14 -60.98 2.42 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.693 0.797 . . . . 0.0 111.392 176.049 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -64.87 -45.25 86.8 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -168.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.31 -36.27 83.54 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 119.082 -0.485 . . . . 0.0 111.81 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.496 ' HA ' HG22 ' A' ' 37' ' ' ILE 0.398 34.2 mt -85.71 -15.34 42.57 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -179.078 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -68.86 -19.81 64.25 Favored 'General case' 0 CA--C 1.553 1.079 0 O-C-N 121.607 -0.683 . . . . 0.0 111.22 168.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -81.75 -45.38 15.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.527 1.131 . . . . 0.0 110.475 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.496 HG22 ' HA ' ' A' ' 34' ' ' LEU . 6.3 tp -72.71 -25.07 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 118.771 -0.633 . . . . 0.0 112.059 173.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.1 t -146.38 134.31 21.37 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.8 ttp85 -70.86 -43.01 69.33 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.351 1.46 . . . . 0.0 111.579 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.5 t -103.65 94.05 5.24 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 123.403 1.573 . . . . 0.0 109.346 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.11 90.83 0.2 Allowed Glycine 0 C--N 1.332 0.348 0 N-CA-C 105.693 -2.963 . . . . 0.0 105.693 -176.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -76.17 144.13 40.71 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -170.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 mt -136.69 128.18 42.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 118.078 0.399 . . . . 0.0 110.084 -175.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.91 149.42 19.36 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 126.402 1.953 . . . . 0.0 110.247 -173.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -129.89 131.89 46.21 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.626 1.17 . . . . 0.0 113.926 -169.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -140.03 152.81 22.95 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 171.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 75.1 p -130.29 154.22 47.85 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.427 0.691 . . . . 0.0 110.796 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -151.43 140.73 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -169.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.589 ' CG2' ' H ' ' A' ' 50' ' ' ASN 0.308 1.4 m -136.53 -84.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-N 119.735 1.152 . . . . 0.0 111.386 169.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.589 ' H ' ' CG2' ' A' ' 49' ' ' VAL 0.49 4.8 t-20 -156.97 -5.88 0.1 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 129.776 3.23 . . . . 0.0 111.713 169.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.0 ptp -88.99 44.45 1.21 Allowed 'General case' 0 CA--C 1.578 2.044 1 N-CA-C 98.994 -4.447 . . . . 0.0 98.994 160.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.552 ' H ' ' C ' ' A' ' 50' ' ' ASN 0.681 14.6 m 14.23 -113.69 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.179 1 C-N-CA 137.324 6.25 . . . . 0.0 116.135 -164.941 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -112.56 136.83 51.63 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 125.727 1.892 . . . . 0.0 112.513 -168.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -124.43 120.87 33.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.654 1.181 . . . . 0.0 108.028 168.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -84.88 98.6 10.42 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.391 1.477 . . . . 0.0 110.426 169.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -86.88 -33.99 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 O-C-N 121.173 -0.954 . . . . 0.0 113.396 -174.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.4 tt -154.1 129.91 10.12 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.534 1.061 . . . . 0.0 111.375 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -78.79 169.23 18.56 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.407 HD11 ' CE3' ' A' ' 101' ' ' TRP . 73.3 mt -51.86 101.27 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.946 1.698 . . . . 0.0 112.075 176.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.0 t -119.9 167.6 11.97 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.648 1.579 . . . . 0.0 112.32 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.87 -11.82 43.56 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.891 1.676 . . . . 0.0 113.372 172.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -86.42 82.92 7.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 125.355 2.503 . . . . 0.0 109.223 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.9 t -64.61 -51.17 64.08 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 128.459 2.704 . . . . 0.0 110.076 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.4 t -65.12 -15.83 62.83 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.582 -1.324 . . . . 0.0 112.028 174.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -78.72 -45.9 20.21 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.259 -0.901 . . . . 0.0 110.132 173.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.473 ' CE1' HD21 ' A' ' 31' ' ' LEU . 6.9 t80 -54.45 -34.74 62.05 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.455 -0.778 . . . . 0.0 111.34 173.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -64.75 -39.18 93.19 Favored 'General case' 0 N--CA 1.481 1.122 0 O-C-N 121.19 -0.944 . . . . 0.0 110.199 -176.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 46.4 tpt85 -75.14 -27.75 59.89 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.345 1.458 . . . . 0.0 109.633 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.9 -36.73 19.74 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.595 0.559 . . . . 0.0 109.931 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.46 -47.77 66.25 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -62.31 -32.7 73.48 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -171.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -84.61 -4.19 58.86 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.205 1.402 . . . . 0.0 114.046 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -62.54 125.48 24.09 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.46 -1.4 . . . . 0.0 110.448 174.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -118.59 147.63 43.52 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.252 1.021 . . . . 0.0 110.344 170.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.9 m -82.5 159.34 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -168.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.2 t -101.93 -150.67 0.41 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 127.715 2.406 . . . . 0.0 112.44 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -159.92 155.89 27.05 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 125.716 1.627 . . . . 0.0 114.573 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -162.12 162.37 28.54 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.999 1.72 . . . . 0.0 112.208 174.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -78.85 -52.64 8.04 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.073 1.749 . . . . 0.0 111.71 -177.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.31 136.17 46.15 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.931 0.892 . . . . 0.0 111.773 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 80.4 m -72.97 -47.84 8.15 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-O 116.178 -1.867 . . . . 0.0 113.475 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.01 148.67 89.75 Favored 'Trans proline' 0 C--N 1.355 0.89 0 CA-C-N 121.94 1.728 . . . . 0.0 110.992 171.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.523 ' HB2' HE22 ' A' ' 85' ' ' GLN . 29.4 mmmt -123.34 174.93 7.01 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.92 1.288 . . . . 0.0 112.576 -169.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -99.74 23.13 37.32 Favored Glycine 0 N--CA 1.482 1.741 0 O-C-N 119.836 -1.79 . . . . 0.0 115.799 -170.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.523 HE22 ' HB2' ' A' ' 83' ' ' LYS . 0.4 OUTLIER -62.13 -17.73 58.73 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 120.359 2.079 . . . . 0.0 116.239 -169.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.496 ' HA ' HG22 ' A' ' 89' ' ' VAL . 4.9 mp -70.56 -14.09 62.36 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.413 ' HA ' HE22 ' A' ' 151' ' ' GLN . 93.4 m-20 -72.87 -49.99 26.58 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 167.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.08 -51.11 70.54 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 116.065 -1.922 . . . . 0.0 111.652 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.496 HG22 ' HA ' ' A' ' 86' ' ' LEU . 28.8 m -52.27 -34.28 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 121.191 1.814 . . . . 0.0 112.135 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.868 HG21 HD22 ' A' ' 156' ' ' LEU . 12.4 t -87.6 -37.64 11.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 CA-C-O 116.768 -1.587 . . . . 0.0 113.03 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -60.54 -46.6 89.58 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 121.862 2.119 . . . . 0.0 109.203 169.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 44.1 t -54.68 -40.19 50.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 125.509 1.524 . . . . 0.0 112.194 175.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.63 -42.32 64.54 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 43.8 mt -76.52 -38.78 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.455 1.102 . . . . 0.0 113.01 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 66.5 m -81.1 61.27 4.59 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.829 1.651 . . . . 0.0 110.619 -169.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.4 mt -50.79 -44.51 58.89 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 128.076 2.55 . . . . 0.0 111.619 -171.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.66 -22.39 66.94 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 114.965 -1.016 . . . . 0.0 113.691 -176.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -87.49 -47.89 8.38 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.963 0.905 . . . . 0.0 110.416 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.9 mp -70.29 -34.45 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.203 0.601 . . . . 0.0 110.769 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 95.2 29.41 8.98 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.23 1.395 . . . . 0.0 114.498 172.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.407 ' CE3' HD11 ' A' ' 59' ' ' LEU . 53.1 m95 -57.46 125.31 22.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.707 1.254 . . . . 0.0 112.952 -174.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -86.38 -177.07 6.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.195 2.198 . . . . 0.0 111.223 170.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -97.13 26.16 4.94 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.317 1.447 . . . . 0.0 114.808 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.69 -128.7 1.82 Allowed Glycine 0 CA--C 1.539 1.534 0 N-CA-C 107.716 -2.154 . . . . 0.0 107.716 169.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.575 HG23 HG13 ' A' ' 4' ' ' VAL 0.308 7.2 t -112.72 152.52 28.98 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.536 -1.332 . . . . 0.0 108.173 167.171 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -130.16 129.88 44.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 117.439 -1.267 . . . . 0.0 110.362 -167.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -126.62 125.26 41.61 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.88 1.673 . . . . 0.0 115.343 -168.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 108' ' ' LEU . 48.7 mt -97.7 103.29 15.22 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.676 0.75 . . . . 0.0 112.305 169.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.536 HG13 HG21 ' A' ' 170' ' ' VAL . 36.0 t -90.78 95.34 5.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 174.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 37.0 tp -94.8 123.84 38.5 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 170' ' ' VAL 0.273 11.6 p -113.83 139.15 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 170.213 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -164.07 156.39 17.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.24 1.816 . . . . 0.0 109.885 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -106.23 -0.2 24.69 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.58 1.552 . . . . 0.0 114.456 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -144.13 179.47 7.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.195 1.398 . . . . 0.0 111.953 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.28 -174.33 0.12 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 122.992 1.377 . . . . 0.0 113.387 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -135.28 158.57 44.02 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.492 1.917 . . . . 0.0 112.691 -169.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -86.65 130.31 34.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.065 1.346 . . . . 0.0 109.862 169.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.474 HD13 ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -110.14 170.21 8.23 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.825 1.25 . . . . 0.0 111.634 177.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.82 133.63 42.52 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.911 0.386 . . . . 0.0 111.87 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.4 mttm 91.94 -16.14 0.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 130.596 3.558 . . . . 0.0 113.008 -174.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -63.61 -28.95 70.28 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 121.484 1.947 . . . . 0.0 112.971 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -69.39 -5.54 24.21 Favored 'General case' 0 CA--C 1.551 0.995 0 O-C-N 121.472 -0.768 . . . . 0.0 112.855 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.9 t -62.77 -34.35 77.06 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.445 1.098 . . . . 0.0 112.469 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.66 -28.44 67.71 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.814 0.734 . . . . 0.0 112.373 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -81.05 4.05 73.11 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.109 1.338 . . . . 0.0 113.811 169.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 10.6 m 75.1 31.73 0.81 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 127.843 2.457 . . . . 0.0 111.6 175.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -115.06 110.87 20.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.553 1.141 . . . . 0.0 111.216 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -96.84 -40.6 8.85 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.347 1.459 . . . . 0.0 112.303 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -66.35 123.06 18.94 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.992 0.814 . . . . 0.0 110.977 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.9 t -65.93 152.75 43.83 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.946 0.899 . . . . 0.0 110.605 175.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 t -68.97 138.27 54.43 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.312 1.053 . . . . 0.0 111.963 174.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.5 p-10 -82.76 -13.37 56.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.159 1.784 . . . . 0.0 113.911 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.2 31.74 63.56 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.838 -0.979 . . . . 0.0 113.017 -176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -107.61 164.99 11.75 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.213 1.405 . . . . 0.0 112.714 174.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 26.2 t -67.51 119.45 12.33 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.864 1.265 . . . . 0.0 110.593 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -123.85 40.79 3.64 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.276 1.43 . . . . 0.0 111.838 174.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.4 tp -122.18 117.95 27.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.755 1.622 . . . . 0.0 108.422 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -120.34 -49.02 2.28 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.463 1.105 . . . . 0.0 108.732 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -86.46 -130.31 0.05 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.727 1.611 . . . . 0.0 108.34 168.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.33 -21.67 7.88 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.089 1.328 . . . . 0.0 113.674 174.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 21.0 mtt -93.26 142.79 26.92 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.788 1.294 . . . . 0.0 112.78 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -64.56 100.44 0.37 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.721 1.208 . . . . 0.0 110.351 169.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -61.77 -40.32 94.74 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.188 0.995 . . . . 0.0 112.593 -174.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 63.8 m -82.24 6.63 16.11 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 23.2 ttp-105 -47.87 -50.72 25.6 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.698 1.135 . . . . 0.0 111.49 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.39 -31.99 68.38 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-O 118.421 -1.21 . . . . 0.0 113.107 -169.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.291 6.4 tp10 -92.66 -84.57 0.01 OUTLIER Pre-proline 0 CA--C 1.554 1.104 0 CA-C-O 115.579 -2.153 . . . . 0.0 112.025 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -66.31 155.14 71.38 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 CA-C-N 124.646 2.695 . . . . 0.0 116.168 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -72.72 161.56 30.59 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 129.913 3.285 . . . . 0.0 113.847 176.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -52.44 138.4 27.47 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.833 0.853 . . . . 0.0 111.281 172.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.665 ' NE2' ' H ' ' A' ' 151' ' ' GLN 0.271 0.0 OUTLIER -82.18 143.78 31.17 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.094 -1.004 . . . . 0.0 112.014 178.85 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 70.6 m -74.99 148.88 39.54 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.401 1.08 . . . . 0.0 112.769 -174.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.442 ' HA ' ' HG ' ' A' ' 156' ' ' LEU 0.296 33.4 t -58.61 -22.06 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -177.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 20.4 t -65.33 -44.66 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 118.893 0.769 . . . . 0.0 111.553 169.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.42 -29.99 59.92 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.552 0.741 . . . . 0.0 110.729 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.868 HD22 HG21 ' A' ' 90' ' ' VAL . 2.1 mt -63.62 -45.76 88.83 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 172.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -53.41 -45.89 69.55 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.222 1.009 . . . . 0.0 112.713 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 76.5 p -69.78 -38.84 76.85 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -174.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.34 -45.86 58.05 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.153 -0.967 . . . . 0.0 112.147 173.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.7 mt -53.25 -40.38 64.56 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 119.923 1.238 . . . . 0.0 113.24 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.73 -28.18 50.72 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -82.7 -34.39 27.33 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.571 1.078 . . . . 0.0 111.536 176.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -72.41 -18.9 61.68 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.843 0.857 . . . . 0.0 111.974 171.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 63.9 39.93 7.81 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.08 1.752 . . . . 0.0 112.314 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.05 143.56 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-O 117.052 -1.451 . . . . 0.0 109.731 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -105.34 115.67 61.64 Favored Pre-proline 0 N--CA 1.481 1.111 0 CA-C-N 121.72 2.055 . . . . 0.0 112.627 170.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -80.38 149.39 19.15 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.635 2.224 . . . . 0.0 113.093 169.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.1 mt -137.22 110.28 7.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.875 1.67 . . . . 0.0 107.107 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -72.45 73.72 1.02 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.933 0.873 . . . . 0.0 112.355 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.536 HG21 HG13 ' A' ' 109' ' ' VAL . 88.1 t -65.54 92.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 O-C-N 120.945 -1.097 . . . . 0.0 111.862 172.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 24.4 m -139.2 138.97 21.67 Favored Pre-proline 0 N--CA 1.479 0.993 0 O-C-N 119.729 -1.857 . . . . 0.0 110.513 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -58.53 152.53 54.48 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.558 2.839 . . . . 0.0 114.01 173.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 72.6 p -46.23 -42.72 14.7 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 116.666 2.098 . . . . 0.0 116.666 -168.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -51.37 -40.84 60.03 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 120.214 1.37 . . . . 0.0 113.509 -171.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.6 8.59 33.27 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.5 t -59.85 -42.92 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 121.036 1.744 . . . . 0.0 110.885 -176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 43.5 mtmt -69.58 -13.45 62.33 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -174.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.443 ' HA ' ' HE2' ' A' ' 181' ' ' LYS 0.265 10.1 t -93.03 -27.5 16.95 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 118.86 0.754 . . . . 0.0 112.476 173.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -76.29 -29.76 57.5 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.49 -1.382 . . . . 0.0 109.509 168.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -58.03 -26.54 62.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.168 0.987 . . . . 0.0 110.818 169.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 178' ' ' THR . 55.3 mtmt -79.4 -40.28 30.43 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.573 -0.705 . . . . 0.0 109.589 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.6 mp -79.65 -18.66 50.94 Favored 'General case' 0 C--O 1.223 -0.303 0 O-C-N 120.668 -1.27 . . . . 0.0 111.532 -175.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.8 t -74.89 -11.52 60.15 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.066 0.46 . . . . 0.0 110.581 168.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.31 -28.67 23.57 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 121.177 -0.952 . . . . 0.0 109.434 168.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -76.85 -26.56 54.41 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.27 91.09 50.03 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.536 1.134 . . . . 0.0 110.654 170.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.06 153.45 32.25 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.596 3.531 . . . . 0.0 113.692 173.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 24.9 pttt 88.29 -19.11 0.23 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 131.464 3.906 . . . . 0.0 113.229 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 11.1 mp -69.64 163.91 24.54 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.794 0.838 . . . . 0.0 110.267 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 36.0 p -123.0 -145.42 0.35 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 169.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.2 tt 178.65 138.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 129.055 2.942 . . . . 0.0 107.977 -168.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -133.52 143.5 15.21 Favored Glycine 0 N--CA 1.463 0.479 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -87.87 90.09 8.24 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.31 133.89 55.73 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.602 169.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 35.2 m -150.74 -158.64 0.94 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.806 1.642 . . . . 0.0 107.703 173.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.34 -24.74 67.51 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 120.882 -1.136 . . . . 0.0 110.522 168.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -85.12 134.96 34.17 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.413 2.285 . . . . 0.0 112.549 173.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 34.7 p -98.41 -0.7 43.08 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.83 2.052 . . . . 0.0 113.448 174.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.2 p -59.75 -55.79 29.93 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 126.546 1.938 . . . . 0.0 113.551 -168.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -69.2 -36.98 77.86 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 122.153 -0.342 . . . . 0.0 111.141 -171.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.22 -50.91 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.925 0.89 . . . . 0.0 110.894 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.48 -30.7 71.1 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-O 118.782 -0.628 . . . . 0.0 111.792 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -74.76 -1.62 22.85 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.246 -1.534 . . . . 0.0 112.912 176.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.06 -33.47 9.25 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 120.582 -1.324 . . . . 0.0 109.862 174.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 86.1 mt -73.75 -40.12 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -65.9 -33.78 76.63 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.545 -0.722 . . . . 0.0 111.479 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -69.96 -25.05 63.45 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 119.059 0.845 . . . . 0.0 112.87 172.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -77.26 -37.24 53.45 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 120.69 -1.256 . . . . 0.0 111.53 173.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -61.14 -32.34 72.04 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.212 0.915 . . . . 0.0 111.69 173.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 54.3 p -75.02 -11.11 60.03 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -71.07 -36.54 72.32 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.487 1.04 . . . . 0.0 110.937 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 1 C--O 1.334 5.501 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -91.98 161.09 14.94 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.012 0.925 . . . . 0.0 111.836 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 t -66.49 127.54 32.71 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.271 -0.893 . . . . 0.0 110.902 169.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.1 t -123.86 135.6 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.394 1.478 . . . . 0.0 109.406 172.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -114.59 113.3 24.2 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 168.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.522 HD23 HD12 ' A' ' 43' ' ' ILE . 59.0 tp -101.21 131.89 46.98 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.056 0.455 . . . . 0.0 111.999 171.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -121.09 111.64 17.7 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 123.631 1.682 . . . . 0.0 109.561 169.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -88.52 107.85 19.1 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.007 -1.906 . . . . 0.0 111.597 175.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.3 tp -100.59 120.14 39.6 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.997 1.319 . . . . 0.0 111.877 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 30.8 mtp -103.97 143.9 32.25 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.88 115.38 4.97 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.701 1.619 . . . . 0.0 109.731 168.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -99.56 35.4 1.99 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.299 1.84 . . . . 0.0 111.951 -174.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 p -75.57 152.85 37.66 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.954 1.302 . . . . 0.0 113.605 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.45 -27.35 60.74 Favored Glycine 0 N--CA 1.478 1.464 0 O-C-N 121.258 -0.901 . . . . 0.0 113.881 -177.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.1 p -65.73 -25.31 67.24 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.396 1.478 . . . . 0.0 113.891 170.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.28 -2.21 48.07 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.659 1.583 . . . . 0.0 114.143 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -70.67 136.62 49.2 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 121.786 2.084 . . . . 0.0 108.136 169.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.76 -50.73 2.01 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -168.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -68.0 -20.29 65.01 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.817 0.847 . . . . 0.0 111.803 169.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -48.94 -49.31 40.87 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.148 1.779 . . . . 0.0 109.963 175.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.5 m -62.82 -37.77 88.08 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 118.796 0.726 . . . . 0.0 112.793 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -62.41 -41.86 99.0 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.269 -1.519 . . . . 0.0 112.034 172.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.7 p -87.36 20.6 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 125.838 1.655 . . . . 0.0 112.126 174.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -119.7 -49.04 2.35 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.068 1.347 . . . . 0.0 109.097 171.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.1 t -59.33 -37.66 78.37 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.834 -0.541 . . . . 0.0 109.966 169.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 17.1 tp -96.39 107.01 19.33 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 168.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 146.49 -48.72 0.66 Allowed Glycine 0 C--N 1.303 -1.276 1 C-N-CA 130.817 4.056 . . . . 0.0 106.603 176.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.1 m -76.17 -36.91 58.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.452 1.501 . . . . 0.0 112.355 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.23 -26.29 66.52 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.538 -0.726 . . . . 0.0 112.312 170.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.97 -57.45 8.69 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.475 172.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.632 HD22 HG21 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -46.95 -55.56 7.9 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.163 0.985 . . . . 0.0 112.399 -176.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -69.77 -43.71 71.62 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -169.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.85 -41.23 78.74 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 117.61 0.187 . . . . 0.0 111.435 176.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.466 HD21 ' CG2' ' A' ' 205' ' ' ILE . 1.0 OUTLIER -69.48 -36.75 76.82 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.678 -1.264 . . . . 0.0 111.275 -177.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -60.22 -24.83 65.15 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.112 0.965 . . . . 0.0 112.434 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 62.8 tt0 -84.69 -42.02 15.7 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.545 1.138 . . . . 0.0 110.658 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.6 mm -64.78 -34.53 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.285 0.634 . . . . 0.0 111.534 172.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 73.9 p -155.0 134.3 12.48 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -60.77 -49.51 77.18 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.141 1.776 . . . . 0.0 113.106 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.2 m -95.31 81.36 3.6 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.71 0.767 . . . . 0.0 109.829 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.52 83.03 0.32 Allowed Glycine 0 C--N 1.337 0.631 0 C-N-CA 127.512 2.482 . . . . 0.0 107.492 -177.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -85.47 146.08 27.12 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 125.484 1.514 . . . . 0.0 108.019 -169.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.632 HG21 HD22 ' A' ' 31' ' ' LEU 0.261 11.9 tt -136.56 141.77 40.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 178.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -131.93 150.77 19.64 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 127.884 2.659 . . . . 0.0 109.816 -175.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -126.79 130.29 49.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.36 146.19 16.63 Favored Glycine 0 C--N 1.343 0.97 0 C-N-CA 124.545 1.069 . . . . 0.0 112.626 178.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.9 t -119.14 143.5 47.17 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.813 1.645 . . . . 0.0 109.918 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.68 151.04 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.944 1.298 . . . . 0.0 108.581 176.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -151.94 -18.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 169.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 63.4 t30 117.42 -10.96 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 130.847 3.659 . . . . 0.0 111.597 -171.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.51 ' O ' HG23 ' A' ' 52' ' ' THR . 64.9 ttp -62.72 -44.21 96.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.93 -1.106 . . . . 0.0 108.585 169.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 51' ' ' MET . 55.5 p 176.13 -164.35 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.89 1 C-N-CA 135.234 5.413 . . . . 0.0 105.19 169.287 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -109.11 133.01 53.57 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 167.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -118.59 121.88 41.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.34 1.067 . . . . 0.0 110.638 171.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -80.57 111.12 16.69 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.761 169.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.5 mm -93.95 -53.6 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.218 1.007 . . . . 0.0 111.531 -173.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 14.8 tp -126.15 123.77 39.01 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.163 0.892 . . . . 0.0 111.897 -175.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -59.09 154.34 16.01 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.086 1.354 . . . . 0.0 112.15 173.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 58.5 mt -59.24 111.01 1.19 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 119.669 1.122 . . . . 0.0 110.884 172.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.1 t -143.49 169.05 18.43 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.371 1.068 . . . . 0.0 112.746 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.33 -10.16 54.99 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.813 2.045 . . . . 0.0 113.841 -178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -81.47 76.39 8.4 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 124.923 2.297 . . . . 0.0 109.978 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.2 t -56.52 -49.33 75.07 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 129.397 3.079 . . . . 0.0 109.294 173.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.3 m -60.68 -17.61 48.81 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.387 1.075 . . . . 0.0 112.065 173.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -87.7 -42.36 12.7 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 118.604 0.638 . . . . 0.0 111.843 174.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.597 ' CD1' HD21 ' A' ' 31' ' ' LEU . 8.3 t80 -57.3 -33.72 67.96 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 118.426 0.557 . . . . 0.0 111.467 172.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -62.29 -45.04 95.06 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.443 1.097 . . . . 0.0 109.928 -174.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -76.21 -33.98 59.26 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 124.677 1.191 . . . . 0.0 108.856 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -82.0 -29.6 31.99 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -175.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.8 tp -67.14 -42.65 84.04 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 169.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -67.46 -30.85 70.68 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -72.52 -15.88 61.78 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -60.57 135.85 57.88 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.438 1.017 . . . . 0.0 112.614 -171.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 75' ' ' VAL . 2.9 tt -127.59 133.96 49.72 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.697 1.199 . . . . 0.0 110.144 -175.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.419 ' N ' HD23 ' A' ' 74' ' ' LEU . 4.2 t -69.55 145.48 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 127.991 2.516 . . . . 0.0 112.939 -173.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.1 t -92.97 -162.09 0.9 Allowed 'General case' 0 CA--C 1.563 1.467 0 C-N-CA 126.108 1.763 . . . . 0.0 112.133 172.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -159.76 125.15 1.44 Allowed Glycine 0 N--CA 1.481 1.638 0 O-C-N 119.742 -1.849 . . . . 0.0 115.129 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -145.88 167.04 24.21 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.541 1.936 . . . . 0.0 112.836 -173.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.1 mt -95.67 -49.18 5.48 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -169.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -74.64 136.81 41.93 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.716 0.689 . . . . 0.0 111.033 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.279 13.0 t -64.1 -42.52 69.44 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-O 114.661 -2.59 . . . . 0.0 115.18 -177.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.66 149.35 73.55 Favored 'Trans proline' 0 C--N 1.359 1.098 0 CA-C-N 123.925 2.437 . . . . 0.0 113.242 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -102.96 165.51 10.98 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.911 0.884 . . . . 0.0 111.994 173.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.45 48.16 3.1 Favored Glycine 0 N--CA 1.48 1.576 0 C-N-CA 125.766 1.651 . . . . 0.0 112.106 172.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -68.34 -44.14 75.95 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -169.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -72.48 -15.82 61.8 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.814 -1.179 . . . . 0.0 112.848 -175.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -58.29 -49.96 75.31 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 120.351 1.432 . . . . 0.0 108.398 168.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.32 -45.77 80.16 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.836 -0.54 . . . . 0.0 111.296 171.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.81 -41.33 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-O 118.178 -0.915 . . . . 0.0 112.294 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 60.4 t -58.91 -53.19 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 119.922 1.237 . . . . 0.0 109.844 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -62.76 -51.92 65.22 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 122.414 0.286 . . . . 0.0 110.846 -173.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.537 HG11 HD13 ' A' ' 108' ' ' LEU . 88.0 t -56.68 -27.98 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 123.471 0.708 . . . . 0.0 111.874 177.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.71 -32.62 23.43 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.83 -31.39 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 119.485 1.039 . . . . 0.0 112.218 -174.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 60.7 m -82.86 59.47 4.85 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.497 1.919 . . . . 0.0 111.125 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.61 -36.01 75.46 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.266 1.427 . . . . 0.0 113.051 -169.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -73.62 -32.97 58.82 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.376 0.512 . . . . 0.0 113.312 -174.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -94.77 -38.51 10.74 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 124.526 1.13 . . . . 0.0 111.354 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.4 mm -63.64 -37.04 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 120.915 1.689 . . . . 0.0 109.537 169.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.27 28.36 22.87 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.131 1.348 . . . . 0.0 113.818 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -57.44 119.65 6.87 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.191 1.495 . . . . 0.0 110.786 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 41.4 mmt-85 -83.42 -158.14 0.28 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.755 2.022 . . . . 0.0 108.805 171.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -81.69 -157.58 0.19 Allowed 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.27 -177.91 53.14 Favored Glycine 0 N--CA 1.424 -2.123 0 CA-C-O 125.541 2.745 . . . . 0.0 108.841 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.7 p -67.96 132.84 48.06 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 108.316 -3.942 . . . . 0.0 106.606 168.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.17 135.22 55.19 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 -177.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.437 ' CE1' HG13 ' A' ' 205' ' ' ILE . 1.8 t80 -138.48 124.62 20.23 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 115.715 1.746 . . . . 0.0 115.715 -166.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.537 HD13 HG11 ' A' ' 92' ' ' VAL . 52.4 tp -105.33 98.3 8.02 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.147 0.43 . . . . 0.0 111.011 177.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 39.5 t -80.45 121.68 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 170.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.412 HD23 ' C ' ' A' ' 110' ' ' LEU . 7.1 tt -109.41 120.85 43.75 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.7 t -111.59 132.4 60.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 O-C-N 124.129 0.893 . . . . 0.0 112.001 176.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.5 t -151.24 179.39 8.34 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.445 1.098 . . . . 0.0 111.283 171.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -125.57 -13.22 6.57 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.653 1.981 . . . . 0.0 114.097 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -137.09 173.55 11.57 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.49 1.516 . . . . 0.0 112.981 -171.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -60.79 -169.61 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 125.673 1.589 . . . . 0.0 114.08 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.88 146.37 25.6 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.537 1.681 . . . . 0.0 115.537 -167.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.506 ' HB3' ' CE2' ' A' ' 150' ' ' TYR . 97.1 m-70 -82.18 93.38 7.06 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.983 1.313 . . . . 0.0 113.458 176.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.626 HD23 ' H ' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -75.69 173.23 11.35 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.856 -1.152 . . . . 0.0 113.012 170.541 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -47.57 149.07 1.25 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.833 0.853 . . . . 0.0 113.119 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . 0.302 38.6 pttt 76.86 -16.09 0.67 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 131.13 3.772 . . . . 0.0 114.635 -175.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -63.21 -38.26 90.48 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.483 1.038 . . . . 0.0 113.173 -175.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . 0.274 13.7 mttt -86.02 12.87 8.56 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 m -62.36 -26.77 68.64 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 118.975 0.807 . . . . 0.0 108.937 167.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.4 mt -61.65 -36.67 81.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.895 1.278 . . . . 0.0 112.361 169.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -85.62 22.75 10.11 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 126.596 2.046 . . . . 0.0 113.437 170.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.321 3.9 t 55.52 28.07 11.22 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.669 2.787 . . . . 0.0 114.226 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 149' ' ' ASP . 20.1 ttp180 -101.61 85.86 2.83 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.89 1.676 . . . . 0.0 110.364 -175.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -80.96 -45.65 16.33 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.187 0.995 . . . . 0.0 112.977 -173.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -60.44 121.09 11.22 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.231 1.012 . . . . 0.0 111.239 -169.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.0 t -68.84 143.49 54.54 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 120.184 1.356 . . . . 0.0 111.052 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.0 t -58.33 130.43 46.69 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.319 -0.863 . . . . 0.0 111.933 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.5 p30 -76.72 -9.97 59.05 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.032 1.333 . . . . 0.0 113.816 176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 71.1 23.17 78.36 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 117.797 -1.557 . . . . 0.0 114.124 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -100.16 168.19 9.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.099 1.759 . . . . 0.0 112.524 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 33.4 t -69.96 136.05 50.09 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.272 -0.893 . . . . 0.0 111.637 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -147.78 37.54 0.89 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.495 1.918 . . . . 0.0 112.053 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 81.7 mt -103.46 136.28 43.5 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.355 1.062 . . . . 0.0 110.768 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -155.29 135.43 13.05 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.338 1.455 . . . . 0.0 110.175 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.3 t0 52.71 27.76 5.59 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.536 1.534 . . . . 0.0 112.951 -169.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 88.06 -6.92 82.87 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.298 1.904 . . . . 0.0 114.793 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 38.7 mtt -98.78 142.59 30.13 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 119.829 1.814 . . . . 0.0 113.62 -174.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -76.32 81.13 3.08 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.14 0.976 . . . . 0.0 110.984 169.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -50.89 -44.61 59.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.303 1.441 . . . . 0.0 112.41 -175.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 94.3 p -78.95 -0.19 30.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -170.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 52' ' ' THR . 1.3 ttp180 -45.12 -39.67 6.23 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 121.125 1.784 . . . . 0.0 113.091 171.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.2 -19.43 79.63 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-O 118.297 -1.279 . . . . 0.0 114.793 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -111.65 -69.18 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.246 0 CA-C-O 116.334 -1.793 . . . . 0.0 113.154 -169.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -74.58 146.95 35.19 Favored 'Trans proline' 0 C--N 1.357 1.026 0 CA-C-N 123.697 2.356 . . . . 0.0 114.128 169.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 127' ' ' ARG . 24.3 t0 -77.6 167.63 21.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.476 2.711 . . . . 0.0 114.606 176.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.506 ' CE2' ' HB3' ' A' ' 117' ' ' HIS . 64.0 m-85 -53.54 148.17 9.82 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.434 1.094 . . . . 0.0 111.947 178.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.7 157.69 17.19 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.984 0.897 . . . . 0.0 112.38 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 73.6 m -87.36 149.27 24.61 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 168.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.8 t -56.8 -30.99 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.618 -1.301 . . . . 0.0 111.343 -175.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.18 -36.18 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.253 1.821 . . . . 0.0 112.964 173.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -75.89 -27.6 57.78 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.332 0.969 . . . . 0.0 111.572 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.52 -47.8 74.7 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.426 168.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -56.69 -37.33 70.73 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 99.2 p -72.24 -49.94 31.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.279 0.945 . . . . 0.0 113.119 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 159' ' ' LYS . 8.7 mmpt? -70.51 -36.15 73.6 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.391 -1.443 . . . . 0.0 113.817 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 84.9 mt -68.58 -35.45 77.39 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.927 0.785 . . . . 0.0 112.05 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.05 -33.9 70.73 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 176.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -79.22 -44.06 22.57 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.096 0.558 . . . . 0.0 110.897 -177.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -84.02 -0.59 52.27 Favored 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 68.96 16.07 8.8 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 127.676 2.391 . . . . 0.0 115.988 168.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 50.8 mt -75.28 139.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 120.623 -1.298 . . . . 0.0 110.319 -174.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.414 ' HB2' ' CD2' ' A' ' 107' ' ' PHE . 11.3 mm-40 -99.45 95.84 3.91 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.097 173.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -73.82 144.82 35.45 Favored 'Trans proline' 0 C--N 1.352 0.754 0 CA-C-N 121.285 1.495 . . . . 0.0 114.564 169.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 5.7 mt -129.89 117.74 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 124.388 1.075 . . . . 0.0 110.754 170.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -78.48 76.09 4.99 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.461 1.124 . . . . 0.0 112.798 178.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.409 ' CG2' HG21 ' A' ' 201' ' ' VAL . 10.8 t -64.38 103.62 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 122.185 0.993 . . . . 0.0 112.483 169.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.407 ' HB ' ' HD2' ' A' ' 172' ' ' PRO . 17.4 m -144.47 157.97 54.97 Favored Pre-proline 0 N--CA 1.484 1.253 0 CA-C-O 117.573 -1.204 . . . . 0.0 111.239 -169.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.407 ' HD2' ' HB ' ' A' ' 171' ' ' VAL . 57.2 Cg_endo -73.87 165.14 32.9 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.603 2.869 . . . . 0.0 111.687 -171.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 73.9 p -52.08 -39.72 60.14 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.334 1.054 . . . . 0.0 113.338 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 35.7 ptt85 -63.18 -23.3 67.37 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.419 ' CE ' ' CE1' ' A' ' 179' ' ' TYR . 78.3 mtp -103.14 -22.87 13.69 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.3 t -56.47 -26.29 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 120.179 1.354 . . . . 0.0 112.009 -168.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.57 -29.88 70.91 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.918 1.287 . . . . 0.0 114.463 175.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 1.2 t -93.83 -37.98 11.47 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.889 0.876 . . . . 0.0 111.575 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.419 ' CE1' ' CE ' ' A' ' 175' ' ' MET . 12.1 m-85 -73.9 -28.5 61.57 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 120.149 -1.594 . . . . 0.0 110.233 175.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.525 ' HA ' HG22 ' A' ' 183' ' ' THR 0.268 17.5 tt0 -66.79 -10.85 51.9 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 119.348 0.976 . . . . 0.0 112.58 172.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -99.3 -7.83 25.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.063 -1.023 . . . . 0.0 113.684 169.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.85 -28.97 22.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.702 1.201 . . . . 0.0 109.406 168.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.525 HG22 ' HA ' ' A' ' 180' ' ' GLU . 15.1 t -85.88 -15.89 40.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.316 -0.865 . . . . 0.0 112.784 177.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 1.1 t -77.59 -25.86 50.25 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 121.302 -0.874 . . . . 0.0 108.751 168.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -80.19 -45.25 18.38 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.181 -0.438 . . . . 0.0 111.551 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 19.3 mt -94.81 106.53 25.25 Favored Pre-proline 0 N--CA 1.483 1.218 0 CA-C-O 118.335 -0.841 . . . . 0.0 109.469 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.87 147.17 67.98 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.41 2.073 . . . . 0.0 111.466 -173.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 60.5 mttm 83.06 -10.21 1.03 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.822 2.849 . . . . 0.0 113.693 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.1 mt -73.37 166.83 22.46 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . 0.48 0.5 OUTLIER -143.47 -161.24 1.23 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 169.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.5 mt -160.52 142.7 4.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 C-N-CA 129.769 3.228 . . . . 0.0 111.982 -165.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -124.64 161.55 19.08 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.917 0.77 . . . . 0.0 111.808 169.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -92.37 100.16 12.79 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.888 1.675 . . . . 0.0 108.019 173.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 13.8 tp -62.74 130.28 44.24 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 114.013 -1.449 . . . . 0.0 108.89 168.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 84.9 p -171.08 -157.49 0.13 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.417 1.487 . . . . 0.0 110.199 170.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.34 -18.62 63.08 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -109.03 133.71 52.63 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.847 1.259 . . . . 0.0 112.204 171.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 73.5 m -91.06 0.02 57.63 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.076 1.35 . . . . 0.0 113.291 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 35.4 m -59.98 -45.84 91.39 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.052 1.741 . . . . 0.0 112.89 -169.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -63.11 -43.76 97.56 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 118.589 -0.72 . . . . 0.0 112.617 -170.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.409 HG21 ' CG2' ' A' ' 170' ' ' VAL . 8.0 p -82.26 -32.56 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 119.558 1.072 . . . . 0.0 113.161 175.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -61.48 -30.45 70.61 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 120.366 1.439 . . . . 0.0 110.95 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -65.97 -15.03 62.63 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 119.541 -1.974 . . . . 0.0 114.223 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.1 mt -103.46 -35.45 8.34 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.952 2.101 . . . . 0.0 109.708 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.466 ' CG2' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -67.37 -39.16 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.856 1.262 . . . . 0.0 108.116 171.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 29.9 ttp-105 -73.95 -42.21 60.86 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 124.008 0.923 . . . . 0.0 110.498 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . 0.331 11.5 m-20 -77.86 -12.06 59.95 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 117.619 -1.632 . . . . 0.0 114.294 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -83.11 -31.92 27.0 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.308 1.043 . . . . 0.0 110.309 168.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -65.74 -45.75 81.44 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.659 -0.65 . . . . 0.0 111.519 170.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 79.8 p -66.83 -9.75 40.72 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.494 ' HA ' ' HE3' ' A' ' 211' ' ' LYS . 0.5 OUTLIER -73.05 -32.01 64.78 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.715 1.005 . . . . 0.0 113.715 176.471 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 13.8 mt . . . . . 0 CA--C 1.571 1.778 0 C-N-CA 125.139 1.375 . . . . 0.0 113.155 172.725 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 120.384 0.135 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -123.52 149.83 44.72 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.115 1.366 . . . . 0.0 110.883 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.5 m -61.16 111.08 1.58 Allowed 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.137 -0.977 . . . . 0.0 112.059 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 67.1 t -110.97 138.02 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.42 1.088 . . . . 0.0 109.8 174.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -116.56 117.94 31.25 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.184 1.393 . . . . 0.0 108.834 169.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.428 HD12 ' CB ' ' A' ' 107' ' ' PHE . 2.4 tp -110.28 130.52 55.53 Favored 'General case' 0 N--CA 1.483 1.225 0 CA-C-N 118.883 0.765 . . . . 0.0 111.78 169.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.402 ' CD2' HG23 ' A' ' 99' ' ' ILE . 28.8 t80 -115.92 114.47 24.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 123.717 1.722 . . . . 0.0 109.092 168.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -88.46 107.66 18.98 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 127.184 2.194 . . . . 0.0 111.859 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.8 mt -92.65 122.02 34.65 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.737 0.815 . . . . 0.0 112.013 170.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.44 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 24.4 mtp -103.41 131.94 50.08 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 174.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -82.15 114.37 3.82 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 108.223 -1.951 . . . . 0.0 108.223 167.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.27 21.2 15.42 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.373 1.469 . . . . 0.0 113.989 -172.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 83.8 p -84.83 168.44 15.11 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 119.679 -1.888 . . . . 0.0 112.699 -169.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.69 -32.16 58.36 Favored Glycine 0 N--CA 1.477 1.369 0 O-C-N 121.401 -0.812 . . . . 0.0 114.045 -170.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 m -63.45 -35.25 79.82 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.793 1.237 . . . . 0.0 112.698 174.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.55 0.09 18.55 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.712 1.605 . . . . 0.0 114.217 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -53.96 -48.42 70.31 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.712 1.205 . . . . 0.0 112.402 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.32 -26.9 64.86 Favored Glycine 0 N--CA 1.474 1.187 0 CA-C-N 118.282 0.492 . . . . 0.0 113.049 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -82.2 -13.39 57.18 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.322 1.449 . . . . 0.0 113.318 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.8 tp -56.04 -46.37 78.91 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.051 1.34 . . . . 0.0 112.024 -178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 t -58.99 -41.03 86.64 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 122.228 1.013 . . . . 0.0 110.819 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -70.47 -19.83 62.92 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.476 -1.39 . . . . 0.0 113.424 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . 0.291 20.1 m -105.97 13.81 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 170.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -108.94 -33.53 6.89 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 167.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.6 t -63.33 -49.51 73.67 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 169.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.401 HD22 HD12 ' A' ' 194' ' ' LEU . 20.8 tp -85.19 102.47 13.33 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 104.74 -2.319 . . . . 0.0 104.74 168.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 153.32 -39.72 0.7 Allowed Glycine 0 C--N 1.298 -1.558 0 CA-C-N 109.132 -3.667 . . . . 0.0 108.395 168.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 64.7 m -76.97 -46.4 24.17 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.555 1.542 . . . . 0.0 109.978 172.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -65.81 -41.25 92.11 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.163 0.985 . . . . 0.0 111.254 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.53 -43.45 76.73 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.556 -176.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.25 -54.05 49.05 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.151 0.98 . . . . 0.0 110.979 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -67.72 -31.9 72.16 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.224 -0.922 . . . . 0.0 113.091 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.53 -49.57 72.97 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.981 0.81 . . . . 0.0 111.516 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 19.0 mt -83.64 -12.37 56.06 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -176.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -60.66 -31.75 70.97 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 120.926 1.694 . . . . 0.0 112.964 170.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -95.52 -27.77 15.21 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 118.96 -0.543 . . . . 0.0 112.06 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.95 -29.09 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 119.334 0.97 . . . . 0.0 109.746 168.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 t -147.12 127.36 13.86 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 169.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -69.48 -27.06 64.89 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.993 1.717 . . . . 0.0 112.359 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 18.3 t -105.03 92.33 4.18 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.345 1.458 . . . . 0.0 108.736 171.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.46 84.51 0.18 Allowed Glycine 0 C--N 1.338 0.684 0 C-N-CA 127.184 2.326 . . . . 0.0 108.382 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 77.3 mtt180 -91.65 135.63 33.73 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -171.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.7 tp -116.61 139.19 44.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 124.83 1.252 . . . . 0.0 110.894 -171.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.5 159.28 24.8 Favored Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.428 1.014 . . . . 0.0 113.036 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -132.27 129.13 39.19 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.37 1.468 . . . . 0.0 113.556 -169.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.72 144.65 16.57 Favored Glycine 0 C--N 1.343 0.926 0 C-N-CA 124.32 0.962 . . . . 0.0 113.513 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.6 m -114.65 136.31 53.19 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.629 1.572 . . . . 0.0 111.455 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.9 tt -156.46 149.94 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 120.578 -1.327 . . . . 0.0 112.402 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.522 HG23 ' H ' ' A' ' 50' ' ' ASN . 2.3 m -150.52 -66.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 125.586 1.554 . . . . 0.0 111.898 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.522 ' H ' HG23 ' A' ' 49' ' ' VAL 0.424 29.8 t30 168.99 -13.61 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.973 1 C-N-CA 133.251 4.62 . . . . 0.0 111.482 169.278 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.0 ttt -49.32 -38.9 29.44 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 165.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.274 10.6 t 164.13 -163.16 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.967 1 C-N-CA 133.06 4.544 . . . . 0.0 109.623 168.147 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -107.98 132.38 53.57 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.812 2.445 . . . . 0.0 105.805 168.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -127.85 125.79 40.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 122.59 1.186 . . . . 0.0 110.1 169.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.73 132.02 35.5 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.921 1.288 . . . . 0.0 110.576 169.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.54 -17.37 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.39 108.6 5.0 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.84 1.655 . . . . 0.0 112.253 176.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.5 ttpm? -61.39 154.25 24.65 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.561 1.544 . . . . 0.0 112.607 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.0 mt -50.71 112.54 0.72 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.719 0.69 . . . . 0.0 111.876 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.8 t -143.9 171.13 14.65 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.999 1.32 . . . . 0.0 111.984 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.55 -6.53 16.93 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.745 1.618 . . . . 0.0 114.765 -170.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.25 93.95 9.67 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 125.645 2.641 . . . . 0.0 105.755 171.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.4 p -76.5 -44.28 35.89 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 131.062 3.745 . . . . 0.0 113.557 -169.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.2 t -59.41 -22.34 61.29 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.758 -0.589 . . . . 0.0 110.662 169.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -71.18 -51.69 23.38 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.183 -0.948 . . . . 0.0 109.971 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -53.77 -37.6 63.6 Favored 'General case' 0 C--O 1.22 -0.449 0 C-N-CA 123.365 0.666 . . . . 0.0 111.85 172.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -67.96 -39.14 83.42 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.291 1.036 . . . . 0.0 109.898 -171.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 32.5 mtp-105 -71.61 -33.88 69.36 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 124.943 1.297 . . . . 0.0 110.152 175.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -79.78 -30.56 40.68 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.409 0.683 . . . . 0.0 109.689 -173.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.12 -54.34 15.46 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.541 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.448 7.7 ptp180 -74.97 -15.04 60.68 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 116.076 1.88 . . . . 0.0 116.076 -169.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.59 2.87 46.69 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 169.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -60.04 155.61 16.58 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.457 1.026 . . . . 0.0 111.742 171.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.97 156.14 46.11 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.401 1.48 . . . . 0.0 111.036 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.84 141.18 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.941 1.296 . . . . 0.0 111.47 -169.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.1 p -94.12 -143.57 0.24 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 125.426 1.49 . . . . 0.0 112.718 176.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -164.75 144.72 9.59 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.561 -1.337 . . . . 0.0 114.262 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -148.65 163.74 36.37 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.214 1.806 . . . . 0.0 112.84 175.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.9 mt -74.44 -59.85 2.54 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.887 1.275 . . . . 0.0 112.573 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.89 136.98 54.88 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.83 0.852 . . . . 0.0 111.965 -172.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 68.6 p -75.72 -34.59 1.56 Allowed Pre-proline 0 N--CA 1.475 0.821 0 CA-C-O 115.512 -2.185 . . . . 0.0 113.307 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.39 140.73 44.8 Favored 'Trans proline' 0 C--N 1.354 0.842 0 CA-C-N 123.078 2.135 . . . . 0.0 108.967 169.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -104.44 -177.18 3.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.65 0.78 . . . . 0.0 112.215 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.08 9.49 72.57 Favored Glycine 0 N--CA 1.483 1.777 0 C-N-CA 124.633 1.111 . . . . 0.0 114.829 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -35.45 -55.61 0.66 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 129.192 2.997 . . . . 0.0 118.667 -169.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 116' ' ' PHE . 7.7 mp -67.29 -18.5 65.22 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 121.526 1.966 . . . . 0.0 113.134 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.32 -24.08 67.7 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.421 1.464 . . . . 0.0 112.411 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -78.41 -44.08 25.77 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.311 -1.493 . . . . 0.0 108.129 167.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.443 HG22 HD13 ' A' ' 110' ' ' LEU . 31.6 t -52.5 -42.32 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 118.204 -0.903 . . . . 0.0 111.277 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.427 HG13 HE21 ' A' ' 91' ' ' GLN . 8.3 p -62.71 -55.81 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.702 1.137 . . . . 0.0 111.783 171.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.427 HE21 HG13 ' A' ' 90' ' ' VAL . 77.1 mm-40 -66.21 -42.33 88.89 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.973 0.806 . . . . 0.0 110.914 -170.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.535 HG11 HD13 ' A' ' 108' ' ' LEU . 78.2 t -60.87 -33.07 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.362 1.065 . . . . 0.0 111.728 171.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.8 68.48 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.671 1.123 . . . . 0.0 111.985 174.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . 0.289 0.0 OUTLIER -96.38 -14.22 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -169.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.24 60.52 3.09 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 121.17 1.804 . . . . 0.0 112.351 173.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.9 mt -50.95 -40.11 56.64 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.899 1.68 . . . . 0.0 111.74 -176.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.72 -31.02 41.67 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.158 0.885 . . . . 0.0 114.852 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -89.38 -39.74 13.21 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.607 1.203 . . . . 0.0 111.132 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.454 HG21 ' CE2' ' A' ' 101' ' ' TRP . 33.6 mm -65.73 -38.49 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 O-C-N 120.988 -1.07 . . . . 0.0 110.048 169.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.07 26.3 34.62 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.152 0.882 . . . . 0.0 113.182 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.454 ' CE2' HG21 ' A' ' 99' ' ' ILE . 72.5 m95 -55.97 130.57 44.37 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 118.229 1.014 . . . . 0.0 112.208 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.5 mtp-105 -104.41 -168.57 1.5 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.407 2.283 . . . . 0.0 111.958 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -86.03 -0.59 55.91 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 117.017 2.229 . . . . 0.0 117.017 -169.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.48 -132.75 3.3 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 120.917 1.69 . . . . 0.0 110.972 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.5 t -99.58 147.58 25.2 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.757 1.223 . . . . 0.0 108.954 174.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.407 ' HB2' ' HA ' ' A' ' 165' ' ' ILE . 97.3 mtt180 -132.15 124.8 29.8 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -168.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.428 ' CB ' HD12 ' A' ' 6' ' ' LEU . 64.5 m-85 -125.01 110.15 13.83 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -169.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.535 HD13 HG11 ' A' ' 92' ' ' VAL . 25.8 tp -92.59 98.05 11.2 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.283 175.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.7 t -83.45 124.64 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 174.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.443 HD13 HG22 ' A' ' 89' ' ' VAL . 20.2 tp -109.65 112.39 24.43 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 118.81 -0.614 . . . . 0.0 110.214 -175.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 10' ' ' MET . 17.1 t -94.83 133.24 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.297 0.639 . . . . 0.0 111.649 172.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.2 t -166.13 151.01 8.2 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.441 1.088 . . . . 0.0 109.826 167.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -110.27 4.54 20.96 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -177.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -140.98 -177.98 5.35 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.156 1.383 . . . . 0.0 112.857 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -60.72 -177.13 0.07 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.72 1.608 . . . . 0.0 112.882 169.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 31.3 t80 -140.94 148.15 39.92 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.675 1.19 . . . . 0.0 112.136 -175.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -80.21 88.92 5.45 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.128 1.371 . . . . 0.0 113.182 174.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.78 165.43 3.98 Favored 'General case' 0 CA--C 1.551 0.99 0 O-C-N 120.395 -1.441 . . . . 0.0 111.83 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -46.91 140.63 4.6 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.684 -0.635 . . . . 0.0 112.387 171.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 56.9 mttp 89.11 -12.28 0.39 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 129.109 2.964 . . . . 0.0 113.192 -174.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -70.36 -10.53 59.29 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 119.864 1.211 . . . . 0.0 112.759 169.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -49.41 -28.97 5.72 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.352 1.861 . . . . 0.0 113.96 168.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 84.9 m -66.09 -31.22 71.96 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.763 2.025 . . . . 0.0 112.877 -168.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.2 -34.13 75.7 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.147 0.579 . . . . 0.0 111.571 174.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -84.47 7.77 71.3 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.65 1.595 . . . . 0.0 114.337 170.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . 0.274 1.3 t 61.41 15.61 6.75 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 129.383 3.073 . . . . 0.0 116.057 173.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.1 mtp85 -99.84 144.09 29.31 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.146 -0.971 . . . . 0.0 109.836 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -126.28 -8.7 6.41 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -169.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -69.74 118.12 12.2 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.706 1.139 . . . . 0.0 109.371 170.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.7 t -76.92 164.99 25.28 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.758 -0.588 . . . . 0.0 110.647 171.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 96.7 p -64.18 138.85 58.65 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -173.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.4 p-10 -82.44 -13.22 57.13 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 174.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.82 9.2 85.06 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.927 1.251 . . . . 0.0 114.199 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -102.12 175.87 5.38 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.669 1.234 . . . . 0.0 111.164 172.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.5 142.91 32.92 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -169.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -142.7 53.82 1.4 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.704 1.602 . . . . 0.0 112.791 -169.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . 0.273 0.0 OUTLIER -140.29 105.53 5.04 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 122.056 0.931 . . . . 0.0 111.27 169.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -89.26 -45.96 9.13 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.217 1.007 . . . . 0.0 111.328 175.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -97.05 8.28 44.84 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.444 2.297 . . . . 0.0 113.565 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 98.76 -12.29 62.7 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 125.747 1.642 . . . . 0.0 114.871 169.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 78.1 mtm -97.05 132.99 42.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.021 1.329 . . . . 0.0 110.375 171.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -64.71 99.03 0.3 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.671 0.748 . . . . 0.0 111.889 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -67.16 -36.34 81.59 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.487 1.515 . . . . 0.0 112.925 -170.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.7 p -85.71 4.47 36.53 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.5 tpp85 -50.51 -42.29 54.71 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 120.503 1.501 . . . . 0.0 112.278 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.2 -33.86 69.34 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 117.974 -1.459 . . . . 0.0 112.724 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.353 82.5 tt0 -89.28 -90.9 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.415 0 CA-C-O 116.112 -1.899 . . . . 0.0 112.537 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.11 156.94 56.16 Favored 'Trans proline' 0 C--N 1.357 1.01 0 CA-C-N 124.135 2.513 . . . . 0.0 116.052 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -62.95 166.3 5.88 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 129.459 3.104 . . . . 0.0 115.037 175.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -62.68 132.8 53.52 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 166.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -57.78 154.34 12.11 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.914 -1.117 . . . . 0.0 113.823 172.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 60.1 p -77.66 162.51 26.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.477 0.711 . . . . 0.0 112.296 174.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 50.9 t -61.36 -39.11 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 121.547 -0.721 . . . . 0.0 111.352 -176.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 23.2 t -81.59 -19.51 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.48 -37.64 88.08 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.241 1.382 . . . . 0.0 108.623 169.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 28.7 mt -77.25 -31.41 55.02 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 116.153 -1.88 . . . . 0.0 114.595 171.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -55.01 -42.19 72.24 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 121.268 1.849 . . . . 0.0 110.994 169.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 11.4 t -62.82 -54.16 43.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.595 0.758 . . . . 0.0 111.387 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.4 tppt? -69.58 -38.87 77.53 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -170.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . 0.294 0.0 OUTLIER -68.77 -33.33 73.7 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 120.537 1.517 . . . . 0.0 111.529 175.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.7 -32.71 64.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -69.29 -46.04 68.15 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.844 1.257 . . . . 0.0 110.056 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -86.26 -8.88 57.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.724 0.81 . . . . 0.0 113.105 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 50.64 49.27 21.2 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.001 1.72 . . . . 0.0 112.456 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.407 ' HA ' ' HB2' ' A' ' 106' ' ' ARG . 68.1 mt -102.69 133.58 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-O 116.535 -1.698 . . . . 0.0 106.967 171.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -103.09 113.46 65.84 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 121.439 1.927 . . . . 0.0 110.365 177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -67.36 152.79 78.52 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 124.074 3.183 . . . . 0.0 114.764 173.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.8 mm -134.26 104.29 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 125.595 1.558 . . . . 0.0 109.371 174.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.55 ' CD2' HD21 ' A' ' 189' ' ' LEU . 23.3 m-85 -73.19 75.98 1.29 Allowed 'General case' 0 N--CA 1.478 0.928 0 O-C-N 119.849 -1.782 . . . . 0.0 112.387 175.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . 0.258 1.9 m -72.13 103.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 123.524 1.63 . . . . 0.0 111.15 169.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 29.0 m -143.05 166.35 20.87 Favored Pre-proline 0 N--CA 1.485 1.318 0 O-C-N 120.33 -1.481 . . . . 0.0 110.447 -169.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -80.19 161.8 23.09 Favored 'Trans proline' 0 C--N 1.35 0.619 0 CA-C-N 122.856 2.056 . . . . 0.0 110.036 -172.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.5 t -52.97 -41.97 65.07 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.952 0.501 . . . . 0.0 111.916 -178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -54.68 -38.67 67.25 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.607 1.163 . . . . 0.0 113.698 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 19.6 mmt -99.75 -9.38 23.1 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.755 1.222 . . . . 0.0 114.175 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -61.89 -29.64 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 120.085 1.311 . . . . 0.0 113.329 -168.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -65.39 -25.07 67.4 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.13 -43.02 20.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.519 0.728 . . . . 0.0 109.955 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -71.02 -30.42 66.62 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.421 1.089 . . . . 0.0 110.535 177.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -65.81 -14.9 62.29 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.122 0.569 . . . . 0.0 111.829 168.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -96.47 -30.69 13.2 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.393 -0.817 . . . . 0.0 111.599 173.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.61 -25.59 61.37 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 119.979 -1.701 . . . . 0.0 110.03 175.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 5.1 t -72.49 -21.99 61.13 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.739 -0.601 . . . . 0.0 111.845 173.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 37.7 m -69.71 -29.74 67.2 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 169.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -88.46 -14.42 37.92 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 24.0 mt -120.35 87.85 41.11 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 124.1 0.96 . . . . 0.0 110.421 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -53.84 134.99 61.54 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.238 2.626 . . . . 0.0 112.903 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 65.2 mttm 85.06 -10.35 0.81 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 129.431 3.092 . . . . 0.0 113.914 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.55 HD21 ' CD2' ' A' ' 169' ' ' PHE . 10.2 tt -65.55 149.4 50.13 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.325 -0.86 . . . . 0.0 109.098 169.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 68.6 p -123.39 -170.22 2.08 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 169.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.0 141.53 2.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 127.083 2.153 . . . . 0.0 108.125 -167.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -132.67 150.86 19.8 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 170.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . 0.262 0.9 OUTLIER -91.44 88.71 6.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 123.128 1.442 . . . . 0.0 109.099 169.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.401 HD12 HD22 ' A' ' 26' ' ' LEU . 1.1 tt -57.5 138.63 54.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.654 169.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 95.0 p -160.18 -152.18 0.28 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.387 1.875 . . . . 0.0 109.026 173.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.85 -26.39 64.15 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.741 1.216 . . . . 0.0 113.19 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -100.85 145.09 29.01 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.73 1.212 . . . . 0.0 113.575 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 26.9 t -96.38 -9.55 29.71 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.699 1.6 . . . . 0.0 112.809 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 59.6 m -61.01 -39.77 91.0 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.582 -1.324 . . . . 0.0 113.484 -168.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -66.29 -42.14 88.77 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.321 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 68.5 t -69.25 -49.01 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.324 0.65 . . . . 0.0 111.232 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.07 -23.41 65.86 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 121.391 -0.818 . . . . 0.0 112.34 -177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -73.83 -3.95 31.79 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.676 -1.265 . . . . 0.0 112.702 175.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 78.0 mt -100.74 -42.16 6.6 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.591 1.556 . . . . 0.0 107.932 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 6.8 mm -70.89 -41.13 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -67.97 -34.62 76.9 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 118.971 -0.538 . . . . 0.0 111.536 172.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -67.33 -35.44 79.42 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 119.786 1.175 . . . . 0.0 112.586 173.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -75.07 -27.87 60.13 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.137 0.975 . . . . 0.0 112.497 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -63.16 -47.28 83.33 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.759 0.824 . . . . 0.0 110.943 173.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 39.2 m -73.19 -13.51 61.17 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -75.23 -11.03 59.98 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 169.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 5.5 mt . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -177.035 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.4 t70 . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -63.05 150.05 43.51 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 121.042 1.747 . . . . 0.0 112.73 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 m -60.01 112.4 1.86 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.666 1.187 . . . . 0.0 112.558 -177.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 t -97.03 144.81 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.931 0.892 . . . . 0.0 110.236 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.55 97.88 5.2 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.063 1.745 . . . . 0.0 108.388 172.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.1 mp -90.9 122.12 33.33 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 121.542 -0.724 . . . . 0.0 112.386 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -119.78 104.2 10.01 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 123.723 1.725 . . . . 0.0 111.13 172.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -85.46 114.72 22.71 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.411 1.885 . . . . 0.0 113.459 -177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.49 120.0 38.15 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.318 1.447 . . . . 0.0 111.154 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 64.0 mtp -100.12 144.0 29.66 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 169.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.9 98.19 2.31 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 168.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.69 33.75 0.52 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.201 1.5 . . . . 0.0 114.753 -169.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 p -80.61 169.56 17.49 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 119.889 -1.757 . . . . 0.0 113.408 173.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -50.72 -34.6 29.13 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 125.346 1.45 . . . . 0.0 116.247 -169.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.0 t -61.78 -29.8 70.38 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.195 0.998 . . . . 0.0 113.033 175.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.16 3.46 20.5 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.298 1.439 . . . . 0.0 114.57 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -66.76 -36.22 81.92 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.433 -1.417 . . . . 0.0 110.908 170.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.36 -28.99 71.98 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 123.426 0.536 . . . . 0.0 112.55 171.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -70.07 -55.04 10.52 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 117.726 0.763 . . . . 0.0 111.842 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 37.0 tp -55.95 -42.17 75.81 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -168.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.5 t -55.9 -46.59 78.34 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 120.053 1.297 . . . . 0.0 111.863 176.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -66.39 -28.08 68.36 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.8 -1.187 . . . . 0.0 112.715 173.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.0 t -77.7 -13.45 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 C-N-CA 124.904 1.282 . . . . 0.0 112.916 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -91.68 -32.32 15.5 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.889 2.076 . . . . 0.0 113.151 -173.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.4 p -83.57 -18.32 38.72 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 167.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.593 ' HG ' ' H ' ' A' ' 27' ' ' GLY . 41.3 tp -87.07 -174.41 4.89 Favored 'General case' 0 N--CA 1.417 -2.111 1 N-CA-C 96.996 -5.187 . . . . 0.0 96.996 164.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.593 ' H ' ' HG ' ' A' ' 26' ' ' LEU . . . 77.47 -42.18 1.94 Allowed Glycine 0 C--N 1.286 -2.227 0 C-N-CA 129.424 3.392 . . . . 0.0 108.497 -169.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.8 m -72.74 -39.72 66.66 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.963 2.105 . . . . 0.0 109.109 169.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -80.22 -27.88 38.67 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.003 0.365 . . . . 0.0 110.8 173.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.8 tp -62.42 -54.88 33.66 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.844 0.858 . . . . 0.0 109.664 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.484 HD13 ' C ' ' A' ' 31' ' ' LEU . 2.4 tm? -59.69 -58.37 8.89 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.627 0.771 . . . . 0.0 110.484 175.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -65.61 -36.26 83.2 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.539 1.063 . . . . 0.0 112.434 -169.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.51 -40.13 43.85 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.265 0.6 OUTLIER -75.21 -20.22 59.39 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.263 -1.523 . . . . 0.0 113.112 175.618 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.12 -4.58 33.56 Favored 'General case' 0 CA--C 1.559 1.295 0 O-C-N 120.933 -1.104 . . . . 0.0 111.366 168.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -95.77 -40.25 9.45 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.628 1.571 . . . . 0.0 112.092 171.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.4 tp -66.22 -26.26 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 120.091 1.314 . . . . 0.0 111.846 171.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.2 t -146.18 138.22 25.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 174.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -55.16 -40.08 70.24 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.301 1.841 . . . . 0.0 112.164 173.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.1 p -117.27 110.31 17.95 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.395 1.478 . . . . 0.0 109.757 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.57 89.14 0.15 Allowed Glycine 0 C--N 1.339 0.736 0 C-N-CA 126.649 2.071 . . . . 0.0 108.801 -169.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.5 mmm-85 -77.27 138.11 39.2 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.402 HG21 HD23 ' A' ' 31' ' ' LEU . 2.5 tp -124.08 133.22 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.258 0.623 . . . . 0.0 110.48 -174.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -144.4 160.54 27.89 Favored Glycine 0 N--CA 1.474 1.202 0 C-N-CA 125.061 1.315 . . . . 0.0 112.722 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -138.69 135.41 34.77 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.006 0.923 . . . . 0.0 112.802 -169.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.39 146.1 18.04 Favored Glycine 0 C--N 1.345 1.056 0 C-N-CA 124.742 1.163 . . . . 0.0 112.443 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 28.4 m -118.52 131.5 56.23 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.227 1.011 . . . . 0.0 111.233 -176.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 7.6 tp -140.09 147.96 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 121.266 -0.896 . . . . 0.0 111.792 175.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -149.74 -107.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 N-CA-C 103.652 -2.721 . . . . 0.0 103.652 168.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -136.09 -2.1 2.34 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.605 1.162 . . . . 0.0 110.858 168.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 57.7 mtp -78.58 41.09 0.39 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.92 2.088 . . . . 0.0 108.354 168.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.315 1.4 t 53.71 -176.13 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 129.618 3.167 . . . . 0.0 113.261 -168.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -87.24 137.88 31.96 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.363 1.465 . . . . 0.0 109.443 174.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -123.73 121.88 36.63 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.88 1.324 . . . . 0.0 110.456 169.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -86.69 100.04 12.19 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.487 1.915 . . . . 0.0 110.291 175.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.0 mm -90.35 -21.22 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 118.164 -0.922 . . . . 0.0 112.887 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 60.7 tp -157.02 111.72 2.76 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -175.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 144.93 43.44 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.715 1.206 . . . . 0.0 110.939 168.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -61.71 125.26 23.18 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.298 0.953 . . . . 0.0 110.169 -175.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 t -135.33 163.37 30.16 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.729 0.811 . . . . 0.0 112.182 -174.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.94 -0.5 55.58 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.995 1.718 . . . . 0.0 111.09 169.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -86.89 82.69 7.72 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 125.659 2.647 . . . . 0.0 109.158 174.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.1 m -61.8 -41.61 97.97 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 131.539 3.936 . . . . 0.0 110.924 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.1 p -63.81 -15.53 59.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.18 1.392 . . . . 0.0 112.323 169.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -86.6 -50.02 7.12 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.01 0.823 . . . . 0.0 110.19 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -55.21 -29.06 57.19 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.308 1.043 . . . . 0.0 112.85 -179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -86.17 -13.12 47.97 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.918 0.887 . . . . 0.0 112.816 -175.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -88.8 -39.42 13.91 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 168.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -74.5 -43.07 57.62 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -169.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.4 tt -67.22 -34.39 77.37 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 123.454 0.471 . . . . 0.0 111.333 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.7 mtm105 -75.69 -18.02 59.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 119.613 -0.835 . . . . 0.0 113.069 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -76.72 -45.17 30.43 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.2 pm0 -62.34 162.65 9.62 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.928 1.24 . . . . 0.0 113.468 -169.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -152.12 152.0 31.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.853 1.261 . . . . 0.0 110.072 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.0 t -73.82 143.89 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 127.925 2.49 . . . . 0.0 113.847 -169.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 71.6 p -108.38 -152.16 0.48 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 126.328 1.851 . . . . 0.0 112.231 173.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.37 160.4 33.05 Favored Glycine 0 N--CA 1.475 1.247 0 O-C-N 120.196 -1.565 . . . . 0.0 114.13 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -155.89 156.88 35.4 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -56.37 -63.8 1.07 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 128.681 2.792 . . . . 0.0 113.261 176.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -72.22 149.21 44.8 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.353 1.061 . . . . 0.0 113.616 -172.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 90.1 m -72.36 -47.01 10.44 Favored Pre-proline 0 N--CA 1.477 0.889 0 CA-C-O 116.138 -1.886 . . . . 0.0 113.287 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -75.09 154.47 42.08 Favored 'Trans proline' 0 C--N 1.352 0.715 0 CA-C-N 122.302 1.858 . . . . 0.0 112.527 169.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . 0.251 0.0 OUTLIER -131.77 179.68 5.92 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.476 1.51 . . . . 0.0 113.455 -178.358 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.94 34.39 4.95 Favored Glycine 0 N--CA 1.482 1.708 0 N-CA-C 119.393 2.517 . . . . 0.0 119.393 -168.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -50.75 -33.53 23.52 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 119.62 1.71 . . . . 0.0 113.648 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.511 HD13 ' CE2' ' A' ' 116' ' ' PHE . 7.4 tp -62.69 -44.08 97.16 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -175.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -57.18 -46.35 82.89 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.252 0.621 . . . . 0.0 109.846 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.08 -58.51 8.34 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 118.496 -0.764 . . . . 0.0 111.034 173.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.536 HG12 HD21 ' A' ' 108' ' ' LEU . 13.4 m -64.99 -25.28 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 119.627 1.103 . . . . 0.0 113.168 -171.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.91 -51.74 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-O 118.083 -0.961 . . . . 0.0 112.16 169.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -57.03 -42.01 79.64 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.974 1.261 . . . . 0.0 110.41 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.482 ' HA ' HD12 ' A' ' 99' ' ' ILE . 38.3 t -57.4 -39.16 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.242 0.617 . . . . 0.0 112.238 176.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.67 -32.22 69.41 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.853 1.056 . . . . 0.0 113.853 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.445 HG23 ' SG ' ' A' ' 135' ' ' CYS . 10.0 tp -102.13 -15.42 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -170.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.33 56.89 3.98 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.534 -1.354 . . . . 0.0 112.847 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.2 mt -55.72 -38.97 70.46 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.465 1.506 . . . . 0.0 111.88 -169.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -86.02 -22.96 47.07 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.524 1.059 . . . . 0.0 114.668 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -92.3 -39.58 11.42 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.465 1.133 . . . . 0.0 111.563 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 92' ' ' VAL . 9.7 mt -81.91 -29.18 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 118.822 0.737 . . . . 0.0 111.264 175.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.34 24.7 39.01 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.027 -0.874 . . . . 0.0 114.891 169.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -49.42 129.26 18.57 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.785 1.234 . . . . 0.0 112.91 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -111.85 173.03 6.55 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.876 1.27 . . . . 0.0 112.434 170.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -81.86 41.58 0.66 Allowed 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 125.671 1.588 . . . . 0.0 115.107 -170.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.14 -126.45 5.5 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 120.592 -1.318 . . . . 0.0 110.437 170.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.6 t -115.96 134.07 55.36 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.638 1.975 . . . . 0.0 107.704 171.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -124.41 131.51 53.5 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 119.093 0.86 . . . . 0.0 110.218 -168.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -127.08 98.5 5.33 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -169.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.536 HD21 HG12 ' A' ' 89' ' ' VAL . 5.6 tt -81.9 99.16 8.91 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.152 172.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.1 t -87.84 124.11 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 174.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 65.4 tp -108.19 117.47 34.23 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.664 1.12 . . . . 0.0 109.267 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.4 t -103.16 128.39 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 124.158 0.911 . . . . 0.0 110.707 170.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.7 t -162.44 163.66 27.54 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.246 1.018 . . . . 0.0 110.882 170.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -121.25 -0.44 9.9 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 116.547 2.055 . . . . 0.0 116.547 -175.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -137.17 172.66 12.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.912 0.885 . . . . 0.0 111.831 172.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -53.43 176.56 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.946 1.699 . . . . 0.0 112.58 174.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.511 ' CE2' HD13 ' A' ' 86' ' ' LEU . 7.2 p90 -146.04 157.19 43.86 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 120.7 -1.25 . . . . 0.0 112.293 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -79.87 133.28 36.24 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.664 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 46.8 mt -100.74 175.07 5.77 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.189 1.796 . . . . 0.0 110.886 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -47.88 137.09 10.28 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.917 0.865 . . . . 0.0 112.828 172.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 69.5 tttt 83.58 -14.45 0.7 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 130.906 3.682 . . . . 0.0 113.719 -178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -63.22 -21.95 66.55 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.526 1.512 . . . . 0.0 113.4 178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.559 ' HE3' ' CZ ' ' A' ' 150' ' ' TYR . 90.1 mttt -78.18 -5.91 53.24 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 172.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.8 -16.75 63.88 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 120.621 1.555 . . . . 0.0 112.34 171.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 57.3 mt -63.25 -24.71 67.99 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.887 0.875 . . . . 0.0 111.515 169.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -90.35 -123.02 2.53 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 126.198 1.856 . . . . 0.0 109.301 169.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.4 p -126.64 0.13 6.8 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.577 1.551 . . . . 0.0 114.319 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -85.56 109.47 18.55 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.789 0.836 . . . . 0.0 111.285 -169.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -94.38 -28.71 15.38 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -175.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -87.17 122.23 30.7 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.702 -0.623 . . . . 0.0 112.491 -169.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.3 t -57.93 144.15 40.27 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.888 0.475 . . . . 0.0 110.388 169.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 42.0 t -59.75 140.9 56.16 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.637 0.775 . . . . 0.0 112.614 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.7 p30 -80.74 -13.51 58.93 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.88 14.42 78.47 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.477 1.037 . . . . 0.0 113.423 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -98.94 170.05 9.0 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.259 1.824 . . . . 0.0 110.536 172.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . 0.445 ' SG ' HG23 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -100.41 145.35 28.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -139.47 45.6 1.93 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.307 1.843 . . . . 0.0 111.592 -170.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.4 tt -110.08 125.13 52.64 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.68 1.992 . . . . 0.0 108.907 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -131.19 -48.66 1.0 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.613 1.165 . . . . 0.0 112.8 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -84.42 -10.66 57.32 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.493 1.517 . . . . 0.0 113.677 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 108.51 -23.71 23.87 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 126.199 1.857 . . . . 0.0 111.477 -169.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 80.8 mmm -82.28 145.83 29.78 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.617 1.167 . . . . 0.0 111.259 172.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -77.47 99.04 5.51 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.174 0.589 . . . . 0.0 109.769 169.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 42.3 ttp-105 -63.28 -38.28 90.56 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.211 1.004 . . . . 0.0 113.563 -170.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.4 p -88.56 7.37 33.55 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 -168.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -47.53 -39.7 16.95 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 121.277 1.853 . . . . 0.0 112.461 169.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.13 -0.65 86.49 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 117.8 -1.555 . . . . 0.0 115.789 -174.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -127.35 -65.8 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 119.889 1.845 . . . . 0.0 110.387 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -58.98 147.25 90.86 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 123.498 2.799 . . . . 0.0 115.625 168.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.527 ' HA ' ' HD2' ' A' ' 122' ' ' LYS . 39.8 t0 -69.46 169.34 12.66 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 128.503 2.721 . . . . 0.0 112.87 169.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.559 ' CZ ' ' HE3' ' A' ' 122' ' ' LYS . 75.6 m-85 -69.0 158.06 35.52 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.423 -1.423 . . . . 0.0 108.211 168.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -78.62 157.45 28.68 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.314 -0.866 . . . . 0.0 111.257 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 92.9 p -92.81 156.18 17.16 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.248 -0.907 . . . . 0.0 110.684 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 46.6 t -55.26 -34.37 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.344 -0.848 . . . . 0.0 112.571 -171.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.9 t -69.93 -33.66 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.412 1.085 . . . . 0.0 111.596 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -68.8 -34.45 75.54 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.499 0.72 . . . . 0.0 111.144 178.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.507 ' CD1' HD11 ' A' ' 86' ' ' LEU . 4.5 mt -65.26 -55.95 15.49 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.009 0.924 . . . . 0.0 110.253 174.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.97 76.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.041 0.937 . . . . 0.0 111.448 -177.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.8 t -58.47 -71.43 0.11 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.166 0.986 . . . . 0.0 111.847 172.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -66.85 -34.48 77.89 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.721 HD22 ' HG3' ' A' ' 167' ' ' PRO . 0.7 OUTLIER -70.76 -26.58 63.42 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 120.163 1.347 . . . . 0.0 112.866 176.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.1 -43.69 64.4 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.768 1.167 . . . . 0.0 113.46 173.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -80.53 -30.67 37.14 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 118.885 0.766 . . . . 0.0 112.578 -177.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -82.48 -5.56 58.78 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.983 0.81 . . . . 0.0 112.242 168.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 60.64 46.91 8.78 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.007 1.323 . . . . 0.0 111.75 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.567 ' HB ' HD23 ' A' ' 160' ' ' LEU . 29.4 mm -100.36 135.51 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.934 1.293 . . . . 0.0 108.057 174.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -100.64 114.35 65.75 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 120.477 1.49 . . . . 0.0 109.903 170.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.721 ' HG3' HD22 ' A' ' 160' ' ' LEU . 4.8 Cg_exo -74.74 145.11 32.11 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.035 1.824 . . . . 0.0 110.594 169.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.417 HG22 HG23 ' A' ' 170' ' ' VAL . 31.5 mt -128.73 102.08 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 125.126 1.37 . . . . 0.0 107.418 177.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -74.37 72.8 1.84 Allowed 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 122.415 1.102 . . . . 0.0 112.342 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.417 HG23 HG22 ' A' ' 168' ' ' ILE . 85.3 t -70.59 97.75 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 O-C-N 120.621 -1.299 . . . . 0.0 111.193 173.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 25.4 m -147.92 145.16 20.23 Favored Pre-proline 0 N--CA 1.484 1.237 0 O-C-N 120.367 -1.458 . . . . 0.0 112.879 -169.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -60.81 156.55 42.66 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 125.111 3.874 . . . . 0.0 116.705 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.5 t -46.62 -58.31 3.95 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.978 1.711 . . . . 0.0 114.471 -170.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -14.67 21.8 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -171.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 26.0 ptm -109.3 -1.6 18.44 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.308 1.443 . . . . 0.0 114.872 172.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 2.2 t -65.46 -33.39 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 120.23 -1.544 . . . . 0.0 111.97 -170.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -70.74 -23.68 62.48 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.861 1.21 . . . . 0.0 113.241 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . 0.262 2.4 t -87.18 -13.39 44.1 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.059 -1.026 . . . . 0.0 112.405 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -96.38 -33.72 11.81 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.073 1.349 . . . . 0.0 109.879 168.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -68.62 -26.7 65.48 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 120.724 -1.235 . . . . 0.0 111.997 176.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -74.0 -23.48 59.45 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 120.052 -1.655 . . . . 0.0 110.445 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 35.5 tp -85.02 -19.48 31.93 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.304 1.842 . . . . 0.0 110.824 174.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 20.6 p -83.65 -6.94 59.57 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.383 0.538 . . . . 0.0 112.019 169.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 6.9 m -88.22 -34.56 17.73 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.678 1.591 . . . . 0.0 108.865 169.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -79.7 -37.34 35.94 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 174.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 51.0 mt -101.16 113.27 65.82 Favored Pre-proline 0 N--CA 1.478 0.963 0 CA-C-O 118.247 -0.882 . . . . 0.0 108.949 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.7 145.2 40.91 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.577 2.185 . . . . 0.0 111.423 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt 73.55 3.98 4.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 127.117 2.167 . . . . 0.0 113.736 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.69 142.6 46.39 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.994 1.718 . . . . 0.0 109.052 169.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 76.5 p -108.55 -158.19 0.64 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.8 tt 177.15 136.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 126.983 2.113 . . . . 0.0 110.129 -168.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -129.57 132.45 7.09 Favored Glycine 0 N--CA 1.469 0.892 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -81.99 79.12 8.59 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 124.069 1.89 . . . . 0.0 109.814 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 28.1 tp -53.98 156.85 2.73 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.662 174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 57.6 p -85.57 156.0 20.93 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.727 -1.233 . . . . 0.0 110.914 169.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.52 -6.63 37.65 Favored 'General case' 0 CA--C 1.552 1.049 0 O-C-N 120.485 -1.384 . . . . 0.0 113.74 174.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -95.76 -30.94 13.44 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 126.862 2.065 . . . . 0.0 112.395 169.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . 0.379 35.3 p 75.61 11.79 3.19 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 131.195 3.798 . . . . 0.0 117.94 168.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.2 t -65.09 -11.46 40.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 119.439 -2.038 . . . . 0.0 114.105 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -73.69 -9.66 58.89 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 172.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 38.3 t -49.89 -47.3 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-N 121.42 1.918 . . . . 0.0 113.67 -174.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -63.84 -32.52 74.06 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.921 -1.112 . . . . 0.0 112.152 -178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -84.83 20.23 1.87 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 97.5 mt -130.52 -36.93 1.41 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.436 2.294 . . . . 0.0 109.419 176.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 50.0 mt -67.57 -48.48 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.687 1.195 . . . . 0.0 109.188 170.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -63.28 -38.47 91.29 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 119.464 -0.895 . . . . 0.0 110.238 174.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -67.44 -39.01 85.4 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.998 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.7 70.85 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.935 1.294 . . . . 0.0 112.488 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.34 -35.76 76.41 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.357 0.663 . . . . 0.0 111.655 173.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.9 t -75.28 -28.59 59.83 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 175.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -66.1 -57.19 8.25 Favored 'General case' 0 CA--C 1.551 1.003 0 O-C-N 120.889 -1.132 . . . . 0.0 111.882 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 11.9 tp . . . . . 0 CA--C 1.579 2.06 0 C-N-CA 126.92 2.088 . . . . 0.0 113.535 -174.965 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.178 0.513 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -84.1 130.36 34.86 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.736 -1.228 . . . . 0.0 110.346 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.9 t -56.27 121.51 9.67 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.578 -0.701 . . . . 0.0 110.176 175.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 t -94.3 155.08 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.648 ' HB2' HD13 ' A' ' 59' ' ' LEU . 3.7 p-10 -151.89 101.63 2.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 122.345 1.069 . . . . 0.0 109.603 169.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.19 142.92 27.06 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.314 1.046 . . . . 0.0 111.717 -171.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -124.45 111.77 16.12 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 123.889 1.804 . . . . 0.0 110.861 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -83.64 101.83 11.78 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.868 -1.969 . . . . 0.0 111.921 175.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.489 HD23 HD13 ' A' ' 110' ' ' LEU . 33.9 tp -102.73 113.28 26.55 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.748 0.819 . . . . 0.0 111.093 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.1 ptm -120.77 151.24 39.82 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 117.244 2.313 . . . . 0.0 117.244 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.55 141.26 23.56 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.52 1.533 . . . . 0.0 113.348 173.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -111.43 32.09 5.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.26 1.824 . . . . 0.0 112.255 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.3 p -78.43 163.58 25.51 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 119.91 -1.744 . . . . 0.0 112.194 171.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -59.81 -19.89 51.06 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 116.484 1.354 . . . . 0.0 116.484 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.5 m -68.58 -28.11 66.65 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 118.709 1.254 . . . . 0.0 112.84 170.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.05 1.75 42.43 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -170.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -69.1 -23.09 63.96 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.526 1.512 . . . . 0.0 112.857 171.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.31 -38.25 39.59 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 169.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -61.38 -43.46 98.84 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.08 1.352 . . . . 0.0 111.091 175.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.409 ' HA ' HG22 ' A' ' 23' ' ' VAL . 27.5 tp -58.17 -42.54 86.23 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 124.755 1.222 . . . . 0.0 112.55 -177.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -51.57 -43.56 62.47 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.157 0.889 . . . . 0.0 113.283 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 75.4 m-80 -95.12 -0.55 53.31 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -175.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 20' ' ' LEU . 20.1 m -99.86 16.01 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-N 119.758 1.163 . . . . 0.0 112.333 169.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -94.73 -40.97 9.5 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.9 t -74.41 -13.8 60.77 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.71 2.004 . . . . 0.0 110.735 167.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.3 tp -81.26 96.29 7.22 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 124.682 2.182 . . . . 0.0 107.261 172.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.48 -51.24 0.09 OUTLIER Glycine 0 C--N 1.299 -1.514 0 CA-C-N 109.131 -3.668 . . . . 0.0 110.978 168.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.6 m -83.99 -37.27 22.43 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.768 1.227 . . . . 0.0 110.888 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -61.58 -38.65 88.34 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.7 0.8 . . . . 0.0 110.723 169.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.4 tp -63.75 -51.66 63.92 Favored 'General case' 0 C--N 1.346 0.419 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.5 mt -56.21 -38.91 71.65 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 118.065 -0.969 . . . . 0.0 113.267 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -60.7 -39.74 89.65 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 120.851 1.66 . . . . 0.0 112.004 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.19 -43.94 60.58 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 171.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.9 mt -73.73 -16.57 61.18 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -69.63 -23.16 63.46 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.879 1.271 . . . . 0.0 113.335 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -73.48 -42.43 61.87 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.116 0.966 . . . . 0.0 109.476 170.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.473 HG23 ' CE1' ' A' ' 209' ' ' TYR . 1.4 mp -63.39 -41.94 94.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.015 1.326 . . . . 0.0 111.632 174.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 t -166.41 149.89 7.25 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 -169.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.5 mmt-85 -76.88 -15.19 59.77 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 175.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.2 p -138.43 132.03 30.75 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.486 1.136 . . . . 0.0 111.058 169.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.96 88.34 0.13 Allowed Glycine 0 C--N 1.336 0.529 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -169.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -73.5 148.24 43.3 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -174.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.6 tt -123.17 135.63 62.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 177.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.434 ' HA3' HD23 ' A' ' 59' ' ' LEU . . . -139.99 161.15 26.34 Favored Glycine 0 N--CA 1.464 0.557 0 C-N-CA 125.361 1.458 . . . . 0.0 110.722 172.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.41 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 91.1 t80 -139.17 138.22 36.75 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -169.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.25 145.27 15.92 Favored Glycine 0 C--N 1.342 0.873 0 C-N-CA 124.491 1.043 . . . . 0.0 112.578 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.3 m -116.13 136.22 53.21 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 125.284 1.434 . . . . 0.0 110.522 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.18 155.31 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.534 1.134 . . . . 0.0 111.197 176.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.1 p -151.93 -65.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 120.656 -1.277 . . . . 0.0 109.02 168.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 177.06 -19.66 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 130.237 3.415 . . . . 0.0 110.081 169.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 54.0 ttm -50.1 -36.84 31.23 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.009 1.324 . . . . 0.0 110.029 167.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 t 167.1 -172.39 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 131.465 3.906 . . . . 0.0 109.782 169.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -103.88 131.28 51.25 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 167.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.6 pm0 -130.26 124.38 32.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 123.064 1.411 . . . . 0.0 110.793 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -94.23 104.68 16.68 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.14 2.176 . . . . 0.0 109.924 178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . 0.361 0.0 OUTLIER -91.22 -70.01 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-O 117.583 -1.199 . . . . 0.0 110.799 179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.8 124.49 38.87 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 121.287 1.858 . . . . 0.0 114.74 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -67.08 168.94 9.24 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.558 1.143 . . . . 0.0 110.336 167.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.648 HD13 ' HB2' ' A' ' 5' ' ' ASP . 13.5 mt -62.1 123.22 17.53 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.276 -0.89 . . . . 0.0 109.349 175.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.8 t -145.14 165.48 28.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.839 1.256 . . . . 0.0 111.291 -176.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -99.69 -7.36 25.74 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.678 1.191 . . . . 0.0 114.009 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -94.52 81.2 3.9 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-O 124.623 2.154 . . . . 0.0 108.906 173.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 43.4 m -73.27 -19.34 61.08 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 127.39 2.276 . . . . 0.0 110.869 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.1 t -67.53 -21.16 65.49 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 167.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -82.55 -35.49 27.15 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 120.778 -1.201 . . . . 0.0 111.038 176.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.41 ' CE2' ' HB2' ' A' ' 45' ' ' PHE . 33.4 t80 -55.66 -24.49 34.25 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.221 1.008 . . . . 0.0 111.384 169.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -77.63 -39.68 44.41 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.916 -1.115 . . . . 0.0 109.413 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -66.02 -36.34 82.99 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.425 1.09 . . . . 0.0 109.743 -172.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -90.42 -23.0 21.15 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.24 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.422 ' HA ' HE21 ' A' ' 73' ' ' GLN . 0.1 OUTLIER -71.46 -20.61 62.07 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.535 -0.728 . . . . 0.0 109.912 169.311 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -75.72 -38.09 58.83 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.69 0.796 . . . . 0.0 112.94 170.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.34 -14.64 26.66 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 116.312 1.968 . . . . 0.0 116.312 -175.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.422 HE21 ' HA ' ' A' ' 70' ' ' LEU . 4.2 pt20 -59.3 150.1 26.92 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.64 1.564 . . . . 0.0 110.12 169.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.7 mt -120.53 161.23 21.66 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.832 0.853 . . . . 0.0 111.484 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.0 t -96.51 143.84 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.191 1.397 . . . . 0.0 110.597 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.5 t -113.44 -169.51 1.51 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 127.369 2.268 . . . . 0.0 112.173 -175.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -153.65 153.86 25.12 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.162 1.363 . . . . 0.0 113.661 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.9 pttm -152.49 160.12 43.27 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.186 1.794 . . . . 0.0 111.037 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -87.81 -32.75 18.89 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -174.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.76 143.05 38.29 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.666 0.786 . . . . 0.0 110.026 174.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.319 13.8 t -73.56 -41.37 5.87 Favored Pre-proline 0 N--CA 1.479 0.977 0 CA-C-O 116.341 -1.79 . . . . 0.0 113.969 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.79 137.62 54.54 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.649 2.233 . . . . 0.0 113.852 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -82.67 155.93 24.1 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.932 1.693 . . . . 0.0 113.528 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.77 45.5 3.22 Favored Glycine 0 N--CA 1.485 1.916 0 O-C-N 120.399 -1.438 . . . . 0.0 109.698 168.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -74.71 -39.91 61.63 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -168.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . 0.26 5.9 mp -68.75 -30.21 68.78 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 117.042 -1.456 . . . . 0.0 110.742 -173.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -57.37 -39.53 76.21 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.979 1.718 . . . . 0.0 111.899 169.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.53 -47.38 86.43 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.302 -1.499 . . . . 0.0 111.176 170.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.0 t -54.44 -31.83 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 124.389 1.076 . . . . 0.0 112.382 172.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.581 ' HA ' HD21 ' A' ' 156' ' ' LEU . 40.9 t -64.75 -65.0 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 123.592 0.757 . . . . 0.0 111.258 172.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.8 mp0 -69.77 -32.62 71.21 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 118.086 -0.959 . . . . 0.0 112.048 -169.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 108' ' ' LEU . 33.0 m -62.53 -20.85 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-N 119.922 1.237 . . . . 0.0 113.403 171.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.02 -45.51 16.46 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 120.057 1.299 . . . . 0.0 112.295 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.5 mt -88.19 -19.85 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -169.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -84.45 60.11 5.83 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 119.996 -1.69 . . . . 0.0 111.698 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.421 ' H ' HD12 ' A' ' 96' ' ' LEU . 6.6 mp -48.26 -38.58 19.02 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.185 1.394 . . . . 0.0 111.128 176.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -83.83 -29.64 31.39 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.602 1.096 . . . . 0.0 115.497 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -89.65 -46.36 8.69 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 118.94 1.37 . . . . 0.0 110.624 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.9 mm -60.67 -49.54 84.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 172.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.61 29.51 8.19 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.177 0.894 . . . . 0.0 113.815 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.558 ' CE3' HD11 ' A' ' 59' ' ' LEU . 14.2 m95 -54.84 119.93 6.09 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 118.46 1.13 . . . . 0.0 111.462 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -95.82 -144.43 0.27 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.41 1.484 . . . . 0.0 111.96 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -102.1 -10.35 19.75 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 -169.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.16 -126.41 1.6 Allowed Glycine 0 C--N 1.349 1.264 0 CA-C-N 120.895 1.68 . . . . 0.0 112.86 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.4 t -112.26 147.53 36.07 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.311 1.845 . . . . 0.0 110.037 -178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.73 132.99 29.88 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 119.73 1.15 . . . . 0.0 113.198 -169.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -123.8 104.94 9.26 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -169.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 92' ' ' VAL . 16.8 tp -85.6 88.66 7.56 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.847 172.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.686 HG21 HG12 ' A' ' 205' ' ' ILE . 54.3 t -79.13 123.7 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 174.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.489 HD13 HD23 ' A' ' 9' ' ' LEU . 47.5 tp -117.2 111.66 19.75 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 123.814 0.696 . . . . 0.0 109.503 -169.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.34 133.26 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.3 t -165.62 158.42 15.51 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 114.129 -1.396 . . . . 0.0 110.683 169.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -106.14 -5.51 19.29 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -174.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -138.57 -179.9 6.08 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.514 1.526 . . . . 0.0 111.423 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.11 -171.33 0.11 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.688 1.595 . . . . 0.0 113.478 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -144.81 150.42 37.13 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.109 1.364 . . . . 0.0 112.499 -170.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -74.16 133.6 42.78 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.859 0.864 . . . . 0.0 110.333 169.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.95 175.22 5.55 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.273 1.429 . . . . 0.0 109.784 170.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.91 142.54 19.07 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.836 -0.54 . . . . 0.0 111.263 169.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.533 ' O ' HG22 ' A' ' 123' ' ' THR . 72.5 mmtt 86.31 -18.06 0.35 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 129.217 3.007 . . . . 0.0 112.667 -173.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -71.58 -19.1 62.19 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 121.061 1.755 . . . . 0.0 113.0 177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -74.22 -16.15 60.98 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.499 -1.375 . . . . 0.0 113.876 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 120' ' ' LYS 0.302 9.5 t -74.7 -6.63 49.86 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 119.556 1.071 . . . . 0.0 113.201 174.162 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.1 mp -64.93 -24.09 67.42 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.104 -0.998 . . . . 0.0 109.752 167.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -88.65 -123.56 2.14 Favored Glycine 0 CA--C 1.538 1.503 0 N-CA-C 108.856 -1.697 . . . . 0.0 108.856 168.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 64.1 p -126.97 16.15 7.35 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.337 1.455 . . . . 0.0 114.1 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.36 125.72 50.84 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.652 1.181 . . . . 0.0 111.932 -169.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -130.43 -20.3 2.98 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -71.52 124.58 24.98 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 121.078 1.763 . . . . 0.0 110.111 170.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.441 ' HA ' ' HB3' ' A' ' 149' ' ' ASP . 15.3 t -75.4 147.23 40.16 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.139 0.575 . . . . 0.0 110.722 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.4 t -63.72 135.58 56.8 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 123.064 1.412 . . . . 0.0 112.602 -175.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -73.94 -10.53 59.74 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.55 2.74 . . . . 0.0 114.832 -170.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.86 15.99 80.63 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.222 -1.321 . . . . 0.0 114.182 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -113.15 170.26 8.34 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.175 1.488 . . . . 0.0 110.632 169.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.3 153.24 18.12 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -169.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -147.88 45.44 1.09 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.027 1.331 . . . . 0.0 113.803 -169.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.41 150.14 20.92 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.342 1.057 . . . . 0.0 109.584 169.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -141.6 -67.79 0.39 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.856 0.862 . . . . 0.0 111.538 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -84.73 -2.64 57.88 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.524 1.53 . . . . 0.0 113.716 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 107.29 -8.72 38.36 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.217 1.865 . . . . 0.0 114.387 -175.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 92.4 mtp -93.41 148.94 21.62 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.308 2.054 . . . . 0.0 111.088 170.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -70.92 100.7 2.0 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.927 -1.108 . . . . 0.0 110.746 173.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -48.36 80.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.355 1.062 . . . . 0.0 110.821 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 43.5 m -74.44 8.06 2.5 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -175.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.25 -24.61 59.9 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.834 -1.166 . . . . 0.0 111.881 169.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.7 -45.23 7.94 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 118.007 -1.441 . . . . 0.0 113.574 -178.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.303 1.7 pm0 -97.97 -62.78 0.11 Allowed Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -169.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -58.54 149.26 76.65 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.438 2.758 . . . . 0.0 117.625 169.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' A' ' 130' ' ' THR . 56.0 t0 -74.81 161.15 29.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.87 2.468 . . . . 0.0 111.631 169.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -59.73 131.74 51.82 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 168.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -81.94 157.06 24.43 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 121.153 1.797 . . . . 0.0 112.624 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.3 m -67.8 152.42 45.6 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.111 0.964 . . . . 0.0 113.101 -176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.15 -26.36 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -169.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.9 m -85.21 -16.17 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -70.03 -27.14 64.42 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.752 1.16 . . . . 0.0 108.494 168.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.581 HD21 ' HA ' ' A' ' 90' ' ' VAL . 15.2 mt -84.22 -32.87 24.28 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-O 117.286 -1.34 . . . . 0.0 114.036 169.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -54.23 -37.37 64.55 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 120.853 1.661 . . . . 0.0 112.398 171.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 89.2 p -68.41 -55.03 13.33 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.835 -0.54 . . . . 0.0 112.119 173.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -66.01 -29.74 70.16 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.6 mp -58.33 -54.58 45.4 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.412 1.085 . . . . 0.0 111.383 170.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.56 -24.63 58.95 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -74.15 -39.8 63.02 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.5 1.12 . . . . 0.0 111.022 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -95.52 1.09 53.77 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 174.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 66.89 30.86 7.53 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.314 1.846 . . . . 0.0 113.863 169.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 48.7 mt -89.64 137.86 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 120.705 -1.247 . . . . 0.0 109.603 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -104.59 97.53 12.55 Favored Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -74.12 150.37 42.64 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.132 1.888 . . . . 0.0 113.465 173.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.495 ' CD1' HG23 ' A' ' 190' ' ' THR . 34.9 mm -139.17 106.28 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.715 1.206 . . . . 0.0 109.702 -174.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.478 ' HB2' HG22 ' A' ' 191' ' ' ILE . 21.2 m-85 -73.01 65.62 0.76 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.657 1.183 . . . . 0.0 113.207 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.69 108.6 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 122.401 1.096 . . . . 0.0 111.187 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 28.3 m -146.3 142.01 17.07 Favored Pre-proline 0 N--CA 1.48 1.039 0 O-C-N 119.873 -1.767 . . . . 0.0 110.708 -174.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -54.17 150.78 30.88 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.197 2.598 . . . . 0.0 114.542 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 47.3 t -44.79 -45.04 9.83 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.347 1.859 . . . . 0.0 114.031 -170.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.33 -36.97 6.84 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.698 1.599 . . . . 0.0 113.782 -172.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 53.5 mtt -123.62 19.19 9.55 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.741 1.217 . . . . 0.0 114.08 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 34.2 t -59.52 -37.5 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 O-C-N 120.488 -1.382 . . . . 0.0 110.589 174.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 180' ' ' GLU . 0.0 OUTLIER -66.71 -22.74 66.06 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -170.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 14.2 t -91.24 -33.21 15.46 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.872 1.269 . . . . 0.0 111.249 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -70.95 -37.02 72.82 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.577 -1.327 . . . . 0.0 110.324 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.534 ' HA ' HG22 ' A' ' 183' ' ' THR 0.353 14.8 pt-20 -73.43 -2.67 23.36 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 169.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.646 ' O ' HG22 ' A' ' 184' ' ' THR . 87.1 tttt -88.63 -43.64 11.2 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.23 -0.919 . . . . 0.0 109.869 169.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . 0.264 4.8 mp -83.84 -10.08 58.3 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 119.288 -2.133 . . . . 0.0 111.93 -174.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.534 HG22 ' HA ' ' A' ' 180' ' ' GLU . 15.1 t -78.16 -19.64 53.57 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 167.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 181' ' ' LYS 0.279 1.3 t -77.41 -19.94 55.38 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 120.881 -1.137 . . . . 0.0 109.655 168.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -83.47 -24.19 31.88 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.345 0.658 . . . . 0.0 111.373 168.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 19.3 mt -119.87 78.71 23.71 Favored Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 124.618 1.167 . . . . 0.0 111.542 170.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.52 142.1 93.85 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.183 1.922 . . . . 0.0 112.122 176.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 62.6 mttm 95.17 -20.34 0.07 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 131.636 3.975 . . . . 0.0 113.331 -171.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.7 tt -71.03 157.48 38.14 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.495 HG23 ' CD1' ' A' ' 168' ' ' ILE 0.495 0.1 OUTLIER -135.36 -160.64 1.07 Allowed 'General case' 0 C--N 1.346 0.416 0 O-C-N 120.009 -1.682 . . . . 0.0 108.169 169.871 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.478 HG22 ' HB2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -146.97 156.29 10.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 129.025 2.93 . . . . 0.0 108.893 -168.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -137.56 134.76 7.17 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 171.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -83.12 82.21 8.35 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 169.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 20.0 tp -62.34 157.85 18.83 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 113.481 -1.691 . . . . 0.0 110.609 169.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 57.5 p -91.43 168.57 11.45 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 121.052 -1.03 . . . . 0.0 112.566 173.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.76 -11.42 60.39 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -104.31 -11.99 16.86 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.842 1.657 . . . . 0.0 114.351 172.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 31.0 m 77.6 -3.85 2.36 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 129.697 3.199 . . . . 0.0 114.657 172.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.4 m -62.75 -14.72 48.01 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.576 1.551 . . . . 0.0 113.935 178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -72.73 -11.98 60.84 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 169.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 6.6 p -58.93 -41.38 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -169.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -62.97 -39.82 95.84 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 120.08 1.309 . . . . 0.0 111.41 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -66.74 -11.85 56.3 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 10.2 mp -109.86 -25.64 10.21 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 127.256 2.222 . . . . 0.0 109.544 -174.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.686 HG12 HG21 ' A' ' 109' ' ' VAL . 48.9 mt -65.79 -52.26 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 166.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . 0.311 30.3 ptt85 -76.34 -21.68 55.85 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 117.513 -1.232 . . . . 0.0 114.22 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -69.78 -13.84 62.48 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 120.427 1.467 . . . . 0.0 114.803 171.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -105.73 -21.89 13.08 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.234 1.414 . . . . 0.0 112.294 -173.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.473 ' CE1' HG23 ' A' ' 37' ' ' ILE . 18.2 t80 -81.99 -25.04 35.11 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.298 2.239 . . . . 0.0 112.154 170.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.3 m -24.09 -44.26 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.881 1 C-N-CA 133.141 4.576 . . . . 0.0 116.745 -168.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -88.92 -44.7 10.25 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 117.961 2.578 . . . . 0.0 117.961 -169.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . 0.256 4.6 mp . . . . . 0 N--CA 1.498 1.971 0 CA-C-N 119.215 0.916 . . . . 0.0 112.5 -169.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.9 t0 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.939 0.4 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -105.41 139.31 40.23 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.806 1.243 . . . . 0.0 110.478 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -66.54 124.59 23.23 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 121.322 -0.861 . . . . 0.0 111.565 178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.2 t -125.1 140.67 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 125.328 1.451 . . . . 0.0 109.327 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -124.6 99.39 6.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.296 1.439 . . . . 0.0 109.194 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.0 123.31 40.69 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.181 -0.95 . . . . 0.0 111.128 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -105.45 105.94 16.21 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 123.701 1.715 . . . . 0.0 109.282 169.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -81.83 112.5 19.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 112.976 -1.92 . . . . 0.0 111.563 173.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.5 tt -111.34 131.54 55.09 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.372 -0.83 . . . . 0.0 112.841 173.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.472 ' SD ' HD21 ' A' ' 70' ' ' LEU . 28.4 mtp -110.61 148.49 32.1 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 115.771 1.767 . . . . 0.0 115.771 177.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.57 121.35 6.45 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.578 1.561 . . . . 0.0 109.209 168.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -110.54 36.38 3.11 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.06 1.744 . . . . 0.0 111.697 -175.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.504 ' OG ' ' HE2' ' A' ' 83' ' ' LYS . 24.4 p -79.09 163.15 25.35 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.705 1.602 . . . . 0.0 113.479 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -56.69 -32.13 61.3 Favored Glycine 0 N--CA 1.477 1.368 0 O-C-N 121.263 -0.898 . . . . 0.0 114.181 -176.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 72.6 p -70.2 -19.52 63.16 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.684 1.193 . . . . 0.0 113.875 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.65 -2.9 48.52 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.199 1.4 . . . . 0.0 112.774 176.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -66.18 134.39 52.63 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.805 -1.184 . . . . 0.0 109.24 169.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.06 -50.63 3.69 Favored Glycine 0 N--CA 1.471 1.011 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -169.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -65.05 -20.8 66.66 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.025 0.93 . . . . 0.0 112.834 171.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.522 ' HA ' HG22 ' A' ' 23' ' ' VAL . 42.1 tp -51.64 -32.82 30.8 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.519 1.528 . . . . 0.0 112.157 172.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.4 t -64.16 -56.65 13.32 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.721 -0.612 . . . . 0.0 110.876 169.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.22 -25.69 66.23 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 120.71 -1.243 . . . . 0.0 113.867 -175.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 20' ' ' LEU . 10.2 m -82.52 -2.55 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 119.015 0.825 . . . . 0.0 112.788 172.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.04 -49.05 3.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.192 0.997 . . . . 0.0 110.125 177.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.8 p -59.15 -20.07 50.49 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.863 1.265 . . . . 0.0 112.421 169.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 tp -110.02 86.55 2.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 127.984 2.514 . . . . 0.0 104.84 169.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 164.3 -43.09 0.31 Allowed Glycine 0 C--N 1.308 -0.977 0 CA-C-N 112.343 -2.208 . . . . 0.0 108.969 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 88.5 p -66.6 -44.74 81.3 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.43 1.092 . . . . 0.0 110.55 169.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -75.31 -25.38 57.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.697 -1.144 . . . . 0.0 112.68 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 mp -62.87 -50.8 69.47 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 120.103 1.32 . . . . 0.0 108.974 170.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.546 HD11 ' HA ' ' A' ' 63' ' ' SER . 0.4 OUTLIER -61.19 -51.27 69.73 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.081 0.552 . . . . 0.0 111.905 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -63.28 -47.52 81.98 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.739 -0.601 . . . . 0.0 110.8 -176.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.24 -44.19 84.45 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 117.871 0.305 . . . . 0.0 111.583 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.471 ' HA ' HG22 ' A' ' 37' ' ' ILE 0.309 2.6 mp -79.9 -11.98 59.77 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -177.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -73.21 -19.3 61.12 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 121.06 -1.025 . . . . 0.0 111.294 167.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -85.67 -41.06 15.51 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.238 1.015 . . . . 0.0 110.516 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.471 HG22 ' HA ' ' A' ' 34' ' ' LEU . 8.8 tt -71.45 -26.01 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 175.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.8 t -149.54 137.3 20.26 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -71.68 -39.84 69.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.874 1.67 . . . . 0.0 111.832 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.7 t -103.21 89.47 3.42 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 122.889 1.328 . . . . 0.0 109.846 172.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.06 84.27 0.31 Allowed Glycine 0 C--N 1.338 0.673 0 N-CA-C 105.627 -2.989 . . . . 0.0 105.627 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.8 tpp85 -84.58 133.92 34.41 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.529 1.532 . . . . 0.0 107.774 -169.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.4 tt -125.97 144.41 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 119.545 1.066 . . . . 0.0 112.296 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -137.27 153.61 21.98 Favored Glycine 0 N--CA 1.461 0.329 0 C-N-CA 125.84 1.686 . . . . 0.0 110.263 -176.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -138.07 130.57 29.32 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -169.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.68 149.69 20.09 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 124.92 1.247 . . . . 0.0 112.901 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.3 p -119.65 144.11 47.35 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.657 1.183 . . . . 0.0 111.553 174.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -140.98 150.44 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 120.518 -1.364 . . . . 0.0 108.961 174.705 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.419 ' N ' HD13 ' A' ' 48' ' ' ILE . 38.1 t -138.36 -68.92 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 170.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.425 ' H ' ' H ' ' A' ' 51' ' ' MET 0.273 1.5 t-20 170.15 -4.05 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.82 1 C-N-CA 134.046 4.938 . . . . 0.0 109.477 169.421 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.425 ' H ' ' H ' ' A' ' 50' ' ' ASN . 26.7 ptt? -54.33 -39.72 67.31 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.118 0.967 . . . . 0.0 109.61 167.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.486 ' HA ' ' HD3' ' A' ' 145' ' ' ARG . 1.2 p 163.74 170.65 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.117 1 C-N-CA 134.355 5.062 . . . . 0.0 108.43 -178.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -89.16 131.21 35.4 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 166.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -123.4 130.31 52.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.677 1.227 . . . . 0.0 110.186 177.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -104.01 104.73 14.73 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.866 2.066 . . . . 0.0 110.429 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.437 ' H ' HD13 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -108.96 -9.35 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -173.497 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.4 tt -157.34 117.22 3.42 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.553 1.069 . . . . 0.0 109.927 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.02 163.74 18.68 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.825 0.85 . . . . 0.0 113.272 172.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.458 HD11 ' CE3' ' A' ' 101' ' ' TRP . 87.4 mt -49.08 104.02 0.06 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.592 1.557 . . . . 0.0 113.334 -169.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.9 p -122.45 161.65 23.15 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.502 1.921 . . . . 0.0 111.221 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.65 6.35 41.95 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 125.722 1.609 . . . . 0.0 112.213 169.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -85.52 76.82 9.99 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 127.706 2.402 . . . . 0.0 107.22 174.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.546 ' HA ' HD11 ' A' ' 31' ' ' LEU . 24.4 p -67.3 -45.7 75.75 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 128.771 2.828 . . . . 0.0 111.43 -169.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.6 t -51.98 -34.93 44.57 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.256 1.022 . . . . 0.0 109.96 170.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -83.74 -37.32 22.82 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -172.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -54.64 -33.55 60.81 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.566 1.075 . . . . 0.0 111.089 169.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -72.52 -34.52 67.66 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.643 -0.661 . . . . 0.0 110.036 -176.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -72.35 -35.1 68.46 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.905 0.882 . . . . 0.0 109.241 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.63 -32.16 28.43 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -172.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.472 HD21 ' SD ' ' A' ' 10' ' ' MET . 3.4 tt -73.61 -41.0 63.39 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 171.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -59.71 -33.19 71.3 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.248 -0.908 . . . . 0.0 113.135 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -80.1 -5.22 55.54 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -64.51 152.56 41.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.771 1.168 . . . . 0.0 112.582 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.7 tt -138.92 137.23 36.27 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.745 1.218 . . . . 0.0 109.756 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.8 t -74.08 138.09 21.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 126.474 1.91 . . . . 0.0 112.044 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 t -101.66 -155.9 0.54 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 125.971 1.708 . . . . 0.0 112.17 172.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -146.86 150.33 22.58 Favored Glycine 0 N--CA 1.478 1.483 0 O-C-N 120.048 -1.657 . . . . 0.0 116.019 -173.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -149.75 162.38 40.37 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.918 2.087 . . . . 0.0 113.262 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -32.1 13.0 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 173.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -94.96 132.11 40.16 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.229 0.922 . . . . 0.0 110.318 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.8 p -74.25 -31.46 1.26 Allowed Pre-proline 0 N--CA 1.472 0.675 0 CA-C-O 114.274 -2.774 . . . . 0.0 115.427 -172.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -68.48 144.95 63.08 Favored 'Trans proline' 0 C--N 1.353 0.771 0 CA-C-N 123.893 2.426 . . . . 0.0 112.264 169.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' HE2' ' OG ' ' A' ' 13' ' ' SER . 12.1 mptt -98.48 -177.3 3.64 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.889 1.276 . . . . 0.0 112.286 -176.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.96 18.28 37.07 Favored Glycine 0 N--CA 1.481 1.652 0 C-N-CA 125.621 1.581 . . . . 0.0 114.327 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -46.72 -39.18 11.11 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -169.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.55 HD23 HD13 ' A' ' 156' ' ' LEU 0.466 5.1 mp -80.49 7.92 8.84 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 119.899 1.227 . . . . 0.0 113.417 -177.63 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -80.41 -49.84 10.91 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 165.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.44 -45.23 94.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 116.893 -1.527 . . . . 0.0 112.369 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -49.95 -36.93 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 120.511 1.505 . . . . 0.0 111.653 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.579 HG21 ' HG3' ' A' ' 151' ' ' GLN . 63.1 t -82.59 -45.14 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.172 0.989 . . . . 0.0 111.4 -178.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -59.57 -49.8 76.38 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.524 1.056 . . . . 0.0 109.672 174.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.437 HG11 HD13 ' A' ' 108' ' ' LEU . 82.2 t -55.97 -42.08 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.203 1.001 . . . . 0.0 111.976 176.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.69 85.52 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.091 -1.006 . . . . 0.0 112.919 177.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.0 mm -87.26 -24.91 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.988 1.315 . . . . 0.0 113.667 -169.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 61.78 3.93 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.812 1.645 . . . . 0.0 110.871 -176.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.4 mt -56.23 -38.63 71.34 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.072 1.349 . . . . 0.0 112.0 -170.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -82.01 -34.49 23.98 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 123.877 0.751 . . . . 0.0 113.47 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -81.66 -45.4 15.81 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 125.334 1.453 . . . . 0.0 110.472 -175.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 22.8 mm -70.69 -33.31 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 118.915 0.78 . . . . 0.0 110.455 170.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.16 31.5 16.86 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.452 1.025 . . . . 0.0 114.542 174.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.458 ' CE3' HD11 ' A' ' 59' ' ' LEU . 23.1 m95 -56.54 129.45 40.89 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.88 1.272 . . . . 0.0 113.096 -177.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.17 170.66 7.83 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.651 1.18 . . . . 0.0 112.55 169.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -74.42 49.49 0.38 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 127.307 2.243 . . . . 0.0 114.053 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.84 -131.02 6.44 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 170.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.9 m -119.33 132.59 55.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.568 2.347 . . . . 0.0 105.7 177.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -124.61 124.79 42.98 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 119.084 0.856 . . . . 0.0 111.405 -168.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -114.04 112.47 23.31 Favored 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 123.977 0.798 . . . . 0.0 110.783 -175.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.437 HD13 HG11 ' A' ' 92' ' ' VAL . 14.5 tp -93.44 105.92 17.94 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 170.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.1 t -89.43 125.58 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 172.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -111.03 115.87 30.2 Favored 'General case' 0 CA--C 1.523 -0.096 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.525 HG13 HD22 ' A' ' 194' ' ' LEU . 60.0 t -108.72 130.88 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 O-C-N 123.674 0.609 . . . . 0.0 112.611 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.4 t -158.17 164.24 36.77 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.305 1.042 . . . . 0.0 111.453 171.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -112.49 -4.36 14.22 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.85 2.06 . . . . 0.0 114.124 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -137.49 -177.36 4.75 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.476 -1.39 . . . . 0.0 113.439 171.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -61.86 -174.64 0.05 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.333 2.253 . . . . 0.0 112.262 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 86' ' ' LEU . 20.8 t80 -140.6 139.46 34.93 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.426 1.09 . . . . 0.0 111.904 -174.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -68.67 108.35 3.34 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.564 1.146 . . . . 0.0 111.721 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.04 177.54 3.68 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.375 0.607 . . . . 0.0 111.527 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.27 148.14 23.5 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.22 -0.925 . . . . 0.0 112.295 172.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? 78.6 -11.19 1.24 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 128.099 2.56 . . . . 0.0 112.668 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.95 -32.5 74.26 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.532 1.133 . . . . 0.0 112.398 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -70.09 0.84 5.41 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 178.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.2 t -58.82 -33.04 69.94 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.052 -1.03 . . . . 0.0 112.417 169.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.6 tp -65.82 -40.89 92.26 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.635 0.774 . . . . 0.0 111.473 171.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.88 27.03 1.13 Allowed Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.588 1.566 . . . . 0.0 113.392 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 62.7 p 61.94 5.89 1.53 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 131.536 3.935 . . . . 0.0 117.038 169.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . 0.3 48.1 mtt180 -109.99 140.75 43.65 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.939 1.245 . . . . 0.0 114.144 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -109.73 -32.37 7.11 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.14 2.576 . . . . 0.0 114.691 -168.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -71.35 123.41 22.25 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.821 0.737 . . . . 0.0 111.292 -173.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.0 t -57.73 158.25 6.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.489 1.116 . . . . 0.0 110.68 172.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 151' ' ' GLN . 20.7 t -70.15 134.43 48.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.977 0.894 . . . . 0.0 111.11 170.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 p30 -78.13 -12.03 59.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.633 1.573 . . . . 0.0 112.647 170.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.19 8.11 73.65 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.876 1.227 . . . . 0.0 114.764 175.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -78.14 174.02 11.61 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 118.896 1.348 . . . . 0.0 109.023 168.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -93.13 148.25 22.18 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 171.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -136.2 27.57 3.17 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.886 1.674 . . . . 0.0 112.232 -171.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.3 mt -87.66 153.12 21.62 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.87 0.868 . . . . 0.0 111.008 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -148.0 -67.21 0.24 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.399 1.079 . . . . 0.0 111.44 172.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.22 9.07 27.1 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.721 1.608 . . . . 0.0 113.729 176.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 105.98 -5.47 39.5 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.803 1.668 . . . . 0.0 115.213 174.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -113.17 149.16 34.03 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.643 1.721 . . . . 0.0 112.277 174.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -70.71 86.61 0.67 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.456 1.102 . . . . 0.0 112.107 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -49.05 -45.11 42.34 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.067 1.347 . . . . 0.0 111.833 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 71.8 m -77.73 -0.14 25.79 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -173.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.486 ' HD3' ' HA ' ' A' ' 52' ' ' THR . 9.4 ttp85 -52.43 -40.33 62.07 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 121.171 1.805 . . . . 0.0 111.658 169.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.7 -25.09 75.92 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 117.617 -1.657 . . . . 0.0 113.156 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . 0.355 42.7 tt0 -96.84 -92.06 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.328 0 CA-C-O 115.465 -2.207 . . . . 0.0 112.041 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.97 152.94 54.71 Favored 'Trans proline' 0 C--N 1.359 1.081 0 CA-C-N 124.241 2.55 . . . . 0.0 116.395 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.01 163.35 7.98 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.819 2.448 . . . . 0.0 114.72 170.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -60.85 139.9 57.82 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 167.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.579 ' HG3' HG21 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -84.11 150.57 25.46 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.613 -1.305 . . . . 0.0 112.396 -174.55 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.1 t -68.85 148.67 49.91 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.401 0.68 . . . . 0.0 111.805 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.0 t -55.85 -29.47 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.565 1.146 . . . . 0.0 111.802 -177.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.3 -40.66 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.34 1.056 . . . . 0.0 112.138 173.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -65.41 -35.87 82.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.327 0.651 . . . . 0.0 110.141 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.55 HD13 HD23 ' A' ' 86' ' ' LEU . 5.2 mt -61.8 -58.12 9.22 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 173.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -54.24 -41.12 68.38 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.486 1.114 . . . . 0.0 112.919 -175.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.8 t -59.65 -54.14 49.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.886 0.874 . . . . 0.0 111.525 173.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -73.64 -33.95 64.75 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 120.824 -1.173 . . . . 0.0 112.903 -172.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 mt -61.1 -38.23 85.55 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.401 1.001 . . . . 0.0 111.978 170.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.63 -33.41 64.52 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.114 0.966 . . . . 0.0 113.514 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -68.35 -47.3 67.83 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.641 1.177 . . . . 0.0 110.496 176.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -74.45 -17.37 60.79 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.492 0.717 . . . . 0.0 111.871 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 62.84 49.26 3.71 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.964 1.706 . . . . 0.0 111.514 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 77.9 mt -117.51 125.79 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.82 1.248 . . . . 0.0 108.465 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -91.42 119.79 68.51 Favored Pre-proline 0 CA--C 1.539 0.551 0 CA-C-O 118.38 -0.819 . . . . 0.0 108.805 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.18 152.59 14.09 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.635 2.223 . . . . 0.0 110.603 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.8 mm -138.54 105.4 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.008 1.323 . . . . 0.0 109.379 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.553 ' CD2' HD11 ' A' ' 189' ' ' LEU . 28.2 m-85 -77.96 82.6 4.31 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.428 -1.42 . . . . 0.0 112.46 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 87.9 t -70.28 104.91 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 114.14 -1.391 . . . . 0.0 112.31 169.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 30.0 m -146.11 144.79 22.45 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -171.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -63.96 154.17 71.65 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 124.742 3.628 . . . . 0.0 114.912 177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 35.7 m -41.22 -51.04 3.59 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.428 2.291 . . . . 0.0 114.877 -169.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -54.54 -26.37 31.53 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 8.9 ttm -106.02 -8.48 17.52 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.565 1.946 . . . . 0.0 114.073 -174.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 40.1 t -55.56 -47.04 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.902 -1.124 . . . . 0.0 112.148 -168.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . 0.317 11.4 pttm -81.09 -6.18 58.51 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 -174.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . 0.255 4.8 t -86.92 -26.87 23.68 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 119.337 0.971 . . . . 0.0 111.129 169.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -83.49 -23.25 32.25 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.694 -1.254 . . . . 0.0 111.471 172.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -34.8 78.49 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.16 -0.963 . . . . 0.0 109.357 167.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . 0.395 0.1 OUTLIER -83.48 1.08 43.47 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 119.915 -1.74 . . . . 0.0 112.893 -178.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -98.56 -25.98 14.56 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 127.965 2.506 . . . . 0.0 107.407 168.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.517 ' HA ' HD23 ' A' ' 189' ' ' LEU . 0.6 OUTLIER -79.23 -18.11 53.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.949 -1.094 . . . . 0.0 113.897 176.276 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 5.3 t -85.3 -24.14 27.82 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.226 0.61 . . . . 0.0 110.004 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -79.62 -38.09 34.65 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 119.333 -0.365 . . . . 0.0 111.527 172.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 35.4 mt -108.66 98.63 29.7 Favored Pre-proline 0 N--CA 1.484 1.227 0 CA-C-N 118.81 0.732 . . . . 0.0 110.037 177.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -55.06 144.89 66.87 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.215 2.61 . . . . 0.0 112.421 169.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt 78.49 -2.47 2.37 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 128.227 2.611 . . . . 0.0 114.849 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.553 HD11 ' CD2' ' A' ' 169' ' ' PHE . 23.2 tp -74.47 152.72 39.39 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.785 1.234 . . . . 0.0 108.464 168.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.3 m -121.12 -153.1 0.53 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 169.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 177.83 114.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 127.427 2.291 . . . . 0.0 108.857 -167.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -109.62 147.1 17.03 Favored Glycine 0 N--CA 1.471 1.001 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 171.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . 0.362 0.9 OUTLIER -95.53 95.66 8.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 124.053 1.882 . . . . 0.0 110.568 177.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.525 HD22 HG13 ' A' ' 111' ' ' VAL . 31.1 tp -51.33 134.14 28.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 111.326 -2.67 . . . . 0.0 111.692 172.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 84.0 p -170.03 -166.9 0.59 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.088 1.755 . . . . 0.0 108.901 171.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -58.58 -18.56 30.95 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 176.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -97.61 129.28 44.73 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.299 1.439 . . . . 0.0 112.429 173.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 70.7 m -88.95 -3.35 58.76 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.625 1.17 . . . . 0.0 113.586 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 31.0 p -61.74 -47.8 83.58 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.81 1.644 . . . . 0.0 112.901 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -62.55 -51.7 66.34 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.342 0.257 . . . . 0.0 110.819 -178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 88.5 t -62.23 -44.74 99.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 O-C-N 121.49 -0.756 . . . . 0.0 112.058 -176.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.21 -26.95 68.35 Favored 'General case' 0 C--O 1.22 -0.493 0 O-C-N 121.186 -0.947 . . . . 0.0 111.92 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -72.31 -10.29 59.59 Favored 'General case' 0 C--O 1.219 -0.502 0 O-C-N 120.208 -1.558 . . . . 0.0 112.607 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 8.2 mp -96.67 -44.3 7.18 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.507 1.523 . . . . 0.0 107.781 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 26.3 mt -75.6 -35.18 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 40.2 mtm180 -71.12 -29.57 65.43 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.34 169.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -69.38 -31.2 69.44 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 120.177 1.353 . . . . 0.0 113.181 169.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -72.77 -31.51 64.95 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 121.173 -0.954 . . . . 0.0 111.057 173.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -68.54 -41.46 79.8 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.475 0.71 . . . . 0.0 112.369 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.1 p -68.43 -11.4 59.66 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -89.91 -0.75 57.75 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.261 1.669 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 -177.002 . . . . . . . . 1 1 . 1 stop_ save_